PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Branchfield, K; Nantie, L; Verheyden, JM; Sui, PF; Wienhold, MD; Sun, X				Branchfield, Kelsey; Nantie, Leah; Verheyden, Jamie M.; Sui, Pengfei; Wienhold, Mark D.; Sun, Xin			Pulmonary neuroendocrine cells function as airway sensors to control lung immune response	SCIENCE			English	Article							SYSTEM; MACROPHAGES; EPITHELIUM; EMPHYSEMA; RECEPTORS	The lung is constantly exposed to environmental atmospheric cues. How it senses and responds to these cues is poorly defined. Here, we show that Roundabout receptor (Robo) genes are expressed in pulmonary neuroendocrine cells (PNECs), a rare, innervated epithelial population. Robo inactivation in mouse lung results in an inability of PNECs to cluster into sensory organoids and triggers increased neuropeptide production upon exposure to air. Excess neuropeptides lead to an increase in immune infiltrates, which in turn remodel the matrix and irreversibly simplify the alveoli. We demonstrate in vivo that PNECs act as precise airway sensors that elicit immune responses via neuropeptides. These findings suggest that the PNEC and neuropeptide abnormalities documented in a wide array of pulmonary diseases may profoundly affect symptoms and progression.	[Branchfield, Kelsey; Nantie, Leah; Verheyden, Jamie M.; Sui, Pengfei; Sun, Xin] Univ Wisconsin, Dept Med Genet, Genet Lab, Madison, WI 53706 USA; [Wienhold, Mark D.] Univ Wisconsin, Dept Pediat, Sch Med & Publ Hlth, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Sun, X (corresponding author), Univ Wisconsin, Dept Med Genet, Genet Lab, Madison, WI 53706 USA.	xsun@wisc.edu			American Heart Association [14PRE20490146]; NIH [T32 GM007133]; NIAID [5T32AI007635]; NHLBI [RO1 HL113870, HL097134, HL122406]; University of Wisconsin; Wisconsin Partnership Program grant [2897]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097134, R01HL113870, R01HL122406] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007635] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007133] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); University of Wisconsin; Wisconsin Partnership Program grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supporting data and methods are presented in the supplementary materials. We thank X. Ai, T, Gomez, and E. Chapman for discussion; N. Hernandez-Santos for immune analysis; L. Ma, M. Tessier-Lavigne, J. Johnson, L. Wadiche, M. Zylka, and Mutant Mouse Regional Resource Center for mouse strains; and A. Lashua for technical support. This work was supported by American Heart Association predoctoral fellowship 14PRE20490146 and NIH predoctoral training grant T32 GM007133 (to K.B.), NIAID postdoctoral fellowship 5T32AI007635 (to L.N.), and NHLBI RO1 HL113870, HL097134, HL122406, University of Wisconsin Romnes Faculty Fellowship, and Wisconsin Partnership Program grant 2897 (to X.S.).	Boers JE, 1996, AM J RESP CRIT CARE, V154, P758, DOI 10.1164/ajrccm.154.3.8810616; Cutz E, 2007, PEDIATR DEVEL PATHOL, V10, P419, DOI 10.2350/07-04-0267.1; Cutz E, 2013, SEMIN CELL DEV BIOL, V24, P40, DOI 10.1016/j.semcdb.2012.09.003; Domyan ET, 2013, DEV CELL, V24, P52, DOI 10.1016/j.devcel.2012.11.018; Dunzendorfer S, 1998, J LEUKOCYTE BIOL, V64, P828, DOI 10.1002/jlb.64.6.828; Englund C, 2002, DEVELOPMENT, V129, P4941; Gu XL, 2014, AM J RESP CELL MOL, V50, P637, DOI 10.1165/rcmb.2013-0199OC; Harris KS, 2006, P NATL ACAD SCI USA, V103, P2208, DOI 10.1073/pnas.0510839103; Hivert B, 2002, MOL CELL NEUROSCI, V21, P534, DOI 10.1006/mcne.2002.1193; Kantarci S, 2007, AM J MED GENET C, V145C, P217, DOI 10.1002/ajmg.c.30132; Kim EJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018472; Kuo CS, 2015, CELL, V163, P394, DOI 10.1016/j.cell.2015.09.021; Linnoila RI, 2006, LAB INVEST, V86, P425, DOI 10.1038/labinvest.3700412; Longoni M, 2014, P NATL ACAD SCI USA, V111, P12450, DOI 10.1073/pnas.1412509111; McCoy ES, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036355; Moore BD, 2012, RESPIRATION, V83, P529, DOI 10.1159/000336835; Mund SI, 2008, DEV DYNAM, V237, P2108, DOI 10.1002/dvdy.21633; PERRIN D G, 1991, Pediatric Pathology, V11, P431; Shifren A, 2007, AM J PHYSIOL-LUNG C, V292, pL778, DOI 10.1152/ajplung.00352.2006; Song H, 2012, P NATL ACAD SCI USA, V109, P17531, DOI 10.1073/pnas.1207238109; Sunday ME, 2004, ENDOCR PATHOL, V15, P91, DOI 10.1385/EP:15:2:091; TJENALOOI S, 1992, AM J PHYSIOL, V263, pH681, DOI 10.1152/ajpheart.1992.263.3.H681; van Rooijen N, 2010, METHODS MOL BIOL, V605, P189, DOI 10.1007/978-1-60327-360-2_13; Wallace AM, 2008, COPD, V5, P13, DOI 10.1080/15412550701817789	24	118	123	2	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 12	2016	351	6274					707	710		10.1126/science.aad7969	http://dx.doi.org/10.1126/science.aad7969			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD3GL	26743624	Green Accepted			2022-12-28	WOS:000369810000040
J	Kang, SK; Murphy, RKJ; Hwang, SW; Lee, SM; Harburg, DV; Krueger, NA; Shin, JH; Gamble, P; Cheng, HY; Yu, S; Liu, ZJ; McCall, JG; Stephen, M; Ying, HZ; Kim, J; Park, G; Webb, RC; Lee, CH; Chung, SJ; Wie, DS; Gujar, AD; Vemulapalli, B; Kim, AH; Lee, KM; Cheng, JJ; Huang, YG; Lee, SH; Braun, PV; Ray, WZ; Rogers, JA				Kang, Seung-Kyun; Murphy, Rory K. J.; Hwang, Suk-Won; Lee, Seung Min; Harburg, Daniel V.; Krueger, Neil A.; Shin, Jiho; Gamble, Paul; Cheng, Huanyu; Yu, Sooyoun; Liu, Zhuangjian; McCall, Jordan G.; Stephen, Manu; Ying, Hanze; Kim, Jeonghyun; Park, Gayoung; Webb, R. Chad; Lee, Chi Hwan; Chung, Sangjin; Wie, Dae Seung; Gujar, Amit D.; Vemulapalli, Bharat; Kim, Albert H.; Lee, Kyung-Mi; Cheng, Jianjun; Huang, Younggang; Lee, Sang Hoon; Braun, Paul V.; Ray, Wilson Z.; Rogers, John A.			Bioresorbable silicon electronic sensors for the brain	NATURE			English	Article							INTRACRANIAL-PRESSURE; TRANSIENT; MANAGEMENT; FRACTURES; MORTALITY	Many procedures in modern clinical medicine rely on the use of electronic implants in treating conditions that range from acute coronary events to traumatic injury(1,2). However, standard permanent electronic hardware acts as a nidus for infection: bacteria form biofilms along percutaneous wires, or seed haematogenously, with the potential to migrate within the body and to provoke immune-mediated pathological tissue reactions(3,4). The associated surgical retrieval procedures, meanwhile, subject patients to the distress associated with re-operation and expose them to additional complications(5-8). Here, we report materials, device architectures, integration strategies, and in vivo demonstrations in rats of implantable, multifunctional silicon sensors for the brain, for which all of the constituent materials naturally resorb via hydrolysis and/or metabolic action(9-12), eliminating the need for extraction. Continuous monitoring of intracranial pressure and temperature illustrates functionality essential to the treatment of traumatic brain injury(2,13); the measurement performance of our resorbable devices compares favourably with that of non-resorbable clinical standards. In our experiments, insulated percutaneous wires connect to an externally mounted, miniaturized wireless potentiostat for data transmission. In a separate set-up, we connect a sensor to an implanted (but only partially resorbable) data-communication system, proving the principle that there is no need for any percutaneous wiring. The devices can be adapted to sense fluid flow, motion, pH or thermal characteristics, in formats that are compatible with the body's abdomen and extremities, as well as the deep brain, suggesting that the sensors might meet many needs in clinical medicine.	[Kang, Seung-Kyun; Lee, Seung Min; Harburg, Daniel V.; Krueger, Neil A.; Ying, Hanze; Kim, Jeonghyun; Webb, R. Chad; Chung, Sangjin; Cheng, Jianjun; Braun, Paul V.; Rogers, John A.] Univ Illinois, Dept Mat Sci & Engn, 1304 W Green St, Urbana, IL 61801 USA; [Kang, Seung-Kyun; Lee, Seung Min; Harburg, Daniel V.; Shin, Jiho; Yu, Sooyoun; Kim, Jeonghyun; Webb, R. Chad; Chung, Sangjin; Wie, Dae Seung; Braun, Paul V.; Rogers, John A.] Univ Illinois, Frederick Seitz Mat Res Lab, Urbana, IL 61801 USA; [Murphy, Rory K. J.; Gamble, Paul; Stephen, Manu; Gujar, Amit D.; Vemulapalli, Bharat; Kim, Albert H.; Ray, Wilson Z.] Washington Univ, Sch Med, Dept Neurol Surg, St Louis, MO 63110 USA; [Hwang, Suk-Won] Korea Univ, KU KIST Grad Sch Converging Sci & Technol, Seoul 136701, South Korea; [Shin, Jiho; Yu, Sooyoun] Univ Illinois, Dept Chem & Biomol Engn, Urbana, IL 61801 USA; [Cheng, Huanyu] Penn State Univ, Mat Res Inst, Dept Engn Sci & Mech, University Pk, PA 16802 USA; [Liu, Zhuangjian] Inst High Performance Comp, Singapore 138632, Singapore; [McCall, Jordan G.] Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA; [Park, Gayoung] Korea Univ, Dept Biomicrosyst Technol, Seoul 136701, South Korea; [Park, Gayoung; Lee, Kyung-Mi] Korea Univ, Coll Med, Dept Biochem & Mol Biol, Seoul 136713, South Korea; [Lee, Chi Hwan] Purdue Univ, Weldon Sch Biomed Engn, Sch Mech Engn, Ctr Implantable Devices,Birck Nanotechnol Ctr, W Lafayette, IN 47907 USA; [Wie, Dae Seung] Purdue Univ, Sch Mech Engn, W Lafayette, IN 47907 USA; [Huang, Younggang] Northwestern Univ, Dept Mech Engn Civil & Environm Engn, Mat Sci & Engn, Evanston, IL 60208 USA; [Huang, Younggang] Northwestern Univ, Skin Dis Res Ctr, Evanston, IL 60208 USA; [Lee, Sang Hoon] Korea Univ, Coll Hlth Sci, Dept Biomed Engn, Seoul 136703, South Korea; [Braun, Paul V.; Rogers, John A.] Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Washington University (WUSTL); Korea University; University of Illinois System; University of Illinois Urbana-Champaign; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of High Performance Computing (IHPC); Washington University (WUSTL); Korea University; Korea University; Korea University Medicine (KU Medicine); Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Northwestern University; Northwestern University; Korea University; University of Illinois System; University of Illinois Urbana-Champaign	Rogers, JA (corresponding author), Univ Illinois, Dept Mat Sci & Engn, 1304 W Green St, Urbana, IL 61801 USA.; Rogers, JA (corresponding author), Univ Illinois, Frederick Seitz Mat Res Lab, Urbana, IL 61801 USA.; Ray, WZ (corresponding author), Washington Univ, Sch Med, Dept Neurol Surg, St Louis, MO 63110 USA.	rayz@wudosis.wustl.edu; jrogers@illinois.edu	Rogers, John/L-2798-2016; Kim, Albert H./HGF-0057-2022; Cheng, Huanyu/J-7379-2015; Cheng, Jianjun/AAF-4301-2019; Kang, Seung-Kyun/L-3053-2017; huang, yonggang/O-6236-2019; Huang, Yonggang/B-6998-2009; HWANG, SUKWON/Q-8329-2018	Cheng, Huanyu/0000-0001-6075-4208; Cheng, Jianjun/0000-0003-2561-9291; Gujar, Amit/0000-0003-0689-6680; HWANG, SUKWON/0000-0002-6883-201X; Lee, Kyung-Mi/0000-0002-5378-9258	Defense Advanced Research Projects Agency; National Institute of Mental Health [F31MH101956]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2015R1C1A1A02037560]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT, and Future Planning [NRF-2007-00107, NRF-2013M3A9D3045719]; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH101956] Funding Source: NIH RePORTER	Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT, and Future Planning; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	S.-K.K. and co-workers are funded by the Defense Advanced Research Projects Agency. J.G.M. is supported by the National Institute of Mental Health, grant F31MH101956. The authors thank M. R. Bruchas at Washington University School of Medicine for providing immunohistochemistry facilities; M. R. MacEwan at Washington University School of Medicine for discussions on animal protocols; A. Manocchi at Transient Electronics Inc. for performing the dissolution test of polyanhydride; and H. Ning at Xerion Advanced Battery Corporation for assistance with running the BET measurements. H.C. was a Howard Hughes Medical Institute International Student Research Fellow. S.-W.H. was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (grant NRF-2015R1C1A1A02037560). G.P. and K.M.L. were supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT, and Future Planning (grants NRF-2007-00107 and NRF-2013M3A9D3045719).	BARTH KNM, 1992, NEUROSURGERY, V30, P138, DOI 10.1227/00006123-199201000-00028; Bettinger CJ, 2010, ADV MATER, V22, P651, DOI 10.1002/adma.200902322; Boutry CM, 2012, PHILOS T R SOC A, V370, P2418, DOI 10.1098/rsta.2011.0439; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS37; Brogan ME, 2015, CURR TREAT OPTION NE, V17, DOI 10.1007/s11940-014-0327-0; Chamis AL, 2001, CIRCULATION, V104, P1029, DOI 10.1161/hc3401.095097; Chang H, 2004, NANO LETT, V4, P1551, DOI 10.1021/nl049267c; Gentile P, 2014, INT J MOL SCI, V15, P3640, DOI 10.3390/ijms15033640; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Haure P, 2003, J NEUROSURG ANESTH, V15, P297, DOI 10.1097/00008506-200310000-00001; Huang X, 2014, ADV MATER, V26, P7371, DOI 10.1002/adma.201403164; Hwang SW, 2014, ACS NANO, V8, P5843, DOI 10.1021/nn500847g; Hwang SW, 2012, SCIENCE, V337, P1640, DOI 10.1126/science.1226325; Irimia-Vladu M, 2014, CHEM SOC REV, V43, P588, DOI 10.1039/c3cs60235d; Kang SK, 2014, ADV FUNCT MATER, V24, P4427, DOI 10.1002/adfm.201304293; Liu C., 2011, FDN MEMS; Luo MD, 2014, J MICROELECTROMECH S, V23, P4, DOI 10.1109/JMEMS.2013.2290111; Maytin M, 2010, CIRC-ARRHYTHMIA ELEC, V3, P413, DOI 10.1161/CIRCEP.110.954107; Meldrum DR, 1997, AM J SURG, V174, P667, DOI 10.1016/S0002-9610(97)00201-8; Mittal R, 2005, INJURY, V36, P333, DOI 10.1016/j.injury.2004.09.015; MORGAN PW, 1953, IND ENG CHEM, V45, P2296, DOI 10.1021/ie50526a044; Moseley P. T., 1994, SENS MATER; Olson SA, 2005, J AM ACAD ORTHOP SUR, V13, P436, DOI 10.5435/00124635-200511000-00003; OTT K, 1976, J NEUROSURG, V44, P80, DOI 10.3171/jns.1976.44.1.0080; Poole JE, 2014, CIRCULATION, V129, P383, DOI 10.1161/CIRCULATIONAHA.112.000762; Stern E, 2007, NATURE, V445, P519, DOI 10.1038/nature05498; Stiefel MF, 2005, J NEUROSURG, V103, P805, DOI 10.3171/jns.2005.103.5.0805; Suehiro E, 2015, J NEUROTRAUM, V32, P353, DOI 10.1089/neu.2014.3584; Timofeev I, 2013, J CEREBR BLOOD F MET, V33, P422, DOI 10.1038/jcbfm.2012.186; Uslaner JM, 2012, NEUROPHARMACOLOGY, V62, P1413, DOI 10.1016/j.neuropharm.2010.11.015; Vajramani GV, 2005, BRIT J NEUROSURG, V19, P496, DOI 10.1080/02688690500495299; Ye TW, 2011, J AM PODIAT MED ASSN, V101, P307, DOI 10.7547/1010307; Yin L, 2015, APPL PHYS LETT, V106, DOI 10.1063/1.4905321; Yin L, 2014, ADV FUNCT MATER, V24, P645, DOI 10.1002/adfm.201301847; Zheng GF, 2005, NAT BIOTECHNOL, V23, P1294, DOI 10.1038/nbt1138	35	559	567	43	752	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 4	2016	530	7588					71	+		10.1038/nature16492	http://dx.doi.org/10.1038/nature16492			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC6BK	26779949				2022-12-28	WOS:000369304500034
J	Oldham, ML; Hite, RK; Steffen, AM; Damko, E; Li, ZL; Walz, T; Chen, J				Oldham, Michael L.; Hite, Richard K.; Steffen, Alanna M.; Damko, Ermelinda; Li, Zongli; Walz, Thomas; Chen, Jue			A mechanism of viral immune evasion revealed by cryo-EM analysis of the TAP transporter	NATURE			English	Article							ANTIGEN-PROCESSING TAP; BEAM-INDUCED MOTION; ABC TRANSPORTER; PEPTIDE-BINDING; P-GLYCOPROTEIN; PROTEIN; RESOLUTION; INHIBITOR; ICP47; SITE	Cellular immunity against viral infection and tumour cells depends on antigen presentation by major histocompatibility complex class I (MHC I) molecules. Intracellular antigenic peptides are transported into the endoplasmic reticulum by the transporter associated with antigen processing (TAP) and then loaded onto the nascent MHC I molecules, which are exported to the cell surface and present peptides to the immune system(1). Cytotoxic T lymphocytes recognize non-self peptides and program the infected or malignant cells for apoptosis. Defects in TAP account for immunodeficiency and tumour development. To escape immune surveillance, some viruses have evolved strategies either to downregulate TAP expression or directly inhibit TAP activity. So far, neither the architecture of TAP nor the mechanism of viral inhibition has been elucidated at the structural level. Here we describe the cryo-electron microscopy structure of human TAP in complex with its inhibitor ICP47, a small protein produced by the herpes simplex virus I. Here we show that the 12 transmembrane helices and 2 cytosolic nucleotide-binding domains of the transporter adopt an inward-facing conformation with the two nucleotide-binding domains separated. The viral inhibitor ICP47 forms a long helical hairpin, which plugs the translocation pathway of TAP from the cytoplasmic side. Association of ICP47 precludes substrate binding and prevents nucleotide-binding domain closure necessary for ATP hydrolysis. This work illustrates a striking example of immune evasion by persistent viruses. By blocking viral antigens from entering the endoplasmic reticulum, herpes simplex virus is hidden from cytotoxic T lymphocytes, which may contribute to establishing a lifelong infection in the host.	[Oldham, Michael L.; Hite, Richard K.; Damko, Ermelinda; Walz, Thomas; Chen, Jue] Rockefeller Univ, 1230 York Ave, New York, NY 10065 USA; [Oldham, Michael L.; Hite, Richard K.; Steffen, Alanna M.; Li, Zongli; Chen, Jue] Howard Hughes Med Inst, 4000 Jones Bridge Rd, Chevy Chase, MD 20815 USA; [Li, Zongli] Harvard Univ, Sch Med, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA	Rockefeller University; Howard Hughes Medical Institute; Harvard University; Harvard Medical School	Chen, J (corresponding author), Rockefeller Univ, 1230 York Ave, New York, NY 10065 USA.; Chen, J (corresponding author), Howard Hughes Med Inst, 4000 Jones Bridge Rd, Chevy Chase, MD 20815 USA.	juechen@rockefeller.edu	Li, Zongli/AAB-9100-2020	Walz, Thomas/0000-0003-2606-2835				Ahn K, 1996, EMBO J, V15, P3247, DOI 10.1002/j.1460-2075.1996.tb00689.x; Aisenbrey C, 2006, J BIOL CHEM, V281, P30365, DOI 10.1074/jbc.M603000200; Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Blum JS, 2013, ANNU REV IMMUNOL, V31, P443, DOI 10.1146/annurev-immunol-032712-095910; Brilot AF, 2012, J STRUCT BIOL, V177, P630, DOI 10.1016/j.jsb.2012.02.003; Campbell MG, 2012, STRUCTURE, V20, P1823, DOI 10.1016/j.str.2012.08.026; Chen SS, 2013, NATURE, V499, P364, DOI 10.1038/nature12232; Corradi V, 2012, J BIOL CHEM, V287, P28099, DOI 10.1074/jbc.M112.381251; DeLano W.L, PYMOL MOL GRAPHICS S; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FRUH K, 1995, NATURE, V375, P415, DOI 10.1038/375415a0; Galocha B, 1997, J EXP MED, V185, P1565, DOI 10.1084/jem.185.9.1565; Gaudet R, 2001, EMBO J, V20, P4964, DOI 10.1093/emboj/20.17.4964; Geng J, 2013, J BIOL CHEM, V288, P37039, DOI 10.1074/jbc.M113.504696; Gerber S, 2008, SCIENCE, V321, P246, DOI 10.1126/science.1156213; Gorbulev S, 2001, P NATL ACAD SCI USA, V98, P3732, DOI 10.1073/pnas.061467898; Grant T, 2015, ELIFE, V4, DOI 10.7554/eLife.06980; Grigorieff N, 2007, J STRUCT BIOL, V157, P117, DOI 10.1016/j.jsb.2006.05.004; Henderson R, 2012, STRUCTURE, V20, P205, DOI 10.1016/j.str.2011.12.014; Herget M, 2011, P NATL ACAD SCI USA, V108, P1349, DOI 10.1073/pnas.1012355108; HILL A, 1995, NATURE, V375, P411, DOI 10.1038/375411a0; HILL AB, 1994, J IMMUNOL, V152, P2736; Hohn M, 2007, J STRUCT BIOL, V157, P47, DOI 10.1016/j.jsb.2006.07.003; Jin MS, 2012, NATURE, V490, P566, DOI 10.1038/nature11448; Kadaba NS, 2008, SCIENCE, V321, P250, DOI 10.1126/science.1157987; Koch J, 2004, J BIOL CHEM, V279, P10142, DOI 10.1074/jbc.M312816200; Leonhardt RM, 2005, J IMMUNOL, V175, P5104, DOI 10.4049/jimmunol.175.8.5104; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Lin DYW, 2015, NATURE, V523, P425, DOI 10.1038/nature14623; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Neumann L, 1997, J MOL BIOL, V272, P484, DOI 10.1006/jmbi.1997.1282; Nijenhuis M, 1996, J IMMUNOL, V157, P5467; Penczek PA, 2014, ULTRAMICROSCOPY, V140, P9, DOI 10.1016/j.ultramic.2014.01.009; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; POWIS SH, 1992, P NATL ACAD SCI USA, V89, P1463, DOI 10.1073/pnas.89.4.1463; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Shintre CA, 2013, P NATL ACAD SCI USA, V110, P9710, DOI 10.1073/pnas.1217042110; Tomazin R, 1996, EMBO J, V15, P3256, DOI 10.1002/j.1460-2075.1996.tb00690.x; van de Weijer ML, 2015, SEMIN IMMUNOL, V27, P125, DOI 10.1016/j.smim.2015.03.010; Verweij MC, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004743; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; Yang ZF, 2012, STRUCTURE, V20, P237, DOI 10.1016/j.str.2011.12.007; YORK IA, 1994, CELL, V77, P525, DOI 10.1016/0092-8674(94)90215-1	46	80	82	0	42	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 28	2016	529	7587					537	+		10.1038/nature16506	http://dx.doi.org/10.1038/nature16506			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB7DD	26789246	Green Accepted, Green Submitted			2022-12-28	WOS:000368673800039
J	Garibaldi, LA; Carvalheiro, LG; Vaissiere, BE; Gemmill-Herren, B; Hipolito, J; Freitas, BM; Ngo, HT; Azzu, N; Saez, A; Astrom, J; An, JD; Blochtein, B; Buchori, D; Garcia, FJC; da Silva, FO; Devkota, K; Ribeiro, MD; Freitas, L; Gaglianone, MC; Goss, M; Irshad, M; Kasina, M; Pacheco, AJS; Kiill, LHP; Kwapong, P; Parra, GN; Pires, C; Pires, V; Rawal, RS; Rizali, A; Saraiva, AM; Veldtman, R; Viana, BF; Witter, S; Zhang, H				Garibaldi, Lucas A.; Carvalheiro, Luisa G.; Vaissiere, Bernard E.; Gemmill-Herren, Barbara; Hipolito, Juliana; Freitas, Breno M.; Ngo, Hien T.; Azzu, Nadine; Saez, Agustin; Astroem, Jens; An, Jiandong; Blochtein, Betina; Buchori, Damayanti; Chamorro Garcia, Fermin J.; da Silva, Fabiana Oliveira; Devkota, Kedar; Ribeiro, Marcia de Fatima; Freitas, Leandro; Gaglianone, Maria C.; Goss, Maria; Irshad, Mohammad; Kasina, Muo; Pacheco Filho, Alipio J. S.; Piedade Kiill, Lucia H.; Kwapong, Peter; Nates Parra, Guiomar; Pires, Carmen; Pires, Viviane; Rawal, Ranbeer S.; Rizali, Akhmad; Saraiva, Antonio M.; Veldtman, Ruan; Viana, Blandina F.; Witter, Sidia; Zhang, Hong			Mutually beneficial pollinator diversity and crop yield outcomes in small and large farms	SCIENCE			English	Article							ECOLOGICAL INTENSIFICATION; BIODIVERSITY; SERVICES; GAPS	Ecological intensification, or the improvement of crop yield through enhancement of biodiversity, may be a sustainable pathway toward greater food supplies. Such sustainable increases may be especially important for the 2 billion people reliant on small farms, many of which are undernourished, yet we know little about the efficacy of this approach. Using a coordinated protocol across regions and crops, we quantify to what degree enhancing pollinator density and richness can improve yields on 344 fields from 33 pollinator-dependent crop systems in small and large farms from Africa, Asia, and Latin America. For fields less than 2 hectares, we found that yield gaps could be closed by a median of 24% through higher flower-visitor density. For larger fields, such benefits only occurred at high flower-visitor richness. Worldwide, our study demonstrates that ecological intensification can create synchronous biodiversity and yield outcomes.	[Garibaldi, Lucas A.] UNRN, Inst Invest Recursos Nat Agroecol & Desarrollo Ru, Sede Andina, RA-8400 San Carlos De Bariloche, Rio Negro, Argentina; [Garibaldi, Lucas A.] Consejo Nacl Invest Cient & Tecn, RA-8400 San Carlos De Bariloche, Rio Negro, Argentina; [Carvalheiro, Luisa G.] Univ Brasilia, Dept Ecol, BR-70910900 Brasilia, DF, Brazil; [Carvalheiro, Luisa G.] Univ Lisbon, Fac Ciencias, CE3C, P-1749016 Lisbon, Portugal; [Carvalheiro, Luisa G.] Nat Biodivers Ctr, NL-2300 RA Leiden, Netherlands; [Vaissiere, Bernard E.] INRA, Abeilles & Environm UR406, F-84914 Avignon 9, France; [Vaissiere, Bernard E.; Azzu, Nadine] UN, FAO, I-00153 Rome, Italy; [Hipolito, Juliana; Viana, Blandina F.] Univ Fed Bahia, Dept Zool, Inst Biol, BR-40170110 Salvador, BA, Brazil; [Freitas, Breno M.; Pacheco Filho, Alipio J. S.] Univ Fed Ceara, Dept Zootecnia, Ctr Ciencias Agr, BR-60021970 Fortaleza, Ceara, Brazil; [Ngo, Hien T.] IPBES Secretariat Intergovt Platform Biodivers &, D-53113 Bonn, Germany; [Saez, Agustin] Univ Nacl Comahue, CONICET, Lab Ecotono, Inst Invest Biodiversidad & Medioambiente, RA-8400 San Carlos De Bariloche, Rio Negro, Argentina; [Astroem, Jens] Norwegian Inst Nat Res, NO-7485 Trondheim, Norway; [An, Jiandong; Zhang, Hong] Chinese Acad Agr Sci, Key Lab Insect Pollinator Biol, Minist Agr, Inst Apicultural Res, Beijing 100093, Peoples R China; [Blochtein, Betina] Pontificia Univ Catolica Rio Grande Sul PUCRS, BR-90619900 Porto Alegre, RS, Brazil; [Buchori, Damayanti] Bogor Agr Univ, Dept Plant Protect, Fac Agr, Bogor 16680, West Java, Indonesia; [Chamorro Garcia, Fermin J.; Nates Parra, Guiomar] Univ Nacl Colombia, Dept Biol, Lab Invest Abejas LABUN, Bogota 11001, Colombia; [da Silva, Fabiana Oliveira] Univ Fed Sergipe, Dept Educ Ciencias Agr & Terra, BR-49680000 Nossa Senhora Da Gloria, SE, Brazil; [Devkota, Kedar] Inst Agr & Anim Sci, Rampur, Chitwan, Nepal; [Ribeiro, Marcia de Fatima; Piedade Kiill, Lucia H.] Embrapa Semiarido, BR-56302970 Petrolina, PE, Brazil; [Freitas, Leandro] Inst Pesquisas Jardim Bot Rio de Janeiro, BR-22460030 Rio de Janeiro, RJ, Brazil; [Gaglianone, Maria C.] Univ Estadual Norte Fluminense, Lab Ciencias Ambientais, BR-28013620 Campos Dos Goytacazes, RJ, Brazil; [Goss, Maria] Univ Zimbabwe, Fac Agr, Dept Crop Sci, Harare, Zimbabwe; [Irshad, Mohammad] Natl Agr Res Ctr, Conservat & Management Pollinators Sustainable Ag, Honey Bee Res Inst, Islamabad, Pakistan; [Kasina, Muo] Kenya Agr & Livestock Res Org Sericulture, Thika 01000, Kenya; [Kwapong, Peter] Univ Cape Coast, Sch Biol Sci, Coll Agr & Nat Sci, Cape Coast, Ghana; [Pires, Carmen] Embrapa Recursos Genet & Biotecnol, BR-70770917 Brasilia, DF, Brazil; [Pires, Viviane] Inst Melo Ambiente & Recursos Hidr INEMA UR Extre, BR-45820970 Eunapolis, BA, Brazil; [Rawal, Ranbeer S.] GB Pant Inst Himalayan Environm & Dev, Almora 263643, Uttarakhand, India; [Rizali, Akhmad] Univ Brawijaya, Fac Agr, Dept Plant Pest Dis, Malang 65145, East Java, Indonesia; [Saraiva, Antonio M.] Univ Sao Paulo, Escola Politecn, BR-05508010 Sao Paulo, SP, Brazil; [Veldtman, Ruan] Kirstenbosch Res Ctr, South African Natl Biodivers Inst, ZA-7735 Claremont, South Africa; [Veldtman, Ruan] Univ Stellenbosch, Conservat Ecol & Entomol, ZA-7602 Matieland, South Africa; [Witter, Sidia] Fundacao Estadual Pesquisa Agr Fepagro Vale Taqua, Ctr Pesquisa Emilio Schenk, BR-95860000 Taquari, RS, Brazil	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidade de Brasilia; Universidade de Lisboa; Naturalis Biodiversity Center; INRAE; Food & Agriculture Organization of the United Nations (FAO); Universidade Federal da Bahia; Universidade Federal do Ceara; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad Nacional del Comahue; Norwegian Institute Nature Research; Chinese Academy of Agricultural Sciences; Institute of Apicultural Research, CAAS; Ministry of Agriculture & Rural Affairs; Pontificia Universidade Catolica Do Rio Grande Do Sul; Bogor Agricultural University; Universidad Nacional de Colombia; Universidade Federal de Sergipe; Tribhuvan University; Institute of Agriculture & Animal Science (IAAS) - Nepal; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Jardim Botanico do Rio de Janeiro; Universidade Estadual do Norte Fluminense; University of Zimbabwe; National Agricultural Research Council - Pakistan; University of Cape Coast; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); G.B. Pant National Institute of Himalayan Environment & Sustainable Development (GBPNIHESD); Brawijaya University; Universidade de Sao Paulo; South African National Biodiversity Institute; Stellenbosch University	Garibaldi, LA (corresponding author), UNRN, Inst Invest Recursos Nat Agroecol & Desarrollo Ru, Sede Andina, Mitre 630, RA-8400 San Carlos De Bariloche, Rio Negro, Argentina.	lgaribaldi@unrn.edu.ar	Saraiva, Antonio M/B-6350-2011; Hipólito, Juliana/AAQ-1457-2020; Blochtein, Betina/B-9412-2014; Devkota, Kedar/AAS-3751-2021; Freitas, Leandro/E-6975-2011; Buchori, Damayanti/L-5878-2017; Felipe Viana, Blandina Felipe/AAH-2606-2022; Åström, Jens/I-6746-2012; Rizali, Akhmad/G-2681-2017; Gaglianone, Maria Cristina/U-5935-2017; Garibaldi, Lucas A/D-7302-2013; Devkota, Kedar/AAM-2340-2021; da Silva, Fabiana Oliveira/S-2565-2019; CHAMORRO, FERMIN J./AAB-6555-2019; de Souza Pacheco Filho, Alipio Jose/AAC-5031-2019; Veldtman, Ruan/I-1131-2019; Freitas, Breno M/F-9509-2012; Carvalheiro, Luisa/D-9414-2012; Silva, Fabiana/GWU-9143-2022; Felipe Viana, Blandina Felipe/AFM-0275-2022	Saraiva, Antonio M/0000-0003-2283-1123; Hipólito, Juliana/0000-0002-0721-3143; Blochtein, Betina/0000-0001-8452-1716; Freitas, Leandro/0000-0002-4146-2514; Buchori, Damayanti/0000-0002-2843-0737; Felipe Viana, Blandina Felipe/0000-0002-4924-1257; Åström, Jens/0000-0002-6114-0440; Rizali, Akhmad/0000-0002-6673-6198; Gaglianone, Maria Cristina/0000-0002-9206-2895; Devkota, Kedar/0000-0002-7365-0851; da Silva, Fabiana Oliveira/0000-0002-6919-7716; CHAMORRO, FERMIN J./0000-0002-2481-5656; de Souza Pacheco Filho, Alipio Jose/0000-0003-2865-2142; Freitas, Breno M/0000-0002-9932-2207; Carvalheiro, Luisa/0000-0001-7655-979X; Felipe Viana, Blandina Felipe/0000-0002-4924-1257; Garibaldi, Lucas Alejandro/0000-0003-0725-4049	Global Environment Fund; United Nations Environment Program; United Nations Food and Agriculture Organization (GEF/UNEP/FAO) Global Pollination Project; Norwegian Environment Agency; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico Brazil; CONICET Argentina [PIP 114-201101-00201]; Norwegian Environment Agency [2012/16642]; Research Council of Norway [225019]; Universidad Nacional de Rio Negro Argentina [PI 40-B-259, PI 40-B-399]	Global Environment Fund; United Nations Environment Program; United Nations Food and Agriculture Organization (GEF/UNEP/FAO) Global Pollination Project; Norwegian Environment Agency; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CONICET Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Norwegian Environment Agency; Research Council of Norway(Research Council of Norway); Universidad Nacional de Rio Negro Argentina	Funding was provided by the Global Environment Fund, United Nations Environment Program, United Nations Food and Agriculture Organization (GEF/UNEP/FAO) Global Pollination Project, with additional support to the Food and Agriculture Organization of the United Nations from the Norwegian Environment Agency for a project on "Building Capacity in the Science-Policy Interface of Pollination Services," and from the International Fund for Agricultural Development for the development of the sampling protocol (18). Other funding: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico Brazil, CONICET Argentina (PIP 114-201101-00201), Norwegian Environment Agency (2012/16642), The Research Council of Norway (225019), and Universidad Nacional de Rio Negro Argentina (PI 40-B-259, PI 40-B-399). The data used in the analyses are available in the supplementary materials. L.A.G., L.G.C., and J.H. compiled data; L.A.G. and L.G.C. analyzed data; L.A.G. wrote the first version of the manuscript; the authors named between L.A.G. and J.As. discussed and revised earlier versions of the manuscript. The authors named between J.An and H.Z. are listed alphabetically, as they contributed equally, gathering field data, providing corrections to subsequent manuscript drafts, and discussing ideas. G. Andersson, B. Geslin, and P. Steward provided insightful comments on previous versions of this paper.	Aizen MA, 2007, ECOLOGY, V88, P271, DOI 10.1890/06-1017; Aizen MA, 2009, CURR BIOL, V19, P915, DOI 10.1016/j.cub.2009.03.071; Bommarco R, 2013, TRENDS ECOL EVOL, V28, P230, DOI 10.1016/j.tree.2012.10.012; Brittain C, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2767; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; Carvalheiro LG, 2011, ECOL LETT, V14, P251, DOI 10.1111/j.1461-0248.2010.01579.x; Chaplin-Kramer R, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1799; Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452; Fraser LH, 2013, FRONT ECOL ENVIRON, V11, P147, DOI 10.1890/110279; Frund J, 2013, ECOLOGY, V94, P2042, DOI 10.1890/12-1620.1; Garibaldi LA, 2014, FRONT ECOL ENVIRON, V12, P439, DOI 10.1890/130330; Garibaldi LA, 2013, SCIENCE, V339, P1608, DOI 10.1126/science.1230200; Garibaldi LA, 2011, P NATL ACAD SCI USA, V108, P5909, DOI 10.1073/pnas.1012431108; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Goulson D, 2015, SCIENCE, V347, DOI 10.1126/science.1255957; Herrero M, 2010, SCIENCE, V327, P822, DOI 10.1126/science.1183725; Hoehn P, 2008, P ROY SOC B-BIOL SCI, V275, P2283, DOI 10.1098/rspb.2008.0405; Kleijn D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8414; Lobell DB, 2009, ANNU REV ENV RESOUR, V34, P179, DOI 10.1146/annurev.environ.041008.093740; Lowder S. K, 2014, 1402 ESA AGR DEV EC; Mueller ND, 2012, NATURE, V490, P254, DOI 10.1038/nature11420; Rundlof M, 2015, NATURE, V521, P77, DOI 10.1038/nature14420; Schleuning M, 2015, ECOGRAPHY, V38, P380, DOI 10.1111/ecog.00983; Seufert V, 2012, NATURE, V485, P229, DOI 10.1038/nature11069; Steward PR., 2014, AGR FOOD SECURITY, V3, P1, DOI DOI 10.1186/2048-7010-3-5; Tittonell P, 2013, FIELD CROP RES, V143, P76, DOI 10.1016/j.fcr.2012.10.007; Tscharntke T, 2005, ECOL LETT, V8, P857, DOI 10.1111/j.1461-0248.2005.00782.x; Vaissiere B.E, 2011, PROTOCOL DETECT ASSE	28	247	262	9	288	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 22	2016	351	6271					388	391		10.1126/science.aac7287	http://dx.doi.org/10.1126/science.aac7287			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB3VH	26798016	Green Published			2022-12-28	WOS:000368440500041
J	Mongin, C; Garakyaraghi, S; Razgoniaeva, N; Zamkov, M; Castellano, FN				Mongin, Cedric; Garakyaraghi, Sofia; Razgoniaeva, Natalia; Zamkov, Mikhail; Castellano, Felix N.			Direct observation of triplet energy transfer from semiconductor nanocrystals	SCIENCE			English	Article							CDSE QUANTUM DOTS; PHOTON UP-CONVERSION; ELECTRON-TRANSFER; NANOPARTICLES; EXCITON; SINGLET; STATES; DARK	Triplet excitons are pervasive in both organic and inorganic semiconductors but generally remain confined to the material in which they originate. We demonstrated by transient absorption spectroscopy that cadmium selenide semiconductor nanoparticles, selectively excited by green light, engage in interfacial Dexter-like triplet-triplet energy transfer with surface-anchored polyaromatic carboxylic acid acceptors, extending the excited-state lifetime by six orders of magnitude. Net triplet energy transfer also occurs from surface acceptors to freely diffusing molecular solutes, further extending the lifetime while sensitizing singlet oxygen in an aerated solution. The successful translation of triplet excitons from semiconductor nanoparticles to the bulk solution implies that such materials are generally effective surrogates for molecular triplets. The nanoparticles could thereby potentially sensitize a range of chemical transformations that are relevant for fields as diverse as optoelectronics, solar energy conversion, and photobiology.	[Mongin, Cedric; Garakyaraghi, Sofia; Castellano, Felix N.] N Carolina State Univ, Dept Chem, Raleigh, NC 27695 USA; [Razgoniaeva, Natalia; Zamkov, Mikhail] Bowling Green State Univ, Dept Phys, Bowling Green, OH 43403 USA; [Razgoniaeva, Natalia; Zamkov, Mikhail] Bowling Green State Univ, Ctr Photochem Sci, Bowling Green, OH 43403 USA	University of North Carolina; North Carolina State University; University System of Ohio; Bowling Green State University; University System of Ohio; Bowling Green State University	Castellano, FN (corresponding author), N Carolina State Univ, Dept Chem, Box 8204, Raleigh, NC 27695 USA.	fncastel@ncsu.edu	Mongin, Cédric/P-3532-2016	Mongin, Cédric/0000-0002-0565-0606; Garakyaraghi, Sofia/0000-0001-7835-1888; Castellano, Felix/0000-0001-7546-8618	Air Force Office of Scientific Research [FA9550-13-1-0106]; Ultrafast Initiative of the U. S. Department of Energy, Office of Science, Office of Basic Energy Sciences, through Argonne National Laboratory [DE-AC02-06CH11357]; NSF [CHE-1465052]; Directorate For Engineering [1236355] Funding Source: National Science Foundation; Division Of Chemistry [1465052] Funding Source: National Science Foundation	Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Ultrafast Initiative of the U. S. Department of Energy, Office of Science, Office of Basic Energy Sciences, through Argonne National Laboratory(United States Department of Energy (DOE)); NSF(National Science Foundation (NSF)); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG)); Division Of Chemistry(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by the Air Force Office of Scientific Research (grant FA9550-13-1-0106) and the Ultrafast Initiative of the U. S. Department of Energy, Office of Science, Office of Basic Energy Sciences, through Argonne National Laboratory under contract no. DE-AC02-06CH11357. M.Z. was supported by NSF (grant CHE-1465052).	Bakalova R, 2004, NAT BIOTECHNOL, V22, P1360, DOI 10.1038/nbt1104-1360; Baker DR, 2010, LANGMUIR, V26, P11272, DOI 10.1021/la100580g; Bruchez M, 1998, SCIENCE, V281, P2013, DOI 10.1126/science.281.5385.2013; Burda C, 1999, J PHYS CHEM B, V103, P1783, DOI 10.1021/jp9843050; Chan WCW, 1998, SCIENCE, V281, P2016, DOI 10.1126/science.281.5385.2016; Coe S, 2002, NATURE, V420, P800, DOI 10.1038/nature01217; COLVIN VL, 1994, NATURE, V370, P354, DOI 10.1038/370354a0; Crooker SA, 2003, APPL PHYS LETT, V82, P2793, DOI 10.1063/1.1570923; Efros AL, 1996, PHYS REV B, V54, P4843, DOI 10.1103/PhysRevB.54.4843; Gur I, 2005, SCIENCE, V310, P462, DOI 10.1126/science.1117908; Han ZJ, 2012, SCIENCE, V338, P1321, DOI 10.1126/science.1227775; HIRAYAMA S, 1982, J CHEM SOC FARAD T 1, V78, P2411, DOI 10.1039/f19827802411; Huang ZY, 2015, CHEM MATER, V27, P7503, DOI 10.1021/acs.chemmater.5b03731; Huang ZY, 2015, NANO LETT, V15, P5552, DOI 10.1021/acs.nanolett.5b02130; Khon E, 2013, NANO LETT, V13, P2016, DOI 10.1021/nl400715n; Knowles KE, 2012, J AM CHEM SOC, V134, P12470, DOI 10.1021/ja3060222; Landry ML, 2014, J CHEM EDUC, V91, P274, DOI 10.1021/ed300568e; MASNOVI JM, 1984, CAN J CHEM, V62, P2552, DOI 10.1139/v84-436; McDonald SA, 2005, NAT MATER, V4, P138, DOI 10.1038/nmat1299; Medintz IL, 2005, NAT MATER, V4, P435, DOI 10.1038/nmat1390; Mengfei M., 2015, NAT PHOTONICS, DOI [10.1038/nphoton.2015.226, DOI 10.1038/NPHOTON.2015.226]; Montalti M., 2006, HDB PHOTOCHEMISTRY; MURRAY CB, 1993, J AM CHEM SOC, V115, P8706, DOI 10.1021/ja00072a025; Niko Y, 2012, TETRAHEDRON, V68, P6177, DOI 10.1016/j.tet.2012.05.072; Reisfeld R, 2000, MATER LETT, V45, P154, DOI 10.1016/S0167-577X(00)00096-3; Robel I, 2007, J AM CHEM SOC, V129, P4136, DOI 10.1021/ja070099a; Samia ACS, 2003, J AM CHEM SOC, V125, P15736, DOI 10.1021/ja0386905; Scholes GD, 2008, ADV FUNCT MATER, V18, P1157, DOI 10.1002/adfm.200800151; Singh-Rachford TN, 2009, INORG CHEM, V48, P2541, DOI 10.1021/ic802114d; Soloviev NV, 2001, J AM CHEM SOC, V123, P2354; Tabachnyk M, 2014, NAT MATER, V13, P1033, DOI [10.1038/NMAT4093, 10.1038/nmat4093]; Thompson NJ, 2014, NAT MATER, V13, P1039, DOI [10.1038/NMAT4097, 10.1038/nmat4097]; Wojdak M, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.233315; Wu KF, 2015, CHEM SCI, V6, P1049, DOI 10.1039/c4sc02994a; Yang HB, 2014, ACS NANO, V8, P10403, DOI 10.1021/nn503751s; Yu WW, 2003, CHEM MATER, V15, P2854, DOI 10.1021/cm034081k; Zenkevich EI, 2011, J PHYS CHEM C, V115, P21535, DOI 10.1021/jp203987r; Zhu HM, 2013, ACCOUNTS CHEM RES, V46, P1270, DOI 10.1021/ar300202d	38	260	262	21	433	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 22	2016	351	6271					369	372		10.1126/science.aad6378	http://dx.doi.org/10.1126/science.aad6378			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB3VH	26798011				2022-12-28	WOS:000368440500036
J	Tsai, HH; Niu, JQ; Munji, R; Davalos, D; Chang, JL; Zhang, HJ; Tien, AC; Kuo, CJ; Chan, JR; Daneman, R; Fancy, SPJ				Tsai, Hui-Hsin; Niu, Jianqin; Munji, Roeben; Davalos, Dimitrios; Chang, Junlei; Zhang, Haijing; Tien, An-Chi; Kuo, Calvin J.; Chan, Jonah R.; Daneman, Richard; Fancy, Stephen P. J.			Oligodendrocyte precursors migrate along vasculature in the developing nervous system	SCIENCE			English	Article							SPINAL-CORD; NEURONAL MIGRATION; CEREBRAL-CORTEX; CELL-MIGRATION; WHITE-MATTER; BRAIN-INJURY; CNS; REMYELINATION; ANGIOGENESIS; MYELINATION	Oligodendrocytes myelinate axons in the central nervous system and develop from oligodendrocyte precursor cells (OPCs) that must first migrate extensively during brain and spinal cord development. We show that OPCs require the vasculature as a physical substrate for migration. We observed that OPCs of the embryonic mouse brain and spinal cord, as well as the human cortex, emerge from progenitor domains and associate with the abluminal endothelial surface of nearby blood vessels. Migrating OPCs crawl along and jump between vessels. OPC migration in vivo was disrupted in mice with defective vascular architecture but was normal in mice lacking pericytes. Thus, physical interactions with the vascular endothelium are required for OPC migration. We identify Wnt-Cxcr4 (chemokine receptor 4) signaling in regulation of OPC-endothelial interactions and propose that this signaling coordinates OPC migration with differentiation.	[Tsai, Hui-Hsin; Niu, Jianqin; Tien, An-Chi; Fancy, Stephen P. J.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94158 USA; [Munji, Roeben; Daneman, Richard] Univ Calif San Diego, Dept Pharmacol, San Diego, CA 92093 USA; [Munji, Roeben; Daneman, Richard] Univ Calif San Diego, Dept Neurosci, San Diego, CA 92093 USA; [Davalos, Dimitrios] Cleveland Clin Fdn, Lerner Res Inst, Dept Neurosci, Cleveland, OH 44195 USA; [Chang, Junlei; Zhang, Haijing; Kuo, Calvin J.] Stanford Univ, Dept Med, Div Hematol, Stanford, CA 94305 USA; [Zhang, Haijing] Cleveland Clin Fdn, Dept Urol, Cleveland, OH 44195 USA; [Zhang, Haijing] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Zhang, Haijing] Duke Univ, Sch Med, Durham, NC 27710 USA; [Chan, Jonah R.; Fancy, Stephen P. J.] UCSF, Dept Neurol, San Francisco, CA 94158 USA; [Fancy, Stephen P. J.] UCSF, Div Neonatol, San Francisco, CA 94158 USA; [Fancy, Stephen P. J.] UCSF, Newborn Brain Res Inst, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Diego; University of California System; University of California San Diego; Cleveland Clinic Foundation; Stanford University; Cleveland Clinic Foundation; Howard Hughes Medical Institute; Duke University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Fancy, SPJ (corresponding author), Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94158 USA.	stephen.fancy@ucsf.edu	Chang, Junlei/K-2696-2017; Davalos, Dimitrios/G-8627-2011; Zhang, JJ H/F-1557-2019	Chang, Junlei/0000-0002-0319-9022; Davalos, Dimitrios/0000-0001-9038-6688; Zhang, JJ H/0000-0003-3077-0770; Kuo, Calvin/0000-0002-7427-5985	University of California [142657]; National Institute of Neurological Disorders and Stroke [1P01 NS083513]; HHMI; American Heart Association [15POST23020039]; NIH [1R01NS064517]; National Multiple Sclerosis Society [RG 5216-A-1]; Race to Erase MS; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS083513, R01NS064517] Funding Source: NIH RePORTER	University of California(University of California System); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); HHMI(Howard Hughes Medical Institute); American Heart Association(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); Race to Erase MS; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank D. Rowitch (UCSF) for Olig2-GFP mice and comments on the manuscript. Procurements of human brain tissues from the UCSF Pediatric Neuropathology Research Laboratory have been supported by grants from the University of California (142657), the National Institute of Neurological Disorders and Stroke (1P01 NS083513), and HHMI. J.C. is supported by an American Heart Association Postdoctoral Fellowship (15POST23020039). This work was supported by grants from the NIH (1R01NS064517 to C.J.K.) and the National Multiple Sclerosis Society (RG 5216-A-1 to S.P.J.F.) and Race to Erase MS (to S.P.J.F.). The supplementary materials contain additional data.	Banisadr G, 2011, NEUROBIOL DIS, V44, P19, DOI 10.1016/j.nbd.2011.05.019; BaronVanEvercooren A, 1996, GLIA, V16, P147, DOI 10.1002/(SICI)1098-1136(199602)16:2<147::AID-GLIA7>3.0.CO;2-0; Biname F, 2013, J NEUROSCI, V33, P10858, DOI 10.1523/JNEUROSCI.5010-12.2013; Choe Y, 2012, DEV NEUROSCI-BASEL, V34, P502, DOI 10.1159/000345353; Daneman R, 2010, NATURE, V468, P562, DOI 10.1038/nature09513; Daneman R, 2009, P NATL ACAD SCI USA, V106, P641, DOI 10.1073/pnas.0805165106; Dziembowska M, 2005, GLIA, V50, P258, DOI 10.1002/glia.20170; Fancy SPJ, 2014, NAT NEUROSCI, V17, P506, DOI 10.1038/nn.3676; Fancy SPJ, 2011, NAT NEUROSCI, V14, P1009, DOI 10.1038/nn.2855; Fancy SPJ, 2009, GENE DEV, V23, P1571, DOI 10.1101/gad.1806309; Finzsch M, 2008, DEVELOPMENT, V135, P637, DOI 10.1242/dev.010454; Franklin RJM, 2008, NAT REV NEUROSCI, V9, P839, DOI 10.1038/nrn2480; Funfschilling U, 2012, NATURE, V485, P517, DOI 10.1038/nature11007; Garcion E, 2001, DEVELOPMENT, V128, P2485; Goldman SA, 2011, NAT NEUROSCI, V14, P1382, DOI 10.1038/nn.2963; Hogan KA, 2004, DEVELOPMENT, V131, P1503, DOI 10.1242/dev.01039; Kessaris N, 2006, NAT NEUROSCI, V9, P173, DOI 10.1038/nn1620; Kokovay E, 2010, CELL STEM CELL, V7, P163, DOI 10.1016/j.stem.2010.05.019; KOMURO H, 1995, J NEUROSCI, V15, P1110; Kuhnert F, 2010, SCIENCE, V330, P985, DOI 10.1126/science.1196554; Lee YJ, 2012, NATURE, V487, P443, DOI 10.1038/nature11314; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; Lu QR, 2002, CELL, V109, P75, DOI 10.1016/S0092-8674(02)00678-5; Miyamoto Y, 2008, J NEUROSCI, V28, P8326, DOI 10.1523/JNEUROSCI.1482-08.2008; Nadarajah B, 2001, NAT NEUROSCI, V4, P143, DOI 10.1038/83967; OROURKE NA, 1992, SCIENCE, V258, P299, DOI 10.1126/science.1411527; Posokhova E, 2015, CELL REP, V10, P123, DOI 10.1016/j.celrep.2014.12.020; SIDMAN RL, 1973, BRAIN RES, V62, P1, DOI 10.1016/0006-8993(73)90617-3; Snapyan M, 2009, J NEUROSCI, V29, P4172, DOI 10.1523/JNEUROSCI.4956-08.2009; Stenman JM, 2008, SCIENCE, V322, P1247, DOI 10.1126/science.1164594; Tsai HH, 2003, DEVELOPMENT, V130, P2095, DOI 10.1242/dev.00424; Tsai HH, 2002, CELL, V110, P373, DOI 10.1016/S0092-8674(02)00838-3; Tsai HH, 2012, SCIENCE, V337, P358, DOI 10.1126/science.1222381; Vanhollebeke B, 2015, ELIFE, V4, DOI 10.7554/eLife.06489; Yuen TJ, 2014, CELL, V158, P383, DOI 10.1016/j.cell.2014.04.052	35	209	211	6	91	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 22	2016	351	6271					379	384		10.1126/science.aad3839	http://dx.doi.org/10.1126/science.aad3839			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB3VH	26798014	Green Accepted			2022-12-28	WOS:000368440500039
J	Currie, BJ; Kaestli, M				Currie, Bart J.; Kaestli, Mirjam			A global picture of melioidosis	NATURE			English	Editorial Material							BURKHOLDERIA-PSEUDOMALLEI; BURDEN		[Currie, Bart J.; Kaestli, Mirjam] Charles Darwin Univ, Menzies Sch Hlth Res, Global & Trop Hlth Div, Darwin, NT 0810, Australia; [Currie, Bart J.] Royal Darwin Hosp, Dept Infect Dis, Darwin, NT, Australia	Charles Darwin University; Menzies School of Health Research	Currie, BJ (corresponding author), Charles Darwin Univ, Menzies Sch Hlth Res, Global & Trop Hlth Div, Darwin, NT 0810, Australia.	bart.currie@menzies.edu.au; mirjam.kaestli@menzies.edu.au		, Mirjam/0000-0002-6053-5141				Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Currie BJ, 2015, SEMIN RESP CRIT CARE, V36, P111, DOI 10.1055/s-0034-1398389; Dance DAB, 2015, CLIN INFECT DIS, V60, P251, DOI 10.1093/cid/ciu768; Inglis TJJ, 2006, APPL ENVIRON MICROB, V72, P6865, DOI 10.1128/AEM.01036-06; Kaestli M, 2012, ENVIRON MICROBIOL, V14, P2058, DOI 10.1111/j.1462-2920.2011.02671.x; Limmathurotsakul D, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2015.8, 10.1038/nmicrobiol.2015.8]; Limmathurotsakul D, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002072; Martiny JBH, 2006, NAT REV MICROBIOL, V4, P102, DOI 10.1038/nrmicro1341; Pearson T, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-78; White NJ, 2003, LANCET, V361, P1715, DOI 10.1016/S0140-6736(03)13374-0	10	26	29	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 21	2016	529	7586					290	291		10.1038/529290a	http://dx.doi.org/10.1038/529290a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DB2QT	26791716				2022-12-28	WOS:000368354800027
J	Gainty, C				Gainty, Caitjan			Mr. Gilbreth's Motion Pictures - The Evolution of Medical Efficiency	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Gainty, Caitjan] Kings Coll London, Dept Hist, London WC2R 2LS, England	University of London; King's College London	Gainty, C (corresponding author), Kings Coll London, Dept Hist, London WC2R 2LS, England.			Gainty, Caitjan/0000-0001-7760-4652				Gainty C, 2012, REPRESENTATIONS, P1, DOI 10.1525/rep.2012.118.1.1; Gilbreth FB, 1915, BOSTON MED SURG J, V172, P774; Kim SJ, 2013, J ROBOTIC SURG, V7, P241; Pool E, 1917, JAMA-J AM MED ASSOC, V19, P1599	4	4	5	1	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 14	2016	374	2					109	111		10.1056/NEJMp1514048	http://dx.doi.org/10.1056/NEJMp1514048			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DA7PQ	26760083	Green Published			2022-12-28	WOS:000367996700005
J	Ganopolski, A; Winkelmann, R; Schellnhuber, HJ				Ganopolski, A.; Winkelmann, R.; Schellnhuber, H. J.			Critical insolation-CO2 relation for diagnosing past and future glacial inception	NATURE			English	Article							CLIMATE; CO2; HYSTERESIS; CYCLES; SYSTEM; MODEL	The past rapid growth of Northern Hemisphere continental ice sheets, which terminated warm and stable climate periods, is generally attributed to reduced summer insolation in boreal latitudes(1-3). Yet such summer insolation is near to its minimum at present(4), and there are no signs of a new ice age(5). This challenges our understanding of the mechanisms driving glacial cycles and our ability to predict the next glacial inception(6). Here we propose a critical functional relationship between boreal summer insolation and global carbon dioxide (CO2) concentration, which explains the beginning of the past eight glacial cycles and might anticipate future periods of glacial inception. Using an ensemble of simulations generated by an Earth system model of intermediate complexity constrained by palaeoclimatic data, we suggest that glacial inception was narrowly missed before the beginning of the Industrial Revolution. The missed inception can be accounted for by the combined effect of relatively high late-Holocene CO2 concentrations and the low orbital eccentricity of the Earth(7). Additionally, our analysis suggests that even in the absence of human perturbations no substantial build-up of ice sheets would occur within the next several thousand years and that the current interglacial would probably last for another 50,000 years. However, moderate anthropogenic cumulative CO2 emissions of 1,000 to 1,500 gigatonnes of carbon will postpone the next glacial inception by at least 100,000 years(8,9). Our simulations demonstrate that under natural conditions alone the Earth system would be expected to remain in the present delicately balanced interglacial climate state, steering clear of both large-scale glaciation of the Northern Hemisphere and its complete deglaciation, for an unusually long time.	[Ganopolski, A.; Winkelmann, R.; Schellnhuber, H. J.] Potsdam Inst Climate Impact Res, D-14412 Potsdam, Germany; [Winkelmann, R.] Univ Potsdam, Inst Phys, D-14476 Potsdam, Germany; [Schellnhuber, H. J.] Santa Fe Inst, Santa Fe, NM 87501 USA	Potsdam Institut fur Klimafolgenforschung; University of Potsdam; The Santa Fe Institute	Ganopolski, A (corresponding author), Potsdam Inst Climate Impact Res, D-14412 Potsdam, Germany.	ganopolski@pik-potsdam.de	Schellnhuber, Hans Joachim/B-2607-2012; Schellnhuber, Hans Joachim/O-3873-2019	Schellnhuber, Hans Joachim/0000-0001-7453-4935; Schellnhuber, Hans Joachim/0000-0001-7453-4935; Winkelmann, Ricarda/0000-0003-1248-3217				Abe-Ouchi A, 2013, NATURE, V500, P190, DOI 10.1038/nature12374; Archer D, 2005, GEOCHEM GEOPHY GEOSY, V6, DOI 10.1029/2004GC000891; Augustin L, 2004, NATURE, V429, P623, DOI 10.1038/nature02599; Berger A, 2002, SCIENCE, V297, P1287, DOI 10.1126/science.1076120; Brovkin V, 2012, CLIM PAST, V8, P251, DOI 10.5194/cp-8-251-2012; Calov R, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024518; Ciais P, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P465; Cochelin ASB, 2006, CLIMATIC CHANGE, V79, P381, DOI 10.1007/s10584-006-9099-1; Elderfield H, 2012, SCIENCE, V337, P704, DOI 10.1126/science.1221294; Ganopolski A, 2011, CLIM PAST, V7, P1415, DOI 10.5194/cp-7-1415-2011; Grant KM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6076; Greve R, 1997, PHILOS T R SOC A, V355, P921, DOI 10.1098/rsta.1997.0050; HAYS JD, 1976, SCIENCE, V194, P1121, DOI 10.1126/science.194.4270.1121; Kemp AC, 2011, P NATL ACAD SCI USA, V108, P11017, DOI 10.1073/pnas.1015619108; Lambeck K., 2010, UNDERSTANDING SEA LE, DOI DOI 10.1002/9781444323276.CH4; Laskar J, 2004, ASTRON ASTROPHYS, V428, P261, DOI 10.1051/0004-6361:20041335; LISIECKI LE, 2005, PALEOCEANOGRAPHY, V0020; Loutre MF, 2003, GLOBAL PLANET CHANGE, V36, P209, DOI 10.1016/S0921-8181(02)00186-8; Masson-Delmotte V, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P383; Mauritsen T, 2012, J ADV MODEL EARTH SY, V4, DOI 10.1029/2012MS000154; Milankovic M., 1941, KANON ERDBESTRAHLUNG; Paillard D, 1998, NATURE, V391, P378, DOI 10.1038/34891; Paillard D, 2006, SCIENCE, V313, P455, DOI 10.1126/science.1131297; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; Petoukhov V, 2000, CLIM DYNAM, V16, P1, DOI 10.1007/PL00007919; Ruddiman WF, 2003, CLIMATIC CHANGE, V61, P261, DOI 10.1023/B:CLIM.0000004577.17928.fa; Stocker BD, 2011, BIOGEOSCIENCES, V8, P69, DOI 10.5194/bg-8-69-2011; Tzedakis PC, 2012, NAT GEOSCI, V5, P138, DOI [10.1038/ngeo1358, 10.1038/NGEO1358]; WEERTMAN J, 1976, NATURE, V261, P17, DOI 10.1038/261017a0; Yin QZ, 2012, CLIM DYNAM, V38, P709, DOI 10.1007/s00382-011-1013-5	30	93	102	2	116	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 14	2016	529	7585					200	U159		10.1038/nature16494	http://dx.doi.org/10.1038/nature16494			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA7WK	26762457				2022-12-28	WOS:000368015700034
J	Sonnenburg, ED; Smits, SA; Tikhonov, M; Higginbottom, SK; Wingreen, NS; Sonnenburg, JL				Sonnenburg, Erica D.; Smits, Samuel A.; Tikhonov, Mikhail; Higginbottom, Steven K.; Wingreen, Ned S.; Sonnenburg, Justin L.			Diet-induced extinctions in the gut microbiota compound over generations	NATURE			English	Article							CARBOHYDRATE-ACTIVE ENZYMES; UNITED-STATES; DIVERSITY; ANNOTATION; DATABASE; TRENDS; FIBER	The gut is home to trillions of microorganisms that have fundamental roles in many aspects of human biology, including immune function and metabolism(1,2). The reduced diversity of the gut microbiota in Western populations compared to that in populations living traditional lifestyles presents the question of which factors have driven microbiota change during modernization. Microbiota-accessible carbohydrates (MACs) found in dietary fibre have a crucial involvement in shaping this microbial ecosystem, and are notably reduced in the Western diet (high in fat and simple carbohydrates, low in fibre) compared with a more traditional diet(3). Here we show that changes in the microbiota of mice consuming a low-MAC diet and harbouring a human microbiota are largely reversible within a single generation. However, over several generations, a low-MAC diet results in a progressive loss of diversity, which is not recoverable after the reintroduction of dietary MACs. To restore the microbiota to its original state requires the administration of missing taxa in combination with dietary MAC consumption. Our data illustrate that taxa driven to low abundance when dietary MACs are scarce are inefficiently transferred to the next generation, and are at increased risk of becoming extinct within an isolated population. As more diseases are linked to the Western microbiota and the microbiota is targeted therapeutically, microbiota reprogramming may need to involve strategies that incorporate dietary MACs as well as taxa not currently present in the Western gut.	[Sonnenburg, Erica D.; Smits, Samuel A.; Higginbottom, Steven K.; Sonnenburg, Justin L.] Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA; [Tikhonov, Mikhail] Harvard Univ, Harvard John A Paulson Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Tikhonov, Mikhail] Harvard Univ, Kavli Inst Bionano Sci & Technol, Cambridge, MA 02138 USA; [Wingreen, Ned S.] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Wingreen, Ned S.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Stanford University; Harvard University; Harvard University; Princeton University; Princeton University	Sonnenburg, JL (corresponding author), Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA.	jsonnenburg@stanford.edu		higginbottom, steven/0000-0002-4609-6840; Tikhonov, Mikhail/0000-0002-9558-1121	National Institutes of Health NIDDK [R01-DK085025]; NSF; Stanford Graduate Fellowship; Simons Foundation; Burroughs Wellcome Fund; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK085025] Funding Source: NIH RePORTER	National Institutes of Health NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NSF(National Science Foundation (NSF)); Stanford Graduate Fellowship(Stanford University); Simons Foundation; Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank M. St. Onge for technical assistance. This work was funded by a grant from National Institutes of Health NIDDK (R01-DK085025 to J.L.S.), an NSF graduate fellowship (to S.A.S.), a Stanford Graduate Fellowship (to S.A.S.), and the Simons Foundation (to M.T.). J.L.S. holds an Investigators in the Pathogenesis of Infectious Disease Award from the Burroughs Wellcome Fund.	Aspeborg H, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-186; Bokulich NA, 2013, NAT METHODS, V10, P57, DOI [10.1038/NMETH.2276, 10.1038/nmeth.2276]; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Clemente JC, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500183; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; El Kaoutari A, 2013, NAT REV MICROBIOL, V11, P497, DOI 10.1038/nrmicro3050; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Karlsson F, 2013, DIABETES, V62, P3341, DOI 10.2337/db13-0844; Kashyap PC, 2013, P NATL ACAD SCI USA, V110, P17059, DOI 10.1073/pnas.1306070110; Kashyap PC, 2013, GASTROENTEROLOGY, V144, P967, DOI 10.1053/j.gastro.2013.01.047; King DE, 2012, J ACAD NUTR DIET, V112, P642, DOI 10.1016/j.jand.2012.01.019; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; Martinez I, 2015, CELL REP, V11, P527, DOI 10.1016/j.celrep.2015.03.049; McGill CR, 2015, NUTRIENTS, V7, P1119, DOI 10.3390/nu7021119; Obregon-Tito AJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7505; Schnorr SL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4654; Sonnenburg ED, 2014, CELL METAB, V20, P779, DOI 10.1016/j.cmet.2014.07.003; Stam MR, 2006, PROTEIN ENG DES SEL, V19, P555, DOI 10.1093/protein/gzl044; Tikhonov M, 2015, ISME J, V9, P68, DOI 10.1038/ismej.2014.117; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Yin YB, 2012, NUCLEIC ACIDS RES, V40, pW445, DOI 10.1093/nar/gks479	26	884	920	16	519	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 14	2016	529	7585					212	U208		10.1038/nature16504	http://dx.doi.org/10.1038/nature16504			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA7WK	26762459	Green Submitted, Green Accepted			2022-12-28	WOS:000368015700037
J	Van den Bergh, GD; Li, B; Brumm, A; Grun, R; Yurnaldi, D; Moore, MW; Kurniawan, I; Setiawan, R; Aziz, F; Roberts, RG; Suyono; Storey, M; Setiabudi, E; Morwood, MJ				Van den Bergh, Gerrit D.; Li, Bo; Brumm, Adam; Gruen, Rainer; Yurnaldi, Dida; Moore, Mark W.; Kurniawan, Iwan; Setiawan, Ruly; Aziz, Fachroel; Roberts, Richard G.; Suyono; Storey, Michael; Setiabudi, Erick; Morwood, Michael J.			Earliest hominin occupation of Sulawesi, Indonesia	NATURE			English	Article							ANOMALOUS FADING CORRECTION; U-SERIES; K-FELDSPAR; QUATERNARY GEOCHRONOLOGY; NORTHERN AUSTRALIA; MODERN HUMANS; LUMINESCENCE; SEDIMENTS; SYSTEM; TEETH	Sulawesi is the largest and oldest island within Wallacea, a vast zone of oceanic islands separating continental Asia from the Pleistocene landmass of Australia and Papua (Sahul). By one million years ago an unknown hominin lineage had colonized Flores immediately to the south(1), and by about 50 thousand years ago, modern humans (Homo sapiens) had crossed to Sahul(2,3). On the basis of position, oceanic currents and biogeographical context, Sulawesi probably played a pivotal part in these dispersals(4). Uranium-series dating of speleothem deposits associated with rock art in the limestone karst region of Maros in southwest Sulawesi has revealed that humans were living on the island at least 40 thousand years ago (ref. 5). Here we report new excavations at Talepu in the Walanae Basin northeast of Maros, where in situ stone artefacts associated with fossil remains of megafauna (Bubalus sp., Stegodon and Celebochoerus) have been recovered from stratified deposits that accumulated from before 200 thousand years ago until about 100 thousand years ago. Our findings suggest that Sulawesi, like Flores, was host to a long-established population of archaic hominins, the ancestral origins and taxonomic status of which remain elusive.	[Van den Bergh, Gerrit D.; Li, Bo; Yurnaldi, Dida; Setiawan, Ruly; Roberts, Richard G.; Morwood, Michael J.] Univ Wollongong, Sch Earth & Environm Sci, Ctr Archaeol Sci, Wollongong, NSW 2522, Australia; [Van den Bergh, Gerrit D.] Naturalis Biodivers Ctr, NL-2333 CR Leiden, Netherlands; [Brumm, Adam; Gruen, Rainer] Griffith Univ, Environm Futures Res Inst, Res Ctr Human Evolut, Nathan, Qld 4111, Australia; [Brumm, Adam] Univ Wollongong, Sch Earth & Environm Sci, Wollongong, NSW 2522, Australia; [Yurnaldi, Dida; Kurniawan, Iwan; Setiawan, Ruly; Aziz, Fachroel; Suyono; Setiabudi, Erick] Geol Agcy, Geol Museum Bandung, Bandung 40122, Indonesia; [Moore, Mark W.] Univ New England, Sch Humanities, Archaeol, Armidale, NSW 2350, Australia; [Storey, Michael] Univ Copenhagen, Nat Hist Museum Denmark, Quadlab, DK-1350 Copenhagen, Denmark	University of Wollongong; Naturalis Biodiversity Center; Griffith University; University of Wollongong; University of New England; University of Copenhagen	Van den Bergh, GD (corresponding author), Univ Wollongong, Sch Earth & Environm Sci, Ctr Archaeol Sci, Wollongong, NSW 2522, Australia.	gert@uow.edu.au; bli@uow.edu.au	Moore, Mark W/B-4729-2015; van den Bergh, Gerrit D/I-7670-2016; Roberts, Richard Graham/B-8245-2013; Grun, Rainer/A-1437-2012; Li, Bo/B-8974-2016	Moore, Mark W/0000-0003-4768-5329; Roberts, Richard Graham/0000-0002-0128-4119; Grun, Rainer/0000-0003-1366-3674; van den Bergh, Gerrit Dirk/0000-0003-1507-3336; Storey, Michael/0000-0002-3126-4637; Li, Bo/0000-0003-4186-4828	Australian Research Council (ARC) [DP0770234/DP1093342, FT100100384]; Geological Survey Institute of Indonesia; ARC [FT140100384, FL130100116, DE130101560, DP1093342]; Villum Foundation; Villum Fonden [00007408] Funding Source: researchfish	Australian Research Council (ARC)(Australian Research Council); Geological Survey Institute of Indonesia(Ministry of Research and Technology of the Republic of Indonesia (RISTEK)); ARC(Australian Research Council); Villum Foundation(Villum Fonden); Villum Fonden(Villum Fonden)	This research was supported by grants from the Australian Research Council (ARC) to M.J.M. (DP0770234/DP1093342) and G.D.v.d.B. (FT100100384), and funds from the Geological Survey Institute of Indonesia. L.B. and R.G.R. are supported by ARC Fellowships FT140100384 and FL130100116, respectively. A.B.'s involvement was supported by ARC fellowship DE130101560. The stone tool analysis was supported by ARC Fellowship DP1093342 to M.W.M., and M.S. was funded by the Villum Foundation. The fieldwork was authorized by the directors of the Geological Survey Institute of Indonesia, A. Djumarma Wirakusumah and Y. Kusumahbrata. We further acknowledge the Indonesian State Ministry of Research and Technology and the National Centre for Archaeology in Jakarta (ARKENAS), for facilitating the research. Field assistants included H. Oktaviana, Dadang, S. Sudjarwadi, Ngaliman, T. Suryana and U. P. Wibowo. During the excavations we were assisted by the landowner, Wahe, and 11 other local labourers. Y. Jafari prepared the sediment samples for optical dating and L. Kinsley assisted with the uranium-series analysis. We thank K. Westaway, D. Granger, B. Pillans and B. Jones for additional field support, and S. van der Mije for allowing access to the vertebrate collection at Naturalis. S. Hayes is thanked for providing feedback on the manuscript.	Aitken M.J., 1998, INTRO OPTICAL DATING; Aubert M, 2014, NATURE, V514, P223, DOI 10.1038/nature13422; Auclair M, 2003, RADIAT MEAS, V37, P487, DOI 10.1016/S1350-4487(03)00018-0; Barker G, 2007, J HUM EVOL, V52, P243, DOI 10.1016/j.jhevol.2006.08.011; BARTSTRA GJ, 1991, CURR ANTHROPOL, V32, P317, DOI 10.1086/203960; BOTTERJENSEN L, 1988, NUCL TRACKS RAD MEAS, V14, P187; Brumm A, 2010, NATURE, V464, P748, DOI 10.1038/nature08844; Butler RF, 1992, PALEOMAGNETISM MAGNE, P103; Buylaert JP, 2009, RADIAT MEAS, V44, P560, DOI 10.1016/j.radmeas.2009.02.007; Clarkson C, 2015, J HUM EVOL, V83, P46, DOI 10.1016/j.jhevol.2015.03.014; Cooper A, 2013, SCIENCE, V342, P321, DOI 10.1126/science.1244869; Eggins SM, 2005, QUATERNARY SCI REV, V24, P2523, DOI 10.1016/j.quascirev.2005.07.006; Elburg MA, 1999, GEOCHIM COSMOCHIM AC, V63, P1155, DOI 10.1016/S0016-7037(98)00298-1; Galbraith RF, 2012, QUAT GEOCHRONOL, V11, P1, DOI 10.1016/j.quageo.2012.04.020; Galbraith RF, 1999, ARCHAEOMETRY, V41, P339, DOI 10.1111/j.1475-4754.1999.tb00987.x; GALBRAITH RF, 1988, TECHNOMETRICS, V30, P271, DOI 10.2307/1270081; Grun R, 2014, PALAEOGEOGR PALAEOCL, V416, P150, DOI 10.1016/j.palaeo.2014.07.023; Grun R, 2005, J HUM EVOL, V49, P316, DOI 10.1016/j.jhevol.2005.04.006; Grun R, 1998, J HUM EVOL, V34, P555, DOI 10.1006/jhev.1997.0211; HOOIJER D A, 1975, Netherlands Journal of Zoology, V25, P46; HOOIJER D. A., 1948, PROC K NEDERLAND AKAD WETENSCHAP AMSTERDAM, V51, P1024; Huntley DJ, 2006, QUATERNARY SCI REV, V25, P2503, DOI 10.1016/j.quascirev.2005.05.011; Huntley DJ, 2001, CAN J EARTH SCI, V38, P1093, DOI 10.1139/e01-013; HUNTLEY DJ, 1985, NATURE, V313, P105, DOI 10.1038/313105a0; HUTTON JT, 1992, NUCL TRACKS RAD MEAS, V20, P367; Indriati E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021562; Jacobs Z, 2015, J ARCHAEOL SCI, V63, P175, DOI 10.1016/j.jas.2015.01.023; Kars RH, 2008, RADIAT MEAS, V43, P786, DOI 10.1016/j.radmeas.2008.01.021; KIRSCHVINK JL, 1980, GEOPHYS J ROY ASTR S, V62, P699, DOI 10.1111/j.1365-246X.1980.tb02601.x; Li B, 2015, QUAT GEOCHRONOL, V27, P119, DOI 10.1016/j.quageo.2015.02.010; Li B, 2014, GEOCHRONOMETRIA, V41, P178, DOI 10.2478/s13386-013-0160-3; Li B, 2014, QUAT GEOCHRONOL, V20, P51, DOI 10.1016/j.quageo.2013.11.001; Li B, 2013, QUAT GEOCHRONOL, V17, P1, DOI 10.1016/j.quageo.2013.03.006; Li B, 2012, QUAT GEOCHRONOL, V10, P24, DOI 10.1016/j.quageo.2011.12.005; Li B, 2011, QUAT GEOCHRONOL, V6, P468, DOI 10.1016/j.quageo.2011.05.001; Li B, 2008, J PHYS D APPL PHYS, V41, DOI 10.1088/0022-3727/41/22/225502; Lian OB, 2006, QUATERNARY SCI REV, V25, P2449, DOI 10.1016/j.quascirev.2005.11.013; Lurcock PC, 2012, GEOCHEM GEOPHY GEOSY, V13, DOI 10.1029/2012GC004098; Mellars P, 2006, P NATL ACAD SCI USA, V103, P9381, DOI 10.1073/pnas.0510792103; Moore MW, 2009, J HUM EVOL, V57, P503, DOI 10.1016/j.jhevol.2008.10.006; MORWOOD M, 2007, DISCOVERY HOBBIT SCI; O'Connor S, 2011, SCIENCE, V334, P1117, DOI 10.1126/science.1207703; OConnor S., 2015, EMERGENCE DIVERSITY, P214; Rivera TA, 2013, CHEM GEOL, V345, P87, DOI 10.1016/j.chemgeo.2013.02.021; Roberts RG, 2015, J ARCHAEOL SCI, V56, P41, DOI 10.1016/j.jas.2015.02.028; Mijares AS, 2010, J HUM EVOL, V59, P123, DOI 10.1016/j.jhevol.2010.04.008; Sambridge M, 2012, QUAT GEOCHRONOL, V9, P42, DOI 10.1016/j.quageo.2012.02.010; Sprintall J, 2014, NAT GEOSCI, V7, P487, DOI [10.1038/NGEO2188, 10.1038/ngeo2188]; Storey M, 2012, P NATL ACAD SCI USA, V109, P18684, DOI 10.1073/pnas.1208178109; Storm P, 2013, J HUM EVOL, V64, P356, DOI 10.1016/j.jhevol.2012.11.002; Sukamto R., 1975, GEOLOGICAL MAP INDON; Summerhayes GR, 2010, SCIENCE, V330, P78, DOI 10.1126/science.1193130; Thiel C, 2011, QUATERN INT, V234, P23, DOI 10.1016/j.quaint.2010.05.018; Thomsen KJ, 2008, RADIAT MEAS, V43, P1474, DOI 10.1016/j.radmeas.2008.06.002; Torsvik TH, 2000, SUPER IAPD INTERACTI; van den Bergh Gert D., 1999, Scripta Geologica, V117, P1; van Heekeren H.R., 1972, STONE AGE INDONESIA, DOI DOI 10.26530/OAPEN_613384; VANHEEKEREN HR, 1949, NATURE, V163, P492, DOI 10.1038/163492b0; Westaway KE, 2007, J HUM EVOL, V53, P709, DOI 10.1016/j.jhevol.2007.06.002; Westaway KE, 2007, QUAT GEOCHRONOL, V2, P337, DOI 10.1016/j.quageo.2006.03.015; Wilson MEJ, 2000, SEDIMENTOLOGY, V47, P395, DOI 10.1046/j.1365-3091.2000.00299.x; WINTLE AG, 1973, NATURE, V245, P143, DOI 10.1038/245143a0; Zaim Y, 2011, J HUM EVOL, V61, P363, DOI 10.1016/j.jhevol.2011.04.009	64	82	82	0	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 14	2016	529	7585					208	U193		10.1038/nature16448	http://dx.doi.org/10.1038/nature16448			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA7WK	26762458	Green Published, Green Submitted			2022-12-28	WOS:000368015700036
J	Girard, J; Amulele, G; Farla, R; Mohiuddin, A; Karato, SI				Girard, Jennifer; Amulele, George; Farla, Robert; Mohiuddin, Anwar; Karato, Shun-ichiro			Shear deformation of bridgmanite and magnesiowustite aggregates at lower mantle conditions	SCIENCE			English	Article							SEISMIC ANISOTROPY; HIGH-PRESSURE; DEEP-MANTLE; CREEP; PEROVSKITE; SYSTEMATICS; RHEOLOGY; STRENGTH	Rheological properties of the lower mantle have strong influence on the dynamics and evolution of Earth. By using the improved methods of quantitative deformation experiments at high pressures and temperatures, we deformed a mixture of bridgmanite and magnesiowustite under the shallow lower mantle conditions. We conducted experiments up to about 100% strain at a strain rate of about 3 x 10(-5) second(-1). We found that bridgmanite is substantially stronger than magnesiowustite and that magnesiowustite largely accommodates the strain. Our results suggest that strain weakening and resultant shear localization likely occur in the lower mantle. This would explain the preservation of long-lived geochemical reservoirs and the lack of seismic anisotropy in the majority of the lower mantle except the boundary layers.	[Girard, Jennifer; Amulele, George; Farla, Robert; Mohiuddin, Anwar; Karato, Shun-ichiro] Yale Univ, Dept Geol & Geophys, New Haven, CT 06520 USA	Yale University	Karato, SI (corresponding author), Yale Univ, Dept Geol & Geophys, New Haven, CT 06520 USA.	shun-ichiro.karato@yale.edu		Girard, Jennifer/0000-0003-4859-1551; Amulele, George/0000-0002-1504-4722	NSF; Directorate For Geosciences [1361276] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This study was supported by a grant from NSF. The experimental facilities at the Brookhaven National Laboratory are supported by the Department of Energy and COMPRES (Consortium for Materials Properties Research in Earth Sciences). We thank D. Weidner and H. Chen for the support at the synchrotron facility at Brookhaven National Laboratory. Z. Jiang provided technical support for the microstructural analyses. All data presented in this paper are available in the supplementary materials.	BEAUCHESNE S, 1990, PHYS EARTH PLANET IN, V61, P182, DOI 10.1016/0031-9201(90)90105-7; BLOOMFIELD JP, 1993, J STRUCT GEOL, V15, P1007, DOI 10.1016/0191-8141(93)90173-8; Chen JH, 2002, NATURE, V419, P824, DOI 10.1038/nature01130; CHRISTENSEN UR, 1994, J GEOPHYS RES-SOL EA, V99, P19867, DOI 10.1029/93JB03403; Cordier P, 2004, NATURE, V428, P837, DOI 10.1038/nature02472; HANDY MR, 1994, J STRUCT GEOL, V16, P287, DOI 10.1016/0191-8141(94)90035-3; Hofmann AW, 1997, NATURE, V385, P219, DOI 10.1038/385219a0; KARATO S, 1989, PHYS EARTH PLANET IN, V55, P234, DOI 10.1016/0031-9201(89)90071-X; KARATO S, 1995, SCIENCE, V270, P458, DOI 10.1126/science.270.5235.458; KARATO S, 1981, PHYS EARTH PLANET IN, V24, P1, DOI 10.1016/0031-9201(81)90074-1; Karato S, 2008, ELEMENTS, V4, P191, DOI 10.2113/GSELEMENTS.4.3.191; Karato SI, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.214106; Karato SI, 1998, PURE APPL GEOPHYS, V151, P565, DOI 10.1007/s000240050130; Karato SI, 2008, DEFORMATION OF EARTH MATERIALS: AN INTRODUCTION TO THE RHEOLOGY OF SOLID EARTH, P1, DOI 10.1017/CBO9780511804892; KOCKS UF, 1970, METALL TRANS, V1, P1121, DOI 10.1007/BF02900224; LANGDON TG, 1970, ACTA METALL MATER, V18, P505, DOI 10.1016/0001-6160(70)90137-9; Madi K, 2005, EARTH PLANET SC LETT, V237, P223, DOI 10.1016/j.epsl.2005.06.027; Marquardt H, 2015, NAT GEOSCI, V8, P311, DOI 10.1038/NGEO2393; Marty B, 2012, EARTH PLANET SC LETT, V313, P56, DOI 10.1016/j.epsl.2011.10.040; Merkel S, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB000920; Merkel S, 2003, EARTH PLANET SC LETT, V209, P351, DOI 10.1016/S0012-821X(03)00098-0; POIRIER JP, 1986, NATURE, V321, P603, DOI 10.1038/321603a0; RINGWOOD AE, 1991, GEOCHIM COSMOCHIM AC, V55, P2083, DOI 10.1016/0016-7037(91)90090-R; van Keken PE, 2002, ANNU REV EARTH PL SC, V30, P493, DOI 10.1146/annurev.earth.30.091201.141236; Wang Y, 2013, GEOCHEM GEOPHY GEOSY, V14, P3389, DOI 10.1002/ggge.20200; Wang ZC, 1999, PHYS EARTH PLANET IN, V110, P51, DOI 10.1016/S0031-9201(98)00130-7; Yamazaki D, 2001, REV SCI INSTRUM, V72, P4207, DOI 10.1063/1.1412858	27	93	96	3	66	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 8	2016	351	6269					144	147		10.1126/science.aad3113	http://dx.doi.org/10.1126/science.aad3113			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4XQ	26721681				2022-12-28	WOS:000367806500034
J	Long, JS; Giotis, ES; Moncorge, O; Frise, R; Mistry, B; James, J; Morisson, M; Iqbal, M; Vignal, A; Skinner, MA; Barclay, WS				Long, Jason S.; Giotis, Efstathios S.; Moncorge, Olivier; Frise, Rebecca; Mistry, Bhakti; James, Joe; Morisson, Mireille; Iqbal, Munir; Vignal, Alain; Skinner, Michael A.; Barclay, Wendy S.			Species difference in ANP32A underlies influenza A virus polymerase host restriction	NATURE			English	Article							REVERSE GENETICS SYSTEM; RNA-POLYMERASE; HUMAN-CELLS; PB2; REPLICATION; ADAPTATION; GENERATION; SUBUNIT; RANGE; RIBONUCLEOPROTEINS	Influenza pandemics occur unpredictably when zoonotic influenza viruses with novel antigenicity acquire the ability to transmit amongst humans(1). Host range breaches are limited by incompatibilities between avian virus components and the human host. Barriers include receptor preference, virion stability and poor activity of the avian virus RNA-dependent RNA polymerase in human cells(2). Mutants of the heterotrimeric viral polymerase components, particularly PB2 protein, are selected during mammalian adaptation, but their mode of action is unknown(3-6). We show that a species-specific difference in host protein ANP32A accounts for the suboptimal function of avian virus polymerase in mammalian cells. Avian ANP32A possesses an additional 33 amino acids between the leucine-rich repeats and carboxy-terminal low-complexity acidic region domains. In mammalian cells, avian ANP32A rescued the suboptimal function of avian virus polymerase to levels similar to mammalian-adapted polymerase. Deletion of the avian-specific sequence from chicken ANP32A abrogated this activity, whereas its insertion into human ANP32A, or closely related ANP32B, supported avian virus polymerase function. Substitutions, such as PB2(E627K), were rapidly selected upon infection of humans with avian H5N1 or H7N9 influenza viruses, adapting the viral polymerase for the shorter mammalian ANP32A. Thus ANP32A represents an essential host partner co-opted to support influenza virus replication and is a candidate host target for novel antivirals.	[Long, Jason S.; Giotis, Efstathios S.; Frise, Rebecca; Mistry, Bhakti; James, Joe; Skinner, Michael A.; Barclay, Wendy S.] Univ London Imperial Coll Sci Technol & Med, Sect Virol, Dept Med, St Marys Campus, London W2 1PG, England; [Moncorge, Olivier] UM, CNRS, Ctr Etud Agents Pathogenes & Biotechnol Sante CPB, FRE 3689, F-34293 Montpellier, France; [James, Joe; Iqbal, Munir] Pirbright Inst, Avian Viral Dis Programme, Ash Rd, Woking GU24 0NF, Surrey, England; [Morisson, Mireille; Vignal, Alain] INRA, UMR INRA Genet Physiol & Syst Elevage, F-31326 Castanet Tolosan, France	Imperial College London; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; INRAE	Barclay, WS (corresponding author), Univ London Imperial Coll Sci Technol & Med, Sect Virol, Dept Med, St Marys Campus, London W2 1PG, England.	w.barclay@imperial.ac.uk	Giotis, Efstathios S/C-4976-2011; Vignal, Alain/I-6253-2017; James, Joe/AAA-5119-2021; Vignal, Alain/AAJ-5697-2021; Moncorge, Olivier/E-3233-2017; Giotis, Efstathios S/AAI-9779-2021	Giotis, Efstathios S/0000-0002-5991-3678; Vignal, Alain/0000-0002-6797-2125; James, Joe/0000-0002-9673-3684; Vignal, Alain/0000-0002-6797-2125; Moncorge, Olivier/0000-0003-0512-1824; Giotis, Efstathios S/0000-0001-8908-7824; Skinner, Michael/0000-0002-0050-4167; Iqbal, Munir/0000-0001-5165-5339; Long, Jason/0000-0002-0251-6487; Barclay, Wendy/0000-0002-3948-0895	BBSRC sLoLa [BB/K002465/1]; Wellcome Trust; Wellcome Trust Programme Grant [087039/Z/08/Z]; MRC [G0600006]; BBSRC Avian Diseases Programme Grant [BBS/E/I/00001708]; BBSRC [BB/L026341/1, BBS/E/I/00001422, BB/L004240/1, BBS/E/I/00001759, BB/K002465/1, BBS/E/I/00001708, BB/L018853/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/L018853/1, BBS/E/I/00001025, BBS/E/I/00001708, BB/K002465/1, BBS/E/I/00001759, BB/L004240/1, BB/L026341/1, BBS/E/I/00001422] Funding Source: researchfish; Medical Research Council [G0600006] Funding Source: researchfish	BBSRC sLoLa(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Wellcome Trust Programme Grant(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC Avian Diseases Programme Grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank G. Maertens, J. Stech, R. Fouchier, A. Cauldwell, G. Roche, J. McCauley, D. Huntley, A. Vaughan, V. Nair and H. Shelton for provision of reagents, advice and discussions. This work was funded by BBSRC sLoLa BB/K002465/1 "Developing Rapid Responses to Emerging Virus Infections of Poultry (DDREVIP)" which funds J.S.L. and E.S.G., B.M. was funded by a Wellcome Trust studentship. R.F. and O.M. were funded by a Wellcome Trust Programme Grant (087039/Z/08/Z). O.M. was funded by MRC (G0600006). M.I. was funded by a BBSRC Avian Diseases Programme Grant (BBS/E/I/00001708).	ALMOND JW, 1977, NATURE, V270, P617, DOI 10.1038/270617a0; Bortz E, 2011, MBIO, V2, DOI 10.1128/mBio.00151-11; Bradel-Tretheway BG, 2011, J VIROL, V85, P8569, DOI 10.1128/JVI.00496-11; Bussey KA, 2010, J VIROL, V84, P4395, DOI 10.1128/JVI.02642-09; Cauldwell AV, 2014, J GEN VIROL, V95, P1193, DOI 10.1099/vir.0.062836-0; Cauldwell AV, 2013, J VIROL, V87, P1278, DOI 10.1128/JVI.02597-12; Crescenzo-Chaigne B, 2002, VIROLOGY, V303, P240, DOI 10.1006/viro.2002.1637; Eisfeld AJ, 2015, NAT REV MICROBIOL, V13, P28, DOI 10.1038/nrmicro3367; Elleman CJ, 2004, VIROLOGY, V321, P144, DOI 10.1016/j.virol.2003.12.009; Flick R, 2001, J VIROL, V75, P1643, DOI 10.1128/JVI.75.4.1643-1655.2001; Gabriel G, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1158; Hoffmann E, 2000, P NATL ACAD SCI USA, V97, P6108, DOI 10.1073/pnas.100133697; Howard W, 2007, AVIAN DIS, V51, P393, DOI 10.1637/7645-050906R1.1; Iqbal M, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-100; Kawakami E, 2011, J VIROL METHODS, V173, P1, DOI 10.1016/j.jviromet.2010.12.014; Long JS, 2013, J VIROL, V87, P9983, DOI 10.1128/JVI.01399-13; Manz B, 2013, J VIROL, V87, P7200, DOI 10.1128/JVI.00980-13; Massin P, 2001, J VIROL, V75, P5398, DOI 10.1128/JVI.75.11.5398-5404.2001; Mehle A, 2008, CELL HOST MICROBE, V4, P111, DOI 10.1016/j.chom.2008.06.007; Mehle A, 2009, P NATL ACAD SCI USA, V106, P21312, DOI 10.1073/pnas.0911915106; Moncorge O, 2013, J VIROL, V87, P384, DOI 10.1128/JVI.01633-12; Moncorge O, 2010, J VIROL, V84, P9978, DOI 10.1128/JVI.01134-10; Morisson M, 2002, GENET SEL EVOL, V34, P521, DOI [10.1051/gse:2002021, 10.1186/1297-9686-34-4-521]; Naffakh N, 2008, ANNU REV MICROBIOL, V62, P403, DOI 10.1146/annurev.micro.62.081307.162746; Neumann G, 1999, P NATL ACAD SCI USA, V96, P9345, DOI 10.1073/pnas.96.16.9345; Neumann G, 2015, VIROLOGY, V479, P234, DOI 10.1016/j.virol.2015.03.009; Obayashi E, 2008, NATURE, V454, P1127, DOI [10.1038/nature07225, 10.5940/jcrsj.50.329]; Paterson D, 2014, J VIROL, V88, P339, DOI 10.1128/JVI.02022-13; Pflug A, 2014, NATURE, V516, P355, DOI 10.1038/nature14008; Pleschka S, 1996, J VIROL, V70, P4188, DOI 10.1128/JVI.70.6.4188-4192.1996; Rameix-Welti MA, 2009, J VIROL, V83, P1320, DOI 10.1128/JVI.00977-08; Reilly PT, 2014, BIOESSAYS, V36, P1062, DOI 10.1002/bies.201400058; Resa-Infante P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003904; Shinya K, 2009, J VIROL, V83, P13015, DOI 10.1128/JVI.01714-09; Steel J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000252; SUBBARAO EK, 1993, J VIROL, V67, P1761, DOI 10.1128/JVI.67.4.1761-1764.1993; Sugiyama K, 2015, ELIFE, V4, DOI 10.7554/eLife.08939; Ulm JW, 2007, VIROLOGY, V363, P245, DOI 10.1016/j.virol.2006.09.048; Van Hoeven N, 2009, P NATL ACAD SCI USA, V106, P3366, DOI 10.1073/pnas.0813172106; Watanabe T, 2014, CELL HOST MICROBE, V16, P795, DOI 10.1016/j.chom.2014.11.002; Weber M, 2015, CELL HOST MICROBE, V17, P309, DOI 10.1016/j.chom.2015.01.005; Whiteley A, 2007, INFLUENZA OTHER RESP, V1, P157, DOI 10.1111/j.1750-2659.2007.00022.x	43	147	153	0	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 7	2016	529	7584					101	+		10.1038/nature16474	http://dx.doi.org/10.1038/nature16474			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6VY	26738596	Green Submitted, Green Accepted			2022-12-28	WOS:000367944900035
J	Gulland, A				Gulland, Anne			MEDICINE AND THE MEDIA Concussion: doctor who took on the might of American football hits the big screen	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												agulland@bmj.com						Belson K., 2015, NY TIMES; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED	2	0	0	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 6	2016	352								h6856	10.1136/bmj.h6856	http://dx.doi.org/10.1136/bmj.h6856			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DA8MO	26738917				2022-12-28	WOS:000368059200015
J	Armstrong, GT; Chen, Y; Yasui, Y; Leisenring, W; Gibson, TM; Mertens, AC; Stovall, M; Oeffinger, KC; Bhatia, S; Krull, KR; Nathan, PC; Neglia, JP; Green, DM; Hudson, MM; Robison, LL				Armstrong, Gregory T.; Chen, Yan; Yasui, Yutaka; Leisenring, Wendy; Gibson, Todd M.; Mertens, Ann C.; Stovall, Marilyn; Oeffinger, Kevin C.; Bhatia, Smita; Krull, Kevin R.; Nathan, Paul C.; Neglia, Joseph P.; Green, Daniel M.; Hudson, Melissa M.; Robison, Leslie L.			Reduction in Late Mortality among 5-Year Survivors of Childhood Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	51st Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer	MAY 29-JUN 02, 2015	Chicago, IL	Amer Soc Clin Oncol			ACUTE LYMPHOBLASTIC-LEUKEMIA; LONG-TERM SURVIVORS; CONTEMPORARY TREATMENT; WILMS-TUMOR; FOLLOW-UP; CHILDREN; CHEMOTHERAPY; EXPERIENCE; RADIATION; OUTCOMES	BACKGROUND Among patients in whom childhood cancer was diagnosed in the 1970s and 1980s, 18% of those who survived for 5 years died within the subsequent 25 years. In recent decades, cancer treatments have been modified with the goal of reducing life-threatening late effects. METHODS We evaluated late mortality among 34,033 patients in the Childhood Cancer Survivor Study cohort who survived at least 5 years after childhood cancer (i.e., cancer diagnosed before the age of 21 years) for which treatment was initiated during the period from 1970 through 1999. The median follow-up was 21 years (range, 5 to 38). We evaluated demographic and disease factors that were associated with death from health-related causes (i.e., conditions that exclude recurrence or progression of the original cancer and external causes but include the late effects of cancer therapy) using cumulative incidence and piecewise exponential models to estimate relative rates and 95% confidence intervals. RESULTS Of the 3958 deaths that occurred during the study period, 1618 (41%) were attributable to health-related causes, including 746 deaths from subsequent neoplasms, 241 from cardiac causes, 137 from pulmonary causes, and 494 from other causes. A reduction in 15-year mortality was observed for death from any cause (from 12.4% in the early 1970s to 6.0% in the 1990s, P<0.001 for trend) and from health-related causes (from 3.5% to 2.1%, P<0.001 for trend). These reductions were attributable to decreases in the rates of death from subsequent neoplasm (P<0.001), cardiac causes (P<0.001), and pulmonary causes (P = 0.04). Changes in therapy according to decade included reduced rates of cranial radiotherapy for acute lymphoblastic leukemia (85% in the 1970s, 51% in the 1980s, and 19% in the 1990s), of abdominal radiotherapy for Wilms' tumor (78%, 53%, and 43%, respectively), of chest radiotherapy for Hodgkin's lymphoma (87%, 79%, and 61%, respectively), and of anthracycline exposure. Reduction in treatment exposure was associated with reduced late mortality among survivors of acute lymphoblastic leukemia and Wilms' tumor. CONCLUSIONS The strategy of lowering therapeutic exposure has contributed to an observed decline in late mortality among 5-year survivors of childhood cancer.	[Armstrong, Gregory T.; Yasui, Yutaka; Gibson, Todd M.; Krull, Kevin R.; Green, Daniel M.; Hudson, Melissa M.; Robison, Leslie L.] St Jude Childrens Res Hosp, Dept Epidemiol & Canc Control, 262 Danny Thomas Pl,Mail Stop 735, Memphis, TN 38105 USA; [Armstrong, Gregory T.; Hudson, Melissa M.] St Jude Childrens Res Hosp, Dept Oncol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Chen, Yan; Yasui, Yutaka] Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada; [Nathan, Paul C.] Hosp Sick Children, 555 Univ Ave, Toronto, ON M5G 1X8, Canada; [Leisenring, Wendy] Fred Hutchinson Canc Res Ctr, Canc Prevent & Clin Stat Programs, 1124 Columbia St, Seattle, WA 98104 USA; [Mertens, Ann C.] Emory Univ, Dept Pediat, Atlanta, GA 30322 USA; [Stovall, Marilyn] Univ Texas MD Anderson Canc Ctr, Dept Radiat Phys, Houston, TX 77030 USA; [Oeffinger, Kevin C.] Mem Sloan Kettering Canc Ctr, Dept Pediat, 1275 York Ave, New York, NY 10021 USA; [Oeffinger, Kevin C.] Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA; [Bhatia, Smita] Univ Alabama Birmingham, Sch Med, Dept Pediat, Birmingham, AL USA; [Neglia, Joseph P.] Univ Minnesota, Sch Med, Dept Pediat, Minneapolis, MN 55455 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Alberta; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Fred Hutchinson Cancer Center; Emory University; University of Texas System; UTMD Anderson Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of Alabama System; University of Alabama Birmingham; University of Minnesota System; University of Minnesota Twin Cities	Armstrong, GT (corresponding author), St Jude Childrens Res Hosp, Dept Epidemiol & Canc Control, 262 Danny Thomas Pl,Mail Stop 735, Memphis, TN 38105 USA.	greg.armstrong@stjude.org	Nathan, Paul/GRR-2377-2022; Krull, Kevin R/N-3882-2018; Robison, Leslie/N-8122-2018; Gibson, Todd M/N-6999-2018; Hudson, Melissa M/N-4441-2018; Armstrong, Gregory/N-8096-2018; Yasui, Yutaka/E-2564-2015	Krull, Kevin R/0000-0002-0476-7001; Gibson, Todd M/0000-0002-8718-699X; Hudson, Melissa M/0000-0001-6984-2407; Yasui, Yutaka/0000-0002-7717-8638; Neglia, Joseph/0000-0002-5525-0598; Nathan, Paul/0000-0003-0334-0871; Leisenring, Wendy/0000-0001-7405-0906	NATIONAL CANCER INSTITUTE [U24CA055727, P30CA021765, U01CA055727, P30CA008748] Funding Source: NIH RePORTER; NCI NIH HHS [U24 CA055727, P30 CA008748, P30 CA021765, CA21765, CA55727] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Armstrong GT, 2014, J CLIN ONCOL, V32, P1218, DOI 10.1200/JCO.2013.51.1055; Armstrong GT, 2010, J CLIN ONCOL, V28, P1224, DOI 10.1200/JCO.2009.24.4608; Armstrong GT, 2009, J CLIN ONCOL, V27, P2328, DOI 10.1200/JCO.2008.21.1425; Cardous-Ubbink MC, 2004, PEDIATR BLOOD CANCER, V42, P563, DOI 10.1002/pbc.20028; Conklin HM, 2012, JNCI-J NATL CANCER I, V104, P1386, DOI 10.1093/jnci/djs344; DANGIO GJ, 1989, CANCER-AM CANCER SOC, V64, P349, DOI 10.1002/1097-0142(19890715)64:2<349::AID-CNCR2820640202>3.0.CO;2-Q; Department of Health and Human Services Centers for Disease Control and Prevention National Center for Health Statistics, COMPR MORT FIL CDC W; DONALDSON SS, 1987, J CLIN ONCOL, V5, P742, DOI 10.1200/JCO.1987.5.5.742; Garwicz S, 2012, INT J CANCER, V131, P1659, DOI 10.1002/ijc.27393; Green DM, 2013, PEDIATR BLOOD CANCER, V60, P1083, DOI 10.1002/pbc.24487; Green DM, 1998, J CLIN ONCOL, V16, P3744, DOI 10.1200/JCO.1998.16.12.3744; Henderson TO, 2010, ANN INTERN MED, V152, P444, DOI 10.7326/0003-4819-152-7-201004060-00009; Hudson MM, 2014, J CLIN ONCOL, V32, P3974, DOI 10.1200/JCO.2014.57.3493; Hudson MM, 2013, JAMA-J AM MED ASSOC, V309, P2371, DOI 10.1001/jama.2013.6296; Hudson MM, 2012, PEDIATR BLOOD CANCER, V58, P334, DOI 10.1002/pbc.23385; Hudson MM, 1997, J CLIN ONCOL, V15, P2205, DOI 10.1200/JCO.1997.15.6.2205; Kremer LCM, 2013, PEDIATR BLOOD CANCER, V60, P543, DOI 10.1002/pbc.24445; Leisenring WM, 2009, J CLIN ONCOL, V27, P2319, DOI 10.1200/JCO.2008.21.1813; LI FP, 1978, J PEDIATR-US, V93, P185, DOI 10.1016/S0022-3476(78)80492-2; LIPSHULTZ SE, 1991, NEW ENGL J MED, V324, P808, DOI 10.1056/NEJM199103213241205; Little R.J.A., 2002, STAT ANAL MISSING DA; Mertens AC, 2001, J CLIN ONCOL, V19, P3163, DOI 10.1200/JCO.2001.19.13.3163; Mertens AC, 2008, JNCI-J NATL CANCER I, V100, P1368, DOI 10.1093/jnci/djn310; Moller TR, 2004, ACTA ONCOL, V43, P711, DOI 10.1080/02841860410002860; Moller TR, 2001, J CLIN ONCOL, V19, P3173; Nathan PC, 2009, J CLIN ONCOL, V27, P2363, DOI 10.1200/JCO.2008.21.1441; National Cancer Institute, 1975, SEER CANC STAT REV C; Oeffinger KC, 2006, NEW ENGL J MED, V355, P1572, DOI 10.1056/NEJMsa060185; Packer RJ, 1997, J NEUROSURG, V86, P747, DOI 10.3171/jns.1997.86.5.0747; Pui CH, 2003, NEW ENGL J MED, V349, P640, DOI 10.1056/NEJMoa035091; Pui CH, 2009, NEW ENGL J MED, V360, P2730, DOI 10.1056/NEJMoa0900386; Reulen RC, 2010, JAMA-J AM MED ASSOC, V304, P172, DOI 10.1001/jama.2010.923; RIES LG, 1983, JNCI-J NATL CANCER I, V70, P693; Robison LL, 2014, NAT REV CANCER, V14, P61, DOI 10.1038/nrc3634; Robison LL, 2009, J CLIN ONCOL, V27, P2308, DOI 10.1200/JCO.2009.22.3339; Schwartz CL, 2009, BLOOD, V114, P2051, DOI 10.1182/blood-2008-10-184143; Stovall M, 2006, RADIAT RES, V166, P141, DOI 10.1667/RR3525.1; SULLIVAN MP, 1982, BLOOD, V60, P948; TAYLOR JMG, 1990, STAT MED, V9, P505, DOI 10.1002/sim.4780090504	39	337	341	0	28	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 3	2016	374	9					833	842		10.1056/NEJMoa1510795	http://dx.doi.org/10.1056/NEJMoa1510795			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	DF2FT	26761625	Green Accepted, Bronze			2022-12-28	WOS:000371158400007
J	Dalerba, P; Sahoo, D; Paik, S; Guo, XQ; Yothers, G; Song, N; Wilcox-Fogel, N; Forgo, E; Rajendran, PS; Miranda, SP; Hisamori, S; Hutchison, J; Kalisky, T; Qian, DL; Wolmark, N; Fisher, GA; van de Rijn, M; Clarke, MF				Dalerba, Piero; Sahoo, Debashis; Paik, Soonmyung; Guo, Xiangqian; Yothers, Greg; Song, Nan; Wilcox-Fogel, Nate; Forgo, Erna; Rajendran, Pradeep S.; Miranda, Stephen P.; Hisamori, Shigeo; Hutchison, Jacqueline; Kalisky, Tomer; Qian, Dalong; Wolmark, Norman; Fisher, George A.; van de Rijn, Matt; Clarke, Michael F.			CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COLORECTAL-CANCER; ADJUVANT CHEMOTHERAPY; STEM-CELLS; EXPRESSION; FLUOROURACIL; MARKER; LEUCOVORIN; RECURRENCE; SIGNATURE; FEATURES	BACKGROUND The identification of high-risk stage II colon cancers is key to the selection of patients who require adjuvant treatment after surgery. Microarray-based multigene-expression signatures derived from stem cells and progenitor cells hold promise, but they are difficult to use in clinical practice. METHODS We used a new bioinformatics approach to search for biomarkers of colon epithelial differentiation across gene-expression arrays and then ranked candidate genes according to the availability of clinical-grade diagnostic assays. With the use of subgroup analysis involving independent and retrospective cohorts of patients with stage II or stage III colon cancer, the top candidate gene was tested for its association with disease-free survival and a benefit from adjuvant chemotherapy. RESULTS The transcription factor CDX2 ranked first in our screening test. A group of 87 of 2115 tumor samples (4.1%) lacked CDX2 expression. In the discovery data set, which included 466 patients, the rate of 5-year disease-free survival was lower among the 32 patients (6.9%) with CDX2-negative colon cancers than among the 434 (93.1%) with CDX2-positive colon cancers (hazard ratio for disease recurrence, 3.44; 95% confidence interval [CI], 1.60 to 7.38; P = 0.002). In the validation data set, which included 314 patients, the rate of 5-year disease-free survival was lower among the 38 patients (12.1%) with CDX2 protein-negative colon cancers than among the 276 (87.9%) with CDX2 protein-positive colon cancers (hazard ratio, 2.42; 95% CI, 1.36 to 4.29; P = 0.003). In both these groups, these findings were independent of the patient's age, sex, and tumor stage and grade. Among patients with stage II cancer, the difference in 5-year disease-free survival was significant both in the discovery data set (49% among 15 patients with CDX2-negative tumors vs. 87% among 191 patients with CDX2-positive tumors, P = 0.003) and in the validation data set (51% among 15 patients with CDX2-negative tumors vs. 80% among 106 patients with CDX2-positive tumors, P = 0.004). In a pooled database of all patient cohorts, the rate of 5-year disease-free survival was higher among 23 patients with stage II CDX2-negative tumors who were treated with adjuvant chemotherapy than among 25 who were not treated with adjuvant chemotherapy (91% vs. 56%, P = 0.006). CONCLUSIONS Lack of CDX2 expression identified a subgroup of patients with high-risk stage II colon cancer who appeared to benefit from adjuvant chemotherapy. (Funded by the National Comprehensive Cancer Network, the National Institutes of Health, and others.)	[Dalerba, Piero] Columbia Univ, Herbert Irving Comprehens Canc Ctr, New York, NY 10032 USA; [Dalerba, Piero] Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Dalerba, Piero] Columbia Univ, Dept Med, New York, NY 10032 USA; [Dalerba, Piero; Sahoo, Debashis; Rajendran, Pradeep S.; Miranda, Stephen P.; Hisamori, Shigeo; Hutchison, Jacqueline; Qian, Dalong; Clarke, Michael F.] Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Guo, Xiangqian; Forgo, Erna; van de Rijn, Matt] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; [Wilcox-Fogel, Nate; Fisher, George A.; Clarke, Michael F.] Stanford Univ, Dept Med, Div Oncol, Stanford, CA 94305 USA; [Sahoo, Debashis] Univ Calif San Diego, Dept Pediat, San Diego, CA 92103 USA; [Sahoo, Debashis] Univ Calif San Diego, Dept Comp Sci & Engn, San Diego, CA 92103 USA; [Kalisky, Tomer] Bar Ilan Univ, Fac Engn, Ramat Gan, Israel; [Paik, Soonmyung; Yothers, Greg; Song, Nan; Wolmark, Norman] NRG Oncol, Natl Surg Adjuvant Breast & Bowel Project, Pittsburgh, PA USA; [Wolmark, Norman] Allegheny Gen Hosp, Allegheny Canc Ctr, Pittsburgh, PA 15212 USA; [Paik, Soonmyung] Yonsei Univ, Coll Med, Severance Biomed Sci Inst, Seoul 120749, South Korea; [Guo, Xiangqian] Henan Univ, Sch Med, Dept Biochem & Mol Biol, Kaifeng, Peoples R China	Columbia University; Columbia University; Columbia University; Stanford University; Stanford University; Stanford University; University of California System; University of California San Diego; University of California System; University of California San Diego; Bar Ilan University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Surgical Adjuvant Breast & Bowel Project; Allegheny General Hospital; Yonsei University; Yonsei University Health System; Henan University	Dalerba, P (corresponding author), Columbia Univ, Irving Canc Res Ctr, Herbert Irving Comprehens Canc Ctr, 1130 St Nicholas Ave,Rm 505A, New York, NY 10032 USA.	pdd2109@columbia.edu; mfclarke@stanford.edu	Dalerba, Piero/E-2543-2018; Guo, Xiangqian/AAN-4599-2020	Dalerba, Piero/0000-0002-8815-4981; Guo, Xiangqian/0000-0001-6645-5786; van de Rijn, Matt/0000-0002-1909-9739; Paik, Soonmyung/0000-0001-9688-6480; Yothers, Greg/0000-0002-7965-7333	National Comprehensive Cancer Network, the National Institutes of Health; NATIONAL CANCER INSTITUTE [U24CA114732, P01CA139490, U24CA196067, U10CA037377, U10CA180868, U54CA126524, UG1CA189867, U10CA180822, R00CA151673] Funding Source: NIH RePORTER	National Comprehensive Cancer Network, the National Institutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funded by the National Comprehensive Cancer Network, the National Institutes of Health, and others.	Altman DG, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001216; Andre T, 2004, NEW ENGL J MED, V350, P2343, DOI 10.1056/NEJMoa032709; Baba Y, 2009, CLIN CANCER RES, V15, P4665, DOI 10.1158/1078-0432.CCR-09-0401; Bae JM, 2015, WORLD J GASTROENTERO, V21, P1457, DOI 10.3748/wjg.v21.i5.1457; Bardia A, 2010, SEMIN ONCOL, V37, P39, DOI 10.1053/j.seminoncol.2009.12.005; Barrier A, 2006, J CLIN ONCOL, V24, P4685, DOI 10.1200/JCO.2005.05.0229; Beck F, 2010, BIOCHEM SOC T, V38, P353, DOI 10.1042/BST0380353; Borrisholt M, 2013, APPL IMMUNOHISTO M M, V21, P64, DOI 10.1097/PAI.0b013e318257f8aa; Chawengsaksophak K, 1997, NATURE, V386, P84, DOI 10.1038/386084a0; Compton C, 2000, CANCER-AM CANCER SOC, V88, P1739, DOI 10.1002/(SICI)1097-0142(20000401)88:7<1739::AID-CNCR30>3.0.CO;2-T; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Dalerba P, 2011, NAT BIOTECHNOL, V29, P1120, DOI 10.1038/nbt.2038; De Sousa E Melo F, 2013, NAT MED, V19, P614, DOI 10.1038/nm.3174; Fang SH, 2014, J AM COLL SURGEONS, V219, P1056, DOI 10.1016/j.jamcollsurg.2014.09.010; Gill S, 2004, J CLIN ONCOL, V22, P1797, DOI 10.1200/JCO.2004.09.059; Grone J, 2011, INT J COLORECTAL DIS, V26, P847, DOI 10.1007/s00384-011-1176-x; Hinoi T, 2001, AM J PATHOL, V159, P2239, DOI 10.1016/S0002-9440(10)63074-X; Jorissen RN, 2009, CLIN CANCER RES, V15, P7642, DOI 10.1158/1078-0432.CCR-09-1431; Kaimaktchiev V, 2004, MODERN PATHOL, V17, P1392, DOI 10.1038/modpathol.3800205; Laibe S, 2012, OMICS, V16, P560, DOI 10.1089/omi.2012.0039; Levin TG, 2010, GASTROENTEROLOGY, V139, P2072, DOI 10.1053/j.gastro.2010.08.053; Li MK, 2004, ADV ANAT PATHOL, V11, P101, DOI 10.1097/00125480-200403000-00004; Liu R, 2007, NEW ENGL J MED, V356, P217, DOI 10.1056/NEJMoa063994; Lugli A, 2008, MODERN PATHOL, V21, P1403, DOI 10.1038/modpathol.2008.117; Merlos-Suarez A, 2011, CELL STEM CELL, V8, P511, DOI 10.1016/j.stem.2011.02.020; Meropol NJ, 2011, J CLIN ONCOL, V29, P3346, DOI 10.1200/JCO.2011.35.4571; Meyerhardt JA, 2005, NEW ENGL J MED, V352, P476, DOI 10.1056/NEJMra040958; National Comprehensive Cancer Network, 2015, CLIN PRACT GUID ONC; O'Connor ES, 2011, J CLIN ONCOL, V29, P3381, DOI 10.1200/JCO.2010.34.3426; Sahoo D, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r157; Sahoo D, 2007, NUCLEIC ACIDS RES, V35, P3705, DOI 10.1093/nar/gkm284; Saltz LB, 2000, NEW ENGL J MED, V343, P905, DOI 10.1056/NEJM200009283431302; Smith JJ, 2010, GASTROENTEROLOGY, V138, P958, DOI 10.1053/j.gastro.2009.11.005; Thorsteinsson M, 2012, INT J COLORECTAL DIS, V27, P1579, DOI 10.1007/s00384-012-1517-4; Tournigand C, 2011, NAT REV CLIN ONCOL, V8, P574, DOI 10.1038/nrclinonc.2011.139; Wang YX, 2004, J CLIN ONCOL, V22, P1564, DOI 10.1200/JCO.2004.08.186; Weichert W, 2004, J CLIN PATHOL, V57, P1160, DOI 10.1136/jcp.2004.016238; Werling RW, 2003, AM J SURG PATHOL, V27, P303, DOI 10.1097/00000478-200303000-00003; Yothers G, 2013, J CLIN ONCOL, V31, P4512, DOI 10.1200/JCO.2012.47.3116; Zlobec I, 2010, INT J CANCER, V127, P367, DOI 10.1002/ijc.25042	40	296	304	3	75	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 21	2016	374	3					211	222		10.1056/NEJMoa1506597	http://dx.doi.org/10.1056/NEJMoa1506597			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DB3IS	26789870	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000368404800006
J	Mandl, KD; Kohane, IS				Mandl, Kenneth D.; Kohane, Isaac S.			Time for a Patient-Driven Health Information Economy?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							RECORDS		[Mandl, Kenneth D.] Harvard Univ, Sch Med, Boston Childrens Hosp, Computat Hlth Informat Program, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Biomed Informat, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School	Mandl, KD (corresponding author), Harvard Univ, Sch Med, Boston Childrens Hosp, Computat Hlth Informat Program, Boston, MA 02115 USA.							D'Amore JD, 2014, J AM MED INFORM ASSN, V21, P1060, DOI 10.1136/amiajnl-2014-002883; Halamka JD, 2008, J AM MED INFORM ASSN, V15, P1, DOI 10.1197/jamia.M2562; Mandl KD, 2001, BMJ-BRIT MED J, V322, P283, DOI 10.1136/bmj.322.7281.283; Mandl KD, 2008, NEW ENGL J MED, V358, P1732, DOI 10.1056/NEJMsb0800220; Mnookin S., 2014, NEW YORKER, P32	5	47	47	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 21	2016	374	3					205	208		10.1056/NEJMp1512142	http://dx.doi.org/10.1056/NEJMp1512142			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DB3IS	26789868	Bronze			2022-12-28	WOS:000368404800004
J	Murakami, K; Gunesdogan, U; Zylicz, JJ; Tang, WWC; Sengupta, R; Kobayashi, T; Kim, S; Butler, R; Dietmann, S; Surani, MA				Murakami, Kazuhiro; Guenesdogan, Ufuk; Zylicz, Jan J.; Tang, Walfred W. C.; Sengupta, Roopsha; Kobayashi, Toshihiro; Kim, Shinseog; Butler, Richard; Dietmann, Sabine; Surani, M. Azim			NANOG alone induces germ cells in primed epiblast in vitro by activation of enhancers	NATURE			English	Article							PLURIPOTENT STEM-CELLS; GROUND-STATE; MOUSE EMBRYO; SELF-RENEWAL; SPECIFICATION; MICE; EXPRESSION; DYNAMICS; LINEAGE; FATE	Nanog, a core pluripotency factor in the inner cell mass of blastocysts, is also expressed in unipotent primordial germ cells (PGCs) in mice(1), where its precise role is yet unclear(2-4). We investigated this in an in vitro model, in which naive pluripotent embryonic stem (ES) cells cultured in basic fibroblast growth factor (bFGF) and activin A develop as epiblast-like cells (EpiLCs) and gain competence for a PGC-like fate(5). Consequently, bone morphogenetic protein 4 (BMP4), or ectopic expression of key germline transcription factors Prdm1, Prdm14 and Tfap2c, directly induce PGC-like cells (PGCLCs) in EpiLCs, but not in ES cells(6-8). Here we report an unexpected discovery that Nanog alone can induce PGCLCs in EpiLCs, independently of BMP4. We propose that after the dissolution of the naive ES-cell pluripotency network during establishment of EpiLCs(9,10), the epigenome is reset for cell fate determination. Indeed, we found genome-wide changes in NANOG-binding patterns between ES cells and EpiLCs, indicating epigenetic resetting of regulatory elements. Accordingly, we show that NANOG can bind and activate enhancers of Prdm1 and Prdm14 in EpiLCs in vitro; BLIMP1 (encoded by Prdm1) then directly induces Tfap2c. Furthermore, while SOX2 and NANOG promote the pluripotent state in ES cells, they show contrasting roles in EpiLCs, as Sox2 specifically represses PGCLC induction by Nanog. This study demonstrates a broadly applicable mechanistic principle for how cells acquire competence for cell fate determination, resulting in the context-dependent roles of key transcription factors during development.	[Murakami, Kazuhiro; Guenesdogan, Ufuk; Zylicz, Jan J.; Tang, Walfred W. C.; Sengupta, Roopsha; Kobayashi, Toshihiro; Kim, Shinseog; Butler, Richard; Surani, M. Azim] Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Cambridge CB2 1QN, England; [Murakami, Kazuhiro; Guenesdogan, Ufuk; Zylicz, Jan J.; Tang, Walfred W. C.; Sengupta, Roopsha; Kobayashi, Toshihiro; Kim, Shinseog; Surani, M. Azim] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3DY, England; [Murakami, Kazuhiro; Guenesdogan, Ufuk; Zylicz, Jan J.; Tang, Walfred W. C.; Sengupta, Roopsha; Kobayashi, Toshihiro; Kim, Shinseog; Dietmann, Sabine; Surani, M. Azim] Univ Cambridge, Wellcome Trust Med Res Council Stem Cell Inst, Cambridge CB2 1QR, England; [Murakami, Kazuhiro] RIKEN, Ctr Dev Biol, Lab Pluripotent Cell Studies, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Murakami, Kazuhiro] Hokkaido Univ, Fac Adv Life Sci, Lab Mol & Cellular Biol, Kita Ku, Sapporo, Hokkaido 0010021, Japan	University of Cambridge; University of Cambridge; University of Cambridge; RIKEN; Hokkaido University	Surani, MA (corresponding author), Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Tennis Court Rd, Cambridge CB2 1QN, England.	a.surani@gurdon.cam.ac.uk	Murakami, Kazuhiro/AAC-4569-2019	Butler, Richard/0000-0002-3885-1332; Kim, Shinseog/0000-0001-9469-7635; Dietmann, Sabine./0000-0001-6672-8457; Zylicz, Jan/0000-0001-9622-5658; Kobayashi, Toshihiro/0000-0001-8019-0008; Gunesdogan, Ufuk/0000-0002-8658-8022; Murakami, Kazuhiro/0000-0003-1759-9542	Japan Society for the Promotion of Science (JSPS); Marie Sklodowska-Curie and a Newton Trust/Leverhulme Trust Early Career fellowship; Wellcome Trust [RG44593, WT096738]; JSPS; Gurdon Institute core grants from the Wellcome Trust [092096]; Cancer Research UK [C6946/A14492]; Medical Research Council [MC_PC_12009] Funding Source: researchfish	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Marie Sklodowska-Curie and a Newton Trust/Leverhulme Trust Early Career fellowship; Wellcome Trust(Wellcome TrustEuropean Commission); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Gurdon Institute core grants from the Wellcome Trust; Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank H. Leitch for ES cell lines, C. Lee for help with animal husbandry, H. Niwa for vectors and conditional Sox2-knockout ES cells, N. Miller, R. Walker and A. Riddell for FACS sorting and J. Bauer for analysis of microarray data. K.M. was supported by the Japan Society for the Promotion of Science (JSPS) Institutional Program for Young Researchers Overseas Visits. U.G. was supported by a Marie Sklodowska-Curie and a Newton Trust/Leverhulme Trust Early Career fellowship. J.J.Z. was a recipient of a Wellcome Trust PhD Studentship (RG44593). T.K. was supported by a JSPS Fellowship for research abroad. This research was supported by Gurdon Institute core grants from the Wellcome Trust (092096) and Cancer Research UK (C6946/A14492), and a grant from the Wellcome Trust to M.A.S. (WT096738).	Adachi K, 2013, MOL CELL, V52, P380, DOI 10.1016/j.molcel.2013.09.002; Aramaki S, 2013, DEV CELL, V27, P516, DOI 10.1016/j.devcel.2013.11.001; Bao SQ, 2012, CELL STEM CELL, V11, P110, DOI 10.1016/j.stem.2012.02.023; Behringer R., 2003, MANIPULATING MOUSE E, P453; Buecker C, 2014, CELL STEM CELL, V14, P838, DOI 10.1016/j.stem.2014.04.003; Campolo F, 2013, STEM CELLS, V31, P1408, DOI 10.1002/stem.1392; Carter AC, 2014, STEM CELL REP, V2, P119, DOI 10.1016/j.stemcr.2013.12.010; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Gillich A, 2012, CELL STEM CELL, V10, P425, DOI 10.1016/j.stem.2012.01.020; Grabole N, 2013, EMBO REP, V14, P629, DOI 10.1038/embor.2013.67; Hackett JA, 2013, SCIENCE, V339, P448, DOI 10.1126/science.1229277; Hajkova P, 2008, NATURE, V452, P877, DOI 10.1038/nature06714; Hayashi K, 2011, CELL, V146, P519, DOI 10.1016/j.cell.2011.06.052; Hoffman JA, 2013, DEVELOPMENT, V140, P1665, DOI 10.1242/dev.087387; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; KOSHIMIZU U, 1995, DEV BIOL, V168, P683, DOI 10.1006/dbio.1995.1113; Kurimoto K, 2015, CELL STEM CELL, V16, P517, DOI 10.1016/j.stem.2015.03.002; Lawson KA, 1999, GENE DEV, V13, P424, DOI 10.1101/gad.13.4.424; Ma ZY, 2011, NAT STRUCT MOL BIOL, V18, P120, DOI 10.1038/nsmb.2000; Magnusdottir E, 2013, NAT CELL BIOL, V15, P905, DOI 10.1038/ncb2798; Marks H, 2012, CELL, V149, P590, DOI 10.1016/j.cell.2012.03.026; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Nakaki F, 2013, NATURE, V501, P222, DOI 10.1038/nature12417; Ng JH, 2013, DEV CELL, V24, P324, DOI 10.1016/j.devcel.2012.12.011; Ohinata Y, 2005, NATURE, V436, P207, DOI 10.1038/nature03813; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Seki Y, 2005, DEV BIOL, V278, P440, DOI 10.1016/j.ydbio.2004.11.025; Sun LT, 2014, DEV BIOL, V392, P182, DOI 10.1016/j.ydbio.2014.06.002; Surani MA, 2007, CELL, V128, P747, DOI 10.1016/j.cell.2007.02.010; West JA, 2009, NATURE, V460, P909, DOI 10.1038/nature08210; Yamaguchi S, 2005, GENE EXPR PATTERNS, V5, P639, DOI 10.1016/j.modgep.2005.03.001; Yamaguchi S, 2009, DEVELOPMENT, V136, P4011, DOI 10.1242/dev.041160; Yamaji M, 2008, NAT GENET, V40, P1016, DOI 10.1038/ng.186; Yeom YI, 1996, DEVELOPMENT, V122, P881; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Yoshimizu T, 1999, DEV GROWTH DIFFER, V41, P675; Zylicz JJ, 2015, ELIFE, V4, DOI 10.7554/eLife.09571	39	109	115	0	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 21	2016	529	7586					403	+		10.1038/nature16480	http://dx.doi.org/10.1038/nature16480			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB2QT	26751055	Green Accepted			2022-12-28	WOS:000368354800048
J	[Anonymous]				[Anonymous]			Sexual harassment must not be kept under wraps	NATURE			English	Editorial Material																			0	3	3	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 21	2016	529	7586					257	257		10.1038/529257a	http://dx.doi.org/10.1038/529257a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DB2QT	26791686	Bronze			2022-12-28	WOS:000368354800006
J	Bauchner, H; Fontanarosa, PB				Bauchner, Howard; Fontanarosa, Phil B.			Death, Dying, and End of Life	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Bauchner, Howard; Fontanarosa, Phil B.] JAMA, Chicago, IL 60611 USA		Bauchner, H (corresponding author), JAMA, 330 N Wabash Ave, Chicago, IL 60611 USA.	howard.bauchner@jamanetwork.org						[Anonymous], 2010, ECONOMIST; [Anonymous], DEATHS AND MORT; [Anonymous], WORLD BIRTH DEATH RA; Chochinov HM, 2016, JAMA-J AM MED ASSOC, V315, P253, DOI 10.1001/jama.2015.17435; Clodfelter RP, 2016, JAMA-J AM MED ASSOC, V315, P251, DOI 10.1001/jama.2015.16242; Dierickx S, 2015, JAMA INTERN MED, V175, P1703, DOI 10.1001/jamainternmed.2015.3982; Gawande A, 2016, JAMA-J AM MED ASSOC, V315, P267, DOI 10.1001/jama.2015.19206; Gostin LO, 2016, JAMA-J AM MED ASSOC, V315, P249, DOI 10.1001/jama.2015.16586; Krumholz HM, 2015, JAMA-J AM MED ASSOC, V314, P355, DOI 10.1001/jama.2015.8035; Lerner BH, 2015, JAMA INTERN MED, V175, P1640, DOI 10.1001/jamainternmed.2015.4086; Orentlicher D, 2014, JAMA-J AM MED ASSOC, V311, P1961, DOI 10.1001/jama.2014.4117; Quill TE, 2016, JAMA-J AM MED ASSOC, V315, P245, DOI 10.1001/jama.2015.16210; Snijdewind MC, 2015, JAMA INTERN MED, V175, P1633, DOI 10.1001/jamainternmed.2015.3978; Yang YT, 2016, JAMA-J AM MED ASSOC, V315, P247, DOI 10.1001/jama.2015.16194	14	9	9	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 19	2016	315	3					270	271		10.1001/jama.2015.19102	http://dx.doi.org/10.1001/jama.2015.19102			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DB2WN	26784774				2022-12-28	WOS:000368371400023
J	Bloomfield, HE				Bloomfield, Hanna E.			Lifestyle-focused text messages reduced LDL-C levels, systolic BP, and BMI in coronary heart disease	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Bloomfield, Hanna E.] Minneapolis VA Med Ctr, Minneapolis, MN 55403 USA; [Bloomfield, Hanna E.] Univ Minnesota, Minneapolis, MN USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; University of Minnesota System; University of Minnesota Twin Cities	Bloomfield, HE (corresponding author), Minneapolis VA Med Ctr, Minneapolis, MN 55403 USA.								0	1	1	0	15	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 19	2016	164	2					JC7	JC7		10.7326/ACPJC-2016-164-2-007	http://dx.doi.org/10.7326/ACPJC-2016-164-2-007			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DB0CI	26784497				2022-12-28	WOS:000368175800006
J	van Saders, JL; Ceillier, T; Metcalfe, TS; Aguirre, VS; Pinsonneault, MH; Garcia, RA; Mathur, S; Davies, GR				van Saders, Jennifer L.; Ceillier, Tugdual; Metcalfe, Travis S.; Aguirre, Victor Silva; Pinsonneault, Marc H.; Garcia, Rafael A.; Mathur, Savita; Davies, Guy R.			Weakened magnetic braking as the origin of anomalously rapid rotation in old field stars	NATURE			English	Article							ANGULAR-MOMENTUM LOSS; STELLAR ROTATION; NGC 6811; KEPLER; CLUSTER; GYROCHRONOLOGY; TARGETS; BINARY; CLOCK; MODEL	A knowledge of stellar ages is crucial for our understanding of many astrophysical phenomena, and yet ages can be difficult to determine. As they become older, stars lose mass and angular momentum, resulting in an observed slowdown in surface rotation(1). The technique of 'gyrochronology' uses the rotation period of a star to calculate its age(2,3). However, stars of known age must be used for calibration, and, until recently, the approach was untested for old stars (older than 1 gigayear, Gyr). Rotation periods are now known for stars in an open cluster of intermediate age(4) (NGC 6819; 2.5 Gyr old), and for old field stars whose ages have been determined with asteroseismology(5,6). The data for the cluster agree with previous period-age relations(4), but these relations fail to describe the asteroseismic sample(7). Here we report stellar evolutionary modelling(5,6,8-10), and confirm the presence of unexpectedly rapid rotation in stars that are more evolved than the Sun. We demonstrate that models that incorporate dramatically weakened magnetic braking for old stars can-unlike existing models-reproduce both the asteroseismic and the cluster data. Our findings might suggest a fundamental change in the nature of ageing stellar dynamos, with the Sun being close to the critical transition to much weaker magnetized winds. This weakened braking limits the diagnostic power of gyrochronology for those stars that are more than halfway through their main-sequence lifetimes.	[van Saders, Jennifer L.] Carnegie Observ, Pasadena, CA 91101 USA; [van Saders, Jennifer L.] Princeton Univ, Dept Astrophys Sci, Princeton, NJ 08544 USA; [van Saders, Jennifer L.; Pinsonneault, Marc H.; Garcia, Rafael A.; Mathur, Savita] Univ Calif Santa Barbara, Kavli Inst Theoret Phys, Santa Barbara, CA 93106 USA; [Ceillier, Tugdual; Garcia, Rafael A.] Univ Paris Diderot, Inst Res Fundamental Laws Universe IRFU,Ctr Sacla, Alternat Energies & Atom Energy Commiss CEA,Lab A, Phys Sci Div DSM,Ctr Natl Etud Spatiales CNRS,Ser, F-91191 Gif Sur Yvette, France; [Metcalfe, Travis S.; Mathur, Savita] Space Sci Inst, Boulder, CO 80301 USA; [Aguirre, Victor Silva; Davies, Guy R.] Aarhus Univ, Dept Phys & Astron, Stellar Astrophys Ctr, DK-8000 Aarhus, Denmark; [Pinsonneault, Marc H.] Ohio State Univ, Dept Astron, Columbus, OH 43210 USA; [Davies, Guy R.] Univ Birmingham, Sch Phys & Astron, Birmingham B15 2TT, W Midlands, England	Carnegie Institution for Science; Princeton University; University of California System; University of California Santa Barbara; CEA; UDICE-French Research Universities; Universite Paris Cite; Aarhus University; University System of Ohio; Ohio State University; University of Birmingham	van Saders, JL (corresponding author), Carnegie Observ, 813 Santa Barbara St, Pasadena, CA 91101 USA.	jvansaders@obs.carnegiescience.edu; rafael.garcia@cea.fr	Mathur, Savita/AAA-3102-2019; Metcalfe, Travis/A-9388-2008	Garcia, Rafael A./0000-0002-8854-3776; Aguirre Borsen-Koch, Victor/0000-0002-6137-903X; Mathur, Savita/0000-0002-0129-0316; van Saders, Jennifer/0000-0002-4284-8638; Metcalfe, Travis/0000-0003-4034-0416	UK Science and Technology Facilities Council (STFC); NASA [NNX15AF13G]; National Science Foundation (NSF) [AST-1411685]; Centre National d'Etudes Spatiales (CNES) at the French Alternative Energies and Atomic Energy Commission (CEA); European Community [312844, 269194]; NSF [NSF PHY11-25915]; Danish National Research Foundation [DNRF106]; ASTERISK project - European Research Council [267864]; VILLUM FONDEN [10118]; Science and Technology Facilities Council [ST/M00077X/1] Funding Source: researchfish; Villum Fonden [00010118] Funding Source: researchfish; STFC [ST/M00077X/1] Funding Source: UKRI	UK Science and Technology Facilities Council (STFC)(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); NASA(National Aeronautics & Space Administration (NASA)); National Science Foundation (NSF)(National Science Foundation (NSF)National Research Foundation of Korea); Centre National d'Etudes Spatiales (CNES) at the French Alternative Energies and Atomic Energy Commission (CEA); European Community(European Commission); NSF(National Science Foundation (NSF)); Danish National Research Foundation(Danmarks Grundforskningsfond); ASTERISK project - European Research Council(European Research Council (ERC)); VILLUM FONDEN(Villum Fonden); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Villum Fonden(Villum Fonden); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	We wish to thank the Kavli Institute for Theoretical Physics and the organizers of the 'Galactic Archaeology and Precision Stellar Astrophysics' program held from January to April 2015. We thank B. Shappee for useful discussions. J.L.v.S. is a Carnegie-Princeton Fellow. T.S.M acknowledges the adopt-a-star crowdfunding program administered by White Dwarf Research Corp. G.R.D. acknowledges the support of the UK Science and Technology Facilities Council (STFC). M.H.P, T.S.M. and S.M. acknowledge support from NASA grant NNX15AF13G and National Science Foundation (NSF) grant AST-1411685. T.C. and R.A.G. received grants from the Centre National d'Etudes Spatiales (CNES) at the French Alternative Energies and Atomic Energy Commission (CEA). R.A.G. also acknowledges funding from the European Community Seventh Framework Programme (FP7/2007-2013) under grants 312844 (SPACEINN) and 269194 (IRSES/ASK). This research was supported in part by the NSF under grant NSF PHY11-25915. Funding for the Stellar Astrophysics Centre is provided by The Danish National Research Foundation (grant agreement DNRF106). This research is supported by the ASTERISK project (ASTERoseismic Investigations with SONG and Kepler) funded by the European Research Council (grant agreement 267864). V.S.A. acknowledges support from VILLUM FONDEN (research grant 10118).	Aguirre VS, 2015, MON NOT R ASTRON SOC, V452, P2127, DOI 10.1093/mnras/stv1388; An D, 2007, ASTROPHYS J, V655, P233, DOI 10.1086/509653; Angus R, 2015, MON NOT R ASTRON SOC, V450, P1787, DOI 10.1093/mnras/stv423; Barnes SA, 2010, ASTROPHYS J, V722, P222, DOI 10.1088/0004-637X/722/1/222; Brown TM, 2014, ASTROPHYS J, V789, DOI 10.1088/0004-637X/789/2/101; Ceillier T, 2016, MON NOT R ASTRON SOC, V456, P119, DOI 10.1093/mnras/stv2622; Chaplin WJ, 2011, ASTROPHYS J, V732, DOI 10.1088/0004-637X/732/1/54; Cohen O, 2009, ASTROPHYS J, V699, P1501, DOI 10.1088/0004-637X/699/2/1501; Davies GR, 2015, MON NOT R ASTRON SOC, V446, P2959, DOI 10.1093/mnras/stu2331; Durney B. R., 1978, Geophysical and Astrophysical Fluid Dynamics, V9, P241; Epstein CR, 2014, ASTROPHYS J, V780, DOI 10.1088/0004-637X/780/2/159; Garcia RA, 2014, ASTRON ASTROPHYS, V572, DOI 10.1051/0004-6361/201423888; Garraffo C, 2015, ASTROPHYS J LETT, V807, DOI 10.1088/2041-8205/807/1/L6; Hartman JD, 2009, ASTROPHYS J, V691, P342, DOI 10.1088/0004-637X/691/1/342; Holman MJ, 1999, ASTRON J, V117, P621, DOI 10.1086/300695; Jeffries MW, 2013, ASTRON J, V146, DOI 10.1088/0004-6256/146/3/58; KAWALER SD, 1988, ASTROPHYS J, V333, P236, DOI 10.1086/166740; Kovacs G, 2014, MON NOT R ASTRON SOC, V442, P2081, DOI 10.1093/mnras/stu946; Mathur S, 2012, ASTROPHYS J, V749, DOI 10.1088/0004-637X/749/2/152; Meibom S, 2015, NATURE, V517, P589, DOI 10.1038/nature14118; Meibom S, 2011, ASTROPHYS J LETT, V733, DOI 10.1088/2041-8205/733/1/L9; Metcalfe TS, 2014, ASTROPHYS J SUPPL S, V214, DOI 10.1088/0067-0049/214/2/27; Metcalfe TS, 2012, ASTROPHYS J LETT, V748, DOI 10.1088/2041-8205/748/1/L10; Morin J, 2011, MON NOT R ASTRON SOC, V418, pL133, DOI 10.1111/j.1745-3933.2011.01159.x; NOYES RW, 1984, ASTROPHYS J, V279, P763, DOI 10.1086/161945; Reville V, 2015, ASTROPHYS J, V798, DOI 10.1088/0004-637X/798/2/116; SKUMANICH A, 1972, ASTROPHYS J, V171, P565, DOI 10.1086/151310; van Saders JL, 2013, ASTROPHYS J, V776, DOI 10.1088/0004-637X/776/2/67; Yontan T, 2015, ASTROPHYS SPACE SCI, V355, P267, DOI 10.1007/s10509-014-2175-5	31	222	223	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 14	2016	529	7585					181	U117		10.1038/nature16168	http://dx.doi.org/10.1038/nature16168			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA7WK	26727162	Green Submitted			2022-12-28	WOS:000368015700030
J	Vo, TV; Das, J; Meyer, MJ; Cordero, NA; Akturk, N; Wei, XM; Fair, BJ; Degatano, AG; Fragoza, R; Liu, LG; Matsuyama, A; Trickey, M; Horibata, S; Grimson, A; Yamano, H; Yoshida, M; Roth, FP; Pleiss, JA; Xia, Y; Yu, HY				Vo, Tommy V.; Das, Jishnu; Meyer, Michael J.; Cordero, Nicolas A.; Akturk, Nurten; Wei, Xiaomu; Fair, Benjamin J.; Degatano, Andrew G.; Fragoza, Robert; Liu, Lisa G.; Matsuyama, Akihisa; Trickey, Michelle; Horibata, Sachi; Grimson, Andrew; Yamano, Hiroyuki; Yoshida, Minoru; Roth, Frederick P.; Pleiss, Jeffrey A.; Xia, Yu; Yu, Haiyuan			A Proteome-wide Fission Yeast Interactome Reveals Network Evolution Principles from Yeasts to Human	CELL			English	Article							GENOME DUPLICATION; STRESS-RESPONSE; SCHIZOSACCHAROMYCES-POMBE; SACCHAROMYCES-CEREVISIAE; GENE DUPLICATION; INTERACTION MAP; COMPLEXES; DROSOPHILA; PATHWAYS; FAMILIES	Here, we present FissionNet, a proteome-wide binary protein interactome for S. pombe, comprising 2,278 high-quality interactions, of which similar to 50% were previously not reported in any species. Fission-Net unravels previously unreported interactions implicated in processes such as gene silencing and pre-mRNA splicing. We developed a rigorous network comparison framework that accounts for assay sensitivity and specificity, revealing extensive species-specific network rewiring between fission yeast, budding yeast, and human. Surprisingly, although genes are better conserved between the yeasts, S. pombe interactions are significantly better conserved in human than in S. cerevisiae. Our framework also reveals that different modes of gene duplication influence the extent to which paralogous proteins are functionally repurposed. Finally, cross-species interactome mapping demonstrates that coevolution of interacting proteins is remarkably prevalent, a result with important implications for studying human disease in model organisms. Overall, FissionNet is a valuable resource for understanding protein functions and their evolution.	[Vo, Tommy V.; Das, Jishnu; Meyer, Michael J.; Fragoza, Robert; Yu, Haiyuan] Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY 14853 USA; [Vo, Tommy V.; Das, Jishnu; Meyer, Michael J.; Cordero, Nicolas A.; Akturk, Nurten; Wei, Xiaomu; Degatano, Andrew G.; Fragoza, Robert; Liu, Lisa G.; Yu, Haiyuan] Cornell Univ, Weill Inst Cell & Mol Biol, Ithaca, NY 14853 USA; [Vo, Tommy V.; Fair, Benjamin J.; Fragoza, Robert; Grimson, Andrew; Pleiss, Jeffrey A.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA; [Meyer, Michael J.] Triinst Training Program Computat Biol & Med, New York, NY 10065 USA; [Wei, Xiaomu] Weill Cornell Coll Med, Dept Med, New York, NY 10021 USA; [Matsuyama, Akihisa; Yoshida, Minoru] RIKEN, Ctr Sustainable Resource Ctr, Chem Genom Res Grp, Wako, Saitama 3510198, Japan; [Trickey, Michelle; Yamano, Hiroyuki] UCL, Inst Canc, London WC1E 6BT, England; [Horibata, Sachi] Cornell Univ, Baker Inst Anim Hlth, Dept Biomed Sci, Ithaca, NY 14853 USA; [Roth, Frederick P.; Xia, Yu] Dana Farber Canc Inst, Ctr Canc Syst Biol, Boston, MA 02215 USA; [Roth, Frederick P.; Xia, Yu] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02215 USA; [Roth, Frederick P.] Univ Toronto, Donnelly Ctr, Toronto, ON M5S 3E1, Canada; [Roth, Frederick P.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 3E1, Canada; [Roth, Frederick P.] Univ Toronto, Dept Comp Sci, Toronto, ON M5S 3E1, Canada; [Roth, Frederick P.] Canadian Inst Adv Res, Toronto, ON M5G 1Z8, Canada; [Roth, Frederick P.] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada; [Xia, Yu] McGill Univ, Fac Engn, Dept Bioengn, Montreal, PQ H3A 0C3, Canada	Cornell University; Cornell University; Cornell University; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; RIKEN; University of London; University College London; Cornell University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; University of Toronto; University of Toronto; University of Toronto; Canadian Institute for Advanced Research (CIFAR); University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; McGill University	Yu, HY (corresponding author), Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY 14853 USA.	haiyuan.yu@cornell.edu	Das, Jishnu/C-6924-2015; Xia, Yu/W-6150-2019; Das, Jishnu/AAK-4950-2020; Roth, Frederick P/H-6308-2011; Yoshida, Minoru/C-8049-2014; Horibata, Sachi/AAC-3204-2020; Matsuyama, Akihisa/P-7805-2016	Das, Jishnu/0000-0002-5747-064X; Xia, Yu/0000-0002-5596-5518; Das, Jishnu/0000-0002-5747-064X; Yoshida, Minoru/0000-0002-4376-5674; Horibata, Sachi/0000-0002-2629-7821; Matsuyama, Akihisa/0000-0002-6135-6276; Meyer, Michael/0000-0003-1587-5347; Fair, Benjamin/0000-0001-6296-5703	Marie Curie Cancer Care; Association for International Cancer Research; Cancer Research UK; NHGRI [HG001715, HG004233]; Krembil Foundation; Canada Excellence Research Chairs Program; Canada Research Chairs Program; NSERC [RGPIN-2014-03892]; NSF [CCF-1219007]; CFI [JELF-33732]; NIGMS [GM098634, GM097358, GM104424]; Direct For Computer & Info Scie & Enginr [1219007] Funding Source: National Science Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG001715, P50HG004233, U41HG001715, U01HG001715] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM105668, R01GM104424, R01GM097358, R01GM098634] Funding Source: NIH RePORTER; Cancer Research UK [13586] Funding Source: researchfish; Worldwide Cancer Research [09-0658] Funding Source: researchfish	Marie Curie Cancer Care; Association for International Cancer Research; Cancer Research UK(Cancer Research UK); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Krembil Foundation; Canada Excellence Research Chairs Program(Canada Research Chairs); Canada Research Chairs Program(Canada Research Chairs); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSF(National Science Foundation (NSF)); CFI(Canada Foundation for Innovation); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Cancer Research UK(Cancer Research UK); Worldwide Cancer Research	We thank D. Moazed for S. pombe strains provided for the analyses of centromeric silencing; S. Forsburg, H. Madhani, and J. Nakayama for providing plasmids for protein expression in S. pombe. We are grateful to M. Smolka for experimental advice; D. Barbash, A. Clark, S. Emr, S. Grewal, D. Lin, D. Shalloway, and members of the Yu lab for discussions. The accession number for the DNA microarray data reported in this paper is NCBI GEO: GSE74354. This work was supported by Marie Curie Cancer Care, Association for International Cancer Research, and Cancer Research UK to M.T. and H. Yamano; NHGRI grants HG001715 and HG004233, Krembil Foundation, and Canada Excellence Research Chairs Program to F.P.R.; Canada Research Chairs Program and grants NSERC RGPIN-2014-03892, NSF CCF-1219007, and CFI JELF-33732 to Y.X.; and NIGMS grants GM098634 to J.A.P. and GM097358 and GM104424 to H.Yu.	Arellano M, 1998, MOL MICROBIOL, V29, P1357, DOI 10.1046/j.1365-2958.1998.01009.x; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bader JS, 2004, NAT BIOTECHNOL, V22, P78, DOI 10.1038/nbt924; Blencowe BJ, 1998, GENE DEV, V12, P996, DOI 10.1101/gad.12.7.996; Braun P, 2011, SCIENCE, V333, P601, DOI 10.1126/science.1203877; Conant GC, 2006, PLOS BIOL, V4, P545, DOI 10.1371/journal.pbio.0040109; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Das J, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003350; Das J, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-92; Dennis MY, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.033; Fares MA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003176; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Fu WQ, 2013, NATURE, V493, P216, DOI 10.1038/nature11690; Gibson TA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000252; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Guan YF, 2007, GENETICS, V175, P933, DOI 10.1534/genetics.106.064329; Hakes L, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r209; He XL, 2005, GENETICS, V169, P1157, DOI 10.1534/genetics.104.037051; Hegele A, 2012, MOL CELL, V45, P567, DOI 10.1016/j.molcel.2011.12.034; Holoch D, 2015, NAT REV GENET, V16, P71, DOI 10.1038/nrg3863; Johnson AE, 2013, CURR BIOL, V23, P1920, DOI 10.1016/j.cub.2013.07.077; Kamada K, 2001, CELL, V106, P71, DOI 10.1016/S0092-8674(01)00417-2; Kasahara M, 2007, CURR OPIN IMMUNOL, V19, P547, DOI 10.1016/j.coi.2007.07.009; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; Matthews LR, 2001, GENOME RES, V11, P2120, DOI 10.1101/gr.205301; Motamedi MR, 2004, CELL, V119, P789, DOI 10.1016/j.cell.2004.11.034; Nepusz T, 2012, NAT METHODS, V9, P471, DOI [10.1038/nmeth.1938, 10.1038/NMETH.1938]; Papp B, 2003, NATURE, V424, P194, DOI 10.1038/nature01771; Pu SY, 2009, NUCLEIC ACIDS RES, V37, P825, DOI 10.1093/nar/gkn1005; Rensing SA, 2014, CURR OPIN PLANT BIOL, V17, P43, DOI 10.1016/j.pbi.2013.11.002; Riley R, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-r89; Roguev A, 2008, SCIENCE, V322, P405, DOI 10.1126/science.1162609; Rolland T, 2014, CELL, V159, P1212, DOI 10.1016/j.cell.2014.10.050; Sahni N, 2015, CELL, V161, P647, DOI 10.1016/j.cell.2015.04.013; Shiozaki K, 1996, GENE DEV, V10, P2276, DOI 10.1101/gad.10.18.2276; Sipiczki M, 2000, GENOME BIOL, V1, DOI [10.1186/gb-2000-1-2-reviews1011, DOI 10.1186/GB-2000-1-2-REVIEWS1011]; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Stenson PD, 2014, HUM GENET, V133, P1, DOI 10.1007/s00439-013-1358-4; Talavera D, 2015, MOL BIOL EVOL, V32, P2456, DOI 10.1093/molbev/msv109; Tardiff DF, 2013, SCIENCE, V342, P979, DOI 10.1126/science.1245321; Ting CT, 2004, P NATL ACAD SCI USA, V101, P12232, DOI 10.1073/pnas.0401975101; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Wang XJ, 2012, NAT BIOTECHNOL, V30, P159, DOI 10.1038/nbt.2106; Wei XM, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004819; Wood V, 2002, NATURE, V415, P871, DOI 10.1038/nature724; Woolcock KJ, 2012, GENE DEV, V26, P683, DOI 10.1101/gad.186866.112; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684; Yu HY, 2011, NAT METHODS, V8, P478, DOI [10.1038/NMETH.1597, 10.1038/nmeth.1597]	49	61	62	1	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 14	2016	164	1-2					310	323		10.1016/j.cell.2015.11.037	http://dx.doi.org/10.1016/j.cell.2015.11.037			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DB2LE	26771498	Bronze, Green Accepted			2022-12-28	WOS:000368339300029
J	Powers, BW; Milstein, A; Jain, SH				Powers, Brian W.; Milstein, Arnold; Jain, Sachin H.			Delivery Models for High-Risk Older Patients Back to the Future?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CARE; HOSPITALIZATION		[Powers, Brian W.] Harvard Univ, Sch Med, Boston, MA USA; [Powers, Brian W.] Harvard Univ, Sch Business, Boston, MA 02163 USA; [Powers, Brian W.; Jain, Sachin H.] CareMore Hlth Syst Anthem Inc, Cerritos, CA 90703 USA; [Milstein, Arnold; Jain, Sachin H.] Stanford Univ, Sch Med, Palo Alto, CA 94304 USA	Harvard University; Harvard Medical School; Harvard University; Stanford University	Jain, SH (corresponding author), CareMore Hlth Syst Anthem Inc, 12900 Pk Plaza Dr,Ste 150, Cerritos, CA 90703 USA.	sachin.jain@caremore.com						*CONGR BUDG OFF, 2005, HIGH COST MED BEN; Meltzer DO, 2014, HEALTH AFFAIR, V33, P770, DOI 10.1377/hlthaff.2014.0072; Naylor MD, 1999, JAMA-J AM MED ASSOC, V281, P613, DOI 10.1001/jama.281.7.613; Peikes D, 2009, JAMA-J AM MED ASSOC, V301, P603, DOI 10.1001/jama.2009.126; Powers BW, 2015, JAMA-J AM MED ASSOC, V313, P795, DOI 10.1001/jama.2014.18171; Wachter RM, 2002, JAMA-J AM MED ASSOC, V287, P487, DOI 10.1001/jama.287.4.487	6	15	15	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 5	2016	315	1					23	24		10.1001/jama.2015.17029	http://dx.doi.org/10.1001/jama.2015.17029			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DA0YH	26746451				2022-12-28	WOS:000367523000007
J	Robbins, TW				Robbins, Trevor W.			Illuminating anhedonia	SCIENCE			English	Editorial Material									[Robbins, Trevor W.] Univ Cambridge, Dept Psychol, Cambridge CB2 3EB, England; [Robbins, Trevor W.] Univ Cambridge, Behav & Clin Neurosci Inst, Cambridge CB2 3EB, England	University of Cambridge; University of Cambridge	Robbins, TW (corresponding author), Univ Cambridge, Dept Psychol, Cambridge CB2 3EB, England.	twr2@cam.ac.uk	Robbins, Trevor W/A-7551-2008	Robbins, Trevor/0000-0003-0642-5977	Medical Research Council [G1000183] Funding Source: Medline; Wellcome Trust [093875] Funding Source: Medline; Medical Research Council [G1000183B] Funding Source: researchfish; MRC [G1000183] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Ferenczi EA, 2016, SCIENCE, V351, DOI 10.1126/science.aac9698; Francois J, 2014, J NEUROSCI, V34, P596, DOI 10.1523/JNEUROSCI.2346-13.2014; Haber SN, 2010, NEUROPSYCHOPHARMACOL, V35, P4, DOI 10.1038/npp.2009.129; Harvey PO, 2007, MOL PSYCHIATR, V12, P767, DOI 10.1038/sj.mp.4002021; Harvey PO, 2010, J PSYCHIATR RES, V44, P707, DOI 10.1016/j.jpsychires.2009.12.008; Keedwell PA, 2005, BIOL PSYCHIAT, V58, P843, DOI 10.1016/j.biopsych.2005.05.019; Roiser JP, 2012, NEUROPSYCHOPHARMACOL, V37, P117, DOI 10.1038/npp.2011.183; Schott BH, 2008, J NEUROSCI, V28, P14311, DOI 10.1523/JNEUROSCI.2058-08.2008; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; Vidal-Gonzalez I, 2006, LEARN MEMORY, V13, P728, DOI 10.1101/lm.306106	10	7	7	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 1	2016	351	6268					24	25		10.1126/science.aad9698	http://dx.doi.org/10.1126/science.aad9698			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ8QM	26721987				2022-12-28	WOS:000367364200024
J	Edwards, N				Edwards, Nigel			THE BEST POLICY What to do about failing NHS organisations Give clinicians power to make continuous improvement	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Edwards, Nigel] Nuffield Trust, London, England		Edwards, N (corresponding author), Nuffield Trust, London, England.							Department of Health, 2013, FIN REP TRUST SPEC A; Ernst & Young, 2013, MIDST NHS FDN TRUST; West Norfold Clinical Commissioning Group, CONT PLANN TEAM CPT	3	0	0	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 31	2015	351								h6972	10.1136/bmj.h6972	http://dx.doi.org/10.1136/bmj.h6972			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DA4PA	26721626				2022-12-28	WOS:000367780700001
J	Johnson, MD; Fish, VL; Doeleman, SS; Marrone, DP; Plambeck, RL; Wardle, JFC; Akiyama, K; Asada, K; Beaudoin, C; Blackburn, L; Blundell, R; Bower, GC; Brinkerink, C; Broderick, AE; Cappallo, R; Chael, AA; Crew, GB; Dexter, J; Dexter, M; Freund, R; Friberg, P; Gold, R; Gurwell, MA; Ho, PTP; Honma, M; Inoue, M; Kosowsky, M; Krichbaum, TP; Lamb, J; Loeb, A; Lu, RS; MacMahon, D; McKinney, JC; Moran, JM; Narayan, R; Primiani, RA; Psaltis, D; Rogers, AEE; Rosenfeld, K; SooHoo, J; Tilanus, RPJ; Titus, M; Vertatschitsch, L; Weintroub, J; Wright, M; Young, KH; Zensus, JA; Ziurys, LM				Johnson, Michael D.; Fish, Vincent L.; Doeleman, Sheperd S.; Marrone, Daniel P.; Plambeck, Richard L.; Wardle, John F. C.; Akiyama, Kazunori; Asada, Keiichi; Beaudoin, Christopher; Blackburn, Lindy; Blundell, Ray; Bower, Geoffrey C.; Brinkerink, Christiaan; Broderick, Avery E.; Cappallo, Roger; Chael, Andrew A.; Crew, Geoffrey B.; Dexter, Jason; Dexter, Matt; Freund, Robert; Friberg, Per; Gold, Roman; Gurwell, Mark A.; Ho, Paul T. P.; Honma, Mareki; Inoue, Makoto; Kosowsky, Michael; Krichbaum, Thomas P.; Lamb, James; Loeb, Abraham; Lu, Ru-Sen; MacMahon, David; McKinney, Jonathan C.; Moran, James M.; Narayan, Ramesh; Primiani, Rurik A.; Psaltis, Dimitrios; Rogers, Alan E. E.; Rosenfeld, Katherine; SooHoo, Jason; Tilanus, Remo P. J.; Titus, Michael; Vertatschitsch, Laura; Weintroub, Jonathan; Wright, Melvyn; Young, Ken H.; Zensus, J. Anton; Ziurys, Lucy M.			Resolved magnetic-field structure and variability near the event horizon of Sagittarius A(star)	SCIENCE			English	Article							SGR-A-ASTERISK; SUPERMASSIVE BLACK-HOLE; ACCRETION FLOW MODELS; NEAR-INFRARED FLARES; GALACTIC-CENTER; CIRCULAR-POLARIZATION; LINEAR-POLARIZATION; STELLAR ORBITS; SIMULATIONS; POLARIMETRY	Near a black hole, differential rotation of a magnetized accretion disk is thought to produce an instability that amplifies weak magnetic fields, driving accretion and outflow. These magnetic fields would naturally give rise to the observed synchrotron emission in galaxy cores and to the formation of relativistic jets, but no observations to date have been able to resolve the expected horizon-scale magnetic-field structure. We report interferometric observations at 1.3-millimeter wavelength that spatially resolve the linearly polarized emission from the Galactic Center supermassive black hole, Sagittarius A*. We have found evidence for partially ordered magnetic fields near the event horizon, on scales of similar to 6 Schwarzschild radii, and we have detected and localized the intrahour variability associated with these fields.	[Johnson, Michael D.; Doeleman, Sheperd S.; Blackburn, Lindy; Blundell, Ray; Chael, Andrew A.; Gurwell, Mark A.; Kosowsky, Michael; Loeb, Abraham; Moran, James M.; Narayan, Ramesh; Primiani, Rurik A.; Rosenfeld, Katherine; Vertatschitsch, Laura; Weintroub, Jonathan; Young, Ken H.] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Fish, Vincent L.; Doeleman, Sheperd S.; Akiyama, Kazunori; Beaudoin, Christopher; Cappallo, Roger; Crew, Geoffrey B.; Kosowsky, Michael; Lu, Ru-Sen; Rogers, Alan E. E.; SooHoo, Jason; Titus, Michael] MIT, Haystack Observ, Westford, MA 01886 USA; [Marrone, Daniel P.; Freund, Robert; Psaltis, Dimitrios; Ziurys, Lucy M.] Univ Arizona, Steward Observ, Tucson, AZ 85721 USA; [Plambeck, Richard L.; Dexter, Matt; MacMahon, David; Wright, Melvyn] Univ Calif Berkeley, Dept Astron, Radio Astron Lab, Berkeley, CA 94720 USA; [Wardle, John F. C.; Kosowsky, Michael] Brandeis Univ, Dept Phys MS 057, Waltham, MA 02454 USA; [Akiyama, Kazunori; Honma, Mareki] Natl Astron Observ Japan, Mitaka, Tokyo 1818588, Japan; [Akiyama, Kazunori] Univ Tokyo, Grad Sch Sci, Dept Astron, Bunkyo Ku, Tokyo 1130033, Japan; [Asada, Keiichi; Ho, Paul T. P.; Inoue, Makoto] Acad Sinica, Inst Astron & Astrophys, Taipei 10617, Taiwan; [Bower, Geoffrey C.] ASIAA, Hilo, HI 96720 USA; [Brinkerink, Christiaan; Tilanus, Remo P. J.] Radboud Univ Nijmegen, Inst Math Astrophys & Particle Phys, Dept Astrophys, NL-6500 GL Nijmegen, Netherlands; [Broderick, Avery E.] Perimeter Inst Theoret Phys, Waterloo, ON N2L 2Y5, Canada; [Broderick, Avery E.] Univ Waterloo, Dept Phys & Astron, Waterloo, ON N2L 3G1, Canada; [Dexter, Jason] Max Planck Inst Extraterr Phys, D-85748 Garching, Germany; [Friberg, Per] James Clerk Maxwell Telescope, East Asia Observ, Hilo, HI 96720 USA; [Gold, Roman; Weintroub, Jonathan] Univ Maryland, Dept Phys, Joint Space Sci Inst, College Pk, MD 20742 USA; [Honma, Mareki] Grad Univ Adv Studies, Mitaka, Tokyo 1818588, Japan; [Krichbaum, Thomas P.; Lu, Ru-Sen; Zensus, J. Anton] Max Planck Inst Radioastron, D-53121 Bonn, Germany; [Lamb, James] CALTECH, Owens Valley Radio Observ, Big Pine, CA 93513 USA; [Tilanus, Remo P. J.] Leiden Univ, Leiden Observ, NL-2300 RA Leiden, Netherlands	Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; Massachusetts Institute of Technology (MIT); University of Arizona; University of California System; University of California Berkeley; Brandeis University; National Institutes of Natural Sciences (NINS) - Japan; National Astronomical Observatory of Japan (NAOJ); University of Tokyo; Academia Sinica - Taiwan; Academia Sinica - Taiwan; Radboud University Nijmegen; Perimeter Institute for Theoretical Physics; University of Waterloo; Max Planck Society; University System of Maryland; University of Maryland College Park; Graduate University for Advanced Studies - Japan; Max Planck Society; California Institute of Technology; Leiden University; Leiden University - Excl LUMC	Johnson, MD (corresponding author), Harvard Smithsonian Ctr Astrophys, 60 Garden St, Cambridge, MA 02138 USA.	mjohnson@cfa.harvard.edu	浅田圭一, Keiichi ASADA/ABC-2456-2020; Gold, Roman/AAX-5851-2021; Ho, Paul/AAZ-5108-2020; Bower, Geoffrey/ABC-8386-2020; Lamb, James/AAY-1701-2021	浅田圭一, Keiichi ASADA/0000-0001-6988-8763; Gold, Roman/0000-0003-2492-1966; Ho, Paul/0000-0002-3412-4306; Bower, Geoffrey/0000-0003-4056-9982; Chael, Andrew/0000-0003-2966-6220; Moran, James/0000-0002-3882-4414; SooHoo, Jason/0000-0003-1938-0720; Krichbaum, T. P./0000-0002-4892-9586; Zensus, J. Anton/0000-0001-7470-3321; Crew, Geoffrey/0000-0002-2079-3189; Gurwell, Mark/0000-0003-0685-3621; Dexter, Jason/0000-0003-3903-0373; Akiyama, Kazunori/0000-0002-9475-4254; Fish, Vincent/0000-0002-7128-9345; Johnson, Michael/0000-0002-4120-3029	NSF; NASA; Gordon and Betty Moore Foundation; NSF University Radio Observatories program; CARMA; Perimeter Institute for Theoretical Physics; Natural Sciences and Engineering Research Council of Canada; Government of Canada through Industry Canada; Province of Ontario through the Ministry of Research and Innovation; Sofja Kovalevskaja award from the Alexander von Humboldt Foundation; Japan Society for the Promotion of Science; Netherlands Organisation for Scientific Research; Direct For Mathematical & Physical Scien [1310896, 1207752, 1126433] Funding Source: National Science Foundation; Division Of Astronomical Sciences [1337663, 1312034] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); NASA(National Aeronautics & Space Administration (NASA)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); NSF University Radio Observatories program(National Science Foundation (NSF)); CARMA; Perimeter Institute for Theoretical Physics; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Government of Canada through Industry Canada; Province of Ontario through the Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario); Sofja Kovalevskaja award from the Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Division Of Astronomical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	EHT research is funded by multiple grants from NSF, by NASA, and by the Gordon and Betty Moore Foundation through a grant to S.D. The SMA is a joint project between the Smithsonian Astrophysical Observatory and the Academia Sinica Institute of Astronomy and Astrophysics. The Arizona Radio Observatory is partially supported through the NSF University Radio Observatories program. The James Clerk Maxwell Telescope was operated by the Joint Astronomy Centre on behalf of the Science and Technology Facilities Council of the UK, the Netherlands Organisation for Scientific Research, and the National Research Council of Canada. Funding for CARMA development and operations was supported by NSF and the CARMA partner universities. We thank Xilinx for equipment donations. A.E.B. receives financial support from the Perimeter Institute for Theoretical Physics and the Natural Sciences and Engineering Research Council of Canada through a Discovery Grant. Research at Perimeter Institute is supported by the Government of Canada through Industry Canada and by the Province of Ontario through the Ministry of Research and Innovation. J.D. receives support from a Sofja Kovalevskaja award from the Alexander von Humboldt Foundation. M.H. was supported by a Japan Society for the Promotion of Science Grant-in-aid. R.P.J.T. receives support from Netherlands Organisation for Scientific Research. Data used in this paper are available in the supplementary materials.	BALBUS SA, 1991, ASTROPHYS J, V376, P214, DOI 10.1086/170270; Bower GC, 1999, ASTROPHYS J, V527, P851, DOI 10.1086/308128; Bower GC, 2005, ASTROPHYS J, V618, pL29, DOI 10.1086/427498; Bower GC, 2002, ASTROPHYS J, V571, P843, DOI 10.1086/340064; Bower GC, 2015, ASTROPHYS J, V802, DOI 10.1088/0004-637X/802/1/69; Broderick AE, 2006, MON NOT R ASTRON SOC, V367, P905, DOI 10.1111/j.1365-2966.2006.10152.x; Bromley BC, 2001, ASTROPHYS J, V555, pL83, DOI 10.1086/322862; Chan CK, 2015, ASTROPHYS J, V799, DOI 10.1088/0004-637X/799/1/1; Dexter J, 2010, ASTROPHYS J, V717, P1092, DOI 10.1088/0004-637X/717/2/1092; Doeleman SS, 2008, NATURE, V455, P78, DOI 10.1038/nature07245; Eckart A, 2006, ASTRON ASTROPHYS, V455, P1, DOI 10.1051/0004-6361:20064948; Fish VL, 2014, ASTROPHYS J, V795, DOI 10.1088/0004-637X/795/2/134; Fish VL, 2011, ASTROPHYS J LETT, V727, DOI 10.1088/2041-8205/727/2/L36; Ghez AM, 2008, ASTROPHYS J, V689, P1044, DOI 10.1086/592738; Gillessen S, 2009, ASTROPHYS J, V692, P1075, DOI 10.1088/0004-637X/692/2/1075; Hirose S, 2004, ASTROPHYS J, V606, P1083, DOI 10.1086/383184; Johnson MD, 2014, ASTROPHYS J, V794, DOI 10.1088/0004-637X/794/2/150; JONES TW, 1979, ASTROPHYS J, V228, P268, DOI 10.1086/156843; Jorstad SG, 2005, ASTRON J, V130, P1418, DOI 10.1086/444593; Markoff S, 2007, MON NOT R ASTRON SOC, V379, P1519, DOI 10.1111/j.1365-2966.2007.12071.x; Marrone DP, 2007, ASTROPHYS J, V654, pL57, DOI 10.1086/510850; Marti-Vidal I, 2015, SCIENCE, V348, P311, DOI 10.1126/science.aaa1784; McKinney JC, 2012, MON NOT R ASTRON SOC, V423, P3083, DOI 10.1111/j.1365-2966.2012.21074.x; Mocz P, 2015, MON NOT R ASTRON SOC, V447, P1498, DOI 10.1093/mnras/stu2555; Moscibrodzka M, 2013, ASTRON ASTROPHYS, V559, DOI 10.1051/0004-6361/201322692; Munoz DJ, 2012, ASTROPHYS J, V745, DOI 10.1088/0004-637X/745/2/115; Narayan R, 2003, PUBL ASTRON SOC JPN, V55, pL69, DOI 10.1093/pasj/55.6.L69; Ozel F, 2000, ASTROPHYS J, V541, P234, DOI 10.1086/309396; Shcherbakov RV, 2013, ASTROPHYS J LETT, V774, DOI 10.1088/2041-8205/774/2/L22; Yuan F, 2003, ASTROPHYS J, V598, P301, DOI 10.1086/378716; Yuan F, 2002, ASTRON ASTROPHYS, V383, P854, DOI 10.1051/0004-6361:20011709; Yuan F, 2014, ANNU REV ASTRON ASTR, V52, P529, DOI 10.1146/annurev-astro-082812-141003; Zamaninasab M, 2014, NATURE, V510, P126, DOI 10.1038/nature13399; Zamaninasab M, 2010, ASTRON ASTROPHYS, V510, DOI 10.1051/0004-6361/200912473	34	150	150	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 4	2015	350	6265					1242	1245		10.1126/science.aac7087	http://dx.doi.org/10.1126/science.aac7087			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX4WG	26785487	Green Submitted			2022-12-28	WOS:000365700500074
J	Kaphan, DM; Levin, MD; Bergman, RG; Raymond, KN; Toste, FD				Kaphan, David M.; Levin, Mark D.; Bergman, Robert G.; Raymond, Kenneth N.; Toste, F. Dean			A supramolecular microenvironment strategy for transition metal catalysis	SCIENCE			English	Article							REDUCTIVE ELIMINATION; DIELS-ALDER; COMPLEXES; HOST; CYCLIZATION; ACCELERATION; ACTIVATION	A self-assembled supramolecular complex is reported to catalyze alkyl-alkyl reductive elimination from high-valent transition metal complexes [such as gold(III) and platinum(IV)], the central bond-forming elementary step in many catalytic processes. The catalytic microenvironment of the supramolecular assembly acts as a functional enzyme mimic, applying the concepts of enzymatic catalysis to a reactivity manifold not represented in biology. Kinetic experiments delineate a Michaelis-Menten-type mechanism, with measured rate accelerations (k(cat)/k(uncat)) upto 1.9x10(7) (here k(cat) and k(uncat) are the Michaelis-Menten enzymatic rate constant and observed uncatalyzed rate constant, respectively). This modality has further been incorporated into a dual catalytic cross-coupling reaction, which requires both the supramolecular microenvironment catalyst and the transition metal catalyst operating in concert to achieve efficient turnover.	[Kaphan, David M.; Bergman, Robert G.; Raymond, Kenneth N.; Toste, F. Dean] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Chem Sci, Berkeley, CA 94720 USA; [Kaphan, David M.; Levin, Mark D.; Bergman, Robert G.; Raymond, Kenneth N.; Toste, F. Dean] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Bergman, RG (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Chem Sci, Berkeley, CA 94720 USA.	rbergman@berkeley.edu; raymond@socrates.berkeley.edu; fdtoste@berkeley.edu	Toste, F. Dean/Y-2556-2019	Toste, F. Dean/0000-0001-8018-2198; Levin, Mark/0000-0002-4461-363X	Division of Chemical Sciences, Geosciences, and Biosciences of the U.S. Department of Energy at Lawrence Berkeley National Laboratory [DE-AC02-05CH11231]; NIH National Institute of General Medical Sciences [R01 GM073932]; NSF Graduate Research Fellowship Program (GRFP) [DGE 1106400]; ARCS Foundation; NSF GRFP; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073932] Funding Source: NIH RePORTER	Division of Chemical Sciences, Geosciences, and Biosciences of the U.S. Department of Energy at Lawrence Berkeley National Laboratory(United States Department of Energy (DOE)); NIH National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NSF Graduate Research Fellowship Program (GRFP)(National Science Foundation (NSF)NSF - Office of the Director (OD)); ARCS Foundation; NSF GRFP(National Science Foundation (NSF)NSF - Office of the Director (OD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the Director, Office of Science, Office of Basic Energy Sciences and the Division of Chemical Sciences, Geosciences, and Biosciences of the U.S. Department of Energy at Lawrence Berkeley National Laboratory (grant DE-AC02-05CH11231) and NIH National Institute of General Medical Sciences (grant R01 GM073932). D.M.K. was supported by an NSF Graduate Research Fellowship Program (GRFP) (grant DGE 1106400), and M.D.L. was supported by the ARCS Foundation and an NSF GRFP. We thank J. N. Brantley and M. S. Winston for helpful discussions and C. G. Canlas for assistance with NMR experiments.	Allen AE, 2012, CHEM SCI, V3, P633, DOI 10.1039/c2sc00907b; Blackmond DG, 2005, ANGEW CHEM INT EDIT, V44, P4302, DOI 10.1002/anie.200462544; Brown CJ, 2015, CHEM REV, V115, P3012, DOI 10.1021/cr4001226; COLLMAN JP, 1978, J AM CHEM SOC, V100, P4766, DOI 10.1021/ja00483a022; Fiedler D, 2006, ANGEW CHEM INT EDIT, V45, P745, DOI 10.1002/anie.200501938; GOLDBERG KI, 1994, J AM CHEM SOC, V116, P1573, DOI 10.1021/ja00083a054; Hart-Cooper WM, 2012, J AM CHEM SOC, V134, P17873, DOI 10.1021/ja308254k; Hartwig J. F., 2010, ORGANOTRANSITION MET, P321; Hastings CJ, 2010, J AM CHEM SOC, V132, P6938, DOI 10.1021/ja102633e; Hazari A, 2012, ANGEW CHEM INT EDIT, V51, P8268, DOI 10.1002/anie.201203264; Jana R, 2011, CHEM REV, V111, P1417, DOI 10.1021/cr100327p; Kang JM, 1997, NATURE, V385, P50, DOI 10.1038/385050a0; KOMIYA S, 1976, J AM CHEM SOC, V98, P7599, DOI 10.1021/ja00440a025; LAU W, 1982, ORGANOMETALLICS, V1, P155, DOI 10.1021/om00061a027; Lavallo V, 2009, SCIENCE, V326, P559, DOI 10.1126/science.1178919; LawrenceKuch P., 1976, J ORGANOMET CHEM, V122, P429; Liberman-Martin AL, 2013, J AM CHEM SOC, V135, P9612, DOI 10.1021/ja404339u; Meeuwissen J, 2010, NAT CHEM, V2, P615, DOI [10.1038/nchem.744, 10.1038/NCHEM.744]; Merlau ML, 2001, ANGEW CHEM INT EDIT, V40, P4239, DOI 10.1002/1521-3773(20011119)40:22<4239::AID-ANIE4239>3.0.CO;2-E; PAULING L, 1948, NATURE, V161, P707, DOI 10.1038/161707a0; Pluth MD, 2007, SCIENCE, V316, P85, DOI 10.1126/science.1138748; Schuster O, 2006, Z NATURFORSCH B, V61, P1; Seechurn CCCJ, 2012, ANGEW CHEM INT EDIT, V51, P5062, DOI 10.1002/anie.201107017; Shen QL, 2007, J AM CHEM SOC, V129, P7734, DOI 10.1021/ja0722473; Silverman R. B., 2002, ORGANIC CHEM ENZYME, P15; Takemoto S, 2013, J AM CHEM SOC, V135, P16837, DOI 10.1021/ja409533s; Wang ZJ, 2011, J AM CHEM SOC, V133, P7358, DOI 10.1021/ja202055v; YAMAMOTO T, 1971, J AM CHEM SOC, V93, P3350, DOI 10.1021/ja00743a009; Yoshizawa M, 2006, SCIENCE, V312, P251, DOI 10.1126/science.1124985; Zhang Q, 2015, NAT CHEM, V7, P197, DOI [10.1038/NCHEM.2181, 10.1038/nchem.2181]; Zhao C, 2013, J AM CHEM SOC, V135, P18802, DOI 10.1021/ja411631v	31	293	292	19	323	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 4	2015	350	6265					1235	1238		10.1126/science.aad3087	http://dx.doi.org/10.1126/science.aad3087			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX4WG	26785485				2022-12-28	WOS:000365700500072
J	Laanisto, L; Hutchings, MJ				Laanisto, Lauri; Hutchings, Michael J.			Comment on "Worldwide evidence of a unimodal relationship between productivity and plant species richness"	SCIENCE			English	Editorial Material							DIVERSITY	Fraser et al. (Reports, 17 July 2015, p. 302) report that a hump-backed model describes the worldwide relationship between productivity and plant species richness in grassland communities. We reanalyze their data from a larger-scale perspective, using local species pool. This influences richness far more strongly than productivity, and, when this is taken into account, the hump- backed richness-productivity relationship disappears.	[Laanisto, Lauri] Estonian Univ Life Sci, Inst Agr & Environm Sci, EE-51014 Tartu, Estonia; [Hutchings, Michael J.] Univ Sussex, Sch Life Sci, Brighton BN1 9QG, Sussex, England	Estonian University of Life Sciences; University of Sussex	Laanisto, L (corresponding author), Estonian Univ Life Sci, Inst Agr & Environm Sci, Kreutzwaldi 5, EE-51014 Tartu, Estonia.	laanisto@ut.ee	Laanisto, Lauri/H-2202-2012	Laanisto, Lauri/0000-0003-2215-7298				Adler PB, 2011, SCIENCE, V333, P1750, DOI 10.1126/science.1204498; [Anonymous], 2015, DRYAD DIGITAL REPOSI; Cornell HV, 2014, ANNU REV ECOL EVOL S, V45, P45, DOI 10.1146/annurev-ecolsys-120213-091759; Fraser LH, 2015, SCIENCE, V349, P302, DOI 10.1126/science.aab3916; Fraser LH, 2014, J VEG SCI, V25, P1160, DOI 10.1111/jvs.12167; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; HUSTON M, 1979, AM NAT, V113, P81, DOI 10.1086/283366; Laanisto L, 2008, GLOBAL ECOL BIOGEOGR, V17, P320, DOI 10.1111/j.1466-8238.2007.00375.x; Lawton JH, 1999, OIKOS, V84, P177, DOI 10.2307/3546712; Pan XB, 2012, SCIENCE, V335, DOI [10.1126/science.1214786, 10.1126/science.1215042]; Partel M, 2007, ECOLOGY, V88, P1091, DOI 10.1890/06-0997; Plutynski, 2008, OXFORD HDB PHILOS BI, P504; Waide RB, 1999, ANNU REV ECOL SYST, V30, P257, DOI 10.1146/annurev.ecolsys.30.1.257; Zobel M, 2008, GLOBAL ECOL BIOGEOGR, V17, P679, DOI 10.1111/j.1466-8238.2008.00400.x; Zobel M, 2016, J VEG SCI, V27, P8, DOI 10.1111/jvs.12333	15	4	4	4	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 4	2015	350	6265								10.1126/science.aad4836	http://dx.doi.org/10.1126/science.aad4836			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX4WG	26785470				2022-12-28	WOS:000365700500056
J	O'Brien, K				O'Brien, Karen			Political agency: The key to tackling climate change	SCIENCE			English	Editorial Material									[O'Brien, Karen] Univ Oslo, Dept Sociol & Human Geog, N-0317 Oslo, Norway	University of Oslo	O'Brien, K (corresponding author), Univ Oslo, Dept Sociol & Human Geog, N-0317 Oslo, Norway.	karen.obrien@sosgeo.uio.no						Ehrhardt-Martinez Karen, 2015, CLIMATE CHANGE SOC S, P93; El Khoury A, 2015, GLOBALIZATION DEV SO; Fowler JH, 2010, P NATL ACAD SCI USA, V107, P5334, DOI 10.1073/pnas.0913149107; Geels FW, 2015, GLOBAL ENVIRON CHANG, V34, P1, DOI 10.1016/j.gloenvcha.2015.04.013; Maiguashca B., 2013, CONT POLITICAL AGENC; Neeff T, 2013, ENVIRON SCI POLICY, V31, P157, DOI 10.1016/j.envsci.2013.04.001; O'Brien K., 2015, ADAPTIVE CHALLENGE C, P1, DOI [10.1017/cbo9781139149389.002, DOI 10.1017/CBO9781139149389.002, 10.1017/CBO9781139149389.002]; Pew Research Center, 2015, GLOB CLIM CHANG BROA; Redclift MR, 2011, CLIMATE CHANGE AND HUMAN SECURITY: THE CHALLENGE TO LOCAL GOVERNANCE UNDER RAPID COASTAL URBANIZATION, P1; Schlitz MM, 2010, J CONSCIOUSNESS STUD, V17, P18; Shove E., 2012, CONT SOC SCI, V6, P2158; Westley FR, 2013, ECOL SOC, V18, DOI 10.5751/ES-05072-180327; Xie J, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.011130	13	57	57	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 4	2015	350	6265					1170	1171		10.1126/science.aad0267	http://dx.doi.org/10.1126/science.aad0267			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CX4WG	26785460				2022-12-28	WOS:000365700500046
J	Runge, CA; Watson, JEM; Butchart, SHM; Hanson, JO; Possingham, HP; Fuller, RA				Runge, Claire A.; Watson, James E. M.; Butchart, Stuart H. M.; Hanson, Jeffrey O.; Possingham, Hugh P.; Fuller, Richard A.			Protected areas and global conservation of migratory birds	SCIENCE			English	Article								Migratory species depend on a suite of interconnected sites. Threats to unprotected links in these chains of sites are driving rapid population declines of migrants around the world, yet the extent to which different parts of the annual cycle are protected remains unknown. We show that just 9% of 1451 migratory birds are adequately covered by protected areas across all stages of their annual cycle, in comparison with 45% of nonmigratory birds. This discrepancy is driven by protected area placement that does not cover the full annual cycle of migratory species, indicating that global efforts toward coordinated conservation planning for migrants are yet to bear fruit. Better-targeted investment and enhanced coordination among countries are needed to conserve migratory species throughout their migratory cycle.	[Runge, Claire A.; Watson, James E. M.] Univ Queensland, Sch Geog Planning & Environm Management, Brisbane, Qld 4072, Australia; [Runge, Claire A.] Univ Calif Santa Barbara, Natl Ctr Ecol Anal & Synth NCEAS, Santa Barbara, CA 93101 USA; [Watson, James E. M.] Wildlife Conservat Soc, Global Conservat Program, New York, NY USA; [Butchart, Stuart H. M.] BirdLife Int, Cambridge CB3 0NA, England; [Hanson, Jeffrey O.; Possingham, Hugh P.; Fuller, Richard A.] Univ Queensland, Sch Biol Sci, Brisbane, Qld 4072, Australia; [Possingham, Hugh P.] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, Ascot SL5 7PY, Berks, England	University of Queensland; National Center for Ecological Analysis & Synthesis; University of California System; University of California Santa Barbara; Wildlife Conservation Society; BirdLife International; University of Queensland; Imperial College London	Runge, CA (corresponding author), Univ Queensland, Sch Geog Planning & Environm Management, Brisbane, Qld 4072, Australia.	claire.runge@uqconnect.edu.au	Runge, Claire/Q-2110-2018; Hanson, Jeffrey O/O-4536-2015; Butchart, Stuart HM/Y-2711-2018; Watson, James Edward Maxwell/D-8779-2013; POSSINGHAM, HUGH/R-8310-2019; Possingham, Hugh/B-1337-2008; Butchart, Stuart/AAJ-1852-2021; Fuller, Richard/B-7971-2008	Runge, Claire/0000-0003-3913-8560; Hanson, Jeffrey O/0000-0002-4716-6134; Watson, James Edward Maxwell/0000-0003-4942-1984; POSSINGHAM, HUGH/0000-0001-7755-996X; Possingham, Hugh/0000-0001-7755-996X; Butchart, Stuart/0000-0002-1140-4049; Fuller, Richard/0000-0001-9468-9678	Australian Government's National Environmental Research Program; Australian Postgraduate Awards; Australian Research Council Centre of Excellence for Environmental Decisions scholarship; Australian Research Council [LP150101059, DP140100733]	Australian Government's National Environmental Research Program(Australian Government); Australian Postgraduate Awards(Australian Government); Australian Research Council Centre of Excellence for Environmental Decisions scholarship(Australian Research Council); Australian Research Council(Australian Research Council)	This work was supported by the Australian Government's National Environmental Research Program, Australian Postgraduate Awards to C.A.R. and J.O.H., and an Australian Research Council Centre of Excellence for Environmental Decisions scholarship to C.A.R. The work was further supported by Australian Research Council Linkage Grant LP150101059 to R.A.F and Discovery Grant DP140100733 to J.E.M.W. We thank V. Jones for comment and discussion and all contributors to BirdLife's International Union for Conservation of Nature Red List assessments. Data describing protected area coverage are available in the supplementary materials databases S1 to S3. C.A.R., R.A.F., and H.P.P. designed the study. C.A.R. analyzed data, created figures, and wrote the manuscript. J.O.H. prepared and analyzed data. All authors discussed the results and edited the manuscript.	[Anonymous], 2010, 10 M C PART CONV BIO; Battley PF, 2012, J AVIAN BIOL, V43, P21, DOI 10.1111/j.1600-048X.2011.05473.x; Bauer S, 2014, SCIENCE, V344, P54, DOI 10.1126/science.1242552; BirdLife International, IUCN RED LIST BIRDS; BirdLife International, 2014, IMP BIRD BIOD AR GLO; Boyd C, 2008, CONSERV LETT, V1, P37, DOI 10.1111/j.1755-263X.2008.00002.x; Butchart SHM, 2015, CONSERV LETT, V8, P329, DOI 10.1111/conl.12158; Convention on the Conservation of Migratory Species of Wild Animals, 2014, UNEPCMSCO911DOC2314; Egevang C, 2010, P NATL ACAD SCI USA, V107, P2078, DOI 10.1073/pnas.0909493107; IUCN UNEP-WCMC, WORLD DAT PROT AR WD; Jones T., 2010, REV CMS NONCMS EXIST; Kirby J. S., 2008, BIRD CONSERV INT S1, V18; Marini MA, 2010, BIOL CONSERV, V143, P102, DOI 10.1016/j.biocon.2009.09.009; Runge CA, 2014, FRONT ECOL ENVIRON, V12, P395, DOI 10.1890/130237; Thompson D'AW., 1910, ARISTOTLE HIST ANIMA; Tulloch VJD, 2015, FRONT ECOL ENVIRON, V13, P91, DOI 10.1890/140022; Venter O, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001891; Watson JEM, 2014, NATURE, V515, P67, DOI 10.1038/nature13947; Watson JEM, 2011, CONSERV BIOL, V25, P324, DOI 10.1111/j.1523-1739.2010.01587.x; White G., 1789, NATURAL HIST ANTIQUI; Wilcove D.S., 2010, NO WAY HOME DECLINE	21	184	193	6	114	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 4	2015	350	6265					1255	1258		10.1126/science.aac9180	http://dx.doi.org/10.1126/science.aac9180			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX4WG	26785490				2022-12-28	WOS:000365700500078
J	Soucie, EL; Weng, ZM; Geirsdottir, L; Molawi, K; Maurizio, J; Fenouil, R; Mossadegh-Keller, N; Gimenez, G; VanHille, L; Beniazza, M; Favret, J; Berruyer, C; Perrin, P; Hacohen, N; Andrau, JC; Ferrier, P; Dubreuil, P; Sidow, A; Sieweke, MH				Soucie, Erinn L.; Weng, Ziming; Geirsdottir, Laufey; Molawi, Kaaweh; Maurizio, Julien; Fenouil, Romain; Mossadegh-Keller, Noushine; Gimenez, Gregory; VanHille, Laurent; Beniazza, Meryam; Favret, Jeremy; Berruyer, Carole; Perrin, Pierre; Hacohen, Nir; Andrau, J. -C.; Ferrier, Pierre; Dubreuil, Patrice; Sidow, Arend; Sieweke, Michael H.			Lineage-specific enhancers activate self-renewal genes in macrophages and embryonic stem cells	SCIENCE			English	Article							TISSUE-RESIDENT MACROPHAGES; RNA INTERFERENCE; IDENTITY; TRANSCRIPTION; EXPRESSION; SCREEN; FATE; INFLAMMATION; PROLIFERATE; MONOCYTES	Differentiated macrophages can self-renew in tissues and expand long term in culture, but the gene regulatory mechanisms that accomplish self-renewal in the differentiated state have remained unknown. Here we show that in mice, the transcription factors MafB and c-Maf repress a macrophage-specific enhancer repertoire associated with a gene network that controls self-renewal. Single-cell analysis revealed that, in vivo, proliferating resident macrophages can access this network by transient down-regulation of Maf transcription factors. The network also controls embryonic stem cell self-renewal but is associated with distinct embryonic stem cell-specific enhancers. This indicates that distinct lineage-specific enhancer platforms regulate a shared network of genes that control self-renewal potential in both stem and mature cells.	[Soucie, Erinn L.; Geirsdottir, Laufey; Molawi, Kaaweh; Maurizio, Julien; Fenouil, Romain; Mossadegh-Keller, Noushine; Gimenez, Gregory; VanHille, Laurent; Beniazza, Meryam; Favret, Jeremy; Berruyer, Carole; Perrin, Pierre; Andrau, J. -C.; Ferrier, Pierre; Sieweke, Michael H.] Univ Aix Marseille, Ctr Immunol Marseille Luminy, UM2, Campus Luminy,Case 906, F-13288 Marseille 09, France; [Soucie, Erinn L.; Geirsdottir, Laufey; Molawi, Kaaweh; Maurizio, Julien; Fenouil, Romain; Mossadegh-Keller, Noushine; Gimenez, Gregory; VanHille, Laurent; Beniazza, Meryam; Favret, Jeremy; Berruyer, Carole; Perrin, Pierre; Andrau, J. -C.; Ferrier, Pierre; Sieweke, Michael H.] INSERM, U1104, F-13258 Marseille, France; [Soucie, Erinn L.; Geirsdottir, Laufey; Molawi, Kaaweh; Maurizio, Julien; Fenouil, Romain; Mossadegh-Keller, Noushine; Gimenez, Gregory; VanHille, Laurent; Beniazza, Meryam; Favret, Jeremy; Berruyer, Carole; Perrin, Pierre; Andrau, J. -C.; Ferrier, Pierre; Sieweke, Michael H.] CNRS, UMR 7280, Marseille, France; [Soucie, Erinn L.; Dubreuil, Patrice] Univ Aix Marseille, INSERM, U1068, Ctr Rech Cancerol Marseille,CNRS,U7258,UM105, Marseille, France; [Weng, Ziming; Sidow, Arend] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; [Molawi, Kaaweh; Sieweke, Michael H.] Max Delbruck Ctr Mol Med Helmholtz Gemeinschaft, 10 Robert Rossle Str, D-13125 Berlin, Germany; [Hacohen, Nir] Broad Inst Harvard Univ & MIT, Cambridge, MA 02142 USA; [Andrau, J. -C.] CNRS, UMR 5535, Inst Genet Mol Montpellier, 1919 Route Mende, F-34293 Montpellier, France; [Sidow, Arend] Stanford Univ, Dept Genet, Stanford, CA 94305 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Stanford University; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Stanford University	Soucie, EL; Sieweke, MH (corresponding author), Univ Aix Marseille, Ctr Immunol Marseille Luminy, UM2, Campus Luminy,Case 906, F-13288 Marseille 09, France.; Soucie, EL; Sieweke, MH (corresponding author), INSERM, U1104, F-13258 Marseille, France.; Soucie, EL; Sieweke, MH (corresponding author), CNRS, UMR 7280, Marseille, France.; Soucie, EL (corresponding author), Univ Aix Marseille, INSERM, U1068, Ctr Rech Cancerol Marseille,CNRS,U7258,UM105, Marseille, France.; Sidow, A (corresponding author), Stanford Univ, Dept Pathol, Stanford, CA 94305 USA.; Sieweke, MH (corresponding author), Max Delbruck Ctr Mol Med Helmholtz Gemeinschaft, 10 Robert Rossle Str, D-13125 Berlin, Germany.; Sidow, A (corresponding author), Stanford Univ, Dept Genet, Stanford, CA 94305 USA.	erinn.soucie@inserm.fr; arend@stanford.edu; sieweke@ciml.univ-mrs.fr	Dubreuil, Patrice/V-4816-2019; Sieweke, Michael/AAR-7515-2020; Soucie, Erinn L/R-1731-2016; dubreuil, patrice/F-5346-2011	Dubreuil, Patrice/0000-0003-1155-1150; Sieweke, Michael/0000-0002-3228-9537; Soucie, Erinn L/0000-0001-6347-3954; dubreuil, patrice/0000-0003-1155-1150; BERRUYER, Carole/0000-0003-0244-8071; Maurizio, Julien/0000-0002-6387-5125; Andrau, Jean-Christophe/0000-0003-0203-8507; Mossadegh-Keller, Noushin/0000-0002-7088-3676	European Union; La Fondation de France; La Ligue Nationale Contre le Cancer (Equipe Labelisee); Human Frontier Science Program long-term fellowship; Stiftung Charite; Fondation ARC pour la Recherche sur le Cancer; Fondation pour la Recherche Medicale [AJE20130728183, DEQ20110421320]; NIH National Institute on Aging [P01AG036695]; Agence Nationale de la Recherche [ANR-11-BSV3-026-01]; Institut National du Cancer [13-10/405/AB-LC-HS]; NATIONAL INSTITUTE ON AGING [P01AG036695] Funding Source: NIH RePORTER	European Union(European Commission); La Fondation de France(Fondation de France); La Ligue Nationale Contre le Cancer (Equipe Labelisee); Human Frontier Science Program long-term fellowship(Human Frontier Science Program); Stiftung Charite; Fondation ARC pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le Cancer); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); NIH National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Agence Nationale de la Recherche(French National Research Agency (ANR)); Institut National du Cancer(Institut National du Cancer (INCA) France); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank N. Spies for advice on statistical analysis, L. Chasson for immunofluorescence processing, and S. Vargas-Aguilar for reagents. The data presented in this manuscript are tabulated in the main paper and in the supplementary materials. Sequencing data can be accessed in Gene Expression Omnibus under accession number GSE75722. E.L.S. received fellowships from the European Union Marie Curie program and La Fondation de France. E.L.S. and P.D. were supported by La Ligue Nationale Contre le Cancer (Equipe Labelisee), K.M. by a Human Frontier Science Program long-term fellowship and Stiftung Charite, L.G. by the Fondation ARC pour la Recherche sur le Cancer, J.-C.A. by the Fondation pour la Recherche Medicale (grant AJE20130728183), A.S. by the NIH National Institute on Aging (grant P01AG036695), and M.H.S. by the Agence Nationale de la Recherche (grant ANR-11-BSV3-026-01) and Institut National du Cancer (grant 13-10/405/AB-LC-HS). M.H.S. is an Einstein-BIH fellow and Fondation pour la Recherche Medicale (grant DEQ20110421320) and INSERM-Helmholtz group leader.	Amit I, 2009, SCIENCE, V326, P257, DOI 10.1126/science.1179050; Aziz A, 2009, SCIENCE, V326, P867, DOI 10.1126/science.1176056; Bakri Y, 2005, BLOOD, V105, P2707, DOI 10.1182/blood-2004-04-1448; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Davies LC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2877; Ding L, 2009, CELL STEM CELL, V4, P403, DOI 10.1016/j.stem.2009.03.009; Fejer G, 2013, P NATL ACAD SCI USA, V110, pE2191, DOI 10.1073/pnas.1302877110; Gaspar-Maia A, 2009, NATURE, V460, P863, DOI 10.1038/nature08212; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Gentek R, 2014, IMMUNOL REV, V262, P56, DOI 10.1111/imr.12224; Ghisletti S, 2010, IMMUNITY, V32, P317, DOI 10.1016/j.immuni.2010.02.008; Gosselin D, 2014, CELL, V159, P1327, DOI 10.1016/j.cell.2014.11.023; Hall J, 2009, CELL STEM CELL, V5, P597, DOI 10.1016/j.stem.2009.11.003; Hamilton JA, 1996, J IMMUNOL, V156, P2553; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hu G, 2009, GENE DEV, V23, P837, DOI 10.1101/gad.1769609; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Jenkins SJ, 2013, J EXP MED, V210, P2477, DOI 10.1084/jem.20121999; Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; MacArthur BD, 2009, NAT REV MOL CELL BIO, V10, P672, DOI 10.1038/nrm2766; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Motohashi H, 2010, NAT IMMUNOL, V11, P695, DOI 10.1038/ni0810-695; Natoli G, 2012, ANNU REV GENET, V46, P1, DOI 10.1146/annurev-genet-110711-155459; Natoli G, 2010, IMMUNITY, V33, P12, DOI 10.1016/j.immuni.2010.07.006; Ostuni R, 2013, CELL, V152, P157, DOI 10.1016/j.cell.2012.12.018; Pritsker M, 2006, P NATL ACAD SCI USA, V103, P6946, DOI 10.1073/pnas.0509861103; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Sieweke MH, 2013, SCIENCE, V342, P946, DOI 10.1126/science.1242974; Valouev A, 2008, NAT METHODS, V5, P829, DOI 10.1038/NMETH.1246; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Wong DJ, 2008, CELL STEM CELL, V2, P333, DOI 10.1016/j.stem.2008.02.009; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Zhang JZ, 2006, STEM CELLS, V24, P2661, DOI 10.1634/stemcells.2006-0017	40	141	144	2	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 12	2016	351	6274							aad5510	10.1126/science.aad5510	http://dx.doi.org/10.1126/science.aad5510			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD3GL	26797145	Green Accepted			2022-12-28	WOS:000369810000032
J	Cassel, C; Penhoet, E; Saunders, R				Cassel, Christine; Penhoet, Ed; Saunders, Robert			Policy Solutions for Better Hearing	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							UNITED-STATES; OLDER-ADULTS; PREVALENCE; CARE		[Cassel, Christine; Saunders, Robert] Natl Qual Forum, 1030 15th St NW,Ste 800, Washington, DC 20005 USA; [Penhoet, Ed] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Saunders, R (corresponding author), Natl Qual Forum, 1030 15th St NW,Ste 800, Washington, DC 20005 USA.	rsaunders@qualityforum.org						Chien W, 2012, ARCH INTERN MED, V172, P292, DOI 10.1001/archinternmed.2011.1408; Donahue A, 2010, EAR HEARING, V31, P2, DOI 10.1097/AUD.0b013e3181cbc783; Lin FR, 2012, ARCH INTERN MED, V172, P369, DOI 10.1001/archinternmed.2011.728; Lin FR, 2011, ARCH INTERN MED, V171, P1851, DOI 10.1001/archinternmed.2011.506; Lin FR, 2011, ARCH NEUROL-CHICAGO, V68, P214, DOI 10.1001/archneurol.2010.362; Office of Inspector General US Department of Veteran Affairs (VA), 2014, 120291080 US DEP VA; President's Council of Advisors on Science and Technology, 2015, AG AM HEAR LOSS IMP; U. S. Preventive Services Task Force, 2012, HEAR LOSS OLD AD SCR; US Food and Drug Administration, 1977, FED REGISTER, V42, P9296; Whitson HE, 2014, JAMA-J AM MED ASSOC, V312, P1739, DOI 10.1001/jama.2014.13535	10	19	19	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 9	2016	315	6					553	554		10.1001/jama.2016.0044	http://dx.doi.org/10.1001/jama.2016.0044			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DD0UJ	26795140				2022-12-28	WOS:000369635200010
J	Raw, M; Mackay, J; Reddy, S				Raw, Martin; Mackay, Judith; Reddy, Srinath			Time to take tobacco dependence treatment seriously	LANCET			English	Editorial Material							INTERVENTIONS; CESSATION; MORTALITY; SMOKING		[Raw, Martin] Int Ctr Tobacco Cessat, London, England; [Raw, Martin] Univ Nottingham, Nottingham NG5 1PB, England; [Mackay, Judith] World Lung Fdn Hong Kong Off, Kowloon, Hong Kong, Peoples R China; [Reddy, Srinath] Delhi Natl Capital Reg, Publ Hlth Fdn India, Gurgaon, Haryana, India	University of Nottingham; Public Health Foundation of India	Raw, M (corresponding author), Int Ctr Tobacco Cessat, London, England.; Raw, M (corresponding author), Univ Nottingham, Nottingham NG5 1PB, England.	martin@martinraw.com		Reddy, K Srinath/0000-0003-3416-3548				[Anonymous], 2015, WHO REP GLOB TOB EP; Bloomberg Philanthropies, 2015, BLOOMB PHIL AW GLOB; Chen ZM, 2015, LANCET, V386, P1447, DOI 10.1016/S0140-6736(15)00340-2; Doll R, 2004, BMJ-BRIT MED J, V328, P1519, DOI 10.1136/bmj.38142.554479.AE; Fidler J, 2013, ADDICTION, V108, P1680, DOI 10.1111/add.12241; Kontis V, 2014, LANCET, V384, P427, DOI 10.1016/S0140-6736(14)60616-4; National Institute for Health and Care Excellence, TOB RET INV TOOL; Pine-Abata H, 2013, ADDICTION, V108, P1476, DOI 10.1111/add.12172; TENGS TO, 1995, RISK ANAL, V15, P369, DOI 10.1111/j.1539-6924.1995.tb00330.x; West R, 2015, ADDICTION, V110, P1388, DOI 10.1111/add.12998; World Health Organization, 2015, WHO FRAM CONV TOB CO; World Health Organization, 2003, WHO FRAM CONV TOB CO; World Health Organization, 2003, POL REC SMOK CESS TR	13	16	16	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 30	2016	387	10017					412	413		10.1016/S0140-6736(15)00950-2	http://dx.doi.org/10.1016/S0140-6736(15)00950-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DC1OX	26803442				2022-12-28	WOS:000368986800008
J	Nelson, CE; Hakim, CH; Ousterout, DG; Thakore, PI; Moreb, EA; Rivera, RMC; Madhavan, S; Pan, XF; Ran, FA; Yan, WX; Asokan, A; Zhang, F; Duan, DS; Gersbach, CA				Nelson, Christopher E.; Hakim, Chady H.; Ousterout, David G.; Thakore, Pratiksha I.; Moreb, Eirik A.; Rivera, Ruth M. Castellanos; Madhavan, Sarina; Pan, Xiufang; Ran, F. Ann; Yan, Winston X.; Asokan, Aravind; Zhang, Feng; Duan, Dongsheng; Gersbach, Charles A.			In vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy	SCIENCE			English	Article							GENE-THERAPY; MDX MOUSE; IMMUNE-RESPONSES; READING FRAME; CELLS; EXPRESSION; MICE; CAS9; DNA; ENDONUCLEASE	Duchenne muscular dystrophy (DMD) is a devastating disease affecting about 1 out of 5000 male births and caused by mutations in the dystrophin gene. Genome editing has the potential to restore expression of a modified dystrophin gene from the native locus to modulate disease progression. In this study, adeno-associated virus was used to deliver the clustered regularly interspaced short palindromic repeats (CRISPR)-Cas9 system to the mdx mouse model of DMD to remove the mutated exon 23 from the dystrophin gene. This includes local and systemic delivery to adult mice and systemic delivery to neonatal mice. Exon 23 deletion by CRISPR-Cas9 resulted in expression of the modified dystrophin gene, partial recovery of functional dystrophin protein in skeletal myofibers and cardiac muscle, improvement of muscle biochemistry, and significant enhancement of muscle force. This work establishes CRISPR-Cas9-based genome editing as a potential therapy to treat DMD.	[Nelson, Christopher E.; Ousterout, David G.; Thakore, Pratiksha I.; Moreb, Eirik A.; Madhavan, Sarina; Gersbach, Charles A.] Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA; [Nelson, Christopher E.; Ousterout, David G.; Thakore, Pratiksha I.; Moreb, Eirik A.; Madhavan, Sarina; Gersbach, Charles A.] Duke Univ, Ctr Genom & Computat Biol, Durham, NC USA; [Hakim, Chady H.; Pan, Xiufang; Duan, Dongsheng] Univ Missouri, Dept Mol Microbiol & Immunol, Columbia, MO USA; [Rivera, Ruth M. Castellanos; Asokan, Aravind] Univ N Carolina, Sch Med, Gene Therapy Ctr, Dept Genet, Chapel Hill, NC USA; [Rivera, Ruth M. Castellanos; Asokan, Aravind] Univ N Carolina, Sch Med, Gene Therapy Ctr, Dept Biochem & Biophys, Chapel Hill, NC USA; [Ran, F. Ann; Yan, Winston X.; Zhang, Feng] Broad Inst MIT & Harvard, Cambridge, MA USA; [Ran, F. Ann] Harvard Univ, Soc Fellows, Cambridge, MA 02138 USA; [Yan, Winston X.] Harvard Univ, Sch Med, Grad Program Biophys, Boston, MA USA; [Yan, Winston X.] Harvard Univ, Sch Med, Harvard Mit Div Hlth Sci & Technol, Boston, MA USA; [Zhang, Feng] MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA; [Zhang, Feng] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Zhang, Feng] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Duan, Dongsheng] Univ Missouri, Dept Neurol, Columbia, MO USA; [Gersbach, Charles A.] Duke Univ, Med Ctr, Dept Orthopaed Surg, Durham, NC USA	Duke University; Duke University; University of Missouri System; University of Missouri Columbia; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); University of Missouri System; University of Missouri Columbia; Duke University	Gersbach, CA (corresponding author), Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA.	charles.gersbach@duke.edu	Macrae, Rhiannon/AAX-1536-2020; Gersbach, Charles/Y-3412-2019; Thakore, Pratiksha I./HDM-5197-2022; Wilson, Matthew H/K-3193-2013	Nelson, Christopher/0000-0002-8423-8854; Duan, Dongsheng/0000-0003-4109-1132	Muscular Dystrophy Association [MDA277360]; Duke-Coulter Translational Partnership Grant; Hartwell Foundation Individual Biomedical Research Award; March of Dimes Foundation Basil O'Connor Starter Scholar Award; NIH Director's New Innovator Award [DP2-OD008586]; Duke/UNC-Chapel Hill CTSA Consortium Collaborative Translational Research Award; NIH Director's Pioneer Award [DP1-MH100706]; NIH [R01DK097768, R01HL089221, P01HL112761, R01NS90634]; Waterman Award from the NSF; Keck Foundation; Damon Runyon Foundation; Searle Scholars Foundation; Merkin Family Foundation; Vallee Foundation; Simons Foundation; Paul G. Allen Foundation; New York Stem Cell Foundation; Bob Metcalfe; Hope for Javier Foundation; Hartwell Foundation Postdoctoral Fellowship; American Heart Association Predoctoral Fellowship; National Institute of General Medical Sciences [T32GM007753]; Paul and Daisy Soros Fellowship; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001111, UL1TR002489] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089221, P01HL112761] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK097768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008313, T32GM007753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH110049, DP1MH100706] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS090634] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD008586] Funding Source: NIH RePORTER	Muscular Dystrophy Association(Muscular Dystrophy Association); Duke-Coulter Translational Partnership Grant; Hartwell Foundation Individual Biomedical Research Award; March of Dimes Foundation Basil O'Connor Starter Scholar Award; NIH Director's New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Duke/UNC-Chapel Hill CTSA Consortium Collaborative Translational Research Award; NIH Director's Pioneer Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Waterman Award from the NSF; Keck Foundation(W.M. Keck Foundation); Damon Runyon Foundation; Searle Scholars Foundation; Merkin Family Foundation; Vallee Foundation; Simons Foundation; Paul G. Allen Foundation; New York Stem Cell Foundation; Bob Metcalfe; Hope for Javier Foundation; Hartwell Foundation Postdoctoral Fellowship; American Heart Association Predoctoral Fellowship(American Heart Association); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Paul and Daisy Soros Fellowship; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank M. Gemberling, T. Reddy, W. Majoros, F. Guilak, K. Zhang and Y. Yue for technical assistance and X. Xiao and E. Smith for helpful discussion. This work was supported by the Muscular Dystrophy Association (MDA277360), a Duke-Coulter Translational Partnership Grant, a Hartwell Foundation Individual Biomedical Research Award, a March of Dimes Foundation Basil O'Connor Starter Scholar Award, and an NIH Director's New Innovator Award (DP2-OD008586) to C.A.G., as well as a Duke/UNC-Chapel Hill CTSA Consortium Collaborative Translational Research Award to C.A.G. and A. A. F.Z. is supported by an NIH Director's Pioneer Award (DP1-MH100706); NIH grant R01DK097768; a Waterman Award from the NSF; the Keck, Damon Runyon, Searle Scholars, Merkin Family, Vallee, Simons, Paul G. Allen, and the New York Stem Cell Foundations; and by Bob Metcalfe. A. A. is supported by NIH grants R01HL089221 and P01HL112761. D.D. is supported by NIH grant R01NS90634 and the Hope for Javier Foundation. C.E.N. is supported by a Hartwell Foundation Postdoctoral Fellowship. P.I.T. was supported by an American Heart Association Predoctoral Fellowship. W.X.Y. is supported by T32GM007753 from the National Institute of General Medical Sciences and a Paul and Daisy Soros Fellowship. F.A.R. is a Junior Fellow at the Harvard Society of Fellows. The SaCas9 gene is openly available through Addgene via a Uniform Biological Material Transfer Agreement. C.A.G., D.G.O., and P.I.T. are inventors on a patent application filed by Duke University related to genome editing for Duchenne muscular dystrophy (WO 2014/197748). F.Z. and F.A.R. are inventors on patents filed by the Broad Institute related to SaCas9 materials (U.S. patents 8,865,406 and 8,906,616 and accepted EP 2898075, from International patent application WO 2014/093635). C.A.G. is a scientific advisor to Editas Medicine, a company engaged in development of therapeutic genome editing. F.Z. is a founder of Editas Medicine and scientific advisor for Editas Medicine and Horizon Discovery. D.D. is a member of the scientific advisory board for Solid GT, a subsidiary of Solid Biosciences.	Aartsma-Rus A, 2009, HUM MUTAT, V30, P293, DOI 10.1002/humu.20918; Al-Zaidy S, 2014, PEDIATR NEUROL, V51, P607, DOI 10.1016/j.pediatrneurol.2014.08.002; Chapdelaine P, 2010, GENE THER, V17, P846, DOI 10.1038/gt.2010.26; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Cirak S, 2011, LANCET, V378, P595, DOI 10.1016/S0140-6736(11)60756-3; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cox DBT, 2015, NAT MED, V21, P121, DOI 10.1038/nm.3793; ENGLAND SB, 1990, NATURE, V343, P180, DOI 10.1038/343180a0; Fairclough RJ, 2013, NAT REV GENET, V14, P373, DOI 10.1038/nrg3460; Goemans NM, 2011, NEW ENGL J MED, V364, P1513, DOI 10.1056/NEJMoa1011367; Goyenvalle A, 2015, NAT MED, V21, P270, DOI 10.1038/nm.3765; Harper SQ, 2002, NAT MED, V8, P253, DOI 10.1038/nm0302-253; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kobayashi YM, 2008, NATURE, V456, P511, DOI 10.1038/nature07414; Lai Y, 2005, NAT BIOTECHNOL, V23, P1435, DOI 10.1038/nbt1153; Lai Y, 2009, J CLIN INVEST, V119, P624, DOI 10.1172/JCI36612; Li DJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015286; Li HL, 2015, STEM CELL REP, V4, P143, DOI 10.1016/j.stemcr.2014.10.013; Long CZ, 2016, SCIENCE, V351, P400, DOI 10.1126/science.aad5725; Long CZ, 2014, SCIENCE, V345, P1184, DOI 10.1126/science.1254445; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mann CJ, 2001, P NATL ACAD SCI USA, V98, P42, DOI 10.1073/pnas.011408598; Mendell JR, 2010, NEW ENGL J MED, V363, P1429, DOI 10.1056/NEJMoa1000228; Mingozzi F, 2013, BLOOD, V122, P23, DOI 10.1182/blood-2013-01-306647; Neri M, 2007, NEUROMUSCULAR DISORD, V17, P913, DOI 10.1016/j.nmd.2007.07.005; Ousterout DG, 2015, MOL THER, V23, P523, DOI 10.1038/mt.2014.234; Ousterout DG, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7244; Ousterout DG, 2013, MOL THER, V21, P1718, DOI 10.1038/mt.2013.111; Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014; Popplewell L, 2013, HUM GENE THER, V24, P692, DOI 10.1089/hum.2013.081; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Shin JH, 2013, MOL THER, V21, P750, DOI 10.1038/mt.2012.283; SICINSKI P, 1989, SCIENCE, V244, P1578, DOI 10.1126/science.2662404; Swiech L, 2015, NAT BIOTECHNOL, V33, P102, DOI 10.1038/nbt.3055; Tabebordbar M, 2016, SCIENCE, V351, P407, DOI 10.1126/science.aad5177; van Putten M, 2013, FASEB J, V27, P2484, DOI 10.1096/fj.12-224170; Wang B, 2000, P NATL ACAD SCI USA, V97, P13714, DOI 10.1073/pnas.240335297; Wang D, 2015, HUM GENE THER, V26, P432, DOI 10.1089/hum.2015.087; Wang Z, 2005, NAT BIOTECHNOL, V23, P321, DOI 10.1038/nbt1073; Xu L, 2016, MOL THER, V24, P564, DOI 10.1038/mt.2015.192; Yin H, 2014, NAT BIOTECHNOL, V32, P551, DOI 10.1038/nbt.2884	43	756	808	8	412	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 22	2016	351	6271					403	407		10.1126/science.aad5143	http://dx.doi.org/10.1126/science.aad5143			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB3VH	26721684	Green Published, Green Accepted, Green Submitted			2022-12-28	WOS:000368440500045
J	Xuan, W; Band, LR; Kumpf, RP; Van Damme, D; Parizot, B; De Rop, G; Opdenacker, D; Moller, BK; Skorzinski, N; Njo, MF; De Rybel, B; Audenaert, D; Nowack, MK; Vanneste, S; Beeckman, T				Xuan, Wei; Band, Leah R.; Kumpf, Robert P.; Van Damme, Daniel; Parizot, Boris; De Rop, Gieljan; Opdenacker, Davy; Moeller, Barbara K.; Skorzinski, Noemi; Njo, Maria F.; De Rybel, Bert; Audenaert, Dominique; Nowack, Moritz K.; Vanneste, Steffen; Beeckman, Tom			Cyclic programmed cell death stimulates hormone signaling and root development in Arabidopsis	SCIENCE			English	Article							AUXIN TRANSPORT; GENE-EXPRESSION; CAP; GRAVITROPISM; ARCHITECTURE; INITIATION; MECHANISM; THALIANA; PATTERNS; MERISTEM	The plant root cap, surrounding the very tip of the growing root, perceives and transmits environmental signals to the inner root tissues. In Arabidopsis thaliana, auxin released by the root cap contributes to the regular spacing of lateral organs along the primary root axis. Here, we show that the periodicity of lateral organ induction is driven by recurrent programmed cell death at the most distal edge of the root cap. We suggest that synchronous bursts of cell death in lateral root cap cells release pulses of auxin to surrounding root tissues, establishing the pattern for lateral root formation. The dynamics of root cap turnover may therefore coordinate primary root growth with root branching in order to optimize the uptake of water and nutrients from the soil.	[Xuan, Wei; Kumpf, Robert P.; Van Damme, Daniel; Parizot, Boris; De Rop, Gieljan; Opdenacker, Davy; Moeller, Barbara K.; Njo, Maria F.; De Rybel, Bert; Audenaert, Dominique; Nowack, Moritz K.; Vanneste, Steffen; Beeckman, Tom] VIB, Dept Plant Syst Biol, B-9052 Ghent, Belgium; [Xuan, Wei; Kumpf, Robert P.; Van Damme, Daniel; Parizot, Boris; De Rop, Gieljan; Opdenacker, Davy; Moeller, Barbara K.; Njo, Maria F.; De Rybel, Bert; Audenaert, Dominique; Nowack, Moritz K.; Vanneste, Steffen; Beeckman, Tom] Univ Ghent, Dept Plant Biotechnol & Bioinformat, B-9052 Ghent, Belgium; [Xuan, Wei] Nanjing Agr Univ, State Key Lab Crop Genet & Germplasm Enhancement, Nanjing 210095, Jiangsu, Peoples R China; [Xuan, Wei] Nanjing Agr Univ, MOA Key Lab Plant Nutr & Fertilizat Lower Middle, Nanjing 210095, Jiangsu, Peoples R China; [Band, Leah R.] Univ Nottingham, Ctr Plant Integrat Biol, Loughborough LE12 5RD, Leics, England; [Skorzinski, Noemi] Max Planck Inst Dev Biol, D-72076 Tubingen, Germany; [De Rybel, Bert] Wageningen Univ, Biochem Lab, NL-6703 HA Wageningen, Netherlands	Flanders Institute for Biotechnology (VIB); Ghent University; Nanjing Agricultural University; Nanjing Agricultural University; University of Nottingham; Max Planck Society; Wageningen University & Research	Beeckman, T (corresponding author), VIB, Dept Plant Syst Biol, Technol Pk 927, B-9052 Ghent, Belgium.	tobee@psb.vib-ugent.be	Beeckman, Tom/ABA-1164-2020; van damme, daniel/F-6139-2014; Vanneste, Steffen/K-8353-2013; Beeckman, Tom/ABI-1703-2020; van damme, daniel/ABA-1397-2020	van damme, daniel/0000-0002-9385-4851; Vanneste, Steffen/0000-0002-9948-9672; Beeckman, Tom/0000-0001-8656-2060; van damme, daniel/0000-0002-9385-4851; PARIZOT, Boris/0000-0003-1445-6925; De Rybel, Bert/0000-0002-9551-042X; Kumpf, Robert P./0000-0002-4046-6935; Band, Leah/0000-0002-6979-1117; Nowack, Moritz/0000-0001-8918-7577; Moller, Barbara/0000-0001-6521-4200	Interuniversity Attraction Poles Programme [IAP VI/33, IUAP P7/29 "MARS"]; Belgian Science Policy Office; Research Foundation-Flanders; Ghent University Special Research Fund; Netherlands Organization for Scientific Research [NWO VIDI 864.13.001]; Chinese Scholarship Council (CSC); University Special Research Fund; 111 Project [B12009]; Innovative Research Team Development Plan of the Ministry of Education of China [IRT1256]; Priority Academic Program Development in Jiangsu Higher Education Institutions; Leverhulme Trust Early Career Fellowship; Biotechnology and Biological Sciences Research Council New Investigator grant; Omics@vib Marie Curie COFUND fellowship; BBSRC [BB/M019837/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/M019837/1] Funding Source: researchfish	Interuniversity Attraction Poles Programme(Belgian Federal Science Policy Office); Belgian Science Policy Office(Belgian Federal Science Policy Office); Research Foundation-Flanders(FWO); Ghent University Special Research Fund(Ghent University); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Chinese Scholarship Council (CSC)(China Scholarship Council); University Special Research Fund; 111 Project(Ministry of Education, China - 111 Project); Innovative Research Team Development Plan of the Ministry of Education of China; Priority Academic Program Development in Jiangsu Higher Education Institutions; Leverhulme Trust Early Career Fellowship(Leverhulme Trust); Biotechnology and Biological Sciences Research Council New Investigator grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Omics@vib Marie Curie COFUND fellowship; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by grants from the Interuniversity Attraction Poles Programme (IAP VI/33 and IUAP P7/29 "MARS") initiated by the Belgian Science Policy Office, the Research Foundation-Flanders, and Ghent University Special Research Fund to T.B. and from the Netherlands Organization for Scientific Research (NWO VIDI 864.13.001) to B.D.R. W.X. is supported by a grant from the Chinese Scholarship Council (CSC) with cofunding from Ghent University Special Research Fund, and a grant sponsored by 111 Project (B12009) and Innovative Research Team Development Plan of the Ministry of Education of China (IRT1256), and Priority Academic Program Development in Jiangsu Higher Education Institutions. L.R.B. is supported by a Leverhulme Trust Early Career Fellowship and a Biotechnology and Biological Sciences Research Council New Investigator grant. B.K.M. and R.P.K. are the recipients of Omics@vib Marie Curie COFUND fellowship, and S.V. is a Postdoctoral Fellow of the Research Foundation-Flanders. We thank M. Bennett (University of ?tlsb=-.03w?>Nottingham, UK), B. Scheres (Wageningen University, the Netherlands), P. N. Benfey (Duke University, USA), J. Friml (Institute of Science and Technology, Austria), L. C. Strader (Washington University, St. Louis, Missouri, USA), M. Geisler (University of Fribourg, Fribourg, Switzerland), and N. Geldner (University of Lausanne, Switzerland) for the kind gifts of materials. We thank M. Van Durme for the help in cloning. The authors declare that they have no conflicts of interest. The supplementary materials contain additional data. W. X. and D. V. D. set up the in vivo root imaging system. W. X., R. P. K., G. D. R., and D. O. performed imaging and analysis. L. R. B. developed the mathematical modeling. W. X., B. D. R., and D. A. collected and analyzed the auxin transport mutants. B. P. and M. F. N. assisted in data analysis and art work. N. S. and M. K. N. provided material for the study. W. X., S. V., and T. B. directed and wrote the manuscript. L. R. B. and B. K. M. helped with the writing. All authors discussed the results and contributed in the finalization of the manuscript.	Baetz U, 2014, TRENDS PLANT SCI, V19, P90, DOI 10.1016/j.tplants.2013.11.006; Band LR, 2014, PLANT CELL, V26, P862, DOI 10.1105/tpc.113.119495; Band LR, 2012, P NATL ACAD SCI USA, V109, P4668, DOI 10.1073/pnas.1201498109; Bao Y, 2014, P NATL ACAD SCI USA, V111, P9319, DOI 10.1073/pnas.1400966111; Bennett T, 2010, PLANT CELL, V22, P640, DOI 10.1105/tpc.109.072272; Blilou I, 2005, NATURE, V433, P39, DOI 10.1038/nature03184; De Rybel B, 2012, NAT CHEM BIOL, V8, P798, DOI [10.1038/NCHEMBIO.1044, 10.1038/nchembio.1044]; De Smet I, 2007, DEVELOPMENT, V134, P681, DOI 10.1242/dev.02753; Ditengou FA, 2008, P NATL ACAD SCI USA, V105, P18818, DOI 10.1073/pnas.0807814105; DOLAN L, 1993, DEVELOPMENT, V119, P71; Driouich A, 2013, CURR OPIN PLANT BIOL, V16, P489, DOI 10.1016/j.pbi.2013.06.010; Fendrych M, 2014, CURR BIOL, V24, P931, DOI 10.1016/j.cub.2014.03.025; Grieneisen VA, 2007, NATURE, V449, P1008, DOI 10.1038/nature06215; Heisler MG, 2005, CURR BIOL, V15, P1899, DOI 10.1016/j.cub.2005.09.052; Henrichs S, 2012, EMBO J, V31, P2965, DOI 10.1038/emboj.2012.120; Kim JY, 2010, J BIOL CHEM, V285, P23307, DOI 10.1074/jbc.M110.105981; Kumpf RP, 2015, J EXP BOT, V66, P5651, DOI 10.1093/jxb/erv295; Laskowski M, 2008, PLOS BIOL, V6, P2721, DOI 10.1371/journal.pbio.0060307; Liao CY, 2015, NAT METHODS, V12, P207, DOI [10.1038/NMETH.3279, 10.1038/nmeth.3279]; Lucas M, 2008, J EXP BOT, V59, P55, DOI 10.1093/jxb/erm171; Moreno-Risueno MA, 2010, SCIENCE, V329, P1306, DOI 10.1126/science.1191937; Plancot B, 2013, PLANT PHYSIOL, V163, P1584, DOI 10.1104/pp.113.222356; Rouse D, 1998, SCIENCE, V279, P1371, DOI 10.1126/science.279.5355.1371; Svistoonoff S, 2007, NAT GENET, V39, P792, DOI 10.1038/ng2041; Swarup R, 2005, NAT CELL BIOL, V7, P1057, DOI 10.1038/ncb1316; Tsuda E, 2011, J BIOL CHEM, V286, P2354, DOI 10.1074/jbc.M110.171165; Van Norman JM, 2013, DEVELOPMENT, V140, P4301, DOI 10.1242/dev.090548; Xuan W, 2015, CURR BIOL, V25, P1381, DOI 10.1016/j.cub.2015.03.046	28	114	116	23	206	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 22	2016	351	6271					384	387		10.1126/science.aad2776	http://dx.doi.org/10.1126/science.aad2776			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB3VH	26798015	Green Accepted			2022-12-28	WOS:000368440500040
J	Li, J; Guo, E				Li, Jian; Guo, Eping			Taenia saginata Infestation	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Li, Jian; Guo, Eping] Hubei Univ Med, Shiyan, Peoples R China	Hubei University of Medicine	Li, J (corresponding author), Hubei Univ Med, Shiyan, Peoples R China.	thgep1962@163.com	Li, Jian/GMW-4332-2022	Li, Jian/0000-0001-9434-7803					0	1	2	0	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 21	2016	374	3					263	263		10.1056/NEJMicm1504801	http://dx.doi.org/10.1056/NEJMicm1504801			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DB3IS	26789874				2022-12-28	WOS:000368404800011
J	Phillips, TJ				Phillips, Thomas J.			Antimatter may matter	NATURE			English	Editorial Material							ANTIHYDROGEN; MASS		[Phillips, Thomas J.] IIT, Dept Phys, Chicago, IL 60616 USA	Illinois Institute of Technology	Phillips, TJ (corresponding author), IIT, Dept Phys, Chicago, IL 60616 USA.	phillips@phys.iit.edu						Ahmadi M, 2016, NATURE, V529, P373, DOI 10.1038/nature16491; Amole C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4955; Benoit-Levy A, 2012, ASTRON ASTROPHYS, V537, DOI 10.1051/0004-6361/201016103; Charman AE, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2787; Doser M, 2012, CLASSICAL QUANT GRAV, V29, DOI 10.1088/0264-9381/29/18/184009; Greenland PT, 1997, CONTEMP PHYS, V38, P181, DOI 10.1080/001075197182397; Hajdukovic DS, 2011, ASTROPHYS SPACE SCI, V334, P215, DOI 10.1007/s10509-011-0744-4; Hori M, 2011, NATURE, V475, P484, DOI 10.1038/nature10260; Kaplan DM, 2015, EPJ WEB CONF, V95, DOI [10.1051/epjconf/20149505008, 10.1051/epjconf/20159505008]; NIETO MM, 1991, PHYS REP, V205, P221, DOI 10.1016/0370-1573(91)90138-C; Perez P, 2012, CLASSICAL QUANT GRAV, V29, DOI 10.1088/0264-9381/29/18/184008	11	1	1	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 21	2016	529	7586					294	295		10.1038/529294a	http://dx.doi.org/10.1038/529294a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB2QT	26791718				2022-12-28	WOS:000368354800030
J	Fankhauser, C; Batschauer, A				Fankhauser, Christian; Batschauer, Alfred			Shadow on the Plant: A Strategy to Exit	CELL			English	Editorial Material							CRYPTOCHROME 1; BLUE-LIGHT; AVOIDANCE; ARABIDOPSIS; RESPONSES	The light spectrum perceived by plants is affected by crowding, which results in the shade avoidance syndrome (SAS). Findings presented by Pedmale et al. bring cryptochromes to the forefront of SAS and elucidate a fascinating molecular crosstalk between photoreceptor systems operating in different wavebands.	[Fankhauser, Christian] Univ Lausanne, Fac Biol & Med, Ctr Integrat Genom, CH-1015 Lausanne, Switzerland; [Batschauer, Alfred] Univ Marburg, Dept Mol Plant Physiol & Photobiol, Fac Biol, D-35043 Marburg, Germany	University of Lausanne; Philipps University Marburg	Fankhauser, C (corresponding author), Univ Lausanne, Fac Biol & Med, Ctr Integrat Genom, CH-1015 Lausanne, Switzerland.	christian.fankhauser@unil.ch; batschau@staff.uni-marburg.de	Fankhauser, Christian/C-4291-2018; Fankhauser, Christian/ABE-8757-2021	Fankhauser, Christian/0000-0003-4719-5901; Fankhauser, Christian/0000-0003-4719-5901				Casal JJ, 2013, ANNU REV PLANT BIOL, V64, P403, DOI 10.1146/annurev-arplant-050312-120221; Keller MM, 2011, PLANT J, V67, P195, DOI 10.1111/j.1365-313X.2011.04598.x; Keuskamp DH, 2011, PLANT J, V67, P208, DOI 10.1111/j.1365-313X.2011.04597.x; Leivar P, 2011, TRENDS PLANT SCI, V16, P19, DOI 10.1016/j.tplants.2010.08.003; Li L, 2012, GENE DEV, V26, P785, DOI 10.1101/gad.187849.112; Lorrain S, 2008, PLANT J, V53, P312, DOI 10.1111/j.1365-313X.2007.03341.x; Ma DB, 2016, P NATL ACAD SCI USA, V113, P224, DOI 10.1073/pnas.1511437113; Pedmale UV, 2016, CELL, V164, P233, DOI 10.1016/j.cell.2015.12.018; Sellaro R, 2010, PLANT PHYSIOL, V154, P401, DOI 10.1104/pp.110.160820; Smith H, 1997, PLANT CELL ENVIRON, V20, P840, DOI 10.1046/j.1365-3040.1997.d01-104.x	10	19	23	1	34	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 14	2016	164	1-2					15	17		10.1016/j.cell.2015.12.043	http://dx.doi.org/10.1016/j.cell.2015.12.043			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DB2LE	26771482	Bronze, Green Submitted, Green Accepted			2022-12-28	WOS:000368339300005
J	Lofgren, J; Nordin, P; Ibingira, C; Matovu, A; Galiwango, E; Wladis, A				Lofgren, Jenny; Nordin, Par; Ibingira, Charles; Matovu, Alphonsus; Galiwango, Edward; Wladis, Andreas			A Randomized Trial of Low-Cost Mesh in Groin Hernia Repair	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MOSQUITO NET MESH; INGUINAL-HERNIA; SOCIETY GUIDELINES; INCOME COUNTRIES; COMMERCIAL MESH; ADULT PATIENTS; GLOBAL HEALTH; SURGERY; HERNIOPLASTY; GHANA	BACKGROUND The most effective method for repair of a groin hernia involves the use of a synthetic mesh, but this type of mesh is unaffordable for many patients in low- and middle-income countries. Sterilized mosquito meshes have been used as a lower-cost alternative but have not been rigorously studied. METHODS We performed a double-blind, randomized, controlled trial comparing low-cost mesh with commercial mesh (both lightweight) for the repair of a groin hernia in adult men in eastern Uganda who had primary, unilateral, reducible groin hernias. Surgery was performed by four qualified surgeons. The primary outcomes were hernia recurrence at 1 year and postoperative complications. RESULTS A total of 302 patients were included in the study. The follow-up rate was 97.3% after 2 weeks and 95.6% after 1 year. Hernia recurred in 1 patient (0.7%) assigned to the low-cost mesh and in no patients assigned to the commercial mesh (absolute risk difference, 0.7 percentage points; 95% confidence interval [CI], -1.2 to 2.6; P=1.0). Postoperative complications occurred in 44 patients (30.8%) assigned to the low-cost mesh and in 44 patients (29.7%) assigned to the commercial mesh (absolute risk difference, 1.0 percentage point; 95% CI, -9.5 to 11.6; P=1.0). CONCLUSIONS Rates of hernia recurrence and postoperative complications did not differ significantly between men undergoing hernia repair with low-cost mesh and those undergoing hernia repair with commercial mesh. (Funded by the Swedish Research Council and others; Current Controlled Trials number, ISRCTN20596933.)	[Lofgren, Jenny; Nordin, Par] Umea Univ, Unit Res Educ & Dev, Dept Publ Hlth & Clin Med, Umea, Sweden; [Wladis, Andreas] Karolinska Inst, Dept Clin Sci & Educ, Stockholm, Sweden; [Ibingira, Charles] Makerere Univ, Sch Biomed Sci, Kampala, Uganda; [Matovu, Alphonsus] Makerere Univ, Sch Med, Kampala, Uganda; [Ibingira, Charles] Mulago Natl Referral Hosp, Kampala, Uganda; [Galiwango, Edward] Iganga Mayuge Hlth & Demog Surveillance Site, Sch Publ Hlth, Iganga, Uganda	Umea University; Karolinska Institutet; Makerere University; Makerere University; Mulago National Referral Hospital	Lofgren, J (corresponding author), Umea Univ Hosp, Dept Surg & Perioperat Sci, Bldg 10 1, S-90185 Umea, Sweden.	jenny.loefgren@gmail.com	Löfgren, Jenny/J-6694-2019; Wladis, Andreas/AAJ-7844-2020; Nordin, Pär/Y-6278-2019	Löfgren, Jenny/0000-0001-5884-0369; Wladis, Andreas/0000-0003-4377-0892; 	Swedish Research Council; Department of Public Health and Clinical Medicine, Unit of Research, Education, and Development, Ostersund, Umea University; Swedish Medical Society; Capio Research Foundation; Rotary Sweden; Church of Sweden, Ostersund; Karolinska Institutet	Swedish Research Council(Swedish Research CouncilEuropean Commission); Department of Public Health and Clinical Medicine, Unit of Research, Education, and Development, Ostersund, Umea University; Swedish Medical Society; Capio Research Foundation; Rotary Sweden; Church of Sweden, Ostersund; Karolinska Institutet(Karolinska Institutet)	Supported by the Swedish Research Council; the Department of Public Health and Clinical Medicine, Unit of Research, Education, and Development, Ostersund, Umea University; the Swedish Medical Society; Capio Research Foundation; Rotary Sweden; the Church of Sweden, Ostersund; and Karolinska Institutet.	ABRAMSON JH, 1978, J EPIDEMIOL COMMUN H, V32, P59, DOI 10.1136/jech.32.1.59; [Anonymous], POV AND EQ; [Anonymous], DCP3 HERN HYDR, DOI Seattle; [Anonymous], HLTH FIN HLTH EXP RA; Beard JH, 2013, WORLD J SURG, V37, P498, DOI 10.1007/s00268-012-1864-x; Brown LD, 2001, STAT SCI, V16, P101, DOI 10.1214/ss/1009213286; Butters M, 2007, BRIT J SURG, V94, P562, DOI 10.1002/bjs.5733; Chao TE, 2014, LANCET GLOB HEALTH, V2, pE334, DOI 10.1016/S2214-109X(14)70213-X; Clarke MG, 2009, HERNIA, V13, P155, DOI 10.1007/s10029-008-0460-3; Franneby U, 2008, BRIT J SURG, V95, P488, DOI 10.1002/bjs.6014; Freudenberg S, 2006, WORLD J SURG, V30, P1784, DOI 10.1007/s00268-006-0108-3; Galukande M, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000243; Grant AM, 2002, ANN SURG, V235, P322; Grimes CE, 2014, WORLD J SURG, V38, P252, DOI 10.1007/s00268-013-2243-y; Kingsnorth A, 2003, LANCET, V362, P1561, DOI 10.1016/S0140-6736(03)14746-0; Kingsnorth AN, 2013, MANAGEMENT ABDOMINAL; Laxminarayan R, 2006, LANCET, V367, P1193, DOI 10.1016/S0140-6736(06)68440-7; LICHTENSTEIN IL, 1989, AM J SURG, V157, P188, DOI 10.1016/0002-9610(89)90526-6; Lofgren J, 2014, BRIT J SURG, V101, P728, DOI 10.1002/bjs.9457; Miserez M, 2014, HERNIA, V18, P151, DOI 10.1007/s10029-014-1236-6; Nationella registergruppen for Svenskt Brackregister, REG LJUMSKBR NAT RAP; Primatesta P, 1996, INT J EPIDEMIOL, V25, P835, DOI 10.1093/ije/25.4.835; Sanders DL, 2013, WORLD J SURG, V37, P737, DOI 10.1007/s00268-012-1900-x; Scott NW., 2002, COCHRANE DB SYST REV, pCD002197, DOI [10.1002/14651858, DOI 10.1002/14651858, DOI 10.1002/14651858.CD002197]; Shillcutt SD, 2013, WORLD J SURG, V37, P32, DOI 10.1007/s00268-012-1808-5; Shillcutt SD, 2010, ARCH SURG-CHICAGO, V145, P954, DOI 10.1001/archsurg.2010.208; Simons MP, 2009, HERNIA, V13, P343, DOI 10.1007/s10029-009-0529-7; Sorensen CG, 2012, HERNIA, V16, P621, DOI 10.1007/s10029-012-0973-7; Stephenson BM, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d7448; Stephenson BM, 2011, WORLD J SURG, V35, P1957, DOI 10.1007/s00268-011-1176-6; The World Bank, HLTH EXP CAP; The World Bank, RUR POP; Tongaonkar RR, 2003, INDIAN J SURG, V65, P89; United Nations Development Programme, HUM DEV REP; Wilhelm TJ, 2007, EUR SURG RES, V39, P312, DOI 10.1159/000104402; World Bank, GDP PER CAP; World Bank, POV OV; Yordanov Y S, 1969, East Afr Med J, V46, P687	38	44	46	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 14	2016	374	2					146	153		10.1056/NEJMoa1505126	http://dx.doi.org/10.1056/NEJMoa1505126			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DA7PQ	26760085	Bronze, Green Published			2022-12-28	WOS:000367996700009
J	Snyder, MW; Kircher, M; Hill, AJ; Daza, RM; Shendure, J				Snyder, Matthew W.; Kircher, Martin; Hill, Andrew J.; Daza, Riza M.; Shendure, Jay			Cell-free DNA Comprises an In Vivo Nucleosome Footprint that Informs Its Tissues-Of-Origin	CELL			English	Article							MATERNAL PLASMA; NUCLEIC-ACIDS; HUMAN GENOME; BONE-MARROW; CANCER; SERUM; DIAGNOSIS; ANEUPLOIDY; BLOOD	Nucleosome positioning varies between cell types. By deep sequencing cell-free DNA (cfDNA), isolated from circulating blood plasma, we generated maps of genome-wide in vivo nucleosome occupancy and found that short cfDNA fragments harbor footprints of transcription factors. The cfDNA nucleosome occupancies correlate well with the nuclear architecture, gene structure, and expression observed in cells, suggesting that they could inform the cell type of origin. Nucleosome spacing inferred from cfDNA in healthy individuals correlates most strongly with epigenetic features of lymphoid and myeloid cells, consistent with hematopoietic cell death as the normal source of cfDNA. We build on this observation to show how nucleosome footprints can be used to infer cell types contributing to cfDNA in pathological states such as cancer. Since this strategy does not rely on genetic differences to distinguish between contributing tissues, it may enable the noninvasive monitoring of a much broader set of clinical conditions than currently possible.	[Snyder, Matthew W.; Kircher, Martin; Hill, Andrew J.; Daza, Riza M.; Shendure, Jay] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Shendure, Jay] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Shendure, J (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.	shendure@uw.edu	Kircher, Martin/HDL-9392-2022; Kircher, Martin/H-6909-2019; Daza, Riza M./HCH-4047-2022; Shendure, Jay/AAU-3684-2021	Kircher, Martin/0000-0001-9278-5471; Snyder, Matthew/0000-0001-7433-4343	NIH [1DP1HG007811]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [DP1HG007811, T32HG000035] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank D. May, J. Vierstra, M. Maurano, F. Huang, and members of the Shendure lab for helpful discussions. This work was funded in part by an NIH Director's Pioneer Award (1DP1HG007811 to J.S.). J.S. is an investigator of the Howard Hughes Medical Institute. A patent application has been filed for aspects of the methods disclosed here (M.W.S., M.K., and J.S.: "Methods of determining tissues and/or cell types giving rise to cfDNA, and methods of identifying a disease or disorder using same"; PCT/US2015/042310).	Andersson R, 2009, GENOME RES, V19, P1732, DOI 10.1101/gr.092353.109; Chan AKC, 2003, ANN CLIN BIOCHEM, V40, P122, DOI 10.1258/000456303763046030; Chang CPY, 2003, CLIN CHIM ACTA, V327, P95, DOI 10.1016/S0009-8981(02)00337-6; Chiu RWK, 2008, P NATL ACAD SCI USA, V105, P20458, DOI 10.1073/pnas.0810641105; Chodavarapu RK, 2010, NATURE, V466, P388, DOI 10.1038/nature09147; Diaz LA, 2014, J CLIN ONCOL, V32, P579, DOI 10.1200/JCO.2012.45.2011; Fan HC, 2008, P NATL ACAD SCI USA, V105, P16266, DOI 10.1073/pnas.0808319105; Fleischhacker M, 2007, BBA-REV CANCER, V1775, P181, DOI 10.1016/j.bbcan.2006.10.001; Fu YT, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000138; Gaffney DJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003036; Galeazzi M, 2003, AUTOIMMUN REV, V2, P50, DOI 10.1016/S1568-9972(02)00101-5; Gansauge MT, 2013, NAT PROTOC, V8, P737, DOI 10.1038/nprot.2013.038; Garcia-Olmo DC, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-8; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Greco FA, 2009, SEMIN ONCOL, V36, P6, DOI 10.1053/j.seminoncol.2008.10.007; Harshman SW, 2013, NUCLEIC ACIDS RES, V41, P9593, DOI 10.1093/nar/gkt700; Holdenrieder S, 2005, CLIN CHEM, V51, P1544, DOI 10.1373/clinchem.2005.049320; Koh W, 2014, P NATL ACAD SCI USA, V111, P7361, DOI 10.1073/pnas.1405528111; Leary RJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004742; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Lo YMD, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001720; Lo YMD, 1999, AM J HUM GENET, V64, P218, DOI 10.1086/302205; Lui YNYN, 2002, CLIN CHEM, V48, P421; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Mouliere F, 2014, MOL ONCOL, V8, P927, DOI 10.1016/j.molonc.2014.02.005; Ong CT, 2014, NAT REV GENET, V15, P234, DOI 10.1038/nrg3663; Pedersen JS, 2014, GENOME RES, V24, P454, DOI 10.1101/gr.163592.113; Rainer TH, 2003, CLIN CHEM, V49, P562, DOI 10.1373/49.4.562; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Sambuy Y, 2005, CELL BIOL TOXICOL, V21, P1, DOI 10.1007/s10565-005-0085-6; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; Schep AN, 2015, GENOME RES, V25, P1757, DOI 10.1101/gr.192294.115; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Snyder TM, 2011, P NATL ACAD SCI USA, V108, P6229, DOI 10.1073/pnas.1013924108; Teif VB, 2012, NAT STRUCT MOL BIOL, V19, P1185, DOI 10.1038/nsmb.2419; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Valouev A, 2011, NATURE, V474, P516, DOI 10.1038/nature10002; Vierstra J, 2014, NAT METHODS, V11, P66, DOI [10.1038/NMETH.2713, 10.1038/nmeth.2713]; Wimberger P, 2011, INT J CANCER, V128, P2572, DOI 10.1002/ijc.25602	40	670	723	8	123	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 14	2016	164	1-2					57	68		10.1016/j.cell.2015.11.050	http://dx.doi.org/10.1016/j.cell.2015.11.050			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DB2LE	26771485	Bronze, Green Accepted			2022-12-28	WOS:000368339300009
J	Yang, CW; Hojer, CD; Zhou, MJ; Wu, XM; Wuster, A; Lee, WP; Yaspan, BL; Chan, AC				Yang, Chiao-Wen; Hojer, Caroline D.; Zhou, Meijuan; Wu, Xiumin; Wuster, Arthur; Lee, Wyne P.; Yaspan, Brian L.; Chan, Andrew C.			Regulation of T Cell Receptor Signaling by DENND1B in T(H)2 Cells and Allergic Disease	CELL			English	Article							GUANINE-NUCLEOTIDE EXCHANGE; EXHALED NITRIC-OXIDE; SUSCEPTIBILITY LOCI; LARGE-SCALE; RAB35; ACTIVATION; CONNECDENN; DOMAIN; FAMILY; MOTIF	The DENN domain is an evolutionary conserved protein module found in all eukaryotes and serves as an exchange factor for Rab-GTPases to regulate diverse cellular functions. Variants in DENND1B are associated with development of childhood asthma and other immune disorders. To understand how DENND1B may contribute to human disease, Dennd1b(-/-) mice were generated and exhibit hyper-allergic responses following antigen challenge. Dennd1b(-/-) T(H)2, but not other T-H cells, exhibit delayed receptor-induced T cell receptor (TCR) downmodulation, enhanced TCR signaling, and increased production of effector cytokines. As DENND1B interacts with AP-2 and Rab35, T(H)2 cells deficient in AP-2 or Rab35 also exhibit enhanced TCR-mediated effector functions. Moreover, human T(H)2 cells carrying asthma-associated DENND1B variants express less DENND1B and phenocopy Dennd1b(-/-) T(H)2 cells. These results provide a molecular basis for how DENND1B, a previously unrecognized regulator of TCR downmodulation in T(H)2 cells, contributes to asthma pathogenesis and how DENN-domaincontaining proteins may contribute to other human disorders.	[Yang, Chiao-Wen; Hojer, Caroline D.] Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA; [Zhou, Meijuan; Wu, Xiumin; Lee, Wyne P.] Genentech Inc, Dept Translat Immunol, San Francisco, CA 94080 USA; [Wuster, Arthur; Yaspan, Brian L.] Genentech Inc, Dept Human Genet, San Francisco, CA 94080 USA; [Wuster, Arthur] Genentech Inc, Dept Bioinformat & Computat Biol, San Francisco, CA 94080 USA; [Chan, Andrew C.] Genentech Inc, Res, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Chan, AC (corresponding author), Genentech Inc, Res, One DNA Way, San Francisco, CA 94080 USA.	acc@gene.com		Wuster, Arthur/0000-0003-4162-5931; Yaspan, Brian/0000-0002-3787-2510				Alcover A, 2000, CRIT REV IMMUNOL, V20, P325; Allaire PD, 2006, J NEUROSCI, V26, P13202, DOI 10.1523/JNEUROSCI.4608-06.2006; Allaire PD, 2010, MOL CELL, V37, P370, DOI 10.1016/j.molcel.2009.12.037; Ansel KM, 2006, ANNU REV IMMUNOL, V24, P607, DOI 10.1146/annurev.immunol.23.021704.115821; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Bachmaier K, 2000, NATURE, V403, P211, DOI 10.1038/35003228; Balagopalan L, 2009, IMMUNOL REV, V232, P84, DOI 10.1111/j.1600-065X.2009.00840.x; Belz GT, 2012, NAT REV IMMUNOL, V12, P101, DOI 10.1038/nri3149; Brodsky FM, 2012, ANNU REV CELL DEV BI, V28, P309, DOI 10.1146/annurev-cellbio-101011-155716; Bromley SK, 2001, ANNU REV IMMUNOL, V19, P375, DOI 10.1146/annurev.immunol.19.1.375; Brownlie RJ, 2013, NAT REV IMMUNOL, V13, P257, DOI 10.1038/nri3403; Chawes BLK, 2015, PEDIATR PULM, V50, P109, DOI 10.1002/ppul.22958; Chawes BLK, 2010, AM J RESP CRIT CARE, V182, P138, DOI 10.1164/rccm.200909-1377OC; Constant SL, 1997, ANNU REV IMMUNOL, V15, P297, DOI 10.1146/annurev.immunol.15.1.297; DIETRICH J, 1994, EMBO J, V13, P2156, DOI 10.1002/j.1460-2075.1994.tb06492.x; Dietrich J, 1997, J CELL BIOL, V138, P271, DOI 10.1083/jcb.138.2.271; Falbel TG, 2003, DEVELOPMENT, V130, P4011, DOI 10.1242/dev.00619; Ferreira MAR, 2011, EUR J HUM GENET, V19, P458, DOI 10.1038/ejhg.2010.191; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Geisler C, 2004, CRIT REV IMMUNOL, V24, P67; Huang J, 2013, IMMUNITY, V39, P846, DOI 10.1016/j.immuni.2013.08.036; Huppa JB, 2003, NAT IMMUNOL, V4, P749, DOI 10.1038/ni951; Kingeter LM, 2010, J IMMUNOL, V185, P4520, DOI 10.4049/jimmunol.1001051; Korasick DA, 2010, J BIOL CHEM, V285, P23340, DOI 10.1074/jbc.M109.090787; Kouranti I, 2006, CURR BIOL, V16, P1719, DOI 10.1016/j.cub.2006.07.020; Lee KH, 2003, SCIENCE, V302, P1218, DOI 10.1126/science.1086507; Levivier E, 2001, BIOCHEM BIOPH RES CO, V287, P688, DOI 10.1006/bbrc.2001.5652; Lindstedt M, 2005, J IMMUNOL, V175, P4839, DOI 10.4049/jimmunol.175.8.4839; Liu HY, 2000, IMMUNITY, V13, P665, DOI 10.1016/S1074-7613(00)00066-2; Liu JZ, 2012, NAT GENET, V44, P1137, DOI 10.1038/ng.2395; Liu XD, 2010, NAT GENET, V42, P658, DOI 10.1038/ng.627; Marat AL, 2012, MOL BIOL CELL, V23, P163, DOI 10.1091/mbc.E11-05-0474; Marat AL, 2011, J BIOL CHEM, V286, P13791, DOI 10.1074/jbc.R110.217067; Marat AL, 2010, J BIOL CHEM, V285, P10627, DOI 10.1074/jbc.M109.050930; Mells GF, 2011, NAT GENET, V43, P329, DOI 10.1038/ng.789; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Morgan JR, 2000, J NEUROSCI, V20, P8667; Murphy MA, 1998, MOL CELL BIOL, V18, P4872, DOI 10.1128/MCB.18.8.4872; Naramura M, 1998, P NATL ACAD SCI USA, V95, P15547, DOI 10.1073/pnas.95.26.15547; Navarro MN, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005477; Patino-Lopez G, 2008, J BIOL CHEM, V283, P18323, DOI 10.1074/jbc.M800056200; Sato M, 2008, EMBO J, V27, P1183, DOI 10.1038/emboj.2008.54; Sleiman PMA, 2010, NEW ENGL J MED, V362, P36, DOI 10.1056/NEJMoa0901867; Smith NLD, 2014, CLIN MICROBIOL INFEC, V20, pO960, DOI 10.1111/1469-0691.12643; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; TELERMAN A, 1987, EUR J IMMUNOL, V17, P991, DOI 10.1002/eji.1830170715; Valitutti S, 1996, EUR J IMMUNOL, V26, P2012, DOI 10.1002/eji.1830260907; Valitutti S, 1997, J EXP MED, V185, P1859, DOI 10.1084/jem.185.10.1859; VALITUTTI S, 1995, NATURE, V375, P148, DOI 10.1038/375148a0; Wheeler DB, 2015, SCIENCE, V350, P211, DOI 10.1126/science.aaa4903; Wu XD, 2011, P NATL ACAD SCI USA, V108, P18672, DOI 10.1073/pnas.1110415108; Xu J, 2015, EMBO REP, V16, P709, DOI 10.15252/embr.201440006; Yoshimura S, 2010, J CELL BIOL, V191, P367, DOI 10.1083/jcb.201008051; Yudushkin IA, 2010, P NATL ACAD SCI USA, V107, P22128, DOI 10.1073/pnas.1016388108	54	37	44	1	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 14	2016	164	1-2					141	155		10.1016/j.cell.2015.11.052	http://dx.doi.org/10.1016/j.cell.2015.11.052			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DB2LE	26774822	Bronze			2022-12-28	WOS:000368339300016
J	Middleton, K				Middleton, Karen			Give patients direct access to physiotherapy	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Middleton, Karen] Leeds Metropolitan Univ, Leeds LS1 3HE, W Yorkshire, England; [Middleton, Karen] Chartered Soc Physiotherapy, London, England	Leeds Beckett University	Middleton, K (corresponding author), Leeds Metropolitan Univ, Leeds LS1 3HE, W Yorkshire, England.	middletonk@csp.org.uk						Briggs T, 2015, GETTING IT RIGHT 1 T, P7; Bury TJ, 2013, PHYS THER, V93, P449, DOI 10.2522/ptj.20120060; Chartered Society of Physiotherapy, 2012, MUSC PHYS PAT SELF R; Chartered Society of Physiotherapy, 2015, PHYS WORKS SELF REF; Chartered Society of Physiotherapy, 2014, FREED INF AUD; Department of Health, 2006, JOINT DOCTRINE INTER; Department of Health, 2008, SELF REF PIL MUSC PH; Holdsworth LK, 2007, PHYSIOTHERAPY, V93, P3, DOI 10.1016/j.physio.2006.05.005; nfpSynergy, 2014, PRIM HEALTHC MON; NHS London, 2012, ALL HLTH PROF MSK TO, P28; Nordeman L, 2006, CLIN J PAIN, V22, P505, DOI 10.1097/01.ajp.0000210696.46250.0d; Royal College of General Practitioners, 2013, 2022 GP VIS GEN PRAC	12	9	9	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 5	2016	352								h6844	10.1136/bmj.h6844	http://dx.doi.org/10.1136/bmj.h6844			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DA8MA	26732983				2022-12-28	WOS:000368057800005
J	Mucci, LA; Hjelmborg, JB; Harris, JR; Czene, K; Havelick, DJ; Scheike, T; Graff, RE; Holst, K; Moller, S; Unger, RH; McIntosh, C; Nuttall, E; Brandt, I; Penney, KL; Hartman, M; Kraft, P; Parmigiani, G; Christensen, K; Koskenvuo, M; Holm, NV; Heikkila, K; Pukkala, E; Skytthe, A; Adami, HO; Kaprio, J				Mucci, Lorelei A.; Hjelmborg, Jacob B.; Harris, Jennifer R.; Czene, Kamila; Havelick, David J.; Scheike, Thomas; Graff, Rebecca E.; Holst, Klaus; Moeller, Soeren; Unger, Robert H.; McIntosh, Christina; Nuttall, Elizabeth; Brandt, Ingunn; Penney, Kathryn L.; Hartman, Mikael; Kraft, Peter; Parmigiani, Giovanni; Christensen, Kaare; Koskenvuo, Markku; Holm, Niels V.; Heikkila, Kauko; Pukkala, Eero; Skytthe, Axel; Adami, Hans-Olov; Kaprio, Jaakko		Nordic Twin Study Canc NorTwinCan	Familial Risk and Heritability of Cancer Among Twins in Nordic Countries	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BREAST-CANCER; MISSING HERITABILITY; ASSOCIATION ANALYSIS; SUSCEPTIBILITY LOCI; PROSTATE-CANCER; POOLED ANALYSIS; REGISTRY; COMPLETENESS; INDIVIDUALS; DISEASE	IMPORTANCE Estimates of familial cancer risk from population-based studies are essential components of cancer risk prediction. OBJECTIVE To estimate familial risk and heritability of cancer types in a large twin cohort. DESIGN, SETTING, AND PARTICIPANTS Prospective study of 80 309 monozygotic and 123 382 same-sex dizygotic twin individuals (N = 203 691) within the population-based registers of Denmark, Finland, Norway, and Sweden. Twins were followed up a median of 32 years between 1943 and 2010. There were 50 990 individuals who died of any cause, and 3804 who emigrated and were lost to follow-up. EXPOSURES Shared environmental and heritable risk factors among pairs of twins. MAIN OUTCOMES AND MEASURES The main outcome was incident cancer. Time-to-event analyses were used to estimate familial risk (risk of cancer in an individual given a twin's development of cancer) and heritability (proportion of variance in cancer risk due to interindividual genetic differences) with follow-up via cancer registries. Statistical models adjusted for age and follow-up time, and accounted for censoring and competing risk of death. RESULTS A total of 27 156 incident cancers were diagnosed in 23 980 individuals, translating to a cumulative incidence of 32%. Cancer was diagnosed in both twins among 1383 monozygotic (2766 individuals) and 1933 dizygotic (2866 individuals) pairs. Of these, 38% of monozygotic and 26% of dizygotic pairs were diagnosed with the same cancer type. There was an excess cancer risk in twins whose co-twin was diagnosed with cancer, with estimated cumulative risks that were an absolute 5%(95% CI, 4%-6%) higher in dizygotic (37%; 95% CI, 36%-38%) and an absolute 14%(95% CI, 12%-16%) higher in monozygotic twins (46%; 95% CI, 44%-48%) whose twin also developed cancer compared with the cumulative risk in the overall cohort (32%). For most cancer types, there were significant familial risks and the cumulative risks were higher in monozygotic than dizygotic twins. Heritability of cancer overall was 33%(95% CI, 30%-37%). Significant heritability was observed for the cancer types of skin melanoma (58%; 95% CI, 43%-73%), prostate (57%; 95% CI, 51%-63%), nonmelanoma skin (43%; 95% CI, 26%-59%), ovary (39%; 95% CI, 23%-55%), kidney (38%; 95% CI, 21%-55%), breast (31%; 95% CI, 11%-51%), and corpus uteri (27%; 95% CI, 11%-43%). CONCLUSIONS AND RELEVANCE In this long-term follow-up study among Nordic twins, there was significant excess familial risk for cancer overall and for specific types of cancer, including prostate, melanoma, breast, ovary, and uterus. This information about hereditary risks of cancers may be helpful in patient education and cancer risk counseling.	[Mucci, Lorelei A.; Havelick, David J.; Graff, Rebecca E.; Unger, Robert H.; Nuttall, Elizabeth; Kraft, Peter; Adami, Hans-Olov] Harvard Univ, TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Mucci, Lorelei A.] Univ Iceland, Div Publ Hlth Sci, Reykjavik, Iceland; [Mucci, Lorelei A.; Penney, Kathryn L.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Channing Div Network Med, Boston, MA 02115 USA; [Hjelmborg, Jacob B.; Czene, Kamila; Moeller, Soeren; Christensen, Kaare; Skytthe, Axel] Univ Southern Denmark, Dept Biostat & Epidemiol, Odense, Denmark; [Hjelmborg, Jacob B.; Czene, Kamila; Moeller, Soeren; Holm, Niels V.; Skytthe, Axel] Univ Southern Denmark, Danish Twin Registry, Odense, Denmark; [Harris, Jennifer R.; Brandt, Ingunn] Norwegian Inst Publ Hlth, Div Epidemiol, Oslo, Norway; [Czene, Kamila; Hartman, Mikael; Adami, Hans-Olov] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Scheike, Thomas; Holst, Klaus] Univ Copenhagen, Dept Biostat, Copenhagen, Denmark; [Graff, Rebecca E.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [McIntosh, Christina; Kraft, Peter; Parmigiani, Giovanni] Harvard Univ, TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Hartman, Mikael] Natl Univ Singapore Hosp, Dept Surg, Singapore 117548, Singapore; [Hartman, Mikael] NUHS, Singapore, Singapore; [Parmigiani, Giovanni] Dana Farber Canc Inst, Dept Computat Biol & Biostat, Boston, MA 02115 USA; [Koskenvuo, Markku; Heikkila, Kauko; Kaprio, Jaakko] Univ Helsinki, Dept Publ Hlth, Hjelt Inst, Helsinki, Finland; [Holm, Niels V.] Odense Univ Hosp, Dept Oncol, DK-5000 Odense, Denmark; [Pukkala, Eero] Finnish Canc Registry, Inst Stat & Epidemiol Canc Res, FIN-00170 Helsinki, Finland; [Pukkala, Eero] Univ Tampere, Sch Hlth Sci, FIN-33101 Tampere, Finland; [Kaprio, Jaakko] Natl Inst Hlth & Welf, Dept Hlth, Helsinki, Finland; [Kaprio, Jaakko] Univ Helsinki, Inst Mol Med, Helsinki, Finland	Harvard University; Harvard T.H. Chan School of Public Health; University of Iceland; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Southern Denmark; University of Southern Denmark; Norwegian Institute of Public Health (NIPH); Karolinska Institutet; University of Copenhagen; University of California System; University of California San Francisco; Harvard University; Harvard T.H. Chan School of Public Health; National University of Singapore; National University of Singapore; Harvard University; Dana-Farber Cancer Institute; University of Helsinki; University of Southern Denmark; Odense University Hospital; Finnish Cancer Registry; Tampere University; Finland National Institute for Health & Welfare; University of Helsinki	Mucci, LA (corresponding author), Harvard Univ, TH Chan Sch Publ Hlth, Dept Epidemiol, 677 Huntington Ave,920E, Boston, MA 02115 USA.	lmucci@hsph.harvard.edu	Heikkilä, Kauko/E-5578-2019; Christensen, Kaare/C-2360-2009; Kraft, Peter/GQH-8448-2022; Möller, Sören/X-8738-2019; Skytthe, Axel E/G-4820-2019; Kaprio, Jaakko/A-1820-2008; Hjelmborg, Jacob/AAN-5966-2020; Hartman, Mikael/B-4324-2011	Heikkilä, Kauko/0000-0002-9256-8028; Christensen, Kaare/0000-0002-5429-5292; Möller, Sören/0000-0003-0858-4269; Skytthe, Axel E/0000-0002-8629-4913; Kaprio, Jaakko/0000-0002-3716-2455; Hjelmborg, Jacob/0000-0001-9630-9149; Scheike, Thomas/0000-0002-2148-4740; Unger, Robert/0000-0001-7047-5456; Kraft, Peter/0000-0002-4472-8103; Hartman, Mikael/0000-0001-5726-9965; Holst, Klaus/0000-0002-1364-6789	Ellison Foundation; Nordic Cancer Union; Academy of Finland [213506, 129680, 265240, 263278]; US BioSHaRE-EU [HEALTH-F4-2010-261433]; Ministry for Higher Education; Odense University Hospital AgeCare program of the Academy of Geriatric Cancer Research; Karolinska Institutet [2368/10-221]; National Cancer Institute [R25 CA098566, R25 CA112355]; NATIONAL CANCER INSTITUTE [R25CA112355, R25CA098566] Funding Source: NIH RePORTER	Ellison Foundation(Lawrence Ellison Foundation); Nordic Cancer Union; Academy of Finland(Academy of Finland); US BioSHaRE-EU; Ministry for Higher Education; Odense University Hospital AgeCare program of the Academy of Geriatric Cancer Research; Karolinska Institutet(Karolinska Institutet); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by funding from the Ellison Foundation (awarded to Drs Mucci and Adami at the Harvard School of Public Health) and the Nordic Cancer Union (awarded to Dr Kaprio). The Finnish Twin Cohort was supported by grants 213506, 129680, 265240, and 263278 from the Academy of Finland and grant agreement HEALTH-F4-2010-261433 from US BioSHaRE-EU. The Swedish Twin Registry was supported by the Ministry for Higher Education. The Danish Twin Cohort was supported by the Odense University Hospital AgeCare program of the Academy of Geriatric Cancer Research. Data collection and research stemming from the Norwegian Twin Registry is supported, in part, from the European Union's Seventh Framework Programme and grant agreement HEALTH-F4-2010-261433 from US BioSHaRE-EU. Dr Mucci is a Prostate Cancer Foundation young investigator. Dr Adami received distinguished professor award 2368/10-221 from the Karolinska Institutet. Dr Graff is supported by National Cancer Institute training grants R25 CA098566 and R25 CA112355.	Al Olama AA, 2015, HUM MOL GENET, V24, P5589, DOI 10.1093/hmg/ddv203; Al Olama AA, 2014, NAT GENET, V46, P1103, DOI 10.1038/ng.3094; American Cancer Society, 2012, CANC FACTS FIG 2012; Amundadottir LT, 2004, PLOS MED, V1, P229, DOI 10.1371/journal.pmed.0010065; Association of the Nordic Cancer Registries, 2001, SURV NORD CANC REG T; Bahcall OG, 2013, NAT GENET, V45, P343, DOI 10.1038/ng.2592; Barlow L, 2009, ACTA ONCOL, V48, P27, DOI 10.1080/02841860802247664; BRAUN MM, 1995, CANCER EPIDEM BIOMAR, V4, P469; Cancer Society of Finland, 2000, CANC INC FINL 2000 2; CANNONALBRIGHT LA, 1994, CANCER RES, V54, P2378; Cheng I, 2014, GUT, V63, P800, DOI 10.1136/gutjnl-2013-305189; Christiansen L, 2003, TWIN RES, V6, P275, DOI 10.1375/twin.6.4.275; Cote ML, 2012, EUR J CANCER, V48, P1957, DOI 10.1016/j.ejca.2012.01.038; Engholm G, 2010, ACTA ONCOL, V49, P725, DOI 10.3109/02841861003782017; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Ghoussaini M, 2012, NAT GENET, V44, P312, DOI 10.1038/ng.1049; GOLDGAR DE, 1994, J NATL CANCER I, V86, P1600, DOI 10.1093/jnci/86.21.1600; Haiman CA, 2011, NAT GENET, V43, P1210, DOI 10.1038/ng.985; Hjelmborg JB, 2014, CANCER EPIDEM BIOMAR, V23, P2303, DOI 10.1158/1055-9965.EPI-13-0568; Jostins L, 2011, HUM MOL GENET, V20, pR182, DOI 10.1093/hmg/ddr378; Kaprio J, 2002, TWIN RES, V5, P358, DOI 10.1375/twin.5.5.358; Kote-Jarai Z, 2011, NAT GENET, V43, P785, DOI 10.1038/ng.882; Li WQ, 2014, CARCINOGENESIS, V35, P2698, DOI 10.1093/carcin/bgu203; Lichtenstein P, 2002, J INTERN MED, V252, P184, DOI 10.1046/j.1365-2796.2002.01032.x; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Lichtenstein P, 2006, TWIN RES HUM GENET, V9, P875, DOI 10.1375/twin.9.6.875; MATTSSON B, 1984, ACTA RADIOL ONCOL, V23, P305, DOI 10.3109/02841868409136026; McGlynn KA, 2012, NAT REV UROL, V9, P339, DOI 10.1038/nrurol.2012.61; Nilsen TS, 2012, TWIN RES HUM GENET, V15, P775, DOI 10.1017/thg.2012.57; Peters U, 2012, HUM GENET, V131, P217, DOI 10.1007/s00439-011-1055-0; Roberts NJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003380; Sampson JN, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv279; Scheike TH, 2014, LIFETIME DATA ANAL, V20, P210, DOI 10.1007/s10985-013-9244-x; Scheurer ME, 2010, AM J EPIDEMIOL, V172, P1099, DOI [10.1093/aje/kwq044, 10.1093/aje/kwq261]; Skytthe A, 2011, SCAND J PUBLIC HEALT, V39, P75, DOI 10.1177/1403494810387966; Southey MC, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3434; Trichopoulos D, 1990, Epidemiology, V1, P95; Wang ZM, 2014, HUM MOL GENET, V23, P6616, DOI 10.1093/hmg/ddu363; Zuk O, 2012, P NATL ACAD SCI USA, V109, P1193, DOI 10.1073/pnas.1119675109	39	418	429	5	42	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 5	2016	315	1					68	76		10.1001/jama.2015.17703	http://dx.doi.org/10.1001/jama.2015.17703			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DA0YH	26746459	Green Accepted, Bronze, Green Submitted			2022-12-28	WOS:000367523000016
J	Muller, V				Mueller, Volker			Microbes in a knight's armor	SCIENCE			English	Editorial Material							ACETOGENIC BACTERIA; CONVERSION; ENERGY; SYNGAS		[Mueller, Volker] Goethe Univ Frankfurt, Inst Mol Biosci, Dept Mol Microbiol & Bioenerget, D-60054 Frankfurt, Germany	Goethe University Frankfurt	Muller, V (corresponding author), Goethe Univ Frankfurt, Inst Mol Biosci, Dept Mol Microbiol & Bioenerget, D-60054 Frankfurt, Germany.	vmueller@bio.uni-frankfurt.de	Mueller, Volker/ABE-4305-2021	Mueller, Volker/0000-0001-7955-5508				Bengelsdorf FR, 2013, ENVIRON TECHNOL, V34, P1639, DOI 10.1080/09593330.2013.827747; Bertsch J, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0393-x; Goldemberg J, 2006, ENERG POLICY, V34, P2185, DOI 10.1016/j.enpol.2005.03.009; Liu C, 2015, NANO LETT, V15, P3634, DOI 10.1021/acs.nanolett.5b01254; Meinshausen M, 2009, NATURE, V458, P1158, DOI 10.1038/nature08017; Nevin KP, 2011, APPL ENVIRON MICROB, V77, P2882, DOI 10.1128/AEM.02642-10; Nevin KP, 2010, MBIO, V1, DOI 10.1128/mBio.00103-10; Nichols EM, 2015, P NATL ACAD SCI USA, V112, P11461, DOI 10.1073/pnas.1508075112; Sakimoto KK, 2016, SCIENCE, V351, P74, DOI 10.1126/science.aad3317; Schuchmann K, 2014, NAT REV MICROBIOL, V12, P809, DOI 10.1038/nrmicro3365; Stern Nicholas, 2007, EC CLIMATE CHANGE; TANNER RS, 1993, INT J SYST BACTERIOL, V43, P232, DOI 10.1099/00207713-43-2-232; VOGEL R, 1994, J PHYS CHEM-US, V98, P3183, DOI 10.1021/j100063a022; Zhang T, 2015, SCIENCE, V350, P738, DOI 10.1126/science.aad6452	14	5	5	0	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 1	2016	351	6268					34	34		10.1126/science.aad8593	http://dx.doi.org/10.1126/science.aad8593			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ8QM	26721992				2022-12-28	WOS:000367364200030
J	Cleary, AS				Cleary, Allison S.			Teamwork: The tumor cell edition	SCIENCE			English	Editorial Material							MUTATIONAL EVOLUTION; PROGENITOR CELLS; PROSTATE-CANCER; MAMMARY CANCERS; BREAST CANCERS; MOUSE MODEL; HETEROGENEITY; HISTORY; INDUCE		[Cleary, Allison S.] Penn State Univ, Coll Med, Hershey, PA 17078 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Cleary, AS (corresponding author), Penn State Univ, Coll Med, Hershey, PA 17078 USA.	acleary@hmc.psu.edu						Archetti M, 2015, P NATL ACAD SCI USA, V112, P1833, DOI 10.1073/pnas.1414653112; Calbo J, 2011, CANCER CELL, V19, P244, DOI 10.1016/j.ccr.2010.12.021; Cho RW, 2008, STEM CELLS, V26, P364, DOI 10.1634/stemcells.2007-0440; Cleary AS, 2014, NATURE, V508, P113, DOI 10.1038/nature13187; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Gundem G, 2015, NATURE, V520, P353, DOI 10.1038/nature14347; HEPPNER GH, 1993, STEM CELLS, V11, P199, DOI 10.1002/stem.5530110306; Kim S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019310; Li Y, 2003, P NATL ACAD SCI USA, V100, P15853, DOI 10.1073/pnas.2136825100; Liu BY, 2004, P NATL ACAD SCI USA, V101, P4158, DOI 10.1073/pnas.0400699101; Marusyk A, 2014, NATURE, V514, P54, DOI 10.1038/nature13556; Mateo F, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-237; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Nik-Zainal S, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.023; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Shah SP, 2012, NATURE, V486, P395, DOI 10.1038/nature10933; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; TSUKAMOTO AS, 1988, CELL, V55, P619, DOI 10.1016/0092-8674(88)90220-6; Zhang M, 2015, CANCER DISCOV, V5, P520, DOI 10.1158/2159-8290.CD-14-1101	19	4	5	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 4	2015	350	6265					1174	1175		10.1126/science.aad7103	http://dx.doi.org/10.1126/science.aad7103			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX4WG	26785463				2022-12-28	WOS:000365700500049
J	Popmintchev, D; Hernandez-Garcia, C; Dollar, F; Mancuso, C; Perez-Hernandez, JA; Chen, MC; Hankla, A; Gao, XH; Shim, B; Gaeta, AL; Tarazkar, M; Romanov, DA; Levis, RJ; Gaffney, JA; Foord, M; Libby, SB; Jaron-Becker, A; Becker, A; Plaja, L; Murnane, MM; Kapteyn, HC; Popmintchev, T				Popmintchev, Dimitar; Hernandez-Garcia, Carlos; Dollar, Franklin; Mancuso, Christopher; Perez-Hernandez, Jose A.; Chen, Ming-Chang; Hankla, Amelia; Gao, Xiaohui; Shim, Bonggu; Gaeta, Alexander L.; Tarazkar, Maryam; Romanov, Dmitri A.; Levis, Robert J.; Gaffney, Jim A.; Foord, Mark; Libby, Stephen B.; Jaron-Becker, Agnieszka; Becker, Andreas; Plaja, Luis; Murnane, Margaret M.; Kapteyn, Henry C.; Popmintchev, Tenio			Ultraviolet surprise: Efficient soft x-ray high-harmonic generation in multiply ionized plasmas	SCIENCE			English	Article							HIGH-ORDER HARMONICS; ATTOSECOND PULSES; LASER; RADIATION; DRIVEN	High-harmonic generation is a universal response of matter to strong femtosecond laser fields, coherently upconverting light to much shorter wavelengths. Optimizing the conversion of laser light into soft x-rays typically demands a trade-off between two competing factors. Because of reduced quantum diffusion of the radiating electron wave function, the emission from each species is highest when a short-wavelength ultraviolet driving laser is used. However, phase matching-the constructive addition of x-ray waves from a large number of atoms-favors longer-wavelength mid-infrared lasers. We identified a regime of high-harmonic generation driven by 40-cycle ultraviolet lasers in waveguides that can generate bright beams in the soft x-ray region of the spectrum, up to photon energies of 280 electron volts. Surprisingly, the high ultraviolet refractive indices of both neutral atoms and ions enabled effective phase matching, even in a multiply ionized plasma. We observed harmonics with very narrow linewidths, while calculations show that the x-rays emerge as nearly time-bandwidth-limited pulse trains of similar to 100 attoseconds.	[Popmintchev, Dimitar; Hernandez-Garcia, Carlos; Dollar, Franklin; Mancuso, Christopher; Hankla, Amelia; Jaron-Becker, Agnieszka; Becker, Andreas; Murnane, Margaret M.; Kapteyn, Henry C.; Popmintchev, Tenio] Univ Colorado, JILA, Boulder, CO 80309 USA; [Hernandez-Garcia, Carlos; Plaja, Luis] Univ Salamanca, Grp Invest Opt Extrema, E-37008 Salamanca, Spain; [Perez-Hernandez, Jose A.] Ctr Laseres Pulsados, E-37008 Salamanca, Spain; [Chen, Ming-Chang] Natl Tsing Hua Univ, Inst Photon Technol, Hsinchu 30013, Taiwan; [Gao, Xiaohui; Shim, Bonggu; Gaeta, Alexander L.] Cornell Univ, Sch Appl & Engn Phys, Ithaca, NY 14853 USA; [Tarazkar, Maryam; Levis, Robert J.] Temple Univ, Dept Chem, Philadelphia, PA 19122 USA; [Romanov, Dmitri A.] Temple Univ, Dept Phys, Philadelphia, PA 19122 USA; [Gaffney, Jim A.; Foord, Mark; Libby, Stephen B.] Lawrence Livermore Natl Lab, Phys & Life Sci, Phys Div, Livermore, CA 94550 USA	University of Colorado System; University of Colorado Boulder; University of Salamanca; National Tsing Hua University; Cornell University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; United States Department of Energy (DOE); Lawrence Livermore National Laboratory	Popmintchev, T (corresponding author), Univ Colorado, JILA, Boulder, CO 80309 USA.	tenio.popmintchev@jila.colorado.edu	Gao, Xiaohui/Z-5131-2019; Gaffney, Jim A/P-3552-2019; Becker, Andreas/K-4402-2013; Popmintchev, Tenio/B-6715-2008; Gaeta, Alexander/AAE-2095-2019; Popmintchev, Dimitar/AAH-1084-2019; Pérez-Hernández, Jose Antonio/N-3254-2014; Kapteyn, Henry C/H-6559-2011; Plaja, Luis/K-8701-2014; Popmintchev, Dimitar/R-8291-2016; Popmintchev, Dimitar/GLU-8991-2022; Hernández-García, Carlos/G-3681-2011; Jaron-Becker, Agnieszka A./C-1227-2014; Libby, Stephen/AAI-5100-2021; Dollar, Franklin/C-9214-2013	Gao, Xiaohui/0000-0002-1084-6515; Popmintchev, Tenio/0000-0002-2023-2226; Popmintchev, Dimitar/0000-0003-4330-8235; Pérez-Hernández, Jose Antonio/0000-0002-1117-0190; Kapteyn, Henry C/0000-0001-8386-6317; Plaja, Luis/0000-0001-8709-7295; Popmintchev, Dimitar/0000-0001-8203-4703; Popmintchev, Dimitar/0000-0001-8203-4703; Hernández-García, Carlos/0000-0002-6153-2647; Jaron-Becker, Agnieszka A./0000-0003-2339-8544; Libby, Stephen/0000-0001-5811-2273; Dollar, Franklin/0000-0003-3346-5763; Gaffney, Jim/0000-0002-2408-0047; Hankla, Amelia (Lia)/0000-0001-9725-5509	Army Research Office [WN11NF-13-1-0259]; NSF PFI AIR; U.S. Department of Energy (DOE) [DE-SC0008803]; Marie Curie International Outgoing Fellowship within the EU Seventh Framework Programme for Research and Technological Development under REA [328334]; NSF [PHY-1125844, PHY-1068706]; AFOSR MURI "Mathematical Modeling and Experimental Validation of Ultrafast Light-Matter Coupling associated with Filamentation in Transparent Media" grant [FA9550-10-1-0561]; Ministry of Science and Technology, Taiwan [102-2112-M-007-025-MY3]; DOE Office of Fusion Energy, HED Laboratory Plasmas program [AT5015033]; DOE, National Nuclear Security Administration [DE-AC52-07NA27344, LLNL-JRNL-676693]; Junta de Castilla y Leon [SA116U13, UIC016]; MINECO [FIS2013-44174-P]; U.S. Department of Energy, Division of Chemical Sciences, Atomic, Molecular and Optical Sciences Program	Army Research Office; NSF PFI AIR(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG)); U.S. Department of Energy (DOE)(United States Department of Energy (DOE)); Marie Curie International Outgoing Fellowship within the EU Seventh Framework Programme for Research and Technological Development under REA; NSF(National Science Foundation (NSF)); AFOSR MURI "Mathematical Modeling and Experimental Validation of Ultrafast Light-Matter Coupling associated with Filamentation in Transparent Media" grant; Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); DOE Office of Fusion Energy, HED Laboratory Plasmas program(United States Department of Energy (DOE)); DOE, National Nuclear Security Administration(National Nuclear Security AdministrationUnited States Department of Energy (DOE)); Junta de Castilla y Leon(Junta de Castilla y Leon); MINECO(Spanish Government); U.S. Department of Energy, Division of Chemical Sciences, Atomic, Molecular and Optical Sciences Program(United States Department of Energy (DOE))	The experimental work was done at JILA, supported by Army Research Office grant WN11NF-13-1-0259, an NSF PFI AIR award, and U.S. Department of Energy (DOE) grant DE-SC0008803 (M.M.M., T.P., and H.C.K.). Theory was supported by a Marie Curie International Outgoing Fellowship within the EU Seventh Framework Programme for Research and Technological Development (2007-2013) under REA grant agreement 328334 (C.H.-G.); Junta de Castilla y Leon (SA116U13, UIC016) and MINECO (FIS2013-44174-P) (C.H.-G. and L.P.); NSF grants PHY-1125844 and PHY-1068706 and AFOSR MURI "Mathematical Modeling and Experimental Validation of Ultrafast Light-Matter Coupling associated with Filamentation in Transparent Media" grant FA9550-10-1-0561 (A.J.-B., R.J.L., X.G., A.L.G., M.M.M., and H.C.K.); Ministry of Science and Technology, Taiwan, grant 102-2112-M-007-025-MY3 (M.-C.C.); U.S. Department of Energy, Division of Chemical Sciences, Atomic, Molecular and Optical Sciences Program (A.B.); and DOE Office of Fusion Energy, HED Laboratory Plasmas program, grant AT5015033 (S.B.L., M.F., and J.A.G.). Lawrence Livermore National Laboratory is operated by Lawrence Livermore National Security LLC for DOE, National Nuclear Security Administration, under contract DE-AC52-07NA27344, LLNL-JRNL-676693. T.P., D.P., M.M.M., and H.C.K. have filed a patent on "Generation of VUV, EUV, X-ray Light Using VUV-UV-VIS Lasers," U.S. patent application 61873794 (2013)/US 20150063385 (2015).	Antoine P, 1997, PHYS REV A, V56, P4960, DOI 10.1103/PhysRevA.56.4960; Arpin P, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.143901; Bauer M, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.025501; Cavalieri AL, 2007, NATURE, V449, P1029, DOI 10.1038/nature06229; Chen MC, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.173901; Chen MC, 2014, P NATL ACAD SCI USA, V111, pE2361, DOI 10.1073/pnas.1407421111; Christov IP, 1997, PHYS REV LETT, V78, P1251, DOI 10.1103/PhysRevLett.78.1251; Cohen O, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.053902; CORKUM PB, 1994, OPT LETT, V19, P1870, DOI 10.1364/OL.19.001870; Drescher M, 2002, NATURE, V419, P803, DOI 10.1038/nature01143; Durfee CG, 1999, PHYS REV LETT, V83, P2187, DOI 10.1103/PhysRevLett.83.2187; FERRAY M, 1988, J PHYS B-AT MOL OPT, V21, pL31, DOI 10.1088/0953-4075/21/3/001; Frolov MV, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.173001; Gibson EA, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.033001; HAIGHT R, 1995, SURF SCI REP, V21, P277, DOI 10.1016/0167-5729(95)00002-X; KRAUSE JL, 1992, PHYS REV LETT, V68, P3535, DOI 10.1103/PhysRevLett.68.3535; KUCHIEV MY, 1987, JETP LETT+, V45, P404; KULANDER KC, 1993, NATO ADV SCI INST SE, V316, P95, DOI 10.1007/978-1-4615-7963-2_10; LEWENSTEIN M, 1994, PHYS REV A, V49, P2117, DOI 10.1103/PhysRevA.49.2117; Mathias S, 2012, P NATL ACAD SCI USA, V109, P4792, DOI 10.1073/pnas.1201371109; MCPHERSON A, 1987, J OPT SOC AM B, V4, P595, DOI 10.1364/JOSAB.4.000595; Miao JW, 2015, SCIENCE, V348, P530, DOI 10.1126/science.aaa1394; Popmintchev D, 2013, CONF LASER ELECTR; Popmintchev T, 2008, OPT LETT, V33, P2128, DOI 10.1364/OL.33.002128; Popmintchev T, 2012, SCIENCE, V336, P1287, DOI 10.1126/science.1218497; Popmintchev T, 2009, P NATL ACAD SCI USA, V106, P10516, DOI 10.1073/pnas.0903748106; Preston SG, 1996, PHYS REV A, V53, pR31, DOI 10.1103/PhysRevA.53.R31; Probst M, 1997, APPL PHYS LETT, V71, P202, DOI 10.1063/1.119500; RAE SC, 1994, OPT COMMUN, V104, P330, DOI 10.1016/0030-4018(94)90565-7; RAE SC, 1992, PHYS REV A, V46, P1084, DOI 10.1103/PhysRevA.46.1084; Rettenberger A, 1997, PHYS REV B, V56, P12092, DOI 10.1103/PhysRevB.56.12092; Rohwer T, 2011, NATURE, V471, P490, DOI 10.1038/nature09829; Rundquist A, 1998, SCIENCE, V280, P1412, DOI 10.1126/science.280.5368.1412; Salieres P, 2012, REP PROG PHYS, V75, DOI 10.1088/0034-4885/75/6/062401; Sansone G, 2006, SCIENCE, V314, P443, DOI 10.1126/science.1132838; Sansone G, 2010, NATURE, V465, P763, DOI 10.1038/nature09084; Seaberg MD, 2011, OPT EXPRESS, V19, P22470, DOI 10.1364/OE.19.022470; SHKOLNIKOV PL, 1994, PHYS REV A, V50, pR4461, DOI 10.1103/PhysRevA.50.R4461; Siemens ME, 2010, NAT MATER, V9, P26, DOI [10.1038/NMAT2568, 10.1038/nmat2568]; Turgut E, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.197201; Voronov SL, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.133902; Wagner NL, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.173902; Zhang BS, 2015, ULTRAMICROSCOPY, V158, P98, DOI 10.1016/j.ultramic.2015.07.006; Zhang XH, 2007, NAT PHYS, V3, P270, DOI 10.1038/nphys541	44	131	132	6	127	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 4	2015	350	6265					1225	1231		10.1126/science.aac9755	http://dx.doi.org/10.1126/science.aac9755			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX4WG	26785483	Green Published			2022-12-28	WOS:000365700500070
J	Harris, AM; Hicks, LA; Qaseem, A				Harris, Aaron M.; Hicks, Lauri A.; Qaseem, Amir		Amer Coll Phys; Ctr Dis Control Prevention	Appropriate Antibiotic Use for Acute Respiratory Tract Infection in Adults: Advice for High-Value Care From the American College of Physicians and the Centers for Disease Control and Prevention	ANNALS OF INTERNAL MEDICINE			English	Article							CLINICAL-PRACTICE GUIDELINE; ACUTE BACTERIAL RHINOSINUSITIS; ACUTE BRONCHITIS; UNITED-STATES; AMBULATORY-CARE; SORE THROAT; PRINCIPLES; PHARYNGITIS; TRIAL; COMMUNICATION	Background: Acute respiratory tract infection (ARTI) is the most common reason for antibiotic prescription in adults. Antibiotics are often inappropriately prescribed for patients with ARTI. This article presents best practices for antibiotic use in healthy adults (those without chronic lung disease or immunocompromising conditions) presenting with ARTI. Methods: A narrative literature review of evidence about appropriate antibiotic use for ARTI in adults was conducted. The most recent clinical guidelines from professional societies were complemented by meta-analyses, systematic reviews, and randomized clinical trials. To identify evidence-based articles, the Cochrane Library, PubMed, MEDLINE, and EMBASE were searched through September 2015 using the following Medical Subject Headings terms: "acute bronchitis," "respiratory tract infection," "pharyngitis," "rhinosinusitis," and "the common cold." High-Value Care Advice 1: Clinicians should not perform testing or initiate antibiotic therapy in patients with bronchitis unless pneumonia is suspected. High-Value Care Advice 2: Clinicians should test patients with symptoms suggestive of group A streptococcal pharyngitis (for example, persistent fevers, anterior cervical adenitis, and tonsillopharyngeal exudates or other appropriate combination of symptoms) by rapid antigen detection test and/or culture for group A Streptococcus. Clinicians should treat patients with antibiotics only if they have confirmed streptococcal pharyngitis. High-Value Care Advice 3: Clinicians should reserve antibiotic treatment for acute rhinosinusitis for patients with persistent symptoms for more than 10 days, onset of severe symptoms or signs of high fever (>39 degrees C) and purulent nasal discharge or facial pain lasting for at least 3 consecutive days, or onset of worsening symptoms following a typical viral illness that lasted 5 days that was initially improving (double sickening). High-Value Care Advice 4: Clinicians should not prescribe antibiotics for patients with the common cold.	[Qaseem, Amir] Amer Coll Physicians, 190 N Independence Mall West, Philadelphia, PA 19106 USA; [Harris, Aaron M.; Hicks, Lauri A.] Ctr Dis Control & Prevent, 1600 Clifton Rd,Mailstop G-37, Atlanta, GA 30329 USA	American College of Physicians; Centers for Disease Control & Prevention - USA	Qaseem, A (corresponding author), Amer Coll Physicians, 190 N Independence Mall West, Philadelphia, PA 19106 USA.	aqaseem@acponline.org			ACP; Centers for Disease Control and Prevention	ACP; Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Financial support for the development of this guideline comes exclusively from the operating budgets of ACP and the Centers for Disease Control and Prevention.	Alcaide ML, 2007, INFECT DIS CLIN N AM, V21, P449, DOI 10.1016/j.idc.2007.03.001; Alcaide ML, 2007, INFECT DIS CLIN N AM, V21, pvii; Aring AM, 2011, AM FAM PHYSICIAN, V83, P1057; Arnold SR, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003539.pub2; Barnett ML, 2014, JAMA-J AM MED ASSOC, V311, P2020, DOI 10.1001/jama.2013.286141; Barnett ML, 2014, JAMA INTERN MED, V174, P138, DOI 10.1001/jamainternmed.2013.11673; Becker LA, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001726.pub5; Benninger MS, 2000, OTOLARYNG HEAD NECK, V122, P1, DOI 10.1016/S0194-5998(00)70135-5; Boivin G, 2002, J INFECT DIS, V186, P1330, DOI 10.1086/344319; Centers for Disease Control and Prevention, 2015, GET SMART KNOW ANT W; Centor R M, 1981, Med Decis Making, V1, P239, DOI 10.1177/0272989X8100100304; Centor RM, 2015, ANN INTERN MED, V162, P241, DOI 10.7326/M14-1305; Chang CC, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006088.pub3; Chow AW, 2012, CLIN INFECT DIS, V54, pE72, DOI [10.1093/cid/cis370, 10.1093/cid/cir1043]; Cooper RJ, 2001, ANN INTERN MED, V134, P509, DOI 10.7326/0003-4819-134-6-200103200-00019; Das RR, 2014, JAMA-J AM MED ASSOC, V311, P1440, DOI 10.1001/jama.2014.1404; De Sutter AIM, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004976.pub3; Fairlie T, 2012, ARCH INTERN MED, V172, P1513, DOI 10.1001/archinternmed.2012.4089; Finkelstein JA, 2008, PEDIATRICS, V121, pE15, DOI 10.1542/peds.2007-0819; Garbutt JM, 2012, JAMA-J AM MED ASSOC, V307, P685, DOI 10.1001/jama.2012.138; Gonzales R, 2001, ANN INTERN MED, V134, P490, DOI 10.7326/0003-4819-134-6-200103200-00015; Gonzales R, 2001, ANN INTERN MED, V134, P521, DOI 10.7326/0003-4819-134-6-200103200-00021; Gonzales R, 2001, ANN INTERN MED, V134, P479, DOI 10.7326/0003-4819-134-6-200103200-00013; Gonzales R, 2001, Eff Clin Pract, V4, P105; Gonzales R, 1997, JAMA-J AM MED ASSOC, V278, P901, DOI 10.1001/jama.278.11.901; Gonzales R, 2008, MED CARE, V46, P597, DOI 10.1097/MLR.0b013e3181653d2e; Gonzales R, 2013, JAMA INTERN MED, V173, P267, DOI 10.1001/jamainternmed.2013.1589; Grijalva CG, 2009, JAMA-J AM MED ASSOC, V302, P758, DOI 10.1001/jama.2009.1163; Heikkinen T, 2003, LANCET, V361, P51, DOI 10.1016/S0140-6736(03)12162-9; Hemila H, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000980.pub4; Hersh AL, 2013, PEDIATRICS, V132, P1146, DOI 10.1542/peds.2013-3260; Hickner JM, 2001, ANN INTERN MED, V134, P498, DOI 10.7326/0003-4819-134-6-200103200-00017; Hicks LA, 2013, NEW ENGL J MED, V368, P1461, DOI 10.1056/NEJMc1212055; Hicks LA, 2011, CLIN INFECT DIS, V53, P631, DOI 10.1093/cid/cir443; Karsch-Volk M, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000530.pub3; Kenealy T, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000247.pub3; King DE, 1996, J FAM PRACTICE, V42, P601; Kristensen LH, 2008, EUR J CLIN MICROBIOL, V27, P779, DOI 10.1007/s10096-008-0496-4; Lemiengre MB, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006089.pub4; Lessa FC, 2015, NEW ENGL J MED, V372, P825, DOI [10.1056/NEJMoa1408913, 10.1056/NEJMc1505190]; Linder Jeffrey A, 2009, Inform Prim Care, V17, P231; Llor C, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5762; Macfarlane J, 2002, BRIT MED J, V324, P91, DOI 10.1136/bmj.324.7329.91; Mainous AG, 2000, FAM MED, V32, P22; Mangione-Smith R, 2001, ARCH PEDIAT ADOL MED, V155, P800, DOI 10.1001/archpedi.155.7.800; Mangione-Smith R, 2015, ANN FAM MED, V13, P221, DOI 10.1370/afm.1785; McCaig Linda E., 2011, Morbidity and Mortality Weekly Report, V60, P1153; Meltzer Eli O, 2004, J Allergy Clin Immunol, V114, P155, DOI 10.1016/j.jaci.2004.09.029; Mosser AG, 2005, AM J RESP CRIT CARE, V171, P645, DOI 10.1164/rccm.200407-970OC; Nuorti J Pekka, 2010, MMWR Recomm Rep, V59, P1; Phillips TG, 2005, J AM BOARD FAM PRACT, V18, P459, DOI 10.3122/jabfm.18.6.459; Price SL, 2011, BRIT J BIOMED SCI, V68, P209, DOI 10.1080/09674845.2011.11978256; Rosenfeld RM, 2015, OTOLARYNG HEAD NECK, V152, pS1, DOI 10.1177/0194599815572097; Schappert Susan M, 2008, Natl Health Stat Report, P1; Schappert Susan M, 2006, Vital Health Stat 13, P1; Scott JG, 2001, J FAM PRACTICE, V50, P853; Shapiro DJ, 2014, J ANTIMICROB CHEMOTH, V69, P234, DOI 10.1093/jac/dkt301; Shehab N, 2008, CLIN INFECT DIS, V47, P735, DOI 10.1086/591126; Shulman ST, 2012, CLIN INFECT DIS, V55, P1279, DOI 10.1093/cid/cis847; Singh M, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001364.pub5; Slavin Raymond G, 2005, J Allergy Clin Immunol, V116, pS13, DOI 10.1016/j.jaci.2005.09.048; Smith SM, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001831.pub5; Smith SM, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000245.pub3; Snow V, 2001, ANN INTERN MED, V134, P518, DOI 10.7326/0003-4819-134-6-200103200-00020; Spinks A, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000023.pub4; Suda KJ, 2013, J ANTIMICROB CHEMOTH, V68, P715, DOI 10.1093/jac/dks445; Tan T, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a437; Turner RB, 1997, ANN ALLERG ASTHMA IM, V78, P531, DOI 10.1016/S1081-1206(10)63213-9; Weissman Jennifer, 2004, Semin Pediatr Infect Dis, V15, P41, DOI 10.1053/j.spid.2004.01.004	69	202	218	0	29	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 15	2016	164	6					425	+		10.7326/M15-1840	http://dx.doi.org/10.7326/M15-1840			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DG6PG	26785402				2022-12-28	WOS:000372207200016
J	Homer, CSE; Malata, A; ten Hoope-Bender, P				Homer, Caroline S. E.; Malata, Address; ten Hoope-Bender, Petra			Supporting women, families, and care providers after stillbirths	LANCET			English	Editorial Material							MIDWIFERY; HEALTH		[Homer, Caroline S. E.] Univ Technol Sydney, Ctr Midwifery Child & Family Hlth, Sydney, NSW 2007, Australia; [Malata, Address] Univ Malawi, Kamuzu Coll Nursing, Lilongwe, Malawi; [Malata, Address] Int Confederat Midwives, The Hague, Netherlands	University of Technology Sydney; University of Malawi	Homer, CSE (corresponding author), Univ Technol Sydney, Ctr Midwifery Child & Family Hlth, Sydney, NSW 2007, Australia.	caroline.homer@uts.edu.au	Homer, Caroline/J-2101-2014	Homer, Caroline/0000-0002-7454-3011				Darmstadt GL, 2011, LANCET, V377, P1550, DOI 10.1016/S0140-6736(11)60099-8; Flenady V, 2014, BJOG-INT J OBSTET GY, V121, P137, DOI 10.1111/1471-0528.13009; Flenady V, 2016, LANCET, V387, P691, DOI 10.1016/S0140-6736(15)01020-X; Froen JF, 2016, LANCET; Heazell AEP, 2016, LANCET, V387, P604, DOI 10.1016/S0140-6736(15)00836-3; Hennegan JM, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008616; Homer CSE, 2014, LANCET, V384, P1146, DOI 10.1016/S0140-6736(14)60790-X; Kinney MV, 2016, LANCET; Lawn JE, 2016, LANCET; Partnership for Maternal Newborn and Child Health, 2011, GLOB REV KEY INT REL; Peters MDJ, 2015, WOMEN BIRTH, V28, P272, DOI 10.1016/j.wombi.2015.07.003; Renfrew MJ, 2014, LANCET, V384, P1129, DOI 10.1016/S0140-6736(14)60789-3; Smith R, 2011, MIDIRS MIDWIFERY DIG, V21, P19; ten Hoope-Bender P, 2014, LANCET, V384, P1226, DOI 10.1016/S0140-6736(14)60930-2; Van Lerberghe W, 2014, LANCET, V384, P1215, DOI 10.1016/S0140-6736(14)60919-3	15	21	25	0	16	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 6	2016	387	10018					516	+		10.1016/S0140-6736(15)01278-7	http://dx.doi.org/10.1016/S0140-6736(15)01278-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DD3PV	26794072	Green Submitted			2022-12-28	WOS:000369835800012
J	Massague, J; Obenauf, AC				Massague, Joan; Obenauf, Anna C.			Metastatic colonization by circulating tumour cells	NATURE			English	Review							BREAST-CANCER CELLS; TO-MESENCHYMAL TRANSITION; STEM-CELLS; BONE METASTASIS; MOUSE MODEL; COLORECTAL-CANCER; LUNG METASTASIS; RAF INHIBITORS; LYSYL OXIDASE; PROGRESSION	Metastasis is the main cause of death in people with cancer. To colonize distant organs, circulating tumour cells must overcome many obstacles through mechanisms that we are only now starting to understand. These include infiltrating distant tissue, evading immune defences, adapting to supportive niches, surviving as latent tumour-initiating seeds and eventually breaking out to replace the host tissue. They make metastasis a highly inefficient process. However, once metastases have been established, current treatments frequently fail to provide durable responses. An improved understanding of the mechanistic determinants of such colonization is needed to better prevent and treat metastatic cancer.	[Massague, Joan; Obenauf, Anna C.] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center	Massague, J (corresponding author), Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10065 USA.	j-massague@ski.mskcc.org		Obenauf, Anna/0000-0002-9556-5914; Massague, Joan/0000-0001-9324-8408	US National Institutes of Health [CA163167, CA129243]; Congressionally Directed Medical Research Programs of the US Department of Defense, Cancer Center Support Grant [P30 CA008748]; Center for Metastasis Research of the Memorial Sloan Kettering Cancer Center; Austrian Science Fund [J3013]; NATIONAL CANCER INSTITUTE [P30CA008748, U54CA163167, P01CA129243] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Congressionally Directed Medical Research Programs of the US Department of Defense, Cancer Center Support Grant; Center for Metastasis Research of the Memorial Sloan Kettering Cancer Center; Austrian Science Fund(Austrian Science Fund (FWF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank K. Ganesh and T. Wiesner for useful input. J.M. was supported by US National Institutes of Health grants CA163167 and CA129243, the Congressionally Directed Medical Research Programs of the US Department of Defense, Cancer Center Support Grant P30 CA008748 and the Center for Metastasis Research of the Memorial Sloan Kettering Cancer Center. A.C.O. was an Erwin Schroedinger Fellowship awardee (J3013, Austrian Science Fund).	Aceto N, 2014, CELL, V158, P1110, DOI 10.1016/j.cell.2014.07.013; Acharyya S, 2012, CELL, V150, P165, DOI 10.1016/j.cell.2012.04.042; Aguirre-Ghiso JA, 2001, MOL BIOL CELL, V12, P863, DOI 10.1091/mbc.12.4.863; Aird WC, 2007, CIRC RES, V100, P158, DOI 10.1161/01.RES.0000255691.76142.4a; Al-Mehdi AB, 2000, NAT MED, V6, P100, DOI 10.1038/71429; Barkan D, 2010, CANCER RES, V70, P5706, DOI 10.1158/0008-5472.CAN-09-2356; Bidwell BN, 2012, NAT MED, V18, P1224, DOI 10.1038/nm.2830; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Bragado P, 2013, NAT CELL BIOL, V15, P1351, DOI 10.1038/ncb2861; Braun S, 2005, NEW ENGL J MED, V353, P793, DOI 10.1056/NEJMoa050434; Budczies J, 2015, ONCOTARGET, V6, P570, DOI 10.18632/oncotarget.2677; Calbo J, 2011, CANCER CELL, V19, P244, DOI 10.1016/j.ccr.2010.12.021; Calon A, 2012, CANCER CELL, V22, P571, DOI 10.1016/j.ccr.2012.08.013; Cameron MD, 2000, CANCER RES, V60, P2541; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Cao ZW, 2014, CANCER CELL, V25, P350, DOI 10.1016/j.ccr.2014.02.005; Carbonell WS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005857; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Chen J, 2012, NATURE, V488, P522, DOI 10.1038/nature11287; Chen Q, 2011, CANCER CELL, V20, P538, DOI 10.1016/j.ccr.2011.08.025; Cleary AS, 2014, NATURE, V508, P113, DOI 10.1038/nature13187; Coleman R, 2015, LANCET, V386, P1353, DOI 10.1016/S0140-6736(15)60908-4; Collignon FP, 2004, AM J TRANSPLANT, V4, P15, DOI 10.1046/j.1600-6143.2003.00289.x; Costa-Silva B, 2015, NAT CELL BIOL, V17, P816, DOI 10.1038/ncb3169; Cox TR, 2015, NATURE, V522, P106, DOI 10.1038/nature14492; Deneve E, 2013, CLIN CHEM, V59, P1384, DOI 10.1373/clinchem.2013.202846; Driessens G, 2012, NATURE, V488, P527, DOI 10.1038/nature11344; Eisinger-Mathason TSK, 2013, CANCER DISCOV, V3, P1190, DOI 10.1158/2159-8290.CD-13-0118; Ell B, 2013, CANCER CELL, V24, P542, DOI 10.1016/j.ccr.2013.09.008; Erler JT, 2009, CANCER CELL, V15, P35, DOI 10.1016/j.ccr.2008.11.012; Erler JT, 2006, NATURE, V440, P1222, DOI 10.1038/nature04695; Eyles J, 2010, J CLIN INVEST, V120, P2030, DOI 10.1172/JCI42002; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Fischer KR, 2015, NATURE, V527, P472, DOI 10.1038/nature15748; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; Gao H, 2012, CELL, V150, P764, DOI 10.1016/j.cell.2012.06.035; Ghajar CM, 2013, NAT CELL BIOL, V15, P807, DOI 10.1038/ncb2767; Giampieri S, 2009, NAT CELL BIOL, V11, P1287, DOI 10.1038/ncb1973; Gilbert LA, 2010, CELL, V143, P355, DOI 10.1016/j.cell.2010.09.043; Gilkes DM, 2013, MOL CANCER RES, V11, P456, DOI 10.1158/1541-7786.MCR-12-0629; Gnant M, 2015, LANCET, V386, P433, DOI 10.1016/S0140-6736(15)60995-3; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Gundem G, 2015, NATURE, V520, P353, DOI 10.1038/nature14347; Gupta GP, 2007, NATURE, V446, P765, DOI 10.1038/nature05760; Hall A, 2009, CANCER METAST REV, V28, P5, DOI 10.1007/s10555-008-9166-3; Hambardzumyan D, 2008, GENE DEV, V22, P436, DOI 10.1101/gad.1627008; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Heyn C, 2006, MAGN RESON MED, V56, P1001, DOI 10.1002/mrm.21029; Higgins MJ, 2011, J CLIN INVEST, V121, P3797, DOI 10.1172/JCI57152; Holohan C, 2013, NAT REV CANCER, V13, P714, DOI 10.1038/nrc3599; Hoshino A, 2015, NATURE, V527, P329, DOI 10.1038/nature15756; Hsu YC, 2014, NAT MED, V20, P847, DOI 10.1038/nm.3643; Huang Q, 2011, NAT MED, V17, P860, DOI 10.1038/nm.2385; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Kang YB, 2013, CANCER CELL, V23, P573, DOI 10.1016/j.ccr.2013.04.017; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Kienast Y, 2010, NAT MED, V16, P116, DOI 10.1038/nm.2072; Kim MY, 2009, CELL, V139, P1315, DOI 10.1016/j.cell.2009.11.025; Kim SW, 2014, NEURO-ONCOLOGY, V16, P1585, DOI 10.1093/neuonc/nou128; Klein CA, 2009, NAT REV CANCER, V9, P302, DOI 10.1038/nrc2627; Kobayashi A, 2011, J EXP MED, V208, P2641, DOI 10.1084/jem.20110840; Korpal M, 2011, NAT MED, V17, P1101, DOI 10.1038/nm.2401; Kreso A, 2014, CELL STEM CELL, V14, P275, DOI 10.1016/j.stem.2014.02.006; Kurtova AV, 2015, NATURE, V517, P209, DOI 10.1038/nature14034; Labelle M, 2011, CANCER CELL, V20, P576, DOI 10.1016/j.ccr.2011.09.009; Lawson DA, 2015, NATURE, V526, P131, DOI 10.1038/nature15260; Le Gal K, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aad3740; Levine JH, 2015, CELL, V162, P184, DOI 10.1016/j.cell.2015.05.047; Li B, 2014, CLIN CANCER RES, V20, P2651, DOI 10.1158/1078-0432.CCR-13-2735; Lito P, 2012, CANCER CELL, V22, P668, DOI 10.1016/j.ccr.2012.10.009; Lu X, 2011, CANCER CELL, V20, P701, DOI 10.1016/j.ccr.2011.11.002; Lu X, 2009, GENE DEV, V23, P1882, DOI 10.1101/gad.1824809; Luzzi KJ, 1998, AM J PATHOL, V153, P865, DOI 10.1016/S0002-9440(10)65628-3; Lynch CC, 2005, CANCER CELL, V7, P485, DOI 10.1016/j.ccr.2005.04.013; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Magnon C, 2013, SCIENCE, V341, P143, DOI 10.1126/science.1236361; Malanchi I, 2012, NATURE, V481, P85, DOI 10.1038/nature10694; Marusyk A, 2014, NATURE, V514, P54, DOI 10.1038/nature13556; Matsuda Y, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2317; McAllister SS, 2014, NAT CELL BIOL, V16, P717, DOI 10.1038/ncb3015; Milsom CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071270; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Minn AJ, 2005, J CLIN INVEST, V115, P44, DOI 10.1172/JCI200522320; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Nagrath S, 2007, NATURE, V450, P1235, DOI 10.1038/nature06385; Naxerova K, 2015, NAT REV CLIN ONCOL, V12, P258, DOI 10.1038/nrclinonc.2014.238; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Nowak DG, 2015, CANCER DISCOV, V5, P636, DOI 10.1158/2159-8290.CD-14-1113; Obenauf AC, 2015, TRENDS CANCER, V1, P76, DOI 10.1016/j.trecan.2015.07.009; Obenauf AC, 2015, NATURE, V520, P368, DOI 10.1038/nature14336; Oskarsson T, 2014, CELL STEM CELL, V14, P306, DOI 10.1016/j.stem.2014.02.002; Oskarsson T, 2011, NAT MED, V17, P867, DOI 10.1038/nm.2379; Padua D, 2008, CELL, V133, P66, DOI 10.1016/j.cell.2008.01.046; Pantel K, 2004, NAT REV CANCER, V4, P448, DOI 10.1038/nrc1370; Paolino M, 2014, NATURE, V507, P508, DOI 10.1038/nature12998; Patel AP, 2014, SCIENCE, V344, P1396, DOI 10.1126/science.1254257; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Pencheva N, 2013, NAT CELL BIOL, V15, P546, DOI 10.1038/ncb2769; Pencheva N, 2012, CELL, V151, P1068, DOI 10.1016/j.cell.2012.10.028; Piskounova E, 2015, NATURE, V527, P186, DOI 10.1038/nature15726; Postow MA, 2015, NEW ENGL J MED, V372, P2006, DOI 10.1056/NEJMoa1414428; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Robinson D, 2015, CELL, V161, P1215, DOI 10.1016/j.cell.2015.05.001; Roh-Johnson M, 2014, ONCOGENE, V33, P4203, DOI 10.1038/onc.2013.377; Schepers AG, 2012, SCIENCE, V337, P730, DOI 10.1126/science.1224676; Schumacher D, 2013, CANCER CELL, V24, P130, DOI 10.1016/j.ccr.2013.05.008; Sethi N, 2011, CANCER CELL, V19, P192, DOI 10.1016/j.ccr.2010.12.022; Sevenich L, 2014, NAT CELL BIOL, V16, P876, DOI 10.1038/ncb3011; Sharma P, 2015, CELL, V161, P205, DOI 10.1016/j.cell.2015.03.030; Shiozawa Y, 2011, J CLIN INVEST, V121, P1298, DOI 10.1172/JCI43414; Smith MP, 2014, CANCER DISCOV, V4, P1214, DOI 10.1158/2159-8290.CD-13-1007; Smyth MJ, 1999, J IMMUNOL, V162, P6658; Sosa MS, 2014, NAT REV CANCER, V14, P611, DOI 10.1038/nrc3793; Strauss DC, 2010, LANCET ONCOL, V11, P790, DOI 10.1016/S1470-2045(10)70024-3; Straussman R, 2012, NATURE, V487, P500, DOI 10.1038/nature11183; Sun Y, 2012, NAT MED, V18, P1359, DOI 10.1038/nm.2890; Tabaries S, 2012, MOL CELL BIOL, V32, P2979, DOI 10.1128/MCB.00299-12; Tabassum DP, 2015, NAT REV CANCER, V15, P473, DOI 10.1038/nrc3971; Takeda K, 2001, NAT MED, V7, P94, DOI 10.1038/83416; Tam WL, 2013, NAT MED, V19, P1438, DOI 10.1038/nm.3336; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tichet M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7993; Tominaga N, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7716; Urosevic J, 2014, NAT CELL BIOL, V16, P685, DOI 10.1038/ncb2977; Valiente M, 2014, CELL, V156, P1002, DOI 10.1016/j.cell.2014.01.040; Vanharanta S, 2013, CANCER CELL, V24, P410, DOI 10.1016/j.ccr.2013.09.007; Vanharanta S, 2013, NAT MED, V19, P50, DOI 10.1038/nm.3029; Wang T, 2015, CLIN CANCER RES, V21, P1652, DOI 10.1158/1078-0432.CCR-14-1554; Wculek SK, 2015, NATURE, V528, P413, DOI 10.1038/nature16140; Weilbaecher KN, 2011, NAT REV CANCER, V11, P411, DOI 10.1038/nrc3055; Weis S, 2004, J CELL BIOL, V167, P223, DOI 10.1083/jcb.200408130; Wong CW, 2001, CANCER RES, V61, P333; Wyckoff J, 2004, CANCER RES, V64, P7022, DOI 10.1158/0008-5472.CAN-04-1449; Yin JJ, 1999, J CLIN INVEST, V103, P197, DOI 10.1172/JCI3523; Zhang XHF, 2013, CELL, V154, P1060, DOI 10.1016/j.cell.2013.07.036; Zhang XHF, 2009, CANCER CELL, V16, P67, DOI 10.1016/j.ccr.2009.05.017; Zheng XF, 2015, NATURE, V527, P525, DOI 10.1038/nature16064; Zhou WY, 2014, CANCER CELL, V25, P501, DOI 10.1016/j.ccr.2014.03.007	144	1070	1111	25	628	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 21	2016	529	7586					298	306		10.1038/nature17038	http://dx.doi.org/10.1038/nature17038			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB2QT	26791720	Green Accepted			2022-12-28	WOS:000368354800031
J	Rafii, S; Butler, JM; Ding, BS				Rafii, Shahin; Butler, Jason M.; Ding, Bi-Sen			Angiocrine functions of organ-specific endothelial cells	NATURE			English	Review							HEMATOPOIETIC STEM-CELLS; BONE-MARROW NICHE; VASCULAR NICHE; SELF-RENEWAL; PROGENITOR CELLS; LIVER-REGENERATION; BLOOD-VESSELS; CD34(+) CELLS; ADULT STEM; EXPANSION	Endothelial cells that line capillaries are not just passive conduits for delivering blood. Tissue-specific endothelium establishes specialized vascular niches that deploy sets of growth factors, known as angiocrine factors. These cues participate actively in the induction, specification, patterning and guidance of organ regeneration, as well as in the maintainance of homeostasis and metabolism. When upregulated following injury, they orchestrate self-renewal and differentiation of tissue-specific resident stem and progenitor cells into functional organs. Uncovering the mechanisms by which organotypic endothelium distributes physiological levels of angiocrine factors both spatially and temporally will lay the foundation for clinical trials that promote organ repair without scarring.	[Rafii, Shahin; Butler, Jason M.; Ding, Bi-Sen] Weill Cornell Med Coll, Div Regenerat Med, Dept Med, Ansary Stem Cell Inst, New York, NY 10065 USA	Cornell University	Rafii, S (corresponding author), Weill Cornell Med Coll, Div Regenerat Med, Dept Med, Ansary Stem Cell Inst, 1300 York Ave, New York, NY 10065 USA.	srafii@med.cornell.edu; jmb2009@med.cornell.edu; bid2004@med.cornell.edu			Ansary Stem Cell Institute; Empire State Stem Cell Board; New York State Department of Health [C026878, C028117, C029156]; Howard Hughes Medical Institute; US National Heart, Lung, and Blood Institute [R01HL115128, R01HL119872, R01HL128158]; US National Cancer Institute [U54CA163167]; US National Institute of Diabetes and Digestive and Kidney Diseases [R01DK095039]; Qatar National Priorities Research Program [NPRP 6-131-3-268]; American Society of Hematology Scholar Award; American Federation for Aging Research grant; Leukemia and Lymphoma Society Quest for Cures award; American Heart Association [12SDG1213004]; NATIONAL CANCER INSTITUTE [U54CA163167] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL119872, R01HL115128, R01HL128158] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095039] Funding Source: NIH RePORTER	Ansary Stem Cell Institute; Empire State Stem Cell Board; New York State Department of Health; Howard Hughes Medical Institute(Howard Hughes Medical Institute); US National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); US National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Qatar National Priorities Research Program(Qatar National Research Fund (QNRF)); American Society of Hematology Scholar Award; American Federation for Aging Research grant; Leukemia and Lymphoma Society Quest for Cures award; American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We acknowledge R. Nachman, D. Hajjar and the late A. Marcus and J. Folkman, whose pioneering work in vascular biology inspired us to uncover the instructive functions of endothelial cells. We thank our colleagues W. Schachterle, M. Poulos, K. Shido, S. Rabbany, P. Kermani, R. Lis, M. Seandel, A. Rafii, D. James, J. Scandura, M. Ginsberg, D. Nolan, G. Davis, Z. Rosenwaks, M. Sadelain, I. Riviere and J. Port for critical review and scientific input. We are grateful to Z. Cao for providing expertise in artwork. We apologize to those scientists whose work we could not highlight owing to space limitations. S. R. was supported by the Ansary Stem Cell Institute, the Empire State Stem Cell Board and New York State Department of Health (C026878, C028117 and C029156), the Howard Hughes Medical Institute, the US National Heart, Lung, and Blood Institute (R01HL115128, R01HL119872 and R01HL128158), the US National Cancer Institute (U54CA163167), the US National Institute of Diabetes and Digestive and Kidney Diseases (R01DK095039) and the Qatar National Priorities Research Program (NPRP 6-131-3-268). J.M.B was supported by the Ansary Stem Cell Institute, an American Society of Hematology Scholar Award, an American Federation for Aging Research grant and a Leukemia and Lymphoma Society Quest for Cures award. B.-S.D was supported by the Ansary Stem Cell Institute and the American Heart Association (12SDG1213004).	Acar M, 2015, NATURE, V526, P126, DOI 10.1038/nature15250; Aird WC, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006429; Almaca J, 2014, P NATL ACAD SCI USA, V111, P17612, DOI 10.1073/pnas.1414053111; Alphonse RS, 2014, CIRCULATION, V129, P2144, DOI 10.1161/CIRCULATIONAHA.114.009124; Andreu-Agullo C, 2009, NAT NEUROSCI, V12, P1514, DOI 10.1038/nn.2437; AUGUSTIN HG, 1994, BIOESSAYS, V16, P901, DOI 10.1002/bies.950161208; Avecilla ST, 2004, NAT MED, V10, P64, DOI 10.1038/nm973; Brandt JE, 1999, BLOOD, V94, P106, DOI 10.1182/blood.V94.1.106.413k01_106_113; Brenet F, 2013, J EXP MED, V210, P623, DOI 10.1084/jem.20121610; Butler JM, 2012, BLOOD, V120, P1344, DOI 10.1182/blood-2011-12-398115; Butler JM, 2010, CELL STEM CELL, V6, P251, DOI 10.1016/j.stem.2010.02.001; Butler JM, 2010, NAT REV CANCER, V10, P138, DOI 10.1038/nrc2791; Cao YH, 2013, CELL METAB, V18, P478, DOI 10.1016/j.cmet.2013.08.008; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Chen MJ, 2009, NATURE, V457, P887, DOI 10.1038/nature07619; Christov C, 2007, MOL BIOL CELL, V18, P1397, DOI 10.1091/mbc.E06-08-0693; Chute JP, 2007, BLOOD, V109, P2365, DOI 10.1182/blood-2006-05-022640; Chute JP, 1999, EXP HEMATOL, V27, P370, DOI 10.1016/S0301-472X(98)00004-6; Chute JP, 2002, BLOOD, V100, P4433, DOI 10.1182/blood-2002-04-1238; Cleaver O, 2003, NAT MED, V9, P661, DOI 10.1038/nm0603-661; Crivellato E, 2007, J ANAT, V211, P415, DOI 10.1111/j.1469-7580.2007.00790.x; Crouch EE, 2015, J NEUROSCI, V35, P4528, DOI 10.1523/JNEUROSCI.1188-14.2015; DeLeve LD, 2015, HEPATOLOGY, V61, P1740, DOI 10.1002/hep.27376; DeLeve LD, 2013, J CLIN INVEST, V123, P1861, DOI 10.1172/JCI66025; Delgado AC, 2014, NEURON, V83, P572, DOI 10.1016/j.neuron.2014.06.015; Ding BS, 2015, J CELL SCI, V128, P2983, DOI 10.1242/jcs.168179; Ding BS, 2014, NATURE, V505, P97, DOI 10.1038/nature12681; Ding BS, 2011, CELL, V147, P539, DOI 10.1016/j.cell.2011.10.003; Ding BS, 2010, NATURE, V468, P310, DOI 10.1038/nature09493; Ding L, 2013, NATURE, V495, P231, DOI 10.1038/nature11885; Ding L, 2012, NATURE, V481, P457, DOI 10.1038/nature10783; Doan PL, 2013, NAT MED, V19, P295, DOI 10.1038/nm.3070; Douville JM, 2007, CAN J PHYSIOL PHARM, V85, P55, DOI 10.1139/Y06-091; Falkowski M, 2003, HISTOCHEM CELL BIOL, V120, P361, DOI 10.1007/s00418-003-0585-5; Follenzi A, 2008, J CLIN INVEST, V118, P935, DOI 10.1172/JCI32748; Ghesquiere B, 2014, NATURE, V511, P167, DOI 10.1038/nature13312; Ginsberg M, 2012, CELL, V151, P559, DOI 10.1016/j.cell.2012.09.032; Goddard LM, 2014, CELL, V156, P549, DOI 10.1016/j.cell.2013.12.025; Goldman SA, 2011, NAT NEUROSCI, V14, P1382, DOI 10.1038/nn.2963; Gomez-Gaviro MV, 2012, P NATL ACAD SCI USA, V109, P1317, DOI 10.1073/pnas.1016199109; Gori JL, 2015, J CLIN INVEST, V125, P1243, DOI 10.1172/JCI79328; Hadland BK, 2015, J CLIN INVEST, V125, P2032, DOI 10.1172/JCI80137; Hamada T, 1998, J EXP MED, V188, P539, DOI 10.1084/jem.188.3.539; Han J, 2015, CELL REP, V10, P1158, DOI 10.1016/j.celrep.2015.01.049; Hedhli N, 2011, CIRCULATION, V123, P2254, DOI 10.1161/CIRCULATIONAHA.110.991125; Heissig B, 2002, CELL, V109, P625, DOI 10.1016/S0092-8674(02)00754-7; Himburg HA, 2012, CELL REP, V2, P964, DOI 10.1016/j.celrep.2012.09.002; Hoehme S, 2010, P NATL ACAD SCI USA, V107, P10371, DOI 10.1073/pnas.0909374107; Hogan BLM, 2014, CELL STEM CELL, V15, P123, DOI 10.1016/j.stem.2014.07.012; Hoggatt J, 2013, NATURE, V495, P365, DOI 10.1038/nature11929; Hooper AT, 2009, CELL STEM CELL, V4, P263, DOI 10.1016/j.stem.2009.01.006; Hu JH, 2014, SCIENCE, V343, P416, DOI 10.1126/science.1244880; Inra CN, 2015, NATURE, V527, P466, DOI 10.1038/nature15530; James D, 2010, NAT BIOTECHNOL, V28, P161, DOI 10.1038/nbt.1605; Kao DI, 2015, STEM CELL REP, V4, P181, DOI 10.1016/j.stemcr.2014.12.008; Katsimpardi L, 2014, SCIENCE, V344, P630, DOI 10.1126/science.1251141; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kim J, 2008, STEM CELLS, V26, P2516, DOI 10.1634/stemcells.2008-0379; Kimura Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026918; Kobayashi H, 2010, NAT CELL BIOL, V12, P1046, DOI 10.1038/ncb2108; Kokovay E, 2010, CELL STEM CELL, V7, P163, DOI 10.1016/j.stem.2010.05.019; Kopp HG, 2006, J CLIN INVEST, V116, P3277, DOI 10.1172/JCI29314; Kunisaki Y, 2013, NATURE, V502, P637, DOI 10.1038/nature12612; Kusumbe AP, 2014, NATURE, V507, P323, DOI 10.1038/nature13145; Lammert E, 2001, SCIENCE, V294, P564, DOI 10.1126/science.1064344; Lazarus A, 2011, DEVELOPMENT, V138, P2359, DOI 10.1242/dev.060723; Le Bras B, 2006, NAT NEUROSCI, V9, P340, DOI 10.1038/nn1646; LeCouter J, 2003, SCIENCE, V299, P890, DOI 10.1126/science.1079562; Lee JH, 2014, CELL, V156, P440, DOI 10.1016/j.cell.2013.12.039; Leventhal C, 1999, MOL CELL NEUROSCI, V13, P450, DOI 10.1006/mcne.1999.0762; Li B, 2010, STEM CELL RES, V4, P17, DOI 10.1016/j.scr.2009.08.001; Li WM, 2003, BLOOD, V102, P4345, DOI 10.1182/blood-2003-03-0729; Li WM, 2004, EXP HEMATOL, V32, P1226, DOI 10.1016/j.exphem.2004.09.001; Licht T, 2015, MECH DEVELOP, V138, P56, DOI 10.1016/j.mod.2015.06.001; Licht T, 2011, P NATL ACAD SCI USA, V108, P5081, DOI 10.1073/pnas.1007640108; Matsumoto K, 2001, SCIENCE, V294, P559, DOI 10.1126/science.1063889; Medvinsky A, 1996, CELL, V86, P897, DOI 10.1016/S0092-8674(00)80165-8; Mirzadeh Z, 2008, CELL STEM CELL, V3, P265, DOI 10.1016/j.stem.2008.07.004; Morrisey EE, 2010, DEV CELL, V18, P8, DOI 10.1016/j.devcel.2009.12.010; Morrison SJ, 2014, NATURE, V505, P327, DOI 10.1038/nature12984; Nikolova G, 2006, DEV CELL, V10, P397, DOI 10.1016/j.devcel.2006.01.015; Nikolova G, 2007, TRENDS CELL BIOL, V17, P19, DOI 10.1016/j.tcb.2006.11.005; Noireaud J, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/923805; Nolan DJ, 2013, DEV CELL, V26, P204, DOI 10.1016/j.devcel.2013.06.017; North TE, 2007, NATURE, V447, P1007, DOI 10.1038/nature05883; Olerud J, 2011, DIABETES, V60, P1946, DOI 10.2337/db10-0277; Ottone C, 2015, CELL CYCLE, V14, P2222, DOI 10.1080/15384101.2015.1049785; Ottone C, 2014, NAT CELL BIOL, V16, P1045, DOI 10.1038/ncb3045; Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3; Pan XM, 2011, TRANSPLANTATION, V92, P1208, DOI 10.1097/TP.0b013e3182356ca7; Petrache I, 2005, NAT MED, V11, P491, DOI 10.1038/nm1238; Nguyen PD, 2014, NATURE, V512, P314, DOI 10.1038/nature13678; Poulos MG, 2015, STEM CELL REP, V5, P881, DOI 10.1016/j.stemcr.2015.08.018; Poulos MG, 2013, CELL REP, V4, P1022, DOI 10.1016/j.celrep.2013.07.048; Pruett ND, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-93; RAFII S, 1994, BLOOD, V84, P10; RAFII S, 1995, BLOOD, V86, P3353, DOI 10.1182/blood.V86.9.3353.bloodjournal8693353; Rafii S, 2015, NAT CELL BIOL, V17, P123, DOI 10.1038/ncb3096; Ramasamy SK, 2015, TRENDS CELL BIOL, V25, P148, DOI 10.1016/j.tcb.2014.11.007; Ramasamy SK, 2014, NATURE, V507, P376, DOI 10.1038/nature13146; Ramirez-Castillejo C, 2006, NAT NEUROSCI, V9, P331, DOI 10.1038/nn1657; Raynaud CM, 2013, STEM CELL RES, V11, P1074, DOI 10.1016/j.scr.2013.07.010; Rivas-Carrillo SD, 2011, TRANSPL P, V43, P3209, DOI 10.1016/j.transproceed.2011.09.082; Rocha AS, 2015, CELL REP, V13, P1757, DOI 10.1016/j.celrep.2015.10.049; Rock JR, 2009, P NATL ACAD SCI USA, V106, P12771, DOI 10.1073/pnas.0906850106; Salter AB, 2009, BLOOD, V113, P2104, DOI 10.1182/blood-2008-06-162941; Sandler VM, 2014, NATURE, V511, P312, DOI 10.1038/nature13547; Seandel M, 2008, CELL CYCLE, V7, P135, DOI 10.4161/cc.7.2.5248; Seandel M, 2007, NATURE, V449, P346, DOI 10.1038/nature06129; Seandel M, 2008, P NATL ACAD SCI USA, V105, P19288, DOI 10.1073/pnas.0805980105; Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505; Shen Q, 2008, CELL STEM CELL, V3, P289, DOI 10.1016/j.stem.2008.07.026; Shmelkov SV, 2005, CIRCULATION, V111, P1175, DOI 10.1161/01.CIR.0000157155.44008.0F; Silva-Vargas V, 2014, NEURON, V83, P507, DOI 10.1016/j.neuron.2014.07.029; Silva-Vargas V, 2013, CURR OPIN NEUROBIOL, V23, P935, DOI 10.1016/j.conb.2013.09.004; Snapyan M, 2009, J NEUROSCI, V29, P4172, DOI 10.1523/JNEUROSCI.4956-08.2009; Talavera-Adame Dodanim, 2015, World J Exp Med, V5, P40, DOI 10.5493/wjem.v5.i2.40; Tang W, 2008, SCIENCE, V322, P583, DOI 10.1126/science.1156232; Tavazoie M, 2008, CELL STEM CELL, V3, P279, DOI 10.1016/j.stem.2008.07.025; Wang B, 2015, NATURE, V524, P180, DOI 10.1038/nature14863; Wang L, 2012, J CLIN INVEST, V122, P1567, DOI 10.1172/JCI58789; Whitman MC, 2009, J COMP NEUROL, V516, P94, DOI 10.1002/cne.22093; Winkler IG, 2012, NAT MED, V18, P1651, DOI 10.1038/nm.2969; Yoshida S, 2007, SCIENCE, V317, P1722, DOI 10.1126/science.1144885; Zachman DK, 2013, STEM CELL RES, V11, P1013, DOI 10.1016/j.scr.2013.07.001	125	485	492	9	182	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 21	2016	529	7586					316	325		10.1038/nature17040	http://dx.doi.org/10.1038/nature17040			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB2QT	26791722	Green Accepted			2022-12-28	WOS:000368354800033
J	Odejide, OO				Odejide, Oreofe O.			A Policy Prescription for Hospice Care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Odejide, Oreofe O.] Dana Farber Canc Inst, Dept Med Oncol, Div Populat Sci, Boston, MA 02215 USA	Harvard University; Dana-Farber Cancer Institute	Odejide, OO (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Div Populat Sci, 450 Brookline Ave, Boston, MA 02215 USA.	oreofe_odejide@dfci.harvard.edu						[Anonymous], MED CAR CHOIC MOD; Brooks GA, 2014, HEALTH AFFAIR, V33, P1793, DOI 10.1377/hlthaff.2014.0280; El-Jawahri AR, 2015, CANCER-AM CANCER SOC, V121, P2840, DOI 10.1002/cncr.29430; National Hospice and Palliative Care Organization, 2019, NHPCO FACTS FIG HOSP; Odejide OO, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djv280; Odejide OO, 2016, JAMA INTERN MED, V176, P263, DOI 10.1001/jamainternmed.2015.6599; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Spettell CM, 2009, J PALLIAT MED, V12, P827, DOI 10.1089/jpm.2009.0089	8	22	22	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 19	2016	315	3					257	258		10.1001/jama.2015.18424	http://dx.doi.org/10.1001/jama.2015.18424			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DB2WN	26784768				2022-12-28	WOS:000368371400017
J	Lee, S; Kopp, F; Chang, TC; Sataluri, A; Chen, BB; Sivakumar, S; Yu, HT; Xie, Y; Mendell, JT				Lee, Sungyul; Kopp, Florian; Chang, Tsung-Cheng; Sataluri, Anupama; Chen, Beibei; Sivakumar, Sushama; Yu, Hongtao; Xie, Yang; Mendell, Joshua T.			Noncoding RNA NORAD Regulates Genomic Stability by Sequestering PUMILIO Proteins	CELL			English	Article							PUF FAMILY; BINDING PROTEINS; EXPRESSION; REVEALS; P53; IDENTIFICATION; TRANSCRIPTION; ANEUPLOIDY; INITIATION; LANDSCAPE	Long noncoding RNAs (lncRNAs) have emerged as regulators of diverse biological processes. Here, we describe the initial functional analysis of a poorly characterized human lncRNA (LINC00657) that is induced after DNA damage, which we termed "noncoding RNA activated by DNA damage", or NORAD. NORAD is highly conserved and abundant, with expression levels of approximately 500-1,000 copies per cell. Remarkably, inactivation of NORAD triggers dramatic aneuploidy in previously karyotypically stable cell lines. NORAD maintains genomic stability by sequestering PUMILIO proteins, which repress the stability and translation of mRNAs to which they bind. In the absence of NORAD, PUMILIO proteins drive chromosomal instability by hyperactively repressing mitotic, DNA repair, and DNA replication factors. These findings introduce a mechanism that regulates the activity of a deeply conserved and highly dosage-sensitive family of RNA binding proteins and reveal unanticipated roles for a lncRNA and PUMILIO proteins in the maintenance of genomic stability.	[Lee, Sungyul; Kopp, Florian; Chang, Tsung-Cheng; Sataluri, Anupama; Mendell, Joshua T.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Chen, Beibei; Xie, Yang] Univ Texas SW Med Ctr Dallas, Quantitat Biomed Res Ctr, Dallas, TX 75390 USA; [Chen, Beibei; Xie, Yang] Univ Texas SW Med Ctr Dallas, Dept Clin Sci, Dallas, TX 75390 USA; [Sivakumar, Sushama; Yu, Hongtao] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Xie, Yang; Mendell, Joshua T.] Univ Texas SW Med Ctr Dallas, Harold C Simmons Comprehens Canc Ctr, Dallas, TX 75390 USA; [Mendell, Joshua T.] Univ Texas SW Med Ctr Dallas, Hamon Ctr Regenerat Sci & Med, Dallas, TX 75390 USA; [Yu, Hongtao; Mendell, Joshua T.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Lee, Sungyul] Johns Hopkins Univ, Sch Med, Pathobiol Grad Program, Baltimore, MD 21205 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; Johns Hopkins University	Mendell, JT (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Biol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	Joshua.Mendell@UTSouthwestern.edu	Sivakumar, Sushama/I-5062-2019	Sivakumar, Sushama/0000-0001-7877-4821; Kopp, Florian/0000-0001-9952-635X; LEE, SUNGYUL/0000-0003-3207-1199	CPRIT [R1008, RP101251, RP120717]; NIH [R01CA120185, R35CA197311, R01CA152301]; Leopoldina Fellowship Program from the German National Academy of Sciences Leopoldina [LPDS 2014-12]; NATIONAL CANCER INSTITUTE [R01CA152301, P30CA142543, R01CA120185, R35CA197311] Funding Source: NIH RePORTER	CPRIT; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leopoldina Fellowship Program from the German National Academy of Sciences Leopoldina; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Tyler Jacks, Rudolf Jaenisch, Keith Joung, David Root, Didier Trono, and Feng Zhang for plasmids; Kathleen Wilson, Sangeeta Patel, and Charles Tiongson in the Veripath Cytogenetics laboratory at University of Texas Southwestern; Vanessa Schmid, Ashley Guzman, and Rachel Bruce in the McDermott Center Next Generation Sequencing Core; and Hamid Mirzaei and David Trudgian in the University of Texas Southwestern Proteomics Core. Stephen Johnson provided valuable assistance with software implementation. We also thank Jose Cabrera for assistance with figure preparation and Nicholas Conrad, Kathryn O'Donnell, Eric Olson, Hao Zhu, and members of the Mendell laboratory for critical reading of the manuscript. This work was supported by grants from CPRIT (R1008 to J.T.M., RP101251 to Y.X., and RP120717 to H.Y.) and the NIH (R01CA120185 and R35CA197311 to J.T.M. and R01CA152301 to Y.X.). J.T.M. and H.Y. are investigators of the Howard Hughes Medical Institute, J.T.M. is a CPRIT Scholar in Cancer Research, and F.K. is supported by the Leopoldina Fellowship Program (LPDS 2014-12) from the German National Academy of Sciences Leopoldina.	Anderson DM, 2015, CELL, V160, P595, DOI 10.1016/j.cell.2015.01.009; Bazzini AA, 2014, EMBO J, V33, P981, DOI 10.1002/embj.201488411; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Chen D, 2012, CURR BIOL, V22, P420, DOI 10.1016/j.cub.2012.01.039; Clemson CM, 2009, MOL CELL, V33, P717, DOI 10.1016/j.molcel.2009.01.026; Driscoll HE, 2013, J NEUROSCI, V33, P9644, DOI 10.1523/JNEUROSCI.0921-13.2013; Faghihi MA, 2008, NAT MED, V14, P723, DOI 10.1038/nm1784; Fatica A, 2014, NAT REV GENET, V15, P7, DOI 10.1038/nrg3606; Galgano A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003164; Ganem NJ, 2007, CURR OPIN GENET DEV, V17, P157, DOI 10.1016/j.gde.2007.02.011; Geigl JB, 2008, TRENDS GENET, V24, P64, DOI 10.1016/j.tig.2007.11.006; Gennarino VA, 2015, CELL, V160, P1087, DOI 10.1016/j.cell.2015.02.012; Gong CG, 2011, NATURE, V470, P284, DOI 10.1038/nature09701; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hacisuleyman E, 2014, NAT STRUCT MOL BIOL, V21, P198, DOI 10.1038/nsmb.2764; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hockemeyer D, 2009, NAT BIOTECHNOL, V27, P851, DOI 10.1038/nbt.1562; Hung T, 2011, NAT GENET, V43, P621, DOI 10.1038/ng.848; Islam S, 2011, GENOME RES, V21, P1160, DOI 10.1101/gr.110882.110; Iyer MK, 2015, NAT GENET, V47, P199, DOI 10.1038/ng.3192; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Jallepalli PV, 2001, CELL, V105, P445, DOI 10.1016/S0092-8674(01)00340-3; Kazazian HH, 2014, MOBILE DNA-UK, V5, DOI 10.1186/1759-8753-5-20; Kedde M, 2010, NAT CELL BIOL, V12, P1014, DOI 10.1038/ncb2105; Kino T, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000568; Kops GJPL, 2005, NAT REV CANCER, V5, P773, DOI 10.1038/nrc1714; Kretz M, 2013, NATURE, V493, P231, DOI 10.1038/nature11661; Li LJ, 2014, TRENDS CELL BIOL, V24, P594, DOI 10.1016/j.tcb.2014.06.003; Lin MF, 2011, BIOINFORMATICS, V27, pI275, DOI 10.1093/bioinformatics/btr209; Liu BD, 2015, CANCER CELL, V27, P370, DOI 10.1016/j.ccell.2015.02.004; Liu XF, 2012, EMBO J, V31, P4415, DOI 10.1038/emboj.2012.292; Masramon L, 2000, CANCER GENET CYTOGEN, V121, P17, DOI 10.1016/S0165-4608(00)00219-3; Michalik KM, 2014, CIRC RES, V114, P1389, DOI 10.1161/CIRCRESAHA.114.303265; Miles WO, 2012, GENE DEV, V26, P356, DOI 10.1101/gad.182568.111; Mili S, 2004, RNA, V10, P1692, DOI 10.1261/rna.7151404; Miller MA, 2011, WIRES RNA, V2, P471, DOI 10.1002/wrna.69; Morris AR, 2008, MOL CELL BIOL, V28, P4093, DOI 10.1128/MCB.00155-08; Narita R, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004417; Ponten F, 2008, J PATHOL, V216, P387, DOI 10.1002/path.2440; Rajagopalan H, 2003, NAT REV CANCER, V3, P695, DOI 10.1038/nrc1165; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Rosenbloom KR, 2013, NUCLEIC ACIDS RES, V41, pD56, DOI 10.1093/nar/gks1172; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Sanchez Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6812; Sander JD, 2011, NAT BIOTECHNOL, V29, P697, DOI 10.1038/nbt.1934; Sander JD, 2010, NUCLEIC ACIDS RES, V38, pW462, DOI 10.1093/nar/gkq319; Sanjana NE, 2012, NAT PROTOC, V7, P171, DOI 10.1038/nprot.2011.431; Spassov DS, 2003, IUBMB LIFE, V55, P359, DOI 10.1080/15216540310001603093; Struhl K, 2007, NAT STRUCT MOL BIOL, V14, P103, DOI 10.1038/nsmb0207-103; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Ulitsky I, 2013, CELL, V154, P26, DOI 10.1016/j.cell.2013.06.020; Vessey JP, 2010, P NATL ACAD SCI USA, V107, P3222, DOI 10.1073/pnas.0907128107; Wang XQ, 2002, CELL, V110, P501, DOI 10.1016/S0092-8674(02)00873-5; Wickens M, 2002, TRENDS GENET, V18, P150, DOI 10.1016/S0168-9525(01)02616-6; Zamore PD, 1997, RNA, V3, P1421	57	515	535	7	125	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 14	2016	164	1-2					69	80		10.1016/j.cell.2015.12.017	http://dx.doi.org/10.1016/j.cell.2015.12.017			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DB2LE	26724866	Green Accepted, Bronze			2022-12-28	WOS:000368339300010
J	Toll, E; Toll, SI				Toll, Elizabeth; Toll, Seymour I.			Old Soldier, Is It Like This?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Toll, Elizabeth] Brown Univ, Warren Alpert Med Sch, Dept Pediat, Providence, RI 02912 USA; [Toll, Elizabeth] Brown Univ, Warren Alpert Med Sch, Dept Med, Providence, RI 02912 USA; [Toll, Elizabeth] Medicine, Providence, RI USA; [Toll, Seymour I.] Bala Cynwyd, Philadelphia, PA USA	Brown University; Brown University	Toll, E (corresponding author), Brown Univ, Warren Alpert Med Sch, Dept Pediat, Providence, RI 02912 USA.	etoll@lifespan.org; spentoll@aol.com							0	1	1	1	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 12	2016	315	2					135	136		10.1001/jama.2015.14928	http://dx.doi.org/10.1001/jama.2015.14928			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DA6XO	26757460				2022-12-28	WOS:000367949200012
J	Bakelar, J; Buchanan, SK; Noinaj, N				Bakelar, Jeremy; Buchanan, Susan K.; Noinaj, Nicholas			The structure of the beta-barrel assembly machinery complex	SCIENCE			English	Article							MEMBRANE PROTEIN BIOGENESIS; GRAM-NEGATIVE BACTERIA; OUTER-MEMBRANE; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; BAM COMPLEX; ESSENTIAL COMPONENT; PERIPLASMIC DOMAIN; YAET COMPLEX; FLEXIBILITY	beta-Barrel outer membrane proteins (OMPs) are found in the outer membranes of Gram-negative bacteria and are essential for nutrient import, signaling, and adhesion. A 200-kilodalton five-component complex called the beta-barrel assembly machinery (BAM) complex has been implicated in the biogenesis of OMPs. We report the structure of the BAM complex from Escherichia coli, revealing that binding of BamCDE modulates the conformation of BamA, the central component, which may serve to regulate the BAM complex. The periplasmic domain of BamA was in a closed state that prevents access to the barrel lumen, which indicates substrate OMPs may not be threaded through the barrel during biogenesis. Further, conformational shifts in the barrel domain lead to opening of the exit pore and rearrangement at the lateral gate.	[Bakelar, Jeremy; Noinaj, Nicholas] Purdue Univ, Dept Biol Sci, Markey Ctr Struct Biol, W Lafayette, IN 47907 USA; [Buchanan, Susan K.] NIDDK, NIH, Bethesda, MD 20892 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Noinaj, N (corresponding author), Purdue Univ, Dept Biol Sci, Markey Ctr Struct Biol, W Lafayette, IN 47907 USA.	nnoinaj@purdue.edu			Department of Biological Sciences at Purdue University; National Institute of Allergy and Infectious Diseases [1K22AI113078-01]; Intramural Research Program of the NIH, National Institute of Diabetes and Digestive and Kidney Diseases; Office of Basic Energy Sciences, Office of Science, U.S. Department of Energy [W-31-109-Eng-38]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K22AI113078] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK036139] Funding Source: NIH RePORTER	Department of Biological Sciences at Purdue University; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Intramural Research Program of the NIH, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Office of Basic Energy Sciences, Office of Science, U.S. Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank H. Bernstein for providing the pJH114 plasmid. J.B. and N.N. are supported by the Department of Biological Sciences at Purdue University and by the National Institute of Allergy and Infectious Diseases (1K22AI113078-01). S.K.B. is supported by the Intramural Research Program of the NIH, National Institute of Diabetes and Digestive and Kidney Diseases. We thank the staff at the Southeast Regional Collaborative Access Team (SER-CAT) beamline at the Advanced Photon Source, Argonne National Laboratory, for their assistance during data collection. Use of the Advanced Photon Source was supported by the Office of Basic Energy Sciences, Office of Science, U.S. Department of Energy, under contract no. W-31-109-Eng-38 (SER-CAT). Coordinates and structure factors for the BamACDE complex have been deposited into the PDB with PDB ID 5EKQ.	Albrecht R, 2014, ACTA CRYSTALLOGR D, V70, P1779, DOI 10.1107/S1399004714007482; Albrecht R, 2011, J BIOL CHEM, V286, P27792, DOI 10.1074/jbc.M111.238931; Dong C, 2012, ACTA CRYSTALLOGR D, V68, P95, DOI 10.1107/S0907444911051031; Gatzeva-Topalova PZ, 2008, STRUCTURE, V16, P1873, DOI 10.1016/j.str.2008.09.014; Gatzeva-Topalova PZ, 2010, STRUCTURE, V18, P1492, DOI 10.1016/j.str.2010.08.012; Gessmann D, 2014, P NATL ACAD SCI USA, V111, P5878, DOI 10.1073/pnas.1322473111; Hagan CL, 2011, ANNU REV BIOCHEM, V80, P189, DOI 10.1146/annurev-biochem-061408-144611; Hagan CL, 2010, SCIENCE, V328, P890, DOI 10.1126/science.1188919; Heuck A, 2011, J MOL BIOL, V406, P659, DOI 10.1016/j.jmb.2011.01.002; Jansen KB, 2015, J BIOL CHEM, V290, P2126, DOI 10.1074/jbc.M114.584524; Jansen KB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049749; Kim KH, 2012, PROTEIN SCI, V21, P751, DOI 10.1002/pro.2069; Kim KH, 2011, J BIOL CHEM, V286, P39116, DOI 10.1074/jbc.M111.298166; Kim KH, 2011, J MOL BIOL, V406, P667, DOI 10.1016/j.jmb.2010.12.020; Kim S, 2007, SCIENCE, V317, P961, DOI 10.1126/science.1143993; Knowles TJ, 2011, EMBO REP, V12, P123, DOI 10.1038/embor.2010.202; Knowles TJ, 2009, NAT REV MICROBIOL, V7, P206, DOI 10.1038/nrmicro2069; Malinverni JC, 2006, MOL MICROBIOL, V61, P151, DOI 10.1111/j.1365-2958.2006.05211.x; Ni DC, 2014, FASEB J, V28, P2677, DOI 10.1096/fj.13-248450; Noinaj N, 2015, CURR OPIN STRUC BIOL, V31, P35, DOI 10.1016/j.sbi.2015.02.012; Noinaj N, 2014, STRUCTURE, V22, P1055, DOI 10.1016/j.str.2014.05.008; Noinaj N, 2013, NATURE, V501, P385, DOI 10.1038/nature12521; Noinaj N, 2011, J MOL BIOL, V407, P248, DOI 10.1016/j.jmb.2011.01.042; O'Neil PK, 2015, BIOCHEMISTRY-US, V54, P6303, DOI 10.1021/acs.biochem.5b00852; Ricci DP, 2012, P NATL ACAD SCI USA, V109, P3487, DOI 10.1073/pnas.1201362109; Ricci DP, 2012, BBA-BIOMEMBRANES, V1818, P1067, DOI 10.1016/j.bbamem.2011.08.020; Rigel NW, 2013, P NATL ACAD SCI USA, V110, P5151, DOI 10.1073/pnas.1302662110; Roman-Hernandez G, 2014, ELIFE, V3, DOI 10.7554/eLife.04234; Sandoval CM, 2011, J MOL BIOL, V409, P348, DOI 10.1016/j.jmb.2011.03.035; Schleiff E, 2005, EMBO REP, V6, P1023, DOI 10.1038/sj.embor.7400563; Sklar JG, 2007, P NATL ACAD SCI USA, V104, P6400, DOI 10.1073/pnas.0701579104; Voulhoux R, 2003, SCIENCE, V299, P262, DOI 10.1126/science.1078973; Webb CT, 2012, TRENDS MICROBIOL, V20, P612, DOI 10.1016/j.tim.2012.08.006; Webb CT, 2012, J MOL BIOL, V422, P545, DOI 10.1016/j.jmb.2012.05.035	34	152	155	1	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 8	2016	351	6269					180	186		10.1126/science.aad3460	http://dx.doi.org/10.1126/science.aad3460			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4XQ	26744406	Green Submitted, Green Accepted			2022-12-28	WOS:000367806500044
J	Meissner, HC				Meissner, H. Cody			Viral Bronchiolitis in Children	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							RESPIRATORY SYNCYTIAL VIRUS; DIMINISHED LUNG-FUNCTION; UNITED-STATES; DISEASE SEVERITY; NEUTRALIZING ANTIBODIES; HOSPITALIZED CHILDREN; INFANTS; INFECTION; ILLNESS; BORN	Few diseases have a greater effect on the health of young children than viral lower respiratory tract illness. Approximately 800,000 children in the United States, or approximately 20% of the annual birth cohort, require outpatient medical attention during the first year of life because of illness caused by respiratory syncytial virus (RSV).(1) Between 2% and 3% of all children younger than 12 months of age are hospitalized with a diagnosis of bronchiolitis, which accounts for between 57,000 and 172,000 hospitalizations annually.(1-4) Estimated nationwide hospital charges for care related to bronchiolitis in children younger than 2 years of age exceeded $1.7 billion in 2009.(5) Globally, in 2005, RSV alone was estimated to cause 66,000 to 199,000 deaths among children younger than 5 years of age, with a disproportionate number of these deaths occurring in resource-limited countries.(6,7) In the United States, by contrast, bronchiolitis due to RSV accounts for fewer than 100 deaths in young children annually.(8) This review describes the current understanding of bronchiolitis, including the increasing number of viruses that are known to cause it, the current understanding of its pathogenesis, the importance of environmental and host genetic factors, and the roles of season, race, and sex in bronchiolitis attack rates and subsequent episodes of wheezing. In addition, guidelines from the American Academy of Pediatrics regarding the diagnosis, management, and prevention of bronchiolitis are summarized.(9,10)	[Meissner, H. Cody] Tufts Univ, Sch Med, Boston, MA 02111 USA; [Meissner, H. Cody] Tufts Med Ctr, Dept Pediat, Boston, MA USA	Tufts University; Tufts Medical Center	Meissner, HC (corresponding author), Tufts Med Ctr, 800 Washington St, Boston, MA 02111 USA.	cmeissner@tuftsmedicalcenter.org						Ahmed F, 2011, VACCINE, V29, P9171, DOI 10.1016/j.vaccine.2011.08.005; [Anonymous], 1998, Pediatrics, V102, P1211; Baraldi E, 2007, NEW ENGL J MED, V357, P1946, DOI 10.1056/NEJMra067279; Bennett BL, 2007, J INFECT DIS, V195, P1532, DOI 10.1086/515575; Blanken MO, 2013, NEW ENGL J MED, V368, P1791, DOI 10.1056/NEJMoa1211917; Bockova J, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.2.e20; Boyce TG, 2000, J PEDIATR-US, V137, P865, DOI 10.1067/mpd.2000.110531; Brady MT, 2014, PEDIATRICS, V134, pE620, DOI [10.1542/peds.2014-1665, 10.1542/peds.2014-1666]; Breese C, 2013, PEDIATRICS, V132, pE341, DOI 10.1542/peds.2013-0303; Broughton S, 2006, ARCH DIS CHILD, V91, P26, DOI 10.1136/adc.2005.087270; Broughton S, 2007, PEDIATR INFECT DIS J, V26, P1019, DOI 10.1097/INF.0b013e318126bbb9; Bucasas KL, 2013, PEDIATR INFECT DIS J, V32, pE68, DOI 10.1097/INF.0b013e318278b4b3; Byington CL, 2015, PEDIATRICS, V135, pE24, DOI 10.1542/peds.2014-2151; Caliskan M, 2013, NEW ENGL J MED, V368, P1398, DOI 10.1056/NEJMoa1211592; Chan JYC, 2015, PEDIATRICS, V135, P607, DOI 10.1542/peds.2014-3060; Chorazy ML, 2013, PEDIATR INFECT DIS J, V32, P460, DOI 10.1097/INF.0b013e31828683ce; Christiaansen AF, 2014, IMMUNOL RES, V59, P109, DOI 10.1007/s12026-014-8540-1; Chu HY, 2014, J INFECT DIS, V210, P1582, DOI 10.1093/infdis/jiu316; Collins PL, 2011, VIRUS RES, V162, P80, DOI 10.1016/j.virusres.2011.09.020; Drysdale SB, 2011, THORAX, V66, P468, DOI 10.1136/thx.2010.148023; Edwards MR, 2012, NAT REV MICROBIOL, V10, P459, DOI 10.1038/nrmicro2801; Eick A, 2008, PEDIATR INFECT DIS J, V27, P207, DOI 10.1097/INF.0b013e31815ac585; El Saleeby CM, 2011, J INFECT DIS, V204, P996, DOI 10.1093/infdis/jir494; Feltes TF, 2003, J PEDIATR-US, V143, P532, DOI 10.1067/S0022-3476(03)00454-2; Foxman EF, 2015, P NATL ACAD SCI USA, V112, P827, DOI 10.1073/pnas.1411030112; Glenn GM, 2015, J INFECT DIS; GLEZEN WP, 1981, J PEDIATR-US, V98, P708, DOI 10.1016/S0022-3476(81)80829-3; Graham BS, 2011, IMMUNOL REV, V239, P149, DOI 10.1111/j.1600-065X.2010.00972.x; Hall CB, 2009, NEW ENGL J MED, V360, P588, DOI 10.1056/NEJMoa0804877; Hall CB, 2001, NEW ENGL J MED, V344, P1917, DOI 10.1056/NEJM200106213442507; Hasegawa K, 2015, J INFECT DIS, V211, P1550, DOI 10.1093/infdis/jiu658; Hasegawa K, 2014, PEDIATR INFECT DIS J, V33, P809, DOI 10.1097/INF.0000000000000293; Hasegawa K, 2013, PEDIATRICS, V132, P28, DOI 10.1542/peds.2012-3877; Haynes AK, 2013, J INFECT DIS, V208, pS246, DOI 10.1093/infdis/jit515; Holman RC, 2004, PEDIATRICS, V114, pE437, DOI 10.1542/peds.2004-0049; Iwane MK, 2013, AM J EPIDEMIOL, V177, P656, DOI 10.1093/aje/kws299; Jain S, 2015, NEW ENGL J MED, V372, P835, DOI 10.1056/NEJMoa1405870; Jansen RR, 2011, J CLIN MICROBIOL, V49, P2631, DOI 10.1128/JCM.02094-10; Jansen RR, 2010, PEDIATR INFECT DIS J, V29, P82, DOI 10.1097/INF.0b013e3181b6de8a; Janssen R, 2007, J INFECT DIS, V196, P826, DOI 10.1086/520886; Le Saux N, 2003, PEDIATR INFECT DIS J, V22, P563, DOI 10.1097/00006454-200306000-00015; Magro M, 2012, P NATL ACAD SCI USA, V109, P3089, DOI 10.1073/pnas.1115941109; Mansbach JM, 2012, ARCH PEDIAT ADOL MED, V166, P700, DOI 10.1001/archpediatrics.2011.1669; Martin ET, 2013, J INFECT DIS, V207, P982, DOI 10.1093/infdis/jis934; Martin ET, 2012, INFLUENZA OTHER RESP, V6, P71, DOI 10.1111/j.1750-2659.2011.00265.x; MARTINEZ FD, 1988, NEW ENGL J MED, V319, P1112, DOI 10.1056/NEJM198810273191702; Meissner HC, 2014, FEIGIN CHERRYS TXB P, P2407; Midulla F, 2010, ARCH DIS CHILD, V95, P35, DOI 10.1136/adc.2008.153361; Mittal V, 2014, PEDIATRICS, V133, pE730, DOI 10.1542/peds.2013-2881; Miyairi I, 2008, CLIN MICROBIOL REV, V21, P686, DOI 10.1128/CMR.00017-08; Mutuc Jeffry D., 2011, Morbidity and Mortality Weekly Report, V60, P1203; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Null D, 1998, PEDIATRICS, V102, P531, DOI 10.1542/peds.102.3.531; O'Brien KL, 2015, LANCET INFECT DIS, V15, P1398, DOI 10.1016/S1473-3099(15)00247-9; Peng D, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-155; Ralston SL, 2014, PEDIATRICS, V134, pE1474, DOI 10.1542/peds.2014-2742; SALAH B, 1988, EUR RESPIR J, V1, P852; Schroeder AR, 2013, PEDIATRICS, V132, pE1194, DOI 10.1542/peds.2013-1501; Schuurhof A, 2010, PEDIATR PULM, V45, P608, DOI 10.1002/ppul.21229; Self WH, 2015, J INFECT DIS; Sigurs N, 2010, THORAX, V65, P1045, DOI 10.1136/thx.2009.121582; Singeton RJ, 2010, J MED VIROL, V82, P1282, DOI 10.1002/jmv.21790; Stevens TP, 2000, ARCH PEDIAT ADOL MED, V154, P55; Stockman LJ, 2012, PEDIATR INFECT DIS J, V31, P5, DOI 10.1097/INF.0b013e31822e68e6; Thomsen SF, 2009, AM J RESP CRIT CARE, V179, P1091, DOI 10.1164/rccm.200809-1471OC; Welliver TP, 2007, J INFECT DIS, V195, P1126, DOI 10.1086/512615; Willson DF, 2001, PEDIATRICS, V108, P851, DOI 10.1542/peds.108.4.851; Wright PF, 2002, J INFECT DIS, V185, P1011, DOI 10.1086/339822; Yusuf S, 2007, EPIDEMIOL INFECT, V135, P1077, DOI 10.1017/S095026880600776X	69	342	358	7	91	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 7	2016	374	1					62	72		10.1056/NEJMra1413456	http://dx.doi.org/10.1056/NEJMra1413456			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DA1UH	26735994				2022-12-28	WOS:000367580500009
J	Oguzhan, A				Oguzhan, Abdurrahman			Percutaneous Rotational Pulmonary Thrombectomy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Oguzhan, Abdurrahman] Erciyes Univ, Sch Med, TR-38039 Kayseri, Turkey	Erciyes University	Oguzhan, A (corresponding author), Erciyes Univ, Sch Med, TR-38039 Kayseri, Turkey.	abdurrahmano@hotmail.com							0	2	2	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 7	2016	374	1					E1	E1		10.1056/NEJMicm1415847	http://dx.doi.org/10.1056/NEJMicm1415847			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DA1UH	26736012				2022-12-28	WOS:000367580500011
J	Imray, CHE; Grocott, MPW; Wilson, MH; Hughes, A; Auerbach, PS				Imray, Christopher H. E.; Grocott, Michael P. W.; Wilson, Mark H.; Hughes, Amy; Auerbach, Paul S.			Extreme, expedition, and wilderness medicine	LANCET			English	Article							HIGH-ALTITUDE ADAPTATION; HYPOXIA; PORTERS; EVEREST; RESUSCITATION; TELEMEDICINE; OXYGENATION; ULTRASOUND; EXERCISE; OUTCOMES	Extreme, expedition, and wilderness medicine are modern and rapidly evolving specialties that address the spirit of adventure and exploration. The relevance of and interest in these specialties are changing rapidly to match the underlying activities, which include global exploration, adventure travel, and military deployments. Extreme, expedition, and wilderness medicine share themes of providing best available medical care in the outdoors, especially in austere or remote settings. Early clinical and logistics decision making can often have important effects on subsequent outcomes. There are lessons to be learned from out-of-hospital care, military medicine, humanitarian medicine, and disaster medicine that can inform in-hospital medicine, and vice-versa. The future of extreme, expedition, and wilderness medicine will be defined by both recipients and practitioners, and empirical observations will be transformed by evidence-based practice.	[Imray, Christopher H. E.] UHCW NHS Trust, Div Translat Med, Warwick Med Sch, Coventry CV2 2DX, W Midlands, England; [Grocott, Michael P. W.] Univ Southampton, Fac Med, Southampton SO9 5NH, Hants, England; [Grocott, Michael P. W.] Southampton NHS Fdn Trust, Univ Hosp, Anaesthesia & Crit Care Res Unit, Southampton, Hants, England; [Grocott, Michael P. W.] NIHR Southampton Resp Biomed Res Unit, Crit Care Res Area, Southampton, Hants, England; [Wilson, Mark H.] Royal London Hosp, Londons Air Ambulance, Inst Prehosp Care, London, England; [Wilson, Mark H.] Univ London Imperial Coll Sci Technol & Med, St Marys Major Trauma Ctr, London, England; [Hughes, Amy] Univ Manchester, UK Int Emergency Trauma & Med Register, UK Med Ebola Response Team, Manchester, Lancs, England; [Auerbach, Paul S.] Stanford Univ, Sch Med, Dept Emergency Med, Stanford, CA 94305 USA	University of Warwick; University of Southampton; University of Southampton; University Hospital Southampton NHS Foundation Trust; Barts Health NHS Trust; Royal London Hospital; Imperial College London; University of Manchester; Stanford University	Imray, CHE (corresponding author), UHCW NHS Trust, Dept Vasc & Endovasc Surg, Specialist Surg Unit, 3rd Floor, Coventry CV2 2DX, W Midlands, England.	christopher.imray@uhcw.nhs.uk	Grocott, Michael/C-4394-2008	Grocott, Michael/0000-0002-9484-7581; Christopher, Imray/0000-0001-9889-6308; imray, chris/0000-0001-8451-4102				Alves J., 2007, CREATIVITY INNOVATIO, V16, P27, DOI [10.1111/j.1467-8691.2007.00417.x, DOI 10.1111/J.1467-8691.2007.00417.X]; Amundsen R., 1976, THE S POLE; Arrich J, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004128.pub2; Auerbach LJ, 2014, WILD ENVIRON MED, V25, P160, DOI 10.1016/j.wem.2014.01.006; Auerbach Paul S, 2005, Travel Med Infect Dis, V3, P179, DOI 10.1016/j.tmaid.2004.07.007; Auerbach PS, 2011, WILDERNESS MED; Basnyat B, 2014, HIGH ALT MED BIOL, V15, P434, DOI 10.1089/ham.2014.1088; Bauer IL, 2003, J TRAVEL MED, V10, P94, DOI 10.2310/7060.2003.31654; Beall CM, 2001, NATURE, V414, P411, DOI 10.1038/35106641; Buckley R., 2006, ADVENTURE TOURISM; Cassel CK, 2011, NEW ENGL J MED, V364, P1169, DOI 10.1056/NEJMsb1012647; Curran-Sills G, 2013, CAN FAM PHYSICIAN, V59, P581; Drew CM, 2011, HIGH ALT MED BIOL, V12, P349, DOI 10.1089/ham.2011.1023; Eccles N, 2012, TELEMEDICINE DEV COU; Edwards LM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010681; Erzurum SC, 2007, P NATL ACAD SCI USA, V104, P17593, DOI 10.1073/pnas.0707462104; Firth PG, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a2654; FitzGerald R, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e873; Gilbert M, 2000, LANCET, V355, P375, DOI 10.1016/S0140-6736(00)01021-7; Gilbert-Kawai ET, 2014, PHYSIOLOGY, V29, P388, DOI 10.1152/physiol.00018.2014; Goodyear SJ, 2013, PERIOPER MED, V2, DOI 10.1186/2047-0525-2-10; Grocott M, 2008, HIGH ALT MED BIOL, V9, P123, DOI 10.1089/ham.2008.1012; Grocott MPW, 2005, WILD ENVIRON MED, V16, P209, DOI 10.1580/PR32-04.1; Gruen RL, 2012, LANCET, V380, P1099, DOI 10.1016/S0140-6736(12)61224-0; Heiner JD, 2010, WILD ENVIRON MED, V21, P137, DOI 10.1016/j.wem.2009.12.028; Hillebrandt D, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e1417; Hillenbrand P, 2006, WILD ENVIRON MED, V17, P87, DOI 10.1580/1080-6032-17.2.87; Holloway CJ, 2011, FASEB J, V25, P792, DOI 10.1096/fj.10-172999; Huxley L, 1913, SCOTTS LAST EXPEDITI; Imray C, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4943; Johnson C., 2015, OXFORD HDB EXPEDITIO; Levett DZ, 2011, SCI REP-UK, V1, DOI 10.1038/srep00109; Levett DZ, 2012, FASEB J, V26, P1431, DOI 10.1096/fj.11-197772; Lipman GS, 2014, ACAD EMERG MED, V21, P204, DOI 10.1111/acem.12304; Martin DS, 2015, BRIT J ANAESTH, V114, P677, DOI 10.1093/bja/aeu404; Martin DS, 2013, EXTREME PHYSIOL MED, V2, DOI 10.1186/2046-7648-2-30; Martin DS, 2013, CRIT CARE MED, V41, P423, DOI 10.1097/CCM.0b013e31826a44f6; Morton PM, 2004, EMERG MED CLIN N AM, V22, P539, DOI 10.1016/j.emc.2004.01.012; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Royal College of Surgeons of Edinburgh, FPHC LAUNCH MOUNT ME; Russell KW, 2013, WILD ENVIRON MED, V24, P136, DOI 10.1016/j.wem.2012.11.013; Scally G, 1998, BRIT MED J, V317, P61, DOI 10.1136/bmj.317.7150.61; Siervo M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094915; Stobdan T, 2008, HIGH ALT MED BIOL, V9, P140, DOI 10.1089/ham.2007.1076; Suzuki K, 2003, MED HYPOTHESES, V61, P385, DOI 10.1016/S0306-9877(03)00178-6; Swenson E.R., 2013, HIGH ALTITUDE HUMAN; Temple RM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2240; Tremayne Vincent, 2009, Nurs Stand, V24, P46; Tuckey H, 2013, EVEREST 1 ASCENT UNT; Wachter RM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e652; Wallace T W, 1995, BMJ, V311, P374; West JB, 2013, HIGH ALTITUDE MEDICINE AND PHYSIOLOGY, 5TH EDITION; Wilson MH, 2011, HIGH ALT MED BIOL, V12, P379, DOI 10.1089/ham.2011.1026; Wilson MH, 2011, J CEREBR BLOOD F MET, V31, P2019, DOI 10.1038/jcbfm.2011.81; Wilson MH, 2011, WILD ENVIRON MED, V22, P54, DOI 10.1016/j.wem.2010.10.007; Yankelson L, 2014, J AM COLL CARDIOL, V64, P463, DOI 10.1016/j.jacc.2014.05.025	56	17	17	1	21	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 19	2015	386	10012					2520	2525		10.1016/S0140-6736(15)01165-4	http://dx.doi.org/10.1016/S0140-6736(15)01165-4			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CZ1LD	26738718				2022-12-28	WOS:000366866400026
J	Matuchansky, C				Matuchansky, Claude			Lifelines	LANCET			English	Editorial Material									[Matuchansky, Claude] Med Honoraire Hop, AP HP, Paris, France; [Matuchansky, Claude] Univ Hosp, Gastroenterol & Nutr Support Dept, Poitiers, France; [Matuchansky, Claude] Lariboisiere Univ Hosp, Paris, France	Assistance Publique Hopitaux Paris (APHP); CHU Poitiers; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite	Matuchansky, C (corresponding author), Paris Diderot Univ, Lariboisiere St Louis Fac Med, F-75010 Paris, France.	claude.matuchansky@wanadoo.fr							0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 19	2015	386	10012					2539	2540		10.1016/S0140-6736(15)01127-7	http://dx.doi.org/10.1016/S0140-6736(15)01127-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CZ1LD	26738720				2022-12-28	WOS:000366866400029
J	Wang, L; Gao, YD; Wen, B; Han, Z; Taniguchi, T; Watanabe, K; Koshino, M; Hone, J; Dean, CR				Wang, Lei; Gao, Yuanda; Wen, Bo; Han, Zheng; Taniguchi, Takashi; Watanabe, Kenji; Koshino, Mikito; Hone, James; Dean, Cory R.			Evidence for a fractional fractal quantum Hall effect in graphene superlattices	SCIENCE			English	Article							HEXAGONAL BORON-NITRIDE; BLOCH ELECTRONS; DIRAC FERMIONS; MAGNETIC-FIELD; CONDUCTANCE; SPECTRUM	The Hofstadter energy spectrum provides a uniquely tunable system to study emergent topological order in the regime of strong interactions. Previous experiments, however, have been limited to low Bloch band fillings where only the Landau level index plays a role. We report measurements of high-mobility graphene superlattices where the complete unit cell of the Hofstadter spectrum is accessible. We observed coexistence of conventional fractional quantum Hall effect (QHE) states together with the integer QHE states associated with the fractal Hofstadter spectrum. At large magnetic field, we observed signatures of another series of states, which appeared at fractional Bloch filling index. These fractional Bloch band QHE states are not anticipated by existing theoretical pictures and point toward a distinct type of many-body state.	[Wang, Lei; Gao, Yuanda; Hone, James] Columbia Univ, Dept Mech Engn, New York, NY 10027 USA; [Wang, Lei] Cornell Nanoscale Sci, Kavli Inst, Ithaca, NY 14853 USA; [Wen, Bo; Han, Zheng; Dean, Cory R.] Columbia Univ, Dept Phys, New York, NY 10027 USA; [Taniguchi, Takashi; Watanabe, Kenji] Natl Inst Mat Sci, Tsukuba, Ibaraki 3050044, Japan; [Koshino, Mikito] Tohoku Univ, Dept Phys, Sendai, Miyagi 9808578, Japan	Columbia University; Columbia University; National Institute for Materials Science; Tohoku University	Dean, CR (corresponding author), Columbia Univ, Dept Phys, 538 W 120th St, New York, NY 10027 USA.	cdean@phys.columbia.edu	Hone, James C/E-1879-2011; TANIGUCHI, Takashi/H-2718-2011; Wang, Lei/K-1160-2012; Koshino, Mikito/C-2550-2012; WATANABE, Kenji/H-2825-2011	Hone, James C/0000-0002-8084-3301; Wang, Lei/0000-0002-1919-9107; Koshino, Mikito/0000-0002-5911-7532; WATANABE, Kenji/0000-0003-3701-8119	Office of Naval Research [N000141310662]; NSF [DMR-1463465]; JSPS [25107005]; National Science Foundation [DMR-0654118]; State of Florida; U.S. Department of Energy; Direct For Mathematical & Physical Scien [1462383] Funding Source: National Science Foundation	Office of Naval Research(Office of Naval Research); NSF(National Science Foundation (NSF)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Science Foundation(National Science Foundation (NSF)); State of Florida; U.S. Department of Energy(United States Department of Energy (DOE)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank A. MacDonald, T. Chakraborty, I. Aleiner, V. Falko, A. F. Young, and B. Hunt for helpful discussions. Supported by Office of Naval Research grant N000141310662 (L.W., Y.G., and J.H.), NSF grant DMR-1463465 (C.R.D.), and JSPS grant-in-aid for scientific research 25107005 (M.K.). A portion of this work was performed at the National High Magnetic Field Laboratory, which is supported by National Science Foundation Cooperative Agreement No. DMR-0654118, the State of Florida and the U.S. Department of Energy.	Albrecht C, 2001, PHYS REV LETT, V86, P147, DOI 10.1103/PhysRevLett.86.147; Chen X, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.075401; Chen ZG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5461; Dean CR, 2013, NATURE, V497, P598, DOI 10.1038/nature12186; Eisenstein JP, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.076801; Ghazaryan A, 2015, J PHYS-CONDENS MAT, V27, DOI 10.1088/0953-8984/27/18/185301; HOFSTADTER DR, 1976, PHYS REV B, V14, P2239, DOI 10.1103/PhysRevB.14.2239; Hunt B, 2013, SCIENCE, V340, P1427, DOI 10.1126/science.1237240; KOL A, 1993, PHYS REV B, V48, P8890, DOI 10.1103/PhysRevB.48.8890; MACDONALD AH, 1985, PHYS REV B, V32, P2291, DOI 10.1103/PhysRevB.32.2291; Melinte S, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.036802; Moon P, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.155406; Pfannkuche D, 1997, PHYS REV B, V56, pR7100, DOI 10.1103/PhysRevB.56.R7100; Ponomarenko LA, 2013, NATURE, V497, P594, DOI 10.1038/nature12187; Schlosser T, 1996, SEMICOND SCI TECH, V11, P1582, DOI 10.1088/0268-1242/11/11S/022; STREDA P, 1982, J PHYS C SOLID STATE, V15, P1299, DOI 10.1088/0022-3719/15/36/006; THOULESS DJ, 1982, PHYS REV LETT, V49, P405, DOI 10.1103/PhysRevLett.49.405; Wang L, 2013, SCIENCE, V342, P614, DOI 10.1126/science.1244358; WANNIER GH, 1978, PHYS STATUS SOLIDI B, V88, P757, DOI 10.1002/pssb.2220880243; Woods CR, 2014, NAT PHYS, V10, P451, DOI [10.1038/NPHYS2954, 10.1038/nphys2954]	30	122	126	6	160	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 4	2015	350	6265					1231	1234		10.1126/science.aad2102	http://dx.doi.org/10.1126/science.aad2102			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX4WG	26785484	Green Submitted			2022-12-28	WOS:000365700500071
J	Miglioretti, DL; Lange, J; van den Broek, JJ; Lee, CI; van Ravesteyn, NT; Ritley, D; Kerlikowske, K; Fenton, JJ; Melnikow, J; de Koning, HJ; Hubbard, RA				Miglioretti, Diana L.; Lange, Jane; van den Broek, Jeroen J.; Lee, Christoph I.; van Ravesteyn, Nicolien T.; Ritley, Dominique; Kerlikowske, Karla; Fenton, Joshua J.; Melnikow, Joy; de Koning, Harry J.; Hubbard, Rebecca A.			Radiation-Induced Breast Cancer Incidence and Mortality From Digital Mammography Screening A Modeling Study	ANNALS OF INTERNAL MEDICINE			English	Article							UNITED-STATES; TOMOSYNTHESIS; RISK; ACCURACY; OBESITY; AGE	Background: Estimates of risk for radiation-induced breast cancer from mammography screening have not considered variation in dose exposure or diagnostic work-up after abnormal screening results. Objective: To estimate distributions of radiation-induced breast cancer incidence and mortality from digital mammography screening while considering exposure from screening and diagnostic mammography and dose variation among women. Design: 2 simulation-modeling approaches. Setting: U.S. population. Patients: Women aged 40 to 74 years. Intervention: Annual or biennial digital mammography screening from age 40, 45, or 50 years until age 74 years. Measurements: Lifetime breast cancer deaths averted (benefits) and radiation-induced breast cancer incidence and mortality (harms) per 100 000 women screened. Results: Annual screening of 100 000 women aged 40 to 74 years was projected to induce 125 breast cancer cases (95% CI, 88 to 178) leading to 16 deaths (CI, 11 to 23), relative to 968 breast cancer deaths averted by early detection from screening. Women exposed at the 95th percentile were projected to develop 246 cases of radiation-induced breast cancer leading to 32 deaths per 100 000 women. Women with large breasts requiring extra views for complete examination (8% of population) were projected to have greater radiation-induced breast cancer risk (266 cancer cases and 35 deaths per 100 000 women) than other women (113 cancer cases and 15 deaths per 100 000 women). Biennial screening starting at age 50 years reduced risk for radiation-induced cancer 5-fold. Limitation: Life-years lost from radiation-induced breast cancer could not be estimated. Conclusion: Radiation-induced breast cancer incidence and mortality from digital mammography screening are affected by dose variability from screening, resultant diagnostic work-up, initiation age, and screening frequency. Women with large breasts may have a greater risk for radiation-induced breast cancer.	[Miglioretti, Diana L.] Univ Calif Davis, Sch Med, Dept Publ Hlth Sci, One Shields Ave,Med Sci Bldg 1C,Room 144, Davis, CA 95616 USA; [Lange, Jane] Grp Hlth Res Inst, 1730 Minor Ave,Suite 1600, Seattle, WA 98101 USA; [van den Broek, Jeroen J.; van Ravesteyn, Nicolien T.; de Koning, Harry J.] Erasmus MC Univ, Med Ctr Rotterdam, Dept Publ Hlth, POB 2040, NL-3000 CA Rotterdam, Netherlands; [Lee, Christoph I.] Univ Washington, Sch Med, Dept Radiol, 825 Eastlake Ave East,G3-200, Seattle, WA 98109 USA; [Ritley, Dominique; Fenton, Joshua J.; Melnikow, Joy] Univ Calif Davis, Ctr Hlth Care Policy & Res, 2103 Stockton Blvd, Sacramento, CA 95817 USA; [Kerlikowske, Karla] San Francisco VA Med Ctr, Gen Internal Med Sect, 111A1,4150 Clement St, San Francisco, CA 94121 USA; [Hubbard, Rebecca A.] Univ Penn, Dept Biostat & Epidemiol, 604 Blockley Hall,423 Guardian Dr, Philadelphia, PA 19104 USA	University of California System; University of California Davis; Erasmus University Rotterdam; Erasmus MC; University of Washington; University of Washington Seattle; University of California System; University of California Davis; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of Pennsylvania	Miglioretti, DL (corresponding author), Univ Calif Davis, Sch Med, Dept Publ Hlth Sci, One Shields Ave,Med Sci Bldg 1C,Room 144, Davis, CA 95616 USA.	dmiglioretti@ucdavis.edu	de+Koning, Harry/AAF-9062-2019; Fenton, Joshua/AAD-4114-2021; Hubbard, Rebecca/Y-6500-2019	de+Koning, Harry/0000-0003-4682-3646; Hubbard, Rebecca/0000-0003-0879-0994; Lee, Christoph/0000-0002-8185-7721; Lange, Jane/0000-0002-0014-9679; Fenton, Joshua/0000-0002-0581-835X	Agency for Healthcare Research and Quality, U.S. Preventive Services Task Force, National Cancer Institute; NATIONAL CANCER INSTITUTE [U01CA152958, P30CA093373, R03CA182986, U54CA163303, U01CA079778, U01CA080098, P01CA154292] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality, U.S. Preventive Services Task Force, National Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Agency for Healthcare Research and Quality, U.S. Preventive Services Task Force, National Cancer Institute.	American Cancer Society, 2015, CANC FACTS FIG 2015; American College of Radiology, 2013, AM COLL RAD BREAST I; BallardBarbash R, 1997, AM J ROENTGENOL, V169, P1001, DOI 10.2214/ajr.169.4.9308451; Buist DSM, 2004, JNCI-J NATL CANCER I, V96, P1432, DOI 10.1093/jnci/djh269; Carney PA, 2003, ANN INTERN MED, V138, P168, DOI 10.7326/0003-4819-138-3-200302040-00008; Ciatto S, 2013, LANCET ONCOL, V14, P583, DOI 10.1016/S1470-2045(13)70134-7; Committee to Assess Health Risks From Exposure to Low Levels of Ionizing Radiation Board on Radiation Effects Research Division on Earth and Life Studies National Research Council of the National Academies, 2006, HLTH RISKS EXP LOW L; de Gonzalez AB, 2012, J RADIOL PROT, V32, P205, DOI 10.1088/0952-4746/32/3/205; Elmore JG, 2004, ARCH INTERN MED, V164, P1140, DOI 10.1001/archinte.164.10.1140; Elmore JG, 2003, JNCI-J NATL CANCER I, V95, P1384, DOI 10.1093/jnci/djg048; Feig SA, 1997, J NATL CANC I MONOGR, P119; Feng SSJ, 2012, RADIOLOGY, V263, P35, DOI 10.1148/radiol.11111789; Friedewald SM, 2014, JAMA-J AM MED ASSOC, V311, P2499, DOI 10.1001/jama.2014.6095; Greenberg JS, 2014, AM J ROENTGENOL, V203, P687, DOI 10.2214/AJR.14.12642; Haas BM, 2013, RADIOLOGY, V269, P694, DOI 10.1148/radiol.13130307; Hardesty LA, 2014, J AM COLL RADIOL, V11, P594, DOI 10.1016/j.jacr.2013.11.025; Harris RP, 2014, JAMA INTERN MED, V174, P281, DOI 10.1001/jamainternmed.2013.12745; Hendrick RE, 2010, RADIOLOGY, V257, P246, DOI 10.1148/radiol.10100570; Hendrick RE, 2010, AM J ROENTGENOL, V194, P362, DOI 10.2214/AJR.08.2114; Hofvind S, 2008, JNCI-J NATL CANCER I, V100, P1082, DOI 10.1093/jnci/djn224; Hubbard RA, 2011, ANN INTERN MED, V155, P481, DOI 10.7326/0003-4819-155-8-201110180-00004; Jacobsen KK, 2015, CANCER EPIDEMIOL, V39, P656, DOI 10.1016/j.canep.2015.05.004; Kerlikowske K, 2008, J NATL CANCER I, V100, P1724, DOI 10.1093/jnci/djn388; Lee CI, 2013, J AM COLL RADIOL, V10, P913, DOI 10.1016/j.jacr.2013.09.010; Mandelblatt JCK, 2015, AHRQ PUBLICATION; McCarthy AM, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju316; Miglioretti DL, 2015, JAMA ONCOL, V1, P1069, DOI 10.1001/jamaoncol.2015.3084; Olgar T, 2012, ROFO-FORTSCHR RONTG, V184, P911, DOI 10.1055/s-0032-1312877; Preston DL, 2002, RADIAT RES, V158, P220, DOI 10.1667/0033-7587(2002)158[0220:REOBCR]2.0.CO;2; Robinson M, 2008, BRIT J RADIOL, V81, P214, DOI 10.1259/bjr/90916004; Rose SL, 2013, AM J ROENTGENOL, V200, P1401, DOI 10.2214/AJR.12.9672; Skaane P, 2013, RADIOLOGY, V267, P47, DOI 10.1148/radiol.12121373; Smith-Bindman R, 2003, JAMA-J AM MED ASSOC, V290, P2129, DOI 10.1001/jama.290.16.2129; Sprague BL, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju255; Svahn TM, 2015, BREAST, V24, P93, DOI 10.1016/j.breast.2014.12.002; TABAR L, 1987, BRIT J CANCER, V55, P547, DOI 10.1038/bjc.1987.112; Tabar L, 1996, INT J CANCER, V66, P413, DOI 10.1002/(SICI)1097-0215(19960516)66:4<413::AID-IJC1>3.0.CO;2-Z; Tan Sita Y G L, 2006, J Natl Cancer Inst Monogr, P56, DOI 10.1093/jncimonographs/lgj009; U.S. Food and Drug Administration, 2015, TRENDS MAMM DOS IM Q; Wells CL, 2014, ACAD RADIOL, V21, P99, DOI 10.1016/j.acra.2013.10.005; Yaffe MJ, 2009, MED PHYS, V36, P5437, DOI 10.1118/1.3250863; Yaffe MJ, 2011, RADIOLOGY, V258, P98, DOI 10.1148/radiol.10100655	42	91	95	0	10	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 16	2016	164	4					205	+		10.7326/M15-1241	http://dx.doi.org/10.7326/M15-1241			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DD7WK	26756460	Green Accepted			2022-12-28	WOS:000370135300011
J	Horton, R; Samarasekera, U				Horton, Richard; Samarasekera, Udani			Stillbirths: ending an epidemic of grief	LANCET			English	Editorial Material									[Horton, Richard; Samarasekera, Udani] The Lancet, London EC2Y 5AS, England		Horton, R (corresponding author), The Lancet, London EC2Y 5AS, England.							Every Woman Every Child, 2015, GLOBAL STRATEGY WOME; Flenady V, 2016, LANCET, V387, P691, DOI 10.1016/S0140-6736(15)01020-X; Froen JF, 2016, LANCET; Heazell AEP, 2016, LANCET, V387, P604, DOI 10.1016/S0140-6736(15)00836-3; Kinney MV, 2016, LANCET; Lawn JE, 2016, LANCET; Mullan Z, 2011, LANCET, V377, P1291, DOI 10.1016/S0140-6736(11)60098-6; UN Independent Accountability Panel. Global Strategy for Women's Children's and Adolescents' Health Strategy and Coordination Group, 2015, GLOB STRAT WOM CHILD	8	27	28	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 6	2016	387	10018					515	+		10.1016/S0140-6736(15)01276-3	http://dx.doi.org/10.1016/S0140-6736(15)01276-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DD3PV	26794071				2022-12-28	WOS:000369835800011
J	Wan, RX; Yan, CY; Bai, R; Wang, L; Huang, M; Wong, CCL; Shi, YG				Wan, Ruixue; Yan, Chuangye; Bai, Rui; Wang, Lin; Huang, Min; Wong, Catherine C. L.; Shi, Yigong			The 3.8 angstrom structure of the U4/U6.U5 tri-snRNP: Insights into spliceosome assembly and catalysis	SCIENCE			English	Article							PRE-MESSENGER-RNA; SMALL NUCLEAR-RNA; METAL-ION CATALYSIS; CRYSTAL-STRUCTURE; ELECTRON-MICROSCOPY; 3-DIMENSIONAL STRUCTURE; YEAST SPLICEOSOME; EXON-LIGATION; EM STRUCTURE; ACTIVE-SITE	Splicing of precursor messenger RNA is accomplished by a dynamic megacomplex known as the spliceosome. Assembly of a functional spliceosome requires a preassembled U4/U6.U5 tri-snRNP complex, which comprises the U5 small nuclear ribonucleoprotein (snRNP), the U4 and U6 small nuclear RNA (snRNA) duplex, and a number of protein factors. Here we report the three-dimensional structure of a Saccharomyces cerevisiae U4/U6.U5 tri-snRNP at an overall resolution of 3.8 angstroms by single-particle electron cryomicroscopy. The local resolution for the core regions of the tri-snRNP reaches 3.0 to 3.5 angstroms, allowing construction of a refined atomic model. Our structure contains U5 snRNA, the extensively base-paired U4/U6 snRNA, and 30 proteins including Prp8 and Snu114, which amount to 8495 amino acids and 263 nucleotides with a combined molecular mass of similar to 1 megadalton. The catalytic nucleotide U80 from U6 snRNA exists in an inactive conformation, stabilized by its base-pairing interactions with U4 snRNA and protected by Prp3. Pre-messenger RNA is bound in the tri-snRNP through base-pairing interactions with U6 snRNA and loop I of U5 snRNA. This structure, together with that of the spliceosome, reveals the molecular choreography of the snRNAs in the activation process of the spliceosomal ribozyme.	[Wan, Ruixue; Yan, Chuangye; Bai, Rui; Wang, Lin; Shi, Yigong] Tsinghua Univ, Beijing Adv Innovat Ctr Struct Biol, Tsinghua Peking Joint Ctr Life Sci, Sch Life Sci,Minist Educ,Key Lab Prot Sci, Beijing 100084, Peoples R China; [Huang, Min; Wong, Catherine C. L.] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Natl Ctr Prot Sci Shanghai, Shanghai 200031, Peoples R China	Tsinghua University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Shi, YG (corresponding author), Tsinghua Univ, Beijing Adv Innovat Ctr Struct Biol, Tsinghua Peking Joint Ctr Life Sci, Sch Life Sci,Minist Educ,Key Lab Prot Sci, Beijing 100084, Peoples R China.	shi-lab@tsinghua.edu.cn	Yan, Chuangye/AAJ-5832-2021	Yan, Chuangye/0000-0001-9338-8048; Shi, Yigong/0000-0003-2030-168X; Wong, Catherine CL/0000-0001-7270-980X	Ministry of Science and Technology [2014ZX09507003006]; National Natural Science Foundation of China [31430020, 31321062]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank X. Fang for technical assistance and the Tsinghua University Branch of the China National Center for Protein Sciences (Beijing) for access to the EM facility. We also thank the Explorer 100 cluster system of the Tsinghua National Laboratory for Information Science and Technology, the Computing Platform of the China National Center for Protein Sciences, and Lenovo for providing high-performance computing. This work was supported by funds from the Ministry of Science and Technology (grant 2014ZX09507003006) and the National Natural Science Foundation of China (grants 31430020 and 31321062). The atomic coordinates have been deposited in the Protein Data Bank under the accession code 3JCM. The cryo-EM maps have been deposited in the Electron Microscopy Data Bank with the accession codes EMD-6561 for the overall map and EMD-6562 to EMD-6573 for the 12 local maps. The authors declare no competing financial interests.	Behzadnia N, 2007, EMBO J, V26, P1737, DOI 10.1038/sj.emboj.7601631; BERGET SM, 1977, P NATL ACAD SCI USA, V74, P3171, DOI 10.1073/pnas.74.8.3171; Bessonov S, 2010, RNA, V16, P2384, DOI 10.1261/rna.2456210; Boehringer D, 2004, NAT STRUCT MOL BIOL, V11, P463, DOI 10.1038/nsmb761; Bon E, 2003, NUCLEIC ACIDS RES, V31, P1121, DOI 10.1093/nar/gkg213; Burge C. B., 1999, RNA WORLD NATURE MOD, V37; Chen WJ, 2014, CURR OPIN STRUC BIOL, V24, P141, DOI 10.1016/j.sbi.2014.01.009; Chen WJ, 2014, RNA, V20, P308, DOI 10.1261/rna.040980.113; CHOW LT, 1977, CELL, V12, P1, DOI 10.1016/0092-8674(77)90180-5; Deckert J, 2006, MOL CELL BIOL, V26, P5528, DOI 10.1128/MCB.00582-06; Dobbyn HC, 2007, BIOCHEM BIOPH RES CO, V360, P857, DOI 10.1016/j.bbrc.2007.06.163; Fabrizio P, 2009, MOL CELL, V36, P593, DOI 10.1016/j.molcel.2009.09.040; Fica SM, 2013, NATURE, V503, P229, DOI 10.1038/nature12734; Galej WP, 2014, CURR OPIN STRUC BIOL, V25, P57, DOI 10.1016/j.sbi.2013.12.002; Galej WP, 2013, NATURE, V493, P638, DOI 10.1038/nature11843; GALISSON F, 1993, NUCLEIC ACIDS RES, V21, P1555, DOI 10.1093/nar/21.7.1555; Golas MM, 2010, MOL CELL, V40, P927, DOI 10.1016/j.molcel.2010.11.023; Gordon PM, 2000, RNA, V6, P199, DOI 10.1017/S1355838200992069; Gottschalk A, 1999, EMBO J, V18, P4535, DOI 10.1093/emboj/18.16.4535; Hacker I, 2008, NAT STRUCT MOL BIOL, V15, P1206, DOI 10.1038/nsmb.1506; Hang J, 2015, SCIENCE, V349, P1191, DOI 10.1126/science.aac8159; Hegele A, 2012, MOL CELL, V45, P567, DOI 10.1016/j.molcel.2011.12.034; Ilagan JO, 2013, RNA, V19, P400, DOI 10.1261/rna.034223.112; Jenkins JL, 2013, NUCLEIC ACIDS RES, V41, P3859, DOI 10.1093/nar/gkt046; Jurica MS, 2004, NAT STRUCT MOL BIOL, V11, P265, DOI 10.1038/nsmb728; Kondo Y, 2015, ELIFE, V4, DOI 10.7554/eLife.04986; Leung AKW, 2011, NATURE, V473, P536, DOI 10.1038/nature09956; Lin PC, 2012, EMBO J, V31, P1579, DOI 10.1038/emboj.2012.7; Liu S, 2007, SCIENCE, V316, P115, DOI 10.1126/science.1137924; Liu S, 2015, ELIFE, V4, DOI 10.7554/eLife.07320; Maroney PA, 2000, MOL CELL, V6, P317, DOI 10.1016/S1097-2765(00)00032-0; Montemayor EJ, 2014, NAT STRUCT MOL BIOL, V21, P544, DOI 10.1038/nsmb.2832; Moore M. J., 1993, COLD SPRING HARBOR M, V24; Mozaffari-Jovin S, 2013, SCIENCE, V341, P80, DOI 10.1126/science.1237515; Ohi MD, 2007, P NATL ACAD SCI USA, V104, P3195, DOI 10.1073/pnas.0611591104; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pomeranz Krummel Daniel A, 2009, Nature, V458, P475, DOI 10.1038/nature07851; Price SR, 1998, NATURE, V394, P645, DOI 10.1038/29234; Reuter K, 1999, J MOL BIOL, V294, P515, DOI 10.1006/jmbi.1999.3258; RUBY SW, 1988, SCIENCE, V242, P1028, DOI 10.1126/science.2973660; Sander B, 2006, MOL CELL, V24, P267, DOI 10.1016/j.molcel.2006.08.021; Sickmier EA, 2006, MOL CELL, V23, P49, DOI 10.1016/j.molcel.2006.05.025; Small EC, 2006, MOL CELL, V23, P389, DOI 10.1016/j.molcel.2006.05.043; Sontheimer EJ, 1997, NATURE, V388, P801, DOI 10.1038/42068; STEITZ TA, 1993, P NATL ACAD SCI USA, V90, P6498, DOI 10.1073/pnas.90.14.6498; Nguyen THD, 2015, NATURE, V523, P47, DOI 10.1038/nature14548; Nguyen THD, 2013, STRUCTURE, V21, P910, DOI 10.1016/j.str.2013.04.017; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; WASSARMAN DA, 1992, SCIENCE, V257, P1918, DOI 10.1126/science.1411506; Weber G, 2010, EMBO J, V29, P4172, DOI 10.1038/emboj.2010.295; Will CL, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003707; Wolf E, 2009, EMBO J, V28, P2283, DOI 10.1038/emboj.2009.171; Yan CY, 2015, SCIENCE, V349, P1182, DOI 10.1126/science.aac7629; Yean SL, 2000, NATURE, V408, P881, DOI 10.1038/35048617; Zhou LJ, 2014, NATURE, V506, P116, DOI 10.1038/nature12803	55	127	132	6	188	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 29	2016	351	6272					466	475		10.1126/science.aad6466	http://dx.doi.org/10.1126/science.aad6466			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB9SW	26743623				2022-12-28	WOS:000368858200028
J	Luchsinger, LL; de Almeida, MJ; Corrigan, DJ; Mumau, M; Snoeck, HW				Luchsinger, Larry L.; de Almeida, Mariana Justino; Corrigan, David J.; Mumau, Melanie; Snoeck, Hans-Willem			Mitofusin 2 maintains haematopoietic stem cells with extensive lymphoid potential	NATURE			English	Article							MITOCHONDRIAL FISSION; ENDOPLASMIC-RETICULUM; FUSION; EXPRESSION; INHIBITOR	Haematopoietic stem cells (HSCs), which sustain production of all blood cell lineages(1), rely on glycolysis for ATP production(2,3), yet little attention has been paid to the role of mitochondria. Here we show in mice that the short isoform of a critical regulator of HSCs, Prdm16 (refs 4, 5), induces mitofusin 2 (Mfn2), a protein involved in mitochondrial fusion and in tethering of mitochondria to the endoplasmic reticulum. Overexpression and deletion studies, including single-cell transplantation assays, revealed that Mfn2 is specifically required for the maintenance of HSCs with extensive lymphoid potential, but not, or less so, for the maintenance of myeloid-dominant HSCs. Mfn2 increased buffering of intracellular Ca2+, an effect mediated through its endoplasmic reticulum-mitochondria tethering activity(6,7), thereby negatively regulating nuclear translocation and transcriptional activity of nuclear factor of activated T cells (Nfat). Nfat inhibition rescued the effects of Mfn2 deletion in HSCs, demonstrating that negative regulation of Nfat is the prime downstream mechanism of Mfn2 in the maintenance of HSCs with extensive lymphoid potential. Mitochondria therefore have an important role in HSCs. These findings provide a mechanism underlying clonal heterogeneity among HSCs8-11 and may lead to the design of approaches to bias HSC differentiation into desired lineages after transplantation.	[Luchsinger, Larry L.; de Almeida, Mariana Justino; Corrigan, David J.; Mumau, Melanie; Snoeck, Hans-Willem] Columbia Univ, Med Ctr, Columbia Ctr Translat Immunol, New York, NY 10032 USA; [Luchsinger, Larry L.; Snoeck, Hans-Willem] Columbia Univ, Dept Med, Med Ctr, New York, NY 10032 USA; [de Almeida, Mariana Justino; Corrigan, David J.; Mumau, Melanie; Snoeck, Hans-Willem] Columbia Univ, Med Ctr, Dept Microbiol & Immunol, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University	Snoeck, HW (corresponding author), Columbia Univ, Med Ctr, Columbia Ctr Translat Immunol, New York, NY 10032 USA.; Snoeck, HW (corresponding author), Columbia Univ, Dept Med, Med Ctr, New York, NY 10032 USA.; Snoeck, HW (corresponding author), Columbia Univ, Med Ctr, Dept Microbiol & Immunol, New York, NY 10032 USA.	hs2680@columbia.edu		Corrigan, David/0000-0002-8239-129X	Druckenmiller Fellowship from the New York Stem Cell Foundation; Ruth L. Kirschstein fellowship [F31 CA196045]; NIH National Center for Research Resources [1S10RR027050-01]; NIH Office of the Director [1S10OD020056-01];  [NIH RO1 CA167286];  [RO1 AG029262]; NATIONAL CANCER INSTITUTE [R01CA167289, F31CA196045] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027050] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073760] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI106711] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG029626] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD020056] Funding Source: NIH RePORTER	Druckenmiller Fellowship from the New York Stem Cell Foundation; Ruth L. Kirschstein fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH Office of the Director(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The pHR-IRES-GFP SIN vector was a gift from R. Creusot. Mfn2<SUP>-/-</SUP> MEFs were a gift from D. Chan. We thank S.-H. Ho and E. A. Schon for assistance and discussion. This work was supported by grant NIH RO1 CA167286 and RO1 AG029262 (H.-W.S.), the Druckenmiller Fellowship from the New York Stem Cell Foundation (L.L.L.), the Ruth L. Kirschstein F31 CA196045 fellowship (D.J.C.), the NIH National Center for Research Resources award 1S10RR027050-01 and the NIH Office of the Director award 1S10OD020056-01.	Aguilo F, 2011, BLOOD, V117, P5057, DOI 10.1182/blood-2010-08-300145; Aramburu J, 1999, SCIENCE, V285, P2129, DOI 10.1126/science.285.5436.2129; AUSUBEL FM, 1999, SHORT PROTOCOLS MOL; Beerman I, 2010, P NATL ACAD SCI USA, V107, P5465, DOI 10.1073/pnas.1000834107; Benz C, 2012, CELL STEM CELL, V10, P273, DOI 10.1016/j.stem.2012.02.007; Chan DC, 2012, ANNU REV GENET, V46, P265, DOI 10.1146/annurev-genet-110410-132529; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Chen HC, 2007, CELL, V130, P548, DOI 10.1016/j.cell.2007.06.026; Chuikov S, 2010, NAT CELL BIOL, V12, P999, DOI 10.1038/ncb2101; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; Dykstra B, 2007, CELL STEM CELL, V1, P218, DOI 10.1016/j.stem.2007.05.015; Dykstra B, 2011, J EXP MED, V208, P2691, DOI 10.1084/jem.20111490; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Li HM, 2011, TRENDS CELL BIOL, V21, P91, DOI 10.1016/j.tcb.2010.09.011; Muller MR, 2009, P NATL ACAD SCI USA, V106, P7034, DOI 10.1073/pnas.0813296106; Muller-Sieburg CE, 2002, BLOOD, V100, P1302, DOI 10.1182/blood.V100.4.1302.h81602001302_1302_1309; Muller-Sieburg CE, 2006, CURR OPIN HEMATOL, V13, P243, DOI 10.1097/01.moh.0000231421.00407.65; Ngoh GA, 2012, J BIOL CHEM, V287, P20321, DOI 10.1074/jbc.M112.359174; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Pham AH, 2012, GENESIS, V50, P833, DOI 10.1002/dvg.22050; Rizzuto R, 2012, NAT REV MOL CELL BIO, V13, P566, DOI 10.1038/nrm3412; Sanjuan-Pla A, 2013, NATURE, V502, P232, DOI 10.1038/nature12495; Shimshek DR, 2002, GENESIS, V32, P19, DOI 10.1002/gene.10023; Shing DC, 2007, J CLIN INVEST, V117, P3696, DOI 10.1172/JCI32390; Simsek T, 2010, CELL STEM CELL, V7, P380, DOI 10.1016/j.stem.2010.07.011; Sorianello E, 2012, CARDIOVASC RES, V94, P38, DOI 10.1093/cvr/cvs006; SZILVASSY SJ, 1990, P NATL ACAD SCI USA, V87, P8736, DOI 10.1073/pnas.87.22.8736; Takubo K, 2013, CELL STEM CELL, V12, P49, DOI 10.1016/j.stem.2012.10.011; Tanaka A, 2008, MOL CELL, V29, P409, DOI 10.1016/j.molcel.2008.02.005; Weksberg DC, 2008, BLOOD, V111, P2444, DOI 10.1182/blood-2007-09-115006; Wu H, 2007, TRENDS CELL BIOL, V17, P251, DOI 10.1016/j.tcb.2007.04.006; Yoshida M, 2004, BLOOD, V103, P2753, DOI 10.1182/blood-2003-07-2482; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855; Zambrowicz BP, 2003, P NATL ACAD SCI USA, V100, P14109, DOI 10.1073/pnas.2336103100	35	153	157	1	30	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 28	2016	529	7587					528	+		10.1038/nature16500	http://dx.doi.org/10.1038/nature16500			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB7DD	26789249	Green Accepted			2022-12-28	WOS:000368673800037
J	Santoro, AE				Santoro, Alyson E.			The do-it-all nitrifier The discovery of bacteria that can oxidize both ammonia and nitrite upends a long-held dogma	SCIENCE			English	Editorial Material							COMPLETE NITRIFICATION		[Santoro, Alyson E.] Univ Maryland, Ctr Environm Sci, Horn Point Lab, Cambridge, MD 21613 USA	University System of Maryland; University of Maryland Center for Environmental Science	Santoro, AE (corresponding author), Univ Maryland, Ctr Environm Sci, Horn Point Lab, Cambridge, MD 21613 USA.	asantoro@umces.edu	Santoro, Alyson E/E-5686-2013	Santoro, Alyson E/0000-0003-2503-8219				Costa E, 2006, TRENDS MICROBIOL, V14, P213, DOI 10.1016/j.tim.2006.03.006; Daims H, 2015, NATURE, V528, P504, DOI 10.1038/nature16461; Koch H, 2015, P NATL ACAD SCI USA, V112, P11371, DOI 10.1073/pnas.1506533112; Koch H, 2014, SCIENCE, V345, P1052, DOI 10.1126/science.1256985; Li M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9933; Palatinszky M, 2015, NATURE, V524, P105, DOI 10.1038/nature14856; Penn J. L., 2014, AM GEOPH UN FALL M S; Pinto AJ, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00054-15; Qin W, 2014, P NATL ACAD SCI USA, V111, P12504, DOI 10.1073/pnas.1324115111; Santoro AE, 2015, P NATL ACAD SCI USA, V112, P1173, DOI 10.1073/pnas.1416223112; Sorokin DY, 2012, ISME J, V6, P2245, DOI 10.1038/ismej.2012.70; van Kessel MAHJ, 2015, NATURE, V528, P555, DOI 10.1038/nature16459	12	32	35	3	134	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 22	2016	351	6271					342	343		10.1126/science.aad9839	http://dx.doi.org/10.1126/science.aad9839			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB3VH	26798002				2022-12-28	WOS:000368440500024
J	Shu, SK; Lin, CY; He, HH; Witwicki, RM; Tabassum, DP; Roberts, JM; Janiszewska, M; Huh, SJ; Liang, Y; Ryan, J; Doherty, E; Mohammed, H; Guo, H; Stover, DG; Ekram, MB; Peluffo, G; Brown, J; D'Santos, C; Krop, IE; Dillon, D; McKeown, M; Ott, C; Qi, J; Ni, M; Rao, PK; Duarte, M; Wu, SY; Chiang, CM; Anders, L; Young, RA; Winer, EP; Letai, A; Barry, WT; Carroll, JS; Long, HW; Brown, M; Liu, XS; Meyer, CA; Bradner, JE; Polyak, K				Shu, Shaokun; Lin, Charles Y.; He, Housheng Hansen; Witwicki, Robert M.; Tabassum, Doris P.; Roberts, Justin M.; Janiszewska, Michalina; Huh, Sung Jin; Liang, Yi; Ryan, Jeremy; Doherty, Ernest; Mohammed, Hisham; Guo, Hao; Stover, Daniel G.; Ekram, Muhammad B.; Peluffo, Guillermo; Brown, Jonathan; D'Santos, Clive; Krop, Ian E.; Dillon, Deborah; McKeown, Michael; Ott, Christopher; Qi, Jun; Ni, Min; Rao, Prakash K.; Duarte, Melissa; Wu, Shwu-Yuan; Chiang, Cheng-Ming; Anders, Lars; Young, Richard A.; Winer, Eric P.; Letai, Antony; Barry, William T.; Carroll, Jason S.; Long, Henry W.; Brown, Myles; Liu, X. Shirley; Meyer, Clifford A.; Bradner, James E.; Polyak, Kornelia			Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer	NATURE			English	Article							SUPER-ENHANCERS; SELECTIVE-INHIBITION; CELL IDENTITY; RNA-SEQ; C-MYC; INFLAMMATION; STRATEGY; LEUKEMIA; SUBTYPES; PP2A	Triple-negative breast cancer (TNBC) is a heterogeneous and clinically aggressive disease for which there is no targeted therapy(1-3). BET bromodomain inhibitors, which have shown efficacy in several models of cancer(4-6), have not been evaluated in TNBC. These inhibitors displace BET bromodomain proteins such as BRD4 from chromatin by competing with their acetyl-lysine recognition modules, leading to inhibition of oncogenic transcriptional programs(7-9). Here we report the preferential sensitivity of TNBCs to BET bromodomain inhibition in vitro and in vivo, establishing a rationale for clinical investigation and further motivation to understand mechanisms of resistance. In paired cell lines selected for acquired resistance to BET inhibition from previously sensitive TNBCs, we failed to identify gatekeeper mutations, new driver events or drug pump activation. BET-resistant TNBC cells remain dependent on wild-type BRD4, which supports transcription and cell proliferation in a bromodomain-independent manner. Proteomic studies of resistant TNBC identify strong association with MED1 and hyper-phosphorylation of BRD4 attributable to decreased activity of PP2A, identified here as a principal BRD4 serine phosphatase. Together, these studies provide a rationale for BET inhibition in TNBC and present mechanism-based combination strategies to anticipate clinical drug resistance.	[Shu, Shaokun; Lin, Charles Y.; He, Housheng Hansen; Witwicki, Robert M.; Tabassum, Doris P.; Roberts, Justin M.; Janiszewska, Michalina; Huh, Sung Jin; Ryan, Jeremy; Doherty, Ernest; Stover, Daniel G.; Ekram, Muhammad B.; Peluffo, Guillermo; Brown, Jonathan; Krop, Ian E.; Dillon, Deborah; McKeown, Michael; Ott, Christopher; Qi, Jun; Ni, Min; Winer, Eric P.; Letai, Antony; Long, Henry W.; Brown, Myles; Bradner, James E.; Polyak, Kornelia] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Shu, Shaokun; Lin, Charles Y.; He, Housheng Hansen; Witwicki, Robert M.; Janiszewska, Michalina; Huh, Sung Jin; Ryan, Jeremy; Stover, Daniel G.; Ekram, Muhammad B.; Peluffo, Guillermo; Brown, Jonathan; Krop, Ian E.; McKeown, Michael; Ott, Christopher; Qi, Jun; Ni, Min; Winer, Eric P.; Letai, Antony; Barry, William T.; Brown, Myles; Bradner, James E.; Polyak, Kornelia] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Shu, Shaokun; Lin, Charles Y.; He, Housheng Hansen; Witwicki, Robert M.; Janiszewska, Michalina; Huh, Sung Jin; Ryan, Jeremy; Stover, Daniel G.; Ekram, Muhammad B.; Peluffo, Guillermo; Brown, Jonathan; Krop, Ian E.; McKeown, Michael; Ott, Christopher; Qi, Jun; Ni, Min; Winer, Eric P.; Letai, Antony; Barry, William T.; Brown, Myles; Bradner, James E.; Polyak, Kornelia] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [He, Housheng Hansen; Guo, Hao; Barry, William T.; Liu, X. Shirley; Meyer, Clifford A.] Harvard Univ, Sch Publ Hlth, Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [He, Housheng Hansen; Guo, Hao; Barry, William T.; Liu, X. Shirley; Meyer, Clifford A.] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [He, Housheng Hansen; Liang, Yi] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON M5G 1L7, Canada; [He, Housheng Hansen] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2M9, Canada; [Doherty, Ernest] Harvard Univ, Cambridge, MA 02138 USA; [Mohammed, Hisham; D'Santos, Clive; Carroll, Jason S.] Univ Cambridge, Cambridge Inst, Canc Res UK, Cambridge CB2 0RE, England; [Dillon, Deborah] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Dillon, Deborah] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Rao, Prakash K.; Duarte, Melissa; Long, Henry W.; Brown, Myles; Liu, X. Shirley; Polyak, Kornelia] Dana Farber Canc Inst, Ctr Funct Canc Epigenet, Boston, MA 02215 USA; [Wu, Shwu-Yuan; Chiang, Cheng-Ming] Univ Texas SW Med Ctr Dallas, Simmons Comprehens Canc Ctr, Dept Biochem, Dallas, TX 75390 USA; [Wu, Shwu-Yuan; Chiang, Cheng-Ming] Univ Texas SW Med Ctr Dallas, Simmons Comprehens Canc Ctr, Dept Pharmacol, Dallas, TX 75390 USA; [Anders, Lars; Young, Richard A.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Liu, X. Shirley; Bradner, James E.; Polyak, Kornelia] Broad Inst, Cambridge, MA 02142 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; Harvard University; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Polyak, K (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA.	james_bradner@dfci.harvard.edu; kornelia_polyak@dfci.harvard.edu	He, Hansen/ABD-8439-2020; Young, Richard A/F-6495-2012; Brown, Myles/AAX-5332-2021; Brown, Myles/B-6906-2008	He, Hansen/0000-0003-2898-3363; Young, Richard A/0000-0001-8855-8647; Brown, Myles/0000-0002-8213-1658; Stover, Daniel/0000-0001-9003-8165; Roberts, Justin/0000-0001-6112-7476; Carroll, Jason/0000-0003-3643-0080	NIH DF/HCC SPORE in Breast Cancer [CA168504, CA080111, CA103867]; Susan G. Komen Foundation; CPRIT [RP110471, RP140367]; Welch Foundation; US Department of Defense CDMRP [BC122003, CA120184]; Princess Margaret Cancer Foundation; Canada Foundation for Innovation; Ontario Research Fund [CFI32372]; NSERC discovery grant [RGPIN-2015-04658]; Harvard Ludwig Center for Cancer Research; NATIONAL CANCER INSTITUTE [P50CA168504, P30CA014051, R01CA103867, P01CA080111] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002668] Funding Source: NIH RePORTER; Cancer Research UK [22310, 20411] Funding Source: researchfish	NIH DF/HCC SPORE in Breast Cancer(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan G. Komen Foundation(Susan G. Komen Breast Cancer Foundation); CPRIT; Welch Foundation(The Welch Foundation); US Department of Defense CDMRP(United States Department of Defense); Princess Margaret Cancer Foundation(University of Toronto); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Ontario Research Fund; NSERC discovery grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Harvard Ludwig Center for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Cancer Research UK(Cancer Research UK)	We thank D. Silver and members of the Polyak and Bradner laboratories for their critical reading of this manuscript and useful discussions. We thank G. Brown for help with creating the word cloud figures. This work was supported by the NIH DF/HCC SPORE in Breast Cancer CA168504 (K.P., E.P.W., I.E.K., D.D., W.T.B., and J.E.B.), CA080111 (K.P. and M.B.), and CA103867 (C.M.C.), Susan G. Komen Foundation (S.S.), CPRIT RP110471 and RP140367 (C.M.C), Welch Foundation (C.M.C.), US Department of Defense CDMRP BC122003 (S.X.L.) and CA120184 (C.Y.L.), Princess Margaret Cancer Foundation (H.H.H.), Canada Foundation for Innovation and Ontario Research Fund CFI32372 (H.H.H.), NSERC discovery grant RGPIN-2015-04658 (H.H.H.), and the Harvard Ludwig Center for Cancer Research (J.E.B., M.B. and K.P.).	Anders L, 2014, NAT BIOTECHNOL, V32, P92, DOI 10.1038/nbt.2776; Belkina AC, 2012, NAT REV CANCER, V12, P465, DOI 10.1038/nrc3256; Bessarabova M, 2011, CANCER RES, V71, P3471, DOI 10.1158/0008-5472.CAN-10-3038; Brown JD, 2014, MOL CELL, V56, P219, DOI 10.1016/j.molcel.2014.08.024; Burstein MD, 2015, CLIN CANCER RES, V21, P1688, DOI 10.1158/1078-0432.CCR-14-0432; Chapuy B, 2013, CANCER CELL, V24, P777, DOI 10.1016/j.ccr.2013.11.003; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Choudhury S, 2013, CELL STEM CELL, V13, P117, DOI 10.1016/j.stem.2013.05.004; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Eichhorn PJA, 2009, BBA-REV CANCER, V1795, P1, DOI 10.1016/j.bbcan.2008.05.005; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Fong CY, 2015, NATURE, V525, P538, DOI 10.1038/nature14888; Gutierrez A, 2014, J CLIN INVEST, V124, P644, DOI 10.1172/JCI65093; Hayashi H, 2015, ONCOGENE, V34, P199, DOI 10.1038/onc.2013.547; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Marotta LLC, 2011, J CLIN INVEST, V121, P2723, DOI 10.1172/JCI44745; Mellacheruvu D, 2013, NAT METHODS, V10, P730, DOI 10.1038/nmeth.2557; Metzger O, 2012, J CLIN ONCOL, V30, P1879, DOI 10.1200/JCO.2011.38.2010; Mohammed H, 2013, CELL REP, V3, P342, DOI 10.1016/j.celrep.2013.01.010; Montero J, 2015, CELL, V160, P977, DOI 10.1016/j.cell.2015.01.042; Puissant A, 2013, CANCER DISCOV, V3, P308, DOI 10.1158/2159-8290.CD-12-0418; Rathert P, 2015, NATURE, V525, P543, DOI 10.1038/nature14898; Rincon R, 2015, ONCOTARGET, V6, P4299, DOI 10.18632/oncotarget.3012; Ryan J, 2013, METHODS, V61, P156, DOI 10.1016/j.ymeth.2013.04.006; Semenza GL, 2013, J CLIN INVEST, V123, P3664, DOI 10.1172/JCI67230; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vaz-Luis I, 2014, J CLIN ONCOL, V32, P2142, DOI 10.1200/JCO.2013.53.1608; Westermarck J, 2008, TRENDS MOL MED, V14, P152, DOI 10.1016/j.molmed.2008.02.001; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Wu SY, 2013, MOL CELL, V49, P843, DOI 10.1016/j.molcel.2012.12.006; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	36	371	383	7	232	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 21	2016	529	7586					413	+		10.1038/nature16508	http://dx.doi.org/10.1038/nature16508			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB2QT	26735014	Green Submitted, Green Accepted, Green Published			2022-12-28	WOS:000368354800050
J	Bekelman, JE; Halpern, SD; Blankart, CR; Bynum, JP; Cohen, J; Fowler, R; Kaasa, S; Kwietniewski, L; Melberg, HO; Onwuteaka-Philipsen, B; Oosterveld-Vlug, M; Pring, A; Schreyogg, J; Ulrich, CM; Verne, J; Wunsch, H; Emanuel, EJ				Bekelman, Justin E.; Halpern, Scott D.; Blankart, Carl Rudolf; Bynum, Julie P.; Cohen, Joachim; Fowler, Robert; Kaasa, Stein; Kwietniewski, Lukas; Melberg, Hans Olav; Onwuteaka-Philipsen, Bregje; Oosterveld-Vlug, Mariska; Pring, Andrew; Schreyoegg, Jonas; Ulrich, Connie M.; Verne, Julia; Wunsch, Hannah; Emanuel, Ezekiel J.		ICELR	Comparison of Site of Death, Health Care Utilization, and Hospital Expenditures for Patients Dying With Cancer in 7 Developed Countries	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							OF-LIFE CARE; LAST YEAR; MEDICARE BENEFICIARIES; UNITED-STATES; END; PLACE; PREFERENCES; POPULATION; DIAGNOSIS; SURVIVAL	IMPORTANCE Differences in utilization and costs of end-of-life care among developed countries are of considerable policy interest. OBJECTIVE To compare site of death, health care utilization, and hospital expenditures in 7 countries: Belgium, Canada, England, Germany, the Netherlands, Norway, and the United States. DESIGN, SETTING, AND PARTICIPANTS Retrospective cohort study using administrative and registry data from 2010. Participants were decedents older than 65 years who died with cancer. Secondary analyses included decedents of any age, decedents older than 65 years with lung cancer, and decedents older than 65 years in the United States and Germany from 2012. MAIN OUTCOMES AND MEASURES Deaths in acute care hospitals, 3 inpatient measures (hospitalizations in acute care hospitals, admissions to intensive care units, and emergency department visits), 1 outpatient measure (chemotherapy episodes), and hospital expenditures paid by insurers (commercial or governmental) during the 180-day and 30-day periods before death. Expenditures were derived from country-specific methods for costing inpatient services. RESULTS The United States (cohort of decedents aged >65 years, N = 211 816) and the Netherlands (N = 7216) had the lowest proportion of decedents die in acute care hospitals (22.2.% and 29.4%, respectively). A higher proportion of decedents died in acute care hospitals in Belgium (N = 21 054; 51.2%), Canada (N = 20 818; 52.1%), England (N = 97 099; 41.7%), Germany (N = 24 434; 38.3%), and Norway (N = 6636; 44.7%). In the last 180 days of life, 40.3% of US decedents had an intensive care unit admission compared with less than 18% in other reporting nations. In the last 180 days of life, mean per capita hospital expenditures were higher in Canada (US $21 840), Norway (US $19 783), and the United States (US $18 500), intermediate in Germany (US $16 221) and Belgium (US $15 699), and lower in the Netherlands (US $10 936) and England (US $9342). Secondary analyses showed similar results. CONCLUSIONS AND RELEVANCE Among patients older than 65 years who died with cancer in 7 developed countries in 2010, end-of-life care was more hospital-centric in Belgium, Canada, England, Germany, and Norway than in the Netherlands or the United States. Hospital expenditures near the end of life were higher in the United States, Norway, and Canada, intermediate in Germany and Belgium, and lower in the Netherlands and England. However, intensive care unit admissions were more than twice as common in the United States as in other countries.	[Bekelman, Justin E.] Univ Penn, Perelman Sch Med, Dept Radiat Oncol, Philadelphia, PA 19104 USA; [Bekelman, Justin E.; Halpern, Scott D.; Ulrich, Connie M.; Emanuel, Ezekiel J.] Univ Penn, Perelman Sch Med, Dept Med Eth & Hlth Policy, Philadelphia, PA 19104 USA; [Halpern, Scott D.] Univ Penn, Perelman Sch Med, Dept Med, Philadelphia, PA 19104 USA; [Halpern, Scott D.] Univ Penn, Perelman Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Blankart, Carl Rudolf; Kwietniewski, Lukas; Schreyoegg, Jonas] Univ Hamburg, Hamburg Ctr Hlth Econ, Hamburg, Germany; [Blankart, Carl Rudolf] Brown Univ, Ctr Gerontol & Hlth Care Res, Sch Publ Hlth, Providence, RI 02912 USA; [Bynum, Julie P.] Dartmouth Coll, Ctr Hlth Policy Res, Geisel Sch Med, Hanover, NH 03755 USA; [Cohen, Joachim] Vrije Univ Brussel, End Of Life Care Res Grp, Brussels, Belgium; [Cohen, Joachim] Univ Ghent, Brussels, Belgium; [Fowler, Robert] Univ Toronto, Dept Med, Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada; [Fowler, Robert; Wunsch, Hannah] Univ Toronto, Dept Crit Care Med, Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada; [Kaasa, Stein] Norwegian Univ Sci & Technol, Dept Canc Res & Mol Med, N-7034 Trondheim, Norway; [Kaasa, Stein] Oslo Univ Hosp, Dept Oncol, Oslo, Norway; [Kaasa, Stein] Univ Oslo, Oslo, Norway; [Melberg, Hans Olav] Univ Oslo, Dept Hlth Management & Hlth Econ, Oslo, Norway; [Melberg, Hans Olav] Univ Oslo, Oslo Ctr Biostat & Epidemiol, Oslo, Norway; [Onwuteaka-Philipsen, Bregje; Oosterveld-Vlug, Mariska] Vrije Univ Amsterdam, Med Ctr, Dept Publ & Occupat Hlth, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands; [Onwuteaka-Philipsen, Bregje; Oosterveld-Vlug, Mariska] Vrije Univ Amsterdam, Med Ctr, Canc Ctr Amsterdam, Amsterdam, Netherlands; [Pring, Andrew; Verne, Julia] Publ Hlth England, Natl End Life Care Intelligence Network, London, England	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Hamburg; Brown University; Dartmouth College; Vrije Universiteit Brussel; Ghent University; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; Norwegian University of Science & Technology (NTNU); University of Oslo; University of Oslo; University of Oslo; University of Oslo; Vrije Universiteit Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; Public Health England	Emanuel, EJ (corresponding author), Univ Penn, Perelman Sch Med, Dept Med Eth & Hlth Policy, 122 Coll Hall, Philadelphia, PA 19104 USA.	mehpchair@upenn.edu	Cohen, Joachim/B-6803-2008; Schreyögg, Jonas/AAY-6182-2021; Blankart, Carl R/Q-7843-2018	Cohen, Joachim/0000-0002-7224-9476; Schreyögg, Jonas/0000-0001-8030-2161; Blankart, Carl R/0000-0001-6719-0038; Melberg, Hans Olav/0000-0002-2349-5902; Onwuteaka-Philipsen, Bregje/0000-0002-9440-1248	Commonwealth Fund [P01-G19783]; National Institute on Aging [P01-G19783]; National Cancer Institute [K07CA163616]; NATIONAL CANCER INSTITUTE [K07CA163616] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K01AG041763, P01AG019783] Funding Source: NIH RePORTER	Commonwealth Fund; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was partially supported by the Commonwealth Fund and the National Institute on Aging (grant P01-G19783) and National Cancer Institute (grant K07CA163616).	Barnato AE, 2009, J GEN INTERN MED, V24, P695, DOI 10.1007/s11606-009-0952-6; Berke EM, 2009, J PALLIAT MED, V12, P128, DOI 10.1089/jpm.2008.0239; Blankart CR, 2012, HEALTH POLICY, V105, P128, DOI 10.1016/j.healthpol.2012.01.006; Brooks GA, 2013, JNCI-J NATL CANCER I, V105, P634, DOI 10.1093/jnci/djt025; Center MM, 2012, EUR UROL, V61, P1079, DOI 10.1016/j.eururo.2012.02.054; Cohen J, 2010, J CLIN ONCOL, V28, P2267, DOI 10.1200/JCO.2009.23.2850; De Roo ML, 2013, J PAIN SYMPTOM MANAG, V46, P556, DOI 10.1016/j.jpainsymman.2012.09.013; Earle CC, 2008, J CLIN ONCOL, V26, P3860, DOI 10.1200/JCO.2007.15.8253; EDDY DM, 1990, JAMA-J AM MED ASSOC, V263, P2493, DOI 10.1001/jama.263.18.2493; Emanuel EJ, 1996, JAMA-J AM MED ASSOC, V275, P1907, DOI 10.1001/jama.275.24.1907; Emanuel EJ, 2002, ARCH INTERN MED, V162, P1722, DOI 10.1001/archinte.162.15.1722; EMANUEL EJ, 1988, AM J MED, V84, P291, DOI 10.1016/0002-9343(88)90428-7; Evans N, 2014, J PAIN SYMPTOM MANAG, V47, P604, DOI 10.1016/j.jpainsymman.2013.04.008; Fields M, 1997, APPROACHING DEATH IM; Flory J, 2004, HEALTH AFFAIR, V23, P194, DOI 10.1377/hlthaff.23.3.194; Foley KM, 2001, IMPROVING PALLIATIVE; Gomes B, 2012, ANN ONCOL, V23, P2006, DOI 10.1093/annonc/mdr602; Goodman DC, 2013, TRENDS CANC CARE NEA; Gruneir A, 2007, MED CARE RES REV, V64, P351, DOI 10.1177/1077558707301810; Health and Social Care Information Centre Office of National Statistics, 2015, CANC DAT OFF NAT STA; Heron Melonie, 2013, Natl Vital Stat Rep, V62, P1; Higginson I J, 2000, J Palliat Med, V3, P287, DOI 10.1089/jpm.2000.3.287; Institute for Clinical Evaluative Sciences, DAT DICT; Institute of Medicine, 2014, DYING AM IMPR QUAL H; Koechlin F, 2014, 75 OECD; Lammens L, 2009, FEASIBILITY STUDY US; Marik PE, 2015, AM J HOSP PALLIAT ME, V32, P703, DOI 10.1177/1049909114537399; Melberg Hans Olav, 2013, Tidsskr Nor Laegeforen, V133, P841, DOI 10.4045/tidsskr.12.0802; Morden NE, 2012, HEALTH AFFAIR, V31, P786, DOI 10.1377/hlthaff.2011.0650; Murthy S, 2012, CRIT CARE, V16, DOI 10.1186/cc11140; National Hospice and Palliative Care Organization, 2012, HOSP CAR AM; National Research Council; Institute of Medicine, 2013, US HLTH INT PERSP SH; Quentin W, 2013, HEALTH AFFAIR, V32, P713, DOI 10.1377/hlthaff.2012.0876; Riley GF, 2010, HEALTH SERV RES, V45, P565, DOI 10.1111/j.1475-6773.2010.01082.x; Rosenwax LK, 2011, MED J AUSTRALIA, V194, P570, DOI 10.5694/j.1326-5377.2011.tb03106.x; Scheller-Kreinsen D, 2011, VALUE HEALTH, V14, P1166, DOI 10.1016/j.jval.2011.07.001; Smeets HM, 2011, J CLIN EPIDEMIOL, V64, P424, DOI 10.1016/j.jclinepi.2010.04.023; Teno JM, 2013, JAMA-J AM MED ASSOC, V309, P470, DOI 10.1001/jama.2012.207624; Wentlandt K, 2012, PUBLIC HLTH PERSPECT, P73	39	311	313	4	57	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 19	2016	315	3					272	283		10.1001/jama.2015.18603	http://dx.doi.org/10.1001/jama.2015.18603			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DB2WN	26784775	Bronze			2022-12-28	WOS:000368371400024
J	Martin, MJ; Eckert, MJ; Schreiber, MA				Martin, Matthew J.; Eckert, Matthew J.; Schreiber, Martin A.			Relationship of a Mandated 1-Hour Evacuation Policy and Outcomes for Combat Casualties	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							IN-HOSPITAL DEATHS; TRAUMA CARE		[Martin, Matthew J.; Eckert, Matthew J.] Madigan Army Med Ctr, Dept Surg, Tacoma, WA 98431 USA; [Schreiber, Martin A.] Oregon Hlth & Sci Univ, Dept Surg, Portland, OR 97201 USA	Madigan Army Medical Center; Oregon Health & Science University	Martin, MJ (corresponding author), US Army, Med Corps, Madigan Army Med Ctr, Dept Surg, 9040-A Fitzsimmons Ave, Tacoma, WA 98431 USA.	matthew.j.martin16.mil@mail.mil						Butler FK, 2012, J TRAUMA ACUTE CARE, V73, pS395, DOI 10.1097/TA.0b013e3182754850; Chatfield-Ball C, 2015, J ROY SOC MED, V108, P93, DOI 10.1177/0141076815570923; Dimick JB, 2014, JAMA-J AM MED ASSOC, V312, P2401, DOI 10.1001/jama.2014.16153; Eastridge BJ, 2012, J TRAUMA ACUTE CARE, V73, pS431, DOI 10.1097/TA.0b013e3182755dcc; Eastridge Brian J, 2009, Am J Surg, V198, P852, DOI 10.1016/j.amjsurg.2009.04.029; Kotwal RS, 2016, JAMA SURG, V151, P15, DOI 10.1001/jamasurg.2015.3104; Langan NR, 2014, JAMA SURG, V149, P904, DOI 10.1001/jamasurg.2014.940; Martin M, 2009, J TRAUMA, V66, pS51, DOI 10.1097/TA.0b013e31819d86ad; Sorbero ME, IMPROVING DEPLOYMENT	9	2	2	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 19	2016	315	3					293	294		10.1001/jama.2015.18744	http://dx.doi.org/10.1001/jama.2015.18744			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DB2WN	26784777				2022-12-28	WOS:000368371400026
J	Drake, EJ; Miller, BR; Shi, C; Tarrasch, JT; Sundlov, JA; Allen, CL; Skiniotis, G; Aldrich, CC; Gulick, AM				Drake, Eric J.; Miller, Bradley R.; Shi, Ce; Tarrasch, Jeffrey T.; Sundlov, Jesse A.; Allen, C. Leigh; Skiniotis, Georgios; Aldrich, Courtney C.; Gulick, Andrew M.			Structures of two distinct conformations of holo-non-ribosomal peptide synthetases	NATURE			English	Article							CARRIER PROTEIN; CONDENSATION DOMAIN; ADENYLATION; CRYSTAL; ENZYME; MECHANISM; MODULE; GENES	Many important natural products are produced by multidomain non-ribosomal peptide synthetases (NRPSs)(1-4). During synthesis, intermediates are covalently bound to integrated carrier domains and transported to neighbouring catalytic domains in an assembly line fashion(5). Understanding the structural basis for catalysis with non-ribosomal peptide synthetases will facilitate bioengineering to create novel products. Here we describe the structures of two different holo-non-ribosomal peptide synthetase modules, each revealing a distinct step in the catalytic cycle. One structure depicts the carrier domain cofactor bound to the peptide bond-forming condensation domain, whereas a second structure captures the installation of the amino acid onto the cofactor within the adenylation domain. These structures demonstrate that a conformational change within the adenylation domain guides transfer of intermediates between domains. Furthermore, one structure shows that the condensation and adenylation domains simultaneously adopt their catalytic conformations, increasing the overall efficiency in a revised structural cycle. These structures and the single-particle electron microscopy analysis demonstrate a highly dynamic domain architecture and provide the foundation for understanding the structural mechanisms that could enable engineering of novel non-ribosomal peptide synthetases.	[Drake, Eric J.; Miller, Bradley R.; Sundlov, Jesse A.; Allen, C. Leigh; Gulick, Andrew M.] Hauptman Woodward Med Res Inst, Buffalo, NY 14203 USA; [Drake, Eric J.; Miller, Bradley R.; Sundlov, Jesse A.; Gulick, Andrew M.] SUNY Buffalo, Dept Biol Struct, Buffalo, NY 14203 USA; [Shi, Ce; Aldrich, Courtney C.] Univ Minnesota, Ctr Drug Design, Minneapolis, MN 55455 USA; [Shi, Ce; Aldrich, Courtney C.] Univ Minnesota, Dept Med Chem, Minneapolis, MN 55455 USA; [Tarrasch, Jeffrey T.; Skiniotis, Georgios] Univ Michigan, Life Sci Inst, Ann Arbor, MI 48109 USA; [Tarrasch, Jeffrey T.; Skiniotis, Georgios] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA	Hauptman Woodward Medical Research Institute; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Gulick, AM (corresponding author), Hauptman Woodward Med Res Inst, 700 Ellicott St, Buffalo, NY 14203 USA.	gulick@hwi.buffalo.edu	Allen, Catherine L/N-4427-2013	Allen, Catherine L/0000-0001-5744-9659; Skiniotis, Georgios/0000-0003-0238-7846; Gulick, Andrew/0000-0003-4238-7453	National Institutes of Health [GM-068440, GM-115601]; Telemedicine and Advanced Technology Research Center of the US Army Medical Research and Materiel Command [W81XWH-11-2-0218]; National Cancer Institute [ACB-12002]; National Institute of General Medical Sciences under Department of Energy [AGM-12006, DE-AC02-06CH11357]; Hauptman-Woodward Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM115601, R01GM068440] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Telemedicine and Advanced Technology Research Center of the US Army Medical Research and Materiel Command; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Sciences under Department of Energy; Hauptman-Woodward Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Sanishvili for assistance with data collection. This work was funded in part by National Institutes of Health GM-068440 (to A.M.G.) and GM-115601 (to G.S.), and Award W81XWH-11-2-0218 from the Telemedicine and Advanced Technology Research Center of the US Army Medical Research and Materiel Command (A.M.G.). Data were collected at the GM/CA beamline of the Advanced Photon Source, which is funded by the National Cancer Institute (ACB-12002) and the National Institute of General Medical Sciences (AGM-12006) under Department of Energy contract number DE-AC02-06CH11357 to A.P.S. A Stafford Fellowship (to B.R.M.) and support from the Hauptman-Woodward Institute is acknowledged.	Adams MD, 2008, J BACTERIOL, V190, P8053, DOI 10.1128/JB.00834-08; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bloudoff K, 2013, J MOL BIOL, V425, P3137, DOI 10.1016/j.jmb.2013.06.003; Clemmer KM, 2011, MICROBIOL-SGM, V157, P2534, DOI 10.1099/mic.0.049791-0; Conti E, 1997, EMBO J, V16, P4174, DOI 10.1093/emboj/16.14.4174; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Dutta S, 2014, NATURE, V510, P512, DOI 10.1038/nature13423; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fischbach MA, 2009, SCIENCE, V325, P1089, DOI 10.1126/science.1176667; Frueh DP, 2008, NATURE, V454, P903, DOI 10.1038/nature07162; Gaudelli NM, 2015, NATURE, V520, P383, DOI 10.1038/nature14100; Giles SK, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0440-6; Goodrich AC, 2015, J AM CHEM SOC, V137, P12100, DOI 10.1021/jacs.5b07772; Gulick AM, 2009, ACS CHEM BIOL, V4, P811, DOI 10.1021/cb900156h; Horswill AR, 2002, BIOCHEMISTRY-US, V41, P2379, DOI 10.1021/bi015647q; Ikeuchi H, 2009, BIOORGAN MED CHEM, V17, P6641, DOI 10.1016/j.bmc.2009.07.071; Jaremko MJ, 2015, J AM CHEM SOC, V137, P11546, DOI 10.1021/jacs.5b04525; Kapust RB, 2001, PROTEIN ENG, V14, P993, DOI 10.1093/protein/14.12.993; Koglin A, 2009, NAT PROD REP, V26, P987, DOI 10.1039/b904543k; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Liu Y, 2011, CHEM BIOL, V18, P1482, DOI 10.1016/j.chembiol.2011.09.018; Luft JR, 2003, J STRUCT BIOL, V142, P170, DOI 10.1016/S1047-8477(03)00048-0; Marahiel MA, 1997, CHEM REV, V97, P2651, DOI 10.1021/cr960029e; Maruyama C, 2012, NAT CHEM BIOL, V8, P791, DOI [10.1038/NCHEMBIO.1040, 10.1038/nchembio.1040]; Mercer AC, 2007, NAT PROD REP, V24, P750, DOI 10.1039/b603921a; Miller BR, 2014, PROTEINS, V82, P2691, DOI 10.1002/prot.24635; Mitchell CA, 2012, BIOCHEMISTRY-US, V51, P3252, DOI 10.1021/bi300112e; Ohi Melanie, 2004, Biol Proced Online, V6, P23, DOI 10.1251/bpo70; Qiao CH, 2007, J AM CHEM SOC, V129, P6350, DOI 10.1021/ja069201e; Reger AS, 2007, BIOCHEMISTRY-US, V46, P6536, DOI 10.1021/bi6026506; Reuter DC, 2003, SYNTHESIS-STUTTGART, P2321, DOI 10.1055/s-2003-41059; Roche ED, 2003, BIOCHEMISTRY-US, V42, P1334, DOI 10.1021/BI026867m; Rumbo-Feal S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072968; RUSNAK F, 1989, BIOCHEMISTRY-US, V28, P6827, DOI 10.1021/bi00443a008; Strieker M, 2010, CURR OPIN STRUC BIOL, V20, P234, DOI 10.1016/j.sbi.2010.01.009; Sundlov JA, 2013, ACTA CRYSTALLOGR D, V69, P1482, DOI 10.1107/S0907444913009372; Sundlov JA, 2012, CHEM BIOL, V19, P188, DOI 10.1016/j.chembiol.2011.11.013; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Tanovic A, 2008, SCIENCE, V321, P659, DOI 10.1126/science.1159850; Urzhumtsev A, 2013, CRYSTALLOGR REV, V19, P230, DOI 10.1080/0889311X.2013.835806; Walsh CT, 2008, ACCOUNTS CHEM RES, V41, P4, DOI 10.1021/ar7000414; Walsh CT, 2010, J AM CHEM SOC, V132, P2469, DOI 10.1021/ja909118a; Wilson DJ, 2010, ANAL BIOCHEM, V404, P56, DOI 10.1016/j.ab.2010.04.033; Yang ZF, 2012, STRUCTURE, V20, P237, DOI 10.1016/j.str.2011.12.007	46	153	157	1	98	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 14	2016	529	7585					235	U289		10.1038/nature16163	http://dx.doi.org/10.1038/nature16163			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA7WK	26762461	Green Submitted, Green Accepted			2022-12-28	WOS:000368015700042
J	Fried, TR				Fried, Terri R.			Shared Decision Making - Finding the Sweet Spot	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Fried, Terri R.] VA Connecticut Healthcare Syst, Clin Epidemiol Res Ctr, West Haven, CT 06516 USA; [Fried, Terri R.] Yale Univ, Sch Med, Dept Med, New Haven, CT 06520 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Yale University	Fried, TR (corresponding author), VA Connecticut Healthcare Syst, Clin Epidemiol Res Ctr, West Haven, CT 06516 USA.							Fried TR, 2011, ARCH INTERN MED, V171, P923, DOI 10.1001/archinternmed.2011.32; Gurmankin AD, 2002, MED DECIS MAKING, V22, P262, DOI 10.1177/02789X02022003008; Man-Son-Hing M, 2005, MED DECIS MAKING, V25, P548, DOI 10.1177/0272989X05280558; McGuire AL, 2005, MED CARE, V43, P466, DOI 10.1097/01.mlr.0000160415.08497.11; Wolf AMD, 2010, CA-CANCER J CLIN, V60, P70, DOI 10.3322/caac.20066	5	98	101	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 14	2016	374	2					104	106		10.1056/NEJMp1510020	http://dx.doi.org/10.1056/NEJMp1510020			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DA7PQ	26760081				2022-12-28	WOS:000367996700003
J	Pourquie, O				Pourquie, Olivier			Standing Up for Sticklebacks	CELL			English	Editorial Material							MUTATIONS	The morphology of the vertebrate skeleton exhibits tremendous plasticity in evolution, allowing adaptation to a wide variety of ecological niches and lifestyles. Indjeian et al. now uncover how the cis regulation of a gene controls skeletal variation in fish and might have contributed to the evolution of bipedalism in humans.	[Pourquie, Olivier] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02215 USA; [Pourquie, Olivier] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Pourquie, O (corresponding author), Harvard Univ, Sch Med, Dept Genet, 77 Ave Louis Pasteur, Boston, MA 02215 USA.	pourquie@genetics.med.harvard.edu	Pourquié, Olivier/CAJ-5443-2022	Pourquié, Olivier/0000-0001-5189-1227				Abzhanov A, 2004, SCIENCE, V305, P1462, DOI 10.1126/science.1098095; Indjeian VB, 2016, CELL, V164, P45, DOI 10.1016/j.cell.2015.12.007; Jones FC, 2012, NATURE, V484, P55, DOI 10.1038/nature10944; O'Brown NM, 2015, ELIFE, V4, DOI 10.7554/eLife.05290; Orgogozo V, 2009, FLY, V3, P117, DOI 10.4161/fly.8836; Pregizer S, 2009, CYTOKINE GROWTH F R, V20, P509, DOI 10.1016/j.cytogfr.2009.10.011; Settle SH, 2003, DEV BIOL, V254, P116, DOI 10.1016/S0012-1606(02)00022-2; STORM EE, 1994, NATURE, V368, P639, DOI 10.1038/368639a0; Wang J, 2016, J BONE MINER RES, V31, P882, DOI 10.1002/jbmr.2761	9	0	0	0	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 14	2016	164	1-2					9	10		10.1016/j.cell.2015.12.052	http://dx.doi.org/10.1016/j.cell.2015.12.052			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DB2LE	26771479	Bronze			2022-12-28	WOS:000368339300002
J	Rabinovich, D; Yaniv, SP; Alyagor, I; Schuldiner, O				Rabinovich, Dana; Yaniv, Shiri P.; Alyagor, Idan; Schuldiner, Oren			Nitric Oxide as a Switching Mechanism between Axon Degeneration and Regrowth during Developmental Remodeling	CELL			English	Article							NUCLEAR RECEPTOR E75; DROSOPHILA DEVELOPMENT; SYNTHASE; HEME; IDENTIFICATION; PROTEIN; GROWTH; CGMP	During development, neurons switch among growth states, such as initial axon outgrowth, axon pruning, and regrowth. By studying the stereotypic remodeling of the Drosophila mushroom body (MB), we found that the heme-binding nuclear receptor E75 is dispensable for initial axon outgrowth of MB gamma neurons but is required for their developmental regrowth. Genetic experiments and pharmacological manipulations on ex-vivo-cultured brains indicate that neuronally generated nitric oxide (NO) promotes pruning but inhibits regrowth. We found that high NO levels inhibit the physical interaction between the E75 and UNF nuclear receptors, likely accounting for its repression of regrowth. Additionally, NO synthase (NOS) activity is downregulated at the onset of regrowth, at least partially, by short inhibitory NOS isoforms encoded within the NOS locus, indicating how NO production could be developmentally regulated. Taken together, these results suggest that NO signaling provides a switching mechanism between the degenerative and regenerative states of neuronal remodeling.	[Rabinovich, Dana; Yaniv, Shiri P.; Alyagor, Idan; Schuldiner, Oren] Weizmann Inst Sci, Dept Mol Cell Biol, IL-7610001 Rehovot, Israel	Weizmann Institute of Science	Schuldiner, O (corresponding author), Weizmann Inst Sci, Dept Mol Cell Biol, IL-7610001 Rehovot, Israel.	oren.schuldiner@weizmann.ac.il	Schuldiner, Oren/K-1353-2012	Schuldiner, Oren/0000-0002-7350-9380; Yaniv, Shiri/0000-0003-1334-5836	Israeli Science Foundation (ISF) [686/11]; European Research Council (ERC)	Israeli Science Foundation (ISF)(Israel Science Foundation); European Research Council (ERC)(European Research Council (ERC))	We thank H. Krause, P. O'Farrell, M. Regulski, J. Skeath, C. Thummel, The Exelixis Collection at Harvard Medical School, and the Bloomington Stock Center for reagents; M. Amosi, O. Fuchs, and O. Mayseless for technical assistance; R. Rotkopf for statistical analyses; A. Halme, K. King-Jones, and H. Krause for discussions and sharing of unpublished observations; and M. Schuldiner, A. Yaron, and the members of the O.S. lab for discussions and critical readings of the manuscript. The FasII (1D4) antibody monoclonal antibodies were obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and maintained by the University of Iowa. This work was supported by the Israeli Science Foundation (ISF, grant 686/11) and the European Research Council (ERC, consolidator grant "Axon-Growth"). The Zeiss LSM710 microscope was purchased with the help of the Adelis Foundation. O.S. is an incumbent of the Rothstein Career Development Chair of Genetic Diseases.	Awasaki T, 2006, NEURON, V50, P855, DOI 10.1016/j.neuron.2006.04.027; Boulanger A, 2015, BBA-GENE REGUL MECH, V1849, P187, DOI 10.1016/j.bbagrm.2014.05.024; BREDT DS, 1990, P NATL ACAD SCI USA, V87, P682, DOI 10.1073/pnas.87.2.682; Caceres L, 2011, GENE DEV, V25, P1476, DOI 10.1101/gad.2064111; Cheng H, 2004, HUM MOL GENET, V13, P1563, DOI 10.1093/hmg/ddh173; Cocchi E., 2015, MOL NEUROBIOL, DOI [http://dx.doi.org/10.1007/s12035-015-9174, DOI 10.1007/S12035-015-9174-]; Cooke RM, 2013, J NEUROSCI, V33, P5626, DOI 10.1523/JNEUROSCI.3659-12.2013; de Rosny E, 2008, BIOCHEMISTRY-US, V47, P13252, DOI 10.1021/bi801691b; Gallo EF, 2011, J NEUROSCI, V31, P6947, DOI 10.1523/JNEUROSCI.0374-11.2011; Garcia-Lopez P, 2010, NEURAL PLAST, V2010, DOI 10.1155/2010/769207; Hakim Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086178; Jaumouille E, 2015, CURR BIOL, V25, P1502, DOI 10.1016/j.cub.2015.04.017; Jenett A, 2012, CELL REP, V2, P991, DOI 10.1016/j.celrep.2012.09.011; Johnston DM, 2011, MOL CELL, V44, P51, DOI 10.1016/j.molcel.2011.07.033; Kanamori T, 2013, SCIENCE, V340, P1475, DOI 10.1126/science.1234879; Keilhoff G, 2002, J NEUROSCI RES, V68, P432, DOI 10.1002/jnr.10229; Lacin H, 2014, DEV BIOL, V388, P117, DOI 10.1016/j.ydbio.2014.01.029; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Luo LQ, 2005, ANNU REV NEUROSCI, V28, P127, DOI 10.1146/annurev.neuro.28.061604.135632; Mollema NJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017494; Moreno-Lopez B, 2011, MOL NEUROBIOL, V43, P41, DOI 10.1007/s12035-010-8159-8; Nikonenko I, 2013, P NATL ACAD SCI USA, V110, pE4142, DOI 10.1073/pnas.1311927110; Rabinovich D, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00327; Raghuram S, 2007, NAT STRUCT MOL BIOL, V14, P1207, DOI 10.1038/nsmb1344; Ray SS, 2007, BIOCHEMISTRY-US, V46, P11865, DOI 10.1021/bi700805x; Regulski M, 2004, CURR BIOL, V14, pR881, DOI 10.1016/j.cub.2004.09.068; Reinking J, 2005, CELL, V122, P195, DOI 10.1016/j.cell.2005.07.005; Riccomagno MM, 2015, ANNU REV CELL DEV BI, V31, P779, DOI 10.1146/annurev-cellbio-100913-013038; Riedl CAL, 2005, BEHAV GENET, V35, P231, DOI 10.1007/s10519-005-3216-1; Schuldiner O, 2015, CELL MOL LIFE SCI, V72, P101, DOI 10.1007/s00018-014-1729-6; Stasiv Y, 2004, GENE DEV, V18, P1812, DOI 10.1101/gad.298004; Stasiv Y, 2001, J BIOL CHEM, V276, P42241, DOI 10.1074/jbc.M105066200; Thomas MSC, 2016, DEVELOPMENTAL SCI, V19, P284, DOI 10.1111/desc.12303; Trippier PC, 2013, J MED CHEM, V56, P3121, DOI 10.1021/jm3015926; Wang Y, 1999, P NATL ACAD SCI USA, V96, P12150, DOI 10.1073/pnas.96.21.12150; Yakubovich N, 2010, CURR BIOL, V20, pR141, DOI 10.1016/j.cub.2009.12.011; Yaniv SP, 2012, CURR BIOL, V22, P1774, DOI 10.1016/j.cub.2012.07.044; Yu FW, 2014, CURR OPIN NEUROBIOL, V27, P192, DOI 10.1016/j.conb.2014.04.005; Zhou L, 2009, NITRIC OXIDE-BIOL CH, V20, P223, DOI 10.1016/j.niox.2009.03.001	39	35	35	2	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 14	2016	164	1-2					170	182		10.1016/j.cell.2015.11.047	http://dx.doi.org/10.1016/j.cell.2015.11.047			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DB2LE	26771490	Bronze, Green Accepted			2022-12-28	WOS:000368339300018
J	Hoppe, LE; Kettle, R; Eisenhut, M; Abubakar, I				Hoppe, Lucy Elizabeth; Kettle, Rachel; Eisenhut, Michael; Abubakar, Ibrahim		Guideline Dev Grp	GUIDELINES Tuberculosis-diagnosis, management, prevention, and control: summary of updated NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Hoppe, Lucy Elizabeth] Natl Inst Hlth & Care Excellence, London SW1A 2BU, England; [Kettle, Rachel] Natl Inst Hlth & Care Excellence, Manchester M1 4BT, Lancs, England; [Eisenhut, Michael] Luton & Dunstable Univ Hosp NHS Fdn Trust, Luton LU4 0DZ, Beds, England; [Abubakar, Ibrahim] UCL, MRC Clin Trials Unit, Infect Dis Epidemiol, London WC1E 6BT, England; [Abubakar, Ibrahim] UCL, MRC Clin Trials Unit, Guideline Dev Grp, London WC1E 6BT, England; [Abubakar, Ibrahim] UCL, Ctr Infect Dis Epidemiol, Infect Dis Epidemiol, London WC1E 6BT, England; [Abubakar, Ibrahim] UCL, Ctr Infect Dis Epidemiol, Guideline Dev Grp, London WC1E 6BT, England	National Institute for Health & Care Excellence; National Institute for Health & Care Excellence; Medical Research Council Clinical Trials Unit; University of London; University College London; Medical Research Council Clinical Trials Unit; University of London; University College London; University of London; University College London; University of London; University College London	Hoppe, LE (corresponding author), Natl Inst Hlth & Care Excellence, London SW1A 2BU, England.	lucy.hoppe@nice.org.uk		Abubakar, Ibrahim/0000-0002-0370-1430				National Institute for Health and Care Excellence, 2011, TUB CLIN DIAGN MAN T, V117; National Institute for Health and Care Excellence, 2012, TUB ID MAN UND SERV, V37; National Institute for Health and Care Excellence, 2016, TUB PREV DIAGN MAN S, V33; National Institute for Health and Care Excellence, 2012, GUID MAN; National Institute for Health and Care Excellence, 2012, METH DEV NICE PUBL H; Public Health England, 2013, IMM INF DIS GREEN BO; Public Health England, 2014, TUB UK 2014 REP; World Health Organization, 2015, GLOB TUB REP 2015	8	30	30	1	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 13	2016	352								h6747	10.1136/bmj.h6747	http://dx.doi.org/10.1136/bmj.h6747			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DB2YL	26762607	Green Submitted			2022-12-28	WOS:000368376500001
J	Dalladay-Simpson, P; Howie, RT; Gregoryanz, E				Dalladay-Simpson, Philip; Howie, Ross T.; Gregoryanz, Eugene			Evidence for a new phase of dense hydrogen above 325 gigapascals	NATURE			English	Article							RAMAN-SPECTROSCOPY; SOLID HYDROGEN; DISSOCIATION; TRANSITION; ATOMS; GPA	Almost 80 years ago it was predicted that, under sufficient compression, the H-H bond in molecular hydrogen (H-2) would break, forming a new, atomic, metallic, solid state of hydrogen(1). Reaching this predicted state experimentally has been one of the principal goals in high-pressure research for the past 30 years. Here, using in situ high-pressure Raman spectroscopy, we present evidence that at pressures greater than 325 gigapascals at 300 kelvin, H-2 and hydrogen deuteride (HD) transform to a new phase-phase V. This new phase of hydrogen is characterized by substantial weakening of the vibrational Raman activity, a change in pressure dependence of the fundamental vibrational frequency and partial loss of the low-frequency excitations. We map out the domain in pressure-temperature space of the suggested phase V in H-2 and HD up to 388 gigapascals at 300 kelvin, and up to 465 kelvin at 350 gigapascals; we do not observe phase V in deuterium (D-2). However, we show that the transformation to phase IV' in D-2 occurs above 310 gigapascals and 300 kelvin. These values represent the largest known isotropic shift in pressure, and hence the largest possible pressure difference between the H-2 and D-2 phases, which implies that the appearance of phase V of D-2 must occur at a pressure of above 380 gigapascals. These experimental data provide a glimpse of the physical properties of dense hydrogen above 325 gigapascals and constrain the pressure and temperature conditions at which the new phase exists. We speculate that phase V may be the precursor to the non-molecular (atomic and metallic) state of hydrogen that was predicted 80 years ago.	[Dalladay-Simpson, Philip; Howie, Ross T.; Gregoryanz, Eugene] Univ Edinburgh, Sch Phys, Edinburgh EH9 3JZ, Midlothian, Scotland; [Dalladay-Simpson, Philip; Howie, Ross T.; Gregoryanz, Eugene] Univ Edinburgh, Ctr Sci Extreme Condit, Edinburgh EH9 3JZ, Midlothian, Scotland; [Gregoryanz, Eugene] Chinese Acad Sci, Inst Solid State Phys, Key Lab Mat Phys, Hefei 230031, Peoples R China; [Howie, Ross T.] Ctr High Pressure Sci & Technol Adv Res, Shanghai 201203, Peoples R China	University of Edinburgh; University of Edinburgh; Chinese Academy of Sciences; Hefei Institutes of Physical Science, CAS	Gregoryanz, E (corresponding author), Univ Edinburgh, Sch Phys, Edinburgh EH9 3JZ, Midlothian, Scotland.; Gregoryanz, E (corresponding author), Univ Edinburgh, Ctr Sci Extreme Condit, Edinburgh EH9 3JZ, Midlothian, Scotland.; Gregoryanz, E (corresponding author), Chinese Acad Sci, Inst Solid State Phys, Key Lab Mat Phys, Hefei 230031, Peoples R China.	e.gregoryanz@ed.ac.uk		Gregoryanz, Eugene/0000-0001-9080-8756; Howie, Ross/0000-0002-7013-8211	UK Engineering and Physical Sciences Research Council (EPSRC) [EP/J003999/1]; EPSRC [EP/G03673X/1]; Engineering and Physical Sciences Research Council [EP/J003999/1, 1110865] Funding Source: researchfish; EPSRC [EP/J003999/1] Funding Source: UKRI	UK Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We are grateful to M. Frost for assistance during experiments. This work is supported by a Leadership Fellowship from the UK Engineering and Physical Sciences Research Council (EPSRC), reference number EP/J003999/1. P.D-S. acknowledges studentship funding from EPSRC grant number EP/G03673X/1.	Akahama Y, 2004, J APPL PHYS, V96, P3748, DOI 10.1063/1.1778482; Akahama Y, 2010, J PHYS CONF SER, V215, DOI 10.1088/1742-6596/215/1/012056; Akahama Y, 2006, J APPL PHYS, V100, DOI 10.1063/1.2335683; Akahama Y, 2010, J PHYS CONF SER, V215, DOI 10.1088/1742-6596/215/1/012195; Akahama Y, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.060101; Azadi S, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.165501; Eremets MI, 2011, NAT MATER, V10, P927, DOI [10.1038/NMAT3175, 10.1038/nmat3175]; Eremets MI, 2009, JETP LETT+, V89, P174, DOI 10.1134/S0021364009040031; Goncharov AF, 2001, P NATL ACAD SCI USA, V98, P14234, DOI 10.1073/pnas.201528198; Gregoryanz E, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.175701; Housecroft C., 2007, INORGANIC CHEM; Howie RT, 2015, NAT MATER, V14, P495, DOI [10.1038/NMAT4213, 10.1038/nmat4213]; Howie RT, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.175501; Howie RT, 2013, J APPL PHYS, V114, DOI 10.1063/1.4818606; Howie RT, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.214104; Howie RT, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.125501; Knudson MD, 2015, SCIENCE, V348, P1455, DOI 10.1126/science.aaa7471; Langmuir I, 1915, J AM CHEM SOC, V37, P417, DOI 10.1021/ja02168a002; Langmuir I, 1914, J AM CHEM SOC, V36, P1708, DOI 10.1021/ja02185a011; Loubeyre P, 2002, NATURE, V416, P613, DOI 10.1038/416613a; McMahon JM, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.165302; Morales MA, 2010, P NATL ACAD SCI USA, V107, P12799, DOI 10.1073/pnas.1007309107; Pickard CJ, 2007, NAT PHYS, V3, P473, DOI 10.1038/nphys625; Subramanian N, 2011, P NATL ACAD SCI USA, V108, P6014, DOI 10.1073/pnas.1102760108; Tamblyn I, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.065702; Van Kranendonk J., 1983, SOLID HYDROGEN; Wigner E, 1935, J CHEM PHYS, V3, P764, DOI 10.1063/1.1749590; Zha CS, 2014, P NATL ACAD SCI USA, V111, P4792, DOI 10.1073/pnas.1402737111; Zha CS, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.146402	29	176	185	6	166	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 7	2016	529	7584					63	+		10.1038/nature16164	http://dx.doi.org/10.1038/nature16164			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6VY	26738591				2022-12-28	WOS:000367944900026
J	El-Zein, A; DeJong, J; Fargues, P; Salti, N; Hanieh, A; Lackner, H				El-Zein, Abbas; DeJong, Jocelyn; Fargues, Philippe; Salti, Nisreen; Hanieh, Adam; Lackner, Helen			Who's been left behind? Why sustainable development goals fail the Arab world	LANCET			English	Editorial Material							HEALTH; DISEASES		[El-Zein, Abbas] Univ Sydney, Sch Civil Engn, Sydney, NSW 2006, Australia; [DeJong, Jocelyn] Amer Univ Beirut, Fac Hlth Sci, Beirut, Lebanon; [Fargues, Philippe] European Univ Inst, Migrat Policy Ctr, Florence, Italy; [Salti, Nisreen] Amer Univ Beirut, Fac Arts & Sci, Dept Econ, Beirut, Lebanon; [Hanieh, Adam] Univ London, Sch Oriental & African Studies, Dept Dev Studies, London, England	University of Sydney; American University of Beirut; European University Institute; American University of Beirut; University of London; University of London School Oriental & African Studies (SOAS)	El-Zein, A (corresponding author), Univ Sydney, Sch Civil Engn, Sydney, NSW 2006, Australia.	abbas.el-zein@sydney.edu.au	El-Zein, Abbas H/E-5811-2011	El-Zein, Abbas H/0000-0003-4935-3299; Salti, Nisreen/0000-0002-4585-6430				Abdulrahim S, 2012, PUBLIC HEALTH IN THE ARABWORLD, P276; Achcar G, 2013, PEOPLE WANT: A RADICAL EXPLORATION OF THE ARAB UPRISING, P1; Darrow M., 2012, YALE HUMAN RIGHTS DE, V15, P55; DLA Piper, 2014, MIGR LAB CONSTR SECT; El-Zein A, 2014, LANCET, V383, P458, DOI 10.1016/S0140-6736(13)62338-7; Fargues P, 2011, ASIAN PAC MIGR J, V20, P273, DOI 10.1177/011719681102000302; HANIEH A, 2011, CAPITALISM, DOI DOI 10.1057/9780230119604; Higgins K, 2013, REFLECTING MDGS MAKI; Kremer M, 2009, WRR VERKENN, P15; Mokdad AH, 2014, LANCET, V383, P309, DOI 10.1016/S0140-6736(13)62189-3; Ottersen OP, 2014, LANCET, V383, P630, DOI 10.1016/S0140-6736(13)62407-1; Rahim HFA, 2014, LANCET, V383, P356, DOI 10.1016/S0140-6736(13)62383-1; Saleh SS, 2014, LANCET, V383, P368, DOI 10.1016/S0140-6736(13)62339-9; Sumner Andy, 2013, POST 2015 DEV AGENDA; Transparency International, 2014, CORR PERC IND 2014 R; *UN ASS UK, 2013, GLOB DEV GOALS LEAV; United Nations, 1995, WORLD SUMM SOC DEV; United Nations Development Programme, 2005, AR HUM DEV REP UN DE; United Nations Development Programme, 2002, AR HUM DEV REP UN DE; United Nations Development Programme, 2009, AR HUM DEV REP UN DE; United Nations Development Programme, 2003, AR HUM DEV REP UN DE; United Nations Development Programme, 2004, AR HUM DEV REP UN DE; United Nations General Assembly, 2015, RES AD GEN ASS 25 SE; United Nations High Commissioner for Refugees, MID TRENDS 2014; World Bank, 2013, MENA DEV REP, P1, DOI 10.1596/978-0-8213-9763-3; World Bank, 2011, WORLD DEVELOPMENT REPORT 2011: CONFLICT, SECURITY AND DEVELOPMENT, P1, DOI 10.1596/978-0-8213-8439-8	26	16	16	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 9	2016	388	10040					207	210		10.1016/S0140-6736(15)01312-4	http://dx.doi.org/10.1016/S0140-6736(15)01312-4			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DQ5TZ	26782981				2022-12-28	WOS:000379269200036
J	Rajkumar, SV				Rajkumar, S. Vincent			Daratumumab in multiple myeloma	LANCET			English	Editorial Material									[Rajkumar, S. Vincent] Mayo Clin, Div Hematol, Rochester, MN 55905 USA	Mayo Clinic	Rajkumar, SV (corresponding author), Mayo Clin, Div Hematol, Rochester, MN 55905 USA.	rajkumar.vincent@mayo.edu	Rajkumar, S. Vincent/AAV-1834-2021	Rajkumar, S. Vincent/0000-0002-5862-1833				Abola MV, 2016, JAMA ONCOL, V2, P139, DOI 10.1001/jamaoncol.2015.3931; Attal M, 2015, ASH ANN M, V126, pA391; Kumar SK, 2014, LEUKEMIA, V28, P1122, DOI 10.1038/leu.2013.313; Lokhorst HM, 2015, NEW ENGL J MED, V373, P1207, DOI 10.1056/NEJMoa1506348; Lonial S, 2016, LANCET; Lonial S, 2015, NEW ENGL J MED, V373, P621, DOI 10.1056/NEJMoa1505654; Moreau P, 2014, ASH ANN M, V124, P176; Rajan AM, 2015, BLOOD CANCER J, V5, DOI 10.1038/bcj.2015.92; Rajkumar SV, 2016, AM J HEMATOL, V91, P90, DOI 10.1002/ajh.24236; Richardson P, 2009, BLOOD, V114, P772, DOI 10.1182/blood-2008-12-196238; Richardson PG, 2014, BLOOD, V123, P1826, DOI 10.1182/blood-2013-11-538835; Richardson PG, 2003, NEW ENGL J MED, V348, P2609, DOI 10.1056/NEJMoa030288; Siegel DS, 2012, BLOOD, V120, P2817, DOI 10.1182/blood-2012-05-425934	13	7	9	1	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 9	2016	387	10027					1490	1492		10.1016/S0140-6736(15)01226-X	http://dx.doi.org/10.1016/S0140-6736(15)01226-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DI8HH	26778537				2022-12-28	WOS:000373741600007
J	de Bernis, L; Kinney, MV; Stones, W; ten Hoope-Bender, P; Vivio, D; Leisher, SH; Bhutta, ZA; Gulmezoglu, M; Mathai, M; Belizan, JM; Franco, L; McDougall, L; Zeitlin, J; Malata, A; Dickson, KE; Lawn, JE				de Bernis, Luc; Kinney, Mary V.; Stones, William; ten Hoope-Bender, Petra; Vivio, Donna; Leisher, Susannah Hopkins; Bhutta, Zulfiqar A.; Guelmezoglu, Metin; Mathai, Matthews; Belizan, Jose M.; Franco, Lynne; McDougall, Lori; Zeitlin, Jennifer; Malata, Address; Dickson, Kim E.; Lawn, Joy E.		Lancet Ending Preventable; Lancet Ending Preventable	Stillbirths: ending preventable deaths by 2030	LANCET			English	Article							NEWBORN HEALTH; NEONATAL DEATH; EVERY NEWBORN; PRETERM BIRTH; COUNTRIES; CARE; SURVIVAL; QUALITY; SYSTEMS; INTERVENTIONS	Efforts to achieve the new worldwide goals for maternal and child survival will also prevent stillbirth and improve health and developmental outcomes. However, the number of annual stillbirths remains unchanged since 2011 and is unacceptably high: an estimated 2.6 million in 2015. Failure to consistently include global targets or indicators for stillbirth in post-2015 initiatives shows that stillbirths are hidden in the worldwide agenda. This Series paper summarises findings from previous papers in this Series, presents new analyses, and proposes specific criteria for successful integration of stillbirths into post-2015 initiatives for women's and children's health. Five priority areas to change the stillbirth trend include intentional leadership; increased voice, especially of women; implementation of integrated interventions with commensurate investment; indicators to measure effect of interventions and especially to monitor progress; and investigation into crucial knowledge gaps. The post-2015 agenda represents opportunities for all stakeholders to act together to end all preventable deaths, including stillbirths.	[de Bernis, Luc] UN Populat Fund, CH-1219 Geneva, Switzerland; [Kinney, Mary V.; Lawn, Joy E.] Save Children, Saving Newborn Lives, Edgemead, South Africa; [Stones, William] Univ St Andrews, Sch Med, St Andrews, Fife, Scotland; [Stones, William] Univ Malawi, Dept Obstet & Gynaecol, Blantyre, Malawi; [Stones, William] Int Federat Gynecol & Obstet, London, England; [Vivio, Donna] US Agcy Int Dev, Global Hlth Bur, Washington, DC 20523 USA; [Leisher, Susannah Hopkins] Univ Queensland, Res Inst, St Lucia, Qld, Australia; [Leisher, Susannah Hopkins] Int Stillbirth Alliance, Millburn, NJ USA; [Bhutta, Zulfiqar A.] Hosp Sick Children, Ctr Global Child Hlth, 555 Univ Ave, Toronto, ON M5G 1X8, Canada; [Bhutta, Zulfiqar A.] Aga Khan Univ, Ctr Excellence Women & Child Hlth, Karachi, Pakistan; [Bhutta, Zulfiqar A.] Int Paediat Assoc, Melbourne, Vic, Australia; [Guelmezoglu, Metin] World Hlth Org, Dept Reprod Hlth & Res, Geneva, Switzerland; [Mathai, Matthews] World Hlth Org, Dept Maternal Child Adolescent Hlth, Geneva, Switzerland; [Belizan, Jose M.] Inst Clin Effectiveness & Hlth Policy, Buenos Aires, DF, Argentina; [Franco, Lynne] EnCompass LLC, Washington, DC USA; [McDougall, Lori] Partnership Maternal Newborn & Child Hlth, Geneva, Switzerland; [Lawn, Joy E.] London Sch Hyg & Trop Med, Ctr Maternal Adolescent Reprod & Child Hlth MARCH, London WC1, England; [Lawn, Joy E.] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1, England; [Zeitlin, Jennifer] Paris Descartes Univ, Sorbonne Paris Cite, Ctr Epidemiol & Stat,Inserm,UMR 1153, Obstetr Perinatal & Pediat Epidemiol Res Team Epo, Paris, France; [Malata, Address] Univ Malawi, Kamuzu Coll Nursing, Lilongwe, Malawi; [Dickson, Kim E.] UNICEF Headquarters, Programmes Div, New York, NY USA	United Nations Population Fund; Save the Children; University of St Andrews; University of Malawi; United States Agency for International Development (USAID); University of Queensland; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Aga Khan University; World Health Organization; World Health Organization; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Malawi; UNICEF	de Bernis, L (corresponding author), UN Populat Fund, CH-1219 Geneva, Switzerland.	lucdebernis1@gmail.com	Leisher, Susannah H H/S-8995-2016; Zeitlin, Jennifer/G-4973-2017; Kinney, Mary V/M-6952-2013; Stones, William/R-8618-2016; Leisher, Susannah/N-4451-2019; Lawn, Joy/ABE-6382-2020	Leisher, Susannah H H/0000-0002-0191-8863; Zeitlin, Jennifer/0000-0002-9568-2969; Kinney, Mary V/0000-0002-2903-0161; Stones, William/0000-0003-0699-2381; Leisher, Susannah/0000-0002-0191-8863; Lawn, Joy/0000-0002-4573-1443; McDougall, Lori/0000-0002-1885-5344; Blencowe, Hannah/0000-0003-1556-3159; Froen Froen, Jahn Frederik/0000-0001-9390-8509; Litch, James/0000-0003-0570-0308; Belizan, Jose/0000-0002-8412-3010	World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		Althabe F, 2015, REPROD HEALTH, V12, DOI 10.1186/1742-4755-12-S2-S8; [Anonymous], 2015, COMM ACT MEAS ANN; [Anonymous], 2011, WHO GUIDELINE INTERM; [Anonymous], 2011, SYSTEMATIC REV PRECO; Ayres-de-Campos D, 2015, INT J GYNECOL OBSTET, V131, P5, DOI 10.1016/j.ijgo.2015.06.018; Bergh AM, 2015, BEST PRACT RES CL OB, V29, P1028, DOI 10.1016/j.bpobgyn.2015.03.017; Bhutta ZA, 2014, LANCET, V384, P347, DOI 10.1016/S0140-6736(14)60792-3; Bhutto ZA, 2011, LANCET, V377, P1523, DOI 10.1016/S0140-6736(10)62269-6; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Blencowe H, 2012, LANCET, V379, P2162, DOI 10.1016/S0140-6736(12)60820-4; Brabin P, 2011, LANCET, V377, P1313, DOI 10.1016/S0140-6736(11)60530-8; Bustreo F, 2013, LANCET GLOB HEALTH, V1, pE176, DOI 10.1016/S2214-109X(13)70059-7; Byrom S., 2015, ROAR SILENCE WHY KIN; CDC, 2014, SAV MOTH GIV LIF MAT; Cowgill KD, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0592-2; Darmstadt GL, 2014, LANCET, V384, P174, DOI 10.1016/S0140-6736(14)60458-X; Dean SV, 2014, REPROD HEALTH, V11, DOI [10.1186/1742-4755-11-S3-S1, 10.1186/1742-4755-11-S3-S3]; Dickson KE, 2014, LANCET, V384, P438, DOI 10.1016/S0140-6736(14)60582-1; Every Woman Every Child, 2015, GLOBAL STRATEGY WOME; Every Woman Every Child, 2015, SAV LIV PROT FUT PRO; Fauveau V, 2007, LANCET, V370, P1310, DOI 10.1016/S0140-6736(07)61571-2; Filippi V, 2006, LANCET, V368, P1535, DOI 10.1016/S0140-6736(06)69384-7; Flenady V., 2016, LANCET; Flenady V, 2011, LANCET, V377, P1703, DOI 10.1016/S0140-6736(11)60064-0; Froen JF, 2011, LANCET, V377, P1353, DOI 10.1016/S0140-6736(10)62232-5; Froen JF, 2016, LANCET; Goldenberg RL, 2013, INT J GYNECOL OBSTET, V122, P230, DOI 10.1016/j.ijgo.2013.04.008; Goldenberg RL, 2011, LANCET, V377, P1798, DOI 10.1016/S0140-6736(10)62235-0; Hafner T, 2013, HEALTH POLICY PLANN, V28, P41, DOI 10.1093/heapol/czs023; Harrison MS, 2015, REPROD HEALTH, V12, DOI 10.1186/1742-4755-12-S2-S9; Heazell AEP, 2016, LANCET; Homer CSE, 2014, LANCET, V384, P1146, DOI 10.1016/S0140-6736(14)60790-X; Hughes D, 2010, SOC SCI MED, V70, P447, DOI 10.1016/j.socscimed.2009.10.031; Kerber KJ, 2007, LANCET, V370, P1358, DOI 10.1016/S0140-6736(07)61578-5; Kerber KJ, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/1471-2393-15-S2-S9; Lalonde A, 2015, INT J GYNECOL OBSTET, V128, P95, DOI 10.1016/j.ijgo.2014.10.013; Langer A, 2015, LANCET, V386, P1165, DOI 10.1016/S0140-6736(15)60497-4; Lassi ZS, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007754.pub3; Lassi ZS, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-S3-S5; Lawn JE, 2016, LANCET; Lawn JE, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.aaa2563; Lawn JE, 2013, PEDIATR RES, V74, P1, DOI 10.1038/pr.2013.202; Lawn JE, 2011, LANCET, V377, P1448, DOI 10.1016/S0140-6736(10)62187-3; Lawn JE, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-S1-S1; Lewis D, 2015, INT J GYNECOL OBSTET, V131, P9, DOI 10.1016/j.ijgo.2015.06.019; Litorp H, 2015, ACTA U UPSAL, V1063, P1; MacDorman Marian F, 2015, Natl Vital Stat Rep, V64, P1; March of Dimes PMNCH Save the Children WHO, 2012, BORN TOO SOON GLOBAL, DOI DOI 10.1016/S0140-6736(12)61970-9; Mason E, 2014, LANCET, V384, P455, DOI 10.1016/S0140-6736(14)60750-9; McDonald R, 2013, EVALUATION COMMISSIO; Michailidis E., 2015, STILLBIRTH YOUR STOR; Michalow J, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0456-9; Moxon SG, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/1471-2393-15-S2-S8; Mullan Z, 2011, LANCET, V377, P1291, DOI 10.1016/S0140-6736(11)60098-6; Pattinson R, 2011, LANCET, V377, P1610, DOI 10.1016/S0140-6736(10)62306-9; Prost A, 2013, LANCET, V381, P1736, DOI 10.1016/S0140-6736(13)60685-6; Reichenheim ME, 2009, ARCH GYNECOL OBSTET, V280, P337, DOI 10.1007/s00404-008-0891-1; Renfrew MJ, 2014, LANCET, V384, P1129, DOI 10.1016/S0140-6736(14)60789-3; Sacks E, 2015, REPROD HEALTH, V12, DOI 10.1186/s12978-015-0042-7; Say Lale, 2004, Reprod Health, V1, P3, DOI 10.1186/1742-4755-1-3; Shiffman J, 2007, LANCET, V370, P1370, DOI 10.1016/S0140-6736(07)61579-7; Souza JP, 2014, BJOG-INT J OBSTET GY, V121, P1, DOI 10.1111/1471-0528.12735; Starrs AM, 2014, LANCET, V384, P211, DOI 10.1016/S0140-6736(14)60838-2; Stenberg K, 2014, LANCET, V383, P1333, DOI 10.1016/S0140-6736(13)62231-X; Strahley A, 2014, ORG NETWORK ANAL COM; ten Hoope-Bender P, 2014, LANCET, V384, P1226, DOI 10.1016/S0140-6736(14)60930-2; The Lancet, 2014, LANCET; The Lancet, 2011, LANCET; The Partnership for Maternal Newborn & Child Health, 2015, CONS UPD GLOB STRAT; The World Bank, 2015, BUS PLAN GLOB FIN FA; Tuncalp O, 2015, BJOG-INT J OBSTET GY, V122, P1045, DOI 10.1111/1471-0528.13451; UN, 2015, UN TRANSF OUR WORLD, DOI [10.1201/b20466-7, DOI 10.1201/B20466-7]; UNFPA WHO ICM, 2014, STATE WORLDS MIDWIFE; Van Lerberghe W, 2014, LANCET, V384, P1215, DOI 10.1016/S0140-6736(14)60919-3; Vogel JP, 2014, BJOG-INT J OBSTET GY, V121, P76, DOI 10.1111/1471-0528.12633; WHA, 2014, WHA6710R; WHO, 2019, GLOB HLTH OBS DAT RE; WHO, 2015, LEV TRENDS CHILD MOR; WHO, 2015, GLOB REF LIST 100 CO; WHO, 2015, GUID TREATM MAL; WHO (World Health Organization), 2015, STRAT END PREV MAT M; WHO (World Health Organization), 2015, TRENDS MATERNAL MORT; WHO's independent Expert Review Group, 2015, EV WOM EV CHILD EV A; World Bank WHO USAID, 2015, MEAS ACC RES HLTH RO; World Health Organization, 2014, EV NEWB ACT PLAN END; World Health Organization, 2013, GUID MAT NEWB CHILD; World Health Organization, 2014, PREVENTION ELIMINATI	87	196	202	2	23	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 13	2016	387	10019					703	716		10.1016/S0140-6736(15)00954-X	http://dx.doi.org/10.1016/S0140-6736(15)00954-X			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DD3QH	26794079	Green Published, Green Accepted, Green Submitted			2022-12-28	WOS:000369837100029
J	Lane, R				Lane, Richard			Address Malata: advancing nursing and midwifery in Malawi	LANCET			English	Editorial Material																			0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 6	2016	387	10018					527	527		10.1016/S0140-6736(16)00040-4	http://dx.doi.org/10.1016/S0140-6736(16)00040-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DD3PV	26794076	Bronze			2022-12-28	WOS:000369835800017
J	Bannister, KW; Stevens, J; Tuntsov, AV; Walker, MA; Johnston, S; Reynolds, C; Bignall, H				Bannister, Keith W.; Stevens, Jamie; Tuntsov, Artem V.; Walker, Mark A.; Johnston, Simon; Reynolds, Cormac; Bignall, Hayley			Real-time detection of an extreme scattering event: Constraints on Galactic plasma lenses	SCIENCE			English	Article							INTERSTELLAR-MEDIUM; THERMAL PRESSURES; RADIO-SOURCES; SCINTILLATION; VARIABILITY; REFRACTION; FREQUENCY; DIRECTION	Extreme scattering events (ESEs) are distinctive fluctuations in the brightness of astronomical radio sources caused by occulting plasma lenses in the interstellar medium. The inferred plasma pressures of the lenses are similar to 10(3) times the ambient pressure, challenging our understanding of gas conditions in the Milky Way. Using a new survey technique, we discovered an ESE while it was in progress. Here we report radio and optical follow-up observations. Modeling of the radio data demonstrates that the lensing structure is a density enhancement and the lens is diverging, ruling out one of two competing physical models. Our technique will uncover many more ESEs, addressing a long-standing mystery of the small-scale gas structure of our Galaxy.	[Bannister, Keith W.; Stevens, Jamie; Johnston, Simon] Commonwealth Sci & Ind Res Org Astron & Space Sci, Epping, NSW 1710, Australia; [Tuntsov, Artem V.; Walker, Mark A.] Manly Astrophys, Manly, NSW 2095, Australia; [Reynolds, Cormac; Bignall, Hayley] Curtin Univ, Int Ctr Radio Astron Res Curtin, Perth, WA 6102, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Curtin University	Bannister, KW (corresponding author), Commonwealth Sci & Ind Res Org Astron & Space Sci, POB 76, Epping, NSW 1710, Australia.	keith.bannister@csiro.au	Johnston, Simon/AAW-8490-2020; Reynolds, Cormac/AFS-0191-2022; Stevens, Jamie/AAY-4369-2020	Johnston, Simon/0000-0002-7122-4963; Reynolds, Cormac/0000-0002-8978-0626; Stevens, Jamie/0000-0002-5841-3348; Bannister, Keith/0000-0003-2149-0363				Cimo G, 2002, PUBL ASTRON SOC AUST, V19, P10, DOI 10.1071/AS01097; Clegg AW, 1998, ASTROPHYS J, V496, P253, DOI 10.1086/305344; Clegg AW, 1996, ASTROPHYS J, V457, pL23, DOI 10.1086/309884; COGNARD I, 1993, NATURE, V366, P320, DOI 10.1038/366320a0; FIEDLER R, 1994, ASTROPHYS J, V430, P581, DOI 10.1086/174432; FIEDLER RL, 1987, NATURE, V326, P675, DOI 10.1038/326675a0; Hamidouche M, 2007, ASTRON ASTROPHYS, V468, P193, DOI 10.1051/0004-6361:20041285; HENRIKSEN RN, 1995, ASTROPHYS J, V441, P70, DOI 10.1086/175336; Jenkins EB, 2001, ASTROPHYS J SUPPL S, V137, P297, DOI 10.1086/323326; Kulkarni S.R., 1988, GALACTIC EXTRAGALACT, P95; Lazio TJW, 2000, ASTROPHYS J, V534, P706, DOI 10.1086/308779; Lazio TJW, 2001, ASTROPHYS J SUPPL S, V136, P265, DOI 10.1086/322531; Lazio TJW, 2001, ASTROPHYS J, V546, P267, DOI 10.1086/318262; Mahony EK, 2011, MON NOT R ASTRON SOC, V417, P2651, DOI 10.1111/j.1365-2966.2011.19427.x; Maitia V, 2003, ASTROPHYS J, V582, P972, DOI 10.1086/344816; Pen UL, 2012, MON NOT R ASTRON SOC, V421, pL132, DOI 10.1111/j.1745-3933.2012.01223.x; Pushkarev AB, 2013, ASTRON ASTROPHYS, V555, DOI 10.1051/0004-6361/201321484; Rickett BJ, 1997, MON NOT R ASTRON SOC, V287, P739, DOI 10.1093/mnras/287.4.739; Rickett BJ, 2002, ASTROPHYS J, V581, P103, DOI 10.1086/344167; ROMANI RW, 1987, NATURE, V328, P324, DOI 10.1038/328324a0; Savolainen T, 2008, ASTRON ASTROPHYS, V489, pL33, DOI 10.1051/0004-6361:200810423; Senkbeil CE, 2008, ASTROPHYS J LETT, V672, pL95, DOI 10.1086/527300; Stix TH., 1992, WAVES PLASMAS; VALTAOJA E, 1992, ASTRON ASTROPHYS, V254, P71; Walker M, 1998, ASTROPHYS J, V498, pL125, DOI 10.1086/311332; Walker MA, 2007, ASTR SOC P, V365, P299; Wilson WE, 2011, MON NOT R ASTRON SOC, V416, P832, DOI 10.1111/j.1365-2966.2011.19054.x	28	48	48	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 22	2016	351	6271					354	356		10.1126/science.aac7673	http://dx.doi.org/10.1126/science.aac7673			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB3VH	26798008	Green Submitted			2022-12-28	WOS:000368440500032
J	Baden, T; Berens, P; Franke, K; Roson, MR; Bethge, M; Euler, T				Baden, Tom; Berens, Philipp; Franke, Katrin; Roson, Miroslav Roman; Bethge, Matthias; Euler, Thomas			The functional diversity of retinal ganglion cells in the mouse	NATURE			English	Article							RECEPTIVE-FIELDS; CLASSIFICATION; IDENTIFICATION; REPRESENTATIONS; ORGANIZATION; RESPONSES; PATHWAYS; PARALLEL; SUBTYPES; SPIKES	In the vertebrate visual system, all output of the retina is carried by retinal ganglion cells. Each type encodes distinct visual features in parallel for transmission to the brain. How many such 'output channels' exist and what each encodes are areas of intense debate. In the mouse, anatomical estimates range from 15 to 20 channels, and only a handful are functionally understood. By combining two-photon calcium imaging to obtain dense retinal recordings and unsupervised clustering of the resulting sample of more than 11,000 cells, here we show that the mouse retina harbours substantially more than 30 functional output channels. These include all known and several new ganglion cell types, as verified by genetic and anatomical criteria. Therefore, information channels from the mouse eye to the mouse brain are considerably more diverse than shown thus far by anatomical studies, suggesting an encoding strategy resembling that used in state-of-the-art artificial vision systems.	[Baden, Tom; Berens, Philipp; Franke, Katrin; Roson, Miroslav Roman; Bethge, Matthias; Euler, Thomas] Bernstein Ctr Computat Neurosci, D-72076 Tubingen, Germany; [Baden, Tom; Berens, Philipp; Franke, Katrin; Roson, Miroslav Roman; Bethge, Matthias; Euler, Thomas] Univ Tubingen, Ctr Integrat Neurosci, D-72076 Tubingen, Germany; [Baden, Tom; Berens, Philipp; Franke, Katrin; Roson, Miroslav Roman; Euler, Thomas] Inst Ophthalm Res, D-72076 Tubingen, Germany; [Berens, Philipp] Baylor Coll Med, Houston, TX 77030 USA; [Berens, Philipp; Bethge, Matthias] Univ Tubingen, Inst Theoret Phys, D-72076 Tubingen, Germany; [Franke, Katrin; Roson, Miroslav Roman] Univ Tubingen, Grad Training Ctr Neurosci, D-72074 Tubingen, Germany; [Bethge, Matthias] Max Planck Inst Biol Cybernet, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Baylor College of Medicine; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Max Planck Society	Euler, T (corresponding author), Bernstein Ctr Computat Neurosci, D-72076 Tubingen, Germany.	thomas.euler@cin.uni-tuebingen.de	Berens, Philipp/A-5653-2009	Berens, Philipp/0000-0002-0199-4727; Baden, Tom/0000-0003-2808-4210; Euler, Thomas/0000-0002-4567-6966; Franke, Katrin/0000-0002-8649-4835	Deutsche Forschungsgemeinschaft (DFG) (Werner Reichardt Centre for Integrative Neuroscience Tubingen) [EXC 307, BA 5283/1-1, BE 5601/1-1]; German Federal Ministry of Education and Research (BMBF) (BCCN Tubingen) [FKZ 01GQ1002]; BW-Stiftung [AZ 1.16101.09]; intramural fortune program of the University of Tubingen [2125-0-0]; National Institute of Neurological Disorders and Stroke of the National Institutes of Health [U01NS090562]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS090562] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft (DFG) (Werner Reichardt Centre for Integrative Neuroscience Tubingen)(German Research Foundation (DFG)); German Federal Ministry of Education and Research (BMBF) (BCCN Tubingen)(Federal Ministry of Education & Research (BMBF)); BW-Stiftung; intramural fortune program of the University of Tubingen; National Institute of Neurological Disorders and Stroke of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank G. Eske for technical support and H. S. Seung, P. R. Martin, and A. S. Tolias for discussion. This work was supported by the Deutsche Forschungsgemeinschaft (DFG) (Werner Reichardt Centre for Integrative Neuroscience Tubingen, EXC 307 to M.B. and T.E.; BA 5283/1-1 to T.B.; BE 5601/1-1 to P.B.), the German Federal Ministry of Education and Research (BMBF) (BCCN Tubingen, FKZ 01GQ1002 to M.B. and T.E.), the BW-Stiftung (AZ 1.16101.09 to T.B.), the intramural fortune program of the University of Tubingen (2125-0-0 to T.B.) and the National Institute of Neurological Disorders and Stroke of the National Institutes of Health (U01NS090562 to T.E.).	Armananzas R, 2015, TRENDS NEUROSCI, V38, P307, DOI 10.1016/j.tins.2015.02.004; Baden T, 2013, NEURON, V80, P1206, DOI 10.1016/j.neuron.2013.09.030; Baden T, 2013, CURR BIOL, V23, P48, DOI 10.1016/j.cub.2012.11.006; BARLOW HB, 1964, J PHYSIOL-LONDON, V173, P377, DOI 10.1113/jphysiol.1964.sp007463; Berson DM, 2010, J COMP NEUROL, V518, P2405, DOI 10.1002/cne.22381; Bleckert A, 2014, CURR BIOL, V24, P310, DOI 10.1016/j.cub.2013.12.020; Breuninger T, 2011, J NEUROSCI, V31, P6504, DOI 10.1523/JNEUROSCI.0616-11.2011; Briggman KL, 2011, J NEUROPHYSIOL, V105, P2601, DOI 10.1152/jn.00722.2010; CLELAND BG, 1974, J PHYSIOL-LONDON, V240, P421, DOI 10.1113/jphysiol.1974.sp010617; Coombs J, 2006, NEUROSCIENCE, V140, P123, DOI 10.1016/j.neuroscience.2006.02.079; Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329; DeVries SH, 1997, J NEUROPHYSIOL, V78, P2048, DOI 10.1152/jn.1997.78.4.2048; Ecker AS, 2014, NEURON, V82, P235, DOI 10.1016/j.neuron.2014.02.006; Ecker JL, 2010, NEURON, V67, P49, DOI 10.1016/j.neuron.2010.05.023; Euler T, 2014, NAT REV NEUROSCI, V15, P507, DOI 10.1038/nrn3783; Euler T, 2009, PFLUG ARCH EUR J PHY, V457, P1393, DOI 10.1007/s00424-008-0603-5; Farrow K, 2013, NEURON, V78, P325, DOI 10.1016/j.neuron.2013.02.014; Farrow K, 2011, J NEUROPHYSIOL, V105, P1516, DOI 10.1152/jn.00331.2010; Feinberg EH, 2015, NATURE, V519, P229, DOI 10.1038/nature14103; Fraley C, 2002, J AM STAT ASSOC, V97, P611, DOI 10.1198/016214502760047131; Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159; Ivanova E, 2010, NEUROSCIENCE, V165, P233, DOI 10.1016/j.neuroscience.2009.10.021; Kim IJ, 2008, NATURE, V452, P478, DOI 10.1038/nature06739; Kong JH, 2005, J COMP NEUROL, V489, P293, DOI 10.1002/cne.20631; Krizhevsky A, 2017, COMMUN ACM, V60, P84, DOI 10.1145/3065386; LETTVIN JY, 1959, P IRE, V47, P1940, DOI 10.1109/JRPROC.1959.287207; LEVICK WR, 1967, J PHYSIOL-LONDON, V188, P285, DOI 10.1113/jphysiol.1967.sp008140; Lewis PM, 2004, DEV BIOL, V270, P393, DOI 10.1016/j.ydbio.2004.03.007; Lim EJ, 2007, NEUROSCI LETT, V424, P199, DOI 10.1016/j.neulet.2007.07.046; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Masland RH, 2012, NEURON, V76, P266, DOI 10.1016/j.neuron.2012.10.002; Morin LP, 2014, J COMP NEUROL, V522, P3733, DOI 10.1002/cne.23635; Nikolaev A, 2013, NAT NEUROSCI, V16, P934, DOI 10.1038/nn.3408; OYSTER CW, 1967, SCIENCE, V155, P841, DOI 10.1126/science.155.3764.841; Rivlin-Etzion M, 2011, J NEUROSCI, V31, P8760, DOI 10.1523/JNEUROSCI.0564-11.2011; Robles E, 2014, CURR BIOL, V24, P2085, DOI 10.1016/j.cub.2014.07.080; RODIECK RW, 1983, BRAIN BEHAV EVOLUT, V23, P121, DOI 10.1159/000121492; Roska B, 2001, NATURE, V410, P583, DOI 10.1038/35069068; ROWE MH, 1977, BRAIN BEHAV EVOLUT, V14, P185, DOI 10.1159/000125660; Sanes JR, 2015, ANNU REV NEUROSCI, V38, P221, DOI 10.1146/annurev-neuro-071714-034120; Schlamp CL, 2013, MOL VIS, V19, P1387; Seung HS, 2014, NEURON, V83, P1262, DOI 10.1016/j.neuron.2014.08.054; Sivyer B, 2010, P NATL ACAD SCI USA, V107, P5628, DOI 10.1073/pnas.0909621107; Sumbul U, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4512; Sun WZ, 2006, J PHYSIOL-LONDON, V576, P197, DOI 10.1113/jphysiol.2006.115857; Tien NW, 2015, J NEUROSCI, V35, P10815, DOI 10.1523/JNEUROSCI.1521-15.2015; Van Wyk M, 2009, VISUAL NEUROSCI, V26, P297, DOI 10.1017/S0952523809990137; Vaney DI, 2012, NAT REV NEUROSCI, V13, P194, DOI 10.1038/nrn3165; Volgyi B, 2009, J COMP NEUROL, V512, P664, DOI 10.1002/cne.21912; Wang YV, 2011, J NEUROSCI, V31, P7670, DOI 10.1523/JNEUROSCI.0629-11.2011; Weng SJ, 2005, J PHYSIOL-LONDON, V562, P915, DOI 10.1113/jphysiol.2004.076695; WERBLIN FS, 1969, J NEUROPHYSIOL, V32, P339, DOI 10.1152/jn.1969.32.3.339; Zhang YF, 2012, P NATL ACAD SCI USA, V109, pE2391, DOI 10.1073/pnas.1211547109; Zhao XY, 2013, J NEUROSCI, V33, P12751, DOI 10.1523/JNEUROSCI.0095-13.2013; Zou H, 2006, J COMPUT GRAPH STAT, V15, P265, DOI 10.1198/106186006X113430	55	470	477	9	153	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 21	2016	529	7586					345	+		10.1038/nature16468	http://dx.doi.org/10.1038/nature16468			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB2QT	26735013	Green Accepted			2022-12-28	WOS:000368354800036
J	Telford, MJ				Telford, Maximilian J.			Evolution A sisterly dispute	NATURE			English	Editorial Material									[Telford, Maximilian J.] UCL, Dept Genet Evolut & Environm, London WC1E 6BT, England	University of London; University College London	Telford, MJ (corresponding author), UCL, Dept Genet Evolut & Environm, Mortimer St, London WC1E 6BT, England.	m.telford@ucl.ac.uk		Moroz, Leonid/0000-0002-1333-3176					0	37	40	1	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 21	2016	529	7586					286	286		10.1038/529286a	http://dx.doi.org/10.1038/529286a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB2QT	26791714				2022-12-28	WOS:000368354800023
J	Shalev, D				Shalev, Daniel			A Final Course	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Shalev, Daniel] New York Presbyterian Columbia Univ, Dept Psychiat, New York, NY USA; [Shalev, Daniel] New York State Psychiat Inst & Hosp, New York, NY 10032 USA	New York State Psychiatry Institute	Shalev, D (corresponding author), New York Presbyterian Columbia Univ, Dept Psychiat, New York, NY USA.	das2043@nyp.org	Shalev, Daniel/AAA-8397-2019	Shalev, Daniel/0000-0002-8168-2255					0	1	1	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 19	2016	315	3					263	264		10.1001/jama.2015.17057	http://dx.doi.org/10.1001/jama.2015.17057			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DB2WN	26784771				2022-12-28	WOS:000368371400020
J	Haering, CH; Gruber, S				Haering, Christian H.; Gruber, Stephan			SnapShot: SMC Protein Complexes Part I	CELL			English	Editorial Material									[Haering, Christian H.] European Mol Biol Lab, D-69117 Heidelberg, Germany; [Gruber, Stephan] Max Planck Inst Biochem, D-82152 Martinsried, Germany	European Molecular Biology Laboratory (EMBL); Max Planck Society	Haering, CH (corresponding author), European Mol Biol Lab, D-69117 Heidelberg, Germany.		Gruber, Stephan/AFC-4848-2022	Gruber, Stephan/0000-0002-0150-0395; Haering, Christian/0000-0001-8301-1722				Gruber S, 2011, MOL MICROBIOL, V81, P855, DOI 10.1111/j.1365-2958.2011.07764.x; Hirano T, 2012, GENE DEV, V26, P1659, DOI 10.1101/gad.194746.112; Nolivos S, 2014, FEMS MICROBIOL REV, V38, P380, DOI 10.1111/1574-6976.12045; Schubert V, 2009, CYTOGENET GENOME RES, V124, P202, DOI 10.1159/000218126; Verver DE, 2016, CHROMOSOMA, V125, P15, DOI 10.1007/s00412-015-0518-9; Xiong B, 2010, ANNU REV BIOCHEM, V79, P131, DOI 10.1146/annurev-biochem-061708-092640	6	24	24	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 14	2016	164	1-2					326	U373		10.1016/j.cell.2015.12.026	http://dx.doi.org/10.1016/j.cell.2015.12.026			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DB2LE	26771499	Bronze			2022-12-28	WOS:000368339300032
J	Hospenthal, MK; Redzej, A; Dodson, K; Ukleja, M; Frenz, B; Rodrigues, C; Hultgren, SJ; DiMaio, F; Egelman, EH; Waksman, G				Hospenthal, Manuela K.; Redzej, Adam; Dodson, Karen; Ukleja, Marta; Frenz, Brandon; Rodrigues, Catarina; Hultgren, Scott J.; DiMaio, Frank; Egelman, Edward H.; Waksman, Gabriel			Structure of a Chaperone-Usher Pilus Reveals the Molecular Basis of Rod Uncoiling	CELL			English	Article							UROPATHOGENIC ESCHERICHIA-COLI; DRIVES FIBER FORMATION; ELECTRON-MICROSCOPY; P-PILI; FIMD USHER; BIOGENESIS; ADHESIN; INFECTIONS; PROTEINS; CATALYST	Types 1 and P pili are prototypical bacterial cell-surface appendages playing essential roles in mediating adhesion of bacteria to the urinary tract. These pili, assembled by the chaperone-usher pathway, are polymers of pilus subunits assembling into two parts: a thin, short tip fibrillum at the top, mounted on a long pilus rod. The rod adopts a helical quaternary structure and is thought to play essential roles: its formation may drive pilus extrusion by preventing backsliding of the nascent growing pilus within the secretion pore; the rod also has striking spring-like properties, being able to uncoil and recoil depending on the intensity of shear forces generated by urine flow. Here, we present an atomic model of the P pilus generated from a 3.8 angstrom resolution cryo-electron microscopy reconstruction. This structure provides the molecular basis for the rod's remarkable mechanical properties and illuminates its role in pilus secretion.	[Hospenthal, Manuela K.; Redzej, Adam; Ukleja, Marta; Rodrigues, Catarina; Waksman, Gabriel] Univ Coll London & Birkbeck, Inst Struct & Mol Biol, London WC1E 7HX, England; [Frenz, Brandon; DiMaio, Frank] Univ Washington, Dept Biochem, Seattle, WA 98105 USA; [Dodson, Karen; Hultgren, Scott J.] Washington Univ, Sch Med, Ctr Womens Infect Dis Res, St Louis, MO 63011 USA; [Dodson, Karen; Hultgren, Scott J.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63011 USA; [Egelman, Edward H.] Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA 22901 USA	University of London; Birkbeck University London; University College London; University of Washington; University of Washington Seattle; Washington University (WUSTL); Washington University (WUSTL); University of Virginia	Egelman, EH (corresponding author), Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA 22901 USA.	egelman@virginia.edu; g.waksman@mail.cryst.bbk.ac.uk	Hospenthal, Manuela/AAU-3210-2020	Hospenthal, Manuela/0000-0003-1175-6826; Egelman, Edward/0000-0003-4844-5212; Ukleja, Marta/0000-0003-0641-571X; Redzej, Adam/0000-0003-2471-289X	MRC [018434]; NIH [EB001567, RO1 AI48689]; Wellcome Trust; BBSRC; Biotechnology and Biological Sciences Research Council [BB/L014211/1] Funding Source: researchfish; Medical Research Council [G0100442, MR/K018434/1] Funding Source: researchfish; Wellcome Trust [098302/Z/12/Z] Funding Source: researchfish; BBSRC [BB/L014211/1] Funding Source: UKRI; MRC [G0100442, MR/K018434/1] Funding Source: UKRI; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048689] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB001567] Funding Source: NIH RePORTER	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was funded by MRC grant 018434 to G.W. and NIH EB001567 to E.H.E. We wish to thank Dr. Carolyn Moores for advice on data collection, Dr. Alistair Siebert (electron Bio-Imaging Centre [eBIC], Diamond Light Source Ltd., UK), and Dr. Kasim Sader (FEI, Oregon, USA) for help in data collection. eBIC is funded by strategic grant from the Wellcome Trust, MRC, and BBSRC to Helen Saibil, David Stuart, Kay Grunewald, and Gerhard Materlik. S.J.H. and K.D. were supported in this work by NIH RO1 AI48689 to S.J.H.	Allen WJ, 2012, CURR OPIN STRUC BIOL, V22, P500, DOI 10.1016/j.sbi.2012.02.001; Barnhart MM, 2000, P NATL ACAD SCI USA, V97, P7709, DOI 10.1073/pnas.130183897; BULLITT E, 1995, NATURE, V373, P164, DOI 10.1038/373164a0; Chin JW, 2002, J AM CHEM SOC, V124, P9026, DOI 10.1021/ja027007w; Choudhury D, 1999, SCIENCE, V285, P1061, DOI 10.1126/science.285.5430.1061; DiMaio F, 2015, NAT METHODS, V12, P361, DOI [10.1038/nmeth.3286, 10.1038/NMETH.3286]; Egelman EH, 2000, ULTRAMICROSCOPY, V85, P225, DOI 10.1016/S0304-3991(00)00062-0; Fallman E, 2005, EMBO REP, V6, P52, DOI 10.1038/sj.embor.7400310; Flores-Mireles AL, 2015, NAT REV MICROBIOL, V13, P269, DOI 10.1038/nrmicro3432; Forero M, 2006, PLOS BIOL, V4, P1509, DOI 10.1371/journal.pbio.0040298; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Geibel S, 2013, NATURE, V496, P243, DOI 10.1038/nature12007; Hahn E, 2002, J MOL BIOL, V323, P845, DOI 10.1016/S0022-2836(02)01005-7; HOSCHUTZKY H, 1989, INFECT IMMUN, V57, P76; JACOBDUBUISSON F, 1994, J BIOL CHEM, V269, P12447; JACOBDUBUISSON F, 1993, EMBO J, V12, P837, DOI 10.1002/j.1460-2075.1993.tb05724.x; KARCH H, 1985, INFECT IMMUN, V47, P549, DOI 10.1128/IAI.47.2.549-554.1985; Klinth JE, 2012, EUR BIOPHYS J BIOPHY, V41, P285, DOI 10.1007/s00249-011-0784-2; Le Trong I, 2010, CELL, V141, P645, DOI 10.1016/j.cell.2010.03.038; LEFFLER H, 1981, INFECT IMMUN, V34, P920, DOI 10.1128/IAI.34.3.920-929.1981; LINDBERG FP, 1984, EMBO J, V3, P1167, DOI 10.1002/j.1460-2075.1984.tb01946.x; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Miyake-Stoner SJ, 2009, BIOCHEMISTRY-US, V48, P5953, DOI 10.1021/bi900426d; Mu XQ, 2006, P NATL ACAD SCI USA, V103, P9861, DOI 10.1073/pnas.0509620103; Nishiyama M, 2008, SCIENCE, V320, P376, DOI 10.1126/science.1154994; Phan G, 2011, NATURE, V474, P49, DOI 10.1038/nature10109; Puorger C, 2008, STRUCTURE, V16, P631, DOI 10.1016/j.str.2008.01.013; Remaut H, 2006, MOL CELL, V22, P831, DOI 10.1016/j.molcel.2006.05.033; Rose RJ, 2008, P NATL ACAD SCI USA, V105, P12873, DOI 10.1073/pnas.0802177105; Sauer FG, 2002, CELL, V111, P543, DOI 10.1016/S0092-8674(02)01050-4; Sauer FG, 1999, SCIENCE, V285, P1058, DOI 10.1126/science.285.5430.1058; Song YF, 2013, STRUCTURE, V21, P1735, DOI 10.1016/j.str.2013.08.005; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Thanassi DG, 1998, CURR OPIN MICROBIOL, V1, P223, DOI 10.1016/S1369-5274(98)80015-5; Verger D, 2007, PLOS PATHOG, V3, P674, DOI 10.1371/journal.ppat.0030073; Vetsch M, 2004, NATURE, V431, P329, DOI 10.1038/nature02891; Waksman G, 2009, NAT REV MICROBIOL, V7, P765, DOI 10.1038/nrmicro2220; Zavialov AV, 2003, CELL, V113, P587, DOI 10.1016/S0092-8674(03)00351-9	38	38	38	0	21	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 14	2016	164	1-2					269	278		10.1016/j.cell.2015.11.049	http://dx.doi.org/10.1016/j.cell.2015.11.049			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DB2LE	26724865	Green Published, Green Accepted, hybrid, Green Submitted			2022-12-28	WOS:000368339300026
J	Indjeian, VB; Kingman, GA; Jones, FC; Guenther, CA; Grimwood, J; Schmutz, J; Myers, RM; Kingsley, DM				Indjeian, Vahan B.; Kingman, Garrett A.; Jones, Felicity C.; Guenther, Catherine A.; Grimwood, Jane; Schmutz, Jeremy; Myers, Richard M.; Kingsley, David M.			Evolving New Skeletal Traits by cis-Regulatory Changes in Bone Morphogenetic Proteins	CELL			English	Article							THREESPINE STICKLEBACKS; GASTEROSTEUS-ACULEATUS; ADAPTIVE EVOLUTION; PELVIC REDUCTION; MORPHOLOGICAL EVOLUTION; 3-SPINED STICKLEBACK; PARALLEL EVOLUTION; MOLECULAR-BASIS; MUTATIONS; GENE	Changes in bone size and shape are defining features of many vertebrates. Here we use genetic crosses and comparative genomics to identify specific regulatory DNA alterations controlling skeletal evolution. Armor bone-size differences in sticklebacks map to a major effect locus overlapping BMP family member GDF6. Freshwater fish express more GDF6 due in part to a transposon insertion, and transgenic overexpression of GDF6 phenocopies evolutionary changes in armorplate size. The human GDF6 locus also has undergone distinctive regulatory evolution, including complete loss of an enhancer that is otherwise highly conserved between chimps and other mammals. Functional tests show that the ancestral enhancer drives expression in hindlimbs but not forelimbs, in locations that have been specifically modified during the human transition to bipedalism. Both gain and loss of regulatory elements can localize BMP changes to specific anatomical locations, providing a flexible regulatory basis for evolving species-specific changes in skeletal form.	[Indjeian, Vahan B.; Guenther, Catherine A.; Kingsley, David M.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Indjeian, Vahan B.; Kingman, Garrett A.; Jones, Felicity C.; Guenther, Catherine A.; Kingsley, David M.] Stanford Univ, Sch Med, Dept Dev Biol, Beckman Ctr B300, Stanford, CA 94305 USA; [Grimwood, Jane; Schmutz, Jeremy; Myers, Richard M.] HudsonAlpha Inst Biotechnol, Huntsville, AL 35806 USA	Howard Hughes Medical Institute; Stanford University; Stanford University; HudsonAlpha Institute for Biotechnology	Kingsley, DM (corresponding author), Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA.	kingsley@stanford.edu	Jones, Felicity C/AAY-3523-2021; Grimwood, Jane/ABD-5737-2021; Schmutz, Jeremy/N-3173-2013	Jones, Felicity C/0000-0002-5027-1031; Schmutz, Jeremy/0000-0001-8062-9172; Roberts Kingman, Garrett/0000-0002-1910-3005	US National Institutes of Health [R01-AR42236]; Center of Excellence in Genomic Science [5P50HG2568]; MRC [MC_UP_1102/11] Funding Source: UKRI; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG002568] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R37AR042236, R01AR042236] Funding Source: NIH RePORTER; Medical Research Council [MC_UP_1102/11] Funding Source: researchfish	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center of Excellence in Genomic Science; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank D. Schluter for the stickleback cross used in the Colosimo et al., 2004 and subsequent QTL mapping studies; G. Bejerano and C. McLean for useful discussions about the human deletions in the GDF6 locus; C. Miller for advice on QTL mapping; C. Lowe for advice on statistics; T. Howes for advice on stickleback transgenics; and M. Bell, A. Pollen, K. Xie, and all members of the Kingsley lab for helpful comments and suggestions. This work was supported in part by US National Institutes of Health grant R01-AR42236 (D.M.K.) and Center of Excellence in Genomic Science award 5P50HG2568 (D.M.K. and R.M.M.). D.M.K. is a Howard Hughes Medical Institute investigator.	Abzhanov A, 2004, SCIENCE, V305, P1462, DOI 10.1126/science.1098095; Albertson RC, 2005, P NATL ACAD SCI USA, V102, P16287, DOI 10.1073/pnas.0506649102; Asai-Coakwell M, 2009, HUM MOL GENET, V18, P1110, DOI 10.1093/hmg/ddp008; Barrett RDH, 2008, SCIENCE, V322, P255, DOI 10.1126/science.1159978; Bell M.A., 1994, EVOLUTIONARY BIOL TH; Bergstrom CA, 2002, CAN J ZOOL, V80, P207, DOI 10.1139/Z01-226; Blount ZD, 2012, NATURE, V489, P513, DOI 10.1038/nature11514; Chan YF, 2010, SCIENCE, V327, P302, DOI 10.1126/science.1182213; Clendenning DE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036789; Cleves PA, 2014, P NATL ACAD SCI USA, V111, P13912, DOI 10.1073/pnas.1407567111; Colosimo PF, 2005, SCIENCE, V307, P1928, DOI 10.1126/science.1107239; Colosimo PF, 2004, PLOS BIOL, V2, P635, DOI 10.1371/journal.pbio.0020109; Erlacher L, 1998, J BONE MINER RES, V13, P383, DOI 10.1359/jbmr.1998.13.3.383; Flower W. H., 1870, INTRO OSTEOLOGY MAMM; Frankel N, 2011, NATURE, V474, P598, DOI 10.1038/nature10200; Fu WQ, 2013, ANNU REV GENOM HUM G, V14, P467, DOI 10.1146/annurev-genom-091212-153509; GILES N, 1983, J ZOOL, V199, P535; Gompel N, 2005, NATURE, V433, P481, DOI 10.1038/nature03235; Gooch KJ, 2002, TISSUE ENG, V8, P591, DOI 10.1089/107632702760240517; Greenwood AK, 2013, CURR BIOL, V23, P1884, DOI 10.1016/j.cub.2013.07.058; Guenther C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000308; Guenther CA, 2014, NAT GENET, V46, P748, DOI 10.1038/ng.2991; Harcourt-Smith WEH, 2004, J ANAT, V204, P403, DOI 10.1111/j.0021-8782.2004.00296.x; Jones FC, 2012, NATURE, V484, P55, DOI 10.1038/nature10944; Kingsley David M., 2007, P41; KINGSLEY DM, 1994, TRENDS GENET, V10, P16, DOI 10.1016/0168-9525(94)90014-0; Knecht AK, 2007, EVOL DEV, V9, P141, DOI 10.1111/j.1525-142X.2007.00145.x; Linnen CR, 2013, SCIENCE, V339, P1312, DOI 10.1126/science.1233213; Lovejoy CO, 2009, SCIENCE, V326, DOI 10.1126/science.1175832; Martin A, 2012, P NATL ACAD SCI USA, V109, P12632, DOI 10.1073/pnas.1204800109; McGregor AP, 2007, NATURE, V448, P587, DOI 10.1038/nature05988; McLean CY, 2011, NATURE, V471, P216, DOI 10.1038/nature09774; Miller CT, 2007, CELL, V131, P1179, DOI 10.1016/j.cell.2007.10.055; Miller CT, 2014, GENETICS, V197, P405, DOI 10.1534/genetics.114.162420; Mortlock DP, 2003, GENOME RES, V13, P2069, DOI 10.1101/gr.1306003; Muffato M, 2010, BIOINFORMATICS, V26, P1119, DOI 10.1093/bioinformatics/btq079; Myhre F, 2009, J FISH BIOL, V75, P2062, DOI 10.1111/j.1095-8649.2009.02404.x; Nochi H, 2004, J BONE MINER RES, V19, P111, DOI 10.1359/jbmr.2004.19.1.111; O'Brown NM, 2015, ELIFE, V4, DOI 10.7554/eLife.05290; Pregizer S, 2009, CYTOKINE GROWTH F R, V20, P509, DOI 10.1016/j.cytogfr.2009.10.011; Rebeiz M, 2009, SCIENCE, V326, P1663, DOI 10.1126/science.1178357; Reed RD, 2011, SCIENCE, V333, P1137, DOI 10.1126/science.1208227; REIMCHEN TE, 1980, CAN J ZOOL, V58, P1232, DOI 10.1139/z80-173; Settle SH, 2003, DEV BIOL, V254, P116, DOI 10.1016/S0012-1606(02)00022-2; Shapiro MD, 2004, NATURE, V428, P717, DOI 10.1038/nature02415; Shapiro MD, 2006, P NATL ACAD SCI USA, V103, P13753, DOI 10.1073/pnas.0604706103; Shen BJ, 2009, INT J BIOL SCI, V5, P192; Stern DL, 2009, SCIENCE, V323, P746, DOI 10.1126/science.1158997; STORM EE, 1994, NATURE, V368, P639, DOI 10.1038/368639a0; Swindler D.R., 1973, ATLAS PRIMATE GROSS; Tassabehji M, 2008, HUM MUTAT, V29, P1017, DOI 10.1002/humu.20741; Wark AR, 2012, G3-GENES GENOM GENET, V2, P1047, DOI 10.1534/g3.112.003079	52	92	93	4	54	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 14	2016	164	1-2					45	56		10.1016/j.cell.2015.12.007	http://dx.doi.org/10.1016/j.cell.2015.12.007			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DB2LE	26774823	Green Accepted, Bronze			2022-12-28	WOS:000368339300008
J	Bond, WJ				Bond, William J.			Ancient grasslands at risk	SCIENCE			English	Editorial Material							GRASSY BIOMES; FIRE; BIODIVERSITY; EXPANSION; DIVERSITY; CERRADO; HOTSPOT		[Bond, William J.] Natl Res Fdn, South African Environm Observat Network, ZA-7735 Claremont, South Africa; [Bond, William J.] Univ Cape Town, Dept Biol Sci, ZA-7701 Rondebosch, South Africa	National Research Foundation - South Africa; South African Environmental Observation Network (SAEON); University of Cape Town	Bond, WJ (corresponding author), Natl Res Fdn, South African Environm Observat Network, Private Bag X7, ZA-7735 Claremont, South Africa.	william.bond@uct.ac.za	Bond, William/AAY-7631-2020	Bond, William/0000-0002-3441-2084				Bond WJ, 2010, BIOL CONSERV, V143, P2395, DOI 10.1016/j.biocon.2009.12.012; Jackson RB, 2008, ENVIRON RES LETT, V3, DOI 10.1088/1748-9326/3/4/044006; Laestadius L., 2011, Unasylva (English ed.), V62, P47; Maurin O, 2014, NEW PHYTOL, V204, P201, DOI 10.1111/nph.12936; Nogueira C, 2011, J BIOGEOGR, V38, P1907, DOI 10.1111/j.1365-2699.2011.02538.x; Noss R., 2012, FORGOTTEN GRASSLANDS, DOI DOI 10.1080/11956860.2016.1148458; Noss RF, 2015, DIVERS DISTRIB, V21, P236, DOI 10.1111/ddi.12278; Overbeck GE, 2007, PERSPECT PLANT ECOL, V9, P101, DOI 10.1016/j.ppees.2007.07.005; Parr CL, 2014, TRENDS ECOL EVOL, V29, P205, DOI 10.1016/j.tree.2014.02.004; Scheiter S, 2012, NEW PHYTOL, V195, P653, DOI 10.1111/j.1469-8137.2012.04202.x; Simon MF, 2009, P NATL ACAD SCI USA, V106, P20359, DOI 10.1073/pnas.0903410106; Veldman JW, 2015, BIOSCIENCE, V65, P1011, DOI 10.1093/biosci/biv118; Veldman JW, 2015, FRONT ECOL ENVIRON, V13, P154, DOI 10.1890/140270; Vorontsova M. S., 2014, MALAGASY NATURE, V8, P14; White F., 1976, GARDENS B SINGAPORE, V29, P57	15	133	133	7	116	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 8	2016	351	6269					120	122		10.1126/science.aad5132	http://dx.doi.org/10.1126/science.aad5132			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA4XQ	26744392				2022-12-28	WOS:000367806500013
J	Lesk, C; Rowhani, P; Ramankutty, N				Lesk, Corey; Rowhani, Pedram; Ramankutty, Navin			Influence of extreme weather disasters on global crop production	NATURE			English	Article							CLIMATE-CHANGE; DROUGHT; MAIZE; HEAT; TRENDS	In recent years, several extreme weather disasters have partially or completely damaged regional crop production(1-5). While detailed regional accounts of the effects of extreme weather disasters exist, the global scale effects of droughts, floods and extreme temperature on crop production are yet to be quantified. Here we estimate for the first time, to our knowledge, national cereal production losses across the globe resulting from reported extreme weather disasters during 1964-2007. We show that droughts and extreme heat significantly reduced national cereal production by 9-10%, whereas our analysis could not identify an effect from floods and extreme cold in the national data. Analysing the underlying processes, we find that production losses due to droughts were associated with a reduction in both harvested area and yields, whereas extreme heat mainly decreased cereal yields. Furthermore, the results highlight similar to 7% greater production damage from more recent droughts and 8-11% more damage in developed countries than in developing ones. Our findings may help to guide agricultural priorities in international disaster risk reduction and adaptation efforts.	[Lesk, Corey; Ramankutty, Navin] McGill Univ, Dept Geog, Montreal, PQ H3A 0B9, Canada; [Rowhani, Pedram] Univ Sussex, Dept Geog, Brighton BN1 9QJ, E Sussex, England; [Ramankutty, Navin] Univ British Columbia, Liu Inst Global Issues, Vancouver, BC V6T 1Z2, Canada; [Ramankutty, Navin] Univ British Columbia, Inst Resources Environm & Sustainabil, Vancouver, BC V6T 1Z2, Canada	McGill University; University of Sussex; University of British Columbia; University of British Columbia	Ramankutty, N (corresponding author), McGill Univ, Dept Geog, Montreal, PQ H3A 0B9, Canada.; Ramankutty, N (corresponding author), Univ British Columbia, Liu Inst Global Issues, Vancouver, BC V6T 1Z2, Canada.; Ramankutty, N (corresponding author), Univ British Columbia, Inst Resources Environm & Sustainabil, Vancouver, BC V6T 1Z2, Canada.	navin.ramankutty@ubc.ca	mahsum, masot/ABC-4546-2020; Ramankutty, Navin/AAM-6074-2020	Ramankutty, Navin/0000-0002-3737-5717; Rowhani, Pedram/0000-0002-0709-9168	Natural Science and Engineering Research Council of Canada; Natural Science and Engineering Research Council of Canada	Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	We thank R. Below, who is in charge of the EM-DAT project at the Centre for Research on the Epidemiology of Disasters, for sharing the data. We thank C. Champalle for testing the original idea using data over East Africa in a class project. This research was supported by a Discovery Grant from the Natural Science and Engineering Research Council of Canada to N.R.	Adams JB, 2003, NATURE, V426, P274, DOI 10.1038/nature02101; Barriopedro D, 2011, SCIENCE, V332, P220, DOI 10.1126/science.1201224; Battisti DS, 2009, SCIENCE, V323, P240, DOI 10.1126/science.1164363; Coumou D, 2012, NAT CLIM CHANGE, V2, P491, DOI 10.1038/NCLIMATE1452; Dai AG, 2013, NAT CLIM CHANGE, V3, P52, DOI [10.1038/nclimate1633, 10.1038/NCLIMATE1633]; Deryng D, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/3/034011; FAO, 2015, IMP NAT HAZ DIS AGR; Gornall J, 2010, PHILOS T R SOC B, V365, P2973, DOI 10.1098/rstb.2010.0158; Greve P, 2014, NAT GEOSCI, V7, P716, DOI [10.1038/ngeo2247, 10.1038/NGEO2247]; Gu L, 2008, BIOSCIENCE, V58, P253, DOI 10.1641/B580311; Iizumi T, 2015, GLOB FOOD SECUR-AGR, V4, P46, DOI 10.1016/j.gfs.2014.11.003; Intergov Panel Clim Chg, 2012, MANAGING THE RISKS OF EXTREME EVENTS AND DISASTERS TO ADVANCE CLIMATE CHANGE ADAPTATION, P1, DOI 10.1017/CBO9781139177245; Johnstone S, 2011, SURVIVAL, V53, P11, DOI 10.1080/00396338.2011.571006; Lobell DB, 2007, ENVIRON RES LETT, V2, DOI 10.1088/1748-9326/2/1/014002; Lobell DB, 2014, SCIENCE, V344, P516, DOI 10.1126/science.1251423; Lobell DB, 2013, NAT CLIM CHANGE, V3, P497, DOI [10.1038/nclimate1832, 10.1038/NCLIMATE1832]; Lobell DB, 2012, NAT CLIM CHANGE, V2, P186, DOI [10.1038/nclimate1356, 10.1038/NCLIMATE1356]; Lobell DB, 2011, SCIENCE, V333, P616, DOI [10.1126/science.1204531, 10.1126/science.1206376]; Lobell DB, 2011, NAT CLIM CHANGE, V1, P42, DOI [10.1038/nclimate1043, 10.1038/NCLIMATE1043]; Moriondo M, 2011, CLIMATIC CHANGE, V104, P679, DOI 10.1007/s10584-010-9871-0; Sheffield J, 2012, NATURE, V491, P435, DOI 10.1038/nature11575; Teixeira EI, 2013, AGR FOREST METEOROL, V170, P206, DOI 10.1016/j.agrformet.2011.09.002; Thornton PK, 2014, GLOBAL CHANGE BIOL, V20, P3313, DOI 10.1111/gcb.12581; Trenberth KE, 2014, NAT CLIM CHANGE, V4, P17, DOI 10.1038/NCLIMATE2067; United Nations Office for Disaster Risk Reduction, 2013, POCK GAR 2013 SHAR R; Welton G., 2011, The impact of Russia's 2010 grain export ban; World Food Program, 2010, PAK FLOOD IMP ASS; World Meteorological Organization, 2014, ATL MORT EC LOSS WEA	28	1348	1406	188	1140	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 7	2016	529	7584					84	+		10.1038/nature16467	http://dx.doi.org/10.1038/nature16467			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6VY	26738594	Green Submitted			2022-12-28	WOS:000367944900031
J	Thomson, AR; Walter, MJ; Kohn, SC; Brooker, RA				Thomson, Andrew R.; Walter, Michael J.; Kohn, Simon C.; Brooker, Richard A.			Slab melting as a barrier to deep carbon subduction	NATURE			English	Article							EXPERIMENTAL CONSTRAINTS; QUARTZ SOLUBILITY; DIAMOND FORMATION; OCEANIC-CRUST; MANTLE; ECLOGITE; PRESSURE; SOLIDUS; ORIGIN; GPA	Interactions between crustal and mantle reservoirs dominate the surface inventory of volatile elements over geological time, moderating atmospheric composition and maintaining a life-supporting planet(1). While volcanoes expel volatile components into surface reservoirs, subduction of oceanic crust is responsible for replenishment of mantle reservoirs(2,3). Many natural, 'superdeep' diamonds originating in the deep upper mantle and transition zone host mineral inclusions, indicating an affinity to subducted oceanic crust(4-7). Here we show that the majority of slab geotherms will intersect a deep depression along the melting curve of carbonated oceanic crust at depths of approximately 300 to 700 kilometres, creating a barrier to direct carbonate recycling into the deep mantle. Low-degree partial melts are alkaline carbonatites that are highly reactive with reduced ambient mantle, producing diamond. Many inclusions in superdeep diamonds are best explained by carbonate melt-peridotite reaction. A deep carbon barrier may dominate the recycling of carbon in the mantle and contribute to chemical and isotopic heterogeneity of the mantle reservoir.	[Thomson, Andrew R.; Walter, Michael J.; Kohn, Simon C.; Brooker, Richard A.] Univ Bristol, Sch Earth Sci, Bristol BS8 1RJ, Avon, England; [Thomson, Andrew R.] UCL, Dept Earth Sci, Mortimer St, London WC1E 6BT, England	University of Bristol; University of London; University College London	Thomson, AR (corresponding author), Univ Bristol, Sch Earth Sci, Bristol BS8 1RJ, Avon, England.; Thomson, AR (corresponding author), UCL, Dept Earth Sci, Mortimer St, London WC1E 6BT, England.	a.r.thomson@ucl.ac.uk	Kohn, simon c/C-5150-2012; Thomson, Andrew R/A-4037-2015	Thomson, Andrew R/0000-0003-2392-3687; Kohn, Simon/0000-0001-6415-8518; Brooker, Richard/0000-0003-4931-9912	NERC [NE/J500033/1, NE/J008583/1]; Natural Environment Research Council [1108948, NE/M000419/1] Funding Source: researchfish; NERC [NE/M000419/1] Funding Source: UKRI	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	A.R.T. acknowledges the support of NERC grant NE/J500033/1. M.J.W. and S.C.K. acknowledge the support of NERC grant NE/J008583/1. We thank S. Kearns and B. Buse for their assistance performing electron probe microanalyses and J. Blundy for contributing ideas and expertise during discussions with the authors.	Ague JJ, 2014, NAT GEOSCI, V7, P355, DOI [10.1038/NGEO2143, 10.1038/ngeo2143]; Alt JC, 1999, GEOCHIM COSMOCHIM AC, V63, P1527, DOI 10.1016/S0016-7037(99)00123-4; Brey GP, 2004, LITHOS, V77, P655, DOI 10.1016/j.lithos.2004.03.013; Bulanova GP, 2010, CONTRIB MINERAL PETR, V160, P489, DOI 10.1007/s00410-010-0490-6; Connolly JAD, 2005, EARTH PLANET SC LETT, V236, P524, DOI 10.1016/j.epsl.2005.04.033; Coogan LA, 2015, EARTH PLANET SC LETT, V415, P38, DOI 10.1016/j.epsl.2015.01.027; Coogan LA, 2013, GEOCHEM GEOPHY GEOSY, V14, P1771, DOI 10.1002/ggge.20113; Dasgupta R, 2005, CONTRIB MINERAL PETR, V149, P288, DOI 10.1007/s00410-004-0649-0; Dasgupta R, 2004, EARTH PLANET SC LETT, V227, P73, DOI 10.1016/j.epsl.2004.08.004; Dasgupta R, 2010, EARTH PLANET SC LETT, V298, P1, DOI 10.1016/j.epsl.2010.06.039; Debret B, 2015, CONTRIB MINERAL PETR, V169, DOI 10.1007/s00410-015-1130-y; Gale A, 2013, GEOCHEM GEOPHY GEOSY, V14, P489, DOI 10.1029/2012GC004334; Gerbode C, 2010, J PETROL, V51, P2067, DOI 10.1093/petrology/egq049; Ghosh S, 2009, CHEM GEOL, V262, P17, DOI 10.1016/j.chemgeo.2008.12.030; Hammouda T, 2003, EARTH PLANET SC LETT, V214, P357, DOI 10.1016/S0012-821X(03)00361-3; Hammouda T, 2000, GEOLOGY, V28, P283, DOI 10.1130/0091-7613(2000)28<283:UMIBCM>2.0.CO;2; Harte B, 2010, MINERAL MAG, V74, P189, DOI 10.1180/minmag.2010.074.2.189; Hernlund J, 2006, AM MINERAL, V91, P295, DOI 10.2138/am.2006.1938; Ickert RB, 2015, GEOCHEM PERSPECT LET, V1, P65, DOI 10.7185/geochemlet.1507; Jackson MG, 2008, EARTH PLANET SC LETT, V276, P175, DOI 10.1016/j.epsl.2008.09.023; Kelley KA, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI 10.1029/2002GC000435; Kerrick DM, 2001, EARTH PLANET SC LETT, V189, P19, DOI 10.1016/S0012-821X(01)00347-8; Keshav S, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2009JB006457; Kessel R, 2005, NATURE, V437, P724, DOI 10.1038/nature03971; Kiseeva ES, 2013, GEOLOGY, V41, P883, DOI 10.1130/G34311.1; Kiseeva ES, 2013, J PETROL, V54, P1555, DOI 10.1093/petrology/egt023; Litasov K, 2010, EARTH PLANET SC LETT, V295, P115, DOI 10.1016/j.epsl.2010.03.030; Litasov KD, 2013, GEOLOGY, V41, P79, DOI 10.1130/G33488.1; Luth RW, 2001, CONTRIB MINERAL PETR, V141, P222, DOI 10.1007/s004100100238; Manning CE, 2004, EARTH PLANET SC LETT, V223, P1, DOI 10.1016/j.epsl.2004.04.030; Manning CE, 2014, NAT GEOSCI, V7, P333, DOI 10.1038/ngeo2152; Martin AM, 2012, J PETROL, V53, P391, DOI 10.1093/petrology/egr066; McDade P, 2002, MINERAL MAG, V66, P1021, DOI 10.1180/0026461026660074; Molina JF, 2000, EARTH PLANET SC LETT, V176, P295, DOI 10.1016/S0012-821X(00)00021-2; Nakamura K, 2004, GEOCHIM COSMOCHIM AC, V68, P4595, DOI 10.1016/j.gca.2004.05.023; Newton RC, 2002, GEOCHIM COSMOCHIM AC, V66, P4165, DOI 10.1016/S0016-7037(02)00998-5; Newton RC, 2000, GEOCHIM COSMOCHIM AC, V64, P2993, DOI 10.1016/S0016-7037(00)00402-6; Newton RC, 2008, EARTH PLANET SC LETT, V274, P241, DOI 10.1016/j.epsl.2008.07.028; Okamoto K, 2004, PHYS EARTH PLANET IN, V146, P283, DOI 10.1016/j.pepi.2003.07.029; Poli S, 2009, EARTH PLANET SC LETT, V278, P350, DOI 10.1016/j.epsl.2008.12.022; Rohrbach A, 2011, NATURE, V472, P209, DOI 10.1038/nature09899; Schilling F, 2004, EUR J MINERAL, V16, P7, DOI 10.1127/0935-1221/2004/0016-0007; Shcheka SS, 2006, EARTH PLANET SC LETT, V245, P730, DOI 10.1016/j.epsl.2006.03.036; Shilobreeva S, 2011, GEOCHIM COSMOCHIM AC, V75, P2237, DOI 10.1016/j.gca.2010.11.027; Stachel T, 2001, EUR J MINERAL, V13, P883, DOI 10.1127/0935-1221/2001/0013/0883; Stagno V, 2015, CONTRIB MINERAL PETR, V169, DOI 10.1007/s00410-015-1111-1; Stagno V, 2013, NATURE, V493, P84, DOI 10.1038/nature11679; Syracuse EM, 2010, PHYS EARTH PLANET IN, V183, P73, DOI 10.1016/j.pepi.2010.02.004; Teagle D.A.H, 2006, P IODP, V309/312; Thomson AR, 2014, CONTRIB MINERAL PETR, V168, DOI 10.1007/s00410-014-1081-8; Walter MJ, 2008, NATURE, V454, P622, DOI 10.1038/nature07132; Walter MJ, 1998, J PETROL, V39, P29, DOI 10.1093/petrology/39.1.29; Walter MJ, 2004, GEOCHIM COSMOCHIM AC, V68, P4267, DOI 10.1016/j.gca.2004.03.014; WALTER MJ, 1995, CAN J PHYS, V73, P273, DOI 10.1139/p95-039; Watson EB, 2002, CONTRIB MINERAL PETR, V142, P640, DOI 10.1007/s00410-001-0327-4; YAXLEY GM, 1994, EARTH PLANET SC LETT, V128, P313, DOI 10.1016/0012-821X(94)90153-8; Zahnle K, 2007, SPACE SCI REV, V129, P35, DOI 10.1007/s11214-007-9225-z; Zedgenizov DA, 2014, CHEM GEOL, V363, P114, DOI 10.1016/j.chemgeo.2013.10.033	59	273	289	18	238	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 7	2016	529	7584					76	+		10.1038/nature16174	http://dx.doi.org/10.1038/nature16174			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6VY	26738593	Green Accepted, Green Published			2022-12-28	WOS:000367944900029
J	Lurie, J; Tomkins-Lane, C				Lurie, Jon; Tomkins-Lane, Christy			Management of lumbar spinal stenosis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							LOW-BACK-PAIN; NEUROGENIC INTERMITTENT CLAUDICATION; RANDOMIZED CONTROLLED-TRIAL; EPIDURAL STEROID INJECTION; UNITED-STATES TRENDS; LONG-TERM OUTCOMES; WALKING CAPACITY; DEGENERATIVE SPONDYLOLISTHESIS; NONOPERATIVE TREATMENT; NONSURGICAL TREATMENT	Lumbar spinal stenosis (LSS) affects more than 200 000 adults in the United States, resulting in substantial pain and disability. It is the most common reason for spinal surgery in patients over 65 years. Lumbar spinal stenosis is a clinical syndrome of pain in the buttocks or lower extremities, with or without back pain. It is associated with reduced space available for the neural and vascular elements of the lumbar spine. The condition is often exacerbated by standing, walking, or lumbar extension and relieved by forward flexion, sitting, or recumbency. Clinical care and research into lumbar spinal stenosis is complicated by the heterogeneity of the condition, the lack of standard criteria for diagnosis and inclusion in studies, and high rates of anatomic stenosis on imaging studies in older people who are completely asymptomatic. The options for non-surgical management include drugs, physiotherapy, spinal injections, lifestyle modification, and multidisciplinary rehabilitation. However, few high quality randomized trials have looked at conservative management. A systematic review concluded that there is insufficient evidence to recommend any specific type of non-surgical treatment. Several different surgical procedures are used to treat patients who do not improve with non-operative therapies. Given that rapid deterioration is rare and that symptoms often wax and wane or gradually improve, surgery is almost always elective and considered only if sufficiently bothersome symptoms persist despite trials of less invasive interventions. Outcomes (leg pain and disability) seem to be better for surgery than for non-operative treatment, but the evidence is heterogeneous and often of limited quality.	[Lurie, Jon] Dartmouth Hitchock Med Ctr, Dartmouth Med Sch, Dept Med, Lebanon, NH 03766 USA; [Tomkins-Lane, Christy] Mt Royal Univ, Dept Hlth & Phys Educ, Calgary, AB, Canada	Dartmouth College; Mount Royal University	Lurie, J (corresponding author), Dartmouth Hitchock Med Ctr, Dartmouth Med Sch, Dept Med, Lebanon, NH 03766 USA.	jon.d.lurie@hitchcock.org			Multidisciplinary Clinical Research Center in Musculoskeletal Diseases at Dartmouth - NIAMS [P60-AR048094, P60-AR062799]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P60AR062799, P60AR048094] Funding Source: NIH RePORTER	Multidisciplinary Clinical Research Center in Musculoskeletal Diseases at Dartmouth - NIAMS; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We have read and understood BMJ policy on declaration of interests and declare the following interests: CTL: none; JDL: consulting for FzioMed and the Informed Medical Decisions Foundation and stock options from NewVert; FzioMed and NewVert produce products related to surgery for intervertebral disc herniation but not for spinal stenosis. This work was supported in part by the Multidisciplinary Clinical Research Center in Musculoskeletal Diseases at Dartmouth, funded by NIAMS (P60-AR048094 and P60-AR062799).	Aalto TJ, 2006, SPINE, V31, pE648, DOI 10.1097/01.brs.0000231727.88477.da; Abdu WA, 2009, SPINE, V34, P2351, DOI 10.1097/BRS.0b013e3181b8a829; Ammendolia C, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010712; Ammendolia C, 2012, SPINE, V37, pE609, DOI 10.1097/BRS.0b013e318240d57d; AMUNDSEN T, 1995, SPINE, V20, P1178, DOI 10.1097/00007632-199505150-00013; Amundsen T, 2000, SPINE, V25, P1424, DOI 10.1097/00007632-200006010-00016; Andreisek G, 2014, EUR RADIOL, V24, P3224, DOI 10.1007/s00330-014-3346-z; Andreisek G, 2013, AM J ROENTGENOL, V201, pW735, DOI 10.2214/AJR.12.10163; Andreisek G, 2011, RADIOLOGY, V261, P681, DOI 10.1148/radiol.11111086; Arbit E, 2001, CLIN ORTHOP RELAT R, P137; Atlas SJ, 2006, CLIN ORTHOP RELAT R, P198, DOI 10.1097/01.blo.0000198722.70138.96; Barz T, 2008, EUR SPINE J, V17, P686, DOI 10.1007/s00586-008-0593-1; Barz T, 2010, SPINE, V35, P892, DOI 10.1097/BRS.0b013e3181c7cf4b; Benoist M, 2002, JOINT BONE SPINE, V69, P450, DOI 10.1016/S1297-319X(02)00429-3; Binder DK, 2002, SEMIN NEUROL, V22, P157, DOI 10.1055/s-2002-36539; BODEN SD, 1990, J BONE JOINT SURG AM, V72A, P403, DOI 10.2106/00004623-199072030-00013; Brown LL, 2012, PAIN PRACT, V12, P333, DOI 10.1111/j.1533-2500.2011.00518.x; Cambron JA, 2014, J MANIP PHYSIOL THER, V37, P396, DOI 10.1016/j.jmpt.2014.05.005; Carragee EJ, 2010, JAMA-J AM MED ASSOC, V303, P1309, DOI 10.1001/jama.2010.402; Chad DA, 2007, NEUROL CLIN, V25, P407, DOI 10.1016/j.ncl.2007.01.003; Cheung JPY, 2014, SPINE, V39, P1067, DOI 10.1097/BRS.0000000000000335; Chou R, 2015, ANN INTERN MED, V163, P373, DOI 10.7326/M15-0934; Ciol MA, 1996, J AM GERIATR SOC, V44, P285, DOI 10.1111/j.1532-5415.1996.tb00915.x; CIRICILLO SF, 1993, WESTERN J MED, V158, P171; Conway J, 2011, SPINE J, V11, P816, DOI 10.1016/j.spinee.2010.10.019; Cook C, 2011, PHYSIOTHER RES INT, V16, P170, DOI 10.1002/pri.500; Coronado-Zarco Roberto, 2009, Spine (Phila Pa 1976), V34, pE818, DOI 10.1097/BRS.0b013e3181afe60a; Dartmouth Institute, 2014, VAR CAR SURG COND SP; de Graaf I, 2006, SPINE, V31, P1168, DOI 10.1097/01.brs.0000216463.32136.7b; de Schepper EIT, 2013, SPINE, V38, pE469, DOI 10.1097/BRS.0b013e31828935ac; Deen HG, 1998, SPINE, V23, P244, DOI 10.1097/00007632-199801150-00019; DEEN HG, 1995, J NEUROSURG, V83, P27, DOI 10.3171/jns.1995.83.1.0027; Deer TR, 2010, PAIN PHYSICIAN, V13, P35; Delitto A, 2015, ANN INTERN MED, V162, P465, DOI 10.7326/M14-1420; Deyo RA, 2005, SPINE, V30, P1441, DOI 10.1097/01.brs.0000166503.37969.8a; Deyo RA, 2013, SPINE, V38, P865, DOI 10.1097/BRS.0b013e31828631b8; Deyo RA, 2010, SPINE J, V10, P625, DOI 10.1016/j.spinee.2010.05.006; Deyo RA, 2010, JAMA-J AM MED ASSOC, V303, P1259, DOI 10.1001/jama.2010.338; ECRI Health Technology Assessment Group, 2001, TREATM DEG LUMB SPIN; Eismont FJ, 2014, J AM ACAD ORTHOP SUR, V22, P203, DOI 10.5435/JAAOS-22-04-203; EVANS JG, 1964, BMJ-BRIT MED J, V2, P985, DOI 10.1136/bmj.2.5415.985; Fischgrund JS, 1997, SPINE, V22, P2807, DOI 10.1097/00007632-199712150-00003; Friedly JL, 2014, NEW ENGL J MED, V371, P11, DOI 10.1056/NEJMoa1313265; Fritz JM, 1998, ARCH PHYS MED REHAB, V79, P700, DOI 10.1016/S0003-9993(98)90048-X; Fritz JM, 2014, SPINE J, V14, P1611, DOI 10.1016/j.spinee.2013.09.044; Frymoyer, 1994, J Am Acad Orthop Surg, V2, P9; Geisser ME, 2007, CLIN J PAIN, V23, P780, DOI 10.1097/AJP.0b013e31815349bf; Genevay S, 2010, SPINE, V35, P803, DOI 10.1097/BRS.0b013e3181bc9454; Genevay S, 2010, BEST PRACT RES CL RH, V24, P253, DOI 10.1016/j.berh.2009.11.001; Haig AJ, 2006, ARCH PHYS MED REHAB, V87, P897, DOI 10.1016/j.apmr.2006.03.016; Haig AJ, 2005, SPINE, V30, P2667, DOI 10.1097/01.brs.0000188400.11490.5f; Haig AJ, 2006, SPINE, V31, P2950, DOI 10.1097/01.brs.0000247791.97032.1e; Haig AJ, 2010, JAMA-J AM MED ASSOC, V303, P71, DOI 10.1001/jama.2009.1946; Haskins R, 2015, J ORTHOP SPORT PHYS, V45, P61, DOI 10.2519/jospt.2015.5723; HERKOWITZ HN, 1991, J BONE JOINT SURG AM, V73A, P802, DOI 10.2106/00004623-199173060-00002; Herno A, 1999, SPINE, V24, P1010, DOI 10.1097/00007632-199905150-00015; HERNO A, 1994, SPINE, V19, P1975, DOI 10.1097/00007632-199409000-00019; Hong PW, 2015, J INVEST SURG, V28, P40, DOI 10.3109/08941939.2014.932474; Hurri H, 1998, J SPINAL DISORD, V11, P110; Iverson MD, 2001, PHYS THER, V81, P1296, DOI 10.1093/ptj/81.7.1296; Jacobs WCH, 2013, BEST PRACT RES CL RH, V27, P673, DOI 10.1016/j.berh.2013.09.009; JENSEN OH, 1989, CLIN RHEUMATOL, V8, P363, DOI 10.1007/BF02030349; JOHNSSON KE, 1987, SPINE, V12, P483, DOI 10.1097/00007632-198706000-00012; JOHNSSON KE, 1992, CLIN ORTHOP RELAT R, P82; Kainer Marion, 2012, Morbidity and Mortality Weekly Report, V61, P839; Kalff Rolf, 2013, Dtsch Arztebl Int, V110, P613, DOI 10.3238/arztebl.2013.0613; Kalichman L, 2008, EUR SPINE J, V17, P327, DOI 10.1007/s00586-007-0543-3; Kalichman L, 2009, SPINE J, V9, P545, DOI 10.1016/j.spinee.2009.03.005; Kato Y, 2009, J ORTHOP SCI, V14, P711, DOI 10.1007/s00776-009-1391-2; Katz JN, 2008, NEW ENGL J MED, V358, P818, DOI 10.1056/NEJMcp0708097; KATZ JN, 1995, ARTHRITIS RHEUM, V38, P1236, DOI 10.1002/art.1780380910; Kim KH, 2013, COMPLEMENT THER MED, V21, P535, DOI 10.1016/j.ctim.2013.08.007; Kim YS, 2009, ASIAN SPINE J, V3, P10, DOI 10.4184/asj.2009.3.1.10; Konno S, 2007, EUR SPINE J, V16, P1951, DOI 10.1007/s00586-007-0402-2; Kornblum MB, 2004, SPINE, V29, P726, DOI 10.1097/01.BRS.0000119398.22620.92; Kreiner DS, 2014, PAIN MED, V15, P196, DOI 10.1111/pme.12305; Kreiner DS, 2013, SPINE J, V13, P734, DOI 10.1016/j.spinee.2012.11.059; Kuittinen P, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-247; LEE CK, 1988, SPINE, V13, P313, DOI 10.1097/00007632-198803000-00015; Lee S, 2010, AM J ROENTGENOL, V194, P1095, DOI 10.2214/AJR.09.2772; Lin SI, 2005, J ORTHOP SPORT PHYS, V35, P220, DOI 10.2519/jospt.2005.35.4.220; Lindsey DP, 2003, SPINE, V28, P2192, DOI 10.1097/01.BRS.0000084877.88192.8E; Liu K, 2015, DRUG DES DEV THER, V9, P707, DOI [10.2147/DDDT.S80948, 10.2147/DDDT.S78070]; Lohman CM, 2006, SPINE, V31, P1834, DOI 10.1097/01.brs.0000227370.65573.ac; Lonne G, 2015, SPINE; Lurie JD, 2008, SPINE, V33, P1605, DOI 10.1097/BRS.0b013e3181791af3; Lurie JD, 2015, SPINE, V40, P63, DOI 10.1097/BRS.0000000000000731; Macedo LG, 2013, PHYS THER, V93, P1646, DOI 10.2522/ptj.20120379; Malmivaara A, 2007, SPINE, V32, P1, DOI 10.1097/01.brs.0000251014.81875.6d; Mamisch N, 2012, RADIOLOGY, V264, P174, DOI 10.1148/radiol.12111930; Manchikanti L, 2015, KOREAN J PAIN, V28, P11, DOI 10.3344/kjp.2015.28.1.11; Mannion AF, 2014, EUR SPINE J, V23, P1903, DOI 10.1007/s00586-014-3284-0; McGregor AH, 2014, SPINE, V39, P1044, DOI 10.1097/BRS.0000000000000355; Minamide A, 2013, J ORTHOP SCI, V18, P693, DOI 10.1007/s00776-013-0435-9; Moojen WA, 2013, BMJ-BRIT MED J, V347, pf6415; Moses RA, 2015, SPINE, V40, P129, DOI 10.1097/BRS.0000000000000672; Nadeau M, 2013, CAN J SURG, V56, P372, DOI 10.1503/cjs.016512; Nagai K, 2014, J SPINAL DISORD TECH, V27, pE136, DOI 10.1097/BSD.0b013e3182a2656b; OOI Y, 1990, SPINE, V15, P544, DOI 10.1097/00007632-199006000-00021; Overdevest GM, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010036.pub2; Pearson A, 2012, SPINE, V37, P1791, DOI 10.1097/BRS.0b013e3182634b04; Pearson A, 2011, SPINE, V36, P219, DOI 10.1097/BRS.0b013e3181d77c21; Pearson A, 2010, SPINE, V35, P298, DOI 10.1097/BRS.0b013e3181bdafd1; Pearson AM, 2013, SPINE, V38, P1799, DOI 10.1097/BRS.0b013e3182a314d0; Peng K, 2015, INT J CLIN EXP MED, V8, P2536; PENNING L, 1992, CLIN BIOMECH, V7, P3, DOI 10.1016/0268-0033(92)90002-L; Phelan EA, 2001, SPINE, V26, P206, DOI 10.1097/00007632-200101150-00016; Podichetty VK, 2004, SPINE, V29, P2343, DOI 10.1097/01.brs.0000143807.78082.7f; PORTER RW, 1992, SPINE, V17, P9, DOI 10.1097/00007632-199201000-00002; Porter RW, 1996, SPINE, V21, P2046, DOI 10.1097/00007632-199609010-00024; Resnick DK, 2014, J NEUROSURG-SPINE, V21, P62, DOI 10.3171/2014.4.SPINE14275; Richards JC, 2005, SPINE, V30, P744, DOI 10.1097/01.brs.0000157483.28505.e3; Sandella DE, 2013, PM&R, V5, P491, DOI 10.1016/j.pmrj.2012.10.001; Schizas C, 2013, SPINE, V38, P2113, DOI 10.1097/01.brs.0000435031.96058.f6; Schizas C, 2010, SPINE, V35, P1919, DOI 10.1097/BRS.0b013e3181d359bd; Schneider M, 2014, CHIROPR MAN THER, V22, DOI 10.1186/2045-709X-22-19; Scholten RJ, 2000, COCHRANE DB SYST REV, V2; SCHONSTROM N, 1989, J ORTHOPAED RES, V7, P115, DOI 10.1002/jor.1100070116; Sengupta DK, 2003, ORTHOP CLIN N AM, V34, P281, DOI 10.1016/S0030-5898(02)00069-X; Slatis P, 2011, EUR SPINE J, V20, P1174, DOI 10.1007/s00586-010-1652-y; Steurer J, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-175; Stromqvist BH, 2013, SPINE, V38, P1436, DOI 10.1097/BRS.0b013e31828ba413; Stuber K, 2009, J CHIROPR MED, V8, P77, DOI 10.1016/j.jcm.2009.02.001; Sugioka T, 2008, FAM PRACT, V25, P237, DOI 10.1093/fampra/cmn031; Suri P, 2010, JAMA-J AM MED ASSOC, V304, P2628, DOI 10.1001/jama.2010.1833; Szpalski M, 2003, EUR SPINE J, V12, pS170, DOI 10.1007/s00586-003-0612-1; Takahashi N, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-259; Tenhula J, 2000, J SPINAL DISORD, V13, P276, DOI 10.1097/00002517-200008000-00002; Tomkins CC, 2010, J BACK MUSCULOSKELET, V23, P31, DOI 10.3233/BMR-2010-0245; Tomkins CC, 2009, SPINE, V34, P2444, DOI 10.1097/BRS.0b013e3181b03fc8; Tomkins-Lane CC, 2014, SPINE J; Tomkins-Lane CC, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-322; Tomkins-Lane CC, 2013, SPINE, V38, pE1554, DOI 10.1097/BRS.0b013e3182a8c2da; Tomkins-Lane CC, 2013, J BACK MUSCULOSKELET, V26, P345, DOI 10.3233/BMR-130390; Tomkins-Lane CC, 2012, ARCH PHYS MED REHAB, V93, P2008, DOI 10.1016/j.apmr.2012.05.014; Tomkins-Lane CC, 2012, J BACK MUSCULOSKELET, V25, P177, DOI 10.3233/BMR-2012-0325; Tomkins-Lane CC, 2012, ARCH PHYS MED REHAB, V93, P647, DOI 10.1016/j.apmr.2011.09.023; VERBIEST H, 1954, J BONE JOINT SURG BR, V36, P230, DOI 10.1302/0301-620X.36B2.230; Wang GH, 2015, EUR SPINE J, V24, P1792, DOI 10.1007/s00586-015-3942-x; Wassenaar M, 2012, EUR SPINE J, V21, P220, DOI 10.1007/s00586-011-2019-8; WATANABE R, 1986, J NEUROSURG, V64, P64, DOI 10.3171/jns.1986.64.1.0064; Watters WC, 2008, SPINE J, V8, P305, DOI 10.1016/j.spinee.2007.10.033; Weinstein JN, 2008, NEW ENGL J MED, V358, P794, DOI 10.1056/NEJMoa0707136; Weinstein JN, 2007, NEW ENGL J MED, V356, P2257, DOI 10.1056/NEJMoa070302; Weinstein JN, 2006, SPINE, V31, P2707, DOI 10.1097/01.brs.0000248132.15231.fe; Weinstein JN, 2010, SPINE, V35, P1329, DOI 10.1097/BRS.0b013e3181e0f04d; Weinstein JN, 2009, J BONE JOINT SURG AM, V91A, P1295, DOI 10.2106/JBJS.H.00913; Whitehurst M, 2001, ARCH PHYS MED REHAB, V82, P464, DOI 10.1053/apmr.2001.20828; Wu AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097142; Yagci I, 2009, AM J PHYS MED REHAB, V88, P843, DOI 10.1097/PHM.0b013e3181b333a9; Yoshihara H, 2015, PAIN PRACT; Zaina F, COCHRANE DA IN PRESS; Zucherman JF, 2005, SPINE, V30, P1351, DOI 10.1097/01.brs.0000166618.42749.d1; Zucherman JF, 2004, EUR SPINE J, V13, P22, DOI 10.1007/s00586-003-0581-4	154	189	203	2	69	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 4	2016	352								h6234	10.1136/bmj.h6234	http://dx.doi.org/10.1136/bmj.h6234			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DA8LR	26727925	Green Published			2022-12-28	WOS:000368056800008
J	Goodell, MA; Rando, TA				Goodell, Margaret A.; Rando, Thomas A.			Stem cells and healthy aging	SCIENCE			English	Review							LIFE-SPAN; CLONAL HEMATOPOIESIS; COGNITIVE FUNCTION; SOMATIC MUTATIONS; CANCER-RISK; AGE; YOUNG; FATE; REJUVENATION; HOMEOSTASIS	Research into stem cells and aging aims to understand how stem cells maintain tissue health, what mechanisms ultimately lead to decline in stem cell function with age, and how the regenerative capacity of somatic stem cells can be enhanced to promote healthy aging. Here, we explore the effects of aging on stem cells in different tissues. Recent research has focused on the ways that genetic mutations, epigenetic changes, and the extrinsic environmental milieu influence stem cell functionality over time. We describe each of these three factors, the ways in which they interact, and how these interactions decrease stem cell health over time. We are optimistic that a better understanding of these changes will uncover potential strategies to enhance stem cell function and increase tissue resiliency into old age.	[Goodell, Margaret A.] Baylor Coll Med, Ctr Cell & Gene Therapy, Stem Cells & Regenerat Med Ctr, Houston, TX 77030 USA; [Goodell, Margaret A.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Rando, Thomas A.] Stanford Univ, Sch Med, Glenn Ctr Biol Aging, Stanford, CA 94305 USA; [Rando, Thomas A.] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Rando, Thomas A.] Vet Adm Palo Alto Hlth Care Syst, Ctr Regenerat Rehabil, Palo Alto, CA 94304 USA	Baylor College of Medicine; Baylor College of Medicine; Stanford University; Stanford University	Goodell, MA (corresponding author), Baylor Coll Med, Ctr Cell & Gene Therapy, Stem Cells & Regenerat Med Ctr, Houston, TX 77030 USA.	goodell@bcm.edu; rando@stanford.edu		Goodell, Margaret A./0000-0003-1111-2932; Rando, Thomas/0000-0001-5843-8564	NATIONAL CANCER INSTITUTE [R01CA183252] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR062185] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK092883] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG023806, R01AG047820, P01AG036695] Funding Source: NIH RePORTER; Veterans Affairs [I01RX001222] Funding Source: NIH RePORTER; VA [5I01RX001222-03] Funding Source: Federal RePORTER; NCI NIH HHS [R01 CA183252] Funding Source: Medline; NIAMS NIH HHS [R01 AR062185] Funding Source: Medline; NIA NIH HHS [P01 AG036695, R01 AG047820, R37 AG023806] Funding Source: Medline; NIDDK NIH HHS [R01 DK092883] Funding Source: Medline; RRD VA [I01 RX001222] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Veterans Affairs(US Department of Veterans Affairs); VA(US Department of Veterans Affairs); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); RRD VA		Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Beerman I, 2013, CELL STEM CELL, V12, P413, DOI 10.1016/j.stem.2013.01.017; Behjati S, 2014, NATURE, V513, P422, DOI 10.1038/nature13448; Biteau B, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001159; Bonnefond A, 2013, NAT GENET, V45, P1040, DOI 10.1038/ng.2700; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Catlin SN, 2011, BLOOD, V117, P4460, DOI 10.1182/blood-2010-08-303537; Challen GA, 2012, NAT GENET, V44, P23, DOI 10.1038/ng.1009; Chen KF, 2015, NAT GENET, V47, P1149, DOI 10.1038/ng.3385; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Conboy IM, 2012, CELL CYCLE, V11, P2260, DOI 10.4161/cc.20437; Dumble M, 2007, BLOOD, V109, P1736, DOI 10.1182/blood-2006-03-010413; Egerman MA, 2015, CELL METAB, V22, P164, DOI 10.1016/j.cmet.2015.05.010; Elabd C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5082; Ergen AV, 2012, BLOOD, V119, P2500, DOI 10.1182/blood-2011-11-391730; Feser J, 2010, MOL CELL, V39, P724, DOI 10.1016/j.molcel.2010.08.015; Franceschi C, 2007, MECH AGEING DEV, V128, P92, DOI 10.1016/j.mad.2006.11.016; Genovese G, 2014, NEW ENGL J MED, V371, P2477, DOI 10.1056/NEJMoa1409405; Greer EL, 2010, NATURE, V466, P383, DOI 10.1038/nature09195; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Jaiswal S, 2014, NEW ENGL J MED, V371, P2488, DOI 10.1056/NEJMoa1408617; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Kirkwood TBL, 2005, CELL, V120, P437, DOI 10.1016/j.cell.2005.01.027; Klein AM, 2011, DEVELOPMENT, V138, P3103, DOI 10.1242/dev.060103; Ko M, 2011, P NATL ACAD SCI USA, V108, P14566, DOI 10.1073/pnas.1112317108; Liu L, 2013, CELL REP, V4, P189, DOI 10.1016/j.celrep.2013.05.043; Liu L, 2011, J CELL BIOL, V193, P257, DOI 10.1083/jcb.201010131; Liu Y, 2009, CELL STEM CELL, V4, P37, DOI 10.1016/j.stem.2008.11.006; Lopez-Garcia C, 2010, SCIENCE, V330, P822, DOI 10.1126/science.1196236; Maegawa S, 2010, GENOME RES, V20, P332, DOI 10.1101/gr.096826.109; Martincorena I, 2015, SCIENCE, V348, P880, DOI 10.1126/science.aaa6806; McKerrell T, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac4428; McKerrell T, 2015, CELL REP, V10, P1239, DOI 10.1016/j.celrep.2015.02.005; Moran-Crusio K, 2011, CANCER CELL, V20, P11, DOI 10.1016/j.ccr.2011.06.001; Naito AT, 2012, CELL, V149, P1298, DOI 10.1016/j.cell.2012.03.047; Quivoron C, 2011, CANCER CELL, V20, P25, DOI 10.1016/j.ccr.2011.06.003; Rando TA, 2012, CELL, V148, P46, DOI 10.1016/j.cell.2012.01.003; Rozhok AI, 2015, P NATL ACAD SCI USA, V112, P8914, DOI 10.1073/pnas.1501713112; Sen P, 2015, GENE DEV, V29, P1362, DOI 10.1101/gad.263707.115; Sinha M, 2014, SCIENCE, V344, P649, DOI 10.1126/science.1251152; Smith LK, 2015, NAT MED, V21, P932, DOI 10.1038/nm.3898; Snippert HJ, 2014, EMBO REP, V15, P62, DOI 10.1002/embr.201337799; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Sun DQ, 2014, CELL STEM CELL, V14, P673, DOI 10.1016/j.stem.2014.03.002; Tomasetti C, 2015, SCIENCE, V347, P78, DOI 10.1126/science.1260825; Vermeulen L, 2013, SCIENCE, V342, P995, DOI 10.1126/science.1243148; Villeda SA, 2014, NAT MED, V20, P659, DOI 10.1038/nm.3569; Villeda SA, 2011, NATURE, V477, P90, DOI 10.1038/nature10357; Welch JS, 2012, CELL, V150, P264, DOI 10.1016/j.cell.2012.06.023; Wright S, 1929, AM NAT, V63, P556, DOI 10.1086/280290; WRIGHT SEWALL, 1932, PROC SIXTH INTERNAT CONGR GENETICS ITHACA NEW YORK, V1, P356; Xie MC, 2014, NAT MED, V20, P1472, DOI 10.1038/nm.3733; Zhang WQ, 2015, SCIENCE, V348, P1160, DOI 10.1126/science.aaa1356	53	170	178	7	114	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 4	2015	350	6265					1199	1204		10.1126/science.aab3388	http://dx.doi.org/10.1126/science.aab3388			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX4WG	26785478				2022-12-28	WOS:000365700500063
J	Riedinger, R; Hong, S; Norte, RA; Slater, JA; Shang, JY; Krause, AG; Anant, V; Aspelmeyer, M; Groblacher, S				Riedinger, Ralf; Hong, Sungkun; Norte, Richard A.; Slater, Joshua A.; Shang, Juying; Krause, Alexander G.; Anant, Vikas; Aspelmeyer, Markus; Groblacher, Simon			Non-classical correlations between single photons and phonons from a mechanical oscillator	NATURE			English	Article							QUANTUM GROUND-STATE; ATOMIC ENSEMBLES; LINEAR OPTICS; RESONATOR; MICROWAVE; MOTION; COMMUNICATION; GENERATION; CONVERSION; MEMORY	Interfacing a single photon with another quantum system is a key capability in modern quantum information science. It allows quantum states of matter, such as spin states of atoms(1,2), atomic ensembles(3,4) or solids(5), to be prepared and manipulated by photon counting and, in particular, to be distributed over long distances. Such light-matter interfaces have become crucial to fundamental tests of quantum physics(6) and realizations of quantum networks(7). Here we report non-classical correlations between single photons and phonons-the quanta of mechanical motionfrom a nanomechanical resonator. We implement a full quantum protocol involving initialization of the resonator in its quantum ground state of motion and subsequent generation and read-out of correlated photon-phonon pairs. The observed violation of a Cauchy-Schwarz inequality is clear evidence for the non-classical nature of the mechanical state generated. Our results demonstrate the availability of on-chip solid-state mechanical resonators as light-matter quantum interfaces. The performance we achieved will enable studies of macroscopic quantum phenomena(8) as well as applications in quantum communication(9), as quantum memories(10) and as quantum transducers(11,12).	[Riedinger, Ralf; Hong, Sungkun; Slater, Joshua A.; Aspelmeyer, Markus] Univ Vienna, Fac Phys, Vienna Ctr Quantum Sci & Technol VCQ, Waehringer Guertel 18, A-1090 Vienna, Austria; [Norte, Richard A.; Krause, Alexander G.; Groblacher, Simon] Delft Univ Technol, Kavli Inst Nanosci, NL-2628 CJ Delft, Netherlands; [Shang, Juying; Anant, Vikas] Photon Spot Inc, Monrovia, CA 91016 USA	University of Vienna; Delft University of Technology	Aspelmeyer, M (corresponding author), Univ Vienna, Fac Phys, Vienna Ctr Quantum Sci & Technol VCQ, Waehringer Guertel 18, A-1090 Vienna, Austria.; Groblacher, S (corresponding author), Delft Univ Technol, Kavli Inst Nanosci, NL-2628 CJ Delft, Netherlands.	markus.aspelmeyer@univie.ac.at; s.groeblacher@tudelft.nl	Riedinger, Ralf/AAJ-5952-2020; Hong, Sungkun/D-3282-2014; Groeblacher, Simon/O-2455-2014; Aspelmeyer, Markus/C-4098-2017; Slater, Joshua A/F-2523-2011	Riedinger, Ralf/0000-0002-0187-2332; Hong, Sungkun/0000-0003-0985-6641; Groeblacher, Simon/0000-0003-3932-7820; Aspelmeyer, Markus/0000-0003-4499-7335; Shang, Ju Ying/0000-0002-6683-5452	Austrian Science Fund (FWF) [P 28172] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF))		Akram U, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/8/083030; Andrews RW, 2014, NAT PHYS, V10, P321, DOI [10.1038/nphys2911, 10.1038/NPHYS2911]; Aspelmeyer M, 2014, REV MOD PHYS, V86, P1391, DOI 10.1103/RevModPhys.86.1391; Bagci T, 2014, NATURE, V507, P81, DOI 10.1038/nature13029; Barzanjeh S, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.130503; Bochmann J, 2013, NAT PHYS, V9, P712, DOI [10.1038/NPHYS2748, 10.1038/nphys2748]; Cabrillo C, 1999, PHYS REV A, V59, P1025, DOI 10.1103/PhysRevA.59.1025; Chan J, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4747726; Chan J, 2011, NATURE, V478, P89, DOI 10.1038/nature10461; Chang DE, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/2/023003; CLAUSER JF, 1974, PHYS REV D, V9, P853, DOI 10.1103/PhysRevD.9.853; Cohen JD, 2015, NATURE, V520, P522, DOI 10.1038/nature14349; Duan LM, 2001, NATURE, V414, P413, DOI 10.1038/35106500; Fiore V, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.133601; Fortsch M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2838; Galland C, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.143602; Hensen B, 2015, NATURE, V526, P682, DOI 10.1038/nature15759; Hofer SG, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.052327; Kimble HJ, 2008, NATURE, V453, P1023, DOI 10.1038/nature07127; Kuzmich A, 2003, NATURE, V423, P731, DOI 10.1038/nature01714; Lee KC, 2011, SCIENCE, V334, P1253, DOI 10.1126/science.1211914; Mandel L, 1995, OPTICAL COHERENCE QU; Meenehan SM, 2015, PHYS REV X, V5, DOI 10.1103/PhysRevX.5.041002; Meenehan SM, 2014, PHYS REV A, V90, DOI 10.1103/PhysRevA.90.011803; Natarajan CM, 2012, SUPERCOND SCI TECH, V25, DOI 10.1088/0953-2048/25/6/063001; O'Connell AD, 2010, NATURE, V464, P697, DOI 10.1038/nature08967; Palomaki TA, 2013, SCIENCE, V342, P710, DOI 10.1126/science.1244563; Poot M, 2012, PHYS REP, V511, P273, DOI 10.1016/j.physrep.2011.12.004; Romero-Isart O, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.052121; Safavi-Naeini AH, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/1/013017; Safavi-Naeini AH, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3507288; Sangouard N, 2011, REV MOD PHYS, V83, P33, DOI 10.1103/RevModPhys.83.33; Stannigel K, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.220501; Stute A, 2013, NAT PHOTONICS, V7, P219, DOI [10.1038/nphoton.2012.358, 10.1038/NPHOTON.2012.358]; Teufel JD, 2011, NATURE, V475, P359, DOI 10.1038/nature10261; van der Wal CH, 2003, SCIENCE, V301, P196, DOI 10.1126/science.1085946; Vanner MR, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.010504; Verhagen E, 2012, NATURE, V482, P63, DOI 10.1038/nature10787; Wallquist M, 2009, PHYS SCRIPTA, VT137, DOI 10.1088/0031-8949/2009/T137/014001; Wilk T, 2007, SCIENCE, V317, P488, DOI 10.1126/science.1143835; Wollman EE, 2015, SCIENCE, V349, P952, DOI 10.1126/science.aac5138; WU LA, 1986, PHYS REV LETT, V57, P2520, DOI 10.1103/PhysRevLett.57.2520; Yilmaz ST, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.033601; Zhao B, 2009, NAT PHYS, V5, P95, DOI 10.1038/NPHYS1153; ZOLLER P, 2004, QUANTUM ENTANGLEMENT	45	272	277	6	108	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 18	2016	530	7590					313	+		10.1038/nature16536	http://dx.doi.org/10.1038/nature16536			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DE0PP	26779950	Green Submitted, Green Accepted			2022-12-28	WOS:000370327100032
J	DeSalvo, KB; Olson, R; Casavale, KO				DeSalvo, Karen B.; Olson, Richard; Casavale, Kellie O.			Dietary Guidelines for Americans	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[DeSalvo, Karen B.; Olson, Richard; Casavale, Kellie O.] US Dept HHS, Washington, DC 20201 USA		DeSalvo, KB (corresponding author), US Dept HHS, Off Assistant Secretary Hlth, 200 Independence Ave SW, Washington, DC 20201 USA.	karen.desalvo@hhs.gov						Dietary Guidelines Advisory Committee to the US Department of Health and Human Services and the US Department of Agriculture, 2015, SCI REP 2015 DIET D; Institute of Medicine, 2013, SOD INT POP ASS EV; Institute of Medicine-IOM, 2008, DIETARY REFERENCE IN; Schwingshackl L, 2015, J ACAD NUTR DIET, V115, P780, DOI 10.1016/j.jand.2014.12.009; U.S. Department of Health and Human Services, 2008, ODPHP PUBL; US Department of Health and Human Services; US Department of Agriculture, 2015, 2015 2020 DIET GUID; Wang DD, 2015, HEALTH AFFAIR, V34, P1916, DOI 10.1377/hlthaff.2015.0640	7	191	195	1	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 2	2016	315	5					457	458		10.1001/jama.2015.18396	http://dx.doi.org/10.1001/jama.2015.18396			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DC2LZ	26746707	Bronze			2022-12-28	WOS:000369049500010
J	Lewis, NS				Lewis, Nathan S.			Research opportunities to advance solar energy utilization	SCIENCE			English	Review							25TH ANNIVERSARY ARTICLE; LITHIUM-ION BATTERY; HYDROGEN-PRODUCTION; WATER OXIDATION; PERFORMANCE; EFFICIENCY; GENERATION; CATALYST; PHOTOANODES; CONVERSION		[Lewis, Nathan S.] CALTECH, Beckman Inst, Div Chem & Chem Engn, Noyes Lab 210, Pasadena, CA 91125 USA; [Lewis, Nathan S.] CALTECH, Kavli Nanosci Inst, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology	Lewis, NS (corresponding author), CALTECH, Beckman Inst, Div Chem & Chem Engn, Noyes Lab 210, Pasadena, CA 91125 USA.	nslewis@caltech.edu			NSF [CHE-1214152]; DOE Office of Science through the Joint Center for Artificial Photosynthesis [DE-SC0004993]; DOE Office of Science [DE-FG02-03ER15483]; Gordon and Betty Moore Foundation [1225]; Division Of Chemistry [1214152] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); DOE Office of Science through the Joint Center for Artificial Photosynthesis; DOE Office of Science(United States Department of Energy (DOE)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Division Of Chemistry(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We acknowledge the NSF, CHE-1214152; the DOE Office of Science through the Joint Center for Artificial Photosynthesis, grant DE-SC0004993; and the DOE Office of Science, grant DE-FG02-03ER15483; and the Gordon and Betty Moore Foundation, grant 1225; for support that enabled the preparation of this Review, and M. Shaner for assistance in the preparation of this manuscript.	Abanades S, 2006, SOL ENERGY, V80, P1611, DOI 10.1016/j.solener.2005.12.005; Abdi FF, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3195; AHARONSHALOM E, 1982, J ELECTROCHEM SOC, V129, P2865, DOI 10.1149/1.2123695; Akhil A. A., 2013, DOE EPRI 2013 ELECT; Alias N, 2015, J POWER SOURCES, V274, P237, DOI 10.1016/j.jpowsour.2014.10.009; America's Energy Future Panel on Electricity from Renewable Resources, 2010, ELECTRICITY FROM REN; American Physical Society Panel on Public Affairs, 2011, DIRECT AIR CAPTURE C; Arriaga LG, 2007, INT J HYDROGEN ENERG, V32, P2247, DOI 10.1016/j.ijhydene.2006.10.067; Augsburger G., 2013, THERMO ECONOMIC OPTI; Ayers K., 2014, PROTON ENERGY SYSTEM; Barre A, 2013, J POWER SOURCES, V241, P680, DOI 10.1016/j.jpowsour.2013.05.040; Benson EE, 2009, CHEM SOC REV, V38, P89, DOI 10.1039/b804323j; BHUSHAN M, 1981, APPL PHYS LETT, V38, P39, DOI 10.1063/1.92124; Bockris J. O. M., 1981, ELECTROCHEMICAL PROC, V2; BOCKRIS JO, 1985, INT J HYDROGEN ENERG, V10, P179, DOI 10.1016/0360-3199(85)90025-4; Boicea VA, 2014, P IEEE, V102, P1777, DOI 10.1109/JPROC.2014.2359545; Calhoun K., 2014, LESSONS FROM AUSTRAL; California Council on Science and Technology, 2011, CALIFORNIAS ENERGY F; California Energy Commission, 2012, RECYCLING OF CDTE TH; Callejas JF, 2014, ACS NANO, V8, P11101, DOI 10.1021/nn5048553; Candelise C, 2012, PROG PHOTOVOLTAICS, V20, P816, DOI 10.1002/pip.2216; Cox CR, 2014, P NATL ACAD SCI USA, V111, P14057, DOI 10.1073/pnas.1414290111; Dillich S., 2012, HYDROGEN PRODUCTION; DOE, 2012, SUNSHOT VISION STUDY; DOE, 2014, FY 2014 PROGRESS REP; Dou LT, 2013, ADV MATER, V25, P6642, DOI 10.1002/adma.201302563; Energy Information Association, 2015, ELECT POWER MONTHLY; Feldberg N, 2012, 2012 38TH IEEE PHOTOVOLTAIC SPECIALISTS CONFERENCE (PVSC), P2524, DOI 10.1109/PVSC.2012.6318108; Fraunhofer ISE (Fraunhofer Institute for Solar Energy Systems), 2014, PHOTOVOLTAICS REPORT; Gerken JB, 2011, J AM CHEM SOC, V133, P14431, DOI 10.1021/ja205647m; Ghasemi H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5449; Goodrich A, 2012, RESIDENTIAL COMMERCI; Goodrich A, 2013, SOL ENERG MAT SOL C, V114, P110, DOI 10.1016/j.solmat.2013.01.030; Green MA, 2015, PROG PHOTOVOLTAICS, V23, P805, DOI 10.1002/pip.2637; Green MA, 2015, PROG PHOTOVOLTAICS, V23, P1, DOI 10.1002/pip.2573; Green MA, 2014, NAT PHOTONICS, V8, P506, DOI [10.1038/nphoton.2014.134, 10.1038/NPHOTON.2014.134]; Green MA, 2012, PROG PHOTOVOLTAICS, V20, P606, DOI 10.1002/pip.2267; Gunther Ma, 2015, CHEM WORLD; Gust D, 2001, ACCOUNTS CHEM RES, V34, P40, DOI 10.1021/ar9801301; Hagfeldt A, 2010, CHEM REV, V110, P6595, DOI 10.1021/cr900356p; Haussener S, 2012, ENERG ENVIRON SCI, V5, P9922, DOI 10.1039/c2ee23187e; Heeger AJ, 2014, ADV MATER, V26, P10, DOI 10.1002/adma.201304373; Heeger AJ, 2010, CHEM SOC REV, V39, P2354, DOI 10.1039/b914956m; Hernandez-Pagan EA, 2012, ENERG ENVIRON SCI, V5, P7582, DOI 10.1039/c2ee03422k; Hoppe H, 2004, J MATER RES, V19, P1924, DOI 10.1557/JMR.2004.0252; Hu S, 2014, SCIENCE, V344, P1005, DOI 10.1126/science.1251428; Huskinson B, 2014, NATURE, V505, P195, DOI 10.1038/nature12909; IEA, 2014, SOLAR THERMAL ELECTR; James B. D., 2009, TECHNOECONOMIC ANALY; Jean J, 2015, ENERG ENVIRON SCI, V8, P1200, DOI 10.1039/c4ee04073b; Jin J, 2014, ENERG ENVIRON SCI, V7, P3371, DOI 10.1039/c4ee01824a; Joly M, 2013, SOL ENERGY, V94, P233, DOI 10.1016/j.solener.2013.05.009; Kanan MW, 2008, SCIENCE, V321, P1072, DOI 10.1126/science.1162018; Kaun B., 2013, COST EFFECTIVENESS O; Khaselev O, 1998, SCIENCE, V280, P425, DOI 10.1126/science.280.5362.425; Kim J, 2012, ENERG ENVIRON SCI, V5, P8417, DOI 10.1039/c2ee21798h; Kim YM, 2012, ENERGY, V43, P402, DOI 10.1016/j.energy.2012.03.076; Kocha SS, 1998, SOL ENERG MAT SOL C, V52, P389, DOI 10.1016/S0927-0248(97)00245-6; Kousksou T, 2014, SOL ENERG MAT SOL C, V120, P59, DOI 10.1016/j.solmat.2013.08.015; Kraemer D, 2011, NAT MATER, V10, P532, DOI [10.1038/NMAT3013, 10.1038/nmat3013]; Lahourcade L, 2013, ADV MATER, V25, P2562, DOI 10.1002/adma.201204718; Leighty W, 2008, INT J ENERG RES, V32, P408, DOI 10.1002/er.1373; Levene J. I., 2005, AN ANALYSIS OF HYDRO; Lewis N.S., 2005, BASIC RESEARCH NEEDS; Lewis NS, 2007, SCIENCE, V315, P798, DOI 10.1126/science.1137014; Li X, 2015, NAT CHEM, V7, P703, DOI [10.1038/nchem.2324, 10.1038/NCHEM.2324]; Li YG, 2014, CHEM SOC REV, V43, P5257, DOI 10.1039/c4cs00015c; Licht S, 2001, INT J HYDROGEN ENERG, V26, P653, DOI 10.1016/S0360-3199(00)00133-6; Licht S, 2000, J PHYS CHEM B, V104, P8920, DOI 10.1021/jp002083b; Luber EJ, 2013, ACS NANO, V7, P8136, DOI 10.1021/nn4034234; Luntz AC, 2014, CHEM REV, V114, P11721, DOI 10.1021/cr500054y; Maeda K, 2010, J PHYS CHEM LETT, V1, P2655, DOI 10.1021/jz1007966; Manners D., 2012, ELECTRONICS WEEKLY; Manthiram A, 2014, CHEM REV, V114, P11751, DOI 10.1021/cr500062v; McCrory CCL, 2015, J AM CHEM SOC, V137, P4347, DOI 10.1021/ja510442p; McKone JR, 2014, CHEM MATER, V26, P407, DOI 10.1021/cm4021518; Mei B, 2014, J PHYS CHEM LETT, V5, P1948, DOI 10.1021/jz500865g; Meier A., 2013, SOL ENERGY, P521; Minami T, 2015, APPL PHYS EXPRESS, V8, DOI 10.7567/APEX.8.022301; Minguzzi A, 2012, CHEM SCI, V3, P217, DOI 10.1039/c1sc00516b; Morris J., 2013, REDUCING SOLAR PV SO; Muhich CL, 2013, SCIENCE, V341, P540, DOI 10.1126/science.1239454; Musk E., 2015, ENERGY STORAGE FOR A; National Renewable Energy Laboratory, 2015, EFFICIENCY CHART; National Research Council National Academy of Engineering, 2004, HYDROGEN EC; Newman J, 2013, J ELECTROCHEM SOC, V160, pF309, DOI 10.1149/2.020304jes; Nozik AJ, 2008, CHEM PHYS LETT, V457, P3, DOI 10.1016/j.cplett.2008.03.094; O'Brien T.F., 2005, HANDBOOK OF CHLOR AL, V1; Olah GA, 2013, ANGEW CHEM INT EDIT, V52, P104, DOI 10.1002/anie.201204995; P. V. Spot Price, 2015, P V SPOT PRICE; PARKINSON BA, 1984, NATURE, V309, P148, DOI 10.1038/309148a0; Perret R., 2011, SOLAR THERMOCHEMICAL; Photovoltaic Power Systems Programme International EnergyAgency, 2015, 2014 SNAPSHOT OF GLO; Pillot C., 2015, PRESENTATION AT 31ST; Polman A, 2012, NAT MATER, V11, P174, DOI 10.1038/nmat3263; RAKHSHANI AE, 1986, SOLID STATE ELECTRON, V29, P7, DOI 10.1016/0038-1101(86)90191-7; Rastler D. M., 2011, ELECTRICITY ENERGY S; Reece SY, 2011, SCIENCE, V334, P645, DOI 10.1126/science.1209816; Richter C, 2009, CONCENTRATING SOLAR; Roske CW, 2015, J PHYS CHEM LETT, V6, P1679, DOI 10.1021/acs.jpclett.5b00495; Russo JM, 2014, OPT EXPRESS, V22, pA528, DOI 10.1364/OE.22.00A528; Schmalansee R., 2015, THE FUTURE OF SOLAR; SESHADRI G, 1994, J ELECTROANAL CHEM, V372, P145, DOI 10.1016/0022-0728(94)03300-5; Shaner MR, 2014, ENERG ENVIRON SCI, V7, P779, DOI 10.1039/c3ee43048k; Sharifi N, 2014, CHEMPHYSCHEM, V15, P3902, DOI 10.1002/cphc.201402299; Smith MB, 2010, CHEM REV, V110, P6891, DOI 10.1021/cr1002613; Solar GIS, 2015, WORLD MAP OF DIRECT; Solar Power Authority, 2010, HIGH TEMPERATURE SOL; Spurgeon JM, 2011, ENERG ENVIRON SCI, V4, P2993, DOI 10.1039/c1ee01203g; Spurgeon JM, 2010, ADV MATER, V22, P3277, DOI 10.1002/adma.201000602; Sun K, 2015, P NATL ACAD SCI USA, V112, P3612, DOI 10.1073/pnas.1423034112; Sun K, 2015, J PHYS CHEM LETT, V6, P592, DOI 10.1021/jz5026195; Torella JP, 2015, P NATL ACAD SCI USA, V112, P2337, DOI 10.1073/pnas.1424872112; Trotochaud L, 2013, J PHYS CHEM LETT, V4, P931, DOI 10.1021/jz4002604; Van Noorden R., 2012, NATURE, DOI [10.1038/nature.2012.10703, DOI 10.1038/NATURE.2012.10703]; Vazquez-Mena O, 2014, NANO LETT, V14, P4280, DOI 10.1021/nl500925n; Walter MG, 2010, CHEM REV, V110, P6446, DOI 10.1021/cr1002326; WASIELEWSKI MR, 1992, CHEM REV, V92, P435, DOI 10.1021/cr00011a005; Weber AZ, 2011, J APPL ELECTROCHEM, V41, P1137, DOI 10.1007/s10800-011-0348-2; Weimer A. W., 2009, DEVELOPMENT OF A SOL; Wilson SS, 2014, ENERG ENVIRON SCI, V7, P3606, DOI 10.1039/c4ee01956c; Wyld Group, 2008, HIGH TEMPERATURE SOL; Zheng C, 2014, ENERG POLICY, V67, P159, DOI 10.1016/j.enpol.2013.12.006	123	1184	1204	79	785	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 22	2016	351	6271							aad1920	10.1126/science.aad1920	http://dx.doi.org/10.1126/science.aad1920			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB3VH	26798020				2022-12-28	WOS:000368440500031
J	Tabebordbar, M; Zhu, KX; Cheng, JKW; Chew, WL; Widrick, JJ; Yan, WX; Maesner, C; Wu, EY; Xiao, R; Ran, FA; Cong, L; Zhang, F; Vandenberghe, LH; Church, GM; Wagers, AJ				Tabebordbar, Mohammadsharif; Zhu, Kexian; Cheng, Jason K. W.; Chew, Wei Leong; Widrick, Jeffrey J.; Yan, Winston X.; Maesner, Claire; Wu, Elizabeth Y.; Xiao, Ru; Ran, F. Ann; Cong, Le; Zhang, Feng; Vandenberghe, Luk H.; Church, George M.; Wagers, Amy J.			In vivo gene editing in dystrophic mouse muscle and muscle stem cells	SCIENCE			English	Article							MUSCULAR-DYSTROPHY; EXONS 45-55; DMD GENE; MICE; DNA; MUTATION; SYSTEM; CAS9	Frame-disrupting mutations in the DMD gene, encoding dystrophin, compromise myofiber integrity and drive muscle deterioration in Duchenne muscular dystrophy (DMD). Removing one or more exons from the mutated transcript can produce an in-frame mRNA and a truncated, but still functional, protein. In this study, we developed and tested a direct gene-editing approach to induce exon deletion and recover dystrophin expression in the mdx mouse model of DMD. Delivery by adeno-associated virus (AAV) of clustered regularly interspaced short palindromic repeats (CRISPR)-Cas9 endonucleases coupled with paired guide RNAs flanking the mutated Dmd exon23 resulted in excision of intervening DNA and restored the Dmd reading frame in myofibers, cardiomyocytes, and muscle stem cells after local or systemic delivery. AAV-Dmd CRISPR treatment partially recovered muscle functional deficiencies and generated a pool of endogenously corrected myogenic precursors in mdx mouse muscle.	[Tabebordbar, Mohammadsharif; Zhu, Kexian; Cheng, Jason K. W.; Maesner, Claire; Wu, Elizabeth Y.; Wagers, Amy J.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Tabebordbar, Mohammadsharif; Zhu, Kexian; Cheng, Jason K. W.; Maesner, Claire; Wu, Elizabeth Y.; Wagers, Amy J.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Tabebordbar, Mohammadsharif; Chew, Wei Leong] Harvard Univ, Sch Med, Biol & Biomed Sci Program, Boston, MA 02115 USA; [Zhu, Kexian] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Chew, Wei Leong; Church, George M.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Widrick, Jeffrey J.] Harvard Univ, Sch Med, Boston Childrens Hosp, Div Genet & Program Genom, Boston, MA 02115 USA; [Yan, Winston X.; Ran, F. Ann; Cong, Le; Zhang, Feng] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Yan, Winston X.; Ran, F. Ann; Cong, Le; Zhang, Feng] MIT, Dept Brain & Cognit Sci, McGovern Inst Brain Res, Cambridge, MA 02139 USA; [Yan, Winston X.; Ran, F. Ann; Cong, Le; Zhang, Feng] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Xiao, Ru; Vandenberghe, Luk H.] Sr,hepens Eye Res Inst, Grousbeck Gene Therapy Ctr, Boston, MA 02114 USA; [Xiao, Ru; Vandenberghe, Luk H.] Massachusetts Eye & Ear Infirm, Boston, MA 02114 USA	Harvard University; Harvard University; Harvard University; Harvard Medical School; Harvard University; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Eye & Ear Infirmary	Wagers, AJ (corresponding author), Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA.	amy_wagers@harvard.edu	Vandenberghe, Luk H./J-6395-2014; Wilson, Matthew H/K-3193-2013; Chew, Wei Leong/GYA-4870-2022; VANDENBERGHE, LUC H./ABH-1765-2020; Macrae, Rhiannon/AAX-1536-2020; Cong, Le/M-9981-2013	Vandenberghe, Luk H./0000-0002-3508-4924; VANDENBERGHE, LUC H./0000-0002-3508-4924; Cong, Le/0000-0003-4725-8714; Wu, Elizabeth/0000-0002-6537-9790; Zhu, Kexian/0000-0002-2321-5085; Chew, Wei Leong/0000-0002-4774-7959; Maesner, Claire C/0000-0002-4988-7058; church, george/0000-0001-6232-9969; Cheng, Jason/0000-0002-1301-276X	Howard Hughes Medical Institute; NIH [1DP2OD004345, 5U01HL100402, 5PN2EY018244]; National Institute of General Medical Sciences (NIGMS), NIH [T2GM007753]; National Institute of Mental Health, NIH [5DP1-MH100706]; National Institute of Diabetes and Digestive and Kidney Diseases, NIH [5R01DK097768-03]; Waterman Award from the NSF; Keck Foundation; New York Stem Cell Foundation; Damon Runyon Foundation; Searle Scholars Foundation; Merkin Foundation; Vallee Foundation; B. Metcalfe; National Science Scholarship from the Agency for Science, Technology, and Research (A*STAR), Singapore; National Human Genome Research Institute (NIGMS), NIH, Centers of Excellence in Genomic Science [P50 HG005550]; Regeneron Pharmaceuticals; Cowen; Jefferies; Sectoral; NATIONAL EYE INSTITUTE [PN2EY018244] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100402] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG005550] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK097768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007598, T32GM007753, T32GM008313] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [DP1MH100706, R01MH110049] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004345] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences (NIGMS), NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Mental Health, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Diabetes and Digestive and Kidney Diseases, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Waterman Award from the NSF; Keck Foundation(W.M. Keck Foundation); New York Stem Cell Foundation; Damon Runyon Foundation; Searle Scholars Foundation; Merkin Foundation; Vallee Foundation; B. Metcalfe; National Science Scholarship from the Agency for Science, Technology, and Research (A*STAR), Singapore; National Human Genome Research Institute (NIGMS), NIH, Centers of Excellence in Genomic Science; Regeneron Pharmaceuticals(Regeneron); Cowen; Jefferies; Sectoral; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank the Harvard Department of Stem Cell and Regenerative Biology-Harvard Stem Cell Institute Flow Cytometry Core, the Schepens Eye Research Institute-Massachusetts Eye and Ear Institute Gene Transfer Vector Core, the Parker lab at Harvard and J. Goldstein for technical assistance. Work was funded in part by grants from Howard Hughes Medical Institute and NIH (1DP2OD004345, 5U01HL100402, and 5PN2EY018244) to A.J.W. M.T. is an Albert J. Ryan fellow. F.A.R. is a Junior Fellow at the Harvard Society of Fellows. W.X.Y. was supported by T2GM007753 from the National Institute of General Medical Sciences (NIGMS), NIH. F.Z. is a New York Stem Cell Foundation Robertson Investigator and is supported by National Institute of Mental Health, NIH (5DP1-MH100706) and National Institute of Diabetes and Digestive and Kidney Diseases, NIH (5R01DK097768-03); a Waterman Award from the NSF; the Keck, New York Stem Cell, Damon Runyon, Searle Scholars, Merkin, and Vallee Foundations; and B. Metcalfe. W.L.C. is supported by the National Science Scholarship from the Agency for Science, Technology, and Research (A*STAR), Singapore. G.M.C. is supported for this work by National Human Genome Research Institute (NIGMS), NIH, Centers of Excellence in Genomic Science, P50 HG005550. Content is solely the responsibility of the authors and does not necessarily represent the official views of NIGMS or NIH. M.T., A.J.W., W.L.C., and G.M.C. are inventors on a patent application (PCT/US15/63181) filed by Harvard University related to in vivo genetic modifications and gene editing in muscle. G.M.C. is an inventor on issued patents (US9023649 and US9074199) filed by Harvard University related to CRISPR. L.H.V. is an inventor on a patent application (US2007036760) filed by the University of Pennsylvania related to AAV capsid sequences. F.Z., L.C., F.A.R., and W.Y. are inventors on patents and patent applications (8,865,406; 8,906,616; and accepted EP 2898075, from international patent application WO 2014/093635) filed by the Broad Institute related to SaCas9-optimized components and systems. A.J.W. is an advisor for Fate Therapeutics. G.M.C and F.Z. are founders and scientific advisors of Editas Medicine, and F.Z. is a scientific advisor for Horizon Discovery. G.M.C. has equity in Caribou/Intellia, Egenesis, and Editas (for full disclosure list, see: http://arep.med.harvard.edu/gmc/tech.html). L.H.V. is cofounder, shareholder, member of the scientific advisory board, and consultant for GenSight Biologics, a consultant to Novartis and Eleven Bio, and has received honoraria and consulting fees from Regeneron Pharmaceuticals and Cowen, Jefferies, and Sectoral. AAV9 vector sequences are available through a material transfer agreement (MTA) from the University of Pennsylvania. SaCas9 plasmids are openly available through a Uniform Biological MTA from Addgene.	Bosnakovski D, 2008, STEM CELLS, V26, P3194, DOI 10.1634/stemcells.2007-1017; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Echigoya Y, 2015, MOL THER-NUCL ACIDS, V4, DOI 10.1038/mtna.2014.76; Goyenvalle A, 2015, NAT MED, V21, P270, DOI 10.1038/nm.3765; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kinali M, 2009, LANCET NEUROL, V8, P918, DOI 10.1016/S1474-4422(09)70211-X; KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6; Long CZ, 2014, SCIENCE, V345, P1184, DOI 10.1126/science.1254445; Lu QL, 2000, J CELL BIOL, V148, P985, DOI 10.1083/jcb.148.5.985; Lu QL, 2003, NAT MED, V9, P1009, DOI 10.1038/nm897; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Nakamura A, 2008, J CLIN NEUROSCI, V15, P757, DOI 10.1016/j.jocn.2006.12.012; Neri M, 2007, NEUROMUSCULAR DISORD, V17, P913, DOI 10.1016/j.nmd.2007.07.005; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; SICINSKI P, 1989, SCIENCE, V244, P1578, DOI 10.1126/science.2662404; Tabebordbar M, 2013, ANNU REV PATHOL-MECH, V8, P441, DOI 10.1146/annurev-pathol-011811-132450; Taglia Antonella, 2015, Acta Myol, V34, P9; van Deutekom JC, 2007, NEW ENGL J MED, V357, P2677, DOI 10.1056/NEJMoa073108; van Putten M, 2014, J MOL CELL CARDIOL, V69, P17, DOI 10.1016/j.yjmcc.2014.01.009; van Putten M, 2013, FASEB J, V27, P2484, DOI 10.1096/fj.12-224170; van Putten M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031937; Vila MC, 2015, SKELET MUSCLE, V5, DOI 10.1186/s13395-015-0070-6; Xu C, 2013, CELL, V155, P909, DOI 10.1016/j.cell.2013.10.023; Zincarelli C, 2008, MOL THER, V16, P1073, DOI 10.1038/mt.2008.76	26	705	754	14	308	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 22	2016	351	6271					407	411		10.1126/science.aad5177	http://dx.doi.org/10.1126/science.aad5177			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB3VH	26721686	Green Accepted, Green Published			2022-12-28	WOS:000368440500046
J	Brown, ED; Wright, GD				Brown, Eric D.; Wright, Gerard D.			Antibacterial drug discovery in the resistance era	NATURE			English	Review							ANTIBIOTIC-RESISTANCE; PROTEIN COMPLEXES; STRUCTURAL BASIS; ESSENTIAL GENES; RESISTOME; IDENTIFICATION; INHIBITORS; GENOME; STREPTOMYCIN; MECHANISMS	The looming antibiotic-resistance crisis has penetrated the consciousness of clinicians, researchers, policymakers, politicians and the public at large. The evolution and widespread distribution of antibiotic-resistance elements in bacterial pathogens has made diseases that were once easily treatable deadly again. Unfortunately, accompanying the rise in global resistance is a failure in antibacterial drug discovery. Lessons from the history of antibiotic discovery and fresh understanding of antibiotic action and the cell biology of microorganisms have the potential to deliver twenty-first century medicines that are able to control infection in the resistance era.	[Brown, Eric D.; Wright, Gerard D.] McMaster Univ, Michael G DeGroote Inst Infect Dis Res, Hamilton, ON L8S 4L8, Canada; [Brown, Eric D.; Wright, Gerard D.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8S 4L8, Canada	McMaster University; McMaster University	Brown, ED (corresponding author), McMaster Univ, Michael G DeGroote Inst Infect Dis Res, Hamilton, ON L8S 4L8, Canada.	ebrown@mcmaster.ca; wrightge@mcmaster.ca	Ren, Guogang/P-4540-2017; Wright, G/ABB-7666-2021	Ren, Guogang/0000-0001-8865-1526; 	Natural Sciences and Engineering Research Council of Canada [RGPIN 04384-2014, RGPIN 237480]; Canada Research Chairs Program; Canadian Institutes of Health Research [MOP-81330, MOP-15496, MT-13536]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Research Chairs Program(Canada Research Chairs); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	The authors thank M. Farha for stimulating discussion with regards to the manuscript and S. French for creating Fig. 3. This work was supported by Discovery grants from the Natural Sciences and Engineering Research Council of Canada to E.D.B. (RGPIN 04384-2014) and G.D.W. (RGPIN 237480), by salary awards from the Canada Research Chairs Program to both E.D.B. and G.D.W., and by grants from the Canadian Institutes of Health Research to E.D.B. (MOP-81330 and MOP-15496) and G.D.W. (MT-13536).	Abraham EP, 1940, NATURE, V146, P837, DOI 10.1038/146837a0; Andersson DI, 2011, FEMS MICROBIOL REV, V35, P901, DOI 10.1111/j.1574-6976.2011.00289.x; Autret N, 2005, FEMS MICROBIOL REV, V29, P703, DOI 10.1016/j.femsre.2004.10.006; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Babu M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002377; Baltz RH, 2006, J IND MICROBIOL BIOT, V33, P507, DOI 10.1007/s10295-005-0077-9; Berdy J, 2005, J ANTIBIOT, V58, P1, DOI 10.1038/ja.2005.1; Bhullar K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034953; Borisy AA, 2003, P NATL ACAD SCI USA, V100, P7977, DOI 10.1073/pnas.1337088100; Brown ED, 2005, CHEM REV, V105, P759, DOI 10.1021/cr030116o; Brown ED, 2013, CAN J MICROBIOL, V59, P153, DOI 10.1139/cjm-2013-0089; Brynildsen MP, 2013, NAT BIOTECHNOL, V31, P160, DOI 10.1038/nbt.2458; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; Cho H, 2014, CELL, V159, P1300, DOI 10.1016/j.cell.2014.11.017; COMROE JH, 1978, AM REV RESPIR DIS, V117, P773; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Cox G, 2013, INT J MED MICROBIOL, V303, P287, DOI 10.1016/j.ijmm.2013.02.009; D'Costa VM, 2011, NATURE, V477, P457, DOI 10.1038/nature10388; D'Costa VM, 2006, SCIENCE, V311, P374, DOI 10.1126/science.1120800; D'Elia MA, 2006, J BACTERIOL, V188, P4183, DOI 10.1128/JB.00197-06; D'Elia MA, 2009, TRENDS MICROBIOL, V17, P433, DOI 10.1016/j.tim.2009.08.005; D'Elia MA, 2009, CHEM BIOL, V16, P548, DOI 10.1016/j.chembiol.2009.04.009; Davies J, 2010, MICROBIOL MOL BIOL R, V74, P417, DOI 10.1128/MMBR.00016-10; Demirci H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2346; Dwyer DJ, 2015, ANNU REV PHARMACOL, V55, P313, DOI 10.1146/annurev-pharmtox-010814-124712; Dwyer DJ, 2014, P NATL ACAD SCI USA, V111, pE2100, DOI 10.1073/pnas.1401876111; Eisenstein BI, 2010, CLIN INFECT DIS, V50, pS10, DOI 10.1086/647938; Ejim L, 2011, NAT CHEM BIOL, V7, P348, DOI [10.1038/NCHEMBIO.559, 10.1038/nchembio.559]; Fahnoe KC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051732; Farha MA, 2015, ANN NY ACAD SCI, V1354, P54, DOI 10.1111/nyas.12803; Farha MA, 2015, P NATL ACAD SCI USA, V112, P11048, DOI 10.1073/pnas.1511751112; Farha MA, 2013, ACS CHEM BIOL, V8, P226, DOI 10.1021/cb300413m; Finley RL, 2013, CLIN INFECT DIS, V57, P704, DOI 10.1093/cid/cit355; Fischbach MA, 2009, SCIENCE, V325, P1089, DOI 10.1126/science.1176667; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; Fleming A, 1929, BRIT J EXP PATHOL, V10, P226; Forsberg KJ, 2014, NATURE, V509, P612, DOI 10.1038/nature13377; Forsberg KJ, 2012, SCIENCE, V337, P1107, DOI 10.1126/science.1220761; Forsyth RA, 2002, MOL MICROBIOL, V43, P1387, DOI 10.1046/j.1365-2958.2002.02832.x; Galloway WRJD, 2009, CHEM COMMUN, P2446, DOI 10.1039/b816852k; Gerber M, 2008, EXPERT OPIN INV DRUG, V17, P547, DOI [10.1517/13543784.17.4.547, 10.1517/13543784.17.4.547 ]; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; Han S, 2010, P NATL ACAD SCI USA, V107, P22002, DOI 10.1073/pnas.1013092107; HENSEL M, 1995, SCIENCE, V269, P400, DOI 10.1126/science.7618105; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Jacobs MA, 2003, P NATL ACAD SCI USA, V100, P14339, DOI 10.1073/pnas.2036282100; Jain P, 2014, MBIO, V5, DOI 10.1128/mBio.01245-14; Joyce AR, 2006, J BACTERIOL, V188, P8259, DOI 10.1128/JB.00740-06; Kim J, 2014, J AM CHEM SOC, V136, P14629, DOI 10.1021/ja508343a; King AM, 2014, NATURE, V510, P503, DOI 10.1038/nature13445; Kobayashi K, 2003, P NATL ACAD SCI USA, V100, P4678, DOI 10.1073/pnas.0730515100; Lewis K, 2012, NATURE, V485, P439, DOI 10.1038/485439a; Ling LL, 2015, NATURE, V517, P455, DOI 10.1038/nature14098; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Liu A, 2010, ANTIMICROB AGENTS CH, V54, P1393, DOI 10.1128/AAC.00906-09; Lok C, 2015, NATURE, V522, P270, DOI 10.1038/522270a; Macarron R, 2011, NAT REV DRUG DISCOV, V10, P188, DOI 10.1038/nrd3368; McArthur AG, 2015, CURR OPIN MICROBIOL, V27, P45, DOI 10.1016/j.mib.2015.07.004; Nesme J, 2015, ENVIRON MICROBIOL, V17, P913, DOI 10.1111/1462-2920.12631; Nichols RJ, 2011, CELL, V144, P143, DOI 10.1016/j.cell.2010.11.052; O'Shea R, 2008, J MED CHEM, V51, P2871, DOI 10.1021/jm700967e; Pathania R, 2009, NAT CHEM BIOL, V5, P849, DOI 10.1038/nchembio.221; Payne DJ, 2007, NAT REV DRUG DISCOV, V6, P29, DOI 10.1038/nrd2201; Perry JA, 2014, CURR OPIN MICROBIOL, V21, P45, DOI 10.1016/j.mib.2014.09.002; Pethe K, 2013, NAT MED, V19, P1157, DOI 10.1038/nm.3262; Rachakonda V, 2013, EUR J MED CHEM, V70, P536, DOI 10.1016/j.ejmech.2013.10.034; Silver LL, 2011, CLIN MICROBIOL REV, V24, P71, DOI 10.1128/CMR.00030-10; Spellberg B, 2015, AM J RESP CRIT CARE, V191, P135, DOI 10.1164/rccm.201410-1894OE; Spellberg B, 2014, CRIT CARE, V18, DOI 10.1186/cc13948; Starkey M, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004321; Swoboda JG, 2009, ACS CHEM BIOL, V4, P875, DOI 10.1021/cb900151k; Tan CM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003592; Taylor PL, 2012, ACS CHEM BIOL, V7, P1547, DOI 10.1021/cb300269g; Theocharidis A, 2009, NAT PROTOC, V4, P1535, DOI 10.1038/nprot.2009.177; Tommasi R, 2015, NAT REV DRUG DISCOV, V14, P529, DOI 10.1038/nrd4572; Turner KH, 2015, P NATL ACAD SCI USA, V112, P4110, DOI 10.1073/pnas.1419677112; van Opijnen T, 2013, NAT REV MICROBIOL, V11, DOI 10.1038/nrmicro3033; Wang H, 2013, CHEM BIOL, V20, P272, DOI 10.1016/j.chembiol.2012.11.013; Wilson MC, 2014, NATURE, V506, P58, DOI 10.1038/nature12959; Wright GD, 2007, NAT REV MICROBIOL, V5, P175, DOI 10.1038/nrmicro1614; Zlitni S, 2013, NAT CHEM BIOL, V9, P796, DOI [10.1038/nchembio.1361, 10.1038/NCHEMBIO.1361]	83	1168	1210	83	1183	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 21	2016	529	7586					336	343		10.1038/nature17042	http://dx.doi.org/10.1038/nature17042			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB2QT	26791724				2022-12-28	WOS:000368354800035
J	Grace, JB; Anderson, TM; Seabloom, EW; Borer, ET; Adler, PB; Harpole, WS; Hautier, Y; Hillebrand, H; Lind, EM; Partel, M; Bakker, JD; Buckley, YM; Crawley, MJ; Damschen, EI; Davies, KF; Fay, PA; Firn, J; Gruner, DS; Hector, A; Knops, JMH; MacDougall, AS; Melbourne, BA; Morgan, JW; Orrock, JL; Prober, SM; Smith, MD				Grace, James B.; Anderson, T. Michael; Seabloom, Eric W.; Borer, Elizabeth T.; Adler, Peter B.; Harpole, W. Stanley; Hautier, Yann; Hillebrand, Helmut; Lind, Eric M.; Paertel, Meelis; Bakker, Jonathan D.; Buckley, Yvonne M.; Crawley, Michael J.; Damschen, Ellen I.; Davies, Kendi F.; Fay, Philip A.; Firn, Jennifer; Gruner, Daniel S.; Hector, Andy; Knops, Johannes M. H.; MacDougall, Andrew S.; Melbourne, Brett A.; Morgan, John W.; Orrock, John L.; Prober, Suzanne M.; Smith, Melinda D.			Integrative modelling reveals mechanisms linking productivity and plant species richness	NATURE			English	Article							STRUCTURAL EQUATION MODELS; NET PRIMARY PRODUCTION; ECOSYSTEM FUNCTION; BIODIVERSITY; DIVERSITY; ECOLOGY; SCALE; HYPOTHESIS	How ecosystem productivity and species richness are interrelated is one of the most debated subjects in the history of ecology(1). Decades of intensive study have yet to discern the actual mechanisms behind observed global patterns(2,3). Here, by integrating the predictions from multiple theories into a single model and using data from 1,126 grassland plots spanning five continents, we detect the clear signals of numerous underlying mechanisms linking productivity and richness. We find that an integrative model has substantially higher explanatory power than traditional bivariate analyses. In addition, the specific results unveil several surprising findings that conflict with classical models(4-7). These include the isolation of a strong and consistent enhancement of productivity by richness, an effect in striking contrast with superficial data patterns. Also revealed is a consistent importance of competition across the full range of productivity values, in direct conflict with some (but not all) proposed models. The promotion of local richness by macroecological gradients in climatic favourability, generally seen as a competing hypothesis(8), is also found to be important in our analysis. The results demonstrate that an integrative modelling approach leads to a major advance in our ability to discern the underlying processes operating in ecological systems.	[Grace, James B.] US Geol Survey, Wetland & Aquat Res Ctr, Lafayette, LA 70506 USA; [Anderson, T. Michael] Wake Forest Univ, Dept Biol, Winston Salem, NC 27109 USA; [Seabloom, Eric W.; Borer, Elizabeth T.; Lind, Eric M.] Univ Minnesota, Ecol Evolut & Behav, St Paul, MN 55108 USA; [Adler, Peter B.] Utah State Univ, Dept Wildland Resources, Logan, UT 84322 USA; [Adler, Peter B.] Utah State Univ, Ctr Ecol, Logan, UT 84322 USA; [Harpole, W. Stanley] UFZ Helmholtz Ctr Environm Res, Dept Physiol Divers, D-04318 Leipzig, Germany; [Harpole, W. Stanley] German Ctr Integrat Biodivers Res iDiv, D-04103 Leipzig, Germany; [Harpole, W. Stanley] Univ Halle Wittenberg, D-06108 Halle, Saale, Germany; [Hautier, Yann] Univ Utrecht, Dept Biol, Ecol & Biodivers Grp, NL-3584 CH Utrecht, Netherlands; [Hillebrand, Helmut] Carl von Ossietzky Univ Oldenburg, Inst Chem & Biol, Marine Environm, D-26381 Wilhelmshaven, Germany; [Paertel, Meelis] Univ Tartu, Inst Ecol & Earth Sci, EE-51005 Tartu, Estonia; [Bakker, Jonathan D.] Univ Washington, Sch Environm & Forest Sci, Seattle, WA 98195 USA; [Buckley, Yvonne M.] Univ Dublin Trinity Coll, Sch Nat Sci, Zool, Dublin 2, Ireland; [Crawley, Michael J.] Univ London Imperial Coll Sci Technol & Med, Dept Biol Sci, Ascot SL5 7PY, Berks, England; [Damschen, Ellen I.; Orrock, John L.] Univ Wisconsin, Dept Zool, Madison, WI 53706 USA; [Davies, Kendi F.; Melbourne, Brett A.] Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA; [Fay, Philip A.] ARS, Grassland Soil & Water Res Lab, USDA, Temple, TX 76502 USA; [Firn, Jennifer] Queensland Univ Technol, Sch Earth Environm & Biol Sci, Brisbane, Qld 4001, Australia; [Gruner, Daniel S.] Univ Maryland, Dept Entomol, College Pk, MD 20742 USA; [Hector, Andy] Univ Oxford, Dept Plant Sci, Oxford OX1 3RB, England; [Knops, Johannes M. H.] Univ Nebraska, Sch Biol Sci, Lincoln, NE 68588 USA; [MacDougall, Andrew S.] Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada; [Morgan, John W.] La Trobe Univ, Dept Ecol Environm & Evolut, Bundoora, Vic 3083, Australia; [Prober, Suzanne M.] CSIRO Land & Water, Wembley, WA 6913, Australia; [Smith, Melinda D.] Colorado State Univ, Dept Biol, Ft Collins, CO 80526 USA	United States Department of the Interior; United States Geological Survey; Wake Forest University; University of Minnesota System; University of Minnesota Twin Cities; Utah System of Higher Education; Utah State University; Utah System of Higher Education; Utah State University; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Martin Luther University Halle Wittenberg; Utrecht University; Carl von Ossietzky Universitat Oldenburg; University of Tartu; Tartu University Institute of Ecology & Earth Sciences; University of Washington; University of Washington Seattle; Trinity College Dublin; Imperial College London; University of Wisconsin System; University of Wisconsin Madison; University of Colorado System; University of Colorado Boulder; United States Department of Agriculture (USDA); Queensland University of Technology (QUT); University System of Maryland; University of Maryland College Park; University of Oxford; University of Nebraska System; University of Nebraska Lincoln; University of Guelph; La Trobe University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Colorado State University	Grace, JB (corresponding author), US Geol Survey, Wetland & Aquat Res Ctr, 700 Cajundome Blvd, Lafayette, LA 70506 USA.	gracej@usgs.gov	Buckley, Yvonne/B-1281-2008; Bakker, Jonathan/I-6960-2013; Hillebrand, Helmut/I-1717-2014; Pärtel, Meelis/D-5493-2012; Fay, Philip A./I-1853-2012; Knops, Johannes/AAA-8546-2020; Harpole, William S/C-2814-2013; Hector, Andrew/H-4199-2011; Prober, Suzanne/G-6465-2010; Gruner, Daniel Stephen/A-5166-2010; Hautier, Yann/D-5426-2015; MacDougall, Andrew S/F-2037-2011; Hautier, Yann/I-2526-2019; Grace, James/B-8472-2009; Smith, Melinda D/J-8987-2014	Buckley, Yvonne/0000-0001-7599-3201; Bakker, Jonathan/0000-0002-8973-2771; Hillebrand, Helmut/0000-0001-7449-1613; Pärtel, Meelis/0000-0002-5874-0138; Fay, Philip A./0000-0002-8291-6316; Harpole, William S/0000-0002-3404-9174; Hector, Andrew/0000-0002-1309-7716; Prober, Suzanne/0000-0002-6518-239X; Gruner, Daniel Stephen/0000-0002-3153-4297; Hautier, Yann/0000-0003-4347-7741; Hautier, Yann/0000-0003-4347-7741; Grace, James/0000-0001-6374-4726; Lind, Eric/0000-0003-3051-7724; MELBOURNE, BRETT/0000-0002-8843-4131; Seabloom, Eric/0000-0001-6780-9259; Borer, Elizabeth/0000-0003-2259-5853	US Geological Survey; Nutrient Network; National Science Foundation (NSF) Research Coordination Network [NSF-DEB-1042132]; National Science Foundation (NSF) Long Term Ecological Research program [NSF-DEB-1234162]; UMN Institute on the Environment [DG-0001-13]; Direct For Biological Sciences [1234162] Funding Source: National Science Foundation; Division Of Environmental Biology [1440484] Funding Source: National Science Foundation	US Geological Survey(United States Geological Survey); Nutrient Network; National Science Foundation (NSF) Research Coordination Network(National Science Foundation (NSF)); National Science Foundation (NSF) Long Term Ecological Research program(National Science Foundation (NSF)); UMN Institute on the Environment; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	J.B.G. was supported by the US Geological Survey Ecosystems and Climate and Land use Change Programs. This work uses data from the Nutrient Network (http://nutnet.org) experiment, funded at the site scale by individual researchers. Coordination and data management were supported by funding to E.T.B. and E.W.S. from the National Science Foundation (NSF) Research Coordination Network (NSF-DEB-1042132) and Long Term Ecological Research (NSF-DEB-1234162 to Cedar Creek LTER) programs and the UMN Institute on the Environment (DG-0001-13). The Minnesota Supercomputer Institute hosts project data. The use of trade, firm, or product names is for descriptive purposes only and does not imply endorsement by the US Government. Support for site-level activities is acknowledged in the Supplementary Information. We thank D. Laughlin for comments on the manuscript.	Adler PB, 2011, SCIENCE, V333, P1750, DOI 10.1126/science.1204498; [Anonymous], 2001, PLANT STRATEGIES VEG; Borer ET, 2014, NATURE, V508, P517, DOI 10.1038/nature13144; Borer ET, 2014, METHODS ECOL EVOL, V5, P65, DOI 10.1111/2041-210X.12125; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Cardinale BJ, 2009, ECOLOGY, V90, P1227, DOI 10.1890/08-1038.1; CHAO A, 1987, BIOMETRICS, V43, P783, DOI 10.2307/2531532; Chao A, 2012, ECOLOGY, V93, P2533, DOI 10.1890/11-1952.1; Chase JM, 2002, NATURE, V416, P427, DOI 10.1038/416427a; Fraser LH, 2015, SCIENCE, V349, P302, DOI 10.1126/science.aab3916; Gelman A., 2007, DATA ANAL USING REGR; Gillman LN, 2006, ECOLOGY, V87, P1234, DOI 10.1890/0012-9658(2006)87[1234:TIOPOT]2.0.CO;2; Grace JB, 2008, ENVIRON ECOL STAT, V15, P191, DOI 10.1007/s10651-007-0047-7; Grace JB, 2015, ECOLOGICAL STATISTICS: CONTEMPORARY THEORY AND APPLICATION, P168; Grace JB, 2014, FUNCT ECOL, V28, P787, DOI 10.1111/1365-2435.12269; Grace JB, 2012, ECOSPHERE, V3, DOI 10.1890/ES12-00048.1; Grace James B., 1999, Perspectives in Plant Ecology Evolution and Systematics, V2, P1, DOI 10.1078/1433-8319-00063; Grace JB, 2010, ECOL MONOGR, V80, P67, DOI 10.1890/09-0464.1; GRIME JP, 1973, NATURE, V242, P344, DOI 10.1038/242344a0; Grime JP, 1997, SCIENCE, V277, P1260, DOI 10.1126/science.277.5330.1260; Hawkins BA, 2003, ECOLOGY, V84, P3105, DOI 10.1890/03-8006; HUSTON M, 1979, AM NAT, V113, P81, DOI 10.1086/283366; Huston MA, 1997, OECOLOGIA, V110, P449, DOI 10.1007/s004420050180; LAUENROTH WK, 1986, ECOL MODEL, V33, P297, DOI 10.1016/0304-3800(86)90045-1; Loreau M., 2002, BIODIVERSITY ECOSYST, P294; Mittelbach GG, 2001, ECOLOGY, V82, P2381, DOI 10.1890/0012-9658(2001)082[2381:WITORB]2.0.CO;2; Muldavin EH, 2008, OECOLOGIA, V155, P123, DOI 10.1007/s00442-007-0880-2; NAEEM S, 1994, NATURE, V368, P734, DOI 10.1038/368734a0; Oberski D, 2014, J STAT SOFTW, V57, P1; Oesterheld M, 2000, METHODS IN ECOSYSTEM SCIENCE, P151; Partel M, 2010, ECOLOGY, V91, P2565, DOI 10.1890/09-1016.1; R Development Core Team, 2012, R LANG ENV STAT COMP; Regan HM, 2002, ECOL APPL, V12, P618, DOI 10.2307/3060967; Richardson, 2005, WORLDCLIM VERSION 13; Rosseel Y, 2013, LAVAAN LATENT VARIAB; Scheiner SM, 2002, EVOL ECOL RES, V4, P1097; Scherber C, 2010, NATURE, V468, P553, DOI 10.1038/nature09492; Schmid B, 2002, TRENDS ECOL EVOL, V17, P113, DOI 10.1016/S0169-5347(01)02422-3; TAYLOR DR, 1990, OIKOS, V58, P239, DOI 10.2307/3545432; Tilman D., 1982, Monographs in Population Biology, pi; Tilman D, 1996, NATURE, V379, P718, DOI 10.1038/379718a0; Tilman D, 2012, P NATL ACAD SCI USA, V109, P10394, DOI 10.1073/pnas.1208240109; Waide RB, 1999, ANNU REV ECOL SYST, V30, P257, DOI 10.1146/annurev.ecolsys.30.1.257; Whittaker RJ, 2010, ECOLOGY, V91, P2522, DOI 10.1890/08-0968.1; Willig MR, 2011, SCIENCE, V333, P1709, DOI 10.1126/science.1212453	45	413	437	61	744	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 21	2016	529	7586					390	+		10.1038/nature16524	http://dx.doi.org/10.1038/nature16524			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB2QT	26760203				2022-12-28	WOS:000368354800045
J	Morrissy, AS; Garzia, L; Shih, DJH; Zuyderduyn, S; Huang, X; Skowron, P; Remke, M; Cavalli, FMG; Ramaswamy, V; Lindsay, PE; Jelveh, S; Donovan, LK; Wang, X; Luu, B; Zayne, K; Li, YS; Mayoh, C; Thiessen, N; Mercier, E; Mungall, KL; Ma, Y; Tse, K; Zeng, T; Shumansky, K; Roth, AJL; Shah, S; Farooq, H; Kijima, N; Holgado, BL; Lee, JJY; Matan-Lithwick, S; Liu, J; Mack, SC; Manno, A; Michealraj, KA; Nor, C; Peacock, J; Qin, L; Reimand, J; Rolider, A; Thompson, YY; Wu, XC; Pugh, T; Ally, A; Bilenky, M; Butterfield, YSN; Carlsen, R; Cheng, Y; Chuah, E; Corbett, RD; Dhalla, N; He, A; Lee, D; Li, HYI; Long, W; Mayo, M; Plettner, P; Qian, JQ; Schein, JE; Tam, A; Wong, T; Birol, I; Zhao, YJ; Faria, CC; Pimentel, J; Nunes, S; Shalaby, T; Grotzer, M; Pollack, IF; Hamilton, RL; Li, XN; Bendel, AE; Fults, DW; Walter, AW; Kumabe, T; Tominaga, T; Collins, VP; Cho, YJ; Hoffman, C; Lyden, D; Wisoff, JH; Garvin, JH; Stearns, DS; Massimi, L; Schuller, U; Sterba, J; Zitterbart, K; Puget, S; Ayrault, O; Dunn, SE; Tirapelli, DPC; Carlotti, CG; Wheeler, H; Hallahan, AR; Ingram, W; MacDonald, TJ; Olson, JJ; Van Meir, EG; Lee, JY; Wang, KC; Kim, SK; Cho, BK; Pietsch, T; Fleischhack, G; Tippelt, S; Ra, YS; Bailey, S; Lindsey, JC; Clifford, SC; Eberhart, CG; Cooper, MK; Packer, RJ; Massimino, M; Garre, ML; Bartels, U; Tabori, U; Hawkins, CE; Dirks, P; Bouffet, E; Rutka, JT; Wechsler-Reya, RJ; Weiss, WA; Collier, LS; Dupuy, AJ; Korshunov, A; Jones, DTW; Kool, M; Northcott, PA; Pfister, SM; Largaespada, DA; Mungall, AJ; Moore, RA; Jabado, N; Bader, GD; Jones, SJM; Malkin, D; Marra, MA; Taylor, MD				Morrissy, A. Sorana; Garzia, Livia; Shih, David J. H.; Zuyderduyn, Scott; Huang, Xi; Skowron, Patryk; Remke, Marc; Cavalli, Florence M. G.; Ramaswamy, Vijay; Lindsay, Patricia E.; Jelveh, Salomeh; Donovan, Laura K.; Wang, Xin; Luu, Betty; Zayne, Kory; Li, Yisu; Mayoh, Chelsea; Thiessen, Nina; Mercier, Eloi; Mungall, Karen L.; Ma, Yusanne; Tse, Kane; Zeng, Thomas; Shumansky, Karey; Roth, Andrew J. L.; Shah, Sohrab; Farooq, Hamza; Kijima, Noriyuki; Holgado, Borja L.; Lee, John J. Y.; Matan-Lithwick, Stuart; Liu, Jessica; Mack, Stephen C.; Manno, Alex; Michealraj, K. A.; Nor, Carolina; Peacock, John; Qin, Lei; Reimand, Juri; Rolider, Adi; Thompson, Yuan Y.; Wu, Xiaochong; Pugh, Trevor; Ally, Adrian; Bilenky, Mikhail; Butterfield, Yaron S. N.; Carlsen, Rebecca; Cheng, Young; Chuah, Eric; Corbett, Richard D.; Dhalla, Noreen; He, An; Lee, Darlene; Li, Haiyan I.; Long, William; Mayo, Michael; Plettner, Patrick; Qian, Jenny Q.; Schein, Jacqueline E.; Tam, Angela; Wong, Tina; Birol, Inanc; Zhao, Yongjun; Faria, Claudia C.; Pimentel, Jose; Nunes, Sofia; Shalaby, Tarek; Grotzer, Michael; Pollack, Ian F.; Hamilton, Ronald L.; Li, Xiao-Nan; Bendel, Anne E.; Fults, Daniel W.; Walter, Andrew W.; Kumabe, Toshihiro; Tominaga, Teiji; Collins, V. Peter; Cho, Yoon-Jae; Hoffman, Caitlin; Lyden, David; Wisoff, Jeffrey H.; Garvin, James H., Jr.; Stearns, Duncan S.; Massimi, Luca; Schueller, Ulrich; Sterba, Jaroslav; Zitterbart, Karel; Puget, Stephanie; Ayrault, Olivier; Dunn, Sandra E.; Tirapelli, Daniela P. C.; Carlotti, Carlos G.; Wheeler, Helen; Hallahan, Andrew R.; Ingram, Wendy; MacDonald, Tobey J.; Olson, Jeffrey J.; Van Meir, Erwin G.; Lee, Ji-Yeoun; Wang, Kyu-Chang; Kim, Seung-Ki; Cho, Byung-Kyu; Pietsch, Torsten; Fleischhack, Gudrun; Tippelt, Stephan; Ra, Young Shin; Bailey, Simon; Lindsey, Janet C.; Clifford, Steven C.; Eberhart, Charles G.; Cooper, Michael K.; Packer, Roger J.; Massimino, Maura; Garre, Maria Luisa; Bartels, Ute; Tabori, Uri; Hawkins, Cynthia E.; Dirks, Peter; Bouffet, Eric; Rutka, James T.; Wechsler-Reya, Robert J.; Weiss, William A.; Collier, Lara S.; Dupuy, Adam J.; Korshunov, Andrey; Jones, David T. W.; Kool, Marcel; Northcott, Paul A.; Pfister, Stefan M.; Largaespada, David A.; Mungall, Andrew J.; Moore, Richard A.; Jabado, Nada; Bader, Gary D.; Jones, Steven J. M.; Malkin, David; Marra, Marco A.; Taylor, Michael D.			Divergent clonal selection dominates medulloblastoma at recurrence	NATURE			English	Article							SUBGROUP MEDULLOBLASTOMA; LYMPHOBLASTIC-LEUKEMIA; CANCER EVOLUTION; SEQUENCING DATA; GENOME; MUTATIONS; HETEROGENEITY; DYNAMICS; IMPACT; CELLS	The development of targeted anti-cancer therapies through the study of cancer genomes is intended to increase survival rates and decrease treatment-related toxicity. We treated a transposon-driven, functional genomic mouse model of medulloblastoma with 'humanized' in vivo therapy (microneurosurgical tumour resection followed by multi-fractionated, image-guided radiotherapy). Genetic events in recurrent murine medulloblastoma exhibit a very poor overlap with those in matched murine diagnostic samples (<5%). Whole-genome sequencing of 33 pairs of human diagnostic and post-therapy medulloblastomas demonstrated substantial genetic divergence of the dominant clone after therapy (<12% diagnostic events were retained at recurrence). In both mice and humans, the dominant clone at recurrence arose through clonal selection of a pre-existing minor clone present at diagnosis. Targeted therapy is unlikely to be effective in the absence of the target, therefore our results offer a simple, proximal, and remediable explanation for the failure of prior clinical trials of targeted therapy.	[Morrissy, A. Sorana; Garzia, Livia; Shih, David J. H.; Huang, Xi; Skowron, Patryk; Cavalli, Florence M. G.; Ramaswamy, Vijay; Donovan, Laura K.; Wang, Xin; Luu, Betty; Zayne, Kory; Farooq, Hamza; Kijima, Noriyuki; Holgado, Borja L.; Lee, John J. Y.; Matan-Lithwick, Stuart; Liu, Jessica; Mack, Stephen C.; Manno, Alex; Michealraj, K. A.; Nor, Carolina; Peacock, John; Qin, Lei; Rolider, Adi; Thompson, Yuan Y.; Wu, Xiaochong; Taylor, Michael D.] Hosp Sick Children, Dev & Stem Cell Biol Program, Toronto, ON M5G 0A4, Canada; [Morrissy, A. Sorana; Garzia, Livia; Shih, David J. H.; Skowron, Patryk; Cavalli, Florence M. G.; Ramaswamy, Vijay; Donovan, Laura K.; Wang, Xin; Luu, Betty; Zayne, Kory; Farooq, Hamza; Kijima, Noriyuki; Holgado, Borja L.; Lee, John J. Y.; Matan-Lithwick, Stuart; Liu, Jessica; Mack, Stephen C.; Manno, Alex; Michealraj, K. A.; Nor, Carolina; Peacock, John; Qin, Lei; Reimand, Juri; Rolider, Adi; Thompson, Yuan Y.; Wu, Xiaochong; Tabori, Uri; Hawkins, Cynthia E.; Dirks, Peter; Bouffet, Eric; Rutka, James T.; Taylor, Michael D.] Hosp Sick Children, Arthur & Sonia Labatt Brain Tumour Res Ctr, Toronto, ON M5G 1X8, Canada; [Shih, David J. H.; Skowron, Patryk; Ramaswamy, Vijay; Wang, Xin; Lee, John J. Y.; Peacock, John; Thompson, Yuan Y.; Rutka, James T.; Taylor, Michael D.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5G 0A4, Canada; [Zuyderduyn, Scott; Reimand, Juri; Bader, Gary D.] Univ Toronto, Donnelly Ctr, Toronto, ON M5S 3E1, Canada; [Remke, Marc] Univ Hosp Dusseldorf, Dept Pediat Oncol Hematol & Clin Immunol, Dusseldorf, Germany; [Ramaswamy, Vijay; Hoffman, Caitlin; Dirks, Peter; Rutka, James T.; Taylor, Michael D.] Hosp Sick Children, Div Neurosurg, Toronto, ON M5S 3E1, Canada; [Lindsay, Patricia E.] Univ Toronto, Dept Radiat Oncol, Toronto, ON M5G 2M9, Canada; [Lindsay, Patricia E.; Jelveh, Salomeh] Univ Hlth Network, Princess Margaret Canc Ctr, Radiat Med Program, Toronto, ON M5G 2M9, Canada; [Li, Yisu; Mayoh, Chelsea; Thiessen, Nina; Mercier, Eloi; Mungall, Karen L.; Ma, Yusanne; Tse, Kane; Zeng, Thomas; Ally, Adrian; Bilenky, Mikhail; Butterfield, Yaron S. N.; Carlsen, Rebecca; Cheng, Young; Chuah, Eric; Corbett, Richard D.; He, An; Lee, Darlene; Li, Haiyan I.; Long, William; Mayo, Michael; Plettner, Patrick; Qian, Jenny Q.; Schein, Jacqueline E.; Tam, Angela; Wong, Tina; Birol, Inanc; Zhao, Yongjun; Mungall, Andrew J.; Moore, Richard A.; Jones, Steven J. M.; Marra, Marco A.] BC Canc Agcy, Canadas Michael Smith Genome Sci Ctr, Vancouver, BC V5Z 4S6, Canada; [Shumansky, Karey; Roth, Andrew J. L.; Shah, Sohrab] BC Canc Agcy, Dept Mol Oncol, Vancouver, BC V5Z 1L3, Canada; [Mack, Stephen C.] Cleveland Clin Fdn, Ctr Stem Cell & Regenerat Med, Cleveland, OH 44195 USA; [Pugh, Trevor] Univ Hlth Network, Princess Margaret Canc Ctr, Clin Genom Res Program, Toronto, ON, Canada; [Birol, Inanc; Jones, Steven J. M.; Marra, Marco A.] Univ British Columbia, Dept Med Genet, Vancouver, BC V6T 1Z3, Canada; [Birol, Inanc] Simon Fraser Univ, Sch Comp Sci, Burnaby, BC V5A 1S6, Canada; [Faria, Claudia C.] Hosp Santa Maria, Ctr Hosp Lisboa Norte, Div Neurosurg, P-1649035 Lisbon, Portugal; [Pimentel, Jose] Hosp Santa Maria, Ctr Hosp Lisboa Norte, Div Pathol, P-1649035 Lisbon, Portugal; [Nunes, Sofia] Inst Portugues Oncol Francisco Gentil, Unidade Neurooncol Pediat, P-1099023 Lisbon, Portugal; [Shalaby, Tarek; Grotzer, Michael] Univ Childrens Hosp Zurich, Dept Oncol, CH-8032 Zurich, Switzerland; [Shalaby, Tarek; Grotzer, Michael] Univ Childrens Hosp Zurich, Dept Neurooncol, CH-8032 Zurich, Switzerland; [Pollack, Ian F.] Univ Pittsburgh, Sch Med, Dept Neurol Surg, Pittsburgh, PA 15224 USA; [Hamilton, Ronald L.] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15213 USA; [Li, Xiao-Nan] Baylor Coll Med, Brain Tumor Program, Childrens Canc Ctr, Houston, TX 77030 USA; [Li, Xiao-Nan] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Bendel, Anne E.] Childrens Hosp & Clin Minnesota, Pediat Hematol Oncol, Minneapolis, MN 55404 USA; [Fults, Daniel W.] Univ Utah, Clin Neurosci Ctr, Dept Neurosurg, Salt Lake City, UT 84132 USA; [Walter, Andrew W.] Alfred I DuPont Hosp Children, Wilmington, DE 19803 USA; [Kumabe, Toshihiro] Kitasato Univ, Sch Med, Dept Neurosurg, Sagamihara, Kanagawa 2520374, Japan; [Tominaga, Teiji] Tohoku Univ, Grad Sch Med, Dept Neurosurg, Sendai, Miyagi 9808574, Japan; [Collins, V. Peter] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England; [Cho, Yoon-Jae] Stanford Univ, Sch Med, Dept Neurosurg, Stanford, CA 94305 USA; [Cho, Yoon-Jae] Stanford Univ, Sch Med, Dept Neurol, Stanford, CA 94305 USA; [Cho, Yoon-Jae] Stanford Univ, Sch Med, Dept Neurol Sci, Stanford, CA 94305 USA; [Lyden, David] Cornell Univ, Weill Med Coll, Dept Pediat, New York, NY 10065 USA; [Lyden, David] Cornell Univ, Weill Med Coll, Dept Cell Biol, New York, NY 10065 USA; [Lyden, David] Cornell Univ, Weill Med Coll, Dept Dev Biol, New York, NY 10065 USA; [Wisoff, Jeffrey H.] NYU Langone Med Ctr, Dept Neurosurg, New York, NY 10016 USA; [Garvin, James H., Jr.] Columbia Univ, Dept Pediat, Div Pediat Hematol Oncol & Stem Cell Transplantat, New York, NY 10032 USA; [Stearns, Duncan S.] Rainbow Babies & Childrens Hosp, Dept Pediat Hematol & Oncol, Cleveland, OH 44106 USA; [Stearns, Duncan S.] Case Western Reserve, Dept Pediat Hematol & Oncol, Cleveland, OH 44106 USA; [Massimi, Luca] Catholic Univ, Sch Med, Pediat Neurosurg, I-00198 Rome, Italy; [Schueller, Ulrich] Univ Munich, Ctr Neuropathol, D-81377 Munich, Germany; [Sterba, Jaroslav; Zitterbart, Karel] Masaryk Univ, Sch Med, Dept Pediat Oncol, Brno 62500, Czech Republic; [Puget, Stephanie] Univ Paris 05, Necker Enfants Malad Hosp, AP HP, Dept Neurosurg, F-75743 Paris, France; [Ayrault, Olivier] Inst Curie, Signaling Dev & Brain Tumors, CNRS, UMR 3347,INSERM,U1021, F-91405 Orsay 5, France; [Dunn, Sandra E.] British Columbia Childrens Hosp, Div Hematol Oncol, Vancouver, BC V6H 3V4, Canada; [Tirapelli, Daniela P. C.; Carlotti, Carlos G.] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Surg & Anat, BR-14049900 Sao Paulo, Brazil; [Wheeler, Helen] Univ Sydney, Kolling Inst Med Res, Sydney, NSW 2065, Australia; [Hallahan, Andrew R.; Ingram, Wendy] Childrens Hlth Queensland, Queensland Childrens Med Res Inst, Brisbane, Qld 4029, Australia; [Hallahan, Andrew R.] Childrens Hlth Queensland, Div Oncol, Brisbane, Qld 4029, Australia; [Ingram, Wendy] Univ Queensland, UQ Child Hlth Res Ctr, Brisbane, Qld 4029, Australia; [MacDonald, Tobey J.] Emory Univ, Sch Med, Pediat Neurooncol Program, Atlanta, GA 30307 USA; [MacDonald, Tobey J.] Emory Univ, Sch Med, Winship Canc Inst, Atlanta, GA 30307 USA; [Olson, Jeffrey J.] Emory Univ, Dept Neurosurg, Sch Med, Atlanta, GA 30322 USA; [Olson, Jeffrey J.; Van Meir, Erwin G.] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA; [Van Meir, Erwin G.] Emory Univ, Sch Med, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA; [Lee, Ji-Yeoun; Wang, Kyu-Chang; Kim, Seung-Ki; Cho, Byung-Kyu] Seoul Natl Univ, Childrens Hosp, Div Pediat Neurosurg, Dept Neurosurg, Seoul 30322, South Korea; [Pietsch, Torsten] Univ Bonn, Inst Neuropathol, D-53105 Bonn, Germany; [Fleischhack, Gudrun; Tippelt, Stephan] Childrens Univ Hosp Essen, D-45147 Essen, Germany; [Ra, Young Shin] Univ Ulsan, Asan Med Ctr, Dept Neurosurg, Seoul 05505, South Korea; [Bailey, Simon; Lindsey, Janet C.; Clifford, Steven C.] Newcastle Univ, Northern Inst Canc Res, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; [Eberhart, Charles G.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Eberhart, Charles G.] Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21205 USA; [Eberhart, Charles G.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Cooper, Michael K.] Vanderbilt Univ Sch Med, Dept Neurol, Nashville, TN 37232 USA; [Packer, Roger J.] Childrens Natl Med Ctr, Dept Neurol, Washington, DC 20010 USA; [Massimino, Maura] Fdn IRCCS Ist Nazl Tumori, I-20133 Milan, Italy; [Garre, Maria Luisa] Ist Giannina Gaslini, UO Neurochirurg, I-16147 Genoa, Italy; [Bartels, Ute; Tabori, Uri; Bouffet, Eric; Malkin, David] Hosp Sick Children, Dept Haematol & Oncol, Toronto, ON M5G 1X8, Canada; [Hawkins, Cynthia E.] Hosp Sick Children, Div Pathol, Toronto, ON M5G 1X8, Canada; [Wechsler-Reya, Robert J.] Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA; [Weiss, William A.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94158 USA; [Weiss, William A.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA; [Weiss, William A.] Univ Calif San Francisco, Dept Neurosurg, San Francisco, CA 94158 USA; [Collier, Lara S.] Univ Wisconsin, Sch Pharmacol, Madison, WI 53715 USA; [Dupuy, Adam J.] Univ Iowa, Mol & Cellular Biol Program, Iowa City, IA 52242 USA; [Korshunov, Andrey] German Canc Res Ctr, Clin Cooperat Unit Neuropathol, D-69120 Heidelberg, Germany; [Jones, David T. W.; Kool, Marcel; Northcott, Paul A.; Pfister, Stefan M.] German Canc Res Ctr, Div Pediat Neurooncol, D-69120 Heidelberg, Germany; [Pfister, Stefan M.] Univ Heidelberg Hosp, Dept Pediat Oncol, D-69120 Heidelberg, Germany; [Largaespada, David A.] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN 55455 USA; [Jabado, Nada] McGill Univ, Div Hematol Oncol, Montreal, PQ H2W 1S6, Canada; [Bader, Gary D.] Univ Toronto, McLaughlin Ctr, Toronto, ON M5G 1L7, Canada; [Bader, Gary D.] Univ Toronto, Dept Mol Genet, Banting & Best Dept Med Res, Toronto, ON M5G 1L7, Canada; [Bader, Gary D.] Univ Toronto, Samuel Lunenfeld Res Inst, Mt Sinai Hosp, Toronto, ON M5G 1L7, Canada; [Jones, Steven J. M.] Simon Fraser Univ, Dept Mol Biol & Biochem, Toronto, ON M5G 1L7, Canada; [Malkin, David] Univ Toronto, Dept Pediat, Toronto, ON M5G 1X8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; British Columbia Cancer Agency; British Columbia Cancer Agency; Cleveland Clinic Foundation; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of British Columbia; Simon Fraser University; Universidade de Lisboa; Hospital Santa Maria; Universidade de Lisboa; Hospital Santa Maria; Portuguese Institute of Oncology; University Children's Hospital Zurich; University Children's Hospital Zurich; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Baylor College of Medicine; Texas Children's Cancer Center; Baylor College of Medicine; Children's Hospitals & Clinics of Minnesota; Utah System of Higher Education; University of Utah; Nemours Alfred I. duPont Hospital for Children; Kitasato University; Tohoku University; University of Cambridge; Stanford University; Stanford University; Stanford University; Cornell University; Cornell University; Cornell University; NYU Langone Medical Center; Columbia University; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Rainbow Babies & Children's Hospital; Case Western Reserve University; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Munich; Masaryk University Brno; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; BC Childrens Hospital; University of British Columbia; Universidade de Sao Paulo; University of Sydney; Kolling Institute of Medical Research; University of Queensland; Emory University; Emory University; Emory University; Emory University; Emory University; Seoul National University (SNU); Seoul National University Hospital; University of Bonn; University of Duisburg Essen; University of Ulsan; Newcastle University - UK; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Vanderbilt University; Children's National Health System; Fondazione IRCCS Istituto Nazionale Tumori Milan; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Sanford Burnham Prebys Medical Discovery Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Wisconsin System; University of Wisconsin Madison; University of Iowa; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; University of Minnesota System; University of Minnesota Twin Cities; McGill University; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Simon Fraser University; University of Toronto	Taylor, MD (corresponding author), Hosp Sick Children, Dev & Stem Cell Biol Program, Toronto, ON M5G 0A4, Canada.	mmarra@bcgsc.ca; mdtaylor@sickkids.ca	Mungall, Andrew J./U-7067-2018; Birol, Inanc/G-5440-2011; Wang, Xin/U-7221-2017; Tirapelli, Daniela PC/F-9230-2012; massimino, maura/K-7310-2016; Carlotti, Carlos G/C-1608-2012; Wang, Xin/O-8779-2019; Shih, David J. H./AAE-8726-2019; Michealraj, Antony/AAJ-7925-2020; Mayoh, Chelsea/AAE-7349-2021; Reimand, Jüri/U-9264-2019; Pfister, Stefan M/F-6860-2013; Fleischhack, Gudrun/AAA-3679-2021; Northcott, Paul A/N-4022-2018; Ingram, Wendy J/F-7317-2010; Jones, David T. W./Z-1963-2019; Pugh, Trevor/Y-2535-2019; Sterba, Jaroslav/N-6156-2016; Hallahan, Andrew R/F-1757-2010; Bader, Gary/C-1176-2009; Huang, Xi/C-2409-2017; Malkin, David/AAW-8715-2021; Wisoff, Jeffrey/AAW-1500-2020; Jones, Steven J/C-3621-2009; Bouffet, Eric/AAB-8999-2020; Jones, David TW/G-9588-2013; Jabado, Nada/AAN-4026-2020; Schein, Jacquie E/G-3674-2015; Garrè, Maria Luisa/K-4205-2018; Marra, Marco A/B-5987-2008	Mungall, Andrew J./0000-0002-0905-2742; Birol, Inanc/0000-0003-0950-7839; Wang, Xin/0000-0001-6292-3087; Tirapelli, Daniela PC/0000-0002-1886-4988; massimino, maura/0000-0002-5506-2001; Carlotti, Carlos G/0000-0002-7055-0564; Wang, Xin/0000-0001-6292-3087; Shih, David J. H./0000-0002-9802-4937; Michealraj, Antony/0000-0002-3967-0816; Mayoh, Chelsea/0000-0002-6398-3046; Reimand, Jüri/0000-0002-2299-2309; Pfister, Stefan M/0000-0002-5447-5322; Northcott, Paul A/0000-0002-1220-5252; Ingram, Wendy J/0000-0002-7063-1081; Pugh, Trevor/0000-0002-8073-5888; Bader, Gary/0000-0003-0185-8861; Huang, Xi/0000-0002-7177-7525; Jones, Steven J/0000-0003-3394-2208; Jones, David TW/0000-0002-2036-5141; Garrè, Maria Luisa/0000-0002-9055-3340; Marra, Marco A/0000-0001-7146-7175; Wang, Xin/0000-0001-8783-4080; Wisoff, Jeffrey/0000-0003-3303-2220; Mack, Stephen C./0000-0001-9620-4742; Weiss, William/0000-0003-2230-9132; Remke, Marc/0000-0002-9404-9993; Grotzer, Michael/0000-0002-1154-2732; Donovan, Laura/0000-0001-5557-5539; Faria, Claudia/0000-0003-1259-9922; Sterba, Jaroslav/0000-0002-8482-8352; Schuller, Ulrich/0000-0002-8731-1121; Dupuy, Adam/0000-0002-8561-4911; Taylor, Michael/0000-0001-7009-3466; Cavalli, Florence M. G./0000-0002-4409-9642; Korshunov, Andrey/0000-0002-5257-3623; Clifford, Steve/0000-0003-4893-2184; Ramaswamy, Vijay/0000-0002-6557-895X	Genome Canada; Genome BC; Terry Fox Research Institute; Ontario Institute for Cancer Research; Pediatric Oncology Group Ontario; Funds from 'The Family of Kathleen Lorette'; Clark H. Smith Brain Tumour Centre; Montreal Children's Hospital Foundation; Hospital for Sick Children; Sonia and Arthur Labatt Brain Tumour Research Centre; Chief of Research Fund; Cancer Genetics Program; Garron Family Cancer Centre; B.R.A.I.N. Child; BC Childhood Cancer Parents Association; Stand Up To Cancer St. Baldrick's Pediatric Dream Team Translational Research Grant [SU2C-AACR-DT1113]; Canadian Cancer Society Research Institute; Garron Family Chair in Childhood Cancer Research; Cure Search for Children's Cancer Foundation; National Institutes of Health [R01CA148699, R01CA159859, CA163722, NS096236]; Pediatric Brain Tumour Foundation; Brainchild and The McLaughlin Centre at the University of Toronto; Swifty Foundation; Davis M. Ferguson Memorial Fund at ABTA; V.R; Ontario Institute for Cancer Research through Government of Ontario; CureSearch for Children's Cancer; German Cancer Aid [109252]; German Federal Ministry of Education and Research (BMBF) [01KU1201A, 0315416C, NGFNplus 01GS0883]; German Childhood Cancer Foundation (Deutsche Kinderkrebsstiftung); Hungarian Brain Research Program Grant [KTIA_13_NAP-A-V/3, NAP-A-II/7]; Janos Bolyai scholarship of the Hungarian Academy of Sciences; St. Baldrick's Foundation; Cure Childhood Cancer Foundation; B.R.A.I.N. Child and Megan's Walk; Dr. Mildred Scheel Foundation; Stephen Buttrum Brain Tumour Research Fellowship; CIHR fellowship; Alberta Innovates-Health Solutions Clinical Fellowship; Cancer Research UK [13457] Funding Source: researchfish; Sparks Charity [09NCL02] Funding Source: researchfish; The Brain Tumour Charity [16/193] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R01CA163722, P30CA077598, R01CA148699, R01CA113636, R01CA159859, P30CA030199] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS096236] Funding Source: NIH RePORTER	Genome Canada(Genome Canada); Genome BC; Terry Fox Research Institute; Ontario Institute for Cancer Research; Pediatric Oncology Group Ontario; Funds from 'The Family of Kathleen Lorette'; Clark H. Smith Brain Tumour Centre; Montreal Children's Hospital Foundation; Hospital for Sick Children; Sonia and Arthur Labatt Brain Tumour Research Centre; Chief of Research Fund; Cancer Genetics Program; Garron Family Cancer Centre; B.R.A.I.N. Child; BC Childhood Cancer Parents Association; Stand Up To Cancer St. Baldrick's Pediatric Dream Team Translational Research Grant; Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); Garron Family Chair in Childhood Cancer Research; Cure Search for Children's Cancer Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pediatric Brain Tumour Foundation; Brainchild and The McLaughlin Centre at the University of Toronto; Swifty Foundation; Davis M. Ferguson Memorial Fund at ABTA; V.R(Swedish Research Council); Ontario Institute for Cancer Research through Government of Ontario; CureSearch for Children's Cancer; German Cancer Aid(Deutsche Krebshilfe); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); German Childhood Cancer Foundation (Deutsche Kinderkrebsstiftung); Hungarian Brain Research Program Grant; Janos Bolyai scholarship of the Hungarian Academy of Sciences(Hungarian Academy of Sciences); St. Baldrick's Foundation; Cure Childhood Cancer Foundation; B.R.A.I.N. Child and Megan's Walk; Dr. Mildred Scheel Foundation(Deutsche Krebshilfe); Stephen Buttrum Brain Tumour Research Fellowship; CIHR fellowship(Canadian Institutes of Health Research (CIHR)); Alberta Innovates-Health Solutions Clinical Fellowship; Cancer Research UK(Cancer Research UK); Sparks Charity; The Brain Tumour Charity; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The MAGIC project is financially supported by: Genome Canada, Genome BC, Terry Fox Research Institute, Ontario Institute for Cancer Research, Pediatric Oncology Group Ontario, Funds from 'The Family of Kathleen Lorette' and the Clark H. Smith Brain Tumour Centre, Montreal Children's Hospital Foundation, Hospital for Sick Children: Sonia and Arthur Labatt Brain Tumour Research Centre, Chief of Research Fund, Cancer Genetics Program, Garron Family Cancer Centre, B.R.A.I.N. Child, and BC Childhood Cancer Parents Association. M.D.T. is also supported by a Stand Up To Cancer St. Baldrick's Pediatric Dream Team Translational Research Grant (SU2C-AACR-DT1113). Stand Up To Cancer is a program of the Entertainment Industry Foundation administered by the American Association for Cancer Research. M.D.T. is supported by The Canadian Cancer Society Research Institute, The Garron Family Chair in Childhood Cancer Research, and grants from the Cure Search for Children's Cancer Foundation, the National Institutes of Health (R01CA148699 R01CA159859), The Pediatric Brain Tumour Foundation, The Terry Fox Research Institute, Brainchild and The McLaughlin Centre at the University of Toronto. M.D.T. is also supported by the Swifty Foundation. L.G. was supported by the Davis M. Ferguson Memorial Fund at ABTA. Alex's Lemonade Stand Young Investigator Award supported V.R. This study was conducted with the support of the Ontario Institute for Cancer Research through funding provided by the Government of Ontario. This work was also supported by a Program Project Grant from the Terry Fox Research Institute, and a Grand Challenge Award from CureSearch for Children's Cancer. Additionally, this work was supported by the PedBrain Tumour Project contributing to the International Cancer Genome Consortium, funded by German Cancer Aid (109252) and by the German Federal Ministry of Education and Research (BMBF, grants 01KU1201A, MedSys 0315416C and NGFNplus 01GS0883). Funding by the German Childhood Cancer Foundation (Deutsche Kinderkrebsstiftung) to S.M.P., G.F. and T.P. The study was also financed by the Hungarian Brain Research Program Grant No. KTIA_13_NAP-A-V/3. and NAP-A-II/7. A.K. was supported by the Janos Bolyai scholarship of the Hungarian Academy of Sciences. E.G.V.M. was supported by NIH R01 grants CA163722 and NS096236, and St. Baldrick's and Cure Childhood Cancer Foundations. We would like to acknowledge R.P. Hill (Ontario Cancer Institute), the Labatt Brain Tumour Research Centre Tumour and Tissue Repository, which is supported by B.R.A.I.N. Child and Megan's Walk. M.R. is supported by a fellowship from the Dr. Mildred Scheel Foundation for Cancer Research/German Cancer Aid. F.M.G.C. is supported by the Stephen Buttrum Brain Tumour Research Fellowship, granted by Brain Tumour Foundation of Canada. V.R. is supported by a CIHR fellowship and an Alberta Innovates-Health Solutions Clinical Fellowship. We would like to thank the Toronto Centre for Phenogenomics for animal housing and veterinary support, and the Preclinical Core II and animal research facility at STTARR (Spatiotemporal Targeting and Amplification of Radiation Response) in Toronto for assistance with CT-guided radiation experiments. We would like to thank Z. Wang for technical help with IHC, S. Archer for technical writing and C. Smith for artwork.	Anderson K, 2011, NATURE, V469, P356, DOI 10.1038/nature09650; Andor N, 2014, BIOINFORMATICS, V30, P50, DOI 10.1093/bioinformatics/btt622; Aparicio S, 2013, NEW ENGL J MED, V368, P842, DOI 10.1056/NEJMra1204892; Boeva V, 2012, BIOINFORMATICS, V28, P423, DOI 10.1093/bioinformatics/btr670; Brett BT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024668; Burrell RA, 2013, NATURE, V501, P338, DOI 10.1038/nature12625; Butterfield YS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102398; Cho YJ, 2011, J CLIN ONCOL, V29, P1424, DOI 10.1200/JCO.2010.28.5148; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Cingolani Pablo, 2012, Frontiers in Genetics, V3, P35, DOI 10.3389/fgene.2012.00035; Clarkson R, 2011, MED PHYS, V38, P845, DOI 10.1118/1.3533947; Collier LS, 2005, NATURE, V436, P272, DOI 10.1038/nature03681; Ding L, 2012, NATURE, V481, P506, DOI 10.1038/nature10738; Dupuy AJ, 2005, NATURE, V436, P221, DOI 10.1038/nature03691; Eirew P, 2015, NATURE, V518, P422, DOI 10.1038/nature13952; Fischer A, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r39; Fraley C, 2012, 597 U WASH; Gerlinger M, 2010, BRIT J CANCER, V103, P1139, DOI 10.1038/sj.bjc.6605912; Govind SK, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-78; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Griffith M, 2013, NAT METHODS, V10, P1209, DOI [10.1038/NMETH.2689, 10.1038/nmeth.2689]; Hill RM, 2015, CANCER CELL, V27, P72, DOI 10.1016/j.ccell.2014.11.002; Hovestadt V, 2014, NATURE, V510, P537, DOI 10.1038/nature13268; Johnson BE, 2014, SCIENCE, V343, P189, DOI 10.1126/science.1239947; Jones DTW, 2012, NATURE, V488, P100, DOI 10.1038/nature11284; Jones SJM, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r82; Kool M, 2014, CANCER CELL, V25, P393, DOI 10.1016/j.ccr.2014.02.004; Kreso A, 2013, SCIENCE, V339, P543, DOI 10.1126/science.1227670; Landau DA, 2013, CELL, V152, P714, DOI 10.1016/j.cell.2013.01.019; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Ma CM, 2001, MED PHYS, V28, P868, DOI 10.1118/1.1374247; Maley CC, 2006, NAT GENET, V38, P468, DOI 10.1038/ng1768; Maley CC, 2004, CANCER EPIDEM BIOMAR, V13, P1375; McGranahan N, 2015, CANCER CELL, V27, P15, DOI 10.1016/j.ccell.2014.12.001; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Moxon-Emre I, 2014, J CLIN ONCOL, V32, P1760, DOI 10.1200/JCO.2013.52.3290; Mullighan CG, 2008, SCIENCE, V322, P1377, DOI 10.1126/science.1164266; Mumert M, 2012, CANCER RES, V72, P4944, DOI 10.1158/0008-5472.CAN-12-1629; Northcott PA, 2014, NATURE, V511, P428, DOI 10.1038/nature13379; Northcott PA, 2012, NAT REV CANCER, V12, P818, DOI 10.1038/nrc3410; Northcott PA, 2012, NATURE, V488, P49, DOI 10.1038/nature11327; Northcott PA, 2012, NAT REV NEUROL, V8, P340, DOI 10.1038/nrneurol.2012.78; Notta F, 2011, NATURE, V469, P362, DOI 10.1038/nature09733; Ollmann M, 2000, CELL, V101, P91, DOI 10.1016/S0092-8674(00)80626-1; Pugh TJ, 2012, NATURE, V488, P106, DOI 10.1038/nature11329; Ramaswamy V, 2013, LANCET ONCOL, V14, P1200, DOI 10.1016/S1470-2045(13)70449-2; Remke M, 2013, ACTA NEUROPATHOL, V126, P917, DOI 10.1007/s00401-013-1198-2; Roth A, 2014, NAT METHODS, V11, P396, DOI [10.1038/nmeth.2883, 10.1038/NMETH.2883]; Rozen S, 2000, Methods Mol Biol, V132, P365; Saunders CT, 2012, BIOINFORMATICS, V28, P1811, DOI 10.1093/bioinformatics/bts271; Shah SP, 2006, BIOINFORMATICS, V22, pE431, DOI 10.1093/bioinformatics/btl238; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; Shih DJH, 2014, J CLIN ONCOL, V32, P886, DOI 10.1200/JCO.2013.50.9539; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Vanner RJ, 2014, CANCER CELL, V26, P33, DOI 10.1016/j.ccr.2014.05.005; Wang X, 2015, ACTA NEUROPATHOL, V129, P449, DOI 10.1007/s00401-015-1389-0; Wu X, 2012, NATURE, V482, P529, DOI 10.1038/nature10825; Zhu SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046724; Zhukova N, 2013, J CLIN ONCOL, V31, P2927, DOI 10.1200/JCO.2012.48.5052	60	201	204	1	75	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 21	2016	529	7586					351	+		10.1038/nature16478	http://dx.doi.org/10.1038/nature16478			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB2QT	26760213	Green Accepted			2022-12-28	WOS:000368354800037
J	White, C				White, Caroline			SEXUAL HEALTH Sexual health services: divided and unprotected	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												cwhite@bmj.com						All-Party Parliamentary Group on Sexual and Reproductive Health in the UK, 2015, BREAK BARR NEED ACC; [Anonymous], 2013, FRAM SEX HLTH IMPR E; Faculty of Sexual and Reproductive Healthcare, 2015, STAT CUTS SEX REPR H; FPA, 2015, UNPR NAT 2015 UPD FI; Local Government Association, HLTH WELLB BOARDS PR; Office of National Statistics, 2014, INT COMP TEEN BIRTHS; Public Health England, 2015, HLTH PROTECTION REPO	7	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 20	2016	352								i309	10.1136/bmj.i309	http://dx.doi.org/10.1136/bmj.i309			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DC4ZT	26791939				2022-12-28	WOS:000369230200019
J	[Anonymous]				[Anonymous]			Euthanasia (Reprinted from JAMA, vol 218, pg 249, 1971)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint							LIFE											ABELSON PH, 1971, SCIENCE, V173, P285, DOI 10.1126/science.173.3994.285; BROWN NK, 1970, J AMER MED ASSOC, V211, P76, DOI 10.1001/jama.211.1.76; LAWS EH, 1971, J MED EDUC, V46, P540; ODONNELL TJ, 1956, MORALS MEDICINE, P55; WILLIAMS RH, 1969, ARCH INTERN MED, V124, P215, DOI 10.1001/archinte.124.2.215; 1971, JAMA, V218, P249	6	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 19	2016	315	3					310	310		10.1001/jama.2015.17071	http://dx.doi.org/10.1001/jama.2015.17071			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DB2WN	26784789				2022-12-28	WOS:000368371400036
J	Godar, M; Lambrecht, BN				Godar, Marie; Lambrecht, Bart N.			A New aDENNDum to Genetics of Childhood Asthma	CELL			English	Editorial Material							VARIANTS; CHILDREN; CELLS	Childhood asthma is typically associated with a polarized Th2 response to inhaled allergens and is influenced by genetics. Yang et al. show that the asthma susceptibility gene DENND1B controls cytokine production in Th2 lymphocytes by controlling the rate of TCR internalization and routing to endosomes, providing a molecular basis for how DENND1B contributes to asthma pathogenesis.	[Godar, Marie; Lambrecht, Bart N.] Univ Ghent VIB, IRC, B-9052 Zwijnaarde, Belgium; [Godar, Marie] Argenx, B-9052 Zwijnaarde, Belgium; [Lambrecht, Bart N.] Ghent Univ Hosp, Dept Resp Med, B-9000 Ghent, Belgium; [Lambrecht, Bart N.] ErasmusMC, Dept Pulm Med, NL-3015 GE Rotterdam, Netherlands	Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; Ghent University Hospital; Erasmus University Rotterdam; Erasmus MC	Lambrecht, BN (corresponding author), Univ Ghent VIB, IRC, B-9052 Zwijnaarde, Belgium.	bart.lambrecht@ugent.be	Lambrecht, Bart N/K-2484-2014	Lambrecht, Bart N/0000-0003-4376-6834				Bradley LM, 2002, EUR J IMMUNOL, V32, P2338, DOI 10.1002/1521-4141(200208)32:8<2338::AID-IMMU2338>3.0.CO;2-R; Chawes BLK, 2015, PEDIATR PULM, V50, P109, DOI 10.1002/ppul.22958; Hammad H, 2015, IMMUNITY, V43, P29, DOI 10.1016/j.immuni.2015.07.007; Iezzi G, 1999, EUR J IMMUNOL, V29, P4092, DOI 10.1002/(SICI)1521-4141(199912)29:12<4092::AID-IMMU4092>3.3.CO;2-1; Lambrecht BN, 2015, NAT IMMUNOL, V16, P45, DOI 10.1038/ni.3049; Marat AL, 2011, J BIOL CHEM, V286, P13791, DOI 10.1074/jbc.R110.217067; Marat AL, 2010, NEW ENGL J MED, V363, P988, DOI 10.1056/NEJMc1002262; Melen E, 2013, CLIN EXP ALLERGY, V43, P463, DOI 10.1111/cea.12054; Sleiman PMA, 2010, NEW ENGL J MED, V362, P36, DOI 10.1056/NEJMoa0901867; Yang CW, 2016, CELL, V164, P141, DOI 10.1016/j.cell.2015.11.052	10	3	3	1	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 14	2016	164	1-2					11	13		10.1016/j.cell.2015.12.045	http://dx.doi.org/10.1016/j.cell.2015.12.045			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DB2LE	26771480	Bronze			2022-12-28	WOS:000368339300003
J	Heemskerk, AD; Bang, ND; Mai, NTH; Chau, TTH; Phu, NH; Loc, PP; Chau, NVV; Hien, TT; Dung, NH; Lan, NTN; Lan, NH; Lan, NN; Phong, LT; Vien, NN; Hien, NQ; Yen, NTB; Ha, DTM; Day, JN; Caws, M; Merson, L; Thinh, TTV; Wolbers, M; Thwaites, GE; Farrar, JJ				Heemskerk, A. Dorothee; Bang, Nguyen D.; Mai, Nguyen T. H.; Chau, Tran T. H.; Phu, Nguyen H.; Loc, Pham P.; Chau, Nguyen V. V.; Hien, Tran T.; Dung, Nguyen H.; Lan, Nguyen T. N.; Lan, Nguyen H.; Lan, Nguyen N.; Phong, Le T.; Vien, Nguyen N.; Hien, Nguyen Q.; Yen, Nguyen T. B.; Ha, Dang T. M.; Day, Jeremy N.; Caws, Maxine; Merson, Laura; Thinh, Tran T. V.; Wolbers, Marcel; Thwaites, Guy E.; Farrar, Jeremy J.			Intensified Antituberculosis Therapy in Adults with Tuberculous Meningitis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PULMONARY TUBERCULOSIS; CEREBROSPINAL-FLUID; STANDARD TREATMENT; MOXIFLOXACIN; RIFAMPICIN; GATIFLOXACIN; LEVOFLOXACIN; REGIMEN; TRIAL; PHARMACOKINETICS	BACKGROUND Tuberculous meningitis is often lethal. Early antituberculosis treatment and adjunctive treatment with glucocorticoids improve survival, but nearly one third of patients with the condition still die. We hypothesized that intensified antituberculosis treatment would enhance the killing of intracerebral Mycobacterium tuberculosis organisms and decrease the rate of death among patients. METHODS We performed a randomized, double-blind, placebo-controlled trial involving human immunodeficiency virus (HIV)-infected adults and HIV-uninfected adults with a clinical diagnosis of tuberculous meningitis who were admitted to one of two Vietnamese hospitals. We compared a standard, 9-month antituberculosis regimen (which included 10 mg of rifampin per kilogram of body weight per day) with an intensified regimen that included higher-dose rifampin (15 mg per kilogram per day) and levofloxacin (20 mg per kilogram per day) for the first 8 weeks of treatment. The primary outcome was death by 9 months after randomization. RESULTS A total of 817 patients (349 of whom were HIV-infected) were enrolled; 409 were randomly assigned to receive the standard regimen, and 408 were assigned to receive intensified treatment. During the 9 months of follow-up, 113 patients in the intensified-treatment group and 114 patients in the standard-treatment group died (hazard ratio, 0.94; 95% confidence interval, 0.73 to 1.22; P=0.66). There was no evidence of a significant differential effect of intensified treatment in the overall population or in any of the subgroups, with the possible exception of patients infected with isoniazid-resistant M. tuberculosis. There were also no significant differences in secondary outcomes between the treatment groups. The overall number of adverse events leading to treatment interruption did not differ significantly between the treatment groups (64 events in the standard-treatment group and 95 events in the intensified-treatment group, P=0.08). CONCLUSIONS Intensified antituberculosis treatment was not associated with a higher rate of survival among patients with tuberculous meningitis than standard treatment. (Funded by the Wellcome Trust and the Li Ka Shing Foundation; Current Controlled Trials number, ISRCTN61649292.)	[Heemskerk, A. Dorothee; Bang, Nguyen D.; Mai, Nguyen T. H.; Chau, Tran T. H.; Phu, Nguyen H.; Hien, Tran T.; Yen, Nguyen T. B.; Ha, Dang T. M.; Day, Jeremy N.; Merson, Laura; Thinh, Tran T. V.; Wolbers, Marcel; Thwaites, Guy E.; Farrar, Jeremy J.] Univ Oxford, Clin Res Unit, Ho Chi Minh City, Vietnam; [Bang, Nguyen D.; Dung, Nguyen H.; Lan, Nguyen T. N.; Lan, Nguyen H.; Ha, Dang T. M.] Pham Ngoc Thach Hosp Tuberculosis & Lung Dis, Ho Chi Minh City, Vietnam; [Phu, Nguyen H.; Loc, Pham P.; Chau, Nguyen V. V.] Hosp Trop Dis, Ho Chi Minh City, Vietnam; [Heemskerk, A. Dorothee; Day, Jeremy N.; Merson, Laura; Wolbers, Marcel; Thwaites, Guy E.; Farrar, Jeremy J.] Univ Oxford, Nuffield Dept Med, Oxford, England; [Caws, Maxine] Univ Liverpool, Liverpool L69 3BX, Merseyside, England	University of Oxford; University of Oxford; University of Liverpool	Heemskerk, AD (corresponding author), Univ Oxford, Clin Res Unit, Ctr Trop Med, 764 Vo Kiet,Quan 5, Ho Chi Minh City, Vietnam.	dheemskerk@oucru.org; gthwaites@oucru.org	Farrar, Jeremy J./HGA-7610-2022; Thwaites, Guy E/R-4993-2019; Thi, Nguyen/AAM-7074-2020	Thwaites, Guy E/0000-0002-2858-2087; Caws, Maxine/0000-0002-9109-350X; Merson, Laura/0000-0002-4168-1960	Wellcome Trust; Li Ka Shing Foundation; MRC [G1100684] Funding Source: UKRI; Medical Research Council [G1100684] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Li Ka Shing Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Supported by the Wellcome Trust and the Li Ka Shing Foundation.	Ardito F, 2001, J CLIN MICROBIOL, V39, P4440, DOI 10.1128/JCM.39.12.4440-4444.2001; Boeree MJ, 2015, AM J RESP CRIT CARE, V191, P1058, DOI 10.1164/rccm.201407-1264OC; Donald PR, 2010, TUBERCULOSIS, V90, P375, DOI 10.1016/j.tube.2010.07.003; Donald PR, 2010, TUBERCULOSIS, V90, P279, DOI 10.1016/j.tube.2010.07.002; ELLARD GA, 1993, AM REV RESPIR DIS, V148, P650, DOI 10.1164/ajrccm/148.3.650; Gillespie SH, 2014, NEW ENGL J MED, V371, P1577, DOI 10.1056/NEJMoa1407426; Heemskerk D, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-25; Jindani A, 2014, NEW ENGL J MED, V371, P1599, DOI 10.1056/NEJMoa1314210; Johnson JL, 2006, INT J TUBERC LUNG D, V10, P605; Marais S, 2010, LANCET INFECT DIS, V10, P803, DOI 10.1016/S1473-3099(10)70138-9; MARSHALL G, 1948, LANCET, V254, P582; Merle CS, 2014, NEW ENGL J MED, V371, P1588, DOI 10.1056/NEJMoa1315817; Mitchison DA, 2000, INT J TUBERC LUNG D, V4, P796; Mitchison DA, 2005, AM J RESP CRIT CARE, V171, P699, DOI 10.1164/rccm.200411-1603OE; NAU R, 1992, J ANTIMICROB CHEMOTH, V29, P719, DOI 10.1093/jac/29.6.719; Peloquin CA, 2008, ANTIMICROB AGENTS CH, V52, P852, DOI 10.1128/AAC.01036-07; Prasad K, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002244.pub3; Ruslami R, 2007, ANTIMICROB AGENTS CH, V51, P2546, DOI 10.1128/AAC.01550-06; Ruslami R, 2013, LANCET INFECT DIS, V13, P27, DOI 10.1016/S1473-3099(12)70264-5; te Brake L, 2015, INT J ANTIMICROB AG, V45, P496, DOI 10.1016/j.ijantimicag.2014.12.027; Team RC., 2013, R LANG ENV STAT COMP; Thwaites GE, 2004, NEW ENGL J MED, V351, P1741, DOI 10.1056/NEJMoa040573; Thwaites G, 2009, J INFECTION, V59, P167, DOI 10.1016/j.jinf.2009.06.011; Thwaites GE, 2013, LANCET NEUROL, V12, P999, DOI 10.1016/S1474-4422(13)70168-6; Thwaites GE, 2011, ANTIMICROB AGENTS CH, V55, P3244, DOI 10.1128/AAC.00064-11; Torok ME, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027821; Torok ME, 2011, CLIN INFECT DIS, V52, P1374, DOI 10.1093/cid/cir230; WHO, 2010, TREATMENT OF TUBERCULOSIS: GUIDELINES, FOURTH EDITION, P1; Wolbers M, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-26	29	149	164	0	30	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 14	2016	374	2					124	134		10.1056/NEJMoa1507062	http://dx.doi.org/10.1056/NEJMoa1507062			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DA7PQ	26760084	Bronze, Green Accepted, Green Published			2022-12-28	WOS:000367996700007
J	Lander, ES				Lander, Eric S.			The Heroes of CRISPR	CELL			English	Review							PROVIDES ACQUIRED-RESISTANCE; HALOFERAX-MEDITERRANEI; IMMUNE-SYSTEM; RNA; DNA; GENOME; GENE; REPEATS; CAS; CLEAVAGE	Three years ago, scientists reported that CRISPR technology can enable precise and efficient genome editing in living eukaryotic cells. Since then, the method has taken the scientific community by storm, with thousands of labs using it for applications from biomedicine to agriculture. Yet, the preceding 20-year journey-the discovery of a strange microbial repeat sequence; its recognition as an adaptive immune system; its biological characterization; and its repurposing for genome engineering-remains little known. This Perspective aims to fill in this backstory-the history of ideas and the stories of pioneers-and draw lessons about the remarkable ecosystem underlying scientific discovery.	[Lander, Eric S.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Lander, Eric S.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Lander, Eric S.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School	Lander, ES (corresponding author), Broad Inst MIT & Harvard, 415 Main St, Cambridge, MA 02142 USA.	lander@broadinstitute.org						Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Barrangou R, 2014, MOL CELL, V54, P234, DOI 10.1016/j.molcel.2014.03.011; Barrangou R, 2012, NAT BIOTECHNOL, V30, P836, DOI 10.1038/nbt.2357; Bibikova M, 2001, MOL CELL BIOL, V21, P289, DOI 10.1128/MCB.21.1.289-297.2001; Bibikova M, 2003, SCIENCE, V300, P764, DOI 10.1126/science.1079512; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Capecchi MR, 2005, NAT REV GENET, V6, P507, DOI 10.1038/nrg1619; Carroll D, 2012, MOL THER, V20, P1658, DOI 10.1038/mt.2012.171; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Haber JE, 2000, MUTAT RES-FUND MOL M, V451, P53, DOI 10.1016/S0027-5107(00)00040-3; Hale CR, 2009, CELL, V139, P945, DOI 10.1016/j.cell.2009.07.040; Horvath P, 2008, J BACTERIOL, V190, P1401, DOI 10.1128/JB.01415-07; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; ISHINO Y, 1987, J BACTERIOL, V169, P5429, DOI 10.1128/jb.169.12.5429-5433.1987; Jansen R, 2002, MOL MICROBIOL, V43, P1565, DOI 10.1046/j.1365-2958.2002.02839.x; Jasin M, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012740; Jiang WY, 2015, ANNU REV MICROBIOL, V69, P209, DOI 10.1146/annurev-micro-091014-104441; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Makarova KS, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-7; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mangold M, 2004, MOL MICROBIOL, V53, P1515, DOI 10.1111/j.1365-2958.2004.04222.x; Marraffini L., 2008, U. S. Provisional Patent Application, Patent No. [61/ 009,317, 61009317]; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Medawar P, 1968, LUCKY JIM; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Mojica FJM, 2000, MOL MICROBIOL, V36, P244, DOI 10.1046/j.1365-2958.2000.01838.x; MOJICA FJM, 1995, MOL MICROBIOL, V17, P85, DOI 10.1111/j.1365-2958.1995.mmi_17010085.x; MOJICA FJM, 1993, MOL MICROBIOL, V9, P613, DOI 10.1111/j.1365-2958.1993.tb01721.x; Mojica FJM, 2012, CRISPR CAS SYSTEMS, P1; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Pandika M., 2014, J DOUDNA CRISPR CODE; Porteus MH, 2003, SCIENCE, V300, P763, DOI 10.1126/science.1078395; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Sapranauskas R, 2011, NUCLEIC ACIDS RES, V39, P9275, DOI 10.1093/nar/gkr606; Sharma CM, 2010, NATURE, V464, P250, DOI 10.1038/nature08756; Siksnys V., 2012, U. S. Provisional Patent Application, Patent No. [61/ 613,373, 61613373]; Sorek R, 2008, NAT REV MICROBIOL, V6, P181, DOI 10.1038/nrmicro1793; Sternberg SH, 2015, MOL CELL, V58, P568, DOI 10.1016/j.molcel.2015.02.032; Travis J, 2015, SCIENCE, V350, P1299, DOI 10.1126/science.350.6266.1299; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; van der Oost J, 2014, NAT REV MICROBIOL, V12, P479, DOI 10.1038/nrmicro3279; Wright AV, 2016, CELL, V164, P29, DOI 10.1016/j.cell.2015.12.035; Zetsche B., 2015, CELL; Zhang F, 2011, NAT BIOTECHNOL, V29, P149, DOI 10.1038/nbt.1775; Zhang FS, 2012, SCI WORLD J, DOI 10.1100/2012/289896	57	252	285	21	360	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 14	2016	164	1-2					18	28		10.1016/j.cell.2015.12.041	http://dx.doi.org/10.1016/j.cell.2015.12.041			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DB2LE	26771483	Bronze			2022-12-28	WOS:000368339300006
J	Alexandrov, LB				Alexandrov, Ludmil B.			Understanding the origins of human cancer	SCIENCE			English	Editorial Material							21 BREAST CANCERS; MUTATIONAL PROCESSES; SOMATIC MUTATIONS; PROSTATE-CANCER; SIGNATURES; GENOMES; HISTORY; BURDEN; REPAIR		[Alexandrov, Ludmil B.] Los Alamos Natl Lab, Theoret Biol & Biophys T6, Los Alamos, NM 87545 USA	United States Department of Energy (DOE); Los Alamos National Laboratory	Alexandrov, LB (corresponding author), Los Alamos Natl Lab, Theoret Biol & Biophys T6, POB 1663, Los Alamos, NM 87545 USA.	lba@lanl.gov	Alexandrov, Ludmil/AAS-1454-2021	Alexandrov, Ludmil/0000-0003-3596-4515				Alexandrov LB, 2014, CURR OPIN GENET DEV, V24, P52, DOI 10.1016/j.gde.2013.11.014; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Alexandrov LB, 2013, CELL REP, V3, P246, DOI 10.1016/j.celrep.2012.12.008; Behjati S, 2014, NATURE, V513, P422, DOI 10.1038/nature13448; Bolli N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms3997; Cooper CS, 2015, NAT GENET, V47, P367, DOI 10.1038/ng.3221; Gundem G, 2015, NATURE, V520, P353, DOI 10.1038/nature14347; Hollstein M, 1999, MUTAT RES-FUND MOL M, V431, P199, DOI 10.1016/S0027-5107(99)00162-1; Hong MKH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7605; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Ju YS, 2014, ELIFE, V3, DOI 10.7554/eLife.02935; Kanu N, 2015, ONCOGENE, V34, P5699, DOI 10.1038/onc.2015.24; Lee DD, 1999, NATURE, V401, P788, DOI 10.1038/44565; Martincorena I, 2015, SCIENCE, V348, P880, DOI 10.1126/science.aaa6806; Nik-Zainal S, 2014, NAT GENET, V46, P487, DOI 10.1038/ng.2955; Nik-Zainal S, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.023; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Papaemmanuil E, 2014, NAT GENET, V46, P116, DOI 10.1038/ng.2874; Schulze K, 2015, NAT GENET, V47, P505, DOI 10.1038/ng.3252; Shlien A, 2015, NAT GENET, V47, P257, DOI 10.1038/ng.3202; Stratton MR, 2011, SCIENCE, V331, P1553, DOI 10.1126/science.1204040; VOGELSTEIN B, 1992, NATURE, V355, P209, DOI 10.1038/355209a0; Wagener R, 2015, LEUKEMIA, V29, P1612, DOI 10.1038/leu.2015.22; Yates LR, 2015, NAT MED, V21, P751, DOI 10.1038/nm.3886	24	24	25	0	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 4	2015	350	6265								10.1126/science.aad7363	http://dx.doi.org/10.1126/science.aad7363			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX4WG	26785464	Green Submitted			2022-12-28	WOS:000365700500050
J	Karimi, E; Boyd, RW				Karimi, Ebrahim; Boyd, Robert W.			Classical entanglement?	SCIENCE			English	Editorial Material							INEQUALITY		[Karimi, Ebrahim; Boyd, Robert W.] Univ Ottawa, Dept Phys, Ottawa, ON K1N 6N5, Canada; [Karimi, Ebrahim; Boyd, Robert W.] Univ Ottawa, Max Planck Ctr Extreme & Quantum Photon, Ottawa, ON K1N 6N5, Canada; [Boyd, Robert W.] Univ Rochester, Inst Opt, Rochester, NY 14627 USA	University of Ottawa; University of Ottawa; University of Rochester	Karimi, E (corresponding author), Univ Ottawa, Dept Phys, Ottawa, ON K1N 6N5, Canada.	ekarimi@uottawa.ca; boydrw@mac.com	Karimi, Ebrahim/V-1253-2019	Karimi, Ebrahim/0000-0002-8168-7304				Bell JS., 1964, PHYS, V1, P195, DOI [10.1103/PhysicsPhysiqueFizika.1.195, 10.1103/Physics-PhysiqueFizika.1.195, DOI 10.1103/PHYSICSPHYSIQUEFIZIKA.1.195]; Einstein A, 1935, PHYS REV, V47, P0777, DOI 10.1103/PhysRev.47.777; Goldin MA, 2010, J OPT SOC AM B, V27, P779, DOI 10.1364/JOSAB.27.000779; Groblacher S, 2007, NATURE, V446, P871, DOI 10.1038/nature05677; Hasegawa Y, 2003, NATURE, V425, P45, DOI 10.1038/nature01881; Karimi E, 2010, PHYS REV A, V82, DOI 10.1103/PhysRevA.82.022115; Leggett AJ, 2003, FOUND PHYS, V33, P1469, DOI 10.1023/A:1026096313729; Qian XF, 2015, OPTICA, V2, P611, DOI 10.1364/OPTICA.2.000611; SCHRODINGER E, 1935, MATH P CAMBRIDGE PHI, V31, P555, DOI DOI 10.1017/S0305004100013554; Song XB, 2015, SCI REP-UK, V5, DOI 10.1038/srep14113; Spreeuw RJC, 1998, FOUND PHYS, V28, P361, DOI 10.1023/A:1018703709245; Toppel F, 2014, NEW J PHYS, V16, DOI 10.1088/1367-2630/16/7/073019	12	67	69	1	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 4	2015	350	6265					1172	1173		10.1126/science.aad7174	http://dx.doi.org/10.1126/science.aad7174			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX4WG	26785462				2022-12-28	WOS:000365700500048
J	Verdin, E				Verdin, Eric			NAD(+) in aging, metabolism, and neurodegeneration	SCIENCE			English	Review							EXTENDS LIFE-SPAN; FATTY-ACID OXIDATION; PROMOTES CELL-SURVIVAL; NICOTINAMIDE RIBOSIDE; CALORIE RESTRICTION; WALLERIAN DEGENERATION; MOUSE MODEL; POLY(ADP-RIBOSE) POLYMERASE; NEUROPROTECTIVE EFFICACY; AMINOPROPYL CARBAZOLES	Nicotinamide adenine dinucleotide (NAD(+)) is a coenzyme found in all living cells. It serves both as a critical coenzyme for enzymes that fuel reduction-oxidation reactions, carrying electrons from one reaction to another, and as a cosubstrate for other enzymes such as the sirtuins and poly(adenosine diphosphate-ribose) polymerases. Cellular NAD(+) concentrations change during aging, and modulation of NAD(+) usage or production can prolong both health span and life span. Here we review factors that regulate NAD(+) and discuss how supplementation with NAD(+) precursors may represent a new therapeutic opportunity for aging and its associated disorders, particularly neurodegenerative diseases.	[Verdin, Eric] Univ Calif San Francisco, Dept Med, Gladstone Inst, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes	Verdin, E (corresponding author), Univ Calif San Francisco, Dept Med, Gladstone Inst, San Francisco, CA 94158 USA.	everdin@gladstone.ucsf.edu	Verdin, Eric/AAB-7999-2019	Verdin, Eric/0000-0003-3703-3183	NIDDK NIH HHS [R24 DK085610] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK085610] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aksoy P, 2006, BIOCHEM BIOPH RES CO, V349, P353, DOI 10.1016/j.bbrc.2006.08.066; Aksoy P, 2006, BIOCHEM BIOPH RES CO, V345, P1386, DOI 10.1016/j.bbrc.2006.05.042; Ame JC, 1999, J BIOL CHEM, V274, P17860, DOI 10.1074/jbc.274.25.17860; Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; Bai P, 2011, CELL METAB, V13, P461, DOI 10.1016/j.cmet.2011.03.004; Banerjee KK, 2012, CELL REP, V2, P1485, DOI 10.1016/j.celrep.2012.11.013; Barbosa MTP, 2007, FASEB J, V21, P3629, DOI 10.1096/fj.07-8290com; Bauer JH, 2009, AGING-US, V1, P38; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Belenky P, 2007, TRENDS BIOCHEM SCI, V32, P12, DOI 10.1016/j.tibs.2006.11.006; Belenky P, 2007, CELL, V129, P473, DOI 10.1016/j.cell.2007.03.024; Berger F, 2005, J BIOL CHEM, V280, P36334, DOI 10.1074/jbc.M508660200; Bock FJ, 2015, MOL CELL, V58, P959, DOI 10.1016/j.molcel.2015.01.037; Bogan KL, 2008, ANNU REV NUTR, V28, P115, DOI 10.1146/annurev.nutr.28.061807.155443; Braidy N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019194; Brown KD, 2014, CELL METAB, V20, P1059, DOI 10.1016/j.cmet.2014.11.003; Burnett C, 2011, NATURE, V477, P482, DOI 10.1038/nature10296; Canto C, 2012, CELL METAB, V15, P838, DOI 10.1016/j.cmet.2012.04.022; Canto C, 2015, CELL METAB, V22, P31, DOI 10.1016/j.cmet.2015.05.023; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Cerutti R, 2014, CELL METAB, V19, P1042, DOI 10.1016/j.cmet.2014.04.001; Chen D, 2008, GENE DEV, V22, P1753, DOI 10.1101/gad.1650608; Conforti L, 2014, NAT REV NEUROSCI, V15, P394, DOI 10.1038/nrn3680; Costford SR, 2010, AM J PHYSIOL-ENDOC M, V298, pE117, DOI 10.1152/ajpendo.00318.2009; De Jesus-Cortes H, 2012, P NATL ACAD SCI USA, V109, P17010, DOI 10.1073/pnas.1213956109; Durieux J, 2011, CELL, V144, P79, DOI 10.1016/j.cell.2010.12.016; Easlon E, 2008, GENE DEV, V22, P931, DOI 10.1101/gad.1648308; Fang EF, 2014, CELL, V157, P882, DOI 10.1016/j.cell.2014.03.026; Feige JN, 2008, CELL METAB, V8, P347, DOI 10.1016/j.cmet.2008.08.017; Feldman JL, 2013, J BIOL CHEM, V288, P31350, DOI 10.1074/jbc.C113.511261; Felici R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076938; Feng FY, 2015, MOL CELL, V58, P925, DOI 10.1016/j.molcel.2015.04.016; Fernandez-Marcos PJ, 2011, AM J CLIN NUTR, V93, p884S, DOI 10.3945/ajcn.110.001917; Fulco M, 2008, DEV CELL, V14, P661, DOI 10.1016/j.devcel.2008.02.004; Garavaglia S, 2012, BIOCHEM J, V441, P131, DOI 10.1042/BJ20111263; Garten A, 2015, NAT REV ENDOCRINOL, V11, P535, DOI 10.1038/nrendo.2015.117; Garten A, 2009, TRENDS ENDOCRIN MET, V20, P130, DOI 10.1016/j.tem.2008.10.004; Gerhart-Hines Z, 2011, MOL CELL, V44, P851, DOI 10.1016/j.molcel.2011.12.005; Gomes AP, 2013, CELL, V155, P1624, DOI 10.1016/j.cell.2013.11.037; GROSS CJ, 1983, J NUTR, V113, P412, DOI 10.1093/jn/113.2.412; Grozio A, 2013, J BIOL CHEM, V288, P25938, DOI 10.1074/jbc.M113.470435; Hallows WC, 2011, MOL CELL, V41, P139, DOI 10.1016/j.molcel.2011.01.002; He WJ, 2012, TRENDS ENDOCRIN MET, V23, P467, DOI 10.1016/j.tem.2012.07.004; Hebert AS, 2013, MOL CELL, V49, P186, DOI 10.1016/j.molcel.2012.10.024; Herranz D, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1001; Hirschey MD, 2011, MOL CELL, V44, P177, DOI 10.1016/j.molcel.2011.07.019; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Houtkooper RH, 2010, ENDOCR REV, V31, P194, DOI 10.1210/er.2009-0026; Hu YD, 2014, J PROTEOME RES, V13, P786, DOI 10.1021/pr4010597; IKEDA M, 1965, J BIOL CHEM, V240, P1395; Imai S, 2013, DIABETES OBES METAB, V15, P26, DOI 10.1111/dom.12171; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Jiang H, 2010, J AM CHEM SOC, V132, P9363, DOI 10.1021/ja101588r; Kaelin WG, 2013, CELL, V153, P56, DOI 10.1016/j.cell.2013.03.004; Kanfi Y, 2012, NATURE, V483, P218, DOI 10.1038/nature10815; Karamanlidis G, 2013, CELL METAB, V18, P239, DOI 10.1016/j.cmet.2013.07.002; Kawahara TLA, 2009, CELL, V136, P62, DOI 10.1016/j.cell.2008.10.052; Khan NA, 2014, EMBO MOL MED, V6, P721, DOI 10.1002/emmm.201403943; Kolthur-Seetharam U, 2006, CELL CYCLE, V5, P873, DOI 10.4161/cc.5.8.2690; Kraus D, 2014, NATURE, V508, P258, DOI 10.1038/nature13198; Kraus WL, 2015, MOL CELL, V58, P902, DOI 10.1016/j.molcel.2015.06.006; Kwon HS, 2012, J IMMUNOL, V188, P2712, DOI 10.4049/jimmunol.1100903; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lanska DJ, 2012, ANN NUTR METAB, V61, P246, DOI 10.1159/000343115; Lim HW, 2015, J EXP MED, V212, P607, DOI 10.1084/jem.20132378; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Lombard DB, 2007, MOL CELL BIOL, V27, P8807, DOI 10.1128/MCB.01636-07; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; LUNN ER, 1989, EUR J NEUROSCI, V1, P27, DOI 10.1111/j.1460-9568.1989.tb00771.x; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Mack TGA, 2001, NAT NEUROSCI, V4, P1199, DOI 10.1038/nn770; Massudi H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042357; MENDOZAALVAREZ H, 1993, J BIOL CHEM, V268, P22575; Mercken EM, 2014, AGING CELL, V13, P787, DOI 10.1111/acel.12220; Michishita E, 2008, NATURE, V452, P492, DOI 10.1038/nature06736; Mitchell SJ, 2014, CELL REP, V6, P836, DOI 10.1016/j.celrep.2014.01.031; Mostoslavsky R, 2006, CELL, V124, P315, DOI 10.1016/J.CEL.2005.11.044; Mouchiroud L, 2013, CELL, V154, P430, DOI 10.1016/j.cell.2013.06.016; Murayama A, 2008, CELL, V133, P627, DOI 10.1016/j.cell.2008.03.030; Nakahata Y, 2009, SCIENCE, V324, P654, DOI 10.1126/science.1170803; Pacholec M, 2010, J BIOL CHEM, V285, P8340, DOI 10.1074/jbc.M109.088682; Peek CB, 2013, SCIENCE, V342, P591, DOI 10.1126/science.1243417; Pieper AA, 2010, CELL, V142, P39, DOI 10.1016/j.cell.2010.06.018; Pirinen E, 2014, CELL METAB, V19, P1034, DOI 10.1016/j.cmet.2014.04.002; Price NL, 2012, CELL METAB, V15, P675, DOI 10.1016/j.cmet.2012.04.003; Pugh TD, 2013, AGING CELL, V12, P672, DOI 10.1111/acel.12091; Qiu XL, 2010, CELL METAB, V12, P662, DOI 10.1016/j.cmet.2010.11.015; Rajamohan SB, 2009, MOL CELL BIOL, V29, P4116, DOI 10.1128/MCB.00121-09; Ramsey KM, 2008, AGING CELL, V7, P78, DOI 10.1111/j.1474-9726.2007.00355.x; Ramsey KM, 2009, SCIENCE, V324, P651, DOI 10.1126/science.1171641; Rardin MJ, 2013, P NATL ACAD SCI USA, V110, P6601, DOI 10.1073/pnas.1302961110; Ristow M, 2011, FREE RADICAL BIO MED, V51, P327, DOI 10.1016/j.freeradbiomed.2011.05.010; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Rogina B, 2004, P NATL ACAD SCI USA, V101, P15998, DOI 10.1073/pnas.0404184101; Rogina B, 2002, SCIENCE, V298, P1745, DOI 10.1126/science.1078986; Satoh A, 2013, CELL METAB, V18, P416, DOI 10.1016/j.cmet.2013.07.013; Scheibye-Knudsen M, 2015, TRENDS CELL BIOL, V25, P158, DOI 10.1016/j.tcb.2014.11.002; Scheibye-Knudsen M, 2014, CELL METAB, V20, P840, DOI 10.1016/j.cmet.2014.10.005; Schmeisser K, 2013, NAT CHEM BIOL, V9, P693, DOI [10.1038/NCHEMBIO.1352, 10.1038/nchembio.1352]; Shackelford Rodney E, 2013, Genes Cancer, V4, P447, DOI 10.1177/1947601913507576; Shimazu T, 2013, SCIENCE, V339, P211, DOI 10.1126/science.1227166; Someya S, 2010, CELL, V143, P802, DOI 10.1016/j.cell.2010.10.002; Tesla R, 2012, P NATL ACAD SCI USA, V109, P17016, DOI 10.1073/pnas.1213960109; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Valenzuela MT, 2002, ONCOGENE, V21, P1108, DOI 10.1038/sj.onc.1205169; van Loosdregt J, 2010, BLOOD, V115, P965, DOI 10.1182/blood-2009-02-207118; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Viswanathan M, 2011, NATURE, V477, pE1, DOI 10.1038/nature10440; Wagner GR, 2012, HUM MOL GENET, V21, P2688, DOI 10.1093/hmg/dds095; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wang G, 2014, CELL, V158, P1324, DOI 10.1016/j.cell.2014.07.040; Yang SJ, 2014, J NUTR BIOCHEM, V25, P66, DOI 10.1016/j.jnutbio.2013.09.004; Yin TC, 2014, CELL REP, V8, P1731, DOI 10.1016/j.celrep.2014.08.030; Yoshino J, 2011, CELL METAB, V14, P528, DOI 10.1016/j.cmet.2011.08.014; Zhang XJ, 2003, J BIOL CHEM, V278, P13503, DOI 10.1074/jbc.M300073200	115	615	633	22	265	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 4	2015	350	6265					1208	1213		10.1126/science.aac4854	http://dx.doi.org/10.1126/science.aac4854			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX4WG	26785480				2022-12-28	WOS:000365700500065
J	Nelson, HD; Fu, R; Cantor, A; Pappas, M; Daeges, M; Humphrey, L				Nelson, Heidi D.; Fu, Rochelle; Cantor, Amy; Pappas, Miranda; Daeges, Monica; Humphrey, Linda			Effectiveness of Breast Cancer Screening: Systematic Review and Meta-analysis to Update the 2009 US Preventive Services Task Force Recommendation	ANNALS OF INTERNAL MEDICINE			English	Review							SWEDISH 2-COUNTY TRIAL; HEALTH-INSURANCE PLAN; WOMEN AGED 40; FOLLOW-UP; STAGE DISTRIBUTION; RANDOMIZED-TRIAL; DEATH RATES; MORTALITY; MAMMOGRAPHY; PROGRAM	Background: In 2009, the U.S. Preventive Services Task Force recommended biennial mammography screening for women aged 50 to 74 years and selective screening for those aged 40 to 49 years. Purpose: To review studies of the effectiveness of breast cancer screening in average-risk women. Data Sources: MEDLINE and Cochrane databases to 4 June 2015. Study Selection: English-language randomized, controlled trials and observational studies of screening with mammography, magnetic resonance imaging, and ultrasonography that reported breast cancer mortality, all-cause mortality, or advanced breast cancer outcomes. Data Extraction: Investigators extracted and confirmed data and dual rated study quality; discrepancies were resolved through consensus. Data Synthesis: Fair-quality evidence from a meta-analysis of mammography trials indicated relative risks (RRs) for breast cancer mortality of 0.92 for women aged 39 to 49 years (95% Cl, 0.75 to 1.02) (9 trials; 3 deaths prevented per 10 000 women over 10 years); 0.86 for those aged 50 to 59 years (Cl, 0.68 to 0.97) (7 trials; 8 deaths prevented per 10 000 women over 10 years); 0.67 for those aged 60 to 69 years (Cl, 0.54 to 0.83) (5 trials; 21 deaths prevented per 10 000 women over 10 years); and 0.80 for those aged 70 to 74 years (Cl, 0.51 to 1.28) (3 trials; 13 deaths prevented per 10 000 women over 10 years). Risk reduction was 25% to 31% for women aged 50 to 69 years in observational studies of mammography screening. All-cause mortality was not reduced with screening. Advanced breast cancer was reduced for women aged 50 years or older (RR, 0.62 [Cl, 0.46 to 0.831)(3 trials) but not those aged 39 to 49 years (RR, 0.98 [Cl, 0.74 to 1.37]) (4 trials); less evidence supported this outcome. Limitations: Most trials used imaging technologies and treatments that are now outdated, and definitions of advanced breast cancer were heterogeneous. Studies of effectiveness based on risk factors, intervals, or other modalities were unavailable or methodologically limited. Conclusion: Breast cancer mortality is generally reduced with mammography screening, although estimates are not statistically significant at all ages and the magnitudes of effect are small. Advanced cancer is reduced with screening for women aged 50 years or older.	[Nelson, Heidi D.; Fu, Rochelle; Cantor, Amy; Pappas, Miranda; Daeges, Monica; Humphrey, Linda] Oregon Hlth & Sci Univ, 3181 SW Sam Jackson Pk Rd,Mail Code BICC, Portland, OR 97239 USA	Oregon Health & Science University	Nelson, HD (corresponding author), Oregon Hlth & Sci Univ, 3181 SW Sam Jackson Pk Rd,Mail Code BICC, Portland, OR 97239 USA.	nelsonh@ohsu.edu		Cantor, Amy/0000-0002-4467-8484	Agency for Healthcare Research and Quality	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Agency for Healthcare Research and Quality.	Alexander FE, 1999, LANCET, V353, P1903, DOI 10.1016/S0140-6736(98)07413-3; Allgood PC, 2008, BRIT J CANCER, V98, P206, DOI 10.1038/sj.bjc.6604123; ANDERSSON I, 1988, BRIT MED J, V297, P943, DOI 10.1136/bmj.297.6654.943; ARON JL, 1986, INT J EPIDEMIOL, V15, P36, DOI 10.1093/ije/15.1.36; Ascunce EN, 2007, J MED SCREEN, V14, P14, DOI 10.1258/096914107780154558; Autier P, 2011, ANN ONCOL, V22, P1726, DOI 10.1093/annonc/mdq633; Autier P, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4411; Autier P, 2009, J CLIN ONCOL, V27, P5919, DOI 10.1200/JCO.2009.22.7041; Barchielli A, 2001, CANCER CAUSE CONTROL, V12, P249, DOI 10.1023/A:1011280204842; Bjurstam N, 2003, CANCER-AM CANCER SOC, V97, P2387, DOI 10.1002/cncr.11361; Blamey RW, 2002, EUR J CANCER, V38, P1458; Blanks RG, 2000, BRIT MED J, V321, P665, DOI 10.1136/bmj.321.7262.665; Bleyer A, 2012, NEW ENGL J MED, V367, P1998, DOI 10.1056/NEJMoa1206809; Block LD, 2013, J GEN INTERN MED, V28, P1447, DOI 10.1007/s11606-013-2482-5; Broeders M, 2012, J MED SCREEN, V19, P14, DOI 10.1258/jms.2012.012078; Buseman S, 2003, CANCER-AM CANCER SOC, V97, P352, DOI 10.1002/cncr.11050; Cabanes A, 2009, CANCER EPIDEMIOL, V33, P169, DOI 10.1016/j.canep.2009.08.010; Calonge N, 2009, ANN INTERN MED, V151, P716, DOI 10.7326/0003-4819-151-10-200911170-00008; CHU KC, 1988, JNCI-J NATL CANCER I, V80, P1125, DOI 10.1093/jnci/80.14.1125; Coldman A, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju261; Coldman AJ, 2008, J MED SCREEN, V15, P182, DOI 10.1258/jms.2008.008064; Dittus K, 2013, J GEN INTERN MED, V28, P1454, DOI 10.1007/s11606-013-2507-0; Duffy SW, 2010, J MED SCREEN, V17, P25, DOI 10.1258/jms.2009.009094; Duffy SW, 2006, CANCER EPIDEM BIOMAR, V15, P45, DOI 10.1158/1055-9965.EPI-05-0349; Duffy SW, 2003, ANN ONCOL, V14, P1196, DOI 10.1093/annonc/mdg322; Edge SB, 2010, AJCC CANC STAGING MA; Fielder HM, 2004, J MED SCREEN, V11, P194, DOI 10.1258/0969141042467304; Frisell J, 1997, BREAST CANCER RES TR, V45, P263, DOI 10.1023/A:1005872617944; Gabe R, 2007, ACTA RADIOL, V48, P948, DOI 10.1080/02841850701501725; Fernandez AG, 2014, TUMOR BIOL, V35, P1945, DOI 10.1007/s13277-013-1260-7; Goel A, 2007, BREAST CANCER RES TR, V102, P339, DOI 10.1007/s10549-006-9334-5; Gorini G, 2004, BRIT J CANCER, V90, P1780, DOI 10.1038/sj.bjc.6601744; Gotzsche PC, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001877.pub5; HABBEMA JDF, 1986, JNCI-J NATL CANCER I, V77, P317; Hakama M, 1997, BRIT MED J, V314, P864; Hardy RJ, 1996, STAT MED, V15, P619, DOI 10.1002/(SICI)1097-0258(19960330)15:6<619::AID-SIM188>3.0.CO;2-A; Harris RP, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(01)00261-6; Harris R, 2011, PREV MED, V53, P108, DOI 10.1016/j.ypmed.2011.07.004; Haukka J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022422; Hellquist BN, 2011, CANCER-AM CANCER SOC, V117, P714, DOI 10.1002/cncr.25650; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hofvind S, 2012, ROFO-FORTSCHR RONTG, V184, P437, DOI 10.1055/s-0031-1299352; Hofvind S, 2013, CANCER-AM CANCER SOC, V119, P3106, DOI 10.1002/cncr.28174; Hubbard RA, 2011, ANN INTERN MED, V155, P481, DOI 10.7326/0003-4819-155-8-201110180-00004; Jensen AR, 2003, ACTA ONCOL, V42, P701, DOI 10.1080/02841860310010556; Jorgensen KJ, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1241; Kalager M, 2010, NEW ENGL J MED, V363, P1203, DOI 10.1056/NEJMoa1000727; Kerlikowske K, 2013, JAMA INTERN MED, V173, P807, DOI 10.1001/jamainternmed.2013.307; Lousdal ML, 2014, EUR J PUBLIC HEALTH, V24, P1017, DOI 10.1093/eurpub/cku015; Melnikow J, 2015, AHRQ PUBLICATION; Miller AB, 2000, JNCI-J NATL CANCER I, V92, P1490, DOI 10.1093/jnci/92.18.1490; Miller AB, 2002, ANN INTERN MED, V137, P305, DOI 10.7326/0003-4819-137-5_Part_1-200209030-00005; MILLER AB, 1992, CAN MED ASSOC J, V147, P1477; MILLER AB, 1992, CAN MED ASSOC J, V147, P1459; Miller Anthony B, 2014, BMJ, V348, pg366, DOI 10.1136/bmj.g366; Mook S, 2011, JNCI-J NATL CANCER I, V103, P585, DOI 10.1093/jnci/djr043; Moss S, 2005, BRIT J CANCER, V92, P949, DOI 10.1038/sj.bjc.6602396; Moss SM, 2012, J MED SCREEN, V19, P26, DOI 10.1258/jms.2012.012079; Moss SM, 2006, LANCET, V368, P2053, DOI 10.1016/S0140-6736(06)69834-6; Moss SM, 2015, LANCET ONCOL, V16, P1123, DOI 10.1016/S1470-2045(15)00128-X; National Center for Health Statistics, TABL 83 PAG 1 3 US M, P1; National Committee for Quality Assurance, STAT HLTH CAR QUAL B; Nelson HD, 2015, AHRQ PUBLICATION; Nelson HD, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0131903, DOI 10.1371/J0URNAL.P0NE.0131903]; Nelson HD, 2012, ANN INTERN MED, V156, P635, DOI 10.7326/0003-4819-156-9-201205010-00006; Nelson HD, 2009, ANN INTERN MED, V151, P727, DOI 10.7326/0003-4819-151-10-200911170-00009; Njor S, 2012, J MED SCREEN, V19, P33, DOI 10.1258/jms.2012.012080; Nystrom L, 2002, LANCET, V359, P909, DOI 10.1016/S0140-6736(02)08020-0; Olivotto IA, 1999, BREAST CANCER RES TR, V54, P73, DOI 10.1023/A:1006152918283; Olsen AH, 2005, BMJ-BRIT MED J, V330, P220, DOI 10.1136/bmj.38313.639236.82; Olsson A, 2009, CANCER EPIDEMIOL, V33, P9, DOI 10.1016/j.canep.2009.04.008; Otten JDM, 2008, INT J CANCER, V123, P1929, DOI 10.1002/ijc.23736; Otto SJ, 2003, LANCET, V361, P1411, DOI 10.1016/S0140-6736(03)13132-7; Otto SJ, 2012, CANCER EPIDEM BIOMAR, V21, P66, DOI 10.1158/1055-9965.EPI-11-0476; Paci E, 2002, EUR J CANCER, V38, P568, DOI 10.1016/S0959-8049(01)00382-3; Parvinen I, 2011, BRIT J CANCER, V105, P1388, DOI 10.1038/bjc.2011.372; Pons-Vigues M, 2008, CANCER DETECT PREV, V32, P162, DOI 10.1016/j.cdp.2008.05.002; Puliti D, 2008, BRIT J CANCER, V99, P423, DOI 10.1038/sj.bjc.6604532; Rose SL, 2013, AM J ROENTGENOL, V200, P1401, DOI 10.2214/AJR.12.9672; Sarkeala T, 2008, BRIT J CANCER, V98, P641, DOI 10.1038/sj.bjc.6604203; Schonberg MA, 2009, J CLIN ONCOL, V27, P1774, DOI 10.1200/JCO.2008.19.9877; SHAPIRO S, 1982, JNCI-J NATL CANCER I, V69, P349; Skaane P, 2013, RADIOLOGY, V267, P47, DOI 10.1148/radiol.12121373; TABAR L, 1995, CANCER, V75, P2507, DOI 10.1002/1097-0142(19950515)75:10<2507::AID-CNCR2820751017>3.0.CO;2-H; Tabar L, 2011, RADIOLOGY, V260, P658, DOI 10.1148/radiol.11110469; U. S. Preventive Services Task Force, 2011, PROC MAN; van Schoor G, 2011, BRIT J CANCER, V104, P910, DOI 10.1038/bjc.2011.44; White E, 2004, JNCI-J NATL CANCER I, V96, P1832, DOI 10.1093/jnci/djh337	88	276	289	2	32	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 16	2016	164	4					244	+		10.7326/M15-0969	http://dx.doi.org/10.7326/M15-0969			20	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DD7WK	26756588				2022-12-28	WOS:000370135300015
J	ten Hoope-Bender, P; Stenberg, K; Sweeny, K				ten Hoope-Bender, Petra; Stenberg, Karin; Sweeny, Kim			Reductions in stillbirths-more than a triple return on investment	LANCET			English	Editorial Material									[Stenberg, Karin] World Hlth Org, Dept Hlth Syst Governance & Financing, Geneva, Switzerland; [Sweeny, Kim] Victoria Univ Technol, Victoria Inst Strateg Econ Studies, Melbourne, Vic 3000, Australia	World Health Organization; Victoria University		tenhoope-bender@bluewin.ch			World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		Flenady V, 2016, LANCET, V387, P691, DOI 10.1016/S0140-6736(15)01020-X; Froen JF, 2016, LANCET; Heazell AEP, 2016, LANCET, V387, P604, DOI 10.1016/S0140-6736(15)00836-3; Jamison DT, 2013, LANCET, V382, P1898, DOI 10.1016/S0140-6736(13)62105-4; Kinney MV, 2016, LANCET; Lawn JE, 2016, LANCET; Partnership for Maternal Newborn and Child Health, 2011, GLOB REV KEY INT REL; Renfrew MJ, 2014, LANCET, V384, P1129, DOI 10.1016/S0140-6736(14)60789-3; Stenberg K, 2014, LANCET, V383, P1333, DOI 10.1016/S0140-6736(13)62231-X; UNICEF, 2014, STAT WORLDS CHILDR 2; Walker N, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-S3-S1	11	12	12	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 6	2016	387	10018					E14	E16		10.1016/S0140-6736(15)01277-5	http://dx.doi.org/10.1016/S0140-6736(15)01277-5			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DD3PV	26794075				2022-12-28	WOS:000369835800002
J	Gawande, A				Gawande, Atul			Quantity and Quality of Life Duties of Care in Life-Limiting Illness	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Gawande, Atul] Brigham & Womens Hosp, Ariadne Labs, Boston, MA 02115 USA; [Gawande, Atul] Harvard Univ, TH Chan Sch Publ Hlth, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health	Gawande, A (corresponding author), Ariadne Labs, 401 Pk Dr,Third Floor E, Boston, MA 02215 USA.	agawande@partners.org						Angus DC, 2016, JAMA-J AM MED ASSOC, V315, P255, DOI 10.1001/jama.2015.18681; Bekelman JE, 2016, JAMA-J AM MED ASSOC, V315, P272, DOI 10.1001/jama.2015.18603; Bernacki RE, 2014, JAMA INTERN MED, V174, P1994, DOI 10.1001/jamainternmed.2014.5271; Blecker S, 2016, JAMA-J AM MED ASSOC, V315, P301, DOI 10.1001/jama.2015.16976; CMS, MED CAR CHOIC MOD; Connor SR, 2007, J PAIN SYMPTOM MANAG, V33, P238, DOI 10.1016/j.jpainsymman.2006.10.010; Institute of Medicine, 2014, DYING AM IMPR QUAL H; Klinger CA, 2014, PALLIATIVE MED, V28, P111, DOI 10.1177/0269216313493342; National Consensus Project for Quality Palliative Care, 2013, CLIN PRACT GUID QUAL; Odejide OO, 2016, JAMA-J AM MED ASSOC, V315, P257, DOI 10.1001/jama.2015.18424; Olson RA, 2014, INT J RADIAT ONCOL, V89, P1092, DOI 10.1016/j.ijrobp.2014.04.048; Prigerson HG, 2015, JAMA ONCOL, V1, P778, DOI 10.1001/jamaoncol.2015.2378; Quill TE, 2016, JAMA-J AM MED ASSOC, V315, P245, DOI 10.1001/jama.2015.16210; Singer AE, 2015, ANN INTERN MED, V162, P175, DOI 10.7326/M13-1609; Temel JS, 2010, NEW ENGL J MED, V363, P733, DOI 10.1056/NEJMoa1000678; Weissman JS, 2016, JAMA-J AM MED ASSOC, V315, P303, DOI 10.1001/jama.2015.17408; Wright AA, 2016, JAMA-J AM MED ASSOC, V315, P284, DOI 10.1001/jama.2015.18604; Yang YT, 2016, JAMA-J AM MED ASSOC, V315, P247, DOI 10.1001/jama.2015.16194	18	38	38	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 19	2016	315	3					267	269		10.1001/jama.2015.19206	http://dx.doi.org/10.1001/jama.2015.19206			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DB2WN	26784773				2022-12-28	WOS:000368371400022
J	Gostin, LO; Roberts, AE				Gostin, Lawrence O.; Roberts, Anna E.			Physician-Assisted Dying A Turning Point?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							EUTHANASIA; END		[Gostin, Lawrence O.; Roberts, Anna E.] Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, Washington, DC 20001 USA	Georgetown University	Gostin, LO (corresponding author), Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, 600 New Jersey Ave NW, Washington, DC 20001 USA.	gostin@law.georgetown.edu		Gostin, Lawrence/0000-0001-5286-4044				[Anonymous], ECONOMIST; Hirschhorn D., TERMINALLY WOMAN WHO; Onwuteaka-Philipsen BD, 2012, LANCET, V380, P908, DOI 10.1016/S0140-6736(12)61034-4; Oregon Public Health Division, 2014, DEATH DIGN ACT ANN R; Peretti-Watel P, 2003, BRIT MED J, V327, P595, DOI 10.1136/bmj.327.7415.595; Stone Kathlyn, 2009, Lancet Neurol, V8, P882, DOI 10.1016/S1474-4422(09)70249-2	6	27	27	0	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 19	2016	315	3					249	250		10.1001/jama.2015.16586	http://dx.doi.org/10.1001/jama.2015.16586			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DB2WN	26784764				2022-12-28	WOS:000368371400013
J	Li, X; Cui, XL; Wang, JQ; Wang, YK; Li, YF; Wang, LY; Wan, HF; Li, TD; Feng, GH; Shuai, L; Li, ZK; Gu, Q; Hao, J; Wang, L; Zhao, XY; Liu, ZH; Wang, XJ; Li, W; Zhou, Q				Li, Xin; Cui, Xiao-Long; Wang, Jia-Qiang; Wang, Yu-Kai; Li, Yu-Fei; Wang, Le-Yun; Wan, Hai-Feng; Li, Tian-Da; Feng, Gui-Hai; Shuai, Ling; Li, Zhi-Kun; Gu, Qi; Hao, Jie; Wang, Liu; Zhao, Xiao-Yang; Liu, Zhong-Hua; Wang, Xiu-Jie; Li, Wei; Zhou, Qi			Generation and Application of Mouse-Rat Allodiploid Embryonic Stem Cells	CELL			English	Article							X-CHROMOSOME INACTIVATION; GENE-EXPRESSION; REGULATORY INFORMATION; SELF-RENEWAL; LINKED GENE; HYBRID; MICE; INJECTION; EVOLUTION; LINES	Mammalian interspecific hybrids provide unique advantages for mechanistic studies of speciation, gene expression regulation, and X chromosome inactivation (XCI) but are constrained by their limited natural resources. Previous artificially generated mammalian interspecific hybrid cells are usually tetraploids with unstable genomes and limited developmental abilities. Here, we report the generation of mouserat allodiploid embryonic stem cells (AdESCs) by fusing haploid ESCs of the two species. The AdESCs have a stable allodiploid genome and are capable of differentiating into all three germ layers and early-stage germ cells. Both the mouse and rat alleles have comparable contributions to the expression of most genes. We have proven AdESCs as a powerful tool to study the mechanisms regulating X chromosome inactivation and to identify X inactivation-escaping genes, as well as to efficiently identify genes regulating phenotypic differences between species. A similar method could be used to create hybrid AdESCs of other distantly related species.	[Li, Xin; Cui, Xiao-Long; Wang, Jia-Qiang; Wang, Yu-Kai; Li, Yu-Fei; Wang, Le-Yun; Wan, Hai-Feng; Li, Tian-Da; Shuai, Ling; Li, Zhi-Kun; Gu, Qi; Hao, Jie; Wang, Liu; Zhao, Xiao-Yang; Li, Wei; Zhou, Qi] Chinese Acad Sci, Inst Zool, State Key Lab Stem Cell & Reprod Biol, Beijing 100101, Peoples R China; [Feng, Gui-Hai; Wang, Xiu-Jie] Chinese Acad Sci, Inst Genet & Dev Biol, Key Lab Genet Network Biol, Beijing 100101, Peoples R China; [Wang, Jia-Qiang; Wang, Le-Yun; Liu, Zhong-Hua] Northeast Agr Univ, Coll Life Sci, Harbin 150030, Peoples R China; [Cui, Xiao-Long] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Northeast Agricultural University - China; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Li, W (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Stem Cell & Reprod Biol, Beijing 100101, Peoples R China.	liwei@ioz.ac.cn; qzhou@ioz.ac.cn	Feng, Guihai/A-5105-2019; Liu, Zhunghua/F-2485-2010; Wang, Xiu-Jie/L-1312-2019; Liu, Zhonghua/AAO-3590-2021; Gu, Qi/AAX-1945-2021; CUI, XIAOLONG/ABB-2030-2020; Wang, Jiaqiang/GQP-0997-2022; CUI, XIAOLONG/GRF-0957-2022	Feng, Guihai/0000-0002-8726-1734; Liu, Zhunghua/0000-0002-9199-6493; Liu, Zhonghua/0000-0002-9199-6493; Gu, Qi/0000-0001-9387-9525; CUI, XIAOLONG/0000-0002-1345-2271; Shuai, Ling/0000-0003-0671-7478; Wang, Jiaqiang/0000-0002-1758-3316	National Basic Research Program of China [2012CBA01300]; National Natural Science of China [91319308, 2014CB964800]; Chinese Academy of Sciences [XDA01020101]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by grants from the National Basic Research Program of China 2012CBA01300 (to Q.Z.), the National Natural Science of China 91319308 (to Q.Z. and X.-J.W.), 2014CB964800 (to W.L.), and the "Strategic Priority Research Program" of the Chinese Academy of Sciences XDA01020101 (to Q.Z.). We thank Ting Li, Qing Meng, and Shi-Wen Li for their help with FACS and confocal laser-scanning microscopy.	Augui S, 2011, NAT REV GENET, V12, P429, DOI 10.1038/nrg2987; Boyle AP, 2014, NATURE, V512, P453, DOI 10.1038/nature13668; Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; Carrel L, 1999, P NATL ACAD SCI USA, V96, P7364, DOI 10.1073/pnas.96.13.7364; CARRITT B, 1977, EXP CELL RES, V106, P71, DOI 10.1016/0014-4827(77)90242-7; Chen YY, 2013, STEM CELL REP, V1, P209, DOI 10.1016/j.stemcr.2013.07.003; Cheng Y, 2014, NATURE, V515, P371, DOI 10.1038/nature13985; Cowan CA, 2005, SCIENCE, V309, P1369, DOI 10.1126/science.1116447; Elling U, 2011, CELL STEM CELL, V9, P563, DOI 10.1016/j.stem.2011.10.012; GARDNER RL, 1971, NATURE, V231, P385, DOI 10.1038/231385a0; Gendrel AV, 2014, ANNU REV CELL DEV BI, V30, P561, DOI 10.1146/annurev-cellbio-101512-122415; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kalantry S, 2006, PLOS GENET, V2, P656, DOI 10.1371/journal.pgen.0020066; Leeb M, 2011, NATURE, V479, P131, DOI 10.1038/nature10448; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li P, 2008, CELL, V135, P1299, DOI 10.1016/j.cell.2008.12.006; Li W, 2014, CELL STEM CELL, V14, P404, DOI 10.1016/j.stem.2013.11.016; Li W, 2012, NATURE, V490, P407, DOI 10.1038/nature11435; MCMAHON A, 1983, J EMBRYOL EXP MORPH, V74, P207; Meek S, 2013, STEM CELLS, V31, P2104, DOI 10.1002/stem.1466; Mihola O, 2009, SCIENCE, V323, P373, DOI 10.1126/science.1163601; Navarro P, 2006, GENE DEV, V20, P2787, DOI 10.1101/gad.389006; Nowak-Imialek M, 2010, CELL REPROGRAM, V12, P55, DOI 10.1089/cell.2009.0045; Ogle Brenda M., 2004, FASEB Journal, V18, P548; Peeters SB, 2014, BIOESSAYS, V36, P746, DOI 10.1002/bies.201400032; Penny GD, 1996, NATURE, V379, P131, DOI 10.1038/379131a0; RASTAN S, 1982, J EMBRYOL EXP MORPH, V71, P11; Stergachis AB, 2014, NATURE, V515, P365, DOI 10.1038/nature13972; Swanson-Wagner RA, 2006, P NATL ACAD SCI USA, V103, P6805, DOI 10.1073/pnas.0510430103; Tang SW, 2009, SCIENCE, V323, P779, DOI 10.1126/science.1169123; THADANI VM, 1980, J EXP ZOOL, V212, P435, DOI 10.1002/jez.1402120316; van Olphen AL, 2002, J VIROL, V76, P5882, DOI 10.1128/JVI.76.12.5882-5892.2002; Wan HF, 2013, CELL RES, V23, P1330, DOI 10.1038/cr.2013.126; Wanet A, 2015, STEM CELLS DEV, V24, P1957, DOI 10.1089/scd.2015.0117; WEISS MC, 1967, P NATL ACAD SCI USA, V58, P1104, DOI 10.1073/pnas.58.3.1104; WEISS MC, 1966, GENETICS, V54, P1095; Wilson MD, 2008, SCIENCE, V322, P434, DOI 10.1126/science.1160930; Yang F, 2010, GENOME RES, V20, P614, DOI 10.1101/gr.103200.109; Yang H, 2013, CELL RES, V23, P1187, DOI 10.1038/cr.2013.93; Yang H, 2012, CELL, V149, P605, DOI 10.1016/j.cell.2012.04.002	40	35	45	2	65	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 14	2016	164	1-2					279	292		10.1016/j.cell.2015.11.035	http://dx.doi.org/10.1016/j.cell.2015.11.035			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DB2LE	26771496	Bronze			2022-12-28	WOS:000368339300027
J	Reimer, JM; Aloise, MN; Harrison, PM; Schmeing, TM				Reimer, Janice M.; Aloise, Martin N.; Harrison, Paul M.; Schmeing, T. Martin			Synthetic cycle of the initiation module of a formylating nonribosomal peptide synthetase	NATURE			English	Article							X-RAY-SCATTERING; CRYSTAL-STRUCTURE; STRUCTURAL-CHARACTERIZATION; BIOLOGICAL MACROMOLECULES; DIFFRACTION DATA; BIOSYNTHESIS; GRAMICIDIN; DOMAIN; ANTIBIOTICS; ADENYLATION	Nonribosomal peptide synthetases (NRPSs) are very large proteins that produce small peptide molecules with wide-ranging biological activities, including environmentally friendly chemicals and many widely used therapeutics(1). NRPSs are macromolecular machines, with modular assembly-line logic, a complex catalytic cycle, moving parts and many active sites(2,3). In addition to the core domains required to link the substrates, they often include specialized tailoring domains, which introduce chemical modifications and allow the product to access a large expanse of chemical space(3,4). It is still unknown how the NRPS tailoring domains are structurally accommodated into megaenzymes or how they have adapted to function in nonribosomal peptide synthesis. Here we present a series of crystal structures of the initiation module of an antibiotic-producing NRPS, linear gramicidin synthetase(5,6). This module includes the specialized tailoring formylation domain, and states are captured that represent every major step of the assembly-line synthesis in the initiation module. The transitions between conformations are large in scale, with both the peptidyl carrier protein domain and the adenylation subdomain undergoing huge movements to transport substrate between distal active sites. The structures highlight the great versatility of NRPSs, as small domains repurpose and recycle their limited interfaces to interact with their various binding partners. Understanding tailoring domains is important if NRPSs are to be utilized in the production of novel therapeutics.	[Reimer, Janice M.; Aloise, Martin N.; Schmeing, T. Martin] McGill Univ, Dept Biochem, Montreal, PQ H3G 0B1, Canada; [Harrison, Paul M.] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada	McGill University; McGill University	Schmeing, TM (corresponding author), McGill Univ, Dept Biochem, 3649 Promenade Sir William Osler, Montreal, PQ H3G 0B1, Canada.	martin.schmeing@mcgill.ca		Reimer, Janice/0000-0002-2664-5523	CIHR [106615]; HFSP CDA; Canada Research Chair in Macromolecular Machines; NSERC Alexander Graham Bell studentship; CIHR Training Grant in Chemical Biology	CIHR(Canadian Institutes of Health Research (CIHR)); HFSP CDA; Canada Research Chair in Macromolecular Machines; NSERC Alexander Graham Bell studentship; CIHR Training Grant in Chemical Biology(Canadian Institutes of Health Research (CIHR))	We thank T. Mintya, D. Avizonis, M.-C. Tang and A. Furtos for experimental support, R. Zamboni, J. Collucci and K. Guerard for small molecule synthesis assistance; J. Jiang, D. Alonzo and D. Rodinov for experimental advice and assistance; S. Labuik and P. Grochulski (Canadian Light Source) for diffraction data collection; R. Gillian (CHESS SAXS beamline G1), M. Pillon and A. Guarne for SAXS help: K. Bloudoff, M. Tarry, A. Haque and A. Beghuis for helpful discussions; and J. Pelletier, N. Rogerson and A. Nahvi for critical reading of the manuscript. This work was supported by CIHR grant 106615, a HFSP CDA and a Canada Research Chair in Macromolecular Machines to T. M. S. J. M. R. is supported by an NSERC Alexander Graham Bell studentship, and M. N. A. by a studentship from the CIHR Training Grant in Chemical Biology.	Acerbo AS, 2015, J SYNCHROTRON RADIAT, V22, P180, DOI 10.1107/S1600577514020360; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Allen CL, 2014, ACTA CRYSTALLOGR D, V70, P1718, DOI 10.1107/S1399004714008311; ALMASSY RJ, 1992, P NATL ACAD SCI USA, V89, P6114, DOI 10.1073/pnas.89.13.6114; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n; Bode HB, 2015, ANGEW CHEM INT EDIT, V54, P10352, DOI 10.1002/anie.201502835; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Cheng YQ, 2006, CHEMBIOCHEM, V7, P471, DOI 10.1002/cbic.200500425; Clardy J, 2006, NAT BIOTECHNOL, V24, P1541, DOI 10.1038/nbt1266; Conti E, 1997, EMBO J, V16, P4174, DOI 10.1093/emboj/16.14.4174; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Goodrich AC, 2015, J AM CHEM SOC, V137, P12100, DOI 10.1021/jacs.5b07772; Gulick AM, 2009, ACS CHEM BIOL, V4, P811, DOI 10.1021/cb900156h; Hosaka T, 2009, NAT BIOTECHNOL, V27, P462, DOI 10.1038/nbt.1538; Hur GH, 2012, NAT PROD REP, V29, P1074, DOI 10.1039/c2np20025b; Jaremko MJ, 2015, J AM CHEM SOC, V137, P11546, DOI 10.1021/jacs.5b04525; Kessler N, 2004, J BIOL CHEM, V279, P7413, DOI 10.1074/jbc.M309658200; Koketsu K, 2012, CURR OPIN CHEM BIOL, V16, P142, DOI 10.1016/j.cbpa.2012.02.021; Konz D, 1997, CHEM BIOL, V4, P927, DOI 10.1016/S1074-5521(97)90301-X; Lai JR, 2006, P NATL ACAD SCI USA, V103, P5314, DOI 10.1073/pnas.0601038103; LAWEN A, 1990, J BIOL CHEM, V265, P11355; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; Ling LL, 2015, NATURE, V517, P455, DOI 10.1038/nature14098; Liu Y, 2007, CHEMBIOCHEM, V8, P617, DOI 10.1002/cbic.200700010; Lohman JR, 2014, PROTEINS, V82, P1210, DOI 10.1002/prot.24485; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mitchell CA, 2012, BIOCHEMISTRY-US, V51, P3252, DOI 10.1021/bi300112e; Nazi I, 2004, ANAL BIOCHEM, V324, P100, DOI 10.1016/j.ab.2003.09.005; Nielsen SS, 2009, J APPL CRYSTALLOGR, V42, P959, DOI 10.1107/S0021889809023863; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pei JM, 2014, METHODS MOL BIOL, V1079, P263, DOI 10.1007/978-1-62703-646-7_17; Reger AS, 2008, BIOCHEMISTRY-US, V47, P8016, DOI 10.1021/bi800696y; Robbel L, 2010, J BIOL CHEM, V285, P27501, DOI 10.1074/jbc.R110.128181; Rouhiainen L, 2000, MOL MICROBIOL, V37, P156, DOI 10.1046/j.1365-2958.2000.01982.x; Schmitt E, 1998, EMBO J, V17, P6819, DOI 10.1093/emboj/17.23.6819; Schneider TL, 2003, BIOCHEMISTRY-US, V42, P9722, DOI 10.1021/bi034792w; Schoenafinger G, 2006, J AM CHEM SOC, V128, P7406, DOI 10.1021/ja0611240; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Skou S, 2014, NAT PROTOC, V9, P1727, DOI 10.1038/nprot.2014.116; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tanovic A, 2008, SCIENCE, V321, P659, DOI 10.1126/science.1159850; Thoden JB, 2013, BIOCHEMISTRY-US, V52, P6114, DOI 10.1021/bi4009006; Tria G, 2015, IUCRJ, V2, P207, DOI 10.1107/S205225251500202X; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wallace BA, 2000, BIOESSAYS, V22, P227, DOI 10.1002/(SICI)1521-1878(200003)22:3<227::AID-BIES4>3.0.CO;2-6; Walsh CT, 2001, CURR OPIN CHEM BIOL, V5, P525, DOI 10.1016/S1367-5931(00)00235-0; Walsh CT, 2004, SCIENCE, V303, P1805, DOI 10.1126/science.1094318; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Weissman KJ, 2015, NAT CHEM BIOL, V11, P660, DOI [10.1038/NCHEMBIO.1883, 10.1038/nchembio.1883]; Yonus H, 2008, J BIOL CHEM, V283, P32484, DOI 10.1074/jbc.M800557200; Zhao CH, 2010, J BIOL CHEM, V285, P20097, DOI 10.1074/jbc.M109.090092	57	101	107	0	83	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 14	2016	529	7585					239	U305		10.1038/nature16503	http://dx.doi.org/10.1038/nature16503			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA7WK	26762462				2022-12-28	WOS:000368015700043
J	Edelman, EJ; Fiellin, DA				Edelman, E. Jennifer; Fiellin, David A.			Alcohol Use	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							PRIMARY-CARE; USE DISORDERS; UNHEALTHY ALCOHOL; UNITED-STATES; CONSUMPTION; MANAGEMENT; PHARMACOTHERAPY; WITHDRAWAL; ADULTS; MISUSE								NATIONAL INSTITUTE ON DRUG ABUSE [K12DA033312] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Allen JP, 1997, J STUD ALCOHOL, V58, P7; Amato L, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008537.pub2; Amato L, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005063.pub3; American Heart Association, 2015, ALC HEART HLTH; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; [Anonymous], PLANN IMPL SCREEN BR; Anton RF, 2006, JAMA-J AM MED ASSOC, V295, P2003, DOI 10.1001/jama.295.17.2003; Babor T., 2001, BRIEF INTERVENTION H; Baliunas D, 2010, INT J PUBLIC HEALTH, V55, P159, DOI 10.1007/s00038-009-0095-x; Berg KM, 2008, AM J MED, V121, P406, DOI 10.1016/j.amjmed.2007.12.012; Berger D, 2015, MED CLIN N AM, V99, P989, DOI 10.1016/j.mcna.2015.05.004; Blondell RD, 2005, AM FAM PHYSICIAN, V71, P495; Bradley KA, 2006, AM J MANAG CARE, V12, P597; Breslow RA, 2015, ALCOHOL CLIN EXP RES, V39, P371, DOI 10.1111/acer.12633; Broyles LM, 2014, SUBST ABUS, V35, P217, DOI 10.1080/08897077.2014.930372; Chou R, 2009, J PAIN, V10, P113, DOI 10.1016/j.jpain.2008.10.008; Dedert EA, 2015, ANN INTERN MED, V163, P205, DOI 10.7326/M15-0285; Fiellin DA, 2000, ANN INTERN MED, V133, P815, DOI 10.7326/0003-4819-133-10-200011210-00015; Friedmann PD, 1998, JAMA-J AM MED ASSOC, V279, P1227, DOI 10.1001/jama.279.15.1227; Goodson CM, 2014, ALCOHOL CLIN EXP RES, V38, P2664, DOI 10.1111/acer.12529; Grant BF, 2015, JAMA PSYCHIAT, V72, P757, DOI 10.1001/jamapsychiatry.2015.0584; Grodensky CA, 2012, J STUD ALCOHOL DRUGS, V73, P899, DOI 10.15288/jsad.2012.73.899; Hannuksela ML, 2007, CLIN CHEM LAB MED, V45, P953, DOI 10.1515/CCLM.2007.190; Harris AHS, 2016, ADDICTION, V111, P195, DOI 10.1111/add.13096; Harris AHS, 2013, PSYCHOL SERV, V10, P410, DOI 10.1037/a0030949; Holt SR, 2014, UNHEALTHY ALCOHOL US; Howard AA, 2004, ANN INTERN MED, V140, P211, DOI 10.7326/0003-4819-140-6-200403160-00011; Humphreys K, 2014, ALCOHOL CLIN EXP RES, V38, P2688, DOI 10.1111/acer.12557; Ipser JC, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007505.pub2; Jonas DE, 2014, JAMA-J AM MED ASSOC, V311, P1889, DOI 10.1001/jama.2014.3628; Jonas DE, 2012, ANN INTERN MED, V157, P645, DOI 10.7326/0003-4819-157-9-201211060-00544; Jones CM, 2014, MMWR-MORBID MORTAL W, V63, P881; Kelly JF, 2015, AM J MED, V128, P8, DOI 10.1016/j.amjmed.2014.07.043; Lapham GT, 2013, MED CARE, V51, P914, DOI 10.1097/MLR.0b013e3182a3e549; Marienfeld C, 2014, ADDICT BEHAV, V39, P434, DOI 10.1016/j.addbeh.2013.05.006; Martin GW, 2012, CAN J PSYCHIAT, V57, P350, DOI 10.1177/070674371205700604; McFadden CB, 2005, AM J HYPERTENS, V18, P276, DOI 10.1016/j.amjhyper.2004.07.020; McNeely J, 2015, J GEN INTERN MED, V30, P1757, DOI 10.1007/s11606-015-3391-6; Minozzi S, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005064.pub3; Mirijello A, 2015, DRUGS, V75, P353, DOI 10.1007/s40265-015-0358-1; National Institute on Alcohol Abuse and Alcoholism, WHAT RISK HEAV DRINK; National Institute on Alcohol Abuse and Alcoholism, 2015, ACL FACTS STAT; National Institute on Alcohol Abuse and Alcoholism, 2015, SPEC POP COOCC DIS; National Institute on Alcohol Abuse and Alcoholism National Institute on Alcohol Abuse and Alcoholism, 2005, HELP PAT WHO DRINK T; Nunes EV, 2004, JAMA-J AM MED ASSOC, V291, P1887, DOI 10.1001/jama.291.15.1887; Patra J, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-258; Reinert DF, 2007, ALCOHOL CLIN EXP RES, V31, P185, DOI 10.1111/j.1530-0277.2006.00295.x; Roerecke M, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0182-6; Saitz R, 2005, NEW ENGL J MED, V352, P596, DOI 10.1056/NEJMcp042262; Samet JH, 2015, LANCET, V385, P1508, DOI 10.1016/S0140-6736(15)60750-4; Scoccianti C, 2015, CANCER EPIDEMIOL, V39, pS67, DOI 10.1016/j.canep.2015.01.007; Soyka M, 2015, PHARMACOPSYCHIATRY, V48, P123, DOI 10.1055/s-0035-1547237; SULLIVAN JT, 1989, BRIT J ADDICT, V84, P1353; Sullivan LE, 2005, AM J MED, V118, P330, DOI 10.1016/j.amjmed.2005.01.007; Turner BJ, 2009, J GEN INTERN MED, V24, P1156, DOI 10.1007/s11606-009-1072-z; US Public Health Service, 2014, PREEXP PROPH PREV HI; Veterans Health Administration/Department of Defense, 2009, VHA DOD CLIN PRACT G; Williams EC, 2015, J GEN INTERN MED, V30, P1125, DOI 10.1007/s11606-015-3248-z; Wurst FM, 2015, ALCOHOL CLIN EXP RES, V39, P2060, DOI 10.1111/acer.12851	59	27	27	0	26	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 5	2016	164	1					ITC1	U27		10.7326/AITC201601050	http://dx.doi.org/10.7326/AITC201601050			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DA4WC	26747315				2022-12-28	WOS:000367801700001
J	Watts, G				Watts, Geoff			Naeem Aon Jafarey Obituary	LANCET			English	Biographical-Item																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 2	2016	387	10013					24	24		10.1016/S0140-6736(15)01304-5	http://dx.doi.org/10.1016/S0140-6736(15)01304-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CZ9ZU	26788563	Bronze			2022-12-28	WOS:000367457300015
J	Lachaud, C; Moreno, A; Marchesi, F; Toth, R; Blow, JJ; Rouse, J				Lachaud, Christophe; Moreno, Alberto; Marchesi, Francesco; Toth, Rachel; Blow, J. Julian; Rouse, John			Ubiquitinated Fancd2 recruits Fan1 to stalled replication forks to prevent genome instability	SCIENCE			English	Article							FANCONI-ANEMIA; DNA-DAMAGE; NUCLEASE; REPAIR; KIAA1018/FAN1; MUTATIONS; PROTEINS; CANCER	Mono-ubiquitination of Fancd2 is essential for repairing DNA interstrand cross-links (ICLs), but the underlying mechanisms are unclear. The Fan1 nuclease, also required for ICL repair, is recruited to ICLs by ubiquitinated (Ub) Fancd2. This could in principle explain how Ub-Fancd2 promotes ICL repair, but we show that recruitment of Fan1 by Ub-Fancd2 is dispensable for ICL repair. Instead, Fan1 recruitment-and activity-restrains DNA replication fork progression and prevents chromosome abnormalities from occurring when DNA replication forks stall, even in the absence of ICLs. Accordingly, Fan1 nuclease-defective knockin mice are cancer-prone. Moreover, we show that a Fan1 variant in high-risk pancreatic cancers abolishes recruitment by Ub-Fancd2 and causes genetic instability without affecting ICL repair. Therefore, Fan1 recruitment enables processing of stalled forks that is essential for genome stability and health.	[Lachaud, Christophe; Toth, Rachel; Rouse, John] Univ Dundee, Coll Life Sci, Sir James Black Ctr, MRC,Prot Phosphorylat & Ubiquitylat Unit, Dundee DD1 5EH, Scotland; [Moreno, Alberto; Blow, J. Julian] Univ Dundee, Coll Life Sci, Ctr Gene Regulat & Express, Sir James Black Ctr, Dundee DD1 5EH, Scotland; [Marchesi, Francesco] Univ Glasgow, Sch Vet Med, Coll Med Vet & Life Sci, Bearsden Rd, Glasgow G61 1QH, Lanark, Scotland	University of Dundee; University of Dundee; University of Glasgow	Rouse, J (corresponding author), Univ Dundee, Coll Life Sci, Sir James Black Ctr, MRC,Prot Phosphorylat & Ubiquitylat Unit, Dundee DD1 5EH, Scotland.	j.rouse@dundee.ac.uk	Lachaud, Christophe/ABC-8596-2021; Blow, J. Julian/B-3977-2009; Marchesi, Francesco/ABF-9255-2021	Lachaud, Christophe/0000-0003-2762-1619; Blow, J. Julian/0000-0002-9524-5849; Marchesi, Francesco/0000-0003-1179-5788	Wellcome Trust [WT096598MA]; Medical Research Council (MRC); MRC [MC_UU_12016/1] Funding Source: UKRI; Medical Research Council [MC_UU_12016/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We are grateful to J. Hastie, H. MacLauchlan, and the Antibody Production Team at Division of Signal Transduction Therapy (DSTT) and the DNA Sequencing Service at the School of Life Sciences, University of Dundee. We thank Centre for Interdisciplinary Research Resource Unit (CIRRU) staff, especially L. Malone and C. Clacher, for help with animal husbandry and G. Gilmour and E. Forsyth for help with genotyping. We thank L. Oxford and L. Stevenson (Veterinary Diagnostic Services, University of Glasgow) for support with tissue processing. We thank A. d'Andrea for Fancd2<SUP>-/-</SUP> mice. We are grateful to L. Feeney for critical reading of this manuscript. We thank A. Connor, A. Smith, S. Gallinger, and G. Zogopoulos for communicating data prior to publication. C. L. is the recipient of a Marie Curie Intra-European fellowship. A.M. was supported by Wellcome Trust Investigator Award WT096598MA to J.J.B. This study was supported by the Medical Research Council (MRC) and the pharmaceutical companies supporting the DSTT (AstraZeneca, Boehringer-Ingelheim, GlaxoSmithKline, Merck KgaA, Janssen Pharmaceutica, and Pfizer) associated with the MRC Protein Phosphorylation and Ubiquitylation Unit. Fan1 nuclease-defective mice are available from J.R. under a material transfer agreement with the University of Dundee.	Auerbach AD, 2009, MUTAT RES-FUND MOL M, V668, P4, DOI 10.1016/j.mrfmmm.2009.01.013; Chaudhury I, 2014, MOL CELL BIOL, V34, P3939, DOI 10.1128/MCB.00457-14; Garcia-Higuera I, 2001, MOL CELL, V7, P249, DOI 10.1016/S1097-2765(01)00173-3; Houghtaling S, 2003, GENE DEV, V17, P2021, DOI 10.1101/gad.1103403; Kile AC, 2015, MOL CELL, V58, P1090, DOI 10.1016/j.molcel.2015.05.013; Kim H, 2012, GENE DEV, V26, P1393, DOI 10.1101/gad.195248.112; Kratz K, 2010, CELL, V142, P77, DOI 10.1016/j.cell.2010.06.022; Liu T, 2010, SCIENCE, V329, P693, DOI 10.1126/science.1192656; Lossaint G, 2013, MOL CELL, V51, P678, DOI 10.1016/j.molcel.2013.07.023; MacKay C, 2010, CELL, V142, P65, DOI 10.1016/j.cell.2010.06.021; Munoz IM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109752; Schlacher K, 2012, CANCER CELL, V22, P106, DOI 10.1016/j.ccr.2012.05.015; Segui N, 2015, GASTROENTEROLOGY, V149, P563, DOI 10.1053/j.gastro.2015.05.056; Smith AL, 2016, CANCER LETT, V370, P302, DOI 10.1016/j.canlet.2015.10.030; Smogorzewska A, 2010, MOL CELL, V39, P36, DOI 10.1016/j.molcel.2010.06.023; Zellweger R, 2015, J CELL BIOL, V208, P563, DOI 10.1083/jcb.201406099; Zhou WB, 2012, NAT GENET, V44, P910, DOI 10.1038/ng.2347	17	86	86	0	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 19	2016	351	6275					846	849		10.1126/science.aad5634	http://dx.doi.org/10.1126/science.aad5634			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DE0PB	26797144	Green Accepted			2022-12-28	WOS:000370325700041
J	[Anonymous]				[Anonymous]			Acupuncture for Treatment of Menopausal Hot Flashes	ANNALS OF INTERNAL MEDICINE			English	Editorial Material																		Ee C, 2016, ANN INTERN MED, V164, P146, DOI 10.7326/M15-1380	1	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 2	2016	164	3					I24	I24		10.7326/P16-9004	http://dx.doi.org/10.7326/P16-9004			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DC4DD	26785248				2022-12-28	WOS:000369169400015
J	Guo, DH; Shibuya, R; Akiba, C; Saji, S; Kondo, T; Nakamura, J				Guo, Donghui; Shibuya, Riku; Akiba, Chisato; Saji, Shunsuke; Kondo, Takahiro; Nakamura, Junji			Active sites of nitrogen-doped carbon materials for oxygen reduction reaction clarified using model catalysts	SCIENCE			English	Article							HIGH ELECTROCATALYTIC ACTIVITY; ARRAYS	Nitrogen (N)-doped carbon materials exhibit high electrocatalytic activity for the oxygen reduction reaction (ORR), which is essential for several renewable energy systems. However, the ORR active site (or sites) is unclear, which retards further developments of high-performance catalysts. Here, we characterized the ORR active site by using newly designed graphite (highly oriented pyrolitic graphite) model catalysts with well-defined p conjugation and well-controlled doping of N species. The ORR active site is created by pyridinic N. Carbon dioxide adsorption experiments indicated that pyridinic N also creates Lewis basic sites. The specific activities per pyridinic N in the HOPG model catalysts are comparable with those of N-doped graphene powder catalysts. Thus, the ORR active sites in N-doped carbon materials are carbon atoms with Lewis basicity next to pyridinic N.	[Guo, Donghui; Kondo, Takahiro; Nakamura, Junji] Univ Tsukuba, Fac Pure & Appl Sci, Tsukuba, Ibaraki 3058573, Japan; [Shibuya, Riku; Akiba, Chisato; Saji, Shunsuke] Univ Tsukuba, Grad Sch Pure & Appl Sci, Tsukuba, Ibaraki 3058573, Japan	University of Tsukuba; University of Tsukuba	Kondo, T (corresponding author), Univ Tsukuba, Fac Pure & Appl Sci, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058573, Japan.	takahiro@irns.tsukuba.ac.jp; nakamura@irns.tsukuba.ac.jp	Nakamura, Junji/ABG-3290-2021; Kondo, Takahiro/I-6311-2019	Nakamura, Junji/0000-0002-2837-0535; Kondo, Takahiro/0000-0001-8457-9387	New Energy and Industrial Technology Development Organization; Japan Science and Technology Agency-Precursory Research for Embryonic Science and Technology (JST-PRESTO) program	New Energy and Industrial Technology Development Organization(New Energy and Industrial Technology Development Organization (NEDO)); Japan Science and Technology Agency-Precursory Research for Embryonic Science and Technology (JST-PRESTO) program	This work was financially supported by the New Energy and Industrial Technology Development Organization and partially supported by the Japan Science and Technology Agency-Precursory Research for Embryonic Science and Technology (JST-PRESTO) program, "New Materials Science and Element Strategy." We thank T. Kashiwagi and K. Kadowaki for support with sample etching and AFM measurements. The advice of T. Okajima and T. Ohsaka concerning the electrode preparation methods for the HOPG model catalysts is gratefully acknowledged. We thank X. Hao for assistance with sample preparation by photolithography. We thank all staff of BL07LSU of Spring-8 for assistance with surface analysis of the HOPG model catalysts. J.N. supervised the project. D.G. and C.A. prepared the model catalysts and performed XPS, AFM, and ORR measurements. R.S. performed CO<INF>2</INF>-TPD analysis and S.S. prepared the N-GNS powder catalysts and performed ORR measurements. All authors discussed the results and D.G., T.K., and J.N. wrote the paper. The authors declare no competing financial interests.	Dai LM, 2015, CHEM REV, V115, P4823, DOI 10.1021/cr5003563; Ding W, 2013, ANGEW CHEM INT EDIT, V52, P11755, DOI 10.1002/anie.201303924; Gong KP, 2009, SCIENCE, V323, P760, DOI 10.1126/science.1168049; Kim H, 2011, PHYS CHEM CHEM PHYS, V13, P17505, DOI 10.1039/c1cp21665a; Kondo T, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.035436; Kusunoki I, 2001, SURF SCI, V492, P315, DOI 10.1016/S0039-6028(01)01430-3; Lai LF, 2012, ENERG ENVIRON SCI, V5, P7936, DOI 10.1039/c2ee21802j; Li B, 2015, PHYS CHEM CHEM PHYS, V17, P6691, DOI 10.1039/c4cp05765a; Li QQ, 2012, J AM CHEM SOC, V134, P18932, DOI 10.1021/ja309270h; Liang HW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5973; Liu RL, 2010, ANGEW CHEM INT EDIT, V49, P2565, DOI 10.1002/anie.200907289; Maldonado S, 2006, CARBON, V44, P1429, DOI 10.1016/j.carbon.2005.11.027; Metiu H, 2012, J PHYS CHEM C, V116, P10439, DOI 10.1021/jp301341t; Niwa H, 2009, J POWER SOURCES, V187, P93, DOI 10.1016/j.jpowsour.2008.10.064; PELS JR, 1995, CARBON, V33, P1641, DOI 10.1016/0008-6223(95)00154-6; Qu LT, 2010, ACS NANO, V4, P1321, DOI 10.1021/nn901850u; Rao CV, 2010, J PHYS CHEM LETT, V1, P2622, DOI 10.1021/jz100971v; Raymundo-Pinero E, 2002, CARBON, V40, P597, DOI 10.1016/S0008-6223(01)00155-5; Shui JL, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400129; Subramanian NP, 2009, J POWER SOURCES, V188, P38, DOI 10.1016/j.jpowsour.2008.11.087; Xing T, 2014, ACS NANO, V8, P6856, DOI 10.1021/nn501506p	21	2767	2813	268	4039	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 22	2016	351	6271					361	365		10.1126/science.aad0832	http://dx.doi.org/10.1126/science.aad0832			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB3VH	26798009				2022-12-28	WOS:000368440500034
J	Dean, J				Dean, Jurrien			Exacting Requirements for Development of the Egg	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Dean, Jurrien] NIDDK, Lab Cellular & Dev Biol, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Dean, J (corresponding author), NIDDK, Lab Cellular & Dev Biol, Bethesda, MD 20892 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK015603] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Almonacid M, 2014, J CELL SCI, V127, P477, DOI 10.1242/jcs.142711; Beall S, 2010, FERTIL STERIL, V94, P2507, DOI 10.1016/j.fertnstert.2010.02.037; Clift D, 2013, NAT REV MOL CELL BIO, V14, P549, DOI 10.1038/nrm3643; Combelles C, 2012, SEMIN REPROD MED, V30, P243, DOI 10.1055/s-0032-1311527; Deng MQ, 2007, DEV CELL, V12, P301, DOI 10.1016/j.devcel.2006.11.008; Feng RZ, 2016, NEW ENGL J MED, V374, P223, DOI 10.1056/NEJMoa1510791; Janke C, 2014, J CELL BIOL, V206, P461, DOI 10.1083/jcb.201406055; Li R, 2013, NAT REV MOL CELL BIO, V14, P141, DOI 10.1038/nrm3531; van Geel M, 2002, AM J HUM GENET, V70, P269, DOI 10.1086/338307	9	11	12	0	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 21	2016	374	3					279	280		10.1056/NEJMe1515512	http://dx.doi.org/10.1056/NEJMe1515512			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DB3IS	26789878				2022-12-28	WOS:000368404800015
J	Feng, RZ; Sang, Q; Kuang, YP; Sun, XX; Yan, Z; Zhang, SZ; Shi, JZ; Tian, GL; Luchniak, A; Fukuda, Y; Li, B; Yu, M; Chen, JL; Xu, Y; Guo, L; Qu, RG; Wang, XQ; Sun, ZG; Liu, M; Shi, HJ; Wang, HY; Feng, Y; Shao, RJ; Chai, RJ; Li, QL; Xing, QH; Zhang, R; Nogales, E; Jin, L; He, L; Gupta, ML; Cowan, NJ; Wang, L				Feng, Ruizhi; Sang, Qing; Kuang, Yanping; Sun, Xiaoxi; Yan, Zheng; Zhang, Shaozhen; Shi, Juanzi; Tian, Guoling; Luchniak, Anna; Fukuda, Yusuke; Li, Bin; Yu, Min; Chen, Junling; Xu, Yao; Guo, Luo; Qu, Ronggui; Wang, Xueqian; Sun, Zhaogui; Liu, Miao; Shi, Huijuan; Wang, Hongyan; Feng, Yi; Shao, Ruijin; Chai, Renjie; Li, Qiaoli; Xing, Qinghe; Zhang, Rui; Nogales, Eva; Jin, Li; He, Lin; Gupta, Mohan L., Jr.; Cowan, Nicholas J.; Wang, Lei			Mutations in TUBB8 and Human Oocyte Meiotic Arrest	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MAMMALIAN OOCYTES; TUBULIN ISOTYPES; BETA-TUBULIN; IN-VITRO; MATURATION; MICROTUBULE; INFERTILITY; MEIOSIS; NUCLEAR	BACKGROUND Human reproduction depends on the fusion of a mature oocyte with a sperm cell to form a fertilized egg. The genetic events that lead to the arrest of human oocyte maturation are unknown. METHODS We sequenced the exomes of five members of a four-generation family, three of whom had infertility due to oocyte meiosis I arrest. We performed Sanger sequencing of a candidate gene, TUBB8, in DNA samples from these members, additional family members, and members of 23 other affected families. The expression of TUBB8 and all other beta-tubulin isotypes was assessed in human oocytes, early embryos, sperm cells, and several somatic tissues by means of a quantitative reverse-transcriptase-polymerase-chain-reaction assay. We evaluated the effect of the TUBB8 mutations on the assembly of the heterodimer consisting of one beta-tubulin polypeptide and one beta-tubulin polypeptide (alpha/beta-tubulin heterodimer) in vitro, on microtubule architecture in HeLa cells, on microtubule dynamics in yeast cells, and on spindle assembly in mouse and human oocytes. RESULTS We identified seven mutations in the primate-specific gene TUBB8 that were responsible for oocyte meiosis I arrest in 7 of the 24 families. TUBB8 expression is unique to oocytes and the early embryo, in which this gene accounts for almost all the expressed beta-tubulin. The mutations affect chaperone-dependent folding and assembly of the alpha/beta-tubulin heterodimer, disrupt microtubule behavior on expression in cultured cells, alter microtubule dynamics in vivo, and cause catastrophic spindle-assembly defects and maturation arrest on expression in mouse and human oocytes. CONCLUSIONS TUBB8 mutations have dominant-negative effects that disrupt microtubule behavior and oocyte meiotic spindle assembly and maturation, causing female infertility. (Funded by the National Basic Research Program of China and others.)	[Feng, Ruizhi; Sang, Qing; Xu, Yao; Qu, Ronggui; Wang, Xueqian; Wang, Hongyan; Li, Qiaoli; Xing, Qinghe; Jin, Li; He, Lin; Wang, Lei] Fudan Univ, State Key Lab Genet Engn, Inst Biomed Sci, MOE Key Lab Contemporary Anthropol, Shanghai 200433, Peoples R China; [Feng, Ruizhi; Sang, Qing; Xu, Yao; Qu, Ronggui; Wang, Xueqian; Wang, Hongyan; Li, Qiaoli; Xing, Qinghe; Jin, Li; He, Lin; Wang, Lei] Fudan Univ, Sch Life Sci, Collaborat Innovat Ctr Genet & Dev, Shanghai 200433, Peoples R China; [Sun, Xiaoxi; Yu, Min; Chen, Junling] Fudan Univ, Obstet & Gynecol Hosp, Shanghai Ji Ai Genet & IVF Inst, Shanghai 200433, Peoples R China; [Guo, Luo] Fudan Univ, Eye & ENT Hosp, Dept Otolaryngol, Shanghai 200433, Peoples R China; [Fukuda, Yusuke] Fudan Univ, Dept Integrat Med & Neurobiol, State Key Lab Med Neurobiol, Shanghai 200433, Peoples R China; [Fukuda, Yusuke] Fudan Univ, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Kuang, Yanping; Yan, Zheng; Zhang, Shaozhen; Li, Bin] Shanghai Jiao Tong Univ, Shanghai Ninth Hosp, Reprod Med Ctr, Shanghai 200030, Peoples R China; [Sun, Zhaogui; Liu, Miao; Shi, Huijuan] Shanghai Jiao Tong Univ, Shanghai Inst Planned Parenthood Res, Shanghai 200030, Peoples R China; [He, Lin] Shanghai Jiao Tong Univ, Bio X Ctr, Key Lab Genet Dev & Neuropsychiat Disorders, Minist Educ, Shanghai 200030, Peoples R China; [Shi, Juanzi] Shaanxi Maternal & Child Care Serv Ctr, Reprod Med Ctr, Xian, Shaanxi, Peoples R China; [Chai, Renjie] Southeast Univ, Inst Life Sci, Minist Educ, Key Lab Dev Genes & Human Dis, Nanjing, Jiangsu, Peoples R China; [Tian, Guoling; Cowan, Nicholas J.] NYU, Langone Med Ctr, Dept Mol Pharmacol & Biochem, New York, NY USA; [Luchniak, Anna; Fukuda, Yusuke; Gupta, Mohan L., Jr.] Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA; [Shao, Ruijin] Univ Gothenburg, Dept Physiol Endocrinol, Inst Neurosci & Physiol, Gothenburg, Sweden; [Gupta, Mohan L., Jr.] Iowa State Univ, Dept Genet Dev & Cell Biol, Ames, IA USA; [Zhang, Rui; Nogales, Eva] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA; [Nogales, Eva] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Nogales, Eva] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA	Fudan University; Fudan University; Fudan University; Fudan University; Fudan University; Fudan University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Southeast University - China; New York University; NYU Langone Medical Center; University of Chicago; University of Gothenburg; Iowa State University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Wang, L (corresponding author), Fudan Univ, State Key Lab Genet Engn, Inst Biomed Sci, MOE Key Lab Contemporary Anthropol, Shanghai 200433, Peoples R China.	nicholas.cowan@nyumc.org; wangleiwanglei@fudan.edu.cn	Kuang, Yanping/T-4070-2019; Luchniak, Anna/AAW-6834-2020; Feng, Yi/P-6817-2019; Xu, Yao/AFL-6014-2022; Shao, Linus R/M-3134-2019; Jin, Li/M-5063-2019; Jin, Li/C-1468-2009; Shao, Linus R/M-3059-2019	Feng, Yi/0000-0002-7156-6023; Xu, Yao/0000-0002-0792-1158; Shao, Linus R/0000-0002-1339-9570; Jin, Li/0000-0002-4546-2415; Shao, Linus R/0000-0002-1339-9570; Feng, Ruizhi/0000-0002-8928-5414; Xing, Qinghe/0000-0003-1780-4761; Shi, Juanzi/0000-0002-9040-7829	National Basic Research Program of China; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094313, P01GM051487, R01GM097376] Funding Source: NIH RePORTER	National Basic Research Program of China(National Basic Research Program of China); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funded by the National Basic Research Program of China and others.	Alushin GM, 2014, CELL, V157, P1117, DOI 10.1016/j.cell.2014.03.053; Bahi-Buisson N, 2014, BRAIN, V137, P1676, DOI 10.1093/brain/awu082; Bergere M, 2001, HUM REPROD, V16, P2136, DOI 10.1093/humrep/16.10.2136; Breuss M, 2014, ADV EXP MED BIOL, V800, P75, DOI 10.1007/978-94-007-7687-6_5; Breuss M, 2012, CELL REP, V2, P1554, DOI 10.1016/j.celrep.2012.11.017; Cowan NJ, 2002, ADV PROTEIN CHEM, V59, P73; EICHENLAUBRITTER U, 1995, HUM REPROD, V10, P2343; Eppig J, 1993, OVARY, P113; Eppig JJ, 1996, REPROD FERT DEVELOP, V8, P485, DOI 10.1071/RD9960485; Hartshorne G, 1999, FERTIL STERIL, V71, P567, DOI 10.1016/S0015-0282(98)00505-6; Holt JE, 2013, CURR TOP DEV BIOL, V102, P207, DOI 10.1016/B978-0-12-416024-8.00007-6; Janke C, 2014, J CELL BIOL, V206, P461, DOI 10.1083/jcb.201406055; Jurema MW, 2006, FERTIL STERIL, V86, P1277, DOI 10.1016/j.fertnstert.2006.02.126; Levran D, 2002, HUM REPROD, V17, P1604, DOI 10.1093/humrep/17.6.1604; Li R, 2013, NAT REV MOL CELL BIO, V14, P141, DOI 10.1038/nrm3531; LUDUENA RF, 1993, MOL BIOL CELL, V4, P445, DOI 10.1091/mbc.4.5.445; Mehlmann LM, 2005, REPRODUCTION, V130, P791, DOI 10.1530/rep.1.00793; Nogales E, 1999, CELL, V96, P79, DOI 10.1016/S0092-8674(00)80961-7; Park JY, 2004, SCIENCE, V303, P682, DOI 10.1126/science.1092463; RUDAK E, 1990, FERTIL STERIL, V54, P292; Santos MA, 2010, REPRODUCTION, V139, P23, DOI 10.1530/REP-09-0187; Schmiady H, 2002, HUM REPROD, V17, P2556, DOI 10.1093/humrep/17.10.2556; Shang ZG, 2014, ELIFE, V3, DOI 10.7554/eLife.04686; Sirajuddin M, 2014, NAT CELL BIOL, V16, P335, DOI 10.1038/ncb2920; Tischfield MA, 2011, CURR OPIN GENET DEV, V21, P286, DOI 10.1016/j.gde.2011.01.003; Tischfield MA, 2010, CELL, V140, P74, DOI 10.1016/j.cell.2009.12.011; Watanabe Y, 2012, NAT REV MOL CELL BIO, V13, P370, DOI 10.1038/nrm3349; Zhang R, 2015, CELL, V162, P849, DOI 10.1016/j.cell.2015.07.012	28	141	152	4	79	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 21	2016	374	3					223	232		10.1056/NEJMoa1510791	http://dx.doi.org/10.1056/NEJMoa1510791			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DB3IS	26789871	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000368404800007
J	Karin, M; Clevers, H				Karin, Michael; Clevers, Hans			Reparative inflammation takes charge of tissue regeneration	NATURE			English	Review							NF-KAPPA-B; TUMOR-NECROSIS-FACTOR; STEM-CELL PROLIFERATION; CHRONIC INTESTINAL INFLAMMATION; CONTROLS LIVER-REGENERATION; ADULT MIDGUT REGENERATION; COLITIS-ASSOCIATED CANCER; TNF-ALPHA; PROGENITOR CELLS; IKK-BETA	Inflammation underlies many chronic and degenerative diseases, but it also mitigates infections, clears damaged cells and initiates tissue repair. Many of the mechanisms that link inflammation to damage repair and regeneration in mammals are conserved in lower organisms, indicating that it is an evolutionarily important process. Recent insights have shed light on the cellular and molecular processes through which conventional inflammatory cytokines and Wnt factors control mammalian tissue repair and regeneration. This is particularly important for regeneration in the gastrointestinal system, especially for intestine and liver tissues in which aberrant and deregulated repair results in severe pathologies.	[Karin, Michael] Univ Calif San Diego, Lab Gene Regulat & Signal Transduct, Dept Pharmacol, Moores Canc Ctr,Sch Med, La Jolla, CA 92093 USA; [Karin, Michael] Univ Calif San Diego, Lab Gene Regulat & Signal Transduct, Dept Pathol, Moores Canc Ctr,Sch Med, La Jolla, CA 92093 USA; [Clevers, Hans] Princess Maxima Ctr, NL-3584 CR Utrecht, Netherlands; [Clevers, Hans] Hubrecht Inst, NL-3584 CR Utrecht, Netherlands; [Clevers, Hans] Univ Med Ctr Utrecht, NL-3584 CX Utrecht, Netherlands	University of California System; University of California San Diego; University of California System; University of California San Diego; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center	Karin, M (corresponding author), Univ Calif San Diego, Lab Gene Regulat & Signal Transduct, Dept Pharmacol, Moores Canc Ctr,Sch Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	karinoffice@ucsd.edu; h.clevers@hubrecht.eu			US National Institutes of Health; Alliance for Lupus Research; Lymphoma and Leukemia Society; Superfund Basic Research Program; Stand Up to Cancer; European Research Council; Alpe d'HuZes/KWF; Netherlands Research Council NWO; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES010337] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alliance for Lupus Research; Lymphoma and Leukemia Society(Leukemia and Lymphoma Society); Superfund Basic Research Program; Stand Up to Cancer; European Research Council(European Research Council (ERC)European Commission); Alpe d'HuZes/KWF; Netherlands Research Council NWO(Netherlands Organization for Scientific Research (NWO)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The authors thank H. Gehart for producing the figures. Owing to space limitations, primary findings have been cited through reviews. Work by M.K., who is an American Cancer Society Research Professor and holder of the Ben and Wanda Hildyard Chair for Mitochondrial and Metabolic Diseases, is supported by the US National Institutes of Health, the Alliance for Lupus Research, the Lymphoma and Leukemia Society and the Superfund Basic Research Program. H.C. is supported by Stand Up to Cancer, the European Research Council, Alpe d'HuZes/KWF and the Netherlands Research Council NWO.	AKERMAN P, 1992, AM J PHYSIOL, V263, pG579, DOI 10.1152/ajpgi.1992.263.4.G579; Anders RA, 2005, J IMMUNOL, V175, P1295, DOI 10.4049/jimmunol.175.2.1295; Anderson CA, 2011, NAT GENET, V43, P246, DOI 10.1038/ng.764; Ando K, 2003, ONCOGENE, V22, P7796, DOI 10.1038/sj.onc.1206965; Apte U, 2008, HEPATOLOGY, V47, P288, DOI 10.1002/hep.21973; Ashton GH, 2010, DEV CELL, V19, P259, DOI 10.1016/j.devcel.2010.07.015; Ayyaz A, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00098; Baddour LM, 2012, NEW ENGL J MED, V367, P842, DOI 10.1056/NEJMcp1107675; Becker C, 2004, IMMUNITY, V21, P491, DOI 10.1016/j.immuni.2004.07.020; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; Ben-Neriah Y, 2011, NAT IMMUNOL, V12, P715, DOI 10.1038/ni.2060; Bohm F, 2010, EMBO MOL MED, V2, P294, DOI 10.1002/emmm.201000085; Bollrath J, 2009, CANCER CELL, V15, P91, DOI 10.1016/j.ccr.2009.01.002; Boulter L, 2012, NAT MED, V18, P572, DOI 10.1038/nm.2667; Brandl K, 2010, P NATL ACAD SCI USA, V107, P19967, DOI 10.1073/pnas.1014669107; Buchon N, 2014, NAT REV IMMUNOL, V14, P796, DOI 10.1038/nri3763; Buczacki SJA, 2013, NATURE, V495, P65, DOI 10.1038/nature11965; Cai J, 2010, GENE DEV, V24, P2383, DOI 10.1101/gad.1978810; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; Chalaris A, 2010, J EXP MED, V207, P1617, DOI 10.1084/jem.20092366; Chang LF, 2006, CELL, V124, P601, DOI 10.1016/j.cell.2006.01.021; Chen LW, 2003, NAT MED, V9, P575, DOI 10.1038/nm849; Choi TY, 2014, GASTROENTEROLOGY, V146, P776, DOI 10.1053/j.gastro.2013.10.019; Chung AS, 2013, NAT MED, V19, P1114, DOI 10.1038/nm.3291; Claud Erika C., 2009, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry, V8, P248; Clevers H, 2014, SCIENCE, V346, P54, DOI 10.1126/science.1248012; Clevers H, 2013, CELL, V154, P274, DOI 10.1016/j.cell.2013.07.004; Clevers HC, 2013, ANNU REV PHYSIOL, V75, P289, DOI 10.1146/annurev-physiol-030212-183744; Cordero JB, 2014, EMBO J, V33, P1474, DOI 10.1002/embj.201387454; Cordero JB, 2012, EMBO J, V31, P3901, DOI 10.1038/emboj.2012.248; CORNELL RP, 1990, HEPATOLOGY, V11, P916, DOI 10.1002/hep.1840110603; Cressman DE, 1996, SCIENCE, V274, P1379, DOI 10.1126/science.274.5291.1379; DeAngelis RA, 2012, J IMMUNOL, V188, P641, DOI 10.4049/jimmunol.1101925; Dupaul-Chicoine J, 2010, IMMUNITY, V32, P367, DOI 10.1016/j.immuni.2010.02.012; Durand A, 2012, P NATL ACAD SCI USA, V109, P8965, DOI 10.1073/pnas.1201652109; Eckmann L, 2008, P NATL ACAD SCI USA, V105, P15058, DOI 10.1073/pnas.0808216105; Egan LJ, 2004, P NATL ACAD SCI USA, V101, P2452, DOI 10.1073/pnas.0306734101; Elliott EI, 2015, IMMUNOL REV, V265, P35, DOI 10.1111/imr.12286; Ely LK, 2009, NAT IMMUNOL, V10, P1245, DOI 10.1038/ni.1813; Ernst M, 2014, SEMIN IMMUNOL, V26, P29, DOI 10.1016/j.smim.2013.12.006; FARBER E, 1956, CANCER RES, V16, P142; Font-Burgada J, 2015, CELL, V162, P766, DOI 10.1016/j.cell.2015.07.026; Fre S, 2005, NATURE, V435, P964, DOI 10.1038/nature03589; Frey MR, 2004, J BIOL CHEM, V279, P44513, DOI 10.1074/jbc.M406253200; Garbers C, 2012, CYTOKINE GROWTH F R, V23, P85, DOI 10.1016/j.cytogfr.2012.04.001; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Grivennikov SI, 2010, CYTOKINE GROWTH F R, V21, P11, DOI 10.1016/j.cytogfr.2009.11.005; Grompe M, 2014, CELL STEM CELL, V15, P257, DOI 10.1016/j.stem.2014.08.004; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Hasselblatt P, 2007, P NATL ACAD SCI USA, V104, P17105, DOI 10.1073/pnas.0706272104; He GB, 2010, CANCER CELL, V17, P286, DOI 10.1016/j.ccr.2009.12.048; Hilliard VC, 2011, AM J PHYSIOL-GASTR L, V301, pG338, DOI 10.1152/ajpgi.00057.2011; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Hu M, 2007, GASTROENTEROLOGY, V133, P1579, DOI 10.1053/j.gastro.2007.08.036; Huch M, 2015, CELL, V160, P299, DOI 10.1016/j.cell.2014.11.050; Huch M, 2013, NATURE, V494, P247, DOI 10.1038/nature11826; Hymowitz SG, 2001, EMBO J, V20, P5332, DOI 10.1093/emboj/20.19.5332; Itoh T, 2009, FEBS LETT, V583, P777, DOI 10.1016/j.febslet.2009.01.022; Iwakura Y, 2011, IMMUNITY, V34, P149, DOI 10.1016/j.immuni.2011.02.012; Jiang HQ, 2012, CURR OPIN GENET DEV, V22, P354, DOI 10.1016/j.gde.2012.04.002; Jiang HQ, 2011, CELL STEM CELL, V8, P84, DOI 10.1016/j.stem.2010.11.026; Johnson R, 2014, NAT REV DRUG DISCOV, V13, P63, DOI 10.1038/nrd4161; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Karpowicz P, 2010, DEVELOPMENT, V137, P4135, DOI 10.1242/dev.060483; Kishimoto T, 2010, INT IMMUNOL, V22, P347, DOI 10.1093/intimm/dxq030; Kolls JK, 2008, NAT REV IMMUNOL, V8, P829, DOI 10.1038/nri2433; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Lee WJ, 2013, ANNU REV CELL DEV BI, V29, P571, DOI 10.1146/annurev-cellbio-101512-122333; Liu SJ, 2013, J BIOL CHEM, V288, P8794, DOI 10.1074/jbc.M112.436204; Liu ZG, 1996, CELL, V87, P565, DOI 10.1016/S0092-8674(00)81375-6; Lopetuso LR, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00181; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Maeda S, 2005, CELL, V121, P977, DOI 10.1016/j.cell.2005.04.014; Maeda S, 2003, IMMUNITY, V19, P725, DOI 10.1016/S1074-7613(03)00301-7; Makki N, 2013, INT J MOL SCI, V14, P20597, DOI 10.3390/ijms141020597; Marshall KM, 2014, J EXP MED, V211, P1793, DOI 10.1084/jem.20131902; Micchelli CA, 2006, NATURE, V439, P475, DOI 10.1038/nature04371; Miyoshi H, 2012, SCIENCE, V338, P108, DOI 10.1126/science.1223821; Moh A, 2007, LAB INVEST, V87, P1018, DOI 10.1038/labinvest.3700630; Monga SS, 2014, GENE EXPRESSION, V16, P51, DOI 10.3727/105221614X13919976902138; Munoz J, 2012, EMBO J, V31, P3079, DOI 10.1038/emboj.2012.166; Nakagawa H, 2014, CANCER CELL, V26, P331, DOI 10.1016/j.ccr.2014.07.001; Nenci A, 2007, NATURE, V446, P557, DOI 10.1038/nature05698; Neu J, 2011, NEW ENGL J MED, V364, P255, DOI 10.1056/NEJMra1005408; Neurath MF, 2014, MUCOSAL IMMUNOL, V7, P6, DOI 10.1038/mi.2013.73; Nikoopour E, 2015, CYTOKINE, V74, P35, DOI 10.1016/j.cyto.2014.09.007; Nowarski R, 2015, CELL, V163, P1444, DOI 10.1016/j.cell.2015.10.072; Panayidou S, 2013, PATHOGENS, V2, P209, DOI 10.3390/pathogens2020209; Papa S, 2008, J CLIN INVEST, V118, P1911, DOI 10.1172/JCI33913; Pappu R, 2012, TRENDS IMMUNOL, V33, P343, DOI 10.1016/j.it.2012.02.008; Park HW, 2015, CELL, V162, P780, DOI 10.1016/j.cell.2015.07.013; POPPER HANS, 1957, JOUR MT SINAI HOSP, V24, P551; POTTEN CS, 1977, NATURE, V269, P518, DOI 10.1038/269518a0; Radaeva S, 2004, HEPATOLOGY, V39, P1332, DOI 10.1002/hep.20184; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rayes N, 2012, BENEF MICROBES, V3, P237, DOI 10.3920/BM2012.0006; Ren FF, 2010, P NATL ACAD SCI USA, V107, P21064, DOI 10.1073/pnas.1012759107; Roche KC, 2015, GASTROENTEROLOGY, V149, P1553, DOI 10.1053/j.gastro.2015.07.004; Rock KL, 2010, ANNU REV IMMUNOL, V28, P321, DOI 10.1146/annurev-immunol-030409-101311; Sakurai T, 2006, P NATL ACAD SCI USA, V103, P10544, DOI 10.1073/pnas.0603499103; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Scheller J, 2011, TRENDS IMMUNOL, V32, P380, DOI 10.1016/j.it.2011.05.005; Schwabe RF, 2006, AM J PHYSIOL-GASTR L, V290, pG583, DOI 10.1152/ajpgi.00422.2005; Schwitalla S, 2013, CELL, V152, P25, DOI 10.1016/j.cell.2012.12.012; Seki E, 2005, HEPATOLOGY, V41, P443, DOI 10.1002/hep.20603; Seki E, 2012, GASTROENTEROLOGY, V143, P307, DOI 10.1053/j.gastro.2012.06.004; Shaukat Z, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/369286; Shaw RL, 2010, DEVELOPMENT, V137, P4147, DOI 10.1242/dev.052506; Sommer F, 2013, NAT REV MICROBIOL, V11, P227, DOI 10.1038/nrmicro2974; Song XY, 2011, NAT IMMUNOL, V12, P1151, DOI 10.1038/ni.2155; Staley BK, 2010, CURR BIOL, V20, P1580, DOI 10.1016/j.cub.2010.07.041; Stanger BZ, 2015, ANNU REV PHYSIOL, V77, P179, DOI 10.1146/annurev-physiol-021113-170255; Stanger BZ, 2005, P NATL ACAD SCI USA, V102, P12443, DOI 10.1073/pnas.0505690102; Stepniak E, 2006, GENE DEV, V20, P2306, DOI 10.1101/gad.390506; Stevens LJ, 2012, MOL BIOL CELL, V23, P1068, DOI 10.1091/mbc.E11-09-0745; Stramer BM, 2007, J INVEST DERMATOL, V127, P1009, DOI 10.1038/sj.jid.5700811; Sugimoto K, 2008, J CLIN INVEST, V118, P534, DOI [10.1172/JC133194, 10.1172/JCI33194]; Sun GP, 2014, CURR TOP DEV BIOL, V108, P95, DOI 10.1016/B978-0-12-391498-9.00003-6; Taniguchi K, 2015, NATURE, V519, P57, DOI 10.1038/nature14228; Taub R, 2004, NAT REV MOL CELL BIO, V5, P836, DOI 10.1038/nrm1489; Tschaharganeh DF, 2013, GASTROENTEROLOGY, V144, P1530, DOI 10.1053/j.gastro.2013.02.009; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; Wang B, 2015, NATURE, V524, P180, DOI 10.1038/nature14863; Wang KP, 2014, IMMUNITY, V41, P1052, DOI 10.1016/j.immuni.2014.11.009; West NR, 2015, NAT REV IMMUNOL, V15, P615, DOI 10.1038/nri3896; Wittkopf N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118401; Xu N, 2011, DEV BIOL, V354, P31, DOI 10.1016/j.ydbio.2011.03.018; Yamada Y, 1998, HEPATOLOGY, V28, P959, DOI 10.1002/hep.510280410; Yamada Y, 1997, P NATL ACAD SCI USA, V94, P1441, DOI 10.1073/pnas.94.4.1441; Yang J, 2014, HEPATOLOGY, V60, P964, DOI 10.1002/hep.27082; Yang W, 2008, CANCER RES, V68, P4287, DOI 10.1158/0008-5472.CAN-07-6691; Yu FX, 2013, GENE DEV, V27, P355, DOI 10.1101/gad.210773.112; Zaki MH, 2010, IMMUNITY, V32, P379, DOI 10.1016/j.immuni.2010.03.003; Zenewicz LA, 2007, IMMUNITY, V27, P647, DOI 10.1016/j.immuni.2007.07.023; Zhang JM, 2009, NAT CELL BIOL, V11, P1444, DOI 10.1038/ncb1993; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720; Zhou DW, 2011, P NATL ACAD SCI USA, V108, pE1312, DOI 10.1073/pnas.1110428108	140	420	438	7	248	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 21	2016	529	7586					307	315		10.1038/nature17039	http://dx.doi.org/10.1038/nature17039			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB2QT	26791721	Green Accepted			2022-12-28	WOS:000368354800032
J	Curry, TA				Curry, Teddi Anderson			What Would Mom Want?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	1	1	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 19	2016	315	3					261	262		10.1001/jama.2015.13326	http://dx.doi.org/10.1001/jama.2015.13326			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DB2WN	26784770				2022-12-28	WOS:000368371400019
J	Ouspenskaia, T; Matos, I; Mertz, AF; Fiore, VF; Fuchs, E				Ouspenskaia, Tamara; Matos, Irina; Mertz, Aaron F.; Fiore, Vincent F.; Fuchs, Elaine			WNT-SHH Antagonism Specifies and Expands Stem Cells prior to Niche Formation	CELL			English	Article							HAIR FOLLICLE MORPHOGENESIS; BETA-CATENIN; BUD DEVELOPMENT; SONIC HEDGEHOG; SELF-RENEWAL; DIFFERENTIATION; DYNAMICS; DROSOPHILA; GERMLINE; SKIN	Adult stem cell (SC) maintenance and differentiation are known to depend on signals received from the niche. Here, however, we demonstrate a mechanism for SC specification and regulation that is niche independent. Using immunofluorescence, live imaging, genetics, cell-cycle analyses, in utero lentiviral transduction, and lineage-tracing, we show that in developing hair buds, SCs are born from asymmetric divisions that differentially display WNT and SHH signaling. Displaced WNTlo suprabasal daughters become SCs that respond to paracrine SHH and symmetrically expand. By contrast, basal daughters remain WNThi. They express but do not respond to SHH and hence maintain slow-cycling, asymmetric divisions. Over time, they become short-lived progenitors, generating differentiating daughters rather than SCs. Thus, in contrast to an established niche that harbors a fixed SC pool whose expelled progeny differentiate, asymmetric divisions first specify and displace early SCs into an environment conducive to expansion and later restrict their numbers by switching asymmetric fates.	[Ouspenskaia, Tamara; Matos, Irina; Mertz, Aaron F.; Fiore, Vincent F.; Fuchs, Elaine] Rockefeller Univ, Howard Hughes Med Inst, Robin Neustein Lab Mammalian Dev & Cell Biol, New York, NY 10065 USA	Howard Hughes Medical Institute; Rockefeller University	Fuchs, E (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Robin Neustein Lab Mammalian Dev & Cell Biol, New York, NY 10065 USA.	fuchslb@rockefeller.edu	Fuchs, Elaine/G-1565-2016	Ouspenskaia, Tamara/0000-0002-5462-7103	Rockefeller University Women and Science; National Science Foundation [DBI-1401728]; NIH [T32-CA009673-37, R37-AR27883, R01-AR31737]; NATIONAL CANCER INSTITUTE [T32CA009673] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR027883, R01AR031737, R37AR027883] Funding Source: NIH RePORTER	Rockefeller University Women and Science; National Science Foundation(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank the following for mice/reagents: R. Kucherlapati (Harvard), R. Kemler (Max-Planck, Freiburg), H. Westphal (NIH), and A. McMahon (U Southern California). We thank E.F. lab members C.P. Lu, S. Beronja, N. Oshimori, R. Adam, and C.A. Rascon for helpful comments and discussions; J. Racelis for technical assistance; L. Polak, J. Levorse, and S. Hacker for assistance with mouse handling and experiments. We thank Comparative Bioscience Center (AAALAC accredited) for care of mice in accordance with NIH guidelines, the Flow Cytometry facility (S. Mazel, Director), and the Bio-Imaging Resource Center (A. North, Director). E.F. is an Investigator of the Howard Hughes Medical Institute (HHMI). T.O. is an HHMI International Graduate Student Fellow. I.M. was the recipient of a Rockefeller University Women and Science Post-doctoral Fellowship. This material is based upon work supported by the National Science Foundation Postdoctoral Research Fellowship in Biology to A.F.M. under award DBI-1401728. This study was supported by grants from the NIH (T32-CA009673-37 to V.F.F. and R37-AR27883 and R01-AR31737 to E.F.).	Adam RC, 2015, NATURE, V521, P366, DOI 10.1038/nature14289; Ahtiainen L, 2014, DEV CELL, V28, P588, DOI 10.1016/j.devcel.2014.02.003; Astudillo P, 2014, CURR MOL MED, V14, P209, DOI 10.2174/1566524014666140128105352; Azzolin L, 2014, CELL, V158, P157, DOI 10.1016/j.cell.2014.06.013; Baeg GH, 2001, DEVELOPMENT, V128, P87; Beronja S, 2013, NATURE, V501, P185, DOI 10.1038/nature12464; Beronja S, 2010, NAT MED, V16, P821, DOI 10.1038/nm.2167; Bhat KM, 1997, DEV DYNAM, V210, P371, DOI 10.1002/(SICI)1097-0177(199712)210:4<371::AID-AJA2>3.0.CO;2-D; Blanpain C, 2014, SCIENCE, V344, P1243, DOI 10.1126/science.1242281; Blanpain C, 2013, NAT REV MOL CELL BIO, V14, P489, DOI 10.1038/nrm3625; Cabello J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000297; Clayton E, 2007, NATURE, V446, P185, DOI 10.1038/nature05574; Clevers H, 2014, SCIENCE, V346, P54, DOI 10.1126/science.1248012; Dansereau David A., 2008, V450, P3, DOI 10.1007/978-1-60327-214-8_1; DasGupta R, 1999, DEVELOPMENT, V126, P4557; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; Gao CX, 2015, ELIFE, V4, DOI 10.7554/eLife.10072; Gat U, 1998, CELL, V95, P605, DOI 10.1016/S0092-8674(00)81631-1; Habib SJ, 2013, SCIENCE, V339, P1445, DOI 10.1126/science.1231077; Hsu YC, 2014, CELL, V157, P935, DOI 10.1016/j.cell.2014.02.057; Hsu YC, 2011, CELL, V144, P92, DOI 10.1016/j.cell.2010.11.049; Huelsken J, 2001, CELL, V105, P533, DOI 10.1016/S0092-8674(01)00336-1; Jamora C, 2003, NATURE, V422, P317, DOI 10.1038/nature01458; Karlsson L, 1999, DEVELOPMENT, V126, P2611; Kodama A, 2003, CELL, V115, P343, DOI 10.1016/S0092-8674(03)00813-4; Kuraguchi M, 2006, PLOS GENET, V2, P1362, DOI 10.1371/journal.pgen.0020146; Larsimont JC, 2015, CELL STEM CELL, V17, P60, DOI 10.1016/j.stem.2015.05.008; Lechler T, 2005, NATURE, V437, P275, DOI 10.1038/nature03922; Li VSW, 2012, CELL, V149, P1245, DOI 10.1016/j.cell.2012.05.002; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Mendoza-Topaz C, 2011, OPEN BIOL, V1, DOI 10.1098/rsob.110013; Noramly S, 1999, DEVELOPMENT, V126, P3509; Nowak JA, 2008, CELL STEM CELL, V3, P33, DOI 10.1016/j.stem.2008.05.009; Pardo-Saganta A, 2015, NATURE, V523, P597, DOI 10.1038/nature14553; Pei YX, 2012, DEVELOPMENT, V139, P1724, DOI 10.1242/dev.050104; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Rhee H, 2006, SCIENCE, V312, P1946, DOI 10.1126/science.1128004; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Scadden DT, 2014, CELL, V157, P41, DOI 10.1016/j.cell.2014.02.013; SCHOFIELD R, 1978, BLOOD CELLS, V4, P7; Shin K, 2011, NATURE, V472, P110, DOI 10.1038/nature09851; Shyer AE, 2015, CELL, V161, P569, DOI 10.1016/j.cell.2015.03.041; Song XQ, 2002, SCIENCE, V296, P1855, DOI 10.1126/science.1069871; St-Jacques B, 1998, CURR BIOL, V8, P1058, DOI 10.1016/S0960-9822(98)70443-9; Sugimura R, 2012, CELL, V150, P351, DOI 10.1016/j.cell.2012.05.041; Sugioka K, 2011, CELL, V146, P941, DOI 10.1016/j.cell.2011.07.043; VANGENDEREN C, 1994, GENE DEV, V8, P2691, DOI 10.1101/gad.8.22.2691; Vidal VPI, 2005, CURR BIOL, V15, P1340, DOI 10.1016/j.cub.2005.06.064; Williams SE, 2014, NAT CELL BIOL, V16, P758, DOI 10.1038/ncb3001; Williams SE, 2011, NATURE, V470, P353, DOI 10.1038/nature09793; Woo WM, 2012, GENE DEV, V26, P1235, DOI 10.1101/gad.187401.112; Yamashita YM, 2003, SCIENCE, V301, P1547, DOI 10.1126/science.1087795; Zhu CH, 2003, DEVELOPMENT, V130, P2579, DOI 10.1242/dev.00499	53	99	104	3	41	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 14	2016	164	1-2					156	169		10.1016/j.cell.2015.11.058	http://dx.doi.org/10.1016/j.cell.2015.11.058			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DB2LE	26771489	Green Accepted, Bronze			2022-12-28	WOS:000368339300017
J	[Anonymous]				[Anonymous]			Naloxegol (Movantik) for Opioid-Induced Constipation (Reprinted from The Medical Letter on Drugs and Therapeutics, vol 57, pg 135, 2015)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint							PAIN											[Anonymous], 2013, Med Lett Drugs Ther, V55, pe44; [Anonymous], 2008, Med Lett Drugs Ther, V50, P63; [Anonymous], 2013, MED LETT DRUGS THER, V55, P5; Bruner HC, 2015, J PAIN RES, V8, P289, DOI 10.2147/JPR.S61326; Chey WD, 2014, NEW ENGL J MED, V370, P2387, DOI 10.1056/NEJMoa1310246; Siemens W, 2015, EXPERT OPIN PHARMACO, V16, P515, DOI 10.1517/14656566.2015.995625; Webster L, 2014, ALIMENT PHARM THER, V40, P771, DOI 10.1111/apt.12899; 2015, MED LETT DRUGS THER, V57, P135; 2008, MED LETT DRUGS THER, V50, P93	9	5	6	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 12	2016	315	2					194	195		10.1001/jama.2015.17459	http://dx.doi.org/10.1001/jama.2015.17459			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DA6XO	26757469				2022-12-28	WOS:000367949200022
J	Da Cruz, S; Cleveland, DW				Da Cruz, Sandrine; Cleveland, Don W.			Disrupted nuclear import-export in neurodegeneration	SCIENCE			English	Editorial Material							NUCLEOCYTOPLASMIC TRANSPORT; REPEAT EXPANSION; HUNTINGTIN; DEATH; PROTEINS		[Da Cruz, Sandrine; Cleveland, Don W.] Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Cleveland, Don W.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego	Da Cruz, S (corresponding author), Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA.	dcleveland@ucsd.edu	Cleveland, Don/AAN-9783-2021	Cleveland, Don/0000-0002-1934-3682	NINDS NIH HHS [R01 NS027036] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS027036] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Banez-Coronel M, 2015, NEURON, V88, P667, DOI 10.1016/j.neuron.2015.10.038; Cohen E, 2006, SCIENCE, V313, P1604, DOI 10.1126/science.1124646; Cornett J, 2005, NAT GENET, V37, P198, DOI 10.1038/ng1503; D'Angelo MA, 2009, CELL, V136, P284, DOI 10.1016/j.cell.2008.11.037; Freibaum BD, 2015, NATURE, V525, P129, DOI 10.1038/nature14974; Jovicic A, 2015, NAT NEUROSCI, V18, P1226, DOI 10.1038/nn.4085; Kaganovich D, 2008, NATURE, V454, P1088, DOI 10.1038/nature07195; Miller SBM, 2015, EMBO J, V34, P778, DOI 10.15252/embj.201489524; Olzscha H, 2011, CELL, V144, P67, DOI 10.1016/j.cell.2010.11.050; Parone PA, 2013, J NEUROSCI, V33, P4657, DOI 10.1523/JNEUROSCI.1119-12.2013; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; Treusch S, 2009, CELL CYCLE, V8, P1668, DOI 10.4161/cc.8.11.8503; Woerner AC, 2016, SCIENCE, V351, P173, DOI 10.1126/science.aad2033; Zhang K, 2015, NATURE, V525, P56, DOI 10.1038/nature14973	15	11	11	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 8	2016	351	6269					125	126		10.1126/science.aad9872	http://dx.doi.org/10.1126/science.aad9872			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA4XQ	26744395	Green Accepted			2022-12-28	WOS:000367806500016
J	Astradsson, A; Aziz, T				Astradsson, Arnar; Aziz, Tipu			Parkinson's disease: fetal cell or stem cell derived treatments	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Astradsson, Arnar] Univ Copenhagen, Glostrup Hosp, Traumat Brain Injury Unit, Dept Neurorehabilitat, DK-1168 Copenhagen, Denmark; [Aziz, Tipu] Univ Oxford, Nuffield Dept Surg Sci, Div Clin Neurol, Neurosurg, Oxford OX1 2JD, England	University of Copenhagen; University of Oxford	Astradsson, A (corresponding author), Univ Copenhagen, Glostrup Hosp, Traumat Brain Injury Unit, Dept Neurorehabilitat, DK-1168 Copenhagen, Denmark.	arnar.astradsson@regionh.dk						Astradsson A, 2015, CLIN EVID, V04, P1203; Coghlan A., 2015, NEW SCI	2	4	4	0	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 7	2016	352								h6340	10.1136/bmj.h6340	http://dx.doi.org/10.1136/bmj.h6340			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DA8MV	26743154				2022-12-28	WOS:000368060000007
J	Lowen, AC				Lowen, Anice C.			VIROLOGY Host protein clips bird flu's wings in mammals	NATURE			English	Editorial Material							MOLECULAR-BASIS; VIRUS; MUTATIONS; PB2; DETERMINANT; NP		[Lowen, Anice C.] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA	Emory University	Lowen, AC (corresponding author), Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA.	anice.lowen@emory.edu						Danzy S, 2014, J VIROL, V88, P13436, DOI 10.1128/JVI.01093-14; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Gabriel G, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040011; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; Linster M, 2014, CELL, V157, DOI 10.1016/j.cell.2014.02.040; Long JS, 2016, NATURE, V529, P101, DOI 10.1038/nature16474; Manz B, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1804; Mehle A, 2008, CELL HOST MICROBE, V4, P111, DOI 10.1016/j.chom.2008.06.007; Moncorge O, 2010, J VIROL, V84, P9978, DOI 10.1128/JVI.01134-10; Munster VJ, 2007, J INFECT DIS, V196, P258, DOI 10.1086/518792; Paterson D, 2014, J VIROL, V88, P339, DOI 10.1128/JVI.02022-13; Rameix-Welti MA, 2009, J VIROL, V83, P1320, DOI 10.1128/JVI.00977-08; Shinya K, 2009, J VIROL, V83, P13015, DOI 10.1128/JVI.01714-09; Steel J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000252; SUBBARAO EK, 1993, J VIROL, V67, P1761, DOI 10.1128/JVI.67.4.1761-1764.1993; Weber M, 2015, CELL HOST MICROBE, V17, P309, DOI 10.1016/j.chom.2015.01.005	16	1	1	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 7	2016	529	7584					30	31		10.1038/529030a	http://dx.doi.org/10.1038/529030a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6VY	26738587				2022-12-28	WOS:000367944900018
J	Lebwohl, B; Green, PHR				Lebwohl, Benjamin; Green, Peter H. R.			Antitissue Transglutaminase IgA for Celiac Disease Testing	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PEDIATRIC-GASTROENTEROLOGY; DIAGNOSIS; HEPATOLOGY; GUIDELINES; NUTRITION; SOCIETY		[Lebwohl, Benjamin; Green, Peter H. R.] Columbia Univ, Celiac Dis Ctr, Dept Med, New York, NY 10032 USA	Columbia University	Green, PHR (corresponding author), Columbia Univ, Celiac Dis Ctr, 180 Ft Washington Ave,Ste 936, New York, NY 10032 USA.	pg11@columbia.edu						AINE L, 1990, J ORAL PATHOL MED, V19, P241, DOI 10.1111/j.1600-0714.1990.tb00834.x; DeGaetani M, 2013, AM J GASTROENTEROL, V108, P647, DOI 10.1038/ajg.2013.45; Hill ID, 2005, J PEDIATR GASTR NUTR, V40, P1, DOI 10.1097/00005176-200501000-00001; Husby S, 2012, J PEDIATR GASTR NUTR, V54, P136, DOI 10.1097/MPG.0b013e31821a23d0; Lebwohl Benjamin, 2012, Gastrointest Endosc Clin N Am, V22, P661, DOI 10.1016/j.giec.2012.07.004; Leffler DA, 2010, AM J GASTROENTEROL, V105, P2520, DOI 10.1038/ajg.2010.276; Ludvigsson JF, 2013, GUT, V62, P43, DOI 10.1136/gutjnl-2011-301346; Reilly NR, 2012, SEMIN IMMUNOPATHOL, V34, P473, DOI 10.1007/s00281-012-0311-2; Rubio-Tapia A, 2013, AM J GASTROENTEROL, V108, P656, DOI 10.1038/ajg.2013.79; Singh P, 2015, AM J GASTROENTEROL, V110, P1539, DOI 10.1038/ajg.2015.296	10	0	0	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 5	2016	315	1					81	82		10.1001/jama.2015.15283	http://dx.doi.org/10.1001/jama.2015.15283			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DA0YH	26746462				2022-12-28	WOS:000367523000019
J	Watts, G				Watts, Geoff			Magdi Yacoub: a lifelong affair with the heart	LANCET			English	Biographical-Item																			0	0	0	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 2	2016	387	10013					21	21		10.1016/S0140-6736(15)01302-1	http://dx.doi.org/10.1016/S0140-6736(15)01302-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CZ9ZU	26766337				2022-12-28	WOS:000367457300013
J	Wilson, MH; Habig, K; Wright, C; Hughes, A; Davies, G; Imray, CHE				Wilson, Mark H.; Habig, Karel; Wright, Christopher; Hughes, Amy; Davies, Gareth; Imray, Chirstopher H. E.			Pre-hospital emergency medicine	LANCET			English	Article							RAPID-SEQUENCE INTUBATION; TRAUMA PATIENTS; HEMORRHAGE CONTROL; HEAD-INJURY; STROKE; HELICOPTER; MANAGEMENT; SERVICES; CARE; DISPATCH	Pre-hospital care is emergency medical care given to patients before arrival in hospital after activation of emergency medical services. It traditionally incorporated a breadth of care from bystander resuscitation to statutory emergency medical services treatment and transfer. New concepts of care including community paramedicine, novel roles such as emergency care practitioners, and physician delivered pre-hospital emergency medicine are re-defining the scope of pre-hospital care. For severely ill or injured patients, acting quickly in the pre-hospital period is crucial with decisions and interventions greatly affecting outcomes. The transfer of skills and procedures from hospital care to pre-hospital medicine enables early advanced care across a range of disciplines. The variety of possible pathologies, challenges of environmental factors, and hazardous situations requires management that is tailored to the patient's clinical need and setting. Pre-hospital clinicians should be generalists with a broad understanding of medical, surgical, and trauma pathologies, who will often work from locally developed standard operating procedures, but who are able to revert to core principles. Pre-hospital emergency medicine consists of not only clinical care, but also logistics, rescue competencies, and scene management skills (especially in major incidents, which have their own set of management principles). Traditionally, research into the hyper-acute phase (the first hour) of disease has been difficult, largely because physicians are rarely present and issues of consent, transport expediency, and resourcing of research. However, the pre-hospital phase is acknowledged as a crucial period, when irreversible pathology and secondary injury to neuronal and cardiac tissue can be prevented. The development of pre-hospital emergency medicine into a sub-specialty in its own right should bring focus to this period of care.	[Wilson, Mark H.; Hughes, Amy; Davies, Gareth] Royal London Hosp, Londons Air Ambulance, Inst Prehosp Care, London E1 1BB, England; [Wilson, Mark H.; Wright, Christopher] Univ London Imperial Coll Sci Technol & Med, St Marys Major Trauma Ctr, London, England; [Habig, Karel] Greater Sydney HEMS Serv, Sydney, NSW, Australia; [Imray, Chirstopher H. E.] UHCW NHS Trust, Warwick Med Sch, Dept Surg, Warwick, England	Barts Health NHS Trust; Royal London Hospital; Imperial College London; University of Warwick	Wilson, MH (corresponding author), Royal London Hosp, Londons Air Ambulance, Inst Prehosp Care, Helipad, London E1 1BB, England.	mark@rcsed.ac.uk		Wilson, Mark/0000-0002-2346-4911				Aerden D, 2014, ACTA CHIR BELG, V114, P228, DOI 10.1080/00015458.2014.11681017; Aguilar SA, 2013, J EMERG MED, V45, P210, DOI 10.1016/j.jemermed.2013.01.044; Ahmed Syed Moied, 2008, J Emerg Trauma Shock, V1, P97, DOI 10.4103/0974-2700.43190; American College of Surgeons, 2012, ADV TRAUM LIF SUPP S; [Anonymous], 2005, JEMS, V30, P14; Aslami H, 2010, NETH J MED, V68, P190; Atkinson JLD, 1998, J TRAUMA, V45, P941, DOI 10.1097/00005373-199811000-00016; Audebert HJ, 2013, NEUROLOGY, V81, P501, DOI 10.1212/WNL.0b013e31829e0fdd; Aylwin CJ, 2008, ANN ROY COLL SURG, V90, P54, DOI 10.1308/003588408X242286; Bernard SA, 2010, ANN SURG, V252, P959, DOI 10.1097/SLA.0b013e3181efc15f; Bredmose PP, 2009, EMERG MED J, V26, P62, DOI 10.1136/emj.2007.052753; Brenner ML, 2013, J TRAUMA ACUTE CARE, V75, P506, DOI 10.1097/TA.0b013e31829e5416; Bukur M, 2011, J SURG RES, V170, pE117, DOI 10.1016/j.jss.2011.04.005; Chaudery M, 2015, J TRAUMA ACUTE CARE, V78, P153, DOI 10.1097/TA.0000000000000472; Chiara O, 2002, INJURY, V33, P553, DOI 10.1016/S0020-1383(02)00123-7; Cooper GE, 1979, P NASA IND WORKSH HE, P255; Davenport R, 2014, CRIT CARE, V18, DOI 10.1186/cc13923; Davies GE, 2011, J TRAUMA, V70, pE75, DOI 10.1097/TA.0b013e3181f6f72f; Davis DP, 2003, J TRAUMA, V54, P444, DOI 10.1097/01.TA.0000053396.02126.CD; Ebinger M, 2014, JAMA-J AM MED ASSOC, V311, P1622, DOI 10.1001/jama.2014.2850; Ebinger M, 2013, JOVE-J VIS EXP, DOI 10.3791/50534; Ellis D, 2010, CASES PREHOSPITAL RE; Fortin JL, 2006, CLIN TOXICOL, V44, P37, DOI 10.1080/15563650600811870; Galvagno SM, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009228.pub2; Galvagno SM, 2012, JAMA-J AM MED ASSOC, V307, P1602, DOI 10.1001/jama.2012.467; Garner AA, 2015, EMERG MED J, V32, P869, DOI 10.1136/emermed-2014-204390; Giannakopoulos GF, 2013, EUR J EMERG MED, V20, P79, DOI 10.1097/MEJ.0b013e328352ac9b; Goldstein P, 2005, Minerva Anestesiol, V71, P297; Gunning M, 2013, SAMJ, S. Afr. med. j., V103, P632, DOI 10.7196/samj.6656; Hacke W, 2004, LANCET, V363, P768; Helmreich RL, 1999, INT J AVIAT PSYCHOL, V9, P19, DOI 10.1207/s15327108ijap0901_2; Hilker M, 2013, THORAC CARDIOVASC SU, V61, P45; Hodgetts TJ, 2006, EMERG MED J, V23, P745, DOI 10.1136/emj.2006.039610; Kleber C, 2013, WORLD J SURG, V37, P1154, DOI 10.1007/s00268-013-1964-2; Knudsen L, 2011, ACTA ANAESTH SCAND, V55, P377, DOI 10.1111/j.1399-6576.2011.02400.x; Kragh JF, 2008, J TRAUMA, V64, pS38, DOI 10.1097/TA.0b013e31816086b1; Lamhaut L, 2012, RESUSCITATION, V83, pE177, DOI 10.1016/j.resuscitation.2012.03.016; Lee C, 2005, EMERG MED J, V22, P660, DOI 10.1136/emj.2005.024489; Lee C, 2007, EMERG MED J, V24, P130, DOI 10.1136/emj.2006.041384; Leis C, 2010, RESUSCITATION, V81, pS50; Lendrum RA, 2013, EMERG MED J, V30, P247, DOI 10.1136/emermed-2012-202302; Lockey D, 2014, BRIT J ANAESTH, V113, P220, DOI 10.1093/bja/aeu227; Lockey DJ, 2013, BMC ANESTHESIOL, V13, DOI 10.1186/1471-2253-13-21; Lyon RM, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-73; Morrison JJ, 2014, SURG-J R COLL SURG E, V12, P119, DOI 10.1016/j.surge.2013.10.004; Morrison JJ, 2013, ANN SURG, V257, P330, DOI 10.1097/SLA.0b013e31827eefcf; Olaussen A, 2012, PREHOSP DISASTER MED, V27, P468, DOI 10.1017/S1049023X12001124; Omori K, 2013, RESUSCITATION, V84, P1045, DOI 10.1016/j.resuscitation.2013.01.014; Patel HC, 2005, LANCET, V366, P1538, DOI 10.1016/S0140-6736(05)67626-X; Qureshi A, 2005, EMERG MED J, V22, P885, DOI 10.1136/emj.2004.015891; Ringh M, 2015, NEW ENGL J MED, V372, P2316, DOI 10.1056/NEJMoa1406038; Shakur H, 2010, LANCET, V376, P23, DOI 10.1016/S0140-6736(10)60835-5; Sherren PB, 2014, EMERG MED J, V31, P229, DOI 10.1136/emermed-2012-201879; Shields A, 2013, EMERG MED J, V30, P350, DOI 10.1136/emermed-2012-201422; Smith AH, 2013, EMERG MED J, V30, P784, DOI 10.1136/emermed-2012-201581; Taylor C, 2012, INJURY, V43, P1843, DOI 10.1016/j.injury.2012.07.184; van Schuppen H, 2015, EUR J EMERG MED, V22, P384, DOI 10.1097/MEJ.0000000000000204; WALL MJ, 1994, J TRAUMA, V36, P131, DOI 10.1097/00005373-199401000-00025; Watkins CL, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-318; Weaver AE., 2013, SCAND J TRAUMA RESUS, V21, pS27, DOI DOI 10.1186/1757-7241-21-S1-S27; Weber JE, 2013, NEUROLOGY, V80, P163, DOI 10.1212/WNL.0b013e31827b90e5; Weiser C, 2013, RESUSCITATION, V84, P883, DOI 10.1016/j.resuscitation.2012.12.017; Wild G, 2013, J ROY ARMY MED CORPS, V159, P24, DOI 10.1136/jramc-2013-000013; Wise D, 2005, EMERG MED J, V22, P22, DOI 10.1136/emj.2003.012963	65	44	44	5	31	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 19	2015	386	10012					2526	2534		10.1016/S0140-6736(15)00985-X	http://dx.doi.org/10.1016/S0140-6736(15)00985-X			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CZ1LD	26738719				2022-12-28	WOS:000366866400027
J	Hanushek, EA; Woessmann, L				Hanushek, Eric A.; Woessmann, Ludger			Knowledge capital, growth, and the East Asian miracle Access to schools achieves only so much if quality is poor	SCIENCE			English	Editorial Material							COGNITIVE SKILLS		[Hanushek, Eric A.] Stanford Univ, Stanford, CA 94305 USA; [Woessmann, Ludger] Ifo Inst, D-80539 Munich, Germany; [Woessmann, Ludger] Univ Munich, D-80539 Munich, Germany	Stanford University; Ifo Institut; University of Munich	Hanushek, EA (corresponding author), Stanford Univ, Stanford, CA 94305 USA.	hanushek@stanford.edu		Hanushek, Eric/0000-0002-7090-7535				Acemoglu D, 2005, HANDB ECON, V22, P385; Acemoglu Daron, 2009, INTRO MODERN EC GROW; Barro R. J., 2015, ED MATTERS GLOBAL SC; BARRO RJ, 1991, Q J ECON, V106, P407, DOI 10.2307/2937943; Bils M, 2000, AM ECON REV, V90, P1160, DOI 10.1257/aer.90.5.1160; Hanushek E., 2015, UNIVERSAL BASIC SKIL; Hanushek EA, 2015, CESIFO BOOK SER, P1, DOI 10.7551/mitpress/9780262029179.001.0001; Hanushek EA, 2013, ENDANGERING PROSPERITY: A GLOBAL VIEW OF THE AMERICAN SCHOOL, P1; Hanushek EA, 2000, AM ECON REV, V90, P1184, DOI 10.1257/aer.90.5.1184; Hanushek EA, 2008, J ECON LIT, V46, P607, DOI 10.1257/jel.46.3.607; Hanushek EA, 2012, J ECON GROWTH, V17, P267, DOI 10.1007/s10887-012-9081-x; Howitt P., 2009, EC GROWTH; Klein J.I, 2012, US ED REFORM NATL SE; LEVINE R, 1992, AM ECON REV, V82, P942; Pritchett L., 2013, REBIRTH ED SCH AINT; Romer P.M, 1989, 3173 NBER, DOI [10.1016/0167-2231(90)90028-J, DOI 10.1016/0167-2231(90)90028-J]	17	40	41	2	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 22	2016	351	6271					344	345		10.1126/science.aad7796	http://dx.doi.org/10.1126/science.aad7796			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DB3VH	26798003				2022-12-28	WOS:000368440500025
J	Balla, T				Balla, Tamas			Lipid code for membrane recycling	NATURE			English	Editorial Material							PHOSPHATIDYLINOSITOL 4-PHOSPHATE		[Balla, Tamas] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Program Dev Neurosci, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Balla, T (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Program Dev Neurosci, NIH, Bethesda, MD 20892 USA.	ballat@mail.nih.gov		Balla, Tamas/0000-0002-9077-3335	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000196] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Amoasii L, 2012, CURR TOP MICROBIOL, V362, P209, DOI 10.1007/978-94-007-5025-8_10; Balla T, 2013, PHYSIOL REV, V93, P1019, DOI 10.1152/physrev.00028.2012; Hammond GRV, 2014, J CELL BIOL, V205, P113, DOI 10.1083/jcb.201312072; Jeschke A, 2015, P NATL ACAD SCI USA, V112, P4636, DOI 10.1073/pnas.1423456112; Ketel K, 2016, NATURE, V529, P408, DOI 10.1038/nature16516; Minogue S, 2006, J CELL SCI, V119, P571, DOI 10.1242/jcs.02752; Ribeiro I, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001295; Simonsen A, 1998, NATURE, V394, P494, DOI 10.1038/28879; Takasuga S, 2013, J BIOCHEM, V154, P211, DOI 10.1093/jb/mvt064; van Weering JRT, 2010, SEMIN CELL DEV BIOL, V21, P371, DOI 10.1016/j.semcdb.2009.11.009; VOLK T, 1990, CELL, V63, P525, DOI 10.1016/0092-8674(90)90449-O; Wandinger-Ness A, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a022616; Wu B, 2015, J CELL SCI, V128, P2957, DOI 10.1242/jcs.156398	13	6	6	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 21	2016	529	7586					292	293		10.1038/nature16868	http://dx.doi.org/10.1038/nature16868			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB2QT	26760211				2022-12-28	WOS:000368354800028
J	Settleman, J				Settleman, Jeff			Bet on drug resistance	NATURE			English	Editorial Material							LEUKEMIA STEM-CELLS; ACQUIRED-RESISTANCE; CANCER		[Settleman, Jeff] Calico Life Sci, San Francisco, CA 94080 USA		Settleman, J (corresponding author), Calico Life Sci, San Francisco, CA 94080 USA.	settleman@calicolabs.com						Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Fong CY, 2015, NATURE, V525, P538, DOI 10.1038/nature14888; Klijn C, 2015, NAT BIOTECHNOL, V33, P306, DOI 10.1038/nbt.3080; Lackner MR, 2012, FUTURE ONCOL, V8, P999, DOI [10.2217/fon.12.86, 10.2217/FON.12.86]; Qi J, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a018663; Rathert P, 2015, NATURE, V525, P543, DOI 10.1038/nature14898; Shu SK, 2016, NATURE, V529, P413, DOI 10.1038/nature16508; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; Wang YZ, 2010, SCIENCE, V327, P1650, DOI 10.1126/science.1186624	10	25	26	1	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 21	2016	529	7586					289	290		10.1038/nature16863	http://dx.doi.org/10.1038/nature16863			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB2QT	26735017				2022-12-28	WOS:000368354800026
J	Shekelle, P				Shekelle, Paul			In patients with type 2 diabetes and CV disease, empagliflozin reduced a composite of CV events at 3.1 years	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Shekelle, Paul] Greater Los Angeles VA Hlth Care Syst, Los Angeles, CA 90095 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System	Shekelle, P (corresponding author), Greater Los Angeles VA Hlth Care Syst, Los Angeles, CA 90095 USA.							American Diabetes Association, 2015, STAT DIAB; [Anonymous], 2013, DIABETES ATLAS; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; U.S. Food and Drug Administration, 2013, SAF AL HUM MED PROD	4	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 19	2016	164	2					JC2	JC2		10.7326/ACPJC-2016-164-2-002	http://dx.doi.org/10.7326/ACPJC-2016-164-2-002			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DB0CI	26784492				2022-12-28	WOS:000368175800001
J	Weissman, JS; Cooper, Z; Hyder, JA; Lipsitz, S; Jiang, W; Zinner, MJ; Prigerson, HG				Weissman, Joel S.; Cooper, Zara; Hyder, Joseph A.; Lipsitz, Stuart; Jiang, Wei; Zinner, Michael J.; Prigerson, Holly G.			End-of-Life Care Intensity for Physicians, Lawyers, and the General Population	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							DEATH		[Weissman, Joel S.; Cooper, Zara; Lipsitz, Stuart; Jiang, Wei; Zinner, Michael J.] Brigham & Womens Hosp, Ctr Surg & Publ Hlth, Boston, MA 02115 USA; [Hyder, Joseph A.] Mayo Clin, Dept Anesthesiol, Rochester, MN USA; [Prigerson, Holly G.] Weill Cornell Med, Ctr Res End Life Care, New York, NY USA	Harvard University; Brigham & Women's Hospital; Mayo Clinic; Cornell University	Weissman, JS (corresponding author), Harvard Univ, Brigham andWomens Hosp, Ctr Surg & Publ Hlth, Dept Surg,Med Sch, 1620 Tremont St,Ste 4-020X, Boston, MA 02120 USA.	jweissman@partners.org	Prigerson, Holly/L-3800-2019; Prigerson, Holly/GWV-3283-2022	Prigerson, Holly/0000-0002-7075-4268; 	NATIONAL CANCER INSTITUTE [R35CA197730] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		HILLIER TA, 1995, ARCH INTERN MED, V155, P1289, DOI 10.1001/archinte.155.12.1289; Huber P. J., 2011, ROBUST STAT; Kwok AC, 2011, LANCET, V378, P1408, DOI 10.1016/S0140-6736(11)61268-3; Nicholas LH, 2011, JAMA-J AM MED ASSOC, V306, P1447, DOI 10.1001/jama.2011.1410; STEENLAND K, 1984, J OCCUP ENVIRON MED, V26, P288; Teno JM, 2013, JAMA-J AM MED ASSOC, V309, P470, DOI 10.1001/jama.2012.207624	6	18	18	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 19	2016	315	3					303	305		10.1001/jama.2015.17408	http://dx.doi.org/10.1001/jama.2015.17408			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DB2WN	26784782	Bronze			2022-12-28	WOS:000368371400030
J	Stern, T; Davis, AM				Stern, Todd; Davis, Andrew M.			Evaluation and Treatment of Patients With Constipation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Stern, Todd; Davis, Andrew M.] Univ Chicago, Chicago, IL 60637 USA	University of Chicago	Davis, AM (corresponding author), Univ Chicago, Gen Internal Med Sect, 4124 N LeClaire Ave, Chicago, IL 60637 USA.	amd@uchicago.edu						American Gastroenterological Association, TREATM CHRON CONST; Jodorkovsky D, 2013, J CLIN GASTROENTEROL, V47, P252, DOI 10.1097/MCG.0b013e318266f43a; Lembo AJ, 2011, NEW ENGL J MED, V365, P527, DOI 10.1056/NEJMoa1010863; Longstreth GF, 2006, GASTROENTEROLOGY, V130, P1480, DOI 10.1053/j.gastro.2005.11.061; Schey R, 2011, DIGEST DIS SCI, V56, P1619, DOI 10.1007/s10620-011-1702-2; Sethi S, 2014, AM J GASTROENTEROL, V109, P250, DOI [10.1038/ajg.2013.423, 10.1038/ajg.2013.448]; Shah BJ, 2015, ANN INTERN MED, V162, DOI 10.7326/AITC201504070; Woodward S, 2014, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD008486.PUB2	8	16	19	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 12	2016	315	2					192	193		10.1001/jama.2015.16995	http://dx.doi.org/10.1001/jama.2015.16995			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DA6XO	26757468				2022-12-28	WOS:000367949200021
J	Charlton, BM; Molgaard-Nielsen, D; Svanstrom, H; Wohlfahrt, J; Pasternak, B; Melbye, M				Charlton, Brittany M.; Molgaard-Nielsen, Ditte; Svanstroem, Henrik; Wohlfahrt, Jan; Pasternak, Bjoern; Melbye, Mads			Maternal use of oral contraceptives and risk of birth defects in Denmark: prospective, nationwide cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SEX-HORMONE EXPOSURE; CONGENITAL-MALFORMATIONS; VITAMIN-A; PREGNANCY; SCORE; REGISTRATION; ASSOCIATION; PERFORMANCE	STUDY QUESTION Is oral contraceptive use around the time of pregnancy onset associated with an increased risk of major birth defects? METHODS In a prospective observational cohort study, data on oral contraceptive use and major birth defects were collected among 880 694 live births from Danish registries between 1997 and 2011. We conservatively assumed that oral contraceptive exposure lasted up to the most recently filled prescription. The main outcome measure was the number of major birth defects throughout one year follow-up (defined according to the European Surveillance of Congenital Anomalies classification). Logistic regression estimated prevalence odds ratios of any major birth defect as well as categories of birth defect subgroups. STUDY ANSWER AND LIMITATIONS Prevalence of major birth defects (per 1000 births) was consistent across each oral contraceptive exposure group (25.1, never users; 25.0, use >3 months before pregnancy onset (reference group); 24.9, use 0-3 months before pregnancy onset (that is, recent use); 24.8, use after pregnancy onset). No increase in prevalence of major birth defects was seen with oral contraceptive exposure among women with recent use before pregnancy (prevalence odds ratio 0.98 (95% confidence interval 0.93 to 1.03)) or use after pregnancy onset (0.95 (0.84 to 1.08)), compared with the reference group. There was also no increase in prevalence of any birth defect subgroup (for example, limb defects). It is unknown whether women took oral contraceptives up to the date of their most recently filled prescription. Also, the rarity of birth defects made disaggregation of the results difficult. Residual confounding was possible, and the analysis lacked information on folate, one of the proposed mechanisms. WHAT THIS STUDY ADDS Oral contraceptive exposure just before or during pregnancy does not appear to be associated with an increased risk of major birth defects.	[Charlton, Brittany M.] Harvard Univ, TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Charlton, Brittany M.] Boston Childrens Hosp, Div Adolescent & Young Adult Med, Boston, MA USA; [Charlton, Brittany M.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Molgaard-Nielsen, Ditte; Svanstroem, Henrik; Wohlfahrt, Jan; Pasternak, Bjoern; Melbye, Mads] Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark; [Melbye, Mads] Univ Copenhagen, Dept Clin Med, Copenhagen, Denmark; [Melbye, Mads] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Statens Serum Institut; University of Copenhagen; Stanford University	Charlton, BM (corresponding author), Harvard Univ, TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.	bcharlton@mail.harvard.edu	Pasternak, Bjorn/H-5739-2012; Charlton, Brittany/AAH-9334-2021	Pasternak, Bjorn/0000-0002-2097-8466; melbye, mads/0000-0001-8264-6785	Harvard T H Chan School of Public Health's Maternal Health Task Force and Department of Epidemiology Rose Travelling Fellowship; Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health [T32HD060454, F32HD084000]; National Cancer Institute, National Institutes of Health [T32CA09001]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [F32HD084000, T32HD060454] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [T32CA009001] Funding Source: NIH RePORTER	Harvard T H Chan School of Public Health's Maternal Health Task Force and Department of Epidemiology Rose Travelling Fellowship; Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	BMC was supported by funds from the Harvard T H Chan School of Public Health's Maternal Health Task Force and Department of Epidemiology Rose Travelling Fellowship; training grant T32HD060454 in reproductive, perinatal, and paediatric epidemiology and award number F32HD084000 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, and the training program in cancer epidemiology under grant T32CA09001 from the National Cancer Institute, National Institutes of Health. The funding agencies had no role in the design and conduct of the study; the collection, management, analysis, and interpretation of the data; the preparation, review, or approval of the manuscript; or the decision to submit the manuscript for publication.	Austin PC, 2009, BIOMETRICAL J, V51, P171, DOI 10.1002/bimj.200810488; Black Amanda, 2004, J Obstet Gynaecol Can, V26, P347; BRACKEN MB, 1978, INT J EPIDEMIOL, V7, P309, DOI 10.1093/ije/7.4.309; BRACKEN MB, 1990, OBSTET GYNECOL, V76, P552; COOK EF, 1989, J CLIN EPIDEMIOL, V42, P317; CZEIZEL AE, 1995, CONTRACEPTION, V51, P19, DOI 10.1016/0010-7824(94)00008-K; GAL I, 1971, BMJ-BRIT MED J, V2, P436, DOI 10.1136/bmj.2.5759.436; Hunter DJ, 2010, CANCER EPIDEM BIOMAR, V19, P2496, DOI 10.1158/1055-9965.EPI-10-0747; JANERICH DT, 1976, BRIT J OBSTET GYNAEC, V83, P617, DOI 10.1111/j.1471-0528.1976.tb00898.x; Kildemoes HW, 2011, SCAND J PUBLIC HEALT, V39, P38, DOI 10.1177/1403494810394717; Knudsen LB, 1998, DAN MED BULL, V45, P320; KRICKER A, 1986, AM J OBSTET GYNECOL, V155, P1072, DOI 10.1016/0002-9378(86)90352-2; LAMMER EJ, 1986, JAMA-J AM MED ASSOC, V255, P3128, DOI 10.1001/jama.255.22.3128; Larsen H, 2003, SCAND J PUBLIC HEALT, V31, P12, DOI 10.1080/14034940210134194; LAURITSEN JG, 1975, ACTA OBSTET GYN SCAN, V54, P261; Lewis DP, 1998, ANN PHARMACOTHER, V32, P802, DOI 10.1345/aph.17297; LI DK, 1995, TERATOLOGY, V51, P30, DOI 10.1002/tera.1420510105; LINN S, 1983, AM J OBSTET GYNECOL, V147, P923, DOI 10.1016/0002-9378(83)90247-8; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; MACKENZIE SG, 1989, AM J EPIDEMIOL, V129, P65, DOI 10.1093/oxfordjournals.aje.a115125; Maden M, 2001, POSTGRAD MED J, V77, P489, DOI 10.1136/pmj.77.910.489; Mosher William D, 2010, Vital Health Stat 23, P1; Pasternak B, 2013, NEW ENGL J MED, V368, P814, DOI 10.1056/NEJMoa1211035; Pedersen CB, 2006, DAN MED BULL, V53, P441; POLEDNAK A P, 1985, Public Health Reviews, V13, P89; RAMANWILMS L, 1995, OBSTET GYNECOL, V85, P141, DOI 10.1016/0029-7844(94)00341-A; Rassen JA, 2012, PHARMACOEPIDEM DR S, V21, P69, DOI 10.1002/pds.3263; ROTHMAN KJ, 1978, NEW ENGL J MED, V299, P522, DOI 10.1056/NEJM197809072991006; Skouby SO, 2004, EUR J CONTRACEP REPR, V9, P57, DOI 10.1080/13625180410001715681; SMITHELLS RW, 1981, DEV MED CHILD NEUROL, V23, P369; Trussell J, 2011, CONTRACEPTION, V83, P397, DOI 10.1016/j.contraception.2011.01.021; VESSEY M, 1979, BRIT J OBSTET GYNAEC, V86, P548, DOI 10.1111/j.1471-0528.1979.tb10808.x; Waller DK, 2010, EPIDEMIOLOGY, V21, P232, DOI 10.1097/EDE.0b013e3181c9fbb3; Watkins ML, 2003, PEDIATRICS, V111, P1152; WERLER MM, 1989, AM J EPIDEMIOL, V129, P415, DOI 10.1093/oxfordjournals.aje.a115145	35	20	21	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 6	2016	352								h6712	10.1136/bmj.h6712	http://dx.doi.org/10.1136/bmj.h6712			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DA8MO	26738512	Green Published, hybrid			2022-12-28	WOS:000368059200012
J	Remuzzi, G; Horton, R				Remuzzi, Giuseppe; Horton, Richard			Italy, the Land of Holy Miracles-revisited	LANCET			English	Editorial Material									[Remuzzi, Giuseppe] IRCCS, Ist Ric Farmacol Mario Negri, I-24126 Bergamo, Italy; [Remuzzi, Giuseppe] Azienda Osped Papa Giovanni XXIII, Dept Med, Unit Nephrol & Dialysis, Bergamo, Italy; [Remuzzi, Giuseppe] Univ Milan, Dept Biomed & Clin Sci, Milan, Italy; [Horton, Richard] The Lancet, London, England	Istituto di Ricerche Farmacologiche Mario Negri IRCCS; ASST Papa Giovanni XXIII; University of Milan	Remuzzi, G (corresponding author), IRCCS, Ist Ric Farmacol Mario Negri, I-24126 Bergamo, Italy.	giuseppe.remuzzi@marionegri.it	Remuzzi, Giuseppe/V-9766-2017	Remuzzi, Giuseppe/0000-0002-6194-3446				Remuzzi G, 2011, LANCET, V379, P1068; Si Francis Laudato, 2015, ENCYCLICAL LETT CARE; The Lancet, 1861, LANCET, V77, P593	3	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 2	2016	387	10013					11	12		10.1016/S0140-6736(15)01094-6	http://dx.doi.org/10.1016/S0140-6736(15)01094-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CZ9ZU	26766333				2022-12-28	WOS:000367457300009
J	Chen, B; Bastian, TS; Shen, CC; Gary, DE; Krucker, S; Glesener, L				Chen, Bin; Bastian, Timothy S.; Shen, Chengcai; Gary, Dale E.; Krucker, Saem; Glesener, Lindsay			Particle acceleration by a solar flare termination shock	SCIENCE			English	Article							X-RAY SOURCE; ELECTRON ACCELERATION; MAGNETIC RECONNECTION; EMISSION MECHANISMS; SIMULATION; EJECTIONS; BURSTS; MODEL	Solar flares-the most powerful explosions in the solar system-are also efficient particle accelerators, capable of energizing a large number of charged particles to relativistic speeds. A termination shock is often invoked in the standard model of solar flares as a possible driver for particle acceleration, yet its existence and role have remained controversial. We present observations of a solar flare termination shock and trace its morphology and dynamics using high-cadence radio imaging spectroscopy. We show that a disruption of the shock coincides with an abrupt reduction of the energetic electron population. The observed properties of the shock are well reproduced by simulations. These results strongly suggest that a termination shock is responsible, at least in part, for accelerating energetic electrons in solar flares.	[Chen, Bin; Shen, Chengcai] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Bastian, Timothy S.] Natl Radio Astron Observ, Charlottesville, VA 22903 USA; [Gary, Dale E.] New Jersey Inst Technol, Newark, NJ 07102 USA; [Krucker, Saem; Glesener, Lindsay] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Krucker, Saem] Univ Appl Sci & Arts Northwestern Switzerland, CH-5210 Windisch, Switzerland; [Glesener, Lindsay] Univ Minnesota, Minneapolis, MN 55455 USA	Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; National Radio Astronomy Observatory (NRAO); New Jersey Institute of Technology; University of California System; University of California Berkeley; FHNW University of Applied Sciences & Arts Northwestern Switzerland; University of Minnesota System; University of Minnesota Twin Cities	Chen, B (corresponding author), Harvard Smithsonian Ctr Astrophys, 60 Garden St, Cambridge, MA 02138 USA.	bin.chen@njit.edu	Chen, Bin/W-4943-2017	Chen, Bin/0000-0002-0660-3350; Glesener, Lindsay/0000-0001-7092-2703	NASA [SP02H1701R, NNM07AB07C, NNX14AK66G, NAS598033]; NASA Living With a Star Jack Eddy Fellowship; NSF SHINE [AGS-1156076, AGS-1358342]; NSF [AST-1312802]; Div Atmospheric & Geospace Sciences [1429512] Funding Source: National Science Foundation; Division Of Astronomical Sciences [1312802] Funding Source: National Science Foundation	NASA(National Aeronautics & Space Administration (NASA)); NASA Living With a Star Jack Eddy Fellowship; NSF SHINE(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); NSF(National Science Foundation (NSF)); Div Atmospheric & Geospace Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Division Of Astronomical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	The authors thank the National Radio Astronomy Observatory (NRAO) staff for their support and E. DeLuca, K. Reeves, H. Tian, J. Lin, A. Warmuth, H. Hudson, A. Caspi, F. Guo, G. Nita, G. Fleishman, and X. Bai for helpful discussions. S. Bourke and G. Hallinan are acknowledged for making their fast radio imaging software AIPSLITE available for B.C. A. K. Tolbert and R. Schwartz are thanked for their help in providing the Fermi/GBM detector response for this flare. Z. Wang and M. DeRosa are thanked for their help on the PFSS extrapolations. The NRAO is a facility of the National Science Foundation (NSF) operated under cooperative agreement by Associated Universities, Inc. The VLA data can be accessed at https://archive.nrao.edu/archive/advquery.jsp, using the observing times as the search criteria. The Solar Dynamics Observatory/AIA, RHESSI, Hinode/XRT, and Solar and Heliospheric Observatory/LASCO data are all available through the Virtual Solar Observatory (http://sdac.virtualsolar.org/cgi/search). B.C. acknowledges support by NASA under contract SP02H1701R from Lockheed-Martin to the Smithsonian Astrophysical Observatory (SAO) and contract NNM07AB07C to SAO, and by the NASA Living With a Star Jack Eddy Fellowship (administered by the University Corporation for Atmospheric Research). C.S.'s work was supported by NSF SHINE grants AGS-1156076 and AGS-1358342 to SAO. D.E.G. acknowledges support from NSF grant AST-1312802 and NASA grant NNX14AK66G to the New Jersey Institute of Technology. S.K. and L.G. are supported by NASA contract NAS598033 for the RHESSI spacecraft.	Aurass H, 2004, ASTROPHYS J, V615, P526, DOI 10.1086/424374; Aurass H, 2013, ASTRON ASTROPHYS, V555, DOI 10.1051/0004-6361/201321111; Aurass H, 2002, ASTRON ASTROPHYS, V384, P273, DOI 10.1051/0004-6361:20011735; Bhattacharjee A, 2009, PHYS PLASMAS, V16, DOI 10.1063/1.3264103; Burgess D, 2006, ASTROPHYS J, V653, P316, DOI 10.1086/508805; Carley EP, 2013, NAT PHYS, V9, P811, DOI [10.1038/nphys2767, 10.1038/NPHYS2767]; Chen B, 2014, ASTROPHYS J, V794, DOI 10.1088/0004-637X/794/2/149; Drake JF, 2006, NATURE, V443, P553, DOI 10.1038/nature05116; FORBES TG, 1986, ASTROPHYS J, V305, P553, DOI 10.1086/164268; Guo F, 2012, ASTROPHYS J, V753, DOI 10.1088/0004-637X/753/1/28; Kim EH, 2008, PHYS PLASMAS, V15, DOI 10.1063/1.2994719; Lemen JR, 2012, SOL PHYS, V275, P17, DOI 10.1007/s11207-011-9776-8; Li G, 2013, ASTROPHYS J, V769, DOI 10.1088/0004-637X/769/1/22; Liu W, 2013, ASTROPHYS J, V767, DOI 10.1088/0004-637X/767/2/168; Mann G, 2009, ASTRON ASTROPHYS, V494, P669, DOI 10.1051/0004-6361:200810099; MASUDA S, 1994, NATURE, V371, P495, DOI 10.1038/371495a0; Matsumoto Y, 2015, SCIENCE, V347, P974, DOI 10.1126/science.1260168; MELROSE DB, 1980, SPACE SCI REV, V26, P3, DOI 10.1007/BF00212597; Miller JA, 1997, J GEOPHYS RES-SPACE, V102, P14631, DOI 10.1029/97JA00976; SHIBATA K, 1995, ASTROPHYS J, V451, pL83, DOI 10.1086/309688; Simoes PJA, 2013, ASTRON ASTROPHYS, V551, DOI 10.1051/0004-6361/201220304; Takasao S, 2015, ASTROPHYS J, V805, DOI 10.1088/0004-637X/805/2/135; THEJAPPA G, 1993, ASTROPHYS J, V416, P831, DOI 10.1086/173281; Tsuneta S, 1998, ASTROPHYS J, V495, pL67, DOI 10.1086/311207; Warmuth A, 2009, ASTRON ASTROPHYS, V494, P677, DOI 10.1051/0004-6361:200810101; Workman JC, 2011, PHYS PLASMAS, V18, DOI 10.1063/1.3631795; Yin L, 1998, GEOPHYS RES LETT, V25, P2609, DOI 10.1029/98GL01989; Yokoyama T, 1998, ASTROPHYS J, V494, pL113, DOI 10.1086/311174; Zharkova VV, 2011, SPACE SCI REV, V159, P357, DOI 10.1007/s11214-011-9803-y	29	91	92	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 4	2015	350	6265					1238	1242		10.1126/science.aac8467	http://dx.doi.org/10.1126/science.aac8467			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX4WG	26785486	Green Submitted			2022-12-28	WOS:000365700500073
J	Gong, GH; Song, MS; Csordas, G; Kelly, DP; Matkovich, SJ; Dorn, GW				Gong, Guohua; Song, Moshi; Csordas, Gyorgy; Kelly, Daniel P.; Matkovich, Scot J.; Dorn, Gerald W., II			Parkin-mediated mitophagy directs perinatal cardiac metabolic maturation in mice	SCIENCE			English	Article							MITOFUSIN 2; MITOCHONDRIAL DYNAMISM; GENE-EXPRESSION; HEART; DISEASE; FUSION; FETAL; CARDIOMYOPATHY; DEFICIENCY; AUTOPHAGY	In developing hearts, changes in the cardiac metabolic milieu during the perinatal period redirect mitochondrial substrate preference from carbohydrates to fatty acids. Mechanisms responsible for this mitochondrial plasticity are unknown. Here, we found that PINK1-Mfn2-Parkin-mediated mitophagy directs this metabolic transformation in mouse hearts. A mitofusin (Mfn) 2 mutant lacking PINK1 phosphorylation sites necessary for Parkin binding (Mfn2 AA) inhibited mitochondrial Parkin translocation, suppressing mitophagy without impairing mitochondrial fusion. Cardiac Parkin deletion or expression of Mfn2 AA from birth, but not after weaning, prevented postnatal mitochondrial maturation essential to survival. Five-week-old Mfn2 AA hearts retained a fetal mitochondrial transcriptional signature without normal increases in fatty acid metabolism and mitochondrial biogenesis genes. Myocardial fatty acylcarnitine levels and cardiomyocyte respiration induced by palmitoylcarnitine were concordantly depressed. Thus, instead of transcriptional reprogramming, fetal cardiomyocyte mitochondria undergo perinatal Parkin-mediated mitophagy and replacement by mature adult mitochondria. Mitophagic mitochondrial removal underlies developmental cardiomyocyte mitochondrial plasticity and metabolic transitioning of perinatal hearts.	[Gong, Guohua; Song, Moshi; Matkovich, Scot J.; Dorn, Gerald W., II] Washington Univ, Sch Med, Dept Internal Med, Ctr Pharmacogen, St Louis, MO 63110 USA; [Csordas, Gyorgy] Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA; [Kelly, Daniel P.] Sanford Burnham Prebys Med Discovery Inst, Cardiovasc Metab Program, Ctr Metab Origins Dis, Orlando, FL USA	Washington University (WUSTL); Jefferson University; Sanford Burnham Prebys Medical Discovery Institute	Dorn, GW (corresponding author), Washington Univ, Sch Med, Dept Internal Med, Ctr Pharmacogen, St Louis, MO 63110 USA.	gdorn@dom.wustl.edu	Matkovich, Scot J/AFP-0908-2022; Matkovich, Scot J/B-9077-2009; Kelly, Daniel/ABG-2056-2021	Matkovich, Scot J/0000-0002-7398-6857; Matkovich, Scot J/0000-0002-7398-6857; Csordas, Gyorgy/0000-0003-3156-1460	NIH [HL59888, HL108943, HL128071, HL122124, HL058493]; American Heart Association [14PRE18970093, 14GRNT20410000]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058493, R01HL059888, R01HL108943, R01HL122124, R01HL128071] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We gratefully acknowledge the invaluable contributions of S. J. Gardell of the Sanford Burnham Prebys Medical Discovery Institute for liquid chromatography tandem mass spectrometry studies; and M. Levy of the Laboratory of Electron Microscopy Sciences, Department of Cell Biology, Washington University School of Medicine, S. de la Fuenta, J. Mishra, and D. Weaver of the Thomas Jefferson University Mito Care Center for TEM analyses. Park2 floxed allele mice were obtained from and used under a Materials Transfer Agreement with Lexicon Pharmaceuticals. The authors declare no conflicts. The data presented in this manuscript are tabulated in the supplementary materials. Both unprocessed and transcriptome-aligned RNA-sequencing reads have been deposited in the National Center for Biotechnology Information Gene Expression Omnibus with accession number GSE68921. This work was supported by NIH HL59888, HL108943, HL128071 (G.W.D.), HL122124 (G.C.), HL058493 (D.P.K.), and American Heart Association grants 14PRE18970093 (M.S.) and 14GRNT20410000 (S.J.M.).	Bartelds B, 2000, CIRCULATION, V102, P926, DOI 10.1161/01.CIR.102.8.926; Bhandari P, 2014, CIRC RES, V114, P257, DOI 10.1161/CIRCRESAHA.114.302734; Chen Y, 2013, SCIENCE, V340, P471, DOI 10.1126/science.1231031; Chen Y, 2012, CIRC RES, V111, P863, DOI 10.1161/CIRCRESAHA.112.266585; Chen Y, 2011, CIRC RES, V109, P1327, DOI 10.1161/CIRCRESAHA.111.258723; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; Dorn GW, 2015, EMBO MOL MED, V7, P865, DOI 10.15252/emmm.201404575; Dudkina NV, 2010, BBA-BIOENERGETICS, V1797, P664, DOI 10.1016/j.bbabio.2009.12.013; Eschenbacher WH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044296; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Kageyama Y, 2014, EMBO J, V33, P2798, DOI 10.15252/embj.201488658; KIM HD, 1992, J MOL CELL CARDIOL, V24, P949, DOI 10.1016/0022-2828(92)91862-Y; Koshiba T, 2004, SCIENCE, V305, P858, DOI 10.1126/science.1099793; Kubli DA, 2013, J BIOL CHEM, V288, P915, DOI 10.1074/jbc.M112.411363; Lapuente-Brun E, 2013, SCIENCE, V340, P1567, DOI 10.1126/science.1230381; Lee S, 2012, HUM MOL GENET, V21, P4827, DOI 10.1093/hmg/dds352; Lee Y, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009324; Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268; LOPASCHUK GD, 1991, AM J PHYSIOL, V261, pH1698, DOI 10.1152/ajpheart.1991.261.6.H1698; Misko A, 2010, J NEUROSCI, V30, P4232, DOI 10.1523/JNEUROSCI.6248-09.2010; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Pickrell AM, 2015, NEURON, V85, P257, DOI 10.1016/j.neuron.2014.12.007; Porter GA, 2011, PROG PEDIATR CARDIOL, V31, P75, DOI 10.1016/j.ppedcard.2011.02.002; Razeghi P, 2001, CIRCULATION, V104, P2923, DOI 10.1161/hc4901.100526; Scarffe LA, 2014, TRENDS NEUROSCI, V37, P315, DOI 10.1016/j.tins.2014.03.004; Shin JH, 2011, CELL, V144, P689, DOI 10.1016/j.cell.2011.02.010; Shirihai OS, 2015, CIRC RES, V116, P1835, DOI 10.1161/CIRCRESAHA.116.306374; Song MS, 2015, CIRC RES, V117, P346, DOI 10.1161/CIRCRESAHA.117.306859; Song MS, 2015, CELL METAB, V21, P195, DOI 10.1016/j.cmet.2014.12.019; Song MS, 2014, CIRC RES, V115, P348, DOI 10.1161/CIRCRESAHA.115.304384; Stanley WC, 2005, PHYSIOL REV, V85, P1093, DOI 10.1152/physrev.00006.2004; Syed F, 2004, CIRC RES, V95, P1200, DOI 10.1161/01.RES.0000150366.08972.7f; Taegtmeyer H, 2010, ANN NY ACAD SCI, V1188, P191, DOI 10.1111/j.1749-6632.2009.05100.x; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Williams JA, 2015, J BIOL CHEM, V290, P10934, DOI 10.1074/jbc.M114.602284; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855	37	266	274	6	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 4	2015	350	6265							aad2459	10.1126/science.aad2459	http://dx.doi.org/10.1126/science.aad2459			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX4WG	26785495	Green Accepted			2022-12-28	WOS:000365700500067
J	Moaddab, A; McCullough, LB; Chervenak, FA; Dildy, GA; Shamshirsaz, AA				Moaddab, Amirhossein; McCullough, Laurence B.; Chervenak, Frank A.; Dildy, Gary A.; Shamshirsaz, Alireza Abdollah			Virginity testing in professional obstetric and gynaecological ethics	LANCET			English	Editorial Material							HEALTH; WOMEN; ATTITUDES		[Moaddab, Amirhossein; Dildy, Gary A.; Shamshirsaz, Alireza Abdollah] Baylor Coll Med, Dept Obstet & Gynecol, Houston, TX 77030 USA; [McCullough, Laurence B.] Baylor Coll Med, Ctr Med Eth & Hlth Policy, Houston, TX 77030 USA; [Chervenak, Frank A.] Cornell Univ, New York Presbyterian Hosp, Weill Med Coll, Dept Obstet & Gynecol, New York, NY 10021 USA	Baylor College of Medicine; Baylor College of Medicine; Cornell University; NewYork-Presbyterian Hospital	McCullough, LB (corresponding author), Baylor Coll Med, Ctr Med Eth & Hlth Policy, Houston, TX 77030 USA.	mccullou@bcm.edu	Chervenak, Frank/P-3555-2017; Sampiev, Abdulmutalip/N-4757-2019	Chervenak, Frank/0000-0002-4600-0853; Sampiev, Abdulmutalip/0000-0002-5100-2239; Dildy, Gary/0000-0003-1586-4357				ACOG Committee on Ethics, 2007, Obstet Gynecol, V109, P239; Chervenak FA., 2014, PROFESSIONAL RESPONS; Chervenak FA, 2009, AM J OBSTET GYNECOL, V201, pe1; Chervenak FA, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.06.006; Chervenak FA, 2009, AM J OBSTET GYNECOL, V201, P335, DOI 10.1016/j.ajog.2009.07.006; Chinkin C, 1995, Gend Dev, V3, P23, DOI 10.1080/741921810; Cook RJ, 2009, INT J GYNECOL OBSTET, V107, P266, DOI 10.1016/j.ijgo.2009.07.032; Cottingham J, 2009, INT J GYNECOL OBSTET, V106, P128, DOI 10.1016/j.ijgo.2009.03.024; EMANS SJ, 1994, J PEDIATR-US, V125, P153, DOI 10.1016/S0022-3476(94)70144-X; Heywood M, 2010, J LAW MED ETHICS, V38, P640, DOI 10.1111/j.1748-720X.2010.00517.x; Juth N, 2013, EUR J CONTRACEP REPR, V18, P451, DOI 10.3109/13625187.2013.837443; Kaplan A, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-851; KOHRMAN A, 1995, PEDIATRICS, V95, P314; Kopelman LM, 2014, J MED PHILOS, V39, P8, DOI 10.1093/jmp/jht055; Moaddab A, 2015, AM J OBSTET GYNECOL, V212, P736, DOI 10.1016/j.ajog.2015.03.049; Pelin SP, 1999, BIOETHICS, V13, P256; Ross LF, 1998, BRIT MED J, V316, P462, DOI 10.1136/bmj.316.7129.462a; Shalhoub-Kevorkian N, 2005, SOC SCI MED, V60, P1187, DOI 10.1016/j.socscimed.2004.07.015; Swedish National Board of Health and Welfare, 2007, FREED RESP A SURV TE; United Nations, 1992, WOMEN 2000, V4, P1	20	3	3	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 2	2016	388	10039					98	100		10.1016/S0140-6736(15)01275-1	http://dx.doi.org/10.1016/S0140-6736(15)01275-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DP9PM	26725366				2022-12-28	WOS:000378828400032
J	Sessler, DI				Sessler, Daniel I.			Perioperative thermoregulation and heat balance	LANCET			English	Review							RANDOMIZED CLINICAL-TRIAL; BROWN ADIPOSE-TISSUE; SHIVERING THRESHOLDS; EPIDURAL-ANESTHESIA; CORE-TEMPERATURE; SWEATING THRESHOLD; FORCED-AIR; TRANSFUSION REQUIREMENT; MALIGNANT HYPERTHERMIA; ISOFLURANE ANESTHESIA	Core body temperature is normally tightly regulated to within a few tenths of a degree. The major thermoregulatory defences in humans are sweating, arteriovenous shunt vasoconstriction, and shivering. The core temperature triggering each response defines its activation threshold. General anaesthetics greatly impair thermoregulation, synchronously reducing the thresholds for vasoconstriction and shivering. Neuraxial anaesthesia also impairs central thermoregulatory control, and prevents vasoconstriction and shivering in blocked areas. Consequently, unwarmed anaesthetised patients become hypothermic, typically by 1-2 degrees C. Hypothermia results initially from an internal redistribution of body heat from the core to the periphery, followed by heat loss exceeding metabolic heat production. Complications of perioperative hypothermia include coagulopathy and increased transfusion requirement, surgical site infection, delayed drug metabolism, prolonged recovery, shivering, and thermal discomfort. Body temperature can be reliably measured in the oesophagus, nasopharynx, mouth, and bladder. The standard-of-care is to monitor core temperature and to maintain normothermia during general and neuraxial anaesthesia.	[Sessler, Daniel I.] Cleveland Clin, Dept Outcomes Res, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Sessler, DI (corresponding author), Cleveland Clin, Dept Outcomes Res, Inst Anesthesiol, 9500 Euclid Ave P77, Cleveland, OH 44195 USA.	ds@or.org						Affourtit Charles, 2007, Novartis Found Symp, V287, P70; ANNADATA R, 1995, ANESTHESIOLOGY, V83, P1205, DOI 10.1097/00000542-199512000-00011; ASTRUP A, 1985, AM J PHYSIOL, V248, pE507, DOI 10.1152/ajpendo.1985.248.5.E507; BISSONNETTE B, 1992, ANESTHESIOLOGY, V76, P387, DOI 10.1097/00000542-199203000-00011; Blatteis CM, 2000, CLIN INFECT DIS, V31, pS168, DOI 10.1086/317522; BURKE WEA, 1991, J APPL PHYSIOL, V71, P1933, DOI 10.1152/jappl.1991.71.5.1933; Caldwell JE, 2000, ANESTHESIOLOGY, V92, P84, DOI 10.1097/00000542-200001000-00018; CARLI F, 1989, BRIT J ANAESTH, V63, P276, DOI 10.1093/bja/63.3.276; Caterina MJ, 2007, AM J PHYSIOL-REG I, V292, pR64, DOI 10.1152/ajpregu.00446.2006; Cornett PM, 2008, MOL PHARMACOL, V74, P1261, DOI 10.1124/mol.108.049684; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; DAVATELIS G, 1989, SCIENCE, V243, P1066, DOI 10.1126/science.2646711; De Witte J, 2002, ANESTHESIOLOGY, V96, P467, DOI 10.1097/00000542-200202000-00036; De Witte JL, 2010, ANESTH ANALG, V110, P829, DOI 10.1213/ANE.0b013e3181cb3ebf; DINARELLO CA, 1984, J CLIN INVEST, V74, P906, DOI 10.1172/JCI111508; Doufas AG, 2008, ANESTH ANALG, V106, P252, DOI 10.1213/01.ane.0000287814.78990.4e; DUFF GW, 1982, YALE J BIOL MED, V55, P437; Eyolfson DA, 2001, EUR J APPL PHYSIOL, V84, P100, DOI 10.1007/s004210000329; Fealey Robert D, 2013, Handb Clin Neurol, V117, P79, DOI 10.1016/B978-0-444-53491-0.00007-9; Feketa VV, 2014, CRIT CARE MED, V42, pE355, DOI 10.1097/CCM.0000000000000229; Frank SM, 1997, JAMA-J AM MED ASSOC, V277, P1127, DOI 10.1001/jama.277.14.1127; FRANK SM, 1995, ANESTHESIOLOGY, V82, P83, DOI 10.1097/00000542-199501000-00012; Frank SM, 1999, J APPL PHYSIOL, V86, P1588, DOI 10.1152/jappl.1999.86.5.1588; Frank SM, 1997, AM J PHYSIOL-REG I, V272, pR557, DOI 10.1152/ajpregu.1997.272.2.R557; GLOSTEN B, 1992, ANESTHESIOLOGY, V77, P10, DOI 10.1097/00000542-199207000-00003; GREEN AR, 1995, PSYCHOPHARMACOLOGY, V119, P247, DOI 10.1007/BF02246288; Greif R, 2003, ACTA ANAESTH SCAND, V47, P847, DOI 10.1034/j.1399-6576.2003.00156.x; HALES JRS, 1985, PFLUG ARCH EUR J PHY, V404, P203, DOI 10.1007/BF00581240; Hasegawa K, 2012, J ANESTH, V26, P168, DOI 10.1007/s00540-011-1306-1; Heier T, 2006, ANESTHESIOLOGY, V104, P1070, DOI 10.1097/00000542-200605000-00025; HEIER T, 1991, ANESTHESIOLOGY, V74, P815, DOI 10.1097/00000542-199105000-00003; Hensel H, 1981, THERMORECEPTION TEMP; Horn EP, 1998, ANESTHESIOLOGY, V88, P108, DOI 10.1097/00000542-199801000-00018; Horn EP, 1998, ANESTHESIOLOGY, V89, P878, DOI 10.1097/00000542-199810000-00012; Horn EP, 1999, ANESTHESIOLOGY, V91, P979, DOI 10.1097/00000542-199910000-00017; Iaizzo PA, 1996, ANESTH ANALG, V82, P803, DOI 10.1097/00000539-199604000-00022; Ikeda T, 1997, ANESTHESIOLOGY, V86, P603, DOI 10.1097/00000542-199703000-00012; Ikeda T, 1998, ANESTHESIOLOGY, V88, P866, DOI 10.1097/00000542-199804000-00004; Ikeda T, 1998, ANESTHESIOLOGY, V88, P858, DOI 10.1097/00000542-199804000-00003; Johnston CE, 1996, EUR J APPL PHYSIOL O, V74, P293, DOI 10.1007/BF00377453; JORIS J, 1994, ANESTHESIOLOGY, V80, P268, DOI 10.1097/00000542-199402000-00006; Kajimura S, 2014, ANNU REV PHYSIOL, V76, P225, DOI 10.1146/annurev-physiol-021113-170252; KARLBERG P, 1965, ACTA PAEDIATR SCAND, V54, P225, DOI 10.1111/j.1651-2227.1965.tb06366.x; Kasner SE, 2002, STROKE, V33, P130, DOI 10.1161/hs0102.101477; Kett DH, 2011, CLIN PHARMACOL THER, V90, P32, DOI 10.1038/clpt.2011.98; Kim JS, 1998, ANESTHESIOLOGY, V88, P851, DOI 10.1097/00000542-199804000-00002; Kim YS, 2013, INT J MED SCI, V10, P1327, DOI 10.7150/ijms.6531; Komatsu R, 2006, BRIT J ANAESTH, V96, P732, DOI 10.1093/bja/ael101; Komatsu R, 2005, ANESTH ANALG, V101, P1368, DOI 10.1213/01.ANE.0000180198.13467.DF; KURZ A, 1995, ANESTHESIOLOGY, V83, P1212, DOI 10.1097/00000542-199512000-00012; Kurz A, 1996, NEW ENGL J MED, V334, P1209, DOI 10.1056/NEJM199605093341901; KURZ A, 1995, J CLIN ANESTH, V7, P359, DOI 10.1016/0952-8180(95)00028-G; KURZ A, 1995, ANESTHESIOLOGY, V83, P293, DOI 10.1097/00000542-199508000-00009; KURZ A, 1995, ANESTH ANALG, V81, P393, DOI 10.1097/00000539-199508000-00032; KURZ A, 1995, ANESTHESIOLOGY, V83, P491, DOI 10.1097/00000542-199509000-00007; Langham GE, 2009, ANESTHESIOLOGY, V111, P90, DOI 10.1097/ALN.0b013e3181a864ca; Larach MG, 2014, ANESTH ANALG, V119, P1359, DOI 10.1213/ANE.0000000000000421; Lenhardt R, 1997, ANESTHESIOLOGY, V87, P1318, DOI 10.1097/00000542-199712000-00009; Lenhardt R, 1999, AM J MED, V106, P550, DOI 10.1016/S0002-9343(99)00068-6; Lenhardt R, 2006, ANESTHESIOLOGY, V105, P1117, DOI 10.1097/00000542-200612000-00011; LESLIE K, 1995, ANESTH ANALG, V80, P1007, DOI 10.1097/00000539-199505000-00027; Leslie K, 1996, ANESTHESIOLOGY, V84, P1327, DOI 10.1097/00000542-199606000-00008; LOPEZ M, 1993, ANESTHESIOLOGY, V78, P1046, DOI 10.1097/00000542-199306000-00006; LOPEZ M, 1994, ANESTHESIOLOGY, V80, P780, DOI 10.1097/00000542-199404000-00009; MATSUKAWA T, 1995, ANESTHESIOLOGY, V82, P662, DOI 10.1097/00000542-199503000-00008; MATSUKAWA T, 1995, ANESTHESIOLOGY, V82, P1169, DOI 10.1097/00000542-199505000-00012; MATSUKAWA T, 1995, ANESTHESIOLOGY, V83, P961, DOI 10.1097/00000542-199511000-00008; Mayer SA, 2001, NEUROLOGY, V56, P292, DOI 10.1212/WNL.56.3.292; MCCAFFREY TV, 1979, J APPL PHYSIOL, V47, P591, DOI 10.1152/jappl.1979.47.3.591; Melling AC, 2001, LANCET, V358, P876, DOI 10.1016/S0140-6736(01)06071-8; NADEL ER, 1973, ARCH SCI PHYSIOL, V27, pA67; Negishi C, 1998, ANESTHESIOLOGY, V88, P1162, DOI 10.1097/00000542-199805000-00005; Negishi C, 2000, CRIT CARE MED, V28, P1295, DOI 10.1097/00003246-200005000-00006; NICE, 2015, IN PER HYP; Orhan-Sungur M, 2006, ANESTHESIOLOGY, V105, pA1224; Ozaki M, 1997, ANESTH ANALG, V84, P1029, DOI 10.1097/00000539-199705000-00014; OZAKI M, 1995, ANESTH ANALG, V80, P1212, DOI 10.1097/00000539-199506000-00025; Park SM, 2012, CRIT CARE MED, V40, P3070, DOI 10.1097/CCM.0b013e31825b931e; Plattner O, 1997, ANESTHESIOLOGY, V86, P772, DOI 10.1097/00000542-199704000-00006; Premkumar LS, 2013, LIFE SCI, V92, P415, DOI 10.1016/j.lfs.2012.08.010; Rajagopalan S, 2008, ANESTHESIOLOGY, V108, P71, DOI 10.1097/01.anes.0000296719.73450.52; REED RL, 1992, J TRAUMA, V33, P465, DOI 10.1097/00005373-199209000-00022; Rosenberg H., 2011, THE COMMUNICATOR; Sawka MN, 2000, AM J CLIN NUTR, V72, p564S, DOI 10.1093/ajcn/72.2.564S; Schlader ZJ, 2011, PHYSIOL BEHAV, V103, P217, DOI 10.1016/j.physbeh.2011.02.002; Schulman Carl I, 2005, Surg Infect (Larchmt), V6, P369; Sessler DI, 2008, ANESTHESIOLOGY, V109, P318, DOI 10.1097/ALN.0b013e31817f6d76; SESSLER DI, 1991, ANESTHESIOLOGY, V75, P985, DOI 10.1097/00000542-199112000-00010; Sessler DI, 2001, ANESTHESIOLOGY, V95, P531, DOI 10.1097/00000542-200108000-00040; SESSLER DI, 1995, ANESTHESIOLOGY, V82, P674, DOI 10.1097/00000542-199503000-00009; Sessler DI, 2000, ANESTHESIOLOGY, V92, P578, DOI 10.1097/00000542-200002000-00042; SESSLER DI, 1993, ANESTH ANALG, V77, P73; Sun Z, 2015, ANESTHESIOLOGY, V122, P276, DOI 10.1097/ALN.0000000000000551; Talke P, 1997, ANESTHESIOLOGY, V87, P835, DOI 10.1097/00000542-199710000-00017; Taniguchi Y, 2011, ANESTH ANALG, V113, P540, DOI 10.1213/ANE.0b013e3182273b19; Tayefeh F, 1998, PFLUG ARCH EUR J PHY, V435, P402, DOI 10.1007/s004240050530; The Vascular events In noncardiac Surgery patIents cOhort evaluatioN (VISION), 2014, ANESTHESIOLOGY, V120, P564, DOI DOI 10.1097/ALN.0000000000000113; Tikuisis P, 2002, EUR J APPL PHYSIOL, V87, P50, DOI 10.1007/s00421-002-0589-1; VALERI CR, 1992, J THORAC CARDIOV SUR, V104, P108; Wadhwa A, 2005, BRIT J ANAESTH, V94, P756, DOI 10.1093/bja/aei105; Xiong JY, 1996, ANESTHESIOLOGY, V85, P240, DOI 10.1097/00000542-199608000-00003; Yoo HS, 2009, ARTHROSCOPY, V25, P510, DOI 10.1016/j.arthro.2008.10.022	102	215	235	8	70	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 25	2016	387	10038					2655	2664		10.1016/S0140-6736(15)00981-2	http://dx.doi.org/10.1016/S0140-6736(15)00981-2			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP3JX	26775126				2022-12-28	WOS:000378390500033
J	Kesselheim, AS; Hwang, TJ				Kesselheim, Aaron S.; Hwang, Thomas J.			Breakthrough Medical Devices and the 21st Century Cures Act	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Kesselheim, Aaron S.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Kesselheim, Aaron S.] Harvard Univ, Sch Med, 1620 Tremont St,Suite 3030, Boston, MA 02120 USA; [Kesselheim, Aaron S.] Brigham & Womens Hosp, Program Regulat Therapeut & Law, Div Pharmacoepidemiol & Pharmacoecon, Dept Med, 1620 Tremont St,Suite 3030, Boston, MA 02120 USA; [Hwang, Thomas J.] Bain Capital Ventures, 200 Clarendon St, Boston, MA 02116 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Kesselheim, AS (corresponding author), Harvard Univ, Sch Med, 1620 Tremont St,Suite 3030, Boston, MA 02120 USA.; Kesselheim, AS (corresponding author), Brigham & Womens Hosp, Program Regulat Therapeut & Law, Div Pharmacoepidemiol & Pharmacoecon, Dept Med, 1620 Tremont St,Suite 3030, Boston, MA 02120 USA.	akesselheim@partners.org	Kesselheim, Aaron/R-6793-2017	Kesselheim, Aaron/0000-0002-8867-2666; Hwang, Thomas/0000-0003-0717-1497				Gartenberg AJ, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g93; Hwang TJ, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g217; Ioannidis JPA, 2005, JAMA-J AM MED ASSOC, V294, P218, DOI 10.1001/jama.294.2.218; Krishnamurti T, 2015, JAMA INTERN MED, V175, P1856, DOI 10.1001/jamainternmed.2015.5355; Reynolds IS, 2014, JAMA INTERN MED, V174, P1773, DOI 10.1001/jamainternmed.2014.4194; Russell SJ, 2014, NEW ENGL J MED, V371, P313, DOI 10.1056/NEJMoa1314474; U.S. Food and Drug Administration, 2015, SUMM SAF EFF DAT NEV; U.S. FOOD & DRUG ADMIN, 2015, EXP ACC PREM APPR NO	8	9	9	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 5	2016	164	7					500	+		10.7326/M15-1906	http://dx.doi.org/10.7326/M15-1906			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DI6QP	26785350				2022-12-28	WOS:000373625300013
J	Westermann, AJ; Forstner, KU; Amman, F; Barquist, L; Chao, YJ; Schulte, LN; Muller, L; Reinhardt, R; Stadler, PF; Vogel, J				Westermann, Alexander J.; Foerstner, Konrad U.; Amman, Fabian; Barquist, Lars; Chao, Yanjie; Schulte, Leon N.; Mueller, Lydia; Reinhardt, Richard; Stadler, Peter F.; Vogel, Joerg			Dual RNA-seq unveils noncoding RNA functions in host-pathogen interactions	NATURE			English	Article							SALMONELLA-TYPHIMURIUM; GENE-EXPRESSION; TRANSCRIPTIONAL REGULATOR; EPITHELIAL-CELLS; PROTEIN; HFQ; INFECTION; VIRULENCE; PCR; INFORMATION	Bacteria express many small RNAs for which the regulatory roles in pathogenesis have remained poorly understood due to a paucity of robust phenotypes in standard virulence assays. Here we use a generic 'dual RNA-seq' approach to profile RNA expression simultaneously in pathogen and host during Salmonella enterica serovar Typhimurium infection and reveal the molecular impact of bacterial riboregulators. We identify a PhoP-activated small RNA, PinT, which upon bacterial internalization temporally controls the expression of both invasion-associated effectors and virulence genes required for intracellular survival. This riboregulatory activity causes pervasive changes in coding and noncoding transcripts of the host. Interspecies correlation analysis links PinT to host cell JAK-STAT signalling, and we identify infection-specific alterations in multiple long noncoding RNAs. Our study provides a paradigm for a sensitive RNA-based analysis of intracellular bacterial pathogens and their hosts without physical separation, as well as a new discovery route for hidden functions of pathogen genes.	[Westermann, Alexander J.; Foerstner, Konrad U.; Barquist, Lars; Chao, Yanjie; Schulte, Leon N.; Vogel, Joerg] Univ Wurzburg, RNA Biol Grp, Inst Mol Infect Biol, Josef Schneider Str 2-D15, D-97080 Wurzburg, Germany; [Foerstner, Konrad U.] Univ Wurzburg, Core Unit Syst Med, Josef Schneider Str 2-D15, D-97080 Wurzburg, Germany; [Amman, Fabian; Mueller, Lydia; Stadler, Peter F.] Univ Leipzig, Dept Comp Sci, Hartelstr 16-18, D-04107 Leipzig, Germany; [Amman, Fabian; Mueller, Lydia; Stadler, Peter F.] Univ Leipzig, Interdisciplinary Ctr Bioinformat, Hartelstr 16-18, D-04107 Leipzig, Germany; [Amman, Fabian; Stadler, Peter F.] Univ Vienna, Inst Theoret Chem, Theoret Biochem Grp, Wahringer Str 17, A-1090 Vienna, Austria; [Reinhardt, Richard] Max Planck Genome Ctr Cologne, Max Planck Inst Plant Breeding Res, Carl von Linne Weg 10, D-50829 Cologne, Germany; [Stadler, Peter F.] Max Planck Inst Math Sci, Inselstr 22, D-04103 Leipzig, Germany; [Stadler, Peter F.] Santa Fe Inst, 1399 Hyde Pk Rd, Santa Fe, NM 87501 USA; [Vogel, Joerg] Univ Wurzburg, Res Ctr Infect Dis ZINF, D-97070 Wurzburg, Germany	University of Wurzburg; University of Wurzburg; Leipzig University; Leipzig University; University of Vienna; Max Planck Society; Max Planck Society; The Santa Fe Institute; University of Wurzburg	Vogel, J (corresponding author), Univ Wurzburg, RNA Biol Grp, Inst Mol Infect Biol, Josef Schneider Str 2-D15, D-97080 Wurzburg, Germany.; Vogel, J (corresponding author), Univ Wurzburg, Res Ctr Infect Dis ZINF, D-97070 Wurzburg, Germany.	joerg.vogel@uni-wuerzburg.de	Barquist, Lars/H-6529-2019; Stadler, Peter F. F/L-7857-2015; Westermann, Alexander J./AAE-8791-2021; Chao, Yanjie/J-1931-2014; Förstner, Konrad U./B-1531-2010; Vogel, Jörg/D-5574-2011	Barquist, Lars/0000-0003-4732-2667; Stadler, Peter F. F/0000-0002-5016-5191; Chao, Yanjie/0000-0002-5735-7954; Förstner, Konrad U./0000-0002-1481-2996; Vogel, Jörg/0000-0003-2220-1404; Amman, Fabian/0000-0002-8646-859X; Schulte, Leon/0000-0001-6814-9344; Muller, Lydia/0000-0001-9544-121X; Reinhardt, Richard/0000-0001-9376-2132	Elite Advancement Ph.D. stipend from the Universitat Bayern e.V., Germany; Alexander von Humboldt Stiftung/Foundation; Bavarian BioSysNet program; BMBF (Bundesministerium fur Bildung und Forschung); BMBF; EGI-Engage project (Horizon) [654142]	Elite Advancement Ph.D. stipend from the Universitat Bayern e.V., Germany; Alexander von Humboldt Stiftung/Foundation(Alexander von Humboldt Foundation); Bavarian BioSysNet program; BMBF (Bundesministerium fur Bildung und Forschung)(Federal Ministry of Education & Research (BMBF)); BMBF(Federal Ministry of Education & Research (BMBF)); EGI-Engage project (Horizon)	We thank S. Gorski for help with the manuscript, C. Sharma and A. Eulalio for comments on the paper and L. Pfeuffer, B. Plaschke and V. McParland for technical assistance. We further thank S. Hoffmann for discussions about bioinformatic analyses, T. Rudel, K. Tedin, T. Meyer and C. Sharma for eukaryotic cell lines, V. Kozjak-Pavlovic for MitoTracker orange dye, T. Strowig for Ribo-Zero reagents, and W.-D. Hardt, M. Kolbe, H. Aiba and A. Eulalio for providing primary antibodies. A.J.W. was the recipient of an Elite Advancement Ph.D. stipend from the Universitat Bayern e.V., Germany. L. B. is supported by a research fellowship from the Alexander von Humboldt Stiftung/Foundation. The Vogel laboratory received funding from the Bavarian BioSysNet program and BMBF (Bundesministerium fur Bildung und Forschung) grant "Next-generation transcriptomics of bacterial infections". This work was further supported by a donation from Baldwin Knauf to the Research Center for Infectious Diseases (ZINF). J.V. and P.F.S. acknowledge support by a joint BMBF grant eBio:RNAsys. This work used the European Grid Infrastructure (EGI) and funding by the EGI-Engage project (Horizon 2020) under grant number 654142.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Barquist L, 2015, ANNU REV GENET, V49, P367, DOI 10.1146/annurev-genet-112414-054804; Bauer S, 2008, BIOINFORMATICS, V24, P1650, DOI 10.1093/bioinformatics/btn250; Becker D, 2006, NATURE, V440, P303, DOI 10.1038/nature04616; BERSCHNEIDER H M, 1989, Gastroenterology, V96, pA41; Bhavsar AP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003518; Bjur E, 2006, INFECT IMMUN, V74, P5140, DOI 10.1128/IAI.00449-06; Browning DD, 2000, AM J PHYSIOL-LUNG C, V279, pL1129, DOI 10.1152/ajplung.2000.279.6.L1129; Bruno VM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000538; Bumann D, 2002, MOL MICROBIOL, V43, P1269, DOI 10.1046/j.1365-2958.2002.02821.x; Caldelari I, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a010298; Chao YJ, 2012, EMBO J, V31, P4005, DOI 10.1038/emboj.2012.229; Chaudhuri RR, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003456; Chen XG, 2013, CELL, V153, P166, DOI 10.1016/j.cell.2013.02.037; Chen ZW, 2010, VET RES, V41, DOI 10.1051/vetres/2009053; Choi JJ, 2013, P NATL ACAD SCI USA, V110, P9499, DOI 10.1073/pnas.1303420110; Choi YS, 2012, BIOCHEM BIOPH RES CO, V421, P305, DOI 10.1016/j.bbrc.2012.04.005; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dauer DJ, 2005, ONCOGENE, V24, P3397, DOI 10.1038/sj.onc.1208469; Eriksson S, 2003, MOL MICROBIOL, V47, P103, DOI 10.1046/j.1365-2958.2003.03313.x; Forstner KU, 2014, BIOINFORMATICS, V30, P3421, DOI 10.1093/bioinformatics/btu533; Gewirtz AT, 1999, INFECT IMMUN, V67, P608, DOI 10.1128/IAI.67.2.608-617.1999; Gong H, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002120; Gottesman S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003798; Groisman EA, 2001, J BACTERIOL, V183, P1835, DOI 10.1128/JB.183.6.1835-1842.2001; Guillier M, 2008, NUCLEIC ACIDS RES, V36, P6781, DOI 10.1093/nar/gkn742; Guo MS, 2014, GENE DEV, V28, P1620, DOI 10.1101/gad.243485.114; Hamatani K, 2006, J HISTOCHEM CYTOCHEM, V54, P773, DOI 10.1369/jhc.5A6859.2006; Hannemann S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003668; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hautefort I, 2008, CELL MICROBIOL, V10, P958, DOI 10.1111/j.1462-5822.2007.01099.x; Hoffmann S, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r34; Holmqvist E, 2010, EMBO J, V29, P1840, DOI 10.1038/emboj.2010.73; Humphrys MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080597; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Kroger C, 2013, CELL HOST MICROBE, V14, P683, DOI 10.1016/j.chom.2013.11.010; Kroger C, 2012, P NATL ACAD SCI USA, V109, pE1277, DOI 10.1073/pnas.1201061109; Kuramochi H, 2006, CLIN CANCER RES, V12, P29, DOI 10.1158/1078-0432.CCR-05-1275; Li Y, 2012, CYTOKINE GROWTH F R, V23, P127, DOI 10.1016/j.cytogfr.2012.04.005; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lober S, 2006, INT J MED MICROBIOL, V296, P435, DOI 10.1016/j.ijmm.2006.05.001; Luo WJ, 2013, BIOINFORMATICS, V29, P1830, DOI 10.1093/bioinformatics/btt285; Malik-Kale P, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00125; Masse E, 2005, J BACTERIOL, V187, P6962, DOI 10.1128/JB.187.20.6962-6971.2005; Mazurkiewicz P, 2006, NAT REV GENET, V7, P929, DOI 10.1038/nrg1984; Moon K, 2013, MOL MICROBIOL, V89, P52, DOI 10.1111/mmi.12257; Myers MG, 2009, SCIENCE, V323, P723, DOI 10.1126/science.1169660; Nicol JW, 2009, BIOINFORMATICS, V25, P2730, DOI 10.1093/bioinformatics/btp472; Oida Y, 2007, MOL CANCER THER, V6, P1440, DOI 10.1158/1535-7163.MCT-06-0374; Ortega AD, 2012, RNA BIOL, V9, P469, DOI 10.4161/rna.19317; Otto C, 2014, BIOINFORMATICS, V30, P1837, DOI 10.1093/bioinformatics/btu146; Padalon-Brauch G, 2008, NUCLEIC ACIDS RES, V36, P1913, DOI 10.1093/nar/gkn050; Papenfort K, 2006, MOL MICROBIOL, V62, P1674, DOI 10.1111/j.1365-2958.2006.05524.x; Papenfort K, 2012, P NATL ACAD SCI USA, V109, pE757, DOI 10.1073/pnas.1119414109; Papenfort K, 2009, MOL MICROBIOL, V74, P139, DOI 10.1111/j.1365-2958.2009.06857.x; Pfeiffer V, 2007, MOL MICROBIOL, V66, P1174, DOI 10.1111/j.1365-2958.2007.05991.x; Prost LR, 2008, MOL MICROBIOL, V69, P503, DOI 10.1111/j.1365-2958.2008.06303.x; Rebhan M, 1997, TRENDS GENET, V13, P163, DOI 10.1016/S0168-9525(97)01103-7; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Risso D, 2014, NAT BIOTECHNOL, V32, P896, DOI 10.1038/nbt.2931; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Santiviago CA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000477; Schulte LN, 2011, EMBO J, V30, P1977, DOI 10.1038/emboj.2011.94; Sharma CM, 2010, NATURE, V464, P250, DOI 10.1038/nature08756; Sittka A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000163; Sittka A, 2007, MOL MICROBIOL, V63, P193, DOI 10.1111/j.1365-2958.2006.05489.x; SONCINI FC, 1995, J BACTERIOL, V177, P4364, DOI 10.1128/jb.177.15.4364-4371.1995; Sorek R, 2010, NAT REV GENET, V11, P9, DOI 10.1038/nrg2695; Stecher B, 2007, PLOS BIOL, V5, P2177, DOI 10.1371/journal.pbio.0050244; STERNBERG NL, 1991, METHOD ENZYMOL, V204, P18; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Uchiya K, 2005, INFECT IMMUN, V73, P5587, DOI 10.1128/IAI.73.9.5587-5594.2005; Urban JH, 2007, NUCLEIC ACIDS RES, V35, P1018, DOI 10.1093/nar/gkl1040; Vogel J, 2011, NAT REV MICROBIOL, V9, P578, DOI 10.1038/nrmicro2615; Vonaesch P, 2014, CELL MICROBIOL, V16, P1723, DOI 10.1111/cmi.12333; Wagner EGH, 2015, ADV GENET, V90, P133, DOI 10.1016/bs.adgen.2015.05.001; Weingartl HM, 2002, J VIROL METHODS, V104, P203, DOI 10.1016/S0166-0934(02)00085-X; Westermann AJ, 2012, NAT REV MICROBIOL, V10, P618, DOI 10.1038/nrmicro2852; Winter SE, 2010, NATURE, V467, P426, DOI 10.1038/nature09415; Wyllie DH, 2000, J IMMUNOL, V165, P7125, DOI 10.4049/jimmunol.165.12.7125; Xie CY, 2014, NUCLEIC ACIDS RES, V42, pD98, DOI 10.1093/nar/gkt1222; Yoon HJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000306	84	291	299	9	233	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 28	2016	529	7587					496	+		10.1038/nature16547	http://dx.doi.org/10.1038/nature16547			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB7DD	26789254				2022-12-28	WOS:000368673800030
J	Adrion, C; Fischer, CS; Wagner, J; Gurkov, R; Mansmann, U; Strupp, M				Adrion, Christine; Fischer, Carolin Simone; Wagner, Judith; Guerkov, Robert; Mansmann, Ulrich; Strupp, Michael		BEMED Study Grp	Efficacy and safety of betahistine treatment in patients with Meniere's disease: primary results of a long term, multicentre, double blind, randomised, placebo controlled, dose defining trial (BEMED trial)	BMJ-BRITISH MEDICAL JOURNAL			English	Article							FOLLOW-UP; CLINICAL-TRIAL; VERTIGO; DIHYDROCHLORIDE; METAANALYSIS; GENTAMICIN; INTENTION; PRESSURE; INCREASE; EPISODES	STUDY QUESTION What is the long term efficacy of betahistine dihydrochloride on the incidence of vertigo attacks in patients with Meniere's disease, compared with placebo? METHODS The BEMED trial is a multicentre, double blind, randomised, placebo controlled, three arm, parallel group, phase III, dose defining superiority trial conducted in 14 German tertiary referral centres (for neurology or ear, nose, and throat). Adults aged 21-80 years (mean age 56 years) with definite unilateral or bilateral Meniere's disease were recruited from March 2008 to November 2012. Participants received placebo (n=74), low dose betahistine (2x24 mg daily, (n=73)), or high dose betahistine (3x48 mg daily, (n=74)) over nine months. The primary outcome was the number of attacks per 30 days, based on patients' diaries during a three month assessment period at months seven to nine. An internet based randomisation schedule performed a concealed 1:1:1 allocation, stratified by study site. Secondary outcomes included the duration and severity of attacks, change in quality of life scores, and several observer-reported parameters to assess changes in audiological and vestibular function. STUDY ANSWER AND LIMITATIONS Incidence of attacks related to Meniere's disease did not differ between the three treatment groups (P=0.759). Compared with placebo, attack rate ratios were 1.036 (95% confidence interval 0.942 to 1.140) and 1.012 (0.919 to 1.114) for low dose and high dose betahistine, respectively. The overall monthly attack rate fell significantly by the factor 0.758 (0.705 to 0.816; P<0.001). The population based, mean monthly incidence averaged over the assessment period was 2.722 (1.304 to 6.309), 3.204 (1.345 to 7.929), and 3.258 (1.685 to 7.266) for the placebo, low dose betahistine, and high dose betahistine groups, respectively. Results were consistent for all secondary outcomes. Treatment was well tolerated with no unexpected safety findings. Without a control group of patients who did not receive any intervention to follow the natural course of the disease, the placebo effect could not be accurately assessed and differentiated from spontaneous remission and fluctuation of symptoms. WHAT THIS STUDY ADDS Current evidence is limited as to whether betahistine prevents vertigo attacks caused by Meniere's disease, compared with placebo. The trial provides information on symptom relief on placebo intervention which is relevant for the design of future studies on potential disease modifying treatments in patients with Meniere's disease.	[Adrion, Christine; Fischer, Carolin Simone; Strupp, Michael] Univ Hosp Munich, German Ctr Vertigo & Balance Disorders, Campus Grosshadern, D-81377 Munich, Germany; [Adrion, Christine; Mansmann, Ulrich] Univ Munich, Inst Med Informat Biometry & Epidemiol, Marchioninistr 15, D-81377 Munich, Germany; [Wagner, Judith; Strupp, Michael] Univ Hosp Munich, Dept Neurol, D-81377 Munich, Germany; [Guerkov, Robert] Univ Hosp Munich, Dept Otorhinolaryngol Head & Neck Surg, D-81377 Munich, Germany	University of Munich; University of Munich; University of Munich; University of Munich	Strupp, M (corresponding author), Univ Hosp Munich, German Ctr Vertigo & Balance Disorders, Campus Grosshadern, D-81377 Munich, Germany.; Strupp, M (corresponding author), Univ Hosp Munich, Dept Neurol, D-81377 Munich, Germany.	Michael.Strupp@med.uni-muenchen.de	Adrion, Christine/AAB-7247-2020; Gürkov, Robert/K-3536-2013	Adrion, Christine/0000-0003-2408-2533; Gürkov, Robert/0000-0002-4195-149X	German Federal Ministry of Education and Research (Bundesministerium fur Buildung und Forschung (BMBF) [01KG0708]; German Centre for Vertigo and Balance Disorders (DSGZ), University Hospital Munich, Campus Grosshadern, Munich, Germany;  [04T-617]	German Federal Ministry of Education and Research (Bundesministerium fur Buildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); German Centre for Vertigo and Balance Disorders (DSGZ), University Hospital Munich, Campus Grosshadern, Munich, Germany; 	This study was not industry sponsored. The study was supported by grants from the German Federal Ministry of Education and Research (Bundesministerium fur Buildung und Forschung (BMBF), support code 01KG0708; sponsor's protocol code no 04T-617). This work was supported by the German Centre for Vertigo and Balance Disorders (DSGZ), University Hospital Munich, Campus Grosshadern, Munich, Germany. The funder had no role in the design, management, data collection, analyses, or interpretation of the data or in the writing of the manuscript or the decision to submit for publication.	Adrion C, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-137; Ahsan SF, 2015, LARYNGOSCOPE, V125, P203, DOI 10.1002/lary.24773; Alexander TH, 2010, OTOLARYNG CLIN N AM, V43, P965, DOI 10.1016/j.otc.2010.05.001; Lopez-Escamez JA, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00265; Barbara M, 2010, ACTA OTO-LARYNGOL, V130, P1256, DOI 10.3109/00016481003782033; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bertlich M, 2015, AUDIOL NEURO-OTOL, V20, P283, DOI 10.1159/000368293; Bertlich M, 2014, INT J AUDIOL, V53, P753, DOI 10.3109/14992027.2014.917208; Buuren S.v., 2018, FLEXIBLE IMPUTATION; Calvert M, 2013, JAMA-J AM MED ASSOC, V309, P814, DOI 10.1001/jama.2013.879; Carpenter J. R., 2007, HLTH TECHNOLOGY ASSE; Christensen R. H. B., 2014, ORDINAL REGRESSION M, P12; Cohen HS, 2000, ARCH OTOLARYNGOL, V126, P881, DOI 10.1001/archotol.126.7.881; Committee for Medicinal Products for Human Use (CHMP), 2007, CPMPEWP7882001 CHMP; Cutler AR, 2012, J NEUROSURG, V117, P507, DOI 10.3171/2012.6.JNS111818; Fisher LM, 2012, OTOL NEUROTOL, V33, P1685, DOI 10.1097/MAO.0b013e31826dba83; GOEBEL G, 1994, HNO, V42, P166; Goto F, 2012, ACTA OTO-LARYNGOL, V132, P893, DOI 10.3109/00016489.2012.663932; Gurkov R, 2012, J LARYNGOL OTOL, V128, P356, DOI 10.1017/S0022215112000102; Gurkov R, 2011, EUR ARCH OTO-RHINO-L, V268, P1743, DOI 10.1007/s00405-011-1573-3; Hallpike C S, 1938, Proc R Soc Med, V31, P1317; Hamill TA, 2006, J AM ACAD AUDIOL, V17, P27, DOI 10.3766/jaaa.17.1.4; Harcourt J, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6544; Harner SG, 2001, OTOL NEUROTOL, V22, P210, DOI 10.1097/00129492-200103000-00016; Harris JP, 2010, AUDIOL NEURO-OTOL, V15, P318, DOI 10.1159/000286213; Hiller W, 2004, INT J AUDIOL, V43, P600, DOI 10.1080/14992020400050077; Huang TS, 2002, OTOLARYNG CLIN N AM, V35, P591, DOI 10.1016/S0030-6665(02)00027-0; Huppert D, 2010, ACTA OTO-LARYNGOL, V130, P644, DOI 10.3109/00016480903382808; Ihler F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039086; Ioannidis JPA, 2001, JAMA-J AM MED ASSOC, V286, P821, DOI 10.1001/jama.286.7.821; JACOBSON GP, 1990, ARCH OTOLARYNGOL, V116, P424; James AL, 2001, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD001873; Lacour M, 2013, J VESTIBUL RES-EQUIL, V23, P139, DOI 10.3233/VES-130496; Lezius F, 2011, EUR ARCH OTO-RHINO-L, V268, P1237, DOI 10.1007/s00405-011-1647-2; Little R.J.A., 2002, STAT ANAL MISSING DA, V2nd Edn, DOI [10.1002/9781119013563, DOI 10.1002/9781119013563]; Lopez-Escamez JA, 2015, J VESTIBUL RES-EQUIL, V25, P1, DOI 10.3233/VES-150549; Minor LB, 2004, CURR OPIN NEUROL, V17, P9, DOI 10.1097/00019052-200402000-00004; Mira E, 2003, EUR ARCH OTO-RHINO-L, V260, P73, DOI 10.1007/s00405-002-0524-4; Molenberghs G, 2004, BIOSTATISTICS, V5, P445, DOI 10.1093/biostatistics/kxh001; MONSELL EM, 1995, OTOLARYNG HEAD NECK, V113, P181, DOI 10.1016/S0194-5998(95)70102-8; Nauta JJP, 2014, EUR ARCH OTO-RHINO-L, V271, P887, DOI 10.1007/s00405-013-2596-8; O'Kelly M., 2014, CLIN TRIALS MISSING, DOI [10.1002/9781118762516, DOI 10.1002/9781118762516]; PAPARELLA MM, 1985, OTOLARYNG HEAD NECK, V93, P148, DOI 10.1177/019459988509300203; Park JJH, 2009, ACTA OTO-LARYNGOL, V129, P1408, DOI 10.3109/00016480902791678; Perez-Garrigues H, 2008, ARCH OTOLARYNGOL, V134, P1149, DOI 10.1001/archotol.134.11.1149; Phillips JS, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008514.pub2; Pullens B, 2011, COCHRANE DB SYST REV, V3; Pullens B, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005395.pub3; R Development Core Team, 2009, R LANG ENV STAT COMP; Sharon JD, 2015, CURR TREAT OPTION NE, V17, DOI 10.1007/s11940-015-0341-x; Smith WK, 2005, J LARYNGOL OTOL, V119, P102, DOI 10.1258/0022215053419871; Strupp M, 2008, ACTA OTO-LARYNGOL, V128, P520, DOI 10.1080/00016480701724912; Taura A, 2014, ACTA OTO-LARYNGOL, V134, P1140, DOI 10.3109/00016489.2014.936624; Teufert KB, 2010, OTOLARYNG CLIN N AM, V43, P1091, DOI 10.1016/j.otc.2010.05.014; Thirlwall AS, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003599.pub2; van Buuren S, 2011, J STAT SOFTW, V45, P1; van Sonsbeek S, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008419.pub2; Wasson J, 2013, J LARYNGOL OTOL, V127, P20, DOI 10.1017/S0022215112002605; Watanabe Y, 2011, ACTA OTO-LARYNGOL, V131, P1178, DOI 10.3109/00016489.2011.600331; Westhofen M, 2009, HNO, V57, P446, DOI 10.1007/s00106-009-1915-2; White IR, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d40; White IR, 2012, CLIN TRIALS, V9, P396, DOI 10.1177/1740774512450098; WLADISLAVOSKYWASERMAN P, 1984, LARYNGOSCOPE, V94, P1098; Yu MS, 2009, OTOLARYNG HEAD NECK, V141, P237, DOI 10.1016/j.otohns.2009.03.014	64	85	92	0	17	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 21	2016	352								h6816	10.1136/bmj.h6816	http://dx.doi.org/10.1136/bmj.h6816			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DC4ZU	26797774	hybrid, Green Published			2022-12-28	WOS:000369230300001
J	Filacchione, G; De Sanctis, MC; Capaccioni, F; Raponi, A; Tosi, F; Ciarniello, M; Cerroni, P; Piccioni, G; Capria, MT; Palomba, E; Bellucci, G; Erard, S; Bockelee-Morvan, D; Leyrat, C; Arnold, G; Barucci, MA; Fulchignoni, M; Schmitt, B; Quirico, E; Jaumann, R; Stephan, K; Longobardo, A; Mennella, V; Migliorini, A; Ammannito, E; Benkhoff, J; Bibring, JP; Blanco, A; Blecka, MI; Carlson, R; Carsenty, U; Colangeli, L; Combes, M; Combi, M; Crovisier, J; Drossart, P; Encrenaz, T; Federico, C; Fink, U; Fonti, S; Ip, WH; Irwin, P; Kuehrt, E; Langevin, Y; Magni, G; McCord, T; Moroz, L; Mottola, S; Orofino, V; Schade, U; Taylor, F; Tiphene, D; Tozzi, GP; Beck, P; Biver, N; Bonal, L; Combe, JP; Despan, D; Flamini, E; Formisano, M; Fornasier, S; Frigeri, A; Grassi, D; Gudipati, MS; Kappel, D; Mancarella, F; Markus, K; Merlin, F; Orosei, R; Rinaldi, G; Cartacci, M; Cicchetti, A; Giuppi, S; Hello, Y; Henry, F; Jacquinod, S; Reess, JM; Noschese, R; Politi, R; Peter, G				Filacchione, G.; De Sanctis, M. C.; Capaccioni, F.; Raponi, A.; Tosi, F.; Ciarniello, M.; Cerroni, P.; Piccioni, G.; Capria, M. T.; Palomba, E.; Bellucci, G.; Erard, S.; Bockelee-Morvan, D.; Leyrat, C.; Arnold, G.; Barucci, M. A.; Fulchignoni, M.; Schmitt, B.; Quirico, E.; Jaumann, R.; Stephan, K.; Longobardo, A.; Mennella, V.; Migliorini, A.; Ammannito, E.; Benkhoff, J.; Bibring, J. P.; Blanco, A.; Blecka, M. I.; Carlson, R.; Carsenty, U.; Colangeli, L.; Combes, M.; Combi, M.; Crovisier, J.; Drossart, P.; Encrenaz, T.; Federico, C.; Fink, U.; Fonti, S.; Ip, W. H.; Irwin, P.; Kuehrt, E.; Langevin, Y.; Magni, G.; McCord, T.; Moroz, L.; Mottola, S.; Orofino, V.; Schade, U.; Taylor, F.; Tiphene, D.; Tozzi, G. P.; Beck, P.; Biver, N.; Bonal, L.; Combe, J-Ph.; Despan, D.; Flamini, E.; Formisano, M.; Fornasier, S.; Frigeri, A.; Grassi, D.; Gudipati, M. S.; Kappel, D.; Mancarella, F.; Markus, K.; Merlin, F.; Orosei, R.; Rinaldi, G.; Cartacci, M.; Cicchetti, A.; Giuppi, S.; Hello, Y.; Henry, F.; Jacquinod, S.; Reess, J. M.; Noschese, R.; Politi, R.; Peter, G.			Exposed water ice on the nucleus of comet 67P/Churyumov-Gerasimenko	NATURE			English	Article							OPTICAL-CONSTANTS; CRYSTALLINE H2O-ICE; SURFACE; VIRTIS; ROSETTA	Although water vapour is the main species observed in the coma of comet 67P/Churyumov-Gerasimenko(1,2) and water is the major constituent of cometary nuclei(3,4), limited evidence for exposed water-ice regions on the surface of the nucleus has been found so far(5,6). The absence of large regions of exposed water ice seems a common finding on the surfaces of many of the comets observed so far(7-9). The nucleus of 67P/Churyumov-Gerasimenko appears to be fairly uniformly coated with dark, dehydrated, refractory and organic-rich material(10). Here we report the identification at infrared wavelengths of water ice on two debris falls in the Imhotep region of the nucleus. The ice has been exposed on the walls of elevated structures and at the base of the walls. A quantitative derivation of the abundance of ice in these regions indicates the presence of millimetre-sized pure water-ice grains, considerably larger than in all previous observations(6,7-9). Although micrometresized water-ice grains are the usual result of vapour recondensation in ice-free layers(6), the occurrence of millimetre-sized grains of pure ice as observed in the Imhotep debris falls is best explained by grain growth by vapour diffusion in ice-rich layers, or by sintering. As a consequence of these processes, the nucleus can develop an extended and complex coating in which the outer dehydrated crust(10) is superimposed on layers enriched in water ice. The stratigraphy observed on 67P/Churyumov-Gerasimenko(11,12) is therefore the result of evolutionary processes affecting the uppermost metres of the nucleus and does not necessarily require a global layering to have occurred at the time of the comet's formation.	[Filacchione, G.; De Sanctis, M. C.; Capaccioni, F.; Raponi, A.; Tosi, F.; Ciarniello, M.; Cerroni, P.; Piccioni, G.; Capria, M. T.; Palomba, E.; Bellucci, G.; Longobardo, A.; Migliorini, A.; Magni, G.; Formisano, M.; Frigeri, A.; Grassi, D.; Rinaldi, G.; Cartacci, M.; Cicchetti, A.; Giuppi, S.; Noschese, R.; Politi, R.] IAPS, INAF, Rome, Italy; [Erard, S.; Bockelee-Morvan, D.; Leyrat, C.; Barucci, M. A.; Fulchignoni, M.; Combes, M.; Crovisier, J.; Drossart, P.; Encrenaz, T.; Tiphene, D.; Biver, N.; Despan, D.; Fornasier, S.; Merlin, F.; Hello, Y.; Henry, F.; Jacquinod, S.; Reess, J. M.] Univ Paris Diderot, UPMC, CNRS, LESIA,Observ Paris, Meudon, France; [Arnold, G.; Jaumann, R.; Stephan, K.; Carsenty, U.; Kuehrt, E.; Moroz, L.; Mottola, S.; Kappel, D.; Markus, K.] DLR, Inst Planetary Res, Berlin, Germany; [Schmitt, B.; Quirico, E.; Beck, P.; Bonal, L.] Univ Grenoble Alpes, CNRS, IPAG, Grenoble, France; [Mennella, V.] Osserv Astron Capodimonte, INAF, I-80131 Naples, Italy; [Ammannito, E.] Univ Calif Los Angeles, Los Angeles, CA USA; [Benkhoff, J.; Colangeli, L.] European Space Agcy ESTEC, Noordwijk, Netherlands; [Bibring, J. P.; Langevin, Y.] CNRS, Inst Astrophys Spatial, F-91405 Orsay, France; [Blanco, A.; Fonti, S.; Orofino, V.; Mancarella, F.] Univ Salento, Dipartimento Matemat & Fis Ennio De Giorgi, Lecce, Italy; [Blecka, M. I.] Polish Acad Sci, Space Res Ctr, PL-01237 Warsaw, Poland; [Carlson, R.; Gudipati, M. S.] NASA JPL, Pasadena, CA USA; [Combi, M.] Univ Michigan, Space Phys Res Lab, Ann Arbor, MI 48109 USA; [Federico, C.] Univ Perugia, I-06100 Perugia, Italy; [Fink, U.] Univ Arizona, Lunar Planetary Lab, Tucson, AZ USA; [Ip, W. H.] Natl Cent Univ, Taipei, Taiwan; [Irwin, P.; Taylor, F.] Univ Oxford, Dept Phys, Oxford, England; [McCord, T.; Combe, J-Ph.] Bear Fight Inst, Winthrop, WA USA; [Schade, U.] Helmholtz Zentrum Berlin Mat & Energie, Berlin, Germany; [Tozzi, G. P.] Osserv Astrofis Arcetri, INAF, I-50125 Florence, Italy; [Flamini, E.] Agenzia Spaziale Italiana, Rome, Italy; [Orosei, R.] INAF, Ist Radioastron, Bologna, Italy; [Peter, G.] DLR, Inst Opt Sensor Syst, Berlin, Germany	Istituto Nazionale Astrofisica (INAF); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Sorbonne Universite; Universite Paris Cite; Helmholtz Association; German Aerospace Centre (DLR); Centre National de la Recherche Scientifique (CNRS); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut de Planetologie et d'Astrophysique de Grenoble (IPAG); Istituto Nazionale Astrofisica (INAF); University of California System; University of California Los Angeles; European Space Agency; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; University of Salento; Centrum Badan Kosmicznych, Polish Academy of Sciences; Polish Academy of Sciences; Space Research Centre of the Polish Academy of Sciences; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of Michigan System; University of Michigan; University of Perugia; University of Arizona; National Central University; University of Oxford; Helmholtz Association; Helmholtz-Zentrum fuer Materialien und Energie GmbH (HZB); Istituto Nazionale Astrofisica (INAF); Agenzia Spaziale Italiana (ASI); Istituto Nazionale Astrofisica (INAF); Helmholtz Association; German Aerospace Centre (DLR)	Filacchione, G (corresponding author), IAPS, INAF, Rome, Italy.	gianrico.filacchione@iaps.inaf.it	Stephan, Katrin/U-2524-2018; Migliorini, Alessandra/AAY-8600-2020; Drossart, Pierre/H-8670-2013; Filacchione, Gianrico/S-2320-2017; Frigeri, Alessandro/F-2151-2010; Bellucci, Giancarlo/ABA-9201-2020; Palomba, Ernesto/E-8287-2017; Tosi, Federico/F-2321-2018; Combi, Michael/J-1697-2012; Jaumann, Ralf/N-1001-2018; Grassi, Davide/B-7916-2018; Piccioni, Giuseppe/T-9272-2017; Formisano, Michelangelo/AAJ-2719-2020; Gudipati, Murthy S/F-7575-2011; Frigeri, Alessandro/K-9679-2019; Schmitt, Bernard/A-1064-2009; quirico, eric/K-9650-2013; De Sanctis, Maria Cristina/G-5232-2013	Migliorini, Alessandra/0000-0001-7386-9215; Filacchione, Gianrico/0000-0001-9567-0055; Frigeri, Alessandro/0000-0002-9140-3977; Bellucci, Giancarlo/0000-0003-0867-8679; Palomba, Ernesto/0000-0002-9101-6774; Tosi, Federico/0000-0003-4002-2434; Combi, Michael/0000-0002-9805-0078; Jaumann, Ralf/0000-0002-9759-6597; Grassi, Davide/0000-0003-1653-3066; Piccioni, Giuseppe/0000-0002-7893-6808; Formisano, Michelangelo/0000-0003-3236-1604; Gudipati, Murthy S/0000-0001-5992-373X; Frigeri, Alessandro/0000-0002-9140-3977; Schmitt, Bernard/0000-0002-1230-6627; quirico, eric/0000-0003-2768-0694; De Sanctis, Maria Cristina/0000-0002-3463-4437; Kappel, David/0000-0002-0518-5548; Blecka, Maria/0000-0002-6473-1211; Raponi, Andrea/0000-0003-4996-0099; Giuppi, Stefano/0000-0001-6900-3427; Mennella, Vito/0000-0001-9525-895X; Taylor, Fred/0000-0002-0675-9769; Rinaldi, Giovanna/0000-0002-2968-0455; Longobardo, Andrea/0000-0002-1797-2741; Capaccioni, Fabrizio/0000-0003-1631-4314; Erard, Stephane/0000-0002-9099-8366; Colangeli, Luigi/0000-0001-6801-9152; Cartacci, Marco/0000-0001-9825-1817; Benkhoff, Johannes/0000-0002-4307-9703; BONAL, Lydie/0000-0002-0655-4034; Irwin, Patrick Gerard Joseph/0000-0002-6772-384X; Politi, Romolo/0000-0002-9793-9780; Noschese, Raffaella/0000-0003-0502-0337; Ciarniello, Mauro/0000-0002-7498-5207; Schade, Ulrich/0000-0002-4194-2235	Italian Space Agency (ASI, Italy); Centre National d'Etudes Spatiales (CNES, France); Deutsches Zentrum fur Luft - und Raumfahrt (DLR, Germany); National Aeronautic and Space Administration (NASA, USA); ASI; CNES; DLR; Science and Technology Facilities Council [ST/K00106X/1, ST/I001948/1, ST/N00082X/1] Funding Source: researchfish; STFC [ST/K00106X/1, ST/I001948/1, ST/N00082X/1] Funding Source: UKRI	Italian Space Agency (ASI, Italy)(Agenzia Spaziale Italiana (ASI)); Centre National d'Etudes Spatiales (CNES, France)(Centre National D'etudes Spatiales); Deutsches Zentrum fur Luft - und Raumfahrt (DLR, Germany)(Helmholtz AssociationGerman Aerospace Centre (DLR)); National Aeronautic and Space Administration (NASA, USA); ASI(Agenzia Spaziale Italiana (ASI)); CNES(Centre National D'etudes Spatiales); DLR(Helmholtz AssociationGerman Aerospace Centre (DLR)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	We thank the following institutions and agencies, which supported this work: Italian Space Agency (ASI, Italy), Centre National d'Etudes Spatiales (CNES, France), Deutsches Zentrum fur Luft - und Raumfahrt (DLR, Germany), National Aeronautic and Space Administration (NASA, USA). VIRTIS was built by a consortium from Italy, France and Germany, under the scientific responsibility of the Istituto di Astrofisica e Planetologia Spaziali (IAPS) of INAF, Rome (Italy), which also led the scientific operations. The VIRTIS instrument development for the ESA has been funded and managed by ASI, with contributions from Observatoire de Meudon financed by CNES and from the DLR. The VIRTIS instrument industrial prime contractor was former Officine Galileo, now Selex ES (Finmeccanica Group) in Campi Bisenzio, Florence, Italy. We also thank the Rosetta Liaison Scientists, the Rosetta Science Ground Segment and the Rosetta Mission Operations Centre for their support in planning the VIRTIS observations. This research has made use of NASA's Astrophysics Data System. This work is dedicated to Angioletta Coradini, conceiver of the VIRTIS instrument.	A'Hearn MF, 2011, SCIENCE, V332, P1396, DOI 10.1126/science.1204054; Ammannito E, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2349308; Auger AT, 2015, ASTRON ASTROPHYS, V583, DOI 10.1051/0004-6361/201525947; BENKHOFF J, 1995, PLANET SPACE SCI, V43, P353, DOI 10.1016/0032-0633(94)00184-S; Capaccioni F, 2015, SCIENCE, V347, DOI 10.1126/science.aaa0628; Ciarniello M, 2015, ASTRON ASTROPHYS, V583, DOI 10.1051/0004-6361/201526307; Ciarniello M, 2011, ICARUS, V214, P541, DOI 10.1016/j.icarus.2011.05.010; Clark RN, 2012, ICARUS, V218, P831, DOI 10.1016/j.icarus.2012.01.008; Coradini A, 2007, SPACE SCI REV, V128, P529, DOI 10.1007/s11214-006-9127-5; De Sanctis MC, 2015, NATURE, V525, P500, DOI 10.1038/nature14869; Ehrenfreund P, 2004, SPACE SCI S, P115; Filacchione G, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2360786; Filacchione G., 2006, THESIS; Fray N, 2009, PLANET SPACE SCI, V57, P2053, DOI 10.1016/j.pss.2009.09.011; Grundy WM, 1998, J GEOPHYS RES-PLANET, V103, P25809, DOI 10.1029/98JE00738; Gulkis S, 2015, SCIENCE, V347, DOI 10.1126/science.aaa0709; Hapke B., 2012, THEORY REFLECTANCE E; Hassig M, 2015, SCIENCE, V347, DOI 10.1126/science.aaa0276; Kossacki KJ, 1999, ICARUS, V142, P202, DOI 10.1006/icar.1999.6196; Massironi M, 2015, NATURE, V526, P402, DOI 10.1038/nature15511; Mastrapa RM, 2008, ICARUS, V197, P307, DOI 10.1016/j.icarus.2008.04.008; Mastrapa RM, 2009, ASTROPHYS J, V701, P1347, DOI 10.1088/0004-637X/701/2/1347; Migliorini A, 2013, ICARUS, V226, P1115, DOI 10.1016/j.icarus.2013.07.027; Mumma MJ, 2011, ANNU REV ASTRON ASTR, V49, P471, DOI 10.1146/annurev-astro-081309-130811; Podolack M., 2004, COMETS, P115; Pommerol A, 2015, ASTRON ASTROPHYS, V583, DOI 10.1051/0004-6361/201525977; Raponi A, 2014, THESIS; Sierks H., 2015, SCIENCE, V347, DOI [10.1126/science.aaa1044, DOI 10.1126/SCIENCE.AAA1044]; Sunshine J. M, 2012, P AST COM MET 2012 C, V1667, P6438; Sunshine JM, 2007, ICARUS, V190, P284, DOI 10.1016/j.icarus.2007.04.024; Sunshine JM, 2006, SCIENCE, V311, P1453, DOI 10.1126/science.1123632; Thomas N, 2015, SCIENCE, V347, DOI 10.1126/science.aaa0440; Tosi F, 2014, ICARUS, V240, P36, DOI 10.1016/j.icarus.2014.03.017; Tosi F., 2015, LUNAR PLANET SCI C, V2156; WARREN SG, 1984, APPL OPTICS, V23, P1206, DOI 10.1364/AO.23.001206	35	92	92	0	49	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 21	2016	529	7586					368	+		10.1038/nature16190	http://dx.doi.org/10.1038/nature16190			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB2QT	26760209				2022-12-28	WOS:000368354800040
J	Lu, J; Lee, YJ; Luo, XY; Lau, KC; Asadi, M; Wang, HH; Brombosz, S; Wen, JG; Zhai, DY; Chen, ZH; Miller, DJ; Jeong, YS; Park, JB; Fang, ZZ; Kumar, B; Salehi-Khojin, A; Sun, YK; Curtiss, LA; Amine, K				Lu, Jun; Lee, Yun Jung; Luo, Xiangyi; Lau, Kah Chun; Asadi, Mohammad; Wang, Hsien-Hau; Brombosz, Scott; Wen, Jianguo; Zhai, Dengyun; Chen, Zonghai; Miller, Dean J.; Jeong, Yo Sub; Park, Jin-Bum; Fang, Zhigang Zak; Kumar, Bijandra; Salehi-Khojin, Amin; Sun, Yang-Kook; Curtiss, Larry A.; Amine, Khalil			A lithium-oxygen battery based on lithium superoxide	NATURE			English	Article							REDUCED GRAPHENE OXIDE; LI-O-2; STABILITY; CATALYST; DISPROPORTIONATION; ARCHITECTURE; REDUCTION; ELECTRODE; CLUSTERS; SPECTRA	Batteries based on sodium superoxide and on potassium superoxide have recently been reported(1-3). However, there have been no reports of a battery based on lithium superoxide (LiO2), despite much research(4-8) into the lithium-oxygen (Li-O-2) battery because of its potential high energy density. Several studies(9-16) of Li-O-2 batteries have found evidence of LiO2 being formed as one component of the discharge product along with lithium peroxide (Li2O2). In addition, theoretical calculations have indicated that some forms of LiO2 may have a long lifetime(17). These studies also suggest that it might be possible to form LiO2 alone for use in a battery. However, solid LiO2 has been difficult to synthesize in pure form(18) because it is thermodynamically unstable with respect to disproportionation, giving Li2O2 (refs 19, 20). Here we show that crystalline LiO2 can be stabilized in a Li-O-2 battery by using a suitable graphene-based cathode. Various characterization techniques reveal no evidence for the presence of Li2O2. A novel templating growth mechanism involving the use of iridium nanoparticles on the cathode surface may be responsible for the growth of crystalline LiO2. Our results demonstrate that the LiO2 formed in the Li-O-2 battery is stable enough for the battery to be repeatedly charged and discharged with a very low charge potential (about 3.2 volts). We anticipate that this discovery will lead to methods of synthesizing and stabilizing LiO2, which could open the way to high-energy-density batteries based on LiO2 as well as to other possible uses of this compound, such as oxygen storage.	[Lu, Jun; Zhai, Dengyun; Chen, Zonghai; Amine, Khalil] Argonne Natl Lab, Chem Sci & Engn Div, Argonne, IL 60439 USA; [Lee, Yun Jung; Jeong, Yo Sub; Park, Jin-Bum; Sun, Yang-Kook] Hanyang Univ, Dept Energy Engn, Seoul 133791, South Korea; [Luo, Xiangyi; Lau, Kah Chun; Wang, Hsien-Hau; Brombosz, Scott; Curtiss, Larry A.] Argonne Natl Lab, Div Mat Sci, Argonne, IL 60439 USA; [Luo, Xiangyi; Fang, Zhigang Zak] Univ Utah, Dept Met Engn, Salt Lake City, UT 84112 USA; [Asadi, Mohammad; Salehi-Khojin, Amin] Univ Illinois, Dept Mech & Ind Engn, Chicago, IL 60607 USA; [Wen, Jianguo; Miller, Dean J.] Argonne Natl Lab, Ctr Nanoscale Mat, Argonne, IL 60439 USA; [Kumar, Bijandra] Univ Louisville, Conn Ctr Renewable Energy Res, Louisville, KY 40292 USA	United States Department of Energy (DOE); Argonne National Laboratory; Hanyang University; United States Department of Energy (DOE); Argonne National Laboratory; Utah System of Higher Education; University of Utah; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; United States Department of Energy (DOE); Argonne National Laboratory; University of Louisville	Curtiss, LA (corresponding author), Argonne Natl Lab, Div Mat Sci, 9700 S Cass Ave, Argonne, IL 60439 USA.	yksun@hanyang.ac.kr; curtiss@anl.gov; amine@anl.gov	Asadi, Mohammad/AAF-6564-2020; Asadi, Mohammad/ABA-9701-2021; Lu, Jun/G-2224-2012; Chen, Zonghai/K-8745-2013; Sun, Yang-Kook/B-9157-2013	Lu, Jun/0000-0003-0858-8577; Sun, Yang-Kook/0000-0002-0117-0170; Kumar, Bijandra/0000-0002-7985-5903	US Department of Energy from the Vehicle Technologies Office, Department of Energy, Office of Energy Efficiency and Renewable Energy [DE-AC02-06CH11357]; Center for Electrochemical Energy Science (CEES), an Energy Frontier Research Center (EFRC) - US Department of Energy, Office of Science, Office of Basic Energy Sciences; University of Illinois-Chicago Chancellor Proof of Concept Fund; INCITE; US Department of Energy, Office of Basic Energy Sciences [DE-AC02-06CH11357]; Human Resources Development of the Korea Institute of Energy Technology Evaluation and Planning (KETEP) - Korea government Ministry of Knowledge Economy [20124010203310]; Basic Science Research Program [NRF-2014R1A2A1A11049801]	US Department of Energy from the Vehicle Technologies Office, Department of Energy, Office of Energy Efficiency and Renewable Energy(United States Department of Energy (DOE)); Center for Electrochemical Energy Science (CEES), an Energy Frontier Research Center (EFRC) - US Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); University of Illinois-Chicago Chancellor Proof of Concept Fund; INCITE; US Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Human Resources Development of the Korea Institute of Energy Technology Evaluation and Planning (KETEP) - Korea government Ministry of Knowledge Economy; Basic Science Research Program	This work was primarily supported by the US Department of Energy under contract DE-AC02-06CH11357 from the Vehicle Technologies Office, Department of Energy, Office of Energy Efficiency and Renewable Energy. We also acknowledge support from the Center for Electrochemical Energy Science (CEES), an Energy Frontier Research Center (EFRC) funded by the US Department of Energy, Office of Science, Office of Basic Energy Sciences (X-ray measurements and analysis). We also acknowledge support from the University of Illinois-Chicago Chancellor Proof of Concept Fund (DEMS measurements). We acknowledge the Conn Renewable Energy Research Center at the University of Louisville for providing the access to the DEMS equipment. We acknowledge grants of computer time through INCITE awards on the BlueGene/Q computer at Argonne National Laboratory and allocations on the CNM Carbon Cluster at Argonne National Laboratory and the LCRC Fusion Cluster at Argonne National Laboratory. Use of the Advanced Photon Source and the Electron Microscopy Center, Center for Nanoscale Materials was supported by the US Department of Energy, Office of Basic Energy Sciences, under contract no. DE-AC02-06CH11357. We acknowledge financial support from the Human Resources Development of the Korea Institute of Energy Technology Evaluation and Planning (KETEP) funded by the Korea government Ministry of Knowledge Economy (no. 20124010203310), and from the Basic Science Research Program (no. NRF-2014R1A2A1A11049801). We acknowledge C. Barile, R. Rooney, R. Assary and P. Redfern for discussions and help on the lithium superoxide reaction mechanism.	ADRIAN FJ, 1973, J CHEM PHYS, V59, P56, DOI 10.1063/1.1679849; Antolini E, 2014, ACS CATAL, V4, P1426, DOI 10.1021/cs4011875; Bikkarolla SK, 2014, FARADAY DISCUSS, V173, P415, DOI 10.1039/c4fd00088a; Black R, 2013, ANGEW CHEM INT EDIT, V52, P392, DOI 10.1002/anie.201205354; BLOCHL PE, 1994, PHYS REV B, V50, P17953, DOI 10.1103/PhysRevB.50.17953; Bruce PG, 2012, NAT MATER, V11, P19, DOI [10.1038/nmat3191, 10.1038/NMAT3191]; Das U, 2014, J PHYS CHEM LETT, V5, P813, DOI 10.1021/jz500084e; DONKERSLOOT HC, 1976, J LESS-COMMON MET, V50, P279, DOI 10.1016/0022-5088(76)90167-3; Giannozzi P, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/39/395502; Gittleson FS, 2015, CHEMELECTROCHEM, V2, P1446, DOI 10.1002/celc.201500218; Gittleson FS, 2014, ACS APPL MATER INTER, V6, P19017, DOI 10.1021/am504900k; Grimme S, 2006, J COMPUT CHEM, V27, P1787, DOI 10.1002/jcc.20495; Ha HW, 2011, ELECTROCHEM SOLID ST, V14, pB70, DOI 10.1149/1.3584092; Hartmann P, 2013, PHYS CHEM CHEM PHYS, V15, P11661, DOI 10.1039/c3cp50930c; Hartmann P, 2013, NAT MATER, V12, P228, DOI [10.1038/NMAT3486, 10.1038/nmat3486]; HUMMERS WS, 1958, J AM CHEM SOC, V80, P1339, DOI 10.1021/ja01539a017; Kang SY, 2013, CHEM MATER, V25, P3328, DOI 10.1021/cm401720n; Kresse G, 1999, PHYS REV B, V59, P1758, DOI 10.1103/PhysRevB.59.1758; Kresse G, 1996, COMP MATER SCI, V6, P15, DOI 10.1016/0927-0256(96)00008-0; Kumar S, 2013, RSC ADV, V3, P21706, DOI 10.1039/c3ra42617c; Lau KC, 2011, J PHYS CHEM C, V115, P23625, DOI 10.1021/jp206796h; LINDSAY DM, 1987, J PHYS CHEM-US, V91, P6158, DOI 10.1021/j100308a020; Lu J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5895; Lu J, 2014, CHEM REV, V114, P5611, DOI 10.1021/cr400573b; Lu J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3383; Mitchell RR, 2013, J PHYS CHEM LETT, V4, P1060, DOI 10.1021/jz4003586; Oh SH, 2012, NAT CHEM, V4, P1004, DOI [10.1038/NCHEM.1499, 10.1038/nchem.1499]; Olivares-Marin M, 2015, NANO LETT, V15, P6932, DOI 10.1021/acs.nanolett.5b02862; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Pickard CJ, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.086403; Pouget EM, 2009, SCIENCE, V323, P1455, DOI 10.1126/science.1169434; Ren XD, 2013, J AM CHEM SOC, V135, P2923, DOI 10.1021/ja312059q; Ren XM, 2011, J MATER CHEM, V21, P10118, DOI 10.1039/c0jm04170j; Ryu WH, 2015, NANO LETT, V15, P434, DOI 10.1021/nl503760n; Sangster J., 1992, J PHASE EQUILIB, V13, P296, DOI DOI 10.1007/BF02667558; Schaltin S, 2015, PHYS CHEM CHEM PHYS, V17, P12575, DOI 10.1039/c5cp00386e; Selvaraj C, 2014, J ELECTROCHEM SOC, V161, pA554, DOI 10.1149/2.055404jes; Thotiyl MMO, 2013, J AM CHEM SOC, V135, P494, DOI 10.1021/ja310258x; Xu YX, 2010, ACS NANO, V4, P4324, DOI 10.1021/nn101187z; Yang JB, 2013, PHYS CHEM CHEM PHYS, V15, P3764, DOI 10.1039/c3cp00069a; Zhai DY, 2014, J PHYS CHEM LETT, V5, P2705, DOI 10.1021/jz501323n; Zhai DY, 2013, J AM CHEM SOC, V135, P15364, DOI 10.1021/ja403199d; Zhuravlev YN, 2010, J STRUCT CHEM+, V51, P1005, DOI 10.1007/s10947-010-0157-1; ZIEGLER M, 1976, HELV PHYS ACTA, V49, P57	44	501	507	46	1215	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 21	2016	529	7586					377	+		10.1038/nature16484	http://dx.doi.org/10.1038/nature16484			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB2QT	26751057	Green Published, Green Submitted			2022-12-28	WOS:000368354800042
J	Quaggin, SE				Quaggin, Susan E.			Kindling the Kidney	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PLURIPOTENT STEM-CELLS; INTERMEDIATE MESODERM; GENERATION		[Quaggin, Susan E.] Northwestern Univ, Div Nephrol & Hypertens, Chicago, IL 60611 USA; [Quaggin, Susan E.] Northwestern Univ, Feinberg Cardiovasc Res Inst, Feinberg Sch Med, Chicago, IL USA	Northwestern University; Northwestern University; Feinberg School of Medicine	Quaggin, SE (corresponding author), Northwestern Univ, Div Nephrol & Hypertens, Chicago, IL 60611 USA.				NHLBI NIH HHS [R01 HL124120] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL124120] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Gonfiotti A, 2014, LANCET, V383, P238, DOI 10.1016/S0140-6736(13)62033-4; Lam AQ, 2014, J AM SOC NEPHROL, V25, P1211, DOI 10.1681/ASN.2013080831; Mae SI, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2378; Pagliuca FW, 2014, CELL, V159, P428, DOI 10.1016/j.cell.2014.09.040; Taguchi A, 2014, CELL STEM CELL, V14, P53, DOI 10.1016/j.stem.2013.11.010; Takasato M, 2015, NATURE, V526, P564, DOI 10.1038/nature15695	6	9	9	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 21	2016	374	3					281	283		10.1056/NEJMcibr1514351	http://dx.doi.org/10.1056/NEJMcibr1514351			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DB3IS	26789879	Green Accepted			2022-12-28	WOS:000368404800016
J	Hategan, A				Hategan, Ana			In older adults with treatment-resistant depression, adding aripiprazole to venlafaxine increased remission at 12 wk	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Hategan, Ana] McMaster Univ, Hamilton, ON, Canada	McMaster University	Hategan, A (corresponding author), McMaster Univ, Hamilton, ON, Canada.							Nelson J Craig, 2008, Neuropsychiatr Dis Treat, V4, P937; Parikh C, 2000, BRIT J CLIN PHARMACO, V49, P539, DOI 10.1046/j.1365-2125.2000.00201.x; Zhou XY, 2015, J CLIN PSYCHIAT, V76, pE487, DOI 10.4088/JCP.14r09204	3	1	1	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 19	2016	164	2					JC10	JC10		10.7326/ACPJC-2016-164-2-010	http://dx.doi.org/10.7326/ACPJC-2016-164-2-010			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DB0CI	26784490				2022-12-28	WOS:000368175800009
J	Betsholtz, C				Betsholtz, Christer			Transcriptional control of endothelial energy	NATURE			English	Editorial Material							HOMEOSTASIS; FOXOS		[Betsholtz, Christer] Uppsala Univ, Dept Immunol Genet & Pathol, S-75105 Uppsala, Sweden; [Betsholtz, Christer] Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden	Uppsala University; Karolinska Institutet	Betsholtz, C (corresponding author), Uppsala Univ, Dept Immunol Genet & Pathol, S-75105 Uppsala, Sweden.	christer.betsholtz@igp.uu.se						Eijkelenboom A, 2013, NAT REV MOL CELL BIO, V14, P83, DOI 10.1038/nrm3507; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Potente M, 2011, CELL, V146, P873, DOI 10.1016/j.cell.2011.08.039; Stine ZE, 2015, CANCER DISCOV, V5, P1024, DOI 10.1158/2159-8290.CD-15-0507; Wilhelm K, 2016, NATURE, V529, P216, DOI 10.1038/nature16498	7	7	7	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 14	2016	529	7585					160	161		10.1038/nature16866	http://dx.doi.org/10.1038/nature16866			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA7WK	26735011				2022-12-28	WOS:000368015700023
J	Kim, H; Ahrlund-Richter, S; Wang, XM; Deisseroth, K; Carlen, M				Kim, Hoseok; Ahrlund-Richter, Sofie; Wang, Xinming; Deisseroth, Karl; Carlen, Marie			Prefrontal Parvalbumin Neurons in Control of Attention	CELL			English	Article							GAMMA-BAND SYNCHRONIZATION; REACTION-TIME-TASK; TOP-DOWN CONTROL; CORTICAL CIRCUITS; VISUAL-CORTEX; INTERNEURON DYSFUNCTION; PREPARATORY ATTENTION; SENSORY PERCEPTION; CINGULATE CORTEX; LONG-RANGE	While signatures of attention have been extensively studied in sensory systems, the neural sources and computations responsible for top-down control of attention are largely unknown. Using chronic recordings in mice, we found that fast-spiking parvalbumin (FS-PV) interneurons in medial prefrontal cortex (mPFC) uniformly show increased and sustained firing during goal-driven attentional processing, correlating to the level of attention. Elevated activity of FS-PV neurons on the timescale of seconds predicted successful execution of behavior. Successful allocation of attention was characterized by strong synchronization of FS-PV neurons, increased gamma oscillations, and phase locking of pyramidal firing. Phase-locked pyramidal neurons showed gamma-phase-dependent rate modulation during successful attentional processing. Optogenetic silencing of FS-PV neurons deteriorated attentional processing, while optogenetic synchronization of FS-PV neurons at gamma frequencies had pro-cognitive effects and improved goal-directed behavior. FS-PV neurons thus act as a functional unit coordinating the activity in the local mPFC circuit during goal-driven attentional processing.	[Kim, Hoseok; Ahrlund-Richter, Sofie; Wang, Xinming; Carlen, Marie] Karolinska Inst, Dept Neurosci, S-17177 Stockholm, Sweden; [Deisseroth, Karl] Stanford Univ, Howard Hughes Med Inst, Clark Ctr W080, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Dept Bioengn, Clark Ctr W080, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Dept Psychiat & Behav Sci, Clark Ctr W080, Stanford, CA 94305 USA	Karolinska Institutet; Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University	Carlen, M (corresponding author), Karolinska Inst, Dept Neurosci, Retzius Vag 8, S-17177 Stockholm, Sweden.	marie.carlen@ki.se	Carlen, Marie Carlen/C-9112-2014	Carlen, Marie Carlen/0000-0003-1658-1631; Kim, Hoseok/0000-0002-2633-7416; Ahrlund-Richter, Sofie/0000-0002-7845-7831	European Research Council [337069]; Knut and Alice Wallenbergs Foundation (Wallenberg Academy Fellow Grant) [KAW 2012.0208]; Ragnar Soderberg Fellow in Medicine Grant; Swedish Brain Foundation (Hjarnfonden, M.C.); NIH; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH075957] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R37DA035377] Funding Source: NIH RePORTER	European Research Council(European Research Council (ERC)European Commission); Knut and Alice Wallenbergs Foundation (Wallenberg Academy Fellow Grant); Ragnar Soderberg Fellow in Medicine Grant; Swedish Brain Foundation (Hjarnfonden, M.C.); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank H. Shin, C.I. Moore, and K. Meletis for invaluable scientific discussions and H. Yang for the graphical abstract. This work was supported by a European Research Council Starting Grant (337069, M.C.), the Knut and Alice Wallenbergs Foundation (Wallenberg Academy Fellow Grant KAW 2012.0208, M.C.), a Ragnar Soderberg Fellow in Medicine Grant (M.C.), the Swedish Brain Foundation (Hjarnfonden, M.C.), and NIH (K.D).	Amitai N, 2010, BIOL PSYCHIAT, V68, P5, DOI 10.1016/j.biopsych.2010.03.004; Atallah BV, 2012, NEURON, V73, P159, DOI 10.1016/j.neuron.2011.12.013; Baluchi F, 2011, TRENDS NEUROSCI, V34, P210, DOI 10.1016/j.tins.2011.02.003; Barak S, 2011, PHARMACOL BIOCHEM BE, V99, P164, DOI 10.1016/j.pbb.2011.03.011; Bari A, 2008, NAT PROTOC, V3, P759, DOI 10.1038/nprot.2008.41; Berndt A, 2014, SCIENCE, V344, P420, DOI 10.1126/science.1252367; Buschman TJ, 2007, SCIENCE, V315, P1860, DOI 10.1126/science.1138071; Buzsaki G, 2012, ANNU REV NEUROSCI, V35, P203, DOI 10.1146/annurev-neuro-062111-150444; Buzsaki Gyorgy, 2012, Dialogues Clin Neurosci, V14, P345; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Carlen M, 2012, MOL PSYCHIATR, V17, P537, DOI 10.1038/mp.2011.31; Cho KKA, 2015, NEURON, V85, P1332, DOI 10.1016/j.neuron.2015.02.019; Clark K, 2015, PROG NEUROBIOL, V132, P59, DOI 10.1016/j.pneurobio.2015.06.006; Courtin J, 2014, NATURE, V505, P92, DOI 10.1038/nature12755; Donnelly NA, 2015, EUR J NEUROSCI, V41, P1524, DOI 10.1111/ejn.12895; Fries P, 2009, ANNU REV NEUROSCI, V32, P209, DOI 10.1146/annurev.neuro.051508.135603; Fujisawa S, 2008, NAT NEUROSCI, V11, P823, DOI 10.1038/nn.2134; Gold JM, 2007, SCHIZOPHR RES, V94, P148, DOI 10.1016/j.schres.2007.04.023; GRAY CM, 1989, P NATL ACAD SCI USA, V86, P1698, DOI 10.1073/pnas.86.5.1698; Gregoriou GG, 2015, BRAIN RES, V1626, P165, DOI 10.1016/j.brainres.2015.02.004; Gregoriou GG, 2014, NAT NEUROSCI, V17, P1003, DOI 10.1038/nn.3742; Gregoriou GG, 2009, SCIENCE, V324, P1207, DOI 10.1126/science.1171402; Hangya B, 2014, CURR OPIN NEUROBIOL, V26, P117, DOI 10.1016/j.conb.2014.01.007; Hasenstaub A, 2005, NEURON, V47, P423, DOI 10.1016/j.neuron.2005.06.016; Hayden BY, 2009, P NATL ACAD SCI USA, V106, P5948, DOI 10.1073/pnas.0812035106; Hu H, 2014, SCIENCE, V345, P529, DOI 10.1126/science.1255263; Isomura Y, 2009, NAT NEUROSCI, V12, P1586, DOI 10.1038/nn.2431; Kepecs A, 2014, NATURE, V505, P318, DOI 10.1038/nature12983; Korotkova T, 2010, NEURON, V68, P557, DOI 10.1016/j.neuron.2010.09.017; Kvitsiani D, 2013, NATURE, V498, P363, DOI 10.1038/nature12176; Lee SH, 2012, NATURE, V488, P379, DOI 10.1038/nature11312; Lewis DA, 2012, TRENDS NEUROSCI, V35, P57, DOI 10.1016/j.tins.2011.10.004; Li L, 2010, BRAIN RES, V1344, P173, DOI 10.1016/j.brainres.2010.05.016; Lustig C, 2013, NEUROSCI BIOBEHAV R, V37, P2099, DOI 10.1016/j.neubiorev.2012.05.009; Marin O, 2012, NAT REV NEUROSCI, V13, P107, DOI 10.1038/nrn3155; Miller EK, 2013, CURR OPIN NEUROBIOL, V23, P216, DOI 10.1016/j.conb.2012.11.011; Moore T, 2003, NATURE, V421, P370, DOI 10.1038/nature01341; Noudoost B, 2010, CURR OPIN NEUROBIOL, V20, P183, DOI 10.1016/j.conb.2010.02.003; Pritchett DL, 2015, CURR OPIN NEUROBIOL, V31, P254, DOI 10.1016/j.conb.2015.02.004; Robbins TW, 2002, PSYCHOPHARMACOLOGY, V163, P362, DOI 10.1007/s00213-002-1154-7; Rossi AF, 2007, J NEUROSCI, V27, P11306, DOI 10.1523/JNEUROSCI.2939-07.2007; Roux L, 2015, NEUROPHARMACOLOGY, V88, P10, DOI 10.1016/j.neuropharm.2014.09.011; Roux L, 2014, CURR OPIN NEUROBIOL, V26, P88, DOI 10.1016/j.conb.2013.12.013; Sachidhanandam S, 2013, NAT NEUROSCI, V16, P1671, DOI 10.1038/nn.3532; Salinas E, 2001, NAT REV NEUROSCI, V2, P539, DOI 10.1038/35086012; Salinas E, 2000, J NEUROSCI, V20, P6193, DOI 10.1523/JNEUROSCI.20-16-06193.2000; Siegle JH, 2014, NAT NEUROSCI, V17, P1371, DOI 10.1038/nn.3797; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Stark E, 2013, NEURON, V80, P1263, DOI 10.1016/j.neuron.2013.09.033; Tiesinga P, 2008, NAT REV NEUROSCI, V9, P97, DOI 10.1038/nrn2315; Tiesinga PH, 2004, J PHYSIOL-PARIS, V98, P296, DOI 10.1016/j.jphysparis.2005.09.002; Totah NKB, 2013, CEREB CORTEX, V23, P729, DOI 10.1093/cercor/bhs057; Totah NKB, 2009, J NEUROSCI, V29, P6418, DOI 10.1523/JNEUROSCI.1142-09.2009; Vinck M, 2013, NEURON, V80, P1077, DOI 10.1016/j.neuron.2013.08.019; Wilson NR, 2012, NATURE, V488, P343, DOI 10.1038/nature11347; Zhang SY, 2014, SCIENCE, V345, P660, DOI 10.1126/science.1254126	56	237	239	1	48	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 14	2016	164	1-2					208	218		10.1016/j.cell.2015.11.038	http://dx.doi.org/10.1016/j.cell.2015.11.038			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DB2LE	26771492	Green Published, hybrid			2022-12-28	WOS:000368339300021
J	Wang, H; Shi, Y; Song, J; Qi, JX; Lu, GW; Yan, JH; Gao, GF				Wang, Han; Shi, Yi; Song, Jian; Qi, Jianxun; Lu, Guangwen; Yan, Jinghua; Gao, George F.			Ebola Viral Glycoprotein Bound to Its Endosomal Receptor Niemann-Pick C1	CELL			English	Article							VIRUS ENTRY REQUIRES; CRYSTAL-STRUCTURE; ZAIRE-EBOLAVIRUS; DC-SIGN; BINDING; MECHANISM; DISEASE; PROTEIN; DOMAIN; NUCLEOPROTEIN	Filoviruses, including Ebola and Marburg, cause fatal hemorrhagic fever in humans and primates. Understanding how these viruses enter host cells could help to develop effective therapeutics. An endosomal protein, Niemann-Pick C1 (NPC1), has been identified as a necessary entry receptor for this process, and priming of the viral glycoprotein (GP) to a fusion-competent state is a prerequisite for NPC1 binding. Here, we have determined the crystal structure of the primed GP (GPcl) of Ebola virus bound to domain C of NPC1 (NPC1-C) at a resolution of 2.3 angstrom. NPC1-C utilizes two protruding loops to engage a hydrophobic cavity on head of GPcl. Upon enzymatic cleavage and NPC1-C binding, conformational change in the GPcl further affects the state of the internal fusion loop, triggering membrane fusion. Our data therefore provide structural insights into filovirus entry in the late endosome and the molecular basis for design of therapeutic inhibitors of viral entry.	[Wang, Han; Shi, Yi; Song, Jian; Qi, Jianxun; Lu, Guangwen; Yan, Jinghua; Gao, George F.] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing 100101, Peoples R China; [Shi, Yi; Gao, George F.] Chinese Acad Sci, Beijing Inst Life Sci, RNIH, Beijing 100101, Peoples R China; [Wang, Han; Shi, Yi; Song, Jian; Qi, Jianxun; Yan, Jinghua; Gao, George F.] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Shi, Yi; Gao, George F.] Chinese Acad Sci, Ctr Influenza Res & Early Warning, Beijing 100101, Peoples R China; [Shi, Yi; Yan, Jinghua; Gao, George F.] Shenzhen Third Peoples Hosp, Shenzhen Key Lab Pathogen & Immun, Shenzhen 518112, Peoples R China; [Lu, Guangwen] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, WCHED, Chengdu 610041, Sichuan, Peoples R China; [Lu, Guangwen] Collaborat Innovat Ctr Biotherapy, Chengdu 610041, Sichuan, Peoples R China; [Yan, Jinghua] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Microbial Physiol & Engn, Beijing 100101, Peoples R China; [Gao, George F.] Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou 310003, Zhejiang, Peoples R China; [Gao, George F.] Chinese Ctr Dis Control & Prevent China CDC, Natl Inst Viral Dis Control & Prevent, Beijing 102206, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Sichuan University; Chinese Academy of Sciences; Institute of Microbiology, CAS; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Gao, GF (corresponding author), Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing 100101, Peoples R China.	gaof@im.ac.cn	Qi, Jianxun/ABF-1646-2021; Lu, Guangwen/HCH-9193-2022; Gao, George Fu/ABD-5229-2021		special project of Ebola virus research from the President Foundation of Chinese Academy of Sciences (CAS); National Natural Science Foundation of China (NSFC) [81590761]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDB08020100]; China Ministry of Science and Technology National 973 Project [2013CB531502, 2014CB542503]; Excellent Young Scientist Program of the Chinese Academy of Sciences; Youth Innovation Promotion Association CAS [2015078]; NSFC Innovative Research Group [81321063]	special project of Ebola virus research from the President Foundation of Chinese Academy of Sciences (CAS); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); China Ministry of Science and Technology National 973 Project; Excellent Young Scientist Program of the Chinese Academy of Sciences; Youth Innovation Promotion Association CAS; NSFC Innovative Research Group	This work was supported by the special project of Ebola virus research from the President Foundation of Chinese Academy of Sciences (CAS), the National Natural Science Foundation of China (NSFC, Grant No. 81590761), Strategic Priority Research Program of the Chinese Academy of Sciences (XDB08020100), and China Ministry of Science and Technology National 973 Project (Grant numbers 2013CB531502 and 2014CB542503). We acknowledge Zheng Fan and Yiwei Liu for assistance with SPR experiments in Core Facility in Institute of Microbiology, CAS. We thank the staff of BL19U1 beamline at National Center for Protein Sciences Shanghai and Shanghai Synchrotron Radiation Facility (Shanghai, People's Republic of China) and BL17U beamline at Shanghai Synchrotron Radiation Facility for assistance during data collection. Xu Yang, Xiaoying Xu, Wenqian Duan, Yan Li, and Qihui Wang were involved in protein preparation and cell culture work during the revision stage of the manuscript. Y.S. is supported by the Excellent Young Scientist Program of the Chinese Academy of Sciences and the Youth Innovation Promotion Association CAS (2015078). G.F.G. is a leading principal investigator of the NSFC Innovative Research Group (Grant number 81321063).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alvarez CP, 2002, J VIROL, V76, P6841, DOI 10.1128/JVI.76.13.6841-6844.2002; Backovic M, 2012, CURR OPIN VIROL, V2, P4, DOI 10.1016/j.coviro.2011.12.005; Bharat TAM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001196; Brecher M, 2012, J VIROL, V86, P364, DOI 10.1128/JVI.05708-11; Brindley MA, 2011, VIROLOGY, V415, P83, DOI 10.1016/j.virol.2011.04.002; Carette JE, 2011, NATURE, V477, P340, DOI 10.1038/nature10348; Carstea ED, 1997, SCIENCE, V277, P228, DOI 10.1126/science.277.5323.228; Chandran K, 2005, SCIENCE, V308, P1643, DOI 10.1126/science.1110656; Cote M, 2011, NATURE, V477, P344, DOI 10.1038/nature10380; Davies JP, 2000, J BIOL CHEM, V275, P24367, DOI 10.1074/jbc.M002184200; Dong SS, 2015, PROTEIN CELL, V6, P351, DOI 10.1007/s13238-015-0163-3; Dube D, 2010, P NATL ACAD SCI USA, V107, P16637, DOI 10.1073/pnas.1008509107; Dube D, 2009, J VIROL, V83, P2883, DOI 10.1128/JVI.01956-08; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feldmann H., 2013, FIELDS VIROLOGY, V1, P923; Feldmann H, 2011, LANCET, V377, P849, DOI 10.1016/S0140-6736(10)60667-8; Flyak AI, 2015, CELL, V160, P893, DOI 10.1016/j.cell.2015.01.031; Geisbert TW, 2007, J INFECT DIS, V196, pS372, DOI 10.1086/520608; Gregory SM, 2011, P NATL ACAD SCI USA, V108, P11211, DOI 10.1073/pnas.1104760108; Harrison SC, 2015, VIROLOGY, V479, P498, DOI 10.1016/j.virol.2015.03.043; Hashiguchi T, 2015, CELL, V160, P904, DOI 10.1016/j.cell.2015.01.041; Hood CL, 2010, J VIROL, V84, P2972, DOI 10.1128/JVI.02151-09; Jemielity S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003232; Kirchdoerfer RN, 2015, CELL REP, V12, P140, DOI 10.1016/j.celrep.2015.06.003; Kondratowicz AS, 2011, P NATL ACAD SCI USA, V108, P8426, DOI 10.1073/pnas.1019030108; Kuhn JH, 2013, ARCH VIROL, V158, P301, DOI 10.1007/s00705-012-1454-0; Kuhn JH, 2010, ARCH VIROL, V155, P445, DOI 10.1007/s00705-010-0600-9; Kwon HJ, 2009, CELL, V137, P1213, DOI 10.1016/j.cell.2009.03.049; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee JE, 2008, NATURE, V454, P177, DOI 10.1038/nature07082; Lee JE, 2009, FUTURE VIROL, V4, P621, DOI 10.2217/FVL.09.56; Leung DW, 2015, CELL REP, V11, P376, DOI 10.1016/j.celrep.2015.03.034; Lu GW, 2013, NATURE, V500, P227, DOI 10.1038/nature12328; MALHERBE H, 1968, LANCET, V1, P1434; Miller EH, 2012, EMBO J, V31, P1947, DOI 10.1038/emboj.2012.53; Mulherkar N, 2011, VIROLOGY, V419, P72, DOI 10.1016/j.virol.2011.08.009; Nanbo A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001121; Neumann G, 2007, J VIROL, V81, P2995, DOI 10.1128/JVI.02486-06; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Qiu XG, 2014, NATURE, V514, P47, DOI 10.1038/nature13777; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Saeed MF, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001110; Sakurai Y, 2015, SCIENCE, V347, P995, DOI 10.1126/science.1258758; Schornberg K, 2006, J VIROL, V80, P4174, DOI 10.1128/JVI.80.8.4174-4178.2006; Schornberg KL, 2009, P NATL ACAD SCI USA, V106, P8003, DOI 10.1073/pnas.0807578106; Shi Y, 2013, SCIENCE, V342, P243, DOI 10.1126/science.1242917; Shi Y, 2011, MOL IMMUNOL, V48, P2198, DOI 10.1016/j.molimm.2011.05.009; Shimojima M, 2007, J INFECT DIS, V196, pS259, DOI 10.1086/520594; SIEGERT R, 1968, DEUT MED WOCHENSCHR, V93, P604, DOI 10.1055/s-0028-1105103; Simmons G, 2003, VIROLOGY, V305, P115, DOI 10.1006/viro.2002.1730; Sleat DE, 2004, P NATL ACAD SCI USA, V101, P5886, DOI 10.1073/pnas.0308456101; Stevens J, 2004, SCIENCE, V303, P1866, DOI 10.1126/science.1093373; Sullivan NJ, 2009, NAT REV MICROBIOL, V7, P393, DOI 10.1038/nrmicro2129; Takada A, 2004, J VIROL, V78, P2943, DOI 10.1128/JVI.78.6.2943-2947.2004; Takada A, 2000, VIROLOGY, V278, P20, DOI 10.1006/viro.2000.0601; Towner JS, 2006, J VIROL, V80, P6497, DOI 10.1128/JVI.00069-06; Uson I, 1999, CURR OPIN STRUC BIOL, V9, P643, DOI 10.1016/S0959-440X(99)00020-2; [王寒 Wang Han], 2015, [科学通报, Chinese Science Bulletin], V60, P3438; Wang XJ, 2005, ARCH BIOCHEM BIOPHYS, V436, P316, DOI 10.1016/j.abb.2005.02.004; White JM, 2008, CRIT REV BIOCHEM MOL, V43, P189, DOI [10.1080/10409230802058320, 10.1080/10409230802058320 ]; Wool-Lewis RJ, 1999, J VIROL, V73, P1419, DOI 10.1128/JVI.73.2.1419-1426.1999; Zhang W, 2010, PROTEIN CELL, V1, P459, DOI 10.1007/s13238-010-0059-1	63	161	168	4	109	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 14	2016	164	1-2					258	268		10.1016/j.cell.2015.12.044	http://dx.doi.org/10.1016/j.cell.2015.12.044			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DB2LE	26771495	Green Published, Bronze			2022-12-28	WOS:000368339300025
J	Yoshimi, A; Baldomero, H; Horowitz, M; Szer, J; Niederwieser, D; Gratwohl, A; Kodera, Y				Yoshimi, Ayami; Baldomero, Helen; Horowitz, Mary; Szer, Jeff; Niederwieser, Dietger; Gratwohl, Alois; Kodera, Yoshihisa		Worldwide Network Blood Marrow	Global Use of Peripheral Blood vs Bone Marrow as Source of Stem Cells for Allogeneic Transplantation in Patients With Bone Marrow Failure	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							APLASTIC-ANEMIA		[Yoshimi, Ayami] Univ Freiburg, Dept Pediat & Adolescent Med, D-79106 Freiburg, Germany; [Baldomero, Helen; Gratwohl, Alois] Univ Basel Hosp, European Soc Blood & Marrow Transplantat Transpla, CH-4031 Basel, Switzerland; [Horowitz, Mary] Med Coll Wisconsin, Ctr Int Blood & Marrow Transplant Res, Milwaukee, WI 53226 USA; [Szer, Jeff] Royal Melbourne Hosp, Australasian Bone Marrow Transplant Recipient Reg, Parkville, Vic 3050, Australia; [Niederwieser, Dietger] Univ Hosp, Dept Hematol Oncol, Leipzig, Germany; [Kodera, Yoshihisa] Aichi Med Univ, Sch Med, Asia Pacific Blood & Marrow Transplant Grp Data C, Nagakute, Aichi 48011, Japan	University of Freiburg; University of Basel; Center for International Blood & Marrow Transplant Research; Medical College of Wisconsin; Royal Melbourne Hospital; Leipzig University; Aichi Medical University	Yoshimi, A (corresponding author), Univ Freiburg, Dept Pediat & Adolescent Med, Mathildenstr 1, D-79106 Freiburg, Germany.	ayami.yoshimi@uniklinik-freiburg.de	horowitz, Mary/ABH-2173-2021	Passweg, Jakob R/0000-0001-7092-3351				Eapen M, 2011, BLOOD, V118, P2618, DOI 10.1182/blood-2011-05-354001; Gratwohl A, 2013, HAEMATOLOGICA, V98, P1282, DOI 10.3324/haematol.2012.076349; Gratwohl A, 2010, JAMA-J AM MED ASSOC, V303, P1617, DOI 10.1001/jama.2010.491; Scheinberg P, 2012, BLOOD, V120, P1185, DOI 10.1182/blood-2011-12-274019; Sureda A, 2015, BONE MARROW TRANSPL, V50, P1037, DOI 10.1038/bmt.2015.6	5	11	11	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 12	2016	315	2					198	200		10.1001/jama.2015.13706	http://dx.doi.org/10.1001/jama.2015.13706			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DA6XO	26757470	Bronze			2022-12-28	WOS:000367949200023
J	Kroger, N; Solano, C; Wolschke, C; Bandini, G; Patriarca, F; Pini, M; Nagler, A; Selleri, C; Risitano, A; Messina, G; Bethge, W; de Oteiza, JP; Duarte, R; Carella, AM; Cimminiello, M; Guidi, S; Finke, J; Mordini, N; Ferra, C; Sierra, J; Russo, D; Petrini, M; Milone, G; Benedetti, F; Heinzelmann, M; Pastore, D; Jurado, M; Terruzzi, E; Narni, F; Volp, A; Ayuk, F; Ruutu, T; Bonifazi, F				Kroeger, Nicolaus; Solano, Carlos; Wolschke, Christine; Bandini, Giuseppe; Patriarca, Francesca; Pini, Massimo; Nagler, Arnon; Selleri, Carmine; Risitano, Antonio; Messina, Giuseppe; Bethge, Wolfgang; Perez de Oteiza, Jaime; Duarte, Rafael; Carella, Angelo Michele; Cimminiello, Michele; Guidi, Stefano; Finke, Juergen; Mordini, Nicola; Ferra, Christelle; Sierra, Jorge; Russo, Domenico; Petrini, Mario; Milone, Giuseppe; Benedetti, Fabio; Heinzelmann, Marion; Pastore, Domenico; Jurado, Manuel; Terruzzi, Elisabetta; Narni, Franco; Voelp, Andreas; Ayuk, Francis; Ruutu, Tapani; Bonifazi, Francesca			Antilymphocyte Globulin for Prevention of Chronic Graft-versus-Host Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							REGULATORY T-CELLS; ANTITHYMOCYTE GLOBULIN; INTERNATIONAL BLOOD; GVHD PROPHYLAXIS; UNRELATED DONORS; BONE-MARROW; TRANSPLANTATION; CYCLOSPORINE; RISK; LEUKEMIA	BACKGROUND Chronic graft-versus-host disease (GVHD) is the leading cause of later illness and death after allogeneic hematopoietic stem-cell transplantation. We hypothesized that the inclusion of antihuman T-lymphocyte immune globulin (ATG) in a myeloablative conditioning regimen for patients with acute leukemia would result in a significant reduction in chronic GVHD 2 years after allogeneic peripheral-blood stem-cell transplantation from an HLA-identical sibling. METHODS We conducted a prospective, multicenter, open-label, randomized phase 3 study of ATG as part of a conditioning regimen. A total of 168 patients were enrolled at 27 centers. Patients were randomly assigned in a 1:1 ratio to receive ATG or not receive ATG, with stratification according to center and risk of disease. RESULTS After a median follow-up of 24 months, the cumulative incidence of chronic GVHD was 32.2% (95% confidence interval [CI], 22.1 to 46.7) in the ATG group and 68.7% (95% CI, 58.4 to 80.7) in the non-ATG group (P<0.001). The rate of 2-year relapse-free survival was similar in the ATG group and the non-ATG group (59.4% [95% CI, 47.8 to 69.2] and 64.6% [95% CI, 50.9 to 75.3], respectively; P=0.21), as was the rate of overall survival (74.1% [95% CI, 62.7 to 82.5] and 77.9% [95% CI, 66.1 to 86.1], respectively; P=0.46). There were no significant between-group differences in the rates of relapse, infectious complications, acute GVHD, or adverse events. The rate of a composite end point of chronic GVHD-free and relapse-free survival at 2 years was significantly higher in the ATG group than in the non-ATG group (36.6% vs. 16.8%, P=0.005). CONCLUSIONS The inclusion of ATG resulted in a significantly lower rate of chronic GVHD after allogeneic transplantation than the rate without ATG. The survival rate was similar in the two groups, but the rate of a composite end point of chronic GVHD-free survival and relapse-free survival was higher with ATG. (Funded by the Neovii Biotech and the European Society for Blood and Marrow Transplantation; ClinicalTrials.gov number, NCT00678275.)	[Kroeger, Nicolaus; Wolschke, Christine; Heinzelmann, Marion; Ayuk, Francis] Univ Med Ctr Hamburg Eppendorf, Hamburg, Germany; [Finke, Juergen] Univ Hosp Freiburg, Freiburg, Germany; [Bethge, Wolfgang] Univ Hosp Tubingen, Tubingen, Germany; [Voelp, Andreas] Psy Consult, Frankfurt, Germany; [Solano, Carlos] Hosp Clin Univ, Valencia, Spain; [Perez de Oteiza, Jaime] Hosp Ramon & Cajal, E-28034 Madrid, Spain; [Duarte, Rafael] Hosp Univ Puerta Hierro Majadahonda, Madrid, Spain; [Ferra, Christelle] Hosp Badalona Germans Trias & Pujol, Inst Catal Oncol, Serv Hematol, Badalona, Spain; [Sierra, Jorge] Hosp Santa Creu & Sant Pau, Barcelona, Spain; [Jurado, Manuel] Hosp Virgen Nieves, Granada, Spain; [Bandini, Giuseppe; Bonifazi, Francesca] Univ Bologna, S Orsola Malpighi Univ Hosp, Bologna, Italy; [Patriarca, Francesca] Univ Udine, DISM, Hematol, Udine, Italy; [Pini, Massimo] Azienda Ospedaliera SS Antonio & Biagio & C Arrig, Alessandria, Italy; [Selleri, Carmine; Risitano, Antonio] Univ Naples Federico II, Naples, Italy; [Messina, Giuseppe] AO Bianchi Melacrino Morelli, Reggio Di Calabria, Italy; [Carella, Angelo Michele] Osped Casa Sollievo Sofferenza IRCCCS, San Giovanni Rotondo, Italy; [Cimminiello, Michele] Azienda Osped San Carlo, Potenza, Italy; [Guidi, Stefano] Azienda Osped Careggi, Florence, Italy; [Mordini, Nicola] Osped Santa Croce & Carle, Cuneo, Italy; [Russo, Domenico] Univ Brescia, Dept Clin & Expt Sci, Brescia, Italy; [Petrini, Mario] Univ Pisa, Dept Clin & Expt Med, Pisa, Italy; [Milone, Giuseppe] Azienda Policlin Vittorio Emanuele, Programma Trapianto Emopoiet Metropolitano, Catania, Italy; [Benedetti, Fabio] Policlin GB Rossi, Verona, Italy; [Pastore, Domenico] Univ Osped, Azienda Osped, Bari, Italy; [Terruzzi, Elisabetta] Osped San Gerardo, Monza, Italy; [Narni, Franco] Policlin Modena, Modena, Italy; [Selleri, Carmine] Univ Salerno, I-84100 Salerno, Italy; [Nagler, Arnon] Chaim Sheba Med Ctr, Ramat Gan, Israel; [Ruutu, Tapani] Helsinki Univ Hosp, Helsinki, Finland	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Freiburg; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Hospital Clinic Universitari de Valencia; Hospital Universitario Ramon y Cajal; Hospital Puerta de Hierro-Majadahonda; Catalan Institute of Oncology; Hospital Germans Trias i Pujol; Hospital of Santa Creu i Sant Pau; Hospital Universitario Virgen de las Nieves; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; University of Udine; Azienda Ospedaliera SS Antonio Biagio Cesare Arrigo; University of Naples Federico II; San Carlo Borromeo Hospital; University of Florence; Azienda Ospedaliero Universitaria Careggi; University of Brescia; University of Pisa; Azienda Ospedaliera Universitaria Policlinico Vittorio Emanuele Presidio Ferraotto; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; San Gerardo Hospital; Universita di Modena e Reggio Emilia; University of Salerno; Chaim Sheba Medical Center; University of Helsinki; Helsinki University Central Hospital	Kroger, N (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Stem Cell Transplantat, Martinistr 52, D-20246 Hamburg, Germany.	nkroeger@uke.de	Solano, Carlos/AAW-4678-2020; Milone, Giuseppe/AAC-6355-2022; bonifazi, francesca/J-5643-2018; Ayuk, Francis/G-8439-2019; selleri, Carmine/AAL-4595-2020; Ferra, Christelle M/K-1158-2017; DUARTE, Rafael F./Q-5884-2018; de Oteyza, Jaime Perez/K-5514-2012; MILONE, GIUSEPPE/D-5137-2011; Patriarca, Francesca/ABH-9856-2020; pini, massimo/K-6654-2016	Solano, Carlos/0000-0003-3702-0817; Milone, Giuseppe/0000-0002-7840-4414; bonifazi, francesca/0000-0003-1544-9911; Ferra, Christelle M/0000-0003-4571-5125; DUARTE, Rafael F./0000-0002-5240-9815; de Oteyza, Jaime Perez/0000-0002-8338-2037; MILONE, GIUSEPPE/0000-0002-7840-4414; pini, massimo/0000-0001-6716-004X; NARNI, Franco/0000-0003-3994-9101	Neovii Biotech; European Society for Blood and Marrow Transplantation	Neovii Biotech; European Society for Blood and Marrow Transplantation	Funded by the Neovii Biotech and the European Society for Blood and Marrow Transplantation; ClinicalTrials.gov number, NCT00678275.	al-Jurf M, 2005, J CLIN ONCOL, V23, P5074, DOI 10.1200/JCO.2005.09.020; Anasetti C, 2012, NEW ENGL J MED, V367, P1487, DOI 10.1056/NEJMoa1203517; Arai S, 2015, BIOL BLOOD MARROW TR, V21, P266, DOI 10.1016/j.bbmt.2014.10.021; Armand P, 2014, BLOOD, V123, P3664, DOI 10.1182/blood-2014-01-552984; Arora M, 2011, BLOOD, V117, P6714, DOI 10.1182/blood-2010-12-323824; Ayuk FA, 2005, EXP HEMATOL, V33, P1531, DOI 10.1016/j.exphem.2005.08.004; Bacigalupo A, 2001, BLOOD, V98, P2942, DOI 10.1182/blood.V98.10.2942; BACIGALUPO A, 1991, BLOOD, V77, P1423; BEARMAN SI, 1988, J CLIN ONCOL, V6, P1562, DOI 10.1200/JCO.1988.6.10.1562; Bonifazi F, 2012, BONE MARROW TRANSPL, V47, P1105, DOI 10.1038/bmt.2011.225; Bruggen MC, 2014, BLOOD, V123, P290, DOI 10.1182/blood-2013-07-514372; Chakraverty R, 2010, BLOOD, V116, P3080, DOI 10.1182/blood-2010-05-286856; Deeg HJ, 1997, BLOOD, V89, P3880, DOI 10.1182/blood.V89.10.3880.3880_3880_3887; Fang LB, 2005, TRANSPLANTATION, V79, P369, DOI 10.1097/01.TP.0000150210.77543.1B; Filipovich AH, 2005, BIOL BLOOD MARROW TR, V11, P945, DOI 10.1016/j.bbmt.2005.09.004; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Finke J, 2009, LANCET ONCOL, V10, P855, DOI 10.1016/S1470-2045(09)70225-6; GLUCKSBERG H, 1974, TRANSPLANTATION, V18, P295, DOI 10.1097/00007890-197410000-00001; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; Gray RJ, 2011, CMPRSK SUBDISTRIBUTI; Kanakry CG, 2014, BLOOD, V124, P3817, DOI 10.1182/blood-2014-07-587477; Kansu E, 2001, BLOOD, V98, P3868, DOI 10.1182/blood.V98.13.3868; Lee SJ, 2003, BIOL BLOOD MARROW TR, V9, P215, DOI 10.1053/bbmt.2003.50026; Martin PJ, 2010, J CLIN ONCOL, V28, P1011, DOI 10.1200/JCO.2009.25.6693; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Pasquini MC, 2012, J CLIN ONCOL, V30, P3194, DOI 10.1200/JCO.2012.41.7071; Passweg JR, 2014, BONE MARROW TRANSPL, V49, P744, DOI 10.1038/bmt.2014.55; Pavletic SZ, 2010, BIOL BLOOD MARROW TR, V16, P871, DOI 10.1016/j.bbmt.2010.04.004; Sarantopoulos S, 2007, CLIN CANCER RES, V13, P6107, DOI 10.1158/1078-0432.CCR-07-1290; Scrucca L, 2007, BONE MARROW TRANSPL, V40, P381, DOI 10.1038/sj.bmt.1705727; Shimony O, 2012, J CLIN IMMUNOL, V32, P173, DOI 10.1007/s10875-011-9599-2; Soiffer RJ, 2011, BLOOD, V117, P6963, DOI 10.1182/blood-2011-01-332007; STORB R, 1989, BLOOD, V73, P1729; Storek J, 1996, AM J HEMATOL, V52, P82, DOI 10.1002/(SICI)1096-8652(199606)52:2<82::AID-AJH3>3.0.CO;2-1; Sullivan K M, 1996, Biol Blood Marrow Transplant, V2, P44; Wingard JR, 2011, J CLIN ONCOL, V29, P2230, DOI 10.1200/JCO.2010.33.7212; Wolschke C, 2014, BONE MARROW TRANSPL, V49, P126, DOI 10.1038/bmt.2013.143; Zorn E, 2005, BLOOD, V106, P2903, DOI 10.1182/blood-2005-03-1257	38	321	325	0	24	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 7	2016	374	1					43	53		10.1056/NEJMoa1506002	http://dx.doi.org/10.1056/NEJMoa1506002			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DA1UH	26735993	Green Published, Bronze			2022-12-28	WOS:000367580500007
J	van Griensven, J; Edwards, T; de Lamballerie, X; Semple, MG; Gallian, P; Baize, S; Horby, PW; Raoul, H; Magassouba, N; Antierens, A; Lomas, C; Faye, O; Sall, AA; Fransen, K; Buyze, J; Ravinetto, R; Tiberghien, P; Claeys, Y; De Crop, M; Lynen, L; Bah, EI; Smith, PG; Delamou, A; De Weggheleire, A; Haba, N				van Griensven, J.; Edwards, T.; de Lamballerie, X.; Semple, M. G.; Gallian, P.; Baize, S.; Horby, P. W.; Raoul, H.; Magassouba, N.; Antierens, A.; Lomas, C.; Faye, O.; Sall, A. A.; Fransen, K.; Buyze, J.; Ravinetto, R.; Tiberghien, P.; Claeys, Y.; De Crop, M.; Lynen, L.; Bah, E. I.; Smith, P. G.; Delamou, A.; De Weggheleire, A.; Haba, N.		Ebola-Tx Consortium	Evaluation of Convalescent Plasma for Ebola Virus Disease in Guinea	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NONHUMAN-PRIMATES; HEMORRHAGIC-FEVER	BACKGROUND In the wake of the recent outbreak of Ebola virus disease (EVD) in several African countries, the World Health Organization prioritized the evaluation of treatment with convalescent plasma derived from patients who have recovered from the disease. We evaluated the safety and efficacy of convalescent plasma for the treatment of EVD in Guinea. METHODS In this nonrandomized, comparative study, 99 patients of various ages (including pregnant women) with confirmed EVD received two consecutive transfusions of 200 to 250 ml of ABO-compatible convalescent plasma, with each unit of plasma obtained from a separate convalescent donor. The transfusions were initiated on the day of diagnosis or up to 2 days later. The level of neutralizing antibodies against Ebola virus in the plasma was unknown at the time of administration. The control group was 418 patients who had been treated at the same center during the previous 5 months. The primary outcome was the risk of death during the period from 3 to 16 days after diagnosis with adjustments for age and the baseline cycle-threshold value on polymerase- chain-reaction assay; patients who had died before day 3 were excluded. The clinically important difference was defined as an absolute reduction in mortality of 20 percentage points in the convalescent-plasma group as compared with the control group. RESULTS A total of 84 patients who were treated with plasma were included in the primary analysis. At baseline, the convalescent-plasma group had slightly higher cycle-threshold values and a shorter duration of symptoms than did the control group, along with a higher frequency of eye redness and difficulty in swallowing. From day 3 to day 16 after diagnosis, the risk of death was 31% in the convalescent-plasma group and 38% in the control group (risk difference, -7 percentage points; 95% confidence interval [CI], -18 to 4). The difference was reduced after adjustment for age and cycle-threshold value (adjusted risk difference, -3 percentage points; 95% CI, -13 to 8). No serious adverse reactions associated with the use of convalescent plasma were observed. CONCLUSIONS The transfusion of up to 500 ml of convalescent plasma with unknown levels of neutralizing antibodies in 84 patients with confirmed EVD was not associated with a significant improvement in survival. (Funded by the European Union's Horizon 2020 Research and Innovation Program and others; ClinicalTrials. gov number, NCT02342171.)	[van Griensven, J.; Fransen, K.; Buyze, J.; Ravinetto, R.; Claeys, Y.; De Crop, M.; Lynen, L.; De Weggheleire, A.] Inst Trop Med, B-2000 Antwerp, Belgium; [Antierens, A.; Lomas, C.] Med Sans Frontieres, Brussels, Belgium; [Ravinetto, R.] Katholieke Univ Leuven, Clin Pharmacol & Pharmacotherapy Dept, Leuven, Belgium; [Edwards, T.; Smith, P. G.] London Sch Hyg & Trop Med, Med Res Council, Trop Epidemiol Grp, London WC1, England; [Semple, M. G.] Univ Liverpool, Inst Translat Med, Liverpool L69 3BX, Merseyside, England; [Semple, M. G.] Univ Liverpool, NIHR, Hlth Protect Res Unit Emerging & Zoonot Infect, Liverpool L69 3BX, Merseyside, England; [Horby, P. W.] Univ Oxford, Ctr Trop Med & Global Hlth, Oxford, England; [de Lamballerie, X.; Gallian, P.] Aix Marseille Univ, Marseille, France; [de Lamballerie, X.] French Inst Res Dev, Marseille, France; [de Lamballerie, X.] Ecole Hautes Etud Sante Publ, Marseille, France; [de Lamballerie, X.; Gallian, P.] Inst Hosp Univ Mediterranee Infect, Marseille, France; [Gallian, P.; Tiberghien, P.] Etab Francais Sang, La Plaine St Denis, France; [Baize, S.] Inst Pasteur, Ctr Int Rech Infectiol, Unite Biol Infect Virales Emergentes, Lyon, France; [Raoul, H.] Lab P4 INSERM Jean Merieux, Lyon, France; [Tiberghien, P.] Univ Franche Comte, Etab Francais Sang, INSERM UMR 1098, F-25030 Besancon, France; [Magassouba, N.] Gamal Abdel Nasser Univ Conakry, Lab Viral Hemorrhag Fever, Conakry, Guinea; [Bah, E. I.] Hop Natl Donka, Serv Malad Infect & Trop, Conakry, Guinea; [Haba, N.] Natl Blood Transfus Ctr, Conakry, Guinea; [Delamou, A.] Natl Ctr Training & Res Rural Hlth Maferinyah, Forecariah, Guinea; [Faye, O.; Sall, A. A.] Inst Pasteur, Dakar, Senegal	Institute of Tropical Medicine (ITM); Doctors Without Borders; KU Leuven; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of London; London School of Hygiene & Tropical Medicine; University of Liverpool; University of Liverpool; University of Oxford; UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Franche-Comte; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar	van Griensven, J (corresponding author), Inst Trop Med, Nationalestr 155, B-2000 Antwerp, Belgium.	jvangriensven@itg.be	Lynen, Lutgarde/AAT-9180-2020; De Weggheleire, Anja/C-7345-2018; Semple, Malcolm Gracie/A-8790-2008; Saez, Almudena M/AAU-9835-2021; Buyze, Jozefien/B-8550-2014; smith, peter/ABH-9627-2020; amsalu, ribka/G-8780-2019; Tiberghien, Pierre/AAH-5878-2019; Lynen, Lutgarde/A-1212-2014	Lynen, Lutgarde/0000-0001-7183-4895; De Weggheleire, Anja/0000-0001-9377-4766; Semple, Malcolm Gracie/0000-0001-9700-0418; Saez, Almudena M/0000-0002-5429-8485; Buyze, Jozefien/0000-0001-6780-380X; smith, peter/0000-0003-0080-7560; Lynen, Lutgarde/0000-0001-7183-4895; Edwards, Tansy/0000-0002-6110-014X; Colebunders, Robert/0000-0002-1919-1340; Horby, Peter/0000-0002-9822-1586; Tiberghien, Pierre/0000-0002-9310-8322; Ingelbeen, Brecht/0000-0002-2214-6858; Baize, Sylvain/0000-0002-3234-7477	European Union; Medical Research Council [MR/K012126/1] Funding Source: researchfish	European Union(European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funded by the European Union's Horizon 2020 Research and Innovation Program and others; ClinicalTrials.gov number, NCT02342171.	Adebamowo C, 2014, LANCET, V384, P1423, DOI 10.1016/S0140-6736(14)61734-7; Agua-Agum J, 2015, NEW ENGL J MED, V372, P1274, DOI 10.1056/NEJMc1415318; [Anonymous], 2015, C RETR OPP INF SEATT; Bah EI, 2015, NEW ENGL J MED, V372, P40, DOI 10.1056/NEJMoa1411249; Casadevall A, 2004, NAT REV MICROBIOL, V2, P695, DOI 10.1038/nrmicro974; Dye JM, 2012, P NATL ACAD SCI USA, V109, P5034, DOI 10.1073/pnas.1200409109; Mair-Jenkins J, 2015, J INFECT DIS, V211, P80, DOI 10.1093/infdis/jiu396; Mora-Rillo M, 2015, LANCET RESP MED, V3, P554, DOI 10.1016/S2213-2600(15)00180-0; Mupapa K, 1999, J INFECT DIS, V179, pS18, DOI 10.1086/514298; Mupapa K, 1999, J INFECT DIS, V179, pS11, DOI 10.1086/514289; Norton EC, 2013, STATA J, V13, P492, DOI 10.1177/1536867X1301300304; Qiu XG, 2014, NATURE, V514, P47, DOI 10.1038/nature13777; Schieffelin JS, 2014, NEW ENGL J MED, V371, P2092, DOI 10.1056/NEJMoa1411680; Sterck A, 2008, MED SANS FRONTIERES; World Health Organization, 2014, INT GUID NAT HLTH AU; World Health Organization, 2015, EB SIT REP WHO	16	348	360	0	53	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 7	2016	374	1					33	42		10.1056/NEJMoa1511812	http://dx.doi.org/10.1056/NEJMoa1511812			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DA1UH	26735992	Bronze, Green Accepted, Green Published			2022-12-28	WOS:000367580500006
J	Zeisler, H; Llurba, E; Chantraine, F; Vatish, M; Staff, AC; Sennstrom, M; Olovsson, M; Brennecke, SP; Stepan, H; Allegranza, D; Dilba, P; Schoedl, M; Hund, M; Verlohren, S				Zeisler, Harald; Llurba, Elisa; Chantraine, Frederic; Vatish, Manu; Staff, Anne Cathrine; Sennstrom, Maria; Olovsson, Matts; Brennecke, Shaun P.; Stepan, Holger; Allegranza, Deirdre; Dilba, Peter; Schoedl, Maria; Hund, Martin; Verlohren, Stefan			Predictive Value of the sFlt-1:PlGF Ratio in Women with Suspected Preeclampsia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GROWTH-FACTOR; ANTIANGIOGENIC FACTORS; ONSET PREECLAMPSIA; ANGIOGENIC FACTORS; TYROSINE KINASE-1; ADVERSE OUTCOMES; PREGNANT-WOMEN; RISK; HYPERTENSION; PREVENTION	BACKGROUND The ratio of soluble fms-like tyrosine kinase 1 (sFlt-1) to placental growth factor (PlGF) is elevated in pregnant women before the clinical onset of preeclampsia, but its predictive value in women with suspected preeclampsia is unclear. METHODS We performed a prospective, multicenter, observational study to derive and validate a ratio of serum sFlt-1 to PlGF that would be predictive of the absence or presence of preeclampsia in the short term in women with singleton pregnancies in whom preeclampsia was suspected (24 weeks 0 days to 36 weeks 6 days of gestation). Primary objectives were to assess whether low sFlt-1:PlGF ratios (at or below a derived cutoff) predict the absence of preeclampsia within 1 week after the first visit and whether high ratios (above the cutoff) predict the presence of preeclampsia within 4 weeks. RESULTS In the development cohort (500 women), we identified an sFlt-1:PlGF ratio cutoff of 38 as having important predictive value. In a subsequent validation study among an additional 550 women, an sFlt-1:PlGF ratio of 38 or lower had a negative predictive value (i.e., no preeclampsia in the subsequent week) of 99.3% (95% confidence interval [CI], 97.9 to 99.9), with 80.0% sensitivity (95% CI, 51.9 to 95.7) and 78.3% specificity (95% CI, 74.6 to 81.7). The positive predictive value of an sFlt-1:PlGF ratio above 38 for a diagnosis of preeclampsia within 4 weeks was 36.7% (95% CI, 28.4 to 45.7), with 66.2% sensitivity (95% CI, 54.0 to 77.0) and 83.1% specificity (95% CI, 79.4 to 86.3). CONCLUSIONS An sFlt-1:PlGF ratio of 38 or lower can be used to predict the short-term absence of preeclampsia in women in whom the syndrome is suspected clinically. (Funded by Roche Diagnostics.)	[Zeisler, Harald] Med Univ Vienna, Dept Obstet & Gynecol, Vienna, Austria; [Llurba, Elisa] Hosp Univ Vall dHebron, Dept Obstet, Maternal Fetal Med Unit, Barcelona, Spain; [Llurba, Elisa] Inst Salud Carlos III, Maternal & Child Hlth & Dev Network, Madrid, Spain; [Chantraine, Frederic] Univ Liege, Dept Obstet & Gynecol, Liege, Belgium; [Vatish, Manu] Univ Oxford, Nuffield Dept Obstet & Gynaecol, Oxford, England; [Staff, Anne Cathrine] Oslo Univ Hosp, Dept Gynecol, Oslo, Norway; [Staff, Anne Cathrine] Oslo Univ Hosp, Dept Obstet, Oslo, Norway; [Staff, Anne Cathrine] Univ Oslo, Oslo, Norway; [Sennstrom, Maria] Karolinska Univ Hosp, Dept Womens & Childrens Hlth, Stockholm, Sweden; [Sennstrom, Maria] Karolinska Inst, Stockholm, Sweden; [Olovsson, Matts] Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden; [Brennecke, Shaun P.] Univ Melbourne, Pregnancy Res Ctr, Dept Perinatal Med, Royal Womens Hosp, Parkville, Vic 3052, Australia; [Brennecke, Shaun P.] Univ Melbourne, Dept Obstet & Gynaecol, Parkville, Vic 3052, Australia; [Stepan, Holger] Univ Leipzig, Dept Obstet, D-04109 Leipzig, Germany; [Dilba, Peter; Schoedl, Maria] Roche Diagnost, Penzberg, Germany; [Verlohren, Stefan] Campus Virchow Klinikum Charite, Dept Obstet, D-13353 Berlin, Germany; [Allegranza, Deirdre; Hund, Martin] Roche Diagnost Int, Rotkreuz, Switzerland	Medical University of Vienna; Hospital Universitari Vall d'Hebron; Instituto de Salud Carlos III; University of Liege; University of Oxford; University of Oslo; University of Oslo; University of Oslo; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Uppsala University; University of Melbourne; University of Melbourne; Leipzig University; Roche Holding; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Roche Holding	Verlohren, S (corresponding author), Campus Virchow Klinikum Charite, Dept Obstet, Augustenburger Pl 1, D-13353 Berlin, Germany.	stefan.verlohren@charite.de	vatish, manu/AAY-8750-2020; Brennecke, Shaun/AFV-3919-2022; Vatish, Manu/B-4458-2018; Hund, Martin/AAY-6541-2021	vatish, manu/0000-0002-6012-2574; Brennecke, Shaun/0000-0003-3070-6971; Verlohren, Stefan/0000-0003-3507-8636; Sennstrom, Maria/0000-0002-6532-022X; Llurba Olive, Elisa/0000-0003-4048-6407	Roche Diagnostics	Roche Diagnostics	Funded by Roche Diagnostics.	ACOG Committee on Obstetric Practice, 2002, Int J Gynaecol Obstet, V77, P67; Alvarez-Fernandez I, 2014, CLIN CHEM LAB MED, V52, P1159, DOI 10.1515/cclm-2013-0901; Ananth CV, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6564; Brown MA, 2001, HYPERTENS PREGNANCY, V20, pIX, DOI 10.1081/PRG-100104165; Chaiworapongsa T, 2014, NAT REV NEPHROL, V10, P466, DOI 10.1038/nrneph.2014.102; Chaiworapongsa T, 2014, J MATERN-FETAL NEO M, V27, P132, DOI 10.3109/14767058.2013.806905; Chappell LC, 2013, CIRCULATION, V128, P2121, DOI 10.1161/CIRCULATIONAHA.113.003215; Duley L, 2009, SEMIN PERINATOL, V33, P130, DOI 10.1053/j.semperi.2009.02.010; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Henderson JT, 2014, ANN INTERN MED, V160, P695, DOI 10.7326/M13-2844; Hernandez-Diaz S, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b2255; Holmes VA, 2013, DIABETES CARE, V36, P3671, DOI 10.2337/dc13-0944; Hund M, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-324; Karumanchi SA, 2007, KIDNEY INT, V71, P959, DOI 10.1038/sj.ki.5002281; KENDALL RL, 1993, P NATL ACAD SCI USA, V90, P10705, DOI 10.1073/pnas.90.22.10705; Lai J, 2014, FETAL DIAGN THER, V35, P240, DOI 10.1159/000359968; Levine RJ, 2006, NEW ENGL J MED, V355, P992, DOI 10.1056/NEJMoa055352; Levine RJ, 2004, NEW ENGL J MED, V350, P672, DOI 10.1056/NEJMoa031884; Lu FX, 2007, AM J OBSTET GYNECOL, V196, DOI 10.1016/j.ajog.2006.12.024; Magann EF, 1999, CLIN OBSTET GYNECOL, V42, P532, DOI 10.1097/00003081-199909000-00009; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; McClure JH, 2011, BRIT J ANAESTH, V107, P127, DOI 10.1093/bja/aer192; Moore AG, 2012, J MATERN-FETAL NEO M, V25, P2651, DOI 10.3109/14767058.2012.713055; Rana S, 2012, CIRCULATION, V125, P911, DOI 10.1161/CIRCULATIONAHA.111.054361; Roberts JM, 2013, OBSTET GYNECOL, V122, P1122, DOI 10.1097/01.AOG.0000437382.03963.88; Simhan HN, 2007, NEW ENGL J MED, V357, P477, DOI 10.1056/NEJMra050435; Skjaerven R, 2002, NEW ENGL J MED, V346, P33, DOI 10.1056/NEJMoa011379; Staff AC, 2013, HYPERTENSION, V61, P932, DOI 10.1161/HYPERTENSIONAHA.111.00250; Stepan H, 2007, THERAPIEHANDBUCH GYN, P45; Vatten LJ, 2007, AM J OBSTET GYNECOL, V196, P239, DOI 10.1016/j.ajog.2006.10.909; Verlohren S, 2010, AM J OBSTET GYNECOL, V202, pe1, DOI DOI 10.1016/j.ajog.2009.09.016; Verlohren S, 2014, HYPERTENSION, V63, P346, DOI 10.1161/HYPERTENSIONAHA.113.01787; Verlohren S, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2011.07.037; Villa PM, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-110; von Dadelszen P, 2003, HYPERTENS PREGNANCY, V22, P143, DOI 10.1081/PRG-120021060; World Health Organization, 2014, WORLD HLTH REP 2005; Xu QS, 2004, J CHEMOMETR, V18, P112, DOI 10.1002/cem.858; Zhang J, 2001, OBSTET GYNECOL, V97, P261, DOI 10.1016/S0029-7844(00)01125-X	38	790	831	6	86	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 7	2016	374	1					13	22		10.1056/NEJMoa1414838	http://dx.doi.org/10.1056/NEJMoa1414838			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DA1UH	26735990	Bronze			2022-12-28	WOS:000367580500004
J	Voorhees, RM; Hegde, RS				Voorhees, Rebecca M.; Hegde, Ramanujan S.			Structure of the Sec61 channel opened by a signal sequence	SCIENCE			English	Article							ENDOPLASMIC-RETICULUM MEMBRANE; PROTEIN-CONDUCTING CHANNEL; TRANSLOCATION CHANNEL; ER MEMBRANE; ESCHERICHIA-COLI; RECOGNITION; COMPLEX; MUTATIONS; ENVIRONMENT; INSERTION	Secreted and integral membrane proteins compose up to one-third of the biological proteome. These proteins contain hydrophobic signals that direct their translocation across or insertion into the lipid bilayer by the Sec61 protein-conducting channel. The molecular basis of how hydrophobic signals within a nascent polypeptide trigger channel opening is not understood. Here, we used cryo-electron microscopy to determine the structure of an active Sec61 channel that has been opened by a signal sequence. The signal supplants helix 2 of Sec61 alpha, which triggers a rotation that opens the central pore both axially across the membrane and laterally toward the lipid bilayer. Comparisons with structures of Sec61 in other states suggest a pathway for how hydrophobic signals engage the channel to gain access to the lipid bilayer.	[Voorhees, Rebecca M.; Hegde, Ramanujan S.] MRC, MRC Lab Mol Biol, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology	Hegde, RS (corresponding author), MRC, MRC Lab Mol Biol, Francis Crick Ave, Cambridge CB2 0QH, England.	rhegde@mrc-lmb.cam.ac.uk		Hegde, Ramanujan/0000-0001-8338-852X; VOORHEES, REBECCA/0000-0003-1640-2293	UK Medical Research Council [MC_UP_A022_1007]; Wellcome Trust; Medical Research Council [MC_UP_A022_1007] Funding Source: researchfish; MRC [MC_UP_A022_1007] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank F. de Haas, V. Ragunath, and C. Savva for help with data collection; S. Chen, G. McMullan, J. Grimmett, and T. Darling for technical support; S. Shao for helpful discussions. This work was supported by the UK Medical Research Council (MC_UP_A022_1007 to RSH) and a Wellcome Trust postdoctoral fellowship (R.M.V.). The Cryo-EM map for the engaged ribosome-Sec61 complex has been deposited with the EMDataBank (EMDB-3245). The Protein Data Bank accession number for the engaged Sec61 complex is 3JC2.	CROWLEY KS, 1993, CELL, V73, P1101, DOI 10.1016/0092-8674(93)90640-C; CROWLEY KS, 1994, CELL, V78, P461, DOI 10.1016/0092-8674(94)90424-3; DERMAN AI, 1993, EMBO J, V12, P879, DOI 10.1002/j.1460-2075.1993.tb05728.x; Egea PF, 2010, P NATL ACAD SCI USA, V107, P17182, DOI 10.1073/pnas.1012556107; Gogala M, 2014, NATURE, V506, P107, DOI 10.1038/nature12950; HIGH S, 1993, J BIOL CHEM, V268, P26745; JUNGNICKEL B, 1995, CELL, V82, P261, DOI 10.1016/0092-8674(95)90313-5; Junne T, 2007, J BIOL CHEM, V282, P33201, DOI 10.1074/jbc.M707219200; Junne T, 2015, J CELL SCI, V128, P1217, DOI 10.1242/jcs.165746; MacKinnon AL, 2014, ELIFE, V3, DOI 10.7554/eLife.01483; Maillard AP, 2007, J BIOL CHEM, V282, P1281, DOI 10.1074/jbc.M610060200; MARTOGLIO B, 1995, CELL, V81, P207, DOI 10.1016/0092-8674(95)90330-5; MOTHES W, 1994, EMBO J, V13, P3973, DOI 10.1002/j.1460-2075.1994.tb06713.x; Mothes W, 1998, J CELL BIOL, V142, P355, DOI 10.1083/jcb.142.2.355; OSBORNE RS, 1993, EMBO J, V12, P3391, DOI 10.1002/j.1460-2075.1993.tb06013.x; Park E, 2014, NATURE, V506, P102, DOI 10.1038/nature12720; Park E, 2012, ANNU REV BIOPHYS, V41, P21, DOI [10.1146/annurev-biophys-050511-102312, 10.1146/annurev-biophys-050511-402312]; Pfeffer S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9403; Plath K, 1998, CELL, V94, P795, DOI 10.1016/S0092-8674(00)81738-9; Smith MA, 2005, J BACTERIOL, V187, P6454, DOI 10.1128/JB.187.18.6454-6465.2005; Trueman SF, 2012, J CELL BIOL, V199, P907, DOI 10.1083/jcb.201207163; Tsukazaki T, 2008, NATURE, V455, P988, DOI 10.1038/nature07421; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; Voorhees RM, 2015, ELIFE, V4, DOI 10.7554/eLife.07975; Voorhees RM, 2014, CELL, V157, P1632, DOI 10.1016/j.cell.2014.05.024; Zimmer J, 2008, NATURE, V455, P936, DOI 10.1038/nature07335	26	131	131	0	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 1	2016	351	6268					88	91		10.1126/science.aad4992	http://dx.doi.org/10.1126/science.aad4992			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ8QM	26721998	Green Accepted			2022-12-28	WOS:000367364200049
J	Zhang, L; Lovinger, GJ; Edelstein, EK; Szymaniak, AA; Chierchia, MP; Morken, JP				Zhang, Liang; Lovinger, Gabriel J.; Edelstein, Emma K.; Szymaniak, Adam A.; Chierchia, Matteo P.; Morken, James P.			Catalytic conjunctive cross-coupling enabled by metal-induced metallate rearrangement	SCIENCE			English	Article							BORON-ATE COMPLEXES; ALKYL-GROUPS; ESTERS; STEREOCHEMISTRY; COMBRETASTATIN; BORANES; ALKENES; HALIDES; AGENTS; ACIDS	Transition metal catalysis plays a central role in contemporary organic synthesis. Considering the tremendously broad array of transition metal-catalyzed transformations, it is remarkable that the underlying elementary reaction steps are relatively few in number. Here, we describe an alternative to the organometallic transmetallation step that is common in many metal-catalyzed reactions, such as Suzuki-Miyaura coupling. Specifically, we demonstrate that vinyl boronic ester ate complexes, prepared by combining organoboronates and organolithium reagents, engage in palladium-induced metallate rearrangement wherein 1,2-migration of an alkyl or aryl group from boron to the vinyl alpha-carbon occurs concomitantly with C-Pd sigma-bond formation. This elementary reaction enables a powerful cross-coupling reaction in which a chiral Pd catalyst merges three simple starting materials-an organolithium, an organoboronic ester, and an organotriflate-into chiral organoboronic esters with high enantioselectivity.	[Zhang, Liang; Lovinger, Gabriel J.; Edelstein, Emma K.; Szymaniak, Adam A.; Chierchia, Matteo P.; Morken, James P.] Boston Coll, Dept Chem, Chestnut Hill, MA 02467 USA	Boston College	Morken, JP (corresponding author), Boston Coll, Dept Chem, Chestnut Hill, MA 02467 USA.	morken@bc.edu			NIH, National Institute of General Medical Sciences [GM 64451]; Boston College; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064451] Funding Source: NIH RePORTER	NIH, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Boston College; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Experimental data are available in the associated Supplementary Materials. This research was supported in part by the NIH, National Institute of General Medical Sciences (GM 64451), and by Boston College. Metrical parameters for the crystal structure of compound 1 are available free of charge from the Cambridge Crystallographic Data Centre under accession number CCDC 1437520.	Aggarwal VK, 2006, PURE APPL CHEM, V78, P215, DOI 10.1351/pac200678020215; Berionni G, 2015, ANGEW CHEM INT EDIT, V54, P2780, DOI 10.1002/anie.201410562; Bottoni A, 2003, J ORG CHEM, V68, P3397, DOI 10.1021/jo026733e; Bruyere D, 2004, TETRAHEDRON, V60, P4007, DOI 10.1016/j.tet.2004.03.023; DRAPER PM, 1970, TETRAHEDRON LETT, P1687; Feeney K, 2015, ORG LETT, V17, P2614, DOI 10.1021/acs.orglett.5b00918; Hall DG, 2011, BORONIC ACIDS, VOL 2: PREPARATION AND APPLICATIONS IN ORGANIC SYNTHESIS, MEDICINE AND MATERIALS, 2ND EDITION, P1, DOI 10.1002/9783527639328; Hughes RP, 2000, J AM CHEM SOC, V122, P2261, DOI 10.1021/ja992407d; Idacavage, 1985, ORG REACT, V33, P1; Ishida N, 2009, ORG LETT, V11, P5434, DOI 10.1021/ol902278q; Jadhav PK, 1997, J AM CHEM SOC, V119, P846, DOI 10.1021/ja9635185; Jia T, 2015, J AM CHEM SOC, V137, P13760, DOI 10.1021/jacs.5b09146; Leonori D, 2015, TOP ORGANOMETAL CHEM, V49, P271, DOI 10.1007/978-3-319-13054-5_9; McDonald RI, 2011, CHEM REV, V111, P2981, DOI 10.1021/cr100371y; MIDLAND MM, 1979, J AM CHEM SOC, V101, P248, DOI 10.1021/ja00495a056; MIYAURA N, 1995, CHEM REV, V95, P2457, DOI 10.1021/cr00039a007; MIYAURA N, 1979, TETRAHEDRON LETT, V20, P3437, DOI 10.1016/S0040-4039(01)95429-2; Nakhla JS, 2006, J AM CHEM SOC, V128, P2893, DOI 10.1021/ja057489m; Perea JJA, 1999, TETRAHEDRON-ASYMMETR, V10, P375; PETTIT GR, 1982, CAN J CHEM, V60, P1374, DOI 10.1139/v82-202; SEYFERTH D, 1961, J AM CHEM SOC, V83, P3583, DOI 10.1021/ja01478a010; Singh R, 2009, SYNTHESIS-STUTTGART, P2471, DOI 10.1055/s-0029-1216891; Su W, 2015, ANGEW CHEM INT EDIT, V54, P12957, DOI 10.1002/anie.201506713; SUZUKI A, 1983, TOP CURR CHEM, V112, P67; SUZUKI A, 1973, J AM CHEM SOC, V95, P3080, DOI 10.1021/ja00790a092; Thomas SP, 2009, CHEM REC, V9, P24, DOI 10.1002/tcr.20168; TOGNI A, 1994, J AM CHEM SOC, V116, P4062, DOI 10.1021/ja00088a047; Zweifel, 1967, J AM CHEM SOC, V89, DOI DOI 10.1021/JA00990A061	28	174	174	9	186	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 1	2016	351	6268					70	74		10.1126/science.aad6080	http://dx.doi.org/10.1126/science.aad6080			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ8QM	26721996	Green Accepted			2022-12-28	WOS:000367364200044
J	Gottlieb, RA; Bernstein, D				Gottlieb, Roberta A.; Bernstein, Daniel			Mitochondria shape cardiac metabolism	SCIENCE			English	Editorial Material							INFLAMMATION; HEART; DNA		[Gottlieb, Roberta A.] Cedars Sinai Med Ctr, Inst Heart, Los Angeles, CA 90048 USA; [Bernstein, Daniel] Stanford Univ, Dept Pediat, Palo Alto, CA 94304 USA	Cedars Sinai Medical Center; Stanford University	Gottlieb, RA (corresponding author), Cedars Sinai Med Ctr, Inst Heart, Los Angeles, CA 90048 USA.	roberta.gottlieb@cshs.org		Bernstein, Daniel/0000-0001-7761-5853	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL132075, P01HL112730] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Andres AM, 2014, ANTIOXID REDOX SIGN, V21, P1960, DOI 10.1089/ars.2013.5416; Chen Y, 2011, CIRC RES, V109, P1327, DOI 10.1161/CIRCRESAHA.111.258723; Gong GH, 2015, SCIENCE, V350, DOI 10.1126/science.aad2459; Hernandez G, 2013, AUTOPHAGY, V9, P1852, DOI 10.4161/auto.26501; Huang CQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020975; Huang CQ, 2010, J CARDIOVASC TRANSL, V3, P365, DOI 10.1007/s12265-010-9189-3; Kamisoglu K, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0783-2; Nadtochiy SM, 2015, J MOL CELL CARDIOL, V88, P64, DOI 10.1016/j.yjmcc.2015.09.008; Oka T, 2012, NATURE, V485, P251, DOI 10.1038/nature10992; Piquereau J, 2013, AUTOPHAGY, V9, P1837, DOI 10.4161/auto.26502; Shimada K, 2012, IMMUNITY, V36, P401, DOI 10.1016/j.immuni.2012.01.009; Sin J, 2016, AUTOPHAGY, V12, P369, DOI 10.1080/15548627.2015.1115172; Wai T, 2015, SCIENCE, V350, DOI 10.1126/science.aad0116	13	23	23	3	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 4	2015	350	6265					1162	1163		10.1126/science.aad8222	http://dx.doi.org/10.1126/science.aad8222			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX4WG	26785456				2022-12-28	WOS:000365700500041
J	Barberon, M; Vermeer, JEM; De Bellis, D; Wang, P; Naseer, S; Andersen, TG; Humbel, BM; Nawrath, C; Takano, J; Salt, DE; Geldner, N				Barberon, Marie; Vermeer, Joop Engelbertus Martinus; De Bellis, Damien; Wang, Peng; Naseer, Sadaf; Andersen, Tonni Grube; Humbel, Bruno Martin; Nawrath, Christiane; Takano, Junpei; Salt, David Edward; Geldner, Niko			Adaptation of Root Function by Nutrient-Induced Plasticity of Endodermal Differentiation	CELL			English	Article							DEFICIENCY STRESS RESPONSES; CASPARIAN STRIP; ABSCISIC-ACID; DEVELOPMENTAL FRAMEWORK; IRON ACQUISITION; FERRIC REDUCTASE; ARABIDOPSIS; SUBERIN; ETHYLENE; SUBERIZATION	Plant roots forage the soil for minerals whose concentrations can be orders of magnitude away from those required for plant cell function. Selective uptake in multicellular organisms critically requires epithelia with extracellular diffusion barriers. In plants, such a barrier is provided by the endodermis and its Casparian strips-cell wall impregnations analogous to animal tight and adherens junctions. Interestingly, the endodermis undergoes secondary differentiation, becoming coated with hydrophobic suberin, presumably switching from an actively absorbing to a protective epithelium. Here, we show that suberization responds to a wide range of nutrient stresses, mediated by the stress hormones abscisic acid and ethylene. We reveal a striking ability of the root to not only regulate synthesis of suberin, but also selectively degrade it in response to ethylene. Finally, we demonstrate that changes in suberization constitute physiologically relevant, adaptive responses, pointing to a pivotal role of the endodermal membrane in nutrient homeostasis.	[Barberon, Marie; Vermeer, Joop Engelbertus Martinus; De Bellis, Damien; Naseer, Sadaf; Andersen, Tonni Grube; Nawrath, Christiane; Geldner, Niko] Univ Lausanne, Dept Plant Mol Biol, CH-1015 Lausanne, Switzerland; [De Bellis, Damien; Humbel, Bruno Martin] Univ Lausanne, Electron Microscopy Facil, CH-1015 Lausanne, Switzerland; [Wang, Peng; Salt, David Edward] Univ Aberdeen, Inst Biol & Environm Sci, Aberdeen AB24 3UU, Scotland; [Takano, Junpei] Hokkaido Univ, Res Fac Agr, Sapporo, Hokkaido 0608589, Japan; [Vermeer, Joop Engelbertus Martinus] Univ Zurich, Inst Plant Biol, Zollikerstr 107, CH-8008 Zurich, Switzerland	University of Lausanne; University of Lausanne; University of Aberdeen; Hokkaido University; University of Zurich	Barberon, M; Geldner, N (corresponding author), Univ Lausanne, Dept Plant Mol Biol, CH-1015 Lausanne, Switzerland.	marie.barberon@unil.ch; niko.geldner@unil.ch	Vermeer, Joop E.M./J-2232-2014; Geldner, Niko/Y-2481-2019; Barberon, Marie/M-3490-2016	Vermeer, Joop E.M./0000-0001-8876-5873; Barberon, Marie/0000-0002-8169-8580; WANG, PENG/0000-0001-5927-6739; Geldner, Niko/0000-0002-2300-9644; De Bellis, Damien/0000-0001-9480-7208	Swiss National Science Foundation (SNSF); European Research Council (ERC); Human Frontiers Science Program (HFSP); UK Biotechnology and Biological Sciences Research Council [BB/L027739/1]; EMBO long-term postdoctoral fellowship; Marie-Curie intra-European fellowships; BBSRC [BB/L027739/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/L027739/1] Funding Source: researchfish	Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); European Research Council (ERC)(European Research Council (ERC)); Human Frontiers Science Program (HFSP)(Human Frontier Science Program); UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EMBO long-term postdoctoral fellowship(European Molecular Biology Organization (EMBO)); Marie-Curie intra-European fellowships; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank the Central Imaging Facility for expert technical support; John Danku, Kayo Konishi, and Tomoko Shimizu for ICP-MS analysis; and Lothar Kalmbach and Sarra Ammar for technical assistance. Jean Daraspe of the Electron Microscopy Facility of the University of Lausanne is thanked for technical expertise and advice. Lothar Kalmbach and Satoshi Fujita are thanked for critical reading of the manuscript. We thank Rochus Franke for helpful discussions and Luis Lopez-Molina, Gregory Vert, Francoise Gosti, Catherine Curie, Malcolm Bennett, and Isabelle Cherel for sharing published materials. This work was funded by grants from the Swiss National Science Foundation (SNSF) and the European Research Council (ERC) to N.G., a Human Frontiers Science Program (HFSP) grant to J.T. and N.G., and the UK Biotechnology and Biological Sciences Research Council Grant (BB/L027739/1) to D.E.S. M.B. was supported by a EMBO long-term postdoctoral fellowship and J.E.M.V. and T.G.A. by Marie-Curie intra-European fellowships.	Alassimone J, 2010, P NATL ACAD SCI USA, V107, P5214, DOI 10.1073/pnas.0910772107; Andersen TG, 2015, CURR OPIN PLANT BIOL, V28, P9, DOI 10.1016/j.pbi.2015.08.004; Barberon M, 2008, NEW PHYTOL, V180, P608, DOI 10.1111/j.1469-8137.2008.02604.x; Barberon M, 2014, PLANT PHYSIOL, V166, P528, DOI 10.1104/pp.114.246124; Baxter I, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000492; Beisson F, 2007, PLANT CELL, V19, P351, DOI 10.1105/tpc.106.048033; Boher P, 2013, J EXP BOT, V64, P3225, DOI 10.1093/jxb/ert163; Botha CEJ, 2008, J EXP BOT, V59, P2945, DOI 10.1093/jxb/ern150; Cailliatte R, 2010, PLANT CELL, V22, P904, DOI 10.1105/tpc.109.073023; CLARKSON DT, 1993, PHILOS T R SOC B, V341, P5, DOI 10.1098/rstb.1993.0086; COTTLE W, 1982, PLANT PHYSIOL, V70, P775, DOI 10.1104/pp.70.3.775; Duan LN, 2013, PLANT CELL, V25, P324, DOI 10.1105/tpc.112.107227; Garcia MJ, 2010, J EXP BOT, V61, P3885, DOI 10.1093/jxb/erq203; Gaymard F, 1998, CELL, V94, P647, DOI 10.1016/S0092-8674(00)81606-2; Geldner N, 2013, ANNU REV PLANT BIOL, V64, P531, DOI 10.1146/annurev-arplant-050312-120050; HAAS DL, 1975, AM J BOT, V62, P336, DOI 10.2307/2442087; Henriques R, 2002, PLANT MOL BIOL, V50, P587, DOI 10.1023/A:1019942200164; Hofer R, 2008, J EXP BOT, V59, P2347, DOI 10.1093/jxb/ern101; Hosmani PS, 2013, P NATL ACAD SCI USA, V110, P14498, DOI 10.1073/pnas.1308412110; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; Kamiya T, 2015, P NATL ACAD SCI USA, V112, P10533, DOI 10.1073/pnas.1507691112; Kosma DK, 2014, PLANT J, V80, P216, DOI 10.1111/tpj.12624; Kostera MI, 2004, J DERMATOL SCI, V34, P3, DOI 10.1016/j.jdermsci.2003.10.003; Krishnamurthy P, 2011, J EXP BOT, V62, P4215, DOI 10.1093/jxb/err135; Krishnamurthy P, 2009, PLANTA, V230, P119, DOI 10.1007/s00425-009-0930-6; Kroemer K., 1903, BIBLIOTHECA BOT, V59, P1; Leung J, 1997, PLANT CELL, V9, P759, DOI 10.1105/tpc.9.5.759; Li XX, 2004, PLANT SOIL, V261, P147, DOI 10.1023/B:PLSO.0000035536.79001.60; Lingam S, 2011, PLANT CELL, V23, P1815, DOI 10.1105/tpc.111.084715; Lucena C, 2006, J EXP BOT, V57, P4145, DOI 10.1093/jxb/erl189; Lux A, 2005, ANN BOT-LONDON, V96, P989, DOI 10.1093/aob/mci266; Marschner H., 1995, MINERAL NUTR HIGHER, V2nd ed.; Melnyk CW, 2015, CURR BIOL, V25, P1306, DOI 10.1016/j.cub.2015.03.032; Meyer CJ, 2013, PLANT ROOTS: THE HIDDEN HALF, 4TH EDITION; Naseer S, 2012, P NATL ACAD SCI USA, V109, P10101, DOI 10.1073/pnas.1205726109; OPARKA KJ, 1994, PLANT J, V6, P759, DOI 10.1046/j.1365-313X.1994.6050759.x; Pfister A, 2014, ELIFE, V3, DOI 10.7554/eLife.03115; Ranathunge K, 2011, PLANT SCI, V180, P399, DOI 10.1016/j.plantsci.2010.11.003; ROBARDS AW, 1973, PROTOPLASMA, V77, P291, DOI 10.1007/BF01276765; ROBARDS AW, 1974, PLANTA, V120, P1, DOI 10.1007/BF00388267; Robbins NE, 2014, PLANT PHYSIOL, V166, P551, DOI 10.1104/pp.114.244871; Romera FJ, 1999, ANN BOT-LONDON, V83, P51, DOI 10.1006/anbo.1998.0793; ROMERA FJ, 1994, PLANT PHYSIOL, V105, P1133, DOI 10.1104/pp.105.4.1133; Roppolo D, 2011, NATURE, V473, P380, DOI 10.1038/nature10070; Schmidt W, 2000, PLANT PHYSIOL, V122, P1109, DOI 10.1104/pp.122.4.1109; Schreiber L, 2010, TRENDS PLANT SCI, V15, P546, DOI 10.1016/j.tplants.2010.06.004; Senoo M, 2007, CELL, V129, P523, DOI 10.1016/j.cell.2007.02.045; Shiono K, 2014, PLANT J, V80, P40, DOI 10.1111/tpj.12614; SOLIDAY CL, 1978, PLANT PHYSIOL, V61, P170, DOI 10.1104/pp.61.2.170; White PJ, 2001, J EXP BOT, V52, P891, DOI 10.1093/jexbot/52.358.891; Wyrsch I, 2015, NEW PHYTOL, V206, P774, DOI 10.1111/nph.13280; Yadav V, 2014, PLANT CELL, V26, P3569, DOI 10.1105/tpc.114.129049; Yeats TH, 2014, PLANT J, V77, P667, DOI 10.1111/tpj.12422	53	285	291	6	177	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 28	2016	164	3					447	459		10.1016/j.cell.2015.12.021	http://dx.doi.org/10.1016/j.cell.2015.12.021			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DC0KU	26777403	Bronze			2022-12-28	WOS:000368906800015
J	Martinez-Zapien, D; Ruiz, FX; Poirson, J; Mitschler, A; Ramirez, J; Forster, A; Cousido-Siah, A; Masson, M; Vande Pol, S; Podjarny, A; Trave, G; Zanier, K				Martinez-Zapien, Denise; Ruiz, Francesc Xavier; Poirson, Juline; Mitschler, Andre; Ramirez, Juan; Forster, Anne; Cousido-Siah, Alexandra; Masson, Murielle; Vande Pol, Scott; Podjarny, Alberto; Trave, Gilles; Zanier, Katia			Structure of the E6/E6AP/p53 complex required for HPV-mediated degradation of p53	NATURE			English	Article							HUMAN-PAPILLOMAVIRUS TYPE-16; E6 ONCOPROTEIN; E6-MEDIATED DEGRADATION; VIRAL ONCOPROTEIN; PROTEIN; IMMORTALIZATION; UBIQUITINATION; LOCALIZATION; ASSOCIATION; DETERMINES	The p53 pro-apoptotic tumour suppressor is mutated or functionally altered in most cancers. In epithelial tumours induced by 'high-risk' mucosal human papilloma viruses, including human cervical carcinoma and a growing number of head-and-neck cancers(1), p53 is degraded by the viral oncoprotein E6 (ref. 2). In this process, E6 binds to a short leucine (L)-rich LxxLL consensus sequence within the cellular ubiquitin ligase E6AP(3). Subsequently, the E6/E6AP heterodimer recruits and degrades p53 (ref. 4). Neither E6 nor E6AP are separately able to recruit p53 (refs 3, 5), and the precise mode of assembly of E6, E6AP and p53 is unknown. Here we solve the crystal structure of a ternary complex comprising full-length human papilloma virus type 16 (HPV-16) E6, the LxxLL motif of E6AP and the core domain of p53. The LxxLL motif of E6AP renders the conformation of E6 competent for interaction with p53 by structuring a p53-binding cleft on E6. Mutagenesis of critical positions at the E6-p53 interface disrupts p53 degradation. The E6-binding site of p53 is distal from previously described DNA-and protein-binding surfaces of the core domain. This suggests that, in principle, E6 may avoid competition with cellular factors by targeting both free and bound p53 molecules. The E6/E6AP/p53 complex represents a prototype of viral hijacking of both the ubiquitin-mediated protein degradation pathway and the p53 tumour suppressor pathway. The present structure provides a framework for the design of inhibitory therapeutic strategies against oncogenesis mediated by human papilloma virus.	[Martinez-Zapien, Denise; Poirson, Juline; Ramirez, Juan; Forster, Anne; Masson, Murielle; Trave, Gilles; Zanier, Katia] Ecole Super Biotechnol Strasbourg, Equipe Labellisee Ligue, Biotechnol & Signalisat Cellulaire UMR 7242, Blvd Sebastien Brant,BP 10413, F-67412 Illkirch Graffenstaden, France; [Ruiz, Francesc Xavier; Mitschler, Andre; Cousido-Siah, Alexandra; Podjarny, Alberto] Univ Strasbourg, CNRS UMR 7104, INSERM U964, IGBMC, 1 Rue Laurent Fries,BP 10142, F-67404 Illkirch Graffenstaden, France; [Vande Pol, Scott] Univ Virginia, Dept Pathol, POB 800904, Charlottesville, VA 22908 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Virginia	Trave, G; Zanier, K (corresponding author), Ecole Super Biotechnol Strasbourg, Equipe Labellisee Ligue, Biotechnol & Signalisat Cellulaire UMR 7242, Blvd Sebastien Brant,BP 10413, F-67412 Illkirch Graffenstaden, France.	gilles.trave@unistra.fr; zanier@unistra.fr	高, 雨莉/HGU-8187-2022; TRAVE, Gilles/P-8577-2016; Pol, Scott Vande/AAO-1068-2020; Ruiz, Francesc Xavier/AAA-1324-2020	Pol, Scott Vande/0000-0002-0587-4802; Ruiz, Francesc Xavier/0000-0002-0457-0030; Cousido-Siah, Alexandra/0000-0002-3051-1560; Podjarny, Alberto/0000-0002-7685-1077	Ligue contre le Cancer, National Institutes of Health [R01CA134737]; l'Agence Nationale de la Recherche [ANR-13-JSV8-004-01]; Instruct (ESFRI); French Infrastructure for Integrated Structural Biology (FRISBI); Fondation pour La Recherche Medicale; NATIONAL CANCER INSTITUTE [R01CA134737] Funding Source: NIH RePORTER	Ligue contre le Cancer, National Institutes of Health; l'Agence Nationale de la Recherche(French National Research Agency (ANR)); Instruct (ESFRI); French Infrastructure for Integrated Structural Biology (FRISBI); Fondation pour La Recherche Medicale(Fondation pour la Recherche Medicale); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work received institutional support from le Centre National de la Recherche Scientifique (CNRS), Universite de Strasbourg, l'Institut National de la Sante et de la Recherche Medicale (INSERM) and Region Alsace. The work was supported by grants from Ligue contre le Cancer, National Institutes of Health (grant R01CA134737 to S.V.P.), l'Agence Nationale de la Recherche (ANR-13-JSV8-004-01), Instruct (ESFRI), the French Infrastructure for Integrated Structural Biology (FRISBI) and Fondation pour La Recherche Medicale (fellowship to F.X.R.F.). We thank P. Poussin-Courmontagne, E. Ennifar, V. Olieric and B. Kieffer for advice. The authors declare that the content is solely their responsibility and does not represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ansari T, 2012, J VIROL, V86, P11386, DOI 10.1128/JVI.01236-12; Bernard X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025981; Cassonnet P, 2011, NAT METHODS, V8, P990, DOI 10.1038/nmeth.1773; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cherry JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084506; Cooper B, 2003, VIROLOGY, V306, P87, DOI 10.1016/S0042-6822(02)00012-0; Davey NE, 2011, TRENDS BIOCHEM SCI, V36, P159, DOI 10.1016/j.tibs.2010.10.002; DeLano W.L, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FOSTER SA, 1994, J VIROL, V68, P5698, DOI 10.1128/JVI.68.9.5698-5705.1994; Fu LP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012816; Gu JJ, 2001, ONCOGENE, V20, P3519, DOI 10.1038/sj.onc.1204454; Hengstermann A, 2001, P NATL ACAD SCI USA, V98, P1218, DOI 10.1073/pnas.031470698; Hiller T, 2006, CANCER EPIDEM BIOMAR, V15, P1262, DOI 10.1158/1055-9965.EPI-05-0778; HUIBREGTSE JM, 1993, MOL CELL BIOL, V13, P4918, DOI 10.1128/MCB.13.8.4918; Li XQ, 1996, J VIROL, V70, P4509, DOI 10.1128/JVI.70.7.4509-4516.1996; Lilyestrom W, 2006, GENE DEV, V20, P2373, DOI 10.1101/gad.1456306; Liu Y, 1999, J VIROL, V73, P7297, DOI 10.1128/JVI.73.9.7297-7307.1999; Malecka KA, 2014, ACS CHEM BIOL, V9, P1603, DOI 10.1021/cb500229d; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mesplede T, 2012, J VIROL, V86, P94, DOI 10.1128/JVI.00751-11; Moon AF, 2010, PROTEIN SCI, V19, P901, DOI 10.1002/pro.368; NAKAGAWA S, 1995, VIROLOGY, V212, P535, DOI 10.1006/viro.1995.1511; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ristriani T, 2009, ONCOGENE, V28, P762, DOI 10.1038/onc.2008.422; Ronchi VP, 2014, J BIOL CHEM, V289, P1033, DOI 10.1074/jbc.M113.517805; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; SCHEFFNER M, 1995, NATURE, V373, P81, DOI 10.1038/373081a0; SCHEFFNER M, 1992, J VIROL, V66, P5100, DOI 10.1128/JVI.66.8.5100-5105.1992; Stutz C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132339; Vande Pol SB, 2013, VIROLOGY, V445, P115, DOI 10.1016/j.virol.2013.04.026; Wang Y, 2007, ACTA CRYSTALLOGR D, V63, P276, DOI 10.1107/S0907444906048499; Bosch FX, 2013, VACCINE, V31, pH1, DOI [10.1016/j.vaccine.2013.10.003, 10.1016/j.vaccine.2013.07.026]; Zanier K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112514; Zanier K, 2013, SCIENCE, V339, P694, DOI 10.1126/science.1229934; Zanier K, 2012, STRUCTURE, V20, P604, DOI 10.1016/j.str.2012.02.001	37	228	242	7	96	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 28	2016	529	7587					541	+		10.1038/nature16481	http://dx.doi.org/10.1038/nature16481			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB7DD	26789255	Green Submitted, Green Accepted			2022-12-28	WOS:000368673800040
J	Roh, EK; Ali, M; Lu, MT; Bradshaw, SH				Roh, Ellen K.; Ali, Mohammed; Lu, Michael T.; Bradshaw, Scott H.			Case 2-2016: An 84-Year-Old Woman with Chest Pain, Dyspnea, and a Rash	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MULTIPLE-MYELOMA; CARDIAC AMYLOIDOSIS; CONGO RED; BLEEDING DISORDERS; CARDIOMYOPATHY; CD19		[Roh, Ellen K.] Massachusetts Gen Hosp, Dept Dermatol, Boston, MA 02114 USA; [Ali, Mohammed] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Lu, Michael T.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Bradshaw, Scott H.] Massachusetts Gen Hosp, Pathol, Boston, MA 02114 USA; [Roh, Ellen K.] Harvard Univ, Sch Med, Dept Dermatol, Boston, MA 02115 USA; [Ali, Mohammed] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Lu, Michael T.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Bradshaw, Scott H.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Roh, EK (corresponding author), Massachusetts Gen Hosp, Dept Dermatol, Boston, MA 02114 USA.			Lu, Michael/0000-0003-4696-9610				Bely M, 2006, ACTA HISTOCHEM, V108, P175, DOI 10.1016/j.acthis.2006.03.017; Bhat R, 2014, EMERG MED CLIN N AM, V32, P673, DOI 10.1016/j.emc.2014.04.009; Bradshaw SH, 2012, CURR OPIN CARDIOL, V27, P143, DOI 10.1097/HCO.0b013e32834fdc7e; BREATHNACH SM, 1988, J AM ACAD DERMATOL, V18, P1, DOI 10.1016/S0190-9622(88)70001-8; Cannizzo E, 2012, AM J CLIN PATHOL, V137, P377, DOI 10.1309/AJCP63TOCFNAMDMS; CARROLL JD, 1982, AM J CARDIOL, V49, P9, DOI 10.1016/0002-9149(82)90270-3; Chen KR, 2008, AM J CLIN DERMATOL, V9, P71, DOI 10.2165/00128071-200809020-00001; CHILD JS, 1976, CHEST, V70, P726, DOI 10.1378/chest.70.6.726; Ely SA, 2002, AM J PATHOL, V160, P1293, DOI 10.1016/S0002-9440(10)62556-4; Howie AJ, 2008, LAB INVEST, V88, P232, DOI 10.1038/labinvest.3700714; Hurwitz A, 2014, EMERG MED CLIN N AM, V32, P691, DOI 10.1016/j.emc.2014.04.010; Kara IO, 2004, SAUDI MED J, V25, P1587; KLEIN AL, 1992, CLEV CLIN J MED, V59, P278, DOI 10.3949/ccjm.59.3.278; KLEIN AL, 1990, J AM COLL CARDIOL, V16, P1135, DOI 10.1016/0735-1097(90)90545-Z; PUCHTLER H, 1965, J HISTOCHEM CYTOCHEM, V13, P693, DOI 10.1177/13.8.693; Rocken C, 2009, Pathologe, V30 Suppl 2, P121, DOI 10.1007/s00292-009-1183-7; Shaughnessy J, 2000, BLOOD, V96, P1505, DOI 10.1182/blood.V96.4.1505.h8001505_1505_1511; Talwar A, 2012, BMJ CASE REP, V2012; Warrington Kenneth J, 2013, Minn Med, V96, P36	19	0	0	1	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 21	2016	374	3					264	274		10.1056/NEJMcpc1502149	http://dx.doi.org/10.1056/NEJMcpc1502149			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DB3IS	26789875				2022-12-28	WOS:000368404800012
J	Stello, D; Cantiello, M; Fuller, J; Huber, D; Garcia, RA; Bedding, TR; Bildsten, L; Aguirre, VS				Stello, Dennis; Cantiello, Matteo; Fuller, Jim; Huber, Daniel; Garcia, Rafael A.; Bedding, Timothy R.; Bildsten, Lars; Aguirre, Victor Silva			A prevalence of dynamo-generated magnetic fields in the cores of intermediate-mass stars	NATURE			English	Article							RED GIANT STARS; K-GIANTS; KEPLER; MODES; ASTEROSEISMOLOGY; BRANCH	Magnetic fields play a part in almost all stages of stellar evolution(1). Most low-mass stars, including the Sun, show surface fields that are generated by dynamo processes in their convective envelopes(2,3). Intermediate-mass stars do not have deep convective envelopes(4), although 10 per cent exhibit strong surface fields that are presumed to be residuals from the star formation process(5). These stars do have convective cores that might produce internal magnetic fields(6), and these fields might survive into later stages of stellar evolution, but information has been limited by our inability to measure the fields below the stellar surface(7). Here we report the strength of dipolar oscillation modes for a sample of 3,600 red giant stars. About 20 per cent of our sample show mode suppression, by strong magnetic fields in the cores(8), but this fraction is a strong function of mass. Strong core fields occur only in red giants heavier than 1.1 solar masses, and the occurrence rate is at least 50 per cent for intermediate-mass stars (1.6-2.0 solar masses), indicating that powerful dynamos were very common in the previously convective cores of these stars.	[Stello, Dennis; Huber, Daniel; Bedding, Timothy R.] Univ Sydney, Sch Phys, Sydney Inst Astron SIfA, Sydney, NSW 2006, Australia; [Stello, Dennis; Huber, Daniel; Bedding, Timothy R.; Aguirre, Victor Silva] Aarhus Univ, Dept Phys & Astron, Stellar Astrophys Ctr, DK-8000 Aarhus C, Denmark; [Cantiello, Matteo; Fuller, Jim; Bildsten, Lars] Univ Calif Santa Barbara, Kavli Inst Theoret Phys, Santa Barbara, CA 93106 USA; [Fuller, Jim] CALTECH, Walter Burke Inst Theoret Phys, TAPIR, Pasadena, CA 91125 USA; [Huber, Daniel] SETI Inst, Mountain View, CA 94043 USA; [Garcia, Rafael A.] Univ Paris Diderot, IRFU, SAp Ctr Saclay, Lab AIM,CEA,DSM,CNRS, F-91191 Gif Sur Yvette, France; [Bildsten, Lars] Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA	University of Sydney; Aarhus University; University of California System; University of California Santa Barbara; California Institute of Technology; UDICE-French Research Universities; Universite Paris Cite; CEA; Centre National de la Recherche Scientifique (CNRS); Universite Paris Saclay; University of California System; University of California Santa Barbara	Stello, D (corresponding author), Univ Sydney, Sch Phys, Sydney Inst Astron SIfA, Sydney, NSW 2006, Australia.	stello@physics.usyd.edu.au	Stello, Dennis/Q-9754-2019; Huber, Daniel/AAE-9440-2019; Bedding, Timothy/AAU-9400-2021	Stello, Dennis/0000-0002-4879-3519; Huber, Daniel/0000-0001-8832-4488; Bedding, Timothy/0000-0001-5222-4661; Aguirre Borsen-Koch, Victor/0000-0002-6137-903X; Cantiello, Matteo/0000-0002-8171-8596; Garcia, Rafael A./0000-0002-8854-3776	Australian Research Council Future Fellowship [FT140100147]; NSF [AST-1205732, PHY11-25915, AST11-09174]; Lee DuBridge Fellowship at Caltech; European Community's Seventh Framework Programme [269194]; CNES; IDEE [ANR-12-BS05-0008]; Australian Research Council's Discovery Projects [DE140101364]; National Aeronautics and Space Administration through the Kepler Participating Scientist Program [NNX14AB92G]; NASA under TCAN [NNX14AB53G]; Danish National Research Foundation [DNRF106]; ASTERISK project (ASTERoseismic Investigations with SONG and Kepler) - the European Research Council [267864]; Villum Fonden [00010118] Funding Source: researchfish; Division Of Astronomical Sciences [1109174] Funding Source: National Science Foundation	Australian Research Council Future Fellowship(Australian Research Council); NSF(National Science Foundation (NSF)); Lee DuBridge Fellowship at Caltech; European Community's Seventh Framework Programme; CNES(Centre National D'etudes Spatiales); IDEE; Australian Research Council's Discovery Projects(Australian Research Council); National Aeronautics and Space Administration through the Kepler Participating Scientist Program; NASA under TCAN; Danish National Research Foundation(Danmarks Grundforskningsfond); ASTERISK project (ASTERoseismic Investigations with SONG and Kepler) - the European Research Council; Villum Fonden(Villum Fonden); Division Of Astronomical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This paper has been written collaboratively, on the web, using Authorea (http://www.authorea.com). We acknowledge the entire Kepler team, whose efforts made these results possible. D.S. is the recipient of an Australian Research Council Future Fellowship (project number FT140100147). J.F. acknowledges support from NSF under grant number AST-1205732 and through a Lee DuBridge Fellowship at Caltech. R.A.G. acknowledges the support of the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement number 269194 (IRSES/ASK), the CNES, and the ANR-12-BS05-0008, IDEE. D.H. acknowledges support by the Australian Research Council's Discovery Projects funding scheme (project number DE140101364) and support by the National Aeronautics and Space Administration under grant number NNX14AB92G issued through the Kepler Participating Scientist Program. This project was supported by NASA under TCAN grant number NNX14AB53G, and by the NSF under grant numbers PHY11-25915 and AST11-09174. Funding for the Stellar Astrophysics Centre is provided by The Danish National Research Foundation (grant agreement number DNRF106). The research is supported by the ASTERISK project (ASTERoseismic Investigations with SONG and Kepler) funded by the European Research Council (grant agreement number 267864).	Auriere M, 2015, ASTRON ASTROPHYS, V574, DOI 10.1051/0004-6361/201424579; Beck PG, 2011, SCIENCE, V332, P205, DOI 10.1126/science.1201939; Bedding TR, 2011, NATURE, V471, P608, DOI 10.1038/nature09935; Braithwaite J, 2004, NATURE, V431, P819, DOI 10.1038/nature02934; Brun AS, 2005, ASTROPHYS J, V629, P461, DOI 10.1086/430430; Busso M, 2007, ASTROPHYS J, V671, P802, DOI 10.1086/522616; Cantiello M, 2014, ASTROPHYS J, V788, DOI 10.1088/0004-637X/788/1/93; Corsaro E, 2015, ASTRON ASTROPHYS, V579, DOI 10.1051/0004-6361/201525895; De Ridder J, 2009, NATURE, V459, P398, DOI 10.1038/nature08022; Donati JF, 2009, ANNU REV ASTRON ASTR, V47, P333, DOI 10.1146/annurev-astro-082708-101833; Duez V, 2010, ASTROPHYS J LETT, V724, pL34, DOI 10.1088/2041-8205/724/1/L34; Dupret MA, 2009, ASTRON ASTROPHYS, V506, P57, DOI 10.1051/0004-6361/200911713; Fuller J, 2015, SCIENCE, V350, P423, DOI 10.1126/science.aac6933; Garcia RA, 2014, ASTRON ASTROPHYS, V563, DOI 10.1051/0004-6361/201322823; Garcia R. A., 2015, EXTRATERRESTRIAL SEI; Gough DO, 1998, NATURE, V394, P755, DOI 10.1038/29472; Huber D, 2010, ASTROPHYS J, V723, P1607, DOI 10.1088/0004-637X/723/2/1607; Kippenhahn R., 1990, STELLAR STRUCTURE EV; LANDSTREET JD, 1992, ASTRON ASTROPHYS REV, V4, P35, DOI 10.1007/BF00873569; Miglio A, 2012, MON NOT R ASTRON SOC, V419, P2077, DOI 10.1111/j.1365-2966.2011.19859.x; MOSS D, 1987, MON NOT R ASTRON SOC, V226, P297, DOI 10.1093/mnras/226.2.297; Mosser B, 2014, ASTRON ASTROPHYS, V572, DOI 10.1051/0004-6361/201425039; Mosser B, 2012, ASTRON ASTROPHYS, V548, DOI 10.1051/0004-6361/201220106; Mosser B, 2012, ASTRON ASTROPHYS, V537, DOI 10.1051/0004-6361/201117352; Nucci MC, 2014, ASTROPHYS J, V787, DOI 10.1088/0004-637X/787/2/141; PARKER EN, 1955, ASTROPHYS J, V122, P293, DOI 10.1086/146087; Power J, 2008, CONTRIB ASTRON OBS S, V38, P443; Salaris M., 2005, EV STARS STELL POP; Stello D, 2008, ASTROPHYS J LETT, V674, pL53, DOI 10.1086/528936; Stello D, 2013, ASTROPHYS J LETT, V765, DOI 10.1088/2041-8205/765/2/L41	30	89	89	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 21	2016	529	7586					364	+		10.1038/nature16171	http://dx.doi.org/10.1038/nature16171			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB2QT	26727160	Green Submitted, Green Accepted			2022-12-28	WOS:000368354800039
J	Kwon, SC; Nguyen, TA; Choi, YG; Jo, MH; Hohng, S; Kim, VN; Woo, JS				Kwon, S. Chul; Tuan Anh Nguyen; Choi, Yeon-Gil; Jo, Myung Hyun; Hohng, Sungchul; Kim, V. Narry; Woo, Jae-Sung			Structure of Human DROSHA	CELL			English	Article							RNA-INTERFERENCE; PRIMARY MICRORNAS; BINDING; DICER; RIBONUCLEASE; RECOGNITION; DGCR8; MECHANISMS; MACHINERY; EVOLUTION	MicroRNA maturation is initiated by RNase III DROSHA that cleaves the stem loop of primary microRNA. DROSHA functions together with its cofactor DGCR8 in a heterotrimeric complex known as Microprocessor. Here, we report the X-ray structure of DROSHA in complex with the C-terminal helix of DGCR8. We find that DROSHA contains two DGCR8-binding sites, one on each RNase III domain (RIIID), which mediate the assembly of Microprocessor. The overall structure of DROSHA is surprisingly similar to that of Dicer despite no sequence homology apart from the C-terminal part, suggesting that DROSHA may have evolved from a Dicer homolog. DROSHA exhibits unique features, including non-canonical zinc-finger motifs, a long insertion in the first RIIID, and the kinked link between Connector helix and RIIID, which explains the 11-bp-measuring "ruler" activity of DROSHA. Our study implicates the evolutionary origin of DROSHA and elucidates the molecular basis of Microprocessor assembly and primary microRNA processing.	[Kwon, S. Chul; Tuan Anh Nguyen; Choi, Yeon-Gil; Kim, V. Narry; Woo, Jae-Sung] Inst for Basic Sci Korea, Ctr RNA Res, Seoul 08826, South Korea; [Kwon, S. Chul; Tuan Anh Nguyen; Choi, Yeon-Gil; Kim, V. Narry; Woo, Jae-Sung] Seoul Natl Univ, Sch Biol Sci, Seoul 08826, South Korea; [Jo, Myung Hyun; Hohng, Sungchul] Seoul Natl Univ, Dept Phys & Astron, Seoul 08826, South Korea; [Jo, Myung Hyun; Hohng, Sungchul] Seoul Natl Univ, Natl Ctr Creat Res Initiat, Seoul 08826, South Korea; [Jo, Myung Hyun; Hohng, Sungchul] Seoul Natl Univ, Inst Appl Phys, Seoul 08826, South Korea; [Hohng, Sungchul] Seoul Natl Univ, Dept Biophys & Chem Biol, Seoul 08826, South Korea	Institute for Basic Science - Korea (IBS); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Kim, VN (corresponding author), Inst for Basic Sci Korea, Ctr RNA Res, Seoul 08826, South Korea.	narrykim@snu.ac.kr; jaesungwoo@snu.ac.kr	Woo, Jae-Sung/J-4531-2017; Kwon, S. Chul/ABG-9415-2020; Kwon, S. Chul/K-2515-2017; Woo, Jae-Sung/T-2343-2019	Woo, Jae-Sung/0000-0001-9163-3433; Kwon, S. Chul/0000-0002-9519-5132; Woo, Jae-Sung/0000-0001-9163-3433; Hohng, Sungchul/0000-0002-7131-2138; Nguyen, Tuan Anh/0000-0001-7793-2699; Jo, Myung Hyun/0000-0003-2745-2843	Institute for Basic Science from the Ministry of Science, ICT, and Future Planning of Korea [IBS-R008-D1]; National Research Foundation of Korea [2009-0081562]	Institute for Basic Science from the Ministry of Science, ICT, and Future Planning of Korea; National Research Foundation of Korea(National Research Foundation of Korea)	We thank the beamline staffs at the Pohang Accelerator Laboratory for assistance with data collection. This work was supported by IBS-R008-D1 of Institute for Basic Science from the Ministry of Science, ICT, and Future Planning of Korea (S.C.K., T.A.N., Y.-G.C., J.-S.W., and V.N.K.) and Creative Research Initiatives (2009-0081562) of the National Research Foundation of Korea (M.H.J. and S.H.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Ameres SL, 2013, NAT REV MOL CELL BIO, V14, P475, DOI 10.1038/nrm3611; Auyeung VC, 2013, CELL, V152, P844, DOI 10.1016/j.cell.2013.01.031; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Blaszczyk J, 2001, STRUCTURE, V9, P1225, DOI 10.1016/S0969-2126(01)00685-2; Cerutti H, 2006, CURR GENET, V50, P81, DOI 10.1007/s00294-006-0078-x; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fang WW, 2015, MOL CELL, V60, P131, DOI 10.1016/j.molcel.2015.08.015; Gan JH, 2006, CELL, V124, P355, DOI 10.1016/j.cell.2005.11.034; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Grimson A, 2008, NATURE, V455, P1193, DOI 10.1038/nature07415; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838; Hammond SM, 2005, FEBS LETT, V579, P5822, DOI 10.1016/j.febslet.2005.08.079; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; Han JJ, 2004, GENE DEV, V18, P3016, DOI 10.1101/gad.1262504; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Knight SW, 2001, SCIENCE, V293, P2269, DOI 10.1126/science.1062039; Landthaler M, 2004, CURR BIOL, V14, P2162, DOI 10.1016/j.cub.2004.11.001; Lee J, 2010, ANGEW CHEM INT EDIT, V49, P9922, DOI 10.1002/anie.201005402; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Ma HM, 2013, P NATL ACAD SCI USA, V110, P20687, DOI 10.1073/pnas.1311639110; MacRae IJ, 2006, COLD SPRING HARB SYM, V71, P73, DOI 10.1101/sqb.2006.71.042; MacRae IJ, 2006, SCIENCE, V311, P195, DOI 10.1126/science.1121638; Masliah G, 2013, CELL MOL LIFE SCI, V70, P1875, DOI 10.1007/s00018-012-1119-x; Maxwell EK, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-714; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mueller Geoffrey A, 2010, Silence, V1, P2, DOI 10.1186/1758-907X-1-2; Mukherjee K, 2013, MOL BIOL EVOL, V30, P627, DOI 10.1093/molbev/mss263; Nicholson AW, 2014, WIRES RNA, V5, P31, DOI 10.1002/wrna.1195; Park JE, 2011, NATURE, V475, P201, DOI 10.1038/nature10198; Quick-Cleveland J, 2014, CELL REP, V7, P1994, DOI 10.1016/j.celrep.2014.05.013; Roth BM, 2013, J BIOL CHEM, V288, P26785, DOI 10.1074/jbc.M112.446880; Senturia R, 2010, PROTEIN SCI, V19, P1354, DOI 10.1002/pro.414; Sohn SY, 2007, NAT STRUCT MOL BIOL, V14, P847, DOI 10.1038/nsmb1294; Tian Y, 2014, MOL CELL, V53, P606, DOI 10.1016/j.molcel.2014.01.003; Nguyen TA, 2015, CELL, V161, P1374, DOI 10.1016/j.cell.2015.05.010; Yeom KH, 2006, NUCLEIC ACIDS RES, V34, P4622, DOI 10.1093/nar/gkl458; Yeom KH, 2011, EMBO REP, V12, P690, DOI 10.1038/embor.2011.100; Zeng Y, 2005, EMBO J, V24, P138, DOI 10.1038/sj.emboj.7600491; Zhang HD, 2004, CELL, V118, P57, DOI 10.1016/j.cell.2004.06.017	45	127	134	0	53	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 14	2016	164	1-2					81	90		10.1016/j.cell.2015.12.019	http://dx.doi.org/10.1016/j.cell.2015.12.019			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DB2LE	26748718	Bronze			2022-12-28	WOS:000368339300011
J	Marcotte, R; Sayad, A; Brown, KR; Sanchez-Garcia, F; Reimand, J; Haider, M; Virtanen, C; Bradner, JE; Bader, GD; Mills, GB; Pe'er, D; Moffat, J; Neel, BG				Marcotte, Richard; Sayad, Azin; Brown, Kevin R.; Sanchez-Garcia, Felix; Reimand, Jueri; Haider, Maliha; Virtanen, Carl; Bradner, James E.; Bader, Gary D.; Mills, Gordon B.; Pe'er, Dana; Moffat, Jason; Neel, Benjamin G.			Functional Genomic Landscape of Human Breast Cancer Drivers, Vulnerabilities, and Resistance	CELL			English	Article							CELL-LINES; DUAL INHIBITION; REVEALS; GROWTH; KINASE; ATM; PHOSPHORYLATION; SUPPRESSION; PATTERNS; SUBTYPE	Large-scale genomic studies have identified multiple somatic aberrations in breast cancer, including copy number alterations and point mutations. Still, identifying causal variants and emergent vulnerabilities that arise as a consequence of genetic alterations remain major challenges. We performed whole-genome small hairpin RNA (shRNA) "dropout screens" on 77 breast cancer cell lines. Using a hierarchical linear regression algorithm to score our screen results and integrate them with accompanying detailed genetic and proteomic information, we identify vulnerabilities in breast cancer, including candidate "drivers," and reveal general functional genomic properties of cancer cells. Comparisons of gene essentiality with drug sensitivity data suggest potential resistance mechanisms, effects of existing anti-cancer drugs, and opportunities for combination therapy. Finally, we demonstrate the utility of this large dataset by identifying BRD4 as a potential target in luminal breast cancer and PIK3CA mutations as a resistance determinant for BET-inhibitors.	[Marcotte, Richard; Sayad, Azin; Haider, Maliha; Virtanen, Carl; Neel, Benjamin G.] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON M5G 1L7, Canada; [Brown, Kevin R.; Reimand, Jueri; Bader, Gary D.; Moffat, Jason] Univ Toronto, Donnelly Ctr, Toronto, ON M5S 3E1, Canada; [Moffat, Jason] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 3E1, Canada; [Sanchez-Garcia, Felix; Pe'er, Dana] Columbia Univ, New York, NY 10027 USA; [Bradner, James E.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Bradner, James E.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02215 USA; [Mills, Gordon B.] Univ Texas MD Anderson Canc Ctr, Sheikh Khalifa Al Nahyan Ben Zayed Inst Personali, Dept Syst Biol, Houston, TX 77030 USA; [Neel, Benjamin G.] NYU Langone Med Ctr, Laura & Isaac Perlmutter Canc Ctr, New York, NY 10016 USA	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University of Toronto; Columbia University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; University of Texas System; UTMD Anderson Cancer Center; NYU Langone Medical Center	Neel, BG (corresponding author), NYU Langone Med Ctr, Laura & Isaac Perlmutter Canc Ctr, New York, NY 10016 USA.	benjamin.neel@nyumc.org	Reimand, Jüri/U-9264-2019; Moffat, Jason/AAC-1110-2020; Bader, Gary/C-1176-2009	Reimand, Jüri/0000-0002-2299-2309; Moffat, Jason/0000-0002-5663-8586; Bader, Gary/0000-0003-0185-8861; Brown, Kevin/0000-0002-5514-2538; Pe'er, Dana/0000-0002-9259-8817	Canadian Foundation for Innovation; Ontario Research Fund; Princess Margaret Cancer Foundation; Canadian Breast Cancer Foundation; NIH [R37 CA49132, P41 GM103504, R01 GM070743, U41 HG006623, PO1 CA099031]; Komen SAC and Promise grant; M.D. Anderson CCSG functional proteomics core [CA16672]; NATIONAL CANCER INSTITUTE [R01CA164729, R01CA049152, P01CA099031, P30CA016672] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U41HG006623] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070743, P41GM103504] Funding Source: NIH RePORTER	Canadian Foundation for Innovation(Canada Foundation for Innovation); Ontario Research Fund; Princess Margaret Cancer Foundation(University of Toronto); Canadian Breast Cancer Foundation(Canadian Cancer Society (CCS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Komen SAC and Promise grant; M.D. Anderson CCSG functional proteomics core; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Canadian Foundation for Innovation (J.M.) and the Ontario Research Fund (B.G.N. and J.M.). B.G.N. was a Canada Research Chair, Tier 1, and work in his laboratory was supported in part by the Princess Margaret Cancer Foundation. R.M. was partly funded by a postdoctoral fellowship from the Canadian Breast Cancer Foundation. This work was also supported by NIH grants R37 CA49132 (B.G.N.), P41 GM103504, R01 GM070743, U41 HG006623 (G.D.B.), and PO1 CA099031 (G.B.M.), a Komen SAC and Promise grant (G.B.M.), and the M.D. Anderson CCSG functional proteomics core (CA16672).	Banerji S, 2012, NATURE, V486, P405, DOI 10.1038/nature11154; Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; BOSHER JM, 1995, P NATL ACAD SCI USA, V92, P744, DOI 10.1073/pnas.92.3.744; Buchwalter G, 2013, CANCER CELL, V23, P753, DOI 10.1016/j.ccr.2013.04.026; Cheung HW, 2011, P NATL ACAD SCI USA, V108, P12372, DOI 10.1073/pnas.1109363108; Cortez D, 1999, SCIENCE, V286, P1162, DOI 10.1126/science.286.5442.1162; Creighton CJ, 2009, P NATL ACAD SCI USA, V106, P13820, DOI 10.1073/pnas.0905718106; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Daemen A, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r110; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; Davoli T, 2013, CELL, V155, P948, DOI 10.1016/j.cell.2013.10.011; Dhillon S, 2015, DRUGS, V75, P543, DOI 10.1007/s40265-015-0379-9; Dou QP, 2014, CURR CANCER DRUG TAR, V14, P517, DOI 10.2174/1568009614666140804154511; Dvinge H, 2013, NATURE, V497, P378, DOI 10.1038/nature12108; Ellis MJ, 2012, NATURE, V486, P353, DOI 10.1038/nature11143; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Flick K, 2013, CELL RES, V23, P870, DOI 10.1038/cr.2013.55; French CA, 2003, CANCER RES, V63, P304; Furne C, 2009, BBA-MOL CELL RES, V1793, P231, DOI 10.1016/j.bbamcr.2008.09.009; Gatei M, 2000, CANCER RES, V60, P3299; Griffith M, 2013, NAT METHODS, V10, P1209, DOI [10.1038/NMETH.2689, 10.1038/nmeth.2689]; Guo WJ, 2012, CELL, V148, P1015, DOI 10.1016/j.cell.2012.02.008; Guo YL, 2012, MOL CANCER THER, V11, P1968, DOI 10.1158/1535-7163.MCT-12-0248; Hart T, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145216; Hennessy BT, 2009, CANCER RES, V69, P4116, DOI 10.1158/0008-5472.CAN-08-3441; Hollestelle A, 2010, BREAST CANCER RES TR, V121, P53, DOI 10.1007/s10549-009-0460-8; Hsu TYT, 2015, NATURE, V525, P384, DOI 10.1038/nature14985; Jamdade VS, 2015, BRIT J PHARMACOL, V172, P4228, DOI 10.1111/bph.13211; Kao J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006146; Kim JH, 2005, BBA-MOL CELL BIOL L, V1736, P244, DOI 10.1016/j.bbalip.2005.08.015; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Konig R, 2007, NAT METHODS, V4, P847, DOI 10.1038/NMETH1089; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Lim E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2560; Lupien M, 2008, CELL, V132, P958, DOI 10.1016/j.cell.2008.01.018; Maire V, 2013, CANCER RES, V73, P813, DOI 10.1158/0008-5472.CAN-12-2633; Marcotte R, 2012, CANCER DISCOV, V2, P172, DOI 10.1158/2159-8290.CD-11-0224; Muranen T, 2012, CANCER CELL, V21, P227, DOI 10.1016/j.ccr.2011.12.024; Netea MG, 2005, P NATL ACAD SCI USA, V102, P16309, DOI 10.1073/pnas.0508237102; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Nijhawan D, 2012, CELL, V150, P842, DOI 10.1016/j.cell.2012.07.023; O'Callaghan Carol, 2014, Int J Cell Biol, V2014, P272689, DOI 10.1155/2014/272689; Pan D, 2013, CANCER J, V19, P461, DOI 10.1097/PPO.0000000000000001; Pao GM, 2000, P NATL ACAD SCI USA, V97, P1020, DOI 10.1073/pnas.97.3.1020; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Petrocca F, 2013, CANCER CELL, V24, P182, DOI 10.1016/j.ccr.2013.07.008; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Rahmani M, 2013, CANCER RES, V73, P1340, DOI 10.1158/0008-5472.CAN-12-1365; Riaz M, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3415; Sanchez-Garcia F, 2014, CELL, V159, P1461, DOI 10.1016/j.cell.2014.10.048; Shah SP, 2012, NATURE, V486, P395, DOI 10.1038/nature10933; Shao DD, 2013, GENOME RES, V23, P665, DOI 10.1101/gr.143586.112; Shi JW, 2014, MOL CELL, V54, P728, DOI 10.1016/j.molcel.2014.05.016; Solimini NL, 2012, SCIENCE, V337, P104, DOI 10.1126/science.1219580; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Stagni V, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7886; Stephens PJ, 2012, NATURE, V486, P400, DOI 10.1038/nature11017; Stratikopoulos EE, 2015, CANCER CELL, V27, P837, DOI 10.1016/j.ccell.2015.05.006; Takemoto M, 2002, EUR J NEUROSCI, V16, P1168, DOI 10.1046/j.1460-9568.2002.02166.x; Tibes R, 2006, MOL CANCER THER, V5, P2512, DOI 10.1158/1535-7163.MCT-06-0334; Timmerman LA, 2013, CANCER CELL, V24, P450, DOI 10.1016/j.ccr.2013.08.020; Worby CA, 2014, ANNU REV BIOCHEM, V83, P641, DOI 10.1146/annurev-biochem-082411-113907; Yu F, 2011, ONCOGENE, V30, P2161, DOI 10.1038/onc.2010.591; Zender L, 2008, CELL, V135, P852, DOI 10.1016/j.cell.2008.09.061; Zhang LS, 2015, ONCOTARGET, V6, P9073, DOI 10.18632/oncotarget.3268	67	257	258	0	64	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 14	2016	164	1-2					293	309		10.1016/j.cell.2015.11.062	http://dx.doi.org/10.1016/j.cell.2015.11.062			17	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DB2LE	26771497	Green Accepted, Bronze			2022-12-28	WOS:000368339300028
J	Yu, RP; Hesk, D; Rivera, N; Pelczer, I; Chirik, PJ				Yu, Renyuan Pony; Hesk, David; Rivera, Nelo; Pelczer, Istvan; Chirik, Paul J.			Iron-catalysed tritiation of pharmaceuticals	NATURE			English	Article							RADIOLABELED COMPOUNDS; H/D EXCHANGE; DISCOVERY; HYDROGENATION; COMPLEXES; TRITIUM; DEUTERATION; ANTAGONIST; DEUTERIUM	A thorough understanding of the pharmacokinetic and pharmacodynamic properties of a drug in animal models is a critical component of drug discovery and development(1-6). Such studies are performed in vivo and in vitro at various stages of the development process-ranging from preclinical absorption, distribution, metabolism and excretion (ADME) studies to late-stage human clinical trials-to elucidate a drug molecule's metabolic profile and to assess its toxicity(2). Radiolabelled compounds, typically those that contain C-14 or H-3 isotopes, are one of the most powerful and widely deployed diagnostics for these studies(4,5). The introduction of radiolabels using synthetic chemistry enables the direct tracing of the drug molecule without substantially altering its structure or function. The ubiquity of C-H bonds in drugs and the relative ease and low cost associated with tritium (H-3) make it an ideal radioisotope with which to conduct ADME studies early in the drug development process(2,4,6). Here we describe an iron-catalysed method for the direct H-3 labelling of pharmaceuticals by hydrogen isotope exchange, using tritium gas as the source of the radioisotope. The site selectivity of the iron catalyst is orthogonal to currently used iridium catalysts and allows isotopic labelling of complementary positions in drug molecules, providing a new diagnostic tool in drug development.	[Yu, Renyuan Pony; Pelczer, Istvan; Chirik, Paul J.] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA; [Hesk, David; Rivera, Nelo] Merck Res Labs, Rahway, NJ 07065 USA	Princeton University; Merck & Company	Chirik, PJ (corresponding author), Princeton Univ, Dept Chem, Princeton, NJ 08544 USA.	pchirik@princeton.edu		Hesk, David/0000-0003-4059-4168	Merck; Intellectual Property Accelerator Fund at Princeton University	Merck(Merck & Company); Intellectual Property Accelerator Fund at Princeton University	Merck and the Intellectual Property Accelerator Fund at Princeton University are acknowledged for financial support. We thank M. Tudge, I. Mergelsberg, L.-C. Campeau and I. Davies for discussions. We also thank D. Schenk and Y. Liu for assistance in <SUP>3</SUP>H NMR assignments.	Atzrodt J, 2007, ANGEW CHEM INT EDIT, V46, P7744, DOI 10.1002/anie.200700039; Brown JA, 2014, ADV SYNTH CATAL, V356, P3551, DOI 10.1002/adsc.201400730; Coleman PJ, 2012, CHEMMEDCHEM, V7, P415, DOI 10.1002/cmdc.201200025; CRABTREE RH, 1977, J ORGANOMET CHEM, V141, P205, DOI 10.1016/S0022-328X(00)92273-3; Danopoulos AA, 2005, CHEM COMMUN, P784, DOI 10.1039/b415562a; Elmore CS, 2009, ANNU REP MED CHEM, V44, P515, DOI 10.1016/S0065-7743(09)04425-X; HESK D, 1995, J LABELLED COMPD RAD, V36, P497, DOI 10.1002/jlcr.2580360514; Isin EM, 2012, CHEM RES TOXICOL, V25, P532, DOI 10.1021/tx2005212; JARMAN M, 1995, CARCINOGENESIS, V16, P683, DOI 10.1093/carcin/16.4.683; Katsnelson A, 2013, NAT MED, V19, P656, DOI 10.1038/nm0613-656; Klei SR, 2002, J AM CHEM SOC, V124, P2092, DOI 10.1021/ja017219d; Lappin G., 2006, RADIOTRACERS DRUG DE; Lischka P, 2010, ANTIMICROB AGENTS CH, V54, P1290, DOI 10.1128/AAC.01596-09; Liu JK, 2005, NEUROCRIT CARE, V2, P124, DOI 10.1385/NCC:2:2:124; Lockley WJS, 2012, J LABELLED COMPD RAD, V55, P235, DOI 10.1002/jlcr.2928; Lockley WJS, 2010, J LABELLED COMPD RAD, V53, P635, DOI 10.1002/jlcr.1851; Ma S, 2014, ANGEW CHEM INT EDIT, V53, P734, DOI 10.1002/anie.201305388; Marathe PH, 2004, CURR PHARM DESIGN, V10, P2991, DOI 10.2174/1381612043383494; Meanwell NA, 2011, J MED CHEM, V54, P2529, DOI 10.1021/jm1013693; Molinaro C, 2012, J ORG CHEM, V77, P2299, DOI 10.1021/jo202620r; Nagasaki T, 2001, J LABELLED COMPD RAD, V44, P993, DOI 10.1002/jlcr.521; Nilsson GN, 2010, J LABELLED COMPD RAD, V53, P662, DOI 10.1002/jlcr.1817; Salter R, 2010, J LABELLED COMPD RAD, V53, P645, DOI 10.1002/jlcr.1814; Skaddan MB, 2004, ORG LETT, V6, P11, DOI 10.1021/ol0359923; Taylor RD, 2014, J MED CHEM, V57, P5845, DOI 10.1021/jm4017625; Vitaku E, 2014, J MED CHEM, V57, P10257, DOI 10.1021/jm501100b; Voges R., 2009, PREPARATION COMPOUND; Yu RP, 2013, J AM CHEM SOC, V135, P13168, DOI [10.1021/ja406608u, 10.1021/ja405608u]; Yu RP, 2012, ACS CATAL, V2, P1760, DOI 10.1021/cs300358m; Zhou JR, 2008, ANGEW CHEM INT EDIT, V47, P5783, DOI 10.1002/anie.200801992	30	228	231	10	131	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 14	2016	529	7585					195	199		10.1038/nature16464	http://dx.doi.org/10.1038/nature16464			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA7WK	26762456				2022-12-28	WOS:000368015700033
J	Bao, W; Tobias, DK; Hu, FB; Chavarro, JE; Zhang, CL				Bao, Wei; Tobias, Deirdre K.; Hu, Frank B.; Chavarro, Jorge E.; Zhang, Cuilin			Pre-pregnancy potato consumption and risk of gestational diabetes mellitus: prospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CORONARY-HEART-DISEASE; FOOD-CONSUMPTION; DIETARY PATTERNS; GLYCEMIC INDEX; LIFE-STYLE; GLUCOSE; REPRODUCIBILITY; QUESTIONNAIRE; REGRESSION; PREGNANCY	STUDY QUESTION What is the association between potato consumption before pregnancy and the risk of gestational diabetes mellitus (GDM)? METHODS This prospective cohort study included 15 632 women from the Nurses' Health Study II (1991-2001). They had no previous GDM or chronic diseases before pregnancy. Consumption of potatoes and other foods was assessed every four years. Incident first time GDM was ascertained from self reports of a physician diagnosis of GDM, which was previously validated by medical records. STUDY ANSWER AND LIMITATIONS Over the 10 year follow-up there were 854 incident cases of GDM among 21 693 singleton pregnancies. After adjustment for age, parity, and dietary and non-dietary factors, women who consumed more potatoes before pregnancy had higher rates of developing GDM. Substitution of two servings a week of total potatoes with other vegetables, legumes, and whole grain foods was significantly associated with a 9-12% lower risk of GDM. Consumption and diabetes were self reported, and severity of diabetes was unknown. More than 90% of women were white. A causal association cannot be assumed.	[Bao, Wei; Zhang, Cuilin] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Epidemiol Branch, Div Intramural Populat Hlth Res, NIH, Rockville, MD 20852 USA; [Tobias, Deirdre K.] Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02115 USA; [Tobias, Deirdre K.; Hu, Frank B.; Chavarro, Jorge E.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Tobias, Deirdre K.; Hu, Frank B.; Chavarro, Jorge E.] Harvard Univ, TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Hu, Frank B.; Chavarro, Jorge E.] Harvard Univ, TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Hu, Frank B.; Chavarro, Jorge E.] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, Boston, MA 02115 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital	Zhang, CL (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Epidemiol Branch, Div Intramural Populat Hlth Res, NIH, Rockville, MD 20852 USA.	zhangcu@mail.nih.gov	Chavarro, Jorge E/AAE-5665-2021; Bao, Wei/AAG-2431-2019	Chavarro, Jorge E/0000-0002-4436-9630; Bao, Wei/0000-0002-7301-5786; Zhang, Cuilin/0000-0002-8014-2708	Intramural Research Program of Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health [HHSN275201000020C]; National Institutes of Health [DK58845, CA50385, P30 DK46200, UM1 CA176726]; American Diabetes Association [7-12-MN-34]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008889] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [UM1CA176726, R01CA050385] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK103720, P30DK046200, R01DK058845] Funding Source: NIH RePORTER	Intramural Research Program of Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by the Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health (contract No HHSN275201000020C). The Nurses' Health Study II was funded by research grants DK58845, CA50385, P30 DK46200, and UM1 CA176726 from the National Institutes of Health. DKT and FBH were supported by a mentored fellowship from the American Diabetes Association (No 7-12-MN-34).	American Diabetes Association, 2004, DIABETES CARE S1, V27, pS88, DOI [10.2337/diacare.27.2007.S88, DOI 10.2337/DIACARE.27.2007.S88]; Bao W, 2014, AM J CLIN NUTR, V99, P1378, DOI 10.3945/ajcn.113.082966; Bao W, 2013, DIABETES CARE, V36, P2001, DOI 10.2337/dc12-2018; Cahill LE, 2014, AM J CLIN NUTR, V100, P667, DOI 10.3945/ajcn.114.084129; Cai WJ, 2012, P NATL ACAD SCI USA, V109, P15888, DOI 10.1073/pnas.1205847109; Camire ME, 2009, CRIT REV FOOD SCI, V49, P823, DOI 10.1080/10408390903041996; Center for Nutrition Policy and Promotion, 2010, DIET GUID AM; Ceriello A, 2008, DIABETES, V57, P1349, DOI 10.2337/db08-0063; Chiuve SE, 2012, J NUTR, V142, P1009, DOI 10.3945/jn.111.157222; Colditz GA, 2005, NAT REV CANCER, V5, P388, DOI 10.1038/nrc1608; Ferrara A, 2002, DIABETES CARE, V25, P1625, DOI 10.2337/diacare.25.9.1625; Forbes GB, 1999, AM J CLIN NUTR, V69, P572; Freedman MR., 2012, J NUTR THER, V1, P1, DOI [DOI 10.6000/1929-5634.2012.01.01.1, 10.6000/1929-5634.2012.01.01.1]; Goldberg T, 2004, J AM DIET ASSOC, V104, P1287, DOI 10.1016/j.jada.2004.05.214; Guallar-Castillon P, 2007, AM J CLIN NUTR, V86, P198, DOI 10.1093/ajcn/86.1.198; Guallar-Castillon P, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e363; Halton TL, 2006, AM J CLIN NUTR, V83, P284; Hanley JA, 2003, AM J EPIDEMIOL, V157, P364, DOI 10.1093/aje/kwf215; HARRIS M, 1979, DIABETES, V28, P1039; Hodge AM, 2004, DIABETES CARE, V27, P2701, DOI 10.2337/diacare.27.11.2701; Hu FB, 1999, AM J EPIDEMIOL, V149, P531, DOI 10.1093/oxfordjournals.aje.a009849; King JC, 2013, ADV NUTR, V4, p393S, DOI 10.3945/an.112.003525; Liu SM, 2004, DIABETES CARE, V27, P2993, DOI 10.2337/diacare.27.12.2993; MAGEE MS, 1993, JAMA-J AM MED ASSOC, V269, P609, DOI 10.1001/jama.269.5.609; McGill CR, 2013, ANN MED, V45, P467, DOI 10.3109/07853890.2013.813633; Metzger BE, 2008, NEW ENGL J MED, V358, P1991, DOI 10.1056/NEJMoa0707943; Montonen J, 2005, EUR J CLIN NUTR, V59, P441, DOI 10.1038/sj.ejcn.1602094; Mozaffarian D, 2011, NEW ENGL J MED, V364, P2392, DOI 10.1056/NEJMoa1014296; Pan A, 2012, ARCH INTERN MED, V172, P555, DOI 10.1001/archinternmed.2011.2287; Pokorn Jan, 2003, Forum Nutr, V56, P348; Qi QB, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1610; Reece EA, 2009, LANCET, V373, P1789, DOI 10.1016/S0140-6736(09)60515-8; Riccardi G, 2008, AM J CLIN NUTR, V87, p269S, DOI 10.1093/ajcn/87.1.269S; Rimm E B, 1990, Epidemiology, V1, P466, DOI 10.1097/00001648-199011000-00009; SALVINI S, 1989, INT J EPIDEMIOL, V18, P858, DOI 10.1093/ije/18.4.858; Schoenaker DAJM, 2015, DIABETOLOGIA, V58, P2726, DOI 10.1007/s00125-015-3742-1; Scholl TO, 2004, AM J EPIDEMIOL, V159, P467, DOI 10.1093/aje/kwh068; Solomon CG, 1997, JAMA-J AM MED ASSOC, V278, P1078, DOI 10.1001/jama.278.13.1078; Tieu J, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006674.pub2; Tobias DK, 2012, AM J CLIN NUTR, V96, P289, DOI 10.3945/ajcn.111.028266; UK National Health Service, EATW PLAT; WACHOLDER S, 1986, AM J EPIDEMIOL, V123, P174, DOI 10.1093/oxfordjournals.aje.a114212; Willett W, 2002, AM J CLIN NUTR, V76, p274S, DOI 10.1093/ajcn/76.1.274S; WILLETT WC, 1988, AM J EPIDEMIOL, V127, P188, DOI 10.1093/oxfordjournals.aje.a114780; Willett WC, 1998, AM J CLIN NUTR, V68, P218, DOI 10.1093/ajcn/68.2.218; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086; WOLF AM, 1994, INT J EPIDEMIOL, V23, P991, DOI 10.1093/ije/23.5.991; Ylonen SK, 2007, DIABETIC MED, V24, P1049, DOI 10.1111/j.1464-5491.2007.02206.x; Zhang CL, 2006, DIABETES CARE, V29, P2223, DOI 10.2337/dc06-0266; Zhang CL, 2011, AM J CLIN NUTR, V94, p1975S, DOI 10.3945/ajcn.110.001032; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	51	36	41	1	40	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 12	2016	352								h6898	10.1136/bmj.h6898	http://dx.doi.org/10.1136/bmj.h6898			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DB2YB	26759275	hybrid, Green Published			2022-12-28	WOS:000368375500001
J	Gandhi, P				Gandhi, Poshak			ASTROPHYSICS Why black holes pulse brightly	NATURE			English	Editorial Material									[Gandhi, Poshak] Univ Southampton, Dept Phys & Astron, Southampton SO17 1BJ, Hants, England	University of Southampton	Gandhi, P (corresponding author), Univ Southampton, Dept Phys & Astron, Southampton SO17 1BJ, Hants, England.	p.gandhi@soton.ac.uk		Gandhi, Poshak/0000-0003-3105-2615	STFC [ST/J003697/2] Funding Source: UKRI	STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))		BOWYER S, 1965, SCIENCE, V147, P394, DOI 10.1126/science.147.3656.394; CASARES J, 1992, NATURE, V355, P614, DOI 10.1038/355614a0; Fender R, 2004, ANNU REV ASTRON ASTR, V42, P317, DOI 10.1146/annurev.astro.42.053102.134031; Khargharia J, 2010, ASTROPHYS J, V716, P1105, DOI 10.1088/0004-637X/716/2/1105; Kimura M, 2016, NATURE, V529, P54, DOI 10.1038/nature16452; Miller-Jones JCA, 2009, ASTROPHYS J LETT, V706, pL230, DOI 10.1088/0004-637X/706/2/L230; WEBSTER BL, 1972, NATURE, V235, P37, DOI 10.1038/235037a0	7	0	0	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 7	2016	529	7584					28	29		10.1038/529028a	http://dx.doi.org/10.1038/529028a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6VY	26738586	Green Accepted			2022-12-28	WOS:000367944900016
J	McCartney, M				McCartney, Margaret			Margaret McCartney: Dishonourable New Year honours	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Clarke M, 2007, J ROY SOC MED, V100, P571, DOI 10.1258/jrsm.100.12.571	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 4	2016	352								i28	10.1136/bmj.i28	http://dx.doi.org/10.1136/bmj.i28			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DA8LR	26728719	Bronze, Green Published			2022-12-28	WOS:000368056800006
J	Gilani, A				Gilani, Artaza			Beyond the tick boxes	SCIENCE			English	Editorial Material									[Gilani, Artaza] Barts Hlth NHS Trust United Kingdom, Whipps Cross Univ Hosp, London, England	Barts Health NHS Trust; University of London; Queen Mary University London	Gilani, A (corresponding author), Barts Hlth NHS Trust United Kingdom, Whipps Cross Univ Hosp, London, England.			Gilani, Artaza/0000-0002-5385-8524					0	0	0	1	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 1	2016	351	6268					98	98		10.1126/science.351.6268.98	http://dx.doi.org/10.1126/science.351.6268.98			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ8QM	26721999				2022-12-28	WOS:000367364200050
J	Blackburn, EH; Epel, ES; Lin, J				Blackburn, Elizabeth H.; Epel, Elissa S.; Lin, Jue			Human telomere biology: A contributory and interactive factor in aging, disease risks, and protection	SCIENCE			English	Review							DNA-DAMAGE; LENGTH; ASSOCIATION; STRESS; CANCER; DYSFUNCTION; WERNER; LIFE; HEALTH; PATHOGENESIS	Telomeres are the protective end-complexes at the termini of eukaryotic chromosomes. Telomere attrition can lead to potentially maladaptive cellular changes, block cell division, and interfere with tissue replenishment. Recent advances in the understanding of human disease processes have clarified the roles of telomere biology, especially in diseases of human aging and in some aging-related processes. Greater overall telomere attrition predicts mortality and aging-related diseases in inherited telomere syndrome patients, and also in general human cohorts. However, genetically caused variations in telomere maintenance either raise or lower risks and progression of cancers, in a highly cancer type-specific fashion. Telomere maintenance is determined by genetic factors and is also cumulatively shaped by nongenetic influences throughout human life; both can interact. These and other recent findings highlight both causal and potentiating roles for telomere attrition in human diseases.	[Blackburn, Elizabeth H.; Lin, Jue] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Epel, Elissa S.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Blackburn, EH (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.	elizabeth.blackburn@ucsf.edu	ravegnini, gloria/K-1330-2016	ravegnini, gloria/0000-0002-7774-402X	NIH [GM026259, CA096840]; Barbro and Bernard Osher Foundation; NATIONAL CANCER INSTITUTE [R01CA096840] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM026259, R01GM026259] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Barbro and Bernard Osher Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank our many colleagues and apologize to those whose work we were unable to cite owing to article length constraints. E.H.B acknowledges support from NIH (grants GM026259 and CA096840) and from the Barbro and Bernard Osher Foundation. E.H.B. and E.E. report no conflicts of interest; E.H.B. and E.E. were former cofounders of a company, Telome Health (now Telomere Diagnostics), but donated all their shares to a nonprofit organization. J.L. owns stock in Telomere Diagnostics.	Alder JK, 2015, P NATL ACAD SCI USA, V112, P5099, DOI 10.1073/pnas.1504780112; Anchelin M, 2013, DIS MODEL MECH, V6, P1101, DOI 10.1242/dmm.011635; Armanios M, 2013, J CLIN INVEST, V123, P996, DOI 10.1172/JCI66370; Armanios M, 2012, NAT REV GENET, V13, P693, DOI 10.1038/nrg3246; Bakaysa SL, 2007, AGING CELL, V6, P769, DOI 10.1111/j.1474-9726.2007.00340.x; Blackburn EH, 2006, NAT MED, V12, P1133, DOI 10.1038/nm1006-1133; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Cesare AJ, 2013, MOL CELL, V51, P141, DOI 10.1016/j.molcel.2013.06.006; Chang S, 2004, NAT GENET, V36, P877, DOI 10.1038/ng1389; Cheung HH, 2014, STEM CELL REP, V2, P534, DOI 10.1016/j.stemcr.2014.02.006; Choi J, 2008, BRAIN BEHAV IMMUN, V22, P600, DOI 10.1016/j.bbi.2007.12.004; Codd V, 2013, NAT GENET, V45, P422, DOI 10.1038/ng.2528; Cohen S, 2013, JAMA-J AM MED ASSOC, V309, P699, DOI 10.1001/jama.2013.613; Collopy LC, 2015, BLOOD, V126, P176, DOI 10.1182/blood-2015-03-633388; Crabbe L, 2007, P NATL ACAD SCI USA, V104, P2205, DOI 10.1073/pnas.0609410104; De Meyer T, 2014, EUR J HUM GENET, V22, P10, DOI 10.1038/ejhg.2013.255; Ding H, 2014, CLIN INTERV AGING, V9, P857, DOI 10.2147/CIA.S60760; Du XB, 2004, MOL CELL BIOL, V24, P8437, DOI 10.1128/MCB.24.19.8437-8446.2004; Entringer S, 2011, P NATL ACAD SCI USA, V108, pE513, DOI 10.1073/pnas.1107759108; Glousker G, 2015, BRIT J HAEMATOL, V170, P457, DOI 10.1111/bjh.13442; Gotlib IH, 2015, MOL PSYCHIATR, V20, P615, DOI 10.1038/mp.2014.119; Gu JA, 2011, CANCER PREV RES, V4, P514, DOI 10.1158/1940-6207.CAPR-11-0063; Guo N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017858; Harel I, 2015, CELL, V160, P1013, DOI 10.1016/j.cell.2015.01.038; Haussmann MF, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2015.0396; Haycock PC, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4227; Hjelmborg JB, 2015, J MED GENET, V52, P297, DOI 10.1136/jmedgenet-2014-102736; Horn S, 2013, SCIENCE, V339, P959, DOI 10.1126/science.1230062; Lapham K, 2015, GENETICS, V200, P1061, DOI 10.1534/genetics.115.178624; Lengacher CA, 2014, BIOL RES NURS, V16, P438, DOI 10.1177/1099800413519495; Lin J, 2015, CANCER EPIDEM BIOMAR, V24, P336, DOI 10.1158/1055-9965.EPI-14-0992; Lin J, 2012, MUTAT RES-FUND MOL M, V730, P85, DOI 10.1016/j.mrfmmm.2011.08.003; Lin TT, 2014, BRIT J HAEMATOL, V167, P214, DOI 10.1111/bjh.13023; Lindqvist D, 2015, NEUROSCI BIOBEHAV R, V55, P333, DOI 10.1016/j.neubiorev.2015.05.007; Ma HX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020466; MASON JM, 1995, TRENDS GENET, V11, P58, DOI 10.1016/S0168-9525(00)88998-2; Maubaret CG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083122; Meier B, 2006, PLOS GENET, V2, P187, DOI 10.1371/journal.pgen.0020018; Missios P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5924; Mourkioti F, 2013, NAT CELL BIOL, V15, P895, DOI 10.1038/ncb2790; Naxerova K, 2015, ELIFE, V4, DOI 10.7554/eLife.09519; Needham BL, 2015, EPIDEMIOLOGY, V26, P528, DOI 10.1097/EDE.0000000000000299; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Petersen S, 1998, EXP CELL RES, V239, P152, DOI 10.1006/excr.1997.3893; Price LH, 2013, BIOL PSYCHIAT, V73, P15, DOI 10.1016/j.biopsych.2012.06.025; Puterman E, 2015, MOL PSYCHIATR, V20, P529, DOI 10.1038/mp.2014.70; Raschenberger J, 2015, SCI REP-UK, V5, DOI 10.1038/srep11887; Rehkopf DH, 2013, EXP GERONTOL, V48, P1266, DOI 10.1016/j.exger.2013.08.005; Rode L, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv074; Sahin E, 2011, NATURE, V470, P359, DOI 10.1038/nature09787; Schutte NS, 2015, DEPRESS ANXIETY, V32, P229, DOI 10.1002/da.22351; Sfeir A, 2012, SCIENCE, V336, P593, DOI 10.1126/science.1218498; Simm A, 2014, EXP GERONTOL, V59, P1, DOI 10.1016/j.exger.2014.11.015; Stanley SE, 2015, J CLIN INVEST, V125, P563, DOI 10.1172/JCI78554; Tarry-Adkins JL, 2013, FASEB J, V27, P379, DOI 10.1096/fj.12-218685; Vulliamy T, 2001, NATURE, V413, P432, DOI 10.1038/35096585; Walne AJ, 2009, BRIT J HAEMATOL, V145, P164, DOI 10.1111/j.1365-2141.2009.07598.x; Walsh KM, 2013, NEURO-ONCOLOGY, V15, P1041, DOI 10.1093/neuonc/not051; Wentzensen IM, 2011, CANCER EPIDEM BIOMAR, V20, P1238, DOI 10.1158/1055-9965.EPI-11-0005; Willeit P, 2011, JAMA-J AM MED ASSOC, V306, P42, DOI 10.1001/jama.2011.901; Xie ZW, 2015, CELL, V160, P928, DOI 10.1016/j.cell.2015.02.002; Ye J, 2014, NAT REV GENET, V15, P491, DOI 10.1038/nrg3743; Zhan YQ, 2015, JAMA NEUROL, V72, P1202, DOI 10.1001/jamaneurol.2015.1513; Zhao JZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079993	64	803	822	18	245	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 4	2015	350	6265					1193	1198		10.1126/science.aab3389	http://dx.doi.org/10.1126/science.aab3389			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX4WG	26785477				2022-12-28	WOS:000365700500062
J	Rister, J; Razzaq, A; Boodram, P; Desai, N; Tsanis, C; Chen, HT; Jukam, D; Desplan, C				Rister, Jens; Razzaq, Ansa; Boodram, Pamela; Desai, Nisha; Tsanis, Cleopatra; Chen, Hongtao; Jukam, David; Desplan, Claude			Single-base pair differences in a shared motif determine differential Rhodopsin expression	SCIENCE			English	Article							HOX SPECIFICITY; PHOTOTRANSDUCTION; PPH13	The final identity and functional properties of a neuron are specified by terminal differentiation genes, which are controlled by specific motifs in compact regulatory regions. To determine how these sequences integrate inputs from transcription factors that specify cell types, we compared the regulatory mechanism of Drosophila Rhodopsin genes that are expressed in subsets of photoreceptors to that of phototransduction genes that are expressed broadly, in all photoreceptors. Both sets of genes share an 11-base pair (bp) activator motif. Broadly expressed genes contain a palindromic version that mediates expression in all photoreceptors. In contrast, each Rhodopsin exhibits characteristic single-bp substitutions that break the symmetry of the palindrome and generate activator or repressor motifs critical for restricting expression to photoreceptor subsets. Sensory neuron subtypes can therefore evolve through single-bp changes in short regulatory motifs, allowing the discrimination of a wide spectrum of stimuli.	[Rister, Jens; Razzaq, Ansa; Boodram, Pamela; Desai, Nisha; Tsanis, Cleopatra; Chen, Hongtao; Jukam, David; Desplan, Claude] NYU, Dept Biol, Ctr Dev Genet, New York, NY 10003 USA	New York University	Desplan, C (corresponding author), NYU, Dept Biol, Ctr Dev Genet, 100 Washington Sq East, New York, NY 10003 USA.	cd38@nyu.edu		Desplan, Claude/0000-0002-6914-1413; Rister, Jens/0000-0002-0023-7417; Jukam, David/0000-0003-4167-2754	National Institutes of Health/National Eye Institute [R01 EY13010, K99EY023995]; European Molecular Biology Organization long-term fellowship [ALTF 462-2008]; New York University Dean's Dissertation Award; NATIONAL EYE INSTITUTE [K99EY023995, R01EY013010] Funding Source: NIH RePORTER	National Institutes of Health/National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); European Molecular Biology Organization long-term fellowship(European Molecular Biology Organization (EMBO)); New York University Dean's Dissertation Award; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank K. Basler, J. Bischof, S. Britt, C. Zuker, the Bloomington Stock Center, and the Vienna Drosophila Resource Center for reagents. We thank T. Blackman for injections and J. Corbo, R. Datta, M. Friedrich, O. Hobert, R. Mann, F. Payre, S. Small, D. Taatjes, and past and present members of the Desplan laboratory for comments on the manuscript. C. D. was supported by National Institutes of Health/National Eye Institute grant R01 EY13010, J. R. by National Institutes of Health/National Eye Institute award K99EY023995 and European Molecular Biology Organization long-term fellowship ALTF 462-2008, and D. J. by a New York University Dean's Dissertation Award. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Crocker J, 2015, CELL, V160, P191, DOI 10.1016/j.cell.2014.11.041; Davidson EH, 2006, REG GEN GEN REG; Deneris ES, 2014, NAT NEUROSCI, V17, P899, DOI 10.1038/nn.3731; Etchberger JF, 2009, DEVELOPMENT, V136, P147, DOI 10.1242/dev.030064; FORTINI ME, 1990, GENE DEV, V4, P444, DOI 10.1101/gad.4.3.444; Jackowska M, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-24; Johnston RJ, 2011, CELL, V145, P956, DOI 10.1016/j.cell.2011.05.003; Jukam D, 2013, SCIENCE, V342, P211, DOI 10.1126/science.1238016; Leung TH, 2004, CELL, V118, P453, DOI 10.1016/j.cell.2004.08.007; LEVINE M, 1989, CELL, V59, P405, DOI 10.1016/0092-8674(89)90024-X; Mahato S, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004484; Mann RS, 2009, CURR TOP DEV BIOL, V88, P63, DOI 10.1016/S0070-2153(09)88003-4; Meijsing SH, 2009, SCIENCE, V324, P407, DOI 10.1126/science.1164265; Mishra M, 2010, DEVELOPMENT, V137, P2895, DOI 10.1242/dev.051722; Papatsenko D, 2001, MECH DEVELOP, V101, P143, DOI 10.1016/S0925-4773(00)00581-5; Rister J, 2013, DEVELOPMENT, V140, P493, DOI 10.1242/dev.079095; Sheng GJ, 1997, GENE DEV, V11, P1122, DOI 10.1101/gad.11.9.1122; Slattery M, 2011, CELL, V147, P1270, DOI 10.1016/j.cell.2011.10.053; STANOJEVIC D, 1991, SCIENCE, V254, P1385, DOI 10.1126/science.1683715; Thanawala SU, 2013, DEV CELL, V25, P93, DOI 10.1016/j.devcel.2013.02.016; WILSON DS, 1995, CELL, V82, P709, DOI 10.1016/0092-8674(95)90468-9; Wray GA, 2007, NAT REV GENET, V8, P206, DOI 10.1038/nrg2063; Yau KW, 2009, CELL, V139, P246, DOI 10.1016/j.cell.2009.09.029; Zelhof AC, 2003, DEVELOPMENT, V130, P4383, DOI 10.1242/dev.00651; Zhu LHJ, 2011, NUCLEIC ACIDS RES, V39, pD111, DOI 10.1093/nar/gkq858	25	25	25	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 4	2015	350	6265					1258	1261		10.1126/science.aab3417	http://dx.doi.org/10.1126/science.aab3417			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX4WG	26785491	Green Accepted			2022-12-28	WOS:000365700500079
J	Siu, AL; Bibbins-Domingo, K; Grossman, DC; Baumann, LC; Davidson, KW; Ebell, M; Garcia, FAR; Gillman, M; Herzstein, J; Kemper, AR; Krist, AH; Kurth, AE; Owens, DK; Phillips, WR; Phipps, MG; Pignone, MP; LeFevre, M				Siu, Albert L.; Bibbins-Domingo, Kirsten; Grossman, David C.; Baumann, Linda Ciofu; Davidson, Karina W.; Ebell, Mark; Garcia, Francisco A. R.; Gillman, Matthew; Herzstein, Jessica; Kemper, Alex R.; Krist, Alex H.; Kurth, Ann E.; Owens, Douglas K.; Phillips, William R.; Phipps, Maureen G.; Pignone, Michael P.; LeFevre, Michael		US Preventive Serv Task Force	Screening for Breast Cancer: US Preventive Services Task Force Recommendation Statement	ANNALS OF INTERNAL MEDICINE			English	Article							CARCINOMA IN-SITU; DIGITAL MAMMOGRAPHY; FILM MAMMOGRAPHY; TOMOSYNTHESIS; WOMEN; DENSITY; RACE; AGE; OVERDIAGNOSIS; ULTRASOUND	Description: Update of the 2009 U.S. Preventive Services Task Force (USPSTF) recommendation on screening for breast cancer. Methods: The USPSTF reviewed the evidence on the following: effectiveness of breast cancer screening in reducing breast cancer-specific and all-cause mortality, as well as the incidence of advanced breast cancer and treatment-related morbidity; harms of breast cancer screening; test performance characteristics of digital breast tomosynthesis as a primary screening strategy; and adjunctive screening in women with increased breast density. In addition, the USPSTF reviewed comparative decision models on optimal starting and stopping ages and intervals for screening mammography; how breast density, breast cancer risk, and comorbidity level affect the balance of benefit and harms of screening mammography; and the number of radiation-induced breast cancer cases and deaths associated with different screening mammography strategies over the course of a woman's lifetime. Population: This recommendation applies to asymptomatic women aged 40 years or older who do not have preexisting breast cancer or a previously diagnosed high-risk breast lesion and who are not at high risk for breast cancer because of a known underlying genetic mutation (such as a BRCA1 or BRCA2 gene mutation or other familial breast cancer syndrome) or a history of chest radiation at a young age. Recommendations: The USPSTF recommends biennial screening mammography for women aged 50 to 74 years. (B recommendation) The decision to start screening mammography in women prior to age 50 years should be an individual one. Women who place a higher value on the potential benefit than the potential harms may choose to begin biennial screening between the ages of 40 and 49 years. (C recommendation) The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening mammography in women aged 75 years or older. (I statement) The USPSTF concludes that the current evidence is insufficient to assess the benefits and harms of digital breast tomosynthesis (DBT) as a primary screening method for breast cancer. (I statement) The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of adjunctive screening for breast cancer using breast ultrasonography, magnetic resonance imaging (MRI), DBT, or other methods in women identified to have dense breasts on an otherwise negative screening mammogram. (I statement)	[Siu, Albert L.] Mt Sinai Sch Med, New York, NY USA; [Siu, Albert L.] James J Peters Vet Affairs Med Ctr, Bronx, NY USA; [Bibbins-Domingo, Kirsten] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Grossman, David C.] Grp Hlth Res Inst, Seattle, WA USA; [Baumann, Linda Ciofu] Univ Wisconsin, Madison, WI USA; [Davidson, Karina W.] Columbia Univ, New York, NY USA; [Ebell, Mark] Univ Georgia, Athens, GA 30602 USA; [Garcia, Francisco A. R.] Pima Cty Dept Hlth, Tucson, AZ USA; [Gillman, Matthew] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Gillman, Matthew] Harvard Pilgrim Hlth Care Inst, Boston, MA USA; [Kemper, Alex R.] Duke Univ, Durham, NC USA; [Krist, Alex H.] Virginia Commonwealth Univ, Richmond, VA USA; [Kurth, Ann E.] NYU, New York, NY USA; [Owens, Douglas K.] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA; [Owens, Douglas K.] Stanford Univ, Stanford, CA 94305 USA; [Phillips, William R.] Univ Washington, Seattle, WA 98195 USA; [Phipps, Maureen G.] Brown Univ, Providence, RI 02912 USA; [Pignone, Michael P.] Univ N Carolina, Chapel Hill, NC USA; [LeFevre, Michael] Univ Missouri, Columbia, MO USA	Icahn School of Medicine at Mount Sinai; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center; University of California System; University of California San Francisco; University of Wisconsin System; University of Wisconsin Madison; Columbia University; University System of Georgia; University of Georgia; Harvard University; Harvard Medical School; Harvard Pilgrim Health Care; Duke University; Virginia Commonwealth University; New York University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; University of Washington; University of Washington Seattle; Brown University; University of North Carolina; University of North Carolina Chapel Hill; University of Missouri System; University of Missouri Columbia	Siu, AL (corresponding author), Mt Sinai Sch Med, New York, NY USA.; Siu, AL (corresponding author), James J Peters Vet Affairs Med Ctr, Bronx, NY USA.		Potter, Joseph E/A-3122-2008; Davidson, Karina/GWC-0996-2022; Davidson, Karina/AAG-2388-2019; Phillips, William R./V-1065-2017	Davidson, Karina/0000-0002-9162-477X; Davidson, Karina/0000-0002-9162-477X; Phillips, William R./0000-0003-2802-4349	U.S. Congress mandates that the Agency for Healthcare Research and Quality	U.S. Congress mandates that the Agency for Healthcare Research and Quality	The USPSTF is an independent, voluntary body. The U.S. Congress mandates that the Agency for Healthcare Research and Quality support the operations of the USPSTF.	American Academy of Family Physicians, 2016, CLIN PREV SERV REC B; American Congress of Obstetricians and Gynecologists, 2015, WELL WOM REC; [Anonymous], 2009, Ann Intern Med, V151, pI, DOI 10.7326/0003-4819-151-9-200911030-00002; [Anonymous], 2011, Obstet Gynecol, V118, P372, DOI 10.1097/AOG.0b013e31822c98e5; [Anonymous], 2015, SEER STAT FACTSH BRE; Barratt A, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h867; Bauer KR, 2007, CANCER, V109, P1721, DOI 10.1002/cncr.22618; Baxter NN, 2004, JNCI-J NATL CANCER I, V96, P443, DOI 10.1093/jnci/djh069; Berg WA, 2012, JAMA-J AM MED ASSOC, V307, P1394, DOI 10.1001/jama.2012.388; Brawley OW, 2009, J NATL CANCER I, V101, P970, DOI 10.1093/jnci/djp185; Carey LA, 2006, JAMA-J AM MED ASSOC, V295, P2492, DOI 10.1001/jama.295.21.2492; Carney PA, 2003, ANN INTERN MED, V138, P168, DOI 10.7326/0003-4819-138-3-200302040-00008; Carter JL, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.g7773; Coldman A, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju261; Conry JA, 2015, OBSTET GYNECOL, V126, P697, DOI 10.1097/AOG.0000000000001055; DeSantis CE, 2016, CA-CANCER J CLIN, V66, P31, DOI 10.3322/caac.21320; Dickinson J, 2011, CAN MED ASSOC J, V183, P1991, DOI 10.1503/cmaj.110334; Esserman LJ, 2013, JAMA-J AM MED ASSOC, V310, P797, DOI 10.1001/jama.2013.108415; Friedewald SM, 2014, JAMA-J AM MED ASSOC, V311, P2499, DOI 10.1001/jama.2014.6095; Gierach GL, 2012, J NATL CANCER I, V104, P1218, DOI 10.1093/jnci/djs327; Giordano L, 2012, J MED SCREEN, V19, P72, DOI 10.1258/jms.2012.012085; Gotzsche PC, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001877.pub5; Griggs JJ, 2007, J CLIN ONCOL, V25, P2522, DOI 10.1200/JCO.2006.10.2749; Hellquist BN, 2011, CANCER-AM CANCER SOC, V117, P714, DOI 10.1002/cncr.25650; Howlader N, 2014, SEER CANC STAT REV; Hubbard RA, 2011, ANN INTERN MED, V155, P481, DOI 10.7326/0003-4819-155-8-201110180-00004; Humphrey LL, 2002, ANN INTERN MED, V137, P347, DOI 10.7326/0003-4819-137-5_Part_1-200209030-00012; Kerlikowske K, 2013, JAMA INTERN MED, V173, P807, DOI 10.1001/jamainternmed.2013.307; Lansdorp-Vogelaar I, 2014, ANN INTERN MED, V161, P104, DOI 10.7326/M13-2867; Lauby-Secretan B, 2015, NEW ENGL J MED, V372, P2353, DOI 10.1056/NEJMsr1504363; Lee CH, 2010, J AM COLL RADIOL, V7, P18, DOI 10.1016/j.jacr.2009.09.022; Mandelblatt JCK, 2015, AHRQ PUBLICATION; Mandelblatt JS, 2016, ANN INTERN MED, V164, P215, DOI 10.7326/M15-1536; Marmot MG, 2013, BRIT J CANCER, V108, P2205, DOI 10.1038/bjc.2013.177; Melnikow J, 2015, AHRQ PUBLICATION; Melnikow J, 2016, ANN INTERN MED, V164, P268, DOI 10.7326/M15-1789; Miglioretti DL, 2016, ANN INTERN MED, V164, P205, DOI 10.7326/M15-1241; Miglioretti DL, 2015, AHRQ PUBLICATION; Narod SA, 2015, JAMA ONCOL, V1, P888, DOI 10.1001/jamaoncol.2015.2510; National Committee for Quality Assurance, 2015, STAT HLTH CAR QUAL B; Nelson HD, 2015, AHRQ PUBLICATION; Nelson HD, 2016, ANN INTERN MED, V164, P256, DOI 10.7326/M15-0970; Nelson HD, 2016, ANN INTERN MED, V164, P244, DOI 10.7326/M15-0969; Nelson HD, 2016, ANN INTERN MED, V164, P226, DOI 10.7326/M15-0971; Nelson HD, 2013, ANN INTERN MED, V158, P604, DOI 10.7326/0003-4819-158-8-201304160-00005; Oeffinger KC, 2015, JAMA-J AM MED ASSOC, V314, P1599, DOI 10.1001/jama.2015.12783; Pisano ED, 2005, NEW ENGL J MED, V353, P1773, DOI 10.1056/NEJMoa052911; Qaseem A, 2007, ANN INTERN MED, V146, P511, DOI 10.7326/0003-4819-146-7-200704030-00007; Roetzheim RG, 1999, J NATL CANCER I, V91, P1409, DOI 10.1093/jnci/91.16.1409; Rose SL, 2013, AM J ROENTGENOL, V200, P1401, DOI 10.2214/AJR.12.9672; Sabatino SA, 2015, MMWR-MORBID MORTAL W, V64, P464; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Siu AL, 2015, JAMA-J AM MED ASSOC, V314, P2021, DOI 10.1001/jama.2015.13154; Skaane P, 2014, RADIOLOGY, V271, P655, DOI 10.1148/radiol.13131391; Skaane P, 2013, RADIOLOGY, V267, P47, DOI 10.1148/radiol.12121373; Souza FH, 2013, BREAST, V22, P217, DOI 10.1016/j.breast.2013.02.013; Sprague BL, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju255; Welch HG, 2015, NEW ENGL J MED, V373, P1685, DOI 10.1056/NEJMp1510443; Wickerham DL, 2013, JNCI-J NATL CANCER I, V105, P1521, DOI 10.1093/jnci/djt268	59	1065	1088	6	98	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 16	2016	164	4					279	+		10.7326/M15-2886	http://dx.doi.org/10.7326/M15-2886			19	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DD7WK	26757170	Green Submitted			2022-12-28	WOS:000370135300018
J	Heazell, AEP; Siassakos, D; Blencowe, H; Burden, C; Bhutta, ZA; Cacciatore, J; Dang, N; Das, J; Flenady, V; Gold, KJ; Mensah, OK; Millum, J; Nuzum, D; O'Donoghue, K; Redshaw, M; Rizvi, A; Roberts, T; Saraki, HET; Storey, C; Wojcieszek, AM; Downe, S				Heazell, Alexander E. P.; Siassakos, Dimitrios; Blencowe, Hannah; Burden, Christy; Bhutta, Zulfiqar A.; Cacciatore, Joanne; Dang, Nghia; Das, Jai; Flenady, Vicki; Gold, Katherine J.; Mensah, Olivia K.; Millum, Joseph; Nuzum, Daniel; O'Donoghue, Keelin; Redshaw, Maggie; Rizvi, Arjumand; Roberts, Tracy; Saraki, H. E. Toyin; Storey, Claire; Wojcieszek, Aleena M.; Downe, Soo		Lancet Ending Preventable Stillbir; Lancet Ending Preventable Stillbir	Stillbirths: economic and psychosocial consequences	LANCET			English	Article							FOLLOW-UP INTERVENTION; PREGNANCY LOSS; MATERNAL MORTALITY; MOTHERS EXPERIENCE; COST-EFFECTIVENESS; NEONATAL DEATH; PERINATAL LOSS; DEPRESSIVE SYMPTOMS; PARENTS EXPERIENCES; SUPPORT GROUPS	Despite the frequency of stillbirths, the subsequent implications are overlooked and underappreciated. We present findings from comprehensive, systematic literature reviews, and new analyses of published and unpublished data, to establish the effect of stillbirth on parents, families, health-care providers, and societies worldwide. Data for direct costs of this event are sparse but suggest that a stillbirth needs more resources than a livebirth, both in the perinatal period and in additional surveillance during subsequent pregnancies. Indirect and intangible costs of stillbirth are extensive and are usually met by families alone. This issue is particularly onerous for those with few resources. Negative effects, particularly on parental mental health, might be moderated by empathic attitudes of care providers and tailored interventions. The value of the baby, as well as the associated costs for parents, families, care providers, communities, and society, should be considered to prevent stillbirths and reduce associated morbidity.	[Heazell, Alexander E. P.] Univ Manchester, Inst Human Dev, Fac Med & Human Sci, Manchester, Lancs, England; [Heazell, Alexander E. P.] Cent Manchester Univ Hosp NHS Fdn Trust, St Marys Hosp, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England; [Heazell, Alexander E. P.; Siassakos, Dimitrios; Flenady, Vicki; Gold, Katherine J.; Storey, Claire; Wojcieszek, Aleena M.] Int Stillbirth Alliance, New York, NY USA; [Siassakos, Dimitrios; Burden, Christy] Univ Bristol, Acad Ctr Womens Hlth, Bristol, Avon, England; [Siassakos, Dimitrios; Burden, Christy] Southmead Hosp, Bristol, Avon, England; [Blencowe, Hannah] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, Ctr Maternal Reprod & Child Hlth, London WC1, England; [Bhutta, Zulfiqar A.] Hosp Sick Children, Ctr Global Child Hlth, Toronto, ON M5G 1X8, Canada; [Bhutta, Zulfiqar A.; Das, Jai; Rizvi, Arjumand] Aga Khan Univ, Ctr Excellence Women & Child Hlth, Karachi, Pakistan; [Cacciatore, Joanne] Arizona State Univ, Tempe, AZ USA; [Dang, Nghia] Hanoi Vinmec Int Gen Hosp, Inst Reprod & Family Hlth, Hanoi, Vietnam; [Flenady, Vicki; Wojcieszek, Aleena M.] Univ Queensland, Mater Res Inst, Brisbane, Qld, Australia; [Gold, Katherine J.] Univ Michigan, Dept Family Med, Ann Arbor, MI 48109 USA; [Gold, Katherine J.] Univ Michigan, Dept Obstet, Ann Arbor, MI 48109 USA; [Mensah, Olivia K.] Krachi Midwifery Training Sch, Kete Krach, Ghana; [Millum, Joseph] NIH, Ctr Clin, Dept Bioeth, Fogarty Int Ctr, Bethesda, MD 20892 USA; [Nuzum, Daniel; O'Donoghue, Keelin] Cork Univ, Matern Hosp, Univ Coll Cork, Dept Obstet & Gynaecol, Cork, Ireland; [Redshaw, Maggie] Univ Oxford, Nuffield Dept Populat Hlth, Natl Perinatal Epidemiol Unit, Oxford, England; [Roberts, Tracy] Univ Birmingham, Sch Hlth & Populat Sci, Hlth Econ Unit, Birmingham, W Midlands, England; [Saraki, H. E. Toyin] Wellbeing Fdn Africa, Lagos, Nigeria; [Downe, Soo] Univ Cent Lancashire, ReaCH Grp, Preston PR1 2HE, Lancs, England; St Marys Hosp, Maternal & Fetal Hlth Res Ctr, Manchester M13 9WL, Lancs, England	University of Manchester; University of Manchester; University of Bristol; Southmead Hospital; University of London; London School of Hygiene & Tropical Medicine; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Aga Khan University; Arizona State University; Arizona State University-Tempe; Mater Research; University of Queensland; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); NIH Fogarty International Center (FIC); University College Cork; University of Oxford; University of Birmingham; University of Central Lancashire; University of Manchester	Heazell, AEP (corresponding author), St Marys Hosp, Maternal & Fetal Hlth Res Ctr, Manchester M13 9WL, Lancs, England.	alexander.heazell@manchester.ac.uk	Nuzum, Daniel/AAS-7841-2020; Wojcieszek, Aleena M/S-8668-2019; Siassakos, Dimitrios/A-6859-2012; Flenady, Vicki Jane/O-9609-2014; Lawn, Joy/ABE-6382-2020; Roberts, Tracy/AAO-4610-2021	Nuzum, Daniel/0000-0002-9907-5680; Wojcieszek, Aleena M/0000-0001-8099-6087; Siassakos, Dimitrios/0000-0002-1078-9856; Flenady, Vicki Jane/0000-0001-8114-7677; Lawn, Joy/0000-0002-4573-1443; Roberts, Tracy/0000-0002-0624-0537; Budd, Jayne/0000-0002-2076-7378; Blencowe, Hannah/0000-0003-1556-3159; Das, Jai/0000-0002-2966-7162; Froen Froen, Jahn Frederik/0000-0001-9390-8509; O'Donoghue, Keelin/0000-0002-4616-2887; Burden, Christy/0000-0001-6409-5238	Save the Children/Saving Newborn Lives; Holly Martin Stillbirth Research Fund; National Institutes of Health Clinical Center; UK Policy Research Programme in the Department of Health; Tommy's and by a Clinician Scientist Fellowship from the UK National Institute of Health Research; National Institute for Health Research (NIHR); National Institutes of Health; Mater Research Institute, University of Queensland, Australia; National Institute for Health Research [CL-2014-25-503, CS-2013-13-009] Funding Source: researchfish	Save the Children/Saving Newborn Lives; Holly Martin Stillbirth Research Fund; National Institutes of Health Clinical Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UK Policy Research Programme in the Department of Health; Tommy's and by a Clinician Scientist Fellowship from the UK National Institute of Health Research; National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mater Research Institute, University of Queensland, Australia; National Institute for Health Research(National Institute for Health Research (NIHR))	HB received grants from Save the Children/Saving Newborn Lives. DS is a member of Department of Health Stillbirth task-and-finish groups, and the PRactical Obstetric Multi-Professional Training maternity foundation. AEPH received grants from Tommy's during the conduct of the paper and was funded by the Holly Martin Stillbirth Research Fund to do qualitative analysis. JM was also supported, in part, by intramural funds from the National Institutes of Health Clinical Center. The views expressed are the author's own and do not represent the position or policy of the US National Institutes of Health, Public Health Service, or the Department of Health and Human Services. This Series paper also reports on independent studies which are part funded by the UK Policy Research Programme in the Department of Health. AEPH is supported by Tommy's and by a Clinician Scientist Fellowship from the UK National Institute of Health Research. This Series paper provides independent research funded by the National Institute for Health Research (NIHR). The views expressed are those of the authors and not necessarily those of the National Health Service, the NIHR, or the Department of Health. KJG receives salary support through a K23 training grant from the National Institutes of Health. None of the funding bodies had any influence on the content and scope of the paper. We thank Mater Research Institute, University of Queensland, Australia, for funding the International Stillbirth Alliance questionnaire. We thank Bishal Mohindru for his assistance in the costs analysis for care in subsequent pregnancies.	Aho AL, 2011, DEATH STUD, V35, P879, DOI 10.1080/07481187.2011.553318; Akiko H., 2009, JAPAN MIDWIFERY J, V23, P59; Andrews, 2010, INT J HUM CARING, V14, P14, DOI DOI 10.20467/1091-5710.14.4.14; Armstrong D, 2001, MCN Am J Matern Child Nurs, V26, P147, DOI 10.1097/00005721-200105000-00012; Avelin P, 2013, MIDWIFERY, V29, P668, DOI 10.1016/j.midw.2012.06.007; Avelin P, 2011, BIRTH-ISS PERINAT C, V38, P150, DOI 10.1111/j.1523-536X.2010.00457.x; Bazile J, 2015, REPROD HEALTH, V12, DOI 10.1186/1742-4755-12-S1-S1; Bennett SM, 2012, COGN BEHAV PRACT, V19, P161, DOI 10.1016/j.cbpra.2011.01.002; Bhutta ZA, 2014, LANCET, V384, P347, DOI 10.1016/S0140-6736(14)60792-3; Bhutto ZA, 2011, LANCET, V377, P1523, DOI 10.1016/S0140-6736(10)62269-6; Blood C, 2014, DEATH STUD, V38, P224, DOI 10.1080/07481187.2013.788584; Cacciatore J, 2009, HEALTH SOC CARE COMM, V17, P167, DOI 10.1111/j.1365-2524.2008.00814.x; Cacciatore J, 2007, J SOC WORK END-LIFE, V3, P59, DOI 10.1300/J457v03n03_06; Cacciatore J, 2007, OMEGA-J DEATH DYING, V55, P71, DOI 10.2190/M447-1X11-6566-8042; Cacciatore J, 2013, OMEGA-J DEATH DYING, V68, P183, DOI 10.2190/OM.68.3.a; Cacciatore J, 2008, BIRTH-ISS PERINAT C, V35, P313, DOI 10.1111/j.1523-536X.2008.00258.x; Christensen H, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5725; Cooke A, 2012, QUAL HEALTH RES, V22, P1435, DOI 10.1177/1049732312452938; Cote-Arsenault D, 2004, WESTERN J NURS RES, V26, P650, DOI 10.1177/0193945904265817; Cote-Arsenault D, 2011, J REPROD INFANT PSYC, V29, P81, DOI 10.1080/02646838.2010.513115; Crawley R, 2013, J REPROD INFANT PSYC, V31, P195, DOI 10.1080/02646838.2013.795216; Downe S, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002237; Dyregrov A, 2011, DEATH STUD, V35, P289, DOI 10.1080/07481187.2010.527753; Erlandsson K, 2010, J CHILD HEALTH CARE, V14, P151, DOI 10.1177/1367493509355621; Evans J, 2012, J CHILD PSYCHOL PSYC, V53, P632, DOI 10.1111/j.1469-7610.2011.02513.x; Farrow VA, 2013, J MATERN-FETAL NEO M, V26, P748, DOI 10.3109/14767058.2012.746953; Forhan M, 2010, AM J OCCUP THER, V64, P142, DOI 10.5014/ajot.64.1.142; Fottrell E, 2010, BRIT J PSYCHIAT, V196, P18, DOI 10.1192/bjp.bp.108.062489; Froen JF, 2011, LANCET, V377, P1353, DOI 10.1016/S0140-6736(10)62232-5; Froen JF, 2016, LANCET; Gausia K, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-451; Gold KJ, 2008, OBSTET GYNECOL, V112, P29, DOI 10.1097/AOG.0b013e31817d0582; Gold KJ, 2013, MATERN CHILD HLTH J, V17, P1835, DOI 10.1007/s10995-012-1203-8; Gold KJ, 2012, WOMEN HEALTH ISS, V22, pE67, DOI 10.1016/j.whi.2011.07.006; Gold KJ, 2010, PEDIATRICS, V125, pE1202, DOI 10.1542/peds.2009-3081; Haws RA, 2010, SOC SCI MED, V71, P1764, DOI 10.1016/j.socscimed.2010.03.051; Heintz E, 2008, BJOG-INT J OBSTET GY, V115, P1676, DOI 10.1111/j.1471-0528.2008.01935.x; Hogue CJR, 2015, PAEDIATR PERINAT EP, V29, P131, DOI 10.1111/ppe.12176; Honest H, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13430; Horey D, 2013, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD009932.PUB2; Hsu MT, 2004, J ADV NURS, V47, P408, DOI 10.1111/j.1365-2648.2004.03119.x; Huberty JL, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-26; Hughes P, 2001, J CHILD PSYCHOL PSYC, V42, P791; Hutti MH, 2011, MCN-AM J MATERN-CHIL, V36, P104, DOI 10.1097/NMC.0b013e3182057335; Iaconelli V., 2013, PSICOL TEOR PRAT, V15, P34; Jamison DT, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P427; Kavanaugh K, 2005, JOGNN-J OBST GYN NEO, V34, P595, DOI 10.1177/0884217505280000; Kelley M, 2011, LANCET, V377, P1636, DOI 10.1016/S0140-6736(11)60279-1; Kelley MC, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-137; Kes A, 2015, REPROD HEALTH, V12, DOI 10.1186/1742-4755-12-S1-S3; Kingdon C, 2015, BIRTH-ISS PERINAT C, V42, P206, DOI 10.1111/birt.12176; Knight L, 2015, REPROD HEALTH, V12, DOI 10.1186/1742-4755-12-S1-S5; Koopmans L, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000452.pub3; Lacasse JR, 2014, DEATH STUD, V38, P589, DOI 10.1080/07481187.2013.820229; Lawn JE, 2016, LANCET, V387, P587, DOI 10.1016/S0140-6736(15)00837-5; Lee C, 2012, J REPROD INFANT PSYC, V30, P62, DOI 10.1080/02646838.2012.661849; LeFevre AE, 2013, B WORLD HEALTH ORGAN, V91, P736, DOI 10.2471/BLT.12.117127; Liisa AA, 2011, SCAND J CARING SCI, V25, P373, DOI 10.1111/j.1471-6712.2010.00837.x; MARKS JS, 1990, AM J PREV MED, V6, P282, DOI 10.1016/S0749-3797(18)30996-6; McCool W, 2009, HEALTH CARE WOMEN IN, V30, P1003, DOI 10.1080/07399330903134455; McCreight BS, 2004, SOCIOL HEALTH ILL, V26, P326, DOI 10.1111/j.1467-9566.2004.00393.x; McKenna L, 2011, CONTEMP NURSE, V38, P76, DOI 10.5172/conu.2011.38.1-2.76; Michalski ST, 2002, AM J OBSTET GYNECOL, V186, P1027, DOI 10.1067/mob.2002.122450; Mills TA, 2014, BJOG-INT J OBSTET GY, V121, P943, DOI 10.1111/1471-0528.12656; Mistry H, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-236; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; Molla M, 2015, REPROD HEALTH, V12, DOI 10.1186/1742-4755-12-S1-S6; Montesinos A, 2013, REV CHIL PEDIATR-CHI, V84, P650, DOI 10.4067/S0370-41062013000600008; Murphy S, 2012, MIDWIFERY, V28, P476, DOI 10.1016/j.midw.2011.06.005; Murphy SL, 2012, BEREAVE CARE, V31, P98, DOI 10.1080/02682621.2012.740277; National Collaborating Centre for Women's and Children's Health, 2015, DIAB PREGN MAN DIAB, P579; Nikkola I, 2013, J CLIN NURS, V22, P1151, DOI 10.1111/j.1365-2702.2012.04247.x; Nuzum D, 2014, BJOG-INT J OBSTET GY, V121, P1020, DOI 10.1111/1471-0528.12695; O'Leary J, 2006, JOGNN-J OBST GYN NEO, V35, P78, DOI 10.1111/J.1552-6909.2006.00017.x; O'Leary J, 2013, J FAM NURS, V19, P324, DOI 10.1177/1074840713495972; Ogwulu CB, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0617-x; Pande RP, 2015, REPROD HEALTH, V12, DOI 10.1186/1742-4755-12-S1-S2; Pattinson R, 2011, LANCET, V377, P1610, DOI 10.1016/S0140-6736(10)62306-9; Personal Social Services Research Unit (PSSRU), 2017, UNIT COSTS HLTH SOCI; Peters MDJ., 2014, PROVIDING CARE FAMIL; Petrou S, 2012, SEMIN FETAL NEONAT M, V17, P170, DOI 10.1016/j.siny.2012.02.001; Phillips J, 2015, BIOETHICS, V29, P413, DOI 10.1111/bioe.12120; Puia DM, 2013, JOGNN-J OBST GYN NEO, V42, P321, DOI 10.1111/1552-6909.12040; Radestad I, 1997, ACTA OBSTET GYN SCAN, V76, P849, DOI 10.3109/00016349709024364; Radestad I., 2013, BR J MIDWIFERY, V17, P178, DOI [DOI 10.12968/bjom.2009.17.3.40082, 10.12968/bjom.2009.17.3.40082, DOI 10.12968/BJOM.2009.17.3.40082]; Ramchandani PG, 2008, J AM ACAD CHILD PSY, V47, P390, DOI 10.1097/CHI.0b013e31816429c2; Reddy UM, 2010, CLIN OBSTET GYNECOL, V53, P700, DOI 10.1097/GRF.0b013e3181eba25e; Redshaw M., 2015, SAFELY DELIVERED NAT; Redshaw M, 2014, LISTENING PARENTS ST; Roberts LR, 2012, J COMMUN HEALTH, V37, P572, DOI 10.1007/s10900-011-9485-0; Robson S, 2006, AUST NZ J OBSTET GYN, V46, P278, DOI 10.1111/j.1479-828X.2006.00591.x; Roehrs C, 2008, JOGNN-J OBST GYN NEO, V37, P631, DOI 10.1111/j.1552-6909.2008.00290.x; Ryninks K, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-203; Saflund K, 2004, BIRTH-ISS PERINAT C, V31, P132, DOI 10.1111/j.0730-7659.2004.00291.x; Sarafino EP., 1994, HLTH PSYCHOL BIOPSYC, P102; Simwaka ANK, 2014, MALAWI MED J, V26, P8; Sisay MM, 2014, J MIDWIFERY WOM HEAL, V59, pS110, DOI 10.1111/jmwh.12156; St John A, 2006, AUST J ADV NURS, V23, P8; Steen SE, 2015, INT J PALLIAT NURS, V21, P79, DOI 10.12968/ijpn.2015.21.2.79; Sun HL, 2011, MCN-AM J MATERN-CHIL, V36, P127, DOI 10.1097/NMC.0b013e3182073629; Sun JC, 2014, INT J NURS STUD, V51, P1153, DOI 10.1016/j.ijnurstu.2013.11.009; Sutherland T, 2010, INT J GYNECOL OBSTET, V108, P289, DOI 10.1016/j.ijgo.2009.11.007; Tarricone R, 2006, HEALTH POLICY, V77, P51, DOI 10.1016/j.healthpol.2005.07.016; Terris-Prestholt F, 2003, SEX TRANSM INFECT, V79, P375, DOI 10.1136/sti.79.5.375; Tseng YF, 2014, RES NURS HEALTH, V37, P219, DOI 10.1002/nur.21594; UNICEF, 2016, UNICEF PHILIPS FDN T; US Bureau of Labor Statistics, 2015, CONS PRIC IND INFL C; van der Sijpt E, 2014, MED ANTHROPOL, V33, P395, DOI 10.1080/01459740.2013.828286; Vijgen SMC, 2011, ACTA OBSTET GYN SCAN, V90, P772, DOI 10.1111/j.1600-0412.2011.01138.x; Warland J, 2011, MIDWIFERY, V27, pE163, DOI 10.1016/j.midw.2010.02.004; WEEKS JW, 1995, AM J OBSTET GYNECOL, V172, P486, DOI 10.1016/0002-9378(95)90561-8	111	284	294	4	60	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 6	2016	387	10018					604	616		10.1016/S0140-6736(15)00836-3	http://dx.doi.org/10.1016/S0140-6736(15)00836-3			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DD3PV	26794073	Green Submitted, Green Accepted, Green Published			2022-12-28	WOS:000369835800038
J	Lechtenberg, BC; Rajput, A; Sanishvili, R; Dobaczewska, MK; Ware, CF; Mace, PD; Riedl, SJ				Lechtenberg, Bernhard C.; Rajput, Akhil; Sanishvili, Ruslan; Dobaczewska, Malgorzata K.; Ware, Carl F.; Mace, Peter D.; Riedl, Stefan J.			Structure of a HOIP/E2 similar to ubiquitin complex reveals RBR E3 ligase mechanism and regulation	NATURE			English	Article							NF-KAPPA-B; LINEAR UBIQUITIN CHAINS; RING DOMAIN; CONJUGATING ENZYME; PARKIN; INSIGHTS; REFINEMENT; ACTIVATION; SHARPIN; SYSTEM	Ubiquitination is a central process affecting all facets of cellular signalling and function(1). A critical step in ubiquitination is the transfer of ubiquitin from an E2 ubiquitin-conjugating enzyme to a substrate or a growing ubiquitin chain, which is mediated by E3 ubiquitin ligases. RING-type E3 ligases typically facilitate the transfer of ubiquitin from the E2 directly to the substrate(2,3). The RING-between-RING (RBR) family of RING-type E3 ligases, however, breaks this paradigm by forming a covalent intermediate with ubiquitin similarly to HECT-type E3 ligases(4-6). The RBR family includes Parkin(4) and HOIP, the central catalytic factor of the LUBAC (linear ubiquitin chain assembly complex)(7). While structural insights into the RBR E3 ligases Parkin and HHARI in their overall auto-inhibited forms are available(8-13), no structures exist of intact fully active RBR E3 ligases or any of their complexes. Thus, the RBR mechanism of action has remained largely unknown. Here we present the first structure, to our knowledge, of the fully active human HOIP RBR in its transfer complex with an E2 similar to ubiquitin conjugate, which elucidates the intricate nature of RBR E3 ligases. The active HOIP RBR adopts a conformation markedly different from that of auto-inhibited RBRs. HOIP RBR binds the E2 similar to ubiquitin conjugate in an elongated fashion, with the E2 and E3 catalytic centres ideally aligned for ubiquitin transfer, which structurally both requires and enables a HECT-like mechanism. In addition, three distinct helix-IBR-fold motifs inherent to RBRs form ubiquitin-binding regions that engage the activated ubiquitin of the E2 similar to ubiquitin conjugate and, surprisingly, an additional regulatory ubiquitin molecule. The features uncovered reveal critical states of the HOIP RBR E3 ligase cycle, and comparison with Parkin and HHARI suggests a general mechanism for RBR E3 ligases.	[Lechtenberg, Bernhard C.; Dobaczewska, Malgorzata K.; Riedl, Stefan J.] Sanford Burnham Prebys Med Discovery Inst, NCI Designated Canc Ctr, 10901 North Torrey Pines Rd, La Jolla, CA 92037 USA; [Rajput, Akhil; Ware, Carl F.] Sanford Burnham Prebys Med Discovery Inst, Infect & Inflammatory Dis Ctr, 10901 North Torrey Pines Rd, La Jolla, CA 92037 USA; [Sanishvili, Ruslan] Argonne Natl Lab, Adv Photon Source, Xray Sci Div, 9700 S Cass Ave, Argonne, IL 60439 USA; [Mace, Peter D.] Univ Otago, Dept Biochem, Dunedin 9054, New Zealand	Sanford Burnham Prebys Medical Discovery Institute; Sanford Burnham Prebys Medical Discovery Institute; United States Department of Energy (DOE); Argonne National Laboratory; University of Otago	Riedl, SJ (corresponding author), Sanford Burnham Prebys Med Discovery Inst, NCI Designated Canc Ctr, 10901 North Torrey Pines Rd, La Jolla, CA 92037 USA.	sriedl@SBPdiscovery.org		Mace, Peter/0000-0003-2175-9537; Lechtenberg, Bernhard Clemens/0000-0002-5674-6894	NIH [R01AA017238]; EMBO Long-term Postdoctoral Fellowship; Rutherford Discovery Fellowship from the New Zealand government; NCI Cancer Center Support Grant [P30CA030199]; DOE Office of Science [DE-AC02-06CH11357]; National Cancer Institute [ACB-12002]; National Institute of General Medical Sciences [AGM-12006]; NATIONAL CANCER INSTITUTE [P30CA030199] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA017238] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EMBO Long-term Postdoctoral Fellowship(European Molecular Biology Organization (EMBO)); Rutherford Discovery Fellowship from the New Zealand government(Royal Society of New Zealand); NCI Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); DOE Office of Science(United States Department of Energy (DOE)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	The authors thank A. Bobkov (SBP Protein Analysis Facility) for performing ITC and AUC experiments, M. Petroski (SBP) for providing UbcH5B and Cdc34 constructs, J. Badger (DeltaG technologies) for assistance in model evaluation and E. Pasquale (SBP) for help with manuscript writing. This work was supported by NIH grant R01AA017238 and institutional funding (S.J.R.), an EMBO Long-term Postdoctoral Fellowship (B.C.L.), a Rutherford Discovery Fellowship from the New Zealand government administered by the Royal Society of New Zealand (P.D.M.) and NCI Cancer Center Support Grant P30CA030199 (SBP Protein Analysis Core Facility). This research used resources of the Advanced Photon Source, a US Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract No. DE-AC02-06CH11357. GM/CA@APS has been funded in whole or in part with Federal funds from the National Cancer Institute (ACB-12002) and the National Institute of General Medical Sciences (AGM-12006).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2015, ACTA CRYSTALLOGR D, V71, P646, DOI 10.1107/S1399004714028132; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Berndsen CE, 2014, NAT STRUCT MOL BIOL, V21, P301, DOI 10.1038/nsmb.2780; Branigan E, 2015, NAT STRUCT MOL BIOL, V22, P597, DOI 10.1038/nsmb.3052; Brzovic PS, 2006, MOL CELL, V21, P873, DOI 10.1016/j.molcel.2006.02.008; Bunkoczi G, 2011, ACTA CRYSTALLOGR D, V67, P303, DOI 10.1107/S0907444910051218; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Dong KC, 2011, STRUCTURE, V19, P1053, DOI 10.1016/j.str.2011.06.010; Dou H, 2012, NAT STRUCT MOL BIOL, V19, P876, DOI 10.1038/nsmb.2379; Drozdetskiy A, 2015, NUCLEIC ACIDS RES, V43, pW389, DOI 10.1093/nar/gkv332; Duda DM, 2013, STRUCTURE, V21, P1030, DOI 10.1016/j.str.2013.04.019; Elliott PR, 2014, MOL CELL, V54, P335, DOI 10.1016/j.molcel.2014.03.018; Emmerich CH, 2013, P NATL ACAD SCI USA, V110, P15247, DOI 10.1073/pnas.1314715110; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Gerlach B, 2011, NATURE, V471, P591, DOI 10.1038/nature09816; Grishin AM, 2014, STRUCTURE, V22, P878, DOI 10.1016/j.str.2014.04.010; Hilgart MC, 2011, J SYNCHROTRON RADIAT, V18, P717, DOI 10.1107/S0909049511029918; Huang L, 1999, SCIENCE, V286, P1321, DOI 10.1126/science.286.5443.1321; Ikeda F, 2011, NATURE, V471, P637, DOI 10.1038/nature09814; Joosten RP, 2014, IUCRJ, V1, P213, DOI 10.1107/S2052252514009324; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kamadurai HB, 2009, MOL CELL, V36, P1095, DOI 10.1016/j.molcel.2009.11.010; Kirisako T, 2006, EMBO J, V25, P4877, DOI 10.1038/sj.emboj.7601360; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Kumar A, 2015, EMBO J, V34, P2506, DOI 10.15252/embj.201592337; Lehninger A., 1993, PRINCIPLES BIOCH; Luna-Vargas MPA, 2011, J STRUCT BIOL, V175, P113, DOI 10.1016/j.jsb.2011.03.017; Mace PD, 2008, J BIOL CHEM, V283, P31633, DOI 10.1074/jbc.M804753200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Metzger MB, 2014, BBA-MOL CELL RES, V1843, P47, DOI 10.1016/j.bbamcr.2013.05.026; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nicholls RA, 2014, ACTA CRYSTALLOGR D, V70, P2487, DOI 10.1107/S1399004714016241; Nicholls RA, 2012, ACTA CRYSTALLOGR D, V68, P404, DOI 10.1107/S090744491105606X; Ozkan E, 2005, P NATL ACAD SCI USA, V102, P18890, DOI 10.1073/pnas.0509418102; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Plechanovova A, 2012, NATURE, V489, P115, DOI 10.1038/nature11376; Plechanovova A, 2011, NAT STRUCT MOL BIOL, V18, P1052, DOI 10.1038/nsmb.2108; Pruneda JN, 2012, MOL CELL, V47, P933, DOI 10.1016/j.molcel.2012.07.001; Riley BE, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2982; Sakata E, 2010, STRUCTURE, V18, P138, DOI 10.1016/j.str.2009.11.007; Sasaki K, 2015, IMMUNOL REV, V266, P175, DOI 10.1111/imr.12308; Sato Y, 2011, P NATL ACAD SCI USA, V108, P20520, DOI 10.1073/pnas.1109088108; Smit JJ, 2012, EMBO J, V31, P3833, DOI 10.1038/emboj.2012.217; Spratt DE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074047; Spratt DE, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2983; Stepanov S, 2011, ACTA CRYSTALLOGR D, V67, P176, DOI 10.1107/S0907444910053916; Stieglitz B, 2013, NATURE, V503, P422, DOI 10.1038/nature12638; Stieglitz B, 2012, EMBO REP, V13, P840, DOI 10.1038/embor.2012.105; Tokunaga F, 2011, NATURE, V471, P633, DOI 10.1038/nature09815; Tokunaga F, 2009, NAT CELL BIOL, V11, P123, DOI 10.1038/ncb1821; Trempe JF, 2013, SCIENCE, V340, P1451, DOI 10.1126/science.1237908; Wauer T, 2015, NATURE, V524, P370, DOI 10.1038/nature14879; Wauer T, 2013, EMBO J, V32, P2099, DOI 10.1038/emboj.2013.125; Wenzel DM, 2011, NATURE, V474, P105, DOI 10.1038/nature09966; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yagi H, 2012, EMBO REP, V13, P462, DOI 10.1038/embor.2012.24; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	59	98	99	4	33	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 28	2016	529	7587					546	+		10.1038/nature16511	http://dx.doi.org/10.1038/nature16511			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB7DD	26789245	Green Accepted			2022-12-28	WOS:000368673800041
J	Emdin, CA; Wong, CX; Hsiao, AJ; Altman, DG; Peters, SAE; Woodward, M; Odutayo, AA				Emdin, Connor A.; Wong, Christopher X.; Hsiao, Allan J.; Altman, Douglas G.; Peters, Sanne A. E.; Woodward, Mark; Odutayo, Ayodele A.			Atrial fibrillation as risk factor for cardiovascular disease and death in women compared with men: systematic review and meta-analysis of cohort studies	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CORONARY-HEART-DISEASE; ALL-CAUSE MORTALITY; ISCHEMIC-STROKE; FOLLOW-UP; ATHEROSCLEROSIS-RISK; GLOBAL BURDEN; SEX; EPIDEMIOLOGY; POPULATION; PREVENTION	OBJECTIVE To determine whether atrial fibrillation is a stronger risk factor for cardiovascular disease and death in women compared with men. DESIGN Meta-analysis of cohort studies. DATA SOURCES Studies published between January 1966 and March 2015, identified through a systematic search of Medline and Embase and review of references. ELIGIBILITY FOR SELECTING STUDIES Cohort studies with a minimum of 50 participants with and 50 without atrial fibrillation that reported sex specific associations between atrial fibrillation and all cause mortality, cardiovascular mortality, stroke, cardiac events (cardiac death and non-fatal myocardial infarction), and heart failure. DATA EXTRACTION Two independent reviewers extracted study characteristics and maximally adjusted sex specific relative risks. Inverse variance weighted random effects meta-analysis was used to pool sex specific relative risks and their ratio. RESULTS 30 studies with 4 371 714 participants were identified. Atrial fibrillation was associated with a higher risk of all cause mortality in women (ratio of relative risks for women compared with men 1.12, 95% confidence interval 1.07 to 1.17) and a significantly stronger risk of stroke (1.99, 1.46 to 2.71), cardiovascular mortality (1.93, 1.44 to 2.60), cardiac events (1.55, 1.15 to 2.08), and heart failure (1.16, 1.07 to 1.27). Results were broadly consistent in sensitivity analyses. CONCLUSION Atrial fibrillation is a stronger risk factor for cardiovascular disease and death in women compared with men, though further research would be needed to determine any causality.	[Emdin, Connor A.; Peters, Sanne A. E.; Woodward, Mark] Univ Oxford, George Inst Global Hlth, Oxford, England; [Wong, Christopher X.] Univ Oxford, Nuffield Dept Populat Hlth, Oxford, England; [Hsiao, Allan J.] MIT, Dept Econ, Cambridge, MA 02139 USA; [Altman, Douglas G.; Odutayo, Ayodele A.] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Ctr Stat Med, Oxford, England; [Woodward, Mark] Univ Sydney, George Inst Global Hlth, Sydney, NSW 2006, Australia; [Odutayo, Ayodele A.] Univ Toronto, Fac Med, Toronto, ON, Canada	University of Oxford; University of Oxford; Massachusetts Institute of Technology (MIT); University of Oxford; George Institute for Global Health; University of Sydney; University of Toronto	Emdin, CA (corresponding author), Univ Oxford, George Inst Global Hlth, Oxford, England.	cemdin@georgeinstitute.org.ukdoi	Wong, Christopher X/A-3227-2011; Woodward, Mark/D-8492-2015; Woodward, Mark/L-6817-2017	Peters, Sanne/0000-0003-0346-5412; Woodward, Mark/0000-0001-9800-5296; Wong, Christopher/0000-0002-1913-6675	Rhodes Scholarships; Neil Hamilton Fairly Fellowship from National Health and Medical Research Council of Australia	Rhodes Scholarships; Neil Hamilton Fairly Fellowship from National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors. CAE, CXW, AJH, and AAO are funded by Rhodes Scholarships. CXW is also supported by a Neil Hamilton Fairly Fellowship from the National Health and Medical Research Council of Australia. No funders were involved in the design, implementation, analysis, or reporting of this study.	Alotaibi GS, 2013, THROMB RES, V132, P185, DOI 10.1016/j.thromres.2013.07.017; Andersson T, 2014, INT J CARDIOL, V177, P91, DOI 10.1016/j.ijcard.2014.09.092; Bejot Y, 2009, NEUROLOGY, V72, P346, DOI 10.1212/01.wnl.0000341280.31919.bd; Benetos A, 2007, B ACAD NAT MED PARIS, V191, P791, DOI 10.1016/S0001-4079(19)33017-1; Benjamin EJ, 1998, CIRCULATION, V98, P946, DOI 10.1161/01.CIR.98.10.946; Bhatnagar P, 2015, HEART, V101, P1182, DOI 10.1136/heartjnl-2015-307516; Bouzas-Mosquera A, 2010, AM J CARDIOL, V105, P1207, DOI 10.1016/j.amjcard.2009.12.037; Bushnell C, 2014, ANN INTERN MED, V160, P853, DOI 10.7326/M14-0762; Bushnell C, 2014, STROKE, V45, P1545, DOI 10.1161/01.str.0000442009.06663.48; CARROLL K, 2001, HLTH STAT Q, V12, P18; Chamberlain AM, 2011, CIRC-HEART FAIL, V4, P740, DOI 10.1161/CIRCHEARTFAILURE.111.962688; Chao TF, 2012, STROKE, V43, P2551, DOI 10.1161/STROKEAHA.112.667865; Chen LY, 2013, JAMA INTERN MED, V173, P29, DOI 10.1001/2013.jamainternmed.744; Chugh SS, 2014, CIRCULATION, V129, P837, DOI 10.1161/CIRCULATIONAHA.113.005119; DAGOSTINO RB, 1994, STROKE, V25, P40, DOI 10.1161/01.STR.25.1.40; de Giuli F, 2005, EUR J HEART FAIL, V7, P295, DOI 10.1016/j.ejheart.2004.10.017; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Friberg J, 2004, AM J CARDIOL, V94, P889, DOI 10.1016/j.amjcard.2004.06.023; Friberg L, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3522; Genovesi S, 2009, NEPHROL DIAL TRANSPL, V24, P2529, DOI 10.1093/ndt/gfp104; Hamaguchi S, 2009, CIRC J, V73, P2084, DOI 10.1253/circj.CJ-09-0316; Hermann DM, 2013, STROKE, V44, P1008, DOI 10.1161/STROKEAHA.111.678078; Hippisley-Cox J, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008503; Hippisley-Cox J, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2573; Hippisley-Cox J, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6624; Humphries KH, 2001, CIRCULATION, V103, P2365; Huxley R, 2006, BMJ-BRIT MED J, V332, P73, DOI 10.1136/bmj.38678.389583.7C; Huxley RR, 2015, LANCET DIABETES ENDO, V3, P198, DOI 10.1016/S2213-8587(14)70248-7; Huxley RR, 2011, LANCET, V378, P1297, DOI 10.1016/S0140-6736(11)60781-2; Iwahana H, 2011, J EPIDEMIOL, V21, P95, DOI 10.2188/jea.JE20090149; Kaarisalo MM, 1997, J AM GERIATR SOC, V45, P1297, DOI 10.1111/j.1532-5415.1997.tb02927.x; Lip GYH, 2015, CIRC-CARDIOVASC QUAL, V8, pS12, DOI 10.1161/CIRCOUTCOMES.114.001556; Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Maisel WH, 2001, ANN INTERN MED, V135, P1061, DOI 10.7326/0003-4819-135-12-200112180-00010; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Nakayama T, 1997, STROKE, V28, P45, DOI 10.1161/01.STR.28.1.45; Ohsawa M, 2007, CIRC J, V71, P814, DOI 10.1253/circj.71.814; Peters SAE, 2014, DIABETOLOGIA, V57, P1542, DOI 10.1007/s00125-014-3260-6; Peters SAE, 2014, LANCET, V383, P1973, DOI 10.1016/S0140-6736(14)60040-4; Roden DM, 2007, EUROPACE, V9, P1, DOI 10.1093/europace/eum165; Ruigomez Ana, 2002, BMC Cardiovasc Disord, V2, P5, DOI 10.1186/1471-2261-2-5; Ryden L, 2013, EUR HEART J, V34, P3035, DOI 10.1093/eurheartj/eht108; Saposnik G, 2011, CIRCULATION, V123, P739, DOI 10.1161/CIRCULATIONAHA.110.983353; Siontis KC, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001002; Soliman EZ, 2015, CIRCULATION, V131, P1843, DOI 10.1161/CIRCULATIONAHA.114.014145; Soliman EZ, 2014, JAMA INTERN MED, V174, pE107, DOI 10.1001/jamainternmed.2013.11912; Stewart S, 2002, AM J MED, V113, P359, DOI 10.1016/S0002-9343(02)01236-6; Stortecky S, 2013, CIRC-CARDIOVASC INTE, V6, P77, DOI 10.1161/CIRCINTERVENTIONS.112.000124; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Tsadok MA, 2012, JAMA-J AM MED ASSOC, V307, P1952, DOI 10.1001/jama.2012.3490; van Wijk I, 2008, J NEUROL NEUROSUR PS, V79, P895, DOI 10.1136/jnnp.2007.133132; Wells GA., 2015, NEWCASTLE OTTAWA SCA; Wolf PA, 1998, ARCH INTERN MED, V158, P229, DOI 10.1001/archinte.158.3.229; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983; Wolfe CDA, 2006, STROKE, V37, P1991, DOI 10.1161/01.STR.0000230647.77889.84	57	179	183	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 19	2016	352								h7013	10.1136/bmj.h7013	http://dx.doi.org/10.1136/bmj.h7013			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DC4ZO	26786546	Green Published, hybrid			2022-12-28	WOS:000369229700002
J	Mulrooney, DA; Armstrong, GT; Huang, SJ; Ness, KK; Ehrhardt, MJ; Joshi, VM; Plana, JC; Soliman, EZ; Green, DM; Srivastava, D; Santucci, A; Krasin, MJ; Robison, LL; Hudson, MM				Mulrooney, Daniel A.; Armstrong, Gregory T.; Huang, Sujuan; Ness, Kirsten K.; Ehrhardt, Matthew J.; Joshi, Vijaya M.; Plana, Juan Carlos; Soliman, Elsayed Z.; Green, Daniel M.; Srivastava, Deokumar; Santucci, Aimee; Krasin, Matthew J.; Robison, Leslie L.; Hudson, Melissa M.			Cardiac Outcomes in Adult Survivors of Childhood Cancer Exposed to Cardiotoxic Therapy A Cross-sectional Study	ANNALS OF INTERNAL MEDICINE			English	Article							CORONARY-ARTERY-DISEASE; CLINICAL HEART-FAILURE; LONG-TERM; 5-YEAR SURVIVORS; VENTRICULAR DYSFUNCTION; CARDIOVASCULAR STATUS; AORTIC REGURGITATION; LATE MORTALITY; RISK-FACTORS; SOLID TUMOR	Background: Studies of cardiac disease among adult survivors of childhood cancer have generally relied on self-reported or registry-based data. Objective: To systematically assess cardiac outcomes among survivors of childhood cancer. Design: Cross-sectional study. Setting: St. Jude Children's Research Hospital. Patients: 1853 adult survivors of childhood cancer, aged 18 years or older, who received cancer-related cardiotoxic therapy at least 10 years earlier. Measurements: Baseline history and physical examination, fasting metabolic and lipid panels, echocardiography, electrocardiography, and 6-minute walk test. Results: One half of the survivors (52.3%) were men with a median age of 8 years (range, 0 to 24 years) at cancer diagnosis and 31 years (range, 18 to 60 years) at evaluation. Cardiomyopathy was present in 7.4% survivors (newly identified at the time of evaluation in 4.7%), coronary artery disease in 3.8% (newly identified in 2.2%), valvular regurgitation or stenosis in 28.0% (newly identified in 24.8%), and conduction or rhythm abnormalities in 4.4% (newly identified in 1.4%). Nearly all survivors were asymptomatic. The prevalence of cardiac conditions increased with age at evaluation, ranging from 3% to 24% among survivors aged 30 to 39 years to 10% to 37% among those aged 40 years or older. In multivariable analysis, survivors exposed to anthracycline doses of 250 mg/m(2) or more had greater odds of cardiomyopathy (odds ratio, 2.7 [ 95% CI, 1.1 to 6.9]) than those who were not exposed. Survivors exposed to heart radiation also had increased odds of cardiomyopathy (odds ratio, 1.9 [ CI, 1.1 to 3.7]) compared with those who were not exposed. Radiation exposure greater than 1500 cGy with any anthracycline exposure conferred the greatest odds for valve findings. Limitations: Sixty-one percent of survivors exposed to anthracycline chemotherapy or cardiac-directed radiation participated. A comparison group and longitudinal assessments were not available. Conclusion: Cardiovascular screening identified considerable subclinical disease among adult survivors of childhood cancer.	[Mulrooney, Daniel A.; Ehrhardt, Matthew J.; Hudson, Melissa M.] St Jude Childrens Res Hosp, Dept Oncol, Memphis, TN 38105 USA; [Armstrong, Gregory T.; Green, Daniel M.; Santucci, Aimee; Robison, Leslie L.; Hudson, Melissa M.] St Jude Childrens Res Hosp, Dept Epidemiol & Canc Control, Memphis, TN 38105 USA; Univ Tennessee, Ctr Hlth Sci, Coll Med, Memphis, TN 38103 USA; [Plana, Juan Carlos] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Soliman, Elsayed Z.] Wake Forest Sch Med, Dept Epidemiol & Prevent, Winston Salem, NC 27157 USA; [Srivastava, Deokumar] St Jude Childrens Res Hosp, Dept Biostat, Memphis, TN 38105 USA; [Krasin, Matthew J.] St Jude Childrens Res Hosp, Dept Radiol Sci, Memphis, TN 38105 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; Baylor College of Medicine; Wake Forest University; St Jude Children's Research Hospital; St Jude Children's Research Hospital	Mulrooney, DA (corresponding author), St Jude Childrens Res Hosp, Div Canc Survivorship, Dept Oncol, 262 Danny Thomas Pl,MS735, Memphis, TN 38105 USA.	daniel.mulrooney@stjude.org	Ness, Kirsten K/N-2550-2018; Soliman, Elsayed Z/AAD-7135-2020; Srivastava, Deo Kumar/P-2435-2017; Robison, Leslie/N-8122-2018; Krasin, Matthew J/D-4188-2018; Hudson, Melissa M/N-4441-2018; Ehrhardt, Matt/N-3105-2018; Armstrong, Gregory/N-8096-2018	Ness, Kirsten K/0000-0002-2084-1507; Soliman, Elsayed Z/0000-0001-5632-8150; Srivastava, Deo Kumar/0000-0001-6693-8120; Hudson, Melissa M/0000-0001-6984-2407; Ehrhardt, Matt/0000-0003-2781-9983; 	National Cancer Institute (Cancer Center Support) [CA21765, U01 CA195547]; American Lebanese Syrian Associated Charities; NATIONAL CANCER INSTITUTE [P30CA021765, U01CA195547] Funding Source: NIH RePORTER	National Cancer Institute (Cancer Center Support)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	By the National Cancer Institute (Cancer Center Support grants CA21765 [to Charles Roberts, Principal Investigator] and U01 CA195547 [to Dr. Hudson, Principal Investigator]) and American Lebanese Syrian Associated Charities.	Adams MJ, 2004, J CLIN ONCOL, V22, P3139, DOI 10.1200/JCO.2004.09.109; Armstrong GT, 2013, J CLIN ONCOL, V31, P3673, DOI 10.1200/JCO.2013.49.3205; Armstrong GT, 2009, J CLIN ONCOL, V27, P2328, DOI 10.1200/JCO.2008.21.1425; Baumgartner H, 2009, EUR J ECHOCARDIOGR, V10, P1, DOI 10.1093/ejechocard/jen303; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; Darby SC, 2013, NEW ENGL J MED, V368, P987, DOI 10.1056/NEJMoa1209825; Heidenreich PA, 2003, J AM COLL CARDIOL, V42, P743, DOI 10.1016/S0735-1097(03)00759-9; Howlader N, 2011, SEER CANC STAT REV 1; Hudson MM, 2013, JAMA-J AM MED ASSOC, V309, P2371, DOI 10.1001/jama.2013.6296; Hudson MM, 2011, PEDIATR BLOOD CANCER, V56, P825, DOI 10.1002/pbc.22875; Hunt SA, 2009, J AM COLL CARDIOL, V53, pE1, DOI 10.1016/j.jacc.2008.11.013; King V, 1996, INT J RADIAT ONCOL, V36, P881, DOI 10.1016/S0360-3016(96)00295-7; Kremer LCM, 2002, ANN ONCOL, V13, P819, DOI 10.1093/annonc/mdf167; Kremer LCM, 2001, J CLIN ONCOL, V19, P191, DOI 10.1200/JCO.2001.19.1.191; Landier W, 2004, J CLIN ONCOL, V22, P4979, DOI 10.1200/JCO.2004.11.032; Landier W, 2012, J CLIN ONCOL, V30, P4401, DOI 10.1200/JCO.2012.43.4951; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Le Deley MC, 2003, J CLIN ONCOL, V21, P1074, DOI 10.1200/JCO.2003.04.100; Lipshultz SE, 2012, J CLIN ONCOL, V30, P1050, DOI 10.1200/JCO.2010.33.7907; Mertens AC, 2008, JNCI-J NATL CANCER I, V100, P1368, DOI 10.1093/jnci/djn310; Mulrooney DA, 2014, CANCER-AM CANCER SOC, V120, P3536, DOI 10.1002/cncr.28925; Mulrooney DA, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4606; Nkomo VT, 2006, LANCET, V368, P1005, DOI 10.1016/S0140-6736(06)69208-8; Ojha RP, 2013, PEDIATR BLOOD CANCER, V60, P856, DOI 10.1002/pbc.24348; Pein F, 2004, BRIT J CANCER, V91, P37, DOI 10.1038/sj.bjc.6601904; Phillips SM, 2015, CANCER EPIDEM BIOMAR, V24, P653, DOI 10.1158/1055-9965.EPI-14-1418; Pollentier Brittany, 2010, Cardiopulm Phys Ther J, V21, P13; Prineas R., 1982, MINNESOTA CODE MANUA; Ratitch B., 2013, PHARMASUG 2013 CHIC; Redfield MM, 2003, JAMA-J AM MED ASSOC, V289, P194, DOI 10.1001/jama.289.2.194; Reid CL, 2007, AM J CARDIOL, V99, P830, DOI 10.1016/j.amjcard.2006.10.048; Robison LL, 2014, NAT REV CANCER, V14, P61, DOI 10.1038/nrc3634; Singh JP, 1999, AM J CARDIOL, V83, P897, DOI 10.1016/S0002-9149(98)01064-9; Stovall M, 2006, RADIAT RES, V166, P141, DOI 10.1667/RR3525.1; Travis LB, 2012, JNCI-J NATL CANCER I, V104, P357, DOI 10.1093/jnci/djr533; Tukenova M, 2010, J CLIN ONCOL, V28, P1308, DOI 10.1200/JCO.2008.20.2267; van Dalen EC, 2006, EUR J CANCER, V42, P3191, DOI 10.1016/j.ejca.2006.08.005; van der Pal HJ, 2015, INT J RADIAT ONCOL, V91, P213, DOI 10.1016/j.ijrobp.2014.09.010; van der Pal HJ, 2012, J CLIN ONCOL, V30, P1429, DOI 10.1200/JCO.2010.33.4730; van der Pal HJ, 2010, ARCH INTERN MED, V170, P1247, DOI 10.1001/archinternmed.2010.233; Velensek V, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-141; Wang TJ, 2003, CIRCULATION, V108, P977, DOI 10.1161/01.CIR.0000085166.44904.79; Wong FL, 2014, ANN INTERN MED, V160, P672, DOI 10.7326/M13-2498; Yeh JM, 2014, ANN INTERN MED, V160, P661, DOI 10.7326/M13-2266; Yusuf S., 1992, NEW ENGL J MED, V327, P685, DOI [DOI 10.1056/NEJM199209033271003, 10.1056/NEJM199209033271003.Erratumin]; Zoghbi WA, 2003, J AM SOC ECHOCARDIOG, V16, P777, DOI 10.1016/S0894-7317(03)00335-3	46	117	120	0	14	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 19	2016	164	2					93	101		10.7326/M15-0424	http://dx.doi.org/10.7326/M15-0424			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DB0CI	26747086	Green Accepted			2022-12-28	WOS:000368175800013
J	Gerbe, F; Sidot, E; Smyth, DJ; Ohmoto, M; Matsumoto, I; Dardalhon, V; Cesses, P; Garnier, L; Pouzolles, M; Brulin, B; Bruschi, M; Harcus, Y; Zimmermann, VS; Taylor, N; Maizels, RM; Jay, P				Gerbe, Francois; Sidot, Emmanuelle; Smyth, Danielle J.; Ohmoto, Makoto; Matsumoto, Ichiro; Dardalhon, Valerie; Cesses, Pierre; Garnier, Laure; Pouzolles, Marie; Brulin, Benedicte; Bruschi, Marco; Harcus, Yvonne; Zimmermann, Valerie S.; Taylor, Naomi; Maizels, Rick M.; Jay, Philippe			Intestinal epithelial tuft cells initiate type 2 mucosal immunity to helminth parasites	NATURE			English	Article							NIPPOSTRONGYLUS-BRASILIENSIS; STEM-CELLS; DIFFERENTIATION; GENERATION; EXPULSION; IL-13; SOX9	Helminth parasitic infections are a major global health and social burden(1). The host defence against helminths such as Nippostrongylus brasiliensis is orchestrated by type 2 cell-mediated immunity(2). Induction of type 2 cytokines, including interleukins (IL) IL-4 and IL-13, induce goblet cell hyperplasia with mucus production, ultimately resulting in worm expulsion(3,4). However, the mechanisms underlying the initiation of type 2 responses remain incompletely understood. Here we show that tuft cells, a rare epithelial cell type in the steady-state intestinal epithelium(5), are responsible for initiating type 2 responses to parasites by a cytokine-mediated cellular relay. Tuft cells have a Th2-related gene expression signature(6) and we demonstrate that they undergo a rapid and extensive IL-4R alpha-dependent amplification following infection with helminth parasites, owing to direct differentiation of epithelial crypt progenitor cells. We find that the Pou2f3 gene is essential for tuft cell specification. Pou2f3(-/-) mice lack intestinal tuft cells and have defective mucosal type 2 responses to helminth infection; goblet cell hyperplasia is abrogated and worm expulsion is compromised. Notably, IL-4R alpha signalling is sufficient to induce expansion of the tuft cell lineage, and ectopic stimulation of this signalling cascade obviates the need for tuft cells in the epithelial cell remodelling of the intestine. Moreover, tuft cells secrete IL-25, thereby regulating type 2 immune responses. Our data reveal a novel function of intestinal epithelial tuft cells and demonstrate a cellular relay required for initiating mucosal type 2 immunity to helminth infection.	[Gerbe, Francois; Sidot, Emmanuelle; Cesses, Pierre; Garnier, Laure; Brulin, Benedicte; Bruschi, Marco; Jay, Philippe] CNRS, UMR 5203, Inst Genom Fonct, F-34094 Montpellier, France; [Gerbe, Francois; Sidot, Emmanuelle; Cesses, Pierre; Garnier, Laure; Brulin, Benedicte; Bruschi, Marco; Jay, Philippe] INSERM, U1191, F-34094 Montpellier, France; [Gerbe, Francois; Sidot, Emmanuelle; Dardalhon, Valerie; Cesses, Pierre; Garnier, Laure; Pouzolles, Marie; Brulin, Benedicte; Bruschi, Marco; Zimmermann, Valerie S.; Taylor, Naomi; Jay, Philippe] Univ Montpellier, F-34000 Montpellier, France; [Smyth, Danielle J.; Harcus, Yvonne; Maizels, Rick M.] Univ Edinburgh, Inst Immunol & Infect Res, Sch Biol Sci, Edinburgh EH9 3JT, Midlothian, Scotland; [Smyth, Danielle J.; Harcus, Yvonne; Maizels, Rick M.] Univ Edinburgh, Ctr Immun Infect & Evolut, Edinburgh EH9 3JT, Midlothian, Scotland; [Ohmoto, Makoto; Matsumoto, Ichiro] Monell Chem Senses Ctr, Philadelphia, PA 19104 USA; [Dardalhon, Valerie; Pouzolles, Marie; Zimmermann, Valerie S.; Taylor, Naomi] CNRS, UMR5535, Inst Genet Mol Montpellier, F-34293 Montpellier, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; University of Edinburgh; University of Edinburgh; Monell Chemical Senses Center; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier	Jay, P (corresponding author), CNRS, UMR 5203, Inst Genom Fonct, F-34094 Montpellier, France.	philippe.jay@igf.cnrs.fr	Taylor, Naomi/H-4016-2014; Jay, Philippe/ABD-9223-2020; Jay, Philippe/I-7116-2016	Jay, Philippe/0000-0003-0156-5700; Jay, Philippe/0000-0003-0156-5700; Bruschi, Marco/0000-0002-8249-0757; , Valerie/0000-0001-8919-0071; Smyth, Danielle/0000-0001-6080-2679	Association pour la Recherche contre le Cancer (ARC) [SL220110603456]; Agence Nationale de la Recherche [ANR-09-BLAN-0368-01, ANR-14-CE14-0025-01]; Institut National du Cancer [INCa 2014-174]; CNRS-NIH International Laboratory grant from the CNRS (LIA-BAGEL); Welcome Trust [106122]; Monell Chemical Senses Center; Ligue Nationale contre le Cancer; LabEx EpiGenMed; Inserm; NIH [P30DC011735]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P30DC011735] Funding Source: NIH RePORTER	Association pour la Recherche contre le Cancer (ARC)(Fondation ARC pour la Recherche sur le CancerFrench National Research Agency (ANR)); Agence Nationale de la Recherche(French National Research Agency (ANR)); Institut National du Cancer(Institut National du Cancer (INCA) France); CNRS-NIH International Laboratory grant from the CNRS (LIA-BAGEL); Welcome Trust(Wellcome Trust); Monell Chemical Senses Center; Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); LabEx EpiGenMed; Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by Association pour la Recherche contre le Cancer (ARC to N.T. and SL220110603456 to P.J.), Agence Nationale de la Recherche (ANR-09-BLAN-0368-01 to P.J., ANR-PolarAttack to V.D. and ANR-14-CE14-0025-01 to P.J. and N.T.), Institut National du Cancer (INCa 2014-174 to P.J.), a CNRS-NIH International Laboratory grant from the CNRS (LIA-BAGEL) to N.T. and the Welcome Trust (Ref. 106122 to R.M.M.). Part of the work was supported by institutional funds of Monell Chemical Senses Center to I.M.; E.S. and M.B. are supported by Ligue Nationale contre le Cancer, M.P. by the LabEx EpiGenMed and N.T. by Inserm. We are grateful to S. Gailhac and C. Mongellaz for their expertise and assistance in immune cell analyses, S. Cording, J. Di Santo and G. Eberl for their generosity and their expertise on ILCs, G. Petrazzo and R. Guedon for technical input, S. Fre and M. Huygues for technical advice, C Legraverend for her expertise and to M. van de Wetering for reagents. We thank F. Gallardo, the PCEA and the IRD A2 facilities for maintenance of mouse colonies, the Montpellier RIO Imaging (MRI) facility, the Monell Histology and Cellular Localization Core (supported by funding from NIH Core Grant P30DC011735 (to R. F. Margolskee, Monell Chemical Senses Center) for some of the histological analyses and Daniel Fisher for critical reading of the manuscript.	Allen JE, 2011, NAT REV IMMUNOL, V11, P375, DOI 10.1038/nri2992; Artis D, 2004, P NATL ACAD SCI USA, V101, P13596, DOI 10.1073/pnas.0404034101; Barner M, 1998, CURR BIOL, V8, P669, DOI 10.1016/S0960-9822(98)70256-8; Bastide P, 2007, J CELL BIOL, V178, P635, DOI 10.1083/jcb.200704152; Bezencon C, 2008, J COMP NEUROL, V509, P514, DOI 10.1002/cne.21768; Bjerknes M, 2012, DEV BIOL, V362, P194, DOI 10.1016/j.ydbio.2011.12.009; Blache P, 2004, J CELL BIOL, V166, P37, DOI 10.1083/jcb.200311021; Buczacki SJA, 2013, NATURE, V495, P65, DOI 10.1038/nature11965; Camberis Mali, 2003, Curr Protoc Immunol, VChapter 19, DOI 10.1002/0471142735.im1912s55; Gerbe F, 2011, J CELL BIOL, V192, P767, DOI 10.1083/jcb.201010127; Gerbe F, 2009, GASTROENTEROLOGY, V137, P2179, DOI 10.1053/j.gastro.2009.06.072; Gierl MS, 2006, GENE DEV, V20, P2465, DOI 10.1101/gad.381806; Herbert DR, 2009, J EXP MED, V206, P2947, DOI 10.1084/jem.20091268; Hotez PJ, 2008, J CLIN INVEST, V118, P1311, DOI 10.1172/JCI34261; ISHIKAWA N, 1993, IMMUNOLOGY, V78, P303; Lawrence RA, 1996, EXP PARASITOL, V84, P65, DOI 10.1006/expr.1996.0090; Matsumoto I, 2011, NAT NEUROSCI, V14, P685, DOI 10.1038/nn.2820; McKenzie GJ, 1998, CURR BIOL, V8, P339, DOI 10.1016/S0960-9822(98)70134-4; Mellitzer G, 2010, J CLIN INVEST, V120, P1708, DOI 10.1172/JCI40794; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Ohmoto M, 2008, MOL CELL NEUROSCI, V38, P505, DOI 10.1016/j.mcn.2008.04.011; Ohmoto M, 2013, BIOSCI BIOTECH BIOCH, V77, P2154, DOI 10.1271/bbb.130454; Reynolds LA, 2012, SEMIN IMMUNOPATHOL, V34, P829, DOI 10.1007/s00281-012-0347-3; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Urban JF, 1998, IMMUNITY, V8, P255, DOI 10.1016/S1074-7613(00)80477-X; van Es JH, 2012, NAT CELL BIOL, V14, P1099, DOI 10.1038/ncb2581; WATANABE N, 1988, P NATL ACAD SCI USA, V85, P4460, DOI 10.1073/pnas.85.12.4460; Yamaguchi T, 2014, BMC NEUROSCI, V15, DOI 10.1186/1471-2202-15-13; Zhao AP, 2010, J IMMUNOL, V185, P6921, DOI 10.4049/jimmunol.1000450	30	482	495	3	98	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 14	2016	529	7585					226	U260		10.1038/nature16527	http://dx.doi.org/10.1038/nature16527			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA7WK	26762460	Green Published, Green Accepted			2022-12-28	WOS:000368015700040
J	Tracy, CL; Dustin, MK; Ewing, RC				Tracy, Cameron L.; Dustin, Megan K.; Ewing, Rodney C.			Reassess New Mexico's nuclear-waste repository	NATURE			English	Editorial Material									[Tracy, Cameron L.; Ewing, Rodney C.] Stanford Univ, Ctr Int Secur & Cooperat, Stanford, CA 94305 USA; [Dustin, Megan K.] Stanford Univ, Dept Geol Sci, Stanford, CA 94305 USA	Stanford University; Stanford University	Tracy, CL (corresponding author), Stanford Univ, Ctr Int Secur & Cooperat, Stanford, CA 94305 USA.	rewing1@stanford.edu		Ewing, Rodney/0000-0001-9472-4031; Tracy, Cameron/0000-0002-0679-8522				Clements T., 2013, ARMS CONTROL TODAY, V43, P8; Ewing R.C., 2010, ACTINIDE TRANSCTINID, VVolume 6, P3813; High Bridge Associates, 2015, PLUT DISP STUD OPT; High Bridge Associates, 2015, REP IND ASS IMP DISP; Maher K, 2013, INORG CHEM, V52, P3510, DOI 10.1021/ic301686d; Perrow C., 1999, NORMAL ACCIDENTS LIV; US Department of Energy, 2014, REP PLUT DISP WORK G; US Department of Energy, 2015, FIN REP PLUT DISP RE; US Department of Energy, 2015, ACC INV REP PHAS 2 R; US Department of Energy, 2014, COMPL REC APPL 2014	10	11	12	1	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 14	2016	529	7585					149	151		10.1038/529149a	http://dx.doi.org/10.1038/529149a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA7WK	26762442	Bronze			2022-12-28	WOS:000368015700013
J	Wong, AYS; Root, A; Douglas, IJ; Chui, CSL; Chan, EW; Ghebremichael-Weldeselassie, Y; Siu, CW; Smeeth, L; Wong, ICK				Wong, Angel Y. S.; Root, Adrian; Douglas, Ian J.; Chui, Celine S. L.; Chan, Esther W.; Ghebremichael-Weldeselassie, Yonas; Siu, Chung-Wah; Smeeth, Liam; Wong, Ian C. K.			Cardiovascular outcomes associated with use of clarithromycin: population based study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CORONARY-HEART-DISEASE; RISK; AZITHROMYCIN; DEATH; TRIAL	Study question What is the association between clarithromycin use and cardiovascular outcomes? Methods In this population based study the authors compared cardiovascular outcomes in adults aged 18 or more receiving oral clarithromycin or amoxicillin during 2005-09 in Hong Kong. Based on age within five years, sex, and calendar year at use, each clarithromycin user was matched to one or two amoxicillin users. The cohort analysis included patients who received clarithromycin (n= 108 988) or amoxicillin (n= 217 793). The self controlled case series and case crossover analysis included those who received Helicobacter pylori eradication treatment containing clarithromycin. The primary outcome was myocardial infarction. Secondary outcomes were all cause, cardiac, or non-cardiac mortality, arrhythmia, and stroke. Study answer and limitations The propensity score adjusted rate ratio of myocardial infarction 14 days after the start of antibiotic treatment was 3.66 (95% confidence interval 2.82 to 4.76) comparing clarithromycin use (132 events, rate 44.4 per 1000 person years) with amoxicillin use (149 events, 19.2 per 1000 person years), but no long term increased risk was observed. Similarly, rate ratios of secondary outcomes increased significantly only with current use of clarithromycin versus amoxicillin, except for stroke. In the self controlled case analysis, there was an association between current use of H pylori eradication treatment containing clarithromycin and cardiovascular events. The risk returned to baseline after treatment had ended. The case crossover analysis also showed an increased risk of cardiovascular events during current use of H pylori eradication treatment containing clarithromycin. The adjusted absolute risk difference for current use of clarithromycin versus amoxicillin was 1.90 excess myocardial infarction events (95% confidence interval 1.30 to 2.68) per 1000 patients. What this study adds Current use of clarithromycin was associated with an increased risk of myocardial infarction, arrhythmia, and cardiac mortality short term but no association with long term cardiovascular risks among the Hong Kong population. Funding, competing interests, data sharing ID was funded by grants from the Medical Research Council for this project. LS was funded by a grant from the Wellcome Trust. The authors have no competing interests. No additional data are available.	[Wong, Angel Y. S.; Chui, Celine S. L.; Chan, Esther W.; Wong, Ian C. K.] Univ Hong Kong, Li Ka Shing Fac Med, Dept Pharmacol & Pharm, Ctr Safe Medicat Practice & Res, Hong Kong, Hong Kong, Peoples R China; [Root, Adrian; Douglas, Ian J.; Smeeth, Liam] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1, England; [Ghebremichael-Weldeselassie, Yonas] Open Univ, Dept Math & Stat, Milton Keynes MK7 6AA, Bucks, England; [Siu, Chung-Wah] Univ Hong Kong, Li Ka Shing Fac Med, Dept Med, Div Cardiol, Hong Kong, Hong Kong, Peoples R China; [Wong, Ian C. K.] UCL Sch Pharm, Res Dept Practice & Policy, London WC1N 1AX, England	University of Hong Kong; University of London; London School of Hygiene & Tropical Medicine; Open University - UK; University of Hong Kong; University of London; University College London	Wong, ICK (corresponding author), UCL Sch Pharm, Res Dept Practice & Policy, London WC1N 1AX, England.	i.wong@ucl.ac.uk	Siu, Chung Wah/C-6947-2011; Chui, Celine SL/A-2046-2014; Chan, Esther Wai Yin/B-3522-2012; Smeeth, Liam/X-5862-2018	Chui, Sze Ling Celine/0000-0003-1513-8726; Wong, Ian Chi Kei/0000-0001-8242-0014; Chan, Esther Wai Yin/0000-0002-7602-9470; Smeeth, Liam/0000-0002-9168-6022; Ghebremichael-Weldeselassie, Yonas/0000-0003-4961-5041	Medical Research Council; Wellcome Trust; MRC [MR/M014649/1, G0802403] Funding Source: UKRI; Medical Research Council [MR/M014649/1, MR/K006584/1, G0802403] Funding Source: researchfish; National Institute for Health Research [NF-SI-0510-10090] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	During the conduct of the study, ID was funded by grants from the Medical Research Council for this project. LS was funded by a grant from the Wellcome Trust. The sponsors had no role in the study design; collection, analysis, and interpretation of the data; the writing of the article; or the decision to submit the manuscript for publication.	Andersen SS, 2010, CARDIOLOGY, V116, P89, DOI 10.1159/000315394; Berg HF, 2005, CLIN INFECT DIS, V40, P358, DOI 10.1086/427111; Bilgin M, 2014, TURK KARDIYOL DERN A, V42, P461, DOI 10.5543/tkda.2014.92891; Cappell MS, 2000, GASTROENTEROL CLIN N, V29, P423, DOI 10.1016/S0889-8553(05)70121-7; Chiu SS, 2002, NEW ENGL J MED, V347, P2097, DOI 10.1056/NEJMoa020546; Chui CSL, 2014, J ANTIMICROB CHEMOTH, V69, P2563, DOI 10.1093/jac/dku145; Douglas IJ, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4388; Ghebremichael-Weldeselassie Y, 2015, SPLINE BASED SELF CO; Gluud C, 2008, CARDIOLOGY, V111, P280, DOI 10.1159/000128994; HAHO/ITD, 2003, CLIN DAT AN REP SYST, P3; Hensey C, 2008, IRISH J MED SCI, V177, P67, DOI 10.1007/s11845-007-0057-3; Ho PL, 2012, REDUCING BACTERIAL R; Hospital Authority, 2015, CLIN SERV PLAN HONG; Jespersen CM, 2006, BRIT MED J, V332, P22, DOI 10.1136/bmj.38666.653600.55; Joensen AM, 2009, J CLIN EPIDEMIOL, V62, P188, DOI 10.1016/j.jclinepi.2008.03.005; Kamochi H, 1999, JPN CIRC J, V63, P421, DOI 10.1253/jcj.63.421; Khan NF, 2010, BRIT J GEN PRACT, V60, DOI 10.3399/bjgp10X483562; Kjoller E, 2014, AM HEART J, V168; Knirsch CA, 2012, NEW ENGL J MED, V367, P772, DOI [10.1056/NEJMoa1003833, 10.1056/NEJMc1207269]; Kundu S, 1997, ANN EMERG MED, V30, P542, DOI 10.1016/S0196-0644(97)70019-2; Lee KL, 1998, AM J MED, V104, P395, DOI 10.1016/S0002-9343(98)00059-X; Maclure M, 2000, ANNU REV PUBL HEALTH, V21, P193, DOI 10.1146/annurev.publhealth.21.1.193; Man KKC, 2015, PEDIATRICS, V135, P40, DOI 10.1542/peds.2014-1738; McCormick N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092286; Schembri S, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1235; Sinisalo J, 2002, CIRCULATION, V105, P1555, DOI 10.1161/01.CIR.0000012544.07696.1F; Smeeth L, 2004, NEW ENGL J MED, V351, P2611, DOI 10.1056/NEJMoa041747; Sturmer T, 2014, J INTERN MED, V275, P570, DOI 10.1111/joim.12197; Sturmer T, 2010, AM J EPIDEMIOL, V172, P843, DOI 10.1093/aje/kwq198; Svanstrom H, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4930; Svanstrom H, 2013, NEW ENGL J MED, V368, P1704, DOI 10.1056/NEJMoa1300799; Tamariz L, 2012, PHARMACOEPIDEM DR S, V21, P148, DOI 10.1002/pds.2340; Whitaker HJ, 2006, STAT MED, V25, P1768, DOI 10.1002/sim.2302; Winkel P, 2015, INT J CARDIOL, V182, P459, DOI 10.1016/j.ijcard.2015.01.020; Zuckerman JM, 2004, INFECT DIS CLIN N AM, V18, P621, DOI 10.1016/j.idc.2004.04.010	35	114	115	0	18	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 14	2016	352								h6926	10.1136/bmj.h6926	http://dx.doi.org/10.1136/bmj.h6926			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DB2YZ	26768836	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000368377900001
J	Gao, S; Lin, Y; Jiao, XC; Sun, YF; Luo, QQ; Zhang, WH; Li, DQ; Yang, JL; Xie, Y				Gao, Shan; Lin, Yue; Jiao, Xingchen; Sun, Yongfu; Luo, Qiquan; Zhang, Wenhua; Li, Dianqi; Yang, Jinlong; Xie, Yi			Partially oxidized atomic cobalt layers for carbon dioxide electroreduction to liquid fuel	NATURE			English	Article							CO2 REDUCTION; ELECTROCHEMICAL REDUCTION; FORMATE; OXIDE; ELECTRODES; CATALYSTS; CO3O4; NANOPARTICLES; HYDROCARBONS; CONVERSION	Electroreduction of CO2 into useful fuels, especially if driven by renewable energy, represents a potentially 'clean' strategy for replacing fossil feedstocks and dealing with increasing CO2 emissions and their adverse effects on climate(1-4). The critical bottleneck lies in activating CO2 into the CO2-radical anion or other intermediates that can be converted further, as the activation usually requires impractically high overpotentials. Recently, electrocatalysts based on oxide-derived metal nanostructures have been shown(5-8) to enable CO2 reduction at low overpotentials. However, it remains unclear how the electrocatalytic activity of these metals is influenced by their native oxides, mainly because microstructural features such as interfaces and defects(9) influence CO2 reduction activity yet are difficult to control. To evaluate the role of the two different catalytic sites, here we fabricate two kinds of four-atom-thick layers: pure cobalt metal, and co-existing domains of cobalt metal and cobalt oxide. Cobalt mainly produces formate (HCOO-) during CO2 electroreduction; we find that surface cobalt atoms of the atomically thin layers have higher intrinsic activity and selectivity towards formate production, at lower overpotentials, than do surface cobalt atoms on bulk samples. Partial oxidation of the atomic layers further increases their intrinsic activity, allowing us to realize stable current densities of about 10 milliamperes per square centimetre over 40 hours, with approximately 90 per cent formate selectivity at an overpotential of only 0.24 volts, which outperforms previously reported metal or metal oxide electrodes evaluated under comparable conditions(1,2,6,7,10). The correct morphology and oxidation state can thus transform a material from one considered nearly non-catalytic for the CO2 electroreduction reaction into an active catalyst. These findings point to new opportunities for manipulating and improving the CO2 electroreduction properties of metal systems, especially once the influence of both the atomic-scale structure and the presence of oxide are mechanistically better understood.	[Gao, Shan; Lin, Yue; Jiao, Xingchen; Sun, Yongfu; Luo, Qiquan; Zhang, Wenhua; Li, Dianqi; Yang, Jinlong; Xie, Yi] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Collaborat Innovat Ctr Chem Energy Mat, Hefei 230026, Anhui, Peoples R China; [Sun, Yongfu; Xie, Yi] Chinese Acad Sci, Hefei Sci Ctr, Hefei 230061, Anhui, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences	Sun, YF; Xie, Y (corresponding author), Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Collaborat Innovat Ctr Chem Energy Mat, Hefei 230026, Anhui, Peoples R China.; Sun, YF; Xie, Y (corresponding author), Chinese Acad Sci, Hefei Sci Ctr, Hefei 230061, Anhui, Peoples R China.	yfsun@ustc.edu.cn; yxie@ustc.edu.cn	Lin, Yue/AAB-5080-2020; Zhang, Wenhua/B-3146-2010; LUO, QI/GQH-7209-2022; shan, gao/AAH-1983-2019; Xie, Yi/B-5753-2009; Yang, Jinlong/D-3465-2009	Zhang, Wenhua/0000-0002-0075-385X; Xie, Yi/0000-0002-1416-5557; Luo, Qiquan/0000-0003-1450-2856; , Yue/0000-0001-5333-511X	National Basic Research Program of China [2015CB932302]; National Nature Science Foundation [21422107, 21331005, 91422303, 21201157, 11321503]; Program for New Century Excellent Talents in University [NCET-13-0546]; Youth Innovation Promotion Association of CAS [CX2340000100]; Chinese Academy of Science [XDB01020300]; Fundamental Research Funds for the Central Universities [WK2340000063]; Scientific Research Grant of the Hefei Science Center of CAS [2015HSC-UE006, 2015HSC-UP015]	National Basic Research Program of China(National Basic Research Program of China); National Nature Science Foundation(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Youth Innovation Promotion Association of CAS; Chinese Academy of Science(Chinese Academy of Sciences); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Scientific Research Grant of the Hefei Science Center of CAS	This work was financially supported by the National Basic Research Program of China (grant number 2015CB932302), the National Nature Science Foundation (grant numbers 21422107, 21331005, 91422303, 21201157 and 11321503), the Program for New Century Excellent Talents in University (grant number NCET-13-0546), the Youth Innovation Promotion Association of CAS (grant number CX2340000100), the Chinese Academy of Science (grant number XDB01020300), the Fundamental Research Funds for the Central Universities (grant number WK2340000063) and the Scientific Research Grant of the Hefei Science Center of CAS (grant numbers 2015HSC-UE006 and 2015HSC-UP015).	Asadi M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5470; Chen YH, 2012, J AM CHEM SOC, V134, P19969, DOI 10.1021/ja309317u; Chen YH, 2012, J AM CHEM SOC, V134, P1986, DOI 10.1021/ja2108799; Gattrell M, 2006, J ELECTROANAL CHEM, V594, P1, DOI 10.1016/j.jelechem.2006.05.013; Huang XF, 2013, J PHYS CHEM C, V117, P26432, DOI 10.1021/jp408630s; Huang XQ, 2011, NAT NANOTECHNOL, V6, P28, DOI [10.1038/nnano.2010.235, 10.1038/NNANO.2010.235]; Kumar B, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3819; Li CW, 2014, NATURE, V508, P504, DOI 10.1038/nature13249; Li CW, 2012, J AM CHEM SOC, V134, P7231, DOI 10.1021/ja3010978; Min XQ, 2015, J AM CHEM SOC, V137, P4701, DOI 10.1021/ja511890h; Popczyk M, 2003, NANOTECHNOLOGY, V14, P341, DOI 10.1088/0957-4484/14/2/346; Rojas TC, 1999, J MATER CHEM, V9, P1011, DOI 10.1039/a808098d; Rosen BA, 2011, SCIENCE, V334, P643, DOI 10.1126/science.1209786; Roy SC, 2010, ACS NANO, V4, P1259, DOI 10.1021/nn9015423; Salavati-Niasari M, 2009, POLYHEDRON, V28, P1065, DOI 10.1016/j.poly.2009.01.012; Sun YF, 2015, ACCOUNTS CHEM RES, V48, P3, DOI 10.1021/ar500164g; Sun YF, 2014, CHEM SCI, V5, P3976, DOI 10.1039/c4sc00565a; Sun YF, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3899; Sun YF, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2066; Tamaki Y, 2012, P NATL ACAD SCI USA, V109, P15673, DOI 10.1073/pnas.1118336109; Varghese B, 2007, ADV FUNCT MATER, V17, P1932, DOI 10.1002/adfm.200700038; Watkins JD, 2014, CHEMSUSCHEM, V7, P284, DOI 10.1002/cssc.201300659; Xie XW, 2009, NATURE, V458, P746, DOI 10.1038/nature07877; Zhang S, 2014, J AM CHEM SOC, V136, P7845, DOI 10.1021/ja5031529; Zhang S, 2014, J AM CHEM SOC, V136, P1734, DOI 10.1021/ja4113885	25	1246	1270	125	2412	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 7	2016	529	7584					68	+		10.1038/nature16455	http://dx.doi.org/10.1038/nature16455			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6VY	26738592				2022-12-28	WOS:000367944900027
J	Simkin, SK; Tuck, K; Garrett, J; Dai, S				Simkin, Samantha K.; Tuck, Katie; Garrett, John; Dai, Shuan			Vitamin A deficiency-an unexpected cause of visual loss	LANCET			English	Editorial Material									[Simkin, Samantha K.; Tuck, Katie; Dai, Shuan] Univ Auckland, Blind & Low Vis Educ Network New Zealand, Auckland 1142, New Zealand; [Simkin, Samantha K.; Dai, Shuan] Univ Auckland, Dept Ophthalmol, Auckland 1142, New Zealand; [Garrett, John] Canterbury Dist Hlth Board, Dept Paediat, Christchurch, New Zealand	University of Auckland; University of Auckland	Dai, S (corresponding author), Univ Auckland, Dept Ophthalmol, Private Bag 92019, Auckland 1142, New Zealand.	shuandai@me.com						Chavala Sai H, 2005, Eur J Intern Med, V16, P447, DOI 10.1016/j.ejim.2005.01.021; Kirby M, 2009, PEDIATR CLIN N AM, V56, P1085, DOI 10.1016/j.pcl.2009.07.003; SOMMER A, 1990, INT OPHTHALMOL, V14, P195, DOI 10.1007/BF00158318; Whatham A, 2008, OPHTHAL PHYSL OPT, V28, P1, DOI 10.1111/j.1475-1313.2007.00531.x	4	6	6	0	12	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 2	2016	387	10013					93	94		10.1016/S0140-6736(15)01233-7	http://dx.doi.org/10.1016/S0140-6736(15)01233-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CZ9ZU	26766346				2022-12-28	WOS:000367457300031
J	Yawar, A				Yawar, Athar			Mr Laurel, Mr Hardy, and the price of success	LANCET			English	Editorial Material												athar.yawar@doctors.org.uk							0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 2	2016	387	10013					22	23		10.1016/S0140-6736(15)01303-3	http://dx.doi.org/10.1016/S0140-6736(15)01303-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CZ9ZU	26788562				2022-12-28	WOS:000367457300014
J	Baym, M; Stone, LK; Kishony, R				Baym, Michael; Stone, Laura K.; Kishony, Roy			Multidrug evolutionary strategies to reverse antibiotic resistance	SCIENCE			English	Review							SUPPRESSIVE DRUG-INTERACTIONS; NEGATIVE CROSS-RESISTANCE; TET GENE-EXPRESSION; ESCHERICHIA-COLI; STAPHYLOCOCCUS-AUREUS; TETRACYCLINE-RESISTANCE; BACTERIAL-RESISTANCE; MYCOBACTERIUM-TUBERCULOSIS; ANTIMICROBIAL RESISTANCE; COLLATERAL SENSITIVITY	Antibiotic treatment has two conflicting effects: the desired, immediate effect of inhibiting bacterial growth and the undesired, long-term effect of promoting the evolution of resistance. Although these contrasting outcomes seem inextricably linked, recent work has revealed several ways by which antibiotics can be combined to inhibit bacterial growth while, counterintuitively, selecting against resistant mutants. Decoupling treatment efficacy from the risk of resistance can be achieved by exploiting specific interactions between drugs, and the ways in which resistance mutations to a given drug can modulate these interactions or increase the sensitivity of the bacteria to other compounds. Although their practical application requires much further development and validation, and relies on advances in genomic diagnostics, these discoveries suggest novel paradigms that may restrict or even reverse the evolution of resistance.	[Baym, Michael; Stone, Laura K.; Kishony, Roy] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Kishony, Roy] Technion Israel Inst Technol, Dept Biol, IL-32000 Haifa, Israel; [Kishony, Roy] Technion Israel Inst Technol, Dept Comp Sci, IL-32000 Haifa, Israel	Harvard University; Harvard Medical School; Technion Israel Institute of Technology; Technion Israel Institute of Technology	Kishony, R (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA.	rkishony@technion.ac.il		Baym, Michael/0000-0003-1303-5598	U.S. National Institutes of Health [R01-GM081617]; European Research Council FP7 ERC [281891]; F. Hoffmann-La Roche Ltd.; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081617] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Research Council FP7 ERC; F. Hoffmann-La Roche Ltd.(Hoffmann-La Roche); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank T. Bollenbach, W. P. Hanage, M. Elowitz, J. Jiao, and D. Van Valen for their thoughtful comments and input. This work was supported in part by U.S. National Institutes of Health grant R01-GM081617, European Research Council FP7 ERC Grant 281891, and F. Hoffmann-La Roche Ltd.	Abraham EP, 1941, LANCET, V2, P177; Alekshun MN, 2007, CELL, V128, P1037, DOI 10.1016/j.cell.2007.03.004; ALLEN NE, 1982, ANTIMICROB AGENTS CH, V22, P824, DOI 10.1128/AAC.22.5.824; Allen RC, 2014, NAT REV MICROBIOL, V12, P300, DOI 10.1038/nrmicro3232; Allison KR, 2011, NATURE, V473, P216, DOI 10.1038/nature10069; Andersson DI, 2010, NAT REV MICROBIOL, V8, P260, DOI 10.1038/nrmicro2319; Azimi L, 2016, GENE, V576, P166, DOI 10.1016/j.gene.2015.10.008; Ball P, 2007, INT J ANTIMICROB AG, V30, pS139, DOI 10.1016/j.ijantimicag.2007.08.016; Blair JMA, 2015, NAT REV MICROBIOL, V13, P42, DOI 10.1038/nrmicro3380; BOCHNER BR, 1980, J BACTERIOL, V143, P926, DOI 10.1128/JB.143.2.926-933.1980; Bollenbach T, 2009, CELL, V139, P707, DOI 10.1016/j.cell.2009.10.025; Bonhoeffer S, 1997, P NATL ACAD SCI USA, V94, P12106, DOI 10.1073/pnas.94.22.12106; Bradley P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10063; Bush K, 2011, NAT REV MICROBIOL, V9, P894, DOI 10.1038/nrmicro2693; CDC, 2013, ANTIBIOTIC RESISTANC; Chaibi EB, 1999, J ANTIMICROB CHEMOTH, V43, P447, DOI 10.1093/jac/43.4.447; Chait R, 2007, NATURE, V446, P668, DOI 10.1038/nature05685; Chait R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015179; Chang QZ, 2015, EVOL APPL, V8, P240, DOI 10.1111/eva.12185; CHAO L, 1978, NATURE, V271, P385, DOI 10.1038/271385a0; Chen GZ, 2011, MOL CELL, V42, P199, DOI 10.1016/j.molcel.2011.04.003; Chevereau G, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20156098; Chopra I, 2001, MICROBIOL MOL BIOL R, V65, P232, DOI 10.1128/MMBR.65.2.232-260.2001; Chow JW, 1999, INT J ANTIMICROB AG, V11, P7, DOI 10.1016/S0924-8579(98)00060-0; CLANCY J, 1995, J ANTIBIOT, V48, P1273, DOI 10.7164/antibiotics.48.1273; Coko M, 2014, CHEM BIOL, V21, P541, DOI 10.1016/j.chembiol.2014.02.012; Cokol M, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.71; De Gelder L, 2004, GENETICS, V168, P1131, DOI 10.1534/genetics.104.033431; DEBEENHOUWER H, 1995, TUBERCLE LUNG DIS, V76, P425, DOI 10.1016/0962-8479(95)90009-8; Deeks SG, 2003, LANCET, V362, P2002, DOI 10.1016/S0140-6736(03)15022-2; Dragosits M, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2012.76; Drawz SM, 2010, CLIN MICROBIOL REV, V23, P160, DOI 10.1128/CMR.00037-09; Ejim L, 2011, NAT CHEM BIOL, V7, P348, DOI [10.1038/NCHEMBIO.559, 10.1038/nchembio.559]; Foucault ML, 2009, ANTIMICROB AGENTS CH, V53, P2354, DOI 10.1128/AAC.01702-08; Fridman O, 2014, NATURE, V513, P418, DOI 10.1038/nature13469; Gadamski G, 2000, WEED SCI, V48, P176, DOI 10.1614/0043-1745(2000)048[0176:NCRITR]2.0.CO;2; Gonzales PR, 2015, NAT CHEM BIOL, V11, P855, DOI 10.1038/nchembio.1911; GRESSEL J, 1990, Z NATURFORSCH C, V45, P470; GRIFFITH JK, 1988, J BACTERIOL, V170, P598, DOI 10.1128/jb.170.2.598-604.1988; Hajduk PJ, 1999, J MED CHEM, V42, P3852, DOI 10.1021/jm990293a; Hammerum AM, 2009, CLIN INFECT DIS, V48, P916, DOI 10.1086/597292; Hastings MD, 2002, P NATL ACAD SCI USA, V99, P13137, DOI 10.1073/pnas.182295999; Hegreness M, 2008, P NATL ACAD SCI USA, V105, P13977, DOI 10.1073/pnas.0805965105; Imamovic L, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006609; Jonas D, 2002, J CLIN MICROBIOL, V40, P1821, DOI 10.1128/JCM.40.5.1821-1823.2002; Katayama Y, 2000, ANTIMICROB AGENTS CH, V44, P1549, DOI 10.1128/AAC.44.6.1549-1555.2000; Keith CT, 2005, NAT REV DRUG DISCOV, V4, P71, DOI 10.1038/nrd1609; Kim S, 2014, P NATL ACAD SCI USA, V111, P14494, DOI 10.1073/pnas.1409800111; King AM, 2014, NATURE, V510, P503, DOI 10.1038/nature13445; Kollef MH, 2006, CLIN INFECT DIS, V43, pS82, DOI 10.1086/504484; Kouyos RD, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0566; Laxminarayan R, 2014, SCIENCE, V345, P1299, DOI 10.1126/science.1254163; Lazar V, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5352; Lazar V, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.57; Lee HH, 2010, NATURE, V467, P82, DOI 10.1038/nature09354; Lehar SM, 2015, NATURE, V527, P323, DOI 10.1038/nature16057; LENSKI RE, 1994, J BACTERIOL, V176, P3140, DOI 10.1128/jb.176.11.3140-3147.1994; Li Q, 2002, ANTIMICROB AGENTS CH, V46, P1262, DOI 10.1128/AAC.46.5.1262-1268.2002; Lieberman TD, 2014, NAT GENET, V46, P82, DOI 10.1038/ng.2848; Lieberman TD, 2011, NAT GENET, V43, P1275, DOI 10.1038/ng.997; Loewe S., 1928, ERGEBN PHYSL, V27, P47, DOI [10.1007/BF02322290, DOI 10.1007/BF02322290]; Lukens AK, 2014, P NATL ACAD SCI USA, V111, P799, DOI 10.1073/pnas.1320886110; Malik M, 2014, J ANTIMICROB CHEMOTH, V69, P3227, DOI 10.1093/jac/dku285; Markham PN, 1996, ANTIMICROB AGENTS CH, V40, P2673, DOI 10.1128/AAC.40.11.2673; Martinez JL, 2015, NAT REV MICROBIOL, V13, P116, DOI 10.1038/nrmicro3399; McClure NS, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1861; MERLIN TL, 1989, ANTIMICROB AGENTS CH, V33, P230, DOI 10.1128/AAC.33.2.230; MERLIN TL, 1989, ANTIMICROB AGENTS CH, V33, P1549, DOI 10.1128/AAC.33.9.1549; Michel JB, 2008, P NATL ACAD SCI USA, V105, P14918, DOI 10.1073/pnas.0800944105; Moreno-Gamez S, 2015, P NATL ACAD SCI USA, V112, pE2874, DOI 10.1073/pnas.1424184112; Munck C, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009940; NELSON ML, 1993, J MED CHEM, V36, P370, DOI 10.1021/jm00055a008; NEYFAKH AA, 1993, ANTIMICROB AGENTS CH, V37, P128, DOI 10.1128/AAC.37.1.128; NGUYEN TNM, 1989, MOL BIOL EVOL, V6, P213; Nichols RJ, 2011, CELL, V144, P143, DOI 10.1016/j.cell.2010.11.052; Okusu H, 1996, J BACTERIOL, V178, P306, DOI 10.1128/JB.178.1.306-308.1996; Oz T, 2014, MOL BIOL EVOL, V31, P2387, DOI 10.1093/molbev/msu191; Pages JM, 2009, BBA-PROTEINS PROTEOM, V1794, P826, DOI 10.1016/j.bbapap.2008.12.011; Pakyz AL, 2009, EPIDEMIOL INFECT, V137, P1679, DOI 10.1017/S0950268809002830; Palmer AC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8385; Palmer AC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5296; Pena-Miller R, 2012, J R SOC INTERFACE, V9, P2488, DOI 10.1098/rsif.2012.0279; Petersen TN, 2015, SCI REP-UK, V5, DOI 10.1038/srep11444; Pluchino KM, 2012, DRUG RESIST UPDATE, V15, P98, DOI 10.1016/j.drup.2012.03.002; Podolsky T, 1996, PLASMID, V36, P112, DOI 10.1006/plas.1996.0038; President's Council of Advisors on Science and Technology, 2014, REP PRES COMB ANT RE, P1, DOI [10.1111/j.0033-0124.1964.033_g.x, DOI 10.1111/J.0033-0124.1964.033_G.X]; READING C, 1977, ANTIMICROB AGENTS CH, V11, P852, DOI 10.1128/AAC.11.5.852; Renau TE, 1999, J MED CHEM, V42, P4928, DOI 10.1021/jm9904598; ROESTAMADJI J, 1995, J AM CHEM SOC, V117, P80, DOI 10.1021/ja00106a009; Ross-Gillespie Adin, 2014, Evolution Medicine and Public Health, P18, DOI 10.1093/emph/eou003; Roux D, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab1621; Rutherford ST, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a012427; Safdar N, 2004, LANCET INFECT DIS, V4, P519, DOI 10.1016/S1473-3099(04)01108-9; Sjolund M, 2005, EMERG INFECT DIS, V11, P1389; Sjolund M, 2003, ANN INTERN MED, V139, P483, DOI 10.7326/0003-4819-139-6-200309160-00011; Smith PA, 2007, NAT CHEM BIOL, V3, P549, DOI 10.1038/nchembio.2007.27; Stermitz FR, 2000, P NATL ACAD SCI USA, V97, P1433, DOI 10.1073/pnas.030540597; Suzuki S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6792; Swoboda JG, 2009, ACS CHEM BIOL, V4, P875, DOI 10.1021/cb900151k; SZYBALSKI W, 1954, APPL MICROBIOL, V2, P57, DOI 10.1128/AEM.2.2.57-63.1954; SZYBALSKI W, 1954, AM REV TUBERC PULM, V69, P267; SZYBALSKI W, 1952, J BACTERIOL, V64, P489, DOI 10.1128/JB.64.4.489-499.1952; TABER HW, 1987, MICROBIOL REV, V51, P439, DOI 10.1128/MMBR.51.4.439-457.1987; Tamma PD, 2012, CLIN MICROBIOL REV, V25, P450, DOI 10.1128/CMR.05041-11; Taylor PL, 2012, ACS CHEM BIOL, V7, P1547, DOI 10.1021/cb300269g; TELENTI A, 1993, LANCET, V341, P647, DOI 10.1016/0140-6736(93)90417-F; Toprak E, 2012, NAT GENET, V44, P101, DOI 10.1038/ng.1034; Torella JP, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000796; van der Zee A, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-27; Vega NM, 2013, P NATL ACAD SCI USA, V110, P14420, DOI 10.1073/pnas.1308085110; Vieira AR, 2011, FOODBORNE PATHOG DIS, V8, P1295, DOI 10.1089/fpd.2011.0950; Vincent BM, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001692; Wang KK, 2016, MOL BIOL EVOL, V33, P492, DOI 10.1093/molbev/msv243; Wegener HC, 2003, CURR OPIN MICROBIOL, V6, P439, DOI 10.1016/j.mib.2003.09.009; Wood KB, 2014, CELL REP, V6, P1073, DOI 10.1016/j.celrep.2014.02.007; World Health Organization, 2016, ANTIMICROBIAL RESIST; Wright GD, 2000, CHEM BIOL, V7, pR127, DOI 10.1016/S1074-5521(00)00126-5; Wright GD, 2011, CHEM COMMUN, V47, P4055, DOI 10.1039/c0cc05111j; Yeh P, 2006, NAT GENET, V38, P489, DOI 10.1038/ng1755; Yeh PJ, 2009, NAT REV MICROBIOL, V7, P460, DOI 10.1038/nrmicro2133; zur Wiesch PA, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004225	123	347	359	23	448	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 1	2016	351	6268							aad3292	10.1126/science.aad3292	http://dx.doi.org/10.1126/science.aad3292			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ8QM	26722002	Green Accepted			2022-12-28	WOS:000367364200034
J	Ferenczi, EA; Zalocusky, KA; Liston, C; Grosenick, L; Warden, MR; Amatya, D; Katovich, K; Mehta, H; Patenaude, B; Ramakrishnan, C; Kalanithi, P; Etkin, A; Knutson, B; Glover, GH; Deisseroth, K				Ferenczi, Emily A.; Zalocusky, Kelly A.; Liston, Conor; Grosenick, Logan; Warden, Melissa R.; Amatya, Debha; Katovich, Kiefer; Mehta, Hershel; Patenaude, Brian; Ramakrishnan, Charu; Kalanithi, Paul; Etkin, Amit; Knutson, Brian; Glover, Gary H.; Deisseroth, Karl			Prefrontal cortical regulation of brainwide circuit dynamics and reward-related behavior	SCIENCE			English	Article							STATE FUNCTIONAL CONNECTIVITY; SUBGENUAL CINGULATE CORTEX; NUCLEUS-ACCUMBENS; DOPAMINE RELEASE; VISUAL-CORTEX; SPIRAL-IN/OUT; FMRI; STIMULATION; ANHEDONIA; SIGNALS	Motivation for reward drives adaptive behaviors, whereas impairment of reward perception and experience (anhedonia) can contribute to psychiatric diseases, including depression and schizophrenia. We sought to test the hypothesis that the medial prefrontal cortex (mPFC) controls interactions among specific subcortical regions that govern hedonic responses. By using optogenetic functional magnetic resonance imaging to locally manipulate but globally visualize neural activity in rats, we found that dopamine neuron stimulation drives striatal activity, whereas locally increased mPFC excitability reduces this striatal response and inhibits the behavioral drive for dopaminergic stimulation. This chronic mPFC overactivity also stably suppresses natural reward-motivated behaviors and induces specific new brainwide functional interactions, which predict the degree of anhedonia in individuals. These findings describe a mechanism by which mPFC modulates expression of reward-seeking behavior, by regulating the dynamical interactions between specific distant subcortical regions.	[Ferenczi, Emily A.; Zalocusky, Kelly A.; Grosenick, Logan; Amatya, Debha; Ramakrishnan, Charu; Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Ferenczi, Emily A.; Zalocusky, Kelly A.; Grosenick, Logan] Stanford Univ, Neurosci Program, Stanford, CA 94305 USA; [Liston, Conor] Weill Cornell Med Coll, Brain Mind Res Inst, New York, NY 10065 USA; [Warden, Melissa R.; Deisseroth, Karl] Cornell Univ, Dept Neurobiol & Behav, Ithaca, NY 14853 USA; [Katovich, Kiefer; Mehta, Hershel; Knutson, Brian] Stanford Univ, Dept Psychol, Stanford, CA 94305 USA; [Patenaude, Brian; Etkin, Amit] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Kalanithi, Paul] Stanford Univ, Dept Neurosurg, Stanford, CA 94305 USA; [Glover, Gary H.] Stanford Univ, Dept Radiol, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Stanford University; Cornell University; Cornell University; Stanford University; Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University	Deisseroth, K (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	deissero@stanford.edu	Etkin, Amit/ABD-5761-2021; Warden, Melissa R/M-9300-2016; mohamady, mahin/G-2175-2016; , Conor Liston/GQH-8931-2022	Warden, Melissa R/0000-0003-2240-3997; Knutson, Brian/0000-0002-7669-426X	Defense Advanced Research Projects Agency Neuro-FAST program; National Institute of Mental Health; National Institute on Drug Abuse (NIDA); NSF; Simons Foundation; Gatsby Foundation; Wiegers Family Fund; Grosfeld Foundation; Reeves Foundation; Snyder Foundation; Woo Foundation; Albert Yu and Mary Bechman Foundation; NIH [P41 EB015891, R00 MH097822]; Bio-X Seed grant; Stanford Neuroscience Institute; Fulbright International Science and Technology Fellowship; Stanford Graduate Fellowship; Gerald J. Lieberman Fellowship; Stanford Neurosciences Program NIH Training Grant; National Research Service Award Predoctoral Fellowship from NIDA [1F31MH105151_01]; NARSAD; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015891] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH105151, R00MH097822, R01MH086373, F30MH010515, DP2MH109982] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R37DA035377] Funding Source: NIH RePORTER	Defense Advanced Research Projects Agency Neuro-FAST program; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NSF(National Science Foundation (NSF)); Simons Foundation; Gatsby Foundation; Wiegers Family Fund; Grosfeld Foundation; Reeves Foundation; Snyder Foundation; Woo Foundation; Albert Yu and Mary Bechman Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bio-X Seed grant; Stanford Neuroscience Institute; Fulbright International Science and Technology Fellowship; Stanford Graduate Fellowship(Stanford University); Gerald J. Lieberman Fellowship; Stanford Neurosciences Program NIH Training Grant; National Research Service Award Predoctoral Fellowship from NIDA; NARSAD(NARSAD); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We declare no conflicts of interest. K.D. is supported by the Defense Advanced Research Projects Agency Neuro-FAST program; the National Institute of Mental Health; the National Institute on Drug Abuse (NIDA); the NSF; the Simons Foundation; the Gatsby Foundation; the Wiegers Family Fund; and the Grosfeld, Reeves, Snyder, Woo, and Albert Yu and Mary Bechman Foundations. G.H.G. is supported by NIH grant P41 EB015891. This research was also supported in part by a Bio-X Seed grant and a Stanford Neuroscience Institute grant to B.K. and K.D. E.A.F. was supported by a Fulbright International Science and Technology Fellowship, a Stanford Graduate Fellowship, and a Gerald J. Lieberman Fellowship. K.A.Z. was supported by the NSF Graduate Research Fellowship Program, the Stanford Neurosciences Program NIH Training Grant, and a National Research Service Award Predoctoral Fellowship from NIDA (1F31MH105151_01). C.L. was supported by NARSAD and NIH grant R00 MH097822. We thank Z. J. Malchano, T. Davidson, L. J. Pisani, and R. Watkins for advice and technical support and the entire Deisseroth laboratory for guidance. Data displayed in Fig. 6 are available as a full online resource data set at http://clarityresourcecenter.org/ofMRI.html.	Aravanis AM, 2007, J NEURAL ENG, V4, pS143, DOI 10.1088/1741-2560/4/3/S02; Arsenault JT, 2013, NEURON, V77, P1174, DOI 10.1016/j.neuron.2013.01.008; Beier KT, 2015, CELL, V162, P622, DOI 10.1016/j.cell.2015.07.015; BERENDSE HW, 1992, J COMP NEUROL, V316, P314, DOI 10.1002/cne.903160305; Berke JD, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00045; Berlim MT, 2014, J AFFECT DISORDERS, V159, P31, DOI 10.1016/j.jad.2014.02.016; Berndt A, 2009, NAT NEUROSCI, V12, P229, DOI 10.1038/nn.2247; Bluhm RL, 2009, PSYCHIAT RES-NEUROIM, V174, P17, DOI 10.1016/j.pscychresns.2009.03.010; Bourne JA, 2001, CNS DRUG REV, V7, P399; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Buracas GT, 2002, NEUROIMAGE, V16, P801, DOI 10.1006/nimg.2002.1116; Buzsaki G, 2012, ANNU REV NEUROSCI, V35, P203, DOI 10.1146/annurev-neuro-062111-150444; Buzsaki G, 2012, NAT REV NEUROSCI, V13, P407, DOI 10.1038/nrn3241; Chang C, 2011, MAGN RESON MED, V65, P1287, DOI 10.1002/mrm.22722; Chaudhury D, 2013, NATURE, V493, P532, DOI 10.1038/nature11713; Christie IN, 2013, NEUROIMAGE, V66, P634, DOI 10.1016/j.neuroimage.2012.10.074; Covington HE, 2010, J NEUROSCI, V30, P16082, DOI 10.1523/JNEUROSCI.1731-10.2010; de la Iglesia-Vaya M, 2014, NEUROIMAGE-CLIN, V6, P171, DOI 10.1016/j.nicl.2014.08.027; De Martino F, 2008, NEUROIMAGE, V43, P44, DOI 10.1016/j.neuroimage.2008.06.037; Deisseroth K, 2014, NATURE, V505, P309, DOI 10.1038/nature12982; Dowd EC, 2010, BIOL PSYCHIAT, V67, P902, DOI 10.1016/j.biopsych.2009.10.020; Dunn RT, 2002, BIOL PSYCHIAT, V51, P387, DOI 10.1016/S0006-3223(01)01244-6; Fiorillo CD, 2003, SCIENCE, V299, P1898, DOI 10.1126/science.1077349; Friedman J, 2008, BIOSTATISTICS, V9, P432, DOI 10.1093/biostatistics/kxm045; Ghazizadeh A, 2012, J NEUROSCI, V32, P726, DOI 10.1523/JNEUROSCI.3891-11.2012; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; Glover GH, 2001, MAGNET RESON MED, V46, P515, DOI 10.1002/mrm.1222; Glover GH, 1996, MAGNET RESON MED, V35, P299, DOI 10.1002/mrm.1910350306; Glover GH, 1999, NEUROIMAGE, V9, P416, DOI 10.1006/nimg.1998.0419; Gorwood Philip, 2008, Dialogues Clin Neurosci, V10, P291; GRACE AA, 1991, NEUROSCIENCE, V41, P1, DOI 10.1016/0306-4522(91)90196-U; Gradinaru V, 2008, BRAIN CELL BIOL, V36, P129, DOI 10.1007/s11068-008-9027-6; Gregoriou GG, 2009, SCIENCE, V324, P1207, DOI 10.1126/science.1171402; Greicius MD, 2007, BIOL PSYCHIAT, V62, P429, DOI 10.1016/j.biopsych.2006.09.020; Gunaydin LA, 2014, CELL, V157, P1535, DOI 10.1016/j.cell.2014.05.017; Haber SN, 2010, NEUROPSYCHOPHARMACOL, V35, P4, DOI 10.1038/npp.2009.129; Hamani C, 2010, BIOL PSYCHIAT, V67, P117, DOI 10.1016/j.biopsych.2009.08.025; Harvey PO, 2007, MOL PSYCHIATR, V12, P767, DOI 10.1038/sj.mp.4002021; Howe MW, 2013, NATURE, V500, P575, DOI 10.1038/nature12475; Igarashi KM, 2014, NATURE, V510, P143, DOI 10.1038/nature13162; Ikemoto S, 2007, BRAIN RES REV, V56, P27, DOI 10.1016/j.brainresrev.2007.05.004; Jackson ME, 2001, J NEUROCHEM, V78, P920, DOI 10.1046/j.1471-4159.2001.00499.x; Juckel G, 2006, NEUROIMAGE, V29, P409, DOI 10.1016/j.neuroimage.2005.07.051; Keedwell PA, 2005, BIOL PSYCHIAT, V58, P843, DOI 10.1016/j.biopsych.2005.05.019; Kelley AE, 2002, J NEUROSCI, V22, P3306; Knutson B, 2004, NEURON, V43, P261, DOI 10.1016/j.neuron.2004.06.030; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; Knutson B, 2005, CURR OPIN NEUROL, V18, P411, DOI 10.1097/01.wco.0000173463.24758.f6; Knutson B, 2007, PSYCHOPHARMACOLOGY, V191, P813, DOI 10.1007/s00213-006-0686-7; Krugel LK, 2009, P NATL ACAD SCI USA, V106, P17951, DOI 10.1073/pnas.0905191106; Kumari V, 2003, BIOL PSYCHIAT, V54, P777, DOI 10.1016/S0006-3223(02)01785-7; Lally N, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.105; Law CS, 2009, MAGN RESON MED, V62, P829, DOI 10.1002/mrm.22056; Lee JH, 2010, NATURE, V465, P788, DOI 10.1038/nature09108; Lim BK, 2012, NATURE, V487, P183, DOI 10.1038/nature11160; Liu HS, 2013, P NATL ACAD SCI USA, V110, P4093, DOI 10.1073/pnas.1207531110; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Luthi A, 2014, NAT NEUROSCI, V17, P1635, DOI 10.1038/nn.3849; Mayberg HS, 2005, NEURON, V45, P651, DOI 10.1016/j.neuron.2005.02.014; Mitterschiffthaler MT, 2003, NEUROREPORT, V14, P177, DOI 10.1097/00001756-200302100-00003; Moghaddam B, 2014, JAMA PSYCHIAT, V71, P197, DOI 10.1001/jamapsychiatry.2013.2080; Nestler EJ, 2006, BIOL PSYCHIAT, V59, P1151, DOI 10.1016/j.biopsych.2005.09.018; Nicola SM, 2000, ANNU REV NEUROSCI, V23, P185, DOI 10.1146/annurev.neuro.23.1.185; Noudoost B, 2011, NATURE, V474, P372, DOI 10.1038/nature09995; O'Doherty JP, 2004, CURR OPIN NEUROBIOL, V14, P769, DOI 10.1016/j.conb.2004.10.016; Phillips PEM, 2003, METH MOLEC MED, V79, P443; Pisauro MA, 2013, J NEUROSCI, V33, P18343, DOI 10.1523/JNEUROSCI.2130-13.2013; Ressler KJ, 2007, NAT NEUROSCI, V10, P1116, DOI 10.1038/nn1944; Robbins TW, 1996, CURR OPIN NEUROBIOL, V6, P228, DOI 10.1016/S0959-4388(96)80077-8; Robinson DL, 2003, CLIN CHEM, V49, P1763, DOI 10.1373/49.10.1763; Russo SJ, 2013, NAT REV NEUROSCI, V14, P609, DOI 10.1038/nrn3381; Schott BH, 2008, J NEUROSCI, V28, P14311, DOI 10.1523/JNEUROSCI.2058-08.2008; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Sesack SR, 2010, NEUROPSYCHOPHARMACOL, V35, P27, DOI 10.1038/npp.2009.93; Siegel M, 2012, NAT REV NEUROSCI, V13, P121, DOI 10.1038/nrn3137; Stuber GD, 2010, J NEUROSCI, V30, P8229, DOI 10.1523/JNEUROSCI.1754-10.2010; Suresh PS, 2011, BIOMED CHROMATOGR, V25, P930, DOI 10.1002/bmc.1547; Tobler PN, 2003, J NEUROSCI, V23, P10402; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; Tye KM, 2013, NATURE, V493, P537, DOI 10.1038/nature11740; Witten IB, 2011, NEURON, V72, P721, DOI 10.1016/j.neuron.2011.10.028; Woodward ND, 2015, JAMA PSYCHIAT, V72, P743, DOI 10.1001/jamapsychiatry.2015.0484; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; Zaldivar D, 2014, CURR BIOL, V24, P2805, DOI 10.1016/j.cub.2014.10.006; Zhang F, 2008, NAT NEUROSCI, V11, P631, DOI 10.1038/nn.2120; Zhao T, 2012, J MACH LEARN RES, V13, P1059	86	307	315	5	198	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 1	2016	351	6268							aac9698	10.1126/science.aac9698	http://dx.doi.org/10.1126/science.aac9698			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ8QM	26722001	Green Accepted			2022-12-28	WOS:000367364200035
J	Simola, DF; Graham, RJ; Brady, CM; Enzmann, BL; Desplan, C; Ray, A; Zwiebel, LJ; Bonasio, R; Reinberg, D; Liebig, J; Berger, SL				Simola, Daniel F.; Graham, Riley J.; Brady, Cristina M.; Enzmann, Brittany L.; Desplan, Claude; Ray, Anandasankar; Zwiebel, Laurence J.; Bonasio, Roberto; Reinberg, Danny; Liebig, Juergen; Berger, Shelley L.			Epigenetic (re)programming of caste-specific behavior in the ant Camponotus floridanus	SCIENCE			English	Article							DIVISION-OF-LABOR; GENOME-WIDE; HISTONE H3; MEMORY; ACETYLATION; PLASTICITY; IDENTIFICATION; TRANSCRIPTION; INHIBITOR; COMPLEX	Eusocial insects organize themselves into behavioral castes whose regulation has been proposed to involve epigenetic processes, including histone modification. In the carpenter ant Camponotus floridanus, morphologically distinct worker castes called minors and majors exhibit pronounced differences in foraging and scouting behaviors. We found that these behaviors are regulated by histone acetylation likely catalyzed by the conserved acetyltransferase CBP. Transcriptome and chromatin analysis in brains of scouting minors fed pharmacological inhibitors of CBP and histone deacetylases (HDACs) revealed hundreds of genes linked to hyperacetylated regions targeted by CBP. Majors rarely forage, but injection of a HDAC inhibitor or small interfering RNAs against the HDAC Rpd3 into young major brains induced and sustained foraging in a CBP-dependent manner. Our results suggest that behavioral plasticity in animals may be regulated in an epigenetic manner via histone modification.	[Simola, Daniel F.; Brady, Cristina M.; Bonasio, Roberto; Berger, Shelley L.] Univ Penn, Dept Cell & Dev Biol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Simola, Daniel F.; Graham, Riley J.; Brady, Cristina M.; Bonasio, Roberto; Berger, Shelley L.] Univ Penn, Program Epigenet, Philadelphia, PA 19104 USA; [Graham, Riley J.; Berger, Shelley L.] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Enzmann, Brittany L.; Liebig, Juergen] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; [Desplan, Claude] NYU, Dept Biol, New York, NY 10003 USA; [Ray, Anandasankar] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA; [Zwiebel, Laurence J.] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37232 USA; [Reinberg, Danny] NYU, Sch Med, Dept Mol Pharmacol & Biochem, New York, NY 10016 USA; [Berger, Shelley L.] Univ Penn, Dept Genet, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; Arizona State University; Arizona State University-Tempe; New York University; University of California System; University of California Riverside; Vanderbilt University; New York University; University of Pennsylvania; Pennsylvania Medicine	Simola, DF (corresponding author), Univ Penn, Dept Cell & Dev Biol, Perelman Sch Med, Philadelphia, PA 19104 USA.	simola@upenn.edu; danny.reinberg@nyumc.org; juergen.liebig@asu.edu; bergers@upenn.edu	Bonasio, Roberto/P-1356-2014	Bonasio, Roberto/0000-0002-0767-0889; Berger, Shelley/0000-0001-5398-4400; Desplan, Claude/0000-0002-6914-1413; Reinberg, Danny/0000-0003-4288-2016; Zwiebel, Laurence/0000-0001-6686-7289; Ray, Anandasankar/0000-0003-4133-2581	Howard Hughes Medical Institute [2009005]; NIH from the University of Pennsylvania [T32HD083185]; NIH [DP2MH107055]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD083185] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [DP2MH107055] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH from the University of Pennsylvania(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank D. Kronauer and I. Fetter-Pruneda for advice on brain injections, and P. Cole, D. Meyers, M. Sammons, P. Shah, and H. Yan for intellectual contributions. Supported by Howard Hughes Medical Institute Collaborative Innovation Award 2009005 (S.L.B., C.D., J.L., A.R., D.R., and L.J.Z.), NIH training grant T32HD083185 in developmental biology from the University of Pennsylvania (D.F.S.), and NIH New Innovator Award DP2MH107055 (R.B.). Sequencing data have been deposited in the National Center for Biotechnology Information Gene Expression Omnibus (www.ncbi.nlm.nih.gov/geo) under accession number GSE69553. Behavioral data are available in tables S7 and S8. C. floridanus SNPs are available in table S9, and gene annotations are available in table S10. Software used for high-throughput sequencing and gene ontology analyses is available on GitHub (https://github.com/dfsimola/glimmr).	Alarcon JM, 2004, NEURON, V42, P947, DOI 10.1016/j.neuron.2004.05.021; Alvarado S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7513; BHATKAR A, 1970, Florida Entomologist, V53, P229, DOI 10.2307/3493193; Bonasio R, 2012, CURR BIOL, V22, P1755, DOI 10.1016/j.cub.2012.07.042; Bonasio R, 2010, SCIENCE, V329, P1068, DOI 10.1126/science.1192428; Bowers EM, 2010, CHEM BIOL, V17, P471, DOI 10.1016/j.chembiol.2010.03.006; CALABI P, 1989, J INSECT BEHAV, V2, P663, DOI 10.1007/BF01065785; Cho YS, 2005, GENOMICS, V86, P606, DOI 10.1016/j.ygeno.2005.07.007; Crump NT, 2011, P NATL ACAD SCI USA, V108, P7814, DOI 10.1073/pnas.1100099108; Dulac C, 2010, NATURE, V465, P728, DOI 10.1038/nature09231; Ehmer B, 2004, J COMP NEUROL, V469, P198, DOI 10.1002/cne.11014; Fischer A, 2007, NATURE, V447, P178, DOI 10.1038/nature05772; Fitzsimons HL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029171; Fjerdingstad EJ, 2006, AM NAT, V167, P390, DOI 10.1086/499545; Gadau J, 1996, MOL ECOL, V5, P785, DOI 10.1111/j.1365-294X.1996.tb00374.x; Gottlicher M, 2001, EMBO J, V20, P6969, DOI 10.1093/emboj/20.24.6969; Gronenberg W, 1996, J EXP BIOL, V199, P2011; Herb BR, 2012, NAT NEUROSCI, V15, P1371, DOI 10.1038/nn.3218; HOLLDOBLER B, 1971, Z VERGL PHYSIOL, V75, P123; Holldobler B., 1990, pi; Iyer SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033634; Jin QH, 2011, EMBO J, V30, P249, DOI 10.1038/emboj.2010.318; Korzus E, 2004, NEURON, V42, P961, DOI 10.1016/j.neuron.2004.06.002; Kucharski R, 2008, SCIENCE, V319, P1827, DOI 10.1126/science.1153069; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Liang ZZS, 2012, SCIENCE, V335, P1225, DOI 10.1126/science.1213962; Lucas C, 2009, P NATL ACAD SCI USA, V106, P6351, DOI 10.1073/pnas.0809463106; Malik AN, 2014, NAT NEUROSCI, V17, P1330, DOI 10.1038/nn.3808; Mersch DP, 2013, SCIENCE, V340, P1090, DOI 10.1126/science.1234316; Milite C, 2015, J MED CHEM, V58, P2779, DOI 10.1021/jm5019687; Orlando DA, 2014, CELL REP, V9, P1163, DOI 10.1016/j.celrep.2014.10.018; Robinson GE, 2005, NAT REV GENET, V6, P257, DOI 10.1038/nrg1575; ROBINSON GE, 1992, ANNU REV ENTOMOL, V37, P637, DOI 10.1146/annurev.en.37.010192.003225; Schrader L, 2015, MOL BIOL EVOL, V32, P1474, DOI 10.1093/molbev/msv039; Simola DF, 2013, GENOME RES, V23, P486, DOI 10.1101/gr.148361.112; Smith CR, 2008, NAT REV GENET, V9, P735, DOI 10.1038/nrg2429; Spannhoff A, 2011, EMBO REP, V12, P238, DOI 10.1038/embor.2011.9; Stroeymeyt N, 2011, J EXP BIOL, V214, P3046, DOI 10.1242/jeb.059188; Suganuma T, 2008, NAT STRUCT MOL BIOL, V15, P364, DOI 10.1038/nsmb.1397; Tie F, 2009, DEVELOPMENT, V136, P3131, DOI 10.1242/dev.037127; Tschinkel W. R, 2013, FIRE ANTS; Vecsey CG, 2007, J NEUROSCI, V27, P6128, DOI 10.1523/JNEUROSCI.0296-07.2007; Wang J, 2013, NATURE, V493, P664, DOI 10.1038/nature11832; WILSON EO, 1976, BEHAV ECOL SOCIOBIOL, V1, P141, DOI 10.1007/BF00299195; WITHERS GS, 1993, NATURE, V364, P238, DOI 10.1038/364238a0; Xia SZ, 2005, CURR BIOL, V15, P603, DOI 10.1016/j.cub.2005.02.059; Yan H, 2014, NAT REV GENET, V15, P677, DOI 10.1038/nrg3787; Zhong Silin, 2011, Cold Spring Harb Protoc, V2011, P940, DOI 10.1101/pdb.prot5652	48	127	132	6	172	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 1	2016	351	6268							aac6633	10.1126/science.aac6633	http://dx.doi.org/10.1126/science.aac6633			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ8QM	26722000	Green Accepted			2022-12-28	WOS:000367364200036
J	Lauer, MS; Krumholz, HM; Topol, EJ				Lauer, Michael S.; Krumholz, Harlan M.; Topol, Eric J.			Time for a prepublication culture in clinical research?	LANCET			English	Editorial Material							SCIENCE		[Lauer, Michael S.] NIH, Off Extramural Res, Bethesda, MD 20892 USA; [Krumholz, Harlan M.] Yale Univ, Dept Med, New Haven, CT 06520 USA; [Topol, Eric J.] Scripps Translat Sci Inst, La Jolla, CA USA	National Institutes of Health (NIH) - USA; Yale University; Scripps Research Institute	Lauer, MS (corresponding author), NIH, Off Extramural Res, Bldg 10, Bethesda, MD 20892 USA.	michael.lauer@nih.gov	, Harlan/AAI-2875-2020		Intramural NIH HHS [Z99 OD999999] Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		ANGELL M, 1991, NEW ENGL J MED, V325, P1371, DOI 10.1056/NEJM199111073251910; [Anonymous], 1969, N Engl J Med, V281, P676; Cook I, 2015, PEERJ, V3, DOI 10.7717/peerj.989; Desjardins-Proulx P, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001563; KASSIRER JP, 1995, NEW ENGL J MED, V332, P1709, DOI 10.1056/NEJM199506223322509; Peters HP, 2013, P NATL ACAD SCI USA, V110, P14102, DOI 10.1073/pnas.1212745110; RELMAN AS, 1981, NEW ENGL J MED, V305, P824, DOI 10.1056/NEJM198110013051408; Ross JS, 2013, JAMA-J AM MED ASSOC, V309, P1355, DOI 10.1001/jama.2013.1299; SPRINT Research Group, 2015, N Engl J Med, V373, P2103, DOI 10.1056/NEJMoa1511939; Topol E., 2015, PATIENT WILL SEE YOU; Topol EJ, 2015, NY TIMES; Vale RD, 2015, P NATL ACAD SCI USA, V112, P13439, DOI 10.1073/pnas.1511912112	12	24	24	0	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 19	2015	386	10012					2447	2449		10.1016/S0140-6736(15)01177-0	http://dx.doi.org/10.1016/S0140-6736(15)01177-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CZ1LD	26738703	Green Accepted			2022-12-28	WOS:000366866400005
J	Himmelstein, DU; Phillips, RS				Himmelstein, David U.; Phillips, Russell S.			Should We Abandon Routine Visits? There Is Little Evidence for or Against	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							HEALTH		[Himmelstein, David U.] CUNY Hunter Coll, Sch Publ Hlth, 255 West 90th St,12A, New York, NY 10024 USA; [Phillips, Russell S.] Harvard Univ, Sch Med, Ctr Primary Care, Med, 635 Huntington Ave, Boston, MA 02115 USA; Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA	City University of New York (CUNY) System; Hunter College (CUNY); Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center	Himmelstein, DU (corresponding author), CUNY Hunter Coll, Sch Publ Hlth, 255 West 90th St,12A, New York, NY 10024 USA.	dhimmels@hunter.cuny.edu						Boulware LE, 2007, ANN INTERN MED, V146, P289, DOI 10.7326/0003-4819-146-4-200702200-00008; DALES L G, 1973, Preventive Medicine, V2, P221, DOI 10.1016/0091-7435(73)90066-2; Emanuel EJ, 2015, NY TIMES; FRIEDMAN GD, 1986, J CHRON DIS, V39, P453, DOI 10.1016/0021-9681(86)90112-8; Holland W., 1977, INT J EPIDEMIOL, V6, P357; Krogsboll LT, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7191; LANNERSTAD O, 1977, SCAND J SOC MED, V5, P137, DOI 10.1177/140349487700500305; SHAPIRO S, 1973, Preventive Medicine, V2, P266, DOI 10.1016/0091-7435(73)90070-4; Starfield B, 2005, MILBANK Q, V83, P457, DOI 10.1111/j.1468-0009.2005.00409.x; Sussman J, 2013, CHOOSING WISELY 5 TH	10	10	10	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 5	2016	164	7					498	+		10.7326/M15-2097	http://dx.doi.org/10.7326/M15-2097			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DI6QP	26747523				2022-12-28	WOS:000373625300012
J	Sands, P; Mundaca-Shah, C; Dzau, VJ				Sands, Peter; Mundaca-Shah, Carmen; Dzau, Victor J.			The Neglected Dimension of Global Security - A Framework for Countering Infectious-Disease Crises	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									[Sands, Peter; Mundaca-Shah, Carmen; Dzau, Victor J.] Harvard Univ, Kennedy Sch, Commiss Global Hlth Risk Framework Future, Cambridge, MA 02138 USA; [Sands, Peter] Harvard Univ, Kennedy Sch, Mossavar Rahmani Ctr Business & Govt, Cambridge, MA 02138 USA; [Mundaca-Shah, Carmen; Dzau, Victor J.] Natl Acad Med, Washington, DC USA	Harvard University; Harvard University; National Academies of Sciences, Engineering & Medicine	Sands, P (corresponding author), Harvard Univ, Kennedy Sch, Commiss Global Hlth Risk Framework Future, Cambridge, MA 02138 USA.; Sands, P (corresponding author), Harvard Univ, Kennedy Sch, Mossavar Rahmani Ctr Business & Govt, Cambridge, MA 02138 USA.								0	120	126	2	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 31	2016	374	13					1281	1287		10.1056/NEJMsr1600236	http://dx.doi.org/10.1056/NEJMsr1600236			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DH8ZM	26761419	Bronze			2022-12-28	WOS:000373085500014
J	Kupfer, JM				Kupfer, Joel M.			The Graying of US Physicians Implications for Quality and the Future Supply of Physicians	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HEALTH-CARE		[Kupfer, Joel M.] Univ Illinois, Coll Med Peoria, Dept Med, 221 NE Glenn Oak Ave, Peoria, IL 61603 USA	University of Illinois System; University of Illinois Peoria	Kupfer, JM (corresponding author), Univ Illinois, Coll Med Peoria, Dept Med, 221 NE Glenn Oak Ave, Peoria, IL 61603 USA.	jmkupfer@comcast.net						[Anonymous], 2015, AMA WIRE        0623; Babbott S, 2014, J AM MED INFORM ASSN, V21, pE100, DOI 10.1136/amiajnl-2013-001875; Choudhry NK, 2005, ANN INTERN MED, V142, P260, DOI 10.7326/0003-4819-142-4-200502150-00008; Funkhouser E, 2011, CIRC-CARDIOVASC QUAL, V4, P99, DOI 10.1161/CIRCOUTCOMES.110.942318; Kohatsu ND, 2004, ARCH INTERN MED, V164, P653, DOI 10.1001/archinte.164.6.653; Korinek LL, 2009, ACAD MED, V84, P1015, DOI 10.1097/ACM.0b013e3181ad00a2; Reid RO, 2010, ARCH INTERN MED, V170, P1442, DOI 10.1001/archinternmed.2010.307; Waljee JF, 2006, ANN SURG, V244, P353, DOI 10.1097/01.sla.0000234803.11991.6d; Young Aaron, 2013, J MED REGUL, V99, P11, DOI [10.30770/2572-1852-99.2.11, DOI 10.30770/2572-1852-99.2.11]	9	18	18	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 26	2016	315	4					341	342		10.1001/jama.2015.18248	http://dx.doi.org/10.1001/jama.2015.18248			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DB5YI	26720141				2022-12-28	WOS:000368589500007
J	Akhmediev, N; Devine, N				Akhmediev, N.; Devine, N.			How Cherenkov radiative losses can improve optical frequency combs Broader optical frequency combs on a photonic chip can help refine time standards	SCIENCE			English	Editorial Material							MODE-LOCKED LASERS; PHASE-CONTROL; SOLITONS; FIBERS		[Akhmediev, N.; Devine, N.] Australian Natl Univ, Opt Sci Grp, Res Sch Phys & Engn, Canberra, ACT 2600, Australia	Australian National University	Akhmediev, N (corresponding author), Australian Natl Univ, Opt Sci Grp, Res Sch Phys & Engn, Canberra, ACT 2600, Australia.	nail.akhmediev@anu.edu.au	Akhmediev, Nail/Y-2537-2019	Akhmediev, Nail/0000-0001-7294-8958				AKHMEDIEV N, 1995, PHYS REV A, V51, P2602, DOI 10.1103/PhysRevA.51.2602; Brasch V, 2016, SCIENCE, V351, P357, DOI 10.1126/science.aad4811; Cundiff ST, 2003, REV MOD PHYS, V75, P325, DOI 10.1103/RevModPhys.75.325; Grelu P, 2012, NAT PHOTONICS, V6, P84, DOI [10.1038/nphoton.2011.345, 10.1038/NPHOTON.2011.345]; HASEGAWA A, 1973, APPL PHYS LETT, V23, P142, DOI 10.1063/1.1654836; Herr T, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.123901; Herr T, 2014, NAT PHOTONICS, V8, P145, DOI [10.1038/NPHOTON.2013.343, 10.1038/nphoton.2013.343]; Jones DJ, 2000, SCIENCE, V288, P635, DOI 10.1126/science.288.5466.635; Levy JS, 2010, NAT PHOTONICS, V4, P37, DOI 10.1038/NPHOTON.2009.259; MOLLENAUER LF, 1980, PHYS REV LETT, V45, P1095, DOI 10.1103/PhysRevLett.45.1095; Mussot A, 2014, PHYS REV X, V4, DOI 10.1103/PhysRevX.4.011054; Newbury NR, 2011, NAT PHOTONICS, V5, P186, DOI 10.1038/nphoton.2011.38; Telle HR, 1999, APPL PHYS B-LASERS O, V69, P327, DOI 10.1007/s003400050813	13	4	4	2	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 22	2016	351	6271					340	341		10.1126/science.aad8694	http://dx.doi.org/10.1126/science.aad8694			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB3VH	26798000				2022-12-28	WOS:000368440500022
J	Ahmadi, M; Baquero-Ruiz, M; Bertsche, W; Butler, E; Capra, A; Carruth, C; Cesar, CL; Charlton, M; Charman, AE; Eriksson, S; Evans, LT; Evetts, N; Fajans, J; Friesen, T; Fujiwara, MC; Gill, DR; Gutierrez, A; Hangst, JS; Hardy, WN; Hayden, ME; Isaac, CA; Ishida, A; Jones, SA; Jonsell, S; Kurchaninov, L; Madsen, N; Maxwell, D; McKenna, JTK; Menary, S; Michan, JM; Momose, T; Munich, JJ; Nolan, P; Olchanski, K; Olin, A; Povilus, A; Pusa, P; Rasmussen, CO; Robicheaux, F; Sacramento, RL; Sameed, M; Sarid, E; Silveira, DM; So, C; Tharp, TD; Thompson, RI; van der Werf, DP; Wurtele, JS; Zhmoginov, AI				Ahmadi, M.; Baquero-Ruiz, M.; Bertsche, W.; Butler, E.; Capra, A.; Carruth, C.; Cesar, C. L.; Charlton, M.; Charman, A. E.; Eriksson, S.; Evans, L. T.; Evetts, N.; Fajans, J.; Friesen, T.; Fujiwara, M. C.; Gill, D. R.; Gutierrez, A.; Hangst, J. S.; Hardy, W. N.; Hayden, M. E.; Isaac, C. A.; Ishida, A.; Jones, S. A.; Jonsell, S.; Kurchaninov, L.; Madsen, N.; Maxwell, D.; McKenna, J. T. K.; Menary, S.; Michan, J. M.; Momose, T.; Munich, J. J.; Nolan, P.; Olchanski, K.; Olin, A.; Povilus, A.; Pusa, P.; Rasmussen, C. O.; Robicheaux, F.; Sacramento, R. L.; Sameed, M.; Sarid, E.; Silveira, D. M.; So, C.; Tharp, T. D.; Thompson, R. I.; van der Werf, D. P.; Wurtele, J. S.; Zhmoginov, A. I.			An improved limit on the charge of antihydrogen from stochastic acceleration	NATURE			English	Article							ELECTRON	Antimatter continues to intrigue physicists because of its apparent absence in the observable Universe. Current theory requires that matter and antimatter appeared in equal quantities after the Big Bang, but the Standard Model of particle physics offers no quantitative explanation for the apparent disappearance of half the Universe. It has recently become possible to study trapped atoms(1-4) of antihydrogen to search for possible, as yet unobserved, differences in the physical behaviour of matter and antimatter. Here we consider the charge neutrality of the antihydrogen atom. By applying stochastic acceleration to trapped antihydrogen atoms, we determine an experimental bound on the antihydrogen charge, Qe, of vertical bar Q vertical bar < 0.71 parts per billion (one standard deviation), in which e is the elementary charge. This bound is a factor of 20 less than that determined from the best previous measurement(5) of the antihydrogen charge. The electrical charge of atoms and molecules of normal matter is known(6) to be no greater than about 10(-21)e for a diverse range of species including H-2, He and SF6. Charge-parity-time symmetry and quantum anomaly cancellation(7) demand that the charge of antihydrogen be similarly small. Thus, our measurement constitutes an improved limit and a test of fundamental aspects of the Standard Model. If we assume charge superposition and use the best measured value of the antiproton charge(8), then we can place a new limit on the positron charge anomaly (the relative difference between the positron and elementary charge) of about one part per billion (one standard deviation), a 25-fold reduction compared to the current best measurement(8),(9).	[Ahmadi, M.; Nolan, P.; Pusa, P.] Univ Liverpool, Dept Phys, Liverpool L69 7ZE, Merseyside, England; [Baquero-Ruiz, M.; Carruth, C.; Charman, A. E.; Evans, L. T.; Fajans, J.; Povilus, A.; So, C.; Wurtele, J. S.; Zhmoginov, A. I.] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Baquero-Ruiz, M.] Ecole Polytech Fed Lausanne, CRPP, CH-1015 Lausanne, Switzerland; [Bertsche, W.] Univ Manchester, Sch Phys & Astron, Manchester M13 9PL, Lancs, England; [Bertsche, W.] Sci Tech Daresbury, Cockcroft Inst, Warrington WA4 4AD, Cheshire, England; [Butler, E.] Univ London Imperial Coll Sci Technol & Med, Blackett Lab, Ctr Cold Matter, London SW7 2AZ, England; [Butler, E.; Ishida, A.] European Org Nucl Res CERN, Dept Phys, CH-1211 Geneva 23, Switzerland; [Capra, A.; Menary, S.] York Univ, Dept Phys & Astron, Toronto, ON M3J 1P3, Canada; [Cesar, C. L.; Sacramento, R. L.; Silveira, D. M.] Univ Fed Rio de Janeiro, Inst Fis, BR-21941972 Rio De Janeiro, Brazil; [Charlton, M.; Eriksson, S.; Isaac, C. A.; Jones, S. A.; Madsen, N.; Maxwell, D.; Sameed, M.; van der Werf, D. P.] Swansea Univ, Dept Phys, Swansea SA2 8PP, W Glam, Wales; [Evetts, N.; Gutierrez, A.; Hardy, W. N.] Univ British Columbia, Dept Phys & Astron, Vancouver, BC V6T 1Z4, Canada; [Friesen, T.; Hangst, J. S.; Rasmussen, C. O.; Tharp, T. D.] Aarhus Univ, Dept Phys & Astron, DK-8000 Aarhus C, Denmark; [Fujiwara, M. C.; Gill, D. R.; Kurchaninov, L.; McKenna, J. T. K.; Michan, J. M.; Olchanski, K.; Olin, A.] TRIUMF, Vancouver, BC V6T 2A3, Canada; [Hayden, M. E.; Munich, J. J.] Simon Fraser Univ, Dept Phys, Burnaby, BC V5A 1S6, Canada; [Jonsell, S.] Stockholm Univ, Dept Phys, SE-10691 Stockholm, Sweden; [Momose, T.] Univ British Columbia, Dept Chem, Vancouver, BC V6T 1Z1, Canada; [Olin, A.] Univ Victoria, Dept Phys & Astron, Victoria, BC V8P 5C2, Canada; [Robicheaux, F.] Purdue Univ, Dept Phys & Astron, W Lafayette, IN 47907 USA; [Sarid, E.] Soreq Nucl Res Ctr, IL-81800 Yavne, Israel; [Thompson, R. I.] Univ Calgary, Dept Phys & Astron, Calgary, AB T2N 1N4, Canada; [Wurtele, J. S.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, ATAP, Berkeley, CA 94720 USA	University of Liverpool; University of California System; University of California Berkeley; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Manchester; STFC Daresbury Laboratory; Imperial College London; York University - Canada; Universidade Federal do Rio de Janeiro; Swansea University; University of British Columbia; Aarhus University; University of British Columbia; Simon Fraser University; Stockholm University; University of British Columbia; University of Victoria; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Calgary; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Fajans, J (corresponding author), Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA.	joel@physics.berkeley.edu; wurtele@berkeley.edu	Jonsell, Svante/J-2251-2016; Madsen, Niels/I-2314-2019; Wurtele, Jonathan S/J-6278-2016; ISHIDA, AKIRA/G-4990-2014; Cesar, Claudio/AAH-4612-2021; Maxwell, Daniel/B-5730-2018; Hardy, Walter Newbold/AAN-7827-2020; Bertsche, William/A-3678-2012; Robicheaux, Francis/F-4343-2014; Fajans, Joel/J-6597-2016	Jonsell, Svante/0000-0003-4969-1714; Madsen, Niels/0000-0002-7372-0784; Wurtele, Jonathan S/0000-0001-8401-0297; ISHIDA, AKIRA/0000-0002-9880-6517; Maxwell, Daniel/0000-0001-5178-9492; Bertsche, William/0000-0002-6565-9282; Capra, Andrea/0000-0001-9499-0380; Cesar, Claudio/0000-0003-2638-0032; Robicheaux, Francis/0000-0002-8054-6040; Jones, Steven/0000-0001-8205-2186; Fajans, Joel/0000-0002-4403-6027; Friesen, Timothy/0000-0002-7017-9662; Rasmussen, Chris Orum/0000-0002-6029-1730; Munich, Justine/0000-0001-7475-3070; Eriksson, Stefan/0000-0002-5390-1879; Kurchaninov, Leonid/0000-0001-9392-3936; van der Werf, Dirk/0000-0001-5436-5214; Sameed, Muhammed/0000-0002-9706-8970; Isaac, Aled/0000-0002-7813-1903; McKenna, Joseph/0000-0002-7838-4230	CNPq (Brazil); FINEP-RENAFAE (Brazil); NSERC, (Canada); NRC/TRIUMF, (Canada); AITF, (Canada); FQRNT (Canada); FNU, (Denmark); Carlsberg Foundation (Denmark); JSPS Postdoctoral Fellowships for Research Abroad (Japan); ISF (Israel); STFC (UK); EPSRC (UK); Royal Society (UK); Leverhulme Trust (UK); DOE (USA); NSF (USA); VR (Sweden); Engineering and Physical Sciences Research Council [1510926, EP/L005522/1, EP/K017373/1, EP/E048951/1, EP/L014769/1, EP/L014718/1, EP/H02431X/1, EP/K040235/1, EP/H026932/1, 1422853, EP/L014734/1] Funding Source: researchfish; Science and Technology Facilities Council [ST/G008248/1] Funding Source: researchfish; EPSRC [EP/H02431X/1, EP/L014734/1, EP/L005522/1, EP/L014769/1, EP/K017373/1, EP/E048951/1, EP/L014718/1, EP/H026932/1, EP/K040235/1] Funding Source: UKRI; STFC [ST/G008248/1] Funding Source: UKRI; Direct For Mathematical & Physical Scien [1500470, 1500538] Funding Source: National Science Foundation	CNPq (Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FINEP-RENAFAE (Brazil)(Financiadora de Inovacao e Pesquisa (Finep)); NSERC, (Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NRC/TRIUMF, (Canada); AITF, (Canada); FQRNT (Canada)(FQRNT); FNU, (Denmark)(Danish Natural Science Research Council); Carlsberg Foundation (Denmark)(Carlsberg Foundation); JSPS Postdoctoral Fellowships for Research Abroad (Japan); ISF (Israel)(Israel Science Foundation); STFC (UK)(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); EPSRC (UK)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Royal Society (UK)(Royal Society of London); Leverhulme Trust (UK)(Leverhulme Trust); DOE (USA)(United States Department of Energy (DOE)); NSF (USA)(National Science Foundation (NSF)); VR (Sweden)(Swedish Research Council); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	All authors except A.E.C. are members of the ALPHA Collaboration. This work was supported by: CNPq, FINEP-RENAFAE (Brazil); NSERC, NRC/TRIUMF, AITF, FQRNT (Canada); FNU, Carlsberg Foundation (Denmark); JSPS Postdoctoral Fellowships for Research Abroad (Japan); ISF (Israel); STFC, EPSRC, the Royal Society and the Leverhulme Trust (UK); DOE, NSF (USA); and VR (Sweden). We thank C. Marshall, J. Strachan and their teams at TRIUMF and Daresbury Laboratory for their contributions to the design and manufacturing of the ALPHA-2 apparatus, and are grateful for the efforts of the CERN AD team, without which these experiments could not have taken place. We thank A. Ballarino, P. Denis and A. Perin for their help in providing and implementing the high-temperature superconductor current leads for the ALPHA-2 magnets.	Amole C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4955; Amole C, 2013, NUCL INSTRUM METH A, V732, P134, DOI 10.1016/j.nima.2013.05.188; Amole C, 2014, NUCL INSTRUM METH A, V735, P319, DOI 10.1016/j.nima.2013.09.043; Amole C, 2012, NATURE, V483, P439, DOI 10.1038/nature10942; Amole C, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/1/015010; Andresen GB, 2012, NUCL INSTRUM METH A, V684, P73, DOI 10.1016/j.nima.2012.04.082; Andresen GB, 2011, NAT PHYS, V7, P558, DOI [10.1038/NPHYS2025, 10.1038/nphys2025]; Andresen GB, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.025002; Andresen GB, 2011, PHYS LETT B, V695, P95, DOI 10.1016/j.physletb.2010.11.004; Andresen GB, 2010, NATURE, V468, P673, DOI 10.1038/nature09610; Baquero-Ruiz M, 2014, NEW J PHYS, V16, DOI 10.1088/1367-2630/16/8/083013; Baquero-Ruiz M., 2013, THESIS; Baur G, 1996, PHYS LETT B, V368, P251, DOI 10.1016/0370-2693(96)00005-6; Berger J.O., 1995, STAT DECISION THEORY, V2nd ed; Bowman JD, 2005, J RES NATL INST STAN, V110, P361, DOI 10.6028/jres.110.054; Bressi G, 2011, PHYS REV A, V83, DOI 10.1103/PhysRevA.83.052101; Capra A., 2015, THESIS; Charman AE, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2787; Donnan PH, 2013, J PHYS B-AT MOL OPT, V46, DOI 10.1088/0953-4075/46/2/025302; Fajans J, 2001, AM J PHYS, V69, P1096, DOI 10.1119/1.1389278; FEE MS, 1993, PHYS REV A, V48, P192, DOI 10.1103/PhysRevA.48.192; Fermi E., 1949, PHYS REV, V75, P1169, DOI DOI 10.1103/PHYSREV.75.1169; Gabrielse G, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.113002; Greenland PT, 1997, CONTEMP PHYS, V38, P181, DOI 10.1080/001075197182397; Hori M, 2011, NATURE, V475, P484, DOI 10.1038/nature10260; HUGHES RJ, 1992, PHYS REV LETT, V69, P578, DOI 10.1103/PhysRevLett.69.578; Jeffreys H., 1961, THEORY PROBABILITY; Kass RE, 1996, J AM STAT ASSOC, V91, P1343, DOI 10.2307/2291752; MURPHY TJ, 1992, PHYS REV A, V46, P5696, DOI 10.1103/PhysRevA.46.5696; Narsky I., 2005, PREPRINT; Olive KA, 2014, CHINESE PHYS C, V38, DOI 10.1088/1674-1137/38/9/090001; Quigg C., 1997, GUAGE THEORIES STRON; RODRIGUEZ CC, 1990, FUND THEOR, V39, P31; SANDARS PGH, 1968, J PHYS PT B ATOM M P, V1, P511, DOI 10.1088/0022-3700/1/3/326	35	35	35	0	36	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 21	2016	529	7586					373	+		10.1038/nature16491	http://dx.doi.org/10.1038/nature16491			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB2QT	26791725	hybrid, Green Published			2022-12-28	WOS:000368354800041
J	Reilly, TF				Reilly, Thomas F.			The Signs and Symptoms of Impending Death (Reprinted from JAMA, vol 66, pg 160, 1916)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																		Reilly TF, 1916, J AMER MED ASSOC, V66, P160	1	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 12	2016	315	2					206	206		10.1001/jama.2015.17070	http://dx.doi.org/10.1001/jama.2015.17070			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DA6XO	26757480				2022-12-28	WOS:000367949200032
J	Tangri, N; Grams, ME; Levey, AS; Coresh, J; Appel, LJ; Astor, BC; Chodick, G; Collins, AJ; Djurdjev, O; Elley, R; Evans, M; Garg, AX; Hallan, SI; Nicer, LA; Ito, S; Jee, SH; Kovesdy, CP; Kronenberg, F; Heerspink, HJL; Marks, A; Nadkarni, GN; Navaneethan, SD; Nelson, RG; Titze, S; Sarnak, MJ; Stengel, B; Woodward, M; Iseki, K				Tangri, Navdeep; Grams, Morgan E.; Levey, Andrew S.; Coresh, Josef; Appel, Lawrence J.; Astor, Brad C.; Chodick, Gabriel; Collins, Allan J.; Djurdjev, Ognjenka; Elley, Raina; Evans, Marie; Garg, Amit X.; Hallan, Stein I.; Nicer, Lesley A.; Ito, Sadayoshi; Jee, Sun Ha; Kovesdy, Csaba P.; Kronenberg, Florian; Heerspink, Hiddo J. Lambers; Marks, Angharad; Nadkarni, Girish N.; Navaneethan, Sankar D.; Nelson, Robert G.; Titze, Stephanie; Sarnak, Mark J.; Stengel, Benedicte; Woodward, Mark; Iseki, Kunitoshi		CKD Prognosis Consortium	Multinational Assessment of Accuracy of Equations for Predicting Risk of Kidney Failure A Meta-analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GLOMERULAR-FILTRATION-RATE; STAGE RENAL-DISEASE; COLLABORATIVE METAANALYSIS; HIGHER ALBUMINURIA; ESTIMATED GFR; ALL-CAUSE; MORTALITY; ASSOCIATION; HYPERTENSION; VALIDATION	IMPORTANCE Identifying patients at risk of chronic kidney disease (CKD) progression may facilitate more optimal nephrology care. Kidney failure risk equations were previously developed and validated in 2 Canadian cohorts. Validation in other regions and in CKD populations not under the care of a nephrologist is needed. OBJECTIVE To evaluate the accuracy of the risk equations across different geographic regions and patient populations through individual participant data meta-analysis. DATA SOURCES Thirty-one cohorts, including 721 357 participants with CKD stages 3 to 5 in more than 30 countries spanning 4 continents, were studied. These cohorts collected data from 1982 through 2014. STUDY SELECTION Cohorts participating in the CKD Prognosis Consortium with data on end-stage renal disease. DATA EXTRACTION AND SYNTHESIS Data were obtained and statistical analyses were performed between July 2012 and June 2015. Using the risk factors from the original risk equations, cohort-specific hazard ratios were estimated and combined in meta-analysis to form new pooled kidney failure risk equations. Original and pooled kidney failure risk equation performance was compared, and the need for regional calibration factors was assessed. MAIN OUTCOMES AND MEASURES Kidney failure (treatment by dialysis or kidney transplant). RESULTS During a median follow-up of 4 years, 23 829 cases of kidney failure were observed. The original risk equations achieved excellent discrimination (ability to differentiate those who developed kidney failure from those who did not) across all cohorts (overall C statistic, 0.90; 95% Cl, 0.89-0.92 at 2 years; C statistic, 0.88; 95% Cl, 0.86-0.90 at 5 years); discrimination in subgroups by age, race, and diabetes status was similar. There was no improvement with the pooled equations. Calibration (the difference between observed and predicted risk) was adequate in North American cohorts, but the original risk equations overestimated risk in some non-North American cohorts. Addition of a calibration factor that lowered the baseline risk by 32.9% at 2 years and 16.5% at 5 years improved the calibration in 12 of 15 and 10 of 13 non-North American cohorts at 2 and 5 years, respectively (P = .04 and P = .02). CONCLUSIONS AND RELEVANCE Kidney failure risk equations developed in a Canadian population showed high discrimination and adequate calibration when validated in 31 multinational cohorts. However, in some regions the addition of a calibration factor may be necessary.	[Tangri, Navdeep] Univ Manitoba, Dept Med, Oaks Gen Hosp 7, Winnipeg, MB, Canada; [Tangri, Navdeep] Univ Manitoba, Dept Community Hlth Sci, Oaks Gen Hosp 7, Winnipeg, MB R3T 2N2, Canada; [Grams, Morgan E.; Appel, Lawrence J.] Johns Hopkins Med Inst, Baltimore, MD 21205 USA; [Levey, Andrew S.; Sarnak, Mark J.] Tufts Med Ctr, Div Nephrol, Boston, MA USA; [Coresh, Josef; Appel, Lawrence J.; Woodward, Mark] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Astor, Brad C.] Univ Wisconsin, Dept Med, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Astor, Brad C.] Univ Wisconsin, Dept Populat Hlth Sci, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Chodick, Gabriel] Tel Aviv Univ, Div Med, Maccabi Healthcare Serv, IL-69978 Tel Aviv, Israel; [Chodick, Gabriel] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel; [Collins, Allan J.] Minneapolis Med Res Fdn Inc, Chron Dis Res Grp, Minneapolis, MN USA; [Collins, Allan J.] Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA; [Djurdjev, Ognjenka] Prov Hlth Serv Author, Dept Measurement & Reporting, Vancouver, BC, Canada; [Elley, Raina] Univ Auckland, Sch Populat Hlth, Dept Gen Practice & Primary Hlth Care, Auckland 1, New Zealand; [Evans, Marie] Karolinska Inst, CLINTEC, Div Renal Med, Stockholm, Sweden; [Garg, Amit X.] Western Univ, Dept Med, Toronto, ON, Canada; [Garg, Amit X.] Western Univ, Dept Epidemiol & Biostat, Toronto, ON, Canada; [Garg, Amit X.] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Hallan, Stein I.] Norwegian Univ Sci Technol, Fac Med, Dept Canc Res & Mol Med, Trondheim, Norway; [Hallan, Stein I.] St Olavs Univ Hosp, Div Nephrol, Dept Med, Trondheim, Norway; [Ito, Sadayoshi] Tohoku Univ, Sch Med, Dept Med, Div Nephrol Endocrinol & Vasc Med, Sendai, Miyagi 980, Japan; [Jee, Sun Ha] Yonsei Univ, Grad Sch Publ Hlth, Inst Hlth Promot, Dept Epidemiol & Hlth Promot, Seoul 120749, South Korea; [Kovesdy, Csaba P.] Memphis Vet Affairs Med Ctr, Memphis, TN USA; [Kovesdy, Csaba P.] Univ Tennessee, Ctr Hlth Sci, Memphis, TN 38163 USA; [Kronenberg, Florian] Med Univ Innsbruck, Div Genet Epidemiol, Dept Med Genet Mol & Clin Pharmacol, A-6020 Innsbruck, Austria; [Heerspink, Hiddo J. Lambers] Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharm & Pharmacol, NL-9700 AB Groningen, Netherlands; [Marks, Angharad] Univ Aberdeen, Div Appl Hlth Sci, Aberdeen, Scotland; [Marks, Angharad] NHS Grampian, Aberdeen, Scotland; [Nadkarni, Girish N.] Icahn Sch Med Mt Sinai, Div Nephrol, Dept Med, New York, NY 10029 USA; [Navaneethan, Sankar D.] Cleveland Clin, Div Nephrol & Hypertens, Cleveland, OH 44106 USA; [Nelson, Robert G.] NIDDK, NIH, Phoenix, AZ USA; [Titze, Stephanie] Univ Erlangen Nurnberg, Dept Hypertens & Nephrol, D-91054 Erlangen, Germany; [Stengel, Benedicte] INSERM, CESP, Villejuif, France; [Stengel, Benedicte] Univ Paris 11, UVSQ, Univ Paris Saclay, Villejuif, France; [Woodward, Mark] Univ Oxford, Nuffield Dept Populat Hlth, George Inst Global Hlth, Oxford, England; [Woodward, Mark] Univ Sydney, George Inst Global Hlth, Sydney, NSW 2006, Australia; [Iseki, Kunitoshi] Univ Hosp Ryukyus, Dialysis Unit, Nishihara, Okinawa, Japan	University of Manitoba; University of Manitoba; Johns Hopkins University; Johns Hopkins Medicine; Tufts Medical Center; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine; Minneapolis Medical Research Foundation; University of Minnesota System; University of Minnesota Twin Cities; University of Auckland; Karolinska Institutet; Western University (University of Western Ontario); Western University (University of Western Ontario); University of Toronto; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Tohoku University; Yonsei University; Yonsei University Health System; US Department of Veterans Affairs; Veterans Health Administration (VHA); Memphis VA Medical Center; University of Tennessee System; University of Tennessee Health Science Center; Medical University of Innsbruck; University of Groningen; University of Aberdeen; Icahn School of Medicine at Mount Sinai; Cleveland Clinic Foundation; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Erlangen Nuremberg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; University of Oxford; George Institute for Global Health; University of Sydney; University of the Ryukyus	Coresh, J (corresponding author), Consortium Data Coordinating Ctr, Chron Kidney Dis Prognosis, 2024 E Monument St, Baltimore, MD 21287 USA.	ckdpc@jhmi.edu	Ito, Sadayoshi/A-3933-2015; Wetzels, Jack F.M./A-1720-2014; Garg, Amit X/G-3295-2011; Kronenberg, Florian/B-1736-2008; Appel, Larry/GLT-2608-2022; Woodward, Mark/D-8492-2015; St Olav Hospital, Medisinsk Klinikk -/AAD-6414-2022; Kalantar-Zadeh, Kamyar/Q-4734-2018; Marks, Angharad/H-5657-2019; de Zeeuw, Dick/E-9080-2014; Woodward, Mark/L-6817-2017; Stengel, Benedicte/G-5730-2015; Heerspink, Hiddo J Lambers/K-3358-2014; Froissart, Marc/L-7493-2014; Metzger, Marie/K-9772-2018	Wetzels, Jack F.M./0000-0002-0650-6921; Kronenberg, Florian/0000-0003-2229-1120; Kalantar-Zadeh, Kamyar/0000-0002-8666-0725; Marks, Angharad/0000-0003-1910-462X; de Zeeuw, Dick/0000-0003-3434-7777; Stengel, Benedicte/0000-0001-9469-0804; Heerspink, Hiddo J Lambers/0000-0002-3126-3730; Jee, Sun Ha/0000-0001-9519-3068; Woodward, Mark/0000-0001-9800-5296; Emberson, Jonathan/0000-0001-7792-9422; Froissart, Marc/0000-0002-4010-3173; Ito, Sadayoshi/0000-0002-5092-3626; Grams, Morgan/0000-0002-4430-6023; /0000-0002-5189-8995; Prescott, Gordon/0000-0002-9156-2361; Townend, Jonathan/0000-0002-5881-5806; Evans, Marie/0000-0001-8650-5795; Metzger, Marie/0000-0003-3597-5409	US National Kidney Foundation; AbbVie; Amgen; Merck; National Institute of Diabetes and Digestive and Kidney Diseases [RO1D1000446-01, K08DK092287]; Chief Scientist Office [CZH/4/656] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R01CA165001] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000424, UL1TR000003, UL1TR001079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007757, U01DK035073, U01DK060963, K23DK002904, U01DK060984, U01DK061022, K08DK092287, U01DK060902, U01DK060990, U01DK061028, ZIADK069062, K23DK067303, U01DK060980, R01DK100446] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS041588] Funding Source: NIH RePORTER	US National Kidney Foundation; AbbVie(AbbVie); Amgen(Amgen); Merck(Merck & Company); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Chief Scientist Office; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The CKD-PC Data Coordinating Center is funded in part by a program grant from the US National Kidney Foundation (NKF funding sources include AbbVie, Amgen, and Merck) and grant RO1D1000446-01 from the National Institute of Diabetes and Digestive and Kidney Diseases. Dr Grams is supported by grant K08DK092287 from the National Institute of Diabetes and Digestive and Kidney Diseases. A variety of sources have supported enrollment and data collection including laboratory measurements, and follow-up in the collaborating cohorts of the CKD-PC. These funding sources include government agencies such as national institutes of health and medical research councils as well as foundations and industry sponsors listed in eAppendix 4 in the Supplement.	Acedillo RR, 2013, NEPHROL DIAL TRANSPL, V28, P1623, DOI 10.1093/ndt/gft044; [Anonymous], 2013, Kidney Int Suppl (2011), V3, P112; Astor BC, 2011, KIDNEY INT, V79, P1331, DOI 10.1038/ki.2010.550; Brier G.W., 1950, MON WEATHER REV, V78, P1, DOI [10.1175/1520-0493(1950)0782.0.CO,2, DOI 10.1175/1520-0493(1950)078<0001:VOFEIT>2.0.CO;2, 10.1175/1520-0493(1950)0782.0.CO;2]; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Coresh J, 2014, JAMA-J AM MED ASSOC, V311, P2518, DOI 10.1001/jama.2014.6634; D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180; de Zeeuw D, 2013, NEW ENGL J MED, V369, P2492, DOI 10.1056/NEJMoa1306033; Drawz PE, 2013, J AM GERIATR SOC, V61, P762, DOI 10.1111/jgs.12223; Elley CR, 2013, DIABETES CARE, V36, P3113, DOI 10.2337/dc13-0190; Fox CS, 2012, LANCET, V380, P1662, DOI 10.1016/S0140-6736(12)61350-6; Fried LF, 2013, NEW ENGL J MED, V369, P1892, DOI 10.1056/NEJMoa1303154; Gansevoort RT, 2011, KIDNEY INT, V80, P93, DOI 10.1038/ki.2010.531; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Grams ME, 2016, NEW ENGL J MED, V374, P411, DOI 10.1056/NEJMoa1510491; Grams ME, 2015, AM J KIDNEY DIS, V66, P591, DOI 10.1053/j.ajkd.2015.02.337; Grams ME, 2015, AM J KIDNEY DIS, V65, P394, DOI 10.1053/j.ajkd.2014.07.026; Hallan SI, 2012, JAMA-J AM MED ASSOC, V308, P2349, DOI 10.1001/jama.2012.16817; Hemmelgarn BR, 2012, JAMA-J AM MED ASSOC, V307, P2507, DOI 10.1001/jama.2012.6455; Isakova T, 2011, JAMA-J AM MED ASSOC, V305, P2432, DOI 10.1001/jama.2011.826; James MT, 2015, AM J KIDNEY DIS, V66, P602, DOI 10.1053/j.ajkd.2015.02.338; Levey AS, 2007, CLIN CHEM, V53, P766, DOI 10.1373/clinchem.2006.077180; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levin A, 2013, KIDNEY INT SUPPL, V3, P5, DOI 10.1038/kisup.2012.77; Mahmoodi BK, 2012, LANCET, V380, P1649, DOI 10.1016/S0140-6736(12)61272-0; Marks A, 2015, NEPHROL DIAL TRANSPL, V30, P1507, DOI 10.1093/ndt/gfv089; Matsushita K, 2015, LANCET DIABETES ENDO, V3, P514, DOI 10.1016/S2213-8587(15)00040-6; Matsushita K, 2012, JAMA-J AM MED ASSOC, V307, P1941, DOI 10.1001/jama.2012.3954; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Nitsch D, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e8713; O'Hare AM, 2007, KIDNEY INT, V71, P555, DOI 10.1038/sj.ki.5002078; O'Hare AM, 2012, AM J KIDNEY DIS, V59, P513, DOI 10.1053/j.ajkd.2011.11.044; Parving HH, 2001, NEW ENGL J MED, V345, P870, DOI 10.1056/NEJMoa011489; Peeters MJ, 2013, NEPHROL DIAL TRANSPL, V28, P1773, DOI 10.1093/ndt/gft063; Shlipak MG, 2013, NEW ENGL J MED, V369, P932, DOI 10.1056/NEJMoa1214234; Tangri N, 2013, ANN INTERN MED, V158, P596, DOI 10.7326/0003-4819-158-8-201304160-00004; Tangri N, 2011, JAMA-J AM MED ASSOC, V305, P1553, DOI 10.1001/jama.2011.451; Tobe SW, 2011, CIRCULATION, V123, P1098, DOI 10.1161/CIRCULATIONAHA.110.964171; Tonelli M, 2011, JAMA-J AM MED ASSOC, V305, P1593, DOI 10.1001/jama.2011.502; Turin TC, 2012, J AM SOC NEPHROL, V23, P1569, DOI 10.1681/ASN.2012020164; van der Velde M, 2011, KIDNEY INT, V79, P1341, DOI 10.1038/ki.2010.536; Wen CP, 2014, KIDNEY INT, V86, P819, DOI 10.1038/ki.2013.553	42	298	303	4	39	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 12	2016	315	2					164	174		10.1001/jama.2015.18202	http://dx.doi.org/10.1001/jama.2015.18202			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DA6XO	26757465	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000367949200018
J	Doshi, P				Doshi, Peter			ANTIBIOTICS Defining antibiotic effectiveness and resistance: how a private party may soon rule judgments over susceptibility testing	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							OUTCOMES; CHILDREN					pdoshi@bmj.com						Casadevall A, 2014, NATURE, V516, P165, DOI 10.1038/516165a; Doshi P, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4013; Lux L.J., 2014, PHARMACOKINETIC PHAR; Tamma PD, 2013, PEDIATR INFECT DIS J, V32, P965, DOI 10.1097/INF.0b013e31829043b3; Tamma PD, 2012, CLIN INFECT DIS, V55, P799, DOI 10.1093/cid/cis545	5	0	0	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 6	2016	352								h6849	10.1136/bmj.h6849	http://dx.doi.org/10.1136/bmj.h6849			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DA8MO	26740024				2022-12-28	WOS:000368059200014
J	Jones, D; Loader, N				Jones, David; Loader, Nancy			Should patients pay to see the GP?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Jones, David] Worthing Dist Hosp, Diabet & Endocrinol, Worthing BN11 2DH, W Sussex, England		Jones, D (corresponding author), Worthing Dist Hosp, Diabet & Endocrinol, Worthing BN11 2DH, W Sussex, England.	david.jones2@wsht.nhs.uk; nancyloader@gmail.com		mammucari, massimo/0000-0002-9515-3549				[Anonymous], 2015, WORLD FACTBOOK; [Anonymous], 2010, B WORLD HEALTH ORGAN, V8, P717; Appleby J, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3944; Augurzky B, 2006, COPAYMENTS GERMAN HL; Australian Bureau of Statistics, POP CLOCK; Australian Institute of Health and Welfare, 2013, AUSTR HOSP STAT EM D; Bautista K., 2013, PULSE; Campbell, 2014, GUARDIAN; Croxson B, 2009, PATIENT FEES METAPHO; Donelly L, 2015, TELEGRAPH; Kings Fund, 2015, WHATS GOING A E KEY; Lind S, 2013, PULSE; Mays N, 2009, CAN PRIMARY HLTH CAR; Middleton J., 2014, NURSING TIMES; MyDr, AUSTR HLTH SYST IT W; NHS Choices, NAT HLTH SERV NHS EN; NHS Choices, HIST NHS ENGL; Nolan A, 2012, SOC SCI MED, V74, P1644, DOI 10.1016/j.socscimed.2012.02.007; Oh J, 2012, PRICING RESTAURANT R; Organisation for Economic Cooperation and Development, HLTH GLANC 2013 OECD; Reform, COST OUR HLTH ROL CH; Rimmer A, 2014, BMJ CAREERS; Starfield B, 2005, MILBANK Q, V83, P457, DOI 10.1111/j.1468-0009.2005.00409.x; Thomson S, 2013, INT PROFILES HLTH CA; Thueringer T, 2014, BBC NEWS; Willey J, 2013, EXPRESS	26	9	9	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 6	2016	352								h6800	10.1136/bmj.h6800	http://dx.doi.org/10.1136/bmj.h6800			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DA8MO	26740244				2022-12-28	WOS:000368059200013
J	McAninch, EA; Bianco, AC				McAninch, Elizabeth A.; Bianco, Antonio C.			The History and Future of Treatment of Hypothyroidism	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							THYROXINE PLUS TRIIODOTHYRONINE; THYROID-DISEASE; DOUBLE-BLIND; THYROTROPIN; GUIDELINES; THERAPY; RADIOIMMUNOASSAY; T3; LEVOTHYROXINE; ASSOCIATION	Thyroid hormone replacement has been used for more than a century to treat hypothyroidism. Natural thyroid preparations (thyroid extract, desiccated thyroid, or thyroglobulin), which contain both thyroxine (T-4) and triiodothyronine (T-3), were the first pharmacologic treatments available and dominated the market for the better part of the 20th century. Dosages were adjusted to resolve symptoms and to normalize the basal metabolic rate and/or serum protein-bound iodine level, but thyrotoxic adverse effects were not uncommon. Two major developments in the 1970s led to a transition in clinical practice: 1) The development of the serum thyroid-stimulating hormone (TSH) radioimmunoassay led to the discovery that many patients were overtreated, resulting in a dramatic reduction in thyroid hormone replacement dosage, and 2) the identification of peripheral deiodinase-mediated T-4-to-T-3 conversion provided a physiologic means to justify L-thyroxine monotherapy, obviating concerns about inconsistencies with desiccated thyroid. Thereafter, L-thyroxine monotherapy at doses to normalize the serum TSH became the standard of care. Since then, a subgroup of thyroid hormone-treated patients with residual symptoms of hypothyroidism despite normalization of the serum TSH has been identified. This has brought into question the inability of L-thyroxine monotherapy to universally normalize serum T-3 levels. New research suggests mechanisms for the inadequacies of L-thyroxine monotherapy and highlights the possible role for personalized medicine based on deiodinase polymorphisms. Understanding the historical events that affected clinical practice trends provides invaluable insight into formulation of an approach to help all patients achieve clinical and biochemical euthyroidism.	[McAninch, Elizabeth A.; Bianco, Antonio C.] Rush Univ, Med Ctr, Chicago, IL 60612 USA	Rush University	McAninch, EA (corresponding author), Rush Univ, Med Ctr, Div Endocrinol & Metab, 1735 West Harrison St,Cohn Bldg,Room 312, Chicago, IL 60612 USA.	Elizabeth_A_McAninch@Rush.edu	Bianco, Antonio/AAK-6336-2020; McAninch, Elizabeth/AAF-6701-2020	Bianco, Antonio/0000-0001-7737-6813; McAninch, Elizabeth/0000-0003-3993-4663	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058538, R01DK065055, R01DK077148] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK065055, R01 DK058538, R01 DK077148] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abdalla SM, 2014, CLIN ENDOCRINOL, V81, P633, DOI 10.1111/cen.12538; ASPER SP, 1953, B JOHNS HOPKINS HOSP, V93, P164; Bettencourt R., 1890, SEM M D, V10, P294; Bianco AC, 2012, EUR THYROID J, V1, P88, DOI 10.1159/000339447; BRAVERMAN LE, 1970, J CLIN INVEST, V49, P855, DOI 10.1172/JCI106304; BRAVERMAN LE, 1964, NEW ENGL J MED, V270, P439, DOI 10.1056/NEJM196402272700903; Bunevicius R, 1999, NEW ENGL J MED, V340, P424, DOI 10.1056/NEJM199902113400603; Canaris GJ, 2000, ARCH INTERN MED, V160, P526, DOI 10.1001/archinte.160.4.526; CARR D, 1988, CLIN ENDOCRINOL, V28, P325, DOI 10.1111/j.1365-2265.1988.tb01219.x; CHALMERS JR, 1949, J CHEM SOC, P3424, DOI 10.1039/jr9490003424; Chesky VE, 1929, HOSP MANAGEMENT GOIT, P209; COBB WE, 1978, AM J HOSP PHARM, V35, P51, DOI 10.1093/ajhp/35.1.51; Cooper DS, 2012, LANCET, V379, P1142, DOI 10.1016/S0140-6736(11)60276-6; COTTON GE, 1971, NEW ENGL J MED, V285, P529, DOI 10.1056/NEJM197109022851001; Dawson R., 1893, MONTREAL MED J, V22, P437; de Castro JPW, 2015, J CLIN INVEST, V125, P769, DOI 10.1172/JCI77588; DeGroot LJ, 1996, THYROID ITS DIS, P351; Duntas LH, 2002, THYROID, V12, P287, DOI 10.1089/10507250252949405; EscobarMorreale HF, 1996, ENDOCRINOLOGY, V137, P2490, DOI 10.1210/en.137.6.2490; EVERED D, 1973, BRIT MED J, V3, P131, DOI 10.1136/bmj.3.5872.131; FRAWLEY TF, 1956, JAMA-J AM MED ASSOC, V160, P646, DOI 10.1001/jama.1956.02960430036007; Garber JR, 2012, THYROID, V22, P1200, DOI 10.1089/thy.2012.0205; GORMAN CA, 1979, J CLIN ENDOCR METAB, V49, P1; GROSS J, 1952, LANCET, V262, P1044; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Gullo D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022552; HART FD, 1950, J ENDOCRINOL, V6, pR34, DOI 10.1677/joe.0.006XXXIV; HERSHMAN JM, 1971, ANN INTERN MED, V74, P481, DOI 10.7326/0003-4819-74-4-481; Hoang TD, 2013, J CLIN ENDOCR METAB, V98, P1982, DOI 10.1210/jc.2012-4107; Hoffenberg R., 1978, WERNERS THYROID FUND, P1255; Ingbar SH, 1968, TXB ENDOCRINOLOGY, P232; Ingbar SH, 1974, TXB ENDOCRINOLOGY, P191; JACKSON IMD, 1978, AM J MED, V64, P284, DOI 10.1016/0002-9343(78)90057-8; Jonklaas J, 2014, THYROID, V24, P1670, DOI 10.1089/thy.2014.0028; Kaufman S C, 1991, Thyroid, V1, P285, DOI 10.1089/thy.1991.1.285; Kazerouni F, 2012, CASP J INTERN MED, V3, P400; Kocher A, 1923, BRIT MED J, V1923, P560, DOI 10.1136/bmj.2.3274.560; LARSEN PR, 1973, J CLIN ENDOCR METAB, V37, P177, DOI 10.1210/jcem-37-2-177; LAVIETES PH, 1964, ANN INTERN MED, V60, P79, DOI 10.7326/0003-4819-60-1-79; Lindholm J, 2011, J THROID RES, V2011, DOI 10.4061/2011/809341; Lundie RA, 1893, EDINBURGH MED J, V38, P996; Ma RS, 2015, THYROID, V25, P455, DOI 10.1089/thy.2014.0537; Mackenzie H W, 1892, Br Med J, V2, P940; MAGNUS-LEVY A, 1947, J Hist Med Allied Sci, V2, P307; MANGIERI CN, 1970, J CLIN ENDOCR METAB, V30, P102, DOI 10.1210/jcem-30-1-102; McAninch EA, 2015, J CLIN ENDOCR METAB, V100, P920, DOI 10.1210/jc.2014-4092; MCGAVACK TH, 1956, AM J MED, V20, P774, DOI 10.1016/0002-9343(56)90159-0; Ord W M, 1893, Br Med J, V2, P217; PALMER W. W., 1934, Bulletin of the New York Academy of Medicine, V10, P52; Panicker V, 2009, J CLIN ENDOCR METAB, V94, P1623, DOI 10.1210/jc.2008-1301; Peeters RP, 2003, J CLIN ENDOCR METAB, V88, P2880, DOI 10.1210/jc.2002-021592; Roberts N, 1996, PSYCHOL PROBLEMS THY, P3; Saravanan P, 2002, CLIN ENDOCRINOL, V57, P577, DOI 10.1046/j.1365-2265.2002.01654.x; Saravanan P, 2006, J CLIN ENDOCR METAB, V91, P3389, DOI 10.1210/jc.2006-0414; SINGER PA, 1995, JAMA-J AM MED ASSOC, V273, P808, DOI 10.1001/jama.273.10.808; Skinner GRB, 1997, BRIT MED J, V314, P1764, DOI 10.1136/bmj.314.7096.1764; SMITH RN, 1970, BRIT MED J, V4, P145, DOI 10.1136/bmj.4.5728.145; Stanbury JB, 1991, A CONSTANT FERMENT; SURKS MI, 1972, J CLIN INVEST, V51, P3104, DOI 10.1172/JCI107137; Surks MI, 2004, JAMA-J AM MED ASSOC, V291, P228, DOI 10.1001/jama.291.2.228; SURKS MI, 1973, J CLIN INVEST, V52, P805, DOI 10.1172/JCI107244; Tanis BC, 1996, CLIN ENDOCRINOL, V44, P643, DOI 10.1046/j.1365-2265.1996.739560.x; Taylor PN, 2014, JAMA INTERN MED, V174, P32, DOI 10.1001/jamainternmed.2013.11312; Thompson WO, 1933, J CLIN INVEST, V12, P235, DOI 10.1172/JCI100492; UTIGER RD, 1971, ANN INTERN MED, V74, P627, DOI 10.7326/0003-4819-74-4-627; Walsh JP, 2006, J CLIN ENDOCR METAB, V91, P2624, DOI 10.1210/jc.2006-0099; Werner SC, 1978, THYROID, P965; Werner SC, 1962, THYROID           ED, P817; Werner SC, 1971, THYROID FUNDAMENTAL, P832; Wiersinga WM, 2012, EUR THYROID J, V1, P55, DOI [10.1159/000339444, 10.1159/000337020]; Wiersinga WM, 2014, NAT REV ENDOCRINOL, V10, P164, DOI 10.1038/nrendo.2013.258; WILLIAMS RH, 1948, J CLIN ENDOCRINOL, V8, P257, DOI 10.1210/jcem-8-3-257; Williams RH, 1955, TXB ENDOCRINOLOGY, P99; Woeber KA, 1979, CONT ENDOCRINOLOGY, P77	74	58	64	0	26	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 5	2016	164	1					50	+		10.7326/M15-1799	http://dx.doi.org/10.7326/M15-1799			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DA4WC	26747302	Green Accepted			2022-12-28	WOS:000367801700010
J	Roth, JA; Ramsey, SD				Roth, Joshua A.; Ramsey, Scott D.			Computed Tomography Screening for Lung Cancer A High-Value Proposition?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							COST-EFFECTIVENESS; TRIAL	IMPORTANCE The US National Lung Screening Trial supports screening for lung cancer among smokers using low-dose computed tomographic (LDCT) scans. The cost-effectiveness of screening in a publicly funded health care system remains a concern. OBJECTIVE To assess the cost-effectiveness of LDCT scan screening for lung cancer within the Canadian health care system. DESIGN, SETTING, AND PARTICIPANTS The Cancer Risk Management Model (CRMM) simulated individual lives within the Canadian population from 2014 to 2034, incorporating cancer risk, disease management, outcome, and cost data. Smokers and former smokers eligible for lung cancer screening (30 pack-year smoking history, ages 55-74 years, for the reference scenario) were modeled, and performance parameters were calibrated to the National Lung Screening Trial (NLST). The reference screening scenario assumes annual scans to age 75 years, 60% participation by 10 years, 70% adherence to screening, and unchanged smoking rates. The CRMM outputs are aggregated, and costs (2008 Canadian dollars) and life-years are discounted 3% annually. MAIN OUTCOMES AND MEASURES The incremental cost-effectiveness ratio. RESULTS Compared with no screening, the reference scenario saved 51 000 quality-adjusted life-years (QALY) and had an incremental cost-effectiveness ratio of CaD $52 000/QALY. If smoking history is modeled for 20 or 40 pack-years, incremental cost-effectiveness ratios of CaD $62 000 and CaD $43 000/QALY, respectively, were generated. Changes in participation rates altered life-years saved but not the incremental cost-effectiveness ratio, while the incremental cost-effectiveness ratio is sensitive to changes in adherence. An adjunct smoking cessation program improving the quit rate by 22.5% improves the incremental cost-effectiveness ratio to CaD $24 000/QALY. CONCLUSIONS AND RELEVANCE Lung cancer screening with LDCT appears cost-effective in the publicly funded Canadian health care system. An adjunct smoking cessation program has the potential to improve outcomes.	[Roth, Joshua A.; Ramsey, Scott D.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98109 USA; [Roth, Joshua A.; Ramsey, Scott D.] Fred Hutchinson Canc Res Ctr, Hutchinson Inst Canc Outcomes Res, 1100 Fairview Ave N,M2-B230, Seattle, WA 98109 USA; [Roth, Joshua A.; Ramsey, Scott D.] Univ Washington, Pharmaceut Outcomes Res & Policy Program, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle	Roth, JA (corresponding author), Fred Hutchinson Canc Res Ctr, Hutchinson Inst Canc Outcomes Res, 1100 Fairview Ave N,M2-B230, Seattle, WA 98109 USA.	jroth@fredhutch.org			Agency for Healthcare Research and Quality [K12HS022982]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K12HS022982] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Dr Roth is supported by a grant (K12HS022982) from the Agency for Healthcare Research and Quality.	Bach PB, 2012, JAMA-J AM MED ASSOC, V307, P2418, DOI 10.1001/jama.2012.5521; Black WC, 2014, NEW ENGL J MED, V371, P1793, DOI 10.1056/NEJMoa1312547; Goffin JR, 2015, JAMA ONCOL, V1, P807, DOI 10.1001/jamaoncol.2015.2472; LAUPACIS A, 1992, CAN MED ASSOC J, V146, P473; Moyer VA, 2014, ANN INTERN MED, V160, P330, DOI 10.7326/M13-2771; Neumann PJ, 2014, NEW ENGL J MED, V371, P796, DOI 10.1056/NEJMp1405158; Pinsky PF, 2015, ANN INTERN MED, V162, P485, DOI 10.7326/M14-2086; Roth JA, 2015, J ONCOL PRACT, V11, P267, DOI 10.1200/JOP.2014.002600; Zeliadt SB, 2015, JAMA INTERN MED, V175, P1530, DOI 10.1001/jamainternmed.2015.3558	9	4	4	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 5	2016	315	1					77	+		10.1001/jama.2015.17877	http://dx.doi.org/10.1001/jama.2015.17877			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DA0YH	26746460				2022-12-28	WOS:000367523000017
J	Fraser, LH; Partel, M; Pither, J; Jentsch, A; Sternberg, M; Zobel, M				Fraser, Lauchlan H.; Paertel, Meelis; Pither, Jason; Jentsch, Anke; Sternberg, Marcelo; Zobel, Martin			Response to Comment on "Worldwide evidence of a unimodal relationship between productivity and plant species richness"	SCIENCE			English	Editorial Material							POOR PREDICTOR; PATTERNS	Laanisto and Hutchings claim that the local species pool is a more important predictor of local plant species richness than biomass and that when the species pool is considered, there is no hump-backed relationship between biomass and richness. However, we show that by calculating a more appropriate measure of species pool, community completeness, both regional and local processes shape local richness.	[Fraser, Lauchlan H.] Thompson Rivers Univ, Dept Nat Resource Sci, Kamloops, BC, Canada; [Paertel, Meelis; Zobel, Martin] Univ Tartu, Inst Ecol & Earth Sci, Dept Bot, EE-50090 Tartu, Estonia; [Pither, Jason] Univ British Columbia, Dept Biol, Kelowna, BC, Canada; [Jentsch, Anke] Univ Bayreuth, Bayreuth Ctr Ecol & Environm Res, Dept Disturbance Ecol, Bayreuth, Germany; [Sternberg, Marcelo] Tel Aviv Univ, Dept Mol Biol & Ecol Plants, IL-69978 Tel Aviv, Israel	University of Tartu; Tartu University Institute of Ecology & Earth Sciences; University of British Columbia; University of Bayreuth; Tel Aviv University	Fraser, LH (corresponding author), Thompson Rivers Univ, Dept Nat Resource Sci, Kamloops, BC, Canada.	lfraser@tru.ca	Sternberg, Marcelo/AFQ-1615-2022; Zobel, Martin/H-1336-2015; Pärtel, Meelis/D-5493-2012	Sternberg, Marcelo/0000-0001-8710-4141; Zobel, Martin/0000-0001-7957-6704; Pärtel, Meelis/0000-0002-5874-0138; Pither, Jason/0000-0002-7490-6839				Adler PB, 2011, SCIENCE, V333, P1750, DOI 10.1126/science.1204498; Chao A., 2005, ENCY STAT SCI, V12, P7907, DOI DOI 10.1890/13-0133.1; Cornwell WK, 2003, OIKOS, V100, P417, DOI 10.1034/j.1600-0706.2003.11697.x; Fraser LH, 2015, SCIENCE, V349, P302, DOI 10.1126/science.aab3916; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; Grace JB, 2012, SCIENCE, V335, DOI 10.1126/science.1214939; GRIME JP, 1973, J ENVIRON MANAGE, V1, P151; Laanisto L, 2015, SCIENCE, V350, DOI 10.1126/science.aad4836; Partel M, 2013, FOLIA GEOBOT, V48, P307, DOI 10.1007/s12224-013-9169-x; Partel M, 2011, TRENDS ECOL EVOL, V26, P124, DOI 10.1016/j.tree.2010.12.004; Pan XB, 2012, SCIENCE, V335, DOI [10.1126/science.1214786, 10.1126/science.1215042]; Szava-Kovats RC, 2012, OIKOS, V121, P321, DOI 10.1111/j.1600-0706.2011.19603.x	12	5	5	1	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 4	2015	350	6265								10.1126/science.aad4874	http://dx.doi.org/10.1126/science.aad4874			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX4WG	26785471	Green Accepted, Green Submitted			2022-12-28	WOS:000365700500057
J	Gabanyi, I; Muller, PA; Feighery, L; Oliveira, TY; Costa-Pinto, FA; Mucida, D				Gabanyi, Ilana; Muller, Paul A.; Feighery, Linda; Oliveira, Thiago Y.; Costa-Pinto, Frederico A.; Mucida, Daniel			Neuro-immune Interactions Drive Tissue Programming in Intestinal Macrophages	CELL			English	Article							GENE-EXPRESSION; RESIDENT MACROPHAGES; MICROGLIAL RESPONSE; DENDRITIC CELLS; ENTERIC NEURONS; LYMPH-NODES; TOLERANCE; BACTERIA; MOUSE; IDENTIFICATION	Proper adaptation to environmental perturbations is essential for tissue homeostasis. In the intestine, diverse environmental cues can be sensed by immune cells, which must balance resistance to microorganisms with tolerance, avoiding excess tissue damage. By applying imaging and transcriptional profiling tools, we interrogated how distinct microenvironments in the gut regulate residentmacrophages. We discovered that macrophages exhibit a high degree of gene-expression specialization dependent on their proximity to the gut lumen. Lamina propria macrophages (LpMs) preferentially expressed a pro-inflammatory phenotype when compared to muscularis macrophages (MMs), which displayed a tissue-protective phenotype. Upon luminal bacterial infection, MMs further enhanced tissue-protective programs, and this was attributed to swift activation of extrinsic sympathetic neurons innervating the gut muscularis and norepinephrine signaling to beta 2 adrenergic receptors on MMs. Our results reveal unique intra-tissue macrophage specialization and identify neuro-immune communication between enteric neurons and macrophages that induces rapid tissue-protective responses to distal perturbations.	[Gabanyi, Ilana; Muller, Paul A.; Feighery, Linda; Costa-Pinto, Frederico A.; Mucida, Daniel] Rockefeller Univ, Lab Mucosal Immunol, 1230 York Ave, New York, NY 10065 USA; [Oliveira, Thiago Y.] Rockefeller Univ, Lab Mol Immunol, 1230 York Ave, New York, NY 10065 USA; [Gabanyi, Ilana; Costa-Pinto, Frederico A.] Univ Sao Paulo, Sch Vet Med, Dept Pathol, Ave Prof Orlando Marques de Paiva 87, BR-05508270 Sao Paulo, Brazil	Rockefeller University; Rockefeller University; Universidade de Sao Paulo	Mucida, D (corresponding author), Rockefeller Univ, Lab Mucosal Immunol, 1230 York Ave, New York, NY 10065 USA.	mucida@rockefeller.edu	Oliveira, Thiago Y/HGA-3848-2022; Costa-Pinto, Frederico/F-7571-2010; Oliveira, Thiago Y/ABF-5186-2020	Oliveira, Thiago Y/0000-0002-2654-0879; Costa-Pinto, Frederico/0000-0003-1135-2354; Oliveira, Thiago Y/0000-0002-2654-0879; Muller, Paul/0000-0002-1957-4763; Gabanyi, Ilana/0000-0001-5886-2525	Kenneth Rainin Foundation Breakthrough Award, a National Institutes of Health [NIH 5R21AI105047]; Leona M. and Harry B. Helmsley Charitable Trust; Crohn's and Colitis Foundation of America; FAPESP (Brazil); CNPq (Brazil); Empire State Stem Cell Fund through NYSDOH [C023046]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI105047] Funding Source: NIH RePORTER	Kenneth Rainin Foundation Breakthrough Award, a National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leona M. and Harry B. Helmsley Charitable Trust; Crohn's and Colitis Foundation of America; FAPESP (Brazil)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq (Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Empire State Stem Cell Fund through NYSDOH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We are indebted to K. Velinzon and N. Thomas for sorting cells, P. Ariel and the Rockefeller University Bio-Imaging Resource Center (BIRC) for their invaluable help with IVM and light sheet microscopy, N. Renier and R. Azevedo for their help with the iDISCO, D. Esterhazy for kindly providing Lyz2<SUP>csfr1-DTR</SUP>CD11c<SUP>eYFP</SUP> mice, M. Bogunovic and M. Merad (Mount Sinai) for their insightful discussions and help with the isolation of MMs and LpMs, J. Farache, G. Shakhar (Weizmann), and G. Victora (Whitehead, MIT) for their help in establishing live multiphoton microscopy of the gut, members of the Nussenzweig lab and The Rockefeller University employees for continuous assistance. We thank S. Tavazoie, V. Ruta, M. Nussenzweig (RU) and members of our laboratory, particularly V. Pedicord for discussions and critical reading and editing of the manuscript. D.M. is supported by a Kenneth Rainin Foundation Breakthrough Award, a National Institutes of Health NIH 5R21AI105047 grant. D.M. and P.A.M. are supported by the Leona M. and Harry B. Helmsley Charitable Trust. L.F. was supported by Crohn's and Colitis Foundation of America. I.G. and F.A.C.-P. were supported by FAPESP and CNPq (Brazil). The BIRC is supported by the Empire State Stem Cell Fund through NYSDOH C023046.	Anitha M, 2012, GASTROENTEROLOGY, V143, P1006, DOI 10.1053/j.gastro.2012.06.034; Ayres JS, 2012, NAT MED, V18, P799, DOI 10.1038/nm.2729; Barron F, 2011, DEVELOPMENT, V138, P2249, DOI 10.1242/dev.056929; Bogunovic M, 2009, IMMUNITY, V31, P513, DOI 10.1016/j.immuni.2009.08.010; Bohorquez DV, 2015, J CLIN INVEST, V125, P782, DOI 10.1172/JCI78361; Cai DM, 2002, NEURON, V35, P711, DOI 10.1016/S0896-6273(02)00826-7; Chiu IM, 2013, NATURE, V501, P52, DOI 10.1038/nature12479; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; del Rey A, 2008, NEUROIMMUNOMODULAT, V15, P29, DOI 10.1159/000135621; Denning TL, 2007, NAT IMMUNOL, V8, P1086, DOI 10.1038/ni1511; Diehl GE, 2013, NATURE, V494, P116, DOI 10.1038/nature11809; El Khoury J, 2007, NAT MED, V13, P432, DOI 10.1038/nm1555; Estevez AG, 2006, J NEUROSCI, V26, P8512, DOI 10.1523/JNEUROSCI.0728-06.2006; Farache J, 2013, IMMUNITY, V38, P581, DOI 10.1016/j.immuni.2013.01.009; Furness JB, 1999, AM J PHYSIOL-GASTR L, V277, pG922, DOI 10.1152/ajpgi.1999.277.5.G922; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Gershon MD, 2007, GASTROENTEROLOGY, V132, P397, DOI 10.1053/j.gastro.2006.11.002; Ghisletti S, 2010, IMMUNITY, V32, P317, DOI 10.1016/j.immuni.2010.02.008; Guereschi MG, 2013, EUR J IMMUNOL, V43, P1001, DOI 10.1002/eji.201243005; Hadis U, 2011, IMMUNITY, V34, P237, DOI 10.1016/j.immuni.2011.01.016; Harris JA, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00076; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; Hendershot TJ, 2007, DEV DYNAM, V236, P93, DOI 10.1002/dvdy.20989; Kinoshita K, 2007, HISTOCHEM CELL BIOL, V127, P41, DOI 10.1007/s00418-006-0223-0; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Li ZS, 2010, J NEUROSCI, V30, P16730, DOI 10.1523/JNEUROSCI.2276-10.2010; Mazzini E, 2014, IMMUNITY, V40, P248, DOI 10.1016/j.immuni.2013.12.012; Medzhitov R, 2012, SCIENCE, V335, P936, DOI 10.1126/science.1214935; Meisel JD, 2014, CELL, V159, P267, DOI 10.1016/j.cell.2014.09.011; Meseguer V, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4125; Muller PA, 2014, CELL, V158, P300, DOI 10.1016/j.cell.2014.04.050; Nakai A, 2014, J EXP MED, V211, P2583, DOI 10.1084/jem.20141132; Neufeld KAM, 2015, NEUROGASTROENT MOTIL, V27, P627, DOI 10.1111/nmo.12534; Nguyen KD, 2011, NATURE, V480, P104, DOI 10.1038/nature10653; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Ohman L, 2010, NAT REV GASTRO HEPAT, V7, P163, DOI 10.1038/nrgastro.2010.4; Okabe Y, 2014, CELL, V157, P832, DOI 10.1016/j.cell.2014.04.016; Parkhurst CN, 2013, CELL, V155, P1596, DOI 10.1016/j.cell.2013.11.030; Phillips RJ, 2012, AUTON NEUROSCI-BASIC, V169, P12, DOI 10.1016/j.autneu.2012.02.004; Pullinger GD, 2010, VET RES, V41, DOI 10.1051/vetres/2010040; Raberg L, 2007, SCIENCE, V318, P812, DOI 10.1126/science.1148526; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Renier N, 2014, CELL, V159, P896, DOI 10.1016/j.cell.2014.10.010; Sanz E, 2009, P NATL ACAD SCI USA, V106, P13939, DOI 10.1073/pnas.0907143106; Schreiber HA, 2013, J EXP MED, V210, P2025, DOI 10.1084/jem.20130903; Soares MP, 2014, TRENDS IMMUNOL, V35, P483, DOI 10.1016/j.it.2014.08.001; SPENGLER RN, 1994, J IMMUNOL, V152, P3024; Tracey KJ, 2009, NAT REV IMMUNOL, V9, P418, DOI 10.1038/nri2566; Tsolis RM, 1999, INFECT IMMUN, V67, P6385; Van Dyken SJ, 2013, ANNU REV IMMUNOL, V31, P317, DOI 10.1146/annurev-immunol-032712-095906; Wang YM, 2015, CELL, V160, P1061, DOI 10.1016/j.cell.2015.01.049; Wang YM, 2012, NAT IMMUNOL, V13, P753, DOI 10.1038/ni.2360; Wilson SR, 2013, CELL, V155, P285, DOI 10.1016/j.cell.2013.08.057; Zariwala HA, 2012, J NEUROSCI, V32, P3131, DOI 10.1523/JNEUROSCI.4469-11.2012; Zigmond E, 2014, IMMUNITY, V40, P720, DOI 10.1016/j.immuni.2014.03.012	57	334	345	3	79	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 28	2016	164	3					378	391		10.1016/j.cell.2015.12.023	http://dx.doi.org/10.1016/j.cell.2015.12.023			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DC0KU	26777404	Green Accepted, Bronze			2022-12-28	WOS:000368906800010
J	Long, CZ; Amoasii, L; Mireault, AA; McAnally, JR; Li, H; Sanchez-Ortiz, E; Bhattacharyya, S; Shelton, JM; Bassel-Duby, R; Olson, EN				Long, Chengzu; Amoasii, Leonela; Mireault, Alex A.; McAnally, John R.; Li, Hui; Sanchez-Ortiz, Efrain; Bhattacharyya, Samadrita; Shelton, John M.; Bassel-Duby, Rhonda; Olson, Eric N.			Postnatal genome editing partially restores dystrophin expression in a mouse model of muscular dystrophy	SCIENCE			English	Article							OFF-TARGET CLEAVAGE; GENE DELIVERY; CRISPR-CAS9; VECTORS; MICE; GLYCOPROTEIN; INJECTION; THERAPY; SYSTEM; BRAIN	CRISPR/Cas9-mediated genome editing holds clinical potential for treating genetic diseases, such as Duchenne muscular dystrophy (DMD), which is caused by mutations in the dystrophin gene. To correct DMD by skipping mutant dystrophin exons in postnatal muscle tissue in vivo, we used adeno-associated virus-9 (AAV9) to deliver gene-editing components to postnatal mdx mice, a model of DMD. Different modes of AAV9 delivery were systematically tested, including intraperitoneal at postnatal day 1 (P1), intramuscular at P12, and retro-orbital at P18. Each of these methods restored dystrophin protein expression in cardiac and skeletal muscle to varying degrees, and expression increased from 3 to 12 weeks after injection. Postnatal gene editing also enhanced skeletal muscle function, as measured by grip strength tests 4 weeks after injection. This method provides a potential means of correcting mutations responsible for DMD and other monogenic disorders after birth.	[Long, Chengzu; Amoasii, Leonela; Mireault, Alex A.; McAnally, John R.; Li, Hui; Sanchez-Ortiz, Efrain; Bhattacharyya, Samadrita; Bassel-Duby, Rhonda; Olson, Eric N.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Long, Chengzu; Amoasii, Leonela; Mireault, Alex A.; McAnally, John R.; Li, Hui; Sanchez-Ortiz, Efrain; Bhattacharyya, Samadrita; Bassel-Duby, Rhonda; Olson, Eric N.] Univ Texas SW Med Ctr Dallas, Hamon Ctr Regenerat Sci & Med, Dallas, TX 75390 USA; [Long, Chengzu; Amoasii, Leonela; Mireault, Alex A.; McAnally, John R.; Li, Hui; Sanchez-Ortiz, Efrain; Bhattacharyya, Samadrita; Bassel-Duby, Rhonda; Olson, Eric N.] Univ Texas SW Med Ctr Dallas, Sen Paul D Wellstone Muscular Dystrophy Cooperat, Dallas, TX 75390 USA; [Shelton, John M.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Olson, EN (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA.	eric.olson@utsouthwestern.edu	LI, HUI/G-1227-2011	LI, HUI/0000-0002-4114-8349	NIH [HL-077439, HL-111665, HL-093039, DK-099653, U01-HL-100401, U54 HD 087351]; Fondation Leducq Networks of Excellence; Robert A. Welch Foundation [1-0025]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD087351] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY012196] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL111665, R01HL093039, U01HL100401, R01HL077439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK099653] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondation Leducq Networks of Excellence; Robert A. Welch Foundation(The Welch Foundation); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank D. Grimm and F. Schmidt for AAV-hCas9 and the sgRNA Cloning Vector plasmids; C. Wang for AAV9 packaging; J. Schneider and P. Mammen for discussions; C. Rodriguez for technical help; Z. Wang for input; S. Rovinsky and E. Plautz (UT Southwestern Neuro-Models Facility) for grip strength testing; X. Li and R. Gordillo (UT Southwestern Mouse Metabolic Phenotyping Core Facility) for CK level measurement; and J. Cabrera for graphics. Supported by NIH grants HL-077439, HL-111665, HL-093039, DK-099653, U01-HL-100401, and U54 HD 087351; Fondation Leducq Networks of Excellence; and the Robert A. Welch Foundation (grant 1-0025, E.N.O.). The pSpCas9(BB)-2A-GFP (PX458) plasmid is available for purchase from Addgene under a material transfer agreement. The University of Texas Southwestern Medical Center and the authors (E.N.O., R.B.-D., J.M.S., C.L., J.R.M.) have filed a patent application (#14/823,563) related to the use of CRISPR/Cas9 technology to treat muscle disease.	Bing C, 2014, J THER ULTRASOUND, V2, DOI 10.1186/2050-5736-2-13; Bosley KS, 2015, NAT BIOTECHNOL, V33, P478, DOI 10.1038/nbt.3227; CAMPBELL KP, 1989, NATURE, V338, P259, DOI 10.1038/338259a0; Cearley CN, 2007, J NEUROSCI, V27, P9928, DOI 10.1523/JNEUROSCI.2185-07.2007; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Davies KE, 2006, NAT REV MOL CELL BIO, V7, P762, DOI 10.1038/nrm2024; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; ERVASTI JM, 1990, NATURE, V345, P315, DOI 10.1038/345315a0; Fairclough RJ, 2013, NAT REV GENET, V14, P373, DOI 10.1038/nrg3460; Godfrey C, 2015, HUM MOL GENET, V24, P4225, DOI 10.1093/hmg/ddv155; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Li HL, 2015, STEM CELL REP, V4, P143, DOI 10.1016/j.stemcr.2014.10.013; Long CZ, 2014, SCIENCE, V345, P1184, DOI 10.1126/science.1254445; Mali P, 2013, NAT METHODS, V10, P957, DOI [10.1038/NMETH.2649, 10.1038/nmeth.2649]; Nowak KJ, 2004, EMBO REP, V5, P872, DOI 10.1038/sj.embor.7400221; Ousterout DG, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7244; Schmidt F, 2015, BIOTECHNOL J, V10, P258, DOI 10.1002/biot.201400529; Senis E, 2014, BIOTECHNOL J, V9, P1402, DOI 10.1002/biot.201400046; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; van Deutekom JCT, 2003, NAT REV GENET, V4, P774, DOI 10.1038/nrg1180; van Putten M, 2014, J MOL CELL CARDIOL, V69, P17, DOI 10.1016/j.yjmcc.2014.01.009; Wang XL, 2015, NAT BIOTECHNOL, V33, P175, DOI 10.1038/nbt.3127; Weber-Adrian D, 2015, GENE THER, V22, P568, DOI 10.1038/gt.2015.25; Xu L, 2016, MOL THER, V24, P564, DOI 10.1038/mt.2015.192; Yokota T, 2007, Acta Myol, V26, P179; Zacchigna S, 2014, CIRC RES, V114, P1827, DOI 10.1161/CIRCRESAHA.114.302331; Zhang HW, 2011, MOL THER, V19, P1440, DOI 10.1038/mt.2011.98; Zincarelli C, 2008, MOL THER, V16, P1073, DOI 10.1038/mt.2008.76	29	633	671	7	231	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 22	2016	351	6271					400	403		10.1126/science.aad5725	http://dx.doi.org/10.1126/science.aad5725			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB3VH	26721683	Green Accepted			2022-12-28	WOS:000368440500044
J	Lembo, AJ; Lacy, BE; Zuckerman, MJ; Schey, R; Dove, LS; Andrae, DA; Davenport, JM; McIntyre, G; Lopez, R; Turner, L; Covington, PS				Lembo, Anthony J.; Lacy, Brian E.; Zuckerman, Marc J.; Schey, Ron; Dove, Leonard S.; Andrae, David A.; Davenport, J. Michael; McIntyre, Gail; Lopez, Rocio; Turner, Lisa; Covington, Paul S.			Eluxadoline for Irritable Bowel Syndrome with Diarrhea	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INDUCED ACUTE-PANCREATITIS; ODDI MOTOR-ACTIVITY; RECEPTOR ANTAGONIST; CONTROLLED-TRIALS; SPHINCTER; ALOSETRON; MORPHINE; CONSTIPATION; LOPERAMIDE; WOMEN	BACKGROUND Effective and safe treatments are needed for patients who have irritable bowel syndrome (IBS) with diarrhea. We conducted two phase 3 trials to assess the efficacy and safety of eluxadoline, a new oral agent with mixed opioid effects (mu- and kappa-opioid receptor agonist and delta-opioid receptor antagonist), in patients with IBS with diarrhea. METHODS We randomly assigned 2427 adults who had IBS with diarrhea to eluxadoline (at a dose of 75 mg or 100 mg) or placebo twice daily for 26 weeks (IBS-3002 trial) or 52 weeks (IBS-3001 trial). The primary end point was the proportion of patients who had a composite response of decrease in abdominal pain and improvement in stool consistency on the same day for at least 50% of the days from weeks 1 through 12 and from weeks 1 through 26. RESULTS For weeks 1 through 12, more patients in the eluxadoline groups (75 mg and 100 mg) than in the placebo group reached the primary end point (IBS-3001 trial, 23.9% with the 75-mg dose and 25.1% with the 100-mg dose vs. 17.1% with placebo; P = 0.01 and P = 0.004, respectively; IBS-3002 trial, 28.9% and 29.6%, respectively, vs. 16.2%; P<0.001 for both comparisons). For weeks 1 through 26, the corresponding rates in IBS-3001 were 23.4% and 29.3% versus 19.0% (P = 0.11 and P<0.001, respectively), and the corresponding rates in IBS-3002 were 30.4% and 32.7% versus 20.2% (P = 0.001 and P<0.001, respectively). The most common adverse events associated with 75 mg of eluxadoline and 100 mg of eluxadoline, as compared with placebo, were nausea (8.1% and 7.5% vs. 5.1%), constipation (7.4% and 8.6% vs. 2.5%), and abdominal pain (5.8% and 7.2% vs. 4.1%). Pancreatitis developed in 5 (2 in the 75-mg group and 3 in the 100-mg group) of the 1666 patients in the safety population (0.3%). CONCLUSIONS Eluxadoline is a new therapeutic agent that reduced symptoms of IBS with diarrhea in men and women, with sustained efficacy over 6 months in patients who received the 100-mg dose twice daily. (Funded by Furiex Pharmaceuticals, an affiliate of Allergan; IBS-3001 and IBS-3002 ClinicalTrials.gov numbers, NCT01553591 and NCT01553747, respectively.)	[Lembo, Anthony J.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Lacy, Brian E.] Geisel Sch Med Dartmouth, Hanover, NH USA; [Zuckerman, Marc J.] Texas Tech Univ, Hlth Sci Ctr, El Paso, TX USA; [Schey, Ron] Temple Univ, Sch Med, Philadelphia, PA 19122 USA; [Dove, Leonard S.; Andrae, David A.; Davenport, J. Michael; McIntyre, Gail; Lopez, Rocio; Turner, Lisa; Covington, Paul S.] Furiex Pharmaceut, Morrisville, NC USA	Harvard University; Harvard Medical School; Dartmouth College; Texas Tech University System; Texas Tech University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Lembo, AJ (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med,Div Gastroenterol, 330 Brookline Ave, Boston, MA 02115 USA.	alembo@bidmc.harvard.edu			Furiex Pharmaceuticals, an affiliate of Allergan [IBS-3001, IBS-3002]	Furiex Pharmaceuticals, an affiliate of Allergan	Funded by Furiex Pharmaceuticals, an affiliate of Allergan; IBS-3001 and IBS-3002 ClinicalTrials.gov numbers, NCT01553591 and NCT01553747, respectively.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Ananthan S, 2006, AAPS J, V8, pE118, DOI 10.1208/aapsj080114; Andresen V, 2008, CLIN GASTROENTEROL H, V6, P545, DOI 10.1016/j.cgh.2007.12.015; Badalov N, 2007, CLIN GASTROENTEROL H, V5, P648, DOI 10.1016/j.cgh.2006.11.023; Banks PA, 2013, GUT, V62, P102, DOI 10.1136/gutjnl-2012-302779; BAUER AJ, 1991, GASTROENTEROLOGY, V101, P970, DOI 10.1016/0016-5085(91)90723-X; BEHAR J, 1984, GASTROENTEROLOGY, V86, P134; Camilleri M, 2001, ARCH INTERN MED, V161, P1733, DOI 10.1001/archinte.161.14.1733; CANN PA, 1984, DIGEST DIS SCI, V29, P239, DOI 10.1007/BF01296258; Chang L, 2005, AM J GASTROENTEROL, V100, P115, DOI 10.1111/j.1572-0241.2005.40365.x; Department of Health and Human Services National Institutes of Health, 2004, NIAAA NEWSLETTER; Dietis N, 2009, BRIT J ANAESTH, V103, P38, DOI 10.1093/bja/aep129; Dove LS, 2013, GASTROENTEROLOGY, V145, P329, DOI 10.1053/j.gastro.2013.04.006; Efskind PS, 1996, SCAND J GASTROENTERO, V31, P463, DOI 10.3109/00365529609006766; Ford AC, 2014, AM J GASTROENTEROL, V109, pS2, DOI 10.1038/ajg.2014.187; GUELRUD M, 1991, GASTROINTEST ENDOSC, V37, P428, DOI 10.1016/S0016-5107(91)70774-8; HANDELSMAN L, 1987, AM J DRUG ALCOHOL AB, V13, P293, DOI 10.3109/00952998709001515; Hastier P, 2000, AM J GASTROENTEROL, V95, P3295; Hastier P, 1997, GUT, V41, P705, DOI 10.1136/gut.41.5.705; HELM JF, 1988, GUT, V29, P1402, DOI 10.1136/gut.29.10.1402; Holzer P, 2009, REGUL PEPTIDES, V155, P11, DOI 10.1016/j.regpep.2009.03.012; Howaizi M, 2000, GASTROEN CLIN BIOL, V24, P589; Hulisz Darrell, 2004, J Manag Care Pharm, V10, P299; KAGAYA T, 1979, Gastroenterologia Japonica, V14, P327; LAVO B, 1987, SCAND J GASTROENTERO, V22, P77, DOI 10.3109/00365528709091003; Lembo AJ, 2004, CLIN GASTROENTEROL H, V2, P675, DOI 10.1016/S1542-3565(04)00284-8; Lembo T, 2001, AM J GASTROENTEROL, V96, P2662; Longstreth GF, 2006, GASTROENTEROLOGY, V130, P1480, DOI 10.1053/j.gastro.2005.11.061; MOSSBERG SM, 1962, ARCH INTERN MED, V109, P429, DOI 10.1001/archinte.1962.03620160055008; Pandol SJ, 2007, PANCREATOLOGY, V7, P105, DOI 10.1159/000104235; Pare P, 2006, CLIN THER, V28, P1726, DOI 10.1016/j.clinthera.2006.10.010; PATCH GG, 1991, J NUCL MED, V32, P1270; Peery AF, 2012, GASTROENTEROLOGY, V143, P1179, DOI 10.1053/j.gastro.2012.08.002; Pimentel M, 2011, NEW ENGL J MED, V364, P22, DOI 10.1056/NEJMoa1004409; ROBERTSTHOMSON IC, 1989, J GASTROEN HEPATOL, V4, P317, DOI 10.1111/j.1440-1746.1989.tb00842.x; Shahedi K, 2013, J GASTROEN HEPATOL, V2, P335; STEINBERG WM, 1980, GASTROENTEROLOGY, V78, P728; Thompson DR, 2001, AM J GASTROENTEROL, V96, P1266, DOI 10.1111/j.1572-0241.2001.03536.x; THUNE A, 1992, CLIN SCI, V82, P169, DOI 10.1042/cs0820169; Trivedi CD, 2005, J CLIN GASTROENTEROL, V39, P709, DOI 10.1097/01.mcg.0000173929.60115.b4; VICECONTE G, 1983, GUT, V24, P20, DOI 10.1136/gut.24.1.20; Vidarsdottir H, 2013, CASE REP GASTROINTES, V2013, DOI 10.1155/2013/517414; Wade PR, 2012, BRIT J PHARMACOL, V167, P1111, DOI 10.1111/j.1476-5381.2012.02068.x	43	196	210	2	28	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 21	2016	374	3					242	253		10.1056/NEJMoa1505180	http://dx.doi.org/10.1056/NEJMoa1505180			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DB3IS	26789872	Bronze			2022-12-28	WOS:000368404800009
J	Hawkes, N				Hawkes, Nigel			BODY POLITIC Calm down everyone: Keogh's action is not explosive stuff	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com						Rimmer A, 2016, BMJ-BRIT MED J, V352, pi130	1	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 13	2016	352								i181	10.1136/bmj.i181	http://dx.doi.org/10.1136/bmj.i181			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DB2YL	26762337				2022-12-28	WOS:000368376500010
J	Lee, CH; Steiner, T; Petrof, EO; Smieja, M; Roscoe, D; Nematallah, A; Weese, JS; Collins, S; Moayyedi, P; Crowther, M; Ropeleski, MJ; Jayaratne, P; Higgins, D; Li, YF; Rau, NV; Kim, PT				Lee, Christine H.; Steiner, Theodore; Petrof, Elaine O.; Smieja, Marek; Roscoe, Diane; Nematallah, Anouf; Weese, J. Scott; Collins, Stephen; Moayyedi, Paul; Crowther, Mark; Ropeleski, Mark J.; Jayaratne, Padman; Higgins, David; Li, Yingfu; Rau, Neil V.; Kim, Peter T.			Frozen vs Fresh Fecal Microbiota Transplantation and Clinical Resolution of Diarrhea in Patients With Recurrent Clostridium difficile Infection A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CARE-ASSOCIATED INFECTIONS; RETENTION ENEMA; EPIDEMIOLOGY; METAANALYSIS; DISEASE; RISK	IMPORTANCE Clostridium difficile infection (CDI) is a major burden in health care and community settings. CDI recurrence is of particular concern because of limited treatment options and associated clinical and infection control issues. Fecal microbiota transplantation (FMT) is a promising, but not readily available, intervention. OBJECTIVE To determine whether frozen-and-thawed (frozen, experimental) FMT is noninferior to fresh (standard) FMT in terms of clinical efficacy among patients with recurrent or refractory CDI and to assess the safety of both types of FMT. DESIGN, SETTING, AND PARTICIPANTS Randomized, double-blind, noninferiority trial enrolling 232 adults with recurrent or refractory CDI, conducted between July 2012 and September 2014 at 6 academic medical centers in Canada. INTERVENTIONS Patients were randomly allocated to receive frozen (n = 114) or fresh (n = 118) FMT via enema. MAIN OUTCOMES AND MEASURES The primary outcome measures were clinical resolution of diarrhea without relapse at 13 weeks and adverse events. Noninferiority margin was set at 15%. RESULTS A total of 219 patients (n = 108 in the frozen FMT group and n = 111 in the fresh FMT group) were included in the modified intention-to-treat (mITT) population and 178 (frozen FMT: n = 91, fresh FMT: n = 87) in the per-protocol population. In the per-protocol population, the proportion of patients with clinical resolution was 83.5% for the frozen FMT group and 85.1% for the fresh FMT group (difference, -1.6% [95% Cl, -10.5% to infinity]; P = .01 for noninferiority). In the mITT population the clinical resolution was 75.0% for the frozen FMT group and 70.3% for the fresh FMT group (difference, 4.7% [95% CI, -5.2% to infinity]; P < .001 for noninferiority). There were no differences in the proportion of adverse or serious adverse events between the treatment groups. CONCLUSIONS AND RELEVANCE Among adults with recurrent or refractory CDI, the use of frozen compared with fresh FMT did not result in worse proportion of clinical resolution of diarrhea. Given the potential advantages of providing frozen FMT, its use is a reasonable option in this setting.	[Lee, Christine H.; Smieja, Marek; Jayaratne, Padman; Kim, Peter T.] McMaster Univ, Dept Pathol & Mol Med, Hamilton Reg Lab, Program Med, Hamilton, ON, Canada; [Lee, Christine H.; Smieja, Marek; Crowther, Mark] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Lee, Christine H.; Smieja, Marek; Crowther, Mark; Jayaratne, Padman; Higgins, David] St Josephs Healthcare Hamilton, Hamilton, ON L8N 4A6, Canada; [Steiner, Theodore; Nematallah, Anouf] Vancouver Hosp, Div Infect Dis, Vancouver, BC, Canada; [Steiner, Theodore; Nematallah, Anouf] Vancouver Hosp, Immun & Infect Res Ctr, Vancouver, BC, Canada; [Steiner, Theodore; Roscoe, Diane; Nematallah, Anouf] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Petrof, Elaine O.; Ropeleski, Mark J.] Queens Univ, Dept Med, Gastrointestinal Dis Res Unit, Kingston, ON K7L 3N6, Canada; [Roscoe, Diane] Vancouver Gen Hosp, Div Med Microbiol & Infect Control, Vancouver, BC, Canada; [Weese, J. Scott] Univ Guelph, Ctr Publ Hlth & Zoonoses, Dept Pathobiol, Guelph, ON N1G 2W1, Canada; [Collins, Stephen; Moayyedi, Paul] McMaster Univ, Dept Med, Div Gastroenterol, Farncombe Family Digest Hlth Res Inst, Hamilton, ON, Canada; [Li, Yingfu] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8N 3Z5, Canada; [Kim, Peter T.] Univ Guelph, Dept Math & Stat, Guelph, ON N1G 2W1, Canada; [Rau, Neil V.] Univ Toronto, Dept Med, Div Infect Dis, Toronto, ON, Canada; [Rau, Neil V.] Halton Healthcare Serv, Oakville, ON, Canada	McMaster University; McMaster University; McMaster University; University of British Columbia; University of British Columbia; University of British Columbia; Queens University - Canada; University of British Columbia; University of Guelph; McMaster University; McMaster University; University of Guelph; University of Toronto	Lee, CH (corresponding author), St Josephs Healthcare Hamilton, 50 Charlton Ave E,424 Luke Wing, Hamilton, ON L8N 4A6, Canada.	clee@mcmaster.ca	Moayyedi, Paul/M-6178-2014	Moayyedi, Paul/0000-0002-3616-9292; Steiner, Ted/0000-0002-3136-6668	Physicians Services Incorporated; Natural Sciences and Engineering Council; National Science Foundation; Gastrointestinal Diseases Research Unit, Kingston General Hospital, Ontario	Physicians Services Incorporated; Natural Sciences and Engineering Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Science Foundation(National Science Foundation (NSF)); Gastrointestinal Diseases Research Unit, Kingston General Hospital, Ontario	The study was funded by Physicians Services Incorporated, Natural Sciences and Engineering Council, National Science Foundation, and Gastrointestinal Diseases Research Unit, Kingston General Hospital, Ontario.	[Anonymous], MED OUTC STUD 36 IT; Bakken JS, 2011, CLIN GASTROENTEROL H, V9, P1044, DOI 10.1016/j.cgh.2011.08.014; Barbut F, 2000, J CLIN MICROBIOL, V38, P2386; Cohen SH, 2010, INFECT CONT HOSP EP, V31, P431, DOI 10.1086/651706; De Paoli P, 2005, FEMS MICROBIOL REV, V29, P897, DOI 10.1016/j.femsre.2005.01.005; Garey KW, 2008, J HOSP INFECT, V70, P298, DOI 10.1016/j.jhin.2008.08.012; Gerding DN, 2015, JAMA-J AM MED ASSOC, V313, P1719, DOI 10.1001/jama.2015.3725; Hamilton MJ, 2012, AM J GASTROENTEROL, V107, P761, DOI 10.1038/ajg.2011.482; Jayaratne PA, 2013, DIAGN MICR INFEC DIS, V75, P121, DOI 10.1016/j.diagmicrobio.2012.10.002; Kaji AH, 2015, JAMA-J AM MED ASSOC, V313, P2371, DOI 10.1001/jama.2015.6645; Kassam Z, 2013, AM J GASTROENTEROL, V108, P500, DOI 10.1038/ajg.2013.59; Kassam Z, 2012, ARCH INTERN MED, V172, P191, DOI 10.1001/archinte.172.2.191; Kelly CP, 2012, CLIN MICROBIOL INFEC, V18, P21, DOI 10.1111/1469-0691.12046; Lee CH, 2014, EUR J CLIN MICROBIOL, V33, P1425, DOI 10.1007/s10096-014-2088-9; Macconnachie AA, 2009, QJM-INT J MED, V102, P781, DOI 10.1093/qjmed/hcp118; Magill SS, 2014, NEW ENGL J MED, V370, P1198, DOI 10.1056/NEJMoa1306801; McFarland LV, 2002, AM J GASTROENTEROL, V97, P1769, DOI 10.1111/j.1572-0241.2002.05839.x; Mitchell BG, 2012, ANTIMICROB RESIST IN, V1, DOI 10.1186/2047-2994-1-20; Noren T, 2004, J CLIN MICROBIOL, V42, P3635, DOI [10.1128/JCM.42.8.3635-3643.2004, 10.1128/jcm.42.8.3635-3643.2004]; Rohlke F, 2010, J CLIN GASTROENTEROL, V44, P567, DOI 10.1097/MCG.0b013e3181dadb10; Satokari R, 2015, ALIMENT PHARM THER, V41, P46, DOI 10.1111/apt.13009; Schumi J, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-106; van Nood E, 2013, NEW ENGL J MED, V368, P407, DOI 10.1056/NEJMoa1205037; Youngster I, 2014, JAMA-J AM MED ASSOC, V312, P1772, DOI 10.1001/jama.2014.13875; Zar FA, 2007, CLIN INFECT DIS, V45, P302, DOI 10.1086/519265; Zimlichman E, 2013, JAMA INTERN MED, V173, P2039, DOI 10.1001/jamainternmed.2013.9763	26	405	436	4	52	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 12	2016	315	2					142	149		10.1001/jama.2015.18098	http://dx.doi.org/10.1001/jama.2015.18098			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DA6XO	26757463	Bronze			2022-12-28	WOS:000367949200016
J	[Anonymous]				[Anonymous]			Coffee and Protein Metabolism (Reprinted from JAMA, vol 66, pg 120, 1916)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																		Liwschitz O., 1914, THESIS; Voit Carl, 1860, UNTERSUCHUNGEN EINFL; 1916, JAMA, V66, P120	3	0	0	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 5	2016	315	1					92	92		10.1001/jama.2015.17069	http://dx.doi.org/10.1001/jama.2015.17069			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DA0YH	26746472				2022-12-28	WOS:000367523000028
J	Ford, AT				Ford, Adam T.			The mechanistic pathways of trophic interactions in human-occupied landscapes	SCIENCE			English	Editorial Material							LARGE CARNIVORES; RECOVERY; PREY		[Ford, Adam T.] Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada	University of Guelph	Ford, AT (corresponding author), Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada.	adamford@uoguelph.ca						Barrueto M, 2014, ECOSPHERE, V5, DOI 10.1890/ES13-00382.1; Chapron G, 2014, SCIENCE, V346, P1517, DOI 10.1126/science.1257553; Dirzo R, 2014, SCIENCE, V345, P401, DOI 10.1126/science.1251817; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Ford A. T., 2011, ANTELOPE CONSERVATIO; Ford AT, 2015, TRENDS ECOL EVOL, V30, P725, DOI 10.1016/j.tree.2015.09.012; Ford AT, 2015, ECOLOGY, V96, P2705, DOI 10.1890/14-2056.1.sm; Ford AT, 2015, J MAMMAL, V96, P918, DOI 10.1093/jmammal/gyv090; Ford AT, 2014, SCIENCE, V346, P346, DOI 10.1126/science.1252753; Ford AT, 2011, WILDLIFE BIOL, V17, P253, DOI 10.2981/09-051; Ford AT, 2010, CONSERV BIOL, V24, P1679, DOI 10.1111/j.1523-1739.2010.01564.x; Pringle RM, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0390; Ripple WJ, 2014, SCIENCE, V343, P151, DOI 10.1126/science.1241484	13	1	1	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 4	2015	350	6265								10.1126/science.aad7134	http://dx.doi.org/10.1126/science.aad7134			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX4WG	26785465				2022-12-28	WOS:000365700500051
J	Fallah, M; Dahn, B; Nyenswah, TG; Massaquoi, M; Skrip, LA; Yamin, D; Mbah, MN; Joe, N; Freeman, S; Harris, T; Benson, Z; Galvani, AP				Fallah, Mosoka; Dahn, Bernice; Nyenswah, Tolbert G.; Massaquoi, Moses; Skrip, Laura A.; Yamin, Dan; Mbah, Martial Ndeffo; Joe, Netty; Freeman, Siedoh; Harris, Thomas; Benson, Zinnah; Galvani, Alison P.			Interrupting Ebola Transmission in Liberia Through Community-Based Initiatives	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Liberia, Minist Hlth, Community Based Initiat, United Nations Dev Programme, Monrovia, Liberia; Univ Liberia, AM Dogliotti Coll Med, Monrovia, Liberia; Yale Univ, Sch Publ Hlth, Ctr Infect Dis Modeling & Anal, New Haven, CT USA; [Fallah, Mosoka; Dahn, Bernice; Nyenswah, Tolbert G.; Massaquoi, Moses; Joe, Netty; Freeman, Siedoh; Harris, Thomas; Benson, Zinnah] POB 10-9009, Monrovia 1000 10, Liberia; [Skrip, Laura A.; Yamin, Dan; Mbah, Martial Ndeffo; Galvani, Alison P.] 135 Coll St,Suite 200, New Haven, CT 06520 USA	Yale University	Fallah, M (corresponding author), POB 10-9009, Monrovia 1000 10, Liberia.	mfallah1969@gmail.com						Centers for Disease Control and Prevention. Ebola (Ebola Virus Disease), 2015, EB EB VIR DIS 2014 W; Dunn FL, 1985, TROPICAL GEOGRAPHICA; Hewlett BS, 2003, EMERG INFECT DIS, V9, P1242; Liberia Institute of Statistics and Geo-Information Services, 2009, 2008 NAT POP HOUS CE; Liljas P., 2014, TIME; The World Bank, 2015, DAT LIB; Yamin D, 2015, ANN INTERN MED, V162, P11, DOI 10.7326/M14-2255	7	30	30	0	10	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 1	2016	164	5					367	U117		10.7326/M15-1464	http://dx.doi.org/10.7326/M15-1464			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DF3CC	26746879				2022-12-28	WOS:000371220300008
J	Taichman, DB; Backus, J; Baethge, C; Bauchner, H; de Leeuw, PW; Drazen, JM; Fletcher, J; Frizelle, FA; Groves, T				Taichman, Darren B.; Backus, Joyce; Baethge, Christopher; Bauchner, Howard; de Leeuw, Peter W.; Drazen, Jeffrey M.; Fletcher, John; Frizelle, Frank A.; Groves, Trish			Sharing clinical trial data: a proposal from the International Committee of Medical Journal Editors	LANCET			English	Editorial Material									[Taichman, Darren B.] Natl Lib Med, Lib Operat, Bethesda, MD 20894 USA; [Frizelle, Frank A.] World Assoc Med Editors, New Delhi, India	National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM)	Taichman, DB (corresponding author), Natl Lib Med, Lib Operat, Bethesda, MD 20894 USA.	dtaichman@acponline.org	de Leeuw, Peter W./J-4552-2016	de Leeuw, Peter W./0000-0002-4949-5812; Pinborg, Anja/0000-0002-8340-104X				Institute of Medicine, 2015, SHAR CLIN TRIAL DAT	1	18	18	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 23	2016	387	10016					E9	E11		10.1016/S0140-6736(15)01279-9	http://dx.doi.org/10.1016/S0140-6736(15)01279-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DB4XI	26803441				2022-12-28	WOS:000368516500001
J	Boel, G; Letso, R; Neely, H; Price, WN; Wong, KH; Su, M; Luff, JD; Valecha, M; Everett, JK; Acton, TB; Xiao, R; Montelione, GT; Aalberts, DP; Hunt, JF				Boel, Gregory; Letso, Reka; Neely, Helen; Price, W. Nicholson; Wong, Kam-Ho; Su, Min; Luff, Jon D.; Valecha, Mayank; Everett, John K.; Acton, Thomas B.; Xiao, Rong; Montelione, Gaetano T.; Aalberts, Daniel P.; Hunt, John F.			Codon influence on protein expression in E. coli correlates with mRNA levels	NATURE			English	Article							STRUCTURAL GENOMICS CONSORTIUM; ESCHERICHIA-COLI; GENE-EXPRESSION; TRANSLATION EFFICIENCY; PRODUCTION PLATFORM; STALLED RIBOSOMES; ELONGATION RATES; USAGE BIAS; IN-VIVO; ABUNDANCE	Degeneracy in the genetic code, which enables a single protein to be encoded by a multitude of synonymous gene sequences, has an important role in regulating protein expression, but substantial uncertainty exists concerning the details of this phenomenon. Here we analyse the sequence features influencing protein expression levels in 6,348 experiments using bacteriophage T7 polymerase to synthesize messenger RNA in Escherichia coli. Logistic regression yields a new codon-influence metric that correlates only weakly with genomic codon-usage frequency, but strongly with global physiological protein concentrations and also mRNA concentrations and lifetimes in vivo. Overall, the codon content influences protein expression more strongly than mRNA-folding parameters, although the latter dominate in the initial similar to 16 codons. Genes redesigned based on our analyses are transcribed with unaltered efficiency but translated with higher efficiency in vitro. The less efficiently translated native sequences show greatly reduced mRNA levels in vivo. Our results suggest that codon content modulates a kinetic competition between protein elongation and mRNA degradation that is a central feature of the physiology and also possibly the regulation of translation in E. coli.	[Boel, Gregory; Letso, Reka; Neely, Helen; Price, W. Nicholson; Wong, Kam-Ho; Su, Min; Luff, Jon D.; Valecha, Mayank; Hunt, John F.] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Boel, Gregory; Letso, Reka; Neely, Helen; Price, W. Nicholson; Wong, Kam-Ho; Su, Min; Luff, Jon D.; Valecha, Mayank; Hunt, John F.] Columbia Univ, Northeast Struct Genom Consortium, New York, NY 10027 USA; [Boel, Gregory] CNRS, UMR8261, Inst Biol Phys Chim, F-75005 Paris, France; [Everett, John K.; Acton, Thomas B.; Xiao, Rong; Montelione, Gaetano T.] Rutgers State Univ, Ctr Adv Biotechnol & Med, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA; [Everett, John K.; Acton, Thomas B.; Xiao, Rong; Montelione, Gaetano T.] Rutgers State Univ, Ctr Adv Biotechnol & Med, Northeast Struct Genom Consortium, Piscataway, NJ 08854 USA; [Montelione, Gaetano T.] Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA; [Aalberts, Daniel P.] Williams Coll, Dept Phys, Williamstown, MA 01267 USA	Columbia University; Columbia University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center; Williams College	Hunt, JF (corresponding author), Columbia Univ, Dept Biol Sci, 702 Fairchild Ctr,MC2434, New York, NY 10027 USA.	aalberts@williams.edu; jfh21@columbia.edu	Boel, Gregory/N-4623-2016	Boel, Gregory/0000-0001-9900-6493; Montelione, Gaetano/0000-0002-9440-3059; Price, Nicholson/0000-0003-0729-290X	NIGMS Protein Structure Initiative [U54-GM094597]; NIH [GM106372]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094597, R15GM106372] Funding Source: NIH RePORTER	NIGMS Protein Structure Initiative(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIGMS Protein Structure Initiative grant U54-GM094597 to the Northeast Structural Genomics Consortium to J.F.H. and G.T.M., and NIH grant GM106372 to D.P.A. We thank B. Klingenberg, R. Gonzalez, M. Gottesman and V. de Crecy-Lagard for advice.	Acton TB, 2005, METHOD ENZYMOL, V394, P210, DOI 10.1016/S0076-6879(05)94008-1; Acton TB, 2011, METHOD ENZYMOL, V493, P21, DOI 10.1016/B978-0-12-381274-2.00002-9; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; [Anonymous], 2012, LANG ENV STAT COMP; Bentele K, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.32; BULMER M, 1991, GENETICS, V129, P897; Cannarrozzi G, 2010, CELL, V141, P355, DOI 10.1016/j.cell.2010.02.036; CASKEY CT, 1968, J MOL BIOL, V37, P99, DOI 10.1016/0022-2836(68)90076-4; Castillo-Mendez MA, 2012, BIOCHIMIE, V94, P662, DOI 10.1016/j.biochi.2011.09.019; Chadani Y, 2011, MOL MICROBIOL, V80, P772, DOI 10.1111/j.1365-2958.2011.07607.x; CHEN GFT, 1994, GENE DEV, V8, P2641, DOI 10.1101/gad.8.21.2641; Chen HY, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20145794; Dana A, 2014, NUCLEIC ACIDS RES, V42, P9171, DOI 10.1093/nar/gku646; Deana A, 1996, J BACTERIOL, V178, P2718, DOI 10.1128/jb.178.9.2718-2720.1996; Dittmar KA, 2005, EMBO REP, V6, P151, DOI 10.1038/sj.embor.7400341; Dong HJ, 1996, J MOL BIOL, V260, P649, DOI 10.1006/jmbi.1996.0428; dos Reis M, 2003, NUCLEIC ACIDS RES, V31, P6976, DOI 10.1093/nar/gkg897; Drummond DA, 2008, CELL, V134, P341, DOI 10.1016/j.cell.2008.05.042; Duval M, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001731; Elf J, 2003, SCIENCE, V300, P1718, DOI 10.1126/science.1083811; Gingold H, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.14; Goodman DB, 2013, SCIENCE, V342, P475, DOI 10.1126/science.1241934; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Harrell Jr F. E., 2014, R PACKAGE VERSION 4; Hunt RC, 2014, TRENDS GENET, V30, P308, DOI 10.1016/j.tig.2014.04.006; IKEMURA T, 1981, J MOL BIOL, V151, P389, DOI 10.1016/0022-2836(81)90003-6; IOST I, 1995, EMBO J, V14, P3252, DOI 10.1002/j.1460-2075.1995.tb07328.x; IOST I, 1992, J BACTERIOL, V174, P619, DOI 10.1128/jb.174.2.619-622.1992; Ishihama Y, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-102; Ivanova N, 2005, J MOL BIOL, V350, P897, DOI 10.1016/j.jmb.2005.05.033; Jansson M, 1996, J BIOMOL NMR, V7, P131; JENSEN PR, 1993, EUR J BIOCHEM, V211, P181, DOI 10.1111/j.1432-1033.1993.tb19885.x; Juncker AS, 2003, PROTEIN SCI, V12, P1652, DOI 10.1110/ps.0303703; Keseler IM, 2013, NUCLEIC ACIDS RES, V41, pD605, DOI 10.1093/nar/gks1027; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; Letzring DP, 2013, RNA, V19, P1208, DOI 10.1261/rna.039446.113; Li GW, 2014, CELL, V157, P624, DOI 10.1016/j.cell.2014.02.033; Li GW, 2012, NATURE, V484, P538, DOI 10.1038/nature10965; Lu JL, 2008, J MOL BIOL, V384, P73, DOI 10.1016/j.jmb.2008.08.089; MURAMATSU T, 1988, NATURE, V336, P179, DOI 10.1038/336179a0; NINIO J, 1986, FEBS LETT, V196, P1, DOI 10.1016/0014-5793(86)80202-2; Nogueira T, 2001, J MOL BIOL, V310, P709, DOI 10.1006/jmbi.2001.4796; NOVICK A, 1957, P NATL ACAD SCI USA, V43, P553, DOI 10.1073/pnas.43.7.553; Pelechano V, 2015, CELL, V161, P1400, DOI 10.1016/j.cell.2015.05.008; Presnyak V, 2015, CELL, V160, P1111, DOI 10.1016/j.cell.2015.02.029; Price W Nicholson 2nd, 2011, Microb Inform Exp, V1, P6, DOI 10.1186/2042-5783-1-6; Quax TEF, 2013, CELL REP, V4, P938, DOI 10.1016/j.celrep.2013.07.049; Reuter JS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-129; Richards J, 2008, BBA-GENE REGUL MECH, V1779, P574, DOI 10.1016/j.bbagrm.2008.02.008; SHAKINESHLEMAN SH, 1988, BIOCHEMISTRY-US, V27, P3975, DOI 10.1021/bi00411a013; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Shoemaker CJ, 2010, SCIENCE, V330, P369, DOI 10.1126/science.1192430; Spencer PS, 2012, J MOL BIOL, V422, P328, DOI 10.1016/j.jmb.2012.06.010; Tuller T, 2010, CELL, V141, P344, DOI 10.1016/j.cell.2010.03.031; Tuller T, 2010, P NATL ACAD SCI USA, V107, P3645, DOI 10.1073/pnas.0909910107; Ude S, 2013, SCIENCE, V339, P82, DOI 10.1126/science.1228985; Vivanco-Dominguez S, 2012, J MOL BIOL, V417, P425, DOI 10.1016/j.jmb.2012.02.008; Wallace EWJ, 2013, MOL BIOL EVOL, V30, P1438, DOI 10.1093/molbev/mst051; Xiao R, 2010, J STRUCT BIOL, V172, P21, DOI 10.1016/j.jsb.2010.07.011; Zhang FL, 2010, SCIENCE, V329, P1534, DOI 10.1126/science.1191701; ZHANG SP, 1991, GENE, V105, P61, DOI 10.1016/0378-1119(91)90514-C	62	213	222	8	160	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 21	2016	529	7586					358	+		10.1038/nature16509	http://dx.doi.org/10.1038/nature16509			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB2QT	26760206	Green Accepted			2022-12-28	WOS:000368354800038
J	Lefkowitz, RJ				Lefkowitz, Robert J.			Alfred Goodman Gilman (1941-2015) OBITUARY	NATURE			English	Biographical-Item									[Lefkowitz, Robert J.] Duke Univ, Howard Hughes Med Inst, Durham, NC 27710 USA; [Lefkowitz, Robert J.] Duke Univ, Med, Durham, NC USA	Duke University; Howard Hughes Medical Institute; Duke University	Lefkowitz, RJ (corresponding author), Duke Univ, Howard Hughes Med Inst, Durham, NC 27710 USA.	lefko001@receptor-biol.duke.edu	Lefkowitz, Robert/AAW-2649-2021					GILMAN A, PUBLICATION LIST	1	1	1	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 21	2016	529	7586					284	284		10.1038/529284a	http://dx.doi.org/10.1038/529284a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB2QT	26791713	Bronze			2022-12-28	WOS:000368354800022
J	Chochinov, HM				Chochinov, Harvey Max			Physician-Assisted Death in Canada	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HEALTH-CARE; EUTHANASIA		[Chochinov, Harvey Max] Univ Manitoba, Winnipeg, MB, Canada	University of Manitoba	Chochinov, HM (corresponding author), CancerCare Manitoba, 3017-675 McDermot Ave, Winnipeg, MB R3E 0V9, Canada.	hchochinov@cancercare.mb.ca		Chochinov, Harvey/0000-0003-2656-4704				Chochinov HM, 2014, CURR ONCOL, V21, pE668, DOI 10.3747/co.21.2239; Marcoux I, 2007, CAN J PUBLIC HEALTH, V98, P235, DOI 10.1007/BF03403719; Marcoux I, 2015, CAN FAM PHYSICIAN, V61, pE196; Schuklenk U, ROYAL SOC CANADA EXP; Wilson KG, 2007, HEALTH PSYCHOL, V26, P314, DOI 10.1037/0278-6133.26.3.314; World Health Organization, WHO DEF PALL CAR	6	15	16	0	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 19	2016	315	3					253	254		10.1001/jama.2015.17435	http://dx.doi.org/10.1001/jama.2015.17435			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DB2WN	26784766				2022-12-28	WOS:000368371400015
J	Gulland, A				Gulland, Anne			HOMELESS HEALTH Keeping homeless patients off the streets	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												agulland@bmj.com						Crisis, 2011, HIDD TRUTH HOM ENGL; Department for Communities and Local Government, 2015, ROUGH SLEEP STAT ENG; Department of Health, 2010, HEALTHC SINGL HOM PE; Healthwatch England, 2015, SAF HOM WHAT HAPP PE; Institute for Health Equity, 2013, WORK HLTH EQ ROL HLT; Royal College of Emergency Medicine, 2015, INCL HLTH CLIN AUD	6	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 19	2016	352								i318	10.1136/bmj.i318	http://dx.doi.org/10.1136/bmj.i318			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DC4ZO	26786634				2022-12-28	WOS:000369229700011
J	Oliver, D				Oliver, David			ACUTE PERSPECTIVE David Oliver: Rehabilitation is part of medicine	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												davidoliver372@googlemail.com						Alzheimer's Society, 2009, COUNT COST CAR PEOPL; Blunt I, 2014, FOCUS A E ATTENDANCE; Covinsky KE, 2003, J AM GERIATR SOC, V51, P451, DOI 10.1046/j.1532-5415.2003.51152.x; Ellis G, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6553; Hubbard RE, 2004, AGE AGEING, V33, P479, DOI 10.1093/ageing/afh164; Mudge AM, 2011, J HOSP MED, V6, P61, DOI 10.1002/jhm.811; NHS Benchmarking Network, 2014, NAT AUD INT CAR SUMM; NHS Benchmarking Network, 2015, RAIS STAND SHAR EXC; Oliver D, 2008, J ROY SOC MED, V101, P168, DOI 10.1258/jrsm.2008.080017; Royal College of Physicians, 2015, HOSP EDG TIM ACT; Young J., 2015, CHANGING CARE SYSTEM	11	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 19	2016	352								i270	10.1136/bmj.i270	http://dx.doi.org/10.1136/bmj.i270			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DC4ZO	26786383	Bronze, Green Published			2022-12-28	WOS:000369229700005
J	Poolman, RW				Poolman, Rudolf W.			In knee OA, adding total knee replacement to nonsurgical treatment improved pain and function at 12 mo	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Poolman, Rudolf W.] Orthoped Surgeon OLVG, Joint Res, Amsterdam, Netherlands		Poolman, RW (corresponding author), Orthoped Surgeon OLVG, Joint Res, Amsterdam, Netherlands.		Poolman, Rudolf/AAM-7815-2020	Poolman, Rudolf/0000-0003-3178-2247				Groen VA, 2015, OBES REV, V16, P161, DOI 10.1111/obr.12236; Kerkhoffs GMMJ, 2012, J BONE JOINT SURG AM, V94A, P1839, DOI 10.2106/JBJS.K.00820; Keurentjes JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059500; Tilbury C, 2015, ACTA ORTHOP, P1	4	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 19	2016	164	2					JC8	JC8		10.7326/ACPJC-2016-164-2-008	http://dx.doi.org/10.7326/ACPJC-2016-164-2-008			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DB0CI	26784498				2022-12-28	WOS:000368175800007
J	Berliner, N; Kurra, C; Chou, D				Berliner, Nancy; Kurra, Chandana; Chou, David			Case 1-2016: An 18-Year-Old Man with Fever, Abdominal Pain, and Thrombocytopenia Hemophagocytic lymphohistiocytosis of an unknown cause.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DIAGNOSIS; ADULTS		[Berliner, Nancy] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Kurra, Chandana] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Kurra, Chandana] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Berliner, Nancy] Harvard Univ, Sch Med, Dept Med, Cambridge, MA 02138 USA; [Kurra, Chandana] Harvard Univ, Sch Med, Dept Radiol, Cambridge, MA 02138 USA; [Chou, David] Harvard Univ, Sch Med, Dept Pathol, Cambridge, MA 02138 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard University	Berliner, N (corresponding author), Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA.			Chou, David/0000-0002-1659-9308				Allen CE, 2008, PEDIATR BLOOD CANCER, V50, P1227, DOI 10.1002/pbc.21423; [Anonymous], 2010, AM J MED, V123; Feldman M, 2013, TRANSL RES, V161, P37, DOI 10.1016/j.trsl.2012.07.006; Gupta A, 2008, PEDIATR BLOOD CANCER, V50, P192, DOI 10.1002/pbc.21441; Henter JI, 2007, PEDIATR BLOOD CANCER, V48, P124, DOI 10.1002/pbc.21039; Parikh SA, 2014, MAYO CLIN PROC, V89, P484, DOI 10.1016/j.mayocp.2013.12.012; Schram AM, 2015, BLOOD, V125, P1548, DOI 10.1182/blood-2014-10-602607; SUSTER S, 1988, HUM PATHOL, V19, P705, DOI 10.1016/S0046-8177(88)80177-1	8	6	6	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 14	2016	374	2					165	173		10.1056/NEJMcpc1501306	http://dx.doi.org/10.1056/NEJMcpc1501306			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DA7PQ	26760088				2022-12-28	WOS:000367996700012
J	Singh, SK; Stogsdill, JA; Pulimood, NS; Dingsdale, H; Kim, YH; Pilaz, LJ; Kim, IH; Manhaes, AC; Rodrigues, WS; Pamukcu, A; Enustun, E; Ertuz, Z; Scheiffele, P; Soderling, SH; Silver, DL; Ji, RR; Medina, AE; Eroglu, C				Singh, Sandeep K.; Stogsdill, Jeff A.; Pulimood, Nisha S.; Dingsdale, Hayley; Kim, Yong Ho; Pilaz, Louis-Jan; Kim, Il Hwan; Manhaes, Alex C.; Rodrigues, Wandilson S., Jr.; Pamukcu, Arin; Enustun, Eray; Ertuz, Zeynep; Scheiffele, Peter; Soderling, Scott H.; Silver, Debra L.; Ji, Ru-Rong; Medina, Alexandre E.; Eroglu, Cagla			Astrocytes Assemble Thalamocortical Synapses by Bridging NRX1 alpha and NL1 via Hevin	CELL			English	Article							OCULAR DOMINANCE PLASTICITY; ALPHA-NEUREXINS; VISUAL-CORTEX; NEUROLIGIN-1; RECEPTORS; CODE	Proper establishment of synapses is critical for constructing functional circuits. Interactions between presynaptic neurexins and postsynaptic neuroligins coordinate the formation of synaptic adhesions. An isoform code determines the direct interactions of neurexins and neuroligins across the synapse. However, whether extracellular linker proteins can expand such a code is unknown. Using a combination of in vitro and in vivo approaches, we found that hevin, an astrocyte-secreted synaptogenic protein, assembles glutamatergic synapses by bridging neurexin-1alpha and neuroligin-1B, two isoforms that do not interact with each other. Bridging of neurexin-1alpha and neuroligin-1B via hevin is critical for the formation and plasticity of thalamocortical connections in the developing visual cortex. These results show that astrocytes promote the formation of synapses by modulating neurexin/neuroligin adhesions through hevin secretion. Our findings also provide an important mechanistic insight into howmutations in these genes may lead to circuit dysfunction in diseases such as autism.	[Singh, Sandeep K.; Stogsdill, Jeff A.; Dingsdale, Hayley; Kim, Il Hwan; Pamukcu, Arin; Enustun, Eray; Ertuz, Zeynep; Soderling, Scott H.; Silver, Debra L.; Eroglu, Cagla] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Pulimood, Nisha S.; Manhaes, Alex C.; Rodrigues, Wandilson S., Jr.; Medina, Alexandre E.] Univ Maryland, Dept Pediat, Sch Med, Baltimore, MD 21201 USA; [Kim, Yong Ho; Ji, Ru-Rong] Duke Univ, Med Ctr, Dept Anesthesiol, Durham, NC 27710 USA; [Pilaz, Louis-Jan; Silver, Debra L.] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA; [Scheiffele, Peter] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland; [Soderling, Scott H.; Silver, Debra L.; Ji, Ru-Rong; Eroglu, Cagla] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; [Soderling, Scott H.; Silver, Debra L.; Eroglu, Cagla] DIBS, Durham, NC 27710 USA	Duke University; University System of Maryland; University of Maryland Baltimore; Duke University; Duke University; University of Basel; Duke University	Singh, SK (corresponding author), Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA.	sandeep.singh@duke.edu; cagla.eroglu@dm.duke.edu	Pamukcu, Arin/AFZ-1637-2022; Ji, Ru-Rong/L-7070-2017; ManhÃes, Alex C/F-5499-2011; Eroglu, Cagla/P-5315-2014	Ji, Ru-Rong/0000-0002-9355-3688; ManhÃes, Alex C/0000-0003-4629-8343; Medina, Alexandre/0000-0003-0517-7756; Dingsdale, Hayley/0000-0002-2919-8722; Pamukcu, Arin/0000-0003-3369-6318; Enustun, Eray/0000-0001-7550-7752; Pulimood, Nisha/0000-0003-0612-1244; Scheiffele, Peter/0000-0002-9516-9399; Silver, Debra/0000-0001-9189-844X; Eroglu, Cagla/0000-0002-7204-0218; Stogsdill, Jeffrey/0000-0002-2694-8735	NIH/NIDA [DA031833]; Brumley Neonatal Perinatal Research Institute; NIH/NIDCR [DE22743]; NIH/NIAAA [AA0130123]; NIH/NIMH [MH103374]; NIH/NINDS [NS083897, NS092419]; Swiss National Science Foundation; HHMI VIP grant; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022743, R01DE017794] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007184] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH103374] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS083897, F31NS092419] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA013023] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA031833] Funding Source: NIH RePORTER	NIH/NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Brumley Neonatal Perinatal Research Institute; NIH/NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIH/NIAAA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIH/NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); HHMI VIP grant; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank Drs. Anne-Marie Craig and Tabreez Siddique for providing Nrx constructs, Dr. Helene Sage for sharing many hevin reagents, and Drs. Anne West and Nicola Allen for critical reading of the manuscript. This research was funded by an NIH/NIDA R01 (DA031833) and Brumley Neonatal Perinatal Research Institute grant to C.E., an NIH/NIDCR R01 (DE22743) to R.R.J., an NIH/NIAAA R01 (AA0130123) to A.E.M, an NIH/NIMH R01 (MH103374) to S.H.S., an R01 NIH/NINDS (NS083897) to D.L.S., and by Swiss National Science Foundation to P.S. S.K.S. and H.D. are Ruth K. Broad International Post-doctoral Fellows. J.A.S. is funded by F31 NIH/NINDS (NS092419). A.P. was funded by an HHMI VIP grant. C.E. is a Holland-Trice Brain Research Scholar, Esther and Joseph Klingenstein Fund Fellow, and Alfred P. Sloan Fellow.	Baudouin S, 2010, CELL, V141, P908, DOI 10.1016/j.cell.2010.05.024; BEAR MF, 1990, J NEUROSCI, V10, P909; Boucard AA, 2005, NEURON, V48, P229, DOI 10.1016/j.neuron.2005.08.026; BOURNE HR, 1993, CELL, V72, P65, DOI 10.1016/S0092-8674(05)80029-7; Budreck EC, 2013, P NATL ACAD SCI USA, V110, P725, DOI 10.1073/pnas.1214718110; Chih B, 2005, SCIENCE, V307, P1324, DOI 10.1126/science.1107470; Chih B, 2006, NEURON, V51, P171, DOI 10.1016/j.neuron.2006.06.005; Chubykin AA, 2007, NEURON, V54, P919, DOI 10.1016/j.neuron.2007.05.029; Chung WS, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020370; Coleman JE, 2009, NEUROSCIENCE, V161, P561, DOI 10.1016/j.neuroscience.2009.03.045; Craig AM, 2007, CURR OPIN NEUROBIOL, V17, P43, DOI 10.1016/j.conb.2007.01.011; De Rubeis S, 2014, NATURE, V515, P209, DOI 10.1038/nature13772; Frenkel MY, 2004, NEURON, V44, P917, DOI 10.1016/j.neuron.2004.12.003; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; Grayton HM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067114; Huang CS, 2005, CELL, V123, P105, DOI 10.1016/j.cell.2005.07.033; Ippolito Dominic M, 2010, J Vis Exp, DOI 10.3791/2270; Jacquemont ML, 2006, J MED GENET, V43, P843, DOI 10.1136/jmg.2006.043166; JOHNSTON IG, 1990, NEURON, V4, P165, DOI 10.1016/0896-6273(90)90452-L; Kahler AK, 2008, AM J MED GENET B, V147B, P1089, DOI 10.1002/ajmg.b.30726; Krahe TE, 2010, J NEUROPHYSIOL, V103, P2700, DOI 10.1152/jn.00442.2009; Kucukdereli H, 2011, P NATL ACAD SCI USA, V108, pE440, DOI 10.1073/pnas.1104977108; Lee H, 2010, J NEUROSCI, V30, P11435, DOI 10.1523/JNEUROSCI.2946-10.2010; Missler M, 2003, NATURE, V423, P939, DOI 10.1038/nature01755; Nair A, 2013, BRAIN, V136, P1942, DOI 10.1093/brain/awt079; Porciatti V, 1999, VISION RES, V39, P3071, DOI 10.1016/S0042-6989(99)00022-X; Purcell AE, 2001, NEUROLOGY, V57, P1618, DOI 10.1212/WNL.57.9.1618; Risher WC, 2014, ELIFE, V3, DOI 10.7554/eLife.04047; Roberts EB, 1998, J NEUROPHYSIOL, V80, P1021, DOI 10.1152/jn.1998.80.3.1021; Sawtell NB, 2003, NEURON, V38, P977, DOI 10.1016/S0896-6273(03)00323-4; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Schreiner D, 2015, ELIFE, V4, DOI 10.7554/eLife.07794; Shigetomi E, 2013, J GEN PHYSIOL, V141, P633, DOI 10.1085/jgp.201210949; Siddiqui TJ, 2010, J NEUROSCI, V30, P7495, DOI 10.1523/JNEUROSCI.0470-10.2010; Smith SL, 2007, NAT NEUROSCI, V10, P370, DOI 10.1038/nn1844; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Tropea D, 2006, NAT NEUROSCI, V9, P660, DOI 10.1038/nn1689; Varoqueaux F, 2006, NEURON, V51, P741, DOI 10.1016/j.neuron.2006.09.003; Vialou V, 2010, NAT NEUROSCI, V13, P745, DOI 10.1038/nn.2551; Weaver MS, 2010, J BIOL CHEM, V285, P5868, DOI 10.1074/jbc.M109.070318; Zhurov V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047581	41	161	168	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 14	2016	164	1-2					183	196		10.1016/j.cell.2015.11.034	http://dx.doi.org/10.1016/j.cell.2015.11.034			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DB2LE	26771491	Bronze, Green Accepted			2022-12-28	WOS:000368339300019
J	Szempruch, AJ; Sykes, SE; Kieft, R; Dennison, L; Becker, AC; Gartrell, A; Martin, WJ; Nakayasu, ES; Almeida, IC; Hajduk, SL; Harrington, JM				Szempruch, Anthony J.; Sykes, Steven E.; Kieft, Rudo; Dennison, Lauren; Becker, Allison C.; Gartrell, Anzio; Martin, William J.; Nakayasu, Ernesto S.; Almeida, Igor C.; Hajduk, Stephen L.; Harrington, John M.			Extracellular Vesicles from Trypanosoma brucei Mediate Virulence Factor Transfer and Cause Host Anemia	CELL			English	Article							RESISTANCE-ASSOCIATED PROTEIN; LYTIC FACTOR; SERUM; COMMUNICATION; CELLS; LOCALIZATION; PARASITEMIA; EXOSOMES; GENE	Intercellular communication between parasites and with host cells provides mechanisms for parasite development, immune evasion, and disease pathology. Bloodstream African trypanosomes produce membranous nanotubes that originate from the flagellar membrane and disassociate into free extracellular vesicles (EVs). Trypanosome EVs contain several flagellar proteins that contribute to virulence, and Trypanosoma brucei rhodesiense EVs contain the serum resistance-associated protein (SRA) necessary for human infectivity. T.b. rhodesiense EVs transfer SRA to non-human infectious trypanosomes, allowing evasion of human innate immunity. Trypanosome EVs can also fuse with mammalian erythrocytes, resulting in rapid erythrocyte clearance and anemia. These data indicate that trypanosome EVs are organelles mediating non-hereditary virulence factor transfer and causing host erythrocyte remodeling, inducing anemia.	[Szempruch, Anthony J.; Sykes, Steven E.; Kieft, Rudo; Dennison, Lauren; Becker, Allison C.; Gartrell, Anzio; Hajduk, Stephen L.; Harrington, John M.] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA; [Martin, William J.] Univ Georgia, Anim Hlth Res Ctr, Athens, GA 30602 USA; [Nakayasu, Ernesto S.] Pacific NW Natl Lab, Div Biol Sci, Richland, WA 99352 USA; [Almeida, Igor C.] Univ Texas El Paso, Dept Biol Sci, Border Biomed Res Ctr, El Paso, TX 79968 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; United States Department of Energy (DOE); Pacific Northwest National Laboratory; University of Texas System; University of Texas El Paso	Hajduk, SL (corresponding author), Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA.	shajduk@bmb.uga.edu; johnmharrin@gmail.com	Almeida, Igor C./AAF-9409-2019; Nakayasu, Ernesto S./AAJ-8374-2020	Almeida, Igor C./0000-0002-2443-8213; Nakayasu, Ernesto S./0000-0002-4056-2695	NIH [AI039033, 2G12MD007592, AI060546]; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR008124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI039033, T32AI060546, R21AI039033] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007592] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by NIH grant AI039033 (S.L.H.) and 2G12MD007592 (BBRC/UTEP, I.C.A.). A.J.S. is supported in part by NIH training grant AI060546. We thank Amy Styer for reagents, Julie Nelson (University of Georgia) and Aaron Rae (Emory University) for assistance with flow cytometry, John Shields and Mary Ard (University of Georgia) for assistance with electron microscopy, the Biomolecule Analysis Core Facility at BBRC/UTEP (2G12MD007592) for the proteomic analysis, and Ragy Ragheb for use and assistance with the NanoSight NS300.	Babudieri B., 1962, Parassitologia, V4, P89; Bayer-Santos E, 2013, J PROTEOME RES, V12, P883, DOI 10.1021/pr300947g; Broadhead R, 2006, NATURE, V440, P224, DOI 10.1038/nature04541; DEGREEF C, 1994, MOL BIOCHEM PARASIT, V68, P277, DOI 10.1016/0166-6851(94)90172-4; Dubey GP, 2011, CELL, V144, P590, DOI 10.1016/j.cell.2011.01.015; Ellis D.S., 1976, Acta Tropica, V33, P151; Emmer BT, 2010, EUKARYOT CELL, V9, P934, DOI 10.1128/EC.00086-10; Evans AGL, 2012, MICROBIOL-SGM, V158, P2742, DOI 10.1099/mic.0.060343-0; Fevrier B, 2004, P NATL ACAD SCI USA, V101, P9683, DOI 10.1073/pnas.0308413101; FREVERT U, 1988, J ULTRA MOL STRUCT R, V99, P124, DOI 10.1016/0889-1605(88)90048-1; Gibson W, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003665; Guther MLS, 2014, J PROTEOME RES, V13, P2796, DOI 10.1021/pr401209w; HERBERT WJ, 1976, EXP PARASITOL, V40, P427, DOI 10.1016/0014-4894(76)90110-7; Jensen BC, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-911; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Magez S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000122; Mantel PY, 2013, CELL HOST MICROBE, V13, P521, DOI 10.1016/j.chom.2013.04.009; Marcilla A, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.25040; Mony BM, 2014, NATURE, V505, P681, DOI 10.1038/nature12864; Naessens J, 2006, INT J PARASITOL, V36, P521, DOI 10.1016/j.ijpara.2006.02.012; Oberholzer M, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.010538; Oberholzer M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000739; Oli MW, 2006, EUKARYOT CELL, V5, P132, DOI 10.1128/EC.5.1.132-139.2006; Panigrahi AK, 2009, PROTEOMICS, V9, P434, DOI 10.1002/pmic.200800477; Proto WR, 2011, J BIOL CHEM, V286, P39914, DOI 10.1074/jbc.M111.292334; Regev-Rudzki N, 2013, CELL, V153, P1120, DOI 10.1016/j.cell.2013.04.029; Remis JP, 2014, ENVIRON MICROBIOL, V16, P598, DOI 10.1111/1462-2920.12187; RIFKIN MR, 1990, P NATL ACAD SCI USA, V87, P801, DOI 10.1073/pnas.87.2.801; Salmon D, 2012, SCIENCE, V337, P463, DOI 10.1126/science.1222753; Schepilewsky E., 1912, INFEKTIONSKRANKHEITE, V65, P79; Schorey JS, 2015, EMBO REP, V16, P24, DOI 10.15252/embr.201439363; Silverman JM, 2010, J CELL SCI, V123, P842, DOI 10.1242/jcs.056465; Stephens NA, 2011, EUKARYOT CELL, V10, P1023, DOI 10.1128/EC.05112-11; Stijlemans B, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003561; Sykes S, 2015, EUKARYOT CELL, V14, P206, DOI 10.1128/EC.00214-14; Truc P, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002256; Twu O, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003482; Vanhamme L, 2003, NATURE, V422, P83, DOI 10.1038/nature01461; VICKERMAN K, 1969, NATURE, V224, P1125, DOI 10.1038/2241125a0; VIDAL M, 1995, J BIOL CHEM, V270, P17823, DOI 10.1074/jbc.270.30.17823; Webb H, 1997, J CELL BIOL, V139, P103, DOI 10.1083/jcb.139.1.103; Wood CR, 2015, TRENDS CELL BIOL, V25, P276, DOI 10.1016/j.tcb.2014.12.008; WRIGHT KA, 1970, J CELL SCI, V6, P285; Xong HV, 1998, CELL, V95, P839, DOI 10.1016/S0092-8674(00)81706-7; Yanez-Mo M, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.27066; Zomer A, 2015, CELL, V161, P1046, DOI 10.1016/j.cell.2015.04.042	46	152	160	6	52	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 14	2016	164	1-2					246	257		10.1016/j.cell.2015.11.051	http://dx.doi.org/10.1016/j.cell.2015.11.051			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DB2LE	26771494	Green Accepted, Bronze			2022-12-28	WOS:000368339300024
J	Wright, AV; Nunez, JK; Doudna, JA				Wright, Addison V.; Nunez, James K.; Doudna, Jennifer A.			Biology and Applications of CRISPR Systems: Harnessing Nature's Toolbox for Genome Engineering	CELL			English	Review							GUIDED SURVEILLANCE COMPLEX; BACTERIAL IMMUNE-SYSTEM; CAS ADAPTIVE IMMUNITY; STAPHYLOCOCCUS-AUREUS CAS9; IN-VITRO RECONSTITUTION; TARGET DNA RECOGNITION; PROCESSES PRE-CRRNA; R-LOOP FORMATION; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE	Bacteria and archaea possess a range of defense mechanisms to combat plasmids and viral infections. Unique among these are the CRISPR-Cas (clustered regularly interspaced short palindromic repeats-CRISPR associated) systems, which provide adaptive immunity against foreign nucleic acids. CRISPR systems function by acquiring genetic records of invaders to facilitate robust interference upon reinfection. In this Review, we discuss recent advances in understanding the diverse mechanisms by which Cas proteins respond to foreign nucleic acids and how these systems have been harnessed for precision genome manipulation in a wide array of organisms.	[Wright, Addison V.; Nunez, James K.; Doudna, Jennifer A.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Howard Hughes Med Inst HHMI, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Ctr RNA Syst Biol, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Innovat Genom Initiat, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Doudna, JA (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.	doudna@berkeley.edu			US National Science Foundation [1244557]	US National Science Foundation(National Science Foundation (NSF))	This work was funded by US National Science Foundation grant number 1244557 to J.A.D. A.V.W. and J.K.N. are NSF Graduate Research Fellows. Megan Hochstrasser provided valuable input on the manuscript.	Anders C, 2014, NATURE, V513, P569, DOI 10.1038/nature13579; Arslan Z, 2014, NUCLEIC ACIDS RES, V42, P7884, DOI 10.1093/nar/gku510; Arslan Z, 2013, NUCLEIC ACIDS RES, V41, P6347, DOI 10.1093/nar/gkt315; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Blackwood JK, 2013, BIOCHEM SOC T, V41, P314, DOI 10.1042/BST20120307; Blosser TR, 2015, MOL CELL, V58, P60, DOI 10.1016/j.molcel.2015.01.028; Blundell JR, 2014, GENOMICS, V104, P417, DOI 10.1016/j.ygeno.2014.09.005; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Bondy-Denomy J, 2013, NATURE, V493, P429, DOI 10.1038/nature11723; Bondy-Denomy J, 2015, NATURE, V526, P136, DOI 10.1038/nature15254; Bondy-Denomy J, 2014, TRENDS MICROBIOL, V22, P218, DOI 10.1016/j.tim.2014.01.007; Borchardt EK, 2015, RNA, V21, P1921, DOI 10.1261/rna.051227.115; Brendel J, 2014, J BIOL CHEM, V289, P7164, DOI 10.1074/jbc.M113.508184; Briner AE, 2014, MOL CELL, V56, P333, DOI 10.1016/j.molcel.2014.09.019; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Bryson AL, 2015, MBIO, V6, DOI 10.1128/mBio.00648-15; Carte J, 2008, GENE DEV, V22, P3489, DOI 10.1101/gad.1742908; Charpentier E, 2015, FEMS MICROBIOL REV, V39, P428, DOI 10.1093/femsre/fuv023; CHOW SA, 1992, SCIENCE, V255, P723, DOI 10.1126/science.1738845; Chylinski K, 2014, NUCLEIC ACIDS RES, V42, P6091, DOI 10.1093/nar/gku241; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; D'Astolfo DS, 2015, CELL, V161, P674, DOI 10.1016/j.cell.2015.03.028; Datsenko KA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1937; Davis KM, 2015, NAT CHEM BIOL, V11, P316, DOI [10.1038/NCHEMBIO.1793, 10.1038/nchembio.1793]; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Deng L, 2013, MOL MICROBIOL, V87, P1088, DOI 10.1111/mmi.12152; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Diez-Villasenor C, 2013, RNA BIOL, V10, P792, DOI 10.4161/rna.24023; Dillingham MS, 2008, MICROBIOL MOL BIOL R, V72, P642, DOI 10.1128/MMBR.00020-08; Dugar G, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003495; Ellinger P, 2012, J STRUCT BIOL, V178, P350, DOI 10.1016/j.jsb.2012.04.006; ENGELMAN A, 1991, CELL, V67, P1211, DOI 10.1016/0092-8674(91)90297-C; Garrett Roger A., 2015, Life-Basel, V5, P783, DOI 10.3390/life5010783; Garside EL, 2012, RNA, V18, P2020, DOI 10.1261/rna.033100.112; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Gesner EM, 2011, NAT STRUCT MOL BIOL, V18, P688, DOI 10.1038/nsmb.2042; Goldberg GW, 2014, NATURE, V514, P633, DOI 10.1038/nature13637; Gong B, 2014, P NATL ACAD SCI USA, V111, P16359, DOI 10.1073/pnas.1410806111; Gori JL, 2015, HUM GENE THER, V26, P443, DOI 10.1089/hum.2015.074; Hale C, 2008, RNA, V14, P2572, DOI 10.1261/rna.1246808; Hale CR, 2009, CELL, V139, P945, DOI 10.1016/j.cell.2009.07.040; Haurwitz RE, 2010, SCIENCE, V329, P1355, DOI 10.1126/science.1192272; Heler R, 2015, NATURE, V519, P199, DOI 10.1038/nature14245; Hochstrasser ML, 2015, TRENDS BIOCHEM SCI, V40, P58, DOI 10.1016/j.tibs.2014.10.007; Hochstrasser ML, 2014, P NATL ACAD SCI USA, V111, P6618, DOI 10.1073/pnas.1405079111; Hooton SPT, 2015, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00744; Howes R, 2015, METHODS MOL BIOL, V1239, P75, DOI 10.1007/978-1-4939-1862-1_5; Huo YW, 2014, NAT STRUCT MOL BIOL, V21, P771, DOI 10.1038/nsmb.2875; Hynes AP, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5399; ISHINO Y, 1987, J BACTERIOL, V169, P5429, DOI 10.1128/jb.169.12.5429-5433.1987; Jackson RN, 2015, MOL CELL, V58, P722, DOI 10.1016/j.molcel.2015.05.023; Jackson RN, 2014, SCIENCE, V345, P1473, DOI 10.1126/science.1256328; Jansen R, 2002, MOL MICROBIOL, V43, P1565, DOI 10.1046/j.1365-2958.2002.02839.x; Jiang FG, 2015, SCIENCE, V348, P1477, DOI 10.1126/science.aab1452; Jiang WY, 2015, ANNU REV MICROBIOL, V69, P209, DOI 10.1146/annurev-micro-091014-104441; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2014, SCIENCE, V343, P1215, DOI 10.1126/science.1247997; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Jore MM, 2011, NAT STRUCT MOL BIOL, V18, P529, DOI 10.1038/nsmb.2019; Juranek S, 2012, RNA, V18, P783, DOI 10.1261/rna.031468.111; Kenchappa CS, 2013, NUCLEIC ACIDS RES, V41, P3424, DOI 10.1093/nar/gks1465; Koo Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033401; Kuhn CD, 2013, TRENDS BIOCHEM SCI, V38, P263, DOI 10.1016/j.tibs.2013.02.008; Kunin V, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r61; Lee HY, 2013, P NATL ACAD SCI USA, V110, P5416, DOI 10.1073/pnas.1302807110; Lee KH, 2012, PROTEINS, V80, P2573, DOI 10.1002/prot.24138; Lemak S, 2013, J AM CHEM SOC, V135, P17476, DOI 10.1021/ja408729b; Levy A, 2015, NATURE, V520, P505, DOI 10.1038/nature14302; Li M, 2014, NUCLEIC ACIDS RES, V42, P2483, DOI 10.1093/nar/gkt1154; Lin S, 2014, ELIFE, V3, DOI 10.7554/eLife.04766; Lintner NG, 2011, J BIOL CHEM, V286, P21643, DOI 10.1074/jbc.M111.238485; Ma EB, 2015, MOL CELL, V60, P398, DOI 10.1016/j.molcel.2015.10.030; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Makarova Kira S, 2015, Methods Mol Biol, V1311, P47, DOI 10.1007/978-1-4939-2687-9_4; Makarova KS, 2013, BIOCHEM SOC T, V41, P1392, DOI 10.1042/BST20130038; Makarova KS, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-38; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Marraffini LA, 2010, NATURE, V463, P568, DOI 10.1038/nature08703; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Maruyama T, 2015, NAT BIOTECHNOL, V33, P538, DOI 10.1038/nbt.3190; MIZUUCHI K, 1991, CELL, V66, P129, DOI 10.1016/0092-8674(91)90145-O; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Mulepati S, 2014, SCIENCE, V345, P1479, DOI 10.1126/science.1256996; Mulepati S, 2013, J BIOL CHEM, V288, P22184, DOI 10.1074/jbc.M113.472233; Mulepati S, 2011, J BIOL CHEM, V286, P31896, DOI 10.1074/jbc.M111.270017; Nam KH, 2012, STRUCTURE, V20, P1574, DOI 10.1016/j.str.2012.06.016; Nihongaki Y, 2015, NAT BIOTECHNOL, V33, P755, DOI 10.1038/nbt.3245; Nishimasu H, 2015, CELL, V162, P1113, DOI 10.1016/j.cell.2015.08.007; Nissim L, 2014, MOL CELL, V54, P698, DOI 10.1016/j.molcel.2014.04.022; Nunez JK, 2015, NATURE, V527, P535, DOI 10.1038/nature15760; Nunez JK, 2015, NATURE, V519, P193, DOI 10.1038/nature14237; Nunez JK, 2014, NAT STRUCT MOL BIOL, V21, P528, DOI 10.1038/nsmb.2820; Osawa T, 2015, MOL CELL, V58, P418, DOI 10.1016/j.molcel.2015.03.018; Paez-Espino D, 2015, MBIO, V6, DOI 10.1128/mBio.00262-15; Paez-Espino D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2440; Patterson AG, 2015, NUCLEIC ACIDS RES, V43, P6038, DOI 10.1093/nar/gkv517; Pawluk A, 2014, MBIO, V5, DOI 10.1128/mBio.00896-14; Plagens A, 2015, FEMS MICROBIOL REV, V39, P442, DOI 10.1093/femsre/fuv019; Plagens A, 2014, NUCLEIC ACIDS RES, V42, P5125, DOI 10.1093/nar/gku120; Plagens A, 2012, J BACTERIOL, V194, P2491, DOI 10.1128/JB.00206-12; Polstein LR, 2015, NAT CHEM BIOL, V11, P198, DOI 10.1038/nchembio.1753; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; Pul U, 2010, MOL MICROBIOL, V75, P1495, DOI 10.1111/j.1365-2958.2010.07073.x; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Rath D, 2015, NUCLEIC ACIDS RES, V43, P237, DOI 10.1093/nar/gku1257; Ratner HK, 2015, CURR OPIN INFECT DIS, V28, P267, DOI 10.1097/QCO.0000000000000154; Redding S, 2015, CELL, V163, P854, DOI 10.1016/j.cell.2015.10.003; Richter C, 2014, NUCLEIC ACIDS RES, V42, P8516, DOI 10.1093/nar/gku527; Richter C, 2013, BIOCHEM SOC T, V41, P1468, DOI 10.1042/BST20130151; Richter G., 2012, PLOS ONE, V7; Rollie C, 2015, ELIFE, V4, DOI [10.7554/eLife.08716, 10.7554/eLife.08716.001]; Rollins MF, 2015, NUCLEIC ACIDS RES, V43, P2216, DOI 10.1093/nar/gkv094; Rutkauskas M, 2015, CELL REP, V10, P1534, DOI 10.1016/j.celrep.2015.01.067; Salvail-Lacoste A, 2013, RNA, V19, P1003, DOI 10.1261/rna.037432.112; Samai P, 2015, CELL, V161, P1164, DOI 10.1016/j.cell.2015.04.027; Sashital DG, 2012, MOL CELL, V46, P606, DOI 10.1016/j.molcel.2012.03.020; Sashital DG, 2011, NAT STRUCT MOL BIOL, V18, P680, DOI 10.1038/nsmb.2043; Schunder E, 2013, INT J MED MICROBIOL, V303, P51, DOI 10.1016/j.ijmm.2012.11.004; Semenova E, 2011, P NATL ACAD SCI USA, V108, P10098, DOI 10.1073/pnas.1104144108; Servick K, 2015, SCIENCE, V349, P131, DOI 10.1126/science.349.6244.131; Shao YM, 2013, STRUCTURE, V21, P385, DOI 10.1016/j.str.2013.01.010; Shmakov S, 2015, MOL CELL, V60, P385, DOI 10.1016/j.molcel.2015.10.008; Shmakov S, 2014, NUCLEIC ACIDS RES, V42, P5907, DOI 10.1093/nar/gku226; Sinkunas T, 2013, EMBO J, V32, P385, DOI 10.1038/emboj.2012.352; Sinkunas T, 2011, EMBO J, V30, P1335, DOI 10.1038/emboj.2011.41; Sokolowski RD, 2014, NUCLEIC ACIDS RES, V42, P6532, DOI 10.1093/nar/gku308; Staals RHJ, 2014, MOL CELL, V56, P518, DOI 10.1016/j.molcel.2014.10.005; Sternberg SH, 2015, NATURE, V527, P110, DOI 10.1038/nature15544; Sternberg SH, 2015, MOL CELL, V58, P568, DOI 10.1016/j.molcel.2015.02.032; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Sternberg SH, 2012, RNA, V18, P661, DOI 10.1261/rna.030882.111; Swarts DC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035888; Szczelkun MD, 2014, P NATL ACAD SCI USA, V111, P9798, DOI 10.1073/pnas.1402597111; Tamulaitis G, 2014, MOL CELL, V56, P506, DOI 10.1016/j.molcel.2014.09.027; Taylor DW, 2015, SCIENCE, V348, P581, DOI 10.1126/science.aaa4535; Tsai SQ, 2014, NAT BIOTECHNOL, V32, P569, DOI 10.1038/nbt.2908; Tsui TKM, 2015, ANNU REV BIOPHYS, V44, P229, DOI 10.1146/annurev-biophys-060414-033939; van der Oost J, 2014, NAT REV MICROBIOL, V12, P479, DOI 10.1038/nrmicro3279; van der Oost J, 2009, TRENDS BIOCHEM SCI, V34, P401, DOI 10.1016/j.tibs.2009.05.002; van Erp PBG, 2015, NUCLEIC ACIDS RES, V43, P8381, DOI 10.1093/nar/gkv793; Chu VT, 2015, NAT BIOTECHNOL, V33, P543, DOI 10.1038/nbt.3198; Vestergaard G, 2014, RNA BIOL, V11, P156, DOI 10.4161/rna.27990; Wang JY, 2015, CELL, V163, P840, DOI 10.1016/j.cell.2015.10.008; Wei YZ, 2015, NUCLEIC ACIDS RES, V43, P1749, DOI 10.1093/nar/gku1407; Wei YZ, 2015, GENE DEV, V29, P356, DOI 10.1101/gad.257550.114; Westra ER, 2014, NAT REV MICROBIOL, V12, P317, DOI 10.1038/nrmicro3241; Westra ER, 2012, MOL CELL, V46, P595, DOI 10.1016/j.molcel.2012.03.018; Wiedenheft B, 2011, NATURE, V477, P486, DOI 10.1038/nature10402; Wiedenheft B, 2011, P NATL ACAD SCI USA, V108, P10092, DOI 10.1073/pnas.1102716108; Wright AV, 2015, P NATL ACAD SCI USA, V112, P2984, DOI 10.1073/pnas.1501698112; Yosef I, 2013, P NATL ACAD SCI USA, V110, P14396, DOI 10.1073/pnas.1300108110; Yosef I, 2012, NUCLEIC ACIDS RES, V40, P5569, DOI 10.1093/nar/gks216; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zetsche B, 2015, NAT BIOTECHNOL, V33, P139, DOI 10.1038/nbt.3149; Zhang Y, 2015, MOL CELL, V60, P242, DOI 10.1016/j.molcel.2015.09.020; Zhang Y, 2013, MOL CELL, V50, P488, DOI 10.1016/j.molcel.2013.05.001; Zhao HT, 2014, NATURE, V515, P147, DOI 10.1038/nature13733; Zuris JA, 2015, NAT BIOTECHNOL, V33, P73, DOI 10.1038/nbt.3081	159	651	700	21	640	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 14	2016	164	1-2					29	44		10.1016/j.cell.2015.12.035	http://dx.doi.org/10.1016/j.cell.2015.12.035			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DB2LE	26771484	Bronze			2022-12-28	WOS:000368339300007
J	Deslee, G; Mal, H; Dutau, H; Bourdin, A; Vergnon, JM; Pison, C; Kessler, R; Jounieaux, V; Thiberville, L; Leroy, S; Marceau, A; Laroumagne, S; Mallet, JP; Dukic, S; Barbe, C; Bulsei, J; Jolly, D; Durand-Zaleski, I; Marquette, CH				Deslee, Gaetan; Mal, Herve; Dutau, Herve; Bourdin, Arnaud; Vergnon, Jean Michel; Pison, Christophe; Kessler, Romain; Jounieaux, Vincent; Thiberville, Luc; Leroy, Sylvie; Marceau, Armelle; Laroumagne, Sophie; Mallet, Jean Pierre; Dukic, Sylvain; Barbe, Coralie; Bulsei, Julie; Jolly, Damien; Durand-Zaleski, Isabelle; Marquette, Charles Hugo		Revolens Study Grp	Lung Volume Reduction Coil Treatment vs Usual Care in Patients With Severe Emphysema The REVOLENS Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COST-EFFECTIVENESS; MEDICAL THERAPY; WALK TEST; SURGERY; VALVES	IMPORTANCE Therapeutic options for severe emphysema are limited. Lung volume reduction using nitinol coils is a bronchoscopic intervention inducing regional parenchymal volume reduction and restoring lung recoil. OBJECTIVE To evaluate the efficacy, safety, cost, and cost-effectiveness of nitinol coils in treatment of severe emphysema. DESIGN, SETTING, AND PARTICIPANTS Multicenter 1:1 randomized superiority trial comparing coils with usual care at 10 university hospitals in France. Enrollment of patients with emphysema occurred from March to October 2013, with 12-month follow-up (last follow-up, December 2014). INTERVENTIONS Patients randomized to usual care (n = 50) received rehabilitation and bronchodilators with or without inhaled corticosteroids and oxygen; those randomized to bilateral coil treatment (n = 50) received usual care plus additional therapy in which approximately 10 coils per lobe were placed in 2 bilateral lobes in 2 procedures. MAIN OUTCOMES AND MEASURES The primary outcome was improvement of at least 54 m in the 6-minute walk test at 6 months (1-sided hypothesis test). Secondary outcomes included changes at 6 and 12 months in the 6-minute walk test, lung function, quality of life as assessed by St George's Respiratory Questionnaire (range, 0-100; 0 being the best and 100 being the worst quality of life; minimal clinically important difference, >= 4), morbidity, mortality, total cost, and cost-effectiveness. RESULTS Among 100 patients, 71 men and 29 women (mean age, 62 years) were included. At 6 months, improvement of at least 54 m was observed in 18 patients (36%) in the coil group and 9 patients (18%) in the usual care group, for a between-group difference of 18% (1-sided 95% Cl, 4% to infinity; P = .03). Mean between-group differences at 6 and 12 months in the coil and usual care groups were +0.09 L (95% Cl, 0.05 L to infinity) (P = .001) and +0.08 L (95% CI, 0.03 L to infinity) (P = .002) for forced expiratory volume in the first second, +21m (95% Cl, -4 m to infinity) (P = .06) and +21m (95% Cl, -5 m to infinity) (P = .12) for 6-minute walk distance, and -13.4 points (95% Cl, -8 points to infinity) and -10.6 points (95% Cl, -5.8 points to infinity) for St George's Respiratory Questionnaire (1-sided P < .001 for both). Within 12 months, 4 deaths occurred in the coil group and 3 in the usual care group. The mean total 1-year per-patient cost difference between groups was $47 908(95% Cl, $47 879-$48 073) (P < .001); the incremental cost-effectiveness ratio was $782 598 per additional quality-adjusted life-year. CONCLUSIONS AND RELEVANCE In this preliminary study of patients with severe emphysema followed up for 6 months, bronchoscopic treatment with nitinol coils compared with usual care resulted in improved exercise capacity with high short-term costs. Further investigation is needed to assess durability of benefit and long-term cost implications.	[Deslee, Gaetan] Hop Univ Reims, INSERM U903, Serv Pneumol, F-51092 Reims, France; [Mal, Herve; Marceau, Armelle] Hop Univ Bichat, Serv Pneumol, Paris, France; [Dutau, Herve; Laroumagne, Sophie] Hop Univ Marseille, Serv Oncol Thorac, Malad Plevre, Pneumol Intervent, Marseille, France; [Bourdin, Arnaud; Mallet, Jean Pierre] Hop Univ Montpellier, Dept Pneumol & Addictol, PhyMedExp, Inserm U1046,CNRS UMR, Montpellier, France; [Vergnon, Jean Michel] Hop Univ St Etienne, Serv Pneumol, St Etienne, France; [Pison, Christophe] Hop Univ Grenoble Alpes, Inserm 1055, Clin Univ Pneumol Pole Thorax & Vaisseaux, Grenoble, France; [Kessler, Romain] Hop Univ Strasbourg, Serv Pneumol, Strasbourg, France; [Jounieaux, Vincent] Hop Univ Amiens, Serv Pneumol, Amiens, France; [Thiberville, Luc] Hop Univ Rouen, Serv Pneumol, Rouen, France; [Leroy, Sylvie; Marquette, Charles Hugo] Hop Univ Nice Sophia Antipolis, Serv Pneumol, IRCAN, UMR CNRS 7284,Inserm 01081,Team 3, Nice, France; [Dukic, Sylvain] Hop Univ Reims, Dept Pharmacovigilance, Reims, France; [Barbe, Coralie; Jolly, Damien] Hop Univ Reims, Pole Rech Innovat, Dept Methodol, Reims, France; [Bulsei, Julie; Durand-Zaleski, Isabelle] AP HP Paris, Unite Rech Clin Econ Sante Ile France, URC Eco IdF, Paris, France	CHU de Reims; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Reims Champagne-Ardenne; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Montpellier; CHU de St Etienne; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; CHU de Rouen; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Nice; UDICE-French Research Universities; Universite Cote d'Azur; CHU de Reims; Universite de Reims Champagne-Ardenne; CHU de Reims; Universite de Reims Champagne-Ardenne; Assistance Publique Hopitaux Paris (APHP)	Deslee, G (corresponding author), Hop Univ Reims, INSERM U903, Serv Pneumol, 45 Rue Cognacq Jay, F-51092 Reims, France.	gdeslee@chu-reims.fr	Leroy, Sylvie SL/A-6903-2017; DESLEE, Gaëtan/G-2625-2013; Jounieaux, Vincent/AAH-4474-2020; CUVELIER, Antoine/F-5965-2014; HACHULLA, ERIC/R-8488-2018; Marquette, Charles Hugo/O-4084-2016	Leroy, Sylvie SL/0000-0002-3465-8180; DESLEE, Gaëtan/0000-0002-4919-5916; Jounieaux, Vincent/0000-0003-2131-6429; CUVELIER, Antoine/0000-0003-0263-1845; HACHULLA, ERIC/0000-0001-7432-847X; Marquette, Charles Hugo/0000-0002-0846-9941; Perotin, Jeanne-Marie/0000-0001-7184-3767; Damien, JOLLY/0000-0002-1133-7907	French Ministry of Health (Direction Generale de l'Offre de Soins)	French Ministry of Health (Direction Generale de l'Offre de Soins)	The REVOLENS Study was supported by an academic grant from the French Ministry of Health (Direction Generale de l'Offre de Soins, PSTIC-2012), which required a randomized trial design associated with an economic evaluation including a cost-effectiveness analysis. The coils were purchased from the manufacturer, PneumRx/BTG.	Chandra D, 2012, CHEST, V142, P1545, DOI 10.1378/chest.11-2702; Come CE, 2015, EUR RESPIR J, V46, P651, DOI 10.1183/09031936.00205614; Deslee G, 2012, REV MAL RESPIR, V29, P1157, DOI 10.1016/j.rmr.2012.09.010; Deslee G, 2014, THORAX, V69, P980, DOI 10.1136/thoraxjnl-2014-205221; Donohue James F, 2005, COPD, V2, P111; Fishman A, 2003, NEW ENGL J MED, V348, P2059; Fishman A, 2001, NEW ENGL J MED, V345, P1075; Hartman JE, 2012, EUR RESPIR J, V40, P1137, DOI 10.1183/09031936.00219111; Herth FJF, 2012, EUR RESPIR J, V39, P1334, DOI 10.1183/09031936.00161611; Herth Felix J F, 2010, Ther Adv Respir Dis, V4, P225, DOI 10.1177/1753465810368553; Holland AE, 2014, EUR RESPIR J, V44, P1428, DOI 10.1183/09031936.00150314; Husereau D, 2013, VALUE HEALTH, V16, P231, DOI 10.1016/j.jval.2013.02.002; Jones Paul W, 2005, COPD, V2, P75; Klooster K, 2014, EXPERT REV MED DEVIC, V11, P481, DOI 10.1586/17434440.2014.929490; Knottnerus JA, 2001, J CLIN EPIDEMIOL, V54, P109, DOI 10.1016/S0895-4356(00)00276-6; Kontogianni K, 2014, RESPIRATION, V88, P52, DOI 10.1159/000358441; Mahler Donald A, 2005, COPD, V2, P99; McCarthy B, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003793.pub3; Naunheim KS, 2006, ANN THORAC SURG, V82, P431, DOI 10.1016/j.athoracsur.2006.05.069; Pietzsch JB, 2014, RESPIRATION, V88, P389, DOI 10.1159/000368088; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; Ramsey SD, 2003, NEW ENGL J MED, V348, P2092; Redelmeier DA, 1997, AM J RESP CRIT CARE, V155, P1278, DOI 10.1164/ajrccm.155.4.9105067; Sciurba FC, 2010, NEW ENGL J MED, V363, P1233, DOI 10.1056/NEJMoa0900928; Shah PL, 2011, LANCET, V378, P997, DOI 10.1016/S0140-6736(11)61050-7; Shah PL, 2013, LANCET RESP MED, V1, P233, DOI 10.1016/S2213-2600(13)70047-X; Slebos DJ, 2015, RESPIRATION, V90, P136, DOI 10.1159/000431384; Slebos DJ, 2012, CHEST, V142, P574, DOI 10.1378/chest.11-0730; Snell GI, 2009, ANN THORAC SURG, V88, P1993, DOI 10.1016/j.athoracsur.2009.06.038; Zoumot Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122656	30	148	152	0	20	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 12	2016	315	2					175	184		10.1001/jama.2015.17821	http://dx.doi.org/10.1001/jama.2015.17821			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DA6XO	26757466	Bronze, Green Submitted			2022-12-28	WOS:000367949200019
J	Ubel, PA				Ubel, Peter A.			Value Promotion in Health Care The Importance of Symmetry	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Ubel, Peter A.] Duke Univ, Sch Med, Sanford Sch Publ Policy, Fuqua Sch Business, Durham, NC 27708 USA	Duke University	Ubel, PA (corresponding author), Duke Univ, Sch Med, Sanford Sch Publ Policy, Fuqua Sch Business, 100 Fuqua Dr,POB 90120, Durham, NC 27708 USA.	peter.ubel@duke.edu						Chernew ME, 2007, HEALTH AFFAIR, V26, pW195, DOI 10.1377/hlthaff.26.2.w195; Choudhry NK, 2011, NEW ENGL J MED, V365, P2088, DOI 10.1056/NEJMsa1107913; Lee JL, 2013, HEALTH AFFAIR, V32, P1251, DOI 10.1377/hlthaff.2012.0902; Linas BP, 2015, ANN INTERN MED, V162, P619, DOI 10.7326/M14-1313; Porter ME, 2010, NEW ENGL J MED, V363, P2477, DOI 10.1056/NEJMp1011024	5	3	3	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 12	2016	315	2					133	134		10.1001/jama.2015.18159	http://dx.doi.org/10.1001/jama.2015.18159			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DA6XO	26720593				2022-12-28	WOS:000367949200011
J	Lucan, SC				Lucan, Sean C.			Thinking Outside the (Lunch) Box	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SCHOOL		[Lucan, Sean C.] Albert Einstein Coll Med, Dept Family & Social Med, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine	Lucan, SC (corresponding author), Albert Einstein Coll Med, Dept Family & Social Med, Bronx, NY 10467 USA.	slucan@yahoo.com	Lucan, Sean/B-3815-2009	Lucan, Sean/0000-0002-4447-9709	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K23HD079606] Funding Source: NIH RePORTER; NICHD NIH HHS [K23HD079606, K23 HD079606] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Lesser LI, 2015, AM FAM PHYSICIAN, V91, P634; Lytle LA, 2006, PREV MED, V43, P8, DOI 10.1016/j.ypmed.2006.03.020; McDermott AJ, 2010, FAM MED, V42, P280; Moss M., 2013, NEW YORK TIMES; Sicherer SH, 2010, PEDIATRICS, V126, P1232, DOI 10.1542/peds.2010-2575; SnackSafely website, SAF SNACK GUID; World Health Organization, WHO CALLS COUNTR RED	7	1	1	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 5	2016	315	1					27	29		10.1001/jama.2015.15971	http://dx.doi.org/10.1001/jama.2015.15971			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DA0YH	26746452	Green Accepted			2022-12-28	WOS:000367523000009
J	Homsy, J; Zaidi, S; Shen, YF; Ware, JS; Samocha, KE; Karczewski, KJ; DePalma, SR; McKean, D; Wakimoto, H; Gorham, J; Jin, SC; Deanfield, J; Giardini, A; Porter, GA; Kim, R; Bilguvar, K; Lopez-Giraldez, F; Tikhonova, I; Mane, S; Romano-Adesman, A; Qi, HJ; Vardarajan, B; Ma, LJ; Daly, M; Roberts, AE; Russell, MW; Mital, S; Newburger, JW; Gaynor, JW; Breitbart, RE; Iossifov, I; Ronemus, M; Sanders, SJ; Kaltman, JR; Seidman, JG; Brueckner, M; Gelb, BD; Goldmuntz, E; Lifton, RP; Seidman, CE; Chung, WK				Homsy, Jason; Zaidi, Samir; Shen, Yufeng; Ware, James S.; Samocha, Kaitlin E.; Karczewski, Konrad J.; DePalma, Steven R.; McKean, David; Wakimoto, Hiroko; Gorham, Josh; Jin, Sheng Chih; Deanfield, John; Giardini, Alessandro; Porter, George A., Jr.; Kim, Richard; Bilguvar, Kaya; Lopez-Giraldez, Francesc; Tikhonova, Irina; Mane, Shrikant; Romano-Adesman, Angela; Qi, Hongjian; Vardarajan, Badri; Ma, Lijiang; Daly, Mark; Roberts, Amy E.; Russell, Mark W.; Mital, Seema; Newburger, Jane W.; Gaynor, J. William; Breitbart, Roger E.; Iossifov, Ivan; Ronemus, Michael; Sanders, Stephan J.; Kaltman, Jonathan R.; Seidman, Jonathan G.; Brueckner, Martina; Gelb, Bruce D.; Goldmuntz, Elizabeth; Lifton, Richard P.; Seidman, Christine E.; Chung, Wendy K.			De novo mutations in congenital heart disease with neurodevelopmental and other congenital anomalies	SCIENCE			English	Article							INTELLECTUAL DISABILITY; AUTISM; SPECTRUM; GENES; OUTCOMES	Congenital heart disease (CHD) patients have an increased prevalence of extracardiac congenital anomalies (CAs) and risk of neurodevelopmental disabilities (NDDs). Exome sequencing of 1213 CHD parent-offspring trios identified an excess of protein-damaging de novo mutations, especially in genes highly expressed in the developing heart and brain. These mutations accounted for 20% of patients with CHD, NDD, and CA but only 2% of patients with isolated CHD. Mutations altered genes involved in morphogenesis, chromatin modification, and transcriptional regulation, including multiple mutations in RBFOX2, a regulator of mRNA splicing. Genes mutated in other cohorts examined for NDD were enriched in CHD cases, particularly those with coexisting NDD. These findings reveal shared genetic contributions to CHD, NDD, and CA and provide opportunities for improved prognostic assessment and early therapeutic intervention in CHD patients.	[Homsy, Jason; Ware, James S.; Samocha, Kaitlin E.; Karczewski, Konrad J.; DePalma, Steven R.; McKean, David; Wakimoto, Hiroko; Gorham, Josh; Daly, Mark; Seidman, Jonathan G.; Seidman, Christine E.] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Homsy, Jason] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; [Zaidi, Samir; Jin, Sheng Chih; Bilguvar, Kaya; Brueckner, Martina; Lifton, Richard P.] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; [Shen, Yufeng; Qi, Hongjian] Columbia Univ, Med Ctr, Dept Syst Biol, New York, NY USA; [Shen, Yufeng; Qi, Hongjian] Columbia Univ, Med Ctr, Dept Biomed Informat, New York, NY USA; [Ware, James S.] Royal Brampton & Harefield NHS Fdn & Trust, NIHR Cardiovasc Biomed Res Unit, London, England; [Ware, James S.] Univ London Imperial Coll Sci Technol & Med, London, England; [Ware, James S.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England; [Samocha, Kaitlin E.; Karczewski, Konrad J.; Daly, Mark] Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Samocha, Kaitlin E.; Karczewski, Konrad J.; Daly, Mark] Harvard Univ, Sch Med, Boston, MA USA; [DePalma, Steven R.; Seidman, Christine E.] Harvard Univ, Howard Hughes Med Inst, Boston, MA 02115 USA; [Deanfield, John; Giardini, Alessandro] UCL, Dept Cardiol, London, England; [Deanfield, John; Giardini, Alessandro] Great Ormond St Hosp Sick Children, London, England; [Porter, George A., Jr.] Univ Rochester, Med Ctr, Sch Med & Dent, Dept Pediat, Rochester, NY 14642 USA; [Kim, Richard] Univ So Calif, Keck Sch Med, Sect Cardiothorac Surg, Los Angeles, CA 90033 USA; [Bilguvar, Kaya; Lopez-Giraldez, Francesc; Tikhonova, Irina; Mane, Shrikant] Yale Univ, Yale Ctr Genome Anal, New Haven, CT USA; [Romano-Adesman, Angela] Steven & Alexandra Cohen Childrens Med Ctr New Yo, New Hyde Pk, NY USA; [Qi, Hongjian] Columbia Univ, Dept Appl Phys & Appl Math, New York, NY USA; [Vardarajan, Badri] Columbia Univ, Dept Neurol, Med Ctr, New York, NY USA; [Ma, Lijiang; Chung, Wendy K.] Columbia Univ, Dept Pediat, Med Ctr, New York, NY 10027 USA; [Roberts, Amy E.] Childrens Hosp, Dept Cardiol, Boston, MA 02115 USA; [Russell, Mark W.] Univ Michigan, Div Pediat Cardiol, Ann Arbor, MI 48109 USA; [Mital, Seema] Univ Toronto, Hosp Sick Children, Dept Pediat, Toronto, ON M5G 1X8, Canada; [Newburger, Jane W.; Breitbart, Roger E.] Boston Childrens Hosp, Dept Cardiol, Boston, MA USA; [Gaynor, J. William] Childrens Hosp Philadelphia, Dept Pediat Cardiac Surg, Philadelphia, PA 19104 USA; [Iossifov, Ivan; Ronemus, Michael] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Sanders, Stephan J.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA USA; [Kaltman, Jonathan R.] NHLBI, Heart Dev & Struct Dis Branch, Div Cardiovasc Sci, NIH, Bethesda, MD 20892 USA; [Gelb, Bruce D.] Icahn Sch Med Mt Sinai, Mindich Child Hlth & Dev Inst, New York, NY 10029 USA; [Gelb, Bruce D.] Icahn Sch Med Mt Sinai, Dept Pediat, New York, NY 10029 USA; [Goldmuntz, Elizabeth] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Goldmuntz, Elizabeth] Childrens Hosp Philadelphia, Div Cardiol, Philadelphia, PA 19104 USA; [Lifton, Richard P.] Yale Univ, Howard Hughes Med Inst, New Haven, CT 06511 USA; [Seidman, Christine E.] Harvard Univ, Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA; [Chung, Wendy K.] Columbia Univ, Dept Med, Med Ctr, New York, NY USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Yale University; Columbia University; Columbia University; Royal Brompton & Harefield NHS Foundation Trust; Imperial College London; Imperial College London; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Howard Hughes Medical Institute; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of Rochester; University of Southern California; Yale University; Northwell Health; North Shore University Hospital; Steven & Alexandra Cohen Children's Medical Center of New York; Columbia University; Columbia University; Columbia University; Harvard University; Boston Children's Hospital; University of Michigan System; University of Michigan; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Harvard University; Boston Children's Hospital; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Cold Spring Harbor Laboratory; University of California System; University of California San Francisco; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Howard Hughes Medical Institute; Yale University; Harvard University; Brigham & Women's Hospital; Columbia University	Gelb, BD (corresponding author), Icahn Sch Med Mt Sinai, Mindich Child Hlth & Dev Inst, New York, NY 10029 USA.	martina.brueckner@yale.edu; bruce.gelb@mssm.edu; goldmuntz@email.chop.edu; richard.lifton@yale.edu; cseidman@genetics.med.harvard.edu; wkc15@cumc.columbia.edu	Daly, Mark J/B-2453-2017; George A, Porter/E-7315-2013; Wang, Guilin/G-8794-2018; López-Giráldez, Francesc/A-5251-2011; Sanders, Stephan/S-8645-2019; Ware, James S/G-5139-2012; Karczewski, Jakub/L-7326-2018	Daly, Mark J/0000-0002-0949-8752; George A, Porter/0000-0003-0726-9988; López-Giráldez, Francesc/0000-0001-7476-9822; Ware, James S/0000-0002-6110-5880; Karczewski, Konrad/0000-0003-2878-4671; DePalma, Steven/0000-0002-0381-5016; Samocha, Kaitlin/0000-0002-1704-3352; Deanfield, John/0000-0001-8806-6052; Sanders, Stephan/0000-0001-9112-5148; Karczewski, Jakub/0000-0001-9322-7842; Jin, Sheng Chih/0000-0002-5777-7262	National Heart, Lung, and Blood Institute (PCGC); National Heart, Lung, and Blood Institute (Pediatric Heart Network); National Heart, Lung, and Blood Institute (Cardiovascular Development Consortium); National Human Genome Research Institute of the National Institutes of Health (NIH); Howard Hughes Medical Institute; Simons Foundation for Autism Research; John S. LaDue Fellowship at Harvard Medical School; Medical Scientist Training Program; National Research Science Award; Academy of Medical Sciences; British Heart Foundation; Wellcome Trust; Arthritis Research UK; NIHR Cardiovascular Biomedical Research Unit at Royal Brompton and Harefield NHS Foundation Trust and Imperial College London; Leducq Foundation; Heart and Stroke Foundation of Ontario; Ted Roger Centre for Heart Research; Kostin Family Innovation Fund; Aaron Stern Professorship at the University of Michigan; Braylon's Gift of Hope Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [UM1HL098166, UM1HL098162, UM1HL098123, T32HL007208, UM1HL098147] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205] Funding Source: NIH RePORTER; Medical Research Council [MR/K006584/1] Funding Source: researchfish; MRC [MC_UP_1102/20] Funding Source: UKRI	National Heart, Lung, and Blood Institute (PCGC); National Heart, Lung, and Blood Institute (Pediatric Heart Network); National Heart, Lung, and Blood Institute (Cardiovascular Development Consortium); National Human Genome Research Institute of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Simons Foundation for Autism Research; John S. LaDue Fellowship at Harvard Medical School; Medical Scientist Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Science Award; Academy of Medical Sciences(Academy of Medical Sciences (AMS)); British Heart Foundation(British Heart Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); Arthritis Research UK(Versus Arthritis); NIHR Cardiovascular Biomedical Research Unit at Royal Brompton and Harefield NHS Foundation Trust and Imperial College London; Leducq Foundation(Leducq Foundation); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Ted Roger Centre for Heart Research; Kostin Family Innovation Fund; Aaron Stern Professorship at the University of Michigan; Braylon's Gift of Hope Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors are grateful to the patients and families who participated in this research and team members who supported subject recruitment and sequencing: D. Awad, C. Breton, K. Celia, C. Duarte, D. Etwaru, N. Fishman, M. Kaspakova, J. Kline, R. Korsin, A. Lanz, E. Marquez, D. Queen, A. Rodriguez, J. Rose, J. K. Sond, D. Warburton, A. Wilpers, and R. Yee (Columbia Medical School); B. McDonough, A. Monafo, J. Stryker (Harvard Medical School); N. Cross (Yale School of Medicine); S. M. Edman, J. L. Garbarini, J. E. Tusi, S. H. Woyciechowski (Children's Hospital of Philadelphia); J. Ellashek and N. Tran (Children's Hospital of Los Angeles); K. Flack L. Panesar, N. Taylor (University College London); D. Gruber and N. Stellato (Steve and Alexandra Cohen Children's Medical Center of New York); D. Guevara, A. Julian, M. Mac Neal, C. Mintz (Icahn School of Medicine at Mount Sinai); and E. Taillie (University of Rochester School of Medicine and Dentistry). We thank P. Candrea, E. Mazaika, K. Pavlik, V. Spotlow, and M. Sotiropoulos for production exome sequences and variant confirmation. This work was supported by grants from the National Heart, Lung, and Blood Institute (PCGC, Pediatric Heart Network, and Cardiovascular Development Consortium) and the National Human Genome Research Institute of the National Institutes of Health (NIH), Howard Hughes Medical Institute, Simons Foundation for Autism Research, John S. LaDue Fellowship at Harvard Medical School, Medical Scientist Training Program and National Research Science Award, Academy of Medical Sciences, British Heart Foundation, Wellcome Trust, Arthritis Research UK and the NIHR Cardiovascular Biomedical Research Unit at Royal Brompton and Harefield NHS Foundation Trust and Imperial College London, Leducq Foundation, Heart and Stroke Foundation of Ontario, Ted Roger Centre for Heart Research, Kostin Family Innovation Fund, Aaron Stern Professorship at the University of Michigan, and Braylon's Gift of Hope Fund. The views expressed are those of the authors and do not necessarily reflect those of the National Heart, Lung, and Blood Institute or NIH. R. P. L. is on the Board of Directors of Roche. J.G.S. and C. E. S. are founders of and own shares in Myocardia, a biotechnology company developing small molecules for the treatment of inherited cardiomyopathy.	Braeutigam C, 2014, ONCOGENE, V33, P1082, DOI 10.1038/onc.2013.50; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; De Rubeis S, 2014, NATURE, V515, P209, DOI 10.1038/nature13772; Deciphering Developmental Disorders Study, 2015, NATURE, V519, P223, DOI 10.1038/nature14135; Dong CL, 2015, HUM MOL GENET, V24, P2125, DOI 10.1093/hmg/ddu733; Egbe A, 2014, ANN PEDIAT CARDIOL, V7, P86, DOI 10.4103/0974-2069.132474; EuroEPINOMICS-RES Consortium Epilepsy Phenome/Genome Project Epi4K Consortium, 2014, AM J HUM GENET, V95, P360; Gallagher TL, 2011, DEV BIOL, V359, P251, DOI 10.1016/j.ydbio.2011.08.025; Gaynor JW, 2015, PEDIATRICS, V135, P816, DOI 10.1542/peds.2014-3825; Gelb B, 2013, CIRC RES, V112, P698, DOI 10.1161/CIRCRESAHA.111.300297; Glessner JT, 2014, CIRC RES, V115, P884, DOI 10.1161/CIRCRESAHA.115.304458; Hickey EJ, 2012, J AM COLL CARDIOL, V59, pS43, DOI 10.1016/j.jacc.2011.04.046; Iossifov I, 2014, NATURE, V515, P216, DOI 10.1038/nature13908; Marino BS, 2012, CIRCULATION, V126, P1143, DOI 10.1161/CIR.0b013e318265ee8a; O'Roak BJ, 2011, NAT GENET, V43, P585, DOI 10.1038/ng.835; Ohye RG, 2010, NEW ENGL J MED, V362, P1980, DOI 10.1056/NEJMoa0912461; Rauch A, 2012, LANCET, V380, P1674, DOI 10.1016/S0140-6736(12)61480-9; Samocha KE, 2014, NAT GENET, V46, P944, DOI 10.1038/ng.3050; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Xu B, 2011, NAT GENET, V43, P864, DOI 10.1038/ng.902; Yeo GW, 2009, NAT STRUCT MOL BIOL, V16, P130, DOI 10.1038/nsmb.1545; Zaidi S, 2013, NATURE, V498, P220, DOI 10.1038/nature12141	22	424	431	4	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 4	2015	350	6265					1262	1266		10.1126/science.aac9396	http://dx.doi.org/10.1126/science.aac9396			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX4WG	26785492	Green Submitted, Green Accepted			2022-12-28	WOS:000365700500080
J	Barlesi, F; Mazieres, J; Merlio, JP; Debieuvre, D; Mosser, J; Lena, H; Ouafik, L; Besse, B; Rouquette, I; Westeel, V; Escande, F; Monnet, I; Lemoine, A; Veillon, R; Blons, H; Audigier-Valette, C; Bringuier, PP; Lamy, R; Beau-Faller, M; Pujol, JL; Sabourin, JC; Penault-Llorca, F; Denis, MG; Lantuejoul, S; Morin, F; Tran, Q; Missy, P; Langlais, A; Milleron, B; Cadranel, J; Soria, JC; Zalcman, G				Barlesi, Fabrice; Mazieres, Julien; Merlio, Jean-Philippe; Debieuvre, Didier; Mosser, Jean; Lena, Herve; Ouafik, L'Houcine; Besse, Benjamin; Rouquette, Isabelle; Westeel, Virginie; Escande, Fabienne; Monnet, Isabelle; Lemoine, Antoinette; Veillon, Remi; Blons, Helene; Audigier-Valette, Clarisse; Bringuier, Pierre-Paul; Lamy, Regine; Beau-Faller, Michele; Pujol, Jean-Louis; Sabourin, Jean-Christophe; Penault-Llorca, Frederique; Denis, Marc G.; Lantuejoul, Sylvie; Morin, Franck; Quan Tran; Missy, Pascale; Langlais, Alexandra; Milleron, Bernard; Cadranel, Jacques; Soria, Jean-Charles; Zalcman, Gerard		Biomarkers France Contributors	Routine molecular profiling of patients with advanced non-small-cell lung cancer: results of a 1-year nationwide programme of the French Cooperative Thoracic Intergroup (IFCT)	LANCET			English	Article							GROWTH-FACTOR RECEPTOR; CLINICAL-PRACTICE; MUTATIONS; CLASSIFICATION; CHEMOTHERAPY; CRIZOTINIB; RELEVANCE; INSTITUTE; THERAPY; PROJECT	Background The molecular profiling of patients with advanced non-small-cell lung cancer (NSCLC) for known oncogenic drivers is recommended during routine care. Nationally, however, the feasibility and effects on outcomes of this policy are unknown. We aimed to assess the characteristics, molecular profiles, and clinical outcomes of patients who were screened during a 1-year period by a nationwide programme funded by the French National Cancer Institute. Methods This study included patients with advanced NSCLC, who were routinely screened for EGFR mutations, ALK rearrangements, as well as HER2 (ERBB2), KRAS, BRAF, and PIK3CA mutations by 28 certified regional genetics centres in France. Patients were assessed consecutively during a 1-year period from April, 2012, to April, 2013. We measured the frequency of molecular alterations in the six routinely screened genes, the turnaround time in obtaining molecular results, and patients' clinical outcomes. This study is registered with ClinicalTrials.gov, number NCT01700582. Findings 18 679 molecular analyses of 17 664 patients with NSCLC were done (of patients with known data, median age was 64.5 years [range 18-98], 65% were men, 81% were smokers or former smokers, and 76% had adenocarcinoma). The median interval between the initiation of analysis and provision of the written report was 11 days (IQR 7-16). A genetic alteration was recorded in about 50% of the analyses; EGFR mutations were reported in 1947 (11%) of 17 706 analyses for which data were available, HER2 mutations in 98 (1%) of 11 723, KRAS mutations in 4894 (29%) of 17 001, BRAF mutations in 262 (2%) of 13 906, and PIK3CA mutations in 252 (2%) of 10 678; ALK rearrangements were reported in 388 (5%) of 8134 analyses. The median duration of follow-up at the time of analysis was 24.9 months (95% CI 24.8-25.0). The presence of a genetic alteration affected first-line treatment for 4176 (51%) of 8147 patients and was associated with a significant improvement in the proportion of patients achieving an overall response in first-line treatment (37% [95% CI 34.7-38.2] for presence of a genetic alteration vs 33% [29.5-35.6] for absence of a genetic alteration; p=0.03) and in second-line treatment (17% [15.0-18.8] vs 9% [6.7-11.9]; p<0.0001). Presence of a genetic alteration was also associated with improved first-line progression-free survival (10.0 months [95% CI 9.2-10.7] vs 7.1 months [6.1-7.9]; p<0.0001) and overall survival (16.5 months [15.0-18.3] vs 11.8 months [10.1-13.5]; p<0.0001) compared with absence of a genetic alteration. Interpretation Routine nationwide molecular profiling of patients with advanced NSCLC is feasible. The frequency of genetic alterations, acceptable turnaround times in obtaining analysis results, and the clinical advantage provided by detection of a genetic alteration suggest that this policy provides a clinical benefit.	[Barlesi, Fabrice] Aix Marseille Univ, Ctr Invest Clin, Assistance Publ Hop Marseille, Multidisciplinary Oncol & Therapeut Innovat Dept, Marseille, France; [Mazieres, Julien] Univ Toulouse 3, Hop Larrey, Ctr Hosp Univ, F-31062 Toulouse, France; [Merlio, Jean-Philippe] Ctr Hosp Univ Bordeaux, Pole Biol & Anat Pathol, Pessac, France; [Merlio, Jean-Philippe] Univ Bordeaux, Histol & Pathol Mol Tumeurs, Bordeaux, France; [Debieuvre, Didier] Hop Emile Muller, Serv Pneumol, Mulhouse, France; [Mosser, Jean] Ctr Hosp Univ Rennes, Dept Genom & Genet Mol, Plateforme INCA, Rennes, France; [Lena, Herve] Ctr Hosp Univ, Hop Pontchaillou, Serv Pneumol, Rennes, France; [Ouafik, L'Houcine] Aix Marseille Univ, Assistance Publ Hop Marseille, Serv Transfert Oncol Biol, Marseille, France; [Besse, Benjamin; Soria, Jean-Charles] Gustave Roussy, Canc Campus, Villejuif, France; [Besse, Benjamin; Soria, Jean-Charles] Univ Paris 11, Chatenay Malabry, France; [Rouquette, Isabelle] Inst Univ Canc Toulouse, Oncopole, Serv Anat Pathol, Toulouse, France; [Westeel, Virginie] Univ Franche Comte, EA3181, Ctr Hosp Univ Jean Minjoz, Serv Pneumol, F-25030 Besancon, France; [Escande, Fabienne] CHU Lille, Dept Biochim & Biol Mol, Ctr Biol Pathol, F-59037 Lille, France; [Monnet, Isabelle] Ctr Hosp Intercommunal Creteil, Serv Pneumol & Pathol Profess, Creteil, France; [Lemoine, Antoinette] Univ Paris 11, Grp Hosp Hop Univ Paris Sud, AP HP, Serv Oncogenet Oncomolpath, Villejuif, France; [Veillon, Remi] Ctr Hosp Univ Bordeaux, Serv Malad Resp, Pessac, France; [Blons, Helene] Univ Paris 05, INSERM, Hop Europeen Georges Pompidou, AP HP,Dept Biol, Paris, France; [Audigier-Valette, Clarisse] Ctr Hosp St Musse, Serv Pneumol, Toulon, France; [Bringuier, Pierre-Paul] Univ Lyon 1, Hop Edouard Herriot, Serv Anat & Cytol Pathol, Hosp Civils Lyon,Lyon Canc Res Ctr,UMR 1057,INSER, F-69365 Lyon, France; [Lamy, Regine] Ctr Hosp Bretagne Sud, Serv Oncol Med, Lorient, France; [Beau-Faller, Michele] CHU Hautepierre, Lab Biochim & Biol Mol & Plate Forme Genom Canc, F-67098 Strasbourg, France; [Pujol, Jean-Louis] CHU Montpellier, Unite Oncol Thorac, Pole Coeur Poumon, Hop Arnaud de Villeneuve, Montpellier, France; [Sabourin, Jean-Christophe] Ctr Hosp Univ Rouen, Dept Anat & Cytol Pathol, Rouen, France; [Penault-Llorca, Frederique] Ctr Jean Perrin, Dept Anat & Cytol Pathol, Clermont Ferrand, France; [Denis, Marc G.] CHU Nantes, Lab Biochim, F-44035 Nantes 01, France; [Lantuejoul, Sylvie] Univ Grenoble 1, Ctr Hosp Univ A Michallon, DACP, Inst Biol & Pathol,INSERM,U823,Inst Albert Bonnio, Grenoble, France; [Morin, Franck; Quan Tran; Missy, Pascale] IFCT, Clin Res Unit, Paris, France; [Langlais, Alexandra] IFCT, Biostat Unit, Paris, France; [Milleron, Bernard; Cadranel, Jacques] Univ Paris 06, Sorbonne Univ, Hop Tenon, AP HP,Serv Pneumol, Paris, France; [Zalcman, Gerard] Univ Caen Basse Normandie, CHU Caen, Serv Pneumol & Oncol Thorac, Ctr Rech Clin, Caen, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CHU Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; CHU Rennes; Universite de Rennes; CHU Rennes; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UNICANCER; Gustave Roussy; UDICE-French Research Universities; Universite Paris Saclay; Universite de Franche-Comte; CHU Besancon; Universite de Lille - ISITE; CHU Lille; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); CHI Creteil; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; UDICE-French Research Universities; Universite Paris Saclay; CHU Bordeaux; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; UNICANCER; Centre Leon Berard; CHU Strasbourg; Universite de Montpellier; CHU de Montpellier; CHU de Rouen; UNICANCER; Centre Jean Perrin; Nantes Universite; CHU de Nantes; CHU Grenoble Alpes; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; CHU de Caen NORMANDIE; Universite de Caen Normandie	Barlesi, F (corresponding author), Aix Marseille Univ, Assistance Publ Hop Marseille, Marseille 20, France.	fabrice.barlesi@ap-hm.fr	lantuejoul, sylvie/N-9315-2017; Richard, nicolas/AAB-6356-2020; Beau-Faller, Michèle/R-3052-2016; Soria, Jean-Charles/F-3619-2014; MAZIERES, JULIEN/M-3986-2014; Rouquette, Isabelle/AAE-6986-2019; ZALCMAN, Gerard/M-8113-2019; Besse, Benjamin/V-1523-2019	lantuejoul, sylvie/0000-0003-4310-6975; Richard, nicolas/0000-0003-0702-7399; Besse, Benjamin/0000-0001-5090-8189; morel, alain/0000-0003-0125-1883; Ouafik, L'Houcine/0000-0002-4848-1232; Labrousse, Francois/0000-0002-3185-4856; MAZIERES, JULIEN/0000-0002-5921-7613; Blons, Helene/0000-0002-0572-8426; Morin, Franck/0000-0002-7510-2787	French Cooperative Thoracic Intergroup (IFCT); French National Cancer Institute (INCa)	French Cooperative Thoracic Intergroup (IFCT); French National Cancer Institute (INCa)(Institut National du Cancer (INCA) France)	This study was sponsored by the French Cooperative Thoracic Intergroup (IFCT) and was funded by an unrestricted grant from the French National Cancer Institute (INCa). We thank the following individuals from INCa (Paris, France) for their constant support: D Maraninchi (past President), A Buzyn (President), F Calvo (past Head of Research Department), and F Nowak. We also thank A Deroy and S Dos Santos (Intergroupe Francophone de Cancerologie Thoracique, Paris, France) for their participation in data collection, monitoring, and computing.	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Andre F, 2012, CLIN CANCER RES, V18, P1555, DOI 10.1158/1078-0432.CCR-11-2201; Azzoli CG, 2011, J CLIN ONCOL, V29, P3825, DOI 10.1200/JCO.2010.34.2774; Barlesi F, 2014, IASLC MULTIDISCIPLIN; Beau-Faller M, 2014, J MOL DIAGN, V16, P45, DOI 10.1016/j.jmoldx.2013.07.009; Beau-Faller M, 2011, J THORAC ONCOL, V6, P1006, DOI 10.1097/JTO.0b013e318211dcee; Blons H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068945; Camidge DR, 2014, J CLIN ONCOL, V32, DOI 10.1200/jco.2014.32.15_suppl.8001; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; Depierre A, 2003, BRIT J CANCER, V89, pS35, DOI 10.1038/sj.bjc.6601083; Goldstraw Peter, 2007, J Thorac Oncol, V2, P706, DOI 10.1097/JTO.0b013e31812f3c1a; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Institut National du Cancer, 2014, SYNTH ACT PLAT HOSP; Institut National du Cancer, 2014, PLAT HOSP GEN MOL CA; Institut National du Cancer, 2014, CANC FRANC 2013 COLL; Kris MG, 2014, JAMA-J AM MED ASSOC, V311, P1998, DOI 10.1001/jama.2014.3741; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Martin P, 2013, J THORAC ONCOL, V8, P530, DOI 10.1097/JTO.0b013e318283d958; Mazieres J, 2013, J CLIN ONCOL, V31, P1997, DOI 10.1200/JCO.2012.45.6095; McLeer-Florin A, 2012, J THORAC ONCOL, V7, P348, DOI 10.1097/JTO.0b013e3182381535; Nowak Frederique, 2013, Am Soc Clin Oncol Educ Book, P332, DOI 10.1200/EdBook_AM.2013.33.332; Nowak F, 2012, NAT REV CLIN ONCOL, V9, P479, DOI 10.1038/nrclinonc.2012.42; Planchard D, 2013, ASCO M, V31, P8009; Reck M, 2014, ANN ONCOL, V25, P27, DOI 10.1093/annonc/mdu199; Sequist LV, 2011, ANN ONCOL, V22, P2616, DOI 10.1093/annonc/mdr489; Serizawa M, 2014, CANCER-AM CANCER SOC, V120, P1471, DOI 10.1002/cncr.28604; Shaw AT, 2013, NEW ENGL J MED, V368, P2385, DOI 10.1056/NEJMoa1214886; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Su ZL, 2011, J MOL DIAGN, V13, P74, DOI 10.1016/j.jmoldx.2010.11.010; Travis WD, 2013, J CLIN ONCOL, V31, P992, DOI 10.1200/JCO.2012.46.9270	30	563	584	3	61	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 2	2016	387	10026					1415	1426		10.1016/S0140-6736(16)00004-0	http://dx.doi.org/10.1016/S0140-6736(16)00004-0			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DI0WH	26777916	Green Submitted			2022-12-28	WOS:000373217500034
J	Laine, C; Dickersin, K; Murow, C				Laine, Christine; Dickersin, Kay; Murow, Cynthia			Time to Douse the Firestorm Around Breast Cancer Screening	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							HIGH-VALUE CARE; AMERICAN-COLLEGE; PHYSICIANS; ADVICE		[Laine, Christine] Amer Coll Physicians, 190 N Independence Mall West, Philadelphia, PA 19106 USA; [Dickersin, Kay] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Murow, Cynthia] Annals Internal Med, New York, NY USA	American College of Physicians; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Laine, C (corresponding author), Amer Coll Physicians, 190 N Independence Mall West, Philadelphia, PA 19106 USA.	claine@acponline.org						Brawley OW, 2012, ANN INTERN MED, V157, P135, DOI 10.7326/0003-4819-157-2-201207170-00460; Calonge N, 2009, ANN INTERN MED, V151, P716, DOI 10.7326/0003-4819-151-10-200911170-00008; Harris RP, 2015, ANN INTERN MED, V162, P712, DOI 10.7326/M14-2327; Mandelblatt JS, 2016, ANN INTERN MED, V164, P215, DOI 10.7326/M15-1536; Miglioretti DL, 2016, ANN INTERN MED, V164, P205, DOI 10.7326/M15-1241; Nelson HD, 2016, ANN INTERN MED, V164, P256, DOI 10.7326/M15-0970; Nelson HD, 2016, ANN INTERN MED, V164, P244, DOI 10.7326/M15-0969; Nelson HD, 2016, ANN INTERN MED, V164, P226, DOI 10.7326/M15-0971; Siu AL, 2016, ANN INTERN MED, V164, P279, DOI 10.7326/M15-2886; US Preventive Services Task Force, 2015, REC STAT BR IN PRESS; Wilt TJ, 2015, ANN INTERN MED, V162, P718, DOI 10.7326/M14-2326	11	3	3	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 16	2016	164	4					303	+		10.7326/M15-2978	http://dx.doi.org/10.7326/M15-2978			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DD7WK	26757446				2022-12-28	WOS:000370135300022
J	Black, DM; Rosen, CJ				Black, Dennis M.; Rosen, Clifford J.			Postmenopausal Osteoporosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BONE-MINERAL DENSITY; ZOLEDRONIC ACID; FRACTURE RISK; ANTIRESORPTIVE THERAPY; VERTEBRAL FRACTURES; RANDOMIZED-TRIAL; WOMEN; ALENDRONATE; PREVENTION; HIP	A 73-year-old asymptomatic white woman with a history of a Colles fracture of the left radius 10 years earlier presents for evaluation. Dual-energy x-ray absorptiometry reveals a bone mineral density (BMD) T score of -2.8 in the lumbar spine and -2.5 in the total hip. How should this case be managed?This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they exist. The article ends with the authors' clinical recommendations.	[Black, Dennis M.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Rosen, Clifford J.] Maine Med Ctr, Res Inst, Scarborough, ME USA	University of California System; University of California San Francisco; Maine Medical Center	Black, DM (corresponding author), Univ Calif San Francisco, Dept Epidemiol & Biostat, Mission Hall,550 16th St,Box 0560, San Francisco, CA 94143 USA.	dblack@psg.ucsf.edu			Eli Lilly; Amgen; Radius Health; Merck; Novartis; Alexion	Eli Lilly(Eli Lilly); Amgen(Amgen); Radius Health; Merck(Merck & Company); Novartis(Novartis); Alexion	Dr. Black reports receiving fees for serving on a data and safety monitoring board from Eli Lilly, fees for a presentation and for serving on an advisory board from Amgen, consulting fees from Radius Health, lecture fees and travel support from Merck and Novartis, and grant support from Alexion. Dr. Rosen reports receiving grant support from Alexion. No other potential conflict of interest relevant to this article was reported.	Adler RA, 2015, J BONE MINER RES; Amin S, 2014, J BONE MINER RES, V29, P581, DOI 10.1002/jbmr.2072; [Anonymous], 2000, NIH Consens Statement, V17, P1; Bauer DC, 2014, JAMA INTERN MED, V174, P1126, DOI 10.1001/jamainternmed.2014.1232; Bauer DC, 2013, NEW ENGL J MED, V369, P1537, DOI 10.1056/NEJMcp1210380; Black DM, 2007, NEW ENGL J MED, V356, P1809, DOI 10.1056/NEJMoa067312; Black DM, 2012, NEW ENGL J MED, V366, P2051, DOI 10.1056/NEJMp1202623; Black DM, 2012, J BONE MINER RES, V27, P243, DOI 10.1002/jbmr.1494; Black DM, 2010, NEW ENGL J MED, V362, P1761, DOI 10.1056/NEJMoa1001086; Black DM, 2006, JAMA-J AM MED ASSOC, V296, P2927, DOI 10.1001/jama.296.24.2927; Black DM, 2005, NEW ENGL J MED, V353, P555, DOI 10.1056/NEJMoa050336; Black DM, 2000, J CLIN ENDOCR METAB, V85, P4118, DOI 10.1210/jc.85.11.4118; Black DM, 1996, LANCET, V348, P1535, DOI 10.1016/S0140-6736(96)07088-2; Cauley JA, 2003, JAMA-J AM MED ASSOC, V290, P1729, DOI 10.1001/jama.290.13.1729; Chesnut CH, 2004, J BONE MINER RES, V19, P1241, DOI 10.1359/JBMR.040325; Compston J, 2013, MATURITAS, V75, P392, DOI 10.1016/j.maturitas.2013.05.013; Cosman F, 2014, OSTEOPOROSIS INT, V25, P2359, DOI 10.1007/s00198-014-2794-2; Cosman F, 2014, J CLIN ENDOCR METAB, V99, P4546, DOI 10.1210/jc.2014-1971; Cosman F, 2014, CURR OSTEOPOROS REP, V12, P385, DOI 10.1007/s11914-014-0237-9; Crandall CJ, 2014, ANN INTERN MED, V161, P711, DOI 10.7326/M14-0317; CUMMINGS SR, 1989, ARCH INTERN MED, V149, P2445, DOI 10.1001/archinte.149.11.2445; Cummings SR, 1998, JAMA-J AM MED ASSOC, V280, P2077, DOI 10.1001/jama.280.24.2077; CUMMINGS SR, 1993, LANCET, V341, P72, DOI 10.1016/0140-6736(93)92555-8; Cummings SR, 2002, LANCET, V359, P1761, DOI 10.1016/S0140-6736(02)08657-9; Cummings SR, 2009, NEW ENGL J MED, V361, P756, DOI 10.1056/NEJMoa0809493; Cummings SR, 2009, JNCI-J NATL CANCER I, V101, P384, DOI 10.1093/jnci/djp018; Eisman JA, 2008, J RHEUMATOL, V35, P488; Ettinger B, 1999, JAMA-J AM MED ASSOC, V282, P637, DOI 10.1001/jama.282.7.637; Evans RK, 2012, J MUSCULOSKEL NEURON, V12, P155; Feldstein AC, 2012, J BONE MINER RES, V27, P977, DOI 10.1002/jbmr.1550; Gedmintas L, 2013, J BONE MINER RES, V28, P1729, DOI 10.1002/jbmr.1893; Harris ST, 1999, JAMA-J AM MED ASSOC, V282, P1344, DOI 10.1001/jama.282.14.1344; Hellstein JW, 2011, J AM DENT ASSOC, V142, P1243, DOI 10.14219/jada.archive.2011.0108; Hinton PS, 2015, BONE, V79, P203, DOI 10.1016/j.bone.2015.06.008; Jackson RD, 2006, NEW ENGL J MED, V354, P669, DOI 10.1056/NEJMoa055218; Jackson RD, 2006, J BONE MINER RES, V21, P817, DOI 10.1359/JBMR.060312; Khan AA, 2015, J BONE MINER RES, V30, P3, DOI 10.1002/jbmr.2405; Khosla S, 2012, J CLIN ENDOCR METAB, V97, P2272, DOI 10.1210/jc.2012-1027; LeBlanc ES, 2015, ANN INTERN MED, V162, P109, DOI 10.7326/M14-1659; Lyles KW, 2007, NEW ENGL J MED, V357, P1799, DOI 10.1056/NEJMoa074941; Marshall D, 1996, BRIT MED J, V312, P1254, DOI 10.1136/bmj.312.7041.1254; McClung MR, 2001, NEW ENGL J MED, V344, P333, DOI 10.1056/NEJM200102013440503; Modi A, 2015, CURR MED RES OPIN, V31, P757, DOI 10.1185/03007995.2015.1016605; Murad MH, 2012, J CLIN ENDOCR METAB, V97, P1871, DOI 10.1210/jc.2011-3060; Neer RM, 2001, NEW ENGL J MED, V344, P1434, DOI 10.1056/NEJM200105103441904; Papaioannou A, 2010, CAN MED ASSOC J, V182, P1864, DOI 10.1503/cmaj.100771; Reginster JY, 2000, OSTEOPOROSIS INT, V11, P83, DOI 10.1007/s001980050010; Reid IR, 2010, J CLIN ENDOCR METAB, V95, P4380, DOI 10.1210/jc.2010-0597; Richman S, 2006, MENOPAUSE, V13, P148, DOI 10.1097/01.gme.0000191205.20738.01; Schilcher J, 2014, NEW ENGL J MED, V371, P974, DOI 10.1056/NEJMc1403799; Shane E, 2014, J BONE MINER RES, V29, P1, DOI 10.1002/jbmr.1998; Wark JD, 2012, OSTEOPOROSIS INT, V23, P503, DOI 10.1007/s00198-011-1563-8; Yates CJ, 2015, J CLIN DENSITOM, V18, P150, DOI 10.1016/j.jocd.2015.01.003; Yun HF, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-112	54	557	580	27	268	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 21	2016	374	3					254	262		10.1056/NEJMcp1513724	http://dx.doi.org/10.1056/NEJMcp1513724			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DB3IS	26789873				2022-12-28	WOS:000368404800010
J	Buffett, B				Buffett, Bruce			Another energy source for the geodynamo	NATURE			English	Editorial Material							EARTHS CORE; IRON; CONDUCTIVITY; SI; NI		[Buffett, Bruce] Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Buffett, B (corresponding author), Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA.							Badro J, 2014, P NATL ACAD SCI USA, V111, P7542, DOI 10.1073/pnas.1316708111; Buffett BA, 2000, SCIENCE, V290, P1338, DOI 10.1126/science.290.5495.1338; Fischer RA, 2015, GEOCHIM COSMOCHIM AC, V167, P177, DOI 10.1016/j.gca.2015.06.026; Gomi H, 2015, PHYS EARTH PLANET IN, V247, P2, DOI 10.1016/j.pepi.2015.04.003; Nimmo F., 2015, TREATISE GEOPHYS, P31; O'Rourke JG, 2016, NATURE, V529, P387, DOI 10.1038/nature16495; Pozzo M, 2012, NATURE, V485, P355, DOI 10.1038/nature11031; Takafuji N, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022773; Tarduno JA, 2010, SCIENCE, V327, P1238, DOI 10.1126/science.1183445; Wahl SM, 2015, EARTH PLANET SC LETT, V410, P25, DOI 10.1016/j.epsl.2014.11.014	10	1	1	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 21	2016	529	7586					288	289		10.1038/529288a	http://dx.doi.org/10.1038/529288a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB2QT	26791715				2022-12-28	WOS:000368354800025
J	O'Rourke, JG; Stevenson, DJ				O'Rourke, Joseph G.; Stevenson, David J.			Powering Earth's dynamo with magnesium precipitation from the core	NATURE			English	Article							TRANSPORT-PROPERTIES; TERRESTRIAL PLANETS; LIGHT-ELEMENTS; HIGH-PRESSURE; SOLAR-SYSTEM; GIANT IMPACT; OUTER CORE; ACCRETION; IRON; CONDUCTIVITY	Earth's global magnetic field arises from vigorous convection within the liquid outer core. Palaeomagnetic evidence reveals that the geodynamo has operated for at least 3.4 billion years(1), which places constraints on Earth's formation and evolution. Available power sources in standard models include compositional convection (driven by the solidifying inner core's expulsion of light elements), thermal convection (from slow cooling), and perhaps heat from the decay of radioactive isotopes. However, recent first-principles calculations(2,3) and diamond-anvil cell experiments(4,5) indicate that the thermal conductivity of iron is two or three times larger than typically assumed in these models. This presents a problem: a large increase in the conductive heat flux along the adiabat (due to the higher conductivity of iron) implies that the inner core is young (less than one billion years old(4)), but thermal convection and radiogenic heating alone may not have been able to sustain the geodynamo during earlier epochs. Here we show that the precipitation of magnesium-bearing minerals from the core could have served as an alternative power source. Equilibration at high temperatures in the aftermath of giant impacts allows a small amount of magnesium (one or two weight per cent) to partition into the core while still producing the observed abundances of siderophile elements in the mantle and avoiding an excess of silicon and oxygen in the core. The transport of magnesium as oxide or silicate from the cooling core to underneath the mantle is an order of magnitude more efficient per unit mass as a source of buoyancy than inner-core growth. We therefore conclude that Earth's dynamo would survive throughout geologic time (from at least 3.4 billion years ago to the present) even if core radiogenic heating were minimal and core cooling were slow.	[O'Rourke, Joseph G.; Stevenson, David J.] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA	California Institute of Technology	O'Rourke, JG (corresponding author), CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA.	jorourke@caltech.edu		O'Rourke, Joseph/0000-0002-1180-996X	National Science Foundation Graduate Research Fellowship [DGE-1144469]	National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF))	This material is based upon work supported by the National Science Foundation Graduate Research Fellowship under grant number DGE-1144469 (J.G.O'R.).	Badro J, 2014, P NATL ACAD SCI USA, V111, P7542, DOI 10.1073/pnas.1316708111; Biggin AJ, 2015, NATURE, V526, P245, DOI 10.1038/nature15523; Canup RM, 2008, PHILOS T R SOC A, V366, P4061, DOI 10.1098/rsta.2008.0101; Canup RM, 2012, SCIENCE, V338, P1052, DOI 10.1126/science.1226073; Chambers JE, 2004, EARTH PLANET SC LETT, V223, P241, DOI 10.1016/j.epsl.2004.04.031; CHIB S, 1995, AM STAT, V49, P327, DOI 10.2307/2684568; Corgne A, 2007, EARTH PLANET SC LETT, V256, P567, DOI 10.1016/j.epsl.2007.02.012; Cuk M, 2012, SCIENCE, V338, P1047, DOI 10.1126/science.1225542; Dahl TW, 2010, EARTH PLANET SC LETT, V295, P177, DOI 10.1016/j.epsl.2010.03.038; de Koker N, 2012, P NATL ACAD SCI USA, V109, P4070, DOI 10.1073/pnas.1111841109; Fischer RA, 2015, GEOCHIM COSMOCHIM AC, V167, P177, DOI 10.1016/j.gca.2015.06.026; Gomi H, 2013, PHYS EARTH PLANET IN, V224, P88, DOI 10.1016/j.pepi.2013.07.010; Helffrich G, 2014, EARTH PLANET SC LETT, V391, P256, DOI 10.1016/j.epsl.2014.01.039; Labrosse S, 2007, NATURE, V450, P866, DOI 10.1038/nature06356; Labrosse S, 2015, PHYS EARTH PLANET IN, V247, P36, DOI 10.1016/j.pepi.2015.02.002; McDonough W. F, 2001, EARTHQUAKE THERMODYN, P3; Nimmo F., 2015, TREATISE GEOPHYS, P31; Nomura R., 2012, AGU FALL M; Ogihara M, 2007, ICARUS, V188, P522, DOI 10.1016/j.icarus.2006.12.006; Palme H., 2013, TREATISE GEOCHEMISTR, P1; POIRIER JP, 1994, PHYS EARTH PLANET IN, V85, P319, DOI 10.1016/0031-9201(94)90120-1; Pozzo M, 2012, NATURE, V485, P355, DOI 10.1038/nature11031; Rubie DC, 2015, ICARUS, V248, P89, DOI 10.1016/j.icarus.2014.10.015; Rubie DC, 2011, EARTH PLANET SC LETT, V301, P31, DOI 10.1016/j.epsl.2010.11.030; Seagle CT, 2013, GEOPHYS RES LETT, V40, P5377, DOI 10.1002/2013GL057930; Shi CY, 2013, NAT GEOSCI, V6, P971, DOI [10.1038/ngeo1956, 10.1038/NGEO1956]; Siebert J, 2013, SCIENCE, V339, P1194, DOI 10.1126/science.1227923; Stevenson DJ, 2003, EARTH PLANET SC LETT, V208, P1, DOI 10.1016/S0012-821X(02)01126-3; Takafuji N, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022773; Tarduno JA, 2010, SCIENCE, V327, P1238, DOI 10.1126/science.1183445; Wade J, 2005, EARTH PLANET SC LETT, V236, P78, DOI 10.1016/j.epsl.2005.05.017; Wahl SM, 2015, EARTH PLANET SC LETT, V410, P25, DOI 10.1016/j.epsl.2014.11.014; Wood BJ, 2006, NATURE, V441, P825, DOI 10.1038/nature04763; Zhang P, 2015, NATURE, V517, P605, DOI 10.1038/nature14090	34	145	147	1	135	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 21	2016	529	7586					387	+		10.1038/nature16495	http://dx.doi.org/10.1038/nature16495			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB2QT	26791727				2022-12-28	WOS:000368354800044
J	Wang, M; Kaufman, RJ				Wang, Miao; Kaufman, Randal J.			Protein misfolding in the endoplasmic reticulum as a conduit to human disease	NATURE			English	Review							BETA-CELL FUNCTION; ER-STRESS; IRE1-ALPHA ACTIVATION; TRANSLATIONAL CONTROL; ALPHA-SYNUCLEIN; HEPATIC LIPOGENESIS; NLRP3 INFLAMMASOME; OXIDATIVE STRESS; KINASE-ACTIVITY; MESSENGER-RNA	In eukaryotic cells, the endoplasmic reticulum is essential for the folding and trafficking of proteins that enter the secretory pathway. Environmental insults or increased protein synthesis often lead to protein misfolding in the organelle, the accumulation of misfolded or unfolded proteins - known as endoplasmic reticulum stress - and the activation of the adaptive unfolded protein response to restore homeostasis. If protein misfolding is not resolved, cells die. Endoplasmic reticulum stress and activation of the unfolded protein response help to determine cell fate and function. Furthermore, endoplasmic reticulum stress contributes to the aetiology of many human diseases.	[Wang, Miao; Kaufman, Randal J.] Sanford Burnham Prebys Med Discovery Inst, Degenerat Dis Program, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute	Kaufman, RJ (corresponding author), Sanford Burnham Prebys Med Discovery Inst, Degenerat Dis Program, 10901 North Torrey Pines Rd, La Jolla, CA 92037 USA.	rkaufman@sbpdiscovery.org			US National Institutes of Health [R37 DK042394, R01 DK088227, R01 DK103183, CA128814]; NATIONAL CANCER INSTITUTE [P01CA128814] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK103183, R01DK088227, R37DK042394] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors apologize to those researchers whose references they were unable to acknowledge due to space limitations. R.J.K. is supported by US National Institutes of Health grants R37 DK042394, R01 DK088227, R01 DK103183 and CA128814.	Acosta-Alvear D, 2007, MOL CELL, V27, P53, DOI 10.1016/j.molcel.2007.06.011; Adolph TE, 2013, NATURE, V503, P272, DOI 10.1038/nature12599; Babour A, 2010, CELL, V142, P256, DOI 10.1016/j.cell.2010.06.006; Back SH, 2009, CELL METAB, V10, P13, DOI 10.1016/j.cmet.2009.06.002; Baleriola J, 2014, CELL, V158, P1159, DOI 10.1016/j.cell.2014.07.001; Biason-Lauber A, 2002, DIABETES, V51, P2301, DOI 10.2337/diabetes.51.7.2301; Birkenfeld AL, 2011, J BIOL CHEM, V286, P36163, DOI 10.1074/jbc.M111.228817; Bobrovnikova-Marjon E, 2008, P NATL ACAD SCI USA, V105, P16314, DOI 10.1073/pnas.0808517105; Bobrovnikova-Marjon E, 2012, MOL CELL BIOL, V32, P2268, DOI 10.1128/MCB.00063-12; Bright MD, 2015, MOL CELL BIOL, V35, P2186, DOI 10.1128/MCB.00013-15; Bronner DN, 2015, IMMUNITY, V43, P451, DOI 10.1016/j.immuni.2015.08.008; Cao SS, 2014, INFLAMM BOWEL DIS, V20, P712, DOI 10.1097/MIB.0000000000000010; Cao SS, 2013, GASTROENTEROLOGY, V144, P989, DOI 10.1053/j.gastro.2013.01.023; Carrara M, 2015, ELIFE, V4, DOI 10.7554/eLife.03522; Chung CY, 2013, SCIENCE, V342, P983, DOI 10.1126/science.1245296; Coelho DS, 2013, CELL REP, V5, P791, DOI 10.1016/j.celrep.2013.09.046; Credle JJ, 2015, NEUROBIOL DIS, V76, P112, DOI 10.1016/j.nbd.2015.02.005; Cullinan SB, 2003, MOL CELL BIOL, V23, P7198, DOI 10.1128/MCB.23.20.7198-7209.2003; Das I, 2015, SCIENCE, V348, P239, DOI 10.1126/science.aaa4484; Delepine M, 2000, NAT GENET, V25, P406, DOI 10.1038/78085; Di Prisco GV, 2014, NAT NEUROSCI, V17, P1073, DOI 10.1038/nn.3754; Engin F, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006534; Feng YX, 2014, CANCER DISCOV, V4, P702, DOI 10.1158/2159-8290.CD-13-0945; Flaherty DP, 2014, ACS MED CHEM LETT, V5, P1278, DOI 10.1021/ml5003234; Fu SN, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa9134; Fu SN, 2011, NATURE, V473, P528, DOI 10.1038/nature09968; Gao Y, 2012, MOL CELL BIOL, V32, P5129, DOI 10.1128/MCB.01009-12; Gardner BM, 2011, SCIENCE, V333, P1891, DOI 10.1126/science.1209126; Ghosh R, 2014, CELL, V158, P534, DOI 10.1016/j.cell.2014.07.002; Halliday M, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.49; Han J, 2013, DIABETOLOGIA, V56, P911, DOI 10.1007/s00125-012-2809-5; Han J, 2015, DIABETES, V64, P2892, DOI 10.2337/db14-1357; Han J, 2013, NAT CELL BIOL, V15, P481, DOI 10.1038/ncb2738; Han KL, 2008, DIABETES, V57, P737, DOI 10.2337/db07-0972; Harding HP, 2009, P NATL ACAD SCI USA, V106, P1832, DOI 10.1073/pnas.0809632106; Harding HP, 2001, MOL CELL, V7, P1153, DOI 10.1016/S1097-2765(01)00264-7; Hasnain SZ, 2014, NAT MED, V20, P1417, DOI 10.1038/nm.3705; Hassler JR, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002277; Hetz C, 2014, NAT REV NEUROSCI, V15, P233, DOI 10.1038/nrn3689; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Hollien J, 2006, SCIENCE, V313, P104, DOI 10.1126/science.1129631; Hu CCA, 2009, EMBO J, V28, P1624, DOI 10.1038/emboj.2009.117; Huang CJ, 2007, DIABETES, V56, P2016, DOI 10.2337/db07-0197; Huh WJ, 2010, GASTROENTEROLOGY, V139, P2038, DOI 10.1053/j.gastro.2010.08.050; Hur KY, 2012, J EXP MED, V209, P307, DOI 10.1084/jem.20111298; Iwakoshi NN, 2007, J EXP MED, V204, P2267, DOI 10.1084/jem.20070525; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Kamimura D, 2008, J IMMUNOL, V181, P5433, DOI 10.4049/jimmunol.181.8.5433; Kars M, 2010, DIABETES, V59, P1899, DOI 10.2337/db10-0308; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; Kaufman RJ, 2014, BBA-MOL CELL RES, V1843, P2233, DOI 10.1016/j.bbamcr.2014.03.022; Kohl S, 2015, NAT GENET, V47, P757, DOI 10.1038/ng.3319; Kondo T, 2013, CELL STEM CELL, V12, P487, DOI 10.1016/j.stem.2013.01.009; Krishnamoorthy J, 2014, CELL CYCLE, V13, P801, DOI 10.4161/cc.27726; Kudo T, 2008, CELL DEATH DIFFER, V15, P364, DOI 10.1038/sj.cdd.4402276; Lee AH, 2008, SCIENCE, V320, P1492, DOI 10.1126/science.1158042; Lee AH, 2011, P NATL ACAD SCI USA, V108, P8885, DOI 10.1073/pnas.1105564108; Lee JS, 2012, AM J TRANSL RES, V4, P102; Lee JH, 2011, NAT MED, V17, P812, DOI 10.1038/nm.2347; Lerner AG, 2012, CELL METAB, V16, P250, DOI 10.1016/j.cmet.2012.07.007; Levi-Ferber M, 2015, ELIFE, V4, DOI 10.7554/eLife.08005; Li K, 2015, J BIOL CHEM, V290, P8185, DOI 10.1074/jbc.M114.633990; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Lu M, 2014, SCIENCE, V345, P98, DOI 10.1126/science.1254312; Lu PD, 2004, EMBO J, V23, P169, DOI 10.1038/sj.emboj.7600030; Mahadevan NR, 2011, P NATL ACAD SCI USA, V108, P6561, DOI 10.1073/pnas.1008942108; Malhotra JD, 2008, P NATL ACAD SCI USA, V105, P18525, DOI 10.1073/pnas.0809677105; Mao T, 2011, P NATL ACAD SCI USA, V108, P15852, DOI 10.1073/pnas.1107394108; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Marhfour I, 2012, DIABETOLOGIA, V55, P2417, DOI 10.1007/s00125-012-2604-3; Martinon F, 2010, NAT IMMUNOL, V11, P411, DOI 10.1038/ni.1857; Menu P, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2011.132; Moreno JA, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006767; Moreno JA, 2012, NATURE, V485, P507, DOI 10.1038/nature11058; Nakagawa H, 2014, CANCER CELL, V26, P331, DOI 10.1016/j.ccr.2014.07.001; Nichols WC, 1998, CELL, V93, P61, DOI 10.1016/S0092-8674(00)81146-0; Ozcan L, 2009, CELL METAB, V9, P35, DOI 10.1016/j.cmet.2008.12.004; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Pottekat A, 2013, CELL REP, V4, P921, DOI 10.1016/j.celrep.2013.07.050; Qiu Q, 2013, EMBO J, V32, P2477, DOI 10.1038/emboj.2013.183; Qiu YF, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000514; Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509; Rutkowski DT, 2006, PLOS BIOL, V4, P2024, DOI 10.1371/journal.pbio.0040374; Rutkowski DT, 2008, DEV CELL, V15, P829, DOI 10.1016/j.devcel.2008.10.015; Sandow JJ, 2014, CELL DEATH DIFFER, V21, P475, DOI 10.1038/cdd.2013.168; Sawkar AR, 2002, P NATL ACAD SCI USA, V99, P15428, DOI 10.1073/pnas.192582899; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Sekine Y, 2015, SCIENCE, V348, P1027, DOI 10.1126/science.aaa6986; Seo J, 2009, DIABETES, V58, P2565, DOI 10.2337/db09-0335; Shaffer AL, 2004, IMMUNITY, V21, P81, DOI 10.1016/j.immuni.2004.06.010; Shimura H, 2001, SCIENCE, V293, P263, DOI 10.1126/science.1060627; Sidrauski C, 2013, ELIFE, V2, DOI 10.7554/eLife.00498; So JS, 2012, CELL METAB, V16, P487, DOI 10.1016/j.cmet.2012.09.004; Song BB, 2008, J CLIN INVEST, V118, P3378, DOI 10.1172/JCI34587; Tam AB, 2014, CELL REP, V9, P850, DOI 10.1016/j.celrep.2014.09.016; Taylor RC, 2013, CELL, V153, P1435, DOI 10.1016/j.cell.2013.05.042; Tersey SA, 2012, DIABETES, V61, P818, DOI 10.2337/db11-1293; Uehara T, 2006, NATURE, V441, P513, DOI 10.1038/nature04782; Upton JP, 2012, SCIENCE, V338, P818, DOI 10.1126/science.1226191; Usui M, 2012, METABOLISM, V61, P1118, DOI 10.1016/j.metabol.2012.01.004; Vidal RL, 2012, HUM MOL GENET, V21, P2245, DOI 10.1093/hmg/dds040; Volmer R, 2013, P NATL ACAD SCI USA, V110, P4628, DOI 10.1073/pnas.1217611110; Wang M, 2014, NAT REV CANCER, V14, P581, DOI 10.1038/nrc3800; Wang R, 2013, J BIOL CHEM, V288, P33824, DOI 10.1074/jbc.M113.503664; Wang SY, 2012, CELL METAB, V16, P473, DOI 10.1016/j.cmet.2012.09.003; Wang XZ, 1996, SCIENCE, V272, P1347, DOI 10.1126/science.272.5266.1347; Wang YG, 2009, NATURE, V460, P534, DOI 10.1038/nature08111; Williams KJ, 2013, CANCER RES, V73, P2850, DOI 10.1158/0008-5472.CAN-13-0382-T; Williams KW, 2014, CELL METAB, V20, P471, DOI 10.1016/j.cmet.2014.06.002; Wu J, 2007, DEV CELL, V13, P351, DOI 10.1016/j.devcel.2007.07.005; Xiao CT, 2011, DIABETES, V60, P918, DOI 10.2337/db10-1433; Yamamoto K, 2007, DEV CELL, V13, P365, DOI 10.1016/j.devcel.2007.07.018; Yang L, 2015, SCIENCE, V349, P500, DOI 10.1126/science.aaa0079; Yu KF, 2014, FEBS J, V281, P2399, DOI 10.1111/febs.12792; Yusta B, 2006, CELL METAB, V4, P391, DOI 10.1016/j.cmet.2006.10.001; Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203; Zhang KZ, 2011, EMBO J, V30, P1357, DOI 10.1038/emboj.2011.52; Zhang KZ, 2005, J CLIN INVEST, V115, P268, DOI 10.1172/JCI200521848; Zhang KZ, 2006, CELL, V124, P587, DOI 10.1016/j.cell.2005.11.040; Zhao LH, 2005, NAT GENET, V37, P974, DOI 10.1038/ng1620; Zhou AX, 2015, CIRC RES, V116, P1736, DOI 10.1161/CIRCRESAHA.116.305602; Zhou JH, 2006, P NATL ACAD SCI USA, V103, P14343, DOI 10.1073/pnas.0606480103; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982; Zuleta A, 2012, BIOCHEM BIOPH RES CO, V420, P558, DOI 10.1016/j.bbrc.2012.03.033	125	833	883	27	325	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 21	2016	529	7586					326	335		10.1038/nature17041	http://dx.doi.org/10.1038/nature17041			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB2QT	26791723				2022-12-28	WOS:000368354800034
J	Allen, KD; Yancy, WS; Bosworth, HB; Coffman, CJ; Jeffreys, AS; Datta, SK; McDuffie, J; Strauss, JL; Oddone, EZ				Allen, Kelli D.; Yancy, William S., Jr.; Bosworth, Hayden B.; Coffman, Cynthia J.; Jeffreys, Amy S.; Datta, Santanu K.; McDuffie, Jennifer; Strauss, Jennifer L.; Oddone, Eugene Z.			A Combined Patient and Provider Intervention for Management of Osteoarthritis in Veterans A Randomized Clinical Trial	ANNALS OF INTERNAL MEDICINE			English	Article							KNEE OSTEOARTHRITIS; OLDER-ADULTS; PHYSICAL-ACTIVITY; LOWER-EXTREMITIES; UNITED-STATES; HIP; OUTCOMES; ARTHRITIS; DISABILITY; CARE	Background: Management of osteoarthritis requires both medical and behavioral strategies, but some recommended therapies are underused. Objective: To examine the effectiveness of a combined patient and provider intervention for improving osteoarthritis outcomes. Design: Cluster randomized clinical trial with assignment to osteoarthritis intervention and usual care groups. (ClinicalTrials.gov: NCT01130740) Setting: Department of Veterans Affairs Medical Center in Durham, North Carolina. Participants: 30 providers (clusters) and 300 outpatients with symptomatic hip or knee osteoarthritis. Intervention: The telephone-based patient intervention focused on weight management, physical activity, and cognitive behavioral pain management. The provider intervention involved delivery of patient-specific osteoarthritis treatment recommendations to primary care providers through the electronic medical record. Measurements: The primary outcome was total score on the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) at 12 months. Secondary outcomes were WOMAC function and pain subscale scores, physical performance (Short Physical Performance Battery), and depressive symptoms (Patient Health Questionnaire-8). Linear mixed models that were adjusted for clustering of providers assessed between-group differences in improvement in outcomes. Results: At 12 months, WOMAC scores were 4.1 points lower (indicating improvement) in the osteoarthritis intervention group versus usual care (95% CI, -7.2 to -1.1 points; P = 0.009). WOMAC function subscale scores were 3.3 points lower in the intervention group (CI, -5.7 to -1.0 points; P = 0.005). WOMAC pain subscale scores (P = 0.126), physical performance, and depressive symptoms did not differ between groups. Although more patients in the osteoarthritis intervention group received provider referral for recommended osteoarthritis treatments, the numbers who received them did not differ. Limitation: The study was conducted in a single Veterans Affairs medical center. Conclusion: The combined patient and provider intervention resulted in modest improvement in self-reported physical function in patients with hip and knee osteoarthritis.	Duke Univ, Durham VA Med Ctr, Durham, NC USA; Duke Univ, Med Ctr, Durham, NC USA; Univ N Carolina, Chapel Hill, NC USA	Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; Duke University; University of North Carolina; University of North Carolina Chapel Hill	Allen, KD (corresponding author), Durham VA Med Ctr, Hlth Serv Res & Dev 152, 508 Fulton St, Durham, NC 27705 USA.	Kelli.allen@va.gov			Department of Veterans Affairs, Health Services Research and Development Service [IIR 10-126]; Career Scientist award [08-027]; Veterans Affairs [I01HX000449] Funding Source: NIH RePORTER	Department of Veterans Affairs, Health Services Research and Development Service(US Department of Veterans Affairs); Career Scientist award; Veterans Affairs(US Department of Veterans Affairs)	This project was supported by the Department of Veterans Affairs, Health Services Research and Development Service (IIR 10-126). Dr. Bosworth is funded by a Career Scientist award (08-027).	Allen KD, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-60; ALTMAN R, 1986, ARTHRITIS RHEUM, V29, P1039, DOI 10.1002/art.1780290816; Altman RD, 2000, ARTHRITIS RHEUM-US, V43, P1905; Angst F, 2001, ARTHRIT RHEUM-ARTHR, V45, P384, DOI 10.1002/1529-0131(200108)45:4<384::AID-ART352>3.0.CO;2-0; Angst F, 2002, J RHEUMATOL, V29, P131; [Anonymous], 1999, STAT MED, V18, P1905; Asch SM, 2004, ANN INTERN MED, V141, P938, DOI 10.7326/0003-4819-141-12-200412210-00010; Balding DJ, 2004, APPL LONGITUDINAL AN; Bellamy N, 2002, J RHEUMATOL, V29, P2473; BELLAMY N, 1988, J RHEUMATOL, V15, P1833; BELLAMY N, 1986, CLIN RHEUMATOL, V5, P231, DOI 10.1007/BF02032362; Bennell KL, 2014, ARTHRITIS RHEUMATOL, V66, P950, DOI 10.1002/art.38317; Black SA, 1998, J GERONTOL A-BIOL, V53, pM188, DOI 10.1093/gerona/53A.3.M188; Borm GF, 2007, J CLIN EPIDEMIOL, V60, P1234, DOI 10.1016/j.jclinepi.2007.02.006; Centers for Disease Control and Prevention (CDC), 2010, MMWR Morb Mortal Wkly Rep, V59, P1261; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P948; Colbert CJ, 2013, ARTHRIT CARE RES, V65, P5, DOI 10.1002/acr.21811; Dhawan A, 2014, ARTHROSCOPY, V30, P65, DOI 10.1016/j.arthro.2013.09.002; DiClemente C.C., 2002, MOTIVATIONAL INTERVI, V2nd ed., P201; Diggle P., 2002, ANAL LONGITUDINAL DA, DOI DOI 10.2307/2983303; Dixon KE, 2007, HEALTH PSYCHOL, V26, P241, DOI 10.1037/0278-6133.26.3.241; Dobson F, 2013, OSTEOARTHR CARTILAGE, V21, P1042, DOI 10.1016/j.joca.2013.05.002; Dunlop DD, 2011, ARTHRITIS RHEUM-US, V63, P3372, DOI 10.1002/art.30562; Ehrich EW, 2000, J RHEUMATOL, V27, P2635; Freedman M., 2007, Morbidity and Mortality Weekly Report, V56, P423; Ganz DA, 2006, ARTHRIT RHEUM-ARTHR, V55, P241, DOI 10.1002/art.21844; GURALNIK JM, 1994, J GERONTOL, V49, pM85, DOI 10.1093/geronj/49.2.M85; Harada ND, 2001, MED SCI SPORT EXER, V33, P962, DOI 10.1097/00005768-200106000-00016; Hedeker D., 2006, LONGITUDINAL DATA AN; Hekler EB, 2012, J PHYS ACT HEALTH, V9, P225, DOI 10.1123/jpah.9.2.225; Hochberg MC, 2012, ARTHRIT CARE RES, V64, P465, DOI 10.1002/acr.21596; Hughes SL, 2006, GERONTOLOGIST, V46, P801, DOI 10.1093/geront/46.6.801; Johnson VL, 2014, BEST PRACT RES CL RH, V28, P5, DOI 10.1016/j.berh.2014.01.004; Klar N, 2000, DESIGN ANAL CLUSTER, DOI [10.17843/rpmesp.2016.333.2293, DOI 10.17843/RPMESP.2016.333.2293]; Kotlarz H, 2009, ARTHRITIS RHEUM-US, V60, P3546, DOI 10.1002/art.24984; Kroenke K, 2009, J AFFECT DISORDERS, V114, P163, DOI 10.1016/j.jad.2008.06.026; Lawrence RC, 2008, ARTHRITIS RHEUM, V58, P26, DOI 10.1002/art.23176; Little R.J.A., 2002, STAT ANAL MISSING DA; Liu GHF, 2009, STAT MED, V28, P2509, DOI 10.1002/sim.3639; Losina E, 2011, ANN INTERN MED, V154, P217, DOI 10.7326/0003-4819-154-4-201102150-00001; Lowe B, 2004, MED CARE, V42, P1194, DOI 10.1097/00005650-200412000-00006; Lubar D, 2010, SEMIN ARTHRITIS RHEU, V39, P323, DOI 10.1016/j.semarthrit.2010.02.002; Mamlin LA, 1998, ARCH FAM MED, V7, P563, DOI 10.1001/archfami.7.6.563; McAlindon TE, 2014, OSTEOARTHR CARTILAGE, V22, P363, DOI 10.1016/j.joca.2014.01.003; McDonough CM, 2010, CLIN GERIATR MED, V26, P387, DOI 10.1016/j.cger.2010.04.001; Messier SP, 2013, JAMA-J AM MED ASSOC, V310, P1263, DOI 10.1001/jama.2013.277669; Nguyen USDT, 2011, ANN INTERN MED, V155, P725, DOI 10.7326/0003-4819-155-11-201112060-00004; Pasquale MK, 2014, PAIN PRACT, V14, P117, DOI 10.1111/papr.12066; Perera S, 2006, J AM GERIATR SOC, V54, P743, DOI 10.1111/j.1532-5415.2006.00701.x; Richmond J, 2010, J BONE JOINT SURG AM, V92A, P990, DOI 10.2106/JBJS.I.00982; Romanova M, 2013, PREV CHRONIC DIS, V10, DOI 10.5888/pcd10.120325; Somers TJ, 2012, PAIN, V153, P1199, DOI 10.1016/j.pain.2012.02.023; Song J, 2006, ARTHRIT RHEUM-ARTHR, V55, P248, DOI 10.1002/art.21842; Song J, 2013, ARTHRIT CARE RES, V65, P195, DOI 10.1002/acr.21803; Stewart AL, 2001, MED SCI SPORT EXER, V33, P1126, DOI 10.1097/00005768-200107000-00010; Swanson AJ, 1999, J NERV MENT DIS, V187, P630, DOI 10.1097/00005053-199910000-00007; US Department of Health and Human Services, 2008, PHYS ACT GUID AM; Weigl M, 2006, OSTEOARTHR CARTILAGE, V14, P641, DOI 10.1016/j.joca.2006.01.001; Zhang W, 2010, OSTEOARTHR CARTILAGE, V18, P476, DOI 10.1016/j.joca.2010.01.013; Zullig LL, 2015, CLIN RHEUMATOL, V34, P1435, DOI 10.1007/s10067-014-2707-y	60	25	25	0	10	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 19	2016	164	2					73	+		10.7326/M15-0378	http://dx.doi.org/10.7326/M15-0378			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DB0CI	26720751	Green Accepted			2022-12-28	WOS:000368175800011
J	Ball, P				Ball, Philip			New chemistry revives elementary question	NATURE			English	Editorial Material												p.ball@btinternet.com							0	3	3	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 14	2016	529	7585					129	129		10.1038/529129a	http://dx.doi.org/10.1038/529129a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA7WK	26762423	Bronze			2022-12-28	WOS:000368015700004
J	McGlynn, EA; Kerr, EA				McGlynn, Elizabeth A.; Kerr, Eve A.			Creating Safe Harbors for Quality Measurement Innovation and Improvement	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[McGlynn, Elizabeth A.] Kaiser Permanente, Ctr Effectiveness & Safety Res, Pasadena, CA 91101 USA; [Kerr, Eve A.] Dept Vet Affairs, Ctr Clin Management Res, Ann Arbor, MI USA; [Kerr, Eve A.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Kerr, Eve A.] Inst Healthcare Policy & Innovat, Ann Arbor, MI USA	Kaiser Permanente; University of Michigan System; University of Michigan	McGlynn, EA (corresponding author), Kaiser Permanente, Ctr Effectiveness & Safety Res, 100 S Los Robles,Third Floor, Pasadena, CA 91101 USA.	elizabeth.a.mcglynn@kp.org						Department for Education, 2022, SUMMARY CO2 MONITORS; Eijkenaar F, 2013, HEALTH POLICY, V110, P115, DOI 10.1016/j.healthpol.2013.01.008; McGlynn EA, 2014, NEW ENGL J MED, V371, P2150, DOI 10.1056/NEJMp1407883; Saini SD, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1247; Schmittdiel JA, 2014, AM J MANAG CARE, V20, pE573; Totten Annette M, 2012, Evid Rep Technol Assess (Full Rep), P1	6	7	7	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 12	2016	315	2					129	130		10.1001/jama.2015.16858	http://dx.doi.org/10.1001/jama.2015.16858			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DA6XO	26757459				2022-12-28	WOS:000367949200009
J	Bossert, TJ; Leisewitz, T				Bossert, Thomas J.; Leisewitz, Thomas			INTERNATIONAL HEALTH CARE SYSTEMS Innovation and Change in the Chilean Health System	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							EQUITY		[Bossert, Thomas J.] Harvard TH Chan Sch Publ Hlth, Boston, MA 02115 USA; [Leisewitz, Thomas] Pontificia Univ Catolica Chile, Santiago, Chile	Harvard University; Harvard T.H. Chan School of Public Health; Pontificia Universidad Catolica de Chile	Bossert, TJ (corresponding author), Harvard TH Chan Sch Publ Hlth, Boston, MA 02115 USA.							Bossert TJ, 2003, B WORLD HEALTH ORGAN, V81, P95; Frenz P, 2014, HEALTH POLICY PLANN, V29, P717, DOI 10.1093/heapol/czt054; Jimenez de la Jara J, 1995, HLTH SECTOR REFORM D, P199; Jimenez J, 2007, HEALTH AFFAIR, V26, P458, DOI 10.1377/hlthaff.26.2.458; Nazzal C, 2008, REV MED CHILE, V136, P1231, DOI /S0034-98872008001000001	5	43	45	1	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 7	2016	374	1					1	5		10.1056/NEJMp1514202	http://dx.doi.org/10.1056/NEJMp1514202			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DA1UH	26735989				2022-12-28	WOS:000367580500001
J	Chawla, DS				Chawla, Dalmeet Singh			THE UNSUNG HEROES OF SCIENTIFIC SOFTWARE	NATURE			English	Editorial Material																			0	22	22	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 7	2016	529	7584					115	116						2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6VY	26738597	Bronze			2022-12-28	WOS:000367944900038
J	Mogabgab, ON; Osman, NY; Wei, K; Batal, I; Loscalzo, J				Mogabgab, Owen N.; Osman, Nora Y.; Wei, Kevin; Batal, Ibrahim; Loscalzo, Joseph			A Complementary Affair	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PRIMARY SJOGRENS-SYNDROME; RANDOMIZED CONTROLLED-TRIAL; DISEASE-ACTIVITY INDEX; CRYOGLOBULINEMIA; RITUXIMAB		[Mogabgab, Owen N.] Univ Texas Southwestern Med Sch, Dept Med, Parkland Hosp, Dallas, TX USA; [Osman, Nora Y.; Wei, Kevin; Loscalzo, Joseph] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Batal, Ibrahim] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Batal, Ibrahim] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Loscalzo, J (corresponding author), Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA.	jloscalzo@partners.org	Loscalzo, Joseph/ABD-8980-2021					Alamanos Y, 2006, RHEUMATOLOGY, V45, P187, DOI 10.1093/rheumatology/kei107; Baldini C, 2014, RHEUMATOLOGY, V53, P839, DOI 10.1093/rheumatology/ket427; Brito-Zeron P, 2007, RHEUMATOLOGY, V46, P1359, DOI 10.1093/rheumatology/kem079; De Vita S, 2012, ARTHRITIS RHEUM-US, V64, P843, DOI 10.1002/art.34331; Goules AV, 2013, ARTHRITIS RHEUM-US, V65, P2945, DOI 10.1002/art.38100; MELTZER M, 1966, AM J MED, V40, P828, DOI 10.1016/0002-9343(66)90199-9; MUSSET L, 1992, CLIN CHEM, V38, P798; Ramos-Casals M, 1998, SEMIN ARTHRITIS RHEU, V28, P200, DOI 10.1016/S0049-0172(98)80037-1; Ramos-Casals M, 2012, BMJ-BRIT MED J, V344, DOI [10.1136/bmj.e3821, 10.1024/1661-8157/a001133]; Ramos-Casals M, 2014, RHEUMATOLOGY, V53, P321, DOI 10.1093/rheumatology/ket349; Seror R, 2013, ARTHRIT CARE RES, V65, P1358, DOI 10.1002/acr.21991; Sneller MC, 2012, ARTHRITIS RHEUM-US, V64, P835, DOI 10.1002/art.34322; Tedeschi A, 2007, BLOOD REV, V21, P183, DOI 10.1016/j.blre.2006.12.002; Theander E, 2004, ARTHRITIS RHEUM-US, V50, P1262, DOI 10.1002/art.20176; Voulgarelis M, 1999, ARTHRITIS RHEUM-US, V42, P1765, DOI 10.1002/1529-0131(199908)42:8<1765::AID-ANR28>3.0.CO;2-V	15	1	1	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 7	2016	374	1					74	81		10.1056/NEJMcps1404086	http://dx.doi.org/10.1056/NEJMcps1404086			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DA1UH	26735996				2022-12-28	WOS:000367580500012
J	Kitzman, DW; Brubaker, P; Morgan, T; Haykowsky, M; Hundley, G; Kraus, WE; Eggebeen, J; Nicklas, BJ				Kitzman, Dalane W.; Brubaker, Peter; Morgan, Timothy; Haykowsky, Mark; Hundley, Gregory; Kraus, William E.; Eggebeen, Joel; Nicklas, Barbara J.			Effect of Caloric Restriction or Aerobic Exercise Training on Peak Oxygen Consumption and Quality of Life in Obese Older Patients With Heart Failure With Preserved Ejection Fraction A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NATRIURETIC PEPTIDE LEVELS; SINGLE-BLIND TRIAL; SKELETAL-MUSCLE; BARIATRIC SURGERY; PHYSICAL FUNCTION; WEIGHT-LOSS; ELDERLY-PATIENTS; INTOLERANCE; CAPACITY; ADULTS	IMPORTANCE More than 80% of patients with heart failure with preserved ejection fraction (HFPEF), the most common form of heart failure among older persons, are overweight or obese. Exercise intolerance is the primary symptom of chronic HFPEF and a major determinant of reduced quality of life (QOL). OBJECTIVE To determine whether caloric restriction (diet) or aerobic exercise training (exercise) improves exercise capacity and QOL in obese older patients with HFPEF. DESIGN, SETTING, AND PARTICIPANTS Randomized, attention-controlled, 2 x 2 factorial trial conducted from February 2009 through November 2014 in an urban academic medical center. Of 577 initially screened participants, 100 older obese participants (mean [SD]: age, 67 years [5]; body mass index, 39.3 [5.6]) with chronic, stable HFPEF were enrolled (366 excluded by inclusion and exclusion criteria, 31 for other reasons, and 80 declined participation). INTERVENTIONS Twenty weeks of diet, exercise, or both; attention control consisted of telephone calls every 2 weeks. MAIN OUTCOMES AND MEASURES Exercise capacity measured as peak oxygen consumption ((V)over dotO(2), mL/kg/min; co-primary outcome) and QOL measured by the Minnesota Living with Heart Failure (MLHF) Questionnaire (score range: 0-105, higher scores indicate worse heart failure-related QOL; co-primary outcome). RESULTS Of the 100 enrolled participants, 26 participants were randomized to exercise; 24 to diet; 25 to exercise + diet; 25 to control. Of these, 92 participants completed the trial. Exercise attendance was 84%(SD, 14%) and diet adherence was 99%(SD, 1%). By main effects analysis, peak (V)over dotO(2) was increased significantly by both interventions: exercise, 1.2 mL/kg body mass/min (95% CI, 0.7 to 1.7), P < .001; diet, 1.3 mL/kg body mass/min (95% CI, 0.8 to 1.8), P < .001. The combination of exercise + diet was additive (complementary) for peak (V)over dotO(2) (joint effect, 2.5 mL/kg/min). There was no statistically significant change in MLHF total score with exercise and with diet (main effect: exercise, -1 unit [95% CI, -8 to 5], P = .70; diet, -6 units [95% CI, -12 to 1], P = .08). The change in peak (V)over dotO(2) was positively correlated with the change in percent lean body mass (r = 0.32; P = .003) and the change in thigh muscle: intermuscular fat ratio (r = 0.27; P = .02). There were no study-related serious adverse events. Body weight decreased by 7%(7 kg [SD, 1]) in the diet group, 3%(4 kg [SD, 1]) in the exercise group, 10% (11 kg [SD, 1] in the exercise + diet group, and 1% (1 kg [SD, 1]) in the control group. CONCLUSIONS AND RELEVANCE Among obese older patients with clinically stable HFPEF, caloric restriction or aerobic exercise training increased peak (V)over dotO(2), and the effects may be additive. Neither intervention had a significant effect on quality of life as measured by the MLHF Questionnaire.	[Kitzman, Dalane W.; Hundley, Gregory] Wake Forest Sch Med, Dept Internal Med, Cardiol Sect, Winston Salem, NC 27157 USA; [Brubaker, Peter] Wake Forest Univ, Dept Hlth & Exercise Sci, Winston Salem, NC 27109 USA; [Morgan, Timothy] Wake Forest Sch Med, Dept Publ Hlth Sci, Winston Salem, NC 27157 USA; [Haykowsky, Mark] Univ Texas Arlington, Coll Nursing & Hlth Innovat, Arlington, TX USA; [Kraus, William E.] Duke Univ, Sch Med, Durham, NC USA; [Eggebeen, Joel] Emory Univ, Sch Med, Atlanta, GA USA; [Nicklas, Barbara J.] Wake Forest Sch Med, Geriatr & Gerontol Sect, Dept Internal Med, Winston Salem, NC 27157 USA	Wake Forest University; Wake Forest University; Wake Forest University; University of Texas System; University of Texas Arlington; Duke University; Emory University; Wake Forest University	Kitzman, DW (corresponding author), Wake Forest Sch Med, Med Ctr Blvd, Winston Salem, NC 27157 USA.	dkitzman@wfubmc.edu	Nicklas, Barbara/AAA-2781-2020	Haykowsky, Mark/0000-0002-7217-2747	National Institutes of Health [R01AG18915, P30AG021332, R01HL093713, R01AG020583]; Kermit Glenn Phillips II Chair in Cardiovascular Medicine at Wake Forest School of Medicine; Mortiz Chair in Geriatric Nursing Research in the College of Nursing and Health Innovation at The University of Texas at Arlington; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001420] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR007122] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093713] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG021332, R01AG020583, R37AG018915, R01AG018915] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kermit Glenn Phillips II Chair in Cardiovascular Medicine at Wake Forest School of Medicine; Mortiz Chair in Geriatric Nursing Research in the College of Nursing and Health Innovation at The University of Texas at Arlington; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by research grants R01AG18915, P30AG021332, R01HL093713, and R01AG020583 from the National Institutes of Health. Also supported in part by the Kermit Glenn Phillips II Chair in Cardiovascular Medicine at Wake Forest School of Medicine (Dr Kitzman) and the Mortiz Chair in Geriatric Nursing Research in the College of Nursing and Health Innovation at The University of Texas at Arlington (Dr Haykowsky).	Anjan VY, 2012, AM J CARDIOL, V110, P870, DOI 10.1016/j.amjcard.2012.05.014; Beavers KM, 2013, AM J CLIN NUTR, V97, P552, DOI 10.3945/ajcn.112.047860; Beavers KM, 2013, J GERONTOL A-BIOL, V68, P80, DOI 10.1093/gerona/gls092; Bharadwaj M, 2013, GERONTOLOGIST, V53, P945; Bowen TS, 2015, EUR J HEART FAIL, V17, P263, DOI 10.1002/ejhf.239; Civitarese AE, 2007, PLOS MED, V4, P485, DOI 10.1371/journal.pmed.0040076; Dhakal BP, 2015, CIRC-HEART FAIL, V8, P286, DOI 10.1161/CIRCHEARTFAILURE.114.001825; Edelmann F, 2011, J AM COLL CARDIOL, V58, P1780, DOI 10.1016/j.jacc.2011.06.054; Flynn KE, 2009, JAMA-J AM MED ASSOC, V301, P1451, DOI 10.1001/jama.2009.457; Haass M, 2011, CIRC-HEART FAIL, V4, P324, DOI 10.1161/CIRCHEARTFAILURE.110.959890; Haykowsky MJ, 2014, AM J CARDIOL, V113, P1211, DOI 10.1016/j.amjcard.2013.12.031; Haykowsky MJ, 2013, J GERONTOL A-BIOL, V68, P968, DOI 10.1093/gerona/glt011; Haykowsky MJ, 2012, J AM COLL CARDIOL, V60, P120, DOI 10.1016/j.jacc.2012.02.055; Haykowsky MJ, 2011, J AM COLL CARDIOL, V58, P265, DOI 10.1016/j.jacc.2011.02.055; Heinonen I, 2012, J APPL PHYSIOL, V112, P1059, DOI 10.1152/japplphysiol.00732.2011; Kenchaiah S, 2002, NEW ENGL J MED, V347, P305, DOI 10.1056/NEJMoa020245; Kitzman DW, 2014, AM J PHYSIOL-HEART C, V306, pH1364, DOI 10.1152/ajpheart.00004.2014; Kitzman DW, 2013, J AM COLL CARDIOL, V62, P584, DOI 10.1016/j.jacc.2013.04.033; Kitzman DW, 2010, CIRC-HEART FAIL, V3, P659, DOI 10.1161/CIRCHEARTFAILURE.110.958785; Kitzman DW, 2002, JAMA-J AM MED ASSOC, V288, P2144, DOI 10.1001/jama.288.17.2144; Kritchevsky SB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121993; Miranda WR, 2013, OBES SURG, V23, P1011, DOI 10.1007/s11695-013-0953-8; Morkedal B, 2014, J AM COLL CARDIOL, V63, P1071, DOI 10.1016/j.jacc.2013.11.035; Nicklas BJ, 2009, AM J CLIN NUTR, V89, P1043, DOI 10.3945/ajcn.2008.26938; Normandin Eve, 2015, Curr Nutr Rep, V4, P143, DOI 10.1007/s13668-015-0123-9; Owan TE, 2006, NEW ENGL J MED, V355, P251, DOI 10.1056/NEJMoa052256; Prior SJ, 2014, DIABETES CARE, V37, P1469, DOI 10.2337/dc13-2358; RECTOR TS, 1992, AM HEART J, V124, P1017, DOI 10.1016/0002-8703(92)90986-6; Redfield MM, 2013, JAMA-J AM MED ASSOC, V309, P1268, DOI 10.1001/jama.2013.2024; RICH MW, 1995, NEW ENGL J MED, V333, P1190, DOI 10.1056/NEJM199511023331806; Ryan D, 2014, OBESITY, V22, pS1, DOI 10.1002/oby.20819; SCHOCKEN DD, 1992, J AM COLL CARDIOL, V20, P301, DOI 10.1016/0735-1097(92)90094-4; Scott JM, 2012, AM J CARDIOL, V110, P1809, DOI 10.1016/j.amjcard.2012.08.015; Sharma K, 2014, CIRC RES, V115, P79, DOI 10.1161/CIRCRESAHA.115.302922; Sjostrom L, 2012, JAMA-J AM MED ASSOC, V307, P56, DOI 10.1001/jama.2011.1914; Stavrakis S, 2013, AM J MED SCI, V345, P211, DOI 10.1097/MAJ.0b013e318271c012; Stehle JR, 2012, J GERONTOL A-BIOL, V67, P1212, DOI 10.1093/gerona/gls178; Villareal DT, 2011, NEW ENGL J MED, V364, P1218, DOI 10.1056/NEJMoa1008234; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wilms B, 2013, OBES SURG, V23, P365, DOI 10.1007/s11695-012-0795-9; Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019	41	409	415	5	76	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 5	2016	315	1					36	46		10.1001/jama.2015.17346	http://dx.doi.org/10.1001/jama.2015.17346			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DA0YH	26746456	Green Accepted, Bronze			2022-12-28	WOS:000367523000013
J	Lin, KW; Gostin, LO				Lin, Kenneth W.; Gostin, Lawrence O.			A Public Health Framework for Screening Mammography Evidence-Based vs Politically Mandated Care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SERVICES TASK-FORCE		[Lin, Kenneth W.] Georgetown Univ, Med Ctr, Dept Family Med, Washington, DC 20007 USA; [Gostin, Lawrence O.] Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, 600 New Jersey Ave NW, Washington, DC 20001 USA	Georgetown University; Georgetown University	Gostin, LO (corresponding author), Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, 600 New Jersey Ave NW, Washington, DC 20001 USA.	gostin@law.georgetown.edu						Mandelblatt JS, 2016, ANN INTERN MED, V164, P215, DOI 10.7326/M15-1536; Nelson HD, 2016, ANN INTERN MED, V164, P244, DOI 10.7326/M15-0969; Oeffinger KC, 2015, JAMA-J AM MED ASSOC, V314, P1599, DOI 10.1001/jama.2015.12783; Siu AL, 2016, ANN INTERN MED, V164, P279, DOI 10.7326/M15-2886; Siu AL, 2015, JAMA-J AM MED ASSOC, V314, P2021, DOI 10.1001/jama.2015.13154; Woolf SH, 2013, JAMA-J AM MED ASSOC, V309, P1899, DOI 10.1001/jama.2013.3448; Young Kerry, 2015, CQ HEALTHBEAT N 1218	7	7	7	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 8	2016	315	10					977	978		10.1001/jama.2016.0322	http://dx.doi.org/10.1001/jama.2016.0322			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DF7LW	26779886				2022-12-28	WOS:000371540200005
J	Wang, CY; Zhang, GS; Ge, SH; Xu, T; Ji, Y; Yang, XG; Leng, YJ				Wang, Chao-Yang; Zhang, Guangsheng; Ge, Shanhai; Xu, Terrence; Ji, Yan; Yang, Xiao-Guang; Leng, Yongjun			Lithium-ion battery structure that self-heats at low temperatures	NATURE			English	Article							PERFORMANCE	Lithium-ion batteries suffer severe power loss at temperatures below zero degrees Celsius, limiting their use in applications such as electric cars in cold climates and high-altitude drones(1,2). The practical consequences of such power loss are the need for larger, more expensive battery packs to perform engine cold cranking, slow charging in cold weather, restricted regenerative braking, and reduction of vehicle cruise range by as much as 40 per cent(3). Previous attempts to improve the low-temperature performance of lithium-ion batteries(4) have focused on developing additives to improve the low-temperature behaviour of electrolytes(5,6), and on externally heating and insulating the cells(7-9). Here we report a lithium-ion battery structure, the 'all-climate battery' cell, that heats itself up from below zero degrees Celsius without requiring external heating devices or electrolyte additives. The self-heating mechanism creates an electrochemical interface that is favourable for high discharge/charge power. We show that the internal warm-up of such a cell to zero degrees Celsius occurs within 20 seconds at minus 20 degrees Celsius and within 30 seconds at minus 30 degrees Celsius, consuming only 3.8 per cent and 5.5 per cent of cell capacity, respectively. The self-heated all-climate battery cell yields a discharge/regeneration power of 1,061/1,425 watts per kilogram at a 50 per cent state of charge and at minus 30 degrees Celsius, delivering 6.4-12.3 times the power of state-of-the-art lithium-ion cells. We expect the all-climate battery to enable engine stop-start technology capable of saving 5-10 per cent of the fuel for 80 million new vehicles manufactured every year(10). Given that only a small fraction of the battery energy is used for self-heating, we envisage that the all-climate battery cell may also prove useful for plug-in electric vehicles, robotics and space exploration applications.	[Wang, Chao-Yang; Zhang, Guangsheng; Yang, Xiao-Guang; Leng, Yongjun] Penn State Univ, Dept Mech & Nucl Engn, University Pk, PA 16802 USA; [Wang, Chao-Yang; Zhang, Guangsheng; Yang, Xiao-Guang; Leng, Yongjun] Penn State Univ, Electrochem Engine Ctr ECEC, University Pk, PA 16802 USA; [Wang, Chao-Yang; Ge, Shanhai; Xu, Terrence; Ji, Yan] EC Power, 341 Sci Pk Rd, State Coll, PA 16803 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Wang, CY (corresponding author), Penn State Univ, Dept Mech & Nucl Engn, University Pk, PA 16802 USA.; Wang, CY (corresponding author), Penn State Univ, Electrochem Engine Ctr ECEC, University Pk, PA 16802 USA.; Wang, CY (corresponding author), EC Power, 341 Sci Pk Rd, State Coll, PA 16803 USA.	cxw31@psu.edu	Zhang, Guangsheng/D-7369-2011; Wang, Chao-Yang/C-4122-2009; Yang, Xiao-Guang/L-5290-2013; Leng, Yongjun/C-6523-2008; Ji, Yan/G-3031-2016; Wang, Chao/GXF-8353-2022	Zhang, Guangsheng/0000-0001-9052-6345; Yang, Xiao-Guang/0000-0002-9880-3682; Leng, Yongjun/0000-0001-9868-0195; Ji, Yan/0000-0001-9088-1670; 				[Anonymous], 2014, NEWSROOM        0320; Armand M, 2008, NATURE, V451, P652, DOI 10.1038/451652a; Chen KB, 2015, J POWER SOURCES, V278, P411, DOI 10.1016/j.jpowsour.2014.12.051; Groger O, 2015, J ELECTROCHEM SOC, V162, pA2605, DOI 10.1149/2.0211514jes; Ji Y, 2013, ELECTROCHIM ACTA, V107, P664, DOI 10.1016/j.electacta.2013.03.147; Ji Y, 2013, J ELECTROCHEM SOC, V160, pA636, DOI 10.1149/2.047304jes; Smart MC, 2007, J POWER SOURCES, V168, P501, DOI 10.1016/j.jpowsour.2006.10.106; Stuart TA, 2004, J POWER SOURCES, V129, P368, DOI 10.1016/j.jpowsour.2003.10.014; Villasenor J., 2012, SCI AM, V24; Vlahinos A., 2002, 2002011975 SAE; Zhang SS, 2002, ELECTROCHEM COMMUN, V4, P928, DOI 10.1016/S1388-2481(02)00490-3	11	420	448	65	1030	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 28	2016	529	7587					515	+		10.1038/nature16502	http://dx.doi.org/10.1038/nature16502			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB7DD	26789253				2022-12-28	WOS:000368673800034
J	Dejana, E; Betsholtz, C				Dejana, Elisabetta; Betsholtz, Christer			Oligodendrocytes follow blood vessel trails in the brain Brain microvasculature is a scaffold for neuroglial migration	SCIENCE			English	Editorial Material							DIFFERENTIATION; BARRIER		[Dejana, Elisabetta; Betsholtz, Christer] Uppsala Univ, Dept Immunol Genet & Pathol, Rudbeck Lab, Uppsala, Sweden; [Dejana, Elisabetta] FIRC Inst Mol Oncol, Milan, Italy; [Dejana, Elisabetta] Univ Milan, Dept Oncol & Hematooncol, Milan, Italy; [Betsholtz, Christer] Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden	Uppsala University; IFOM - FIRC Institute of Molecular Oncology; University of Milan; Karolinska Institutet	Dejana, E (corresponding author), Uppsala Univ, Dept Immunol Genet & Pathol, Rudbeck Lab, Uppsala, Sweden.	elisabetta.dejana@igp.uu.se; christer.betsholtz@igp.uu.se		DEJANA, ELISABETTA/0000-0002-0007-0426	European Research Council [268870] Funding Source: Medline	European Research Council(European Research Council (ERC)European Commission)		Dunn GP, 2012, GENE DEV, V26, P756, DOI 10.1101/gad.187922.112; Funfschilling U, 2012, NATURE, V485, P517, DOI 10.1038/nature11007; Kessaris N, 2006, NAT NEUROSCI, V9, P173, DOI 10.1038/nn1620; Kuhnert F, 2010, SCIENCE, V330, P985, DOI 10.1126/science.1196554; Lammert E, 2001, SCIENCE, V294, P564, DOI 10.1126/science.1064344; Nikolova G, 2006, DEV CELL, V10, P397, DOI 10.1016/j.devcel.2006.01.015; Stenman JM, 2008, SCIENCE, V322, P1247, DOI 10.1126/science.1164594; Tsai HH, 2016, SCIENCE, V351, P379, DOI 10.1126/science.aad3839; Vanhollebeke B., 2015, ELIFE, V8, P4; Watkins S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5196; Zeisel A, 2015, SCIENCE, V347, P1138, DOI 10.1126/science.aaa1934; Zhou YL, 2014, J CLIN INVEST, V124, P3825, DOI 10.1172/JCI76431	12	3	3	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 22	2016	351	6271					341	342		10.1126/science.aaf1139	http://dx.doi.org/10.1126/science.aaf1139			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB3VH	26798001				2022-12-28	WOS:000368440500023
J	Chisolm, MS; Payne, JL				Chisolm, Margaret S.; Payne, Jennifer L.			Management of psychotropic drugs during pregnancy	BMJ-BRITISH MEDICAL JOURNAL			English	Review							SEROTONIN-REUPTAKE INHIBITORS; PERSISTENT PULMONARY-HYPERTENSION; IN-UTERO EXPOSURE; ANTIDEPRESSANT USE; MATERNAL USE; DEPRESSIVE SYMPTOMS; OPIOID DEPENDENCE; ATYPICAL ANTIPSYCHOTICS; CONGENITAL-MALFORMATIONS; 1ST-TRIMESTER EXPOSURE	Psychiatric conditions (including substance misuse disorders) are serious, potentially life threatening illnesses that can be successfully treated by psychotropic drugs, even during pregnancy. Because few rigorously designed prospective studies have examined the safety of these drugs during pregnancy, the default clinical recommendation has been to discontinue them, especially during the first trimester. However, in the past decade, as more evidence has accumulated, it seems that most psychotropic drugs are relatively safe to use in pregnancy and that not using them when indicated for serious psychiatric illness poses a greater risk to both mother and child, including tragic outcomes like suicide and infanticide. This review presents an up to date and careful examination of the most rigorous scientific studies on the effects of psychotropic drugs in pregnancy. The lack of evidence in several areas means that definite conclusions cannot be made about the risks and benefits of all psychotropic drug use in pregnancy.	[Chisolm, Margaret S.; Payne, Jennifer L.] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD USA	Johns Hopkins University	Payne, JL (corresponding author), Womens Mood Disorders Ctr, Baltimore, MD 21205 USA.	Jpayne5@jhmi.edu			Astra Zeneca; Johnson and Johnson; Pfizer; Eli Lilly	Astra Zeneca(AstraZeneca); Johnson and Johnson(Johnson & JohnsonJohnson & Johnson USA); Pfizer(Pfizer); Eli Lilly(Eli Lilly)	We have read and understood BMJ policy on declaration of interests and declare the following: MSC: no support from any organization for the submitted work and no competing interests. JLP: No support from any organization for the submitted work. JLP has received legal consulting fees from Astra Zeneca, Johnson and Johnson, Pfizer, and Eli Lilly.	ACOG Committee on Health Care for Underserved Women, 2012, Obstet Gynecol, V119, P1070, DOI 10.1097/AOG.0b013e318256496e; ACOG Committee on Practice Bulletins--Obstetrics, 2008, Obstet Gynecol, V111, P1001, DOI 10.1097/AOG.0b013e31816fd910; Addis A, 2000, PSYCHOL MED, V30, P89, DOI 10.1017/S0033291799001270; Alto WA, 2011, AM J OBSTET GYNECOL, V205, P302, DOI 10.1016/j.ajog.2011.04.001; Altshuler LL, 1996, AM J PSYCHIAT, V153, P592; Alwan S, 2007, NEW ENGL J MED, V356, P2684, DOI 10.1056/NEJMoa066584; Alwan S, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.02.015; Alwan S, 2009, CNS DRUGS, V23, P493, DOI 10.2165/00023210-200923060-00004; Andersson L, 2003, AM J OBSTET GYNECOL, V189, P148, DOI 10.1067/mob.2003.336; Andrade SE, 2009, PHARMACOEPIDEM DR S, V18, P246, DOI 10.1002/pds.1710; Ashman SB, 2002, DEV PSYCHOPATHOL, V14, P333, DOI 10.1017/S0954579402002080; Barnes TRE, 2011, J PSYCHOPHARMACOL, V25, P567, DOI 10.1177/0269881110391123; Bearer C, 1997, ENVIRON HEALTH PERSP, V105, P202; Black RA, 2003, AM FAM PHYSICIAN, V67, P2517; Bolea-Alamanac BM, 2014, BRIT J CLIN PHARMACO, V77, P96, DOI 10.1111/bcp.12138; Brennan PA, 2008, J CHILD PSYCHOL PSYC, V49, P1099, DOI 10.1111/j.1469-7610.2008.01914.x; Bro SP, 2015, CLIN EPIDEMIOL, V7, P139, DOI 10.2147/CLEP.S72906; Bromley RL, 2013, J NEUROL NEUROSUR PS, V84, P637, DOI 10.1136/jnnp-2012-304270; Brunner E, 2013, BMC PHARMACOL TOXICO, V14, DOI 10.1186/2050-6511-14-38; Byatt N, 2013, ACTA PSYCHIAT SCAND, V127, P94, DOI 10.1111/acps.12042; Byatt N, 2014, GEN HOSP PSYCHIAT, V36, P644, DOI 10.1016/j.genhosppsych.2014.07.011; Chambers CD, 2006, NEW ENGL J MED, V354, P579, DOI 10.1056/NEJMoa052744; Christensen J, 2013, JAMA-J AM MED ASSOC, V309, P1696, DOI 10.1001/jama.2013.2270; Chun-Fai-Chan B, 2005, AM J OBSTET GYNECOL, V192, P932, DOI 10.1016/j.ajog.2004.09.027; Clark CT, 2013, AM J PSYCHIAT, V170, P1240, DOI 10.1176/appi.ajp.2013.13010006; Cohen LS, 2006, JAMA-J AM MED ASSOC, V295, P499, DOI 10.1001/jama.295.5.499; COHEN LS, 1994, JAMA-J AM MED ASSOC, V271, P146, DOI 10.1001/jama.271.2.146; Cole JA, 2007, PHARMACOEPIDEM DR S, V16, P474, DOI 10.1002/pds.1296; Coppola D, 2007, DRUG SAFETY, V30, P247, DOI 10.2165/00002018-200730030-00006; Croen LA, 2011, ARCH GEN PSYCHIAT, V68, P1104, DOI 10.1001/archgenpsychiatry.2011.73; Cunningham F.G., 2010, WILLIAMS OBSTET; Cunnington M, 2005, NEUROLOGY, V64, P955, DOI 10.1212/01.WNL.0000154515.94346.89; Dadashova R, 2012, MENT ILLN, V4, P96, DOI 10.4081/mi.2012.e19; Davis EP, 2005, DEV NEUROSCI-BASEL, V27, P299, DOI 10.1159/000086709; Davis J, 1993, ANTIPSYCHOTIC DRUGS, P183; Davis RL, 2007, PHARMACOEPIDEM DR S, V16, P1086, DOI 10.1002/pds.1462; Debelak K, 2013, AM J ADDICTION, V22, P252, DOI 10.1111/j.1521-0391.2012.12005.x; DeVane C Lindsay, 2006, J Psychopharmacol, V20, P54, DOI 10.1177/1359786806066054; Diego MA, 2004, PSYCHIATRY, V67, P63, DOI 10.1521/psyc.67.1.63.31251; Dolk H, 2008, NEUROLOGY, V71, P714, DOI 10.1212/01.wnl.0000316194.98475.d8; Einarson TR, 2005, PHARMACOEPIDEM DR S, V14, P823, DOI 10.1002/pds.1084; Essex MJ, 2002, BIOL PSYCHIAT, V52, P776, DOI 10.1016/S0006-3223(02)01553-6; Fejzo MS, 2013, EUR J OBSTET GYN R B, V170, P71, DOI 10.1016/j.ejogrb.2013.04.017; Field T, 2006, INFANT BEHAV DEV, V29, P445, DOI 10.1016/j.infbeh.2006.03.003; Field T, 2010, INFANT BEHAV DEV, V33, P409, DOI 10.1016/j.infbeh.2010.04.005; Fischer G, 2006, ADDICTION, V101, P275, DOI 10.1111/j.1360-0443.2006.01321.x; Food and Drug Administration, DRUG SAF COMM ANT DR; Fujii H, 2013, NEUROLOGY, V80, P1565, DOI 10.1212/WNL.0b013e31828f18c1; Fullerton CA, 2014, PSYCHIAT SERV, V65, P146, DOI 10.1176/appi.ps.201300235; Gentile S, 2004, ANN PHARMACOTHER, V38, P1265, DOI 10.1345/aph.1D485; Gentile S, 2010, SCHIZOPHRENIA BULL, V36, P518, DOI 10.1093/schbul/sbn107; GILBERT PL, 1995, ARCH GEN PSYCHIAT, V52, P173; Gilboa SM, 2014, EXPERT OPIN DRUG SAF, V13, P1667, DOI 10.1517/14740338.2014.970164; Grace S L, 2003, Arch Womens Ment Health, V6, P263, DOI 10.1007/s00737-003-0024-6; Grof P, 2000, J AFFECT DISORDERS, V61, P31, DOI 10.1016/S0165-0327(99)00197-4; Habermann F, 2013, J CLIN PSYCHOPHARM, V33, P453, DOI 10.1097/JCP.0b013e318295fe12; Haervig KB, 2014, PHARMACOEPIDEM DR S, V23, P526, DOI 10.1002/pds.3600; HAGEMAN JR, 1984, AM J DIS CHILD, V138, P592, DOI 10.1001/archpedi.1984.02140440076021; Halligan SL, 2004, BIOL PSYCHIAT, V55, P376, DOI 10.1016/j.biopsych.2003.09.013; Hanley GE, 2014, BEST PRACT RES CL OB, V28, P37, DOI 10.1016/j.bpobgyn.2013.09.001; Hemels MEH, 2005, ANN PHARMACOTHER, V39, P803, DOI 10.1345/aph.1E547; Hernandez-Diaz S, 2007, PEDIATRICS, V120, pE272, DOI 10.1542/peds.2006-3037; Holmes LB, 2006, BIRTH DEFECTS RES A, V76, P318; Holmes LB, 2012, BIRTH DEFECTS RES A, V94, P599, DOI 10.1002/bdra.23028; Howard LM, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g7394; Humphreys C, 2007, CAN FAM PHYSICIAN, V53, P1153; Huybrechts KF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092778; Huybrechts KF, 2015, JAMA-J AM MED ASSOC, V313, P2142, DOI 10.1001/jama.2015.5605; Hviid A, 2013, NEW ENGL J MED, V369, P2406, DOI 10.1056/NEJMoa1301449; Iqbal MM, 2002, PSYCHIAT SERV, V53, P39, DOI 10.1176/appi.ps.53.1.39; JACOBSON SJ, 1992, LANCET, V339, P530, DOI 10.1016/0140-6736(92)90346-5; Jimenez-Solem E, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001148; Johnson KC, 2012, ARCH GEN PSYCHIAT, V69, P787, DOI 10.1001/archgenpsychiatry.2012.160; Jones HE, 2005, DRUG ALCOHOL DEPEN, V79, P1, DOI 10.1016/j.drugalcdep.2004.11.013; Jones HE, 2008, J SUBST ABUSE TREAT, V35, P245, DOI 10.1016/j.jsat.2007.10.007; Jones HE, 2008, AM J ADDICTION, V17, P372, DOI 10.1080/10550490802266276; Jones HE, 2013, NEUROTOXICOL TERATOL, V39, P110, DOI 10.1016/j.ntt.2013.05.003; Jones HE, 2013, ADDICTION, V108, P233, DOI 10.1111/j.1360-0443.2012.03811.x; Jones HE, 2012, ADDICTION, V107, P28, DOI 10.1111/j.1360-0443.2012.04036.x; Jones HE, 2012, ADDICTION, V107, P5, DOI 10.1111/j.1360-0443.2012.04035.x; Jones HE, 2012, DRUGS, V72, P747, DOI 10.2165/11632820-000000000-00000; Jones HE, 2010, NEW ENGL J MED, V363, P2320, DOI 10.1056/NEJMoa1005359; Kallen B, 2006, REPROD TOXICOL, V21, P221, DOI 10.1016/j.reprotox.2005.11.006; Kallen B, 2008, PHARMACOEPIDEM DR S, V17, P801, DOI 10.1002/pds.1570; Kallen BAJ, 2007, BIRTH DEFECTS RES A, V79, P301, DOI 10.1002/bdra.20327; Kaltenbach K, 1998, OBSTET GYN CLIN N AM, V25, P139, DOI 10.1016/S0889-8545(05)70362-4; KALTENBACH K, 1984, NEUROBEH TOXICOL TER, V6, P271; Kandall SR, 1999, CLIN PERINATOL, V26, P173, DOI 10.1016/S0095-5108(18)30077-0; KENDELL RE, 1987, BRIT J PSYCHIAT, V151, P499, DOI 10.1192/bjp.151.4.499; Khalifeh H, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2260; Khazaie H, 2013, PSYCHIAT RES, V210, P901, DOI 10.1016/j.psychres.2013.08.017; Kieler H, 2012, BMJ-BRIT MED J, V344, pd8012, DOI DOI 10.1136/BMJ.D8012; Li D, 2009, HUM REPROD, V24, P146, DOI 10.1093/humrep/den342; Lin AE, 2004, BIRTH DEFECTS RES A, V70, P534, DOI 10.1002/bdra.20051; Louik C, 2007, NEW ENGL J MED, V356, P2675, DOI 10.1056/NEJMoa067407; Marcus SM, 2003, J WOMEN HEALTH GEN-B, V12, P373, DOI 10.1089/154099903765448880; Mattick RP, 2002, COCHRANE DB SYST REV, V4; Mattick RP, 2009, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD002209; MINOZZI S, 2013, COCHRANE DB SYST REV, V12, DOI DOI 10.1002/14651858.CD006318.PUB3; Molgaard-Nielsen D, 2011, JAMA-J AM MED ASSOC, V305, P1996, DOI 10.1001/jama.2011.624; Moses-Kolko EL, 2005, JAMA-J AM MED ASSOC, V293, P2372, DOI 10.1001/jama.293.19.2372; Mosher WD, 1996, FAM PLANN PERSPECT, V28, P4, DOI 10.2307/2135956; Nakhai-Pour HR, 2010, CAN MED ASSOC J, V182, P1031, DOI 10.1503/cmaj.091208; Newham JJ, 2008, BRIT J PSYCHIAT, V192, P333, DOI 10.1192/bjp.bp.107.041541; Newport DJ, 2007, AM J PSYCHIAT, V164, P1214, DOI 10.1176/appi.ajp.2007.06111886; Nulman I, 1997, NEW ENGL J MED, V336, P258, DOI 10.1056/NEJM199701233360404; O'Brien L, 2008, J OBSTET GYNAECOL CA, V30, P696, DOI 10.1016/S1701-2163(16)32918-8; O'Connor TG, 2005, BIOL PSYCHIAT, V58, P211, DOI 10.1016/j.biopsych.2005.03.032; Oberlander TF, 2004, J CLIN PSYCHIAT, V65, P230; Oberlander TF, 2008, BIRTH DEFECTS RES B, V83, P68, DOI 10.1002/bdrb.20144; Okun ML, 2015, AM J OBSTET GYNECOL, V212, P428, DOI 10.1016/j.ajog.2014.10.1106; Orr ST, 2007, J WOMENS HEALTH, V16, P535, DOI 10.1089/jwh.2006.0116; PASTUSZAK A, 1993, JAMA-J AM MED ASSOC, V269, P2246, DOI 10.1001/jama.269.17.2246; Paton C, 2008, BRIT J PSYCHIAT, V192, P321, DOI 10.1192/bjp.bp.108.049585; Pavek P, 2009, CURR DRUG METAB, V10, P520, DOI 10.2174/138920009788897993; Payne JL, 2007, AM J PSYCHIAT, V164, P1329, DOI 10.1176/appi.ajp.2007.07030390; Payne JL, 2009, CLIN OBSTET GYNECOL, V52, P469, DOI 10.1097/GRF.0b013e3181b52e20; Pearlstein T, 2013, WOMENS HEALTH, V9, P605, DOI [10.2217/whe.13.54, 10.2217/WHE.13.54]; Peng M, 2013, PSYCHOPHARMACOLOGY, V228, P577, DOI 10.1007/s00213-013-3060-6; Pottegard A, 2014, J CLIN PSYCHIAT, V75, pE88, DOI 10.4088/JCP.13m08708; Rahimi R, 2006, REPROD TOXICOL, V22, P571, DOI 10.1016/j.reprotox.2006.03.019; Rai D, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2059; Ramos E, 2008, BRIT J PSYCHIAT, V192, P344, DOI 10.1192/bjp.bp.107.042523; Reis M, 2010, PSYCHOL MED, V40, P1723, DOI 10.1017/S0033291709992194; Reis M, 2008, J CLIN PSYCHOPHARM, V28, P279, DOI 10.1097/JCP.0b013e318172b8d5; Reis M, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002166; Robinson GE, 2012, J POPUL THER CLIN PH, V19, pE380; Ross LE, 2013, JAMA PSYCHIAT, V70, P436, DOI 10.1001/jamapsychiatry.2013.684; Seeman MV, 2013, ACTA PSYCHIAT SCAND, V127, P12, DOI 10.1111/j.1600-0447.2012.01897.x; Seeman MV, 2004, AM J PSYCHIAT, V161, P1324, DOI 10.1176/appi.ajp.161.8.1324; Shiu Jennifer R, 2012, Can J Hosp Pharm, V65, P380; Simon GE, 2002, AM J PSYCHIAT, V159, P2055, DOI 10.1176/appi.ajp.159.12.2055; Soyka M, 2013, CNS DRUGS, V27, P653, DOI 10.1007/s40263-013-0072-z; Stine SM, 2009, AM J DRUG ALCOHOL AB, V35, P429, DOI 10.3109/00952990903374080; THIELS C, 1987, PHARMACOPSYCHIATRY, V20, P133, DOI 10.1055/s-2007-1017092; Tracy TS, 2005, AM J OBSTET GYNECOL, V192, P633, DOI 10.1016/j.ajog.2004.08.030; Unger A, 2010, J ADDICT DIS, V29, P217, DOI 10.1080/10550881003684814; US National Library of Medicine, SEARCH STRAT US CREA; Vigod SN, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2298; Viguera AC, 1997, ARCH GEN PSYCHIAT, V54, P49; Viguera AC, 2000, AM J PSYCHIAT, V157, P179, DOI 10.1176/appi.ajp.157.2.179; Viguera AC, 2007, AM J PSYCHIAT, V164, P1817, DOI 10.1176/appi.ajp.2007.06101639; Walsh-Sukys MC, 2000, PEDIATRICS, V105, P14, DOI 10.1542/peds.105.1.14; Wang LH, 2010, CLIN PHARMACOL THER, V88, P369, DOI 10.1038/clpt.2010.97; Wang S, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001681; Ward RM, 2000, PEDIATRICS, V105, P880; Webb RT, 2004, COCHRANE DB SYST REV, V2; WEBSTER PAC, 1973, LANCET, V2, P318; Wichman CL, 2009, MAYO CLIN PROC, V84, P23, DOI 10.4065/84.1.23; Wilson KL, 2011, AM J PERINAT, V28, P19, DOI 10.1055/s-0030-1262507; Winklbaur B, 2008, ADDICTION, V103, P1429, DOI 10.1111/j.1360-0443.2008.02283.x; Wong S, 2011, J OBSTET GYNAECOL CA, V33, P367, DOI 10.1016/S1701-2163(16)34855-1; Yonkers KA, 2014, ANNU REV CLIN PSYCHO, V10, P369, DOI 10.1146/annurev-clinpsy-032813-153626; Yonkers KA, 2012, EPIDEMIOLOGY, V23, P677, DOI 10.1097/EDE.0b013e31825838e9; Yonkers KA, 2009, GEN HOSP PSYCHIAT, V31, P403, DOI [10.1097/AOG.0b013e3181ba0632, 10.1016/j.genhosppsych.2009.04.003]; ZUCKERMAN B, 1989, AM J OBSTET GYNECOL, V160, P1107, DOI 10.1016/0002-9378(89)90170-1	156	60	60	0	39	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 20	2016	352								h5918	10.1136/bmj.h5918	http://dx.doi.org/10.1136/bmj.h5918			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DC4ZT	26791406				2022-12-28	WOS:000369230200001
J	Hirsch, C				Hirsch, Calvin			Review: Calcium supplementation and risk for fracture in persons > 50 years of age	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Hirsch, Calvin] Univ Calif Davis, Sacramento, CA 95817 USA	University of California System; University of California Davis	Hirsch, C (corresponding author), Univ Calif Davis, Sacramento, CA 95817 USA.								0	1	2	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 19	2016	164	2					JC4	JC4		10.7326/ACPJC-2016-164-2-004	http://dx.doi.org/10.7326/ACPJC-2016-164-2-004			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DB0CI	26784494				2022-12-28	WOS:000368175800003
J	Yang, YT; Curlin, FA				Yang, Y. Tony; Curlin, Farr A.			Why Physicians Should Oppose Assisted Suicide	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Yang, Y. Tony] George Mason Univ, Dept Hlth Adm & Policy, Fairfax, VA 22030 USA; [Curlin, Farr A.] Duke Univ, Trent Ctr Bioeth Humanities & Hist Med, Durham, NC USA	George Mason University; Duke University	Yang, YT (corresponding author), George Mason Univ, Dept Hlth Adm & Policy, 4400 Univ Dr,MS 1J3, Fairfax, VA 22030 USA.	ytyang@gmu.edu						*AMA, H140952 AMA; [Anonymous], OR DEATH DIGN ACT 20; Botelho G., 2015, CNN             1006; Burt RA, 1996, HASTINGS CENT REP, V26, P30, DOI 10.2307/3528468; Edelstein L, 1943, HIPPOCRATIC OATH TEX; Maynard Brittany, 2014, CNN             1102; Snyder L, 2001, ANN INTERN MED, V135, P209, DOI 10.7326/0003-4819-135-3-200108070-00015	7	21	21	0	41	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 19	2016	315	3					247	248		10.1001/jama.2015.16194	http://dx.doi.org/10.1001/jama.2015.16194			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DB2WN	26784763				2022-12-28	WOS:000368371400012
J	Gignoux, E; Azman, AS; de Smet, M; Azuma, P; Massaquoi, M; Job, D; Tiffany, A; Petrucci, R; Sterk, E; Potet, J; Suzuki, M; Kurth, A; Cannas, A; Bocquin, A; Strecker, T; Logue, C; Pottage, T; Yue, C; Cabrol, JC; Serafini, M; Ciglenecki, I				Gignoux, Etienne; Azman, Andrew S.; de Smet, Martin; Azuma, Philippe; Massaquoi, Moses; Job, Dorian; Tiffany, Amanda; Petrucci, Roberta; Sterk, Esther; Potet, Julien; Suzuki, Motoi; Kurth, Andreas; Cannas, Angela; Bocquin, Anne; Strecker, Thomas; Logue, Christopher; Pottage, Thomas; Yue, Constanze; Cabrol, Jean-Clement; Serafini, Micaela; Ciglenecki, Iza			Effect of Artesunate-Amodiaquine on Mortality Related to Ebola Virus Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							FALCIPARUM-MALARIA; AFRICA	BACKGROUND Malaria treatment is recommended for patients with suspected Ebola virus disease (EVD) in West Africa, whether systematically or based on confirmed malaria diagnosis. At the Ebola treatment center in Foya, Lofa County, Liberia, the supply of artemether-lumefantrine, a first-line antimalarial combination drug, ran out for a 12-day period in August 2014. During this time, patients received the combination drug artesunate-amodiaquine; amodiaquine is a compound with anti-Ebola virus activity in vitro. No other obvious change in the care of patients occurred during this period. METHODS We fit unadjusted and adjusted regression models to standardized patient-level data to estimate the risk ratio for death among patients with confirmed EVD who were prescribed artesunate-amodiaquine (artesunate-amodiaquine group), as compared with those who were prescribed artemether-lumefantrine (artemether-lumefantrine group) and those who were not prescribed any antimalarial drug (no-antimalarial group). RESULTS Between June 5 and October 24, 2014, a total of 382 patients with confirmed EVD were admitted to the Ebola treatment center in Foya. At admission, 194 patients were prescribed artemether-lumefantrine and 71 were prescribed artesunate-amodiaquine. The characteristics of the patients in the artesunate-amodiaquine group were similar to those in the artemether-lumefantrine group and those in the no-antimalarial group. A total of 125 of the 194 patients in the artemether-lumefantrine group (64.4%) died, as compared with 36 of the 71 patients in the artesunate-amodiaquine group (50.7%). In adjusted analyses, the artesunate-amodiaquine group had a 31% lower risk of death than the artemether-lumefantrine group (risk ratio, 0.69; 95% confidence interval, 0.54 to 0.89), with a stronger effect observed among patients without malaria. CONCLUSIONS Patients who were prescribed artesunate-amodiaquine had a lower risk of death from EVD than did patients who were prescribed artemether-lumefantrine. However, our analyses cannot exclude the possibility that artemether-lumefantrine is associated with an increased risk of death or that the use of artesunate-amodiaquine was associated with unmeasured patient characteristics that directly altered the risk of death.	[Gignoux, Etienne; Tiffany, Amanda] Epictr, Paris, France; [Potet, Julien] Med Sans Frontieres Access Campaign, Paris, France; [Bocquin, Anne] INSERM, Lab P4 Jean Merieux, F-69008 Lyon, France; [Gignoux, Etienne; Azman, Andrew S.; Job, Dorian; Tiffany, Amanda; Petrucci, Roberta; Sterk, Esther; Suzuki, Motoi; Cabrol, Jean-Clement; Serafini, Micaela; Ciglenecki, Iza] Med Sans Frontieres, CH-1202 Geneva, Switzerland; [Azman, Andrew S.] Johns Hopkins Univ, Dept Epidemiol, Baltimore, MD USA; [de Smet, Martin] Med Sans Frontieres, Brussels, Belgium; [Azuma, Philippe; Massaquoi, Moses] Minist Hlth & Social Welf, Monrovia, CA USA; [Suzuki, Motoi] Nagasaki Univ, Inst Trop Med, Nagasaki 852, Japan; [Kurth, Andreas; Cannas, Angela; Bocquin, Anne; Strecker, Thomas; Logue, Christopher; Pottage, Thomas; Yue, Constanze] European Mobile Lab Consortium, Hamburg, Germany; [Kurth, Andreas; Yue, Constanze] Robert Koch Inst, Berlin, Germany; [Strecker, Thomas] Univ Marburg, Inst Virol, D-35032 Marburg, Germany; [Cannas, Angela] Ist Nazl Malattie Infett L Spallanzani, Rome, Italy; [Logue, Christopher; Pottage, Thomas] Publ Hlth England, Porton Down, England	Doctors Without Borders; Institut National de la Sante et de la Recherche Medicale (Inserm); Doctors Without Borders; Johns Hopkins University; Doctors Without Borders; Nagasaki University; Robert Koch Institute; Philipps University Marburg; IRCCS Lazzaro Spallanzani; Public Health England	Ciglenecki, I (corresponding author), Med Sans Frontieres, Rue Lausanne 78, CH-1202 Geneva, Switzerland.	iza.ciglenecki@geneva.msf.org	Strecker, Thomas/AAR-8442-2020; Logue, Christopher H/ABH-3469-2020	Azman, Andrew/0000-0001-8662-9077; Pottage, Thomas/0000-0002-8062-853X; Strecker, Thomas/0000-0002-7857-937X; Suzuki, Motoi/0000-0002-8340-0880	European Commission [IFS 2011/272-372]	European Commission(European CommissionEuropean Commission Joint Research Centre)	We thank Philippe Calain, Martin Friede, Armand Sprecher, Michel Van Herp, Isabel Rodriguez-Barraquer, Sophie Masson, Stephan Gunther, and Patricia Kahn for their valuable comments; all the staff at the Ebola treatment center in Foya for collecting the data; all the staff at the European Mobile Laboratory (EMlab) units in Gueckedou, Foya, Munich, and Hamburg (the EMLab Consortium was supported by the European Commission [contract IFS 2011/272-372]); and Mikhail Martchenko and Joel West for their encouragement to explore the potential association between amodiaquine and Ebola virus disease.	Adjei GO, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-420; Agresti A, 2013, CATEGORICAL DATA ANA; [Anonymous], 2014, GUID TEMP MAL CONTR; Aylward B, 2014, NEW ENGL J MED, V371, P1481, DOI 10.1056/NEJMoa1411100; Bah EI, 2015, NEW ENGL J MED, V372, P40, DOI 10.1056/NEJMoa1411249; Burnham K.P., 2002, MODEL SELECTION MULT, VSecond edition; Falzarano D, 2015, EMERG INFECT DIS, V21, P1065, DOI 10.3201/eid2106.150176; KRUSKAL WH, 1952, ANN MATH STAT, V23, P525, DOI 10.1214/aoms/1177729332; Madrid PB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060579; NEFTEL KA, 1986, BRIT MED J, V292, P721, DOI 10.1136/bmj.292.6522.721; Novartis Pharmaceuticals, 2015, COART; Rumore MM., 2012, INT J CASE REP IMAGE, V3, P1; Schieffelin JS, 2014, NEW ENGL J MED, V371, P2092, DOI 10.1056/NEJMoa1411680; Sterk E, 2008, FILOVIRUS HAEMORRHAG; Taylor WRJ, 2006, B WORLD HEALTH ORGAN, V84, P956, DOI 10.2471/BLT.06.031492; World Health Organization, 2014, CLIN MAN PAT VIR HAE; World Health Organization, 2014, CAS DEF REC EB MARB; World Health Organization, 1997, GUID SAF TRANSP INF; World Health Organization, 2015, EB SIT REP WHO; Yeka A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113311; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090; Zwang JL, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-260	22	79	84	0	34	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 7	2016	374	1					23	32		10.1056/NEJMoa1504605	http://dx.doi.org/10.1056/NEJMoa1504605			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DA1UH	26735991	Bronze			2022-12-28	WOS:000367580500005
J	Soled, S				Soled, Stuart			Silica-supported catalysts get a new breath of life	SCIENCE			English	Editorial Material									[Soled, Stuart] ExxonMobil Res & Engn Co, Corp Strateg Res, East Annandale, NJ 08801 USA	Exxon Mobil Corporation	Soled, S (corresponding author), ExxonMobil Res & Engn Co, Corp Strateg Res, 1545 Route 22, East Annandale, NJ 08801 USA.	stu.soled@exxonmobil.com						[Anonymous], 2013, WORLD CAT IND STUD 2; BRUNELLE JP, 1979, 2ND INT S SCI BAS PR, P211; Cho HR, 2015, CATAL TODAY, V246, P143, DOI 10.1016/j.cattod.2014.09.029; Munnik P, 2011, J PHYS CHEM C, V115, P14698, DOI 10.1021/jp111778g; Munnik P, 2014, ACS CATAL, V4, P3219, DOI 10.1021/cs5006772; Regalbuto J. R., 2010, SILICA SILICATES MOD, V42, P345; Soled S., 2009, SYNTHESIS SOLID CATA, P353; Wolters M, 2011, J PHYS CHEM C, V115, P3332, DOI 10.1021/jp1081406	8	41	41	4	93	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 4	2015	350	6265					1171	1172		10.1126/science.aad2204	http://dx.doi.org/10.1126/science.aad2204			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CX4WG	26785461				2022-12-28	WOS:000365700500047
J	Lonial, S; Weiss, BM; Usmani, SZ; Singhal, S; Chari, A; Bahlis, NJ; Belch, A; Krishnan, A; Vescio, RA; Mateos, MV; Mazumder, A; Orlowski, RZ; Sutherland, HJ; Blade, J; Scott, EC; Oriol, A; Berdeja, J; Gharibo, M; Stevens, DA; LeBlanc, R; Sebag, M; Callander, N; Jakubowiak, A; White, D; de la Rubia, J; Richardson, PG; Lisby, S; Feng, HB; Uhlar, CM; Khan, I; Ahmadi, T; Voorhees, PM				Lonial, Sagar; Weiss, Brendan M.; Usmani, Saad Z.; Singhal, Seema; Chari, Ajai; Bahlis, Nizar J.; Belch, Andrew; Krishnan, Amrita; Vescio, Robert A.; Victoria Mateos, Maria; Mazumder, Amitabha; Orlowski, Robert Z.; Sutherland, Heather J.; Blade, Joan; Scott, Emma C.; Oriol, Albert; Berdeja, Jesus; Gharibo, Mecide; Stevens, Don A.; LeBlanc, Richard; Sebag, Michael; Callander, Natalie; Jakubowiak, Andrzej; White, Darrell; de la Rubia, Javier; Richardson, Paul G.; Lisby, Steen; Feng, Huaibao; Uhlar, Clarissa M.; Khan, Imran; Ahmadi, Tahamtan; Voorhees, Peter M.			Daratumumab monotherapy in patients with treatment-refractory multiple myeloma (SIRIUS): an open-label, randomised, phase 2 trial	LANCET			English	Article							ELOTUZUMAB; MULTICENTER; SURVIVAL; THERAPY; RISK	Background New treatment options are needed for patients with multiple myeloma that is refractory to proteasome inhibitors and immunomodulatory drugs. We assessed daratumumab, a novel CD38-targeted monoclonal antibody, in patients with refractory multiple myeloma. Methods In this open-label, multicentre, phase 2 trial done in Canada, Spain, and the USA, patients (age >= 18 years) with multiple myeloma who were previously treated with at least three lines of therapy (including proteasome inhibitors and immunomodulatory drugs), or were refractory to both proteasome inhibitors and immunomodulatory drugs, were randomly allocated in a 1:1 ratio to receive intravenous daratumumab 8 mg/kg or 16 mg/kg in part 1 stage 1 of the study, to decide the dose for further assessment in part 2. Patients received 8 mg/kg every 4 weeks, or 16 mg/kg per week for 8 weeks (cycles 1 and 2), then every 2 weeks for 16 weeks (cycles 3-6), and then every 4 weeks thereafter (cycle 7 and higher). The allocation schedule was computer-generated and randomisation, with permuted blocks, was done centrally with an interactive web response system. In part 1 stage 2 and part 2, patients received 16 mg/kg dosed as in part 1 stage 1. The primary endpoint was overall response rate (partial response [PR] + very good PR + complete response [CR] + stringent CR). All patients who received at least one dose of daratumumab were included in the analysis. The trial is registered with ClinicalTrials.gov, number NCT01985126. Findings The study is ongoing. In part 1 stage 1 of the study, 18 patients were randomly allocated to the 8 mg/kg group and 16 to the 16 mg/kg group. Findings are reported for the 106 patients who received daratumumab 16 mg/kg in parts 1 and 2. Patients received a median of five previous lines of therapy (range 2-14). 85 (80%) patients had previously received autologous stem cell transplantation, 101 (95%) were refractory to the most recent proteasome inhibitors and immunomodulatory drugs used, and 103 (97%) were refractory to the last line of therapy. Overall responses were noted in 31 patients (29.2%, 95% CI 20.8-38.9)-three (2.8%, 0.6-8.0) had a stringent CR, ten (9.4%, 4.6-16.7) had a very good PR, and 18 (17.0%, 10.4-25.5) had a PR. The median time to first response was 1.0 month (range 0.9-5.6). Median duration of response was 7.4 months (95% CI 5.5-not estimable) and progression-free survival was 3.7 months (95% CI 2.8-4.6). The 12-month overall survival was 64.8% (95% CI 51.2-75.5) and, at a subsequent cutoff, median overall survival was 17.5 months (95% CI 13.7-not estimable). Daratumumab was well tolerated; fatigue (42 [40%] patients) and anaemia (35 [33%]) of any grade were the most common adverse events. No drug-related adverse events led to treatment discontinuation. Interpretation Daratumumab monotherapy showed encouraging efficacy in heavily pretreated and refractory patients with multiple myeloma, with a favourable safety profile in this population of patients.	[Lonial, Sagar] Emory Univ, Dept Hematol & Med Oncol, Winship Canc Inst, 201 Dowman Dr, Atlanta, GA 30322 USA; [Weiss, Brendan M.] Univ Penn, Abramson Canc Ctr, Dept Med, Div Hematol Oncol, Philadelphia, PA 19104 USA; [Weiss, Brendan M.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Usmani, Saad Z.] Carolinas Healthcare Syst, Levine Canc Inst, Charlotte, NC USA; [Singhal, Seema] Northwestern Univ, Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Div Hematol Oncol, Chicago, IL 60611 USA; [Chari, Ajai] Mt Sinai Sch Med, Tisch Canc Inst, New York, NY USA; [Bahlis, Nizar J.] Univ Calgary, Tom Baker Canc Ctr, Calgary, AB, Canada; [Belch, Andrew] Cross Canc Inst, Edmonton, AB T6G 1Z2, Canada; [Krishnan, Amrita] City Hope Natl Med Ctr, Judy & Bernard Briskin Myeloma Ctr, Duarte, CA USA; [Vescio, Robert A.] Samuel Oschin Comprehens Canc Inst, Cedars Sinai Outpatient Canc Ctr, Los Angeles, CA USA; [Victoria Mateos, Maria] Univ Hosp Salamanca, Inst Invest Biomed Salamanca, Salamanca, Spain; [Mazumder, Amitabha] NYU Langone Med Ctr, Perlmutter Canc Ctr, New York, NY USA; [Orlowski, Robert Z.] Univ Texas MD Anderson Canc Ctr, Dept Lymphoma & Myeloma, Houston, TX 77030 USA; [Sutherland, Heather J.] Univ British Columbia, Leukemia Bone Marrow Transplant Program, Vancouver, BC V5Z 1M9, Canada; [Blade, Joan] Hosp Clin Barcelona, Inst Invest Biomed August Pi & Sunyer, Barcelona, Spain; [Scott, Emma C.] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA; [Oriol, Albert] Hosp Badalona Germans Trias & Pujol, Inst Josep Carreras, Inst Catala Oncol, Barcelona, Spain; [Berdeja, Jesus] Sarah Cannon Res Inst, Nashville, TN USA; [Gharibo, Mecide] Rutgers State Univ, Robert Wood Johnson Med Sch, Rutgers Canc Inst New Jersey, New Brunswick, NJ 08903 USA; [Stevens, Don A.] Norton Hlth Care, Louisville, KY USA; [LeBlanc, Richard] Hop Maison Neuve Rosemont, Montreal, PQ H1T 2M4, Canada; [Sebag, Michael] Royal Victoria Hosp, Montreal, PQ H3A 1A1, Canada; [Callander, Natalie] Univ Wisconsin, Sch Med, Madison, WI USA; [Jakubowiak, Andrzej] Univ Chicago Med, Chicago, IL USA; [White, Darrell] Dalhousie Univ, Halifax, NS, Canada; [White, Darrell] Queen Elizabeth 2 Hlth Sci Ctr, Halifax, NS, Canada; [de la Rubia, Javier] Hosp Dr Peset, Valencia, Spain; [de la Rubia, Javier] Univ Catolica San Vicente Martir, Valencia, Spain; [Richardson, Paul G.] Harvard Univ, Sch Med, Dana Farber Canc Inst, 44 Binney St, Boston, MA 02115 USA; [Lisby, Steen] Genmab, Copenhagen, Denmark; [Feng, Huaibao; Khan, Imran] Janssen Res & Dev, Raritan, NJ USA; [Uhlar, Clarissa M.; Ahmadi, Tahamtan] Janssen Res & Dev, Spring House, PA USA; [Voorhees, Peter M.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Div Hematol & Oncol, Chapel Hill, NC 27599 USA	Emory University; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Carolinas HealthCare System; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center; Icahn School of Medicine at Mount Sinai; Tom Baker Cancer Clinic; University of Calgary; University of Alberta; City of Hope; Cedars Sinai Medical Center; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); NYU Langone Medical Center; University of Texas System; UTMD Anderson Cancer Center; University of British Columbia; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Oregon Health & Science University; Catalan Institute of Oncology; Hospital Germans Trias i Pujol; Institut de Recerca Contra la Leucemia Josep Carreras (IJC); Sarah Cannon Research Institute; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Universite de Montreal; McGill University; Royal Victoria Hospital; University of Wisconsin System; University of Wisconsin Madison; Dalhousie University; Queen Elizabeth II Health Sciences Centre; Universidad Catolica de Valencia San Vicente Martir; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Genmab; Johnson & Johnson; Janssen Pharmaceuticals; Johnson & Johnson; Janssen Pharmaceuticals; University of North Carolina; University of North Carolina Chapel Hill	Lonial, S (corresponding author), Emory Univ, Dept Hematol & Med Oncol, Winship Canc Inst, 201 Dowman Dr, Atlanta, GA 30322 USA.	sloni01@emory.edu	Oriol, Albert/K-9923-2017; Usmani, Saad Z/HCI-4676-2022; Usmani, Saad Z/H-2705-2012	Oriol, Albert/0000-0001-6804-2221; Usmani, Saad Z/0000-0002-5484-8731; de la Rubia, Javier/0000-0002-8354-768X; Orlowski, Robert/0000-0002-5723-4129	Janssen Research Development; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	Janssen Research Development; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Janssen Research & Development.	Chapuy CI, 2015, TRANSFUSION, V55, P1545, DOI 10.1111/trf.13069; Chng WJ, 2014, LEUKEMIA, V28, P269, DOI 10.1038/leu.2013.247; de Vries A, 2012, BLOOD, V120; de Weers M, 2011, J IMMUNOL, V186, P1840, DOI 10.4049/jimmunol.1003032; Durie BGM, 2006, LEUKEMIA, V20, P1467, DOI 10.1038/sj.leu.2404284; Harousseau JL, 2009, J CLIN ONCOL, V27, P5720, DOI 10.1200/JCO.2008.21.1060; Kapoor P, 2013, J CLIN ONCOL, V31, P4529, DOI 10.1200/JCO.2013.49.0086; Kumar SK, 2012, LEUKEMIA, V26, P149, DOI 10.1038/leu.2011.196; Kumar SK, 2008, BLOOD, V111, P2516, DOI 10.1182/blood-2007-10-116129; Kuroda J, 2013, EXPERT REV ANTICANC, V13, P1081, DOI 10.1586/14737140.2013.829641; Lammerts van Bueren J, 2014, 56 ASH ANN M EXP SAN; Laubach JP, 2015, CLIN CANCER RES, V21, P2660, DOI 10.1158/1078-0432.CCR-14-3190; Lokhorst HM, 2015, NEW ENGL J MED, V373, P1207, DOI 10.1056/NEJMoa1506348; Lonial S, 2015, NEW ENGL J MED, V373, P621, DOI 10.1056/NEJMoa1505654; Moreau P, 2014, ASH ANN M, V124, P176; Overdijk MB, 2015, MABS-AUSTIN, V7, P311, DOI 10.1080/19420862.2015.1007813; Plesner T, 2014, BLOOD, V124, DOI 10.1182/blood.V124.21.84.84; Rajkumar SV, 2011, BLOOD, V117, P4691, DOI 10.1182/blood-2010-10-299487; Richardson PG, 2014, BLOOD, V123, P1826, DOI 10.1182/blood-2013-11-538835; Rollig C, 2015, LANCET, V385, P2197, DOI 10.1016/S0140-6736(14)60493-1; Miguel JS, 2013, LANCET ONCOL, V14, P1055, DOI 10.1016/S1470-2045(13)70380-2; Siegel DS, 2012, BLOOD, V120, P2817, DOI 10.1182/blood-2012-05-425934; Turesson I, 2010, J CLIN ONCOL, V28, P830, DOI 10.1200/JCO.2009.25.4177; *US DEP HHS, COMM TERM CRIT ADV E; Zonder JA, 2012, BLOOD, V120, P552, DOI 10.1182/blood-2011-06-360552	25	584	604	5	80	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 9	2016	387	10027					1551	1560		10.1016/S0140-6736(15)01120-4	http://dx.doi.org/10.1016/S0140-6736(15)01120-4			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DI8HH	26778538	Green Submitted			2022-12-28	WOS:000373741600031
J	Gerhard, GS; Paynton, B; Popoff, SN				Gerhard, Glenn S.; Paynton, Barbara; Popoff, Steven N.			Integrating Cadaver Exome Sequencing Into a First-Year Medical Student Curriculum	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							EDUCATION; GENOMICS		[Gerhard, Glenn S.; Paynton, Barbara; Popoff, Steven N.] Temple Univ, Lewis Katz Sch Med, Philadelphia, PA 19140 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Gerhard, GS (corresponding author), Temple Univ, Lewis Katz Sch Med, Dept Med Genet & Mol Biochem, 3500 N Broad St,960 Med Educ & Res Bldg, Philadelphia, PA 19140 USA.	gsgerhard@temple.edu						American College of Medical Genetics and Genomics, AM COLL MED GEN GEN; Boers SN, 2015, TRENDS MOL MED, V21, P148, DOI 10.1016/j.molmed.2015.01.002; Korf BR, 2014, GENET MED, V16, P804, DOI 10.1038/gim.2014.35; Linderman MD, 2015, BMC MED GENOMICS, V8, DOI 10.1186/s12920-015-0124-y; Sanderson SC, 2015, GENET MED, V17, P866, DOI 10.1038/gim.2014.203; Vernez SL, 2013, GENOME MED, V5, DOI 10.1186/gm428; Xu JF, 2002, NAT GENET, V32, P321, DOI 10.1038/ng994	7	16	16	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 9	2016	315	6					555	556		10.1001/jama.2015.19465	http://dx.doi.org/10.1001/jama.2015.19465			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DD0UJ	26752678				2022-12-28	WOS:000369635200011
J	Jain, S; Wheeler, JR; Walters, RW; Agrawal, A; Barsic, A; Parker, R				Jain, Saumya; Wheeler, Joshua R.; Walters, Robert W.; Agrawal, Anurag; Barsic, Anthony; Parker, Roy			ATPase-Modulated Stress Granules Contain a Diverse Proteome and Substructure	CELL			English	Article							TRANSFER-RNA SYNTHETASE; SACCHAROMYCES-CEREVISIAE; MESSENGER-RNA; PHASE-SEPARATION; BINDING PROTEINS; LIQUID DROPLETS; P-BODIES; ALS; AGGREGATION; COMPLEX	Stress granules are mRNA-protein granules that form when translation initiation is limited, and they are related to pathological granules in various neurodegenerative diseases. Super-resolution microscopyreveals stable substructures, referred to as cores, within stress granules that can be purified. Proteomic analysis of stress granule cores reveals a dense network of protein-protein interactions and links between stress granules and human diseases and identifies ATP-dependent helicases and protein remodelers as conserved stress granule components. ATP is required for stress granule assembly and dynamics. Moreover, multipleATP-drivenmachines affect stress granules differently, with the CCT complex inhibiting stress granule assembly, while the MCM and RVB complexes promote stress granule persistence. Our observations suggest that stress granules contain a stable core structure surrounded by a dynamic shell with assembly, disassembly, and transitions between the core and shell modulated by numerous protein and RNA remodeling complexes.	[Jain, Saumya; Wheeler, Joshua R.; Walters, Robert W.; Parker, Roy] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80303 USA; [Agrawal, Anurag; Barsic, Anthony] Double Helix LLC, Boulder, CO 80309 USA; [Parker, Roy] Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80303 USA	University of Colorado System; University of Colorado Boulder; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder	Parker, R (corresponding author), Univ Colorado, Dept Chem & Biochem, Boulder, CO 80303 USA.; Parker, R (corresponding author), Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80303 USA.	roy.parker@colorado.edu	Agrawal, Anurag/AAJ-7027-2020; Core, BioFrontiers Advanced Light Microscopy/O-6175-2019	Agrawal, Anurag/0000-0002-2493-0603; 	Howard Hughes Medical Institute;  [NIH-F30N2093682];  [NSF-IIP-1353638];  [NIH-GM045443]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001082] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045443, R01GM079097, T32GM008497, R37GM045443, P01GM105537] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F30NS093682] Funding Source: NIH RePORTER; Div Of Industrial Innovation & Partnersh [1353638] Funding Source: National Science Foundation	Howard Hughes Medical Institute(Howard Hughes Medical Institute); ; ; ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Div Of Industrial Innovation & Partnersh(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	We thank the Drubin, Horovitz, Tye, Kralj, and Kohno labs for strains and plasmids. We thank Anne Webb, Carolyn Decker, Sarah Mitchell, David Protter, and the Parker Lab for helpful discussions and feedback on the manuscript. We thank the CU Mass Spectrometry Facility, CU Biofrontiers, and MCDB microscopy cores. This work was funded by NIH-F30N2093682 (J.R.W.), NSF-IIP-1353638 (Double Helix LLC), NIH-GM045443 (R.P.), and the Howard Hughes Medical Institute (R.P.). SIM in MCDB was made possible by equipment supplements to R01 GM79097 (D. Xue) and P01 GM105537 (M. Winey).	Berg J, 2009, NAT METHODS, V6, P161, DOI [10.1038/NMETH.1288, 10.1038/nmeth.1288]; Blasco H, 2013, HUM MUTAT, V34, P953, DOI 10.1002/humu.22329; Brangwynne CP, 2011, P NATL ACAD SCI USA, V108, P4334, DOI 10.1073/pnas.1017150108; Brangwynne CP, 2009, SCIENCE, V324, P1729, DOI 10.1126/science.1172046; Brengues M, 2007, MOL BIOL CELL, V18, P2592, DOI 10.1091/mbc.E06-12-1149; Buchan JR, 2008, J CELL BIOL, V183, P441, DOI 10.1083/jcb.200807043; Buchan JR, 2014, RNA BIOL, V11, P1019, DOI 10.4161/15476286.2014.972208; Buchan JR, 2013, CELL, V153, P1461, DOI 10.1016/j.cell.2013.05.037; Buchan JR, 2011, J CELL SCI, V124, P228, DOI 10.1242/jcs.078444; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Castello A, 2012, CELL, V149, P1393, DOI 10.1016/j.cell.2012.04.031; Decker CJ, 2007, J CELL BIOL, V179, P437, DOI 10.1083/jcb.200704147; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; Elbaum-Garfinkle S, 2015, P NATL ACAD SCI USA, V112, P7189, DOI 10.1073/pnas.1504822112; Evgrafov OV, 2004, NAT GENET, V36, P602, DOI 10.1038/ng1354; Frugier M, 2003, J MOL BIOL, V331, P375, DOI 10.1016/s0022-2836(03)00767-8; Gilks N, 2004, MOL BIOL CELL, V15, P5383, DOI 10.1091/mbc.E04-08-0715; Guo WR, 2011, NAT STRUCT MOL BIOL, V18, P822, DOI 10.1038/nsmb.2053; Hilliker A, 2011, MOL CELL, V43, P962, DOI 10.1016/j.molcel.2011.08.008; Iwaki A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061748; Jordanova A, 2006, NAT GENET, V38, P197, DOI 10.1038/ng1727; Kakihara Y, 2012, BBA-MOL CELL RES, V1823, P101, DOI 10.1016/j.bbamcr.2011.08.016; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; Kim HJ, 2013, NATURE, V495, P467, DOI 10.1038/nature11922; Kroschwald S, 2015, ELIFE, V4, DOI 10.7554/eLife.06807; Labib K, 2000, SCIENCE, V288, P1643, DOI 10.1126/science.288.5471.1643; Leitner A, 2012, STRUCTURE, V20, P814, DOI 10.1016/j.str.2012.03.007; Li YR, 2013, J CELL BIOL, V201, P361, DOI 10.1083/jcb.201302044; Lin Y, 2015, MOL CELL, V60, P208, DOI 10.1016/j.molcel.2015.08.018; Loschi M, 2009, J CELL SCI, V122, P3973, DOI 10.1242/jcs.051383; Mitchell SF, 2013, NAT STRUCT MOL BIOL, V20, P127, DOI 10.1038/nsmb.2468; Molliex A, 2015, CELL, V163, P123, DOI 10.1016/j.cell.2015.09.015; Munch C, 2004, NEUROLOGY, V63, P724, DOI 10.1212/01.WNL.0000134608.83927.B1; Nott TJ, 2015, MOL CELL, V57, P936, DOI 10.1016/j.molcel.2015.01.013; Ohn T, 2008, NAT CELL BIOL, V10, P1224, DOI 10.1038/ncb1783; Patel SS, 2007, CELL, V129, P83, DOI 10.1016/j.cell.2007.01.044; Pavani SRP, 2008, OPT EXPRESS, V16, P3484, DOI 10.1364/OE.16.003484; Pavani SRP, 2009, P NATL ACAD SCI USA, V106, P2995, DOI 10.1073/pnas.0900245106; Ramaswami M, 2013, CELL, V154, P727, DOI 10.1016/j.cell.2013.07.038; Reijns MAM, 2008, J CELL SCI, V121, P2463, DOI 10.1242/jcs.024976; Ribbeck K, 2002, EMBO J, V21, P2664, DOI 10.1093/emboj/21.11.2664; Rinn J, 2014, SCIENCE, V345, P1240, DOI 10.1126/science.1252966; Rossor AM, 2012, J NEUROL NEUROSUR PS, V83, P6, DOI 10.1136/jnnp-2011-300952; Shen XT, 2000, NATURE, V406, P541, DOI 10.1038/35020123; Shin JH, 2006, J BIOL CHEM, V281, P26914, DOI 10.1074/jbc.M605518200; Smith BN, 2014, NEURON, V84, P324, DOI 10.1016/j.neuron.2014.09.027; Tam S, 2006, NAT CELL BIOL, V8, P1155, DOI 10.1038/ncb1477; Trcek T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8962; Tsang CK, 2007, CELL CYCLE, V6, P25, DOI 10.4161/cc.6.1.3675; Walters RW, 2015, RNA, V21, P1660, DOI 10.1261/rna.053116.115; Weber SC, 2012, CELL, V149, P1188, DOI 10.1016/j.cell.2012.05.022; Yang XX, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004763; Yoon JH, 2010, J CELL BIOL, V189, P813, DOI 10.1083/jcb.200912019	54	748	755	13	157	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 28	2016	164	3					487	498		10.1016/j.cell.2015.12.038	http://dx.doi.org/10.1016/j.cell.2015.12.038			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DC0KU	26777405	Green Accepted, Bronze			2022-12-28	WOS:000368906800018
J	Luo, CT; Liao, W; Dadi, S; Toure, A; Li, MO				Luo, Chong T.; Liao, Will; Dadi, Saida; Toure, Ahmed; Li, Ming O.			Graded Foxo1 activity in T-reg cells differentiates tumour immunity from spontaneous autoimmunity	NATURE			English	Article							TRANSCRIPTION FACTORS; L-SELECTIN; MIGRATION; TOLERANCE; ULTRAFAST; SURVIVAL; CANCER; CCR7	Regulatory T (T-reg) cells expressing the transcription factor Foxp3 have a pivotal role in maintaining immunological self-tolerance(1-5); yet, excessive T-reg cell activities suppress anti-tumour immune responses(6-8). Compared to the resting T-reg (rT(reg)) cell phenotype in secondary lymphoid organs, T-reg cells in non-lymphoid tissues exhibit an activated T-reg (aT(reg)) cell phenotype(9-11). However, the function of aT(reg) cells and whether their generation can be manipulated are largely unexplored. Here we show that the transcription factor Foxo1, previously demonstrated to promote T-reg cell suppression of lymphoproliferative diseases(12,13), has an unexpected function in inhibiting aT(reg)-cell-mediated immune tolerance in mice. We find that aT(reg) cells turned over at a slower rate than rT(reg) cells, but were not locally maintained in tissues. aT(reg) cell differentiation was associated with repression of Foxo1-dependent gene transcription, concomitant with reduced Foxo1 expression, cytoplasmic localization and enhanced phosphorylation at the Akt sites. T-reg-cell-specific expression of an Akt-insensitive Foxo1 mutant prevented downregulation of lymphoid organ homing molecules, and impeded T-reg cell homing to non-lymphoid organs, causing CD8(+) T-cell-mediated autoimmune diseases. Compared to T-reg cells from healthy tissues, tumour-infiltrating T-reg cells downregulated Foxo1 target genes more substantially. Expression of the Foxo1 mutant at a lower dose was sufficient to deplete tumour-associated T-reg cells, activate effector CD8(+) T cells, and inhibit tumour growth without inflicting autoimmunity. Thus, Foxo1 inactivation is essential for the migration of aT(reg) cells that have a crucial function in suppressing CD8(+) T-cell responses; and the Foxo signalling pathway in T-reg cells can be titrated to break tumour immune tolerance preferentially.	[Luo, Chong T.; Dadi, Saida; Toure, Ahmed; Li, Ming O.] Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY 10065 USA; [Luo, Chong T.] Mem Sloan Kettering Canc Ctr, Louis V Gerstner Jr Grad Sch Biomed Sci, New York, NY 10065 USA; [Liao, Will] New York Genome Ctr, New York, NY 10013 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Li, MO (corresponding author), Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY 10065 USA.	lim@mskcc.org		Luo, Chong/0000-0002-3477-5969; Dadi-Mehmetaj, Saida/0000-0002-2215-5324; li, ming/0000-0002-1383-0535	National Institutes of Health [RO1 AI102888-01A1]; Ludwig Center for Cancer Immunology; Memorial Sloan Kettering Cancer Center Support Grant/Core Grant [P30 CA008748]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI102888] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ludwig Center for Cancer Immunology; Memorial Sloan Kettering Cancer Center Support Grant/Core Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank A. Rudensky for the Foxp3<SUP>Cre</SUP> mouse strain and S. Abrams for the AT-3 cell line. We also thank the Li laboratory for discussions. This work was supported by the National Institutes of Health (RO1 AI102888-01A1 to M.O.L.), Ludwig Center for Cancer Immunology (M.O.L.), and the Memorial Sloan Kettering Cancer Center Support Grant/Core Grant (P30 CA008748).	Ali K, 2014, NATURE, V510, P407, DOI 10.1038/nature13444; Bauer CA, 2014, J CLIN INVEST, V124, P2425, DOI 10.1172/JCI66375; Benoist C, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007021; Bluestone JA, 2015, J CLIN INVEST, V125, P2250, DOI 10.1172/JCI78089; Bos PD, 2013, J EXP MED, V210, P2435, DOI 10.1084/jem.20130762; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Fabre S, 2008, J IMMUNOL, V181, P2980, DOI 10.4049/jimmunol.181.5.2980; Franklin RA, 2014, SCIENCE, V344, P921, DOI 10.1126/science.1252510; Harrow J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s4; Hedrick SM, 2012, NAT REV IMMUNOL, V12, P649, DOI 10.1038/nri3278; Huehn J, 2004, J EXP MED, V199, P303, DOI 10.1084/jem.20031562; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Kerdiles YM, 2010, IMMUNITY, V33, P890, DOI 10.1016/j.immuni.2010.12.002; Kerdiles YM, 2009, NAT IMMUNOL, V10, P176, DOI 10.1038/ni.1689; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Levine AG, 2014, NAT IMMUNOL, V15, P1070, DOI 10.1038/ni.3004; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liao Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt214; Luo CT, 2013, TRENDS IMMUNOL, V34, P531, DOI 10.1016/j.it.2013.08.003; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; Mueller SN, 2013, ANNU REV IMMUNOL, V31, P137, DOI 10.1146/annurev-immunol-032712-095954; Nishikawa H, 2010, INT J CANCER, V127, P759, DOI 10.1002/ijc.25429; Ouyang WM, 2012, NATURE, V491, P554, DOI 10.1038/nature11581; Ouyang WM, 2011, TRENDS IMMUNOL, V32, P26, DOI 10.1016/j.it.2010.10.005; Ouyang WM, 2009, IMMUNITY, V30, P358, DOI 10.1016/j.immuni.2009.02.003; Quezada SA, 2011, IMMUNOL REV, V241, P104, DOI 10.1111/j.1600-065X.2011.01007.x; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Shevach EM, 2011, ADV IMMUNOL, V112, P137, DOI 10.1016/B978-0-12-387827-4.00004-8; Shimizu J, 1999, J IMMUNOL, V163, P5211; Smigiel KS, 2014, J EXP MED, V211, P121, DOI 10.1084/jem.20131142; Stewart TJ, 2007, J IMMUNOL, V179, P2851, DOI 10.4049/jimmunol.179.5.2851; Stringer JR, 2005, P NATL ACAD SCI USA, V102, P2408, DOI 10.1073/pnas.0401340102; Sugiyama D, 2013, P NATL ACAD SCI USA, V110, P17945, DOI 10.1073/pnas.1316796110; Vahl JC, 2014, IMMUNITY, V41, P722, DOI 10.1016/j.immuni.2014.10.012; Wan YSY, 2006, NAT IMMUNOL, V7, P851, DOI 10.1038/ni1355; Wang LG, 2012, BIOINFORMATICS, V28, P2184, DOI 10.1093/bioinformatics/bts356; Wright DE, 2001, SCIENCE, V294, P1933, DOI 10.1126/science.1064081; Zou WP, 2006, NAT REV IMMUNOL, V6, P295, DOI 10.1038/nri1806	40	132	134	1	43	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 28	2016	529	7587					532	+		10.1038/nature16486	http://dx.doi.org/10.1038/nature16486			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB7DD	26789248	Green Accepted			2022-12-28	WOS:000368673800038
J	Saab, AS; Nave, KA				Saab, Aiman S.; Nave, Klaus-Armin			A mechanism for myelin injury	NATURE			English	Editorial Material							NMDA RECEPTORS; CHANNELS		[Saab, Aiman S.] Max Planck Inst Expt Med, Dept Neurogenet, Hermann Rein Str 3, D-37075 Gottingen, Germany; [Nave, Klaus-Armin] Univ Zurich, Inst Pharmacol & Toxicol, Zurich, Switzerland; [Nave, Klaus-Armin] Neurosci Ctr Zurich, Zurich, Switzerland	Max Planck Society; University of Zurich	Saab, AS (corresponding author), Max Planck Inst Expt Med, Dept Neurogenet, Hermann Rein Str 3, D-37075 Gottingen, Germany.; Nave, KA (corresponding author), Neurosci Ctr Zurich, Zurich, Switzerland.	asaab@pharma.uzh.ch; nave@em.mpg.de						Follett PL, 2000, J NEUROSCI, V20, P9235; Hamilton NB, 2016, NATURE, V529, P523, DOI 10.1038/nature16519; Karadottir R, 2005, NATURE, V438, P1162, DOI 10.1038/nature04302; Micu I, 2006, NATURE, V439, P988, DOI 10.1038/nature04474; Micu I, 2016, EXP NEUROL, V276, P41, DOI 10.1016/j.expneurol.2015.10.006; Nagatomo K, 2008, P NATL ACAD SCI USA, V105, P17373, DOI 10.1073/pnas.0809769105; Nave KA, 2010, NATURE, V468, P244, DOI 10.1038/nature09614; Salter MG, 2005, NATURE, V438, P1167, DOI 10.1038/nature04301; Tekkok SB, 2007, J CEREBR BLOOD F MET, V27, P1540, DOI 10.1038/sj.jcbfm.9600455; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]	10	11	12	0	9	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 28	2016	529	7587					474	475		10.1038/nature16865	http://dx.doi.org/10.1038/nature16865			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB7DD	26760205				2022-12-28	WOS:000368673800025
J	Seneviratne, SI; Donat, MG; Pitman, AJ; Knutti, R; Wilby, RL				Seneviratne, Sonia I.; Donat, Markus G.; Pitman, Andy J.; Knutti, Reto; Wilby, Robert L.			Allowable CO2 emissions based on regional and impact-related climate targets	NATURE			English	Article							EXTREMES INDEXES; CMIP5; PRECIPITATION; TEMPERATURE; ENSEMBLE; PATTERN; BIASES	Global temperature targets, such as the widely accepted limit of an increase above pre-industrial temperatures of two degrees Celsius, may fail to communicate the urgency of reducing carbon dioxide (CO2) emissions. The translation of CO2 emissions into regional-and impact-related climate targets could be more powerful because such targets are more directly aligned with individual national interests. We illustrate this approach using regional changes in extreme temperatures and precipitation. These scale robustly with global temperature across scenarios, and thus with cumulative CO2 emissions. This is particularly relevant for changes in regional extreme temperatures on land, which are much greater than changes in the associated global mean.	[Seneviratne, Sonia I.; Knutti, Reto] Swiss Fed Inst Technol, Dept Environm Syst Sci, Inst Atmospher & Climate Sci, Zurich, Switzerland; [Donat, Markus G.; Pitman, Andy J.] Univ New S Wales, ARC Ctr Excellence Climate Syst Sci, Sydney, NSW, Australia; [Donat, Markus G.; Pitman, Andy J.] Univ New S Wales, Climate Change Res Ctr, Sydney, NSW, Australia; [Wilby, Robert L.] Univ Loughborough, Dept Geog, Loughborough, Leics, England	Swiss Federal Institutes of Technology Domain; ETH Zurich; ARC Centre of Excellence for Climate System Science; University of New South Wales Sydney; University of New South Wales Sydney; Loughborough University	Seneviratne, SI (corresponding author), Swiss Fed Inst Technol, Dept Environm Syst Sci, Inst Atmospher & Climate Sci, Zurich, Switzerland.	sonia.seneviratne@ethz.ch	Knutti, Reto/B-8763-2008; Pitman, Andrew J/A-7353-2011; Donat, Markus/J-8331-2012; Seneviratne, Sonia I./G-8761-2011	Knutti, Reto/0000-0001-8303-6700; Pitman, Andrew J/0000-0003-0604-3274; Donat, Markus/0000-0002-0608-7288; Seneviratne, Sonia I./0000-0001-9528-2917	European Community's Seventh Framework Programme [FP7-IDEAS-ERC-617518]; Australian Research Council (ARC) Centre of Excellence for Climate System Science [CE110001028]; ARC [DE150100456]	European Community's Seventh Framework Programme(European Commission); Australian Research Council (ARC) Centre of Excellence for Climate System Science(Australian Research Council); ARC(Australian Research Council)	S.I.S. acknowledges the European Research Council (ERC) 'DROUGHT-HEAT' project funded by the European Community's Seventh Framework Programme (grant agreement FP7-IDEAS-ERC-617518). A.J.P. and M.G.D. were supported by the Australian Research Council (ARC) Centre of Excellence for Climate System Science (grant number CE110001028). M.G.D. was also supported by the ARC (grant number DE150100456). This work contributes to the World Climate Research Programme (WCRP) Grand Challenge on Extremes. We acknowledge the WCRP Working Group on Coupled Modelling, which is responsible for CMIP, and we thank the climate modelling groups for producing and making available their model output. For CMIP the US Department of Energy's Program for Climate Model Diagnosis and Intercomparison provides coordinating support and led development of software infrastructure in partnership with the Global Organization for Earth System Science Portals. We thank N. Maher for help with processing CMIP5 data. The climate extremes indices calculated for the different CMIP5 runs were obtained from the Environment Canada CLIMDEX website (http://www.cccma.ec.gc.ca/data/climdex/).	Allen MR, 2009, NATURE, V458, P1163, DOI 10.1038/nature08019; Boisier JP, 2015, NAT CLIM CHANGE, V5, P656, DOI [10.1038/NCLIMATE2658, 10.1038/nclimate2658]; Christensen JH, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P1217; Church J. A, 2013, CLIMATE CHANGE 2013, DOI DOI 10.1017/CBO9781107415324; Council of the European Union, 2008, CLIM CHANG INT SEC; Degu AM, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046482; Deser C, 2012, NAT CLIM CHANGE, V2, P775, DOI 10.1038/NCLIMATE1562; Diffenbaugh NS, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043888; Drijfhout S, 2015, P NATL ACAD SCI USA, V112, pE5777, DOI 10.1073/pnas.1511451112; Fischer EM, 2014, GEOPHYS RES LETT, V41, P8554, DOI 10.1002/2014GL062018; Friedlingstein P, 2014, NAT GEOSCI, V7, P709, DOI [10.1038/NGEO2248, 10.1038/ngeo2248]; Frieler K, 2012, J CLIMATE, V25, P3117, DOI 10.1175/JCLI-D-11-00199.1; Hall A, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025127; Hanewinkel M, 2013, NAT CLIM CHANGE, V3, P203, DOI [10.1038/nclimate1687, 10.1038/NCLIMATE1687]; Hansen J, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0080954, 10.1371/journal.pone.0081648]; Herger N, 2015, GEOPHYS RES LETT, V42, P3486, DOI 10.1002/2015GL063569; Hunt ASP, 2014, CLIM RES, V59, P89, DOI 10.3354/cr01200; Intergovernmental Panel on Climate Change (IPCC), 2013, CLIM CHANG 2013 PHYS; IPCC, 2014, CONTRIBUTION WORKING; IPCC, 2018, CLIMATE CHANGE 2013, DOI DOI 10.1017/CBO9781107415324; Jeong SJ, 2014, NAT CLIM CHANGE, V4, P615, DOI [10.1038/nclimate2266, 10.1038/NCLIMATE2266]; Karl TR, 2015, SCIENCE, V348, P1469, DOI 10.1126/science.aaa5632; Kelley CP, 2015, P NATL ACAD SCI USA, V112, P3241, DOI 10.1073/pnas.1421533112; Kharin VV, 2007, J CLIMATE, V20, P1419, DOI 10.1175/JCLI4066.1; Kirtman B., 2013, CLIM CHANG 2013 PHYS, DOI [10.18203/2319-2003.ijbcp20175200, DOI 10.1017/CBO9781107415324]; Knutti R, 2015, CLIMATIC CHANGE, V133, P361, DOI 10.1007/s10584-015-1340-3; Lehner F, 2015, NAT CLIM CHANGE, V5, P731, DOI 10.1038/NCLIMATE2660; Lenton TM, 2008, P NATL ACAD SCI USA, V105, P1786, DOI 10.1073/pnas.0705414105; Levy H, 2013, J GEOPHYS RES-ATMOS, V118, P4521, DOI 10.1002/jgrd.50192; Luyssaert S, 2014, NAT CLIM CHANGE, V4, P389, DOI [10.1038/nclimate2196, 10.1038/NCLIMATE2196]; Masato G, 2013, J CLIMATE, V26, P7044, DOI 10.1175/JCLI-D-12-00466.1; Matthews HD, 2009, NATURE, V459, P829, DOI 10.1038/nature08047; Meinshausen M, 2009, NATURE, V458, P1158, DOI 10.1038/nature08017; Mueller B, 2014, GEOPHYS RES LETT, V41, P128, DOI 10.1002/2013GL058055; Murray V, 2012, MANAGING THE RISKS OF EXTREME EVENTS AND DISASTERS TO ADVANCE CLIMATE CHANGE ADAPTATION, P487; Orlowsky B, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/7/074007; Orlowsky B, 2013, HYDROL EARTH SYST SC, V17, P1765, DOI 10.5194/hess-17-1765-2013; Orlowsky B, 2012, CLIMATIC CHANGE, V110, P669, DOI 10.1007/s10584-011-0122-9; Pal J. S., 2015, NATURE CLIM CHANGE; Pitman AJ, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039076; Schewe J, 2014, P NATL ACAD SCI USA, V111, P3245, DOI 10.1073/pnas.1222460110; Seneviratne SI, 2006, NATURE, V443, P205, DOI 10.1038/nature05095; Seneviratne SI, 2014, NAT CLIM CHANGE, V4, P161, DOI 10.1038/nclimate2145; Seneviratne SI, 2013, GEOPHYS RES LETT, V40, P5212, DOI 10.1002/grl.50956; Seneviratne SI, 2012, MANAGING THE RISKS OF EXTREME EVENTS AND DISASTERS TO ADVANCE CLIMATE CHANGE ADAPTATION, P109; Serreze MC, 2011, GLOBAL PLANET CHANGE, V77, P85, DOI 10.1016/j.gloplacha.2011.03.004; Sillmann J, 2013, J GEOPHYS RES-ATMOS, V118, P1716, DOI 10.1002/jgrd.50203; Sillmann J, 2013, J GEOPHYS RES-ATMOS, V118, P2473, DOI 10.1002/jgrd.50188; Sutton R, 2015, PHILOS T R SOC A, V373, DOI 10.1098/rsta.2014.0426; Sutton RT, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028164; Taylor CM, 2012, NATURE, V489, P423, DOI 10.1038/nature11377; Taylor KE, 2012, B AM METEOROL SOC, V93, P485, DOI 10.1175/BAMS-D-11-00094.1; Trenberth KE, 2013, EARTHS FUTURE, V1, P19, DOI 10.1002/2013EF000165; Tschakert P, 2015, CLIM CHANG RESPONSES, V2, P1, DOI [10.1186/s40665-015-0010-z, DOI 10.1186/S40665-015-0010-Z]; UNFCCC (U. N. Framew. Conv. Clim. Change), 2015, REP STRUCT EXP DIAL; Victor DG, 2014, NATURE, V514, P30, DOI 10.1038/514030a; Wei JF, 2013, J HYDROMETEOROL, V14, P275, DOI 10.1175/JHM-D-12-079.1; Wilby RL, 2008, ENVIRON PLANN B, V35, P902, DOI 10.1068/b33066t; Zhang XB, 2011, WIRES CLIM CHANGE, V2, P851, DOI 10.1002/wcc.147	59	358	376	24	255	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 28	2016	529	7587					477	483		10.1038/nature16542	http://dx.doi.org/10.1038/nature16542			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB7DD	26789252	Green Accepted, Green Published			2022-12-28	WOS:000368673800027
J	Chen, Q; Yan, MH; Cao, ZH; Li, X; Zhang, YF; Shi, JC; Feng, GH; Peng, HY; Zhang, XD; Zhang, Y; Qian, JJ; Duan, EK; Zhai, QW; Zhou, Q				Chen, Qi; Yan, Menghong; Cao, Zhonghong; Li, Xin; Zhang, Yunfang; Shi, Junchao; Feng, Gui-hai; Peng, Hongying; Zhang, Xudong; Zhang, Ying; Qian, Jingjing; Duan, Enkui; Zhai, Qiwei; Zhou, Qi			Sperm tsRNAs contribute to intergenerational inheritance of an acquired metabolic disorder	SCIENCE			English	Article							INDUCED TRANSGENERATIONAL INHERITANCE; SMALL RNAS; PARAMUTATION; RAT	Increasing evidence indicates that metabolic disorders in offspring can result from the father's diet, but the mechanism remains unclear. In a paternal mouse model given a high-fat diet (HFD), we showed that a subset of sperm transfer RNA-derived small RNAs (tsRNAs), mainly from 5' transfer RNA halves and ranging in size from 30 to 34 nucleotides, exhibited changes in expression profiles and RNA modifications. Injection of sperm tsRNA fractions from HFD males into normal zygotes generated metabolic disorders in the F-1 offspring and altered gene expression of metabolic pathways in early embryos and islets of F-1 offspring, which was unrelated to DNA methylation at CpG-enriched regions. Hence, sperm tsRNAs represent a paternal epigenetic factor that may mediate intergenerational inheritance of diet-induced metabolic disorders.	[Chen, Qi; Cao, Zhonghong; Li, Xin; Zhang, Yunfang; Shi, Junchao; Feng, Gui-hai; Peng, Hongying; Zhang, Xudong; Zhang, Ying; Qian, Jingjing; Duan, Enkui; Zhou, Qi] Chinese Acad Sci, Inst Zool, State Key Lab Stem Cell & Reprod Biol, Beijing 100101, Peoples R China; [Yan, Menghong; Zhai, Qiwei] Chinese Acad Sci, Shanghai Inst Biol Sci, Ctr Excellence Mol Cell Sci, Key Lab Nutr & Metab, Shanghai 200031, Peoples R China; [Chen, Qi] Univ Nevada, Sch Med, Dept Physiol & Cell Biol, Reno, NV 89512 USA; [Peng, Hongying] Beijing Univ Chinese Med, Beijing Royal Integrat Med Hosp, Beijing, Peoples R China; [Cao, Zhonghong; Zhang, Yunfang; Shi, Junchao; Zhang, Xudong; Qian, Jingjing] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Nevada System of Higher Education (NSHE); University of Nevada Reno; Beijing University of Chinese Medicine; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Chen, Q (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Stem Cell & Reprod Biol, Beijing 100101, Peoples R China.	cqi@medicine.nevada.edu; duane@ioz.ac.cn; qwzhai@sibs.ac.cn; qzhou@ioz.ac.cn	Chen, Qi/W-1759-2019; Zhang, Xudong/AAL-2617-2020; Chen, Qi/K-4059-2019; cao, zhonghong/AAQ-9968-2020; xin, chen/AAF-9544-2020; Shi, Junchao/J-4909-2019; Feng, Guihai/A-5105-2019	Zhang, Xudong/0000-0002-5964-0067; Chen, Qi/0000-0001-6353-9589; Shi, Junchao/0000-0002-1548-5069; Feng, Guihai/0000-0002-8726-1734; Cao, Zhonghong/0000-0003-1138-0080; Zhang, Ying/0000-0003-4082-5026; Zhai, Qiwei/0000-0002-9617-7403	National Basic Research Program of China [2012CBA01300, 2015CB943000, 2014CB542300]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDA01000000]; National Natural Science Foundation of China [81490742, 31200879, 31300960, 31300957, 81472181, 31470768, 81321062]	National Basic Research Program of China(National Basic Research Program of China); Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Raw data are archived in the Gene Expression Omnibus under accession number GSE75544. This research was supported by the National Basic Research Program of China (grants 2012CBA01300 to Q.Zho., 2015CB943000 to Q.C., and 2014CB542300 to Q.Zha.), the Strategic Priority Research Program of the Chinese Academy of Sciences (grant XDA01000000 to Q.Zho. and E.D), and the National Natural Science Foundation of China (grants 81490742 to E.D., 31200879 to Q.C., 31300960 to H.P., 31300957 to Y.Z., 81472181 to M.Y., and 31470768 and 81321062 to Q.Zha.).	Carone BR, 2010, CELL, V143, P1084, DOI 10.1016/j.cell.2010.12.008; Cho YS, 2012, NAT GENET, V44, P67, DOI 10.1038/ng.1019; Daxinger L, 2012, NAT REV GENET, V13, P153, DOI 10.1038/nrg3188; Dibble CC, 2015, TRENDS CELL BIOL, V25, P545, DOI 10.1016/j.tcb.2015.06.002; Fullston T, 2013, FASEB J, V27, P4226, DOI 10.1096/fj.12-224048; Gapp K, 2014, NAT NEUROSCI, V17, P667, DOI 10.1038/nn.3695; Grandjean V, 2009, DEVELOPMENT, V136, P3647, DOI 10.1242/dev.041061; Holoch D, 2015, NAT REV GENET, V16, P71, DOI 10.1038/nrg3863; Jimenez-Palomares M, 2015, AM J PHYSIOL-ENDOC M, V308, pE450, DOI 10.1152/ajpendo.00260.2014; Jodar M, 2013, HUM REPROD UPDATE, V19, P604, DOI 10.1093/humupd/dmt031; Kiani J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003498; Lane M, 2014, SCIENCE, V345, P756, DOI 10.1126/science.1254400; Liebers R, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004296; Ng SF, 2010, NATURE, V467, P963, DOI 10.1038/nature09491; Peng HY, 2012, CELL RES, V22, P1609, DOI 10.1038/cr.2012.141; Radford EJ, 2014, SCIENCE, V345, P785, DOI 10.1126/science.1255903; Rando OJ, 2012, CELL, V151, P702, DOI 10.1016/j.cell.2012.10.020; Rassoulzadegan M, 2006, NATURE, V441, P469, DOI 10.1038/nature04674; Rechavi O, 2014, CELL, V158, P277, DOI 10.1016/j.cell.2014.06.020; Rodgers AB, 2015, P NATL ACAD SCI USA, V112, P13699, DOI 10.1073/pnas.1508347112; Siklenka K, 2015, SCIENCE, V350, DOI 10.1126/science.aab2006; Tuorto F, 2012, NAT STRUCT MOL BIOL, V19, P900, DOI 10.1038/nsmb.2357; Wagner KD, 2008, DEV CELL, V14, P962, DOI 10.1016/j.devcel.2008.03.009; Wei YC, 2014, P NATL ACAD SCI USA, V111, P1873, DOI 10.1073/pnas.1321195111; Yan MH, 2013, ANAL CHEM, V85, P12173, DOI 10.1021/ac4036026; Yan W, 2014, MOL CELL ENDOCRINOL, V398, P24, DOI 10.1016/j.mce.2014.09.008; Yuan SQ, 2015, SCI REP-UK, V5, DOI 10.1038/srep09266; Zhang YF, 2014, J MOL CELL BIOL, V6, P172, DOI 10.1093/jmcb/mjt052	28	709	752	10	265	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 22	2016	351	6271					397	400		10.1126/science.aad7977	http://dx.doi.org/10.1126/science.aad7977			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB3VH	26721680	Green Published			2022-12-28	WOS:000368440500043
J	Montoy, JCC; Dow, WH; Kaplan, BC				Montoy, Juan Carlos C.; Dow, William H.; Kaplan, Beth C.			Patient choice in opt-in, active choice, and opt-out HIV screening: randomized clinical trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HEALTH-CARE SETTINGS; EMERGENCY-DEPARTMENTS; ROUTINE; INFECTION; RISK; INCREASE; CONSENT; INTERVENTION; PREVALENCE	STUDY QUESTION What is the effect of default test offers-opt-in, opt-out, and active choice-on the likelihood of acceptance of an HIV test among patients receiving care in an emergency department? METHODS This was a randomized clinical trial conducted in the emergency department of an urban teaching hospital and regional trauma center. Patients aged 13-64 years were randomized to opt-in, opt-out, and active choice HIV test offers. The primary outcome was HIV test acceptance percentage. The Denver Risk Score was used to categorize patients as being at low, intermediate, or high risk of HIV infection. STUDY ANSWER AND LIMITATIONS 38.0% (611/1607) of patients in the opt-in testing group accepted an HIV test, compared with 51.3% (815/1628) in the active choice arm (difference 13.3%, 95% confidence interval 9.8% to 16.7%) and 65.9% (1031/1565) in the opt-out arm (difference 27.9%, 24.4% to 31.3%). Compared with active choice testing, opt-out testing led to a 14.6 (11.1 to 18.1) percentage point increase in test acceptance. Patients identified as being at intermediate and high risk were more likely to accept testing than were those at low risk in all arms (difference 6.4% (3.4% to 9.3%) for intermediate and 8.3% (3.3% to 13.4%) for high risk). The opt-out effect was significantly smaller among those reporting high risk behaviors, but the active choice effect did not significantly vary by level of reported risk behavior. Patients consented to inclusion in the study after being offered an HIV test, and inclusion varied slightly by treatment assignment. The study took place at a single county hospital in a city that is somewhat unique with respect to HIV testing; although the test acceptance percentages themselves might vary, a different pattern for opt-in versus active choice versus opt-out test schemes would not be expected. WHAT THIS PAPER ADDS Active choice is a distinct test regimen, with test acceptance patterns that may best approximate patients' true preferences. Opt-out regimens can substantially increase HIV testing, and opt-in schemes may reduce testing, compared with active choice testing.	[Montoy, Juan Carlos C.] Univ Calif San Francisco, Dept Emergency Med, 505 Parnassus Ave, San Francisco, CA 94143 USA; [Dow, William H.] Univ Calif Berkeley, Sch Publ Hlth, 239 Univ Hall 7360, Berkeley, CA 94720 USA; [Kaplan, Beth C.] Univ Calif San Francisco, Dept Emergency Med, 1001 Potrero Ave, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California Berkeley; University of California System; University of California San Francisco	Montoy, JCC (corresponding author), Univ Calif San Francisco, Dept Emergency Med, 505 Parnassus Ave, San Francisco, CA 94143 USA.	juancarlos.montoy@ucsf.edu		Dow, William/0000-0002-4080-1668	National Institute on Aging [NIA 1RC4AG039078]; NATIONAL INSTITUTE ON AGING [RC4AG039078] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by grant NIA 1RC4AG039078 from the National Institute on Aging (awarded to WHD and BCK). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute on Aging or the National Institutes of Health. The sponsors had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; or the decision to submit the manuscript for publication.	Ai CR, 2003, ECON LETT, V80, P123, DOI 10.1016/S0165-1765(03)00032-6; [Anonymous], 2006, MMWR RECOMM REP; [Anonymous], 2021, HIV TESTING NEW HIV; [Anonymous], HIV TEST INCR UPT EF; Aronson ID, 2015, AIDS BEHAV, V19, P516, DOI 10.1007/s10461-014-0853-5; Berg LJ, 2012, ACAD EMERG MED, V19, P894, DOI 10.1111/j.1553-2712.2012.01401.x; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Brown J, 2007, JAIDS-J ACQ IMM DEF, V46, P395, DOI 10.1097/QAI.0b013e3181582d82; Burns F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035212; Calderon Y, 2009, AIDS PATIENT CARE ST, V23, P749, DOI 10.1089/apc.2008.0270; Caplin A, 2001, Q J ECON, V116, P55, DOI 10.1162/003355301556347; Choi J. J., 2006, BEHAV PUBLIC FINANCE, P304; Choi JJ, 2003, AM ECON REV, V93, P180, DOI 10.1257/000282803321947010; Consedine NS, 2004, CANCER EPIDEM BIOMAR, V13, P501; Deblonde J, 2011, HEALTH POLICY, V103, P101, DOI 10.1016/j.healthpol.2011.06.012; Hamill M, 2007, BMJ-BRIT MED J, V334, P1352, DOI 10.1136/bmj.39218.404201.94; Haukoos JS, 2015, JAIDS-J ACQ IMM DEF, V68, P599, DOI 10.1097/QAI.0000000000000518; Haukoos JS, 2012, AM J EPIDEMIOL, V175, P838, DOI 10.1093/aje/kwr389; Haukoos JS, 2012, ACAD EMERG MED, V19, P287, DOI 10.1111/j.1553-2712.2012.01290.x; Haukoos JS, 2010, JAMA-J AM MED ASSOC, V304, P284, DOI 10.1001/jama.2010.953; Haukoos JS, 2009, ACAD EMERG MED, V16, P1096, DOI 10.1111/j.1553-2712.2009.00546.x; Hoover JB, 2013, JAIDS-J ACQ IMM DEF, V62, P90, DOI 10.1097/QAI.0b013e3182742933; Jayaraman GC, 2003, CAN MED ASSOC J, V168, P679; Kendrick SR, 2004, AIDS, V18, P2208, DOI 10.1097/00002030-200411050-00017; Koszegi B, 2003, J HEALTH ECON, V22, P1073, DOI 10.1016/j.jhealeco.2003.06.002; KREPS DM, 1978, ECONOMETRICA, V46, P185, DOI 10.2307/1913656; Lerman C, 1999, JAMA-J AM MED ASSOC, V281, P1618, DOI 10.1001/jama.281.17.1618; Lubelchek RJ, 2011, ANN EMERG MED, V58, pS65, DOI 10.1016/j.annemergmed.2011.03.027; Lyons MS, 2013, JAIDS-J ACQ IMM DEF, V64, P315, DOI 10.1097/QAI.0b013e3182a21611; Lyons MS, 2009, ACAD EMERG MED, V16, P168, DOI 10.1111/j.1553-2712.2008.00300.x; MacKellar DA, 2011, SEX TRANSM DIS, V38, P419, DOI 10.1097/OLQ.0b013e31820369dd; Madrian BC, 2001, Q J ECON, V116, P1149, DOI 10.1162/003355301753265543; Merchant RC, 2008, PUBLIC HEALTH REP, V123, P27, DOI 10.1177/00333549081230S305; Merchant RC, 2014, ACAD EMERG MED, V21, P752, DOI 10.1111/acem.12419; Merchant RC, 2010, JAMA-J AM MED ASSOC, V304, P348, DOI 10.1001/jama.2010.996; Merchant RC, 2010, POSTGRAD MED, V122, P61, DOI 10.3810/pgm.2010.01.2100; Mounier-Jack S, 2008, HIV MED, V9, P13, DOI 10.1111/j.1468-1293.2008.00585.x; O'Connor AM, 2009, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001431.pub2, 10.1002/14651858.CD001431.pub3, 10.1002/14651858.CD001431.pub4]; Oster E, 2011, 17629 NBER; Pisculli ML, 2011, AIDS BEHAV, V15, P734, DOI 10.1007/s10461-010-9837-2; Qaseem A, 2009, ANN INTERN MED, V150, P125, DOI 10.7326/0003-4819-150-2-200901200-00300; Rayment M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039530; Schwarcz S, 2007, JAIDS-J ACQ IMM DEF, V44, P112, DOI 10.1097/01.qai.0000247228.30128.dc; Simpson WM, 1999, BRIT MED J, V318, P1660, DOI 10.1136/bmj.318.7199.1660; Stringer EM, 2001, OBSTET GYNECOL, V98, P1104, DOI 10.1016/S0029-7844(01)01631-3; Torian Lucia, 2011, Morbidity and Mortality Weekly Report, V60, P689; White DAE, 2011, JAIDS-J ACQ IMM DEF, V58, P277, DOI 10.1097/QAI.0b013e318231916d; White DAE, 2011, ANN EMERG MED, V58, pS89, DOI 10.1016/j.annemergmed.2011.03.032; WHO Regional Office for Europe, 2010, SCAL HIV TEST COUNS; Zetola NM, 2008, PUBLIC HEALTH REP, V123, P41, DOI 10.1177/00333549081230S306; Zetola NM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002591	51	77	77	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 19	2016	352								h6895	10.1136/bmj.h6895	http://dx.doi.org/10.1136/bmj.h6895			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DC4ZO	26786744	Green Published, hybrid			2022-12-28	WOS:000369229700001
J	Crucifix, M				Crucifix, Michel			Earth's narrow escape from a big freeze	NATURE			English	Editorial Material									[Crucifix, Michel] Catholic Univ Louvain, Earth & Life Inst, B-1348 Louvain La Neuve, Belgium	Universite Catholique Louvain	Crucifix, M (corresponding author), Catholic Univ Louvain, Earth & Life Inst, B-1348 Louvain La Neuve, Belgium.	michel.crucifix@uclouvain.be						Archer D, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002625; Crucifix M, 2009, EUR PHYS J-SPEC TOP, V174, P11, DOI 10.1140/epjst/e2009-01087-5; Ganopolski A, 2016, NATURE, V529, P200, DOI 10.1038/nature16494; Hargreaves JC, 2002, CLIM DYNAM, V19, P371, DOI 10.1007/s00382-002-0241-0; Loutre MF, 2000, CLIMATIC CHANGE, V46, P61, DOI 10.1023/A:1005559827189; Menviel L, 2012, PALEOCEANOGRAPHY, V27, DOI 10.1029/2011PA002224; Ruddiman WF, 2013, ANNU REV EARTH PL SC, V41, P45, DOI 10.1146/annurev-earth-050212-123944	7	1	1	1	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 14	2016	529	7585					162	163		10.1038/529162a	http://dx.doi.org/10.1038/529162a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA7WK	26762453				2022-12-28	WOS:000368015700024
J	Butt, CA				Butt, Carrie A.			"A Montrouge"-Rosa La Rouge Henri de Toulouse-Lautrec	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 12	2016	315	2					116	117		10.1001/jama.2015.14047	http://dx.doi.org/10.1001/jama.2015.14047			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DA6XO	26757451				2022-12-28	WOS:000367949200001
J	Press, MJ; Rajkumar, R; Conway, PH				Press, Matthew J.; Rajkumar, Rahul; Conway, Patrick H.			Medicare's New Bundled Payments Design, Strategy, and Evolution	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Press, Matthew J.; Rajkumar, Rahul; Conway, Patrick H.] Ctr Medicare & Medicaid Serv, Baltimore, MD 21244 USA	Centers for Medicare & Medicaid Services	Rajkumar, R (corresponding author), Ctr Medicare & Medicaid Serv, 7500 Secur Blvd,Mailstop WB 06-05, Baltimore, MD 21244 USA.	Rahul.Rajkumar@cms.hhs.gov						Burwell SM, 2015, NEW ENGL J MED, V372, P897, DOI 10.1056/NEJMp1500445; Friedberg MW, 2018, EFFECTS HLTH CARE PA; Howell BL, 2015, JAMA-J AM MED ASSOC, V313, P2317, DOI 10.1001/jama.2015.2902; Rajkumar R, 2014, JAMA-J AM MED ASSOC, V311, P1967, DOI 10.1001/jama.2014.3703	4	119	119	1	20	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 12	2016	315	2					131	132		10.1001/jama.2015.18161	http://dx.doi.org/10.1001/jama.2015.18161			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DA6XO	26720889				2022-12-28	WOS:000367949200010
J	Basu, J; Zaremba, JD; Cheung, SK; Hitti, FL; Zemelman, BV; Losonczy, A; Siegelbaum, SA				Basu, Jayeeta; Zaremba, Jeffrey D.; Cheung, Stephanie K.; Hitti, Frederick L.; Zemelman, Boris V.; Losonczy, Attila; Siegelbaum, Steven A.			Gating of hippocampal activity, plasticity, and memory by entorhinal cortex long-range inhibition	SCIENCE			English	Article							GABAERGIC NEURONS; SPATIAL REPRESENTATION; OBJECT RECOGNITION; DENDRITIC SPIKES; PLACE CELLS; CA1; INPUT; INTERNEURONS; POTENTIALS; DIVERSITY	The cortico-hippocampal circuit is critical for storage of associational memories. Most studies have focused on the role in memory storage of the excitatory projections from entorhinal cortex to hippocampus. However, entorhinal cortex also sends inhibitory projections, whose role in memory storage and cortico-hippocampal activity remains largely unexplored. We found that these long-range inhibitory projections enhance the specificity of contextual and object memory encoding. At the circuit level, these g-aminobutyric acid (GABA)-releasing projections target hippocampal inhibitory neurons and thus act as a disinhibitory gate that transiently promotes the excitation of hippocampal CA1 pyramidal neurons by suppressing feedforward inhibition. This enhances the ability of CA1 pyramidal neurons to fire synaptically evoked dendritic spikes and to generate a temporally precise form of heterosynaptic plasticity. Long-range inhibition from entorhinal cortex may thus increase the precision of hippocampal-based long-term memory associations by assessing the salience of mnemonormation to the immediate sensory input.	[Basu, Jayeeta; Zaremba, Jeffrey D.; Cheung, Stephanie K.; Hitti, Frederick L.; Losonczy, Attila; Siegelbaum, Steven A.] Columbia Univ, Med Ctr, Kavli Brain Inst, Dept Neurosci, New York, NY 10032 USA; [Zemelman, Boris V.] Univ Texas Austin, Austin, TX 78712 USA	Columbia University; University of Texas System; University of Texas Austin	Basu, J (corresponding author), NYU, Sch Med, NYU Neurosci Inst, Dept Neurosci & Physiol, 450 East 29th St, New York, NY 10016 USA.	jayeeta.basu@nyumc.org; sas8@columbia.edu	Core, Vector/CAF-4832-2022	Basu, Jayeeta/0000-0002-7559-0936; Hitti, Frederick L/0000-0002-5308-9817; Zemelman, Boris/0000-0003-2463-4887; Zaremba, Jeffrey/0000-0001-6531-5474	NARSAD Young Investigator grant; Ruth L. Kirschstein F30 National Research Service Award from the National Institute of Mental Health (NIMH), NIH; NIMH [1R01MH100510, 1R01MH100631]; Searle Scholars Program; Human Frontier Science Program; McKnight Memory and Cognitive Disorders Award; National Institute of Neurological Disorders and Stroke, NIH [R01NS036658]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH100510, R01MH100631] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036658] Funding Source: NIH RePORTER	NARSAD Young Investigator grant(NARSAD); Ruth L. Kirschstein F30 National Research Service Award from the National Institute of Mental Health (NIMH), NIH; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Searle Scholars Program; Human Frontier Science Program(Human Frontier Science Program); McKnight Memory and Cognitive Disorders Award; National Institute of Neurological Disorders and Stroke, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank K. Deisseroth, S. Sternson, Z. J. Huang, and G. Fishell for generously sharing reagents and transgenic mice. We thank V. Jayaraman, R. A. Kerr, D. S. Kim, L. L. Looger, and K. Svoboda from the GENIE Project, Janelia Farm Research Campus, Howard Hughes Medical Institute, for the use of the GCaMP6f-encoding virus. We are grateful to G. Buzsaki, R. Tsien, R. Hen, Al. Dranovsky, C. Kellendonk, S. Fusi, R. Bruno, and A. Das for invaluable discussions on the study and C. Magnus, S. Sternson, C. Denny, A. Katzman, and M. Russo for critical technical advice. We are also indebted to J. Kupferman, Z. Rosen, A. Masurkar, Q. Sun, and T. Bock for helpful comments on previous versions of the manuscript. This work was supported by a NARSAD Young Investigator grant to J.B.; a Ruth L. Kirschstein F30 National Research Service Award from the National Institute of Mental Health (NIMH), NIH, to F.L.H.; a Human Frontier Science Program grant and a grant (1R01MH100510) from NIMH to B.V.Z.; a grant (1R01MH100631) from NIMH and support from the Searle Scholars Program, Human Frontier Science Program, and the McKnight Memory and Cognitive Disorders Award to A. L.; and a grant (R01NS036658) from National Institute of Neurological Disorders and Stroke, NIH, and support from the Howard Hughes Medical Institute to S.A S.	Ainge JA, 2006, BEHAV BRAIN RES, V167, P183, DOI 10.1016/j.bbr.2005.09.005; AMARAL DG, 1989, NEUROSCIENCE, V31, P571, DOI 10.1016/0306-4522(89)90424-7; Basu J, 2013, NEURON, V79, P1208, DOI 10.1016/j.neuron.2013.07.001; Bittner KC, 2015, NAT NEUROSCI, V18, P1133, DOI 10.1038/nn.4062; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Brun VH, 2008, NEURON, V57, P290, DOI 10.1016/j.neuron.2007.11.034; Brun VH, 2002, SCIENCE, V296, P2243, DOI 10.1126/science.1071089; BUZSAKI G, 1984, PROG NEUROBIOL, V22, P131, DOI 10.1016/0301-0082(84)90023-6; Buzsaki G, 2013, NAT NEUROSCI, V16, P130, DOI 10.1038/nn.3304; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Chrobak JJ, 2000, HIPPOCAMPUS, V10, P457, DOI 10.1002/1098-1063(2000)10:4<457::AID-HIPO12>3.0.CO;2-Z; Clark RE, 2000, J NEUROSCI, V20, P8853; Cohen SJ, 2015, BEHAV BRAIN RES, V285, P105, DOI 10.1016/j.bbr.2014.08.002; Cohen SJ, 2013, CURR BIOL, V23, P1685, DOI 10.1016/j.cub.2013.07.002; Cope DW, 2002, NEUROSCIENCE, V109, P63, DOI 10.1016/S0306-4522(01)00440-7; Daw MI, 2009, J NEUROSCI, V29, P11112, DOI 10.1523/JNEUROSCI.5760-08.2009; Denny CA, 2012, HIPPOCAMPUS, V22, P1188, DOI 10.1002/hipo.20964; Donato F, 2013, NATURE, V504, P272, DOI 10.1038/nature12866; Dudman JT, 2007, NEURON, V56, P866, DOI 10.1016/j.neuron.2007.10.020; Edelstein Arthur, 2010, Curr Protoc Mol Biol, VChapter 14, DOI 10.1002/0471142727.mb1420s92; Fyhn M, 2004, SCIENCE, V305, P1258, DOI 10.1126/science.1099901; Gambino F, 2014, NATURE, V515, P116, DOI 10.1038/nature13664; Golding NL, 2002, NATURE, V418, P326, DOI 10.1038/nature00854; Golding NL, 1998, NEURON, V21, P1189, DOI 10.1016/S0896-6273(00)80635-2; Hargreaves EL, 2005, SCIENCE, V308, P1792, DOI 10.1126/science.1110449; Hefft S, 2005, NAT NEUROSCI, V8, P1319, DOI 10.1038/nn1542; Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159; Hitti FL, 2014, NATURE, V508, P88, DOI 10.1038/nature13028; Igarashi KM, 2014, NATURE, V510, P143, DOI 10.1038/nature13162; Jacob W, 2012, NEUROBIOL LEARN MEM, V98, P47, DOI 10.1016/j.nlm.2012.04.008; Jarsky T, 2005, NAT NEUROSCI, V8, P1667, DOI 10.1038/nn1599; Kaifosh P, 2014, FRONT NEUROINFORM, V8, DOI 10.3389/fninf.2014.00080; Kaifosh P, 2013, NAT NEUROSCI, V16, P1182, DOI 10.1038/nn.3482; Kamondi A, 1998, J NEUROSCI, V18, P3919; Kitamura T, 2014, SCIENCE, V343, P896, DOI 10.1126/science.1244634; Klausberger T, 2005, J NEUROSCI, V25, P9782, DOI 10.1523/JNEUROSCI.3269-05.2005; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Kupferman JV, 2014, CELL, V158, P1335, DOI 10.1016/j.cell.2014.07.035; Larkum ME, 1999, NATURE, V398, P338, DOI 10.1038/18686; Lee SH, 2011, J PHYSIOL-LONDON, V589, P891, DOI 10.1113/jphysiol.2010.198499; Losonczy A, 2008, NATURE, V452, P436, DOI 10.1038/nature06725; Lovett-Barron M, 2014, SCIENCE, V343, P857, DOI 10.1126/science.1247485; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Magnus CJ, 2011, SCIENCE, V333, P1292, DOI 10.1126/science.1206606; Maren S, 2013, NAT REV NEUROSCI, V14, P417, DOI 10.1038/nrn3492; Melzer S, 2012, SCIENCE, V335, P1506, DOI 10.1126/science.1217139; Miyoshi G, 2010, J NEUROSCI, V30, P1582, DOI 10.1523/JNEUROSCI.4515-09.2010; Murray AJ, 2011, NAT NEUROSCI, V14, P297, DOI 10.1038/nn.2751; Nakashiba T, 2008, SCIENCE, V319, P1260, DOI 10.1126/science.1151120; Pawelzik H, 2002, J COMP NEUROL, V443, P346, DOI 10.1002/cne.10118; Roux L, 2015, NEUROPHARMACOLOGY, V88, P10, DOI 10.1016/j.neuropharm.2014.09.011; Royer S, 2012, NAT NEUROSCI, V15, P769, DOI 10.1038/nn.3077; Schomburg EW, 2014, NEURON, V84, P470, DOI 10.1016/j.neuron.2014.08.051; Sheffield MEJ, 2015, NATURE, V517, P200, DOI 10.1038/nature13871; Suh J, 2011, SCIENCE, V334, P1415, DOI 10.1126/science.1210125; Takahashi H, 2009, NEURON, V62, P102, DOI 10.1016/j.neuron.2009.03.007; Taniguchi H, 2011, NEURON, V71, P995, DOI 10.1016/j.neuron.2011.07.026; Tricoire L, 2011, J NEUROSCI, V31, P10948, DOI 10.1523/JNEUROSCI.0323-11.2011; WITTER MP, 1991, J COMP NEUROL, V307, P437, DOI 10.1002/cne.903070308; Yamamoto M, 2009, GENESIS, V47, P107, DOI 10.1002/dvg.20474; YECKEL MF, 1990, P NATL ACAD SCI USA, V87, P5832, DOI 10.1073/pnas.87.15.5832; Zhang F, 2010, NAT PROTOC, V5, P439, DOI 10.1038/nprot.2009.226	62	132	136	2	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 8	2016	351	6269					138	+		10.1126/science.aaa5694	http://dx.doi.org/10.1126/science.aaa5694			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4XQ	26744409	Green Accepted			2022-12-28	WOS:000367806500030
J	Alley, DE; Asomugha, CN; Conway, PH; Sanghavi, DM				Alley, Dawn E.; Asomugha, Chisara N.; Conway, Patrick H.; Sanghavi, Darshak M.			Accountable Health Communities - Addressing Social Needs through Medicare and Medicaid	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Alley, Dawn E.; Asomugha, Chisara N.; Conway, Patrick H.; Sanghavi, Darshak M.] Ctr Medicare & Medicaid Serv, Baltimore, MD 21244 USA	Centers for Medicare & Medicaid Services	Alley, DE (corresponding author), Ctr Medicare & Medicaid Serv, Baltimore, MD 21244 USA.							Adler NE, 2015, NEW ENGL J MED, V372, P698, DOI 10.1056/NEJMp1413945; [Anonymous], 2013, MMWR SURVEILL SUM S3, V62, P139; Eggleston EM, 2014, JAMA-J AM MED ASSOC, V311, P797, DOI 10.1001/jama.2014.163; McGinnis JM, 2002, HEALTH AFFAIR, V21, P78, DOI 10.1377/hlthaff.21.2.78; Sandberg SF, 2014, HEALTH AFFAIR, V33, P1975, DOI 10.1377/hlthaff.2014.0648	5	357	358	0	22	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 7	2016	374	1					8	11		10.1056/NEJMp1512532	http://dx.doi.org/10.1056/NEJMp1512532			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DA1UH	26731305				2022-12-28	WOS:000367580500003
J	van Rooij, E				van Rooij, Eva			Cardiac Repair after Myocardial Infarction	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							HEART; REGENERATION		[van Rooij, Eva] Royal Netherlands Acad Arts & Sci, Hubrecht Inst, Utrecht, Netherlands; [van Rooij, Eva] Univ Med Ctr, Dept Cardiol, Utrecht, Netherlands	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center	van Rooij, E (corresponding author), Royal Netherlands Acad Arts & Sci, Hubrecht Inst, Utrecht, Netherlands.							Masters M, 2014, STEM CELL RES, V13, P683, DOI 10.1016/j.scr.2014.04.007; Ogura Y, 2012, CIRCULATION, V126, P1728, DOI 10.1161/CIRCULATIONAHA.112.115089; Oshima Y, 2008, CIRCULATION, V117, P3099, DOI 10.1161/CIRCULATIONAHA.108.767673; Senyo SE, 2014, STEM CELL RES, V13, P532, DOI 10.1016/j.scr.2014.09.003; Wei K, 2015, NATURE, V525, P479, DOI 10.1038/nature15372	5	20	20	2	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 7	2016	374	1					85	87		10.1056/NEJMcibr1512011	http://dx.doi.org/10.1056/NEJMcibr1512011			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DA1UH	26735998	Green Published			2022-12-28	WOS:000367580500014
J	Kaeberlein, M; Rabinovitch, PS; Martin, GM				Kaeberlein, Matt; Rabinovitch, Peter S.; Martin, George M.			Healthy aging: The ultimate preventative medicine	SCIENCE			English	Review							LIFE-SPAN; CALORIC RESTRICTION; SENESCENT CELLS; CHRONIC DISEASE; LONGEVITY; REJUVENATION; MORTALITY; METFORMIN; BLOOD; MTOR	Age is the greatest risk factor for nearly every major cause of mortality in developed nations. Despite this, most biomedical research focuses on individual disease processes without much consideration for the relationships between aging and disease. Recent discoveries in the field of geroscience, which aims to explain biological mechanisms of aging, have provided insights into molecular processes that underlie biological aging and, perhaps more importantly, potential interventions to delay aging and promote healthy longevity. Here we describe some of these advances, along with efforts to move geroscience from the bench to the clinic. We also propose that greater emphasis should be placed on research into basic aging processes, because interventions that slow aging will have a greater effect on quality of life compared with disease-specific approaches.	[Kaeberlein, Matt; Rabinovitch, Peter S.; Martin, George M.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Martin, George M.] Univ Calif Los Angeles, Mol Biol Inst, Los Angeles, CA 90095 USA	University of Washington; University of Washington Seattle; University of California System; University of California Los Angeles	Kaeberlein, M (corresponding author), Univ Washington, Dept Pathol, Seattle, WA 98195 USA.	kaeber@uw.edu			Nathan Shock Center of Excellence in the Basic Biology of Aging, NIA [P30AG013280]; NATIONAL INSTITUTE ON AGING [R24AG042328, P30AG013280] Funding Source: NIH RePORTER	Nathan Shock Center of Excellence in the Basic Biology of Aging, NIA; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Geroscience in our laboratories and the labs of others at the University of Washington is supported by the Nathan Shock Center of Excellence in the Basic Biology of Aging, NIA grant P30AG013280.	Ash AS, 2015, J GERONTOL A-BIOL, V70, P971, DOI 10.1093/gerona/glv015; Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600; Bannister CA, 2014, DIABETES OBES METAB, V16, P1165, DOI 10.1111/dom.12354; de Jesus BB, 2012, CURR OPIN CELL BIOL, V24, P739, DOI 10.1016/j.ceb.2012.09.004; Bitto A, 2014, CELL METAB, V20, P2, DOI 10.1016/j.cmet.2014.06.007; Blackburn EH, 2015, SCIENCE, V350, P1193, DOI 10.1126/science.aab3389; Burch JB, 2014, J GERONTOL A-BIOL, V69, pS1, DOI 10.1093/gerona/glu041; Campisi J, 2014, INTERD T GERONT GERI, V39, P45, DOI 10.1159/000358899; Chen C, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000559; Colman RJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4557; Conboy MJ, 2013, AGING CELL, V12, P525, DOI 10.1111/acel.12065; Dai Dao-Fu, 2014, Longev Healthspan, V3, P6, DOI 10.1186/2046-2395-3-6; Dai DF, 2014, AGING CELL, V13, P529, DOI 10.1111/acel.12203; De Haes W, 2014, P NATL ACAD SCI USA, V111, pE2501, DOI 10.1073/pnas.1321776111; Flynn JM, 2013, AGING CELL, V12, P851, DOI 10.1111/acel.12109; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; Goldman DP, 2013, HEALTH AFFAIR, V32, P1698, DOI 10.1377/hlthaff.2013.0052; Gonzalez-Freire M, 2015, J GERONTOL A-BIOL, V70, P1334, DOI 10.1093/gerona/glv070; Goodell MA, 2015, SCIENCE, V350, P1199, DOI 10.1126/science.aab3388; Gravehamp Claudia, 2013, Critical Reviews in Oncogenesis, V18, P585; Harrison DE, 2014, AGING CELL, V13, P273, DOI 10.1111/acel.12170; Hayden EC, 2015, NATURE, V522, P265, DOI 10.1038/522265a; Hayden EC, 2014, NATURE, V514, P546, DOI 10.1038/514546a; Imai S, 2014, TRENDS CELL BIOL, V24, P464, DOI 10.1016/j.tcb.2014.04.002; Johnson SC, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007316; Johnson SC, 2013, NATURE, V493, P338, DOI 10.1038/nature11861; Kaeberlein M, 2016, VET PATHOL, V53, P291, DOI 10.1177/0300985815591082; Kaeberlein Matt, 2013, F1000Prime Rep, V5, P5, DOI 10.12703/P5-5; Mannick JB, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009892; Mercken EM, 2012, AGEING RES REV, V11, P390, DOI 10.1016/j.arr.2011.11.005; Mitchell SJ, 2014, CELL REP, V6, P836, DOI 10.1016/j.celrep.2014.01.031; Olshansky SJ, 2007, ANN NY ACAD SCI, V1114, P11, DOI 10.1196/annals.1396.050; Omodei D, 2011, FEBS LETT, V585, P1537, DOI 10.1016/j.febslet.2011.03.015; Scudellari M, 2015, NATURE, V517, P426, DOI 10.1038/517426a; Verdin E, 2015, SCIENCE, V350, P1208, DOI 10.1126/science.aac4854; Wang BWE, 2002, ARCH INTERN MED, V162, P2285, DOI 10.1001/archinte.162.20.2285; Wang Y, 2015, SCIENCE, V350, P1204, DOI 10.1126/science.aac4357; Zhu Y, 2015, AGING CELL, V14, P644, DOI 10.1111/acel.12344; Zouboulis CC, 2012, REJUV RES, V15, P302, DOI 10.1089/rej.2011.1249	39	157	161	5	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 4	2015	350	6265					1191	1193		10.1126/science.aad3267	http://dx.doi.org/10.1126/science.aad3267			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CX4WG	26785476	Green Accepted			2022-12-28	WOS:000365700500061
J	Tchernev, G; Chokoeva, AA				Tchernev, Georgi; Chokoeva, Anastasiya Atanasova			Melanoma in a Chinese dragon tattoo	LANCET			English	Editorial Material									[Tchernev, Georgi; Chokoeva, Anastasiya Atanasova] Onkoderma Policlin Dermatol & Dermatol Surg, Sofia 1000, Bulgaria		Chokoeva, AA (corresponding author), Onkoderma Policlin Dermatol & Dermatol Surg, Sofia 1000, Bulgaria.	assia_chokoeva@abv.bgw							0	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 16	2022	399	10334					E37	E37		10.1016/S0140-6736(15)01038-7	http://dx.doi.org/10.1016/S0140-6736(15)01038-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	1G1JN	26724176				2022-12-28	WOS:000795611300001
J	Forkel, M; Carvalhais, N; Rodenbeck, C; Keeling, R; Heimann, M; Thonicke, K; Zaehle, S; Reichstein, M				Forkel, Matthias; Carvalhais, Nuno; Roedenbeck, Christian; Keeling, Ralph; Heimann, Martin; Thonicke, Kirsten; Zaehle, Soenke; Reichstein, Markus			Enhanced seasonal CO2 exchange caused by amplified plant productivity in northern ecosystems	SCIENCE			English	Article							ATMOSPHERIC CO2; VEGETATION; AGRICULTURE; LATITUDES; CYCLE	Atmospheric monitoring of high northern latitudes (above 40 degrees N) has shown an enhanced seasonal cycle of carbon dioxide (CO2) since the 1960s, but the underlying mechanisms are not yet fully understood. The much stronger increase in high latitudes relative to low ones suggests that northern ecosystems are experiencing large changes in vegetation and carbon cycle dynamics. We found that the latitudinal gradient of the increasing CO2 amplitude is mainly driven by positive trends in photosynthetic carbon uptake caused by recent climate change and mediated by changing vegetation cover in northern ecosystems. Our results underscore the importance of climate-vegetation-carbon cycle feedbacks at high latitudes; moreover, they indicate that in recent decades, photosynthetic carbon uptake has reacted much more strongly to warming than have carbon release processes.	[Forkel, Matthias; Carvalhais, Nuno; Roedenbeck, Christian; Heimann, Martin; Zaehle, Soenke; Reichstein, Markus] Max Planck Inst Biogeochem, D-07745 Jena, Germany; [Carvalhais, Nuno] Univ Nova Lisboa, Fac Ciencias & Tecnol, CENSE, Dept Ciencias & Engn Ambiente, Caparica, Portugal; [Keeling, Ralph] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Heimann, Martin] Univ Helsinki, Dept Phys Sci, Helsinki, Finland; [Thonicke, Kirsten] Potsdam Inst Climate Impact Res, D-14473 Potsdam, Germany; [Reichstein, Markus] Michael Stifel Ctr Jena Data Driven & Simulat Sci, D-07743 Jena, Germany; [Forkel, Matthias] Vienna Univ Technol, Dept Geodesy & Geoinformat, A-1040 Vienna, Austria	Max Planck Society; Universidade Nova de Lisboa; University of California System; University of California San Diego; Scripps Institution of Oceanography; University of Helsinki; Potsdam Institut fur Klimafolgenforschung; Technische Universitat Wien	Forkel, M; Carvalhais, N (corresponding author), Max Planck Inst Biogeochem, D-07745 Jena, Germany.; Carvalhais, N (corresponding author), Univ Nova Lisboa, Fac Ciencias & Tecnol, CENSE, Dept Ciencias & Engn Ambiente, Caparica, Portugal.; Forkel, M (corresponding author), Vienna Univ Technol, Dept Geodesy & Geoinformat, A-1040 Vienna, Austria.	matthias.forkel@geo.tuwien.ac.at; ncarval@bgc-jena.mpg.de	Zaehle, Sönke/C-9528-2017; Reichstein, Markus/A-7494-2011; Forkel, Matthias/O-5592-2019; Heimann, Martin/H-7807-2016	Zaehle, Sönke/0000-0001-5602-7956; Reichstein, Markus/0000-0001-5736-1112; Forkel, Matthias/0000-0003-0363-9697; Heimann, Martin/0000-0001-6296-5113; Carvalhais, Nuno/0000-0003-0465-1436	European Union [283080, 242316, 283201]; U.S. Department of Energy [DE-SC0012167]; NSF [1304270]; NOVA [UID/AMB/04085/2013]	European Union(European Commission); U.S. Department of Energy(United States Department of Energy (DOE)); NSF(National Science Foundation (NSF)); NOVA	We thank the following institutions and scientists that acquired and provided CO<INF>2</INF> site data: E. Dlugokencky (NOAA), Scripps Institution of Oceanography, D. Worthy (Environment Canada), F. Meinhardt (Umweltbundesamt), R. Langenfelds and P. Krummel (CSIRO), and H. Koide (JMA). We further thank the following groups, institutions, or scientists for sharing their data sets: AFS, CRU, EC/JRC, ECMWF, GIMMS, NCEP, NRCan, L. Giglio (UMD), M. Jung (MPI-BGC), and S. E. Mikaloff Fletcher (National Institute of Water and Atmospheric Research). We thank S. Schaphoff (PIK) for comments on LPJmL and I. C. Prentice and R. Thomas for comments on the manuscript. Supported by the European Union (FP7) through the projects GEOCARBON (283080), CARBONES (242316), and EMBRACE (283201); U.S. Department of Energy grant DE-SC0012167; NSF grant 1304270; and NOVA grant UID/AMB/04085/2013. Table S7 provides an overview of used data and how it can be obtained. Results from factorial model experiments with LPJmL+TM3 are available at http://doi.pangaea.de/10.1594/PANGAEA.856722.	Anav A, 2015, REV GEOPHYS, V53, P785, DOI 10.1002/2015RG000483; BACASTOW RB, 1985, J GEOPHYS RES-ATMOS, V90, P10529, DOI 10.1029/JD090iD06p10529; Barichivich J, 2013, GLOBAL CHANGE BIOL, V19, P3167, DOI 10.1111/gcb.12283; Beck PSA, 2011, GLOBAL CHANGE BIOL, V17, P2853, DOI 10.1111/j.1365-2486.2011.02412.x; Beer C, 2010, SCIENCE, V329, P834, DOI 10.1126/science.1184984; Berner LT, 2013, GLOBAL CHANGE BIOL, V19, P3449, DOI 10.1111/gcb.12304; Bondeau A, 2007, GLOBAL CHANGE BIOL, V13, P679, DOI 10.1111/j.1365-2486.2006.01305.x; Forkel M, 2014, BIOGEOSCIENCES, V11, P7025, DOI 10.5194/bg-11-7025-2014; Forkel M, 2015, GLOBAL CHANGE BIOL, V21, P3414, DOI 10.1111/gcb.12950; Graven HD, 2013, SCIENCE, V341, P1085, DOI 10.1126/science.1239207; Gray JM, 2014, NATURE, V515, P398, DOI 10.1038/nature13957; Heimann M., 2003, 5 M PLANCK I BIOG; Heimann M., 1989, ASPECTS CLIMATE VARI, P277; Intergovernmental Panel on Climate Change (IPCC), 2013, CLIM CHANG 2013 PHYS; Jung M, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2010JG001566; Keeling CD, 1996, NATURE, V382, P146, DOI 10.1038/382146a0; Lucht W, 2002, SCIENCE, V296, P1687, DOI 10.1126/science.1071828; MacBean N, 2014, NATURE, V515, P351, DOI 10.1038/515351a; Myers-Smith IH, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/4/045509; Myneni RB, 1997, NATURE, V386, P698, DOI 10.1038/386698a0; Norby RJ, 2005, P NATL ACAD SCI USA, V102, P18052, DOI 10.1073/pnas.0509478102; Randerson JT, 1997, GLOBAL BIOGEOCHEM CY, V11, P535, DOI 10.1029/97GB02268; Reichstein M, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL027880; Reichstein M, 2013, NATURE, V500, P287, DOI 10.1038/nature12350; Rodenbeck C, 2003, ATMOS CHEM PHYS, V3, P1919; Schaphoff S, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/1/014026; Sitch S, 2003, GLOBAL CHANGE BIOL, V9, P161, DOI 10.1046/j.1365-2486.2003.00569.x; Thonicke K, 2010, BIOGEOSCIENCES, V7, P1991, DOI 10.5194/bg-7-1991-2010; Trumbore S, 2015, SCIENCE, V349, P814, DOI 10.1126/science.aac6759; Zeng N, 2014, NATURE, V515, P394, DOI 10.1038/nature13893; Zhu ZC, 2013, REMOTE SENS-BASEL, V5, P927, DOI 10.3390/rs5020927	31	239	250	23	267	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 12	2016	351	6274					696	699		10.1126/science.aac4971	http://dx.doi.org/10.1126/science.aac4971			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD3GL	26797146				2022-12-28	WOS:000369810000037
J	Rosenbaum, L				Rosenbaum, Lisa			Falling Together - Empathetic Care for the Dying	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		Bloom P., 2013, JUST BABIES ORIGINS; Institute of Medicine, 2015, DYING AM IMPR QUAL H; Kalanithi P, 2014, NY TIMES; Kalanithi Paul, 2016, BREATH BECOMES AIR; Nuland Sherwin B., 1993, WE REFLECTIONS LIFES; Weeks JC, 2012, NEW ENGL J MED, V367, P1616, DOI 10.1056/NEJMoa1204410	6	5	5	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 11	2016	374	6					587	590		10.1056/NEJMms1516444	http://dx.doi.org/10.1056/NEJMms1516444			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DD2ME	26759931				2022-12-28	WOS:000369755800015
J	Machner, MP; Storz, G				Machner, Matthias P.; Storz, Gisela			Small RNA with a large impact	NATURE			English	Editorial Material							EPITHELIAL-CELLS; GENE-EXPRESSION; INFECTION		[Machner, Matthias P.; Storz, Gisela] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Div Mol & Cellular Biol, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Machner, MP; Storz, G (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Div Mol & Cellular Biol, Bethesda, MD 20892 USA.	machnerm@mail.nih.gov; storzg@mail.nih.gov		Machner, Matthias/0000-0002-6971-7451	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001608, ZIAHD008893] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Hannemann S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003668; Hautefort I, 2008, CELL MICROBIOL, V10, P958, DOI 10.1111/j.1462-5822.2007.01099.x; Mandlik A, 2011, CELL HOST MICROBE, V10, P165, DOI 10.1016/j.chom.2011.07.007; SLAUCH JM, 1994, METHOD ENZYMOL, V235, P481; Stecher B, 2007, PLOS BIOL, V5, P2177, DOI 10.1371/journal.pbio.0050244; Uchiya K, 2005, INFECT IMMUN, V73, P5587, DOI 10.1128/IAI.73.9.5587-5594.2005; Wagner EGH, 2015, ADV GENET, V90, P133, DOI 10.1016/bs.adgen.2015.05.001; Westermann AJ, 2016, NATURE, V529, P496, DOI 10.1038/nature16547; Xiu L, 2015, GENET MOL RES, V14, P16948, DOI 10.4238/2015.December.15.1	9	5	6	0	14	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 28	2016	529	7587					472	+		10.1038/nature16872	http://dx.doi.org/10.1038/nature16872			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DB7DD	26789251	Green Accepted			2022-12-28	WOS:000368673800023
J	Liu, YZ; Ma, YH; Zhao, YB; Sun, XX; Gandara, F; Furukawa, H; Liu, Z; Zhu, HY; Zhu, CH; Suenaga, K; Oleynikov, P; Alshammari, AS; Zhang, X; Terasaki, O; Yaghi, OM				Liu, Yuzhong; Ma, Yanhang; Zhao, Yingbo; Sun, Xixi; Gandara, Felipe; Furukawa, Hiroyasu; Liu, Zheng; Zhu, Hanyu; Zhu, Chenhui; Suenaga, Kazutomo; Oleynikov, Peter; Alshammari, Ahmad S.; Zhang, Xiang; Terasaki, Osamu; Yaghi, Omar M.			Weaving of organic threads into a crystalline covalent organic framework	SCIENCE			English	Article							COPPER(I)	A three-dimensional covalent organic framework (COF-505) constructed from helical organic threads, designed to be mutually weaving at regular intervals, has been synthesized by imine condensation reactions of aldehyde functionalized copper(I)-bisphenanthroline tetrafluoroborate, Cu(PDB)(2)(BF4), and benzidine (BZ). The copper centers are topologically independent of the weaving within the COF structure and serve as templates for bringing the threads into a woven pattern rather than the more commonly observed parallel arrangement. The copper(I) ions can be reversibly removed and added without loss of the COF structure, for which a tenfold increase in elasticity accompanies its demetalation. The threads in COF-505 have many degrees of freedom for enormous deviations to take place between them, throughout the material, without undoing the weaving of the overall structure.	[Liu, Yuzhong; Zhao, Yingbo; Sun, Xixi; Furukawa, Hiroyasu; Yaghi, Omar M.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Dept Chem, Div Mat Sci, Berkeley, CA 94720 USA; [Ma, Yanhang; Oleynikov, Peter; Terasaki, Osamu] Stockholm Univ, Dept Mat & Environm Chem, SE-10691 Stockholm, Sweden; [Liu, Yuzhong; Zhao, Yingbo; Sun, Xixi; Furukawa, Hiroyasu; Yaghi, Omar M.] Kavli Energy NanoSci Inst, Berkeley, CA USA; [Gandara, Felipe] CSIC, Dept New Architectures Mat Chem, Mat Sci Inst Madrid, Madrid 28049, Spain; [Liu, Zheng; Suenaga, Kazutomo] Natl Inst Adv Ind Sci & Technol, Nanomat Res Inst, Tsukuba, Ibaraki 3058565, Japan; [Zhu, Hanyu; Zhang, Xiang] Univ Calif Berkeley, NSF Nanoscale Sci & Engn Ctr NSEC, Berkeley, CA 94720 USA; [Zhu, Chenhui] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Adv Light Source, Berkeley, CA 94720 USA; [Alshammari, Ahmad S.; Yaghi, Omar M.] King Abdulaziz City Sci & Technol, Riyadh 11442, Saudi Arabia; [Zhang, Xiang] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Mat Sci, Berkeley, CA 94720 USA; [Terasaki, Osamu] ShanghaiTech Univ, Sch Phys Sci & Technol, Shanghai 201210, Peoples R China	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Stockholm University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencia de Materiales de Madrid (ICMM); National Institute of Advanced Industrial Science & Technology (AIST); National Science Foundation (NSF); University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; King Abdulaziz City for Science & Technology; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; ShanghaiTech University	Terasaki, O (corresponding author), Stockholm Univ, Dept Mat & Environm Chem, SE-10691 Stockholm, Sweden.	terasaki@mmk.su.se; yaghi@berkeley.edu	Suenaga, Kazu/E-2339-2014; Zhang, Xiang/F-6905-2011; McCoy, Tina/P-3402-2019; Gándara, Felipe/B-9198-2013; Furukawa, Hiroyasu/C-5910-2008; Zhao, Yingbo/AGG-0822-2022; Gandara, Felipe/H-3168-2017; Ma, Yanhang/AAA-4438-2020; Yaghi, Omar M/C-6749-2013; Terasaki, Osamu/Y-1137-2018; Liu, Yuzhong/P-7198-2017; Alshammari, Ahmad/AAX-4355-2020; Liu, Zheng/E-6119-2018	Suenaga, Kazu/0000-0002-6107-1123; Gándara, Felipe/0000-0002-1671-6260; Furukawa, Hiroyasu/0000-0002-6082-1738; Gandara, Felipe/0000-0002-1671-6260; Terasaki, Osamu/0000-0001-5803-0817; Liu, Yuzhong/0000-0001-5614-1951; Alshammari, Ahmad/0000-0001-8907-6164; Liu, Zheng/0000-0001-9095-7647; Yaghi, Omar/0000-0002-5611-3325; Zhu, Hanyu/0000-0003-3376-5352; Zhang, Xiang/0000-0002-3272-894X; Ma, Yanhang/0000-0003-4814-3740	Spanish Ministry of Economy and Competitiveness through the Juan de la Cierva program; JST Research Acceleration Program; Vetenskapsradet, Japan; JEOL Ltd, Japan; EXSELENT, Sweden; 3DEM-Natur, Sweden; BK21Plus, Korea; Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy [DE-AC02-05CH11231]; National Science Foundation (NSF) [DMR-1344290];  [25390023]	Spanish Ministry of Economy and Competitiveness through the Juan de la Cierva program; JST Research Acceleration Program; Vetenskapsradet, Japan; JEOL Ltd, Japan; EXSELENT, Sweden; 3DEM-Natur, Sweden; BK21Plus, Korea; Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy(United States Department of Energy (DOE)); National Science Foundation (NSF)(National Science Foundation (NSF)); 	The structures of COF-505 and Cu(PDB)<INF>2</INF>(BF<INF>4</INF>) are available free of charge from the Cambridge Crystallographic Data Centre under the reference numbers CCDC-1434851 and CCDC-1434852, respectively. This research was supported by BASF SE (Ludwigshafen, Germany) for synthesis and basic characterization, and the U.S. Department of Defense, Defense Threat Reduction Agency (HDTRA 1-12-1-0053) for mechanical properties. We thank C. Canlas for his assistance with solid-state NMR and A. Schoedel (Yaghi group), B. Zhang, and Y. Liu (Molecular Foundry, Lawrence Berkeley National Laboratory) for helpful discussions. This work was also supported by the Spanish Ministry of Economy and Competitiveness through the Juan de la Cierva program (F.G.); a Grant-in-Aid for Scientific Research (C) (25390023) and JST Research Acceleration Program (Z.L. and K.S.); grants from Vetenskapsradet (Y.M. and P.O.) and JEOL Ltd (P.O.), Japan; EXSELENT and 3DEM-Natur, Sweden (O.T.); and BK21Plus, Korea (O.T.). Beamline 7.3.3 of the Advanced Light Source is supported by the Director of the Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy under contract DE-AC02-05CH11231. The AFM study was supported by the National Science Foundation (NSF) (grant DMR-1344290). The data reported in the paper are presented in the supplementary materials.	Alexandrov EV, 2012, ACTA CRYSTALLOGR A, V68, P484, DOI 10.1107/S0108767312019034; Batten SR, 1998, ANGEW CHEM INT EDIT, V37, P1460, DOI 10.1002/(SICI)1521-3773(19980619)37:11<1460::AID-ANIE1460>3.0.CO;2-Z; Blatov VA, 2004, CRYSTENGCOMM, V6, P377, DOI 10.1039/b409722j; Carlucci L, 2003, COORDIN CHEM REV, V246, P247, DOI 10.1016/S0010-8545(03)00126-7; Chen BL, 2001, SCIENCE, V291, P1021, DOI 10.1126/science.1056598; DIETRICHBUCHECKER CO, 1984, J AM CHEM SOC, V106, P3043, DOI 10.1021/ja00322a055; DIETRICHBUCHECKER CO, 1989, ANGEW CHEM INT EDIT, V28, P189, DOI 10.1002/anie.198901891; Gemmi M, 2013, Z KRIST-CRYST MATER, V228, P51, DOI 10.1524/zkri.2013.1559; Jimenez MC, 2000, ANGEW CHEM INT EDIT, V39, P3284, DOI 10.1002/1521-3773(20000915)39:18<3284::AID-ANIE3284>3.0.CO;2-7; Linke M, 2000, J AM CHEM SOC, V122, P11834, DOI 10.1021/ja002018f; Maji TK, 2007, NAT MATER, V6, P142, DOI 10.1038/nmat1827; Miller MT, 1998, INORG CHEM, V37, P2285, DOI 10.1021/ic971164s; Mugnaioli E, 2012, ANGEW CHEM INT EDIT, V51, P7041, DOI 10.1002/anie.201200845; Oliver WC, 2004, J MATER RES, V19, P3, DOI 10.1557/jmr.2004.19.1.3; Pakhomova SV, 2001, J ANAL CHEM+, V56, P910, DOI 10.1023/A:1012301210071; Scaltrito DV, 2000, COORDIN CHEM REV, V208, P243, DOI 10.1016/S0010-8545(00)00309-X; Sun QM, 2014, J MATER CHEM A, V2, P17828, DOI 10.1039/c4ta03419h; Tan JC, 2011, CHEM SOC REV, V40, P1059, DOI 10.1039/c0cs00163e; Uribe-Romo FJ, 2009, J AM CHEM SOC, V131, P4570, DOI 10.1021/ja8096256; WU XL, 1993, J MAGN RESON SER A, V102, P205, DOI 10.1006/jmra.1993.1092; Yaghi OM, 2003, NATURE, V423, P705, DOI 10.1038/nature01650; Zhang YB, 2013, J AM CHEM SOC, V135, P16336, DOI 10.1021/ja409033p	22	308	315	79	812	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 22	2016	351	6271					365	369		10.1126/science.aad4011	http://dx.doi.org/10.1126/science.aad4011			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB3VH	26798010				2022-12-28	WOS:000368440500035
J	Boettiger, AN; Bintu, B; Moffitt, JR; Wang, SY; Beliveau, BJ; Fudenberg, G; Imakaev, M; Mirny, LA; Wu, CT; Zhuang, XW				Boettiger, Alistair N.; Bintu, Bogdan; Moffitt, Jeffrey R.; Wang, Siyuan; Beliveau, Brian J.; Fudenberg, Geoffrey; Imakaev, Maxim; Mirny, Leonid A.; Wu, Chao-ting; Zhuang, Xiaowei			Super-resolution imaging reveals distinct chromatin folding for different epigenetic states	NATURE			English	Article							3D GENOME; ORGANIZATION; VISUALIZATION; PRINCIPLES; DOMAINS	Metazoan genomes are spatially organized at multiple scales, from packaging of DNA around individual nucleosomes to segregation of whole chromosomes into distinct territories1-5. At the intermediate scale of kilobases to megabases, which encompasses the sizes of genes, gene clusters and regulatory domains, the three-dimensional (3D) organization of DNA is implicated in multiple gene regulatory mechanisms(2-4,6-8), but understanding this organization remains a challenge. At this scale, the genome is partitioned into domains of different epigenetic states that are essential for regulating gene expression(9-11). Here we investigate the 3D organization of chromatin in different epigenetic states using super-resolution imaging. We classified genomic domains in Drosophila cells into transcriptionally active, inactive or Polycomb-repressed states, and observed distinct chromatin organizations for each state. All three types of chromatin domains exhibit power-law scaling between their physical sizes in 3D and their domain lengths, but each type has a distinct scaling exponent. Polycomb-repressed domains show the densest packing and most intriguing chromatin folding behaviour, in which chromatin packing density increases with domain length. Distinct from the self-similar organization displayed by transcriptionally active and inactive chromatin, the Polycomb-repressed domains are characterized by a high degree of chromatin intermixing within the domain. Moreover, compared to inactive domains, Polycomb-repressed domains spatially exclude neighbouring active chromatin to a much stronger degree. Computational modelling and knockdown experiments suggest that reversible chromatin interactions mediated by Polycomb-group proteins play an important role in these unique packaging properties of the repressed chromatin. Taken together, our super-resolution images reveal distinct chromatin packaging for different epigenetic states at the kilobase-to-megabase scale, a length scale that is directly relevant to genome regulation.	[Boettiger, Alistair N.; Bintu, Bogdan; Moffitt, Jeffrey R.; Wang, Siyuan; Zhuang, Xiaowei] Harvard Univ, Howard Hughes Med Inst, Dept Chem & Chem Biol, Dept Phys, Cambridge, MA 02138 USA; [Beliveau, Brian J.; Wu, Chao-ting] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Fudenberg, Geoffrey; Imakaev, Maxim; Mirny, Leonid A.] MIT, Inst Med Engn & Sci, Cambridge, MA 02139 USA; [Fudenberg, Geoffrey; Imakaev, Maxim; Mirny, Leonid A.] MIT, Dept Phys, Cambridge, MA 02139 USA	Harvard University; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Zhuang, XW (corresponding author), Harvard Univ, Howard Hughes Med Inst, Dept Chem & Chem Biol, Dept Phys, Cambridge, MA 02138 USA.	zhuang@chemistry.harvard.edu	Mirny, Leonid/ABE-8083-2020	Mirny, Leonid/0000-0002-0785-5410; Beliveau, Brian/0000-0003-1314-3118; Boettiger, Alistair/0000-0002-3554-5196; Wang, Siyuan (Steven)/0000-0001-6550-4064	National Institutes of Health; Damon Runyon Foundation postdoctoral fellowship; Helen Hay Whitney Foundation postdoctoral fellowship; Jane Coffin Childs Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [DP1GM106412, R01GM105637, R01GM114190] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Damon Runyon Foundation postdoctoral fellowship; Helen Hay Whitney Foundation postdoctoral fellowship; Jane Coffin Childs Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank H. Babcock for help with instrumentation and technical advice, J. Kondev for discussions about the data, A. Goloborodko for sharing custom OpenMM force-field, and S. Nguyen for discussions on RNAi knockdown protocol. This work was supported in part by the National Institutes of Health (X.Z., C.W., L.A.M.). A.N.B. acknowledges support by the Damon Runyon Foundation postdoctoral fellowship. J.R.M. acknowledges support of the Helen Hay Whitney Foundation postdoctoral fellowship. S.W. acknowledges support of the Jane Coffin Childs Foundation postdoctoral fellowship. X.Z. is a Howard Hughes Medical Institute Investigator.	Beliveau BJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8147; Beliveau BJ, 2012, P NATL ACAD SCI USA, V109, P21301, DOI 10.1073/pnas.1213818110; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Bickmore WA, 2013, ANNU REV GENOM HUM G, V14, P67, DOI 10.1146/annurev-genom-091212-153515; Bickmore WA, 2013, CELL, V152, P1270, DOI 10.1016/j.cell.2013.02.001; Boyle S, 2011, CHROMOSOME RES, V19, P901, DOI 10.1007/s10577-011-9245-0; Chen KH, 2015, SCIENCE, V348, DOI 10.1126/science.aaa6090; Cheutin T, 2014, CURR OPIN GENET DEV, V25, P30, DOI 10.1016/j.gde.2013.11.016; Cremer T, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003889; Filion GJ, 2010, CELL, V143, P212, DOI 10.1016/j.cell.2010.09.009; Galupa R, 2015, CURR OPIN GENET DEV, V31, P57, DOI 10.1016/j.gde.2015.04.002; Gibcus JH, 2013, MOL CELL, V49, P773, DOI 10.1016/j.molcel.2013.02.011; Gomez-Diaz E, 2014, TRENDS CELL BIOL, V24, P703, DOI 10.1016/j.tcb.2014.08.003; Gorkin DU, 2014, CELL STEM CELL, V14, P762, DOI 10.1016/j.stem.2014.05.017; Grossniklaus U, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a019331; Halverson JD, 2014, REP PROG PHYS, V77, DOI 10.1088/0034-4885/77/2/022601; Huang B, 2008, SCIENCE, V319, P810, DOI 10.1126/science.1153529; Isono K, 2013, DEV CELL, V26, P565, DOI 10.1016/j.devcel.2013.08.016; Kornberg RD, 1999, CELL, V98, P285, DOI 10.1016/S0092-8674(00)81958-3; Levine M, 2014, CELL, V157, P13, DOI 10.1016/j.cell.2014.02.009; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Mirny LA, 2011, CHROMOSOME RES, V19, P37, DOI 10.1007/s10577-010-9177-0; Nicodemi M, 2014, CURR OPIN CELL BIOL, V28, P90, DOI 10.1016/j.ceb.2014.04.004; Rivera CM, 2013, CELL, V155, P39, DOI 10.1016/j.cell.2013.09.011; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Sexton T, 2015, CELL, V160, P1049, DOI 10.1016/j.cell.2015.02.040; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; Simon JA, 2013, MOL CELL, V49, P808, DOI 10.1016/j.molcel.2013.02.013; Spitz F, 2012, NAT REV GENET, V13, P613, DOI 10.1038/nrg3207; Yamada NA, 2011, CYTOGENET GENOME RES, V132, P248, DOI 10.1159/000322717	30	479	494	7	274	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 21	2016	529	7586					418	+		10.1038/nature16496	http://dx.doi.org/10.1038/nature16496			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB2QT	26760202	Green Submitted, Green Accepted, Green Published			2022-12-28	WOS:000368354800051
J	McNeil, BI; Sasse, TP				McNeil, Ben I.; Sasse, Tristan P.			Future ocean hypercapnia driven by anthropogenic amplification of the natural CO2 cycle	NATURE			English	Article							HOMING ABILITY; ACIDIFICATION; PREDATOR; FLUXES; CMIP5; FISH	High carbon dioxide (CO2) concentrations in sea-water (ocean hypercapnia) can induce neurological, physiological and behavioural deficiencies in marine animals(1-10). Prediction of the onset and evolution of hypercapnia in the ocean requires a good understanding of annual variations in oceanic CO2 concentration, but there is a lack of relevant global observational data. Here we identify global ocean patterns of monthly variability in carbon concentration using observations that allow us to examine the evolution of surface-ocean CO2 levels over the entire annual cycle under increasing atmospheric CO2 concentrations. We predict that the present-day amplitude of the natural oscillations in oceanic CO2 concentration will be amplified by up to tenfold in some regions by 2100, if atmospheric CO2 concentrations continue to rise throughout this century (according to the RCP8.5 scenario of the Intergovernmental Panel on Climate Change)(11). The findings from our data are broadly consistent with projections from Earth system climate models(12-15). Our predicted amplification of the annual CO2 cycle displays distinct global patterns that may expose major fisheries in the Southern, Pacific and North Atlantic oceans to hypercapnia many decades earlier than is expected from average atmospheric CO2 concentrations. We suggest that these ocean 'CO2 hotspots' evolve as a combination of the strong seasonal dynamics of CO2 concentration and the long-term effective storage of anthropogenic CO2 in the oceans that lowers the buffer capacity in these regions, causing a nonlinear amplification of CO2 concentration over the annual cycle. The onset of ocean hypercapnia (when the partial pressure of CO2 in sea-water exceeds 1,000 micro-atmospheres) is forecast for atmospheric CO2 concentrations that exceed 650 parts per million, with hypercapnia expected in up to half the surface ocean by 2100, assuming a high-emissions scenario (RCP8.5)(11). Such extensive ocean hypercapnia has detrimental implications for fisheries during the twenty-first century.	[McNeil, Ben I.; Sasse, Tristan P.] Univ New S Wales, Climate Change Res Ctr, Sydney, NSW, Australia; [McNeil, Ben I.] Thinkable Org, Sydney, NSW, Australia; [Sasse, Tristan P.] Univ New S Wales, Sch Math & Stat, Sydney, NSW, Australia	University of New South Wales Sydney; University of New South Wales Sydney	McNeil, BI (corresponding author), Univ New S Wales, Climate Change Res Ctr, Sydney, NSW, Australia.	b.mcneil@unsw.edu.au		McNeil, Ben/0000-0001-5765-7087	Australian Research Council [DP110104955]	Australian Research Council(Australian Research Council)	We thank R. Matear and A. Lenton from the CSIRO for conversations, performing initial model runs and analysis of CMIP5 model output for use here. We acknowledge the World Climate Research Programme's Working Group on Coupled Modelling, which is responsible for CMIP, and we thank the climate modelling groups (Hadley Centre, IPSL, Can and GFDL) for producing their models and making the output openly accessible. For CMIP, the US Department of Energy's Program for Climate Model Diagnosis and Intercomparison provides coordinating support, and led the development of software infrastructure in partnership with the Global Organization for Earth System Science Portals. We acknowledge support from the Australian Research Council discovery grant DP110104955.	Aumont O, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002591; Byrne M, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0439; Cripps IL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022736; Devine BM, 2013, MAR BIOL, V160, P1955, DOI 10.1007/s00227-012-2051-1; Devine BM, 2012, OECOLOGIA, V168, P269, DOI 10.1007/s00442-011-2081-2; Dixson DL, 2010, ECOL LETT, V13, P68, DOI 10.1111/j.1461-0248.2009.01400.x; Dunne JP, 2013, J CLIMATE, V26, P2247, DOI 10.1175/JCLI-D-12-00150.1; Egleston ES, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2008GB003407; Fabry VJ, 2008, ICES J MAR SCI, V65, P414, DOI 10.1093/icesjms/fsn048; Ferrari MCO, 2011, ECOL LETT, V14, P1143, DOI 10.1111/j.1461-0248.2011.01683.x; Food and Agriculture Organization of the United Nations, 2014, STAT WORLD FISH AQ 2, P9; Ishii M, 2014, BIOGEOSCIENCES, V11, P709, DOI 10.5194/bg-11-709-2014; Jones CD, 2011, GEOSCI MODEL DEV, V4, P543, DOI 10.5194/gmd-4-543-2011; Jutfelt F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065825; Key RM, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002247; Kohonen T., 2001, SELF ORG MAPS; Lenton A, 2013, BIOGEOSCIENCES, V10, P4037, DOI 10.5194/bg-10-4037-2013; Maas AE, 2012, BIOGEOSCIENCES, V9, P747, DOI 10.5194/bg-9-747-2012; Meinshausen M, 2011, CLIMATIC CHANGE, V109, P213, DOI 10.1007/s10584-011-0156-z; Munday PL, 2009, P NATL ACAD SCI USA, V106, P1848, DOI 10.1073/pnas.0809996106; Nilsson GE, 2012, NAT CLIM CHANGE, V2, P201, DOI [10.1038/nclimate1352, 10.1038/NCLIMATE1352]; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Sabine CL, 2004, SCIENCE, V305, P367, DOI 10.1126/science.1097403; Sarma VVSS, 2013, BIOGEOSCIENCES, V10, P7035, DOI 10.5194/bg-10-7035-2013; Sasse TP, 2013, BIOGEOSCIENCES, V10, P4319, DOI 10.5194/bg-10-4319-2013; Schuster U, 2009, DEEP-SEA RES PT II, V56, P620, DOI 10.1016/j.dsr2.2008.12.011; Shaw EC, 2013, GLOBAL CHANGE BIOL, V19, P1632, DOI 10.1111/gcb.12154; Shaw EC, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007655; Spady BL, 2014, BIOL OPEN, V3, P1063, DOI 10.1242/bio.20149894; Taylor KE, 2012, B AM METEOROL SOC, V93, P485, DOI 10.1175/BAMS-D-11-00094.1; Volff JN, 2005, HEREDITY, V94, P280, DOI 10.1038/sj.hdy.6800635; Watson SA, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2377; Yang D, 2012, J CLIMATE, V25, P8148, DOI 10.1175/JCLI-D-11-00715.1	33	123	123	3	110	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 21	2016	529	7586					383	+		10.1038/nature16156	http://dx.doi.org/10.1038/nature16156			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB2QT	26791726				2022-12-28	WOS:000368354800043
J	Tan, KR; Cullen, KA; Arguin, PM				Tan, Kathrine R.; Cullen, Karen A.; Arguin, Paul M.			Case 28-2015: A Man with Febrile Symptoms after Traveling from Liberia	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter									[Tan, Kathrine R.; Cullen, Karen A.; Arguin, Paul M.] Ctrs Dis Control & Prevent, Atlanta, GA 30329 USA	Centers for Disease Control & Prevention - USA	Tan, KR (corresponding author), Ctrs Dis Control & Prevent, Atlanta, GA 30329 USA.	ktan@cdc.gov			Intramural CDC HHS [CC999999] Funding Source: Medline	Intramural CDC HHS		[Anonymous], 2015, N ENGL J MED, V373, P1060; Centers for Disease Control and Prevention, MAL DIAGN US; Centers for Disease Control and Prevention, 2014, GUID MAL DIAGN PAT S; Centers for Disease Control and Prevention, 2015, GUID MON MOV PERS PO	4	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 21	2016	374	3					293	294		10.1056/NEJMc1512873	http://dx.doi.org/10.1056/NEJMc1512873			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DB3IS	26789898	Green Accepted			2022-12-28	WOS:000368404800034
J	Valgimigli, M; Santucci, A				Valgimigli, Marco; Santucci, Andrea			Bivalirudin in Acute Coronary Syndromes REPLY	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter							HEPARIN		[Valgimigli, Marco; Santucci, Andrea] Univ Hosp Bern, CH-3010 Bern, Switzerland	University of Bern; University Hospital of Bern	Valgimigli, M (corresponding author), Univ Hosp Bern, CH-3010 Bern, Switzerland.		Valgimigli, Marco/AAE-9103-2019	Valgimigli, Marco/0000-0002-4353-7110				Han YL, 2015, JAMA-J AM MED ASSOC, V313, P1336, DOI 10.1001/jama.2015.2323; Navarese EP, 2015, JACC-CARDIOVASC INTE, V8, P201, DOI 10.1016/j.jcin.2014.10.003; Rudolph V, 2008, J PHARMACOL EXP THER, V327, P324, DOI 10.1124/jpet.108.142414; Steg PG, 2013, NEW ENGL J MED, V369, P2207, DOI 10.1056/NEJMoa1311096	4	2	2	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 21	2016	374	3					285	286						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DB3IS	26789881				2022-12-28	WOS:000368404800019
J	Ast, T; Michaelis, S; Schuldiner, M				Ast, Tslil; Michaelis, Susan; Schuldiner, Maya			The Protease Ste24 Clears Clogged Translocons	CELL			English	Article							ENDOPLASMIC-RETICULUM MEMBRANE; SACCHAROMYCES-CEREVISIAE; A-FACTOR; PROTEOLYTIC ACTIVITY; SECRETORY PROTEINS; SEC61 TRANSLOCON; ER MEMBRANE; PRELAMIN-A; YEAST; DEGRADATION	Translocation into the endoplasmic reticulum (ER) is the first step in the biogenesis of thousands of eukaryotic endomembrane proteins. Although functional ER translocation has been avidly studied, little is known about the quality control mechanisms that resolve faulty translocational states. One such faulty state is translocon clogging, in which the substrate fails to properly translocate and obstructs the translocon pore. To shed light on the machinery required to resolve clogging, we carried out a systematic screen in Saccharomyces cerevisiae that highlighted a role for the ER metalloprotease Ste24. We could demonstrate that Ste24 approaches the translocon upon clogging, and it interacts with and generates cleavage fragments of the clogged protein. Importantly, these functions are conserved in the human homolog, ZMPSTE24, although disease-associated mutant forms of ZMPSTE24 fail to clear the translocon. These results shed light on a new and critical task of Ste24, which safeguards the essential process of translocation.	[Ast, Tslil; Schuldiner, Maya] Weizmann Inst Sci, Dept Mol Genet, IL-7610001 Rehovot, Israel; [Michaelis, Susan] Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA	Weizmann Institute of Science; Johns Hopkins University	Schuldiner, M (corresponding author), Weizmann Inst Sci, Dept Mol Genet, IL-7610001 Rehovot, Israel.	maya.schuldiner@weizmann.ac.il	Ast, Tslil/ABF-5110-2021; Schuldiner, Maya/C-9488-2009	Ast, Tslil/0000-0002-6927-6238; Schuldiner, Maya/0000-0001-9947-115X	Adams Fellowship Program of the Israel Academy of Sciences and Humanities; Adelis Foundation; Berlin Family Foundation; NIH [R01GM041223]; Minerva Foundation; Israeli Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041223] Funding Source: NIH RePORTER	Adams Fellowship Program of the Israel Academy of Sciences and Humanities; Adelis Foundation; Berlin Family Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Minerva Foundation; Israeli Science Foundation(Israel Science Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Michal Eisenberg and Idan Frumkin for their insightful comments on this manuscript. We are indebted to Marius Lemberg, Richard Zimmermann, Shachar Dagan, Oren Schuldiner, and M.S. lab members for many fruitful discussions. We are grateful to Randy Schekman, Matthias Seedorf, Marius Lemberg, Peter Walter, Yves Bourbonnais, Richard Zimmermann, Stephen High, Naama Barkai, Howard Riezman, Won-Ki Huh, Jeffrey Brodsky, Hans Merzendorfer, and Michal Sharon for plasmids and reagents. We thank the NIH AIDS Reagent Program, Division of AIDS, NIAID, NIH, for supplying lopinavir and tipranavir. We are very grateful to Idan Frumkin for his help with the liquid growth assay. T.A. is supported by the Adams Fellowship Program of the Israel Academy of Sciences and Humanities. This work was supported by the generous support of the Adelis Foundation and the Berlin Family Foundation New Scientist Fund, a grant from the NIH (R01GM041223) for S.M., as well as the Minerva Foundation and the Israeli Science Foundation for M.S.	Ast T, 2014, J CELL SCI, V127, P3017, DOI 10.1242/jcs.144386; Ast T, 2013, CRIT REV BIOCHEM MOL, V48, P273, DOI 10.3109/10409238.2013.782999; Ast T, 2013, CELL, V152, P1134, DOI 10.1016/j.cell.2013.02.003; Avci D, 2014, MOL CELL, V56, P630, DOI 10.1016/j.molcel.2014.10.012; Aviram N, 2014, CURR OPIN CELL BIOL, V29, P8, DOI 10.1016/j.ceb.2014.02.004; Barrowman J, 2012, HUM MOL GENET, V21, P4084, DOI 10.1093/hmg/dds233; Belle A, 2006, P NATL ACAD SCI USA, V103, P13004, DOI 10.1073/pnas.0605420103; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhamidipati A, 2005, MOL CELL, V19, P741, DOI 10.1016/j.molcel.2005.07.027; Breslow DK, 2008, NAT METHODS, V5, P711, DOI 10.1038/nmeth.1234; Chen YJ, 2005, NUCLEIC ACIDS RES, V33, pD169; Coffinier C, 2007, P NATL ACAD SCI USA, V104, P13432, DOI 10.1073/pnas.0704212104; Cohen Y, 2011, METHODS MOL BIOL, V781, P127, DOI 10.1007/978-1-61779-276-2_8; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; FujimuraKamada K, 1997, J CELL BIOL, V136, P271, DOI 10.1083/jcb.136.2.271; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Grudnik P, 2009, BIOL CHEM, V390, P775, DOI 10.1515/BC.2009.102; Hamman BD, 1997, CELL, V89, P535, DOI 10.1016/S0092-8674(00)80235-4; Harada Y, 2011, J BIOL CHEM, V286, P2956, DOI 10.1074/jbc.M110.159517; Jan CH, 2014, SCIENCE, V346, P716, DOI 10.1126/science.1257521; Johnson N, 2012, J CELL SCI, V125, P3612, DOI 10.1242/jcs.102608; Jonikas MC, 2009, SCIENCE, V323, P1693, DOI 10.1126/science.1167983; Kim H, 2006, P NATL ACAD SCI USA, V103, P11142, DOI 10.1073/pnas.0604075103; Lang S, 2012, J CELL SCI, V125, P1958, DOI 10.1242/jcs.096727; Lee C, 2001, MOL CELL, V7, P627, DOI 10.1016/S1097-2765(01)00209-X; LEE DH, 1991, BIOCHEM INT, V23, P689; Merksamer PI, 2008, CELL, V135, P933, DOI 10.1016/j.cell.2008.10.011; Michaelis S, 2013, SCIENCE, V339, P1529, DOI 10.1126/science.1236764; Michaelis S, 2012, MICROBIOL MOL BIOL R, V76, P626, DOI 10.1128/MMBR.00010-12; Ng DTW, 1996, J CELL BIOL, V134, P269, DOI 10.1083/jcb.134.2.269; Ngosuwan J, 2003, J BIOL CHEM, V278, P7034, DOI 10.1074/jbc.M210544200; Park E, 2012, ANNU REV BIOPHYS, V41, P21, DOI [10.1146/annurev-biophys-050511-102312, 10.1146/annurev-biophys-050511-402312]; Plath K, 2000, J CELL BIOL, V151, P167, DOI 10.1083/jcb.151.1.167; Plath K, 1998, CELL, V94, P795, DOI 10.1016/S0092-8674(00)81738-9; Pryor EE, 2013, SCIENCE, V339, P1600, DOI 10.1126/science.1232048; Quigley A, 2013, SCIENCE, V339, P1604, DOI 10.1126/science.1231513; Rabinovich E, 2002, MOL CELL BIOL, V22, P626, DOI 10.1128/MCB.22.2.626-634.2002; Rubenstein EM, 2012, J CELL BIOL, V197, P761, DOI 10.1083/jcb.201203061; Sakoh M, 2005, J BIOL CHEM, V280, P33305, DOI 10.1074/jbc.M506180200; Sato BK, 2006, YEAST, V23, P1053, DOI 10.1002/yea.1407; SCHLENSTEDT G, 1995, J CELL BIOL, V129, P979, DOI 10.1083/jcb.129.4.979; Schmidt WK, 1998, P NATL ACAD SCI USA, V95, P11175, DOI 10.1073/pnas.95.19.11175; Shao SC, 2011, CELL, V147, P1576, DOI 10.1016/j.cell.2011.11.048; Sung MK, 2007, YEAST, V24, P767, DOI 10.1002/yea.1504; Suzuki T, 2000, J CELL BIOL, V149, P1039, DOI 10.1083/jcb.149.5.1039; Taura M, 2013, FREE RADICAL BIO MED, V65, P778, DOI 10.1016/j.freeradbiomed.2013.08.161; Tipper DJ, 2002, MOL BIOL CELL, V13, P1158, DOI 10.1091/mbc.01-10-0488; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; van den Ent F, 2006, J BIOCHEM BIOPH METH, V67, P67, DOI 10.1016/j.jbbm.2005.12.008; Vembar SS, 2010, J BIOL CHEM, V285, P22484, DOI 10.1074/jbc.M110.102186; von der Malsburg K, 2015, MOL BIOL CELL, V26, P2168, DOI 10.1091/mbc.E15-01-0040; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Yofe I, 2014, YEAST, V31, P77, DOI 10.1002/yea.2998; Young BP, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-354; Young SG, 2005, J LIPID RES, V46, P2531, DOI 10.1194/jlr.R500011-JLR200	56	62	62	1	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 14	2016	164	1-2					103	114		10.1016/j.cell.2015.11.053	http://dx.doi.org/10.1016/j.cell.2015.11.053			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DB2LE	26771486	Green Accepted, Bronze			2022-12-28	WOS:000368339300013
J	Bei, FF; Lee, HHC; Liu, XF; Gunner, G; Jin, H; Ma, L; Wang, C; Hou, LJ; Hensch, TK; Frank, E; Sanes, JR; Chen, CF; Fagiolini, M; He, ZG				Bei, Fengfeng; Lee, Henry Hing Cheong; Liu, Xuefeng; Gunner, Georgia; Jin, Hai; Ma, Long; Wang, Chen; Hou, Lijun; Hensch, Takao K.; Frank, Eric; Sanes, Joshua R.; Chen, Chinfei; Fagiolini, Michela; He, Zhigang			Restoration of Visual Function by Enhancing Conduction in Regenerated Axons	CELL			English	Article							SPINAL-CORD-INJURY; RETINAL GANGLION-CELLS; CORTICOSPINAL TRACT; OPTIC-NERVE; RETINOGENICULATE SYNAPSE; ADULT CNS; 4-AMINOPYRIDINE; PLASTICITY; ABILITY; RECOVERY	Although a number of repair strategies have been shown to promote axon outgrowth following neuronal injury in the mammalian CNS, it remains unclear whether regenerated axons establish functional synapses and support behavior. Here, in both juvenile and adult mice, we show that either PTEN and SOCS3 co-deletion, or co-overexpression of osteopontin (OPN)/insulin-like growth factor 1 (IGF1)/ciliary neurotrophic factor (CNTF), induces regrowth of retinal axons and formation of functional synapses in the superior colliculus (SC) but not significant recovery of visual function. Further analyses suggest that regenerated axons fail to conduct action potentials from the eye to the SC due to lack of myelination. Consistent with this idea, administration of voltage-gated potassium channel blockers restores conduction and results in increased visual acuity. Thus, enhancing both regeneration and conduction effectively improves function after retinal axon injury.	[Bei, Fengfeng; Lee, Henry Hing Cheong; Liu, Xuefeng; Gunner, Georgia; Jin, Hai; Ma, Long; Wang, Chen; Hensch, Takao K.; Chen, Chinfei; Fagiolini, Michela; He, Zhigang] Harvard Univ, Sch Med, Childrens Hosp, FM Kirby Neurobiol Ctr,Dept Neurol, Boston, MA 02115 USA; [Hensch, Takao K.; Sanes, Joshua R.] Harvard Univ, Ctr Brain Sci, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Jin, Hai; Hou, Lijun] ChangZheng Hosp, Dept Neurosurg, Shanghai 200003, Peoples R China; [Frank, Eric] Tufts Univ, Dept Physiol, Boston, MA 02111 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Naval Medical University; Tufts University	Fagiolini, M (corresponding author), Harvard Univ, Sch Med, Childrens Hosp, FM Kirby Neurobiol Ctr,Dept Neurol, 300 Longwood Ave, Boston, MA 02115 USA.	michela.fagiolini@childrens.harvard.edu; zhigang.he@childrens.harvard.edu	Hensch, Takao/L-4182-2019; Lee, Henry/GVS-2114-2022; Lee, Henry HC/S-6014-2016; Liu, Xuefeng/M-6258-2016	Lee, Henry HC/0000-0003-4975-7330; fagiolini, michela/0000-0003-2807-803X	NEI; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; NIH [P30 HD018655, P30EY012196]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655, U54HD090255] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY013613, P30EY012196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS070300, R01NS095959] Funding Source: NIH RePORTER	NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Drs. D. Chen and K. Cho for advising on the surgical procedure and Dr. R. Shi for discussion on 4-AP. This study was supported by grants from NEI and a grant from Dr. Miriam and Sheldon G. Adelson Medical Research Foundation (Z.H.). IDDRC and viral cores supported by the grants NIH P30 HD018655 and P30EY012196 were used for this study.	Ackman JB, 2014, CURR OPIN NEUROBIOL, V24, P166, DOI 10.1016/j.conb.2013.11.011; Alilain WJ, 2011, NATURE, V475, P196, DOI 10.1038/nature10199; Alto LT, 2009, NAT NEUROSCI, V12, P1106, DOI 10.1038/nn.2365; Belin S, 2015, NEURON, V86, P1000, DOI 10.1016/j.neuron.2015.03.060; Blackmore MG, 2012, P NATL ACAD SCI USA, V109, P7517, DOI 10.1073/pnas.1120684109; Blesch A, 2009, TRENDS NEUROSCI, V32, P41, DOI 10.1016/j.tins.2008.09.008; Blight AR, 1991, J NEUROTRAUM, V8, P103, DOI 10.1089/neu.1991.8.103; Bonfanti L, 1996, J NEUROSCI, V16, P4186; BOSTOCK H, 1981, J PHYSIOL-LONDON, V313, P301, DOI 10.1113/jphysiol.1981.sp013666; Cafferty WBJ, 2006, J NEUROSCI, V26, P12242, DOI 10.1523/JNEUROSCI.3827-06.2006; Cang JH, 2013, ANNU REV NEUROSCI, V36, P51, DOI 10.1146/annurev-neuro-062012-170341; Case LC, 2005, CURR BIOL, V15, pR749, DOI 10.1016/j.cub.2005.09.008; Chen DF, 1997, NATURE, V385, P434, DOI 10.1038/385434a0; Chew DJ, 2012, PROG BRAIN RES, V201, P253, DOI 10.1016/B978-0-444-59544-7.00013-5; Cregg JM, 2014, EXP NEUROL, V253, P197, DOI 10.1016/j.expneurol.2013.12.024; de Lima S, 2012, P NATL ACAD SCI USA, V109, P9149, DOI 10.1073/pnas.1119449109; Donovan WH, 2000, SPINAL CORD, V38, P7, DOI 10.1038/sj.sc.3100931; Duan X, 2015, NEURON, V85, P1244, DOI 10.1016/j.neuron.2015.02.017; Dunlop SA, 2007, J COMP NEUROL, V505, P46, DOI 10.1002/cne.21477; Fawcett James W, 2012, Handb Clin Neurol, V109, P503, DOI 10.1016/B978-0-444-52137-8.00031-0; Garcia-Alias G, 2009, NAT NEUROSCI, V12, P1145, DOI 10.1038/nn.2377; Gibson EM, 2014, SCIENCE, V344, P487, DOI 10.1126/science.1252304; Goldberg JL, 2002, NEURON, V33, P689, DOI 10.1016/S0896-6273(02)00602-5; Grijalva I, 2010, ARCH MED RES, V41, P567, DOI 10.1016/j.arcmed.2010.10.001; Hayes KC, 2004, CNS DRUG REV, V10, P295; Hellal F, 2011, SCIENCE, V331, P928, DOI 10.1126/science.1201148; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Hong YK, 2011, CURR OPIN NEUROBIOL, V21, P228, DOI 10.1016/j.conb.2011.02.007; Hooks BM, 2006, NEURON, V52, P281, DOI 10.1016/j.neuron.2006.07.007; Huberman AD, 2011, TRENDS NEUROSCI, V34, P464, DOI 10.1016/j.tins.2011.07.002; Kahles F, 2014, MOL METAB, V3, P384, DOI 10.1016/j.molmet.2014.03.004; Kang E, 2013, J NEUROSCI, V33, P17789, DOI 10.1523/JNEUROSCI.1500-13.2013; Lang BT, 2015, NATURE, V518, P404, DOI 10.1038/nature13974; Lee JK, 2008, RESTOR NEUROL NEUROS, V26, P175; Liu K, 2010, NAT NEUROSCI, V13, P1075, DOI 10.1038/nn.2603; Lu Y, 2014, CURR OPIN NEUROBIOL, V27, P135, DOI 10.1016/j.conb.2014.03.007; Luo XT, 2013, EXP NEUROL, V247, P653, DOI 10.1016/j.expneurol.2013.03.001; Masseck OA, 2009, ANN NY ACAD SCI, V1164, P430, DOI 10.1111/j.1749-6632.2009.03854.x; McKenzie IA, 2014, SCIENCE, V346, P318, DOI 10.1126/science.1254960; Mi S, 2013, CNS DRUGS, V27, P493, DOI 10.1007/s40263-013-0068-8; Moore DL, 2009, SCIENCE, V326, P298, DOI 10.1126/science.1175737; Park KK, 2008, SCIENCE, V322, P963, DOI 10.1126/science.1161566; Prusky GT, 2004, INVEST OPHTH VIS SCI, V45, P4611, DOI 10.1167/iovs.04-0541; Ruschel J, 2015, SCIENCE, V348, P347, DOI 10.1126/science.aaa2958; Schwab ME, 2014, CURR OPIN NEUROBIOL, V27, P53, DOI 10.1016/j.conb.2014.02.011; Shah RD, 2008, J NEUROSCI, V28, P292, DOI 10.1523/JNEUROSCI.4276-07.2008; Silver J, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020602; Smith KJ, 2000, BRAIN, V123, P171, DOI 10.1093/brain/123.1.171; Smith PD, 2009, NEURON, V64, P617, DOI 10.1016/j.neuron.2009.11.021; SO KF, 1981, EXP NEUROL, V72, P379, DOI 10.1016/0014-4886(81)90231-4; Sun F, 2011, NATURE, V480, P372, DOI 10.1038/nature10594; Sun WJ, 2010, J NEUROPHYSIOL, V103, P469, DOI 10.1152/jn.00154.2009; Toosy AT, 2014, LANCET NEUROL, V13, P83, DOI 10.1016/S1474-4422(13)70259-X; Wahl AS, 2014, SCIENCE, V344, P1250, DOI 10.1126/science.1253050; WAXMAN SG, 1993, ANN NEUROL, V33, P121, DOI 10.1002/ana.410330202; Woodruff RH, 1999, GLIA, V25, P216, DOI 10.1002/(SICI)1098-1136(19990201)25:3<216::AID-GLIA2>3.0.CO;2-L; Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956; Zuchero JB, 2013, CURR OPIN NEUROBIOL, V23, P914, DOI 10.1016/j.conb.2013.06.005; Zukor K, 2013, J NEUROSCI, V33, P15350, DOI 10.1523/JNEUROSCI.2510-13.2013	59	142	148	0	47	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 14	2016	164	1-2					219	232		10.1016/j.cell.2015.11.036	http://dx.doi.org/10.1016/j.cell.2015.11.036			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DB2LE	26771493	Green Accepted, Bronze			2022-12-28	WOS:000368339300022
J	Erb, DK				Erb, Dawn K.			Photons from dwarf galaxy zap hydrogen	NATURE			English	Editorial Material							CONTINUUM; REIONIZATION; CONSTRAINTS; RADIATION; COMPACT; LEAKAGE; ESCAPE		[Erb, Dawn K.] Univ Wisconsin, Dept Phys, Leonard E Parker Ctr Gravitat Cosmol & Astrophys, Milwaukee, WI 53211 USA	University of Wisconsin System; University of Wisconsin Milwaukee	Erb, DK (corresponding author), Univ Wisconsin, Dept Phys, Leonard E Parker Ctr Gravitat Cosmol & Astrophys, Milwaukee, WI 53211 USA.	erbd@uwm.edu						Ade PAR, 2014, ASTRON ASTROPHYS, V571, DOI 10.1051/0004-6361/201321591; Bergvall N, 2006, ASTRON ASTROPHYS, V448, P513, DOI 10.1051/0004-6361:20053788; Borthakur S, 2014, SCIENCE, V346, P216, DOI 10.1126/science.1254214; Fan XH, 2006, ANNU REV ASTRON ASTR, V44, P415, DOI 10.1146/annurev.astro.44.051905.092514; Izotov YI, 2016, NATURE, V529, P178, DOI 10.1038/nature16456; Leitet E, 2013, ASTRON ASTROPHYS, V553, DOI 10.1051/0004-6361/201118370; Robertson BE, 2013, ASTROPHYS J, V768, DOI 10.1088/0004-637X/768/1/71; Steidel CC, 2001, ASTROPHYS J, V546, P665, DOI 10.1086/318323; Vanzella E, 2012, ASTROPHYS J, V751, DOI 10.1088/0004-637X/751/1/70	9	1	1	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 14	2016	529	7585					159	160		10.1038/529159a	http://dx.doi.org/10.1038/529159a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA7WK	26762452				2022-12-28	WOS:000368015700022
J	O'Donnell, C; Sejnowski, TJ				O'Donnell, Cian; Sejnowski, Terrence J.			Street View of the Cognitive Map	CELL			English	Editorial Material							HIPPOCAMPAL PLACE CELLS; FIRING PROPERTIES; HEAD DIRECTION; UNIT-ACTIVITY; RAT	To understand the origins of spatial navigational signals, Acharya et al. record the activity of hippocampal neurons in rats running in open two-dimensional environments in both the real world and in virtual reality. They find that a subset of hippocampal neurons have directional tuning that persists in virtual reality, where vestibular cues are absent.	[O'Donnell, Cian] Univ Bristol, Fac Engn, Dept Comp Sci, Bristol BS8 1UB, Avon, England; [Sejnowski, Terrence J.] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; [Sejnowski, Terrence J.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92161 USA	University of Bristol; Howard Hughes Medical Institute; Salk Institute; University of California System; University of California San Diego	Sejnowski, TJ (corresponding author), Salk Inst Biol Studies, Howard Hughes Med Inst, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	sejnowski@salk.edu	Sejnowski, Terrence/AAV-5558-2021		Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Acharya L, 2016, CELL, V164, P197, DOI 10.1016/j.cell.2015.12.015; Aghajan ZM, 2015, NAT NEUROSCI, V18, P121, DOI 10.1038/nn.3884; Hartley T, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2012.0510; MCNAUGHTON BL, 1983, EXP BRAIN RES, V52, P41; MULLER RU, 1994, J NEUROSCI, V14, P7235; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; Rolls ET, 1999, HIPPOCAMPUS, V9, P467; Rubin A, 2014, J NEUROSCI, V34, P1067, DOI 10.1523/JNEUROSCI.5393-12.2014; Stackman RW, 1997, J NEUROSCI, V17, P4349	10	1	1	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 14	2016	164	1-2					13	15		10.1016/j.cell.2015.12.051	http://dx.doi.org/10.1016/j.cell.2015.12.051			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DB2LE	26771481	Bronze, Green Accepted			2022-12-28	WOS:000368339300004
J	Dawes, AJ; Maggard-Gibbons, M; Maher, AR; Booth, MJ; Miake-Lye, I; Beroes, JM; Shekelle, PG				Dawes, Aaron J.; Maggard-Gibbons, Melinda; Maher, Alicia R.; Booth, Marika J.; Miake-Lye, Isomi; Beroes, Jessica M.; Shekelle, Paul G.			Mental Health Conditions Among Patients Seeking and Undergoing Bariatric Surgery A Meta-analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BINGE-EATING DISORDER; GASTRIC BYPASS; WEIGHT-LOSS; DEPRESSIVE SYMPTOMS; PREVALENCE; ASSOCIATION; CANDIDATES; ALCOHOL; IMPACT; PSYCHOPATHOLOGY	IMPORTANCE Bariatric surgery is associated with sustained weight loss and improved physical health status for severely obese individuals. Mental health conditions may be common among patients seeking bariatric surgery; however, the prevalence of these conditions and whether they are associated with postoperative outcomes remains unknown. OBJECTIVE To determine the prevalence of mental health conditions among bariatric surgery candidates and recipients, to evaluate the association between preoperative mental health conditions and health outcomes following bariatric surgery, and to evaluate the association between surgery and the clinical course of mental health conditions. DATA SOURCES We searched PubMed. MEDLINE on OVID, and PsycINFO for studies published between January 1988 and November 2015. Study quality was assessed using an adapted tool for risk of bias; quality of evidence was rated based on GRADE (Grading of Recommendations Assessment, Development and Evaluation) criteria. FINDINGS We identified 68 publications meeting inclusion criteria: 59 reporting the prevalence of preoperative mental health conditions (65 363 patients) and 27 reporting associations between preoperative mental health conditions and postoperative outcomes (50182 patients). Among patients seeking and undergoing bariatric surgery, the most common mental health conditions, based on random-effects estimates of prevalence, were depression (19% [95% CI, 14%-25%]) and binge eating disorder (17% [95% CI, 13%-21%]). There was conflicting evidence regarding the association between preoperative mental health conditions and postoperative weight loss. Neither depression nor binge eating disorder was consistently associated with differences in weight outcomes. Bariatric surgery was, however, consistently associated with postoperative decreases in the prevalence of depression (7 studies; 8%-74% decrease) and the severity of depressive symptoms (6 studies; 40%-70% decrease). CONCLUSIONS AND RELEVANCE Mental health conditions are common among bariatric surgery patients in particular, depression and binge eating disorder. There is inconsistent evidence regarding the association between preoperative mental health conditions and postoperative weight loss. Moderate-quality evidence supports an association between bariatric surgery and lower rates of depression postoperatively.	[Dawes, Aaron J.; Maggard-Gibbons, Melinda] Univ Calif Los Angeles, David Geffen Sch Med, Dept Surg, Los Angeles, CA 90095 USA; [Dawes, Aaron J.; Maggard-Gibbons, Melinda; Miake-Lye, Isomi; Beroes, Jessica M.; Shekelle, Paul G.] Vet Affairs Greater Los Angeles Healthcare Syst, Los Angeles, CA USA; [Dawes, Aaron J.] Univ Calif Los Angeles, Vet Affairs RobertWood Johnson Clin Scholars Prog, Los Angeles, CA 90095 USA; [Dawes, Aaron J.; Miake-Lye, Isomi] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Hlth Policy & Management, Los Angeles, CA 90095 USA; [Maggard-Gibbons, Melinda; Maher, Alicia R.; Booth, Marika J.; Shekelle, Paul G.] RAND Corp, Southern Calif Evidence Based Practice Ctr, Santa Monica, CA USA; [Maher, Alicia R.] Akasha Ctr Integrat Med, Santa Monica, CA USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; RAND Corporation	Dawes, AJ (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Surg, Ronald Reagan UCLA Med Ctr, 757Westwood Plaza,B711, Los Angeles, CA 90095 USA.	adawes@mednet.ucla.edu	Dawes, Aaron/I-1680-2019	Dawes, Aaron/0000-0003-4574-6765	Department of Veterans Affairs; VA Office of Academic Affiliations through the VA/Robert Wood Johnson Clinical Scholars Program	Department of Veterans Affairs(US Department of Veterans Affairs); VA Office of Academic Affiliations through the VA/Robert Wood Johnson Clinical Scholars Program	The publication is based on a systematic review conducted by the Evidence-based Synthesis program funded by the Department of Veterans Affairs. Dr Dawes was supported by the VA Office of Academic Affiliations through the VA/Robert Wood Johnson Clinical Scholars Program.	Adams TD, 2007, NEW ENGL J MED, V357, P753, DOI 10.1056/NEJMoa066603; Adams TD, 2012, JAMA-J AM MED ASSOC, V308, P1122, DOI 10.1001/2012.jama.11164; Ahmed AT, 2013, BIPOLAR DISORD, V15, P753, DOI 10.1111/bdi.12109; Arterburn DE, 2015, JAMA-J AM MED ASSOC, V313, P62, DOI 10.1001/jama.2014.16968; Bagalman E, 2014, PREVALENCE MENTAL IL; Balshem H, 2011, J CLIN EPIDEMIOL, V64, P401, DOI 10.1016/j.jclinepi.2010.07.015; Bauchowitz AU, 2005, PSYCHOSOM MED, V67, P825, DOI 10.1097/01.psy.0000174173.32271.01; Bhatti JA, 2016, JAMA SURG, V151, P226, DOI 10.1001/jamasurg.2015.3414; Booth H, 2015, J AFFECT DISORDERS, V174, P644, DOI 10.1016/j.jad.2014.12.050; Buchwald H., 2004, JAMA (Journal of the American Medical Association), V292, P1724, DOI 10.1001/jama.292.14.1724; Buchwald H, 2009, AM J MED, V122, P248, DOI 10.1016/j.amjmed.2008.09.041; CDC, 2012, MMWR-MORBID MORTAL W, V60, P1747; Center for Behavioral Health Statistics and Quality, 2014, STAT EST AD MENT ILL, DOI [10.3886/ICPSR34481.v1, DOI 10.3886/ICPSR34481.V1]; Christou NV, 2008, SURG OBES RELAT DIS, V4, P691, DOI 10.1016/j.soard.2008.08.025; Cremieux PY, 2010, OBES SURG, V20, P861, DOI 10.1007/s11695-010-0163-6; Department of Veterans Affairs/Department of Defense, 2014, DOD CLIN PRACT GUID; Dixon JB, 2016, INT J OBESITY, V40, P291, DOI 10.1038/ijo.2015.156; Dixon JB, 2003, ARCH INTERN MED, V163, P2058, DOI 10.1001/archinte.163.17.2058; Fuchs HF, 2016, SURG ENDOSC, V30, P251, DOI 10.1007/s00464-015-4196-8; Gade H, 2015, OBES SURG, V25, P2112, DOI 10.1007/s11695-015-1673-z; Hayden JA, 2006, ANN INTERN MED, V144, P427, DOI 10.7326/0003-4819-144-6-200603210-00010; Hayden MJ, 2014, OBES SURG, V24, P1469, DOI 10.1007/s11695-014-1207-0; Hayden MJ, 2011, OBES SURG, V21, P328, DOI 10.1007/s11695-010-0215-y; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hsu LKG, 1998, PSYCHOSOM MED, V60, P338, DOI 10.1097/00006842-199805000-00021; Hudson JI, 2007, BIOL PSYCHIAT, V61, P348, DOI 10.1016/j.biopsych.2006.03.040; Kalarchian MA, 2015, PSYCHOSOM MED, DOI [10.1016/j.soard.2015.08.483, DOI 10.1016/J.SOARD.2015.08.483]; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; King WC, 2012, JAMA-J AM MED ASSOC, V307, P2516, DOI 10.1001/jama.2012.6147; Kokkinos A, 2013, OBES SURG, V23, P31, DOI 10.1007/s11695-012-0743-8; Lapidoth JD, 2011, EAT WEIGHT DISORD-ST, V16, pE263, DOI 10.1007/BF03327470; Lavender JM, 2014, J PSYCHIATR RES, V59, P148, DOI 10.1016/j.jpsychires.2014.08.004; Legenbauer T, 2011, COMPR PSYCHIAT, V52, P301, DOI 10.1016/j.comppsych.2010.06.012; Legenbauer T, 2009, OBESITY FACTS, V2, P227, DOI 10.1159/000226278; Livhits M, 2011, OBES REV, V12, P142, DOI 10.1111/j.1467-789X.2010.00720.x; Livhits M, 2012, OBES SURG, V22, P70, DOI 10.1007/s11695-011-0472-4; Maggard Gibbons MA, 052262014 VAESP; Maggard MA, 2005, ANN INTERN MED, V142, P547, DOI 10.7326/0003-4819-142-7-200504050-00013; Maggard-Gibbons M, 2013, JAMA-J AM MED ASSOC, V309, P2250, DOI 10.1001/jama.2013.4851; Malik S, 2014, COMPR PSYCHIAT, V55, P248, DOI 10.1016/j.comppsych.2013.08.021; Marek RJ, 2014, INT J EAT DISORDER, V47, P553, DOI 10.1002/eat.22268; Mitchell JE, 2014, OBESITY, V22, P1799, DOI 10.1002/oby.20738; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; Moorehead MK, 2004, SUGGESTIONS PRESURGI; Morseth MS, 2016, OBES SURG, V26, P588, DOI 10.1007/s11695-015-1790-8; Muller A, 2013, CURR PSYCHIAT REP, V15, DOI 10.1007/s11920-013-0397-9; National Eating Disorders Association, BING EAT DIS; Nijamkin MP, 2013, J NUTR EDUC BEHAV, V45, P620, DOI 10.1016/j.jneb.2013.04.264; Nyaga VN, 2014, ARCH PUBLIC HEALTH, V72, DOI 10.1186/2049-3258-72-39; Odom J, 2010, OBES SURG, V20, P349, DOI 10.1007/s11695-009-9895-6; Peterhansel C, 2013, OBES REV, V14, P369, DOI 10.1111/obr.12014; Polston JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083741; Reeves William C., 2011, Morbidity and Mortality Weekly Report, V60, P1; Ryden Anna, 2006, Surg Obes Relat Dis, V2, P549, DOI 10.1016/j.soard.2006.07.006; Santry HP, 2006, OBES SURG, V16, P59, DOI 10.1381/096089206775222096; Sockalingam S, 2015, OBES SURG, V25, P514, DOI 10.1007/s11695-014-1443-3; Spadola CE, 2015, ALCOHOL CLIN EXP RES, V39, P1582, DOI 10.1111/acer.12805; Substance Abuse and Mental Health Services Administration (SAMHSA), 2014, RES 2013 NAT SURV DR; Svensson PA, 2013, OBESITY, V21, P2444, DOI 10.1002/oby.20397; Thanos PK, 2012, OBES SURG, V22, P1884, DOI 10.1007/s11695-012-0749-2; Thompson SG, 2002, STAT MED, V21, P1559, DOI 10.1002/sim.1187; Tindle HA, 2010, AM J MED, V123, P1036, DOI 10.1016/j.amjmed.2010.06.016; van Hout GCM, 2005, OBES SURG, V15, P552, DOI 10.1381/0960892053723484; White MA, 2015, OBES SURG, V25, P1909, DOI 10.1007/s11695-015-1631-9; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25; Wise ES, 2016, SURG ENDOSC, V30, P480, DOI 10.1007/s00464-015-4225-7	66	262	269	3	35	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 12	2016	315	2					150	163		10.1001/jama.2015.18118	http://dx.doi.org/10.1001/jama.2015.18118			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DA6XO	26757464	Bronze			2022-12-28	WOS:000367949200017
J	Behnia, K				Behnia, Kamran			Finding merit in dividing neighbors	SCIENCE			English	Editorial Material							SNSE; PBTE		[Behnia, Kamran] LPEM ESPCI, F-75005 Paris, France		Behnia, K (corresponding author), LPEM ESPCI, 10 Rue Vauquelin, F-75005 Paris, France.	kamran.behnia@espci.fr	Behnia, Kamran/AHC-5765-2022	Behnia, Kamran/0000-0001-8997-5645				An JM, 2008, SOLID STATE COMMUN, V148, P417, DOI 10.1016/j.ssc.2008.09.027; BURDETT JK, 1981, J CHEM PHYS, V75, P5764, DOI 10.1063/1.442014; JENSEN JD, 1978, PHYS REV B, V18, P5567, DOI 10.1103/PhysRevB.18.5567; LITTLEWOOD PB, 1980, J PHYS C SOLID STATE, V13, P4855, DOI 10.1088/0022-3719/13/26/009; Peierls R., 1991, MORE SURPRISES THEOR; Zhao LD, 2016, SCIENCE, V351, P141, DOI 10.1126/science.aad3749; Zhao LD, 2014, NATURE, V508, P373, DOI 10.1038/nature13184	8	14	14	0	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 8	2016	351	6269					124	124		10.1126/science.aad8688	http://dx.doi.org/10.1126/science.aad8688			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA4XQ	26744394	Green Submitted			2022-12-28	WOS:000367806500015
J	Moseley, GE; Edwards, RL; Wendt, KA; Cheng, H; Dublyansky, Y; Lu, YB; Boch, R; Spotl, C				Moseley, Gina E.; Edwards, R. Lawrence; Wendt, Kathleen A.; Cheng, Hai; Dublyansky, Yuri; Lu, Yanbin; Boch, Ronny; Spoetl, Christoph			Reconciliation of the Devils Hole climate record with orbital forcing	SCIENCE			English	Article							CHRONOLOGY AICC2012; ANTARCTIC ICE; VEIN CALCITE; SEA; ISOTOPE; NEVADA; HISTORY; CORE	The driving force behind Quaternary glacial-interglacial cycles and much associated climate change is widely considered to be orbital forcing. However, previous versions of the iconic Devils Hole (Nevada) subaqueous calcite record exhibit shifts to interglacial values similar to 10,000 years before orbitally forced ice age terminations, and interglacial durations similar to 10,000 years longer than other estimates. Our measurements from Devils Hole 2 replicate virtually all aspects of the past 204,000 years of earlier records, except for the timing during terminations, and they lower the age of the record near Termination II by similar to 8000 years, removing both similar to 10,000-year anomalies. The shift to interglacial values now broadly coincides with the rise in boreal summer insolation, the marine termination, and the rise in atmospheric CO2, which is consistent with mechanisms ultimately tied to orbital forcing.	[Moseley, Gina E.; Wendt, Kathleen A.; Dublyansky, Yuri; Boch, Ronny; Spoetl, Christoph] Univ Innsbruck, Inst Geol, A-6020 Innsbruck, Austria; [Edwards, R. Lawrence; Wendt, Kathleen A.; Cheng, Hai; Lu, Yanbin] Univ Minnesota, Dept Earth Sci, Minneapolis, MN 55455 USA; [Cheng, Hai] Xi An Jiao Tong Univ, Inst Global Environm Change, Xian 710049, Peoples R China	University of Innsbruck; University of Minnesota System; University of Minnesota Twin Cities; Xi'an Jiaotong University	Moseley, GE (corresponding author), Univ Innsbruck, Inst Geol, Innrain 52, A-6020 Innsbruck, Austria.	gina.moseley@uibk.ac.at	CHENG, HAI/H-3413-2017; Edwards, R. Lawrence/I-3124-2014; Dublyansky, Yuri/AAM-6110-2020	CHENG, HAI/0000-0002-5305-9458; Edwards, R. Lawrence/0000-0002-7027-5881; Dublyansky, Yuri/0000-0003-1433-9999; Boch, Ronny/0000-0002-4535-8597; Moseley, Gina/0000-0002-5618-5759	Austrian Science Fund (FWF) [FP263050]; NSF [1103403, 1103320]; NSFC [41230524]; Div Atmospheric & Geospace Sciences [1103403] Funding Source: National Science Foundation; Division Of Earth Sciences [1337693] Funding Source: National Science Foundation	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); NSF(National Science Foundation (NSF)); NSFC(National Natural Science Foundation of China (NSFC)); Div Atmospheric & Geospace Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was supported by the Austrian Science Fund (FWF) project no. FP263050 to C.S. and in part by NSF grants 1103403 to R.L.E. and H.C., 1103320 to R.L.E., and NSFC grant 41230524 to H.C. This research was conducted under research permit numbers DEVA-2010-SCI-0004 and DEVA-2015-SCI-0006 issued by Death Valley National Park. We thank I. J. Winograd for providing the study with sample DH-2, M. Wimmer for preparation and measurement of the stable isotopes, K. Wilson and R. Freeze for assistance in the field, and M. Cross for discussion of Great Basin paleoclimate. Data can be downloaded from the National Oceanic and Atmospheric Administration's National Centers for Environmental Information (www.ncdc.noaa.gov/paleo/paleo.html).	BACON MP, 1982, J GEOPHYS RES-OCEANS, V87, P2045, DOI 10.1029/JC087iC03p02045; Bazin L, 2013, CLIM PAST, V9, P1715, DOI 10.5194/cp-9-1715-2013; BERGER AL, 1978, J ATMOS SCI, V35, P2362, DOI 10.1016/0033-5894(78)90064-9; BROECKER WS, 1992, NATURE, V359, P779, DOI 10.1038/359779a0; Cheng H, 2009, SCIENCE, V326, P248, DOI 10.1126/science.1177840; COPLEN TB, 1994, SCIENCE, V263, P361, DOI 10.1126/science.263.5145.361; Cross M, 2015, QUATERNARY SCI REV, V127, P186, DOI 10.1016/j.quascirev.2015.06.016; CROWLEY TJ, 1994, SCIENCE, V265, P1566, DOI 10.1126/science.265.5178.1566; Drysdale RN, 2009, SCIENCE, V325, P1527, DOI 10.1126/science.1170371; EDWARDS RL, 1993, SCIENCE, V259, P1626, DOI 10.1126/science.259.5101.1626; Edwards RL, 1997, SCIENCE, V276, P782, DOI 10.1126/science.276.5313.782; EMILIANI C, 1955, J GEOL, V63, P538, DOI 10.1086/626295; GALLUP CD, 1994, SCIENCE, V263, P796, DOI 10.1126/science.263.5148.796; Grootes P. M., 1993, GEOPH MONOG SERIES, V78, P37; HAYS JD, 1976, SCIENCE, V194, P1121, DOI 10.1126/science.194.4270.1121; Herbert TD, 2001, SCIENCE, V293, P71, DOI 10.1126/science.1059209; IMBRIE J, 1985, J GEOL SOC LONDON, V142, P417, DOI 10.1144/gsjgs.142.3.0417; Kluge T, 2014, EARTH PLANET SC LETT, V400, P251, DOI 10.1016/j.epsl.2014.05.047; KUTZBACH JE, 1988, SCIENCE, V241, P1043, DOI 10.1126/science.241.4869.1043; Lachniet MS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4805; Lisiecki I. E., 2005, PALEOCEANOGRAPHY, V20, P1; LUDWIG KR, 1993, NATURE, V362, P596, DOI 10.1038/362596b0; LUDWIG KR, 1993, SCIENCE, V259, P1626, DOI 10.1126/science.259.5101.1626-a; LUDWIG KR, 1992, SCIENCE, V258, P284, DOI 10.1126/science.258.5080.284; Luthi D, 2008, NATURE, V453, P379, DOI 10.1038/nature06949; Marino G, 2015, NATURE, V522, P197, DOI 10.1038/nature14499; McManus JF, 1999, SCIENCE, V283, P971, DOI 10.1126/science.283.5404.971; Moran SB, 1997, EARTH PLANET SC LETT, V150, P151, DOI 10.1016/S0012-821X(97)00081-2; Munroe JS, 2013, GEOL SOC AM BULL, V125, P322, DOI 10.1130/B30696.1; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; SHACKLETON NJ, 1993, NATURE, V362, P596, DOI 10.1038/362596a0; Shakun JD, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048560; Steponaitis E, 2015, QUATERNARY SCI REV, V127, P174, DOI 10.1016/j.quascirev.2015.04.011; Thomas AL, 2009, SCIENCE, V324, P1186, DOI 10.1126/science.1168754; Veres D, 2013, CLIM PAST, V9, P1733, DOI 10.5194/cp-9-1733-2013; WINOGRAD IJ, 1988, SCIENCE, V242, P1275, DOI 10.1126/science.242.4883.1275; WINOGRAD IJ, 1992, SCIENCE, V258, P255, DOI 10.1126/science.258.5080.255; Winograd IJ, 1997, QUATERNARY RES, V48, P141, DOI 10.1006/qres.1997.1918; Winograd IJ, 2006, QUATERNARY RES, V66, P202, DOI 10.1016/j.yqres.2006.06.003	39	39	40	0	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 8	2016	351	6269					165	168		10.1126/science.aad4132	http://dx.doi.org/10.1126/science.aad4132			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4XQ	26744404				2022-12-28	WOS:000367806500040
J	Waters, CN; Zalasiewicz, J; Summerhayes, C; Barnosky, AD; Poirier, C; Galuszka, A; Cearreta, A; Edgeworth, M; Ellis, EC; Ellis, M; Jeandel, C; Leinfelder, R; McNeill, JR; Richter, DD; Steffen, W; Syvitski, J; Vidas, D; Wagreich, M; Williams, M; An, ZS; Grinevald, J; Odada, E; Oreskes, N; Wolfe, AP				Waters, Colin N.; Zalasiewicz, Jan; Summerhayes, Colin; Barnosky, Anthony D.; Poirier, Clement; Galuszka, Agnieszka; Cearreta, Alejandro; Edgeworth, Matt; Ellis, Erle C.; Ellis, Michael; Jeandel, Catherine; Leinfelder, Reinhold; McNeill, J. R.; Richter, Daniel deB.; Steffen, Will; Syvitski, James; Vidas, Davor; Wagreich, Michael; Williams, Mark; An Zhisheng; Grinevald, Jacques; Odada, Eric; Oreskes, Naomi; Wolfe, Alexander P.			The Anthropocene is functionally and stratigraphically distinct from the Holocene	SCIENCE			English	Review							ICE-CORE; ANTHROPOGENIC TRANSFORMATION; INTERNATIONAL-COMMISSION; ISOTOPE CONSTRAINTS; FLY-ASH; CARBON; SEA; AGE; RADIOCARBON; VARIABILITY	Human activity is leaving a pervasive and persistent signature on Earth. Vigorous debate continues about whether this warrants recognition as a new geologic time unit known as the Anthropocene. We review anthropogenic markers of functional changes in the Earth system through the stratigraphic record. The appearance of manufactured materials in sediments, including aluminum, plastics, and concrete, coincides with global spikes in fallout radionuclides and particulates from fossil fuel combustion. Carbon, nitrogen, and phosphorus cycles have been substantially modified over the past century. Rates of sea-level rise and the extent of human perturbation of the climate system exceed Late Holocene changes. Biotic changes include species invasions worldwide and accelerating rates of extinction. These combined signals render the Anthropocene stratigraphically distinct from the Holocene and earlier epochs.	[Waters, Colin N.; Ellis, Michael] British Geol Survey, Keyworth NG12 5GG, Notts, England; [Zalasiewicz, Jan; Williams, Mark] Univ Leicester, Dept Geol, Leicester LE1 7RH, Leics, England; [Summerhayes, Colin] Univ Cambridge, Scott Polar Res Inst, Cambridge CB2 1ER, England; [Barnosky, Anthony D.] Univ Calif Berkeley, Dept Integrat Biol, Museum Paleontol, Berkeley, CA 94720 USA; [Barnosky, Anthony D.] Univ Calif Berkeley, Museum Vertebrate Zool, Berkeley, CA 94720 USA; [Poirier, Clement] Univ Caen Normandie, CNRS, Morphodynam Continentale & Cotiere, F-14000 Caen, France; [Galuszka, Agnieszka] Jan Kochanowski Univ Humanities & Sci, Inst Chem, Geochem & Environm Div, PL-25406 Kielce, Poland; [Cearreta, Alejandro] Univ Basque Country, Dept Estratig & Paleontol, Fac Ciencia & Tecnol, E-48080 Bilbao, Spain; [Edgeworth, Matt] Univ Leicester, Sch Archaeol & Ancient Hist, Leicester LE1 7RH, Leics, England; [Ellis, Erle C.] Univ Maryland Baltimore Cty, Dept Geog & Environm Syst, Baltimore, MD 21250 USA; [Jeandel, Catherine] Univ Toulouse 3, CNRS, Ctr Natl Etud Spatiales, Lab Etud Geophys & Oceanog Spatiales,Inst Rech De, F-31400 Toulouse, France; [Leinfelder, Reinhold] Free Univ Berlin, Dept Geol Sci, D-12249 Berlin, Germany; [McNeill, J. R.] Georgetown Univ, Washington, DC USA; [Richter, Daniel deB.] Duke Univ, Nicholas Sch Environm, Durham, NC 27516 USA; [Steffen, Will] Australian Natl Univ, Canberra, ACT 0200, Australia; [Syvitski, James] Univ Colorado, Dept Geol Sci, Boulder, CO 80309 USA; [Vidas, Davor] Fridtjof Nansen Inst Polhogda, Marine Affairs & Law Sea Programme, Lysaker, Norway; [Wagreich, Michael] Univ Vienna, Dept Geodynam & Sedimentol, A-1090 Vienna, Austria; [An Zhisheng] Chinese Acad Sci, Inst Earth Environm, State Key Lab Loess & Quaternary Geol, Xian 710061, Peoples R China; [An Zhisheng] Beijing Normal Univ, Beijing 100875, Peoples R China; [Grinevald, Jacques] Inst Hautes Etud Int & Dev, CH-1211 Geneva 11, Switzerland; [Odada, Eric] Univ Nairobi, Dept Geol, Nairobi, Kenya; [Oreskes, Naomi] Harvard Univ, Dept Hist Sci, Cambridge, MA 02138 USA; [Wolfe, Alexander P.] Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada	UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Geological Survey; University of Leicester; University of Cambridge; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Centre National de la Recherche Scientifique (CNRS); Universite de Caen Normandie; Jan Kochanowski University; University of Basque Country; University of Leicester; University System of Maryland; University of Maryland Baltimore County; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Laboratoire d'Etudes en Geophysique et oceanographie spatiales; Free University of Berlin; Georgetown University; Duke University; Australian National University; University of Colorado System; University of Colorado Boulder; University of Vienna; Chinese Academy of Sciences; Institute of Earth Environment, CAS; Beijing Normal University; University of Nairobi; Harvard University; University of Alberta	Waters, CN (corresponding author), British Geol Survey, Keyworth NG12 5GG, Notts, England.		AN, Zhisheng/F-8834-2012; Ellis, Erle C./B-8264-2008; Ellis, Michael Alexander A/M-4505-2018; Haygarth, Philip Matthew/F-6790-2014; Williams, Mark/B-7590-2009; Vidas, Davor/AAV-2767-2020; Wagreich, Michael/D-2279-2013; Ellis, Michael/AAP-2039-2020; Gałuszka, Agnieszka/D-5434-2011; Cearreta, Alejandro/B-3008-2009; Richter, D.D./AAN-4583-2021; Poirier, Clement/B-9652-2015	Ellis, Erle C./0000-0002-2006-3362; Ellis, Michael Alexander A/0000-0002-6613-3565; Williams, Mark/0000-0002-7987-6069; Wagreich, Michael/0000-0002-8828-0857; Ellis, Michael/0000-0002-6613-3565; Gałuszka, Agnieszka/0000-0002-2497-2627; Cearreta, Alejandro/0000-0003-0100-1454; an, zhi sheng/0000-0002-9538-9826; Vidas, Davor/0000-0001-8134-7425; Syvitski, Jaia/0000-0003-3116-6997; Poirier, Clement/0000-0002-8311-8463	British Geological Survey's Engineering Geology program; NERC [bgs05001, bgs05002] Funding Source: UKRI; Natural Environment Research Council [bgs05002, bgs05001] Funding Source: researchfish; Directorate For Geosciences [1450657, 1331846] Funding Source: National Science Foundation; ICER [1450554] Funding Source: National Science Foundation	British Geological Survey's Engineering Geology program; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); ICER(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	C.W. and M.E. publish with the permission of the Executive Director, British Geological Survey, Natural Environment Research Council; the former is funded by the British Geological Survey's Engineering Geology program. We thank three referees, along with I. Fairchild, I. Hajdas, and S. Price, for their comments. This paper is a contribution of the Anthropocene Working Group (AWG), part of the Subcommission on Quaternary Stratigraphy of the International Commission on Stratigraphy. The AWG receives no direct funding to carry out its research, and the authors declare no competing financial interests.	Ahmed M, 2013, NAT GEOSCI, V6, P339, DOI [10.1038/NGEO1797, 10.1038/ngeo1797]; [Anonymous], 2013, HIST DAT GLOB ENV NE; [Anonymous], 2013, PLASTICS FACTS 2013; Barnosky AD, 2014, ANTHROPOCENE REV, V1, P225, DOI 10.1177/2053019614547433; Barnosky AD, 2014, GEOL SOC SPEC PUBL, V395, P149, DOI 10.1144/SP395.6; Barnosky AD, 2011, NATURE, V471, P51, DOI 10.1038/nature09678; BLUNIER T, 1995, NATURE, V374, P46, DOI 10.1038/374046a0; Brown A, 2013, ANTHROPOCENE, V1, P3, DOI 10.1016/j.ancene.2013.06.002; Canfield DE, 2010, SCIENCE, V330, P192, DOI 10.1126/science.1186120; Carpenter SR, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/1/014009; Ceballos G, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400253; Church JA, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P1137; Corcoran PL, 2015, ENVIRON SCI-PROC IMP, V17, P1363, DOI 10.1039/c5em00188a; Crutzen PJ, 2002, NATURE, V415, P23, DOI 10.1038/415023a; Cui Y, 2011, NAT GEOSCI, V4, P481, DOI [10.1038/ngeo1179, 10.1038/NGEO1179]; Dean JR, 2014, ANTHROPOCENE REV, V1, P276, DOI 10.1177/2053019614541631; Deschamps P, 2012, NATURE, V483, P559, DOI 10.1038/nature10902; Douglas I., 2000, J IND ECOL, V4, P9, DOI [10.1162/108819800569771, DOI 10.1162/108819800569771]; Edgeworth M, 2015, ANTHROPOCENE REV, V2, P33, DOI 10.1177/2053019614565394; Ellis EC, 2011, PHILOS T R SOC A, V369, P1010, DOI 10.1098/rsta.2010.0331; Ellis EC, 2010, GLOBAL ECOL BIOGEOGR, V19, P589, DOI 10.1111/j.1466-8238.2010.00540.x; Elsig J, 2009, NATURE, V461, P507, DOI 10.1038/nature08393; Felis T, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1973; Ferretti DF, 2005, SCIENCE, V309, P1714, DOI 10.1126/science.1115193; Ford JR, 2014, GEOL SOC SPEC PUBL, V395, P55, DOI 10.1144/SP395.12; Galloway JN, 2008, SCIENCE, V320, P889, DOI 10.1126/science.1136674; Galuszka A, 2014, GEOL SOC SPEC PUBL, V395, P221, DOI 10.1144/SP395.5; Gehrels WR, 2013, GLOBAL PLANET CHANGE, V100, P263, DOI 10.1016/j.gloplacha.2012.10.020; Goldewijk KK, 2010, HOLOCENE, V20, P565, DOI 10.1177/0959683609356587; Hancock GJ, 2014, GEOL SOC SPEC PUBL, V395, P265, DOI 10.1144/SP395.15; Hansen J, 2010, REV GEOPHYS, V48, DOI 10.1029/2010RG000345; Harvey MC, 2008, GEOLOGY, V36, P355, DOI 10.1130/G24646A.1; Hastings MG, 2009, SCIENCE, V324, P1288, DOI 10.1126/science.1170510; Hastings MG, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2005GB002502; Holland E. A., 2005, GLOBAL N CYCLE FLUXE, DOI [10.3334/ORNLDAAC/797, DOI 10.3334/ORNLDAAC/797]; Holtgrieve GW, 2011, SCIENCE, V334, P1545, DOI 10.1126/science.1212267; Hooke RL, 2012, GSA TODAY, V22, P4, DOI DOI 10.1130/GSAT151A.1; Hua Q, 2013, RADIOCARBON, V55, P2059, DOI 10.2458/azu_js_rc.v55i2.16177; IPCC, 2013, CLIMATE CHANGE 2022; Jambeck JR, 2015, SCIENCE, V347, P768, DOI 10.1126/science.1260352; Jarvis KE, 2001, ENVIRON SCI TECHNOL, V35, P1031, DOI 10.1021/es0001512; Kelly T. D., 2010, US GEOLOGICAL SURVEY, V140; Kemp AC, 2015, EARTH PLANET SC LETT, V428, P217, DOI 10.1016/j.epsl.2015.07.034; Kidwell SM, 2015, P NATL ACAD SCI USA, V112, P4922, DOI 10.1073/pnas.1403660112; Lewis SL, 2015, NATURE, V519, P171, DOI 10.1038/nature14258; Loulergue L., 2008, WORLD DATA CTR PALEO, V2008-054; Meure CM, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026152; Malm A, 2014, ANTHROPOCENE REV, V1, P62, DOI 10.1177/2053019613516291; McDougall I, 2005, NATURE, V433, P733, DOI 10.1038/nature03258; McNeill J. R., 2011, OXFORD HDB WORLD HIS, P325; Meyfroidt P, 2011, ANNU REV ENV RESOUR, V36, P343, DOI 10.1146/annurev-environ-090710-143732; Mitchell L, 2013, SCIENCE, V342, P964, DOI 10.1126/science.1238920; Muir D.C.G., 2007, LOCHNAGAR NATURAL HI, P375, DOI [10.1007/1-4020-3986-7_16, DOI 10.1007/1-4020-3986-7_16]; Novakov T, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016345; Oldfield F, 2015, ANTHROPOCENE REV, V2, P3, DOI 10.1177/2053019614534402; Paull CK, 2006, MAR GEOL, V233, P21, DOI 10.1016/j.margeo.2006.07.008; Pillans B, 2012, GEOLOGIC TIME SCALE 2012, VOLS 1 & 2, P979, DOI 10.1016/B978-0-444-59425-9.00030-5; Reimer PJ, 2013, RADIOCARBON, V55, P1869, DOI 10.2458/azu_js_rc.55.16947; Remane J, 1996, EPISODES, V19, P77, DOI 10.18814/epiiugs/1996/v19i3/007; Rose NL, 2015, ENVIRON SCI TECHNOL, V49, P4155, DOI 10.1021/acs.est.5b00543; Rubino M, 2013, J GEOPHYS RES-ATMOS, V118, P8482, DOI 10.1002/jgrd.50668; Ruddiman WF, 2003, CLIMATIC CHANGE, V61, P261, DOI 10.1023/B:CLIM.0000004577.17928.fa; Ruddiman WF, 2015, SCIENCE, V348, P38, DOI 10.1126/science.aaa7297; Ruddiman WF, 2013, ANNU REV EARTH PL SC, V41, P45, DOI 10.1146/annurev-earth-050212-123944; Sapart CJ, 2012, NATURE, V490, P85, DOI 10.1038/nature11461; Schmitt J, 2012, SCIENCE, V336, P711, DOI 10.1126/science.1217161; Sidle RC, 2012, NAT GEOSCI, V5, P437, DOI 10.1038/ngeo1512; Smith AG, 2015, GEOL SOC SPEC PUBL, V404, P37, DOI 10.1144/SP404.8; Steffen W, 2007, AMBIO, V36, P614, DOI 10.1579/0044-7447(2007)36[614:TAAHNO]2.0.CO;2; Steffen W, 2015, ANTHROPOCENE REV, V2, P81, DOI 10.1177/2053019614564785; Steffen W, 2011, PHILOS T R SOC A, V369, P842, DOI 10.1098/rsta.2010.0327; Summerhayes Colin P., 2015, EARTHS CLIMATE EVOLU; Swindles GT, 2015, SCI REP-UK, V5, DOI 10.1038/srep10264; Syvitski JPM, 2011, PHILOS T R SOC A, V369, P957, DOI 10.1098/rsta.2010.0329; Thompson RC, 2004, SCIENCE, V304, P838, DOI 10.1126/science.1094559; UNSCEAR, 2000, SOURC EFF ION RAD RE, V1; Vane CH, 2011, PHILOS T R SOC A, V369, P1085, DOI 10.1098/rsta.2010.0298; Vinther BM, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006921; Walker MJC, 2012, J QUATERNARY SCI, V27, P649, DOI 10.1002/jqs.2565; Wanner H, 2015, J GEOL SOC LONDON, V172, P254, DOI 10.1144/jgs2013-101; Waters CN, 2015, B ATOM SCI, V71, P46, DOI 10.1177/0096340215581357; Waters CN, 2014, GEOL SOC SPEC PUBL, V395, P1, DOI 10.1144/SP395.18; Wilkinson IP, 2014, GEOL SOC SPEC PUBL, V395, P185, DOI 10.1144/SP395.14; Williams M, 2015, ANTHROPOCENE REV, V2, P196, DOI 10.1177/2053019615591020; Wolfe AP, 2013, EARTH-SCI REV, V116, P17, DOI 10.1016/j.earscirev.2012.11.001; Wolff EW, 2014, GEOL SOC SPEC PUBL, V395, P255, DOI 10.1144/SP395.10; Wolff EW, 2011, PHILOS T R SOC A, V369, P2133, DOI 10.1098/rsta.2010.0225; Zalasiewicz J., 2008, GSA TODAY, V18, P4, DOI [DOI 10.1130/GSAT01802A.1, 10.1130/GSAT01802A.1]; Zalasiewicz J., ORIGINS; Zalasiewicz J, 2015, ANTHROPOCENE REV, V2, P117, DOI 10.1177/2053019615587056; Zalasiewicz J, 2014, ANTHROPOCENE, V6, P3, DOI 10.1016/j.ancene.2014.07.002; Zalasiewicz J, 2015, QUATERN INT, V383, P196, DOI 10.1016/j.quaint.2014.11.045; Zalasiewicz J, 2014, ANTHROPOCENE REV, V1, P34, DOI 10.1177/2053019613514953; Zalasiewicz J, 2014, GEOL SOC SPEC PUBL, V395, P109, DOI 10.1144/SP395.2; Zalasiewicz J, 2014, GEOL SOC SPEC PUBL, V395, P39, DOI 10.1144/SP395.16	95	1011	1045	54	1143	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 8	2016	351	6269					137	+		10.1126/science.aad2622	http://dx.doi.org/10.1126/science.aad2622			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4XQ	26744408				2022-12-28	WOS:000367806500029
J	Gewin, V				Gewin, Virginia			DATA SHARING An open mind on open data	NATURE			English	Editorial Material																		[Anonymous], 2015, SCIENCE, DOI [DOI 10.1126/SCIENCE.AAC4716, DOI 10.1126/science.aac4716]; Magee AF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110268; Nosek BA, 2015, SCIENCE, V348, P1422, DOI 10.1126/science.aab2374	3	106	109	4	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 7	2016	529	7584					117	119		10.1038/nj7584-117a	http://dx.doi.org/10.1038/nj7584-117a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6VY	26744755	Bronze			2022-12-28	WOS:000367944900039
J	Jackman, SL; Turecek, J; Belinsky, JE; Regehr, WG				Jackman, Skyler L.; Turecek, Josef; Belinsky, Justine E.; Regehr, Wade G.			The calcium sensor synaptotagmin 7 is required for synaptic facilitation	NATURE			English	Article							PAIRED-PULSE FACILITATION; TRANSMITTER RELEASE; CA2+ SENSOR; BUFFER SATURATION; GRANULE CELL; TRANSMISSION; SYNAPSES; CHANNELS; VII; POTENTIATION	It has been known for more than 70 years that synaptic strength is dynamically regulated in a use-dependent manner(1). At synapses with a low initial release probability, closely spaced presynaptic action potentials can result in facilitation, a short-term form of enhancement in which each subsequent action potential evokes greater neurotransmitter release(2). Facilitation can enhance neurotransmitter release considerably and can profoundly influence information transfer across synapses(3), but the underlying mechanism remains a mystery. One proposed mechanism is that a specialized calcium sensor for facilitation transiently increases the probability of release(2,4), and this sensor is distinct from the fast sensors that mediate rapid neurotransmitter release. Yet such a sensor has never been identified, and its very existence has been disputed(5,6). Here we show that synaptotagmin 7 (Syt7) is a calcium sensor that is required for facilitation at several central synapses. In Syt7-knockout mice, facilitation is eliminated even though the initial probability of release and the presynaptic residual calcium signals are unaltered. Expression of wild-type Syt7 in presynaptic neurons restored facilitation, whereas expression of a mutated Syt7 with a calcium-insensitive C2A domain did not. By revealing the role of Syt7 in synaptic facilitation, these results resolve a longstanding debate about a widespread form of short-term plasticity, and will enable future studies that may lead to a deeper understanding of the functional importance of facilitation.	[Jackman, Skyler L.; Turecek, Josef; Belinsky, Justine E.; Regehr, Wade G.] Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Regehr, WG (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.	wade_regehr@hms.harvard.edu		Turecek, Josef/0000-0001-9843-1877	National Institutes of Health (NIH) [NS032405]; Nancy Lurie Marks Foundation; Vision Core; NINDS P30 Core Center grant [NS072030]; Nancy Lurie Marks Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS032405, R01NS032405, P30NS072030] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nancy Lurie Marks Foundation; Vision Core; NINDS P30 Core Center grant; Nancy Lurie Marks Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank P. Kaeser and L. Bickford for help with producing AAVs, B. Sabatini and J. Levasseur for help with plasmids, K. Ennis, M. Ocana and the Neurobiology Imaging Center for help with immunohistochemistry, B. Sabatini, P. Kaeser, D. Fioravante, C. Hull and L. Glickfeld for comments on the manuscript. This work was supported by grants from the National Institutes of Health (NIH; NS032405) and Nancy Lurie Marks Foundation to W.G.R., the Vision Core and NINDS P30 Core Center grant (NS072030) to the Neurobiology Imaging Center at Harvard Medical School, and a Nancy Lurie Marks Fellowship to S.L.J.	Abbott LF, 2004, NATURE, V431, P796, DOI 10.1038/nature03010; Atluri PP, 1996, J NEUROSCI, V16, P5661; Bacaj T, 2013, NEURON, V80, P947, DOI 10.1016/j.neuron.2013.10.026; Bertram R, 1996, J NEUROPHYSIOL, V75, P1919, DOI 10.1152/jn.1996.75.5.1919; Blatow M, 2003, NEURON, V38, P79, DOI 10.1016/S0896-6273(03)00196-X; Brenowitz SD, 2003, J NEUROSCI, V23, P6373; CELIO MR, 1990, NEUROSCIENCE, V35, P375, DOI 10.1016/0306-4522(90)90091-H; Chakrabarti S, 2003, J CELL BIOL, V162, P543, DOI 10.1083/jcb.200305131; DESCHENES M, 1990, EUR J NEUROSCI, V2, P140, DOI 10.1111/j.1460-9568.1990.tb00406.x; DINGLEDINE R, 1981, BRAIN RES, V207, P218, DOI 10.1016/0006-8993(81)90697-1; Felmy F, 2003, NEURON, V37, P801, DOI 10.1016/S0896-6273(03)00085-0; FENG T. P., 1940, CHINESE JOUR PHYSIOL, V15, P367; Geiger JRP, 2000, NEURON, V28, P927, DOI 10.1016/S0896-6273(00)00164-1; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Gustavsson N, 2008, P NATL ACAD SCI USA, V105, P3992, DOI 10.1073/pnas.0711700105; Hui EF, 2005, P NATL ACAD SCI USA, V102, P5210, DOI 10.1073/pnas.0500941102; Jackman SL, 2014, J NEUROSCI, V34, P7704, DOI 10.1523/JNEUROSCI.4694-13.2014; Kaeser PS, 2014, ANNU REV PHYSIOL, V76, P333, DOI 10.1146/annurev-physiol-021113-170338; Kamiya H, 1996, J PHYSIOL-LONDON, V493, P447, DOI 10.1113/jphysiol.1996.sp021395; KAMIYA H, 1994, NATURE, V371, P603, DOI 10.1038/371603a0; Kim JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018556; Klyachko VA, 2006, PLOS BIOL, V4, P1187, DOI 10.1371/journal.pbio.0040207; Kreitzer AC, 2000, J NEUROSCI, V20, P1348; LI C, 1995, NATURE, V375, P594, DOI 10.1038/375594a0; Liu H, 2014, TRANSL NEURODEGENER, V3, DOI 10.1186/2047-9158-3-7; LOMO T, 1971, EXP BRAIN RES, V12, P46; MacLeod KM, 2007, J NEUROPHYSIOL, V97, P2863, DOI 10.1152/jn.01030.2006; MANABE T, 1994, SCIENCE, V265, P1888, DOI 10.1126/science.7916483; Maravall M, 2000, BIOPHYS J, V78, P2655, DOI 10.1016/S0006-3495(00)76809-3; Martinez I, 2000, J CELL BIOL, V148, P1141, DOI 10.1083/jcb.148.6.1141; Matveev V, 2004, BIOPHYS J, V86, P2691, DOI 10.1016/S0006-3495(04)74324-6; Mochida S, 2008, NEURON, V57, P210, DOI 10.1016/j.neuron.2007.11.036; Mongillo G, 2008, SCIENCE, V319, P1543, DOI 10.1126/science.1150769; Muller M, 2008, J PHYSIOL-LONDON, V586, P5503, DOI 10.1113/jphysiol.2008.155838; Regehr WG, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005702; Sabatini BL, 2000, NATURE, V408, P589, DOI 10.1038/35046076; SABATINI BL, 1995, NEUROPHARMACOLOGY, V34, P1453, DOI 10.1016/0028-3908(95)00129-T; Sippy T, 2003, NAT NEUROSCI, V6, P1031, DOI 10.1038/nn1117; Sudhof TC, 2013, NAT MED, V19, P1227, DOI 10.1038/nm.3338; Sugita S, 2001, NEURON, V30, P459, DOI 10.1016/S0896-6273(01)00290-2; Tsujimoto T, 2002, SCIENCE, V295, P2276, DOI 10.1126/science.1068278; Wen H, 2010, P NATL ACAD SCI USA, V107, P13906, DOI 10.1073/pnas.1008598107; Zhao MD, 1996, BIOPHYS J, V70, P896, DOI 10.1016/S0006-3495(96)79633-9; Zolotukhin S, 1999, GENE THER, V6, P973, DOI 10.1038/sj.gt.3300938; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	46	181	184	0	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 7	2016	529	7584					88	+		10.1038/nature16507	http://dx.doi.org/10.1038/nature16507			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6VY	26738595	Green Published, Green Accepted			2022-12-28	WOS:000367944900032
J	Kim, W; Kweon, E				Kim, Woojin; Kweon, Euiyong			Hyperviscosity-Related Retinopathy in Waldenstrom's Macroglobulinemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Kim, Woojin; Kweon, Euiyong] Chonbuk Natl Univ Hosp, Jeonju, South Korea	Jeonbuk National University; Jeonbuk National University Hospital	Kim, W (corresponding author), Chonbuk Natl Univ Hosp, Jeonju, South Korea.	key@jbnu.ac.kr							0	2	4	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 7	2016	374	1					73	73		10.1056/NEJMicm1501103	http://dx.doi.org/10.1056/NEJMicm1501103			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DA1UH	26735995				2022-12-28	WOS:000367580500010
J	Kamerow, D				Kamerow, Douglas			YANKEE DOODLING A modest proposal on gun control-and a real one	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Kamerow, Douglas] Georgetown Univ, Robert Graham Ctr policy Studies Primary Care, Washington, DC 20057 USA; [Kamerow, Douglas] Georgetown Univ, Family Med, Washington, DC 20057 USA	Georgetown University; Georgetown University	Kamerow, D (corresponding author), Georgetown Univ, Robert Graham Ctr policy Studies Primary Care, Washington, DC 20057 USA.	dkamerow@aafp.org		Kamerow, Douglas/0000-0001-7000-9957				Dickey J, 2015, WASHINGTON POST; Dyer O, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6672; Editorial Board, 2015, WASHINGTON POST 1231; Lichtblau Eric, 2016, NY TIMES	4	2	2	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 6	2016	352								i69	10.1136/bmj.i69	http://dx.doi.org/10.1136/bmj.i69			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DA8MO	26739275				2022-12-28	WOS:000368059200003
J	Khodaee, M; Seyfert, J				Khodaee, Morteza; Seyfert, Jonathan			CASE REVIEW Not a typical case of bilateral knee osteoarthritis	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SYNOVIAL OSTEOCHONDROMATOSIS; CHONDROMATOSIS		[Khodaee, Morteza; Seyfert, Jonathan] Univ Colorado, Sch Med, Family Med, AFW Clin, Denver, CO 80217 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Khodaee, M (corresponding author), Univ Colorado, Sch Med, Family Med, AFW Clin, Denver, CO 80217 USA.	morteza.khodaee@ucdenver.edu						Ackerman D, 2008, J ARTHROPLASTY, V23, P395, DOI 10.1016/j.arth.2007.06.014; Hallam P, 2001, KNEE, V8, P239, DOI 10.1016/S0968-0160(01)00084-9; Hamada J, 2005, J SHOULDER ELB SURG, V14, P653, DOI 10.1016/j.jse.2004.12.004; Ji JH, 2015, KNEE SURG SPORT TR A, V23, P2624, DOI 10.1007/s00167-014-3024-3; KRANSDORF MJ, 1993, RADIOGRAPHICS, V13, P853, DOI 10.1148/radiographics.13.4.8356273; Mackenzie Hugh, 2010, J Med Case Rep, V4, P113, DOI 10.1186/1752-1947-4-113; MAURICE H, 1988, J BONE JOINT SURG BR, V70, P807, DOI 10.1302/0301-620X.70B5.3192585; Milgram J W, 1979, Bull Hosp Joint Dis, V40, P38; MILGRAM JW, 1977, J BONE JOINT SURG AM, V59, P792, DOI 10.2106/00004623-197759060-00013; MILGRAM JW, 1976, J BONE JOINT SURG AM, V58, P264, DOI 10.2106/00004623-197658020-00020; Ryan R S, 2005, Australas Radiol, V49, P95, DOI 10.1111/j.1440-1673.2005.01416.x; VILLACIN AB, 1979, HUM PATHOL, V10, P439, DOI 10.1016/S0046-8177(79)80050-7	12	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 6	2016	352								i39	10.1136/bmj.i39	http://dx.doi.org/10.1136/bmj.i39			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DA8MO	26739165				2022-12-28	WOS:000368059200002
J	Riggare, S				Riggare, Sara			Self referral to physiotherapy and other services would empower patients and doctors	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Riggare, Sara] Karolinska Inst, Hlth Informat Ctr, Dept Learning Informat Management & Eth, S-17177 Stockholm, Sweden	Karolinska Institutet	Riggare, S (corresponding author), Karolinska Inst, Hlth Informat Ctr, Dept Learning Informat Management & Eth, S-17177 Stockholm, Sweden.	sara.riggare@ki.se		Riggare, Sara/0000-0002-2256-7310				DOSHAY LJ, 1962, NEW ENGL J MED, V266, P878, DOI 10.1056/NEJM196204262661709; Ferguson T, 2004, BMJ-BRIT MED J, V328, P1148, DOI 10.1136/bmj.328.7449.1148; Fox S, 2008, ENGAGED E PATIENT PO; Kremer JAM, 2011, MINERVA MED, V102, P505; Krey J, 2015, DAGENS MED; Marshall M, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2117; Stockholm County Council, 2015, PROJ 4D ARTR	7	1	1	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 5	2016	352								h6977	10.1136/bmj.h6977	http://dx.doi.org/10.1136/bmj.h6977			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DA8MA	26733363				2022-12-28	WOS:000368057800007
J	Lozada-Hidalgo, M; Hu, S; Marshall, O; Mishchenko, A; Grigorenko, AN; Dryfe, RAW; Radha, B; Grigorieva, IV; Geim, AK				Lozada-Hidalgo, M.; Hu, S.; Marshall, O.; Mishchenko, A.; Grigorenko, A. N.; Dryfe, R. A. W.; Radha, B.; Grigorieva, I. V.; Geim, A. K.			Sieving hydrogen isotopes through two-dimensional crystals	SCIENCE			English	Article							ELECTROLYTIC HYDROGEN; DEUTERIUM SEPARATION; PROTON CONDUCTIVITY; LAYER GRAPHENE; WATER; TRANSPORT; MECHANISM	One-atom-thick crystals are impermeable to atoms and molecules, but hydrogen ions (thermal protons) penetrate through them. We show that monolayers of graphene and boron nitride can be used to separate hydrogen ion isotopes. Using electrical measurements and mass spectrometry, we found that deuterons permeate through these crystals much slower than protons, resulting in a separation factor of approximate to 10 at room temperature. The isotope effect is attributed to a difference of approximate to 60 milli-electron volts between zero-point energies of incident protons and deuterons, which translates into the equivalent difference in the activation barriers posed by two-dimensional crystals. In addition to providing insight into the proton transport mechanism, the demonstrated approach offers a competitive and scalable way for hydrogen isotope enrichment.	[Lozada-Hidalgo, M.; Hu, S.; Marshall, O.; Mishchenko, A.; Grigorenko, A. N.; Radha, B.; Grigorieva, I. V.; Geim, A. K.] Univ Manchester, Sch Phys & Astron, Manchester M13 9PL, Lancs, England; [Dryfe, R. A. W.] Univ Manchester, Sch Chem, Manchester M13 9PL, Lancs, England	University of Manchester; University of Manchester	Lozada-Hidalgo, M (corresponding author), Univ Manchester, Sch Phys & Astron, Manchester M13 9PL, Lancs, England.	marcelo.lozadahidalgo@manchester.ac.uk; geim@manchester.ac.uk	Geim, Andre K/J-7888-2012; Boya, Radha/A-2602-2012; Mishchenko, Artem/C-7561-2011; Boya, Radha/G-7794-2017; Lozada-Hidalgo, Marcelo/U-1642-2017; Marshall, Owen/C-2080-2017	Geim, Andre K/0000-0003-2861-8331; Boya, Radha/0000-0002-1495-1961; Mishchenko, Artem/0000-0002-0427-5664; Boya, Radha/0000-0003-1345-7029; Lozada-Hidalgo, Marcelo/0000-0003-3216-7537; Marshall, Owen/0000-0002-4533-7956	European Research Council; Lloyd's Register Foundation; Graphene Flagship; Royal Society; Air Force Office of Scientific Research; Office of Naval Research; Consejo Nacional de Ciencia y Tecnologia (Mexico)	European Research Council(European Research Council (ERC)European Commission); Lloyd's Register Foundation; Graphene Flagship; Royal Society(Royal Society of London); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Office of Naval Research(Office of Naval Research); Consejo Nacional de Ciencia y Tecnologia (Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by the European Research Council, Lloyd's Register Foundation, the Graphene Flagship, the Royal Society, the Air Force Office of Scientific Research, and the Office of Naval Research. M.L.-H. acknowledges a Ph.D. studentship provided by the Consejo Nacional de Ciencia y Tecnologia (Mexico). The reported results are included in a patent application "Graphene-Proton Transport," which is mostly based on (5).	Achtyl JL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7539; BEENAKKER JJM, 1995, CHEM PHYS LETT, V232, P379, DOI 10.1016/0009-2614(94)01372-3; Berry V, 2013, CARBON, V62, P1, DOI 10.1016/j.carbon.2013.05.052; Britnell L, 2012, NANO LETT, V12, P1707, DOI 10.1021/nl3002205; Bunch JS, 2008, NANO LETT, V8, P2458, DOI 10.1021/nl801457b; CONWAY BE, 1958, PROC R SOC LON SER-A, V247, P400, DOI 10.1098/rspa.1958.0194; CONWAY BE, 1960, PROC R SOC LON SER-A, V256, P128, DOI 10.1098/rspa.1960.0097; Feindel KW, 2007, J POWER SOURCES, V173, P86, DOI 10.1016/j.jpowsour.2007.04.079; HIBINO T, 1993, J ELECTROCHEM SOC, V140, P2588, DOI 10.1149/1.2220867; Hu S, 2014, NATURE, V516, P227, DOI 10.1038/nature14015; Kim KS, 2009, NATURE, V457, P706, DOI 10.1038/nature07719; Koenig SP, 2012, NAT NANOTECHNOL, V7, P728, DOI [10.1038/NNANO.2012.162, 10.1038/nnano.2012.162]; Kreuer KD, 1996, CHEM MATER, V8, P610, DOI 10.1021/cm950192a; KREUER KD, 1995, SOLID STATE IONICS, V77, P157, DOI 10.1016/0167-2738(94)00265-T; Leenaerts O, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.3021413; MARLING JB, 1980, J CHEM PHYS, V72, P5603, DOI 10.1063/1.438978; Marx D, 1999, NATURE, V397, P601, DOI 10.1038/17579; Marx D, 2006, CHEMPHYSCHEM, V7, P1848, DOI 10.1002/cphc.200600128; Mauritz KA, 2004, CHEM REV, V104, P4535, DOI 10.1021/cr0207123; Miao M, 2013, PHYS CHEM CHEM PHYS, V15, P16132, DOI 10.1039/c3cp52318g; Miller, 2001, CANADIAN NUCL SOC B, V22, P1; Paris A, 2013, ADV FUNCT MATER, V23, P1628, DOI 10.1002/adfm.201202355; Rae HK, 1978, ACS S SERIES; Reina A, 2009, NANO LETT, V9, P30, DOI 10.1021/nl801827v; ROLSTON JH, 1976, J PHYS CHEM-US, V80, P1064, DOI 10.1021/j100551a008; Tsetseris L, 2014, CARBON, V67, P58, DOI 10.1016/j.carbon.2013.09.055; Wang WL, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/12/125012; WIBERG KB, 1955, CHEM REV, V55, P713, DOI 10.1021/cr50004a004; Zhao XB, 2006, J PHYS CHEM B, V110, P9947, DOI 10.1021/jp060748p	29	193	202	27	466	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 1	2016	351	6268					68	70		10.1126/science.aac9726	http://dx.doi.org/10.1126/science.aac9726			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ8QM	26721995	Green Submitted			2022-12-28	WOS:000367364200043
J	Young, R; Gill, JJ				Young, Ry; Gill, Jason J.			Phage therapy redux - What is to be done?	SCIENCE			English	Editorial Material							BACTERIOPHAGE		[Young, Ry; Gill, Jason J.] Texas A&M Univ, Ctr Phage Technol, College Stn, TX 77843 USA; [Young, Ry] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA; [Gill, Jason J.] Texas A&M Univ, Dept Anim Sci, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Young, R (corresponding author), Texas A&M Univ, Ctr Phage Technol, College Stn, TX 77843 USA.	ryland@tamu.edu; jason.gill@tamu.edu		Gill, Jason/0000-0002-9494-6053; Young, Ry/0000-0001-8001-2914	NIAID NIH HHS [R13 AI069717] Funding Source: Medline; NIGMS NIH HHS [R37 GM027099, R01 GM027099] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R13AI069717] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM027099, R01GM027099] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ando H, 2015, CELL SYST, V1, P187, DOI 10.1016/j.cels.2015.08.013; Barr JJ, 2015, P NATL ACAD SCI USA, V112, P13675, DOI 10.1073/pnas.1508355112; Brussow H, 2002, CELL, V108, P13, DOI 10.1016/S0092-8674(01)00637-7; Fischetti VA, 2008, CURR OPIN MICROBIOL, V11, P393, DOI 10.1016/j.mib.2008.09.012; Ge P, 2015, NAT STRUCT MOL BIOL, V22, P377, DOI 10.1038/nsmb.2995; Ghequire MGK, 2015, TRENDS MICROBIOL, V23, P587, DOI 10.1016/j.tim.2015.07.011; Gill J, 2011, EMERGING TRENDS IN ANTIBACTERIAL DISCOVERY: ANSWERING THE CALL TO ARMS, P367; Nannapaneni R, 2015, BIOFILMS FOOD ENV, P131; Nobrega FL, 2015, TRENDS MICROBIOL, V23, P185, DOI 10.1016/j.tim.2015.01.006; Reyes A, 2013, P NATL ACAD SCI USA, V110, P20236, DOI 10.1073/pnas.1319470110; Summers WC, 2001, ANNU REV MICROBIOL, V55, P437, DOI 10.1146/annurev.micro.55.1.437; Williams SR, 2008, APPL ENVIRON MICROB, V74, P3868, DOI 10.1128/AEM.00141-08	12	79	87	0	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 4	2015	350	6265					1163	1164		10.1126/science.aad6791	http://dx.doi.org/10.1126/science.aad6791			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX4WG	26785457	Green Accepted			2022-12-28	WOS:000365700500042
J	Birnbaum, J; Gadi, VK; Markowitz, E; Etzioni, R				Birnbaum, Jeanette; Gadi, Vijayakrishna K.; Markowitz, Elan; Etzioni, Ruth			The Effect of Treatment Advances on the Mortality Results of Breast Cancer Screening Trials: A Microsimulation Model	ANNALS OF INTERNAL MEDICINE			English	Article							MAMMOGRAPHY; METAANALYSIS	Background: Mammography trials, which are the primary sources of evidence for screening benefit, were conducted decades ago. Whether advances in systemic therapies have rendered previously observed benefits of screening less significant is unknown. Objective: To compare the outcomes of breast cancer screening trials had they been conducted using contemporary systemic treatments with outcomes of trials conducted with previously used treatments. Design: Computer simulation model of 3 virtual screening trials with similar reductions in advanced-stage cancer cases but reflecting treatment patterns in 1975 (prechemotherapy era), 1999, or 2015 (treatment according to receptor status). Data Sources: Meta-analyses of screening and treatment trials; study of dissemination of primary systemic treatments; SEER (Surveillance, Epidemiology, and End Results) registry. Target Population: U.S. women aged 50 to 74 years. Time Horizon: 10 and 25 years. Perspective: Population. Intervention: Mammography, chemotherapy, tamoxifen, aromatase inhibitors, and trastuzumab. Outcome Measures: Breast cancer mortality rate ratio (MRR) and absolute risk reduction (ARR) obtained by the difference in cumulative breast cancer mortality between control and screening groups. Results of Base-Case Analysis: At 10 years, screening in a 1975 trial yielded an MRR of 90% and an ARR of 5 deaths per 10 000 women. A 2015 screening trial yielded a 10-year MRR of 90% and an ARR of 3 deaths per 10 000 women. Results of Sensitivity Analysis: Greater reductions in advanced-stage disease yielded a greater screening effect, but MRRs remained similar across trials. However, ARRs were consistently lower under contemporary treatments. When contemporary treatments were available only for early-stage cases, the MRR was 88%. Limitation: Disease models simplify reality and cannot capture all breast cancer subtypes. Conclusion: Advances in systemic therapies for breast cancer have not substantively reduced the relative benefits of screening but have likely reduced the absolute benefits because of their positive effect on breast cancer survival.	[Birnbaum, Jeanette] Univ Washington, Dept Hlth Serv, 1959 Northeast Pacific St, Seattle, WA 98195 USA; [Gadi, Vijayakrishna K.] Univ Washington, Div Med Oncol, Dept Med, 825 Eastlake Ave East, Seattle, WA 98109 USA; [Markowitz, Elan; Etzioni, Ruth] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, 1100 Fairview Ave North,M2-B230,POB 19024, Seattle, WA 98109 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center	Etzioni, R (corresponding author), Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, 1100 Fairview Ave North,M2-B230,POB 19024, Seattle, WA 98109 USA.	retzioni@fredhutch.org			University of Washington; National Cancer Institute; NATIONAL CANCER INSTITUTE [R01CA192402] Funding Source: NIH RePORTER	University of Washington(University of Washington); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	University of Washington and National Cancer Institute.	Agency for Healthcare Research and Quality, 2008, AHRQ PUBLICATION; Albain K, 2012, LANCET, V379, P432, DOI 10.1016/S0140-6736(11)61625-5; Albain KS, 2009, BREAST, V18, pS141, DOI 10.1016/S0960-9776(09)70290-5; Autier P, 2009, J CLIN ONCOL, V27, P5919, DOI 10.1200/JCO.2009.22.7041; Balduzzi S, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006242.pub2; Berry DA, 2005, NEW ENGL J MED, V353, P1784, DOI 10.1056/NEJMoa050518; Berry DA, 2013, BREAST, V22, pS73, DOI 10.1016/j.breast.2013.07.013; Biller-Andorno N, 2014, NEW ENGL J MED, V370, P1965, DOI 10.1056/NEJMp1401875; Bleyer A, 2012, NEW ENGL J MED, V367, P1998, DOI 10.1056/NEJMoa1206809; Calonge N, 2009, ANN INTERN MED, V151, P716, DOI 10.7326/0003-4819-151-10-200911170-00008; Chuang SL, 2014, APMIS, V122, P699, DOI 10.1111/apm.12294; Chung C, 2014, J ONCOL PHARM PRACT, V20, P11, DOI 10.1177/1078155212474047; Davies C, 2011, LANCET, V378, P771, DOI 10.1016/S0140-6736(11)60993-8; Dowsett M, 2010, J CLIN ONCOL, V28, P509, DOI 10.1200/JCO.2009.23.1274; Elmore JG, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3824; Etzioni R, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju058; Etzioni R, 2013, ANN INTERN MED, V158, P831, DOI 10.7326/0003-4819-158-11-201306040-00008; Etzioni R, 2013, MED CARE, V51, P295, DOI 10.1097/MLR.0b013e31827da979; Fitzpatrick-Lewis D, BREAST CANC SYSTEMAT; Gotzsche PC, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001877.pub5; Harris R, 2014, ANN INTERN MED, V160, P861, DOI 10.7326/M14-0616; Ismail-Khan R, 2010, CANCER CONTROL, V17, P173, DOI 10.1177/107327481001700305; Juni P, 2014, ANN INTERN MED, V160, P864, DOI 10.7326/M14-0569; Kalager M, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1403; Kalia M, 2013, METABOLISM, V62, pS11, DOI 10.1016/j.metabol.2012.08.016; Kolata G., 2011, NY TIMES; Ludwig JA, 2005, NAT REV CANCER, V5, P845, DOI 10.1038/nrc1739; Mariotto Angela B, 2006, J Natl Cancer Inst Monogr, P7, DOI 10.1093/jncimonographs/lgj003; Marmot MG, 2012, LANCET, V380, P1778, DOI 10.1016/S0140-6736(12)61611-0; Marmot MG, 2013, JAMA-J AM MED ASSOC, V309, P2553, DOI 10.1001/jama.2013.6822; Miller AB, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g366; Moja L, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006243.pub2; Moyer VA, 2012, ANN INTERN MED, V157, P120, DOI 10.7326/0003-4819-157-2-201207170-00459; National Cancer Institute, SURV EP END RES PROG; National Cancer Institute, 2015, DEVCAN PROB DEV DYIN; Ong MS, 2015, HEALTH AFFAIR, V34, P576, DOI 10.1377/hlthaff.2014.1087; Sledge GW, 2014, J CLIN ONCOL, V32, P1979, DOI 10.1200/JCO.2014.55.4139; Smith RA, 2014, CANCER EPIDEM BIOMAR, V23, P1139, DOI 10.1158/1055-9965.EPI-13-0946; Wever EM, 2011, MED DECIS MAKING, V31, P550, DOI 10.1177/0272989X10396717; Wilmoth JR, 2005, BERKELEY MORTALITY D; Woolf SH, 2012, JAMA-J AM MED ASSOC, V307, P565, DOI 10.1001/jama.2012.100	41	30	30	0	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 16	2016	164	4					236	+		10.7326/M15-0754	http://dx.doi.org/10.7326/M15-0754			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DD7WK	26756332	Green Accepted			2022-12-28	WOS:000370135300014
J	Melnikow, J; Fenton, JJ; Whitlock, EP; Miglioretti, DL; Weyrich, MS; Thompson, JH; Shah, K				Melnikow, Joy; Fenton, Joshua J.; Whitlock, Evelyn P.; Miglioretti, Diana L.; Weyrich, Meghan S.; Thompson, Jamie H.; Shah, Kunal			Supplemental Screening for Breast Cancer in Women With Dense Breasts: A Systematic Review for the US Preventive Services Task Force	ANNALS OF INTERNAL MEDICINE			English	Review							MAMMOGRAPHIC DENSITY; BI-RADS; DIGITAL MAMMOGRAPHY; ASYMPTOMATIC WOMEN; ULTRASOUND; TOMOSYNTHESIS; MRI; PERFORMANCE; IMAGES	Background: Screening mammography has lower sensitivity and specificity in women with dense breasts, who experience higher breast cancer risk. Purpose: To perform a systematic review of reproducibility of Breast Imaging Reporting and Data System (BI-RADS) density categorization and test performance and clinical outcomes of supplemental screening with breast ultrasonography, magnetic resonance imaging (MRI), and digital breast tomosynthesis (DBT) in women with dense breasts and negative mammography results. Data Sources: MEDLINE, PubMed, EMBASE, and Cochrane database from January 2000 to July 2015. Study Selection: Studies reporting BI-RADS density reproducibility or supplemental screening results for women with dense breasts. Data Extraction: Quality assessment and abstraction of 24 studies from 7 countries; 6 studies were good-quality. Data Synthesis: Three good-quality studies reported reproducibility of BI-RADS density; 13% to 19% of women were recategorized between "dense" and "nondense" at subsequent screening. Two good-quality studies reported that sensitivity of ultrasonography for women with negative mammography results ranged from 80% to 83%; specificity, from 86% to 94%; and positive predictive value (PPV), from 3% to 8%. The sensitivity of MRI ranged from 75% to 100%; specificity, from 78% to 94%; and PPV, from 3% to 33% (3 studies). Rates of additional cancer detection with ultrasonography were 4.4 per 1000 examinations (89% to 93% invasive); recall rates were 14%. Use of MRI detected 3.5 to 28.6 additional cancer cases per 1000 examinations (34% to 86% invasive); recall rates were 12% to 24%. Rates of cancer detection with DBT increased by 1.4 to 2.5 per 1000 examinations compared with mammography alone (3 studies). Recall rates ranged from 7% to 11%, compared with 7% to 17% with mammography alone. No studies examined breast cancer outcomes. Limitations: Good-quality evidence was sparse. Studies were small and Cls were wide. Definitions of recall were absent or inconsistent. Conclusion: Density ratings may be recategorized on serial screening mammography. Supplemental screening of women with dense breasts finds additional breast cancer but increases false-positive results. Use of DBT may reduce recall rates. Effects of supplemental screening on breast cancer outcomes remain unclear.	[Melnikow, Joy; Fenton, Joshua J.; Weyrich, Meghan S.] Univ Calif Davis, Ctr Healthcare Policy & Res, 2103 Stockton Blvd, Sacramento, CA 95817 USA; [Whitlock, Evelyn P.; Thompson, Jamie H.] Kaiser Permanente Ctr Hlth Res, 3800 North Interstate Ave, Portland, OR 97227 USA; [Miglioretti, Diana L.] Univ Calif Davis, Sch Med, Dept Publ Hlth Sci, One Shields Ave,Med Sci 1C,Room 145, Davis, CA 95616 USA; [Shah, Kunal] Columbia Univ, 6380 Lerner Hall,2920 Broadway, New York, NY 10027 USA	University of California System; University of California Davis; Kaiser Permanente; University of California System; University of California Davis; Columbia University	Melnikow, J (corresponding author), Univ Calif Davis, Ctr Healthcare Policy & Res, 2103 Stockton Blvd, Sacramento, CA 95817 USA.		Fenton, Joshua/AAD-4114-2021	Shah, Kunal/0000-0001-6227-1015; Fenton, Joshua/0000-0002-0581-835X	Agency for Healthcare Research and Quality; NATIONAL CANCER INSTITUTE [P01CA154292, P30CA093373] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Agency for Healthcare Research and Quality.	American Cancer Society, 2014, AM CANC SOC REC EARL; American College of Radiology, 2012, ACR STAT REP BREAST; [Anonymous], 2015, ARE YOU DENSE DENSE; Berg WA, 2012, JAMA-J AM MED ASSOC, V307, P1394, DOI 10.1001/jama.2012.388; Bernardi G, 2012, G CHIR, V33, P81; Besheli LD, 2014, CLIN RADIOL, V69, P661, DOI 10.1016/j.crad.2014.01.003; Bottorff JL, 2007, CAN J NURS RES, V39, P39; Brancato B, 2007, TUMORI, V93, P562; Brem RF, 2015, RADIOLOGY, V274, P663, DOI 10.1148/radiol.14132832; Carmona-Sanchez E, 2013, GYNECOL ENDOCRINOL, V29, P1067, DOI 10.3109/09513590.2013.831831; Centers for Disease Control and Prevention (CDC), 2014, BREAST CANC RAT RAC; Ciatto S, 2013, LANCET ONCOL, V14, P583, DOI 10.1016/S1470-2045(13)70134-7; Committee on Gynecologic Practice, 2014, Obstet Gynecol, V123, P910, DOI 10.1097/01.AOG.0000445584.44898.7d; Corsetti V, 2011, EUR J CANCER, V47, P1021, DOI 10.1016/j.ejca.2010.12.002; del Carmen MG, 2003, CANCER-AM CANCER SOC, V98, P590, DOI 10.1002/cncr.11517; Feng SSJ, 2012, RADIOLOGY, V263, P35, DOI 10.1148/radiol.11111789; Gard CC, 2015, BREAST J, V21, P481, DOI 10.1111/tbj.12443; Gierach GL, 2012, J NATL CANCER I, V104, P1218, DOI 10.1093/jnci/djs327; Girardi V, 2013, BREAST, V22, P806, DOI 10.1016/j.breast.2013.02.010; Giuliano V, 2013, CLIN IMAG, V37, P480, DOI 10.1016/j.clinimag.2012.09.018; Gur D, 2012, ACAD RADIOL, V19, P166, DOI 10.1016/j.acra.2011.10.003; Haas BM, 2013, RADIOLOGY, V269, P694, DOI 10.1148/radiol.13130307; Harvey JA, 2013, RADIOLOGY, V266, P752, DOI 10.1148/radiol.12120221; Hooley RJ, 2012, RADIOLOGY, V265, P59, DOI 10.1148/radiol.12120621; Kelly KM, 2010, EUR RADIOL, V20, P734, DOI 10.1007/s00330-009-1588-y; Kriege M, 2006, BREAST CANCER RES TR, V100, P109, DOI 10.1007/s10549-006-9230-z; Kuhl CK, 2014, J CLIN ONCOL, V32, P2304, DOI 10.1200/JCO.2013.52.5386; Lee CH, 2010, J AM COLL RADIOL, V7, P18, DOI 10.1016/j.jacr.2009.09.022; Leong LCH, 2012, ANN ACAD MED SINGAP, V41, P432; Lucas NP, 2010, J CLIN EPIDEMIOL, V63, P854, DOI 10.1016/j.jclinepi.2009.10.002; McCarthy AM, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju316; Melnikow J, 2015, AHRQ PUBLICATION; Miglioretti DL, 2015, AHRQ PUBLICATION; National Comprehensive Cancer Network, 2014, BREAST CANC SCREEN D; National Institute for Health and Clinical Excellence, 2006, GUID MAN; Nelson HD, 2015, AHRQ PUBLICATION; Olgar T, 2012, ROFO-FORTSCHR RONTG, V184, P911, DOI 10.1055/s-0032-1312877; Parris T, 2013, BREAST J, V19, P64, DOI 10.1111/tbj.12053; Redondo A, 2012, BRIT J RADIOL, V85, P1465, DOI 10.1259/bjr/21256379; Rose SL, 2013, AM J ROENTGENOL, V200, P1401, DOI 10.2214/AJR.12.9672; Spayne MC, 2012, BREAST J, V18, P326, DOI 10.1111/j.1524-4741.2012.01250.x; Sprague BL, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju255; US Preventive Services Task Force, 2013, US PREV SERV TASK FO; Venturini E, 2013, RADIOLOGY, V268, P347, DOI 10.1148/radiol.13122278; Weigert J, 2012, BREAST J, V18, P517, DOI 10.1111/tbj.12003; Youk JH, 2011, EUR RADIOL, V21, P667, DOI 10.1007/s00330-010-1955-8	46	202	210	4	47	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 16	2016	164	4					268	+		10.7326/M15-1789	http://dx.doi.org/10.7326/M15-1789			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DD7WK	26757021	Green Accepted			2022-12-28	WOS:000370135300017
J	Hansen, SG; Wu, HL; Burwitz, BJ; Hughes, CM; Hammond, KB; Ventura, AB; Reed, JS; Gilbride, RM; Ainslie, E; Morrow, DW; Ford, JC; Selseth, AN; Pathak, R; Malouli, D; Legasse, AW; Axthelm, MK; Nelson, JA; Gillespie, GM; Walters, LC; Brackenridge, S; Sharpe, HR; Lopez, CA; Fruh, K; Korber, BT; McMichael, AJ; Gnanakaran, S; Sacha, JB; Picker, LJ				Hansen, Scott G.; Wu, Helen L.; Burwitz, Benjamin J.; Hughes, Colette M.; Hammond, Katherine B.; Ventura, Abigail B.; Reed, Jason S.; Gilbride, Roxanne M.; Ainslie, Emily; Morrow, David W.; Ford, Julia C.; Selseth, Andrea N.; Pathak, Reesab; Malouli, Daniel; Legasse, Alfred W.; Axthelm, Michael K.; Nelson, Jay A.; Gillespie, Geraldine M.; Walters, Lucy C.; Brackenridge, Simon; Sharpe, Hannah R.; Lopez, Cesar A.; Frueh, Klaus; Korber, Bette T.; McMichael, Andrew J.; Gnanakaran, S.; Sacha, Jonah B.; Picker, Louis J.			Broadly targeted CD8(+) T cell responses restricted by major histocompatibility complex E	SCIENCE			English	Article							MHC-CLASS-I; HIGHLY PATHOGENIC SIV; HLA-E EXPRESSION; SURFACE EXPRESSION; RECEPTORS; BINDING; RHESUS	Major histocompatibility complex E (MHC-E) is a highly conserved, ubiquitously expressed, nonclassical MHC class Ib molecule with limited polymorphism that is primarily involved in the regulation of natural killer (NK) cells. We found that vaccinating rhesus macaques with rhesus cytomegalovirus vectors in which genes Rh157.5 and Rh157.4 are deleted results in MHC-E-restricted presentation of highly varied peptide epitopes to CD8 alpha beta(+) T cells, at similar to 4 distinct epitopes per 100 amino acids in all tested antigens. Computational structural analysis revealed that MHC-E provides heterogeneous chemical environments for diverse side-chain interactions within a stable, open binding groove. Because MHC-E is up-regulated to evade NK cell activity in cells infected with HIV, simian immunodeficiency virus, and other persistent viruses, MHC-E-restricted CD8(+) T cell responses have the potential to exploit pathogen immune-evasion adaptations, a capability that might endow these unconventional responses with superior efficacy.	[Hansen, Scott G.; Wu, Helen L.; Burwitz, Benjamin J.; Hughes, Colette M.; Hammond, Katherine B.; Ventura, Abigail B.; Reed, Jason S.; Gilbride, Roxanne M.; Ainslie, Emily; Morrow, David W.; Ford, Julia C.; Selseth, Andrea N.; Pathak, Reesab; Malouli, Daniel; Legasse, Alfred W.; Axthelm, Michael K.; Nelson, Jay A.; Frueh, Klaus; Sacha, Jonah B.; Picker, Louis J.] Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Beaverton, OR 97006 USA; [Hansen, Scott G.; Wu, Helen L.; Burwitz, Benjamin J.; Hughes, Colette M.; Hammond, Katherine B.; Ventura, Abigail B.; Reed, Jason S.; Gilbride, Roxanne M.; Ainslie, Emily; Morrow, David W.; Ford, Julia C.; Selseth, Andrea N.; Pathak, Reesab; Malouli, Daniel; Legasse, Alfred W.; Axthelm, Michael K.; Nelson, Jay A.; Frueh, Klaus; Sacha, Jonah B.; Picker, Louis J.] Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Beaverton, OR 97006 USA; [Gillespie, Geraldine M.; Walters, Lucy C.; Brackenridge, Simon; Sharpe, Hannah R.; McMichael, Andrew J.] Univ Oxford, Nuffield Dept Med, Oxford OX37FZ, England; [Lopez, Cesar A.; Korber, Bette T.; Gnanakaran, S.] Los Alamos Natl Lab, Theoret Biol & Biophys Grp, POB 1663, Los Alamos, NM 87545 USA; [Korber, Bette T.] New Mexico Consortium, Los Alamos, NM 87545 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon National Primate Research Center; University of Oxford; United States Department of Energy (DOE); Los Alamos National Laboratory	Sacha, JB; Picker, LJ (corresponding author), Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Beaverton, OR 97006 USA.; Sacha, JB; Picker, LJ (corresponding author), Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Beaverton, OR 97006 USA.	sacha@ohsu.edu; pickerl@ohsu.edu	Malouli, Daniel/AAX-1855-2021	Malouli, Daniel/0000-0003-1287-7283; Brackenridge, Simon/0000-0002-0587-7560; Walters, Lucy/0000-0002-8406-2828; Sharpe, Hannah/0000-0002-1194-2429; Gnanakaran, S/0000-0002-9368-3044; Frueh, Klaus/0000-0001-8014-3877; Korber, Bette/0000-0002-2026-5757	NIH [P01-AI094417, R37-AI054292, R01-DE021291, R01-AI095113, R01-AI117802, R01-AI059457, U24-OD010850, P51-OD011092, P50-GM065794, HHSN272201100013C]; Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery of the National Institute of Allergy and Infectious Diseases [UM1-AI100645-01]; Bill and Melinda Gates Foundation [OPP1108533, OPP1133649]; Aeras Global TB Vaccine Foundation; Center for Nonlinear Studies at the Los Alamos National Laboratory (LANL); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI117802, R01AI059457, P01AI094417, R01AI095113, F31AI122471, UM1AI100645, R37AI054292] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE021291] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM065794, P50GM085273] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011092, U24OD010850, U42OD023038] Funding Source: NIH RePORTER; Medical Research Council [MR/K012037/1] Funding Source: researchfish; MRC [MR/K012037/1] Funding Source: UKRI	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery of the National Institute of Allergy and Infectious Diseases; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Aeras Global TB Vaccine Foundation; Center for Nonlinear Studies at the Los Alamos National Laboratory (LANL); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We are grateful to T. van Hall for the HLA-E*01:03 transfectant; D. Geraghty for the 4D12 mAb; D. O'Connor and R. Wiseman for 454-based MHC typing; and Y. Guo, D. Laddy, and M. Stone (Aeras) for provision of the 68-1 RhCMV construct expressing the M. tb. RpFA protein. We thank A. Townsend for help with the graphics; E. McDonald, A. Klug, A. Bhusari, G. Xu, J. Bae, C. Kahl, S. Hagen, A. Sylwester, and L. Boshears for technical or administrative assistance; J. Theiler for coding assistance; and P. Borrow for helpful discussions on HLA-E biology and peptide binding. This research was supported by NIH grants P01-AI094417, R37-AI054292, R01-DE021291, R01-AI095113, R01-AI117802, R01-AI059457, U24-OD010850, P51-OD011092, and P50-GM065794 and contract HHSN272201100013C; the Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery (grant UM1-AI100645-01) of the National Institute of Allergy and Infectious Diseases; the Bill and Melinda Gates Foundation (Global Health grants OPP1108533 and OPP1133649); the Aeras Global TB Vaccine Foundation; and the Center for Nonlinear Studies at the Los Alamos National Laboratory (LANL). LANL institutional computing was used for carrying out all-atom molecular dynamics simulations. The content is solely the responsibility of the authors and does not necessarily represent the official views of NIH or other funders. The Oregon Health & Science University (OHSU) has submitted a provisional patent entitled "Methods and compositions useful in generating non-canonical CD8<SUP>+</SUP> T cell responses" (inventors: L. J. P., K.F., J.B.S, D. M, and S.G.H.). OHSU and L. J. P., S.G.H., K.F., and J.A.N. have a substantial financial interest in TomegaVax, a company that may have a commercial interest in the results of this research and technology. L. J. P., K.F., and J.A.N. serve on the board of TomegaVax, and K.F. is also an uncompensated officer of the company. The potential individual and institutional conflicts of interest have been reviewed and managed by OHSU. Additional data used in this report are available as supplementary materials on Science Online.	Arlettaz L, 2004, EUR J IMMUNOL, V34, P3456, DOI 10.1002/eji.200425210; Braud VM, 1998, NATURE, V391, P795, DOI 10.1038/35869; Caccamo N, 2022, EUR J IMMUNOL, DOI 10.1002/eji.201445193; Camilli G, 2016, J LEUKOCYTE BIOL, V99, P121, DOI 10.1189/jlb.1A0415-172R; Goulder PJR, 2008, NAT REV IMMUNOL, V8, P619, DOI 10.1038/nri2357; Hansen SG, 2013, NATURE, V502, P100, DOI 10.1038/nature12519; Hansen SG, 2013, SCIENCE, V340, P940, DOI 10.1126/science.1237874; Hansen SG, 2011, NATURE, V473, P523, DOI 10.1038/nature10003; Hoare HL, 2008, J MOL BIOL, V377, P1297, DOI 10.1016/j.jmb.2008.01.098; Lampen MH, 2013, MOL IMMUNOL, V53, P126, DOI 10.1016/j.molimm.2012.07.009; Lee N, 1998, J IMMUNOL, V160, P4951; Lee N, 1998, P NATL ACAD SCI USA, V95, P5199, DOI 10.1073/pnas.95.9.5199; Lilja AE, 2008, P NATL ACAD SCI USA, V105, P19950, DOI 10.1073/pnas.0811063106; Liu TF, 2014, J CHEM INF MODEL, V54, P2233, DOI 10.1021/ci500393h; Lodoen MB, 2005, NAT REV MICROBIOL, V3, P59, DOI 10.1038/nrmicro1066; Nattermann J, 2005, ANTIVIR THER, V10, P95; Nattermann J, 2005, AM J PATHOL, V166, P443, DOI 10.1016/S0002-9440(10)62267-5; Neefjes J, 2011, NAT REV IMMUNOL, V11, P823, DOI 10.1038/nri3084; Nikolich-Zugich J, 2004, MICROBES INFECT, V6, P501, DOI 10.1016/j.micinf.2004.01.006; O'Connor DH, 2002, NAT MED, V8, P493, DOI 10.1038/nm0502-493; Picker LJ, 2012, ANNU REV MED, V63, P95, DOI 10.1146/annurev-med-042010-085643; Pietra G, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/907092; Prod'homme V, 2012, J IMMUNOL, V188, P2794, DOI 10.4049/jimmunol.1102068; Richards R, 2011, J VIROL, V85, P8766, DOI 10.1128/JVI.05021-11; Wieten L, 2014, TISSUE ANTIGENS, V84, P523, DOI 10.1111/tan.12478; Wiseman RW, 2009, NAT MED, V15, P1322, DOI 10.1038/nm.2038; Yewdell JW, 2006, IMMUNITY, V25, P533, DOI 10.1016/j.immuni.2006.09.005	30	194	209	1	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 12	2016	351	6274					714	720		10.1126/science.aac9475	http://dx.doi.org/10.1126/science.aac9475			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD3GL	26797147	Green Accepted			2022-12-28	WOS:000369810000042
J	Kiguli, J; Munabi, IG; Ssegujja, E; Nabaliisa, J; Kabonesa, C; Kiguli, S; Josaphat, B				Kiguli, Juliet; Munabi, Ian G.; Ssegujja, Eric; Nabaliisa, Joyce; Kabonesa, Consolata; Kiguli, Sarah; Josaphat, Byamugisha			Stillbirths in sub-Saharan Africa: unspoken grief	LANCET			English	Editorial Material							PREGNANCY LOSS; EXPERIENCES; MORTALITY; MOTHERS; CARE		[Kiguli, Juliet] Makerere Univ, Coll Hlth Sci, Dept Behav Sci & Community Hlth, Kampala, Uganda; [Kiguli, Juliet; Ssegujja, Eric; Nabaliisa, Joyce] Makerere Univ, Coll Hlth Sci, Sch Publ Hlth, Kampala, Uganda; [Munabi, Ian G.] Makerere Univ, Coll Hlth Sci, Sch Biomed Sci, Kampala, Uganda; [Kiguli, Sarah; Josaphat, Byamugisha] Makerere Univ, Coll Hlth Sci, Sch Med, Kampala, Uganda; [Kabonesa, Consolata] Makerere Univ, Coll Human & Social Sci, Women & Gender Studies, Kampala, Uganda	Makerere University; Makerere University; Makerere University; Makerere University; Makerere University	Kiguli, J (corresponding author), Makerere Univ, Coll Hlth Sci, Dept Behav Sci & Community Hlth, POB 7072, Kampala, Uganda.	jkiguli@musph.ac.ug						Beyeza-Kashesya J, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-247; Cacciatore J, 2008, J FAM SOC WORK, V11, P351, DOI 10.1080/10522150802451667; Chou D, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4255; Froen JF, 2011, LANCET, V377, P1353, DOI 10.1016/S0140-6736(10)62232-5; Haws RA, 2010, SOC SCI MED, V71, P1764, DOI 10.1016/j.socscimed.2010.03.051; Kiguli J, 2015, GLOBAL HEALTH ACTION, V8, DOI 10.3402/gha.v8.24011; Koster W, 2010, SOC SCI MED, V71, P1788, DOI 10.1016/j.socscimed.2010.06.033; Lawn JE, 2016, LANCET; Moxon SG, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/1471-2393-15-S2-S7; Munabi Ian G, 2015, BMC Res Notes, V8, P205, DOI 10.1186/s13104-015-1183-z; Sisay MM, 2014, J MIDWIFERY WOM HEAL, V59, pS110, DOI 10.1111/jmwh.12156; van der Sijpt E, 2010, SOC SCI MED, V71, P1773, DOI 10.1016/j.socscimed.2010.03.055	12	24	24	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 6	2016	387	10018					E16	E18		10.1016/S0140-6736(15)01171-X	http://dx.doi.org/10.1016/S0140-6736(15)01171-X			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DD3PV	26794074				2022-12-28	WOS:000369835800003
J	Ndukaife, JC; Shalaev, VM; Boltasseva, A				Ndukaife, Justus C.; Shalaev, Vladimir M.; Boltasseva, Alexandra			Plasmonics-turning loss into gain The optical losses associated with plasmonic materials could be used in applications	SCIENCE			English	Editorial Material							GOLD		[Ndukaife, Justus C.; Shalaev, Vladimir M.; Boltasseva, Alexandra] Purdue Univ, Sch Elect & Comp Engn, W Lafayette, IN 47907 USA; [Ndukaife, Justus C.; Shalaev, Vladimir M.; Boltasseva, Alexandra] Purdue Univ, Birck Nanotechnol Ctr, W Lafayette, IN 47907 USA; [Ndukaife, Justus C.] Purdue Univ Calumet, Water Inst, Hammond, IN 46323 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University	Ndukaife, JC (corresponding author), Purdue Univ, Sch Elect & Comp Engn, W Lafayette, IN 47907 USA.	aeb@purdue.edu	Boltasseva, Alexandra/C-1674-2019; ndukaife, justus/N-3337-2016; Shalaev, Vladimir M./B-9331-2019	Boltasseva, Alexandra/0000-0001-8905-2605; Shalaev, Vladimir M./0000-0001-8976-1102; Ndukaife, Justus/0000-0002-8524-0657				Brongersma ML, 2015, NAT NANOTECHNOL, V10, P25, DOI [10.1038/NNANO.2014.311, 10.1038/nnano.2014.311]; Challener WA, 2009, NAT PHOTONICS, V3, P303, DOI 10.1038/NPHOTON.2009.71; Guler U, 2015, MATER TODAY, V18, P227, DOI 10.1016/j.mattod.2014.10.039; Hirsch LR, 2003, P NATL ACAD SCI USA, V100, P13549, DOI 10.1073/pnas.2232479100; Khurgin JB, 2015, NAT NANOTECHNOL, V10, P2, DOI 10.1038/nnano.2014.310; Lenert A, 2014, NAT NANOTECHNOL, V9, P126, DOI [10.1038/nnano.2013.286, 10.1038/NNANO.2013.286]; Lukianova-Hleb EY, 2014, NAT MED, V20, P778, DOI 10.1038/nm.3484; Naik GV, 2013, ADV MATER, V25, P3264, DOI 10.1002/adma.201205076; Ndukaife JC, 2016, NAT NANOTECHNOL, V11, P53, DOI [10.1038/nnano.2015.248, 10.1038/NNANO.2015.248]; Rousseau E, 2009, NAT PHOTONICS, V3, P514, DOI 10.1038/NPHOTON.2009.144; Roxworthy BJ, 2014, NANO LETT, V14, P4687, DOI 10.1021/nl501788a; Zijlstra P, 2009, NATURE, V459, P410, DOI 10.1038/nature08053	12	63	63	3	123	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 22	2016	351	6271					334	335		10.1126/science.aad9864	http://dx.doi.org/10.1126/science.aad9864			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB3VH	26797997				2022-12-28	WOS:000368440500019
J	Gross, K				Gross, Kevin			Biodiversity and productivity entwined	NATURE			English	Editorial Material							PLANT-SPECIES RICHNESS		[Gross, Kevin] N Carolina State Univ, Biomath Program, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University	Gross, K (corresponding author), N Carolina State Univ, Biomath Program, Raleigh, NC 27695 USA.	kevin_gross@ncsu.edu	Gross, Kevin/AAX-1589-2020					Adler PB, 2011, SCIENCE, V333, P1750, DOI 10.1126/science.1204498; Borer ET, 2014, METHODS ECOL EVOL, V5, P65, DOI 10.1111/2041-210X.12125; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Cardinale BJ, 2009, ECOLOGY, V90, P1227, DOI 10.1890/08-1038.1; Fraser LH, 2015, SCIENCE, V349, P302, DOI 10.1126/science.aab3916; GRIME JP, 1973, NATURE, V242, P344, DOI 10.1038/242344a0; Kline R. B, 2015, PRINCIPLES PRACTICE, DOI DOI 10.1111/j.1467-8721.2009.01598.x; Mittelbach GG, 2001, ECOLOGY, V82, P2381, DOI 10.1890/0012-9658(2001)082[2381:WITORB]2.0.CO;2; Schmid B, 2002, TRENDS ECOL EVOL, V17, P113, DOI 10.1016/S0169-5347(01)02422-3; Willig MR, 2011, SCIENCE, V333, P1709, DOI 10.1126/science.1212453	10	11	12	11	119	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 21	2016	529	7586					293	294		10.1038/nature16867	http://dx.doi.org/10.1038/nature16867			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB2QT	26760204				2022-12-28	WOS:000368354800029
J	Bates, ER				Bates, Eric R.			Review: In patients with previous MI, long-term DAPT reduces CV events and increases major bleeding	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Bates, Eric R.] Univ Michigan, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Bates, ER (corresponding author), Univ Michigan, Ann Arbor, MI 48109 USA.							Bonaca MP, 2015, NEW ENGL J MED, V372, P1791, DOI 10.1056/NEJMoa1500857; Levine GN, 2011, J AM COLL CARDIOL, V58, pE44, DOI 10.1016/j.jacc.2011.08.007; Windecker S, 2014, EUR HEART J, V35, P2541, DOI [10.1093/eurheartj/ehu278, 10.5603/KP.2014.0224, 10.1093/ejcts/ezu366]; Yeh RW, 2015, AM HEART ASS SCI SES	4	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 19	2016	164	2					JC9	JC9		10.7326/ACPJC-2016-164-2-009	http://dx.doi.org/10.7326/ACPJC-2016-164-2-009			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DB0CI	26784499				2022-12-28	WOS:000368175800008
J	Clodfelter, RP; Adashi, EY				Clodfelter, Ryan P.; Adashi, Eli Y.			The Liberty to Die California Enacts Physician Aid-in-Dying Law	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Clodfelter, Ryan P.; Adashi, Eli Y.] Brown Univ, Warren Alpert Med Sch, Providence, RI 02905 USA	Brown University	Adashi, EY (corresponding author), Brown Univ, Dept Obstet & Gynecol, Warren Alpert Med Sch, 101 Dudley St, Providence, RI 02905 USA.	eli_adashi@brown.edu						Annas GJ, 1997, NEW ENGL J MED, V337, P1098, DOI 10.1056/NEJM199710093371523; [Anonymous], STRONG VOT SUPP END; Boudreau J Donald, 2013, N Engl J Med, V368, P1450, DOI 10.1056/NEJMclde1302615; Dugan Andrew, GALLUP; Meisel A, 2014, RIGHT DIE LAE END OF; Patients Rights Council, ATT LEG EUTH ASS SUI	6	14	14	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 19	2016	315	3					251	252		10.1001/jama.2015.16242	http://dx.doi.org/10.1001/jama.2015.16242			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DB2WN	26784765				2022-12-28	WOS:000368371400014
J	Hurley, R				Hurley, Richard			THE BMJ WINTER APPEAL 2015-6 Vandals force volunteer doctors to close clinic in Calais's refugee camp	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												rhurley@bmj.com							0	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 14	2016	352								i182	10.1136/bmj.i182	http://dx.doi.org/10.1136/bmj.i182			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DB2YZ	26769821	Green Published, Bronze			2022-12-28	WOS:000368377900008
J	Hamilton, I; Gilmore, I				Hamilton, Ian; Gilmore, Ian			Could campaigns like Dry January do more harm than good?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Hamilton, Ian] York Univ, Dept Hlth Sci, York, N Yorkshire, England; [Gilmore, Ian] Univ Liverpool, Liverpool L69 3BX, Merseyside, England	University of York - UK; University of Liverpool	Hamilton, I (corresponding author), York Univ, Dept Hlth Sci, York, N Yorkshire, England.	ian.hamilton@york.ac.uk; I.Gilmore@liverpool.ac.uk						Awissi DK, 2013, INTENS CARE MED, V39, P16, DOI 10.1007/s00134-012-2758-y; Boniface S, 2013, EUR J PUBLIC HEALTH, V23, P1076, DOI 10.1093/eurpub/ckt016; Das AK, 2014, CLIN MED, V14, P141, DOI 10.7861/clinmedicine.14-2-141; De Visser RO, 2015, HLTH PSYCHOL; Department of Health, 2016, ALC GUID REV REP GUI; Health and Social Care Information Centre, 2015, STAT ALC; Mehta G, 2015, CILN EXPT       1116; Public Health England, ANN REP ACC 2014 201; Rao R, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007525; Wolstenholme A, 2012, ALCOHOL POLICY EUROP	10	5	5	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 13	2016	352								i143	10.1136/bmj.i143	http://dx.doi.org/10.1136/bmj.i143			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DB2YL	26762325				2022-12-28	WOS:000368376500008
J	Smoliga, JM; Weiss, P; Rundell, KW				Smoliga, James M.; Weiss, Pnina; Rundell, Kenneth W.			Exercise induced bronchoconstriction in adults: evidence based diagnosis and management	BMJ-BRITISH MEDICAL JOURNAL			English	Review							INDUCED LARYNGEAL OBSTRUCTION; EUCAPNIC VOLUNTARY HYPERPNEA; CLINICAL IMMUNOLOGY EAACI; RESPIRATORY SOCIETY ERS; JOINT TASK-FORCE; INDUCED ASTHMA; AIRWAY HYPERRESPONSIVENESS; INDUCED BRONCHOSPASM; CONSENSUS CONFERENCE; ALLERGIC DISORDERS		[Smoliga, James M.] High Point Univ, Dept Phys Therapy, High Point, NC 27268 USA; [Weiss, Pnina] Yale Univ, Sch Med, Pediat Resp Med, New Haven, CT 06520 USA; [Rundell, Kenneth W.] Commonwealth Med Coll, Scranton, PA USA	Yale University; Geisinger Commonwealth School of Medicine	Smoliga, JM (corresponding author), High Point Univ, Dept Phys Therapy, High Point, NC 27268 USA.	jsmoliga@highpoint.edu		Smoliga, James/0000-0002-1895-5687				Anderson SD, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-120; Anderson SD, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-4; Anderson SD, 2003, CLIN REV ALLERG IMMU, V24, P27, DOI 10.1385/CRIAI:24:1:27; Anderson SD, 2001, BRIT J SPORT MED, V35, P344, DOI 10.1136/bjsm.35.5.344; Ansley L, 2012, ALLERGY, V67, P390, DOI 10.1111/j.1398-9995.2011.02762.x; BECK KC, 1994, AM J RESP CRIT CARE, V149, P352, DOI 10.1164/ajrccm.149.2.8306029; Becker JM, 2004, J ALLERGY CLIN IMMUN, V113, P264, DOI 10.1016/j.jaci.2003.10.052; Bonini M, 2013, COCHRANE DB SYST REV, V10; Brannan JD, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-144; Carlsen KH, 2008, ALLERGY, V63, P492, DOI 10.1111/j.1398-9995.2008.01663.x; Carlsen KH, 2008, ALLERGY, V63, P387, DOI 10.1111/j.1398-9995.2008.01662.x; Christensen PM, 2015, EUR RESPIR REV, V24, P445, DOI 10.1183/16000617.00006513; Crapo RO, 2000, AM J RESP CRIT CARE, V161, P309; EDMUNDS AT, 1978, AM REV RESPIR DIS, V117, P247; Eichenberger PA, 2013, SPORTS MED, V43, P1157, DOI 10.1007/s40279-013-0077-2; Fisk MZ, 2010, PHYSICIAN SPORTSMED, V38, P28, DOI 10.3810/psm.2010.12.1822; Fitch KD, 2008, J ALLERGY CLIN IMMUN, V122, P254, DOI 10.1016/j.jaci.2008.07.003; Giannini D, 1997, J ASTHMA, V34, P105, DOI 10.3109/02770909709075654; Goldstein MF, 2001, CHEST, V119, P1001, DOI 10.1378/chest.119.4.1001; Heimdal JH, 2006, LARYNGOSCOPE, V116, P52, DOI 10.1097/01.mlg.0000184528.16229.ba; Helenius IJ, 1996, THORAX, V51, P628, DOI 10.1136/thx.51.6.628; Helenius IJ, 1998, BRIT J SPORT MED, V32, P125, DOI 10.1136/bjsm.32.2.125; Holzer K, 2002, J ALLERGY CLIN IMMUN, V110, P374, DOI 10.1067/mai.2002.127784; Johansson H, 2015, THORAX, V70, P57, DOI 10.1136/thoraxjnl-2014-205738; Karjalainen EM, 2000, AM J RESP CRIT CARE, V161, P2086, DOI 10.1164/ajrccm.161.6.9907025; MANGLA PK, 1981, CLIN ALLERGY, V11, P433, DOI 10.1111/j.1365-2222.1981.tb01616.x; MILLQVIST E, 1995, ALLERGY, V50, P221, DOI 10.1111/j.1398-9995.1995.tb01137.x; Millqvist E, 2000, ALLERGY, V55, P672, DOI 10.1034/j.1398-9995.2000.00558.x; Nelson HS, 2006, CHEST, V129, P15, DOI 10.1378/chest.129.1.15; Nielsen EW, 2013, MED SCI SPORT EXER, V45, P2030, DOI 10.1249/MSS.0b013e318298b19a; Parsons JP, 2013, AM J RESP CRIT CARE, V187, P1016, DOI 10.1164/rccm.201303-0437ST; Parsons JP, 2005, CHEST, V128, P3966, DOI 10.1378/chest.128.6.3966; Randolph CC, 2006, MED SCI SPORT EXER, V38, P2053, DOI 10.1249/01.mss.0000235357.31932.43; Rundell KW, 2008, J ALLERGY CLIN IMMUN, V122, P238, DOI 10.1016/j.jaci.2008.06.014; Rundell KW, 2015, COMPR PHYSIOL, V5, P579, DOI 10.1002/cphy.c130013; Rundell KW, 2013, CURR SPORT MED REP, V12, P41, DOI 10.1249/JSR.0b013e318281e471; Rundell KW, 2005, INHAL TOXICOL, V17, P99, DOI 10.1080/08958370590899479; Rundell KW, 2004, CHEST, V125, P909, DOI 10.1378/chest.125.3.909; Rundell KW, 2000, MED SCI SPORT EXER, V32, P309, DOI 10.1097/00005768-200002000-00010; Rundell KW, 2003, CHEST, V123, P468, DOI 10.1378/chest.123.2.468; Stickland MK, 2012, MED SCI SPORT EXER, V44, P383, DOI 10.1249/MSS.0b013e31822fb73a; van Leeuwen JC, 2011, ARCH DIS CHILD, V96, P664, DOI 10.1136/adc.2010.209411; Weiler JM, 2014, J ALLER CL IMM-PRACT, V2, P275, DOI 10.1016/j.jaip.2013.11.001; Weiler John M, 2010, Ann Allergy Asthma Immunol, V105, pS1, DOI 10.1016/j.anai.2010.09.021; Weiss Pnina, 2009, Allergy Asthma Clin Immunol, V5, P7, DOI 10.1186/1710-1492-5-7	45	14	14	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 13	2016	352								h6951	10.1136/bmj.h6951	http://dx.doi.org/10.1136/bmj.h6951			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DB2YL	26762594				2022-12-28	WOS:000368376500002
J	Kistin, CJ; Tompson, MC; Cabral, HJ; Sege, RD; Winter, MR; Silverstein, M				Kistin, Caroline J.; Tompson, Martha C.; Cabral, Howard J.; Sege, Robert D.; Winter, Michael R.; Silverstein, Michael			Subsequent Maltreatment in Children With Disabilities After an Unsubstantiated Report for Neglect	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							ABUSE		[Kistin, Caroline J.; Silverstein, Michael] Boston Med Ctr, Dept Pediat, Boston, MA 02118 USA; [Tompson, Martha C.] Boston Univ, Dept Psychol & Brain Sci, Boston, MA 02215 USA; [Cabral, Howard J.] Boston Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Boston, MA USA; [Sege, Robert D.] Ctr Study Social Policy, Washington, DC USA; [Winter, Michael R.] Boston Univ, Sch Publ Hlth, Data Coordinating Ctr, Boston, MA USA	Boston Medical Center; Boston University; Boston University; Boston University	Kistin, CJ (corresponding author), Boston Med Ctr, Dept Pediat, 89 E Newton St,Vose 3, Boston, MA 02118 USA.	caroline.kistin@bmc.org		Sege, Robert/0000-0003-1260-4787	NICHD NIH HHS [K23 HD078503, K23 HD078503-02] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K23HD078503] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Chaffin M, 2006, CHILD MALTREATMENT, V11, P301, DOI 10.1177/1077559506291261; Dubowitz H, 2011, CHILD ABUSE NEGLECT, V35, P96, DOI 10.1016/j.chiabu.2010.09.003; Felitti VJ, 1998, AM J PREV MED, V14, P245, DOI 10.1016/S0749-3797(98)00017-8; Fluke JD, 2008, CHILD MALTREATMENT, V13, P76, DOI 10.1177/1077559507311517; Kohl PL, 2009, CHILD MALTREATMENT, V14, P17, DOI 10.1177/1077559508326030; U. S. Department of Health and Human Services, 2013, ADM CHILDR FAM ADM C	6	11	11	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 5	2016	315	1					85	87		10.1001/jama.2015.12912	http://dx.doi.org/10.1001/jama.2015.12912			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DA0YH	26746463	Green Accepted, Bronze			2022-12-28	WOS:000367523000020
J	Fyfe, JWB; Watson, AJB				Fyfe, James W. B.; Watson, Allan J. B.			When two reactions become one	SCIENCE			English	Editorial Material									[Fyfe, James W. B.; Watson, Allan J. B.] Univ Strathclyde, Dept Pure & Appl Chem, WestCHEM, Glasgow G1 1XL, Lanark, Scotland	University of Strathclyde	Fyfe, JWB (corresponding author), Univ Strathclyde, Dept Pure & Appl Chem, WestCHEM, Glasgow G1 1XL, Lanark, Scotland.	allan.watson.100@strath.ac.uk		Fyfe, James William Buchanan/0000-0001-8501-9197	Engineering and Physical Sciences Research Council [1628052] Funding Source: researchfish	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Hall DG, 2011, BORONIC ACIDS, VOL 2: PREPARATION AND APPLICATIONS IN ORGANIC SYNTHESIS, MEDICINE AND MATERIALS, 2ND EDITION, P1, DOI 10.1002/9783527639328; Ishida N, 2009, ORG LETT, V11, P5434, DOI 10.1021/ol902278q; Lennox AJJ, 2013, ANGEW CHEM INT EDIT, V52, P7362, DOI 10.1002/anie.201301737; MIYAURA N, 1979, TETRAHEDRON LETT, V20, P3437, DOI 10.1016/S0040-4039(01)95429-2; Suzuki A, 2002, J ORGANOMET CHEM, V653, P83, DOI 10.1016/S0022-328X(02)01269-X; Thomas SP, 2009, CHEM REC, V9, P24, DOI 10.1002/tcr.20168; Zhang L, 2016, SCIENCE, V351, P70, DOI 10.1126/science.aad6080	7	0	0	0	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 1	2016	351	6268					26	27		10.1126/science.aad8698	http://dx.doi.org/10.1126/science.aad8698			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ8QM	26721989				2022-12-28	WOS:000367364200026
J	Sakimoto, KK; Wong, AB; Yang, PD				Sakimoto, Kelsey K.; Wong, Andrew Barnabas; Yang, Peidong			Self-photosensitization of nonphotosynthetic bacteria for solar-to-chemical production	SCIENCE			English	Article							CARBON-DIOXIDE; H-2 PRODUCTION; CADMIUM; FUELS; PRECIPITATION; CONVERSION; FIXATION; HYDROGEN; BIOMASS; HYBRIDS	Improving natural photosynthesis can enable the sustainable production of chemicals. However, neither purely artificial nor purely biological approaches seem poised to realize the potential of solar-to-chemical synthesis. We developed a hybrid approach, whereby we combined the highly efficient light harvesting of inorganic semiconductors with the high specificity, low cost, and self-replication and -repair of biocatalysts. We induced the self-photosensitization of a nonphotosynthetic bacterium, Moorella thermoacetica, with cadmium sulfide nanoparticles, enabling the photosynthesis of acetic acid from carbon dioxide. Biologically precipitated cadmium sulfide nanoparticles served as the light harvester to sustain cellular metabolism. This self-augmented biological system selectively produced acetic acid continuously over several days of light-dark cycles at relatively high quantum yields, demonstrating a self-replicating route toward solar-to-chemical carbon dioxide reduction.	[Sakimoto, Kelsey K.; Wong, Andrew Barnabas; Yang, Peidong] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Sakimoto, Kelsey K.; Wong, Andrew Barnabas; Yang, Peidong] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Mat Sci Div, Berkeley, CA 94720 USA; [Yang, Peidong] Univ Calif Berkeley, Dept Mat Sci & Engn, Berkeley, CA 94720 USA; [Yang, Peidong] Kavli Energy NanoSci Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Yang, PD (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	p_yang@berkeley.edu	Wong, Andrew/AAW-3799-2020; McCoy, Tina/P-3402-2019	Sakimoto, Kelsey/0000-0001-9636-7920; Wong, Andrew/0000-0002-0731-1931	U.S. Department of Energy [DE-AC02-05CH11231]; Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy [DE-AC02-05CH11231]; NSF [DMR-1507914]; NSF Graduate Research Fellowship Program [DGE-1106400]; Division Of Materials Research [1507914] Funding Source: National Science Foundation	U.S. Department of Energy(United States Department of Energy (DOE)); Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy(United States Department of Energy (DOE)); NSF(National Science Foundation (NSF)); NSF Graduate Research Fellowship Program(National Science Foundation (NSF)); Division Of Materials Research(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	The interface design part of this work was supported by the U.S. Department of Energy under contract no. DE-AC02-05CH11231 (PChem). Work at the Molecular Foundry was supported by the Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy under contract no. DE-AC02-05CH11231. Solar-to-chemical production experiments were supported by NSF (grant DMR-1507914). The authors thank J. J. Gallagher and M. C. Y. Chang for the original inoculum of M. thermoacetica ATCC 39073. K.K.S acknowledges support from the NSF Graduate Research Fellowship Program under grant DGE-1106400. The authors thank the National Center for Electron Microscopy. All data are available in the body of the paper or in the supplementary materials.	Appel AM, 2013, CHEM REV, V113, P6621, DOI 10.1021/cr300463y; Blankenship RE, 2011, SCIENCE, V332, P805, DOI 10.1126/science.1200165; Brown KA, 2012, J AM CHEM SOC, V134, P5627, DOI 10.1021/ja2116348; Cha HG, 2015, NAT CHEM, V7, P328, DOI [10.1038/NCHEM.2194, 10.1038/nchem.2194]; Crookes-Goodson WJ, 2008, CHEM SOC REV, V37, P2403, DOI 10.1039/b702825n; CUNNINGHAM DP, 1993, APPL ENVIRON MICROB, V59, P7, DOI 10.1128/AEM.59.1.7-14.1993; DANIEL SL, 1990, J BACTERIOL, V172, P4464, DOI 10.1128/jb.172.8.4464-4471.1990; Deutzmann JS, 2015, MBIO, V6, DOI 10.1128/mBio.00496-15; Drake HL, 2004, RES MICROBIOL, V155, P868, DOI 10.1016/j.resmic.2004.10.001; Ducat DC, 2012, CURR OPIN CHEM BIOL, V16, P337, DOI 10.1016/j.cbpa.2012.05.002; Dumas E, 2010, ENVIRON SCI TECHNOL, V44, P1464, DOI 10.1021/es902898d; Fast AG, 2012, CURR OPIN CHEM ENG, V1, P380, DOI 10.1016/j.coche.2012.07.005; Giraldo JP, 2014, NAT MATER, V13, P400, DOI [10.1038/NMAT3890, 10.1038/nmat3890]; Gronenberg LS, 2013, CURR OPIN CHEM BIOL, V17, P462, DOI 10.1016/j.cbpa.2013.03.037; Gust D, 2009, ACCOUNTS CHEM RES, V42, P1890, DOI 10.1021/ar900209b; Hankamer B, 2007, PHYSIOL PLANTARUM, V131, P10, DOI 10.1111/j.1399-3054.2007.00924.x; Hawkins AS, 2013, CURR OPIN BIOTECH, V24, P376, DOI 10.1016/j.copbio.2013.02.017; Holmes JD, 1995, PHOTOCHEM PHOTOBIOL, V62, P1022; Jensen HM, 2010, P NATL ACAD SCI USA, V107, P19213, DOI 10.1073/pnas.1009645107; King PW, 2013, BBA-BIOENERGETICS, V1827, P949, DOI 10.1016/j.bbabio.2013.03.006; Kita A, 2013, J BIOSCI BIOENG, V115, P347, DOI 10.1016/j.jbiosc.2012.10.013; Lapinsonniere L, 2012, CHEMSUSCHEM, V5, P995, DOI 10.1002/cssc.201100835; Larkum AWD, 2010, CURR OPIN BIOTECH, V21, P271, DOI 10.1016/j.copbio.2010.03.004; Liu BS, 2014, PHYS CHEM CHEM PHYS, V16, P8751, DOI 10.1039/c3cp55317e; Liu C, 2015, NANO LETT, V15, P3634, DOI 10.1021/acs.nanolett.5b01254; Logan BE, 2012, SCIENCE, V337, P686, DOI 10.1126/science.1217412; MEYER TJ, 1989, ACCOUNTS CHEM RES, V22, P163, DOI 10.1021/ar00161a001; Nevin KP, 2011, APPL ENVIRON MICROB, V77, P2882, DOI 10.1128/AEM.02642-10; Rosenbaum M, 2011, BIORESOURCE TECHNOL, V102, P324, DOI 10.1016/j.biortech.2010.07.008; Schuchmann K, 2014, NAT REV MICROBIOL, V12, P809, DOI 10.1038/nrmicro3365; Torella JP, 2015, P NATL ACAD SCI USA, V112, P2337, DOI 10.1073/pnas.1424872112; Van Eerten-Jansen MCAA, 2013, ACS SUSTAIN CHEM ENG, V1, P513, DOI 10.1021/sc300168z; VOGEL R, 1994, J PHYS CHEM-US, V98, P3183, DOI 10.1021/j100063a022; Wang CL, 2001, APPL MICROBIOL BIOT, V56, P425, DOI 10.1007/s002530100660	34	571	611	130	1195	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 1	2016	351	6268					74	77		10.1126/science.aad3317	http://dx.doi.org/10.1126/science.aad3317			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ8QM	26721997	Green Submitted			2022-12-28	WOS:000367364200045
J	Popova, S; Lange, S; Shield, K; Mihic, A; Chudley, AE; Mukherjee, RAS; Bekmuradov, D; Rehm, J				Popova, Svetlana; Lange, Shannon; Shield, Kevin; Mihic, Alanna; Chudley, Albert E.; Mukherjee, Raja A. S.; Bekmuradov, Dennis; Rehm, Jurgen			Comorbidity of fetal alcohol spectrum disorder: a systematic review and meta-analysis	LANCET			English	Article							NATIONAL EPIDEMIOLOGIC SURVEY; PRENATAL ALCOHOL; CANADIAN GUIDELINES; HIGH PREVALENCE; UNITED-STATES; CHILDREN; EXPOSURE; MANIFESTATIONS; IMPAIRMENT; DISABILITY	Background Fetal alcohol spectrum disorder (FASD) is related to many comorbidities because of the permanent effects of prenatal alcohol exposure on the fetus. We aimed to identify the comorbid conditions that co-occur in individuals with FASD and estimate the pooled prevalence of comorbid conditions occurring in individuals with fetal alcohol syndrome (FAS). Methods We did a systematic literature search of studies reporting on the comorbidity and cause of death in individuals with FASD using multiple electronic bibliographic databases, searching for studies published up to July, 2012. We included original research published in a peer-reviewed journal in the English language. We used the following criteria for determining study quality: use of an established FASD diagnostic guideline, study setting, method of data collection, and sample size. All comorbid disease conditions were coded according to the International Classification of Diseases, tenth revision (ICD-10). To estimate the pooled prevalence of comorbid conditions found to co-occur in individuals with FAS, we did meta-analyses assuming a random-effects model. Findings Of 5068 studies found, 127 met eligibility criteria for data extraction. From those studies, we identified 428 comorbid conditions co-occurring in individuals with FASD, spanning across 18 of 22 chapters of the ICD-10. The most prevalent disease conditions were within the sections of congenital malformations, deformities, and chromosomal abnormalities, and mental and behavioural disorders. 33 studies reported data for frequency in a total of 1728 participants with FAS. The five comorbid conditions with the highest pooled prevalence (between 50% and 91%) included abnormal results of function studies of peripheral nervous system and special senses, conduct disorder, receptive language disorder, chronic serous otitis media, and expressive language disorder. Interpretation The high prevalence of comorbid conditions in individuals with FASD highlights the importance of assessing prenatal alcohol exposure as a substantial clinical risk factor for comorbidity. The harmful effects of alcohol on a developing fetus represent many cases of preventable disability, and thus, alcohol use during pregnancy should be recognised as a public health problem globally.	[Popova, Svetlana; Lange, Shannon; Shield, Kevin; Rehm, Jurgen] Ctr Addict & Mental Hlth, Social & Epidemiol Res Dept, Toronto, ON M5S 2S1, Canada; [Popova, Svetlana; Mihic, Alanna; Rehm, Jurgen] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Popova, Svetlana] Univ Toronto, Factor Inwentash Fac Social Work, Toronto, ON, Canada; [Popova, Svetlana; Lange, Shannon; Shield, Kevin; Rehm, Jurgen] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Chudley, Albert E.] Univ Manitoba, Program Genet & Metab, Childrens Hosp, Dept Pediat & Child Hlth, Winnipeg, MB, Canada; [Chudley, Albert E.] Univ Manitoba, Dept Biochem & Med Genet, Winnipeg, MB, Canada; [Mukherjee, Raja A. S.] Surrey & Borders Partnership NHS Fdn Trust, Specialist Behav Clin, Oxted, Surrey, England; [Bekmuradov, Dennis] Ryerson Univ, Sch Occupat & Publ Hlth, Toronto, ON, Canada; [Rehm, Jurgen] Tech Univ Dresden, Epidemiol Res Unit, Klin Psychol & Psychotherapie, D-01062 Dresden, Germany	University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto; University of Toronto; University of Toronto; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Manitoba; Toronto Metropolitan University; Technische Universitat Dresden	Popova, S (corresponding author), Ctr Addict & Mental Hlth, 33 Russell St, Toronto, ON M5S 2S1, Canada.	lana.popova@camh.ca	Shield, Kevin/AAR-8220-2020	Mukherjee, Raja/0000-0002-2171-928X; Shield, Kevin/0000-0003-1871-8849	Public Health Agency of Canada	Public Health Agency of Canada	Public Health Agency of Canada.	Amendah DD, 2011, NEUROTOXICOL TERATOL, V33, P322, DOI 10.1016/j.ntt.2010.10.008; [Anonymous], TITLE ERROR; Astley SJ, 2004, PAEDIATR PERINAT EP, V18, P344, DOI 10.1111/j.1365-3016.2004.00582.x; BEATTIE JO, 1983, BMJ-BRIT MED J, V287, P17, DOI 10.1136/bmj.287.6384.17; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bell SH, 2010, ALCOHOL CLIN EXP RES, V34, P1084, DOI 10.1111/j.1530-0277.2010.01184.x; Bertrand J., 2004, FETAL ALCOHOL SYNDRO; Bluestone CD, 1998, INT J PEDIATR OTORHI, V42, P207, DOI 10.1016/S0165-5876(97)00147-X; Boyle CA, 2011, PEDIATRICS, V127, P1034, DOI 10.1542/peds.2010-2989; Burd L, 2003, NEUROTOXICOL TERATOL, V25, P697, DOI 10.1016/j.ntt.2003.07.014; BURD L, 1989, PHYSIOL BEHAV, V46, P39, DOI 10.1016/0031-9384(89)90318-1; Burd L, 1999, ADDICT BIOL, V4, P329, DOI 10.1080/13556219971542; Burd L, 2008, BIRTH DEFECTS RES A, V82, P217, DOI 10.1002/bdra.20445; Centers for Disease Control and Prevention (CDC), 1995, MMWR Morb Mortal Wkly Rep, V44, P249; Chudley AE, 2005, CAN MED ASSOC J, V172, pS1, DOI 10.1503/cmaj.1040302; Chudley AE, 2010, MANAGEMENT GENETIC S, P363; Chudley AE, 2008, ARCH DIS CHILD, V93, P721, DOI 10.1136/adc.2008.137109; Church MW, 1997, ALCOHOL CLIN EXP RES, V21, P227, DOI 10.1111/j.1530-0277.1997.tb03754.x; CLARREN SK, 1978, NEW ENGL J MED, V298, P1063, DOI 10.1056/NEJM197805112981906; Clarren SK, 2011, J POPUL THER CLIN PH, V18, pE494; COCHRAN WG, 1954, BIOMETRICS, V10, P101, DOI 10.2307/3001666; Compton WM, 2007, ARCH GEN PSYCHIAT, V64, P566, DOI 10.1001/archpsyc.64.5.566; Congdon N, 2004, ARCH OPHTHALMOL-CHIC, V122, P477; Crede S, 2011, DRUG ALCOHOL DEPEN, V115, P175, DOI 10.1016/j.drugalcdep.2010.10.019; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egeland GM, 1998, AM J PUBLIC HEALTH, V88, P781, DOI 10.2105/AJPH.88.5.781; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Elgen I, 2007, ACTA PAEDIATR, V96, P237, DOI 10.1111/j.1651-2227.2007.00026.x; Famy C, 1998, AM J PSYCHIAT, V155, P552, DOI 10.1176/ajp.155.4.552; FREEMAN MF, 1950, ANN MATH STAT, V21, P607, DOI 10.1214/aoms/1177729756; Goodlett CR, 2005, EXP BIOL MED, V230, P394, DOI 10.1177/15353702-0323006-07; Habbick BF, 1997, CAN J PUBLIC HEALTH, V88, P181, DOI 10.1007/BF03403884; Habbick BF, 1996, CAN J PUBLIC HEALTH, V87, P204; HALLIDAY HL, 1982, BRIT J OBSTET GYNAEC, V89, P892, DOI 10.1111/j.1471-0528.1982.tb05052.x; HANSON JW, 1976, JAMA-J AM MED ASSOC, V235, P1458, DOI 10.1001/jama.235.14.1458; Hasin DS, 2007, ARCH GEN PSYCHIAT, V64, P830, DOI 10.1001/archpsyc.64.7.830; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hoyme HE, 2005, PEDIATRICS, V115, P39, DOI 10.1542/peds.2004-0259; Hug TE, 2000, J AAPOS, V4, P200, DOI 10.1067/mpa.2000.105278; Jones KL, 2010, AM J MED GENET A, V152A, P2731, DOI 10.1002/ajmg.a.33675; Kalberg WO, 2006, ALCOHOL CLIN EXP RES, V30, P2037, DOI 10.1111/j.1530-0277.2006.00250.x; Kvigne VL, 2004, J PEDIATR-US, V145, P635, DOI 10.1016/j.jpeds.2004.07.015; Landgren M, 2010, PEDIATRICS, V125, pE1178, DOI 10.1542/peds.2009-0712; Lange S, 2013, PEDIATRICS, V132, pE980, DOI 10.1542/peds.2013-0066; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Lim SS, 2013, LANCET, V381, P628; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; LOSER H, 1977, BRIT HEART J, V39, P1374; MAJEWSKI F, 1978, NERVENARZT, V49, P410; Majewski F., 1986, DER KINDERARZT, V8, P1127; Martin Joyce A, 2013, Natl Vital Stat Rep, V62, P1; May PA, 2001, ALCOHOL RES HEALTH, V25, P159; May PA, 2007, DRUG ALCOHOL DEPEN, V88, P259, DOI 10.1016/j.drugalcdep.2006.11.007; May PA, 2011, INT J ENV RES PUB HE, V8, P2331, DOI 10.3390/ijerph8062331; May PA, 2009, DEV DISABIL RES REV, V15, P176, DOI 10.1002/ddrr.68; Nock MK, 2006, PSYCHOL MED, V36, P699, DOI 10.1017/S0033291706007082; [Пальчик Александр Бейнусович Palchik А.B.], 2011, [Обозрение психиатрии и медицинской психологии им. В.М. Бехтерева, Obozrenie psikhiatrii i meditsinskoi psikhologii im. V.M. Bekhtereva], P17; Petkovic G, 2010, REPROD TOXICOL, V29, P237, DOI 10.1016/j.reprotox.2009.11.006; Popova S, 2010, 1 EUR C FASD GROW AW; Popova S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060434; Popova S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-570; Popova S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043024; Popova S, 2011, ALCOHOL ALCOHOLISM, V46, P490, DOI 10.1093/alcalc/agr029; Public Health Agency of Canada (PHAC), 2003, FETAL ALCOHOL SPECTR; Ribeiro IM, 2007, EUR J OPHTHALMOL, V17, P104, DOI 10.1177/112067210701700114; Roberts G, 2000, BEST PRACTICES FETAL; ROBINSON GC, 1987, CAN MED ASSOC J, V137, P203; ROSETT HL, 1980, ALCOHOL CLIN EXP RES, V4, P119, DOI 10.1111/j.1530-0277.1980.tb05626.x; ROSSIG C, 1994, NEUROPEDIATRICS, V25, P245, DOI 10.1055/s-2008-1073029; Rutter M, 2009, INT J EPIDEMIOL, V38, P3, DOI 10.1093/ije/dyn253; Sampson PD, 1997, TERATOLOGY, V56, P317, DOI 10.1002/(SICI)1096-9926(199711)56:5<317::AID-TERA5>3.0.CO;2-U; SANDOR GGS, 1981, J PEDIATR-US, V98, P771, DOI 10.1016/S0022-3476(81)80842-6; SMITH DF, 1981, NEUROBEH TOXICOL TER, V3, P145; SOKOL RJ, 1989, ALCOHOL CLIN EXP RES, V13, P597, DOI 10.1111/j.1530-0277.1989.tb00384.x; SPOHR HL, 1993, LANCET, V341, P907, DOI 10.1016/0140-6736(93)91207-3; STEINHAUSEN HC, 1982, J DEV BEHAV PEDIATR, V3, P49, DOI 10.1097/00004703-198206000-00001; Stratton K., 1996, FETAL ALCOHOL SYNDRO; Streissguth AP, 1996, UNDERSTANDING THE OC; Stromland K, 1996, PEDIATRICS, V97, P845; Stromland K, 1996, ACTA PAEDIATR, V85, P1463, DOI 10.1111/j.1651-2227.1996.tb13953.x; Swayze VW, 1997, PEDIATRICS, V99, P232, DOI 10.1542/peds.99.2.232; Tomblin JB, 1997, J SPEECH LANG HEAR R, V40, P1245, DOI 10.1044/jslhr.4006.1245; TREDWELL SJ, 1982, SPINE, V7, P331, DOI 10.1097/00007632-198207000-00002; Urban M, 2008, SAMJ S AFR MED J, V98, P877; Viljoen DL, 2005, J STUD ALCOHOL, V66, P593, DOI 10.15288/jsa.2005.66.593; *WHO, 1978, INT CLASS DIS; World Health Organization, 2007, INT CLASS DIS REL HL; World Health Organization, 2021, LANCET	89	234	236	3	80	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 5	2016	387	10022					978	987		10.1016/S0140-6736(15)01345-8	http://dx.doi.org/10.1016/S0140-6736(15)01345-8			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DF8XP	26777270				2022-12-28	WOS:000371644200031
J	Bernecky, C; Herzog, F; Baumeister, W; Plitzko, JM; Cramer, P				Bernecky, Carrie; Herzog, Franz; Baumeister, Wolfgang; Plitzko, Juergen M.; Cramer, Patrick			Structure of transcribing mammalian RNA polymerase II	NATURE			English	Article							TRANSCRIPTION ELONGATION; CRYSTAL-STRUCTURE; ATOMIC-STRUCTURE; COMPLEX; ARCHITECTURE; RESOLUTION; PROTEIN; DNA; INITIATION; SYSTEM	RNA polymerase (Pol) II produces messenger RNA during transcription of protein-coding genes in all eukaryotic cells. The Pol II structure is known at high resolution from X-ray crystallography for two yeast species(1-3). Structural studies of mammalian Pol II, however, remain limited to low-resolution electron microscopy analysis of human Pol II and its complexes with various proteins(4-10). Here we report the 3.4 angstrom resolution cryo-electron microscopy structure of mammalian Pol II in the form of a transcribing complex comprising DNA template and RNA transcript. We use bovine Pol II, which is identical to the human enzyme except for seven amino-acid residues. The obtained atomic model closely resembles its yeast counterpart, but also reveals unknown features. Binding of nucleic acids to the polymerase involves 'induced fit' of the mobile Pol II clamp and active centre region. DNA downstream of the transcription bubble contacts a conserved 'TPSA motif' in the jaw domain of the Pol II subunit RPB5, an interaction that is apparently already established during transcription initiation(7). Upstream DNA emanates from the active centre cleft at an angle of approximately 105 degrees with respect to downstream DNA. This position of upstream DNA allows for binding of the general transcription elongation factor DSIF (SPT4-SPT5) that we localize over the active centre cleft in a conserved position on the clamp domain of Pol II. Our results define the structure of mammalian Pol II in its functional state, indicate that previous crystallographic analysis of yeast Pol II is relevant for understanding gene transcription in all eukaryotes, and provide a starting point for a mechanistic analysis of human transcription.	[Bernecky, Carrie; Cramer, Patrick] Max Planck Inst Biophys Chem, Dept Mol Biol, Fassberg 11, D-37077 Gottingen, Germany; [Herzog, Franz] Univ Munich, Gene Ctr Munich, Feodor Lynen Str 25, D-81377 Munich, Germany; [Baumeister, Wolfgang; Plitzko, Juergen M.] Max Planck Inst Biochem, Dept Mol Struct Biol, Klopferspitz 18, D-82152 Martinsried, Germany	Max Planck Society; University of Munich; Max Planck Society	Cramer, P (corresponding author), Max Planck Inst Biophys Chem, Dept Mol Biol, Fassberg 11, D-37077 Gottingen, Germany.	pcramer@mpibpc.mpg.de	Plitzko, Juergen M/H-9576-2014; Herzog, Franz/G-4832-2012	Plitzko, Juergen M/0000-0002-6402-8315; Herzog, Franz/0000-0001-8270-1449; Bernecky, Carrie/0000-0003-0893-7036	Alexander von Humboldt Foundation; Deutsche Forschungsgemeinschaft [SFB860]; European Research Council; Volkswagen Foundation	Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Research Council(European Research Council (ERC)European Commission); Volkswagen Foundation(Volkswagen)	We thank E. Wolf for providing bovine thymus. We thank D. Pollmann for preparation of human DSIF, and M. Hemann for generation of peptides for mass spectrometry. We thank J. Schuller and C. Plaschka for assistance with EM data collection. We thank D. Tegunov and C. Plaschka for discussions about EM data processing. We thank D. Haselbach and W. Liu for assistance with cryo-EM grid preparation. We thank O. Berninghausen for providing access to a Tecnai Spirit microscope. C.B. was supported by the Alexander von Humboldt Foundation. P.C. was supported by the Deutsche Forschungsgemeinschaft (SFB860), the Advanced Grant 'TRANSIT' of the European Research Council, and the Volkswagen Foundation.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andrecka J, 2009, NUCLEIC ACIDS RES, V37, P5803, DOI 10.1093/nar/gkp601; Armache KJ, 2003, P NATL ACAD SCI USA, V100, P6964, DOI 10.1073/pnas.1030608100; Bai XC, 2015, NATURE, V525, P212, DOI 10.1038/nature14892; Barnes CO, 2015, MOL CELL, V59, P258, DOI 10.1016/j.molcel.2015.06.034; Belogurov GA, 2010, MOL MICROBIOL, V76, P286, DOI 10.1111/j.1365-2958.2010.07056.x; Bernecky C, 2012, J MOL BIOL, V417, P387, DOI 10.1016/j.jmb.2012.02.014; Bernecky C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000603; Brueckner F, 2008, NAT STRUCT MOL BIOL, V15, P811, DOI 10.1038/nsmb.1458; Brueckner F, 2007, SCIENCE, V315, P859, DOI 10.1126/science.1135400; Bushnell DA, 2003, P NATL ACAD SCI USA, V100, P6969, DOI 10.1073/pnas.1130601100; Cardone G, 2013, J STRUCT BIOL, V184, P226, DOI 10.1016/j.jsb.2013.08.002; Chang LF, 2015, NATURE, V522, P450, DOI 10.1038/nature14471; Chen SX, 2013, ULTRAMICROSCOPY, V135, P24, DOI 10.1016/j.ultramic.2013.06.004; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cheng B, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn630; Cheung ACM, 2011, NATURE, V471, P249, DOI 10.1038/nature09785; Cramer P, 2000, SCIENCE, V288, P640, DOI 10.1126/science.288.5466.640; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fishburn J, 2015, P NATL ACAD SCI USA, V112, P3961, DOI 10.1073/pnas.1417709112; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; He Y, 2013, NATURE, V495, P481, DOI 10.1038/nature11991; Herzog F, 2012, SCIENCE, V337, P1348, DOI 10.1126/science.1221483; Hirtreiter A, 2010, NUCLEIC ACIDS RES, V38, P4040, DOI 10.1093/nar/gkq135; Hu X, 2006, P NATL ACAD SCI USA, V103, P9506, DOI 10.1073/pnas.0603702103; Kassube SA, 2013, J MOL BIOL, V425, P3639, DOI 10.1016/j.jmb.2012.08.024; Kassube SA, 2013, NAT STRUCT MOL BIOL, V20, P892, DOI 10.1038/nsmb.2596; Kettenberger H, 2004, MOL CELL, V16, P955, DOI 10.1016/j.molcel.2004.11.040; Korinek A, 2011, J STRUCT BIOL, V175, P394, DOI 10.1016/j.jsb.2011.06.003; Kostek SA, 2006, STRUCTURE, V14, P1691, DOI 10.1016/j.str.2006.09.011; Li WT, 2014, NUCLEIC ACIDS RES, V42, P7069, DOI 10.1093/nar/gku333; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Liang B, 2015, CELL, V162, P314, DOI 10.1016/j.cell.2015.06.018; Martinez-Rucobo FW, 2015, MOL CELL, V58, P1079, DOI 10.1016/j.molcel.2015.04.004; Martinez-Rucobo FW, 2013, BBA-GENE REGUL MECH, V1829, P9, DOI 10.1016/j.bbagrm.2012.09.002; Martinez-Rucobo FW, 2011, EMBO J, V30, P1302, DOI 10.1038/emboj.2011.64; Meka H, 2005, NUCLEIC ACIDS RES, V33, P6435, DOI 10.1093/nar/gki945; Missra A, 2010, P NATL ACAD SCI USA, V107, P11301, DOI 10.1073/pnas.1000681107; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Plaschka C, 2015, NATURE, V518, P376, DOI 10.1038/nature14229; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Sainsbury S, 2013, NATURE, V493, P437, DOI 10.1038/nature11715; Scheres SHW, 2015, J STRUCT BIOL, V189, P114, DOI 10.1016/j.jsb.2014.11.010; Scheres SHW, 2014, ELIFE, V3, DOI 10.7554/eLife.03665; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Scheres SHW, 2012, NAT METHODS, V9, P853, DOI 10.1038/nmeth.2115; Sevostyanova A, 2010, NUCLEIC ACIDS RES, V38, P7432, DOI 10.1093/nar/gkq623; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Spahr H, 2009, P NATL ACAD SCI USA, V106, P9185, DOI 10.1073/pnas.0903361106; Stein N, 2008, J APPL CRYSTALLOGR, V41, P641, DOI 10.1107/S0021889808006985; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Urnavicius L, 2015, SCIENCE, V347, P1441, DOI 10.1126/science.aaa4080; Wang D, 2006, CELL, V127, P941, DOI 10.1016/j.cell.2006.11.023; Wenzel S, 2010, BIOCHEM J, V425, P373, DOI 10.1042/BJ20091422; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wu YM, 2012, EMBO J, V31, P3575, DOI 10.1038/emboj.2012.205	59	130	132	2	51	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 28	2016	529	7587					551	+		10.1038/nature16482	http://dx.doi.org/10.1038/nature16482			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB7DD	26789250				2022-12-28	WOS:000368673800042
J	Hosten, O; Engelsen, NJ; Krishnakumar, R; Kasevich, MA				Hosten, Onur; Engelsen, Nils J.; Krishnakumar, Rajiv; Kasevich, Mark A.			Measurement noise 100 times lower than the quantum-projection limit using entangled atoms	NATURE			English	Article							INTERFEROMETRY; STATES	Quantum metrology uses quantum entanglement-correlations in the properties of microscopic systems-to improve the statistical precision of physical measurements(1). When measuring a signal, such as the phase shift of a light beam or an atomic state, a prominent limitation to achievable precision arises from the noise associated with the counting of uncorrelated probe particles. This noise, commonly referred to as shot noise or projection noise, gives rise to the standard quantum limit (SQL) to phase resolution. However, it can be mitigated down to the fundamental Heisenberg limit by entangling the probe particles. Despite considerable experimental progress in a variety of physical systems, a question that persists is whether these methods can achieve performance levels that compare favourably with optimized conventional (non-entangled) systems. Here we demonstrate an approach that achieves unprecedented levels of metrological improvement using half a million Rb-87 atoms in their 'clock' states. The ensemble is 20.1 +/- 0.3 decibels (100-fold) spin-squeezed via an optical-cavity-based measurement. We directly resolve small microwave-induced rotations 18.5 +/- 0.3 decibels (70-fold) beyond the SQL. The single-shot phase resolution of 147 microradians achieved by the apparatus is better than that achieved by the best engineered cold atom sensors despite lower atom numbers(2,3). We infer entanglement of more than 680 +/- 35 particles in the atomic ensemble. Applications include atomic clocks(4), inertial sensors(5), and fundamental physics experiments such as tests of general relativity(6) or searches for electron electric dipole moment(7). To this end, we demonstrate an atomic clock measurement with a quantum enhancement of 10.5 +/- 0.3 decibels (11-fold), limited by the phase noise of our microwave source.	[Hosten, Onur; Engelsen, Nils J.; Krishnakumar, Rajiv; Kasevich, Mark A.] Stanford Univ, Dept Phys, Stanford, CA 94305 USA	Stanford University	Kasevich, MA (corresponding author), Stanford Univ, Dept Phys, Stanford, CA 94305 USA.	kasevich@stanford.edu	Engelsen, Nils Johan/L-5865-2017; Compans, Richard W/I-4087-2013	Engelsen, Nils Johan/0000-0001-8044-4629; Compans, Richard W/0000-0003-2360-335X	DTRA; NSSEFF fellowship; ONR	DTRA(United States Department of DefenseDefense Threat Reduction Agency); NSSEFF fellowship; ONR(Office of Naval Research)	We thank I. Teper, G. Vrijsen and J. Lee for technical contributions to the experiment. This work was support by DTRA, an NSSEFF fellowship and the ONR.	Abadie J, 2011, NAT PHYS, V7, P962, DOI [10.1038/NPHYS2083, 10.1038/nphys2083]; Appel J, 2009, P NATL ACAD SCI USA, V106, P10960, DOI 10.1073/pnas.0901550106; Biedermann GW, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.170802; Bloom BJ, 2014, NATURE, V506, P71, DOI 10.1038/nature12941; Bohnet JG, 2014, NAT PHOTONICS, V8, P731, DOI [10.1038/nphoton.2014.151, 10.1038/NPHOTON.2014.151]; Borregaard J, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.090801; Chen J., 2003, B AM PHYS SOC, VAPR03; Chen ZL, 2014, PHYS REV A, V89, DOI 10.1103/PhysRevA.89.043837; Eberle T, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.251102; Eichler C, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.110502; Gaaloul N, 2010, ACTA ASTRONAUT, V67, P1059, DOI 10.1016/j.actaastro.2010.06.043; Geiger R, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1479; Giovannetti V, 2004, SCIENCE, V306, P1330, DOI 10.1126/science.1104149; Gross C, 2010, NATURE, V464, P1165, DOI 10.1038/nature08919; Guena J, 2014, METROLOGIA, V51, P108, DOI 10.1088/0026-1394/51/1/108; Hamley CD, 2012, NAT PHYS, V8, P305, DOI [10.1038/nphys2245, 10.1038/NPHYS2245]; KITAGAWA M, 1993, PHYS REV A, V47, P5138, DOI 10.1103/PhysRevA.47.5138; Lee J, 2014, OPT LETT, V39, P4005, DOI 10.1364/OL.39.004005; Leroux ID, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.250801; Leroux ID, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.073602; Lucke B, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.155304; Muessel W, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.103004; Riedel MF, 2010, NATURE, V464, P1170, DOI 10.1038/nature08988; Rocco E, 2014, NEW J PHYS, V16, DOI 10.1088/1367-2630/16/9/093046; Schleier-Smith MH, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.073604; Sewell RJ, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.253605; Sorensen AS, 2001, PHYS REV LETT, V86, P4431, DOI 10.1103/PhysRevLett.86.4431; Takano T, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.033601; Taylor MA, 2013, NAT PHOTONICS, V7, P229, DOI [10.1038/nphoton.2012.346, 10.1038/NPHOTON.2012.346]; WINELAND DJ, 1994, PHYS REV A, V50, P67, DOI 10.1103/PhysRevA.50.67	30	274	278	4	130	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 28	2016	529	7587					505	+		10.1038/nature16176	http://dx.doi.org/10.1038/nature16176			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB7DD	26751056				2022-12-28	WOS:000368673800032
J	Burkett, JP; Andari, E; Johnson, ZV; Curry, DC; de Waal, FBM; Young, LJ				Burkett, J. P.; Andari, E.; Johnson, Z. V.; Curry, D. C.; de Waal, F. B. M.; Young, L. J.			Oxytocin-dependent consolation behavior in rodents	SCIENCE			English	Article							SOCIAL-BEHAVIOR; EMPATHY; PAIN; RECONCILIATION; AFFILIATION; ALTRUISM; STRESS	Consolation behavior toward distressed others is common in humans and great apes, yet our ability to explore the biological mechanisms underlying this behavior is limited by its apparent absence in laboratory animals. Here, we provide empirical evidence that a rodent species, the highly social and monogamous prairie vole (Microtus ochrogaster), greatly increases partner-directed grooming toward familiar conspecifics (but not strangers) that have experienced an unobserved stressor, providing social buffering. Prairie voles also match the fear response, anxiety-related behaviors, and corticosterone increase of the stressed cagemate, suggesting an empathy mechanism. Exposure to the stressed cagemate increases activity in the anterior cingulate cortex, and oxytocin receptor antagonist infused into this region abolishes the partner-directed response, showing conserved neural mechanisms between prairie vole and human.	[Burkett, J. P.; Andari, E.; Johnson, Z. V.; Young, L. J.] Emory Univ, Atlanta, GA 30322 USA; [Burkett, J. P.; Andari, E.; Johnson, Z. V.; Curry, D. C.; de Waal, F. B. M.; Young, L. J.] Emory Univ, Ctr Translat Social Neurosci, Atlanta, GA USA; [Burkett, J. P.; Andari, E.; Johnson, Z. V.; Curry, D. C.; de Waal, F. B. M.; Young, L. J.] Emory Univ, Yerkes Natl Primate Res Ctr, Atlanta, GA USA; [de Waal, F. B. M.] Univ Utrecht, Utrecht, Netherlands; [Young, L. J.] Emory Univ, Dept Psychiat, Atlanta, GA USA	Emory University; Emory University; Emory University; Utrecht University; Emory University	Burkett, JP (corresponding author), Emory Univ, Atlanta, GA 30322 USA.	jpburke@emory.edu; lyoun03@emory.edu	Andari, Elissar/M-4717-2019; Young, Larry/HGE-5031-2022; Gomila, Antoni/I-1342-2012; Burkett, James/GLU-4290-2022	Burkett, James/0000-0002-6357-5499; Andari, Elissar/0000-0002-9745-2745; Curry, Daniel/0000-0002-4418-8119	National Institutes of Health [1P50MH100023, R01MH096983]; NIH [NIGMS T32GM08605-10, F31 MH102911-01, OD P51OD011132]; Emory University (Emory Neuroscience Initiative Scholars Program in Interdisciplinary Neuroscience Research); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008605] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH100023, F31MH102911, R01MH096983] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS096050] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011132] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Emory University (Emory Neuroscience Initiative Scholars Program in Interdisciplinary Neuroscience Research); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by grants from the National Institutes of Health (1P50MH100023 and R01MH096983) to L.J.Y. and by predoctoral fellowships from the NIH (NIGMS T32GM08605-10, F31 MH102911-01) and Emory University (Emory Neuroscience Initiative Scholars Program in Interdisciplinary Neuroscience Research) to J.P.B. Additional support was provided by a grant from the NIH (OD P51OD011132) to Yerkes National Primate Research Center. We gratefully acknowledge colony management by L. Mathews, cage design and assembly by G. Feldpausch, and assistance from F. Haddad, L. Hearn, L. S. Jones, K. Kittelberger, R. C. Pearcy, M. Reyes, and M. Carr-Reynolds.	Andari E, 2010, P NATL ACAD SCI USA, V107, P4389, DOI 10.1073/pnas.0910249107; Bartal IBA, 2011, SCIENCE, V334, P1427, DOI 10.1126/science.1210789; Batson CD, 2009, SOCIAL NEUROSCIENCE OF EMPATHY, P3; Berridge KC, 2015, NEURON, V86, P646, DOI 10.1016/j.neuron.2015.02.018; Buchanan TW, 2012, SOC NEUROSCI-UK, V7, P191, DOI 10.1080/17470919.2011.588723; Chen QL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004387; CHURCH RM, 1959, J COMP PHYSIOL PSYCH, V52, P132, DOI 10.1037/h0043531; Clay Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055206; Cools AKA, 2008, ETHOLOGY, V114, P53, DOI 10.1111/j.1439-0310.2007.01443.x; de Waal F. B. M., 1996, REACHING THOUGHT MIN; de Waal FBM, 2008, ANNU REV PSYCHOL, V59, P279, DOI 10.1146/annurev.psych.59.103006.093625; DEWAAL FBM, 1979, BEHAV ECOL SOCIOBIOL, V5, P55, DOI 10.1007/BF00302695; Domes G, 2007, BIOL PSYCHIAT, V61, P731, DOI 10.1016/j.biopsych.2006.07.015; Fraser ON, 2008, P NATL ACAD SCI USA, V105, P8557, DOI 10.1073/pnas.0804141105; Fraser ON, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010605; GETZ LL, 1972, J MAMMAL, V53, P310, DOI 10.2307/1379167; GETZ LL, 1993, J MAMMAL, V74, P44, DOI 10.2307/1381904; Hurlemann R, 2010, J NEUROSCI, V30, P4999, DOI 10.1523/JNEUROSCI.5538-09.2010; Jeon D, 2010, NAT NEUROSCI, V13, P482, DOI 10.1038/nn.2504; Kikusui T, 2006, PHILOS T R SOC B, V361, P2215, DOI 10.1098/rstb.2006.1941; Kim EJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015077; Lamm C, 2011, NEUROIMAGE, V54, P2492, DOI 10.1016/j.neuroimage.2010.10.014; Langford DJ, 2006, SCIENCE, V312, P1967, DOI 10.1126/science.1128322; Numan M, 2016, HORM BEHAV, V77, P98, DOI 10.1016/j.yhbeh.2015.05.015; Nunes S., 2007, RODENT SOC ECOLOGICA; Palagi E, 2014, PEERJ, V2, DOI 10.7717/peerj.519; Palagi E, 2009, ANIM BEHAV, V78, P979, DOI 10.1016/j.anbehav.2009.07.017; Plotnik JM, 2014, PEERJ, V2, DOI 10.7717/peerj.278; Preston SD, 2002, BEHAV BRAIN SCI, V25, P1, DOI 10.1017/S0140525X02000018; Preston SD, 2013, PSYCHOL BULL, V139, P1305, DOI 10.1037/a0031755; RICE GE, 1962, J COMP PHYSIOL PSYCH, V55, P123, DOI 10.1037/h0042276; Romero T, 2010, P NATL ACAD SCI USA, V107, P12110, DOI 10.1073/pnas.1006991107; Sanders J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074609; Schino G, 2004, J COMP PSYCHOL, V118, P340, DOI 10.1037/0735-7036.118.3.340; Seed AM, 2007, CURR BIOL, V17, P152, DOI 10.1016/j.cub.2006.11.025; Smith AS, 2014, BIOL PSYCHIAT, V76, P281, DOI 10.1016/j.biopsych.2013.09.017; WATANABE S, 1986, BEHAV PROCESS, V13, P269, DOI 10.1016/0376-6357(86)90089-6; ZAHNWAXLER C, 1992, DEV PSYCHOL, V28, P126, DOI 10.1037/0012-1649.28.1.126	38	303	309	7	183	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 22	2016	351	6271					375	378		10.1126/science.aac4785	http://dx.doi.org/10.1126/science.aac4785			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB3VH	26798013	Green Accepted			2022-12-28	WOS:000368440500038
J	Isasi, R; Kleiderman, E; Knoppers, BM				Isasi, R.; Kleiderman, E.; Knoppers, B. M.			Editing policy to fit the genome? Framing genome editing policy requires setting thresholds of acceptability	SCIENCE			English	Editorial Material									[Isasi, R.] Univ Miami, Dr John T MacDonald Fdn, Dept Human Genet, Miami, FL 33136 USA; [Isasi, R.; Kleiderman, E.; Knoppers, B. M.] McGill Univ, Ctr Genom & Policy, Dept Human Genet, Fac Med, Montreal, PQ H3A 1A4, Canada	University of Miami; McGill University	Isasi, R (corresponding author), Univ Miami, Dr John T MacDonald Fdn, Dept Human Genet, Miami, FL 33136 USA.	rosario.isasi@icloud.com						Baltimore D, 2015, SCIENCE, V348, P36, DOI 10.1126/science.aab1028; Bioethics Advisory Committee of Singapore, 2015, ETH GUID HUM BIOM RE; Caplan AL, 2015, EMBO REP, V16, P1421, DOI 10.15252/embr.201541337; Cressey D., 2015, NATURE, DOI [10.1038/nature.2015.18394, DOI 10.1038/NATURE.2015.18394]; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Isasi RM, 2006, EUR J HEALTH LAW, V13, P9, DOI 10.1163/157180906777036328; Isasi RM, 2006, HUM REPROD, V21, P2474, DOI 10.1093/humrep/del235; Knoppers BM, 2006, ANNU REV GENOM HUM G, V7, P201, DOI 10.1146/annurev.genom.7.080505.115753; Knoppers BM, 2004, HUM REPROD, V19, P2695, DOI 10.1093/humrep/deh505; LaFountaine JS, 2015, INT J PHARMACEUT, V494, P180, DOI 10.1016/j.ijpharm.2015.08.029; Lanphier E, 2015, NATURE, V519, P410, DOI 10.1038/519410a; Organizing Committee for the International Summit on Human Gene Editing, 2015, ORG COMM INT SUMM HU; Sugarman J, 2015, EMBO REP, V16, P879, DOI 10.15252/embr.201540879; The Hinxton Group, 2015, STAT GEN ED TECHN HU	14	77	79	3	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 22	2016	351	6271					337	339		10.1126/science.aad6778	http://dx.doi.org/10.1126/science.aad6778			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB3VH	26797999				2022-12-28	WOS:000368440500021
J	Marte, B; Shadan, S; Thomas, C; Kahrstrom, CT; Weiss, U				Marte, Barbara; Shadan, Sadaf; Thomas, Clare; Kahrstrom, Christina Tobin; Weiss, Ursula			FRONTIERS IN BIOLOGY	NATURE			English	Editorial Material																			0	0	0	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 21	2016	529	7586					297	297		10.1038/529297a	http://dx.doi.org/10.1038/529297a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB2QT	26791719	Bronze			2022-12-28	WOS:000368354800054
J	Song, JR; Ampatzis, K; Bjornfors, ER; El Manira, A				Song, Jianren; Ampatzis, Konstantinos; Bjoernfors, E. Rebecka; El Manira, Abdeljabbar			Motor neurons control locomotor circuit function retrogradely via gap junctions	NATURE			English	Article							MAMMALIAN SPINAL-CORD; EXCITATORY INTERNEURONS; ADULT ZEBRAFISH; ELECTRICAL SYNAPSES; REFLEX INHIBITION; RENSHAW CELLS; TRANSMISSION; MOTONEURONS; RECRUITMENT; BRAIN	Motor neurons are the final stage of neural processing for the execution of motor behaviours. Traditionally, motor neurons have been viewed as the 'final common pathway', serving as passive recipients merely conveying to the muscles the final motor program generated by upstream interneuron circuits(1,2). Here we reveal an unforeseen role of motor neurons in controlling the locomotor circuit function via gap junctions in zebrafish. These gap junctions mediate a retrograde analogue propagation of voltage fluctuations from motor neurons to control the synaptic release and recruitment of the upstream V2a interneurons that drive locomotion. Selective inhibition of motor neurons during ongoing locomotion de-recruits V2a interneurons and strongly influences locomotor circuit function. Rather than acting as separate units, gap junctions unite motor neurons and V2a interneurons into functional ensembles endowed with a retrograde analogue computation essential for locomotor rhythm generation. These results show that motor neurons are not a passive recipient of motor commands but an integral component of the neural circuits responsible for motor behaviour.	[Song, Jianren; Ampatzis, Konstantinos; Bjoernfors, E. Rebecka; El Manira, Abdeljabbar] Karolinska Inst, Dept Neurosci, S-17177 Stockholm, Sweden	Karolinska Institutet	El Manira, A (corresponding author), Karolinska Inst, Dept Neurosci, S-17177 Stockholm, Sweden.	Abdel.ElManira@ki.se		Song, Jianren/0000-0001-6949-7455; Ampatzis, Konstantinos/0000-0001-7998-6463; El Manira, Abdel/0000-0001-5920-9384	Swedish Research Council; Karolinska Institute; Swedish Brain Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Karolinska Institute(Karolinska Institutet); Swedish Brain Foundation	We thank C. Wyart, S. Grillner, O. Kiehn and G. Silberberg as well as the members of our lab for comments on an early version of the manuscript. We are grateful to A. Baradel, C. Wyart, S. Higashijima and H. Baier for providing the zebrafish lines used in this study. This study was supported by grants from the Swedish Research Council, Karolinska Institute and the Swedish Brain Foundation.	Ampatzis K, 2014, NEURON, V83, P934, DOI 10.1016/j.neuron.2014.07.018; Ampatzis K, 2013, J NEUROSCI, V33, P10875, DOI 10.1523/JNEUROSCI.0896-13.2013; Arrenberg AB, 2009, P NATL ACAD SCI USA, V106, P17968, DOI 10.1073/pnas.0906252106; Ausborn J, 2012, P NATL ACAD SCI USA, V109, pE3631, DOI 10.1073/pnas.1216256110; Bautista W, 2014, NEUROSCIENCE, V263, P159, DOI 10.1016/j.neuroscience.2013.12.057; Bennett MVL, 2004, NEURON, V41, P495, DOI 10.1016/S0896-6273(04)00043-1; Connors BW, 2004, ANNU REV NEUROSCI, V27, P393, DOI 10.1146/annurev.neuro.26.041002.131128; Curti S, 2004, J NEUROSCI, V24, P3999, DOI 10.1523/JNEUROSCI.0077-04.2004; El Manira A, 2014, CURR OPIN NEUROBIOL, V29, P133, DOI 10.1016/j.conb.2014.06.016; ELMANIRA A, 1993, J NEUROPHYSIOL, V69, P2248, DOI 10.1152/jn.1993.69.6.2248; Gabriel JP, 2011, NAT NEUROSCI, V14, P93, DOI 10.1038/nn.2704; Hamzei-Sichani F, 2012, FRONT NEUROANAT, V6, DOI 10.3389/fnana.2012.00013; Herberholz J, 2002, J NEUROSCI, V22, P9078; Kimura Y, 2006, J NEUROSCI, V26, P5684, DOI 10.1523/JNEUROSCI.4993-05.2006; KORN H, 1977, NEUROSCIENCE, V2, P851, DOI 10.1016/0306-4522(77)90111-7; Kyriakatos A, 2011, J NEUROSCI, V31, P8422, DOI 10.1523/JNEUROSCI.1012-11.2011; Li WC, 2009, J PHYSIOL-LONDON, V587, P1677, DOI 10.1113/jphysiol.2008.166942; Liddell EGT, 1925, P R SOC LOND B-CONTA, V97, P488, DOI 10.1098/rspb.1925.0016; Ljunggren EE, 2014, J NEUROSCI, V34, P134, DOI 10.1523/JNEUROSCI.4087-13.2014; Mentis GZ, 2005, P NATL ACAD SCI USA, V102, P7344, DOI 10.1073/pnas.0502788102; Nishimaru H, 2005, P NATL ACAD SCI USA, V102, P5245, DOI 10.1073/pnas.0501331102; NOGA BR, 1987, EXP BRAIN RES, V66, P99; PEREDA AE, 1995, J NEUROSCI, V15, P5943; Pereda AE, 2014, NAT REV NEUROSCI, V15, P250, DOI 10.1038/nrn3708; Personius KE, 2007, P NATL ACAD SCI USA, V104, P11808, DOI 10.1073/pnas.0703357104; PRATT CA, 1987, J NEUROPHYSIOL, V57, P56, DOI 10.1152/jn.1987.57.1.56; Rash JE, 1996, P NATL ACAD SCI USA, V93, P4235, DOI 10.1073/pnas.93.9.4235; Rekling JC, 2000, J NEUROSCI, V20, part. no.; Saint-Amant L, 2000, J NEUROSCI, V20, P3964; Satou C, 2013, DEVELOPMENT, V140, P3927, DOI 10.1242/dev.099531; Satou C, 2012, J NEUROSCI, V32, P1771, DOI 10.1523/JNEUROSCI.5500-11.2012; Schoonheim PJ, 2010, J NEUROSCI, V30, P7111, DOI 10.1523/JNEUROSCI.5193-09.2010; Scott EK, 2007, NAT METHODS, V4, P323, DOI 10.1038/NMETH1033; Serrano-Velez JL, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00066; Sherrington CS, 1925, P R SOC LOND B-CONTA, V97, P519, DOI 10.1098/rspb.1925.0017; SILLAR KT, 1994, EUR J MORPHOL, V32, P293; SLESINGER P, 1985, J COMP PHYSIOL A, V157, P15, DOI 10.1007/BF00611090; Tresch MC, 2000, NAT NEUROSCI, V3, P593, DOI 10.1038/75768; Vivar C, 2012, EUR J NEUROSCI, V35, P76, DOI 10.1111/j.1460-9568.2011.07930.x; Wyart C, 2009, NATURE, V461, P407, DOI 10.1038/nature08323; Zhang HY, 2009, J PHYSIOL-LONDON, V587, P4455, DOI 10.1113/jphysiol.2009.173468; ZIPSER B, 1976, J NEUROPHYSIOL, V39, P713, DOI 10.1152/jn.1976.39.4.713	42	83	83	9	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 21	2016	529	7586					399	+		10.1038/nature16497	http://dx.doi.org/10.1038/nature16497			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB2QT	26760208				2022-12-28	WOS:000368354800047
J	Hossack, MR; Paraoan, M				Hossack, Martin Raymond; Paraoan, Marius			SPOT DIAGNOSIS Anatomical conundrum	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Hossack, Martin Raymond; Paraoan, Marius] Royal Albert Edward Infirm, Wigan & Leigh NHS Fdn Trust, Dept Colorectal Surg, Wigan, England		Hossack, MR (corresponding author), Royal Albert Edward Infirm, Wigan & Leigh NHS Fdn Trust, Dept Colorectal Surg, Wigan, England.	martinhossack@doctors.net.uk		Hossack, Martin/0000-0002-1327-8103					0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 19	2016	352								i192	10.1136/bmj.i192	http://dx.doi.org/10.1136/bmj.i192			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DC4ZO	26785677				2022-12-28	WOS:000369229700004
J	Moore, KA; Rubin, EB; Halpern, SD				Moore, Kendra A.; Rubin, Emily B.; Halpern, Scott D.			The Problems With Physician Orders for Life-Sustaining Treatment	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Moore, Kendra A.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Moore, Kendra A.; Rubin, Emily B.; Halpern, Scott D.] Univ Penn, Fostering Improvement End Of Life Decis Sci FIELD, Philadelphia, PA 19104 USA; [Rubin, Emily B.; Halpern, Scott D.] Univ Penn, Div Pulm Allergy & Crit Care Med, Dept Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania	Halpern, SD (corresponding author), Univ Penn, 719 Blockley Hall,423 Guardian Dr, Philadelphia, PA 19104 USA.	shalpern@exchange.upenn.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL098054] Funding Source: NIH RePORTER; NHLBI NIH HHS [T32 HL098054] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		[Anonymous], PHYS ORD LIF SUST TR; [Anonymous], 2006, NAT FRAM PREF PRACT; Auriemma CL, 2014, JAMA INTERN MED, V174, P1085, DOI 10.1001/jamainternmed.2014.1183; Fromme EK, 2014, J AM GERIATR SOC, V62, P1246, DOI 10.1111/jgs.12889; Hickman SE, 2015, J AM GERIATR SOC, V63, P341, DOI 10.1111/jgs.13248; Hickman SE, 2011, J AM GERIATR SOC, V59, P2091, DOI 10.1111/j.1532-5415.2011.03656.x; Mirarchi FL, 2015, J PATIENT SAF, V11, P9, DOI 10.1097/PTS.0000000000000164; Mirarchi FL, 2015, J PATIENT SAF, V11, P1, DOI 10.1097/PTS.0000000000000165	8	32	32	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 19	2016	315	3					259	260		10.1001/jama.2015.17362	http://dx.doi.org/10.1001/jama.2015.17362			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DB2WN	26784769	Green Accepted			2022-12-28	WOS:000368371400018
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED Margaret McCartney: Regulation doesn't guarantee safety	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material													mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358	National Institute for Health Research [CL-2014-01-003, ACF-2008-01-008] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		O'Dowd A, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6903	1	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 18	2016	352								i96	10.1136/bmj.i96	http://dx.doi.org/10.1136/bmj.i96			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DC4ZM	26783248	Green Published, Bronze			2022-12-28	WOS:000369229500019
J	Lin, HZ; Kuzminov, FI; Park, J; Lee, S; Falkowski, PG; Gorbunov, MY				Lin, Hanzhi; Kuzminov, Fedor I.; Park, Jisoo; Lee, SangHoon; Falkowski, Paul G.; Gorbunov, Maxim Y.			The fate of photons absorbed by phytoplankton in the global ocean	SCIENCE			English	Article							CHLOROPHYLL FLUORESCENCE; SOUTHERN-OCEAN; PHOTOSYNTHESIS; LIMITATION; ATLANTIC	Solar radiation absorbed by marine phytoplankton can follow three possible paths. By simultaneously measuring the quantum yields of photochemistry and chlorophyll fluorescence in situ, we calculate that, on average, similar to 60% of absorbed photons are converted to heat, only 35% are directed toward photochemical water splitting, and the rest are reemitted as fluorescence. The spatial pattern of fluorescence yields and lifetimes strongly suggests that photochemical energy conversion is physiologically limited by nutrients. Comparison of in situ fluorescence lifetimes with satellite retrievals of solar-induced fluorescence yields suggests that the mean values of the latter are generally representative of the photophysiological state of phytoplankton; however, the signal-to-noise ratio is unacceptably low in extremely oligotrophic regions, which constitute 30% of the open ocean.	[Lin, Hanzhi; Kuzminov, Fedor I.; Falkowski, Paul G.; Gorbunov, Maxim Y.] Rutgers State Univ, Dept Marine & Coastal Sci, Environm Biophys & Mol Ecol Program, New Brunswick, NJ 08903 USA; [Park, Jisoo; Lee, SangHoon] Korea Polar Res Inst, Inchon, South Korea; [Falkowski, Paul G.] Rutgers State Univ, Dept Earth & Planetary Sci, Piscataway, NJ USA	Rutgers State University New Brunswick; Korea Institute of Ocean Science & Technology (KIOST); Korea Polar Research Institute (KOPRI); Rutgers State University New Brunswick	Falkowski, PG (corresponding author), Rutgers State Univ, Dept Marine & Coastal Sci, Environm Biophys & Mol Ecol Program, 71 Dudley Rd, New Brunswick, NJ 08903 USA.	falko@marine.rutgers.edu; gorbunov@marine.rutgers.edu	Lin, Hanzhi/H-6660-2016	Lin, Hanzhi/0000-0003-2153-4733	NASA Ocean Biology and Biogeochemistry Program [NNX08AC24G]; Strategic Environmental Research and Development Program [SI-1334]; Institute of Marine and Coastal Sciences; Bennett L. Smith Endowment; Russian Science Foundation [14-17-00451]; Korea Polar Research Institute [PP15020]	NASA Ocean Biology and Biogeochemistry Program(National Aeronautics & Space Administration (NASA)); Strategic Environmental Research and Development Program; Institute of Marine and Coastal Sciences; Bennett L. Smith Endowment; Russian Science Foundation(Russian Science Foundation (RSF)); Korea Polar Research Institute(Korea Polar Research Institute of Marine Research Placement (KOPRI))	We thank E. Boyle, P. Quinn, K. Thamatrakoln, and V. Fadeev for providing ship time and the captains and crews of research vessels Oceanus, Knorr, Melville, Akademik Yoffe, and Araon. This research was supported by grants NNX08AC24G from the NASA Ocean Biology and Biogeochemistry Program and SI-1334 from the Strategic Environmental Research and Development Program to M.Y.G. and P.G.F. H.L. and F.I.K. were supported by Institute of Marine and Coastal Sciences postdoctoral fellowships and the Bennett L. Smith Endowment to P.G.F. M.Y.G and F.I.K. were in part supported by grant 14-17-00451 from the Russian Science Foundation. J.P. and S.L. were supported by grant PP15020 from the Korea Polar Research Institute. All fluorescence data are deposited at PANGAEA (Publishing Network for Geoscientific and Environmental Data) under accession number PDI-11228.	Abbott MarkR., 1999, ALGORITHM THEORETICA; Alderkamp AC, 2010, LIMNOL OCEANOGR, V55, P1248, DOI 10.4319/lo.2010.55.3.1248; Antoine D, 1996, GLOBAL BIOGEOCHEM CY, V10, P57, DOI 10.1029/95GB02832; Behrenfeld MJ, 2009, BIOGEOSCIENCES, V6, P779, DOI 10.5194/bg-6-779-2009; Behrenfeld MJ, 2006, NATURE, V442, P1025, DOI 10.1038/nature05083; Behrenfeld MJ, 1997, LIMNOL OCEANOGR, V42, P1, DOI 10.4319/lo.1997.42.1.0001; Behrenfeld MJ, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002299; Bibby TS, 2008, DEEP-SEA RES PT II, V55, P1310, DOI 10.1016/j.dsr2.2008.01.014; Boyd PW, 2000, NATURE, V407, P695, DOI 10.1038/35037500; BRADBURY M, 1983, PROC R SOC SER B-BIO, V220, P251, DOI 10.1098/rspb.1983.0098; Bricaud A, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2004JC002419; Browning TJ, 2014, GLOBAL BIOGEOCHEM CY, V28, P510, DOI 10.1002/2013GB004773; BUTLER WL, 1977, P NATL ACAD SCI USA, V74, P3382, DOI 10.1073/pnas.74.8.3382; Falkowski P.G., 2007, AQUATIC PHOTOSYNTHES; Falkowski P.G., 1992, OCEANOGRAPHY, V5, P84, DOI [DOI 10.5670/OCEANOG.1992.14, 10.5670/oceanog.1992.14]; FALKOWSKI PG, 1991, NATURE, V352, P55, DOI 10.1038/352055a0; FALKOWSKI PG, 1995, AUST J PLANT PHYSIOL, V22, P341, DOI 10.1071/PP9950341; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Huot Y, 2013, REMOTE SENS ENVIRON, V132, P238, DOI 10.1016/j.rse.2013.01.003; KOLBER Z, 1993, LIMNOL OCEANOGR, V38, P1646, DOI 10.4319/lo.1993.38.8.1646; KRAUSE GH, 1991, ANNU REV PLANT PHYS, V42, P313, DOI 10.1146/annurev.pp.42.060191.001525; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE; Moore CM, 2013, NAT GEOSCI, V6, P701, DOI [10.1038/NGEO1765, 10.1038/ngeo1765]; MOREL A, 1981, DEEP-SEA RES, V28, P1375, DOI 10.1016/0198-0149(81)90039-X; Raven JA, 1999, PHOTOSYNTH RES, V60, P111, DOI 10.1023/A:1006282714942; Schrader PS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018753; Suggett DJ, 2009, MAR ECOL PROG SER, V376, P1, DOI 10.3354/meps07830; Tchernov D, 2004, P NATL ACAD SCI USA, V101, P13531, DOI 10.1073/pnas.0402907101; VASSILIEV IR, 1995, PLANT PHYSIOL, V109, P963, DOI 10.1104/pp.109.3.963	30	51	51	4	110	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 15	2016	351	6270					264	267		10.1126/science.aab2213	http://dx.doi.org/10.1126/science.aab2213			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA9AM	26743625				2022-12-28	WOS:000368098600038
J	Compton, WM; Jones, CM; Baldwin, GT				Compton, Wilson M.; Jones, Christopher M.; Baldwin, Grant T.			Relationship between Nonmedical Prescription-Opioid Use and Heroin Use	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							UNITED-STATES; RISK BEHAVIORS; DRUG-USERS; ABUSE; OVERDOSE; EPIDEMIC; MISUSE; INJECTION; DIVERSION; NALOXONE		[Compton, Wilson M.] NIDA, NIH, Silver Spring, MD USA; [Jones, Christopher M.] US FDA, Silver Spring, MD USA; [Baldwin, Grant T.] Ctr Dis Control & Prevent, Div Unintent Injury Prevent, Atlanta, GA USA	National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); US Food & Drug Administration (FDA); Centers for Disease Control & Prevention - USA	Compton, WM (corresponding author), NIDA, NIH, 6001 Execut Blvd,MSC 9581, Bethesda, MD 20892 USA.	wcompton@nida.nih.gov						[Anonymous], 2013, ADDR PRESCR DRUG AB; [Anonymous], 2015, PUB DEP JUST, VDEA-DCT-DIR-002-15; [Anonymous], 2013, CBHSQ DATA REV; [Anonymous], 2013, DAWN REP HIGHL 2011; [Anonymous], 2014, HHS PUBL; Association of State and Territorial Health Officials, 2013, ASTHO PRESCR DRUG MI; Becker WC, 2008, DRUG ALCOHOL DEPEN, V94, P38, DOI 10.1016/j.drugalcdep.2007.09.018; Cassidy TA, 2014, PAIN MED, V15, P440, DOI 10.1111/pme.12295; Center for Behavioral Health Statistics and Quality, 2015, 2014 NAT SURV DRUG U; Centers for Disease Control and Prevention, 2015, WID RANG ONL DAT EP; Centers for Disease Control and Prevention National Center for Injury Prevention and Control Division of Unintentional Injury Prevention, COMM EL GUID PRESCR; Cicero TJ, 2015, JAMA PSYCHIAT, V72, P424, DOI 10.1001/jamapsychiatry.2014.3043; Cicero TJ, 2014, JAMA PSYCHIAT, V71, P821, DOI 10.1001/jamapsychiatry.2014.366; Cicero TJ, 2012, NEW ENGL J MED, V367, P187, DOI 10.1056/NEJMc1204141; Coffin PO, 2013, ANN INTERN MED, V158, P1, DOI 10.7326/0003-4819-158-1-201301010-00003; Comer SD, 2008, NEUROPSYCHOPHARMACOL, V33, P1179, DOI 10.1038/sj.npp.1301479; Compton WM, 2013, ANN INTERN MED, V158, P65, DOI 10.7326/0003-4819-158-1-201301010-00013; Dart RC, 2015, NEW ENGL J MED, V372, P241, DOI [10.1056/NEJMsa1406143, 10.1056/NEJMc1501822]; Dasgupta N, 2014, DRUG ALCOHOL DEPEN, V145, P238, DOI 10.1016/j.drugalcdep.2014.10.005; Davis WR, 2008, DRUG ALCOHOL DEPEN, V92, P267, DOI 10.1016/j.drugalcdep.2007.08.008; Dick AW, 2015, HEALTH AFFAIR, V34, P1028, DOI 10.1377/hlthaff.2014.1205; Franklin G, 2015, AM J PUBLIC HEALTH, V105, P463, DOI 10.2105/AJPH.2014.302367; George O, 2010, NEUROSCI BIOBEHAV R, V35, P232, DOI 10.1016/j.neubiorev.2010.05.002; Grau LE, 2007, AM J ADDICTION, V16, P166, DOI 10.1080/10550490701375293; Han B, 2015, JAMA-J AM MED ASSOC, V314, P1468, DOI 10.1001/jama.2015.11859; Havens JR, 2009, AM J DRUG ALCOHOL AB, V35, P18, DOI 10.1080/00952990802326298; Inciardi JA, 2009, PAIN MED, V10, P537, DOI 10.1111/j.1526-4637.2009.00603.x; Institute of Medicine, 2011, REL PAIN AM BLUEPR T; Johnson H, 2014, MMWR-MORBID MORTAL W, V63, P569; Jones CM, 2015, MMWR-MORBID MORTAL W, V64, P719; Jones CM, 2015, AM J PUBLIC HEALTH, V105, pE55, DOI 10.2105/AJPH.2015.302664; Jones CM, 2013, DRUG ALCOHOL DEPEN, V132, P95, DOI 10.1016/j.drugalcdep.2013.01.007; Jones CM, 2013, JAMA-J AM MED ASSOC, V309, P657, DOI 10.1001/jama.2013.272; Jones JD, 2011, AM J ADDICTION, V20, P190, DOI 10.1111/j.1521-0391.2011.00120.x; Khosla N, 2011, ADDICT BEHAV, V36, P1282, DOI 10.1016/j.addbeh.2011.07.046; Kolodny A, 2015, ANNU REV PUBL HEALTH, V36, P559, DOI 10.1146/annurev-publhealth-031914-122957; Kreek MJ., 2002, NEUROPSYCHOPHARMACOL, P1491; Lankenau SE, 2012, INT J DRUG POLICY, V23, P37, DOI 10.1016/j.drugpo.2011.05.014; Levy B, 2015, AM J PREV MED; Maher CE, 2005, LIFE SCI, V77, P1140, DOI 10.1016/j.lfs.2005.03.004; Manchikanti L, 2012, PAIN PHYSICIAN, V15, pES9; Mars SG, 2015, SOC SCI MED, V140, P44, DOI 10.1016/j.socscimed.2015.06.032; Mars SG, 2014, INT J DRUG POLICY, V25, P257, DOI 10.1016/j.drugpo.2013.10.004; Mateu-Gelabert P, 2015, J SUBST ABUSE TREAT, V48, P13, DOI 10.1016/j.jsat.2014.07.002; Meiman J, 2015, DRUG ALCOHOL DEPEN, V152, P177, DOI 10.1016/j.drugalcdep.2015.04.002; National Governors Association, 2012, 6 STRAT RED PRESCR D; National Institute on Drug Abuse Community Epidemiology Working Group, 2014, EP TRENDS DRUG AB P; Office of National Drug Control Policy US Executive Office of the President, 2011, EP RESP AM PRESCR DR; Paone D, 2015, MMWR-MORBID MORTAL W, V64, P491; Paulozzi LJ, 2012, J SAFETY RES, V43, P283, DOI 10.1016/j.jsr.2012.08.009; Peavy KM, 2012, J PSYCHOACTIVE DRUGS, V44, P259, DOI 10.1080/02791072.2012.704591; Pollini RA, 2011, SUBST ABUSE REHABIL, V2, P173, DOI 10.2147/SAR.S24800; Pud D, 2006, EUR J PAIN, V10, P103, DOI 10.1016/j.ejpain.2005.01.010; Rudd RA., 2014, MMWR MORB MORTAL WKL, V63, P849; Siegal HA, 2003, AM FAM PHYSICIAN, V67, P942; Spoth R, 2013, AM J PUBLIC HEALTH, V103, P665, DOI 10.2105/AJPH.2012.301209; Surratt HL, 2014, PHARMACOEPIDEM DR S, V23, P314, DOI 10.1002/pds.3553; Surratt Hilary L, 2006, J Opioid Manag, V2, P283; TERNES J W, 1990, Advances in Alcohol and Substance Abuse, V9, P27; Unick G, 2014, ADDICTION, V109, P1889, DOI 10.1111/add.12664; Unick GJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054496; Volkow ND, 1999, J PHARMACOL EXP THER, V291, P409; Volkow ND, 2014, NEW ENGL J MED, V370, P2063, DOI 10.1056/NEJMp1402780; Walley AY, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f174; Weiss RD, 2011, ARCH GEN PSYCHIAT, V68, P1238, DOI 10.1001/archgenpsychiatry.2011.121	65	765	765	0	151	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 14	2016	374	2					154	163		10.1056/NEJMra1508490	http://dx.doi.org/10.1056/NEJMra1508490			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DA7PQ	26760086	Bronze			2022-12-28	WOS:000367996700010
J	Izotov, YI; Orlitova, I; Schaerer, D; Thuan, TX; Verhamme, A; Guseva, NG; Worseck, G				Izotov, Y. I.; Orlitova, I.; Schaerer, D.; Thuan, T. X.; Verhamme, A.; Guseva, N. G.; Worseck, G.			Eight per cent leakage of Lyman continuum photons from a compact, star-forming dwarf galaxy	NATURE			English	Article							EMISSION-LINE GALAXIES; STARBURST GALAXIES; LY-ALPHA; SKY; ULTRAVIOLET; DUST; REIONIZATION; METALLICITY; EXTINCTION; RADIATION	One of the key questions in observational cosmology is the identification of the sources responsible for ionization of the Universe after the cosmic 'Dark Ages', when the baryonic matter was neutral. The currently identified distant galaxies are insufficient to fully reionize the Universe by redshift z approximate to 6 (refs 1-3), but low-mass, star-forming galaxies are thought to be responsible for the bulk of the ionizing radiation(4-6). As direct observations at high redshift are difficult for a variety of reasons, one solution is to identify local proxies of this galaxy population. Starburst galaxies at low redshifts, however, generally are opaque to Lyman continuum photons(7-9). Small escape fractions of about 1 to 3 per cent, insufficient to ionize much surrounding gas, have been detected only in three low-redshift galaxies(10,11). Here we report far-ultraviolet observations of the nearby low-mass star-forming galaxy J0925+ 1403. The galaxy is leaking ionizing radiation with an escape fraction of about 8 per cent. The total number of photons emitted during the starburst phase is sufficient to ionize intergalactic medium material that is about 40 times as massive as the stellar mass of the galaxy.	[Izotov, Y. I.; Guseva, N. G.] Natl Acad Sci Ukraine, Main Astron Observ, 27 Zabolotnoho St, UA-03680 Kiev, Ukraine; [Orlitova, I.] Acad Sci Czech Republ, Inst Astron, Prague 14100, Czech Republic; [Schaerer, D.; Verhamme, A.] Univ Geneva, Observ Geneve, CH-1290 Versoix, Switzerland; [Schaerer, D.] CNRS, IRAP, F-31400 Toulouse, France; [Thuan, T. X.] Univ Virginia, Dept Astron, Charlottesville, VA 22904 USA; [Worseck, G.] Max Planck Inst Astron, D-69117 Heidelberg, Germany	National Academy of Sciences Ukraine; Main Astronomical Observatory of NASU; Czech Academy of Sciences; Astronomical Institute of the Czech Academy of Sciences; University of Geneva; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); University of Virginia; Max Planck Society	Izotov, YI (corresponding author), Natl Acad Sci Ukraine, Main Astron Observ, 27 Zabolotnoho St, UA-03680 Kiev, Ukraine.	izotov@mao.kiev.ua	Orlitova, Ivana/G-6429-2014	Orlitova, Ivana/0000-0002-9813-401X; Worseck, Gabor/0000-0003-0960-3580; Guseva, Natalia Grigirievna/0000-0002-7938-614X; Verhamme, Anne/0000-0002-2201-1865; Schaerer, Daniel/0000-0001-7144-7182	NASA [NAS 5-26555]; NASA from STScI [HST-GO-13744.001-A]; Czech Science Foundation [GACR 14-20666P]; NASA	NASA(National Aeronautics & Space Administration (NASA)); NASA from STScI; Czech Science Foundation(Grant Agency of the Czech Republic); NASA(National Aeronautics & Space Administration (NASA))	This Letter is based on observations made with the NASA/ESA HST, obtained from the data archive at the Space Telescope Science Institute (STScI), which is operated by the Association of Universities for Research in Astronomy, Inc., under NASA contract NAS 5-26555. Support for this work was provided by NASA through grant number HST-GO-13744.001-A from the STScI. I.O. acknowledges a grant GACR 14-20666P of the Czech Science Foundation. The SDSS is managed by the Astrophysical Research Consortium for the Participating Institutions. GALEX is a NASA mission managed by the Jet Propulsion Laboratory. This research has made use of the NASA/IPAC Extragalactic Database (NED) which is operated by the Jet Propulsion Laboratory, California Institute of Technology, under contract with NASA.	Ade PAR, 2014, ASTRON ASTROPHYS, V571, DOI 10.1051/0004-6361/201321591; Aller L. H., 1984, ASTROPHYSICS SPACE S, V112; [Anonymous], 2013, WIDE FIELD INFRARED; BALDWIN JA, 1981, PUBL ASTRON SOC PAC, V93, P5, DOI 10.1086/130766; Borthakur S, 2014, SCIENCE, V346, P216, DOI 10.1126/science.1254214; BOUCHET P, 1985, ASTRON ASTROPHYS, V149, P330; Cardamone C, 2009, MON NOT R ASTRON SOC, V399, P1191, DOI 10.1111/j.1365-2966.2009.15383.x; CARDELLI JA, 1989, ASTROPHYS J, V345, P245, DOI 10.1086/167900; Deharveng JM, 2001, ASTRON ASTROPHYS, V375, P805, DOI 10.1051/0004-6361:20010920; Ekstrom S, 2012, ASTRON ASTROPHYS, V537, DOI 10.1051/0004-6361/201117751; Girardi L, 2000, ASTRON ASTROPHYS SUP, V141, P371, DOI 10.1051/aas:2000126; Gordon KD, 2003, ASTROPHYS J, V594, P279, DOI 10.1086/376774; Gordon KD, 1998, ASTROPHYS J, V500, P816, DOI 10.1086/305774; Grimes JP, 2009, ASTROPHYS J SUPPL S, V181, P272, DOI 10.1088/0067-0049/181/1/272; Guseva NG, 2006, ASTROPHYS J, V644, P890, DOI 10.1086/503865; Henry A, 2015, ASTROPHYS J, V809, DOI 10.1088/0004-637X/809/1/19; Hillier DJ, 1998, ASTROPHYS J, V496, P407, DOI 10.1086/305350; HUMMER DG, 1987, MON NOT R ASTRON SOC, V224, P801, DOI 10.1093/mnras/224.3.801; Iwata I, 2009, ASTROPHYS J, V692, P1287, DOI 10.1088/0004-637X/692/2/1287; Izotov YI, 2015, MON NOT R ASTRON SOC, V451, P2251, DOI 10.1093/mnras/stv1115; Izotov YI, 2014, ASTRON ASTROPHYS, V570, DOI 10.1051/0004-6361/201423539; Izotov YI, 2014, ASTRON ASTROPHYS, V561, DOI 10.1051/0004-6361/201322338; Izotov YI, 2006, ASTRON ASTROPHYS, V448, P955, DOI 10.1051/0004-6361:20053763; IZOTOV YI, 1994, ASTROPHYS J, V435, P647, DOI 10.1086/174843; Izotov YI, 2011, ASTROPHYS J, V734, DOI 10.1088/0004-637X/734/2/82; Izotov YI, 2011, ASTROPHYS J, V728, DOI 10.1088/0004-637X/728/2/161; Jaskot AE, 2014, ASTROPHYS J LETT, V791, DOI 10.1088/2041-8205/791/2/L19; Jaskot AE, 2013, ASTROPHYS J, V766, DOI 10.1088/0004-637X/766/2/91; Kauffmann G, 2003, MON NOT R ASTRON SOC, V341, P33, DOI 10.1046/j.1365-8711.2003.06291.x; Kennicutt RC, 1998, ANNU REV ASTRON ASTR, V36, P189, DOI 10.1146/annurev.astro.36.1.189; Kroupa P, 2001, MON NOT R ASTRON SOC, V322, P231, DOI 10.1046/j.1365-8711.2001.04022.x; Leitet E, 2013, ASTRON ASTROPHYS, V553, DOI 10.1051/0004-6361/201118370; Leitherer C, 1999, ASTROPHYS J SUPPL S, V123, P3, DOI 10.1086/313233; LEITHERER C, 1995, ASTROPHYS J, V454, pL19, DOI 10.1086/309760; Leitherer C, 2014, ASTROPHYS J SUPPL S, V212, DOI 10.1088/0067-0049/212/1/14; Lejeune T, 1997, ASTRON ASTROPHYS SUP, V125, P229, DOI 10.1051/aas:1997373; MATHIS JS, 1990, ANNU REV ASTRON ASTR, V28, P37, DOI 10.1146/annurev.aa.28.090190.000345; MEYNET G, 1994, ASTRON ASTROPHYS SUP, V103, P97; Mitra S, 2013, MON NOT R ASTRON SOC, V428, pL1, DOI 10.1093/mnrasl/sls001; Murthy J, 2014, ASTROPHYS J SUPPL S, V213, DOI 10.1088/0067-0049/213/2/32; Nakajima K, 2014, MON NOT R ASTRON SOC, V442, P900, DOI 10.1093/mnras/stu902; Pauldrach A. W. A., 1998, Astronomical Society of the Pacific Conference Series, V131, P258; Robertson BE, 2013, ASTROPHYS J, V768, DOI 10.1088/0004-637X/768/1/71; SALPETER EE, 1955, ASTROPHYS J, V121, P161, DOI 10.1086/145971; SCHMUTZ W, 1992, PUBL ASTRON SOC PAC, V104, P1164, DOI 10.1086/133104; Stasinska G, 2015, ASTRON ASTROPHYS, V576, DOI 10.1051/0004-6361/201425389; Steidel CC, 2001, ASTROPHYS J, V546, P665, DOI 10.1086/318323; Syphers D, 2012, ASTRON J, V143, DOI 10.1088/0004-6256/143/4/100; Verhamme A, 2015, ASTRON ASTROPHYS, V578, DOI 10.1051/0004-6361/201423978; Wise JH, 2009, ASTROPHYS J, V693, P984, DOI 10.1088/0004-637X/693/1/984; Worseck G, 2011, ASTROPHYS J LETT, V733, DOI 10.1088/2041-8205/733/2/L24; Wright EL, 2006, PUBL ASTRON SOC PAC, V118, P1711, DOI 10.1086/510102; Yajima H, 2011, MON NOT R ASTRON SOC, V412, P411, DOI 10.1111/j.1365-2966.2010.17920.x	53	174	174	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 14	2016	529	7585					178	180		10.1038/nature16456	http://dx.doi.org/10.1038/nature16456			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA7WK	26762455	Green Submitted			2022-12-28	WOS:000368015700029
J	Kana, MA				Kana, Musa Abubakar			"Publish or perish" is good for African research	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PUBLICATION; HEALTH		[Kana, Musa Abubakar] Kaduna State Univ, Dept Community Med, Epidemiol & Publ Hlth, Kaduna, Nigeria; [Kana, Musa Abubakar] Univ Porto, Inst Publ Hlth, Epidemiol Res Unit, P-4100 Oporto, Portugal	Universidade do Porto	Kana, MA (corresponding author), Kaduna State Univ, Dept Community Med, Epidemiol & Publ Hlth, Kaduna, Nigeria.	musakana77@yahoo.com		Kana, Musa/0000-0002-5766-7610				Adibi Payman, 2015, J Educ Health Promot, V4, P14, DOI 10.4103/2277-9531.154023; ALTMAN DG, 1994, BRIT MED J, V308, P283, DOI 10.1136/bmj.308.6924.283; Archibong IA, 2010, J COLL TEACH LEARN, V7, P10; Baggs JG, 2008, RES NURS HEALTH, V31, P295, DOI 10.1002/nur.20280; De Rond M, 2005, J MANAGE INQUIRY, V14, P321, DOI 10.1177/1056492605276850; Farjo N, 2015, AM J ORTHOD DENTOFAC, V147, P680, DOI 10.1016/j.ajodo.2015.01.020; Geuna A, 2003, MINERVA, V41, P277, DOI 10.1023/B:MINE.0000005155.70870.bd; Haug CJ, 2015, NEW ENGL J MED, V373, P2393, DOI 10.1056/NEJMp1512330; Holmgren M, 2004, PLOS BIOL, V2, P10, DOI 10.1371/journal.pbio.0020001; Langer A, 2004, B WORLD HEALTH ORGAN, V82, P802; LaPorte R, 2013, BMJ-BRIT MED J, P346; Lown B, 2006, GLOBALIZATION HEALTH, V2, DOI 10.1186/1744-8603-2-3; McGrail M., 2006, HIGH EDUC RES DEV, V25, P19, DOI DOI 10.1080/07294360500453053; Mckee M, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001209; Nordling L, 2015, NATURE, V520, P142, DOI 10.1038/520142a; Paraje G, 2005, SCIENCE, V308, P959, DOI 10.1126/science.1108705; Radford DR, 1999, BRIT DENT J, V187, P376, DOI 10.1038/sj.bdj.bdj0284a; Shen CY, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0469-2; Song Fujian, 2014, PLoS One, V9, pe110418, DOI 10.1371/journal.pone.0110418; Uthman OA, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006340; van Dalen HP, 2012, J AM SOC INF SCI TEC, V63, P1282, DOI 10.1002/asi.22636; Volmink J, 2005, BMJ-BRIT MED J, V331, P705, DOI 10.1136/bmj.331.7519.705	22	4	4	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 14	2016	352								i121	10.1136/bmj.i121	http://dx.doi.org/10.1136/bmj.i121			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DB2YZ	26768332				2022-12-28	WOS:000368377900006
J	Mansoor, AM; Mansoor, SE				Mansoor, Andre M.; Mansoor, Steven E.			Lancisi's Sign	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Mansoor, Andre M.; Mansoor, Steven E.] Oregon Hlth & Sci Univ, Portland, OR 97201 USA	Oregon Health & Science University	Mansoor, AM (corresponding author), Oregon Hlth & Sci Univ, Portland, OR 97201 USA.	mansooan@ohsu.edu							0	4	4	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 14	2016	374	2					E2	E2		10.1056/NEJMicm1502066	http://dx.doi.org/10.1056/NEJMicm1502066			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DA7PQ	26760104				2022-12-28	WOS:000367996700001
J	Wilhelm, K; Happel, K; Eelen, G; Schoors, S; Oellerich, MF; Lim, R; Zimmermann, B; Aspalter, IM; Franco, CA; Boettger, T; Braun, T; Fruttiger, M; Rajewsky, K; Keller, C; Bruning, JC; Gerhardt, H; Carmeliet, P; Potente, M				Wilhelm, Kerstin; Happel, Katharina; Eelen, Guy; Schoors, Sandra; Oellerich, Mark F.; Lim, Radiance; Zimmermann, Barbara; Aspalter, Irene M.; Franco, Claudio A.; Boettger, Thomas; Braun, Thomas; Fruttiger, Marcus; Rajewsky, Klaus; Keller, Charles; Bruening, Jens C.; Gerhardt, Holger; Carmeliet, Peter; Potente, Michael			FOXO1 couples metabolic activity and growth state in the vascular endothelium	NATURE			English	Article							TRANSCRIPTION FACTOR; GENE-EXPRESSION; MYC; IDENTIFICATION; ANGIOGENESIS; CELLS; MICE; MAINTENANCE; HOMEOSTASIS; INSULIN	Endothelial cells (ECs) are plastic cells that can switch between growth states with different bioenergetic and biosynthetic requirements(1). Although quiescent in most healthy tissues, ECs divide and migrate rapidly upon proangiogenic stimulation(2,3). Adjusting endothelial metabolism to the growth state is central to normal vessel growth and function(1,4), yet it is poorly understood at the molecular level. Here we report that the forkhead box O (FOXO) transcription factor FOXO1 is an essential regulator of vascular growth that couples metabolic and proliferative activities in ECs. Endothelial-restricted deletion of FOXO1 in mice induces a profound increase in EC proliferation that interferes with coordinated sprouting, thereby causing hyperplasia and vessel enlargement. Conversely, forced expression of FOXO1 restricts vascular expansion and leads to vessel thinning and hypobranching. We find that FOXO1 acts as a gatekeeper of endothelial quiescence, which decelerates metabolic activity by reducing glycolysis and mitochondrial respiration. Mechanistically, FOXO1 suppresses signalling by MYC (also known as c-MYC), a powerful driver of anabolic metabolism and growth(5,6). MYC ablation impairs glycolysis, mitochondrial function and proliferation of ECs while its EC-specific overexpression fuels these processes. Moreover, restoration of MYC signalling in FOXO1-overexpressing endothelium normalizes metabolic activity and branching behaviour. Our findings identify FOXO1 as a critical rheostat of vascular expansion and define the FOXO1-MYC transcriptional network as a novel metabolic checkpoint during endothelial growth and proliferation.	[Wilhelm, Kerstin; Happel, Katharina; Oellerich, Mark F.; Lim, Radiance; Zimmermann, Barbara; Potente, Michael] Max Planck Inst Heart & Lung Res, Angiogenesis & Metab Lab, D-61231 Bad Nauheim, Germany; [Eelen, Guy; Schoors, Sandra; Carmeliet, Peter] Univ Leuven, Dept Oncol, Vesalius Res Ctr, Lab Angiogenesis & Neurovasc Link, B-3000 Leuven, Belgium; [Eelen, Guy; Schoors, Sandra; Carmeliet, Peter] VIB, Vesalius Res Ctr, Lab Angiogenesis & Neurovasc Link, B-3000 Leuven, Belgium; [Aspalter, Irene M.; Gerhardt, Holger] Canc Res UK, London Res Inst, Vasc Biol Lab, London WC2A 3LY, England; [Franco, Claudio A.] Univ Lisbon, Fac Med, Inst Med Mol, Vasc Morphogenesis Lab, P-1649028 Lisbon, Portugal; [Boettger, Thomas; Braun, Thomas] Max Planck Inst Heart & Lung Res, Dept Cardiac Dev & Remodeling, D-61231 Bad Nauheim, Germany; [Fruttiger, Marcus] UCL, UCL Inst Ophthalmol, London EC1V 9EL, England; [Rajewsky, Klaus; Gerhardt, Holger] Max Delbruck Ctr Mol Med MDC, D-13125 Berlin, Germany; [Keller, Charles] Childrens Canc Therapy Dev Inst, Beaverton, OR 97005 USA; [Bruening, Jens C.] Univ Cologne, Max Planck Inst Metab Res, Excellence Cluster Cellular Stress Responses Agin, D-50931 Cologne, Germany; [Bruening, Jens C.] Univ Cologne, CMMC, Ctr Endocrinol Diabet & Prevent Med CEDP, D-50931 Cologne, Germany; [Gerhardt, Holger] VIB, Vesalius Res Ctr, Vasc Patterning Lab, B-3000 Leuven, Belgium; [Gerhardt, Holger] Univ Leuven, B-3000 Leuven, Belgium; [Gerhardt, Holger] DZHK German Ctr Cardiovasc Res, D-13347 Berlin, Germany; [Gerhardt, Holger] BIH, D-10117 Berlin, Germany; [Potente, Michael] Int Inst Mol & Cell Biol, PL-02109 Warsaw, Poland; [Potente, Michael] DZHK German Ctr Cardiovasc Res, D-13347 Berlin, Germany	Max Planck Society; KU Leuven; Flanders Institute for Biotechnology (VIB); Cancer Research UK; Universidade de Lisboa; Max Planck Society; University of London; University College London; Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Cologne; University of Cologne; Flanders Institute for Biotechnology (VIB); KU Leuven; German Centre for Cardiovascular Research; Berlin Institute of Health; Miedzynarodowy Instytut Biologii Molekularnej i Komorkowej; German Centre for Cardiovascular Research	Potente, M (corresponding author), Max Planck Inst Heart & Lung Res, Angiogenesis & Metab Lab, D-61231 Bad Nauheim, Germany.	michael.potente@mpi-bn.mpg.de	Boettger, Thomas/E-3406-2012; Franco, Claudio A/D-8117-2015; Carmeliet, Peter/AAQ-5140-2020; Braun, Thomas/B-2310-2008; Gerhardt, Holger/G-4610-2011; Wilhelm, Kerstin/AAX-5025-2020; Franco, Claudio A/B-1060-2013	Boettger, Thomas/0000-0003-4280-8449; Franco, Claudio A/0000-0002-2861-3883; Carmeliet, Peter/0000-0001-7961-1821; Gerhardt, Holger/0000-0002-3030-0384; Wilhelm, Kerstin/0000-0001-8159-2850; Franco, Claudio A/0000-0002-2861-3883; Potente, Michael/0000-0002-5689-0036; Aspalter, Irene Maria/0000-0002-6155-9006; Keller, Charles/0000-0003-2505-7487; Fruttiger, Marcus/0000-0002-6962-5485; Braun, Thomas/0000-0002-6165-4804; Rajewsky, Klaus/0000-0002-6633-6370; Lim, Radiance/0000-0002-9865-7064	Max Planck Society; European Research Council (ERC) [311546]; Deutsche Forschungsgemeinschaft [SFB 834]; Excellence Cluster Cardiopulmonary System [EXC 147/1]; Cluster of Excellence Macromolecular Complexes [EXC115]; Foundation Leducq Transatlantic Network (ARTEMIS); LOEWE grant Ub-Net; European Molecular Biology Organization Young Investigator Programme; Austrian Academy of Sciences; European Union FP7 Marie Curie Post-doctoral Fellowship; FCT [IF/00412/2012]; ERC [268921, 269073]; National Institutes of Health [K08CA090438]; Cancer Research UK; ERC consolidator grant (REshape); Lister Institute of Preventive Medicine; British Council under BIRAX Initiative; Flemish Government; Flanders Science Fund [FWO G.0834.13N]; MRC [G0501711] Funding Source: UKRI; Medical Research Council [G0501711] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [K08CA090438] Funding Source: NIH RePORTER	Max Planck Society(Max Planck SocietyFoundation CELLEX); European Research Council (ERC)(European Research Council (ERC)European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Excellence Cluster Cardiopulmonary System(German Research Foundation (DFG)); Cluster of Excellence Macromolecular Complexes; Foundation Leducq Transatlantic Network (ARTEMIS); LOEWE grant Ub-Net; European Molecular Biology Organization Young Investigator Programme(European Molecular Biology Organization (EMBO)); Austrian Academy of Sciences; European Union FP7 Marie Curie Post-doctoral Fellowship; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); ERC(European Research Council (ERC)European Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research UK(Cancer Research UK); ERC consolidator grant (REshape); Lister Institute of Preventive Medicine; British Council under BIRAX Initiative; Flemish Government(European Commission); Flanders Science Fund; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank F. W. Alt and I. Aifantis for Myc<SUP>fl/fl</SUP> mice, and T. Enders, J. Sperling and K. Wilson for assistance with the mouse colony. The research of M.P. is supported by the Max Planck Society, the European Research Council (ERC) Starting Grant ANGIOMET (311546), the Deutsche Forschungsgemeinschaft (SFB 834), the Excellence Cluster Cardiopulmonary System (EXC 147/1), the Cluster of Excellence Macromolecular Complexes (EXC115), the Foundation Leducq Transatlantic Network (ARTEMIS), the LOEWE grant Ub-Net, and the European Molecular Biology Organization Young Investigator Programme. S.S. was supported by a PhD fellowship of the Belgian Science Policy (IWT) and I. M. A. is a recipient of a DOC-fFORTE fellowship of the Austrian Academy of Sciences. C.A.F was supported by a European Union FP7 Marie Curie Post-doctoral Fellowship and a FCT grant (IF/00412/2012). The research of K.R. is supported by an ERC Advanced Grant (268921) and C.K. received support from the National Institutes of Health K08CA090438. The research of H.G. is supported by Cancer Research UK, an ERC consolidator grant (REshape), the Foundation Leducq Transatlantic Network (ARTEMIS), the Lister Institute of Preventive Medicine and the British Council under the BIRAX Initiative. The work of P.C. is funded by long-term structural funding: Methusalem Funding by the Flemish Government, ERC Advanced Research Grant (269073), and FWO G.0834.13N from the Flanders Science Fund.	Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; Adhikary S, 2005, NAT REV MOL CELL BIO, V6, P635, DOI 10.1038/nrm1703; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Claxton S, 2008, GENESIS, V46, P74, DOI 10.1002/dvg.20367; Daly C, 2004, GENE DEV, V18, P1060, DOI 10.1101/gad.1189704; Dang CV, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a014217; de Alboran IM, 2001, IMMUNITY, V14, P45, DOI 10.1016/S1074-7613(01)00088-7; De Bock K, 2013, CELL METAB, V18, P634, DOI 10.1016/j.cmet.2013.08.001; Delpuech O, 2007, MOL CELL BIOL, V27, P4917, DOI 10.1128/MCB.01789-06; Eijkelenboom A, 2013, NAT REV MOL CELL BIO, V14, P83, DOI 10.1038/nrm3507; Fantin A, 2013, NAT PROTOC, V8, P418, DOI 10.1038/nprot.2013.015; Ferber EC, 2012, CELL DEATH DIFFER, V19, P968, DOI 10.1038/cdd.2011.179; Gan BY, 2010, CANCER CELL, V18, P472, DOI 10.1016/j.ccr.2010.10.019; Ghesquiere B, 2014, NATURE, V511, P167, DOI 10.1038/nature13312; Guarani V, 2011, NATURE, V473, P234, DOI 10.1038/nature09917; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hermeking H, 2000, P NATL ACAD SCI USA, V97, P2229, DOI 10.1073/pnas.050586197; Jensen KS, 2011, EMBO J, V30, P4554, DOI 10.1038/emboj.2011.323; Keller C, 2004, GENE DEV, V18, P2614, DOI 10.1101/gad.1244004; Koni PA, 2001, J EXP MED, V193, P741, DOI 10.1084/jem.193.6.741; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Kress TR, 2011, MOL CELL, V41, P445, DOI 10.1016/j.molcel.2011.01.023; Menssen A, 2002, P NATL ACAD SCI USA, V99, P6274, DOI 10.1073/pnas.082005599; Miyamoto K, 2007, CELL STEM CELL, V1, P101, DOI 10.1016/j.stem.2007.02.001; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Nemoto S, 2002, SCIENCE, V295, P2450, DOI 10.1126/science.1069004; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Pitulescu ME, 2010, NAT PROTOC, V5, P1518, DOI 10.1038/nprot.2010.113; Potente M, 2005, J CLIN INVEST, V115, P2382, DOI 10.1172/JCI23126; Potente M, 2011, CELL, V146, P873, DOI 10.1016/j.cell.2011.08.039; Ramaswamy S, 2002, CANCER CELL, V2, P81, DOI 10.1016/S1535-6108(02)00086-7; Salih DAM, 2008, CURR OPIN CELL BIOL, V20, P126, DOI 10.1016/j.ceb.2008.02.005; Sander S, 2012, CANCER CELL, V22, P167, DOI 10.1016/j.ccr.2012.06.012; Sengupta A, 2012, DEV DYNAM, V241, P803, DOI 10.1002/dvdy.23759; Stohr O, 2013, AGE, V35, P83, DOI 10.1007/s11357-011-9333-2; Taddei A, 2008, NAT CELL BIOL, V10, P923, DOI 10.1038/ncb1752; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Tsuchiya K, 2012, CELL METAB, V15, P372, DOI 10.1016/j.cmet.2012.01.018; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; Yeo H, 2013, EMBO J, V32, P2589, DOI 10.1038/emboj.2013.186; Zeller KI, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r69	42	312	325	4	108	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 14	2016	529	7585					216	U226		10.1038/nature16498	http://dx.doi.org/10.1038/nature16498			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA7WK	26735015	Green Accepted			2022-12-28	WOS:000368015700038
J	Maixner, F; Krause-Kyora, B; Turaev, D; Herbig, A; Hoopmann, MR; Hallows, JL; Kusebauch, U; Vigl, EE; Malfertheiner, P; Megraud, F; O'Sullivan, N; Cipollini, G; Coia, V; Samadelli, M; Engstrand, L; Linz, B; Moritz, RL; Grimm, R; Krause, J; Nebel, A; Moodley, Y; Rattei, T; Zink, A				Maixner, Frank; Krause-Kyora, Ben; Turaev, Dmitrij; Herbig, Alexander; Hoopmann, Michael R.; Hallows, Janice L.; Kusebauch, Ulrike; Vigl, Eduard Egarter; Malfertheiner, Peter; Megraud, Francis; O'Sullivan, Niall; Cipollini, Giovanna; Coia, Valentina; Samadelli, Marco; Engstrand, Lars; Linz, Bodo; Moritz, Robert L.; Grimm, Rudolf; Krause, Johannes; Nebel, Almut; Moodley, Yoshan; Rattei, Thomas; Zink, Albert			The 5300-year-old Helicobacter pylori genome of the Iceman	SCIENCE			English	Article							ORIGIN; MIGRATION; SEQUENCES; INFERENCE; INSIGHTS	The stomach bacterium Helicobacter pylori is one of the most prevalent human pathogens. It has dispersed globally with its human host, resulting in a distinct phylogeographic pattern that can be used to reconstruct both recent and ancient human migrations. The extant European population of H. pylori is known to be a hybrid between Asian and African bacteria, but there exist different hypotheses about when and where the hybridization took place, reflecting the complex demographic history of Europeans. Here, we present a 5300-year-old H. pylori genome from a European Copper Age glacier mummy. The "Iceman" H. pylori is a nearly pure representative of the bacterial population of Asian origin that existed in Europe before hybridization, suggesting that the African population arrived in Europe within the past few thousand years.	[Maixner, Frank; O'Sullivan, Niall; Cipollini, Giovanna; Coia, Valentina; Samadelli, Marco; Zink, Albert] European Acad Bozen Bolzano EURAC, Inst Mummies & Iceman, I-39100 Bolzano, Italy; [Krause-Kyora, Ben; Nebel, Almut] Univ Kiel, Inst Clin Mol Biol, D-24105 Kiel, Germany; [Turaev, Dmitrij; Rattei, Thomas] Univ Vienna, Dept Microbiol & Ecosyst Sci, CUBE Div Computat Syst Biol, A-1090 Vienna, Austria; [Herbig, Alexander; Krause, Johannes] Univ Tubingen, Inst Archaeol Sci, D-72072 Tubingen, Germany; [Herbig, Alexander; Krause, Johannes] Max Planck Inst Sci Human Hist, D-07745 Jena, Germany; [Hoopmann, Michael R.; Hallows, Janice L.; Kusebauch, Ulrike; Moritz, Robert L.] Inst Syst Biol, Seattle, WA 98109 USA; [Vigl, Eduard Egarter] Scuola Super Sanitaria Prov Claudian, I-39100 Bolzano, Italy; [Malfertheiner, Peter] Otto Von Guericke Univ, Dept Gastroenterol Hepatol & Infect Dis, D-39120 Magdeburg, Germany; [Megraud, Francis] Univ Bordeaux, Ctr Natl Reference Helicobacters & Campylobacters, F-33076 Bordeaux, France; [Megraud, Francis] INSERM, U853, F-33076 Bordeaux, France; [Engstrand, Lars] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, S-14183 Stockholm, Sweden; [Linz, Bodo] Penn State Univ, Dept Vet & Biomed Sci, University Pk, PA 16802 USA; [Grimm, Rudolf] Univ Calif Davis, Robert Mondavi Inst Food Sci, Davis, CA 95616 USA; [Moodley, Yoshan] Univ Venda, Dept Zool, ZA-0950 Thohoyandou, South Africa; [Moodley, Yoshan] Univ Vet Med Vienna, Konrad Lorenz Inst Ethol, Dept Integrat Biol & Evolut, A-1160 Vienna, Austria	European Academy of Bozen-Bolzano; University of Kiel; University of Vienna; Eberhard Karls University of Tubingen; Institute for Systems Biology (ISB); Otto von Guericke University; UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Karolinska Institutet; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of California System; University of California Davis; University of Venda; University of Veterinary Medicine Vienna	Maixner, F (corresponding author), European Acad Bozen Bolzano EURAC, Inst Mummies & Iceman, Viale Druso 1, I-39100 Bolzano, Italy.	frank.maixner@eurac.edu; albert.zink@eurac.edu	Krause, Johannes/E-6640-2015; Maixner, Frank/AAY-7033-2020; Zink, Albert/P-4024-2015; Krause-Kyora, Ben/AAH-3660-2021; Krause, Johannes/AFP-2642-2022; Rattei, Thomas/F-1366-2011; Moritz, Robert L/B-9222-2011; Nebel, Almut/E-4196-2010	Krause, Johannes/0000-0001-5475-4690; Zink, Albert/0000-0002-1461-747X; Krause-Kyora, Ben/0000-0001-9435-2872; Krause, Johannes/0000-0001-9144-3920; Rattei, Thomas/0000-0002-0592-7791; Malfertheiner, Peter/0000-0001-8439-9036; O'Sullivan, Niall/0000-0002-3840-4292; Samadelli, Marco/0000-0002-3799-0189; Herbig, Alexander/0000-0003-1176-1166; Moodley, Yoshan/0000-0003-4216-2924; Megraud, Francis/0000-0002-2481-1612; Hoopmann, Michael/0000-0001-7029-7792; Maixner, Frank/0000-0003-2846-8994	South Tyrolean grant [14]; Ernst Ludwig Ehrlich Studienwerk; University of Vienna; Graduate School Human Development in Landscapes; Excellence Cluster Inflammation at Interfaces; European Research Council (ERC) starting grant APGREID; National Institutes of Health from the National Institute of General Medical Sciences/Center for Systems Biology [R01 GM087221, S10 RR027584, 2P50 GM076547]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM076547, R01GM087221] Funding Source: NIH RePORTER	South Tyrolean grant; Ernst Ludwig Ehrlich Studienwerk; University of Vienna; Graduate School Human Development in Landscapes; Excellence Cluster Inflammation at Interfaces; European Research Council (ERC) starting grant APGREID(European Research Council (ERC)); National Institutes of Health from the National Institute of General Medical Sciences/Center for Systems Biology; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge the following funding sources: the South Tyrolean grant legge 14 (F.M., N.O.S., G.C., V.C., M.S., and A.Z.), the Ernst Ludwig Ehrlich Studienwerk, dissertation completion fellowship of the University of Vienna (D.T.), the Graduate School Human Development in Landscapes and the Excellence Cluster Inflammation at Interfaces (B.K. and A.N.), the European Research Council (ERC) starting grant APGREID (J.K. and A.H.), the National Institutes of Health from the National Institute of General Medical Sciences under grants R01 GM087221 (R.M.), S10 RR027584 (R.M.), and 2P50 GM076547/Center for Systems Biology (R.M). E. Leproust and O. Hardy are highly acknowledged for their help in the RNA bait design. We thank the sequencing team of the Institute of Clinical Molecular Biology at Kiel University for support and expertise. We are grateful to E. Hutten for proofreading of the main text. We are grateful to Olympus, Italy, for providing us with equipment for endoscopy. F.M. and A.Z. conceived the investigation. F.M., B.K., D.T., R.G., J.K., A.N., Y.M., T.R., and A. Z. designed experiments. P.M., L.E., E.E.V., M.S., F.M., and A. Z. were involved in the sampling campaign. F.M., B.K., M.R.H., J.H., U.K., and G.C. performed laboratory work. F.M., B.K., D.T., A.H., M.R.H., N.O.S., B.L., R.L.M., R.G., J.K., Y.M., and T.R. performed analyses. F. M. wrote the manuscript with contributions from B.K., D.T., A.H., M.R.H., U.K., N.O.S., V.C., B.L., R.L.M., R.G., J.K., Y.M., A.N., T.R., and A. Z. Data are available from the European Nucleotide Archive under accession no. ERP012908. The authors declare no competing interests.	Andersson AF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002836; Falush D, 2003, GENETICS, V164, P1567; Falush D, 2003, SCIENCE, V299, P1582, DOI 10.1126/science.1080857; Gaddy JA, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004450; Gostner P, 2011, J ARCHAEOL SCI, V38, P3425, DOI 10.1016/j.jas.2011.08.003; Haak W, 2015, NATURE, V522, P207, DOI 10.1038/nature14317; Jones KR, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00115; Keller A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1701; Lawson DJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002453; Lazaridis I, 2014, NATURE, V513, P409, DOI 10.1038/nature13673; Leach ST, 2008, CAN J GASTROENTEROL, V22, P461, DOI 10.1155/2008/308942; Linz B, 2007, NATURE, V445, P915, DOI 10.1038/nature05562; Malfertheiner P, 2009, LANCET, V374, P1449, DOI 10.1016/S0140-6736(09)60938-7; Moodley Y, 2009, GENOME DYNAM, V6, P62, DOI 10.1159/000235763; Moodley Y, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002693; Moodley Y, 2009, SCIENCE, V323, P527, DOI 10.1126/science.1166083; Muller W, 2003, SCIENCE, V302, P862, DOI 10.1126/science.1089837; Peek RM, 2002, NAT REV CANCER, V2, P28, DOI 10.1038/nrc703; Pritchard JK, 2000, GENETICS, V155, P945; Sawyer S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034131; Segata N, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r42; Suerbaum S, 2007, NAT REV MICROBIOL, V5, P441, DOI 10.1038/nrmicro1658; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Wirth T, 2004, P NATL ACAD SCI USA, V101, P4746, DOI 10.1073/pnas.0306629101	24	134	139	0	82	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 8	2016	351	6269					162	165		10.1126/science.aad2545	http://dx.doi.org/10.1126/science.aad2545			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4XQ	26744403	Green Accepted			2022-12-28	WOS:000367806500039
J	Sarewitz, D				Sarewitz, Daniel			Constructive engagement is the key to climate action	NATURE			English	Editorial Material									[Sarewitz, Daniel] Arizona State Univ, Consortium Sci Policy & Outcomes, Washington, DC USA	Arizona State University	Sarewitz, D (corresponding author), Arizona State Univ, Consortium Sci Policy & Outcomes, Washington, DC USA.	daniel.sarewitz@asu.edu							0	2	2	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 7	2016	529	7584					6	6		10.1038/529006a	http://dx.doi.org/10.1038/529006a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA6VY	26738572	Bronze			2022-12-28	WOS:000367944900002
J	Colchero, MA; Popkin, BM; Rivera, JA; Ng, SW				Arantxa Colchero, M.; Popkin, Barry M.; Rivera, Juan A.; Ng, Shu Wen			Beverage purchases from stores in Mexico under the excise tax on sugar sweetened beverages: observational study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							DIFFERENCE-IN-DIFFERENCES; PUBLIC-HEALTH; WEIGHT-GAIN; BODY-WEIGHT; CONSUMPTION; PRICES; ADULTS; FOOD; OBESITY; INFERENCE	Study question What has been the effect on purchases of beverages from stores in Mexico one year after implementation of the excise tax on sugar sweetened beverages? METHODS In this observational study the authors used data on the purchase of beverages in Mexico from January 2012 to December 2014 from an unbalanced panel of 6253 households providing 205 112 observations in 53 cities with more than 50 000 inhabitants. To test whether the post-tax trend in purchases was significantly different from the pretax trend, the authors used a difference in difference fixed effects model, which adjusts for both macroeconomic variables that can affect the purchase of beverages over time, and pre-existing trends. The variables used in the analysis included demographic information on household composition (age and sex of household members) and socioeconomic status (low, middle, and high). The authors compared the predicted volumes (mL/capita/day) of taxed and untaxed beverages purchased in 2014-the observed post-tax period-with the estimated volumes that would have been purchased if the tax had not been implemented (counterfactual) based on pretax trends. STUDY ANSWER AND LIMITATIONS Relative to the counterfactual in 2014, purchases of taxed beverages decreased by an average of 6% (-12 mL/capita/day), and decreased at an increasing rate up to a 12% decline by December 2014. All three socioeconomic groups reduced purchases of taxed beverages, but reductions were higher among the households of low socioeconomic status, averaging a 9% decline during 2014, and up to a 17% decrease by December 2014 compared with pretax trends. Purchases of untaxed beverages were 4% (36 mL/capita/day) higher than the counterfactual, mainly driven by an increase in purchases of bottled plain water. WHAT THIS STUDY ADDS The tax on sugar sweetened beverages was associated with reductions in purchases of taxed beverages and increases in purchases of untaxed beverages. Continued monitoring is needed to understand purchases longer term, potential substitutions, and health implications.	[Arantxa Colchero, M.] Inst Nacl Salud Publ, Ctr Hlth Syst Res, Cuernavaca, Morelos, Mexico; [Popkin, Barry M.; Ng, Shu Wen] Univ N Carolina, Dept Nutr, Chapel Hill, NC 27516 USA; [Popkin, Barry M.; Ng, Shu Wen] Univ N Carolina, Carolina Populat Ctr, Chapel Hill, NC 27516 USA; [Rivera, Juan A.] Inst Nacl Salud Publ, Nutr & Hlth Res Ctr, Mexico City, DF, Mexico	Instituto Nacional de Salud Publica; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Instituto Nacional de Salud Publica	Ng, SW (corresponding author), Univ N Carolina, Dept Nutr, Chapel Hill, NC 27516 USA.	shuwen@unc.edu	Popkin, Barry/T-6633-2019	Rivera, Juan A./0000-0003-2586-4908	Bloomberg Philanthropies; Robert Wood Johnson Foundation; Instituto Nacional de Salud Publica; Carolina Population Center	Bloomberg Philanthropies; Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); Instituto Nacional de Salud Publica; Carolina Population Center	This work was supported by grants from Bloomberg Philanthropies and the Robert Wood Johnson Foundation and by the Instituto Nacional de Salud Publica and the Carolina Population Center. The funders had no role in the study design or the analysis and interpretation of the data. All authors and their institutions reserve intellectual freedom from the funders.	Andreyeva T, 2011, PREV MED, V52, P413, DOI 10.1016/j.ypmed.2011.03.013; [Anonymous], 2015, INT BUSINESS TIMES; [Anonymous], 2015, ORG EC COOPERATION D; Colchero MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144408; Athey S, 2006, ECONOMETRICA, V74, P431, DOI 10.1111/j.1468-0262.2006.00668.x; Barquera S, 2013, OBES REV, V14, P69, DOI 10.1111/obr.12096; Barquera S, 2008, J NUTR, V138, P2454, DOI 10.3945/jn.108.092163; Barquera S, 2013, SALUD PUBLICA MEXICO, V55, pS151, DOI 10.21149/spm.v55s2.5111; Barquera S, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-47; BECKER GS, 1988, J POLIT ECON, V96, P675, DOI 10.1086/261558; Belotti F, 2015, STATA J, V15, P3, DOI 10.1177/1536867X1501500102; Brownell KD, 2009, NEW ENGL J MED, V361, P1599, DOI 10.1056/NEJMhpr0905723; Case B, 2014, BLOOMBERG NEWS; Colchero MA, 2015, ECON HUM BIOL, V19, P129, DOI 10.1016/j.ehb.2015.08.007; Comision Nacional de los Salarios Minimos, 2014, TABL SAL MIN GEN PRO; de Ruyter JC, 2012, NEW ENGL J MED, V367, P1397, DOI 10.1056/NEJMoa1203034; Donald SG, 2007, REV ECON STAT, V89, P221, DOI 10.1162/rest.89.2.221; DUAN N, 1983, J AM STAT ASSOC, V78, P605, DOI 10.2307/2288126; Ebbeling CB, 2012, NEW ENGL J MED, V367, P1407, DOI 10.1056/NEJMoa1203388; Falbe J, 2015, AM J PUBLIC HEALTH, V105, P2194, DOI 10.2105/AJPH.2015.302881; Finkelstein EA, 2010, ARCH INTERN MED, V170, P2028, DOI 10.1001/archinternmed.2010.449; Grogger J, 2015, 21197 NBER; Grossman M, 1998, J HEALTH ECON, V17, P427, DOI 10.1016/S0167-6296(97)00046-5; Gruber J, 2001, Q J ECON, V116, P1261, DOI 10.1162/003355301753265570; Guthrie A, 2014, WALL STREET J; Gutierrez JP, 2012, ENCUESTA NACL SALUD; HAINES PS, 1988, AM J AGR ECON, V70, P543, DOI 10.2307/1241492; Institute of Heallth Metrics and Evaluation, 2014, MEX GLOB BURD DIS; Instituto Nacional de Estadfstica y Geografia, 2014, ENC NAC OC EMPL IND; Instituto Nacional de Estadistica y Geografia, 2008, ENC NAC INGR GAST HO; Jensen JD, 2013, FOOD POLICY, V42, P18, DOI 10.1016/j.foodpol.2013.06.004; Lesser LI, 2007, PLOS MED, V4, P41, DOI 10.1371/journal.pmed.0040005; Malik VS, 2006, AM J CLIN NUTR, V84, P274; Malik VS, 2013, AM J CLIN NUTR, V98, P1084, DOI 10.3945/ajcn.113.058362; Malik VS, 2010, DIABETES CARE, V33, P2477, DOI 10.2337/dc10-1079; Morenga LT, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e7492; Mytton OT, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2931; Ng SW, 2014, AM J PREV MED, V47, P508, DOI 10.1016/j.amepre.2014.05.029; Ng Shu Wen, 2012, J Acad Nutr Diet, V112, P41, DOI 10.1016/j.jada.2011.09.015; Popkin BM, 2016, LANCET DIABETES ENDO, V4, P174, DOI 10.1016/S2213-8587(15)00419-2; Powell LM, 2013, OBES REV, V14, P110, DOI 10.1111/obr.12002; Powell LM, 2009, MILBANK Q, V87, P229, DOI 10.1111/j.1468-0009.2009.00554.x; Rivera JA, 2012, DETERMINANTES SOCIAL, P269; Rivera Juan A, 2008, Salud pública Méx, V50, P173; Rivera-Dommarco J, 2001, ENCUESTA NACL NUTR 1; Romero-Martinez M, 2013, SALUD PUBLICA MEXICO, V55, pS332, DOI 10.21149/spm.v55s2.5132; StataCorp, 2014, STAT STAT SOFTW REL; Stern D, 2014, J NUTR, V144, P949, DOI 10.3945/jn.114.190652; Juan SV, 2010, SALUD PUBLICA MEXICO, V52, pS2, DOI 10.1590/s0036-36342010000700002; Wolf A, 2008, OBES REV, V9, P151, DOI 10.1111/j.1467-789X.2007.00389.x	50	470	482	6	159	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 6	2016	352								h6704	10.1136/bmj.h6704	http://dx.doi.org/10.1136/bmj.h6704			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DA8MO	26738745	hybrid, Green Published			2022-12-28	WOS:000368059200010
J	Tan, CZ; Novoa, R; Chen, JK				Tan, Caroline Z.; Novoa, Roberto; Chen, Jennifer K.			Erythematous Plaques on the Buttock	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CELLULITIS WELLS-SYNDROME; DIAGNOSIS		[Tan, Caroline Z.; Novoa, Roberto; Chen, Jennifer K.] Stanford Univ, Sch Med, Dept Dermatol, Redwood City, CA 94063 USA	Stanford University	Chen, JK (corresponding author), Stanford Univ, Sch Med, Dept Dermatol, 450 Broadway St,Pavilion C Second Floor MC 5334, Redwood City, CA 94063 USA.	jenniferkchen@stanford.edu						ABERER W, 1988, J AM ACAD DERMATOL, V18, P105, DOI 10.1016/S0190-9622(88)70016-X; Boura P, 2006, ANN RHEUM DIS, V65, P839, DOI 10.1136/ard.2005.044685; Caputo R, 2006, ARCH DERMATOL, V142, P1157, DOI 10.1001/archderm.142.9.1157; COLDIRON BM, 1989, ARCH DERMATOL, V125, P1625, DOI 10.1001/archderm.125.12.1625; Heelan K, 2013, J DERMATOL CASE REP, V7, P113, DOI 10.3315/jdcr.2013.1157; Moossavi M, 2003, INT J DERMATOL, V42, P62, DOI 10.1046/j.1365-4362.2003.01705.x; Sinno H, 2012, CAN J PLAST SURG, V20, P91, DOI 10.1177/229255031202000204; Tugnet N, 2012, RHEUMATOLOGY, V51, P195, DOI 10.1093/rheumatology/ker322	8	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 5	2016	315	1					79	80		10.1001/jama.2015.13562	http://dx.doi.org/10.1001/jama.2015.13562			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DA0YH	26746461				2022-12-28	WOS:000367523000018
J	Couroucli, XI				Couroucli, Xanthi I.			Vitamin A deficiency in adolescents: rare or underdiagnosed?	LANCET			English	Editorial Material									[Couroucli, Xanthi I.] Baylor Coll Med, Dept Pediat, Sect Neonatol, Houston, TX 77030 USA	Baylor College of Medicine	Couroucli, XI (corresponding author), Baylor Coll Med, Dept Pediat, Div Neonatol, 6621 Fannin, Houston, TX 77030 USA.	xanthic@bcm.edu						Al Tanoury Z, 2013, J LIPID RES, V54, P1761, DOI 10.1194/jlr.R030833; Barnett J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055293; Jamison DT, 2013, LANCET, V382, P1898, DOI 10.1016/S0140-6736(13)62105-4; Rosen MJ, 2015, JAMA PEDIAT, V169, P1; Simkin SK, 2016, LANCET, V387, P93, DOI 10.1016/S0140-6736(15)01233-7; Sommer A, 2014, JAMA OPHTHALMOL, V132, P115, DOI 10.1001/jamaophthalmol.2013.5309	6	5	5	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 2	2016	387	10013					94	94		10.1016/S0140-6736(15)00995-2	http://dx.doi.org/10.1016/S0140-6736(15)00995-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CZ9ZU	26766347				2022-12-28	WOS:000367457300032
J	Wai, T; Garcia-Prieto, J; Baker, MJ; Merkwirth, C; Benit, P; Rustin, P; Ruperez, FJ; Barbas, C; Ibanez, B; Langer, T				Wai, Timothy; Garcia-Prieto, Jaime; Baker, Michael J.; Merkwirth, Carsten; Benit, Paule; Rustin, Pierre; Javier Ruperez, Francisco; Barbas, Coral; Ibanez, Borja; Langer, Thomas			Imbalanced OPA1 processing and mitochondrial fragmentation cause heart failure in mice	SCIENCE			English	Article							CYTOCHROME-C RELEASE; DIET-INDUCED OBESITY; PROTEOLYTIC CLEAVAGE; SKELETAL-MUSCLE; PROTEASE OMA1; MOUSE HEARTS; GLUCOSE-HOMEOSTASIS; MITOFUSIN 2; FUSION; METABOLISM	Mitochondrial morphology is shaped by fusion and division of their membranes. Here, we found that adult myocardial function depends on balanced mitochondrial fusion and fission, maintained by processing of the dynamin-like guanosine triphosphatase OPA1 by the mitochondrial peptidases YME1L and OMA1. Cardiac-specific ablation of Yme1l in mice activated OMA1 and accelerated OPA1 proteolysis, which triggered mitochondrial fragmentation and altered cardiac metabolism. This caused dilated cardiomyopathy and heart failure. Cardiac function and mitochondrial morphology were rescued by Oma1 deletion, which prevented OPA1 cleavage. Feeding mice a high-fat diet or ablating Yme1l in skeletal muscle restored cardiac metabolism and preserved heart function without suppressing mitochondrial fragmentation. Thus, unprocessed OPA1 is sufficient to maintain heart function, OMA1 is a critical regulator of cardiomyocyte survival, and mitochondrial morphology and cardiac metabolism are intimately linked.	[Wai, Timothy; Baker, Michael J.; Merkwirth, Carsten; Langer, Thomas] Univ Cologne, Inst Genet, D-50674 Cologne, Germany; [Wai, Timothy; Langer, Thomas] Max Planck Inst Biol Aging, Cologne, Germany; [Garcia-Prieto, Jaime; Ibanez, Borja] Ctr Nacl Invest Cardiovasc Carlos III CNIC, Myocardial Pathophysiol Area, Madrid, Spain; [Benit, Paule; Rustin, Pierre] Hop Robert Debre, INSERM, UMR 1141, F-75019 Paris, France; [Benit, Paule; Rustin, Pierre] Univ Paris 07, Fac Med Denis Diderot, Paris, France; [Javier Ruperez, Francisco; Barbas, Coral] Univ San Pablo CEU, Fac Pharm, Ctr Metabol & Bioanal CEMBIO, Madrid 28668, Spain; [Ibanez, Borja] Fdn Jimenez Diaz Hosp, IIS, Dept Cardiol, Madrid, Spain; [Langer, Thomas] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50931 Cologne, Germany; [Langer, Thomas] Univ Cologne, Ctr Mol Med CMMC, D-50931 Cologne, Germany	University of Cologne; Max Planck Society; Centro Nacional de Investigaciones Cardiovasculares (CNIC); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; San Pablo CEU University; University of Cologne; University of Cologne	Ibanez, B (corresponding author), Ctr Nacl Invest Cardiovasc Carlos III CNIC, Myocardial Pathophysiol Area, Madrid, Spain.	bibanez@cnic.es; thomas.langer@uni-koeln.de	Merkwirth, Carsten/H-5992-2012; Barbas, Coral/K-3871-2014; Ibáñez, Borja/J-6993-2014; Rupérez, Francisco Javier/I-8360-2012; Wai, Timothy/AAA-7226-2019	Merkwirth, Carsten/0000-0001-8895-3495; Barbas, Coral/0000-0003-4722-491X; Ibáñez, Borja/0000-0002-5036-254X; Rupérez, Francisco Javier/0000-0001-6457-6234; Langer, Thomas/0000-0003-1250-1462; Wai, Timothy/0000-0002-6770-6222	Human Frontiers Science Program; Deutsche Forschungsgemeinschaft; European Research Council; Spanish Ministry of Economy and Competitiveness (MINECO) through the Carlos III Institute of Health-Fondo de Investigacion Sanitaria; Spanish Ministry of Economy and Competitiveness (MINECO) through European Regional Development Fund (ERDF/FEDER) funds [PI13/01979]; Networks for Cooperative Research in Health (RETIC) [RD12/0042/0054]; Ministry of Economy and Competitiveness; Pro-CNIC Foundation	Human Frontiers Science Program(Human Frontier Science Program); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Research Council(European Research Council (ERC)European Commission); Spanish Ministry of Economy and Competitiveness (MINECO) through the Carlos III Institute of Health-Fondo de Investigacion Sanitaria; Spanish Ministry of Economy and Competitiveness (MINECO) through European Regional Development Fund (ERDF/FEDER) funds; Networks for Cooperative Research in Health (RETIC); Ministry of Economy and Competitiveness; Pro-CNIC Foundation	We thank K. Lemke, H. Bank, E. Barth, V. Zorita, and M. Gomez for technical assistance; A. Polykratis and C. Uthoff-Hachenberg for genetic engineering assistance; A. Pun-Garcia and R. Villena-Gutierrez for cardiomyocyte isolations; A. V. Alonso Lopez, L. Flores Ruiz, and J. Jimenez-Borreguero for echocardiography evaluation; I. Bilbao, C. Velasco, and J. Ruiz-Cabello for PET-CT evaluation; A. Ferrarini and D. Dudzik for help in metabolomics; G. Rapl for single-cell sorting of cardiac fibroblasts; P. Frommolt for microarray quality control; and J. Bruning for discussion. This work was supported by a fellowship of the Human Frontiers Science Program to T.W., by grants of the Deutsche Forschungsgemeinschaft and the European Research Council to T.L., and by a grant from the Spanish Ministry of Economy and Competitiveness (MINECO) through the Carlos III Institute of Health-Fondo de Investigacion Sanitaria and European Regional Development Fund (ERDF/FEDER) funds (PI13/01979) and Networks for Cooperative Research in Health (RETIC) (RD12/0042/0054) to B.I. The CNIC is supported by the Ministry of Economy and Competitiveness and the Pro-CNIC Foundation. B.I. is Princess of Girona awardee in science. F.J.R. and C.B. acknowledge MINECO CTQ 2014-55279-R. The authors declare no competing or financial interests. The mice used in this study are available under a materials transfer agreement from the authors. The data are included in the main manuscript and the supplementary materials. Author contributions: M.J.B. generated the floxed Oma1 mouse, T.W. generated the floxed Yme1l mouse, hmYKO mice, hmOKO mice, hmDKO mice, cYKO mice, and cDKO mice. C. M. designed targeting constructs. P.B. and P. R. performed oxygen consumption measurements, F.J.R. and C.B. performed the acylcarnitine profiling, and T.W. and J. G.-P. performed all other experiments. T.W., J. G.-P., B.I., and T.L. drafted the manuscript.	Agah R, 1997, J CLIN INVEST, V100, P169, DOI 10.1172/JCI119509; Anand R, 2014, J CELL BIOL, V204, P919, DOI 10.1083/jcb.201308006; Baker MJ, 2014, EMBO J, V33, P578, DOI 10.1002/embj.201386474; Benit P, 2006, CLIN CHIM ACTA, V374, P81, DOI 10.1016/j.cca.2006.05.034; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; Burte F, 2015, NAT REV NEUROL, V11, P11, DOI 10.1038/nrneurol.2014.228; Chambers Kari T, 2011, J Biol Chem, V286, P11155, DOI 10.1074/jbc.M110.217349; Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200; Chen L, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.003012; Chen Y, 2012, CIRC RES, V111, P863, DOI 10.1161/CIRCRESAHA.112.266585; Chen Y, 2011, CIRC RES, V109, P1327, DOI 10.1161/CIRCRESAHA.111.258723; Cipolat S, 2004, P NATL ACAD SCI USA, V101, P15927, DOI 10.1073/pnas.0407043101; Civiletto G, 2015, CELL METAB, V21, P845, DOI 10.1016/j.cmet.2015.04.016; Dietrich MO, 2013, CELL, V155, P188, DOI 10.1016/j.cell.2013.09.004; Dorn GW, 2015, J MOL CELL CARDIOL, V78, P123, DOI 10.1016/j.yjmcc.2014.09.015; Dorn GW, 2015, CIRC RES, V116, P167, DOI 10.1161/CIRCRESAHA.116.303554; Ehses S, 2009, J CELL BIOL, V187, P1023, DOI 10.1083/jcb.200906084; El-Khoury R, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003182; Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025; Friedman JR, 2014, NATURE, V505, P335, DOI 10.1038/nature12985; Friedman JR, 2011, SCIENCE, V334, P358, DOI 10.1126/science.1207385; Garcia-Prieto J, 2014, BASIC RES CARDIOL, V109, DOI 10.1007/s00395-014-0422-0; Gomes LC, 2011, AUTOPHAGY, V7, P1251, DOI 10.4161/auto.7.10.16771; Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220; Griparic L, 2007, J CELL BIOL, V178, P757, DOI 10.1083/jcb.200704112; HACKENBROCK CR, 1966, J CELL BIOL, V30, P269, DOI 10.1083/jcb.30.2.269; Handschin C, 2007, J CLIN INVEST, V117, P3463, DOI 10.1172/JCI31785; Hansson A, 2004, P NATL ACAD SCI USA, V101, P3136, DOI 10.1073/pnas.0308710100; Head B, 2009, J CELL BIOL, V187, P959, DOI 10.1083/jcb.200906083; Huss JM, 2005, J CLIN INVEST, V115, P547, DOI 10.1172/JCI200524405; Ikeda Y, 2015, CIRC RES, V116, P264, DOI 10.1161/CIRCRESAHA.116.303356; Ishihara N, 2006, EMBO J, V25, P2966, DOI 10.1038/sj.emboj.7601184; Jiang X, 2014, P NATL ACAD SCI USA, V111, P14782, DOI 10.1073/pnas.1417253111; Jing EX, 2011, P NATL ACAD SCI USA, V108, P14608, DOI 10.1073/pnas.1111308108; Kageyama Y, 2014, EMBO J, V33, P2798, DOI 10.15252/embj.201488658; Kasahara A, 2013, SCIENCE, V342, P734, DOI 10.1126/science.1241359; Kolwicz SC, 2011, CARDIOVASC RES, V90, P194, DOI 10.1093/cvr/cvr071; Korobova F, 2013, SCIENCE, V339, P464, DOI 10.1126/science.1228360; Lowes BD, 2002, NEW ENGL J MED, V346, P1357, DOI 10.1056/NEJMoa012630; Mishra P, 2014, NAT REV MOL CELL BIO, V15, P634, DOI 10.1038/nrm3877; Mishra P, 2014, CELL METAB, V19, P630, DOI 10.1016/j.cmet.2014.03.011; Mourier A, 2015, J CELL BIOL, V208, P429, DOI 10.1083/jcb.201411100; Nasrallah CM, 2014, NAT REV ENDOCRINOL, V10, P650, DOI 10.1038/nrendo.2014.160; Olichon A, 2003, J BIOL CHEM, V278, P7743, DOI 10.1074/jbc.C200677200; Ong SB, 2010, CIRCULATION, V121, P2012, DOI 10.1161/CIRCULATIONAHA.109.906610; Papanicolaou KN, 2012, CIRC RES, V111, P1012, DOI 10.1161/CIRCRESAHA.112.274142; Papanicolaou KN, 2011, MOL CELL BIOL, V31, P1309, DOI 10.1128/MCB.00911-10; Park CB, 2007, CELL, V130, P273, DOI 10.1016/j.cell.2007.05.046; Patten DA, 2014, EMBO J, V33, P2676, DOI 10.15252/embj.201488349; Piquereau J, 2012, CARDIOVASC RES, V94, P408, DOI 10.1093/cvr/cvs117; Potting C, 2013, CELL METAB, V18, P287, DOI 10.1016/j.cmet.2013.07.008; Quiros PM, 2015, NAT REV MOL CELL BIO, V16, P345, DOI 10.1038/nrm3984; Quiros PM, 2012, EMBO J, V31, P2117, DOI 10.1038/emboj.2012.70; Riehle C, 2013, J CLIN INVEST, V123, P5319, DOI 10.1172/JCI71171; Roy M, 2015, CURR OPIN CELL BIOL, V33, P111, DOI 10.1016/j.ceb.2015.02.001; Ruan Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.414; Ruzzenente B, 2012, EMBO J, V31, P443, DOI 10.1038/emboj.2011.392; Sankaralingam S, 2015, DIABETES, V64, P1643, DOI 10.2337/db14-1050; Sebastian D, 2012, P NATL ACAD SCI USA, V109, P5523, DOI 10.1073/pnas.1108220109; Song MS, 2015, CELL METAB, V21, P273, DOI 10.1016/j.cmet.2014.12.011; Song ZY, 2007, J CELL BIOL, V178, P749, DOI 10.1083/jcb.200704110; Sun Z, 2011, J BIOL CHEM, V286, P33301, DOI 10.1074/jbc.M111.277707; Tondera D, 2009, EMBO J, V28, P1589, DOI 10.1038/emboj.2009.89; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Varanita T, 2015, CELL METAB, V21, P834, DOI 10.1016/j.cmet.2015.05.007; Wikstrom JD, 2014, EMBO J, V33, P418, DOI 10.1002/embj.201385014; Xiao X, 2014, AM J PHYSIOL-RENAL, V306, pF1318, DOI 10.1152/ajprenal.00036.2014; Yan J, 2009, CIRCULATION, V119, P2818, DOI 10.1161/CIRCULATIONAHA.108.832915; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855; Zhang K, 2014, EMBO REP, V15, P576, DOI 10.1002/embr.201338240	70	286	296	5	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 4	2015	350	6265							aad0116	10.1126/science.aad0116	http://dx.doi.org/10.1126/science.aad0116			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX4WG	26785494				2022-12-28	WOS:000365700500068
J	Nissen, SE				Nissen, Steven E.			US Dietary Guidelines: An Evidence-Free Zone	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							WOMEN; RISK; CONSUMPTION; SUGAR; SODA		[Nissen, Steven E.] Cleveland Clin, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Nissen, SE (corresponding author), Cleveland Clin, Dept Cardiovasc Med, 9500 Euclid Ave, Cleveland, OH 44195 USA.	nissens@ccf.org						[Anonymous], 1970, SUMMARY CIRCULATION, V41, P1186; Bao Y, 2013, BRIT J CANCER, V109, P2911, DOI 10.1038/bjc.2013.665; Chowdhury R, 2014, ANN INTERN MED, V160, P398, DOI 10.7326/M13-1788; Estruch R, 2013, NEW ENGL J MED, V368, P1279, DOI 10.1056/NEJMoa1200303; Lin J, 2011, CLIN J AM SOC NEPHRO, V6, P160, DOI 10.2215/CJN.03260410; Schernhammer ES, 2012, AM J CLIN NUTR, V96, P1419, DOI 10.3945/ajcn.111.030833; Teicholz N., 2014, BIG FAT SURPRISE WHY; US Department of Health and Human Services and USDA, 2015, DIET GUID AM 2015 20; Varraso R, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h286	9	24	24	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 19	2016	164	8					558	+		10.7326/M16-0035	http://dx.doi.org/10.7326/M16-0035			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ5OH	26783992				2022-12-28	WOS:000374257900015
J	Greenberg, B; Butler, J; Felker, GM; Ponikowski, P; Voors, AA; Desai, AS; Barnard, D; Bouchard, A; Jaski, B; Lyon, AR; Pogoda, JM; Rudy, JJ; Zsebo, KM				Greenberg, Barry; Butler, Javed; Felker, G. Michael; Ponikowski, Piotr; Voors, Adriaan A.; Desai, Akshay S.; Barnard, Denise; Bouchard, Alain; Jaski, Brian; Lyon, Alexander R.; Pogoda, Janice M.; Rudy, Jeffrey J.; Zsebo, Krisztina M.			Calcium upregulation by percutaneous administration of gene therapy in patients with cardiac disease (CUPID 2): a randomised, multinational, double-blind, placebo-controlled, phase 2b trial	LANCET			English	Article							SARCOPLASMIC-RETICULUM CA2+-ATPASE; HEART-FAILURE; MYOCARDIAL-FUNCTION; DELIVERY; MODEL; EXPRESSION	Background Sarcoplasmic/endoplasmic reticulum Ca2+-ATPase (SERCA2a) activity is deficient in the failing heart. Correction of this abnormality by gene transfer might improve cardiac function. We aimed to investigate the clinical benefits and safety of gene therapy through infusion of adeno-associated virus 1 (AAV1)/SERCA2a in patients with heart failure and reduced ejection fraction. Methods We did this randomised, multinational, double-blind, placebo-controlled, phase 2b trial at 67 clinical centres and hospitals in the USA, Europe, and Israel. High-risk ambulatory patients with New York Heart Association class II-IV symptoms of heart failure and a left ventricular ejection fraction of 0.35 or less due to an ischaemic or non-ischaemic cause were randomly assigned (1: 1), via an interactive voice and web-response system, to receive a single intracoronary infusion of 1 x 10(13) DNase-resistant particles of AAV1/SERCA2a or placebo. Randomisation was stratified by country and by 6 min walk test distance. All patients, physicians, and outcome assessors were masked to treatment assignment. The primary efficacy endpoint was time to recurrent events, defined as hospital admission because of heart failure or ambulatory treatment for worsening heart failure. Primary efficacy endpoint analyses and safety analyses were done by modified intention to treat. This trial is registered with ClinicalTrials.gov, number NCT01643330. Findings Between July 9, 2012, and Feb 5, 2014, we randomly assigned 250 patients to receive either AAV1/SERCA2a (n= 123) or placebo (n= 127); 243 (97%) patients comprised the modified intention-to-treat population. Patients were followed up for at least 12 months; median follow-up was 17.5 months (range 1.8-29.4 months). AAV1/SERCA2a did not improve time to recurrent events compared with placebo (104 vs 128 events; hazard ratio 0.93, 95% CI 0.53-1.65; p= 0.81). No safety signals were noted. 20 (16%) patients died in the placebo group and 25 (21%) patients died in the AAV1/SERCA2a group; 18 and 22 deaths, respectively, were adjudicated as being due to cardiovascular causes. Interpretation CUPID 2 is the largest gene transfer study done in patients with heart failure so far. Despite promising results from previous studies, AAV1/SERCA2a at the dose tested did not improve the clinical course of patients with heart failure and reduced ejection fraction. Although we did not find evidence of improved outcomes at the dose of AAV1/SERCA2a studied, our findings should stimulate further research into the use of gene therapy to treat patients with heart failure and help inform the design of future gene therapy trials.	[Greenberg, Barry; Barnard, Denise] Univ Calif San Diego, Sulpizio Cardiovasc Ctr, La Jolla, CA 92037 USA; [Butler, Javed] SUNY Stony Brook, Stony Brook, NY 11794 USA; [Felker, G. Michael] Duke Univ, Sch Med, Durham, NC USA; [Ponikowski, Piotr] Wroclaw Med Univ, Wroclaw, Poland; [Ponikowski, Piotr] Mil Hosp, Wroclaw, Poland; [Voors, Adriaan A.] Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands; [Desai, Akshay S.] Brigham & Womens Hosp, Div Cardiovasc, 75 Francis St, Boston, MA 02115 USA; [Bouchard, Alain] Cardiol PC, Birmingham, AL USA; [Jaski, Brian] Sharp Mem Hosp & Rehabil Ctr, San Diego Cardiac Ctr, San Diego, CA USA; [Lyon, Alexander R.] Royal Brompton Hosp, London SW3 6LY, England; [Lyon, Alexander R.] Univ London Imperial Coll Sci Technol & Med, London, England; [Pogoda, Janice M.; Rudy, Jeffrey J.] Celladon Corp, San Diego, CA USA; [Zsebo, Krisztina M.] Biovest Consulting, Santa Barbara, CA USA	University of California System; University of California San Diego; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Duke University; Wroclaw Medical University; University of Groningen; Harvard University; Brigham & Women's Hospital; Sharp Memorial Hospital Rehabilitation & Physical Therapy; Royal Brompton Hospital; Imperial College London	Greenberg, B (corresponding author), Univ Calif San Diego, Sulpizio Cardiovasc Ctr, Adv Heart Failure Treatment Program, La Jolla, CA 92037 USA.	bgreenberg@ucsd.edu	Felker, Michael/AAX-2288-2021; Voors, Adriaan/ABE-6784-2020; Ponikowski, Piotr/O-6454-2015; Desai, Akshay/ABE-7250-2020	Ponikowski, Piotr/0000-0002-3391-7064; Felker, Gary/0000-0002-5931-1239	Celladon Corporation; Celladon; National Institute for Health Research Cardiovascular Biomedical Research Unit; Royal Brompton Hospital; British Heart Foundation; British Heart Foundation [FS/11/67/28954] Funding Source: researchfish	Celladon Corporation; Celladon; National Institute for Health Research Cardiovascular Biomedical Research Unit; Royal Brompton Hospital; British Heart Foundation(British Heart Foundation); British Heart Foundation(British Heart Foundation)	This trial was funded by Celladon Corporation. Celladon also provided funding for manuscript and graphics support. We thank all the investigators (appendix) and patients involved in this study, Roger Hajjar (Mount Sinai, New York, NY, USA) for his guidance on AAV1/SERCA2a development, Sharon L Cross for providing manuscript support, and Julia Andres for providing graphics support on behalf of Celladon. ARL wishes to acknowledge support from the National Institute for Health Research Cardiovascular Biomedical Research Unit, Royal Brompton Hospital, and the British Heart Foundation.	Beltrami CA, 1997, ADV CLIN PATH, V1, P597; Byrne MJ, 2008, GENE THER, V15, P1550, DOI 10.1038/gt.2008.120; [Center for Biologics Evaluation and Research (CBER) Center for Drug Evaluation and Research (CDER)], 1998, GUID IND E9 STAT PRI; del Monte F, 2001, CIRCULATION, V104, P1424, DOI 10.1161/hc3601.095574; Eisner D, 2013, CIRC RES, V113, P958, DOI 10.1161/CIRCRESAHA.113.302187; Greenberg B, 2014, JACC-HEART FAIL, V2, P84, DOI 10.1016/j.jchf.2013.09.008; HASENFUSS G, 1994, CIRC RES, V75, P434, DOI 10.1161/01.RES.75.3.434; Hasenfuss G, 2002, J MOL CELL CARDIOL, V34, P951, DOI 10.1006/jmcc.2002.2037; Jaski BE, 2009, J CARD FAIL, V15, P171, DOI 10.1016/j.cardfail.2009.01.013; Jessup M, 2011, CIRCULATION, V124, P304, DOI 10.1161/CIRCULATIONAHA.111.022889; Karakikes I, 2012, MOL THER, V20, P565, DOI 10.1038/mt.2011.268; Kawase Y, 2008, J AM COLL CARDIOL, V51, P1112, DOI 10.1016/j.jacc.2007.12.014; Kho C, 2012, NAT REV CARDIOL, V9, P717, DOI 10.1038/nrcardio.2012.145; Liu L, 2004, BIOMETRICS, V60, P747, DOI 10.1111/j.0006-341X.2004.00225.x; Liu L, 2008, STAT MED, V27, P2665, DOI 10.1002/sim.3077; Mariani JA, 2011, EUR J HEART FAIL, V13, P247, DOI 10.1093/eurjhf/hfq234; Mingozzi F, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005795; Moher David, 2010, BMJ, V340, pc869, DOI [10.1016/j.jclinepi.2010.03.004, 10.1136/bmj.c869]; National Heart Lung and Blood Institute, 2012, MORB MORT 2012 CHART; Nelson W, 2003, RECURRENT EVENTS DAT; Sakata S, 2007, J MOL CELL CARDIOL, V42, P852, DOI 10.1016/j.yjmcc.2007.01.003; Urabe M, 2006, MOL THER, V13, P823, DOI 10.1016/j.ymthe.2005.11.024; Wolfram JA, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000119; Zouein Fouad A, 2013, F1000Prime Rep, V5, P27, DOI 10.12703/P5-27; Zsebo K, 2014, CIRC RES, V114, P101, DOI 10.1161/CIRCRESAHA.113.302421	25	251	262	1	37	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 19	2016	387	10024					1178	1186		10.1016/S0140-6736(16)00082-9	http://dx.doi.org/10.1016/S0140-6736(16)00082-9			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DG9OB	26803443	Green Submitted			2022-12-28	WOS:000372412000029
J	Laurent, S; Boutouyrie, P				Laurent, Stephane; Boutouyrie, Pierre			Blood pressure lowering trials: wrapping up the topic?	LANCET			English	Editorial Material							EUROPEAN-SOCIETY; HYPERTENSION; GUIDELINES; MANAGEMENT		[Laurent, Stephane; Boutouyrie, Pierre] Hop Europeen Georges Pompidou, AP HP, Dept Pharmacol, INSERM,UMR 970, F-75015 Paris, France; [Laurent, Stephane; Boutouyrie, Pierre] Univ Paris 05, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Laurent, S (corresponding author), Hop Europeen Georges Pompidou, AP HP, Dept Pharmacol, INSERM,UMR 970, F-75015 Paris, France.; Laurent, S (corresponding author), Univ Paris 05, Paris, France.	stephane.laurent@egp.aphp.fr	boutouyrie, pierre/HGT-8201-2022	boutouyrie, pierre/0000-0002-4375-3569				Ettehad D, 2016, LANCET, V387, P957, DOI 10.1016/S0140-6736(15)01225-8; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/ehm236, 10.1093/eurheartj/eht151]; National Institute for Health and Care Excellence (NICE), 2011, HYP AD DIAGN MAN; SPRINT Research Group, 2015, N Engl J Med, V373, P2103, DOI 10.1056/NEJMoa1511939; Thomopoulos C, 2015, J HYPERTENS, V33, P1321, DOI 10.1097/HJH.0000000000000614; Weber MA, 2014, J HYPERTENS, V32, P3, DOI [10.1111/jch.12237, 10.1097/HJH.0000000000000065]; Zanchetti A, 2014, J HYPERTENS, V32, P1888, DOI 10.1097/HJH.0000000000000254; Zanchetti A, 2009, J HYPERTENS, V27, P923, DOI 10.1097/HJH.0b013e32832aa6b5	9	2	3	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 5	2016	387	10022					923	924		10.1016/S0140-6736(15)01344-6	http://dx.doi.org/10.1016/S0140-6736(15)01344-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DF8XP	26724177				2022-12-28	WOS:000371644200007
J	Kotchen, TA; Cowley, AW; Liang, MY				Kotchen, Theodore A.; Cowley, Allen W., Jr.; Liang, Mingyu			Ushering Hypertension Into a New Era of Precision Medicine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							EPIGENETICS		[Kotchen, Theodore A.] Med Coll Wisconsin, Dept Med, 9200 W Wisconsin Ave, Milwaukee, WI 53226 USA; [Cowley, Allen W., Jr.; Liang, Mingyu] Med Coll Wisconsin, Dept Physiol, Ctr Syst Mol Med, Milwaukee, WI 53226 USA	Medical College of Wisconsin; Medical College of Wisconsin	Kotchen, TA (corresponding author), Med Coll Wisconsin, Dept Med, 9200 W Wisconsin Ave, Milwaukee, WI 53226 USA.	tkotchen@mcw.edu	Liang, Mingyu/A-2331-2008		NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001436] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL082798] Funding Source: NIH RePORTER; NCATS NIH HHS [UL1 TR001436, UL1TR001436] Funding Source: Medline; NHLBI NIH HHS [P01 HL082798, HL-082798] Funding Source: Medline	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Cowley AW, 2012, HYPERTENSION, V59, P899, DOI 10.1161/HYPERTENSIONAHA.111.190116; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Feinberg AP, 2015, JAMA-J AM MED ASSOC, V314, P1129, DOI 10.1001/jama.2015.10414; Friso S, 2015, TRANSL RES, V165, P154, DOI 10.1016/j.trsl.2014.06.007; Go AS, 2014, HYPERTENSION, V63, P878, DOI 10.1161/HYP.0000000000000003; Joyner MJ, 2015, JAMA-J AM MED ASSOC, V314, P999, DOI 10.1001/jama.2015.7725; Laragh JH, 2011, AM J HYPERTENS, V24, P1164, DOI 10.1038/ajh.2011.171; Liang MY, 2013, SEMIN NEPHROL, V33, P392, DOI [10.1016/j.semnephro1.2013.05.011, 10.1016/j.semnephrol.2013.05.011]; PICKERING GW, 1955, ANN INTERN MED, V43, P1153, DOI 10.7326/0003-4819-43-6-1153	9	54	55	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 26	2016	315	4					343	344		10.1001/jama.2015.18359	http://dx.doi.org/10.1001/jama.2015.18359			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DB5YI	26769233	Green Accepted			2022-12-28	WOS:000368589500008
J	Tang, M; Chen, K; Rudnick, RL				Tang, Ming; Chen, Kang; Rudnick, Roberta L.			Archean upper crust transition from mafic to felsic marks the onset of plate tectonics	SCIENCE			English	Article							EARLY CONTINENTAL-CRUST; GROWTH; GEOCHEMISTRY; EVOLUTION; SEDIMENTS	The Archean Eon witnessed the production of early continental crust, the emergence of life, and fundamental changes to the atmosphere. The nature of the first continental crust, which was the interface between the surface and deep Earth, has been obscured by the weathering, erosion, and tectonism that followed its formation. We used Ni/Co and Cr/Zn ratios in Archean terrigenous sedimentary rocks and Archean igneous/metaigneous rocks to track the bulk MgO composition of the Archean upper continental crust. This crust evolved from a highly mafic bulk composition before 3.0 billion years ago to a felsic bulk composition by 2.5 billion years ago. This compositional change was attended by a fivefold increase in the mass of the upper continental crust due to addition of granitic rocks, suggesting the onset of global plate tectonics at similar to 3.0 billion years ago.	[Tang, Ming; Chen, Kang; Rudnick, Roberta L.] Univ Maryland, Dept Geol, College Pk, MD 20742 USA; [Chen, Kang] China Univ Geosci, Sch Earth Sci, State Key Lab Geol Proc & Mineral Resources, Wuhan 430074, Peoples R China	University System of Maryland; University of Maryland College Park; China University of Geosciences	Tang, M (corresponding author), Univ Maryland, Dept Geol, College Pk, MD 20742 USA.	tangmyes@gmail.com	Rudnick, Roberta Lyn/J-2398-2013	Rudnick, Roberta Lyn/0000-0003-1559-7463; Chen, Kang/0000-0003-3148-8128	NSF [EAR 0948549]; Wylie Fellowship; Division Of Earth Sciences [0948549] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Wylie Fellowship; Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This project was supported by NSF grant EAR 0948549 and a Wylie Fellowship to M.T. We appreciate discussions with C. Hawkesworth, S. McLennan, K. Condie, N. Arndt, I. Puchtel, R. Gaschnig, D. Lowe, A. Hessler, and J. Hurowitz. We also thank three anonymous reviewers for their constructive comments. Geochemical data for the sedimentary rocks and Archean craton rocks (http://georoc.mpch-mainz.gwdg.de/georoc/) used in this work are available in the supplementary materials.	Albarede F, 1998, TECTONOPHYSICS, V296, P1, DOI 10.1016/S0040-1951(98)00133-4; [Anonymous], 1985, CONTINENTAL CRUST; Arndt NT, 2013, GEOCHEM PERSPECT, V2, P405, DOI 10.7185/geochempersp.2.3; Bedard JH, 2006, GEOCHIM COSMOCHIM AC, V70, P1188, DOI 10.1016/j.gca.2005.11.008; BOUGAULT H, 1974, EARTH PLANET SC LETT, V24, P249, DOI 10.1016/0012-821X(74)90103-4; Condie KC, 1998, EARTH PLANET SC LETT, V163, P97, DOI 10.1016/S0012-821X(98)00178-2; CONDIE KC, 1993, CHEM GEOL, V104, P1, DOI 10.1016/0009-2541(93)90140-E; Condie KC, 2010, PRECAMBRIAN RES, V180, P227, DOI 10.1016/j.precamres.2010.03.008; Dhuime B, 2015, NAT GEOSCI, V8, P552, DOI [10.1038/ngeo2466, 10.1038/NGEO2466]; Dhuime B, 2012, SCIENCE, V335, P1334, DOI 10.1126/science.1216066; FENG R, 1990, GEOCHIM COSMOCHIM AC, V54, P1061, DOI 10.1016/0016-7037(90)90439-R; Foley S, 2002, NATURE, V417, P837, DOI 10.1038/nature00799; Frei R, 2009, NATURE, V461, P250, DOI 10.1038/nature08266; Gaschnig RM, 2014, EARTH PLANET SC LETT, V408, P87, DOI 10.1016/j.epsl.2014.10.002; Gerya T, 2014, GONDWANA RES, V25, P442, DOI 10.1016/j.gr.2012.11.008; Herzberg C, 2007, GEOCHEM GEOPHY GEOSY, V8, DOI 10.1029/2006GC001390; Holland HD., 1984, CHEM EVOLUTION ATMOS; HORN I, 1994, CHEM GEOL, V117, P193, DOI 10.1016/0009-2541(94)90128-7; Johnson TE, 2014, NAT GEOSCI, V7, P47, DOI [10.1038/NGEO2019, 10.1038/ngeo2019]; Keller CB, 2015, NATURE, V523, P301, DOI 10.1038/nature14584; LEEMAN WP, 1977, EARTH PLANET SC LETT, V35, P247, DOI 10.1016/0012-821X(77)90128-5; Martin H, 2002, GEOLOGY, V30, P319, DOI 10.1130/0091-7613(2002)030<0319:SCITTG>2.0.CO;2; MCLENNAN SM, 1983, PRECAMBRIAN RES, V22, P93, DOI 10.1016/0301-9268(83)90060-8; MICHALOPOULOS P, 1995, SCIENCE, V270, P614, DOI 10.1126/science.270.5236.614; Pearson DG, 2007, NATURE, V449, P202, DOI 10.1038/nature06122; Rapp RP, 2003, NATURE, V425, P605, DOI 10.1038/nature02031; Rudnick R.L., 2004, TREATISE GEOCHEMISTR, P1, DOI DOI 10.1016/B0-08-043751-6/03016-4; RUDNICK RL, 1995, NATURE, V378, P571, DOI 10.1038/378571a0; Shirey SB, 2011, SCIENCE, V333, P434, DOI 10.1126/science.1206275; Smithies RH, 2000, EARTH PLANET SC LETT, V182, P115, DOI 10.1016/S0012-821X(00)00236-3; Tang M, 2015, GEOLOGY, V43, P703, DOI 10.1130/G36641.1	31	259	276	35	257	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 22	2016	351	6271					372	375		10.1126/science.aad5513	http://dx.doi.org/10.1126/science.aad5513			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB3VH	26798012				2022-12-28	WOS:000368440500037
J	Ketel, K; Krauss, M; Nicot, AS; Puchkov, D; Wieffer, M; Muller, R; Subramanian, D; Schultz, C; Laporte, J; Haucke, V				Ketel, Katharina; Krauss, Michael; Nicot, Anne-Sophie; Puchkov, Dmytro; Wieffer, Marnix; Mueller, Rainer; Subramanian, Devaraj; Schultz, Carsten; Laporte, Jocelyn; Haucke, Volker			A phosphoinositide conversion mechanism for exit from endosomes	NATURE			English	Article							LINKED MYOTUBULAR MYOPATHY; PHOSPHATIDYLINOSITOL 4-KINASE; CELL REGULATION; II-ALPHA; TRAFFICKING; COMPLEX; PHOSPHATASES; MULTIPLE; RECEPTOR; 3-KINASE	Phosphoinositides are a minor class of short-lived membrane phospholipids that serve crucial functions in cell physiology ranging from cell signalling and motility to their role as signposts of compartmental membrane identity(1,2). Phosphoinositide 4-phosphates such as phosphatidylinositol 4-phosphate (PI(4)P) and phosphatidylinositol 4,5-bisphosphate (PI(4,5)P-2) are concentrated at the plasma membrane, on secretory organelles(3), and on lysosomes(4), whereas phosphoinositide 3-phosphates, most notably phosphatidylinositol 3-phosphate (PI(3)P)(5), are a hallmark of the endosomal system(1,2). Directional membrane traffic between endosomal and secretory compartments, although inherently complex, therefore requires regulated phosphoinositide conversion. The molecular mechanism underlying this conversion of phosphoinositide identity during cargo exit from endosomes by exocytosis is unknown. Here we report that surface delivery of endosomal cargo requires hydrolysis of PI(3) P by the phosphatidylinositol 3-phosphatase MTM1, an enzyme whose loss of function leads to X-linked centronuclear myopathy (also called myotubular myopathy) in humans(6). Removal of endosomal PI(3) P by MTM1 is accompanied by phosphatidylinositol 4-kinase-2 alpha (PI4K2 alpha)-dependent generation of PI(4) P and recruitment of the exocyst tethering complex to enable membrane fusion. Our data establish a mechanism for phosphoinositide conversion from PI(3) P to PI(4) P at endosomes en route to the plasma membrane and suggest that defective phosphoinositide conversion at endosomes underlies X-linked centronuclear myopathy caused by mutation of MTM1 in humans.	[Ketel, Katharina; Krauss, Michael; Puchkov, Dmytro; Haucke, Volker] Leibniz Inst Mol Pharmacol, D-13125 Berlin, Germany; [Nicot, Anne-Sophie; Laporte, Jocelyn] Strasbourg Univ, INSERM, U964, CNRS,UMR7104,Dept Translat Med & Neurogenet,IGBMC, F-67404 Illkirch Graffenstaden, France; [Wieffer, Marnix; Haucke, Volker] Free Univ Berlin, Fac Biol Chem & Pharm, D-14195 Berlin, Germany; [Mueller, Rainer; Subramanian, Devaraj; Schultz, Carsten] European Mol Biol Lab, Cell Biol & Biophys Unit, D-69117 Heidelberg, Germany; [Haucke, Volker] Charite, NeuroCure Cluster Excellence, D-10117 Berlin, Germany	Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Free University of Berlin; European Molecular Biology Laboratory (EMBL); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Haucke, V (corresponding author), Leibniz Inst Mol Pharmacol, D-13125 Berlin, Germany.	haucke@fmp-berlin.de	Laporte, Jocelyn/H-6801-2016; Nicot, Anne-Sophie/GSE-6467-2022	Mueller, Rainer/0000-0003-3464-494X; Puchkov, Dmytro/0000-0001-8341-4847; laporte, jocelyn/0000-0001-8256-5862; Haucke, Volker/0000-0003-3119-6993; Schultz, Carsten/0000-0002-5824-2171; Krauss, Michael/0000-0003-1010-9723	German Research Foundation [SFB740/C8, SFB958/A11]; Agence Nationale de la Recherche [ANR-14-CE12-0009/13-BSV2-0004]	German Research Foundation(German Research Foundation (DFG)); Agence Nationale de la Recherche(French National Research Agency (ANR))	We thank L. Pluska for initial studies on PI4K2 alpha-exocyst, I. Ganley for fluorescently labelled p40-Phox, M. Ringling, M. Muhlbauer, L. von Oertzen, and S. Zillmann for technical assistance, and A. Marat for comments. This work was supported by grants from the German Research Foundation (SFB740/C8 to V.H. and SFB958/A11 to M.K.) and Agence Nationale de la Recherche (ANR-14-CE12-0009/13-BSV2-0004 to J.L.).	Amoasii L, 2012, CURR TOP MICROBIOL, V362, P209, DOI 10.1007/978-94-007-5025-8_10; Bago R, 2014, BIOCHEM J, V463, P413, DOI 10.1042/BJ20140889; Balla T, 2013, PHYSIOL REV, V93, P1019, DOI 10.1152/physrev.00028.2012; Buj-Bello A, 2002, P NATL ACAD SCI USA, V99, P15060, DOI 10.1073/pnas.212498399; Cao CH, 2008, MOL BIOL CELL, V19, P3334, DOI 10.1091/mbc.E08-04-0367; Cullen PJ, 2012, NAT CELL BIOL, V14, P29, DOI 10.1038/ncb2374; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Diesenberg K, 2015, J CELL SCI, V128, P397, DOI 10.1242/jcs.162206; Dowling JJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000372; Gordon DE, 2010, TRAFFIC, V11, P1191, DOI 10.1111/j.1600-0854.2010.01087.x; Guo J, 2003, P NATL ACAD SCI USA, V100, P3995, DOI 10.1073/pnas.0230488100; Hammond GRV, 2014, J CELL BIOL, V205, P113, DOI 10.1083/jcb.201312072; Hammond GRV, 2012, SCIENCE, V337, P727, DOI 10.1126/science.1222483; Hammond GRV, 2009, BIOCHEM J, V422, P23, DOI 10.1042/BJ20090428; Herman GE, 1999, J PEDIATR-US, V134, P206, DOI 10.1016/S0022-3476(99)70417-8; Hertzog M, 2011, BIOCHEM J, V433, P403, DOI 10.1042/BJ20101214; Hsu VW, 2012, NAT REV MOL CELL BIO, V13, P1, DOI 10.1038/nrm3332; Jovic M, 2014, J CELL SCI, V127, P3745, DOI 10.1242/jcs.148809; Laporte J, 2000, HUM MUTAT, V15, P393, DOI 10.1002/(SICI)1098-1004(200005)15:5<393::AID-HUMU1>3.0.CO;2-R; Laporte J, 2001, ANN NEUROL, V50, P42, DOI 10.1002/ana.1033; Lorenzo O, 2006, J CELL SCI, V119, P2953, DOI 10.1242/jcs.03040; Minogue S, 2006, J CELL SCI, V119, P571, DOI 10.1242/jcs.02752; Mizuno-Yamasaki E, 2010, DEV CELL, V18, P828, DOI 10.1016/j.devcel.2010.03.016; Mossinger J, 2012, EMBO REP, V13, P1087, DOI 10.1038/embor.2012.164; Munson MJ, 2015, EMBO J, V34, P2272, DOI 10.15252/embj.201590992; Posor Y, 2013, NATURE, V499, P233, DOI 10.1038/nature12360; Raiborg C, 2013, FEBS J, V280, P2730, DOI 10.1111/febs.12116; Ribeiro I, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001295; Schmidt MR, 2009, P NATL ACAD SCI USA, V106, P15344, DOI 10.1073/pnas.0904268106; Subramanian D, 2010, NAT CHEM BIOL, V6, P324, DOI 10.1038/nchembio.348; Takahashi S, 2012, J CELL SCI, V125, P4049, DOI 10.1242/jcs.102913; Wang YJ, 2003, CELL, V114, P299, DOI 10.1016/S0092-8674(03)00603-2	32	112	114	0	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 21	2016	529	7586					408	+		10.1038/nature16516	http://dx.doi.org/10.1038/nature16516			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB2QT	26760201	Green Submitted			2022-12-28	WOS:000368354800049
J	Cripe, LD				Cripe, Larry D.			Hope Is the Thing With Feathers	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Cripe, Larry D.] Indiana Univ, Simon Canc Ctr, Indianapolis, IN 46204 USA; [Cripe, Larry D.] Indiana Univ Sch Med, Div Hematol Oncol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University Bloomington	Cripe, LD (corresponding author), Indiana Univ, Simon Canc Ctr, Indianapolis, IN 46204 USA.	lcripe@iu.edu							0	3	3	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 19	2016	315	3					265	266		10.1001/jama.2015.18557	http://dx.doi.org/10.1001/jama.2015.18557			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DB2WN	26784772				2022-12-28	WOS:000368371400021
J	Lip, GYH; Lane, DA				Lip, Gregory Y. H.; Lane, Deirdre A.			The 5-factor ORBIT bleeding score predicted major bleeding at 2 years in patients with atrial fibrillation	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Lip, Gregory Y. H.; Lane, Deirdre A.] Univ Birmingham, Birmingham, W Midlands, England	University of Birmingham	Lip, GYH (corresponding author), Univ Birmingham, Birmingham, W Midlands, England.		Lane, Deirdre/AAX-1866-2020	Lane, Deirdre/0000-0002-5604-9378				Senoo K, 2015, AM J MED	1	2	2	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 19	2016	164	2					JC11	JC11		10.7326/ACPJC-2016-164-2-011	http://dx.doi.org/10.7326/ACPJC-2016-164-2-011			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DB0CI	26784491				2022-12-28	WOS:000368175800010
J	Quill, TE; Back, AL; Block, SD				Quill, Timothy E.; Back, Anthony L.; Block, Susan D.			Responding to Patients Requesting Physician-Assisted Death Physician Involvement at the Very End of Life	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SUICIDE; CARE		[Quill, Timothy E.] Univ Rochester, Med Ctr, Palliat Care Div, Dept Med, Rochester, NY 14642 USA; [Back, Anthony L.] Univ Washington, Harborview Med Ctr, Seattle, WA 98104 USA; [Back, Anthony L.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Back, Anthony L.] Univ Washington, Cambia Palliat Care Ctr Excellence, Seattle, WA 98195 USA; [Block, Susan D.] Dana Farber Canc Inst, Dept Psychosocial Oncol & Palliat Care, Boston, MA 02115 USA; [Block, Susan D.] Brigham & Womens Hosp, Dept Psychiat, Boston, MA 02115 USA; [Block, Susan D.] Harvard Univ, Brigham & Womens Hosp, Sch Publ Hlth, Ariadne Labs, Boston, MA 02115 USA	University of Rochester; Harborview Medical Center; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard T.H. Chan School of Public Health	Quill, TE (corresponding author), Univ Rochester, Med Ctr, Ctr Eth, POB 687,601 Elmwood Ave,Room G-7824, Rochester, NY 14642 USA.	timothy_quill@urmc.rochester.edu						BLOCH SD, 1994, ARCH INTERN MED, V154, P2039, DOI 10.1001/archinte.154.18.2039; Ganzini L, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1682; Meier DE, 2001, JAMA-J AM MED ASSOC, V286, P3007, DOI 10.1001/jama.286.23.3007; Oregon Health Authority, DEATH DIGN ACT; QUILL TE, 1993, JAMA-J AM MED ASSOC, V270, P870, DOI 10.1001/jama.270.7.870; Quill TE, 1997, JAMA-J AM MED ASSOC, V278, P2099, DOI 10.1001/jama.278.23.2099; Tolle SW, 2004, J CLIN ETHIC, V15, P111	7	55	55	0	35	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 19	2016	315	3					245	246		10.1001/jama.2015.16210	http://dx.doi.org/10.1001/jama.2015.16210			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DB2WN	26784762				2022-12-28	WOS:000368371400011
J	Mansournia, MA; Altman, DG				Mansournia, Mohammad Ali; Altman, Douglas G.			STATISTICS NOTES Inverse probability weighting	BMJ-BRITISH MEDICAL JOURNAL			English	Article							TRIAL		[Mansournia, Mohammad Ali] Univ Tehran Med Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Tehran, Iran; [Altman, Douglas G.] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Ctr Stat Med, Oxford OX3 7LD, England	Tehran University of Medical Sciences; University of Oxford	Mansournia, MA (corresponding author), Univ Tehran Med Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Tehran, Iran.	mansournia_ma@yahoo.com			Cancer Research UK [16895] Funding Source: researchfish	Cancer Research UK(Cancer Research UK)		Alonso A, 2006, EUR J EPIDEMIOL, V21, P351, DOI 10.1007/s10654-006-9008-y; Freemantle N, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6409; Kerry SM, 1998, BMJ-BRIT MED J, V316, P54, DOI 10.1136/bmj.316.7124.54; KORN EL, 1991, AM J PUBLIC HEALTH, V81, P1166, DOI 10.2105/AJPH.81.9.1166; Regan MM, 2011, LANCET ONCOL, V12, P1101, DOI 10.1016/S1470-2045(11)70270-4; Robins JM, 2000, EPIDEMIOLOGY, V11, P550, DOI 10.1097/00001648-200009000-00011; Seaman SR, 2013, STAT METHODS MED RES, V22, P278, DOI 10.1177/0962280210395740; VazquezBarquero JL, 1997, BRIT J PSYCHIAT, V170, P529, DOI 10.1192/bjp.170.6.529; Xian Y, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3786	9	242	244	11	27	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 15	2016	352								i189	10.1136/bmj.i189	http://dx.doi.org/10.1136/bmj.i189			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DB2ZI	26773001	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000368378800001
J	Gee, CE; Oertner, TG				Gee, Christine E.; Oertner, Thomas G.			Pull out the stops for plasticity	NATURE			English	Editorial Material							LONG-TERM POTENTIATION; DENDRITIC SPINES; SK CHANNELS; RECEPTORS; SRC		[Gee, Christine E.; Oertner, Thomas G.] Univ Med Ctr Hamburg Eppendorf, Ctr Mol Neurobiol Hamburg ZMNH, D-20251 Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf	Gee, CE (corresponding author), Univ Med Ctr Hamburg Eppendorf, Ctr Mol Neurobiol Hamburg ZMNH, D-20251 Hamburg, Germany.	thomas.oertner@zmnh.uni-hamburg.de	Oertner, Thomas/F-2214-2010; Gee, Christine E/E-9241-2013	Oertner, Thomas/0000-0002-2312-7528; Gee, Christine E/0000-0003-0345-3665				Benquet P, 2002, J NEUROSCI, V22, P9679; Bloodgood BL, 2007, CURR OPIN NEUROBIOL, V17, P345, DOI 10.1016/j.conb.2007.04.003; Brzosko Z, 2015, ELIFE, V4, DOI 10.7554/eLife.09685; Buchanan KA, 2010, NEURON, V68, P948, DOI 10.1016/j.neuron.2010.11.018; Giessel AJ, 2010, NEURON, V68, P936, DOI 10.1016/j.neuron.2010.09.004; Lu YM, 1998, SCIENCE, V279, P1363, DOI 10.1126/science.279.5355.1363; Nevian T, 2006, J NEUROSCI, V26, P11001, DOI 10.1523/JNEUROSCI.1749-06.2006; Ngo-Anh TJ, 2005, NAT NEUROSCI, V8, P642, DOI 10.1038/nn1449; Tigaret C. M., 2016, NATURE COMMUN; Wang HS, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00189; Yu XM, 1997, SCIENCE, V275, P674, DOI 10.1126/science.275.5300.674	11	5	6	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 14	2016	529	7585					164	165		10.1038/529164a	http://dx.doi.org/10.1038/529164a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA7WK	26762454				2022-12-28	WOS:000368015700026
J	Iacobucci, G; Rimmer, A				Iacobucci, Gareth; Rimmer, Abi			DOCTORS' STRIKE 2016 From the picket line: junior doctors speak out	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Rimmer, Abi] BMJ Careers, London, England										0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 14	2016	352								i193	10.1136/bmj.i193	http://dx.doi.org/10.1136/bmj.i193			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DB2YZ	26769587				2022-12-28	WOS:000368377900009
J	Kusiak, A				Kusiak, Andrew			Share data on wind energy	NATURE			English	Editorial Material									[Kusiak, Andrew] Univ Iowa, Mech & Ind Engn, Iowa City, IA USA; [Kusiak, Andrew] Univ Iowa, Intelligent Syst Lab, Iowa City, IA USA	University of Iowa; University of Iowa	Kusiak, A (corresponding author), Univ Iowa, Mech & Ind Engn, Iowa City, IA USA.; Kusiak, A (corresponding author), Univ Iowa, Intelligent Syst Lab, Iowa City, IA USA.	andrew-kusiak@uiowa.edu	Kusiak, Andrew/F-7935-2015					Kusiak A., 2015, IND ENG, V47, P38; Kusiak A, 2012, WIND SYST MAG, V3, P36; Kusiak A, 2013, ENERGY, V60, P1, DOI 10.1016/j.energy.2013.07.051; Kusiak A, 2013, IEEE T SUSTAIN ENERG, V4, P756, DOI 10.1109/TSTE.2013.2246590; Zhang ZJ, 2014, IEEE T SUSTAIN ENERG, V5, P228, DOI 10.1109/TSTE.2013.2281354; Zhang ZJ, 2012, IEEE T ENERGY CONVER, V27, P526, DOI 10.1109/TEC.2012.2189887	6	38	39	2	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 7	2016	529	7584					19	21		10.1038/529019a	http://dx.doi.org/10.1038/529019a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6VY	26738579	Bronze			2022-12-28	WOS:000367944900009
J	Molgaard-Nielsen, D; Svanstrom, H; Melbye, M; Hviid, A; Pasternak, B				Molgaard-Nielsen, Ditte; Svanstrom, Henrik; Melbye, Mads; Hviid, Anders; Pasternak, Bjorn			Association Between Use of Oral Fluconazole During Pregnancy and Risk of Spontaneous Abortion and Stillbirth	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CONGENITAL-MALFORMATIONS; VAGINAL CANDIDOSIS; OUTCOMES; CANDIDIASIS; EXPOSURE; PATIENT; INFECTION; REGISTRY; COHORT	IMPORTANCE Vaginal candidiasis is common during pregnancy. Although intravaginal formulations of topical azole antifungals are first-line treatment for pregnant women, oral fluconazole is often used despite limited safety information. OBJECTIVE To study the association between oral fluconazole exposure during pregnancy and the risk of spontaneous abortion and stillbirth. DESIGN, SETTING, AND PARTICIPANTS Nationwide register-based cohort study in Denmark, 1997-2013. From a cohort of 1 405 663 pregnancies, oral fluconazole-exposed pregnancies were compared with up to 4 unexposed pregnancies matched on propensity score, maternal age, calendar year, and gestational age (based on gestational age at first day of treatment with eligible controls surviving through this date). To test for confounding by indication, pregnancies exposed to intravaginal formulations of topical azoles were used as an additional comparator group. EXPOSURES Filled prescriptions for oral fluconazole were obtained from the National Prescription Register. MAIN OUTCOMES AND MEASURES Hazard ratios (HRs) for spontaneous abortion and stillbirth, estimated using proportional hazards regression. RESULTS Among 3315 women exposed to oral fluconazole from 7 through 22 weeks' gestation, 147 experienced a spontaneous abortion, compared with 563 among 13 246 unexposed matched women. There was a significantly increased risk of spontaneous abortion associated with fluconazole exposure (HR, 1.48; 95% CI, 1.23-1.77). Among 5382 women exposed to fluconazole from gestational week 7 to birth, 21 experienced a stillbirth, compared with 77 among 21 506 unexposed matched women. There was no significant association between fluconazole exposure and stillbirth (HR, 1.32 [95% CI, 0.82-2.14]). Using topical azole exposure as the comparison, 130 of 2823 women exposed to fluconazole vs 118 of 2823 exposed to topical azoles had a spontaneous abortion (HR, 1.62 [95% CI, 1.26-2.07]); 20 of 4301 women exposed to fluconazole vs 22 of 4301 exposed to topical azoles had a stillbirth (HR, 1.18 [95% CI, 0.64-2.16]). CONCLUSIONS AND RELEVANCE In this nationwide cohort study in Denmark, use of oral fluconazole in pregnancy was associated with a statistically significant increased risk of spontaneous abortion compared with risk among unexposed women and women with topical azole exposure in pregnancy. Until more data on the association are available, cautious prescribing of fluconazole in pregnancy may be advisable. Although the risk of stillbirth was not significantly increased, this outcome should be investigated further.	[Molgaard-Nielsen, Ditte; Svanstrom, Henrik; Melbye, Mads; Hviid, Anders; Pasternak, Bjorn] Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen S, Denmark	Statens Serum Institut	Molgaard-Nielsen, D (corresponding author), Statens Serum Inst, Dept Epidemiol Res, Artillerivej 5, DK-2300 Copenhagen S, Denmark.	dnl@ssi.dk	Pasternak, Bjorn/H-5739-2012; Hviid, Anders/AAH-4319-2020	Pasternak, Bjorn/0000-0002-2097-8466; Hviid, Anders/0000-0002-7509-9127; melbye, mads/0000-0001-8264-6785	Danish Medical Research Council	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by the Danish Medical Research Council.	Aleck KA, 1997, AM J MED GENET, V72, P253, DOI 10.1002/(SICI)1096-8628(19971031)72:3&lt;253::AID-AJMG1&gt;3.0.CO;2-S; Austin PC, 2009, BIOMETRICAL J, V51, P171, DOI 10.1002/bimj.200810488; Buhimschi CS, 2009, OBSTET GYNECOL, V113, P166, DOI 10.1097/AOG.0b013e31818d6788; Christensen B, 2000, J ANTIMICROB CHEMOTH, V46, P29, DOI 10.1093/jac/46.suppl_1.29; Cotch MF, 1998, AM J OBSTET GYNECOL, V178, P374, DOI 10.1016/S0002-9378(98)80028-8; DANESHMEND TK, 1986, J ANTIMICROB CHEMOTH, V18, P507, DOI 10.1093/jac/18.4.507; Eckert LO, 2006, NEW ENGL J MED, V355, P1244, DOI 10.1056/NEJMcp053720; Goldenberg RL, 2000, NEW ENGL J MED, V342, P1500, DOI 10.1056/NEJM200005183422007; Hay PE, 2004, CURR OPIN INFECT DIS, V17, P41, DOI 10.1097/00001432-200402000-00008; HO CY, 1970, AM J OBSTET GYNECOL, V106, P705, DOI 10.1016/0002-9378(70)90394-7; HOOD IC, 1983, HUM PATHOL, V14, P984, DOI 10.1016/S0046-8177(83)80178-6; INMAN W, 1994, EUR J CLIN PHARMACOL, V46, P115, DOI 10.1007/BF00199872; Jick SS, 1999, PHARMACOTHERAPY, V19, P221, DOI 10.1592/phco.19.3.221.30919; Jorgensen Finn Stener, 2003, Ugeskr Laeger, V165, P4409; Kildemoes HW, 2011, SCAND J PUBLIC HEALT, V39, P38, DOI 10.1177/1403494810394717; Knudsen LB, 1998, DAN MED BULL, V45, P320; LEE BE, 1992, PEDIATR INFECT DIS J, V11, P1062, DOI 10.1097/00006454-199211120-00017; Lohse Sarah Rytter, 2010, Clin Epidemiol, V2, P247, DOI 10.2147/CLEP.S13815; Lopez-Rangel E, 2005, BIRTH DEFECTS RES A, V73, P919, DOI 10.1002/bdra.20189; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Marotta F, 2010, EXPERT OPIN DRUG MET, V6, P461, DOI 10.1517/17425251003592111; Mastroiacovo P, 1996, AM J OBSTET GYNECOL, V175, P1645, DOI 10.1016/S0002-9378(96)70119-9; Meizoso T, 2008, ARCH GYNECOL OBSTET, V278, P173, DOI 10.1007/s00404-007-0554-7; Michels TC, 2007, AM FAM PHYSICIAN, V76, P1341; Molgaard-Nielsen D, 2013, NEW ENGL J MED, V369, P830, DOI 10.1056/NEJMoa1301066; Nilas L, CANDIDA VAGINIT; Norgaard M, 2008, J ANTIMICROB CHEMOTH, V62, P172, DOI 10.1093/jac/dkn157; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; Pfizer, DIFL PROD INF; Pursley TJ, 1996, CLIN INFECT DIS, V22, P336, DOI 10.1093/clinids/22.2.336; Rassen JA, 2012, PHARMACOEPIDEM DR S, V21, P69, DOI 10.1002/pds.3263; RITTER W, 1982, CHEMOTHERAPY, V28, P37, DOI 10.1159/000238150; Roque H, 1999, J PERINAT MED, V27, P253, DOI 10.1515/JPM.1999.036; Sobel JD, 2007, LANCET, V369, P1961, DOI 10.1016/S0140-6736(07)60917-9; The Danish Health and Medicines Authority, 2004, BIRTH REG; TOOLEY PJH, 1985, PRACTITIONER, V229, P655; WHYTE RK, 1982, ARCH DIS CHILD, V57, P528, DOI 10.1136/adc.57.7.528; WILCOX AJ, 1988, NEW ENGL J MED, V319, P189, DOI 10.1056/NEJM198807283190401; Wilton LV, 1998, BRIT J OBSTET GYNAEC, V105, P882, DOI 10.1111/j.1471-0528.1998.tb10234.x; Xu RH, 2012, PHARMACOEPIDEM DR S, V21, P844, DOI 10.1002/pds.3301	40	55	62	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 5	2016	315	1					58	67		10.1001/jama.2015.17844	http://dx.doi.org/10.1001/jama.2015.17844			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DA0YH	26746458	Bronze			2022-12-28	WOS:000367523000015
J	Van Driest, SL; Wells, QS; Stallings, S; Bush, WS; Gordon, A; Nickerson, DA; Kim, JH; Crosslin, DR; Jarvik, GP; Carrell, DS; Ralston, JD; Larson, EB; Bielinski, SJ; Olson, JE; Ye, Z; Kullo, IJ; Abul-Husn, NS; Scott, SA; Bottinger, E; Almoguera, B; Connolly, J; Chiavacci, R; Hakonarson, H; Rasmussen-Torvik, LJ; Pan, V; Persell, SD; Smith, M; Chisholm, RL; Kitchner, TE; He, MM; Brilliant, MH; Wallace, JR; Doheny, KF; Shoemaker, B; Li, RL; Manolio, TA; Callis, TE; Macaya, D; Williams, MS; Carey, D; Kapplinger, JD; Ackerman, MJ; Ritchie, MD; Denny, JC; Roden, DM				Van Driest, Sara L.; Wells, Quinn S.; Stallings, Sarah; Bush, William S.; Gordon, Adam; Nickerson, Deborah A.; Kim, Jerry H.; Crosslin, David R.; Jarvik, Gail P.; Carrell, David S.; Ralston, James D.; Larson, Eric B.; Bielinski, Suzette J.; Olson, Janet E.; Ye, Zi; Kullo, Iftikhar J.; Abul-Husn, Noura S.; Scott, Stuart A.; Bottinger, Erwin; Almoguera, Berta; Connolly, John; Chiavacci, Rosetta; Hakonarson, Hakon; Rasmussen-Torvik, Laura J.; Pan, Vivian; Persell, Stephen D.; Smith, Maureen; Chisholm, Rex L.; Kitchner, Terrie E.; He, Max M.; Brilliant, Murray H.; Wallace, John R.; Doheny, Kimberly F.; Shoemaker, Benjamin; Li, Rongling; Manolio, Teri A.; Callis, Thomas E.; Macaya, Daniela; Williams, Marc S.; Carey, David; Kapplinger, Jamie D.; Ackerman, Michael J.; Ritchie, Marylyn D.; Denny, Joshua C.; Roden, Dan M.			Association of Arrhythmia-Related Genetic Variants With Phenotypes Documented in Electronic Medical Records	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LONG-QT SYNDROME; CARDIAC SODIUM-CHANNEL; INCIDENTAL FINDINGS; SEQUENCE VARIANTS; EMERGE NETWORK; PREVALENCE; GENOMICS; RETURN; SCN5A; SUSCEPTIBILITY	IMPORTANCE Large-scale DNA sequencing identifies incidental rare variants in established Mendelian disease genes, but the frequency of related clinical phenotypes in unselected patient populations is not well established. Phenotype data from electronic medical records (EMRs) may provide a resource to assess the clinical relevance of rare variants. OBJECTIVE To determine the clinical phenotypes from EMRs for individuals with variants designated as pathogenic by expert review in arrhythmia susceptibility genes. DESIGN, SETTING, AND PARTICIPANTS This prospective cohort study included 2022 individuals recruited for nonantiarrhythmic drug exposure phenotypes from October 5, 2012, to September 30, 2013, for the Electronic Medical Records and Genomics Network Pharmacogenomics project from 7 US academic medical centers. Variants in SCN5A and KCNH2, disease genes for long QT and Brugada syndromes, were assessed for potential pathogenicity by 3 laboratories with ion channel expertise and by comparison with the ClinVar database. Relevant phenotypes were determined from EMRs, with data available from 2002 (or earlier for some sites) through September 10, 2014. EXPOSURES One or more variants designated as pathogenic in SCN5A or KCNH2. MAIN OUTCOMES AND MEASURES Arrhythmia or electrocardiographic (ECG) phenotypes defined by International Classification of Diseases, Ninth Revision (ICD-9) codes, ECG data, and manual EMR review. RESULTS Among 2022 study participants (median age, 61 years [interquartile range, 56-65 years]; 1118 [55%] female; 1491 [74%] white), a total of 122 rare (minor allele frequency < 0.5%) nonsynonymous and splice-site variants in 2 arrhythmia susceptibility genes were identified in 223 individuals (11% of the study cohort). Forty-two variants in 63 participants were designated potentially pathogenic by at least 1 laboratory or ClinVar, with low concordance across laboratories (Cohen k = 0.26). An ICD-9 code for arrhythmia was found in 11 of 63 (17%) variant carriers vs 264 of 1959 (13%) of those without variants (difference, +4%; 95% CI, -5% to +13%; P = .35). In the 1270 (63%) with ECGs, corrected QT intervals were not different in variant carriers vs those without (median, 429 vs 439 milliseconds; difference, -10 milliseconds; 95% CI, -16 to +3 milliseconds; P = .17). After manual review, 22 of 63 participants (35%) with designated variants had any ECG or arrhythmia phenotype, and only 2 had corrected QT interval longer than 500 milliseconds. CONCLUSIONS AND RELEVANCE Among laboratories experienced in genetic testing for cardiac arrhythmia disorders, there was low concordance in designating SCN5A and KCNH2 variants as pathogenic. In an unselected population, the putatively pathogenic genetic variants were not associated with an abnormal phenotype. These findings raise questions about the implications of notifying patients of incidental genetic findings.	[Van Driest, Sara L.; Wells, Quinn S.; Stallings, Sarah; Bush, William S.; Shoemaker, Benjamin; Denny, Joshua C.; Roden, Dan M.] Vanderbilt Univ, Med Ctr, Nashville, TN 37232 USA; [Bush, William S.] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Gordon, Adam; Nickerson, Deborah A.; Kim, Jerry H.; Crosslin, David R.; Jarvik, Gail P.] Univ Washington, Seattle, WA 98195 USA; [Carrell, David S.; Ralston, James D.; Larson, Eric B.] Grp Hlth Res Inst, Seattle, WA USA; [Bielinski, Suzette J.; Olson, Janet E.; Ye, Zi; Kullo, Iftikhar J.; Kapplinger, Jamie D.; Ackerman, Michael J.] Mayo Clin, Rochester, MN USA; [Abul-Husn, Noura S.; Scott, Stuart A.; Bottinger, Erwin] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Almoguera, Berta; Connolly, John; Chiavacci, Rosetta; Hakonarson, Hakon] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Hakonarson, Hakon] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Rasmussen-Torvik, Laura J.; Pan, Vivian; Persell, Stephen D.; Smith, Maureen; Chisholm, Rex L.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Kitchner, Terrie E.; He, Max M.; Brilliant, Murray H.] Marshfield Clin Res Fdn, Marshfield, WI USA; [Wallace, John R.; Ritchie, Marylyn D.] Penn State Univ, University Pk, PA 16802 USA; [Doheny, Kimberly F.] Johns Hopkins Sch Med, Baltimore, MD USA; [Li, Rongling; Manolio, Teri A.] NHGRI, NIH, Bethesda, MD 20892 USA; [Callis, Thomas E.] Transgenomic, New Haven, CT USA; [Macaya, Daniela] GeneDx, Gaithersburg, MD USA; [Williams, Marc S.; Carey, David; Ritchie, Marylyn D.] Geisinger Hlth Syst, Danville, PA USA	Vanderbilt University; Case Western Reserve University; University of Washington; University of Washington Seattle; Mayo Clinic; Icahn School of Medicine at Mount Sinai; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Northwestern University; Feinberg School of Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Johns Hopkins University; Johns Hopkins Medicine; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Geisinger Health System	Roden, DM (corresponding author), Vanderbilt Univ, Med Ctr, 2215B Garland Ave,Room 1285, Nashville, TN 37232 USA.	dan.roden@vanderbilt.edu	Zi, Ye/GWM-3932-2022; Bush, William/N-1369-2019; Denny, Josh/AAL-3359-2021; Roden, Dan/ABD-5412-2021; Bielinski, Suzette/A-2238-2009; Chisholm, Rex/B-3418-2009	Bush, William/0000-0002-9729-6519; Denny, Josh/0000-0002-3049-7332; Bielinski, Suzette/0000-0002-2905-5430; Abul-Husn, Noura/0000-0002-5179-1944; Pan, Vivian/0000-0002-1666-9273; Gordon, Adam/0000-0002-2058-7289; Scott, Stuart/0000-0001-5720-1864; Connolly, John/0000-0003-4396-1226; Rasmussen-Torvik, Laura/0000-0002-0820-7300; Chisholm, Rex/0000-0002-5638-3990	National Human Genome Research Institute (NHGRI) [U01HG006828, U01HG006830, U01HG006389, U01HG006382, U01HG006375, U01HG006379, U01HG006380, U01HG006388, U01HG006378, U01HG006385]; National Center for Advancing Translational Sciences (NCATS) [UL1TR000427]; National Institute on Aging [U01AG006781]; NHGRI [U01HG004438]; NCATS [UL1TR000445]; National Institute of General Medical Sciences grants [U19GM61388, R01GM28157, U01HG005137, R01CA138461, R01AG034676]; Windland Smith Rice Comprehensive Sudden Cardiac Death Program (Mayo Clinic); National Institutes of Health [U19GM61388, U19HL069757, U01GM097119]; NATIONAL CANCER INSTITUTE [R01CA138461] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000427, UL1TR000445] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U19HL069757, F30HL127904] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG008657, U01HG006385, U01HG008701, U01HG006379, U01HG006830, U01HG006388, U01HG006828, U01HG005137, U01HG008672, U01HG006375, U01HG006389, U01HG006380, U01HG006378, U01HG004438, U01HG006382, U01HG008684] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007454, T32GM082773, K23GM104401, U19GM061388, R01GM028157, U01GM097119] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U01AG006781, R01AG034676] Funding Source: NIH RePORTER	National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Center for Advancing Translational Sciences (NCATS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NCATS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Institute of General Medical Sciences grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Windland Smith Rice Comprehensive Sudden Cardiac Death Program (Mayo Clinic); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The eMERGE Network was initiated and funded by the National Human Genome Research Institute (NHGRI) through the following grants: U01HG006828 (Cincinnati Children's Hospital Medical Center/Boston Children's Hospital); U01HG006830 (Children's Hospital of Philadelphia); U01HG006389 (Essentia Institute of Rural Health, Marshfield Clinic Research Foundation, and Pennsylvania State University); U01HG006382 (Geisinger Clinic); U01HG006375 (Group Health Cooperative, University of Washington); U01HG006379 (Mayo Clinic); U01HG006380 (Icahn School of Medicine at Mount Sinai); U01HG006388 (Northwestern University); U01HG006378 (Vanderbilt University Medical Center); and U01HG006385 (Vanderbilt University Medical Center serving as the Coordinating Center). Additional support was provided by National Center for Advancing Translational Sciences (NCATS) grant UL1TR000427 (University of Wisconsin, Marshfield Clinic); National Institute on Aging grant U01AG006781 (Group Health Cooperative, University of Washington); NHGRI grant U01HG004438 (Johns Hopkins School of Medicine); NCATS grant UL1TR000445 (Vanderbilt University Medical Center); National Institute of General Medical Sciences grants U19GM61388, R01GM28157, U01HG005137, R01CA138461, R01AG034676; and the Windland Smith Rice Comprehensive Sudden Cardiac Death Program (Mayo Clinic). The sequencing platform was developed by the next-generation sequencing centers of the Pharmacogenomics Research Network supported by National Institutes of Health grants U19GM61388, U19HL069757, and U01GM097119.	Ackerman MJ, 2004, HEART RHYTHM, V1, P600, DOI 10.1016/j.hrthm.2004.07.013; Ackerman MJ, 2003, MAYO CLIN PROC, V78, P1479, DOI 10.4065/78.12.1479; Amendola LM, 2015, GENOME RES, V25, P305, DOI 10.1101/gr.183483.114; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Clayton EW, 2012, GENET MED, V14, P473, DOI 10.1038/gim.2012.10; Crosslin DR, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0181-z; Ng D, 2013, CIRC-CARDIOVASC GENE, V6, P337, DOI 10.1161/CIRCGENETICS.113.000039; Denny JC, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002823; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Earle N, 2013, HEART RHYTHM, V10, P233, DOI 10.1016/j.hrthm.2012.10.043; Goldenberg I, 2008, CURR PROB CARDIOLOGY, V33, P629, DOI 10.1016/j.cpcardiol.2008.07.002; Green RC, 2013, GENET MED, V15, P565, DOI 10.1038/gim.2013.73; Green RC, 2012, GENET MED, V14, P405, DOI 10.1038/gim.2012.21; Hwang HW, 2005, J MED GENET, V42, DOI 10.1136/jmg.2004.027995; Jarvik GP, 2014, AM J HUM GENET, V94, P818, DOI 10.1016/j.ajhg.2014.04.009; Korf BR, 2013, JAMA-J AM MED ASSOC, V309, P1511, DOI 10.1001/jama.2013.3239; Lahtinen AM, 2013, ANN MED, V45, P328, DOI 10.3109/07853890.2013.783995; Landrum MJ, 2014, NUCLEIC ACIDS RES, V42, pD980, DOI 10.1093/nar/gkt1113; MacArthur DG, 2014, NATURE, V508, P469, DOI 10.1038/nature13127; Newton KM, 2013, J AM MED INFORM ASSN, V20, pE147, DOI 10.1136/amiajnl-2012-000896; Patel SS, 2009, PACE, V32, P704, DOI 10.1111/j.1540-8159.2009.02354.x; Pathak J, 2013, J AM MED INFORM ASSN, V20, pE206, DOI 10.1136/amiajnl-2013-002428; Quaglini S, 2006, EUR HEART J, V27, P1824, DOI 10.1093/eurheartj/ehl115; Rasmussen-Torvik LJ, 2014, CLIN PHARMACOL THER, V96, P482, DOI 10.1038/clpt.2014.137; Rehm HL, 2015, NEW ENGL J MED, V372, P2235, DOI 10.1056/NEJMsr1406261; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Schwartz PJ, 2013, J AM COLL CARDIOL, V62, P169, DOI 10.1016/j.jacc.2013.04.044; Schwartz PJ, 2009, CIRCULATION, V120, P1761, DOI 10.1161/CIRCULATIONAHA.109.863209; Splawski I, 1998, GENOMICS, V51, P86, DOI 10.1006/geno.1998.5361; Tabor HK, 2014, AM J HUM GENET, V95, P183, DOI 10.1016/j.ajhg.2014.07.006; VINCENT GM, 1992, NEW ENGL J MED, V327, P846, DOI 10.1056/NEJM199209173271204; Wang Q, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.013300; Wang Q, 1996, GENOMICS, V34, P9, DOI 10.1006/geno.1996.0236; Watson M, 2013, GENET MED, V15, P664, DOI 10.1038/gim.2013.82; Wolf SM, 2012, GENET MED, V14, P361, DOI 10.1038/gim.2012.23	35	124	125	0	33	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 5	2016	315	1					47	57		10.1001/jama.2015.17701	http://dx.doi.org/10.1001/jama.2015.17701			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DA0YH	26746457	Green Accepted, Bronze			2022-12-28	WOS:000367523000014
J	Hama, T; Kouchi, A; Watanabe, N				Hama, Tetsuya; Kouchi, Akira; Watanabe, Naoki			Statistical ortho-to-para ratio of water desorbed from ice at 10 kelvin	SCIENCE			English	Article							NUCLEAR-SPIN CONVERSION; AMORPHOUS SOLID WATER; INTERSTELLAR WATER; MOLECULES; VAPOR; SURFACES; STATE; COMET; H2O	The anomalously low ortho-to-para ratios (OPRs) exhibited by gaseous water in space have been used to determine the formation temperature (<50 kelvin) of ice on cold interstellar dust. This approach assumes that the OPR of water desorbed from ice is related to the ice formation temperature on the dust. However, we report that water desorbed from ice at 10 kelvin shows a statistical high-temperatureOPRof 3, even when the ice is produced in situ by hydrogenation of O-2, a known formation process of interstellar water. This invalidates the assumed relation between OPR and temperature. The necessary reinterpretation of the low OPRs will help elucidate the chemical history of interstellar water from molecular clouds and processes in the early solar system, including comet formation.	[Hama, Tetsuya; Kouchi, Akira; Watanabe, Naoki] Hokkaido Univ, Inst Low Temp Sci, Sapporo, Hokkaido 0600819, Japan	Hokkaido University	Hama, T (corresponding author), Hokkaido Univ, Inst Low Temp Sci, Sapporo, Hokkaido 0600819, Japan.	hama@lowtem.hokudai.ac.jp	Kouchi, Akira/A-4759-2012; HAMA, Tetsuya/A-9766-2012; WATANABE, Naoki/A-7451-2012	HAMA, Tetsuya/0000-0002-4991-4044; WATANABE, Naoki/0000-0001-8408-2872	Japan Society for the Promotion of Science KAKENHI grant [24224012]; Ministry of Education, Culture, Sports, Science and Technology KAKENHI grant [25108002]; Grants-in-Aid for Scientific Research [25108001, 26410001] Funding Source: KAKEN	Japan Society for the Promotion of Science KAKENHI grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science and Technology KAKENHI grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank Y. Kimura, H. Hidaka, Y. Oba, H. Ueta, Y. Kunisada, T. Sugimoto, and A. Yabushita for helpful comments and discussions. This work was supported by Japan Society for the Promotion of Science KAKENHI grant 24224012 and Ministry of Education, Culture, Sports, Science and Technology KAKENHI grant 25108002. The authors declare no conflicts of interest. All the data reported in this manuscript are presented in the main paper and in the supplementary materials. The REMPI spectrum data used to create the figures are available as additional supplementary data files.	Abouaf-Marguin L, 2007, CHEM PHYS LETT, V447, P232, DOI 10.1016/j.cplett.2007.09.014; Andersson S, 2008, ASTRON ASTROPHYS, V491, P907, DOI 10.1051/0004-6361:200810374; Buntkowsky G, 2008, Z PHYS CHEM, V222, P1049, DOI 10.1524/zpch.2008.5359; Cacciani P, 2012, PHYS REV A, V85, DOI 10.1103/PhysRevA.85.012521; Choi Y, 2014, ASTRON ASTROPHYS, V572, DOI 10.1051/0004-6361/201424007; Crovisier J, 2006, FARADAY DISCUSS, V133, P375, DOI 10.1039/b516786h; Gerlich D, 2006, PHILOS T R SOC A, V364, P3007, DOI 10.1098/rsta.2006.1865; Goldman M., 1970, SPIN TEMPERATURE NUC; Hama T, 2011, ASTROPHYS J LETT, V738, DOI 10.1088/2041-8205/738/1/L15; Hama T, 2013, CHEM REV, V113, P8783, DOI 10.1021/cr4000978; Hama T, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3386577; Herbst E, 2015, EPJ WEB CONF, V84, DOI 10.1051/epjconf/20158406002; Hogerheijde MR, 2011, SCIENCE, V334, P338, DOI 10.1126/science.1208931; Horke DA, 2014, ANGEW CHEM INT EDIT, V53, P11965, DOI 10.1002/anie.201405986; Kravchuk T, 2011, SCIENCE, V331, P319, DOI 10.1126/science.1200433; Limbach HH, 2006, CHEMPHYSCHEM, V7, P551, DOI 10.1002/cphc.200500559; MEIJER G, 1986, J CHEM PHYS, V85, P6914, DOI 10.1063/1.451845; Miani A, 2004, J CHEM PHYS, V120, P2732, DOI 10.1063/1.1633261; MUMMA MJ, 1986, SCIENCE, V232, P1523, DOI 10.1126/science.232.4757.1523; MUMMA MJ, 1987, ASTRON ASTROPHYS, V187, P419; Oba Y, 2009, ASTROPHYS J, V701, P464, DOI 10.1088/0004-637X/701/1/464; Sliter R, 2011, J PHYS CHEM A, V115, P9682, DOI 10.1021/jp201125k; Tanner CM, 2013, J PHYS CHEM A, V117, P10105, DOI 10.1021/jp400958f; Tennyson J, 2001, J PHYS CHEM REF DATA, V30, P735, DOI 10.1063/1.1364517; Tielens AGGM, 2013, REV MOD PHYS, V85, P1021, DOI 10.1103/RevModPhys.85.1021; van Dishoeck EF, 2013, CHEM REV, V113, P9043, DOI 10.1021/cr4003177; Western C. M., PGOPHER PROGRAM SIMU; Willacy K, 2015, SPACE SCI REV, V197, P151, DOI 10.1007/s11214-015-0167-6; WITTEBORT RJ, 1988, J AM CHEM SOC, V110, P5668, DOI 10.1021/ja00225a013; Yabushita A, 2009, ASTROPHYS J LETT, V699, pL80, DOI 10.1088/0004-637X/699/2/L80; Yang CH, 2010, PHYS CHEM CHEM PHYS, V12, P13983, DOI 10.1039/c0cp00946f	31	45	45	0	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 1	2016	351	6268					65	67		10.1126/science.aad4026	http://dx.doi.org/10.1126/science.aad4026			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ8QM	26721994				2022-12-28	WOS:000367364200042
J	Byrd, L				Byrd, Larry			Fetal alcohol spectrum disorder: complexity from comorbidity	LANCET			English	Editorial Material							PREVALENCE		[Byrd, Larry] Univ N Dakota, Sch Med & Hlth Sci, Grand Forks, ND 58203 USA	University of North Dakota Grand Forks	Byrd, L (corresponding author), Univ N Dakota, Sch Med & Hlth Sci, Grand Forks, ND 58203 USA.	larry.burd@med.und.edu						American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; Burd L, 2003, NEUROTOXICOL TERATOL, V25, P697, DOI 10.1016/j.ntt.2003.07.014; Burd L, 2008, BIRTH DEFECTS RES A, V82, P217, DOI 10.1002/bdra.20445; Li Q, 2012, MATERN CHILD HLTH J, V16, P1332, DOI 10.1007/s10995-011-0844-3; Lupton C, 2004, AM J MED GENET C, V127C, P42, DOI 10.1002/ajmg.c.30015; May PA, 2014, PEDIATRICS, V134, P855, DOI 10.1542/peds.2013-3319; Popova S, 2015, LANCET, DOI [http://dx.doi.org/10.1016/S0140-6736(15)01345-8, DOI 10.1016/S0140-6736(15)013458]; Williams AD, 2013, BIRTH DEFECTS RES A, V97, P489, DOI 10.1002/bdra.23127	8	18	18	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 5	2016	387	10022					926	927		10.1016/S0140-6736(15)01346-X	http://dx.doi.org/10.1016/S0140-6736(15)01346-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DF8XP	26777271				2022-12-28	WOS:000371644200009
J	Thornell, A; Angenete, E; Bisgaard, T; Bock, D; Burcharth, J; Heath, J; Pommergaard, HC; Rosenberg, J; Stilling, N; Skullman, S; Haglind, E				Thornell, Anders; Angenete, Eva; Bisgaard, Thue; Bock, David; Burcharth, Jakob; Heath, Jane; Pommergaard, Hans-Christian; Rosenberg, Jacob; Stilling, Nikolaj; Skullman, Stefan; Haglind, Eva			Laparoscopic Lavage for Perforated Diverticulitis With Purulent Peritonitis	ANNALS OF INTERNAL MEDICINE			English	Article							SF-36 HEALTH SURVEY; QUALITY-OF-LIFE; HARTMANNS PROCEDURE; PRIMARY ANASTOMOSIS; GENERALIZED PERITONITIS; PRIMARY RESECTION; POPULATION; SURGERY; COLON; STRATEGIES	Background: Perforated diverticulitis with purulent peritonitis has traditionally been treated with open colon resection and stoma formation with risk for reoperations, morbidity, and mortality. Laparoscopic lavage alone has been suggested as definitive treatment. Objective: To compare laparoscopic lavage with open colon resection and colostomy (Hartmann procedure) for perforated diverticulitis with purulent peritonitis. Design: Randomized, controlled, multicenter, open-label trial. (ISRCTN registry number: ISRCTN82208287) Setting: 9 hospitals in Sweden and Denmark. Patients: Patients who have confirmed Hinchey grade III perforated diverticulitis with purulent peritonitis at diagnostic laparoscopy. Intervention: Randomization between laparoscopic lavage and the Hartmann procedure. Measurements: Primary outcome was the percentage of patients having 1 or more reoperations within 12 months. Key secondary outcomes were number of reoperations, hospital read-missions, total length of hospital stay during 12 months, and adverse events. Results: A total of 43 and 40 patients were randomly assigned to laparoscopic lavage and the Hartmann procedure with a me-dian (first, third quartiles) follow-up of 372 days (336, 394) and 378 days (226, 396), respectively. Fewer patients in the laparoscopic group (12 of 43; 27.9%) than in the Hartmann group (25 of 40; 62.5%) had at least 1 reoperation within 12 months (relative risk reduction, 59%; relative risk, 0.41 [95% CI, 0.23 to 0.72]; P = 0.004). Mortality and severe adverse events did not differ between groups. Total length of hospital stay (days) within 12 months was shorter for the laparoscopic group than the Hartmann group, with a reduction of 35% (relative risk, 0.65 [CI, 0.45 to 0.94]; P = 0.047). After 12 months, 3 patients in the laparoscopic group and 11 in the Hartmann group had a stoma. Limitation: Not all patients presenting with suspected diverticulitis were enrolled. Conclusion: Laparoscopic lavage reduced the need for reoperations, had a similar safety profile to the Hartmann procedure, and may be an appropriate treatment of choice for acute perforated diverticulitis with purulent peritonitis.	[Thornell, Anders; Angenete, Eva; Bock, David; Haglind, Eva] Univ Gothenburg, Sahlgrenska Univ Hosp Ostra, Scandinavian Surg Outcomes Res Grp, Dept Surg,Inst Clin Sci, S-41685 Gothenburg, Sweden; [Bisgaard, Thue] Univ Copenhagen, Hvidovre Hosp, Div Surg, Gastro Unit, Kettegard Alle 30, DK-2650 Hvidovre, Denmark; [Burcharth, Jakob] Univ Copenhagen, Herlev Hosp, Dept Surg, Herlev Ringvej 75, DK-2730 Herlev, Denmark; [Stilling, Nikolaj] Odense Univ Hosp, Dept Surg, DK-5000 Odense C, Denmark; [Skullman, Stefan] Skaraborg Hosp, Dept Surg, S-54185 Skovde, Sweden	Sahlgrenska University Hospital; University of Gothenburg; University of Copenhagen; University of Copenhagen; Herlev & Gentofte Hospital; University of Southern Denmark; Odense University Hospital	Haglind, E (corresponding author), Univ Gothenburg, Sahlgrenska Univ Hosp Ostra, Scandinavian Surg Outcomes Res Grp, Dept Surg,Inst Clin Sci, S-41685 Gothenburg, Sweden.	eva.haglind@vgregion.se	Burcharth, Jakob/S-9147-2019; Angenete, Eva/AAG-8383-2020; Pommergaard, Hans-Christian/GSN-8028-2022	Burcharth, Jakob/0000-0001-8367-7831; Angenete, Eva/0000-0001-9966-4904; Pommergaard, Hans-Christian/0000-0001-7068-1946; Rosenberg, Jacob/0000-0002-0063-1086	Sahlgrenska University Hospital; Swedish Research Council [2012-1770]; Health and Medical Care Committee of Regional Executive Board and Region Vastra Gotaland; Adlerbertska Research Foundation; Alice Swenzons Foundation; Anna-Lisa and Bror Bjornsson Foundation; Swedish Society of Medicine; Faith Regen Foundation; Goteborg Medical Society; Sahlgrenska University Hospital Health Technology Assessment Center; Johan & Jacob Soderberg Foundation; Bengt Ihre Foundation; Wilhelm & Martina Lundgren Foundation; Magnus Bergvall Foundation; Ruth and Richard Julin Foundation; Signe and Olof Wallenius Foundation; Adlerbertska Foundation; Mary von Sydow Foundation	Sahlgrenska University Hospital; Swedish Research Council(Swedish Research CouncilEuropean Commission); Health and Medical Care Committee of Regional Executive Board and Region Vastra Gotaland; Adlerbertska Research Foundation; Alice Swenzons Foundation; Anna-Lisa and Bror Bjornsson Foundation; Swedish Society of Medicine; Faith Regen Foundation; Goteborg Medical Society; Sahlgrenska University Hospital Health Technology Assessment Center; Johan & Jacob Soderberg Foundation; Bengt Ihre Foundation; Wilhelm & Martina Lundgren Foundation; Magnus Bergvall Foundation; Ruth and Richard Julin Foundation; Signe and Olof Wallenius Foundation; Adlerbertska Foundation; Mary von Sydow Foundation	From Sahlgrenska University Hospital, Swedish Research Council (2012-1770), the Health and Medical Care Committee of the Regional Executive Board and Region Vastra Gotaland, Adlerbertska Research Foundation, Alice Swenzons Foundation, Anna-Lisa and Bror Bjornsson Foundation, Swedish Society of Medicine, Faith Regen Foundation, Goteborg Medical Society, Sahlgrenska University Hospital Health Technology Assessment Center, Johan & Jacob Soderberg Foundation, Bengt Ihre Foundation, Wilhelm & Martina Lundgren Foundation, Magnus Bergvall Foundation, Ruth and Richard Julin Foundation, Signe and Olof Wallenius Foundation, Adlerbertska Foundation and Mary von Sydow Foundation.	Abbas S, 2007, INT J COLORECTAL DIS, V22, P351, DOI 10.1007/s00384-005-0059-4; Andeweg CS, 2013, DIGEST SURG, V30, P278, DOI 10.1159/000354035; Anegawa G, 2013, SURG TODAY, V43, P1150, DOI 10.1007/s00595-013-0514-8; Angenete E, 2016, ANN SURG, V263, P117, DOI 10.1097/SLA.0000000000001061; Bjork S, 1999, HEALTH ECON, V8, P117; Bjorner JB, 1998, J CLIN EPIDEMIOL, V51, P991, DOI 10.1016/S0895-4356(98)00091-2; Bretz F, 2011, BIOMETRICAL J, V53, P894, DOI 10.1002/bimj.201000239; Brooks R, 1996, HEALTH POLICY, V37, P53, DOI 10.1016/0168-8510(96)00822-6; Burstrom K, 2001, HEALTH POLICY, V55, P51, DOI 10.1016/S0168-8510(00)00111-1; Cirocchi R, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000334; Clavien PA, 2009, ANN SURG, V250, P187, DOI 10.1097/SLA.0b013e3181b13ca2; Constantinides VA, 2007, ANN SURG, V245, P94, DOI 10.1097/01.sla.0000225357.82218.ce; Dmitrienko A, 2003, STAT MED, V22, P2387, DOI 10.1002/sim.1526; Dowson HM, 2013, VALUE HEALTH, V16, P367, DOI 10.1016/j.jval.2012.11.005; EuroQol Group, 2014, EQ 5D 3 L; Hinchey E J, 1978, Adv Surg, V12, P85; HUGHES LE, 1969, GUT, V10, P336, DOI 10.1136/gut.10.5.336; Jacobs DO, 2007, NEW ENGL J MED, V357, P2057, DOI 10.1056/NEJMcp073228; Janson M, 2007, SURG ENDOSC, V21, P747, DOI 10.1007/s00464-007-9217-9; Kodeda K, 2013, BRIT J SURG, V100, P1100, DOI 10.1002/bjs.9166; Liang S, 2012, SURG ENDOSC, V26, P2835, DOI 10.1007/s00464-012-2255-y; McCullagh P., 1989, GEN LINEAR MODELS, V2nd; Myers E, 2008, BRIT J SURG, V95, P97, DOI 10.1002/bjs.6024; Oberkofler CE, 2012, ANN SURG, V256, P819, DOI 10.1097/SLA.0b013e31827324ba; Paspatis GA, 2001, INT J COLORECTAL DIS, V16, P257, DOI 10.1007/s003840100304; Salem L, 2004, DIS COLON RECTUM, V47, P1953, DOI 10.1007/s10350-004-0701-1; Schultz JK, 2015, JAMA-J AM MED ASSOC, V314, P1364, DOI 10.1001/jama.2015.12076; Strate LL, 2012, DIGEST DIS, V30, P35, DOI 10.1159/000335707; Sullivan M, 1998, J CLIN EPIDEMIOL, V51, P1105, DOI 10.1016/S0895-4356(98)00102-4; SULLIVAN M, 1995, SOC SCI MED, V41, P1349, DOI 10.1016/0277-9536(95)00125-Q; Thornell A, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-186; Thornell A, 2011, DAN MED BULL, V58; Vennix S, 2015, LANCET, DOI [10.1016/S0140-6736(15)61168-0, DOI 10.1016/S0140-6736(15)61168-0:]; Vermeulen J, 2009, COLORECTAL DIS, V11, P619, DOI 10.1111/j.1463-1318.2008.01667.x; Ware JE, 1998, J CLIN EPIDEMIOL, V51, P1167, DOI 10.1016/S0895-4356(98)00108-5; WARE JE, 1995, MED CARE, V33, pAS264, DOI 10.1097/00005650-199501001-00005; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Winter DC HA, 2009, LAPLAND LAPAROSCOPIC; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	40	60	61	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 2	2016	164	3					137	U115		10.7326/M15-1210	http://dx.doi.org/10.7326/M15-1210			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DC4DD	26784672				2022-12-28	WOS:000369169400002
J	Gutierrez-Puebla, E				Gutierrez-Puebla, Enrique			Interlacing molecular threads Materials with a fabric-like microstructure are highly elastic	SCIENCE			English	Editorial Material							NETWORKS		[Gutierrez-Puebla, Enrique] CSIC, Inst Ciencia Mat Madrid, Madrid 28049, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencia de Materiales de Madrid (ICMM)	Gutierrez-Puebla, E (corresponding author), CSIC, Inst Ciencia Mat Madrid, Madrid 28049, Spain.	egutierrez@icmm.csic.es	Gutierrez-Puebla, Enrique/A-5392-2011	Gutierrez-Puebla, Enrique/0000-0002-2878-3540				Alexandrov EV, 2012, ACTA CRYSTALLOGR A, V68, P484, DOI 10.1107/S0108767312019034; BALL RC, 1981, POLYMER, V22, P1010, DOI 10.1016/0032-3861(81)90284-6; El-Kaderi HM, 2007, SCIENCE, V316, P268, DOI 10.1126/science.1139915; Furukawa H, 2013, SCIENCE, V341, P974, DOI 10.1126/science.1230444; Liu YZ, 2016, SCIENCE, V351, P365, DOI 10.1126/science.aad4011; Prikhod'ko AI, 2008, J AM CHEM SOC, V130, P448, DOI 10.1021/ja078216p; Waller PJ, 2015, ACCOUNTS CHEM RES, V48, P3053, DOI 10.1021/acs.accounts.5b00369	7	0	0	2	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 22	2016	351	6271					336	336		10.1126/science.aad9671	http://dx.doi.org/10.1126/science.aad9671			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB3VH	26797998				2022-12-28	WOS:000368440500020
J	Maselli, DJ; Peters, JI				Maselli, Diego J.; Peters, Jay I.			Review: In COPD, tiotropium improves lung function and reduces adverse events compared with ipratropium bromide	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Maselli, Diego J.; Peters, Jay I.] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio	Maselli, DJ (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA.							Barnes PJ, 2000, CHEST, V117, P63; Gosens R, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-73; Meurs H, 2013, CURR OPIN PHARMACOL, V13, P316, DOI 10.1016/j.coph.2013.04.004; Salpeter SR, 2006, J GEN INTERN MED, V21, P1011, DOI 10.1111/j.1525-1497.2006.00507.x	4	1	1	0	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 19	2016	164	2					JC6	JC6		10.7326/ACPJC-2016-164-2-006	http://dx.doi.org/10.7326/ACPJC-2016-164-2-006			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DB0CI	26784496				2022-12-28	WOS:000368175800005
J	Wald, A				Wald, Arnold			Constipation Advances in Diagnosis and Treatment	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							OPIOID-INDUCED CONSTIPATION; IRRITABLE-BOWEL-SYNDROME; PLACEBO-CONTROLLED TRIAL; DOUBLE-BLIND; EFFICACY; PRUCALOPRIDE; LUBIPROSTONE; MANAGEMENT; SAFETY; TOLERABILITY	IMPORTANCE Chronic constipation accounts for at least 8 million annual visits to health care providers in the United States and is associated with large expenditures for diagnostic testing and prescription and nonprescription laxatives. OBSERVATIONS Strong evidence for efficacy has been established for stimulant and osmotic laxatives, new intestinal secretogogues, and peripherally restricted p-opiate receptor antagonists, the latter a major advance in the treatment of opioid-induced constipation (OIC). An algorithm provided to evaluate chronic idiopathic constipation (CIC) that is refractory to available laxatives focuses on the importance of defecation disorders and biofeedback therapies. When used appropriately, available stimulant laxatives such as senna and bisacodyl are both safe and effective when used long-term. There is a paucity of (and a strong desire for) studies that compare inexpensive laxatives with newer agents that work by other mechanisms. CONCLUSIONS AND RELEVANCE The choice of treatment for CIC and OIC should be based on cost as well as efficacy. The small subgroup of patients who do not respond to currently available laxatives requires further evaluation at experienced centers that are capable of performing studies of defecation and colonic transit.	[Wald, Arnold] Univ Wisconsin, Sch Med & Publ Hlth, Div Gastroenterol & Hepatol, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison	Wald, A (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Div Gastroenterol & Hepatol, Centennial Bldg,1685 Highland Ave,Fourth Floor, Madison, WI 53705 USA.	axw@medicine.wisc.edu						[Anonymous], 2015, MED LETT DRUGS THER, V57, P135; Atluri DK, 2014, NEUROGASTROENT MOTIL, V26, P499, DOI 10.1111/nmo.12292; Balshem H, 2011, J CLIN EPIDEMIOL, V64, P401, DOI 10.1016/j.jclinepi.2010.07.015; Barish CF, 2010, DIGEST DIS SCI, V55, P1090, DOI 10.1007/s10620-009-1068-x; Bharucha AE, 2013, GASTROENTEROLOGY, V144, P218, DOI 10.1053/j.gastro.2012.10.028; Bharucha AE, 2010, AM J GASTROENTEROL, V105, P786, DOI 10.1038/ajg.2010.70; Chey WD, 2014, NEW ENGL J MED, V370, P2387, DOI 10.1056/NEJMoa1310246; Chiarioni G, 2014, CLIN GASTROENTEROL H, V12, P2049, DOI 10.1016/j.cgh.2014.03.013; Cinca R, 2013, ALIMENT PHARM THER, V37, P876, DOI 10.1111/apt.12278; Cryer B, 2014, PAIN MED, V15, P1825, DOI 10.1111/pme.12437; Drug Enforcement Administration Department of Justice, 2015, Fed Regist, V80, P3468; Ford AC, 2014, AM J GASTROENTEROL, V109, pS2, DOI 10.1038/ajg.2014.187; Ford AC, 2013, AM J GASTROENTEROL, V108, P1566, DOI 10.1038/ajg.2013.169; Ford Alexander C, 2013, Gastroenterology, V145, P897, DOI 10.1053/j.gastro.2013.08.032; Freedman MD, 1997, J CLIN PHARMACOL, V37, P904, DOI 10.1002/j.1552-4604.1997.tb04264.x; Heidelbaugh JJ, 2015, AM J GASTROENTEROL, V110, P580, DOI 10.1038/ajg.2015.67; Jamal MM, 2015, AM J GASTROENTEROL, V110, P725, DOI 10.1038/ajg.2015.106; Johanson JF, 2007, ALIMENT PHARM THER, V25, P599, DOI 10.1111/j.1365-2036.2006.03238.x; Kamm MA, 2011, CLIN GASTROENTEROL H, V9, P577, DOI 10.1016/j.cgh.2011.03.026; Lembo AJ, 2011, NEW ENGL J MED, V365, P527, DOI 10.1056/NEJMoa1010863; Leppert W, 2014, CURR DRUG TARGETS, V15, P124, DOI 10.2174/13894501113149990210; Mueller-Lissner S, 2010, AM J GASTROENTEROL, V105, P897, DOI 10.1038/ajg.2010.41; Muller-Lissner SA, 2005, AM J GASTROENTEROL, V100, P232, DOI 10.1111/j.1572-0241.2005.40885.x; Nelson AD, 2015, THER ADV GASTROENTER, V8, P206, DOI 10.1177/1756283X15578608; Quigley EMM, 2013, DIGEST DIS SCI, V58, P2446, DOI 10.1007/s10620-013-2766-y; Rao SSC, 2010, AM J GASTROENTEROL, V105, P890, DOI 10.1038/ajg.2010.53; Schey R, 2011, DIGEST DIS SCI, V56, P1619, DOI 10.1007/s10620-011-1702-2; Shah ND, 2008, AM J GASTROENTEROL, V103, P1746, DOI 10.1111/j.1572-0241.2008.01910.x; Shailubhai K, 2013, DIGEST DIS SCI, V58, P2580, DOI 10.1007/s10620-013-2684-z; Shin A, 2014, ALIMENT PHARM THER, V39, P239, DOI 10.1111/apt.12571; Tack J, 2015, UNITED EUR GASTROENT, V3, P471, DOI 10.1177/2050640615604543; US Food and Drug Administration, FDA APPR NEW EXT REL; Wald A, 2003, J CLIN GASTROENTEROL, V36, P386, DOI 10.1097/00004836-200305000-00004; Wald A, 2014, AM J GASTROENTEROL, V109, P1141, DOI 10.1038/ajg.2014.190; Webster L, 2013, PAIN, V154, P1542, DOI 10.1016/j.pain.2013.04.024; Wong RK, 2010, AM J GASTROENTEROL, V105, P2228, DOI 10.1038/ajg.2010.200; Yiannakou Y, 2015, AM J GASTROENTEROL, V110, P741, DOI 10.1038/ajg.2015.115	37	76	82	1	19	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 12	2016	315	2					185	191		10.1001/jama.2015.16994	http://dx.doi.org/10.1001/jama.2015.16994			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DA6XO	26757467				2022-12-28	WOS:000367949200020
J	Cabezas-Wallscheid, N; Trumpp, A				Cabezas-Wallscheid, Nina; Trumpp, Andreas			Potency finds its niches	SCIENCE			English	Editorial Material							HEMATOPOIETIC STEM-CELLS; PROGENITORS; HOMEOSTASIS; HIERARCHY		[Cabezas-Wallscheid, Nina; Trumpp, Andreas] Heidelberg Inst Stem Cell Technol & Expt Med HI S, D-69120 Heidelberg, Germany; [Cabezas-Wallscheid, Nina; Trumpp, Andreas] Deutsch Krebsforschungszentrum DKFZ, Div Stem Cells & Canc, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ)	Cabezas-Wallscheid, N (corresponding author), Heidelberg Inst Stem Cell Technol & Expt Med HI S, D-69120 Heidelberg, Germany.	a.trumpp@dkfz-heidelberg.de	Trumpp, Andreas/Z-2141-2019	Trumpp, Andreas/0000-0002-6212-3466				Cabezas-Wallscheid N, 2014, CELL STEM CELL, V15, P507, DOI 10.1016/j.stem.2014.07.005; Guo GJ, 2013, CELL STEM CELL, V13, P492, DOI 10.1016/j.stem.2013.07.017; Haas S, 2015, CELL STEM CELL, V17, P422, DOI 10.1016/j.stem.2015.07.007; Khan JA, 2016, SCIENCE, V351, P176, DOI 10.1126/science.aad0084; Kondo M, 2003, ANNU REV IMMUNOL, V21, P759, DOI 10.1146/annurev.immunol.21.120601.141007; Mendelson A, 2014, NAT MED, V20, P833, DOI 10.1038/nm.3647; Morrison SJ, 2014, NATURE, V505, P327, DOI 10.1038/nature12984; Notta F, 2016, SCIENCE, V351, P139, DOI 10.1126/science.aab2116; Pronk CJH, 2007, CELL STEM CELL, V1, P428, DOI 10.1016/j.stem.2007.07.005; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Yamamoto R, 2013, CELL, V154, P1112, DOI 10.1016/j.cell.2013.08.007	12	3	3	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 8	2016	351	6269					126	127		10.1126/science.aae0325	http://dx.doi.org/10.1126/science.aae0325			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA4XQ	26744396				2022-12-28	WOS:000367806500017
J	Chen, JH				Chen, Jiuhua			Lower-mantle materials under pressure	SCIENCE			English	Editorial Material							SEISMIC TOMOGRAPHY; WHOLE-MANTLE; FLOW; PEROVSKITE; CONVECTION; VISCOSITY; MODEL		[Chen, Jiuhua] Jilin Univ, Ctr High Pressure Sci & Technol Adv Res, Changchun 130015, Peoples R China; [Chen, Jiuhua] Florida Int Univ, Dept Mech & Mat Engn, Ctr Study Matter Extreme Condit, Miami, FL 33199 USA	Jilin University; State University System of Florida; Florida International University	Chen, JH (corresponding author), Jilin Univ, Ctr High Pressure Sci & Technol Adv Res, Changchun 130015, Peoples R China.	chenj@fiu.edu						Chen JH, 2002, NATURE, V419, P824, DOI 10.1038/nature01130; Chen JH, 2010, J PHYS CHEM SOLIDS, V71, P1032, DOI 10.1016/j.jpcs.2010.03.001; Forte AM, 1996, GEOPHYS RES LETT, V23, P1147, DOI 10.1029/96GL00964; Girard J, 2016, SCIENCE, V351, P144, DOI 10.1126/science.aad3113; Hafkenscheid E, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2005JB003791; HANDY MR, 1994, J STRUCT GEOL, V16, P287, DOI 10.1016/0191-8141(94)90035-3; Kido M, 1998, PHYS EARTH PLANET IN, V107, P307, DOI 10.1016/S0031-9201(98)00077-6; KNITTLE E, 1987, SCIENCE, V235, P668, DOI 10.1126/science.235.4789.668; Panning M, 2006, GEOPHYS J INT, V167, P361, DOI 10.1111/j.1365-246X.2006.03100.x; Stadler G, 2010, SCIENCE, V329, P1033, DOI 10.1126/science.1191223; Wen LX, 1997, EARTH PLANET SC LETT, V146, P367, DOI 10.1016/S0012-821X(96)00238-5; Yamazaki D, 2001, AM MINERAL, V86, P385	12	6	7	3	87	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 8	2016	351	6269					122	123		10.1126/science.aad7813	http://dx.doi.org/10.1126/science.aad7813			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA4XQ	26744393				2022-12-28	WOS:000367806500014
J	Day, RS				Day, Roger S.			Want a letter? You write it for me	SCIENCE			English	Editorial Material								A few years back, I asked two colleagues for letters of support for my grant proposal. One colleague drafted a letter personally. The other, citing heavy time pressures, asked me to draft the letter myself. I was sympathetic, but I felt queasy pretending to be someone else as I described my own work. To appease my conscience, I wrote as myself: "I" meant me and "you" meant my colleague. This was risky. If the colleague simply signed and sent the letter, neglecting the required pronoun switcheroo, the letter would instantly reveal its true originator. I am grateful that the colleague saved me that embarrassment, and even added authentic language to the letter.	[Day, Roger S.] Univ Pittsburgh, Biomed Informat & Biostat, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Day, RS (corresponding author), Univ Pittsburgh, Biomed Informat & Biostat, Pittsburgh, PA 15260 USA.	SciCareerEditor@aaas.org							0	2	2	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 8	2016	351	6269					198	198		10.1126/science.351.6269.198	http://dx.doi.org/10.1126/science.351.6269.198			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA4XQ	26744407				2022-12-28	WOS:000367806500046
J	McCartney, M				McCartney, Margaret			Margaret McCartney: Bruce Keogh's letter to junior doctors: the importance of independence	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Brunet M, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g7235; Cooper C., 2016, INDEPENDENT; Gentleman A., 2013, GUARDIAN; Ipsos MORI, 2015, TRUST PROF; Siriwardena N, 2010, QUALITY OUTCOMES FRA	5	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 8	2016	352								i141	10.1136/bmj.i141	http://dx.doi.org/10.1136/bmj.i141			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DA8NF	26746428	Bronze, Green Published			2022-12-28	WOS:000368061200004
J	Larochelle, MR; Liebschutz, JM; Zhang, F; Ross-Degnan, D; Wharam, JF				Larochelle, Marc R.; Liebschutz, Jane M.; Zhang, Fang; Ross-Degnan, Dennis; Wharam, J. Frank			Opioid Prescribing After Nonfatal Overdose and Association With Repeated Overdose A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							CHRONIC NONCANCER PAIN; UNITED-STATES; CONTROLLED SUBSTANCES; RISK-FACTORS; THERAPY; DEPENDENCE; DEATHS; ABUSE; PRESCRIPTIONS; GUIDELINES	Background: Nonfatal opioid overdose is an opportunity to identify and treat substance use disorders, but treatment patterns after the overdose are unknown. Objective: To determine prescribed opioid dosage after an opioid overdose and its association with repeated overdose. Design: Retrospective cohort study. Setting: A large U.S. health insurer. Participants: 2848 commercially insured patients aged 18 to 64 years who had a nonfatal opioid overdose during long-term opioid therapy for noncancer pain between May 2000 and December 2012. Measurements: Nonfatal opioid overdose was identified using International Classification of Diseases, Ninth Revision, Clinical Modification, codes from emergency department or inpatient claims. The primary outcome was daily morphine-equivalent dosage (MED) of opioids dispensed from 60 days before to up to 730 days after the index overdose. We categorized dosages as large (>= 100 mg MED), moderate (50 to <100 mg MED), low (<50 mg MED), or none (0 mg MED). Secondary outcomes included time to repeated overdose stratified by daily dosage as a time-varying covariate. Results: Over a median follow-up of 299 days, opioids were dispensed to 91% of patients after an overdose. Seven percent of patients (n = 212) had a repeated opioid overdose. At 2 years, the cumulative incidence of repeated overdose was 17% (95% CI, 14% to 20%) for patients receiving high dosages of opioids after the index overdose, 15% (CI, 10% to 21%) for those receiving moderate dosages, 9% (CI, 6% to 14%) for those receiving low dosages, and 8% (CI, 6% to 11%) for those receiving no opioids. Limitation: The cohort was limited to commercially insured adults. Conclusion: Almost all patients continue to receive prescription opioids after an overdose. Opioid discontinuation after overdose is associated with lower risk for repeated overdose.	[Larochelle, Marc R.; Liebschutz, Jane M.; Zhang, Fang; Ross-Degnan, Dennis; Wharam, J. Frank] Harvard Univ, Sch Med, Harvard Pilgrim Hlth Care Inst, Boston, MA USA; [Larochelle, Marc R.; Liebschutz, Jane M.; Zhang, Fang; Ross-Degnan, Dennis; Wharam, J. Frank] Boston Univ, Sch Med, Boston, MA 02118 USA; [Larochelle, Marc R.; Liebschutz, Jane M.; Zhang, Fang; Ross-Degnan, Dennis; Wharam, J. Frank] Boston Med Ctr, Boston, MA 02118 USA	Harvard Pilgrim Health Care; Harvard University; Harvard Medical School; Boston University; Boston Medical Center	Larochelle, MR (corresponding author), Boston Med Ctr, 801 Massachusetts Ave,2nd Floor, Boston, MA 02118 USA.	marc.larochelle@bmc.org	Zhang, Fang/HHN-2153-2022	Wharam, James/0000-0003-2053-0757	Health Resources and Services Administration	Health Resources and Services Administration(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA))	Health Resources and Services Administration.	Bohnert ASB, 2011, JAMA-J AM MED ASSOC, V305, P1315, DOI 10.1001/jama.2011.370; Bohnert ASB, 2011, MED CARE, V49, P393, DOI 10.1097/MLR.0b013e318202aa27; Boscarino JA, 2010, ADDICTION, V105, P1776, DOI 10.1111/j.1360-0443.2010.03052.x; Boudreau D, 2009, PHARMACOEPIDEM DR S, V18, P1166, DOI 10.1002/pds.1833; Cai R., 2010, Morbidity and Mortality Weekly Report, V59, P705; Caudill-Slosberg MA, 2004, PAIN, V109, P514, DOI 10.1016/j.pain.2004.03.006; Chou R, 2009, J PAIN, V10, P113, DOI 10.1016/j.jpain.2008.10.008; Coolen P., 2009, Morbidity and Mortality Weekly Report, V58, P1171; Daubresse M, 2014, PHARMACOEPIDEM DR S, V23, P419, DOI 10.1002/pds.3487; Dunn KM, 2010, ANN INTERN MED, V152, P85, DOI 10.7326/0003-4819-152-2-201001190-00006; Edlund MJ, 2007, PAIN, V129, P355, DOI 10.1016/j.pain.2007.02.014; Edlund MJ, 2010, DRUG ALCOHOL DEPEN, V112, P90, DOI 10.1016/j.drugalcdep.2010.05.017; Garcia AM, 2013, J LAW MED ETHICS, V41, P42, DOI 10.1111/jlme.12037; Injury Surveillance Workgroup, 2012, CONS REC NAT STAT PO; Ives TJ, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-46; Jones CM, 2013, JAMA-J AM MED ASSOC, V309, P657, DOI 10.1001/jama.2013.272; Manchikanti L, 2012, PAIN PHYSICIAN, V15, pS67; Mattick RP, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002207.pub4; Paulozzi Leonard J., 2011, Morbidity and Mortality Weekly Report, V60, P1487; Snapinn SM, 2005, AM STAT, V59, P301, DOI 10.1198/000313005X70371; Sullivan MD, 2008, PAIN, V138, P440, DOI 10.1016/j.pain.2008.04.027; Unick GJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054496; Von Korff M, 2008, CLIN J PAIN, V24, P521, DOI 10.1097/AJP.0b013e318169d03b; Walley AY, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f174	24	119	121	2	14	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 5	2016	164	1					1	+		10.7326/M15-0038	http://dx.doi.org/10.7326/M15-0038			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DA4WC	26720742				2022-12-28	WOS:000367801700005
J	Smith, JM				Smith, Jeanette M.			Day of Sounds Alice Baber	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																		BABER MSA, 1982, WOMANS ART J, V3, P40; DELALLIER A, 1982, WOMANS ART J, V3, P44	2	0	0	1	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 5	2016	315	1					12	13		10.1001/jama.2015.14034	http://dx.doi.org/10.1001/jama.2015.14034			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DA0YH	26746439				2022-12-28	WOS:000367523000001
J	Buel, GR; Blenis, J				Buel, Gwen R.; Blenis, John			Seeing mTORC1 specificity	SCIENCE			English	Editorial Material							SESTRINS; COMPLEX		[Buel, Gwen R.; Blenis, John] Weill Cornell Med Coll, Dept Pharmacol, Meyer Canc Ctr, New York, NY 10065 USA	Cornell University	Buel, GR (corresponding author), Weill Cornell Med Coll, Dept Pharmacol, Meyer Canc Ctr, New York, NY 10065 USA.	job2064@med.cornell.edu						Aylett CHS, 2016, SCIENCE, V351, P48, DOI 10.1126/science.aaa3870; Budanov AV, 2008, CELL, V134, P451, DOI 10.1016/j.cell.2008.06.028; Chantranupong L, 2014, CELL REP, V9, P1, DOI 10.1016/j.celrep.2014.09.014; Kim JS, 2015, SCI REP-UK, V5, DOI 10.1038/srep09502; Lee JH, 2013, CELL METAB, V18, P792, DOI 10.1016/j.cmet.2013.08.018; Parmigiani A, 2014, CELL REP, V9, P1281, DOI 10.1016/j.celrep.2014.10.019; Peng M, 2014, CELL, V159, P122, DOI 10.1016/j.cell.2014.08.038; Saxton RA, 2016, SCIENCE, V351, P53, DOI 10.1126/science.aad2087; Schalm SS, 2002, CURR BIOL, V12, P632, DOI 10.1016/S0960-9822(02)00762-5; Wang SY, 2015, SCIENCE, V347, P188, DOI 10.1126/science.1257132; Wolfson RL, 2016, SCIENCE, V351, P43, DOI 10.1126/science.aab2674; Yang HJ, 2013, NATURE, V497, P217, DOI 10.1038/nature12122; Yip CK, 2010, MOL CELL, V38, P768, DOI 10.1016/j.molcel.2010.05.017	13	3	4	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 1	2016	351	6268					25	26		10.1126/science.aad9696	http://dx.doi.org/10.1126/science.aad9696			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ8QM	26721988				2022-12-28	WOS:000367364200025
J	O'Toole, PW; Jeffery, IB				O'Toole, Paul W.; Jeffery, Ian B.			Gut microbiota and aging	SCIENCE			English	Editorial Material							HEALTH; DIET	The potential for the gut microbiota to affect health has a particular relevance for older individuals. This is because the microbiota may modulate aging-related changes in innate immunity, sarcopaenia, and cognitive function, all of which are elements of frailty. Both cell culture-dependent and -independent studies show that the gut microbiota of older people differs from that of younger adults. There is no chronological threshold or age at which the composition of the microbiota suddenly alters; rather, changes occur gradually with time. Our detailed analyses have separated the microbiota into groups associated with age, long-term residential care, habitual diet, and degree of retention of a core microbiome. We are beginning to understand how these groups change with aging and how they relate to clinical phenotypes. These data provide a framework for analyzing microbiota-health associations, distinguishing correlation from causation, identifying microbiota interaction with physiological aging processes, and developing microbiota-based health surveillance for older adults.	[O'Toole, Paul W.] Natl Univ Ireland Univ Coll Cork, Sch Microbiol, Cork T12 Y337, Ireland; Natl Univ Ireland Univ Coll Cork, APC Microbiome Inst, Cork T12 Y337, Ireland	University College Cork; University College Cork	O'Toole, PW (corresponding author), Natl Univ Ireland Univ Coll Cork, Sch Microbiol, Cork T12 Y337, Ireland.	pwotoole@ucc.ie	O'Toole, Paul W/G-1593-2012	O'Toole, Paul W/0000-0001-5377-0824; Jeffery, Ian/0000-0001-9183-7292	Science Foundation Ireland of the government of Ireland; Department of Agriculture, Food, and the Marine of the government of Ireland; General Mills International; Kerry Group	Science Foundation Ireland of the government of Ireland(Science Foundation Ireland); Department of Agriculture, Food, and the Marine of the government of Ireland; General Mills International; Kerry Group	Work in the I.B.J. and P.W.O.T. laboratories is funded by awards from Science Foundation Ireland and the Department of Agriculture, Food, and the Marine of the government of Ireland and by General Mills International and the Kerry Group, who had no influence on the content of this review.	Biagi E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010667; Claesson MJ, 2012, NATURE, V488, P178, DOI 10.1038/nature11319; Claesson MJ, 2011, P NATL ACAD SCI USA, V108, P4586, DOI 10.1073/pnas.1000097107; Clark RI, 2015, CELL REP, V12, P1656, DOI 10.1016/j.celrep.2015.08.004; Flint HJ, 2012, NAT REV GASTRO HEPAT, V9, P577, DOI 10.1038/nrgastro.2012.156; Fontana L, 2015, CELL, V161, P106, DOI 10.1016/j.cell.2015.02.020; Hegazy AN, 2015, SCIENCE, V349, P929, DOI 10.1126/science.aad0865; Jeffery IB, 2016, ISME J, V10, P170, DOI 10.1038/ismej.2015.88; Rampelli S, 2013, AGING-US, V5, P902, DOI 10.18632/aging.100623; Santoro A, 2014, MECH AGEING DEV, V136, P3, DOI 10.1016/j.mad.2013.12.001	10	511	530	18	157	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 4	2015	350	6265					1214	1215		10.1126/science.aac8469	http://dx.doi.org/10.1126/science.aac8469			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX4WG	26785481				2022-12-28	WOS:000365700500066
J	Scheid, JF				Scheid, Johannes F.			HIV-specific B cell response in patients with broadly neutralizing serum activity	SCIENCE			English	Editorial Material							ANTIBODIES; VIREMIA; MICE		[Scheid, Johannes F.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Scheid, Johannes F.] Rockefeller Univ, New York, NY 10021 USA	Harvard University; Massachusetts General Hospital; Rockefeller University	Scheid, JF (corresponding author), Massachusetts Gen Hosp, Boston, MA 02114 USA.	fscheid@partners.org						Burton DR, 2015, NAT IMMUNOL, V16, P571, DOI 10.1038/ni.3158; Caskey M, 2015, NATURE, V522, P487, DOI 10.1038/nature14411; Dey B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000445; Diskin R, 2011, SCIENCE, V334, P1289, DOI 10.1126/science.1213782; Dosenovic P, 2015, CELL, V161, P1505, DOI 10.1016/j.cell.2015.06.003; Klein F, 2012, NATURE, V492, P118, DOI 10.1038/nature11604; Kwong PD, 2012, IMMUNITY, V37, P412, DOI 10.1016/j.immuni.2012.08.012; Mouquet H, 2010, NATURE, V467, P591, DOI 10.1038/nature09385; Pietzsch J, 2010, J EXP MED, V207, P1995, DOI 10.1084/jem.20101176; Pietzsch J, 2010, J VIROL, V84, P5032, DOI 10.1128/JVI.00154-10; Scharf L, 2014, CELL REP, V7, P785, DOI 10.1016/j.celrep.2014.04.001; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Scheid JF, 2009, J IMMUNOL METHODS, V343, P65, DOI 10.1016/j.jim.2008.11.012; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Shingai M, 2013, NATURE, V503, P277, DOI 10.1038/nature12746; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Zhou TQ, 2015, CELL, V161, P1280, DOI 10.1016/j.cell.2015.05.007	18	2	2	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 4	2015	350	6265								10.1126/science.aad7133	http://dx.doi.org/10.1126/science.aad7133			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX4WG	26785466	Green Submitted			2022-12-28	WOS:000365700500052
J	Yan, KK; Fujita, M				Yan, KaKing; Fujita, Makoto			A speedy marriage in supramolecular catalysis	SCIENCE			English	Editorial Material							REDUCTIVE ELIMINATION; COMPLEXES		[Yan, KaKing; Fujita, Makoto] Univ Tokyo, Dept Dept Appl Chem, Tokyo, Japan	University of Tokyo	Yan, KK (corresponding author), Univ Tokyo, Dept Dept Appl Chem, Tokyo, Japan.	yan.kaking@appchem.t.u-tokyo.ac.jp; mfujita@appchem.t.u-tokyo.ac.jp	Yan, KaKing/GMW-4606-2022					CRAM DJ, 1991, ANGEW CHEM INT EDIT, V30, P1024, DOI 10.1002/anie.199110241; Dalton DM, 2015, J AM CHEM SOC, V137, P10128, DOI 10.1021/jacs.5b06317; Hastings CJ, 2008, J AM CHEM SOC, V130, P10977, DOI 10.1021/ja8013055; Hyster TK, 2012, SCIENCE, V338, P500, DOI 10.1126/science.1226132; Iwasawa T, 2007, SCIENCE, V317, P493, DOI 10.1126/science.1143272; Kaphan DM, 2015, SCIENCE, V350, P1235, DOI 10.1126/science.aad3087; Kaphan DM, 2015, J AM CHEM SOC, V137, P9202, DOI 10.1021/jacs.5b01261; KOMIYA S, 1976, J AM CHEM SOC, V98, P7599, DOI 10.1021/ja00440a025; Leung DH, 2007, J AM CHEM SOC, V129, P2746, DOI 10.1021/ja068688o; Mal P, 2009, SCIENCE, V324, P1697, DOI 10.1126/science.1175313; TAMAKI A, 1974, J AM CHEM SOC, V96, P6140, DOI 10.1021/ja00826a029; Wang ZQ, 2009, CHEM SOC REV, V38, P1315, DOI 10.1039/b802258p; Wolf WJ, 2014, NAT CHEM, V6, P159, DOI [10.1038/NCHEM.1822, 10.1038/nchem.1822]; Wolfenden R, 2001, ACCOUNTS CHEM RES, V34, P938, DOI 10.1021/ar000058i; Yoshizawa M, 2006, SCIENCE, V312, P251, DOI 10.1126/science.1124985	15	18	18	6	172	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 4	2015	350	6265					1165	1166		10.1126/science.aad7245	http://dx.doi.org/10.1126/science.aad7245			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX4WG	26785458				2022-12-28	WOS:000365700500043
J	Flenady, V; Wojcieszek, AM; Middleton, P; Ellwood, D; Erwich, JJ; Coory, M; Khong, TY; Silver, RM; Smith, GCS; Boyle, FM; Lawn, JE; Blencowe, H; Leisher, SH; Gross, MM; Horey, D; Farrales, L; Bloomfield, F; McCowan, L; Brown, SJ; Joseph, KS; Zeitlin, J; Reinebrant, HE; Ravaldi, C; Vannacci, A; Cassidy, J; Cassidy, P; Farquhar, C; Wallace, E; Siassakos, D; Heazell, AEP; Storey, C; Sadler, L; Petersen, S; Froen, JF; Goldenberg, RL				Flenady, Vicki; Wojcieszek, Aleena M.; Middleton, Philippa; Ellwood, David; Erwich, Jan Jaap; Coory, Michael; Khong, T. Yee; Silver, Robert M.; Smith, Gordon C. S.; Boyle, Frances M.; Lawn, Joy E.; Blencowe, Hannah; Leisher, Susannah Hopkins; Gross, Mechthild M.; Horey, Dell; Farrales, Lynn; Bloomfield, Frank; McCowan, Lesley; Brown, Stephanie J.; Joseph, K. S.; Zeitlin, Jennifer; Reinebrant, Hanna E.; Ravaldi, Claudia; Vannacci, Alfredo; Cassidy, Jillian; Cassidy, Paul; Farquhar, Cindy; Wallace, Euan; Siassakos, Dimitrios; Heazell, Alexander E. P.; Storey, Claire; Sadler, Lynn; Petersen, Scott; Froen, J. Frederik; Goldenberg, Robert L.		Lancet Ending Preventable; Lancet Stillbirths High-Income	Stillbirths: recall to action in high-income countries	LANCET			English	Article							FETAL-GROWTH RESTRICTION; PRENATAL-CARE; HEALTH DISPARITIES; WOMENS EXPERIENCES; PREGNANCY OUTCOMES; INFANT-MORTALITY; ANTENATAL CARE; UNITED-STATES; RISK; BIRTH	Variation in stillbirth rates across high-income countries and large equity gaps within high-income countries persist. If all high-income countries achieved stillbirth rates equal to the best performing countries, 19 439 late gestation ( 28 weeks or more) stillbirths could have been avoided in 2015. The proportion of unexplained stillbirths is high and can be addressed through improvements in data collection, investigation, and classification, and with a better understanding of causal pathways. Substandard care contributes to 20-30% of all stillbirths and the contribution is even higher for late gestation intrapartum stillbirths. National perinatal mortality audit programmes need to be implemented in all high-income countries. The need to reduce stigma and fatalism related to stillbirth and to improve bereavement care are also clear, persisting priorities for action. In high-income countries, a woman living under adverse socioeconomic circumstances has twice the risk of having a stillborn child when compared to her more advantaged counterparts. Programmes at community and country level need to improve health in disadvantaged families to address these inequities.	[Flenady, Vicki; Wojcieszek, Aleena M.; Leisher, Susannah Hopkins; Horey, Dell; Reinebrant, Hanna E.; Petersen, Scott] Univ Queensland, Mater Res Inst, Brisbane, Qld, Australia; [Boyle, Frances M.] Univ Queensland, Sch Publ Hlth, Brisbane, Qld, Australia; [Flenady, Vicki; Wojcieszek, Aleena M.; Middleton, Philippa; Ellwood, David; Erwich, Jan Jaap; Coory, Michael; Khong, T. Yee; Silver, Robert M.; Boyle, Frances M.; Leisher, Susannah Hopkins; Farrales, Lynn; McCowan, Lesley; Reinebrant, Hanna E.; Ravaldi, Claudia; Cassidy, Paul; Wallace, Euan; Siassakos, Dimitrios; Heazell, Alexander E. P.; Storey, Claire] Int Stillbirth Alliance, Millburn, NJ USA; [Middleton, Philippa] Univ Adelaide, Womens & Childrens Hlth Res Inst, Adelaide, SA, Australia; [Ellwood, David] Griffith Univ, Gold Coast, Qld, Australia; [Ellwood, David] Gold Coast Univ Hosp, Gold Coast, Qld, Australia; [Erwich, Jan Jaap] Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands; [Coory, Michael] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Khong, T. Yee] Univ Adelaide, SA Pathol, Adelaide, SA, Australia; [Silver, Robert M.] Univ Utah, Hlth Sci Ctr, Salt Lake City, UT USA; [Smith, Gordon C. S.] Natl Inst Hlth Res, Biomed Res Ctr, Cambridge, England; [Smith, Gordon C. S.] Univ Cambridge, Cambridge, England; [Lawn, Joy E.; Blencowe, Hannah] London Sch Hyg & Trop Med, London WC1, England; [Gross, Mechthild M.] Hannover Med Sch, Hannover, Germany; [Gross, Mechthild M.] Zurich Univ Appl Sci, Inst Midwifery, Winterthur, Switzerland; [Horey, Dell] La Trobe Univ, Melbourne, Vic, Australia; [Farrales, Lynn] Still Life Canada Stillbirth & Neonatal Death Ed, Vancouver, BC, Canada; [Bloomfield, Frank; McCowan, Lesley] Univ Auckland, Liggins Inst, Auckland 1, New Zealand; [Farquhar, Cindy] Univ Auckland, Auckland 1, New Zealand; [Brown, Stephanie J.] Univ Melbourne, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Brown, Stephanie J.] Univ Melbourne, Gen Practice & Primary Hlth Care Acad Ctr, Parkville, Vic 3052, Australia; [Farrales, Lynn; Joseph, K. S.] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Zeitlin, Jennifer] Paris Descartes Univ, Natl Sante & Rech Med, Obstet Perinatal & Paediat Epidemiol Res Team, Ctr Epidemiol & Biostat,U1153, Paris, France; [Ravaldi, Claudia; Vannacci, Alfredo] CiaoLapo Onlus, Char High Risk Pregnancies & Perinatal Grief Supp, Prato, Italy; [Vannacci, Alfredo] Univ Florence, Dept Neurosci Psychol Drug Res & Child Hlth, Florence, Italy; [Cassidy, Jillian; Cassidy, Paul] Umamanita, Girona, Spain; [Wallace, Euan] Monash Univ, Melbourne, Vic 3004, Australia; [Siassakos, Dimitrios] Univ Bristol, Bristol, Avon, England; [Siassakos, Dimitrios] Southmead Hosp, Bristol, Avon, England; [Heazell, Alexander E. P.] Univ Manchester, Fac Med & Human Sci, Inst Human Dev, Manchester, Lancs, England; [Heazell, Alexander E. P.] St Marys Hosp, Cent Manchester Univ Hosp, NHS Fdn Trust, Manchester M13 0JH, Lancs, England; [Petersen, Scott] Mater Hlth Serv, Brisbane, Qld, Australia; [Froen, J. Frederik] Norwegian Inst Publ Hlth, Dept Int Publ Hlth, Oslo, Norway; [Froen, J. Frederik] Univ Bergen, Ctr Intervent Sci Maternal & Child Hlth, Bergen, Norway; [Goldenberg, Robert L.] Columbia Univ, Dept Obstet & Gynecol, New York, NY USA	Mater Research; University of Queensland; University of Queensland; University of Adelaide; Womens & Childrens Hospital Australia; Griffith University; Gold Coast University Hospital; University of Groningen; Murdoch Children's Research Institute; SA Pathology; University of Adelaide; Utah System of Higher Education; University of Utah; University of Cambridge; University of Cambridge; University of London; London School of Hygiene & Tropical Medicine; Hannover Medical School; Zurich University of Applied Sciences; La Trobe University; University of Auckland; University of Auckland; Murdoch Children's Research Institute; University of Melbourne; University of Melbourne; University of British Columbia; UDICE-French Research Universities; Universite Paris Cite; University of Florence; Monash University; University of Bristol; Southmead Hospital; University of Manchester; Oxford University Hospitals NHS Foundation Trust; University of Manchester; Mater Health Services; Norwegian Institute of Public Health (NIPH); University of Bergen; Columbia University	Flenady, V (corresponding author), Univ Queensland, Mater Res Inst, Mater Hlth Serv, Brisbane, Qld, Australia.	vicki.flenady@mater.uq.edu.au	Smith, Gordon/A-8070-2008; Cassidy, Paul Richard/ABA-9474-2020; Blondel, Beatrice/G-5011-2017; Wallace, Euan M/K-6774-2015; Smith, Lucy K/S-6593-2019; Flenady, Vicki Jane/O-9609-2014; Vannacci, Alfredo/A-1708-2008; Brown, Stephanie/AAE-1662-2019; de Wall, Sabine/V-2413-2019; Siassakos, Dimitrios/A-6859-2012; Ravaldi, Claudia/AAO-4128-2020; Boyle, Fran/F-9139-2012; Murphy, Margaret/H-9149-2019; Wojcieszek, Aleena M/S-8668-2019; Leisher, Susannah/N-4451-2019; Leisher, Susannah H H/S-8995-2016; Cronin, Robin/AAX-4378-2020; Zeitlin, Jennifer/G-4973-2017; Reinebrant, Hanna/D-7879-2011; Horey, Dell/AAE-1918-2021; Gross, Mechthild M/S-4186-2018; Ellwood, David Alan/GNW-4485-2022; Usynina, Anna/L-5073-2017; Lawn, Joy/ABE-6382-2020; Gibbons, Kristen/J-3429-2014; Kildea, Sue/I-1548-2014	Smith, Gordon/0000-0003-2124-0997; Cassidy, Paul Richard/0000-0001-8475-9919; Wallace, Euan M/0000-0002-4506-5233; Smith, Lucy K/0000-0001-9470-0793; Flenady, Vicki Jane/0000-0001-8114-7677; Vannacci, Alfredo/0000-0001-5259-2026; de Wall, Sabine/0000-0002-5216-2787; Siassakos, Dimitrios/0000-0002-1078-9856; Ravaldi, Claudia/0000-0002-7219-5359; Boyle, Fran/0000-0003-1665-2137; Murphy, Margaret/0000-0001-9979-9462; Wojcieszek, Aleena M/0000-0001-8099-6087; Leisher, Susannah/0000-0002-0191-8863; Leisher, Susannah H H/0000-0002-0191-8863; Cronin, Robin/0000-0002-8304-8004; Zeitlin, Jennifer/0000-0002-9568-2969; Reinebrant, Hanna/0000-0003-4061-4923; Horey, Dell/0000-0001-7594-7694; Gross, Mechthild M/0000-0001-6348-0054; Ellwood, David Alan/0000-0003-4512-6443; Usynina, Anna/0000-0002-5346-3047; Lawn, Joy/0000-0002-4573-1443; Blencowe, Hannah/0000-0003-1556-3159; Joseph, K.S./0000-0003-2317-5607; Froen Froen, Jahn Frederik/0000-0001-9390-8509; Gordijn, Sanne/0000-0003-3915-8609; Ibiebele, Ibinabo/0000-0001-6024-2958; Gibbons, Kristen/0000-0002-5679-0932; Kildea, Sue/0000-0001-8591-4968; Gordon, Adrienne/0000-0002-2328-1066; Brown, Stephanie/0000-0001-9812-0067; McCowan, Lesley/0000-0001-9915-7873	Saving Newborn Lives/Save the Children; Norwegian Agency for Development Cooperation; Centre for Intervention Science in Maternal and Child Health - funded by the Research Council of Norway through Centers of Excellence scheme and the University of Bergen, Norway; Canadian Research Chair in Psychosocial Family Health; National Institute for Health Research [CS-2013-13-009] Funding Source: researchfish	Saving Newborn Lives/Save the Children; Norwegian Agency for Development Cooperation; Centre for Intervention Science in Maternal and Child Health - funded by the Research Council of Norway through Centers of Excellence scheme and the University of Bergen, Norway; Canadian Research Chair in Psychosocial Family Health; National Institute for Health Research(National Institute for Health Research (NIHR))	HB received grants from Saving Newborn Lives/Save the Children, during the conduct of the study. JFF was funded in part by a technical support grant from the Norwegian Agency for Development Cooperation and by the Centre for Intervention Science in Maternal and Child Health, which is funded by the Research Council of Norway through its Centers of Excellence scheme and the University of Bergen, Norway. We sincerely thank every parent, care provider, and community member who gave their time to complete the International Stillbirth Alliance (ISA) web-based surveys. We thank the ISA Network, the International Confederation of Midwives, the International Federation of Gynaecology and Obstetrics, ISA member organisations, and further national organisations that supported the dissemination of surveys. We also thank Translators Without Borders for assisting with survey translations. Mater Research Institute, University of Queensland, Australia provided infrastructure and funding for the research team to enable this work to be undertaken. The Canadian Research Chair in Psychosocial Family Health provided funding for revision of the translation of the French web-based survey of care providers.	Adams EK, 2013, MEDICARE MEDICAID RE, P3; Allanson E, 2016, WHO B IN PRESS; Auger N, 2013, CAN MED ASSOC J, V185, pE256, DOI 10.1503/cmaj.120945; Blencowe H, 2016, LANCET; Boerleider AW, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-81; Bradley NM, 2015, PERINATAL MORTALITY; Braveman P, 2006, ANNU REV PUBL HEALTH, V27, P167, DOI 10.1146/annurev.publhealth.27.021405.102103; BRETT KM, 1994, AM J OBSTET GYNECOL, V170, P41; Brown SJ, 2015, BIRTH-ISS PERINAT C, V42, P27, DOI 10.1111/birt.12143; Bryant AS, 2010, AM J OBSTET GYNECOL, V202, P335, DOI 10.1016/j.ajog.2009.10.864; Bukowski R, 2011, JAMA-J AM MED ASSOC, V306, P2459, DOI 10.1001/jama.2011.1823; Cha S, 2014, J INTERPERS VIOLENCE, V29, P911, DOI 10.1177/0886260513505711; Colgan TJ, 2012, ARCH PATHOL LAB MED, V136, P90, DOI 10.5858/arpa.2011-0188-OA; Conde-Agudelo A, 2015, BJOG-INT J OBSTET GY, V122, P41, DOI 10.1111/1471-0528.13096; Crump C, 2013, EPIDEMIOLOGY, V24, P270, DOI 10.1097/EDE.0b013e318280da0f; Dehlendorf C, 2013, AM J PUBLIC HEALTH, V103, P1772, DOI 10.2105/AJPH.2013.301339; Dehlendorf C, 2010, AM J OBSTET GYNECOL, V202, P212, DOI 10.1016/j.ajog.2009.12.003; Drysdale H, 2012, MED J AUSTRALIA, V197, P278, DOI 10.5694/mja12.10125; Duley L, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004659.pub2; Ego A, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-182; Ellis A, BMC PREGNAN IN PRESS; Eskes M, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005652; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Flenady V, 2011, LANCET, V377, P1703, DOI 10.1016/S0140-6736(11)60064-0; Flenady V, 2011, LANCET, V377, P1331, DOI 10.1016/S0140-6736(10)62233-7; Froen JF, 2011, LANCET, V377, P1353, DOI 10.1016/S0140-6736(10)62232-5; Froen JF, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-22; Froen JF, BMC PREGNAN IN PRESS; Froen JF, 2016, LANCET; Gardosi J, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003942; Gibson-Helm ME, 2015, BIRTH-ISS PERINAT C, V42, P116, DOI 10.1111/birt.12159; Gilbert NL, 2015, HEALTH REP, V26, P3; Gordon A, 2014, COCHRANE DB SYST REV, V5; Gordon A, 2015, OBSTET GYNECOL, V125, P347, DOI 10.1097/AOG.0000000000000627; Gulmezoglu AM, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004945; Heazell AEP, 2015, ULTRASOUND OBST GYN, V46, P641, DOI 10.1002/uog.15738; Heazell AEP, 2016, LANCET; Hilder L, 2014, SERIES AUSTR I HLTH, V29; Hogue CJR, 2013, AM J EPIDEMIOL, V177, P755, DOI 10.1093/aje/kws381; Hussey MA, 2007, CONTEMP CLIN TRIALS, V28, P182, DOI 10.1016/j.cct.2006.05.007; Ibiebele I, 2014, BJOG, V122, P1476; Ivers N, 2012, COCHRANE DB SYST REV, V6, DOI DOI 10.1002/14651858.CD000259.PUB3; Joseph KS, 2013, CAN MED ASSOC J, V185, pE345, DOI 10.1503/cmaj.121372; Joseph KS, 2012, BMJ-BRIT MED J, V344, pe746; Khalil A, 2013, ULTRASOUND OBST GYN, V41, P278, DOI 10.1002/uog.12313; Khong TY, ARCH PATHOL IN PRESS; King-Hele S, 2009, ARCH DIS CHILD-FETAL, V94, pF105, DOI 10.1136/adc.2007.135459; Kinney MV, 2016, LANCET; Kooper AJA, 2014, MOL CYTOGENET, V7, DOI 10.1186/1755-8166-7-6; Korteweg FJ, 2008, OBSTET GYNECOL, V111, P865, DOI 10.1097/AOG.0b013e31816a4ee3; Korteweg FJ, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2011.10.026; Lawn JE, 2016, LANCET; Luo ZC, 2008, PAEDIATR PERINAT EP, V22, P341, DOI 10.1111/j.1365-3016.2008.00938.x; MacDorman Marian F, 2015, Natl Vital Stat Rep, V64, P1; MacDorman MF, 2011, SEMIN PERINATOL, V35, P200, DOI 10.1053/j.semperi.2011.02.017; MacDorman Marian F, 2009, Natl Vital Stat Rep, V57, P1; MANGESI L, 2007, COCHRANE DB SYST REV, V1; Marmot M, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3617; Marufu TC, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1552-5; McCowan LME, 2014, INT C STILLB SIDS BA, P038; Mehta P, 2014, CURR OPIN OBSTET GYN, V26, P531, DOI 10.1097/GCO.0000000000000119; Michie S, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-42; Middleton PF, 2015, J PAEDIATR CHILD H, V51, P106; Mistry H, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-236; Mogos MF, 2016, J INTERPERS VIOLENCE, V31, P444, DOI 10.1177/0886260514555869; Mohangoo AD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024727; Mondal D, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0220-4; Monier I, 2015, BJOG-INT J OBSTET GY, V122, P518, DOI 10.1111/1471-0528.13148; Moore JE, 2014, BIRTH-ISS PERINAT C, V41, P138, DOI 10.1111/birt.12080; Mulherin K, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-19; National Collaborating Centre for Women's and Children's Health, 2008, NICE GUID ANT CAR; New Zealand Ministry of Health, 2012, MAT CONS SURV 2011; Ovesen PG, 2015, J MATERN-FETAL NEO M, V28, P1720, DOI 10.3109/14767058.2014.966677; Owusu JT, 2013, INT J GYNECOL OBSTET, V121, P261, DOI 10.1016/j.ijgo.2013.01.013; Perinatal and Maternal Mortality Review Committee, 2008, PER PAED PATH SERV P; Perinatal and Maternal Mortality Review Committee, 2015, 9 PER MAT MORT REV C; Pinar H, 2014, OBSTET GYNECOL, V123, P325, DOI 10.1097/AOG.0000000000000100; Platts J, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-171; Prosser SJ, 2013, FINDINGS HAVING BABY; Ptacek I, 2014, PLACENTA, V35, P552, DOI 10.1016/j.placenta.2014.05.011; Ravelli ACJ, 2011, J EPIDEMIOL COMMUN H, V65, P696, DOI 10.1136/jech.2009.095406; Reddy UM, 2012, NEW ENGL J MED, V367, P2185, DOI 10.1056/NEJMoa1201569; Redshaw M, 2014, LISTENING PARENTS ST; Renfrew MJ, 2014, LANCET, V384, P1129, DOI 10.1016/S0140-6736(14)60789-3; Robboy SJ, 2013, ARCH PATHOL LAB MED, V137, P1723, DOI 10.5858/arpa.2013-0200-OA; Rodger MA, 2014, BLOOD, V123, P822, DOI 10.1182/blood-2013-01-478958; Salas XR, 2015, CAN J PUBLIC HEALTH, V106, pE79, DOI [10.17269/CJPH.106.4757, 10.17269/cjph.106.4757]; Schummers L, 2015, OBSTET GYNECOL, V125, P133, DOI 10.1097/AOG.0000000000000591; Seaton SE, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001100; Smith D, 2011, BJOG-INT J OBSTET GY, V118, P779, DOI 10.1111/j.1471-0528.2011.02924.x; Sovio U, 2015, LANCET, V386, P2089, DOI 10.1016/S0140-6736(15)00131-2; Spong CY, 2011, OBSTET GYNECOL, V118, P323, DOI 10.1097/AOG.0b013e3182255999; Stacey T, 2012, AUST NZ J OBSTET GYN, V52, P242, DOI 10.1111/j.1479-828X.2011.01406.x; Stolp H, 1951, J WOMENS HEALTH, V24, P875; Vrijenhoek T, 2015, EUR J HUM GENET, V23, P1142, DOI 10.1038/ejhg.2014.279; Ward TCS, 2013, MATERN CHILD HLTH J, V17, P1753, DOI 10.1007/s10995-012-1194-5; Weightman AL, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000964; West Midlands Perinatal Institute, 2010, CONF ENQ INTR REL DE; Yelland J, 2015, IMPLEMENT SCI, V10, DOI 10.1186/s13012-015-0251-z; Zeitlin J, BMC PREGNAN IN PRESS; Zhang S, 2013, MATERN CHILD HLTH J, V17, P1518, DOI 10.1007/s10995-012-1162-0; [No title captured]	103	314	323	1	70	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 13	2016	387	10019					691	702		10.1016/S0140-6736(15)01020-X	http://dx.doi.org/10.1016/S0140-6736(15)01020-X			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DD3QH	26794070	Green Submitted, Green Published, Green Accepted			2022-12-28	WOS:000369837100028
J	Shanahan, J				Shanahan, Jesse			Disability is not a disqualification	SCIENCE			English	Editorial Material									[Shanahan, Jesse] Wesleyan Univ, Astron, Middletown, CT 06459 USA	Wesleyan University	Shanahan, J (corresponding author), Wesleyan Univ, Astron, Middletown, CT 06459 USA.	SciCareerEditor@aaas.org							0	3	3	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 22	2016	351	6271					418	418		10.1126/science.351.6271.418	http://dx.doi.org/10.1126/science.351.6271.418			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB3VH	26798017				2022-12-28	WOS:000368440500047
J	Boland, CR; Goel, A				Boland, C. Richard; Goel, Ajay			Prognostic Subgroups among Patients with Stage II Colon Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							COLORECTAL-CANCER; BIOMARKERS		[Boland, C. Richard] Baylor Univ, Med Ctr, Ctr Gastrointestinal Res, Dallas, TX 75246 USA; Baylor Univ, Med Ctr, Ctr Epigenet, Canc Prevent & Gen,Baylor Res Inst, Dallas, TX USA; Baylor Univ, Med Ctr, Baylor Charles A Sammons Canc Ctr, Dallas, TX USA	Baylor University; Baylor University Medical Center; Baylor Scott & White Health; Baylor University; Baylor University Medical Center; Baylor University; Baylor University Medical Center; Texas Oncology-Baylor Charles A Sammons Cancer Center	Boland, CR (corresponding author), Baylor Univ, Med Ctr, Ctr Gastrointestinal Res, Dallas, TX 75246 USA.			Goel, Ajay/0000-0003-1396-6341	NATIONAL CANCER INSTITUTE [R01CA181572, R01CA072851, U01CA187956] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA181572, U01 CA187956, R01 CA072851] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Benson AB, 2004, J CLIN ONCOL, V22, P3408, DOI 10.1200/JCO.2004.05.063; Carethers JM, 2015, GASTROENTEROLOGY, V149, P1177, DOI 10.1053/j.gastro.2015.06.047; Dalerba P, 2016, NEW ENGL J MED, V374, P211, DOI 10.1056/NEJMoa1506597; Ebert MPA, 2012, NEW ENGL J MED, V366, P44, DOI 10.1056/NEJMoa1009473; Kneuertz PJ, 2015, JAMA SURG, V150, P402, DOI 10.1001/jamasurg.2014.3572; Lewis C, 2015, SUPPORT CARE CANC; Marshall JL, 2010, ONCOLOGY-NY, V24, P9; Meyerhardt JA, 2005, NEW ENGL J MED, V352, P476, DOI 10.1056/NEJMra040958; Okugawa Y, 2015, GASTROENTEROLOGY, V149, P1204, DOI 10.1053/j.gastro.2015.07.011; Zhang JX, 2013, LANCET ONCOL, V14, P1295, DOI 10.1016/S1470-2045(13)70491-1	10	23	25	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 21	2016	374	3					277	278		10.1056/NEJMe1514353	http://dx.doi.org/10.1056/NEJMe1514353			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DB3IS	26789877	Green Accepted			2022-12-28	WOS:000368404800014
J	Snell-Rood, E				Snell-Rood, Emilie			Bring biologists into biomimetics	NATURE			English	Editorial Material							EVOLUTION; SILK		[Snell-Rood, Emilie] Univ Minnesota, Ecol Evolut & Behav, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities	Snell-Rood, E (corresponding author), Univ Minnesota, Ecol Evolut & Behav, St Paul, MN 55108 USA.	emilies@umn.edu						Bhushan B, 2009, PHILOS T R SOC A, V367, P1445, DOI 10.1098/rsta.2009.0011; BOZEMAN B, 2004, J TECHNOLOGY TRANSFE, V29, P365, DOI DOI 10.1023/B:JOTT.0000034128.39526.6b; Kurz P, 2016, TOP CURR CHEM, V371, P49, DOI 10.1007/128_2015_634; Otten LG, 2005, BIOMOL ENG, V22, P1, DOI 10.1016/j.bioeng.2005.02.002; Saranathan V, 2010, P NATL ACAD SCI USA, V107, P11676, DOI 10.1073/pnas.0909616107; Swanson BO, 2006, EVOLUTION, V60, P2539; Teule F, 2012, P NATL ACAD SCI USA, V109, P923, DOI 10.1073/pnas.1109420109; Tian X, 2013, NATURE, V499, P346, DOI 10.1038/nature12234; Vukusic P, 2003, NATURE, V424, P852, DOI 10.1038/nature01941; Wegst UGK, 2015, NAT MATER, V14, P23, DOI [10.1038/NMAT4089, 10.1038/nmat4089]	10	53	53	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 21	2016	529	7586					277	278		10.1038/529277a	http://dx.doi.org/10.1038/529277a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB2QT	26791704	Bronze			2022-12-28	WOS:000368354800014
J	Angus, DC; Truog, RD				Angus, Derek C.; Truog, Robert D.			Toward Better ICU Use at the End of Life	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							INTENSIVE-CARE; UNITED-STATES; MEDICARE; GROWTH; TRENDS		[Angus, Derek C.] Univ Pittsburgh, Dept Crit Care Med, Sch Med, Pittsburgh, PA 15261 USA; [Truog, Robert D.] Harvard Univ, Sch Med, Ctr Bioeth, Boston, MA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; Harvard Medical School	Angus, DC (corresponding author), Univ Pittsburgh, Dept Crit Care Med, 3550 Terrace St,614 Scaife Hall, Pittsburgh, PA 15261 USA.	angusdc@upmc.edu	Angus, Derek C/E-9671-2012					Angus DC, 2004, CRIT CARE MED, V32, P638, DOI 10.1097/01.CCM.0000114816.62331.08; Arnold RM, 2015, J CRIT CARE, V30, P250, DOI 10.1016/j.jcrc.2014.11.016; Emanuel EJ, JAMA-J AM MED ASSOC, DOI [10.1001/jama.2015.18603, DOI 10.1001/JAMA.2015.18603]; Milbrandt EB, 2008, CRIT CARE MED, V36, P2504, DOI 10.1097/CCM.0b013e318183ef84; Riley GF, 2010, HEALTH SERV RES, V45, P565, DOI 10.1111/j.1475-6773.2010.01082.x; Schenker Y, 2015, JAMA-J AM MED ASSOC, V314, P1565, DOI 10.1001/jama.2015.11217; Wallace DJ, 2015, AM J RESP CRIT CARE, V191, P410, DOI 10.1164/rccm.201409-1746OC; Wunsch H, 2008, CRIT CARE MED, V36, P2787, DOI 10.1097/CCM.0b013e318186aec8	8	48	48	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 19	2016	315	3					255	256		10.1001/jama.2015.18681	http://dx.doi.org/10.1001/jama.2015.18681			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DB2WN	26784767				2022-12-28	WOS:000368371400016
J	Hotta, M; Ota, M				Hotta, Moeko; Ota, Mitsuhito			Alopecia in a Boy With Nephrotic Syndrome	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							TINEA-CAPITIS; MANAGEMENT		[Hotta, Moeko; Ota, Mitsuhito] Chitose City Hosp, Dept Dermatol, Chitose 0668550, Japan		Ota, M (corresponding author), Chitose City Hosp, Dept Dermatol, Hokkou 2, Chitose 0668550, Japan.	ota@med.hokudai.ac.jp						Brissos Joao, 2013, BMJ Case Rep, V2013, DOI 10.1136/bcr-2013-200594; Buckley DA, 2000, BMJ-BRIT MED J, V320, P1389, DOI 10.1136/bmj.320.7246.1389; Chang HJ, 2011, JAMA-J AM MED ASSOC, V306, P1263, DOI 10.1001/jama.2011.1290; Cremer G, 1997, DERMATOLOGY, V194, P8, DOI 10.1159/000246048; Fuller LC, 2014, BRIT J DERMATOL, V171, P454, DOI 10.1111/bjd.13196; Fuller LC, 2003, BMJ-BRIT MED J, V326, P539, DOI 10.1136/bmj.326.7388.539; Leiva-Salinas M, 2015, INT J DERMATOL, V54, P800, DOI 10.1111/ijd.12691; Mirmirani P, 2013, J AM ACAD DERMATOL, V69, P916, DOI 10.1016/j.jaad.2013.08.031; Nenoff P, 2015, J DTSCH DERMATOL GES, V13, P387, DOI [10.1111/ddg.12689_suppl, 10.1111/ddg.12689]; Zaraa I, 2013, MYCOSES, V56, P110, DOI 10.1111/j.1439-0507.2012.02219.x	10	2	3	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 19	2016	315	3					295	296		10.1001/jama.2015.13673	http://dx.doi.org/10.1001/jama.2015.13673			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DB2WN	26784778				2022-12-28	WOS:000368371400027
J	Wright, AA; Keating, NL; Ayanian, JZ; Chrischilles, EA; Kahn, KL; Ritchie, CS; Weeks, JC; Earle, CC; Landrum, MB				Wright, Alexi A.; Keating, Nancy L.; Ayanian, John Z.; Chrischilles, Elizabeth A.; Kahn, Katherine L.; Ritchie, Christine S.; Weeks, Jane C.; Earle, Craig C.; Landrum, Mary B.			Family Perspectives on Aggressive Cancer Care Near the End of Life	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							OF-LIFE; MEDICARE BENEFICIARIES; ETHNIC-DIFFERENCES; OUTCOMES RESEARCH; DEATH; QUALITY; HEALTH; PLACE; ASSOCIATIONS; HOSPICE	IMPORTANCE Patients with advanced-stage cancer are receiving increasingly aggressive medical care near death, despite growing concerns that this reflects poor-quality care. OBJECTIVE To assess the association of aggressive end-of-life care with bereaved family members' perceptions of the quality of end-of-life care and patients' goal attainment. DESIGN, SETTING, AND PARTICIPANTS Interviews with 1146 family members of Medicare patients with advanced-stage lung or colorectal cancer in the Cancer Care Outcomes Research and Surveillance study (a multiregional, prospective, observational study) who died by the end of 2011 (median, 144.5 days after death; interquartile range, 85.0-551.0 days). EXPOSURES Claims-based quality measures of aggressive end-of-life care (ie, intensive care unit [ICU] admission or repeated hospitalizations or emergency department visits during the last month of life; chemotherapy <= 2 weeks of death; no hospice or <= 3 days of hospice services; and deaths occurring in the hospital). MAIN OUTCOMES AND MEASURES Family member-reported quality rating of "excellent" for end-of-life care. Secondary outcomes included patients' goal attainment (ie, end-of-life care congruent with patients' wishes and location of death occurred in preferred place). RESULTS Of 1146 patients with cancer (median age, 76.0 years [interquartile range, 65.0-87.0 years]; 55.8% male), bereaved family members reported excellent end-of-life care for 51.3%. Family members reported excellent end-of-life care more often for patients who received hospice care for longer than 3 days (58.8% [352/599]) than those who did not receive hospice care or received 3 or fewer days (43.1% [236/547]) (adjusted difference, 16.5 percentage points [95% CI, 10.7 to 22.4 percentage points]). In contrast, family members of patients admitted to an ICU within 30 days of death reported excellent end-of-life care less often (45.0% [68/151]) than those who were not admitted to an ICU within 30 days of death (52.3% [520/995]) (adjusted difference, -9.4 percentage points [95% CI, -18.2 to -0.6 percentage points]). Similarly, family members of patients who died in the hospital reported excellent end-of-life care less often (42.2% [194/460]) than those who did not die in the hospital (57.4% [394/686]) (adjusted difference, -17.0 percentage points [95% CI, -22.9 to -11.1 percentage points]). Family members of patients who did not receive hospice care or received 3 or fewer days were less likely to report that patients died in their preferred location (40.0% [152/380]) than those who received hospice care for longer than 3 days (72.8% [287/394]) (adjusted difference, -34.4 percentage points [95% CI, -41.7 to -27.0 percentage points]). CONCLUSIONS AND RELEVANCE Among family members of older patients with fee-for service Medicare who died of lung or colorectal cancer, earlier hospice enrollment, avoidance of ICU admissions within 30 days of death, and death occurring outside the hospital were associated with perceptions of better end-of-life care. These findings are supportive of advance care planning consistent with the preferences of patients.	[Wright, Alexi A.; Weeks, Jane C.] Harvard Univ, Dana Farber Canc Inst, Dept Med Oncol, Sch Med, Boston, MA 02215 USA; [Keating, Nancy L.; Landrum, Mary B.] Harvard Univ, Dept Hlth Care Policy, Sch Med, Boston, MA 02215 USA; [Keating, Nancy L.] Brigham & Womens Hosp, Div Gen Med, Boston, MA 02115 USA; [Ayanian, John Z.] Univ Michigan, Inst Healthcare Policy & Innovat, Div Gen Med, Ann Arbor, MI 48109 USA; [Ayanian, John Z.] Univ Michigan, Sch Publ Hlth, Dept Hlth Management & Policy, Ann Arbor, MI 48109 USA; [Ayanian, John Z.] Univ Michigan, Gerald R Ford Sch Publ Policy, Ann Arbor, MI 48109 USA; [Chrischilles, Elizabeth A.] Univ Iowa, Coll Publ Hlth, Dept Epidemiol, Iowa City, IA USA; [Kahn, Katherine L.] RAND Corp, Santa Monica, CA USA; [Kahn, Katherine L.] Univ Calif Los Angeles, Div Gen Internal Med, Los Angeles, CA USA; [Ritchie, Christine S.] Univ Calif San Francisco, Dept Med, Div Geriatr, San Francisco, CA USA; [Earle, Craig C.] Inst Clin Evaluat Sci, Toronto, ON, Canada	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Iowa; RAND Corporation; University of California System; University of California Los Angeles; University of California System; University of California San Francisco; University of Toronto	Wright, AA (corresponding author), Harvard Univ, Dana Farber Canc Inst, Dept Med Oncol, Sch Med, 450 Brookline Ave,Dana 1133, Boston, MA 02215 USA.	alexi_wright@dfci.harvard.edu	Kahn, Katherine/AAE-2857-2020	Kahn, Katherine/0000-0002-6605-1455; Chrischilles, Elizabeth/0000-0002-1843-1955	National Cancer Institute [R01 CA91753, 5U01CA093344-08, K24 CA181510]; Cancer Care Outcomes Research and Surveillance (CanCORS) Consortium [U01 CA093344, U01 CA093324, U01 CA093332, U01 CA093348, U01 CA093329, U01 CA093339, U01 CA093326, R01 CA1604021];  [K07 166210]; NATIONAL CANCER INSTITUTE [R01CA164021, P30CA086862, U01CA093324, U01CA093329, U01CA093326, U01CA093344, U01CA093332, R01CA104021, R01CA091753, U01CA093348, K24CA181510, U01CA093339, K07CA166210] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Care Outcomes Research and Surveillance (CanCORS) Consortium; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grant R01 CA91753 from the National Cancer Institute (awarded to Dr Earle) and grants U01 CA093344 (awarded to Dana-Farber Cancer Institute), U01 CA093324 (awarded to Harvard Medical School and Northern California Cancer Center), U01 CA093332 (awarded to Dana-Farber Cancer Institute and Cancer Research Network), U01 CA093348 (awarded to RAND Corporation and University of California, Los Angeles), U01 CA093329 (awarded to University of Alabama, Birmingham), U01 CA093339 (awarded to University of Iowa), U01 CA093326 (awarded to the University of North Carolina), and R01 CA1604021 (awarded to Dr Keating) from the Cancer Care Outcomes Research and Surveillance (CanCORS) Consortium. CanCORS II work was funded by grant 5U01CA093344-08 from the National Cancer Institute (awarded to the CanCORS Consortium Statistical Coordinating Center). Dr Wright is supported by grant K07 166210 and Dr Keating is supported by K24 CA181510 from the National Cancer Institute.	Ayanian JZ, 2010, J CLIN ONCOL, V28, P4154, DOI 10.1200/JCO.2009.27.3268; Ayanian JZ, 2004, J CLIN ONCOL, V22, P2992, DOI 10.1200/JCO.2004.06.020; Barnato AE, 2009, J GEN INTERN MED, V24, P695, DOI 10.1007/s11606-009-0952-6; Catalano PJ, 2013, MED CARE, V51, pE9, DOI 10.1097/MLR.0b013e318222a711; Cutler D, PHYS BELIEFS PATIENT; DiBiasio EL, 2015, J PAIN SYMPTOM MANAG, V50, P17, DOI 10.1016/j.jpainsymman.2015.01.006; Earle CC, 2005, INT J QUAL HEALTH C, V17, P505, DOI 10.1093/intqhc/mzi061; Earle CC, 2003, J CLIN ONCOL, V21, P1133, DOI 10.1200/JCO.2003.03.059; Earle CC, 2004, J CLIN ONCOL, V22, P315, DOI 10.1200/JCO.2004.08.136; Earle CC, 2008, J CLIN ONCOL, V26, P3860, DOI 10.1200/JCO.2007.15.8253; FLEMING C, 1992, MED CARE, V30, P377, DOI 10.1097/00005650-199205000-00001; GREER DS, 1986, J CHRON DIS, V39, P9, DOI 10.1016/0021-9681(86)90103-7; He Y, 2010, STAT METHODS MED RES, V19, P653, DOI 10.1177/0962280208101273; Higginson I J, 2000, J Palliat Med, V3, P287, DOI 10.1089/jpm.2000.3.287; Jacobson Joseph O, 2012, Am Soc Clin Oncol Educ Book, pe70, DOI 10.14694/EdBook_AM.2012.32.e70; Obermeyer Z, 2014, JAMA, V312, P1888; Obermeyer Z, 2015, HEALTH AFFAIR, V34, P993, DOI 10.1377/hlthaff.2014.1055; Smith AK, 2010, J PAIN SYMPTOM MANAG, V39, P972, DOI 10.1016/j.jpainsymman.2009.10.004; Smith AK, 2009, J AM GERIATR SOC, V57, P153, DOI 10.1111/j.1532-5415.2008.02081.x; Spiegelman D, 2005, AM J EPIDEMIOL, V162, P199, DOI 10.1093/aje/kwi188; Temel JS, 2010, NEW ENGL J MED, V363, P733, DOI 10.1056/NEJMoa1000678; Teno JM, 2004, JAMA-J AM MED ASSOC, V291, P88, DOI 10.1001/jama.291.1.88; Teno JM, 2015, J PALLIAT MED, V18, P662, DOI 10.1089/jpm.2015.0039; Teno JM, 2013, JAMA-J AM MED ASSOC, V309, P470, DOI 10.1001/jama.2012.207624; WALLSTON KA, 1988, MED CARE, V26, P177, DOI 10.1097/00005650-198802000-00008; Weeks JC, 2012, NEW ENGL J MED, V367, P1616, DOI 10.1056/NEJMoa1204410; Weeks JC, 1998, JAMA-J AM MED ASSOC, V279, P1709, DOI 10.1001/jama.279.21.1709; Wright AA, 2008, JAMA-J AM MED ASSOC, V300, P1665, DOI 10.1001/jama.300.14.1665; Wright AA, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1219; Wright AA, 2010, J CLIN ONCOL, V28, P4457, DOI 10.1200/JCO.2009.26.3863; Zhang BH, 2009, ARCH INTERN MED, V169, P480, DOI 10.1001/archinternmed.2008.587	31	272	276	5	48	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 19	2016	315	3					284	292		10.1001/jama.2015.18604	http://dx.doi.org/10.1001/jama.2015.18604			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DB2WN	26784776	Green Accepted, Bronze			2022-12-28	WOS:000368371400025
J	Ellam, T; Twohig, H; Khwaja, A				Ellam, Timothy; Twohig, Helen; Khwaja, Arif			Chronic kidney disease in elderly people: disease or disease label?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							EPIDEMIOLOGY; AWARENESS; AGE		[Ellam, Timothy; Khwaja, Arif] Sheffield Teaching Hosp NHS Fdn Trust, No Gen Hosp, Sheffield Kidney Inst, Sheffield S5 7AU, S Yorkshire, England; [Ellam, Timothy] Univ Sheffield, Dept Cardiovasc Sci, Sheffield, S Yorkshire, England; [Twohig, Helen] No Gen Hosp, Acad Unit Primary Med Care, Sheffield S5 7AU, S Yorkshire, England	Northern General Hospital; University of Sheffield; University of Sheffield; Northern General Hospital	Khwaja, A (corresponding author), Sheffield Teaching Hosp NHS Fdn Trust, No Gen Hosp, Sheffield Kidney Inst, Sheffield S5 7AU, S Yorkshire, England.	arif.khwaja@sth.nhs.uk		Khwaja, Arif/0000-0002-4690-3649; Twohig, Helen/0000-0001-8781-1268	British Heart Foundation [FS/11/74/29015] Funding Source: researchfish	British Heart Foundation(British Heart Foundation)		Coresh J, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5553; Crinson I, 2010, BRIT J GEN PRACT, V60, P403, DOI 10.3399/bjgp10X502100; El Nahas M, 2010, KIDNEY INT, V78, P14, DOI 10.1038/ki.2010.123; Gansevoort RT, 2013, LANCET, V382, P339, DOI 10.1016/S0140-6736(13)60595-4; Hallan SI, 2012, JAMA-J AM MED ASSOC, V308, P2349, DOI 10.1001/jama.2012.16817; Healthtalk, WORDS DOCT US EXPL K; Marks A, 2012, NEPHROL DIAL TRANSPL, V27, P65, DOI 10.1093/ndt/gfr746; McIntyre NJ, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X636047; National Institute for Health and Care Excellence, 2014, EARL ID MAN CHRON KI, P182; National Institute for Health and Care Excellence, 2014, CARD RISK ASS MOD BL, P181; O'Hare AM, 2007, J AM SOC NEPHROL, V18, P2758, DOI 10.1681/ASN.2007040422; O'Hare AM, 2014, JAMA INTERN MED, V174, P391, DOI 10.1001/jamainternmed.2013.13328; Plantinga LC, 2008, ARCH INTERN MED, V168, P2268, DOI 10.1001/archinte.168.20.2268; Poggio ED, 2009, KIDNEY INT, V75, P1079, DOI 10.1038/ki.2009.11; QRISK2, CARD DIS RISK SCOR; Shlipak MG, 2013, NEW ENGL J MED, V369, P932, DOI 10.1056/NEJMoa1214234; Stevens PE, 2007, KIDNEY INT, V72, P92, DOI 10.1038/sj.ki.5002273; Tangri N, 2013, ANN INTERN MED, V158, P596, DOI 10.7326/0003-4819-158-8-201304160-00004; UK Renal Registry, 16 UK REN REG; Wolf G, 2002, AM J KIDNEY DIS, V39, P1, DOI 10.1053/ajkd.2002.29865	20	24	25	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 18	2016	352								h6559	10.1136/bmj.h6559	http://dx.doi.org/10.1136/bmj.h6559			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DC4ZM	26780947				2022-12-28	WOS:000369229500001
J	Freeman, SA; Goyette, J; Furuya, W; Woods, EC; Bertozzi, CR; Bergmeier, W; Hinz, B; van der Merwe, PA; Das, R; Grinstein, S				Freeman, Spencer A.; Goyette, Jesse; Furuya, Wendy; Woods, Elliot C.; Bertozzi, Carolyn R.; Bergmeier, Wolfgang; Hinz, Boris; van der Merwe, P. Anton; Das, Raibatak; Grinstein, Sergio			Integrins Form an Expanding Diffusional Barrier that Coordinates Phagocytosis	CELL			English	Article							T-CELL-RECEPTOR; PHOSPHATIDYLINOSITOL 3-KINASE; MEDIATED PHAGOCYTOSIS; PLASMA-MEMBRANE; ACTIVATION; CD45; SEGREGATION; SYNAPSE; MODEL; CD148	Phagocytosis is initiated by lateral clustering of receptors, which in turn activates Src-family kinases (SFKs). Activation of SFKs requires depletion of tyrosine phosphatases from the area of particle engagement. We investigated how the major phosphatase CD45 is excluded from contact sites, using single-molecule tracking. The mobility of CD45 increased markedly upon engagement of Fc gamma receptors. While individual CD45 molecules moved randomly, they were displaced from the advancing phagocytic cup by an expanding diffusional barrier. Bymicropatterning IgG, the ligand of Fc gamma receptors, we found that the barrier extended well beyond the perimeter of the receptor-ligand engagement zone. Second messengers generated by Fc gamma receptors activated integrins, which formed an actin-tethered diffusion barrier that excluded CD45. The expanding integrin wave facilitates the zippering of Fc gamma receptors onto the target and integrates the information from sparse receptor-ligand complexes, coordinating the progression and ultimate closure of the phagocytic cup.	[Freeman, Spencer A.; Furuya, Wendy; Grinstein, Sergio] Hosp Sick Children, Program Cell Biol, Toronto, ON M5G 1X8, Canada; [Goyette, Jesse; van der Merwe, P. Anton] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Woods, Elliot C.; Bertozzi, Carolyn R.] Stanford Univ, Dept Chem, Stanford, CA 94305 USA; [Woods, Elliot C.; Bertozzi, Carolyn R.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Bergmeier, Wolfgang] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Hinz, Boris] Univ Toronto, Fac Dent, Matrix Dynam Grp, Toronto, ON M5S 3E2, Canada; [Das, Raibatak] Univ Colorado, Dept Integrat Biol, Denver, CO 80217 USA; [Grinstein, Sergio] St Michaels Hosp, Keenan Res Ctr, Toronto, ON M5S 1T8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Oxford; Stanford University; Howard Hughes Medical Institute; Stanford University; University of North Carolina; University of North Carolina Chapel Hill; University of Toronto; University of Colorado System; University of Colorado Denver; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Grinstein, S (corresponding author), Hosp Sick Children, Program Cell Biol, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	sergio.grinstein@sickkids.ca	Goyette, Jesse/AAW-4701-2021	Goyette, Jesse/0000-0002-1008-1890; Woods, Elliot/0000-0003-2920-8334; Hinz, Boris/0000-0002-0526-393X	Heart and Stroke Foundation of Canada; Canadian Institutes of Health Research [FDN-143202, 287720, 135060, 286920]; NIH [GM59907]; Wellcome Trust [101799/Z/13/Z]; MRC [G19/31, G9722488] Funding Source: UKRI; Medical Research Council [G19/31, G9722488] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059907] Funding Source: NIH RePORTER	Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. D. Coombs for helpful discussions. S.A.F. is funded by a fellowship from the Heart and Stroke Foundation of Canada. This work was supported by grants from the Canadian Institutes of Health Research (FDN-143202, 287720, 135060, and 286920) to S.G. and B.H. and a grant to C.R.B. from the NIH (GM59907). J.G. and P.A.V. are funded by the Wellcome Trust (Grant 101799/Z/13/Z).	Araki N, 1996, J CELL BIOL, V135, P1249, DOI 10.1083/jcb.135.5.1249; Batista FD, 2001, NATURE, V411, P489, DOI 10.1038/35078099; Bergmeier W, 2007, J CLIN INVEST, V117, P1699, DOI 10.1172/JCI30575; Boehm Tobias K., 2008, Human Antibodies, V17, P45; Bohdanowicz M, 2010, J CELL BIOL, V191, P999, DOI 10.1083/jcb.201004005; Cairo CW, 2010, J BIOL CHEM, V285, P11392, DOI 10.1074/jbc.M109.075648; Cordoba SP, 2013, BLOOD, V121, P4295, DOI 10.1182/blood-2012-07-442251; Cox D, 1999, J BIOL CHEM, V274, P1240, DOI 10.1074/jbc.274.3.1240; Davis SJ, 2006, NAT IMMUNOL, V7, P803, DOI 10.1038/ni1369; Drbal K, 2007, INT IMMUNOL, V19, P675, DOI 10.1093/intimm/dxm032; Flannagan RS, 2012, ANNU REV PATHOL-MECH, V7, P61, DOI 10.1146/annurev-pathol-011811-132445; Gloerich M, 2011, TRENDS CELL BIOL, V21, P615, DOI 10.1016/j.tcb.2011.07.001; Golebiewska U, 2011, MOL BIOL CELL, V22, P3498, DOI 10.1091/mbc.E11-02-0114; Goodridge HS, 2011, NATURE, V472, P471, DOI 10.1038/nature10071; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; GRIFFIN FM, 1975, J EXP MED, V142, P1263, DOI 10.1084/jem.142.5.1263; Hermiston ML, 2009, IMMUNOL REV, V228, P288, DOI 10.1111/j.1600-065X.2008.00752.x; James JR, 2012, NATURE, V487, P64, DOI 10.1038/nature11220; Jaqaman K, 2011, CELL, V146, P593, DOI 10.1016/j.cell.2011.06.049; Johnson KG, 2000, P NATL ACAD SCI USA, V97, P10138, DOI 10.1073/pnas.97.18.10138; Jones SL, 1998, J BIOL CHEM, V273, P10556, DOI 10.1074/jbc.273.17.10556; Kawasaki H, 1998, P NATL ACAD SCI USA, V95, P13278, DOI 10.1073/pnas.95.22.13278; Marshall JG, 2001, J CELL BIOL, V153, P1369, DOI 10.1083/jcb.153.7.1369; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Sage PT, 2012, J IMMUNOL, V188, P3686, DOI 10.4049/jimmunol.1102594; Stolla M, 2011, BLOOD, V118, P1113, DOI 10.1182/blood-2011-03-342352; Torres AJ, 2008, P NATL ACAD SCI USA, V105, P17238, DOI 10.1073/pnas.0802138105; van der Merwe PA, 2011, NAT REV IMMUNOL, V11, P47, DOI 10.1038/nri2887; Varma R, 2006, IMMUNITY, V25, P117, DOI 10.1016/j.immuni.2006.04.010; Yakubenko VP, 2002, J BIOL CHEM, V277, P48635, DOI 10.1074/jbc.M208877200; Yamauchi S, 2012, FEBS LETT, V586, P3229, DOI 10.1016/j.febslet.2012.06.041; Ye F, 2010, J CELL BIOL, V188, P157, DOI 10.1083/jcb.200908045; Yoshida S, 2009, J CELL SCI, V122, P3250, DOI 10.1242/jcs.053207; Zhang X, 2008, NAT CELL BIOL, V10, P1062, DOI 10.1038/ncb1765; Zhu JH, 2008, MOL CELL, V32, P849, DOI 10.1016/j.molcel.2008.11.018; Zhu JW, 2008, IMMUNITY, V28, P183, DOI 10.1016/j.immuni.2007.11.024	37	108	110	3	48	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 14	2016	164	1-2					128	140		10.1016/j.cell.2015.11.048	http://dx.doi.org/10.1016/j.cell.2015.11.048			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DB2LE	26771488	Green Accepted, Green Submitted, Bronze			2022-12-28	WOS:000368339300015
J	Hartzband, P; Groopman, J				Hartzband, Pamela; Groopman, Jerome			Medical Taylorism	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							HEALTH; CARE		[Hartzband, Pamela] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Hartzband, P (corresponding author), Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA.							Blumenthal D, 2015, JAMA-J AM MED ASSOC, V313, P1901, DOI 10.1001/jama.2015.4862; Lepore J, 2009, NEW YORKER, P12; Samuels M, 2014, FORBES; Swensen SJ, 2010, NEW ENGL J MED, V362, DOI 10.1056/NEJMp0911199; Taylor FrederickWinslow., 1911, PRINCIPLES SCI MANAG	5	48	49	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 14	2016	374	2					106	108		10.1056/NEJMp1512402	http://dx.doi.org/10.1056/NEJMp1512402			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DA7PQ	26760082				2022-12-28	WOS:000367996700004
J	Lee, SB; Frattini, V; Bansal, M; Castano, AM; Sherman, D; Hutchinson, K; Bruce, JN; Califano, A; Liu, GC; Cardozo, T; Iavarone, A; Lasorella, A				Lee, Sang Bae; Frattini, Veronique; Bansal, Mukesh; Castano, Angelica M.; Sherman, Dan; Hutchinson, Keino; Bruce, Jeffrey N.; Califano, Andrea; Liu, Guangchao; Cardozo, Timothy; Iavarone, Antonio; Lasorella, Anna			An ID2-dependent mechanism for VHL inactivation in cancer	NATURE			English	Article							PROTEIN-KINASE DYRK1A; UBIQUITIN LIGASE HUWE1; LOOP-HELIX PROTEINS; NEURAL STEM-CELLS; DOWN-SYNDROME; NEURONAL DIFFERENTIATION; TRANSCRIPTIONAL ACTIVITY; INHIBITS PROLIFERATION; PROGENITOR CELLS; EXPRESSION	Mechanisms that maintain cancer stem cells are crucial to tumour progression. The ID2 protein supports cancer hallmarks including the cancer stem cell state. HIF alpha transcription factors, most notably HIF2 alpha (also known as EPAS1), are expressed in and required for maintenance of cancer stem cells (CSCs). However, the pathways that are engaged by ID2 or drive HIF2 alpha accumulation in CSCs have remained unclear. Here we report that DYRK1A and DYRK1B kinases phosphorylate ID2 on threonine 27 (Thr27). Hypoxia downregulates this phosphorylation via inactivation of DYRK1A and DYRK1B. The activity of these kinases is stimulated in normoxia by the oxygen-sensing prolyl hydroxylase PHD1 (also known as EGLN2). ID2 binds to the VHL ubiquitin ligase complex, displaces VHL-associated Cullin 2, and impairs HIF2 alpha ubiquitylation and degradation. Phosphorylation of Thr27 of ID2 by DYRK1 blocks ID2-VHL interaction and preserves HIF2 alpha ubiquitylation. In glioblastoma, ID2 positively modulates HIF2 alpha activity. Conversely, elevated expression of DYRK1 phosphorylates Thr27 of ID2, leading to HIF2 alpha destabilization, loss of glioma stemness, inhibition of tumour growth, and a more favourable outcome for patients with glioblastoma.	[Lee, Sang Bae; Frattini, Veronique; Castano, Angelica M.; Liu, Guangchao; Iavarone, Antonio; Lasorella, Anna] Columbia Univ, Med Ctr, Inst Canc Genet, New York, NY 10032 USA; [Bansal, Mukesh; Califano, Andrea] Columbia Univ, Med Ctr, Dept Syst Biol, New York, NY 10032 USA; [Bansal, Mukesh; Califano, Andrea] Columbia Univ, Med Ctr, Ctr Computat Biol & Bioinformat, New York, NY 10032 USA; [Sherman, Dan; Hutchinson, Keino; Cardozo, Timothy] NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY 10014 USA; [Bruce, Jeffrey N.] Columbia Univ, Med Ctr, Dept Neurosurg, New York, NY 10032 USA; [Iavarone, Antonio] Columbia Univ, Med Ctr, Dept Neurol, New York, NY 10032 USA; [Iavarone, Antonio; Lasorella, Anna] Columbia Univ, Med Ctr, Dept Pathol, New York, NY 10032 USA; [Lasorella, Anna] Columbia Univ, Med Ctr, Dept Pediat, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University; New York University; Columbia University; Columbia University; Columbia University; Columbia University	Lasorella, A (corresponding author), Columbia Univ, Med Ctr, Inst Canc Genet, New York, NY 10032 USA.	ai2102@columbia.edu; al2179@columbia.edu	Bruce, Jeffrey N/AAC-5307-2022	Califano, Andrea/0000-0003-4742-3679; LEE, SANG BAE/0000-0002-4031-8051; Hutchinson, Keino/0000-0001-7492-6365; Iavarone, Antonio/0000-0002-0683-4634	National Institute of Health [R01CA101644, R01CA131126]; Chemotherapy Foundation; American Brain Tumor Association (ABTA);  [R01CA178546 and R01NS061776];  [NRF-2013R1A6A3A03063888]; NATIONAL CANCER INSTITUTE [R01CA127643, R01CA190891, R01CA178546, R01CA131126, R01CA085628, R01CA101644] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS061776] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chemotherapy Foundation; American Brain Tumor Association (ABTA); ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank N. Sherman for phospho-ID2 and ID2-associated proteins analysis by mass spectrometry, C. Warnecke for the plasmid expressing HIF2 alpha-TM, Z. Ronai for Flag-PHD1, Flag-PHD2, and Flag-PHD3, plasmids, A. Flores-Morales for the plasmid expressing Flag-SOCS2, M. Pagano for cDNAs for RBX1, Elongin B, Elongin C, and K. H. Kim for pcDNA-VHL. We thank D. D'Arca for preparation of VHL and HIF alpha constructs. This work was supported by National Institute of Health grants to A. L. (R01CA101644 and R01CA131126), and A. I. (R01CA178546 and R01NS061776 and a grant from The Chemotherapy Foundation). V. F. is supported by a fellowship from the American Brain Tumor Association (ABTA). S. B. L. was supported by NRF-2013R1A6A3A03063888 fellowship.	ABAGYAN R, 1994, J MOL BIOL, V235, P983, DOI 10.1006/jmbi.1994.1052; Almond David, 2010, J Vis Exp, DOI 10.3791/2118; Alvarez MJ, 2014, BIOCONDUCTOR, P1; Aranda S, 2011, FASEB J, V25, P449, DOI 10.1096/fj.10-165837; Becker W, 2012, CELL CYCLE, V11, P3389, DOI 10.4161/cc.21404; Bordner AJ, 2006, PROTEINS, V63, P512, DOI 10.1002/prot.20831; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; Cawthorne Christopher, 2007, J Biomol Tech, V18, P120; Chakrabarti L, 2007, J NEUROSCI, V27, P11483, DOI 10.1523/JNEUROSCI.3406-07.2007; Contestabile A, 2007, HIPPOCAMPUS, V17, P665, DOI 10.1002/hipo.20308; Deleyrolle LP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015844; Giorgi FM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109569; Gockler N, 2009, FEBS J, V276, P6324, DOI 10.1111/j.1742-4658.2009.07346.x; Gordan JD, 2007, CANCER CELL, V11, P335, DOI 10.1016/j.ccr.2007.02.006; Guimera J, 1996, HUM MOL GENET, V5, P1305, DOI 10.1093/hmg/5.9.1305; Hammerle B, 2011, DEVELOPMENT, V138, P2543, DOI 10.1242/dev.066167; Hara E, 1997, EMBO J, V16, P332, DOI 10.1093/emboj/16.2.332; Hibaoui Y, 2014, EMBO MOL MED, V6, P259, DOI 10.1002/emmm.201302848; Himpel S, 2000, J BIOL CHEM, V275, P2431, DOI 10.1074/jbc.275.4.2431; Himpel S, 2001, BIOCHEM J, V359, P497, DOI 10.1042/0264-6021:3590497; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kamura T, 1999, SCIENCE, V284, P657, DOI 10.1126/science.284.5414.657; Keith B, 2012, NAT REV CANCER, V12, P9, DOI 10.1038/nrc3183; Kershaw NJ, 2015, STRUCTURE, V23, P435, DOI 10.1016/j.str.2015.02.003; Kondo K, 2003, PLOS BIOL, V1, P439, DOI 10.1371/journal.pbio.0000083; Lasorella A, 2005, MOL CELL BIOL, V25, P3563, DOI 10.1128/MCB.25.9.3563-3574.2005; Lasorella A, 2014, NAT REV CANCER, V14, P77, DOI 10.1038/nrc3638; Lauth M, 2010, NAT STRUCT MOL BIOL, V17, P718, DOI 10.1038/nsmb.1833; Lee K, 2000, CANCER RES, V60, P3631; Li Z, 2009, CANCER CELL, V15, P501, DOI 10.1016/j.ccr.2009.03.018; Litovchick L, 2011, GENE DEV, V25, P801, DOI 10.1101/gad.2034211; Lofstedt T, 2004, J BIOL CHEM, V279, P39223, DOI 10.1074/jbc.M402904200; Mao JH, 2002, J BIOL CHEM, V277, P35156, DOI 10.1074/jbc.M206743200; Miinea CP, 2003, BIOTECHNIQUES, V34, P828, DOI 10.2144/03344pt01; Nam HS, 2009, CELL STEM CELL, V5, P515, DOI 10.1016/j.stem.2009.08.017; Nguyen HC, 2015, STRUCTURE, V23, P441, DOI 10.1016/j.str.2014.12.014; Niola F, 2013, J CLIN INVEST, V123, P405, DOI 10.1172/JCI63811; Niola F, 2012, NAT CELL BIOL, V14, P477, DOI 10.1038/ncb2490; Ohta T, 1999, MOL CELL, V3, P535, DOI 10.1016/S1097-2765(00)80482-7; Park J, 2010, J BIOL CHEM, V285, P31895, DOI 10.1074/jbc.M110.147520; Perk J, 2005, NAT REV CANCER, V5, P603, DOI 10.1038/nrc1673; Pietras A, 2009, P NATL ACAD SCI USA, V106, P16805, DOI 10.1073/pnas.0904606106; Pozo N, 2013, J CLIN INVEST, V123, P2475, DOI 10.1172/JCI63623; Reynolds BA, 1996, DEV BIOL, V175, P1, DOI 10.1006/dbio.1996.0090; Semenza GL, 2001, CELL, V107, P1, DOI 10.1016/S0092-8674(01)00518-9; Tropepe V, 1999, DEV BIOL, V208, P166, DOI 10.1006/dbio.1998.9192; Vandeputte DAA, 2002, GLIA, V38, P329, DOI 10.1002/glia.10076; Wang K, 2009, NAT BIOTECHNOL, V27, P829, DOI 10.1038/nbt.1563; Warnecke C, 2004, FASEB J, V18, P1462, DOI 10.1096/fj.04-1640fje; Yabut O, 2010, J NEUROSCI, V30, P4004, DOI 10.1523/JNEUROSCI.4711-09.2010; Yang EJ, 2001, J BIOL CHEM, V276, P39819, DOI 10.1074/jbc.M104091200; Zhao XD, 2008, NAT CELL BIOL, V10, P643, DOI 10.1038/ncb1727; Zhao X, 2009, DEV CELL, V17, P210, DOI 10.1016/j.devcel.2009.07.009	53	86	88	1	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 14	2016	529	7585					172	U93		10.1038/nature16475	http://dx.doi.org/10.1038/nature16475			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA7WK	26735018	Green Accepted			2022-12-28	WOS:000368015700028
J	Farrior, CE; Bohlman, SA; Hubbell, S; Pacala, SW				Farrior, C. E.; Bohlman, S. A.; Hubbell, S.; Pacala, S. W.			Dominance of the suppressed: Power-law size structure in tropical forests	SCIENCE			English	Article							GENERAL QUANTITATIVE THEORY; TREE SIZE; NEOTROPICAL FOREST; METABOLIC ECOLOGY; TEMPERATE FOREST; GROWTH; DISTRIBUTIONS; DYNAMICS; MODEL; DISTURBANCES	Tropical tree size distributions are remarkably consistent despite differences in the environments that support them. With data analysis and theory, we found a simple and biologically intuitive hypothesis to explain this property, which is the foundation of forest dynamics modeling and carbon storage estimates. After a disturbance, new individuals in the forest gap grow quickly in full sun until they begin to overtop one another. The two-dimensional space-filling of the growing crowns of the tallest individuals relegates a group of losing, slow-growing individuals to the understory. Those left in the understory follow a power-law size distribution, the scaling of which depends on only the crown area-to-diameter allometry exponent: a well-conserved value across tropical forests.	[Farrior, C. E.] Natl Inst Math & Biol Synth, Knoxville, TN 37996 USA; [Farrior, C. E.] Univ Texas Austin, Dept Integrat Biol, Austin, TX 78712 USA; [Bohlman, S. A.] Univ Florida, Sch Forest Resources & Conservat, Gainesville, FL 32611 USA; [Bohlman, S. A.; Hubbell, S.] Smithsonian Trop Res Inst, Balboa, Ancon, Panama; [Hubbell, S.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA 90095 USA; [Pacala, S. W.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA	University of Tennessee System; University of Tennessee Knoxville; University of Texas System; University of Texas Austin; State University System of Florida; University of Florida; Smithsonian Institution; Smithsonian Tropical Research Institute; University of California System; University of California Los Angeles; Princeton University	Farrior, CE (corresponding author), Natl Inst Math & Biol Synth, Knoxville, TN 37996 USA.	cfarrior@nimbios.org			Carbon Mitigation Initiative of Princeton University; National Institute for Mathematical and Biological Synthesis (NSF, The University of Tennessee, Knoxville) [DBI-1300426]; Direct For Biological Sciences [1300426] Funding Source: National Science Foundation	Carbon Mitigation Initiative of Princeton University(Princeton University); National Institute for Mathematical and Biological Synthesis (NSF, The University of Tennessee, Knoxville); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank J. Chave, H. C. Muller-Landau, and R. Chisholm for helpful discussion and L. Comita for sharing data. We gratefully acknowledge the support of the Carbon Mitigation Initiative of Princeton University and the National Institute for Mathematical and Biological Synthesis (NSF grant no. DBI-1300426, The University of Tennessee, Knoxville). The BCI forest dynamics research project was founded by S. P. Hubbell and R. B. Foster and is now managed by R. Condit, S. Lao, and R. Perez under the Center for Tropical Forest Science and Smithsonian Tropical Research in Panama. Numerous organizations have provided funding, principally in the United States. NSF and hundreds of field workers have contributed. The data are publicly available at http://ctfs.arnarb.harvard.edu/webatlas/datasets/bci.	Bohlman S, 2012, J ECOL, V100, P508, DOI 10.1111/j.1365-2745.2011.01935.x; CANHAM CD, 1988, ECOLOGY, V69, P786, DOI 10.2307/1941027; Chambers JQ, 2013, P NATL ACAD SCI USA, V110, P3949, DOI 10.1073/pnas.1202894110; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Condit R, 1998, TROPICAL FOREST CENS; Coomes DA, 2003, ECOL LETT, V6, P980, DOI 10.1046/j.1461-0248.2003.00520.x; Coomes DA, 2007, J ECOL, V95, P1084, DOI 10.1111/j.1365-2745.2007.01280.x; Cyr H, 2004, ECOLOGY, V85, P1802, DOI 10.1890/03-0695; Duncanson LI, 2015, GLOBAL ECOL BIOGEOGR, V24, P1465, DOI 10.1111/geb.12371; Enquist BJ, 2001, NATURE, V410, P655, DOI 10.1038/35070500; Enquist BJ, 1998, NATURE, V395, P163, DOI 10.1038/25977; Enquist BJ, 2009, P NATL ACAD SCI USA, V106, P7046, DOI 10.1073/pnas.0812303106; Hubbell SP, 1999, SCIENCE, V283, P554, DOI 10.1126/science.283.5401.554; HUBBELL SP, 1992, OIKOS, V63, P48, DOI 10.2307/3545515; Lai JS, 2013, OIKOS, V122, P1636, DOI 10.1111/j.1600-0706.2013.00436.x; Marvin DC, 2014, P NATL ACAD SCI USA, V111, pE5224, DOI 10.1073/pnas.1412999111; Medvigy D, 2009, J GEOPHYS RES-BIOGEO, V114, DOI 10.1029/2008JG000812; Muller-Landau HC, 2006, ECOL LETT, V9, P589, DOI 10.1111/j.1461-0248.2006.00915.x; Muller-Landau HC, 2006, ECOL LETT, V9, P575, DOI 10.1111/j.1461-0248.2006.00904.x; Purves DW, 2008, P NATL ACAD SCI USA, V105, P17018, DOI 10.1073/pnas.0807754105; Ruger N, 2012, FUNCT ECOL, V26, P759, DOI 10.1111/j.1365-2435.2012.01981.x; Shinozaki K, 1964, JAPANESE J ECOL, V14, P133, DOI DOI 10.18960/SEITAI.14.4_133; Stumpf MPH, 2012, SCIENCE, V335, P665, DOI 10.1126/science.1216142; UHL C, 1988, ECOLOGY, V69, P751, DOI 10.2307/1941024; Wang XG, 2009, OIKOS, V118, P25, DOI 10.1111/j.0030-1299.2008.16598.x; West GB, 1999, NATURE, V400, P664, DOI 10.1038/23251; West GB, 2009, P NATL ACAD SCI USA, V106, P7040, DOI 10.1073/pnas.0812294106	27	74	76	1	91	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 8	2016	351	6269					155	157		10.1126/science.aad0592	http://dx.doi.org/10.1126/science.aad0592			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4XQ	26744402				2022-12-28	WOS:000367806500037
J	Garcia-Prat, L; Martinez-Vicente, M; Perdiguero, E; Ortet, L; Rodriguez-Ubreva, J; Rebollo, E; Ruiz-Bonilla, V; Gutarra, S; Ballestar, E; Serrano, AL; Sandri, M; Munoz-Canoves, P				Garcia-Prat, Laura; Martinez-Vicente, Marta; Perdiguero, Eusebio; Ortet, Laura; Rodriguez-Ubreva, Javier; Rebollo, Elena; Ruiz-Bonilla, Vanessa; Gutarra, Susana; Ballestar, Esteban; Serrano, Antonio L.; Sandri, Marco; Munoz-Canoves, Pura			Autophagy maintains stemness by preventing senescence	NATURE			English	Article							SKELETAL-MUSCLE; MUSCULAR-DYSTROPHY; SATELLITE CELLS; LIFE-SPAN; P38 MAPK; QUIESCENT; PATHWAYS; SUPPORTS; NICHE; ROS	During ageing, muscle stem-cell regenerative function declines. At advanced geriatric age, this decline is maximal owing to transition from a normal quiescence into an irreversible senescence state. How satellite cells maintain quiescence and avoid senescence until advanced age remains unknown. Here we report that basal autophagy is essential to maintain the stem-cell quiescent state in mice. Failure of autophagy in physiologically aged satellite cells or genetic impairment of autophagy in young cells causes entry into senescence by loss of proteostasis, increased mitochondrial dysfunction and oxidative stress, resulting in a decline in the function and number of satellite cells. Re-establishment of autophagy reverses senescence and restores regenerative functions in geriatric satellite cells. As autophagy also declines in human geriatric satellite cells, our findings reveal autophagy to be a decisive stem-cell-fate regulator, with implications for fostering muscle regeneration in sarcopenia.	[Garcia-Prat, Laura; Perdiguero, Eusebio; Ortet, Laura; Ruiz-Bonilla, Vanessa; Gutarra, Susana; Serrano, Antonio L.; Munoz-Canoves, Pura] Pompeu Fabra Univ UPF, Cell Biol Grp, Dept Expt & Hlth Sci, CIBER Neurodegenerat Dis CIBERNED, E-08003 Barcelona, Spain; [Martinez-Vicente, Marta] Vall dHebron Res Inst, Neurodegenerat Dis Res Grp, CIBERNED, E-08035 Barcelona, Spain; [Rodriguez-Ubreva, Javier; Ballestar, Esteban] Bellvitge Biomed Res Inst IDIBELL, Chromatin & Dis Grp, Canc Epigenet & Biol Programme PEBC, E-08907 Lhospitalet De Llobregat, Spain; [Rebollo, Elena] CSIC, Adv Fluorescence Microscopy Unit, Mol Biol Inst Barcelona IBMB, E-08028 Barcelona, Spain; [Sandri, Marco] Univ Padua, Dept Biomed Sci, I-35100 Padua, Italy; [Sandri, Marco] Telethon Inst Genet & Med TIGEM, I-80131 Naples, Italy; [Munoz-Canoves, Pura] ICREA, E-08908 Barcelona, Spain	CIBERNED; Pompeu Fabra University; CIBERNED; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB); University of Padua; Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); ICREA	Munoz-Canoves, P (corresponding author), Pompeu Fabra Univ UPF, Cell Biol Grp, Dept Expt & Hlth Sci, CIBER Neurodegenerat Dis CIBERNED, E-08003 Barcelona, Spain.; Munoz-Canoves, P (corresponding author), ICREA, E-08908 Barcelona, Spain.	pura.munoz@upf.edu	Perdiguero, Eusebio/F-3178-2013; Martinez-Vicente, Marta/K-4312-2014; Munoz-Canoves, Pura/B-3889-2015; Ballestar, Esteban/ABG-8561-2020; Serrano, A/I-9198-2014; Cortada, Laura Ortet/I-1204-2015	Perdiguero, Eusebio/0000-0003-3529-8989; Martinez-Vicente, Marta/0000-0001-7053-2625; Cortada, Laura Ortet/0000-0002-3774-1844; Garcia-Prat, Laura/0000-0002-3786-4852; Rebollo, Elena/0000-0001-8899-0317; Ballestar, Esteban/0000-0002-1400-2440; RODRIGUEZ-UBREVA, JAVIER/0000-0003-4707-4536	MINECO, Spain [SAF2012-38547, SAF2015-67369-R, PLE2009-0124, SAF2009-08374]; "Maria de Maeztu" Programme for Units of Excellence in RD [MDM-2014-0370]; AFM; E-Rare/ERANET; Fundacio Marato TV3; MDA; EU-FP7 (Myoage); EU-FP7 (Optistem); EU-FP7 (Endostem); DuchennePP-NL; ISCIII, Spain [FIS-PS09/01267, FIS-PI13/02512, CP09/00184, PI14/01529]; CIBERNED; European Union ERC [282310-MyoPHAGY]; Foundation Leducq; Programa de Formacion de Personal Investigador (Spain); ICREA Funding Source: Custom	MINECO, Spain; "Maria de Maeztu" Programme for Units of Excellence in RD; AFM(Association Francaise contre les Myopathies); E-Rare/ERANET; Fundacio Marato TV3; MDA(Muscular Dystrophy Association); EU-FP7 (Myoage); EU-FP7 (Optistem); EU-FP7 (Endostem); DuchennePP-NL; ISCIII, Spain(Instituto de Salud Carlos III); CIBERNED(Instituto de Salud Carlos III); European Union ERC(European Research Council (ERC)); Foundation Leducq(Leducq Foundation); Programa de Formacion de Personal Investigador (Spain); ICREA(ICREA)	We are indebted to G. Marino for the gift of GFP-LC3 transgenic mice, C. Keller and M. Capecchi for Pax-Cre mouse lines, J. Ruberte for TEM studies help, E. Masliah and K. Kosberg for Atg7 lentivirus; M. Raya, M. Jardi, and V. Lukesova for their technical contributions, and especially J. Guerra for help in microarray experiments and P. Sousa-Victor for initial findings; J. Martin-Caballero (PRBB Animal Facility) and O. Fornas (UPF/CRG FACS Facility) for technical help, and the KS Society. The authors acknowledge funding from MINECO, Spain (SAF2012-38547, SAF2015-67369-R, PLE2009-0124; SAF2009-08374; "Maria de Maeztu" Programme for Units of Excellence in R&D MDM-2014-0370), AFM, E-Rare/ERANET, Fundacio Marato TV3, MDA, EU-FP7 (Myoage, Optistem and Endostem) and DuchennePP-NL. M. M.-V. acknowledges funding from ISCIII, Spain (FIS-PS09/01267, FIS-PI13/02512, CP09/00184, PI14/01529) and CIBERNED; and MS from the European Union ERC (282310-MyoPHAGY) and Foundation Leducq. L.G.-P. was supported by a Predoctoral Fellowship from Programa de Formacion de Personal Investigador (Spain).	Bernet JD, 2014, NAT MED, V20, P265, DOI 10.1038/nm.3465; Blagosklonny MV, 2013, CANCER BIOL THER, V14, P1092, DOI 10.4161/cbt.27350; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Breitkreutz BJ, 2001, GENOME BIOL, V2; Capparelli C, 2012, CELL CYCLE, V11, P2285, DOI 10.4161/cc.20718; Carnio S, 2014, CELL REP, V8, P1509, DOI 10.1016/j.celrep.2014.07.061; Chakkalakal JV, 2012, NATURE, V490, P355, DOI 10.1038/nature11438; Cheung TH, 2013, NAT REV MOL CELL BIO, V14, P329, DOI 10.1038/nrm3591; Comai G, 2014, CURR TOP DEV BIOL, V110, P1, DOI 10.1016/B978-0-12-405943-6.00001-4; Cosgrove BD, 2014, NAT MED, V20, P255, DOI 10.1038/nm.3464; Crews L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009313; Cuervo AM, 2005, AUTOPHAGY, V1, P131, DOI 10.4161/auto.1.3.2017; Flach J, 2014, NATURE, V512, P198, DOI 10.1038/nature13619; Fukada SI, 2007, STEM CELLS, V25, P2448, DOI 10.1634/stemcells.2007-0019; Garcia-Prat L, 2013, FEBS J, V280, P4051, DOI 10.1111/febs.12221; Grounds Miranda D, 2014, Bioarchitecture, V4, P81, DOI 10.4161/bioa.29668; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Hulsen T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-488; Ito K, 2006, NAT MED, V12, P446, DOI 10.1038/nm1388; Kamentsky L, 2011, BIOINFORMATICS, V27, P1179, DOI 10.1093/bioinformatics/btr095; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Kodama R, 2013, GENES CELLS, V18, P32, DOI 10.1111/gtc.12015; Lee AC, 1999, J BIOL CHEM, V274, P7936, DOI 10.1074/jbc.274.12.7936; Lee JH, 2010, SCIENCE, V327, P1223, DOI 10.1126/science.1182228; Lerner C, 2013, AGING CELL, V12, P966, DOI 10.1111/acel.12122; Liu L, 2013, CELL REP, V4, P189, DOI 10.1016/j.celrep.2013.05.043; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Mandal PK, 2011, NAT REV MOL CELL BIO, V12, P198, DOI 10.1038/nrm3060; Masiero E, 2009, CELL METAB, V10, P507, DOI 10.1016/j.cmet.2009.10.008; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Montarras D, 2013, FEBS J, V280, P4036, DOI 10.1111/febs.12372; Morselli E, 2011, J CELL BIOL, V192, P615, DOI 10.1083/jcb.201008167; Munoz-Espin D, 2014, NAT REV MOL CELL BIO, V15, P482, DOI 10.1038/nrm3823; Narita M, 2011, SCIENCE, V332, P966, DOI 10.1126/science.1205407; Pallafacchina G, 2010, STEM CELL RES, V4, P77, DOI 10.1016/j.scr.2009.10.003; Perdiguero E, 2007, EMBO J, V26, P1245, DOI 10.1038/sj.emboj.7601587; Perez-Mancera PA, 2014, NAT REV CANCER, V14, P547, DOI 10.1038/nrc3773; Price FD, 2014, NAT MED, V20, P1174, DOI 10.1038/nm.3655; Ramsey MR, 2006, NAT CELL BIOL, V8, P1213, DOI 10.1038/ncb1106-1213; Rubinsztein DC, 2011, CELL, V146, P682, DOI 10.1016/j.cell.2011.07.030; Sacco A, 2010, CELL, V143, P1059, DOI 10.1016/j.cell.2010.11.039; Shao LJ, 2011, INT J HEMATOL, V94, P24, DOI 10.1007/s12185-011-0872-1; Sousa-Victor P, 2015, TRENDS ENDOCRIN MET, V26, P287, DOI 10.1016/j.tem.2015.03.006; Sousa-Victor P, 2014, NATURE, V506, P316, DOI 10.1038/nature13013; Suelves M, 2007, J CELL BIOL, V178, P1039, DOI 10.1083/jcb.200705127; Tang AH, 2014, EMBO J, V33, P2782, DOI 10.15252/embj.201488278; Tierney MT, 2014, NAT MED, V20, P1182, DOI 10.1038/nm.3656; van Deursen JM, 2014, NATURE, V509, P439, DOI 10.1038/nature13193; Warr MR, 2013, NATURE, V494, P323, DOI 10.1038/nature11895; Yin H, 2013, PHYSIOL REV, V93, P23, DOI 10.1152/physrev.00043.2011; Young ARJ, 2009, GENE DEV, V23, P798, DOI 10.1101/gad.519709; Zhu JH, 2011, METHODS MOL BIOL, V793, P325, DOI 10.1007/978-1-61779-328-8_21	54	739	788	20	329	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 7	2016	529	7584					37	+		10.1038/nature16187	http://dx.doi.org/10.1038/nature16187			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6VY	26738589				2022-12-28	WOS:000367944900022
J	Gale, CP; Camm, AJ				Gale, Chris P.; Camm, A. John			PRACTICE POINTER Assessment of palpitations	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HEALTHY-SUBJECTS; ARRHYTHMIAS; RISK; PATIENT		[Gale, Chris P.] Univ Leeds, Leeds Inst Cardiovasc & Metab Med, Leeds, W Yorkshire, England; [Gale, Chris P.] York Teaching Hosp NHS Fdn Trust, York, N Yorkshire, England; [Camm, A. John] St Georges Univ London, Div Clin Sci, London, England; [Camm, A. John] Univ London Imperial Coll Sci Technol & Med, Brompton Hosp, London, England	University of Leeds; St Georges University London; Imperial College London; Royal Brompton Hospital	Gale, CP (corresponding author), Univ Leeds, Leeds Inst Cardiovasc & Metab Med, Leeds, W Yorkshire, England.	c.p.gale@leeds.ac.uk		Gale, Chris/0000-0003-4732-382X				Baman TS, 2010, HEART RHYTHM, V7, P865, DOI 10.1016/j.hrthm.2010.03.036; Banning AS, 2013, EUR HEART J, V34, P236, DOI 10.1093/eurheartj/ehs356; BARSKY AJ, 1994, J GEN INTERN MED, V9, P306, DOI 10.1007/BF02599176; Barsky AJ, 2001, ANN INTERN MED, V134, P832, DOI 10.7326/0003-4819-134-9_Part_2-200105011-00006; Binns H, 2002, BMJ-BRIT MED J, V324, P927, DOI 10.1136/bmj.324.7343.927; de Asmundis C, 2014, EUROPACE, V16, P1231, DOI 10.1093/europace/eut411; Driver and Vehicle Licensing Agency, 2014, MED PRACT GLANC GUID; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; HISS RG, 1962, CIRCULATION, V25, P947, DOI 10.1161/01.CIR.25.6.947; KENNEDY HL, 1985, NEW ENGL J MED, V312, P193, DOI 10.1056/NEJM198501243120401; Kinlay S, 1996, ANN INTERN MED, V124, P16, DOI 10.7326/0003-4819-124-1_Part_1-199601010-00003; Lessmeier TJ, 1997, ARCH INTERN MED, V157, P537, DOI 10.1001/archinte.157.5.537; Sajadieh A, 2006, AM J CARDIOL, V97, P1351, DOI 10.1016/j.amjcard.2005.11.067; Thavendiranathan P, 2009, JAMA-J AM MED ASSOC, V302, P2135, DOI 10.1001/jama.2009.1673; Weber BE, 1996, AM J MED, V100, P138, DOI 10.1016/S0002-9343(97)89451-X; Wolff A, 2009, BR J CARDIOL, V16, P182	16	12	12	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 6	2016	352								h5649	10.1136/bmj.h5649	http://dx.doi.org/10.1136/bmj.h5649			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DA8MO	26739319				2022-12-28	WOS:000368059200008
J	Bauchner, H; Berwick, D; Fontanarosa, PB				Bauchner, Howard; Berwick, Donald; Fontanarosa, Phil B.			Innovations in Health Care Delivery and the Future of Medicine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SCIENTIFIC DISCOVERY		[Berwick, Donald] IHI, Cambridge, MA USA		Bauchner, H (corresponding author), JAMA Network, 330 N Wabash Ave, Chicago, IL 60611 USA.	howard.bauchner@jamanetwork.org						Berwick D, 2015, JAMA-J AM MED ASSOC, V314, P675, DOI 10.1001/jama.2015.9257; Fontanarosa PB, 2015, JAMA-J AM MED ASSOC, V313, P145, DOI 10.1001/jama.2014.17937; Ioannidis JPA, 2015, JAMA-J AM MED ASSOC, V314, P1135, DOI 10.1001/jama.2015.9629; Ioannidis JPA, 2015, JAMA-J AM MED ASSOC, V313, P663, DOI 10.1001/jama.2014.17662; Khanna RR, 2016, JAMA-J AM MED ASSOC, V315, P21, DOI 10.1001/jama.2015.17025; Komaroff AL, 2015, JAMA-J AM MED ASSOC, V314, P1133, DOI 10.1001/jama.2015.10893; Powers BW, 2016, JAMA-J AM MED ASSOC, V315, P23, DOI 10.1001/jama.2015.17029	7	9	9	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 5	2016	315	1					30	31		10.1001/jama.2015.17452	http://dx.doi.org/10.1001/jama.2015.17452			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DA0YH	26746453				2022-12-28	WOS:000367523000010
J	Eckel, ZC; Zhou, CY; Martin, JH; Jacobsen, AJ; Carter, WB; Schaedler, TA				Eckel, Zak C.; Zhou, Chaoyin; Martin, John H.; Jacobsen, Alan J.; Carter, William B.; Schaedler, Tobias A.			3D PRINTING Additive manufacturing of polymer-derived ceramics	SCIENCE			English	Article							MICROSCALE TRUSS STRUCTURES; WAVE-GUIDES; AMORPHOUS CERAMICS; OXIDATION; BEHAVIOR; SICO; CRISTOBALITE; FABRICATION; SYSTEM; RANGE	The tidal disruption of a star by a supermassive black hole leads to a short-lived thermal flare. Despite extensive searches, radio follow-up observations of known thermal stellar tidal disruption flares (TDFs) have not yet produced a conclusive detection. We present a detection of variable radio emission from a thermal TDF, which we interpret as originating from a newly launched jet. The multiwavelength properties of the source present a natural analogy with accretion-state changes of stellar mass black holes, which suggests that all TDFs could be accompanied by a jet. In the rest frame of the TDF, our radio observations are an order of magnitude more sensitive than nearly all previous upper limits, explaining how these jets, if common, could thus far have escaped detection.	[Eckel, Zak C.; Zhou, Chaoyin; Martin, John H.; Jacobsen, Alan J.; Carter, William B.; Schaedler, Tobias A.] HRL Labs LLC, Malibu, CA 90265 USA	HRL Laboratories	Schaedler, TA (corresponding author), HRL Labs LLC, 3011 Malibu Canyon Rd, Malibu, CA 90265 USA.	taschaedler@hrl.com			HRL Laboratories; LLC; Defense Advanced Research Projects Agency [W91CRB-10-0305]	HRL Laboratories; LLC; Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA))	The authors gratefully acknowledge financial support by HRL Laboratories, LLC, and the Defense Advanced Research Projects Agency under the Materials with Controlled Microstructural Architecture program managed by J. Goldwasser (contract no. W91CRB-10-0305) and thank N. Verma (University of California, Santa Barbara) for TEM analysis and C. G. Levi and C. S. Roper for useful discussions. Patent applications have been filed under serial numbers 62/183580, 62/128410, and 62/092733 with the U.S. Patent and Trademark office.	Beals MD, 1944, J AM CERAM SOC, V27, P285, DOI 10.1111/j.1151-2916.1944.tb14471.x; Chollon G, 2000, J EUR CERAM SOC, V20, P1959, DOI 10.1016/S0955-2219(00)00101-1; Colombo P, 2001, J AM CERAM SOC, V84, P2245, DOI 10.1111/j.1151-2916.2001.tb00996.x; Colombo P., 2010, POLYM DERIVED CERAMI; Colombo P, 2010, J AM CERAM SOC, V93, P1805, DOI 10.1111/j.1551-2916.2010.03876.x; Coppala J. A., 1979, P INT S FACT DENS SI, P400; Deckers J, 2014, J CERAM SCI TECHNOL, V5, P245, DOI 10.4416/JCST2014-00032; Geyer N. M., 1961, P MAT S 13 15 SEPT P; Gibson J.L., 1997, CELLULAR SOLIDS STRU, DOI [10.1017/cbo9781139878326, DOI 10.1017/CBO9781139878326]; Huang LP, 2003, J CHEM PHYS, V118, P1487, DOI 10.1063/1.1529684; Jacobsen AJ, 2008, ACTA MATER, V56, P2540, DOI 10.1016/j.actamat.2008.01.051; Jacobsen AJ, 2007, ACTA MATER, V55, P6724, DOI 10.1016/j.actamat.2007.08.036; Jacobsen AJ, 2007, ADV MATER, V19, P3892, DOI 10.1002/adma.200700797; Liew LA, 2002, SENSOR ACTUAT A-PHYS, V95, P120, DOI 10.1016/S0924-4247(01)00723-3; Martinez-Crespiera S, 2011, SENSOR ACTUAT A-PHYS, V169, P242, DOI 10.1016/j.sna.2011.04.041; Modena S, 2005, J AM CERAM SOC, V88, P339, DOI 10.1111/j.1551-2916.2005.00043.x; Opila E, 2004, J MATER SCI, V39, P5969, DOI 10.1023/B:JMSC.0000041693.32531.d1; Riedel R, 1996, NATURE, V382, P796, DOI 10.1038/382796a0; Saha A, 2007, J AM CERAM SOC, V90, P578, DOI 10.1111/j.1551-2916.2006.01423.x; Saha A, 2006, J AM CERAM SOC, V89, P2188, DOI 10.1111/j.1551-2916.2006.00920.x; Schaedler TA, 2011, SCIENCE, V334, P962, DOI 10.1126/science.1211649; Schulz M, 2004, ADV ENG MATER, V6, P676, DOI 10.1002/adem.200400082; Travitzky N, 2014, ADV ENG MATER, V16, P729, DOI 10.1002/adem.201400097; TRIPP WC, 1976, J AM CERAM SOC, V59, P399, DOI 10.1111/j.1151-2916.1976.tb09505.x; TRIPP WC, 1971, J ELECTROCHEM SOC, V118, P1195, DOI 10.1149/1.2408279; Varga T, 2007, J AM CERAM SOC, V90, P3213, DOI 10.1111/j.1551-2916.2007.01874.x; Wohlers T. T., 2013, WOHLERS REPORT; Xu TH, 2011, CERAM INT, V37, P2555, DOI 10.1016/j.ceramint.2011.03.053; Zaheer M, 2012, CHEM SOC REV, V41, P5102, DOI 10.1039/c2cs15326b; Zocca A, 2015, J AM CERAM SOC, V98, P1983, DOI 10.1111/jace.13700	30	622	669	61	1360	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 1	2016	351	6268					58	62		10.1126/science.aad2688	http://dx.doi.org/10.1126/science.aad2688			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ8QM	26721993				2022-12-28	WOS:000367364200040
J	Jaramillo, F; Destouni, G				Jaramillo, Fernando; Destouni, Georgia			Local flow regulation and irrigation raise global human water consumption and footprint	SCIENCE			English	Article							GUIDING HUMAN-DEVELOPMENT; CLIMATE-CHANGE; FRAGMENTATION; DRIVERS; SYSTEMS; STORAGE; RUNOFF; DAMS; BLUE	Flow regulation and irrigation alter local freshwater conditions, but their global effects are highly uncertain. We investigated these global effects from 1901 to 2008, using hydroclimatic observations in 100 large hydrological basins. Globally, we find consistent and dominant effects of increasing relative evapotranspiration from both activities, and decreasing temporal runoff variability from flow regulation. The evapotranspiration effect increases the long-term average human consumption of fresh water by 3563 +/- 979 km(3)/year from 1901-1954 to 1955-2008. This increase raises a recent estimate of the current global water footprint of humanity by around 18%, to 10,688 +/- 979 km(3)/year. The results highlight the global impact of local water-use activities and call for their relevant account in Earth system modeling.	[Jaramillo, Fernando; Destouni, Georgia] Stockholm Univ, Dept Phys Geog, SE-10691 Stockholm, Sweden; [Jaramillo, Fernando; Destouni, Georgia] Stockholm Univ, Bolin Ctr Climate Res, SE-10691 Stockholm, Sweden; [Jaramillo, Fernando] Univ Gothenburg, Dept Biol & Environm Sci, S-40530 Gothenburg, Sweden	Stockholm University; Stockholm University; University of Gothenburg	Jaramillo, F (corresponding author), Stockholm Univ, Dept Phys Geog, SE-10691 Stockholm, Sweden.	fernando.jaramillo@natgeo.su.se	Jaramillo, Fernando/T-4713-2017; Destouni, Georgia/M-9662-2016; Destouni, Georgia/AAS-5375-2020	Jaramillo, Fernando/0000-0002-6769-0136; Destouni, Georgia/0000-0001-9408-4425; Destouni, Georgia/0000-0001-9408-4425	Swedish Research Council (VR) [2009-3221]; Stockholm University; BECC strategic research area of Lund University; University of Gothenburg	Swedish Research Council (VR)(Swedish Research Council); Stockholm University; BECC strategic research area of Lund University; University of Gothenburg	The Swedish Research Council (VR, project 2009-3221), the strategic environmental research project Ekoklim at Stockholm University, and the BECC strategic research area of Lund University and the University of Gothenburg have funded this study. All data used in our analysis are included in the supplementary materials available on Science Online. The authors thank the anonymous reviewers for their suggestions and recommendations, which have considerably improved this manuscript, as well as J.-O. Persson from the Department of Mathematics at Stockholm University for his statistical advice.	Arora VK, 2002, J HYDROL, V265, P164, DOI 10.1016/S0022-1694(02)00101-4; Berghuijs WR, 2014, NAT CLIM CHANGE, V4, P583, DOI [10.1038/nclimate2246, 10.1038/NCLIMATE2246]; Boucher O, 2004, CLIM DYNAM, V22, P597, DOI 10.1007/s00382-004-0402-4; Bring A, 2015, EARTHS FUTURE, V3, P206, DOI 10.1002/2014EF000296; Budyko MI., 1974, CLIMATE LIFE; Destouni G, 2013, NAT CLIM CHANGE, V3, P213, DOI [10.1038/NCLIMATE1719, 10.1038/nclimate1719]; Doll P, 2009, HYDROL EARTH SYST SC, V13, P2413; DYNESIUS M, 1994, SCIENCE, V266, P753, DOI 10.1126/science.266.5186.753; Gerten D, 2015, SCIENCE, V348, DOI 10.1126/science.aab0031; Haddeland I, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026047; Hoekstra AY, 2014, SCIENCE, V344, P1114, DOI 10.1126/science.1248365; Hoekstra AY, 2012, P NATL ACAD SCI USA, V109, P3232, DOI 10.1073/pnas.1109936109; Jaramillo F, 2015, SCIENCE, V348, DOI 10.1126/science.aaa9629; Jaramillo F, 2014, GEOPHYS RES LETT, V41, P8377, DOI 10.1002/2014GL061848; Lehner B, 2011, FRONT ECOL ENVIRON, V9, P494, DOI 10.1890/100125; Levi L, 2015, AMBIO, V44, P624, DOI 10.1007/s13280-015-0641-0; Mekonnen MM, 2012, HYDROL EARTH SYST SC, V16, P179, DOI 10.5194/hess-16-179-2012; Mekonnen MM, 2011, HYDROL EARTH SYST SC, V15, P1577, DOI 10.5194/hess-15-1577-2011; Milly PCD, 2008, SCIENCE, V319, P573, DOI 10.1126/science.1151915; MILLY PCD, 1994, WATER RESOUR RES, V30, P2143, DOI 10.1029/94WR00586; Nilsson C, 2005, SCIENCE, V308, P405, DOI 10.1126/science.1107887; Piao SL, 2007, P NATL ACAD SCI USA, V104, P15242, DOI 10.1073/pnas.0707213104; Poff NL, 2007, P NATL ACAD SCI USA, V104, P5732, DOI 10.1073/pnas.0609812104; Rost S, 2008, ADV GEOSCIENCES, V18, P43, DOI [DOI 10.5194/ADGEO-18-43-2008, DOI 10.5194/ADGE0-18-43-2008]; Rost S, 2008, WATER RESOUR RES, V44, DOI 10.1029/2007WR006331; Shibuo Y, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031465; Siebert S, 2010, HYDROL EARTH SYST SC, V14, P1863, DOI 10.5194/hess-14-1863-2010; Siebert S., 2013, GLOBAL MAP IRRIGATIO; Steffen W, 2015, SCIENCE, V347, DOI 10.1126/science.1259855; Sterling SM, 2013, NAT CLIM CHANGE, V3, P385, DOI [10.1038/NCLIMATE1690, 10.1038/nclimate1690]; Vorosmarty CJ, 1997, AMBIO, V26, P210; World Commission on Dams, 2000, DAMS DEV NEW FRAMEWO	32	180	185	9	184	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 4	2015	350	6265					1248	1251		10.1126/science.aad1010	http://dx.doi.org/10.1126/science.aad1010			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX4WG	26785489				2022-12-28	WOS:000365700500076
J	Tegn, N; Abdelnoor, M; Aaberge, L; Endresen, K; Smith, P; Aakhus, S; Gjertsen, E; Dahl-Hofseth, O; Ranhoff, AH; Gullestad, L; Bendz, B				Tegn, Nicolai; Abdelnoor, Michael; Aaberge, Lars; Endresen, Knut; Smith, Pal; Aakhus, Svend; Gjertsen, Erik; Dahl-Hofseth, Ola; Ranhoff, Anette Hylen; Gullestad, Lars; Bendz, Bjorn		Eighty Study Investigators	Invasive versus conservative strategy in patients aged 80 years or older with non-ST-elevation myocardial infarction or unstable angina pectoris (After Eighty study): an open-label randomised controlled trial	LANCET			English	Article							ACUTE CORONARY SYNDROMES; GLOBAL REGISTRY; ELDERLY-PATIENTS; COMPETING RISKS; FRISC II; MANAGEMENT; OUTCOMES; PREDICTORS; MORTALITY; ROUTINE	Background Non-ST-elevation myocardial infarction (NSTEMI) and unstable angina pectoris are frequent causes of hospital admission in the elderly. However, clinical trials targeting this population are scarce, and these patients are less likely to receive treatment according to guidelines. We aimed to investigate whether this population would benefit from an early invasive strategy versus a conservative strategy. Methods In this open-label randomised controlled multicentre trial, patients aged 80 years or older with NSTEMI or unstable angina admitted to 16 hospitals in the South-East Health Region of Norway were randomly assigned to an invasive strategy (including early coronary angiography with immediate assessment for percutaneous coronary intervention, coronary artery bypass graft, and optimum medical treatment) or to a conservative strategy (optimum medical treatment alone). A permuted block randomisation was generated by the Centre for Biostatistics and Epidemiology with stratification on the inclusion hospitals in opaque concealed envelopes, and sealed envelopes with consecutive inclusion numbers were made. The primary outcome was a composite of myocardial infarction, need for urgent revascularisation, stroke, and death and was assessed between Dec 10, 2010, and Nov 18, 2014. An intention-to-treat analysis was used. This study is registered with ClinicalTrials.gov, number NCT01255540. Findings During a median follow-up of 1.53 years of participants recruited between Dec 10, 2010, and Feb 21, 2014, the primary outcome occurred in 93 (40.6%) of 229 patients assigned to the invasive group and 140 (61.4%) of 228 patients assigned to the conservative group (hazard ratio [HR] 0.53 [95% CI 0.41-0.69], p= 0.0001). Five patients dropped out of the invasive group and one from the conservative group. HRs for the four components of the primary composite endpoint were 0.52 (0.35-0.76; p= 0.0010) for myocardial infarction, 0.19 (0.07-0.52; p= 0.0010) for the need for urgent revascularisation, 0.60 (0.25-1.46; p= 0.2650) for stroke, and 0.89 (0.62-1.28; p= 0.5340) for death from any cause. The invasive group had four (1.7%) major and 23 (10.0%) minor bleeding complications whereas the conservative group had four (1.8%) major and 16 (7.0%) minor bleeding complications. Interpretation In patients aged 80 years or more with NSTEMI or unstable angina, an invasive strategy is superior to a conservative strategy in the reduction of composite events. Efficacy of the invasive strategy was diluted with increasing age (after adjustment for creatinine and effect modification). The two strategies did not differ in terms of bleeding complications.	[Tegn, Nicolai; Aaberge, Lars; Endresen, Knut; Aakhus, Svend; Gullestad, Lars; Bendz, Bjorn] Oslo Univ Hosp, Dept Cardiol, Oslo, Norway; [Abdelnoor, Michael] Oslo Univ Hosp, Ctr Biostat & Epidemiol, Oslo, Norway; [Abdelnoor, Michael] Oslo Univ Hosp, Ctr Clin Heart Res, Oslo, Norway; [Tegn, Nicolai; Smith, Pal; Gullestad, Lars; Bendz, Bjorn] Univ Oslo, Fac Med, Oslo, Norway; [Smith, Pal] Akershus Univ Hosp, Dept Cardiol, Lorenskog, Norway; [Gjertsen, Erik] Drammen Hosp, Dept Cardiol, Drammen, Norway; [Dahl-Hofseth, Ola] Lillehammer Hosp, Dept Cardiol, Lillehammer, Norway; [Ranhoff, Anette Hylen] Univ Bergen, Diakonhjemmet Hosp, Bergen, Norway; [Ranhoff, Anette Hylen] Univ Bergen, Dept Clin Sci, Bergen, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo; Diakonhjemmet Hospital; University of Bergen; University of Bergen	Bendz, B (corresponding author), Univ Oslo, Rikshosp, Dept Cardiol, Oslo Univ Hosp, N-0424 Oslo, Norway.	bbendz@ous-hf.no	abdelnoor, michael/K-4248-2019		Norwegian Health Association (ExtraStiftelsen); Inger and John Fredriksen Heart Foundation	Norwegian Health Association (ExtraStiftelsen); Inger and John Fredriksen Heart Foundation	Norwegian Health Association (ExtraStiftelsen) and Inger and John Fredriksen Heart Foundation.	Alexander KP, 2007, CIRCULATION, V115, P2549, DOI 10.1161/CIRCULATIONAHA.107.182615; Amsterdam EA, 2014, CIRCULATION, V130, pE344, DOI [10.1161/CIR.0000000000000134, 10.1161/CIR.0000000000000151]; Andersen PK, 2012, INT J EPIDEMIOL, V41, P861, DOI 10.1093/ije/dyr213; Avezum A, 2005, AM HEART J, V149, P67, DOI 10.1016/j.ahj.2004.06.003; Boden WE, 1998, NEW ENGL J MED, V338, P1785, DOI 10.1056/NEJM199806183382501; Brieger D, 2004, CHEST, V126, P461, DOI 10.1378/chest.126.2.461; Cannon CP, 2001, NEW ENGL J MED, V344, P1879, DOI 10.1056/NEJM200106213442501; Damman P, 2012, HEART, V98, P207, DOI 10.1136/heartjnl-2011-300453; de Winter RJ, 2005, NEW ENGL J MED, V353, P1095, DOI 10.1056/NEJMoa044259; Devlin G, 2008, EUR HEART J, V29, P1275, DOI 10.1093/eurheartj/ehn124; Eagle KA, 2004, JAMA-J AM MED ASSOC, V291, P2727, DOI 10.1001/jama.291.22.2727; Fox KAA, 2005, LANCET, V366, P914, DOI 10.1016/S0140-6736(05)67222-4; Fox KAA, 2010, J AM COLL CARDIOL, V55, P2435, DOI 10.1016/j.jacc.2010.03.007; Granger CB, 2003, ARCH INTERN MED, V163, P2345, DOI 10.1001/archinte.163.19.2345; Hamm CW, 2011, EUR HEART J, V32, P2999, DOI 10.1093/eurheartj/ehr236; Kleinbaum D.G., 2005, SURVIVAL ANAL SELF L; Kleinbaum DG, 1982, EPIDEMIOLOGIC RES PR; Koller MT, 2012, STAT MED, V31, P1089, DOI 10.1002/sim.4384; Kolte D, 2013, AM J MED, V126, P1076, DOI 10.1016/j.amjmed.2013.07.024; McKay J, 2005, ATLAS HEART DIS STRO; Moscucci M, 2003, EUR HEART J, V24, P1815, DOI 10.1016/S0195-668X(03)00485-8; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; POCOCK SJ, 1990, STAT MED, V9, P657, DOI 10.1002/sim.4780090612; Rao SV, 2006, J AM COLL CARDIOL, V47, P809, DOI 10.1016/j.jacc.2005.09.060; Savonitto S, 2012, JACC-CARDIOVASC INTE, V5, P906, DOI 10.1016/j.jcin.2012.06.008; Thygesen K, 2007, CIRCULATION, V116, P2634, DOI 10.1161/CIRCULATIONAHA.107.187397; Valgimigli M, 2015, LANCET, V385, P2465, DOI 10.1016/S0140-6736(15)60292-6; Wallentin L, 2000, LANCET, V356, P9, DOI 10.1016/S0140-6736(00)02427-2; Windecker S, 2014, EUR HEART J, V35, P2541, DOI [10.1093/eurheartj/ehu278, 10.5603/KP.2014.0224, 10.1093/ejcts/ezu366]; Zwarenstein M, 2009, J CLIN EPIDEMIOL, V62, P461, DOI 10.1016/j.jclinepi.2009.01.011	30	253	276	3	35	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 12	2016	387	10023					1057	1065		10.1016/S0140-6736(15)01166-6	http://dx.doi.org/10.1016/S0140-6736(15)01166-6			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DG0SD	26794722				2022-12-28	WOS:000371775000025
J	Nelson, HD; O'Meara, ES; Kerlikowske, K; Balch, S; Miglioretti, D				Nelson, Heidi D.; O'Meara, Ellen S.; Kerlikowske, Karla; Balch, Steven; Miglioretti, Diana			Factors Associated With Rates of False-Positive and False -Negative Results From Digital Mammography Screening: An Analysis of Registry Data	ANNALS OF INTERNAL MEDICINE			English	Article							SERVICES TASK-FORCE; BREAST-CANCER RISK; UNITED-STATES; COMMUNITY PRACTICE; HORMONE-THERAPY; WOMEN; TOMOSYNTHESIS; US; DENSITY; RECOMMENDATION	Background: Women screened with digital mammography may receive false-positive and false-negative results and subsequent imaging and biopsies. How these outcomes vary by age, time since the last screening, and individual risk factors is unclear. Objective: To determine factors associated with false-positive and false-negative digital mammography results, additional imaging, and biopsies among a general population of women screened for breast cancer. Design: Analysis of registry data. Setting: Participating facilities at 5 U.S. Breast Cancer Surveillance Consortium breast imaging registries with linkages to pathology databases and tumor registries. Patients: 405 191 women aged 40 to 89 years screened with digital mammography between 2003 and 2011. A total of 2963 were diagnosed with invasive cancer or ductal carcinoma in situ within 12 months of screening. Measurements: Rates of false-positive and false-negative results and recommendations for additional imaging and biopsies from a single screening round; comparisons by age, time since the last screening, and risk factors. Results: Rates of false-positive results (121.2 per 1000 women [95% Cl, 105.6 to 138.7]) and recommendations for additional imaging (124.9 per 1000 women [Cl, 109.3 to 142.3]) were highest among women aged 40 to 49 years and decreased with increasing age. Rates of false-negative results (1.0 to 1.5 per 1000 women) and recommendations for biopsy (15.6 to 17.5 per 1000 women) did not differ greatly by age. Results did not differ by time since the last screening. False-positive rates were higher for women with risk factors, particularly family history of breast cancer; previous benign breast biopsy result; high breast density; and, for younger women, low body mass index. Limitations: Confounding by variation in patient-level characteristics and outcomes across registries and regions may have been present. Some factors, such as numbers of first- and second-degree relatives with breast cancer and diagnoses associated with previous benign biopsy results, were not examined. Conclusion: False-positive mammography results and additional imaging are common, particularly for younger women and those with risk factors, whereas biopsies occur less often. Rates of false-negative results are low.	[Nelson, Heidi D.] Oregon Hlth & Sci Univ, 3181 SW Sam Jackson Pk Rd,Mail Code BICC, Portland, OR 97239 USA; [O'Meara, Ellen S.; Balch, Steven] Grp Hlth Res Inst, 1730 Minor Ave,Suite 1600, Seattle, WA 98101 USA; [Kerlikowske, Karla] VAMC 111A1, San Francisco VA Med Ctr, 4150 Clement St, San Francisco, CA 94121 USA; [Miglioretti, Diana] Univ Calif Davis, 1 Shields Ave,Med Sci 1C,Room 145, Davis, CA 95616 USA	Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of California System; University of California Davis	Nelson, HD (corresponding author), Oregon Hlth & Sci Univ, 3181 SW Sam Jackson Pk Rd,Mail Code BICC, Portland, OR 97239 USA.	nelsonh@ohsu.edu			Agency for Healthcare Research and Quality; National Cancer Institute; NATIONAL CANCER INSTITUTE [P01CA154292, U54CA163303] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Agency for Healthcare Research and Quality and National Cancer Institute.	BallardBarbash R, 1997, AM J ROENTGENOL, V169, P1001, DOI 10.2214/ajr.169.4.9308451; Boyd NF, 2007, NEW ENGL J MED, V356, P227, DOI 10.1056/NEJMoa062790; Braithwaite D, 2013, JNCI-J NATL CANCER I, V105, P334, DOI 10.1093/jnci/djs645; Brem RF, 2015, RADIOLOGY, V274, P663, DOI 10.1148/radiol.14132832; Calonge N, 2009, ANN INTERN MED, V151, P716, DOI 10.7326/0003-4819-151-10-200911170-00008; Ciatto S, 2013, LANCET ONCOL, V14, P583, DOI 10.1016/S1470-2045(13)70134-7; Cook AJ, 2010, J CLIN EPIDEMIOL, V63, P441, DOI 10.1016/j.jclinepi.2009.06.008; Coopey SB, 2012, BREAST CANCER RES TR, V136, P627, DOI 10.1007/s10549-012-2318-8; D'Orsi CJ, 2003, BREAST IMAGING REPOR, P229; Diagnostic Imaging, 2015, BREAST DENS NOT LAWS; Dittus K, 2013, J GEN INTERN MED, V28, P1454, DOI 10.1007/s11606-013-2507-0; Friedewald SM, 2014, JAMA-J AM MED ASSOC, V311, P2499, DOI 10.1001/jama.2014.6095; Henderson LM, 2015, AM J ROENTGENOL, V205, P676, DOI 10.2214/AJR.14.13904; Hofvind S, 2012, BRIT J RADIOL, V85, pE1226, DOI 10.1259/bjr/15168178; Huang ZP, 1997, JAMA-J AM MED ASSOC, V278, P1407, DOI 10.1001/jama.278.17.1407; Hubbard RA, 2011, ANN INTERN MED, V155, P481, DOI 10.7326/0003-4819-155-8-201110180-00004; Hubbard RA, 2010, STAT METHODS MED RES, V19, P429, DOI 10.1177/0962280209359842; Jacobsen KK, 2015, INT J CANCER, V137, P2198, DOI 10.1002/ijc.29593; Jacobsen KK, 2015, CANCER EPIDEMIOL, V39, P656, DOI 10.1016/j.canep.2015.05.004; Kerlikowske K, 2003, J CLIN ONCOL, V21, P4314, DOI 10.1200/JCO.2003.05.151; Kerlikowske K, 2015, ANN INTERN MED, V162, P673, DOI 10.7326/M14-1465; Kerlikowske K, 2013, JAMA INTERN MED, V173, P807, DOI 10.1001/jamainternmed.2013.307; Kerlikowske K, 2011, ANN INTERN MED, V155, P493, DOI 10.7326/0003-4819-155-8-201110180-00005; Lee CI, 2015, RADIOLOGY, V274, P772, DOI 10.1148/radiol.14141237; Lee CI, 2013, J AM COLL RADIOL, V10, P913, DOI 10.1016/j.jacr.2013.09.010; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Moskowitz CS, 2014, J CLIN ONCOL, V32, P2217, DOI 10.1200/JCO.2013.54.4601; National Cancer Institute, 2009, BCSC GLOSS TERMS; National Cancer Institute, 2004, NIH PUBLICATION, V04-5490; National Cancer Institute, 2012, MAMM; National Comprehensive Cancer Network, 2014, NCCN CLIN PRACT GUID; Nelson HD, 2015, 1405201EF1 AHRQ; Nelson HD, 2014, ANN INTERN MED, V160, P255, DOI 10.7326/M13-1684; Nelson HD, 2012, ANN INTERN MED, V157, P104, DOI 10.7326/0003-4819-157-2-201207170-00466; Nelson HD, 2012, ANN INTERN MED, V156, P635, DOI 10.7326/0003-4819-156-9-201205010-00006; Nelson HD, 2009, ANN INTERN MED, V151, P727, DOI 10.7326/0003-4819-151-10-200911170-00009; O'Meara ES, 2013, CANCER-AM CANCER SOC, V119, P3959, DOI 10.1002/cncr.28310; Pharoah PDP, 1997, INT J CANCER, V71, P800, DOI 10.1002/(SICI)1097-0215(19970529)71:5<800::AID-IJC18>3.3.CO;2-R; Rosenberg RD, 2006, RADIOLOGY, V241, P55, DOI 10.1148/radiol.2411051504; Skaane P, 2013, RADIOLOGY, V267, P47, DOI 10.1148/radiol.12121373; Tice JA, 2008, ANN INTERN MED, V148, P337, DOI 10.7326/0003-4819-148-5-200803040-00004; Tice JA, 2013, JNCI-J NATL CANCER I, V105, P1043, DOI 10.1093/jnci/djt124	42	99	101	0	15	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 16	2016	164	4					226	+		10.7326/M15-0971	http://dx.doi.org/10.7326/M15-0971			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DD7WK	26756902	Green Accepted			2022-12-28	WOS:000370135300013
J	Nelson, HD; Pappas, M; Cantor, A; Griffin, J; Daeges, M; Humphrey, L				Nelson, Heidi D.; Pappas, Miranda; Cantor, Amy; Griffin, Jessica; Daeges, Monica; Humphrey, Linda			Harms of Breast Cancer Screening: Systematic Review to Update the 2009 US Preventive Services Task Force Recommendation	ANNALS OF INTERNAL MEDICINE			English	Review							FALSE-POSITIVE MAMMOGRAPHY; QUALITY-OF-LIFE; WOMEN AGED 40; DIGITAL MAMMOGRAPHY; FOLLOW-UP; PSYCHOLOGICAL CONSEQUENCES; REPEAT PARTICIPATION; RANDOMIZED-TRIAL; RE-ATTENDANCE; SHORT-TERM	Background: In 2009, the U.S. Preventive Services Tasic Force recommended biennial mammography screening for women aged 50 to 74 years and selective screening for those aged 40 to 49 years. Purpose: To review studies of screening in average-risk women with mammography, magnetic resonance imaging, or ultrasonography that reported on false-positive results, overdiagnosis, anxiety, pain, and radiation exposure. Data Sources: MEDLINE and Cochrane databases through December 2014, Study Selection: English-language systematic reviews, randomized trials, and observational studies of screening. Data Extraction: Investigators extracted and confirmed data from studies and dual-rated study quality. Discrepancies were resolved through consensus. Data Synthesis: Based on 2 studies of U.S. data, 10-year cumulative rates of false-positive mammography results and biopsies were higher with annual than biennial screening (61% vs. 42% and 7% vs. 5%, respectively) and for women aged 40 to 49 years, those with dense breasts, and those using combination hormone therapy. Twenty-nine studies using different methods reported overdiagnosis rates of 0% to 54%; rates from randomized trials were 11% to 22%. Women with false-positive results re-ported more anxiety, distress, and breast cancer-specific worry, although results varied across 80 observational studies. Thirtynine observational studies indicated that some women reported pain during mammography (1% to 77%); of these, 11% to 46% declined future screening. Models estimated 2 to 11 screening related deaths from radiation-induced cancer per 100 000 women using digital mammography, depending on age and screening interval. Five observational studies of tomosynthesis and mammography indicated increased biopsies but reduced recalls compared with mammography alone. Limitations: Studies of overdiagnosis were highly heterogeneous, and estimates varied depending on the analytic approach. Studies of anxiety and pain used different outcome measures. Radiation exposure was based on models. Conclusion: False-positive results are common and are higher for annual screening, younger women, and women with dense breasts. Although overdiagnosis, anxiety, pain, and radiation exposure may cause harm, their effects on individual women are difficult to estimate and vary widely.	[Nelson, Heidi D.; Pappas, Miranda; Cantor, Amy; Griffin, Jessica; Daeges, Monica; Humphrey, Linda] Oregon Hlth & Sci Univ, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA	Oregon Health & Science University	Nelson, HD (corresponding author), Oregon Hlth & Sci Univ, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	nelsonh@ohsu.edu		Cantor, Amy/0000-0002-4467-8484	Agency for Healthcare Research and Quality	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Agency for Healthcare Research and Quality.	Alimoglu Emel, 2004, Tani Girisim Radyol, V10, P213; Armstrong K, 2007, ANN INTERN MED, V146, P516, DOI 10.7326/0003-4819-146-7-200704030-00008; Aro AR, 1996, EUR J CANCER, V32A, P1674, DOI 10.1016/0959-8049(96)00140-2; Aro AR, 2000, EUR J CANCER, V36, P1089, DOI 10.1016/S0959-8049(00)00065-4; Bennett IC, 1994, BREAST DIS, V7, P35; Biesheuvel C, 2007, LANCET ONCOL, V8, P1129, DOI 10.1016/S1470-2045(07)70380-7; Bleyer A, 2012, NEW ENGL J MED, V367, P1998, DOI 10.1056/NEJMoa1206809; Bond Mary, 2013, Evid Based Med, V18, P54, DOI 10.1136/eb-2012-100608; Bredal IS, 2013, EUR J CANCER, V49, P805, DOI 10.1016/j.ejca.2012.09.001; Brett J, 2005, PSYCHO-ONCOLOGY, V14, P917, DOI 10.1002/pon.904; Brett J, 1998, J PUBLIC HEALTH MED, V20, P396, DOI 10.1093/oxfordjournals.pubmed.a024793; Brett J, 2001, J PUBLIC HEALTH MED, V23, P292, DOI 10.1093/pubmed/23.4.292; Brewer NT, 2007, ANN INTERN MED, V146, P502, DOI 10.7326/0003-4819-146-7-200704030-00006; Brodersen J, 2013, ANN FAM MED, V11, P106, DOI 10.1370/afm.1466; Calonge N, 2009, ANN INTERN MED, V151, P716, DOI 10.7326/0003-4819-151-10-200911170-00008; Chiarelli AM, 2009, JNCI-J NATL CANCER I, V101, P1236, DOI 10.1093/jnci/djp241; Ciatto S, 2013, LANCET ONCOL, V14, P583, DOI 10.1016/S1470-2045(13)70134-7; Cockburn J, 1994, J Med Screen, V1, P7; Coldman A, 2013, CAN MED ASSOC J, V185, pE492, DOI 10.1503/cmaj.121791; de Gelder R, 2011, PREV MED, V53, P134, DOI 10.1016/j.ypmed.2011.06.009; de Gelder R, 2011, EPIDEMIOL REV, V33, P111, DOI 10.1093/epirev/mxr009; Dibble SL, 2005, WOMEN HEALTH ISS, V15, P55, DOI 10.1016/j.whi.2004.12.001; Donella P, 2009, EUR J CANCER, V45, P3166, DOI 10.1016/j.ejca.2009.06.014; Drossaert CHC, 2002, J MED SCREEN, V9, P168, DOI 10.1136/jms.9.4.168; Drossaert CHC, 1996, PATIENT EDUC COUNS, V28, P121, DOI 10.1016/0738-3991(96)00889-0; Drossaert CHC, 2001, J MED SCREEN, V8, P204, DOI 10.1136/jms.8.4.204; Duffy SW, 2008, BRIT J CANCER, V99, P1176, DOI 10.1038/sj.bjc.6604638; Duffy SW, 2010, J MED SCREEN, V17, P25, DOI 10.1258/jms.2009.009094; Dullum JR, 2000, RADIOLOGY, V214, P547, DOI 10.1148/radiology.214.2.r00fe23547; Ekeberg O, 2001, BREAST, V10, P20, DOI 10.1054/brst.2000.0177; Elmore G, 1998, NEW ENGL J MED, V338, P1089, DOI 10.1056/NEJM199804163381601; Espasa R, 2012, J CANCER EDUC, V27, P780, DOI 10.1007/s13187-012-0349-9; Etzioni R, 2013, ANN INTERN MED, V158, P831, DOI 10.7326/0003-4819-158-11-201306040-00008; Falk RS, 2013, INT J CANCER, V133, P705, DOI 10.1002/ijc.28052; Fitzpatrick P, 2011, J MED SCREEN, V18, P30, DOI 10.1258/jms.2010.010104; Friedewald SM, 2014, JAMA-J AM MED ASSOC, V311, P2499, DOI 10.1001/jama.2014.6095; Gibson CJ, 2009, J PUBLIC HEALTH-UK, V31, P554, DOI 10.1093/pubmed/fdp064; Gilbert FJ, 1998, EUR J CANCER, V34, P2010, DOI 10.1016/S0959-8049(98)00294-9; GRAM IT, 1990, BRIT J CANCER, V62, P1018, DOI 10.1038/bjc.1990.430; Gunsoy NB, 2014, BRIT J CANCER, V110, P2412, DOI 10.1038/bjc.2014.206; Haas BM, 2013, RADIOLOGY, V269, P694, DOI 10.1148/radiol.13130307; Hafslund B, 2012, CANCER NURS, V35, pE26, DOI 10.1097/NCC.0b013e3182341ddb; Hafslund B, 2009, SCAND J CARING SCI, V23, P539, DOI 10.1111/j.1471-6712.2008.00634.x; Harris RP, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(01)00261-6; Hellquist BN, 2012, J MED SCREEN, V19, P14, DOI 10.1258/jms.2012.011104; Hendrick RE, 2010, RADIOLOGY, V257, P246, DOI 10.1148/radiol.10100570; Hislop TG, 2002, BREAST CANCER RES TR, V76, P245, DOI 10.1023/A:1020820103126; Hubbard RA, 2011, ANN INTERN MED, V155, P481, DOI 10.7326/0003-4819-155-8-201110180-00004; Jorgensen Karsten J, 2009, BMC Womens Health, V9, P36, DOI 10.1186/1472-6874-9-36; Kalager M, 2012, ANN INTERN MED, V156, P491, DOI 10.7326/0003-4819-156-7-201204030-00005; Kerlikowske K, 2013, JAMA INTERN MED, V173, P807, DOI 10.1001/jamainternmed.2013.307; Keyzer-Dekker CMG, 2012, BREAST, V21, P83, DOI 10.1016/j.breast.2011.08.137; Klompenhouwer EG, 2014, BREAST CANCER RES TR, V145, P429, DOI 10.1007/s10549-014-2959-x; KORNGUTH PJ, 1993, RADIOLOGY, V186, P99, DOI 10.1148/radiology.186.1.8416595; Lambertz CK, 1998, PREMEDICATION ACETAM; Lampic C, 2003, EUR J CANCER, V39, P1730, DOI 10.1016/S0959-8049(02)00451-3; Lampic C, 2001, EUR J CANCER, V37, P463, DOI 10.1016/S0959-8049(00)00426-3; LERMAN C, 1991, ANN INTERN MED, V114, P657, DOI 10.7326/0003-4819-114-8-657; LIDBRINK E, 1995, EUR J CANCER, V31A, P932, DOI 10.1016/0959-8049(95)00017-8; Lowe JB, 1999, CANCER, V85, P1114, DOI 10.1002/(SICI)1097-0142(19990301)85:5<1114::AID-CNCR15>3.0.CO;2-Y; Marmot MG, 2013, BRIT J CANCER, V108, P2205, DOI 10.1038/bjc.2013.177; Marmot MG, 2012, LANCET, V380, P1778, DOI 10.1016/S0140-6736(12)61611-0; Martinez-Alonso M, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2620; Maxwell AJ, 2013, J MED SCREEN, V20, P91, DOI 10.1177/0969141313499147; McCann J, 2002, BREAST CANCER RES, V4, DOI 10.1186/bcr455; Meldrum P, 1994, J Med Screen, V1, P245; Melnikow J, 2015, AHRQ PUBLICATION; Miller AB, 2000, JNCI-J NATL CANCER I, V92, P1490, DOI 10.1093/jnci/92.18.1490; Miller AB, 2002, ANN INTERN MED, V137, P305, DOI 10.7326/0003-4819-137-5_Part_1-200209030-00005; Miller AB, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g366; Miller D, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002942.pub2; Morrell S, 2010, CANCER CAUSE CONTROL, V21, P275, DOI 10.1007/s10552-009-9459-z; Nelson HD, 2015, AHRQ PUBLICATION; Nelson HD., 2014, AHRQ PUBLICATION; Nelson HD, 2012, ANN INTERN MED, V156, P635, DOI 10.7326/0003-4819-156-9-201205010-00006; Nelson HD, 2009, ANN INTERN MED, V151, P727, DOI 10.7326/0003-4819-151-10-200911170-00009; Njor SH, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1064; O'Sullivan I, 2001, J MED SCREEN, V8, P145, DOI 10.1136/jms.8.3.145; Ong G, 1997, J Med Screen, V4, P158; ORTON M, 1991, BRIT J GEN PRACT, V41, P320; Papas MA, 2005, J COMMUN HEALTH, V30, P253, DOI 10.1007/s10900-005-3704-5; Poulos A, 1997, Australas Radiol, V41, P247, DOI 10.1111/j.1440-1673.1997.tb00668.x; Puliti D, 2012, J MED SCREEN, V19, P42, DOI 10.1258/jms.2012.012082; Rose SL, 2013, AM J ROENTGENOL, V200, P1401, DOI 10.2214/AJR.12.9672; Rutter DR, 1997, BREAST, V6, P120, DOI 10.1016/S0960-9776(97)90551-8; Sandin B, 2002, J PSYCHOSOM RES, V52, P303, DOI 10.1016/S0022-3999(01)00227-6; Seigneurin A, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d7017; Shrestha S, 2001, RADIOGRAPHY, V7, P271, DOI DOI 10.1053/RADI.2001.0344; Sjolin M, 1994, Vard Nord Utveckl Forsk, V14, P11; Skaane P, 2013, RADIOLOGY, V267, P47, DOI 10.1148/radiol.12121373; Tosteson ANA, 2014, JAMA INTERN MED, V174, P954, DOI 10.1001/jamainternmed.2014.981; U. S. Preventive Services Task Force, 2011, PROC MAN; Whelehan P, 2013, BREAST, V22, P389, DOI 10.1016/j.breast.2013.03.003; Yaffe MJ, 2011, RADIOLOGY, V258, P98, DOI 10.1148/radiol.10100655; Yen AMF, 2012, CANCER-AM CANCER SOC, V118, P5728, DOI 10.1002/cncr.27580; Zackrisson S, 2006, BRIT MED J, V332, P689, DOI 10.1136/bmj.38764.572569.7C; Zahl Per-Henrik, 2012, Tidsskr Nor Laegeforen, V132, P414, DOI 10.4045/tidsskr.11.0195	97	217	224	3	44	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 16	2016	164	4					256	+		10.7326/M15-0970	http://dx.doi.org/10.7326/M15-0970			21	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DD7WK	26756737				2022-12-28	WOS:000370135300016
J	Hamilton, NB; Kolodziejczyk, K; Kougioumtzidou, E; Attwell, D				Hamilton, Nicola B.; Kolodziejczyk, Karolina; Kougioumtzidou, Eleni; Attwell, David			Proton-gated Ca2+-permeable TRP channels damage myelin in conditions mimicking ischaemia	NATURE			English	Article							WHITE-MATTER; NMDA RECEPTORS; NEURONAL DEATH; GLIAL-CELLS; GLUTAMATE; INJURY; CALCIUM; HYPOXIA; OLIGODENDROCYTES; DEPOLARIZATION	The myelin sheaths wrapped around axons by oligodendrocytes are crucial for brain function. In ischaemia myelin is damaged in a Ca2+-dependent manner, abolishing action potential propagation(1,2). This has been attributed to glutamate release activating Ca2+-permeable N-methyl-d-aspartate (NMDA) receptors(2-4). Surprisingly, we now show that NMDA does not raise the intracellular Ca2+ concentration ([Ca2+](i)) in mature oligodendrocytes and that, although ischaemia evokes a glutamate-triggered membrane current(4), this is generated by a rise of extracellular [K+] and decrease of membrane K+ conductance. Nevertheless, ischaemia raises oligodendrocyte [Ca2+](i), [Mg2+](i) and [H+](i), and buffering intracellular pH reduces the [Ca2+](i) and [Mg2+](i) increases, showing that these are evoked by the rise of [H+](i). The H+-gated [Ca2+](i) elevation is mediated by channels with characteristics of TRPA1, being inhibited by ruthenium red, isopentenyl pyrophosphate, HC-030031, A967079 or TRPA1 knockout. TRPA1 block reduces myelin damage in ischaemia. These data suggest that TRPA1-containing ion channels could be a therapeutic target in white matter ischaemia.	[Hamilton, Nicola B.; Kolodziejczyk, Karolina; Kougioumtzidou, Eleni; Attwell, David] UCL, Dept Neurosci Physiol & Pharmacol, Gower St, London WC1E 6BT, England; [Kolodziejczyk, Karolina] Univ British Columbia, Dept Psychiat, 2255 Wesbrook Mall, Vancouver, BC V6T 1Z3, Canada	University of London; University College London; University of British Columbia	Hamilton, NB; Attwell, D (corresponding author), UCL, Dept Neurosci Physiol & Pharmacol, Gower St, London WC1E 6BT, England.	nicola.hamilton-whitaker@ucl.ac.uk; d.attwell@ucl.ac.uk	Hamilton-Whitaker, Nicola/H-8867-2012; Attwell, David/ABE-6750-2020	Hamilton-Whitaker, Nicola/0000-0002-0168-8068; 	Wellcome Trust; ERC Advanced Investigator Award; EU (Leukotreat)	Wellcome Trust(Wellcome Trust); ERC Advanced Investigator Award; EU (Leukotreat)	Supported by a Wellcome Trust Programme Grant and Senior Investigator Award, an ERC Advanced Investigator Award, and the EU (Leukotreat). We thank P. Marcaggi for help with ion-sensitive electrodes, and J. Sexton and J. Wood for knockout mice. K. Kolodziejczyk was in the 4 year PhD Programme in Neuroscience at UCL. We thank L. Arancibia-Carcamo, M. Ford, A. Gibb, R. Jolivet, J. Kittler, M. Sajic, A. Silver and K. Smith for comments on the manuscript.	Aarts M, 2003, CELL, V115, P863, DOI 10.1016/S0092-8674(03)01017-1; Agrawal SK, 1997, J NEUROSCI, V17, P1055; Allen NJ, 2005, J NEUROSCI, V25, P848, DOI 10.1523/JNEUROSCI.4157-04.2005; Back SA, 2007, J CEREBR BLOOD F MET, V27, P334, DOI 10.1038/sj.jcbfm.9600344; Bakiri Y, 2008, GLIA, V56, P233, DOI 10.1002/glia.20608; Bang S, 2011, PAIN, V152, P1156, DOI 10.1016/j.pain.2011.01.044; Butenko O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039959; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Cao X, 2012, J BIOL CHEM, V287, P25905, DOI 10.1074/jbc.M112.364869; Chen J, 2011, PAIN, V152, P1165, DOI 10.1016/j.pain.2011.01.049; Clapham DE, 2007, CELL, V129, P220, DOI 10.1016/j.cell.2007.03.034; Davies AL, 2013, ANN NEUROL, V74, P815, DOI 10.1002/ana.24006; De Biase LM, 2010, J NEUROSCI, V30, P3600, DOI 10.1523/JNEUROSCI.6000-09.2010; Hamann M, 2005, BRAIN, V128, P2408, DOI 10.1093/brain/awh619; Hamilton N, 2008, GLIA, V56, P734, DOI 10.1002/glia.20649; Karadottir R, 2005, NATURE, V438, P1162, DOI 10.1038/nature04302; Keynes RG, 2003, BIOCHEM J, V369, P399, DOI 10.1042/BJ20020933; Kukley M, 2010, J NEUROSCI, V30, P8320, DOI 10.1523/JNEUROSCI.0854-10.2010; Lesage F, 1996, EMBO J, V15, P1004, DOI 10.1002/j.1460-2075.1996.tb00437.x; Li S, 1999, J Neurosci, V19, pRC16; Limbrick DD, 2003, CELL CALCIUM, V33, P69, DOI 10.1016/S0143-4160(02)00054-4; Lundgaard I, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001743; Marcaggi P, 2004, EUR J NEUROSCI, V19, P966, DOI 10.1111/j.0953-816X.2004.03165.x; McCarran WJ, 2007, J NEUROSCI, V27, P4220, DOI 10.1523/JNEUROSCI.5542-06.2007; McNamara CR, 2007, P NATL ACAD SCI USA, V104, P13525, DOI 10.1073/pnas.0705924104; Micu I, 2006, NATURE, V439, P988, DOI 10.1038/nature04474; Nilius B, 2014, PHARMACOL REV, V66, P676, DOI 10.1124/pr.113.008268; Rossi DJ, 2000, NATURE, V403, P316, DOI 10.1038/35002090; Salter MG, 2005, NATURE, V438, P1167, DOI 10.1038/nature04301; Sarrafzadeh AS, 2003, BRIT J NEUROSURG, V17, P340, DOI 10.1080/02688690310001601234; STYS PK, 1990, P NATL ACAD SCI USA, V87, P4212, DOI 10.1073/pnas.87.11.4212; Wang YYY, 2010, J NEUROSCI, V30, P12958, DOI 10.1523/JNEUROSCI.2715-10.2010; Yuan XQ, 1998, DEVELOPMENT, V125, P2901	33	101	108	2	31	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 28	2016	529	7587					523	+		10.1038/nature16519	http://dx.doi.org/10.1038/nature16519			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB7DD	26760212	Green Accepted, Bronze, Green Submitted			2022-12-28	WOS:000368673800036
J	Chi, KR				Chi, Kelly Rae			FINDING FUNCTION IN MYSTERY TRANSCRIPTS	NATURE			English	Editorial Material							NONCODING RNA											Au KF, 2013, P NATL ACAD SCI USA, V110, pE4821, DOI 10.1073/pnas.1320101110; Cabili MN, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0586-4; Chu C, 2015, CELL, V161, P404, DOI 10.1016/j.cell.2015.03.025; Durruthy-Durruthy J, 2016, NAT GENET, V48, P44, DOI 10.1038/ng.3449; Hangauer MJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003569; Jinek M, 2014, SCIENCE, V343, P1215, DOI 10.1126/science.1247997; McHugh CA, 2015, NATURE, V521, P232, DOI 10.1038/nature14443; Minajigi A, 2015, SCIENCE, V349, DOI [10.1126/science.aab2276, 10.1126/science.aab2276 aab2276]; Novikova IV, 2012, NUCLEIC ACIDS RES, V40, P5034, DOI 10.1093/nar/gks071; Spitale RC, 2013, NAT CHEM BIOL, V9, P18, DOI [10.1038/NCHEMBIO.1131, 10.1038/nchembio.1131]	10	4	4	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 21	2016	529	7586					423	425		10.1038/529423a	http://dx.doi.org/10.1038/529423a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB2QT	26791729	Bronze			2022-12-28	WOS:000368354800052
J	Ditkofsky, N; Hanna, T				Ditkofsky, Noah; Hanna, Tarek			Spontaneous Retropharyngeal Hematoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Ditkofsky, Noah] Univ Toronto, Toronto, ON, Canada; [Hanna, Tarek] Emory Univ, Atlanta, GA 30322 USA	University of Toronto; Emory University	Ditkofsky, N (corresponding author), Univ Toronto, Toronto, ON, Canada.	noah.ditkofsky@sunnybrook.ca	Ditkofsky, Noah/AAE-7817-2021	Ditkofsky, Noah/0000-0002-5851-8166; Hanna, Tarek/0000-0002-8906-6182					0	3	3	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 21	2016	374	3					E3	E3		10.1056/NEJMicm1505596	http://dx.doi.org/10.1056/NEJMicm1505596			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DB3IS	26789902				2022-12-28	WOS:000368404800001
J	Longo, DL; Drazen, JM				Longo, Dan L.; Drazen, Jeffrey M.			Data Sharing	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		Dalerba P, 2016, NEW ENGL J MED, V374, P211, DOI 10.1056/NEJMoa1506597	1	238	240	1	32	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 21	2016	374	3					276	277		10.1056/NEJMe1516564	http://dx.doi.org/10.1056/NEJMe1516564			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DB3IS	26789876	Bronze			2022-12-28	WOS:000368404800013
J	Powers, BW; Chaguturu, SK				Powers, Brian W.; Chaguturu, Sreekanth K.			ACOs and High-Cost Patients	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Powers, Brian W.; Chaguturu, Sreekanth K.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Powers, Brian W.] Harvard Univ, Sch Business, Boston, MA 02115 USA; [Chaguturu, Sreekanth K.] Partners HealthCare, Boston, MA USA; [Chaguturu, Sreekanth K.] Massachusetts Gen Hosp, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Harvard University; Partners Healthcare System; Harvard University; Massachusetts General Hospital	Powers, BW (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.							Brown RS, 2012, HEALTH AFFAIR, V31, P1156, DOI 10.1377/hlthaff.2012.0393; Coughlin TA, 2009, INQUIRY-J HEALTH CAR, V46, P405, DOI 10.5034/inquiryjrnl_46.4.405; Druss BG, 2011, 21 RW JOHNS FDN; Hong CS, 2014, NEW ENGL J MED, V371, P491, DOI 10.1056/NEJMp1401755	4	36	36	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 21	2016	374	3					203	205		10.1056/NEJMp1511131	http://dx.doi.org/10.1056/NEJMp1511131			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DB3IS	26789867				2022-12-28	WOS:000368404800003
J	Prasad, V; Lenzer, J; Newman, DH				Prasad, Vinay; Lenzer, Jeanne; Newman, David H.			Why cancer screening has never been shown to "save lives"-and what we can do about it	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							LUNG-CANCER; PROSTATE-CANCER; MORTALITY; TRIALS; BENEFITS; MAMMOGRAPHY; PROGRAMS; BREAST; HARMS; DEATHS		[Prasad, Vinay] Oregon Hlth & Sci Univ, Div Hematol & Med Oncol, Knight Canc Inst, Portland, OR 97239 USA; [Newman, David H.] Icahn Sch Med Mt Sinai, Dept Emergency Med, New York, NY 10029 USA	Oregon Health & Science University; Icahn School of Medicine at Mount Sinai	Prasad, V (corresponding author), Oregon Hlth & Sci Univ, Div Hematol & Med Oncol, Knight Canc Inst, Portland, OR 97239 USA.	prasad@ohsu.edu						Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Bach PB, 2012, ANN INTERN MED, V157, P571, DOI 10.7326/0003-4819-157-8-201210160-00524; Baker Stuart G, 2002, BMC Med Res Methodol, V2, P11, DOI 10.1186/1471-2288-2-11; Bell KJL, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1566; Benard VB, 2014, MMWR-MORBID MORTAL W, V63, P1004; Biller-Andorno N, 2014, NEW ENGL J MED, V370, P1965, DOI 10.1056/NEJMp1401875; Birnbaum JK, 2015, CANCER EPIDEM BIOMAR, V24, P677, DOI 10.1158/1055-9965.EPI-14-1224; Black WC, 2002, JNCI-J NATL CANCER I, V94, P167, DOI 10.1093/jnci/94.3.167; Bleyer A, 2012, NEW ENGL J MED, V367, P1998, DOI 10.1056/NEJMoa1206809; Brawley OW, 2005, J CLIN ONCOL, V23, P293, DOI 10.1200/JCO.2005.06.107; Brodersen J, 2013, ANN FAM MED, V11, P106, DOI 10.1370/afm.1466; Chou R, 2011, ANN INTERN MED, V155, P762, DOI 10.7326/0003-4819-155-11-201112060-00375; Domenighetti G, 2003, INT J EPIDEMIOL, V32, P816, DOI 10.1093/ije/dyg257; Doshi P, 2014, BMJ-BRIT MED J, V2014, P348, DOI 10.1136; Doshi P, 2013, TRENDS PHARMACOL SCI, V34, P645, DOI 10.1016/j.tips.2013.10.006; Doshi P, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2865; Esserman LJ, 2013, JAMA-J AM MED ASSOC, V310, P797, DOI 10.1001/jama.2013.108415; Fall K, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000197; Fang F, 2010, JNCI-J NATL CANCER I, V102, P307, DOI 10.1093/jnci/djp537; Gallina A, 2008, INT J CANCER, V123, P647, DOI 10.1002/ijc.23559; Gotzsche PC, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001877.pub5; Haines IE, 2013, JNCI-J NATL CANCER I, V105, P1534, DOI 10.1093/jnci/djt248; Heleno B, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5334; Hersch J, 2014, BMJ OPEN, V4, DOI [10.1136/bmjopen-2014-004990, 10.1136/bmjopen-2014-006016]; Hoffmann TC, 2015, JAMA INTERN MED, V175, P274, DOI 10.1001/jamainternmed.2014.6016; Humphrey L, 2013, SCREENING LUNG CANC; Hunt Ian, 2006, Interact Cardiovasc Thorac Surg, V5, P483, DOI 10.1510/icvts.2006.130518; Ilic D, 2011, BJU INT, V107, P882, DOI 10.1111/j.1464-410X.2010.10032.x; Johansson M, 2015, LANCET, V385, P1597, DOI 10.1016/S0140-6736(15)60258-6; Jorgensen KJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2587; Juffs HG, 2002, J NATL CANCER I, V94, P156; Kopans DB, 2014, WALL STREET J; Lauer MS, 2013, NEW ENGL J MED, V369, P1579, DOI 10.1056/NEJMp1310102; Loeb S, 2011, J UROLOGY, V186, P1830, DOI 10.1016/j.juro.2011.06.057; Ma JM, 2013, CANCER-AM CANCER SOC, V119, P1381, DOI 10.1002/cncr.27813; Manser RL, 2003, THORAX, V58, P784, DOI 10.1136/thorax.58.9.784; Marcus PM, 2000, J NATL CANCER I, V92, P1308, DOI 10.1093/jnci/92.16.1308; Moayyedi P, 2006, AM J GASTROENTEROL, V101, P380, DOI 10.1111/j.1572-0241.2006.00537.x; Neugut AI, 2010, JAMA-J AM MED ASSOC, V304, P461, DOI 10.1001/jama.2010.1001; Newman DH, 2010, JNCI-J NATL CANCER I, V102, P1008, DOI 10.1093/jnci/djq190; Pace LE, 2014, JAMA-J AM MED ASSOC, V311, P1327, DOI 10.1001/jama.2014.1398; Patz EF, 2014, JAMA INTERN MED, V174, P269, DOI 10.1001/jamainternmed.2013.12738; Prasad V, 2014, CLEV CLIN J MED, V82, P146, DOI 10.3949/ccjm.82a.14058; Prasad Vinay, 2013, Ecancermedicalscience, V7, ped27, DOI 10.3332/ecancer.2013.ed27; Prasad V, 2013, MAYO CLIN PROC, V88, P790, DOI 10.1016/j.mayocp.2013.05.012; Roth JA, 2015, J ONCOL PRACT, V11, P267, DOI 10.1200/JOP.2014.002600; Saghir Z, 2012, THORAX, V67, P296, DOI 10.1136/thoraxjnl-2011-200736; Saquib N, 2015, INT J EPIDEMIOL, V44, P264, DOI 10.1093/ije/dyu140; Shaukat A, 2013, NEW ENGL J MED, V369, P1106, DOI 10.1056/NEJMoa1300720; Tsubono Y, 2004, NEW ENGL J MED, V350, P2010, DOI 10.1056/NEJM200405063501922; Woloshin S, 2012, NEW ENGL J MED, V367, P1677, DOI 10.1056/NEJMp1209407; Zahl PH, 2013, BRIT J CANCER, V109, P2014, DOI 10.1038/bjc.2013.427; Zhu CS, 2013, JNCI-J NATL CANCER I, V105, P1684, DOI 10.1093/jnci/djt281	53	64	66	1	127	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 6	2016	352								h6080	10.1136/bmj.h6080	http://dx.doi.org/10.1136/bmj.h6080			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DA8MO	26740343				2022-12-28	WOS:000368059200009
J	Sokol, DK				Sokol, Daniel K.			Cautionary tales about DNACPR	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material											Sokol, DK (corresponding author), 112 Kings Bench Walk, London, England.							Dreaper J., 2015, BBC NEWS; Dyer C, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g4094; Dyer C, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e7503; Fins J, 2006, PALLIATIVE ETHIC CAR; Varney M, 2015, LETS TALK DNRS	5	9	9	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 5	2016	352								i26	10.1136/bmj.i26	http://dx.doi.org/10.1136/bmj.i26			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DA8MA	26733107				2022-12-28	WOS:000368057800002
J	Hurtley, S; Roberts, L; Ray, LB; Purnell, BA; Ash, C				Hurtley, Stella; Roberts, Leslie; Ray, L. Bryan; Purnell, Beverly A.; Ash, Caroline			TOWARD HEALTHY AGING PUTTING OFF THE INEVITABLE	SCIENCE			English	Editorial Material																			0	0	0	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 4	2015	350	6265					1180	1181		10.1126/science.350.6265.1180	http://dx.doi.org/10.1126/science.350.6265.1180			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CX4WG	26785472				2022-12-28	WOS:000365700500058
J	Rosell, R; Karachaliou, N				Rosell, Rafael; Karachaliou, Niki			Large-scale screening for somatic mutations in lung cancer	LANCET			English	Editorial Material									[Rosell, Rafael] Hosp Badalona Germans Trias & Pujol, Catalan Inst Oncol, Badalona 08916, Spain; [Karachaliou, Niki] Autonomous Univ Barcelona, Germans Trias & Pujol Hlth Sci Res Inst & Hosp, Badalona, Spain	Catalan Institute of Oncology; Hospital Germans Trias i Pujol; Autonomous University of Barcelona	Rosell, R (corresponding author), Hosp Badalona Germans Trias & Pujol, Catalan Inst Oncol, Badalona 08916, Spain.	rrosell@iconcologia.net						Barlesi F., 2016, LANCET; Chen Z, 2014, NAT REV CANCER, V14, P535, DOI 10.1038/nrc3775; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; Gandara DR, 2015, CLIN CANCER RES, V21, P2236, DOI 10.1158/1078-0432.CCR-14-3039; Heist R. S., 2012, CANCER CELL, V21, p[448, e2], DOI DOI 10.1016/J.CCR.2012.03.007; Konig K, 2015, J THORAC ONCOL, V10, P1049, DOI 10.1097/JTO.0000000000000570; Kris MG, 2014, JAMA-J AM MED ASSOC, V311, P1998, DOI 10.1001/jama.2014.3741; Matsumoto S, 2014, J CLIN ONCOL S, V32, p5s; Paik PK, 2015, CANCER DISCOV, V5, P842, DOI 10.1158/2159-8290.CD-14-1467; Rose R, 2014, LANCET RESP MED, V2, P966, DOI 10.1016/S2213-2600(14)70259-0; Rosell R, 2013, LANCET, V382, P720, DOI 10.1016/S0140-6736(13)61715-8; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; Rosell R, 2009, NEW ENGL J MED, V361, P958, DOI 10.1056/NEJMoa0904554; Scheffler M, 2015, ONCOTARGET, V6, P1315, DOI 10.18632/oncotarget.2834; Seidel D, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006802	15	79	88	2	12	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 2	2016	387	10026					1354	1356		10.1016/S0140-6736(15)01125-3	http://dx.doi.org/10.1016/S0140-6736(15)01125-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DI0WH	26777918				2022-12-28	WOS:000373217500010
J	Psaltis, PJ; Nicholls, SJ				Psaltis, Peter J.; Nicholls, Stephen J.			Management of acute coronary syndrome in the very elderly	LANCET			English	Editorial Material							CONSERVATIVE TREATMENT; INVASIVE STRATEGY; OUTCOMES; AGE; OCTOGENARIANS; ROUTINE		[Psaltis, Peter J.] Univ Adelaide, Sch Med, Adelaide, SA, Australia; [Psaltis, Peter J.] South Australian Hlth & Med Res Inst, Vasc Res Ctr, Heart Hlth Theme, Adelaide, SA 5000, Australia	University of Adelaide; South Australian Health & Medical Research Institute (SAHMRI)	Psaltis, PJ (corresponding author), Univ Adelaide, Sch Med, Adelaide, SA, Australia.; Psaltis, PJ (corresponding author), South Australian Hlth & Med Res Inst, Vasc Res Ctr, Heart Hlth Theme, Adelaide, SA 5000, Australia.	peter.psaltis@sahmri.com		Nicholls, Stephen/0000-0002-9668-4368; Psaltis, Peter/0000-0003-0222-5468				Angeli F, 2014, CATHETER CARDIO INTE, V83, P686, DOI 10.1002/ccd.25307; Bach RG, 2004, ANN INTERN MED, V141, P186, DOI 10.7326/0003-4819-141-3-200408030-00007; Bagnall AJ, 2009, AM J CARDIOL, V103, P1530, DOI 10.1016/j.amjcard.2009.01.369; Damman P, 2012, HEART, V98, P207, DOI 10.1136/heartjnl-2011-300453; Devlin G, 2008, EUR HEART J, V29, P1275, DOI 10.1093/eurheartj/ehn124; Hamm CW, 2011, EUR HEART J, V32, P2999, DOI 10.1093/eurheartj/ehr236; Jaguszewski M, 2015, CLIN RES CARDIOL, V104, P51, DOI 10.1007/s00392-014-0756-5; Kolte D, 2013, AM J MED, V126, P1076, DOI 10.1016/j.amjmed.2013.07.024; Rosengren A, 2006, EUR HEART J, V27, P789, DOI 10.1093/eurheartj/ehi774; Savonitto S, 2012, JACC-CARDIOVASC INTE, V5, P906, DOI 10.1016/j.jcin.2012.06.008; Spoon DB, 2014, CIRCULATION, V129, P1286, DOI 10.1161/CIRCULATIONAHA.113.006518; Tegn N, 2016, LANCET	12	9	10	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 12	2016	387	10023					1029	1030		10.1016/S0140-6736(16)00036-2	http://dx.doi.org/10.1016/S0140-6736(16)00036-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DG0SD	26794723				2022-12-28	WOS:000371775000004
J	Greene, JA; Anderson, G; Sharfstein, JM				Greene, Jeremy A.; Anderson, Gerard; Sharfstein, Joshua M.			Role of the FDA in Affordability of Off-Patent Pharmaceuticals	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Greene, Jeremy A.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Greene, Jeremy A.] Johns Hopkins Univ, Sch Med, Inst Hist Med, Baltimore, MD USA; [Anderson, Gerard; Sharfstein, Joshua M.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Greene, JA (corresponding author), Inst Hist Med, 1900 E Monument St, Baltimore, MD 21215 USA.	greene@jhmi.edu						FDA, FY 2014 PERF REP PRE; FDA, 2012, DOX HYDR LIP INJ; Kindy Kimberly, 2013, WASHINGTON POST; Office of Generic Drugs Center for Drug Evaluation and Research FDA, 2014, POL PROC PRIOR REV O; Woodward C, 2012, CAN MED ASSOC J, V184, pE119, DOI 10.1503/cmaj.109-4081	5	24	24	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 2	2016	315	5					461	462		10.1001/jama.2015.18720	http://dx.doi.org/10.1001/jama.2015.18720			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DC2LZ	26747694				2022-12-28	WOS:000369049500012
J	Kleinstiver, BP; Pattanayak, V; Prew, MS; Tsai, SQ; Nguyen, NT; Zheng, ZL; Joung, JK				Kleinstiver, Benjamin P.; Pattanayak, Vikram; Prew, Michelle S.; Tsai, Shengdar Q.; Nguyen, Nhu T.; Zheng, Zongli; Joung, J. Keith			High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects	NATURE			English	Article							RNA-GUIDED ENDONUCLEASE; CRISPR/CAS9 SYSTEMS; DUAL-RNA; CAS9; DNA; SPECIFICITY; CLEAVAGE; TALENS; INTERROGATION; COMPLEX	CRISPR-Cas9 nucleases are widely used for genome editing but can induce unwanted off-target mutations. Existing strategies for reducing genome-wide off-target effects of the widely used Streptococcus pyogenes Cas9 (SpCas9) are imperfect, possessing only partial or unproven efficacies and other limitations that constrain their use. Here we describe SpCas9-HF1, a high-fidelity variant harbouring alterations designed to reduce non-specific DNA contacts. SpCas9-HF1 retains on-target activities comparable to wild-type SpCas9 with > 85% of single-guide RNAs (sgRNAs) tested in human cells. Notably, with sgRNAs targeted to standard non-repetitive sequences, SpCas9-HF1 rendered all or nearly all off-target events undetectable by genome-wide break capture and targeted sequencing methods. Even for atypical, repetitive target sites, the vast majority of off-target mutations induced by wild-type SpCas9 were not detected with SpCas9-HF1. With its exceptional precision, SpCas9-HF1 provides an alternative to wild-type SpCas9 for research and therapeutic applications. More broadly, our results suggest a general strategy for optimizing genome-wide specificities of other CRISPR-RNA-guided nucleases.	[Kleinstiver, Benjamin P.; Pattanayak, Vikram; Prew, Michelle S.; Tsai, Shengdar Q.; Nguyen, Nhu T.; Joung, J. Keith] Massachusetts Gen Hosp, Ctr Canc Res, Mol Pathol Unit, Charlestown, MA 02129 USA; [Kleinstiver, Benjamin P.; Pattanayak, Vikram; Prew, Michelle S.; Tsai, Shengdar Q.; Nguyen, Nhu T.; Joung, J. Keith] Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Charlestown, MA 02129 USA; [Kleinstiver, Benjamin P.; Pattanayak, Vikram; Tsai, Shengdar Q.; Joung, J. Keith] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Zheng, Zongli] City Univ Hong Kong, Dept Biomed Sci, Hong Kong, Hong Kong, Peoples R China	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; City University of Hong Kong	Joung, JK (corresponding author), Massachusetts Gen Hosp, Ctr Canc Res, Mol Pathol Unit, Charlestown, MA 02129 USA.; Joung, JK (corresponding author), Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Charlestown, MA 02129 USA.; Joung, JK (corresponding author), Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA.	jjoung@mgh.harvard.edu	Tsai, Shengdar Q./G-4600-2012; Huang, ZhiXin/H-5123-2017; Kleinstiver, Benjamin/K-4498-2014; zheng, zongli/C-7309-2008; Zheng, Zongli/B-2917-2011	Tsai, Shengdar Q./0000-0001-9161-3993; Huang, ZhiXin/0000-0003-0705-1970; Kleinstiver, Benjamin/0000-0002-5469-0655; Zheng, Zongli/0000-0003-4849-4903; Prew, Michelle/0000-0001-7247-3024	Natural Sciences and Engineering Research Council of Canada Postdoctoral Fellowship; Massachusetts General Hospital (MGH) Department of Pathology; MGH Tosteson; Fund for Medical Discovery Fellowship; US National Institutes of Health (NIH) Director's Pioneer Award [DP1 GM105378]; NIH [R01 GM107427, R01 GM088040]; Jim and Ann Orr MGH Research Scholar Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088040, DP1GM105378, R01GM107427] Funding Source: NIH RePORTER	Natural Sciences and Engineering Research Council of Canada Postdoctoral Fellowship(Natural Sciences and Engineering Research Council of Canada (NSERC)); Massachusetts General Hospital (MGH) Department of Pathology; MGH Tosteson; Fund for Medical Discovery Fellowship; US National Institutes of Health (NIH) Director's Pioneer Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jim and Ann Orr MGH Research Scholar Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	B.P.K. is supported by a Natural Sciences and Engineering Research Council of Canada Postdoctoral Fellowship. V.P. was supported by the Massachusetts General Hospital (MGH) Department of Pathology. S.Q.T. is supported by an MGH Tosteson and Fund for Medical Discovery Fellowship. J.K.J. is supported by a US National Institutes of Health (NIH) Director's Pioneer Award (DP1 GM105378), NIH R01 GM107427, NIH R01 GM088040, and the Jim and Ann Orr MGH Research Scholar Award.	Anders C, 2014, NATURE, V513, P569, DOI 10.1038/nature13579; Bae S, 2014, BIOINFORMATICS, V30, P1473, DOI 10.1093/bioinformatics/btu048; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cradick TJ, 2013, NUCLEIC ACIDS RES, V41, P9584, DOI 10.1093/nar/gkt714; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Esvelt KM, 2013, NAT METHODS, V10, P1116, DOI [10.1038/NMETH.2681, 10.1038/nmeth.2681]; Fonfara I, 2014, NUCLEIC ACIDS RES, V42, P2577, DOI 10.1093/nar/gkt1074; Frock RL, 2015, NAT BIOTECHNOL, V33, P179, DOI 10.1038/nbt.3101; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Guilinger JP, 2014, NAT BIOTECHNOL, V32, P577, DOI 10.1038/nbt.2909; Guilinger JP, 2014, NAT METHODS, V11, P429, DOI 10.1038/nmeth.2845; Hou ZG, 2013, P NATL ACAD SCI USA, V110, P15644, DOI 10.1073/pnas.1313587110; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jiang FG, 2015, SCIENCE, V348, P1477, DOI 10.1126/science.aab1452; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2014, SCIENCE, V343, P1215, DOI 10.1126/science.1247997; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kim D, 2015, NAT METHODS, V12, P237, DOI [10.1038/nmeth.3284, 10.1038/NMETH.3284]; Kleinstiver BP, 2015, NAT BIOTECHNOL, V33, P1293, DOI 10.1038/nbt.3404; Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592; Knight SC, 2015, SCIENCE, V350, P823, DOI 10.1126/science.aac6572; Lin YN, 2014, NUCLEIC ACIDS RES, V42, P7473, DOI 10.1093/nar/gku402; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Reyon D, 2012, NAT BIOTECHNOL, V30, P460, DOI 10.1038/nbt.2170; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Shmakov S, 2015, MOL CELL, V60, P385, DOI 10.1016/j.molcel.2015.10.008; Slaymaker I. M., 2015, SCIENCE; Sternberg SH, 2015, NATURE, V527, P110, DOI 10.1038/nature15544; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Tsai SQ, 2014, NAT BIOTECHNOL, V32, P569, DOI 10.1038/nbt.2908; Wang XL, 2015, NAT BIOTECHNOL, V33, P175, DOI 10.1038/nbt.3127; Wyvekens N, 2015, HUM GENE THER, V26, P425, DOI 10.1089/hum.2015.084; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038	45	1526	1741	18	762	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 28	2016	529	7587					490	+		10.1038/nature16526	http://dx.doi.org/10.1038/nature16526			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB7DD	26735016	Green Accepted, Green Submitted			2022-12-28	WOS:000368673800029
J	Shah, MR; Lauer, MS				Shah, Monica R.; Lauer, Michael S.			Striking the Right Balance in Heart Failure	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							ENALAPRIL; MORTALITY; MORBIDITY; SURVIVAL; TRIAL		[Shah, Monica R.] NHLBI, Div Cardiovasc Sci, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Shah, MR (corresponding author), NHLBI, Div Cardiovasc Sci, 6701 Rockledge Dr,Room 8174, Bethesda, MD 20892 USA.	shahmr@nhlbi.nih.gov						Braunwald E, 2015, J AM COLL CARDIOL, V65, P1029, DOI 10.1016/j.jacc.2015.01.033; Cheng RK, 2014, AM HEART J, V168, P721, DOI 10.1016/j.ahj.2014.07.008; Cohn JN, 2001, NEW ENGL J MED, V345, P1667, DOI 10.1056/NEJMoa010713; McMurray JJV, 2014, NEW ENGL J MED, V371, P993, DOI 10.1056/NEJMoa1409077; Moe GW, 2015, CAN J CARDIOL, V31, P3, DOI 10.1016/j.cjca.2014.10.022; Packer M, 1996, NEW ENGL J MED, V334, P1349, DOI 10.1056/NEJM199605233342101; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; SWEDBERG K, 1987, NEW ENGL J MED, V316, P1429; Vodovar N, 2015, JACC-HEART FAIL, V3, P629, DOI 10.1016/j.jchf.2015.03.011; YUSUF S, 1991, NEW ENGL J MED, V325, P293, DOI 10.1056/NEJM199108013250501	10	3	3	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 19	2016	164	2					125	+		10.7326/M15-2587	http://dx.doi.org/10.7326/M15-2587			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DB0CI	26720859				2022-12-28	WOS:000368175800018
J	Michelucci, P; Dickinson, JL				Michelucci, Pietro; Dickinson, Janis L.			The power of crowds	SCIENCE			English	Editorial Material									[Michelucci, Pietro] Human Computat Inst, Fairfax, VA 22032 USA; [Dickinson, Janis L.] Cornell Univ, Cornell Lab Ornithol, Ithaca, NY 14850 USA	Cornell University	Michelucci, P (corresponding author), Human Computat Inst, Fairfax, VA 22032 USA.	pem@humancomputation.org		Michelucci, Pietro/0000-0002-9819-7221				Luengo-Oroz MA, 2012, J MED INTERNET RES, V14, P207, DOI 10.2196/jmir.2338; Bowser A., 2015, HUMAN COMPUTATION, V2, P19, DOI 10.15346/hcv2i1.3; Easley David, 2015, P 16 ACM C EC COMP, P679; Giles J, 2005, NATURE, V438, P900, DOI 10.1038/438900a; Gowers T, 2009, NATURE, V461, P879, DOI 10.1038/461879a; Greene K., 2012, SECUR INFORM, V1, P12; Kim JS, 2014, NATURE, V509, P331, DOI 10.1038/nature13240; Lasecki W. S., 2014, HUM COMPUT, DOI 10.15346/hc.v1i1.29; Little G., 2009, P ACM SIGKDD WORKSH, P29, DOI DOI 10.1145/1600150.1600159; Luther K, 2015, PROCEEDINGS OF THE 2015 ACM INTERNATIONAL CONFERENCE ON COMPUTER-SUPPORTED COOPERATIVE WORK AND SOCIAL COMPUTING (CSCW'15), P473, DOI 10.1145/2675133.2675283; McDonald D.W., 2014, INTERACTIONS, V21, P72; Nickerson J., 2011, CHI WORKSH CROWDS HU, P1; Quinn A.J., 2011, P 29 INT C HUM FACT, P1403; von Ahn L., 2005, THESIS; von Ahn L, 2008, SCIENCE, V321, P1465, DOI 10.1126/science.1160379	15	78	90	2	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 1	2016	351	6268					32	33		10.1126/science.aad6499	http://dx.doi.org/10.1126/science.aad6499			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CZ8QM	26721991				2022-12-28	WOS:000367364200029
J	Amigo, I				Amigo, Ignacio			science made me a better parent	SCIENCE			English	Editorial Material									[Amigo, Ignacio] Univ Sao Paulo, Inst Chem, Dept Biochem, BR-05508 Sao Paulo, Brazil	Universidade de Sao Paulo	Amigo, I (corresponding author), Univ Sao Paulo, Inst Chem, Dept Biochem, BR-05508 Sao Paulo, Brazil.	SciCareerEditor@aaas.org							0	0	0	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 4	2015	350	6265					1286	1286		10.1126/science.350.6265.1286	http://dx.doi.org/10.1126/science.350.6265.1286			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CX4WG	26785493				2022-12-28	WOS:000365700500083
J	Ettehad, D; Emdin, CA; Kiran, A; Anderson, SG; Callender, T; Emberson, J; Chalmers, J; Rodgers, A; Rahimi, K				Ettehad, Dena; Emdin, Connor A.; Kiran, Amit; Anderson, Simon G.; Callender, Thomas; Emberson, Jonathan; Chalmers, John; Rodgers, Anthony; Rahimi, Kazem			Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis	LANCET			English	Review							PROSPECTIVELY-DESIGNED OVERVIEWS; TYPE-2 DIABETES-MELLITUS; CHRONIC KIDNEY-DISEASE; HEART-FAILURE; HIGH-RISK; MILD HYPERTENSION; OUTCOME INCIDENCE; ACTIVE TREATMENT; TRIAL; MORTALITY	Background The benefits of blood pressure lowering treatment for prevention of cardiovascular disease are well established. However, the extent to which these effects differ by baseline blood pressure, presence of comorbidities, or drug class is less clear. We therefore performed a systematic review and meta-analysis to clarify these differences. Method For this systematic review and meta-analysis, we searched MEDLINE for large-scale blood pressure lowering trials, published between Jan 1, 1966, and July 7, 2015, and we searched the medical literature to identify trials up to Nov 9, 2015. All randomised controlled trials of blood pressure lowering treatment were eligible for inclusion if they included a minimum of 1000 patient-years of follow-up in each study arm. No trials were excluded because of presence of baseline comorbidities, and trials of antihypertensive drugs for indications other than hypertension were eligible. We extracted summary-level data about study characteristics and the outcomes of major cardiovascular disease events, coronary heart disease, stroke, heart failure, renal failure, and all-cause mortality. We used inverse variance weighted fixed-effects meta-analyses to pool the estimates. Results We identified 123 studies with 613 815 participants for the tabular meta-analysis. Meta-regression analyses showed relative risk reductions proportional to the magnitude of the blood pressure reductions achieved. Every 10 mm Hg reduction in systolic blood pressure significantly reduced the risk of major cardiovascular disease events (relative risk [RR] 0.80, 95% CI 0.77-0.83), coronary heart disease (0.83, 0.78-0.88), stroke (0.73, 0.68-0.77), and heart failure (0.72, 0.67-0.78), which, in the populations studied, led to a significant 13% reduction in all-cause mortality (0.87, 0.84-0.91). However, the effect on renal failure was not significant (0.95, 0.84-1.07). Similar proportional risk reductions (per 10 mm Hg lower systolic blood pressure) were noted in trials with higher mean baseline systolic blood pressure and trials with lower mean baseline systolic blood pressure (all p(trend) > 0.05). There was no clear evidence that proportional risk reductions in major cardiovascular disease differed by baseline disease history, except for diabetes and chronic kidney disease, for which smaller, but significant, risk reductions were detected. beta blockers were inferior to other drugs for the prevention of major cardiovascular disease events, stroke, and renal failure. Calcium channel blockers were superior to other drugs for the prevention of stroke. For the prevention of heart failure, calcium channel blockers were inferior and diuretics were superior to other drug classes. Risk of bias was judged to be low for 113 trials and unclear for 10 trials. Heterogeneity for outcomes was low to moderate; the I-2 statistic for heterogeneity for major cardiovascular disease events was 41%, for coronary heart disease 25%, for stroke 26%, for heart failure 37%, for renal failure 28%, and for all-cause mortality 35%. Interpretation Blood pressure lowering significantly reduces vascular risk across various baseline blood pressure levels and comorbidities. Our results provide strong support for lowering blood pressure to systolic blood pressures less than 130 mm Hg and providing blood pressure lowering treatment to individuals with a history of cardiovascular disease, coronary heart disease, stroke, diabetes, heart failure, and chronic kidney disease.	[Ettehad, Dena; Emdin, Connor A.; Kiran, Amit; Anderson, Simon G.; Callender, Thomas; Rahimi, Kazem] Univ Oxford, George Inst Global Hlth, Oxford OX1 3BD, England; [Emberson, Jonathan] Univ Oxford, Clin Trial Serv Unit, Oxford OX1 3BD, England; [Emberson, Jonathan] Univ Oxford, Epidemiol Studies Unit, Oxford OX1 3BD, England; [Anderson, Simon G.] Univ Manchester, Inst Cardiovasc Sci, Manchester, Lancs, England; [Callender, Thomas] Kings Coll Hosp NHS Fdn Trust, London, England; [Chalmers, John; Rodgers, Anthony] Univ Sydney, George Inst Global Hlth, Sydney, NSW 2006, Australia	University of Oxford; University of Oxford; University of Oxford; University of Manchester; King's College Hospital NHS Foundation Trust; George Institute for Global Health; University of Sydney	Rahimi, K (corresponding author), Univ Oxford, George Inst Global Hlth, Oxford OX1 3BD, England.	kazem.rahimi@georgeinstitute.ox.ac.uk	Rahimi, Kazem/AAA-4250-2022; Anderson, Simon G/AGM-2359-2022; Rahimi, Kazem/Q-1279-2015	Anderson, Simon G/0000-0002-8896-073X; Emberson, Jonathan/0000-0001-7792-9422; Chalmers, John/0000-0002-9931-0580; Rodgers, Anthony/0000-0003-1282-1896; Callender, Thomas/0000-0001-8440-9433; Rahimi, Kazem/0000-0002-4807-4610	National Institute for Health Research; Oxford Martin School; National Institute of Health Research (NIHR) Oxford Biomedical Research Centre; NIHR Career Development Fellowship; Clarendon Fund; Rhodes Trust; NIHR; National Institute for Health Research [CL-2012-06-001, CDF-2013-06-012] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR)); Oxford Martin School; National Institute of Health Research (NIHR) Oxford Biomedical Research Centre(National Institute for Health Research (NIHR)); NIHR Career Development Fellowship; Clarendon Fund; Rhodes Trust; NIHR(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	National Institute for Health Research and Oxford Martin School.; KR is supported by the National Institute of Health Research (NIHR) Oxford Biomedical Research Centre and an NIHR Career Development Fellowship. DE is supported by the Clarendon Fund and CAE is supported by the Rhodes Trust. The work of The George Institute is supported by the Oxford Martin School. SGA is an Academic Clinical Lecturer in Cardiology and is funded by the NIHR. We would like to thank Hisatomi Arima and Hiroaki Shimokawa for providing additional information relating to their studies, and Allan J Hsiao for support with translation.	Agodoa L, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5680; Anand IS, 2007, J AM COLL CARDIOL, V49, P32, DOI 10.1016/j.jacc.2006.04.109; ANNESI I, 1989, STAT MED, V8, P1515, DOI 10.1002/sim.4780081211; [Anonymous], 1991, JAMA, V265, P3255; Asayama K, 2012, HYPERTENS RES, V35, P1102, DOI 10.1038/hr.2012.125; Baigent C, 2010, OXFORD TXB MED, P31; Beckett NS, 2008, NEW ENGL J MED, V358, P1887, DOI 10.1056/NEJMoa0801369; Chadban SJ, 2003, J AM SOC NEPHROL, V14, pS131, DOI 10.1097/01.ASN.0000070152.11927.4A; Chaturvedi V, 2003, EUR HEART J, V24, P475, DOI 10.1016/S0195-668X(02)00804-7; COLLINS R, 1990, LANCET, V335, P827, DOI 10.1016/0140-6736(90)90944-Z; Coresh J, 2003, AM J KIDNEY DIS, V41, P1, DOI 10.1053/ajkd.2003.50007; Cushman WC, 2010, NEW ENGL J MED, V362, P1575, DOI 10.1056/NEJMoa1001286; Di Angelantonio E, 2015, JAMA-J AM MED ASSOC, V314, P52, DOI 10.1001/jama.2015.7008; Emdin CA, 2015, JAMA-J AM MED ASSOC, V313, P603, DOI 10.1001/jama.2014.18574; Estacio RO, 1998, NEW ENGL J MED, V338, P645, DOI 10.1056/NEJM199803053381003; Gong LS, 1996, J HYPERTENS, V14, P1237, DOI 10.1097/00004872-199610000-00013; GREENBERG G, 1985, BMJ-BRIT MED J, V291, P97; Hansson L, 1999, LANCET, V353, P611, DOI 10.1016/S0140-6736(98)05012-0; Hansson L, 1998, LANCET, V351, P1755, DOI 10.1016/S0140-6736(98)04311-6; HELGELAND A, 1980, AM J MED, V69, P725, DOI 10.1016/0002-9343(80)90438-6; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hollaway LC, 2008, WOODHEAD PUBL MATER, P1; Ioannidis JP, 2009, PLOS MED, V6, pE; Jamerson K, 2008, NEW ENGL J MED, V359, P2417, DOI 10.1056/NEJMoa0806182; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Kanamasa K, 1999, CANCER, V85, P1369, DOI 10.1002/(SICI)1097-0142(19990315)85:6<1369::AID-CNCR21>3.0.CO;2-5; Kjaergard LL, 2001, ANN INTERN MED, V135, P982, DOI 10.7326/0003-4819-135-11-200112040-00010; Kuramoto K, 1999, HYPERTENSION, V34, P1129; Law MR, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1665; Lawes CMM, 2003, J HYPERTENS, V21, P707, DOI 10.1097/01.hjh.0000052492.18130.07; Levine TB, 2000, CIRCULATION, V101, P758, DOI 10.1161/01.CIR.101.7.758; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Lewis EJ, 2001, NEW ENGL J MED, V345, P851, DOI 10.1056/NEJMoa011303; Liu LS, 1998, J HYPERTENS, V16, P1823, DOI 10.1097/00004872-199816120-00016; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/ehm236, 10.1093/eurheartj/eht151]; McMurray J, 2006, J AM COLL CARDIOL, V47, P726, DOI 10.1016/j.jacc.2005.09.055; MEADE TW, 1992, BMJ-BRIT MED J, V304, P405; Meredith PA, 2008, J AM COLL CARDIOL, V52, P2000, DOI 10.1016/j.jacc.2008.09.011; Neal B, 2000, LANCET, V356, P1955; NICE, 2011, CLIN MAN PRIM HYP AD; Nissen SE, 2004, JAMA-J AM MED ASSOC, V292, P2217, DOI 10.1001/jama.292.18.2217; Ogawa H, 2012, AM J MED, V125, P981, DOI 10.1016/j.amjmed.2011.12.010; Ogihara T, 2011, GERIATR GERONTOL INT, V11, P414, DOI 10.1111/j.1447-0594.2011.00690.x; Parving HH, 2012, NEW ENGL J MED, V367, P2204, DOI 10.1056/NEJMoa1208799; Patel A, 2007, LANCET, V370, P829, DOI 10.1016/S0140-6736(07)61303-8; Perkovic V, 2008, KIDNEY INT, V73, P473, DOI 10.1038/sj.ki.5002701; PROGRESS Collaborat Grp, 2001, LANCET, V358, P1556; Rahimi K, 2013, CIRCULATION, V128, P2283, DOI 10.1161/CIRCULATIONAHA.113.006218; Rapsomaniki E, 2014, LANCET, V383, P1899, DOI 10.1016/S0140-6736(14)60685-1; Rouleau JL, 2004, J AM COLL CARDIOL, V43, P1423, DOI 10.1016/j.jacc.2003.11.037; Ruggenenti P, 2004, NEW ENGL J MED, V351, P1941, DOI 10.1056/NEJMoa042167; Schrier RW, 2007, NAT CLIN PRACT NEPHR, V3, P428, DOI 10.1038/ncpneph0559; Schrier RW, 2002, KIDNEY INT, V61, P1086, DOI 10.1046/j.1523-1755.2002.00213.x; SPRINT Research Group, 2015, N Engl J Med, V373, P2103, DOI 10.1056/NEJMoa1511939; Staessen JA, 1997, LANCET, V350, P757, DOI 10.1016/S0140-6736(97)05381-6; Stearne MR, 1998, BRIT MED J, V317, P713; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Sundstrom J, 2015, ANN INTERN MED, V162, P184, DOI 10.7326/M14-0773; Thomopoulos C, 2015, J HYPERTENS, V33, P195, DOI 10.1097/HJH.0000000000000447; Thomopoulos C, 2014, J HYPERTENS, V32, P2285, DOI 10.1097/HJH.0000000000000378; Turnbull F, 2003, LANCET, V362, P1527; Wang JG, 2000, ARCH INTERN MED, V160, P211, DOI 10.1001/archinte.160.2.211; WHO, 2013, GLOB BRIEF HYP; WHO Int Soc Hyperten Blood Press Lower, 1998, J HYPERTENS, V16, P127; WILHELMSEN L, 1987, J HYPERTENS, V5, P561, DOI 10.1097/00004872-198710000-00009; Wright JT, 2014, ANN INTERN MED, V160, P499, DOI 10.7326/M13-2981; Wright JT, 2002, JAMA-J AM MED ASSOC, V288, P2421, DOI 10.1001/jama.288.19.2421; Xie XF, 2016, LANCET, V387, P435, DOI 10.1016/S0140-6736(15)00805-3; Yusuf S, 2000, NEW ENGL J MED, V342, P145; Yusuf S, 2008, NEW ENGL J MED, V359, P1225, DOI 10.1056/NEJMoa0804593	70	1763	1859	19	39	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 5	2016	387	10022					957	967		10.1016/S0140-6736(15)01225-8	http://dx.doi.org/10.1016/S0140-6736(15)01225-8			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DF8XP	26724178	Bronze			2022-12-28	WOS:000371644200029
J	Brasch, V; Geiselmann, M; Herr, T; Lihachev, G; Pfeiffer, MHP; Gorodetsky, ML; Kippenberg, TJ				Brasch, V.; Geiselmann, M.; Herr, T.; Lihachev, G.; Pfeiffer, M. H. P.; Gorodetsky, M. L.; Kippenberg, T. J.			Photonic chip-based optical frequency comb using soliton Cherenkov radiation	SCIENCE			English	Article							TEMPORAL CAVITY SOLITONS; MICRORESONATOR; COLLOQUIUM; DISPERSION; FIBERS	Optical solitons are propagating pulses of light that retain their shape because nonlinearity and dispersion balance each other. In the presence of higher-order dispersion, optical solitons can emit dispersive waves via the process of soliton Cherenkov radiation. This process underlies supercontinuum generation and is of critical importance in frequency metrology. Using a continuous wave-pumped, dispersion-engineered, integrated silicon nitride microresonator, we generated continuously circulating temporal dissipative Kerr solitons. The presence of higher-order dispersion led to the emission of red-shifted soliton Cherenkov radiation. The output corresponds to a fully coherent optical frequency comb that spans two-thirds of an octave and whose phase we were able to stabilize to the sub-Hertz level. By preserving coherence over a broad spectral bandwidth, our device offers the opportunity to develop compact on-chip frequency combs for frequency metrology or spectroscopy.	[Brasch, V.; Geiselmann, M.; Herr, T.; Pfeiffer, M. H. P.; Kippenberg, T. J.] Ecole Polytech Fed Lausanne, CH-1015 Lausanne, Switzerland; [Lihachev, G.; Gorodetsky, M. L.] Russian Quantum Ctr, Skolkovo 143025, Russia; [Lihachev, G.; Gorodetsky, M. L.] Moscow MV Lomonosov State Univ, Fac Phys, Moscow 119991, Russia	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Russian Quantum Center; Lomonosov Moscow State University	Kippenberg, TJ (corresponding author), Ecole Polytech Fed Lausanne, CH-1015 Lausanne, Switzerland.	tobias.kippenberg@epfl.ch	Kippenberg, T. J./B-3133-2013; Gorodetsky, Michael/C-5938-2008	Kippenberg, T. J./0000-0002-3408-886X; Gorodetsky, Michael/0000-0002-5159-2742; Herr, Tobias/0000-0002-5966-6697; Brasch, Victor/0000-0002-0354-2847	European Space Agency [ESTEC CN 4000108280/12/NL/PA, ESTEC CN 4000105962/12/NL/PA]; Swiss National Science Foundation; Defense Advanced Research Projects Agency, Defense Sciences Office [W911NF-11-1-0202]; Air Force Office of Scientific Research, Air Force Material Command [FA9550-15-1-0099]; Russian Foundation for Basic Research [13-02-00271]; Ministry of Education and Science of the Russian Federation [4.585.21.0005]; Hasler foundation; MSCA-COFUND program at EPFL	European Space Agency(European Space AgencyEuropean Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Defense Advanced Research Projects Agency, Defense Sciences Office(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Air Force Office of Scientific Research, Air Force Material Command(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Ministry of Education and Science of the Russian Federation(Ministry of Education and Science, Russian Federation); Hasler foundation; MSCA-COFUND program at EPFL	Supported by European Space Agency contracts ESTEC CN 4000108280/12/NL/PA and ESTEC CN 4000105962/12/NL/PA, the Swiss National Science Foundation, and contract W911NF-11-1-0202 from the Defense Advanced Research Projects Agency, Defense Sciences Office. This material is based on work supported by the Air Force Office of Scientific Research, Air Force Material Command, under award FA9550-15-1-0099. M.L.G. and G.L. were supported by Russian Foundation for Basic Research grant 13-02-00271 and the Ministry of Education and Science of the Russian Federation project 4.585.21.0005. M.G. acknowledges support from the Hasler foundation and the MSCA-COFUND program at EPFL. All samples were fabricated at the Centre for MicroNanotechnology (CMi) at EPFL.	AKHMEDIEV N, 1995, PHYS REV A, V51, P2602, DOI 10.1103/PhysRevA.51.2602; Akhmediev N., 2008, DISSIPATIVE SOLITONS; Chembo YK, 2013, PHYS REV A, V87, DOI 10.1103/PhysRevA.87.053852; Coen S, 2013, OPT LETT, V38, P37, DOI 10.1364/OL.38.000037; Cundiff ST, 2003, REV MOD PHYS, V75, P325, DOI 10.1103/RevModPhys.75.325; Del'Haye P, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.053903; Del'Haye P, 2007, NATURE, V450, P1214, DOI 10.1038/nature06401; Del'Haye P, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.063901; Del'Haye P, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.263901; Erkintalo M, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.223904; Ferdous F, 2011, NAT PHOTONICS, V5, P770, DOI 10.1038/nphoton.2011.255; Foster MA, 2011, OPT EXPRESS, V19, P14233, DOI 10.1364/OE.19.014233; Hasegawa A., 2003, OPTICAL SOLITONS FIB; Herr T, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.123901; Herr T, 2014, NAT PHOTONICS, V8, P145, DOI [10.1038/NPHOTON.2013.343, 10.1038/nphoton.2013.343]; Herr T, 2012, NAT PHOTONICS, V6, P480, DOI [10.1038/nphoton.2012.127, 10.1038/NPHOTON.2012.127]; Jang JK, 2014, OPT LETT, V39, P5503, DOI 10.1364/OL.39.005503; Kippenberg TJ, 2011, SCIENCE, V332, P555, DOI 10.1126/science.1193968; Lamont MRE, 2013, OPT LETT, V38, P3478, DOI 10.1364/OL.38.003478; Leo F, 2010, NAT PHOTONICS, V4, P471, DOI [10.1038/nphoton.2010.120, 10.1038/NPHOTON.2010.120]; Levy JS, 2010, NAT PHOTONICS, V4, P37, DOI 10.1038/NPHOTON.2009.259; Matsko AB, 2011, OPT LETT, V36, P2845, DOI 10.1364/OL.36.002845; Milian C, 2015, PHYS REV A, V92, DOI 10.1103/PhysRevA.92.033851; Milian C, 2014, OPT EXPRESS, V22, P3732, DOI 10.1364/OE.22.003732; Moss DJ, 2013, NAT PHOTONICS, V7, P597, DOI [10.1038/NPHOTON.2013.183, 10.1038/nphoton.2013.183]; Papp SB, 2014, OPTICA, V1, P10, DOI 10.1364/OPTICA.1.000010; Pfeifle J, 2014, NAT PHOTONICS, V8, P375, DOI 10.1038/nphoton.2014.57; Skryabin DV, 2010, REV MOD PHYS, V82, P1287, DOI 10.1103/RevModPhys.82.1287; Udem T, 2002, NATURE, V416, P233, DOI 10.1038/416233a; WAI PKA, 1986, OPT LETT, V11, P464, DOI 10.1364/OL.11.000464	30	461	480	23	222	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 22	2016	351	6271					357	360		10.1126/science.aad4811	http://dx.doi.org/10.1126/science.aad4811			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB3VH	26721682	Green Submitted			2022-12-28	WOS:000368440500033
J	Ware, JS; Li, J; Mazaika, E; Yasso, CM; DeSouza, T; Cappola, TP; Tsai, EJ; Hilfiker-Kleiner, D; Kamiya, CA; Mazzarotto, F; Cook, SA; Halder, I; Prasad, SK; Pisarcik, J; Hanley-Yanez, K; Alharethi, R; Damp, J; Hsich, E; Elkayam, U; Sheppard, R; Kealey, A; Alexis, J; Ramani, G; Safirstein, J; Boehmer, J; Pauly, DF; Wittstein, IS; Thohan, V; Zucker, MJ; Liu, P; Gorcsan, J; McNamara, DM; Seidman, CE; Seidman, JG; Arany, Z				Ware, James S.; Li, Jian; Mazaika, Erica; Yasso, Christopher M.; DeSouza, Tiffany; Cappola, Thomas P.; Tsai, Emily J.; Hilfiker-Kleiner, Denise; Kamiya, Chizuko A.; Mazzarotto, Francesco; Cook, Stuart A.; Halder, Indrani; Prasad, Sanjay K.; Pisarcik, Jessica; Hanley-Yanez, Karen; Alharethi, Rami; Damp, Julie; Hsich, Eileen; Elkayam, Uri; Sheppard, Richard; Kealey, Angela; Alexis, Jeffrey; Ramani, Gautam; Safirstein, Jordan; Boehmer, John; Pauly, Daniel F.; Wittstein, Ilan S.; Thohan, Vinay; Zucker, Mark J.; Liu, Peter; Gorcsan, John, III; McNamara, Dennis M.; Seidman, Christine E.; Seidman, Jonathan G.; Arany, Zoltan		IMAC-2 IPAC Invest	Shared Genetic Predisposition in Peripartum and Dilated Cardiomyopathies	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							FAMILIAL OCCURRENCE; MUTATIONS; OUTCOMES; GENOME	BACKGROUND Peripartum cardiomyopathy shares some clinical features with idiopathic dilated cardiomyopathy, a disorder caused by mutations in more than 40 genes, including TTN, which encodes the sarcomere protein titin. METHODS In 172 women with peripartum cardiomyopathy, we sequenced 43 genes with variants that have been associated with dilated cardiomyopathy. We compared the prevalence of different variant types (nonsense, frameshift, and splicing) in these women with the prevalence of such variants in persons with dilated cardiomyopathy and with population controls. RESULTS We identified 26 distinct, rare truncating variants in eight genes among women with peripartum cardiomyopathy. The prevalence of truncating variants (26 in 172 [15%]) was significantly higher than that in a reference population of 60,706 persons (4.7%, P = 1.3x10(-7)) but was similar to that in a cohort of patients with dilated cardiomyopathy (55 of 332 patients [17%], P = 0.81). Two thirds of identified truncating variants were in TTN, as seen in 10% of the patients and in 1.4% of the reference population (P = 2.7x10(-10)); almost all TTN variants were located in the titin A-band. Seven of the TTN truncating variants were previously reported in patients with idiopathic dilated cardiomyopathy. In a clinically well-characterized cohort of 83 women with peripartum cardiomyopathy, the presence of TTN truncating variants was significantly correlated with a lower ejection fraction at 1-year follow-up (P = 0.005). CONCLUSIONS The distribution of truncating variants in a large series of women with peripartum cardiomyopathy was remarkably similar to that found in patients with idiopathic dilated cardiomyopathy. TTN truncating variants were the most prevalent genetic predisposition in each disorder.	[Ware, James S.; Mazaika, Erica; Yasso, Christopher M.; Seidman, Christine E.; Seidman, Jonathan G.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Seidman, Christine E.] Howard Hughes Med Inst, Boston, MA 02115 USA; [Ware, James S.; Mazaika, Erica; Seidman, Christine E.; Seidman, Jonathan G.] Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA; [Li, Jian; DeSouza, Tiffany; Cappola, Thomas P.; Arany, Zoltan] Univ Penn, Cardiovasc Inst, Philadelphia, PA 19104 USA; [Li, Jian; DeSouza, Tiffany; Cappola, Thomas P.; Arany, Zoltan] Univ Penn, Perelman Sch Med, Dept Med, Philadelphia, PA 19104 USA; [Halder, Indrani; Pisarcik, Jessica; Hanley-Yanez, Karen; Gorcsan, John, III; McNamara, Dennis M.] Univ Pittsburgh, Med Ctr, Inst Heart & Vasc, Pittsburgh, PA USA; [Boehmer, John] Penn State Hershey Med Ctr, Hershey, PA USA; [Ware, James S.; Mazzarotto, Francesco; Prasad, Sanjay K.] Univ London Imperial Coll Sci Technol & Med, Natl Hlth Res Royal Brompton Cardiovasc Biomed Re, London, England; [Ware, James S.; Mazzarotto, Francesco; Cook, Stuart A.; Prasad, Sanjay K.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England; [Tsai, Emily J.] Columbia Univ, Dept Med, Div Cardiol, Coll Phys & Surg, New York, NY USA; [Alexis, Jeffrey] Univ Rochester, Rochester, NY USA; [Hilfiker-Kleiner, Denise] Hannover Med Sch, Dept Cardiol & Angiol, Hannover, Germany; [Kamiya, Chizuko A.] Natl Cerebral & Cardiovasc Ctr, Dept Perinatol & Gynecol, Osaka, Japan; [Cook, Stuart A.] Natl Heart Ctr, Singapore, Singapore; [Cook, Stuart A.] Duke Natl Univ Singapore, Singapore, Singapore; [Alharethi, Rami] Intermt Med Ctr, Murray, UT USA; [Damp, Julie] Vanderbilt Univ, Nashville, TN 37235 USA; [Hsich, Eileen] Cleveland Clin, Cleveland, OH USA; [Elkayam, Uri] Univ So Calif, Los Angeles, CA USA; [Sheppard, Richard] McGill Univ, Montreal, PQ, Canada; [Sheppard, Richard] McGill Univ, Jewish Gen Hosp, Montreal, PQ H3T 1E2, Canada; [Kealey, Angela] Univ Calgary, Calgary, AB, Canada; [Liu, Peter] Univ Toronto, Toronto, ON, Canada; [Ramani, Gautam] Univ Maryland, College Pk, MD 20742 USA; [Wittstein, Ilan S.] Johns Hopkins Univ Hosp, Baltimore, MD 21287 USA; [Safirstein, Jordan] Morristown Mem Hosp, Morristown, NJ USA; [Zucker, Mark J.] Newark Beth Israel Med Ctr, Newark, NJ USA; [Pauly, Daniel F.] Univ Missouri, Truman Med Ctr, Kansas City, MO USA; [Thohan, Vinay] Wake Forest Univ, Baptist Med Ctr, Winston Salem, NC 27109 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Brigham & Women's Hospital; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Imperial College London; Imperial College London; Columbia University; University of Rochester; Hannover Medical School; National Cerebral & Cardiovascular Center - Japan; National Heart Centre Singapore; National University of Singapore; Intermountain Healthcare; Intermountain Medical Center; Vanderbilt University; Cleveland Clinic Foundation; University of Southern California; McGill University; McGill University; University of Calgary; University of Toronto; University System of Maryland; University of Maryland College Park; Johns Hopkins University; Johns Hopkins Medicine; Atlantic Health System; Newark Beth Israel Medical Center; University of Missouri System; University of Missouri Kansas City; Wake Forest University; Wake Forest Baptist Medical Center	Arany, Z (corresponding author), Univ Penn, 3400 Civ Blvd 11-106, Philadelphia, PA 19104 USA.	zarany@mail.med.upenn.edu	Mazzarotto, Francesco/E-1843-2017; Ware, James S/G-5139-2012	Mazzarotto, Francesco/0000-0002-6159-9980; Ware, James S/0000-0002-6110-5880; Tsai, Emily/0000-0002-5098-1463; Boehmer, John/0000-0002-8024-1589; Bozkurt, Biykem/0000-0002-6362-0253; Zucker, Mark/0000-0002-2999-0146	National Institutes of Health [HL094499, HL080494, HL88577, HL102429]; Fondation Leducq; National Institute for Health Research Cardiovascular Biomedical Research Unit at Royal Brompton and Harefield NHS Foundation Trust and Imperial College London; Regenerative Biology and Reconstructive Therapies (REBIRTH) 2 Cluster of Excellence; Bundesministerium fur Bildung und Forschung; Howard Hughes Medical Institute; Academy of Medical Sciences (AMS) [AMS-SGCL9-Ware] Funding Source: researchfish; British Heart Foundation [FS/13/13/29819, SP/10/10/28431, FS/15/81/31817] Funding Source: researchfish; Medical Research Council [MC_U120085815] Funding Source: researchfish; Wellcome Trust [107469/Z/15/Z] Funding Source: researchfish; MRC [MC_U120085815] Funding Source: UKRI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084553, RC1HL102429, R01HL094499, R56HL125420, R01HL080494, K08HL109159, R01HL088577] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondation Leducq(Leducq Foundation); National Institute for Health Research Cardiovascular Biomedical Research Unit at Royal Brompton and Harefield NHS Foundation Trust and Imperial College London; Regenerative Biology and Reconstructive Therapies (REBIRTH) 2 Cluster of Excellence; Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Academy of Medical Sciences (AMS)(Academy of Medical Sciences (AMS)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by grants from the National Institutes of Health (HL094499, to Dr. Arany; HL080494, to Dr. J.G. Seidman; HL88577, to Dr. Cappola; and HL102429, to Dr. McNamara), the Fondation Leducq (to Drs. Ware, C.E. Seidman, and J.G. Seidman), the National Institute for Health Research Cardiovascular Biomedical Research Unit at Royal Brompton and Harefield NHS Foundation Trust and Imperial College London (to Dr. Ware), Regenerative Biology and Reconstructive Therapies (REBIRTH) 2 Cluster of Excellence and Bundesministerium fur Bildung und Forschung (to Dr. Hilfiker-Kleiner), and Howard Hughes Medical Institute (to Dr. C.E. Seidman).	Arad M, 2005, NEW ENGL J MED, V352, P362, DOI 10.1056/NEJMoa033349; Bello N, 2013, J AM COLL CARDIOL, V62, P1715, DOI 10.1016/j.jacc.2013.08.717; Bello NA, 2015, TRENDS CARDIOVAS MED, V25, P499, DOI 10.1016/j.tcm.2015.01.004; Cheng VE, 2013, HEART LUNG CIRC, V22, P677, DOI 10.1016/j.hlc.2012.11.015; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Elkayam U, 2011, J AM COLL CARDIOL, V58, P659, DOI 10.1016/j.jacc.2011.03.047; Giliberto F, 2014, J NEUROL SCI, V336, P36, DOI 10.1016/j.jns.2013.09.036; Goland S, 2013, J CARD FAIL, V19, P214, DOI 10.1016/j.cardfail.2013.03.004; Haghikia A, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0366-9; Halkein J, 2013, J CLIN INVEST, V123, P2143, DOI 10.1172/JCI64365; Herman DS, 2012, NEW ENGL J MED, V366, P619, DOI 10.1056/NEJMoa1110186; Hilfiker-Kleiner D, 2007, CELL, V128, P589, DOI 10.1016/j.cell.2006.12.036; Hilfiker-Kleiner D, 2014, NAT REV CARDIOL, V11, P364, DOI 10.1038/nrcardio.2014.37; Horne BD, 2011, CIRC-CARDIOVASC GENE, V4, P359, DOI 10.1161/CIRCGENETICS.110.959205; Kamiya CA, 2011, CIRC J, V75, P1975, DOI 10.1253/circj.CJ-10-1214; MASSAD LS, 1993, OBSTET GYNECOL, V81, P886; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; McNamara DM, 2015, J AM COLL CARDIOL, V66, P905, DOI 10.1016/j.jacc.2015.06.1309; McNamara DM, 2011, J AM COLL CARDIOL, V58, P1112, DOI 10.1016/j.jacc.2011.05.033; McTiernan CF, 2013, CIRCULATION, V128; Morales A, 2010, CIRCULATION, V121, P2176, DOI 10.1161/CIRCULATIONAHA.109.931220; Ntusi NBA, 2011, SAMJ S AFR MED J, V101, P394; Patten IS, 2012, NATURE, V485, P333, DOI 10.1038/nature11040; PEARL W, 1995, AM HEART J, V129, P421, DOI 10.1016/0002-8703(95)90032-2; PIERCE JA, 1963, ARCH INTERN MED, V111, P651, DOI 10.1001/archinte.1963.03620290117016; Pugh TJ, 2014, GENET MED, V16, P601, DOI 10.1038/gim.2013.204; Roberts AM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010134; Sliwa K, 2006, LANCET, V368, P687, DOI 10.1016/S0140-6736(06)69253-2; Toib A, 2010, J AM COLL CARDIOL, V55, P408, DOI 10.1016/j.jacc.2009.11.019; Stormo Gary D, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1110s43, 10.1002/0471250953.bi1201s43]; van Spaendonck-Zwarts KY, 2014, EUR HEART J, V35, P2165, DOI 10.1093/eurheartj/ehu050	31	288	292	1	32	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 21	2016	374	3					233	241		10.1056/NEJMoa1505517	http://dx.doi.org/10.1056/NEJMoa1505517			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DB3IS	26735901	Green Published, Green Accepted			2022-12-28	WOS:000368404800008
J	Iglehart, JK				Iglehart, John K.			Future of Long-Term Care and the Expanding Role of Medicaid Managed Care	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							SERVICES											[Anonymous], 2011, COMMUNICATION; [Anonymous], 1991, NAT LONG TERM CAR CH; Barry C, 2015, EARLY INSIGHTS ONE C; Bernstein N., 2014, NY TIMES, pA1; Bipartisan Policy Center, 2014, AM LONG TERM CAR CRI; Butler L, 2013, COMMISSION LONG TERM; Congressional Budget Office, 2013, RIS DEM LONG TERM SE; Department of Health and Human Services, 2011, REP ACT MARK LEG AN; Eiken S, 2015, MED EXPENDITURES LON; Eiken S, 2013, J AGING SOC POLICY, V25, P134, DOI 10.1080/08959420.2013.766054; Favreault MM, 2015, HEALTH AFFAIR, V34, P2181, DOI 10.1377/hlthaff.2015.1226; FEDER J, 2014, ST LOUIS U J HLTH LA, V8, P47; Frank RG, 2013, MAKING PROGR EXPADIN; Genworth Financial Inc., 2015, GENW 2015 COST CAR S; Goldberg L, 2013, SOCIAL INSURANCE CRI; Kemper P, 2005, INQUIRY-J HEALTH CAR, V42, P335, DOI 10.5034/inquiryjrnl_42.4.335; Medicaid and CHIP Payment and Access Commission, 2014, C MED CHIP WASH DC M; Ng T., 2014, MED HOME COMMUNITY B; OShaughnessy Carol, 2014, BASICS NATL SPENDING; Pear R, 2015, NY TIMES, pA14; Reaves E., 2015, MED LONG TERM CARE S MED LONG TERM CARE S; Redfoot D., 2013, AGING BABY BOOM GROW; Reinhard S, 2015, AARP            0716; Reinhard SC, 2014, RAISING EXPECTATIONS; Social Security and Medicare Boards of Trustees, SUMM 2015 ANN REP; Stevenson DG, 2008, NEW ENGL J MED, V358, P1985, DOI 10.1056/NEJMp0802347; Stevenson DG, 2010, HEALTH AFFAIR, V29, P96, DOI 10.1377/hlthaff.2009.0920; Stone RI, 2015, FAMILY CAREGIVING NE, P57, DOI DOI 10.1016/B978-0-12-417046-9.00006-4; The Associated Press-NORC Center for Public Affairs Research, 2015, REP LONG TERM CAR AM; Weil AR, 2015, HEALTH AFFAIR, V34, P2015, DOI 10.1377/hlthaff.2015.1450	30	4	4	1	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 14	2016	374	2					182	187		10.1056/NEJMhpr1510026	http://dx.doi.org/10.1056/NEJMhpr1510026			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DA7PQ	26760091				2022-12-28	WOS:000367996700017
J	Pedmale, UV; Huang, SSC; Zander, M; Cole, BJ; Hetzel, J; Ljung, K; Reis, PAB; Sridevi, P; Nito, K; Nery, JR; Ecker, JR; Chory, J				Pedmale, Ullas V.; Huang, Shao-shan Carol; Zander, Mark; Cole, Benjamin J.; Hetzel, Jonathan; Ljung, Karin; Reis, Pedro A. B.; Sridevi, Priya; Nito, Kazumasa; Nery, Joseph R.; Ecker, Joseph R.; Chory, Joanne			Cryptochromes Interact Directly with PIFs to Control Plant Growth in Limiting Blue Light	CELL			English	Article							SHADE AVOIDANCE-RESPONSE; ARABIDOPSIS-THALIANA; PHYTOCHROME-B; TRANSCRIPTION FACTOR; CIRCADIAN CLOCK; VASCULAR BUNDLES; HYPOCOTYL GROWTH; AUXIN; BINDING; ARCHITECTURE	Sun-loving plants have the ability to detect and avoid shading through sensing of both blue and red light wavelengths. Higher plant cryptochromes (CRYs) control how plants modulate growth in response to changes in blue light. For growth under a canopy, where blue light is diminished, CRY1 and CRY2 perceive this change and respond by directly contacting two bHLH transcription factors, PIF4 and PIF5. These factors are also known to be controlled by phytochromes, the red/far-red photoreceptors; however, transcriptome analyses indicate that the gene regulatory programs induced by the different light wavelengths are distinct. Our results indicate that CRYs signal by modulating PIF activity genome wide and that these factors integrate binding of different plant photoreceptors to facilitate growth changes under different light conditions.	[Pedmale, Ullas V.; Ecker, Joseph R.; Chory, Joanne] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; [Pedmale, Ullas V.; Huang, Shao-shan Carol; Zander, Mark; Cole, Benjamin J.; Hetzel, Jonathan; Reis, Pedro A. B.; Nito, Kazumasa; Ecker, Joseph R.; Chory, Joanne] Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA; [Huang, Shao-shan Carol; Nery, Joseph R.; Ecker, Joseph R.] Salk Inst Biol Studies, Genom Anal Lab, La Jolla, CA 92037 USA; [Cole, Benjamin J.; Hetzel, Jonathan] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Ljung, Karin] Swedish Univ Agr Sci, Dept Forest Genet & Plant Physiol, Umea Plant Sci Ctr, SE-90183 Umea, Sweden; [Reis, Pedro A. B.] Univ Fed Vicosa, Natl Inst Sci & Technol Plant Pest Interact, Dept Bioquim & Biol Mol BIOAGRO, BR-36570000 Vicosa, MG, Brazil; [Sridevi, Priya] Univ Calif San Diego, Sch Med, Dept Med, Div Hematol Oncol, La Jolla, CA 92093 USA	Howard Hughes Medical Institute; Salk Institute; Salk Institute; Salk Institute; University of California System; University of California San Diego; Swedish University of Agricultural Sciences; Umea University; Universidade Federal de Vicosa; University of California System; University of California San Diego	Pedmale, UV (corresponding author), Salk Inst Biol Studies, Howard Hughes Med Inst, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	upedmale@salk.edu; chory@salk.edu	Reis, Pedro Augusto Braga/U-4103-2019; Ljung, Karin/AAE-8691-2019; Nery, Joseph/AAE-8422-2019; Ecker, Joseph R/B-9144-2008	Reis, Pedro Augusto Braga/0000-0003-2396-3662; Ljung, Karin/0000-0003-2901-189X; Nery, Joseph/0000-0003-0153-5659; Ecker, Joseph R/0000-0001-5799-5895; Cole, Benjamin/0000-0001-9652-624X	Swedish Governmental Agency for Innovation Systems; Swedish Research Council; Marianne and Marcus Wallenberg Foundation; DFG [Za-730/1-1]; NIH [T32GM007240, R01-GM52413]; Rose Hills Foundation; H.A. and Mary K. Chapman Charitable Trust; DOE [FG02-04ER15517]; NSF [MCB-1024999]; Gordon and Betty Moore Foundation [GBMF3034]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052413, T32GM007240] Funding Source: NIH RePORTER	Swedish Governmental Agency for Innovation Systems(Vinnova); Swedish Research Council(Swedish Research CouncilEuropean Commission); Marianne and Marcus Wallenberg Foundation; DFG(German Research Foundation (DFG)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rose Hills Foundation; H.A. and Mary K. Chapman Charitable Trust; DOE(United States Department of Energy (DOE)); NSF(National Science Foundation (NSF)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Z. Avramova, T. Yamashino, and C. Fankhauser for XTH33ox, ATHB2ox, and pin seeds; C. Lin and A. Nagatani for CRY and PHY antiserum; C. Lagarias for phycocyanobilin; Y. Jaillais, A. Seluzicki, C. Procko, and D. O'Keefe for critical reading of the draft; and R. Granbom for assistance with the IAA measurements. K.L. was funded by the Swedish Governmental Agency for Innovation Systems, the Swedish Research Council, and the Marianne and Marcus Wallenberg Foundation. M.Z. was supported by DFG (Za-730/1-1). J.H. was supported by the NIH (T32GM007240), the Rose Hills Foundation, and the H.A. and Mary K. Chapman Charitable Trust. J.R.E. was supported by DOE (FG02-04ER15517), the NSF (MCB-1024999), and the Gordon and Betty Moore Foundation (GBMF3034). J.C. and J.R.E. are investigators of the Howard Hughes Medical Institute. NIH grant R01-GM52413 to J.C. funded this study.	Ballare CL, 1999, TRENDS PLANT SCI, V4, P97, DOI 10.1016/S1360-1385(99)01383-7; Boron AK, 2014, PLANT CELL REP, V33, P697, DOI 10.1007/s00299-014-1591-x; Bouly JP, 2007, J BIOL CHEM, V282, P9383, DOI 10.1074/jbc.M609842200; Casal Jorge J, 2012, Arabidopsis Book, V10, pe0157, DOI 10.1199/tab.0157; Ceriani MF, 1999, SCIENCE, V285, P553, DOI 10.1126/science.285.5427.553; Chen F, 2014, PLANT CELL, V26, P1949, DOI 10.1105/tpc.114.123950; Chory J, 2010, PLANT J, V61, P982, DOI 10.1111/j.1365-313X.2009.04105.x; Cole B, 2011, PLANT J, V65, P991, DOI 10.1111/j.1365-313X.2010.04476.x; Cosgrove DJ, 2002, PLANT CELL PHYSIOL, V43, P1436, DOI 10.1093/pcp/pcf180; Crocco CD, 2010, PLANT J, V64, P551, DOI 10.1111/j.1365-313X.2010.04360.x; Depuydt S, 2011, CURR BIOL, V21, pR365, DOI 10.1016/j.cub.2011.03.013; Endo M, 2005, PLANT CELL, V17, P1941, DOI 10.1105/tpc.105.032342; Endo M, 2007, PLANT CELL, V19, P84, DOI 10.1105/tpc.106.048157; Firulli BA, 2007, J BIOL CHEM, V282, P27536, DOI 10.1074/jbc.M702613200; Guo HW, 2003, CELL, V115, P667, DOI 10.1016/S0092-8674(03)00969-3; Hornitschek P, 2012, PLANT J, V71, P699, DOI 10.1111/j.1365-313X.2012.05033.x; Hornitschek P, 2009, EMBO J, V28, P3893, DOI 10.1038/emboj.2009.306; Keller MM, 2011, PLANT J, V67, P195, DOI 10.1111/j.1365-313X.2011.04598.x; Keuskamp DH, 2011, PLANT J, V67, P208, DOI 10.1111/j.1365-313X.2011.04597.x; Keuskamp DH, 2010, P NATL ACAD SCI USA, V107, P22740, DOI 10.1073/pnas.1013457108; Keuskamp DH, 2010, PLANT SIGNAL BEHAV, V5, P655, DOI 10.4161/psb.5.6.11401; Khanna R, 2004, PLANT CELL, V16, P3033, DOI 10.1105/tpc.104.025643; KIELISZEWSKI MJ, 1994, PLANT J, V5, P157, DOI 10.1046/j.1365-313X.1994.05020157.x; Koini MA, 2009, CURR BIOL, V19, P408, DOI 10.1016/j.cub.2009.01.046; Kozuka T, 2011, PLANT CELL, V23, P3684, DOI 10.1105/tpc.111.085852; Kunihiro A, 2010, BIOSCI BIOTECH BIOCH, V74, P2538, DOI 10.1271/bbb.100586; Langmesser S, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-41; Lee CM, 2012, P NATL ACAD SCI USA, V109, P15054, DOI 10.1073/pnas.1211295109; Leivar P, 2014, PLANT CELL, V26, P56, DOI 10.1105/tpc.113.120857; Li L, 2012, GENE DEV, V26, P785, DOI 10.1101/gad.187849.112; Lin CT, 1998, P NATL ACAD SCI USA, V95, P2686, DOI 10.1073/pnas.95.5.2686; Liu HT, 2008, SCIENCE, V322, P1535, DOI 10.1126/science.1163927; Lorrain S, 2008, PLANT J, V53, P312, DOI 10.1111/j.1365-313X.2007.03341.x; Martinez-Garcia JF, 2000, SCIENCE, V288, P859, DOI 10.1126/science.288.5467.859; Mas P, 2000, NATURE, V408, P207, DOI 10.1038/35041583; Mazzella MA, 2001, PLANT CELL ENVIRON, V24, P155, DOI 10.1111/j.1365-3040.2001.00653.x; Ni WM, 2014, SCIENCE, V344, P1160, DOI 10.1126/science.1250778; Nusinow DA, 2011, NATURE, V475, P398, DOI 10.1038/nature10182; Oh E, 2014, ELIFE, V3, DOI 10.7554/eLife.03031; Park E, 2012, PLANT J, V72, P537, DOI 10.1111/j.1365-313X.2012.05114.x; Pedmale UV, 2007, J BIOL CHEM, V282, P19992, DOI 10.1074/jbc.M702551200; Pierik R, 2009, PLANT PHYSIOL, V149, P1701, DOI 10.1104/pp.108.133496; Sellaro R, 2010, PLANT PHYSIOL, V154, P401, DOI 10.1104/pp.110.160820; Sessa G, 2005, GENE DEV, V19, P2811, DOI 10.1101/gad.364005; SMITH H, 1982, ANNU REV PLANT PHYS, V33, P481, DOI 10.1146/annurev.pp.33.060182.002405; Tao Y, 2008, CELL, V133, P164, DOI 10.1016/j.cell.2008.01.049; Toth R, 2001, PLANT PHYSIOL, V127, P1607, DOI 10.1104/pp.010467; Yu X, 2007, PLANT CELL, V19, P3146, DOI 10.1105/tpc.107.053017; Zhang Y, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003244	50	322	339	16	219	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 14	2016	164	1-2					233	245		10.1016/j.cell.2015.12.018	http://dx.doi.org/10.1016/j.cell.2015.12.018			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DB2LE	26724867	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000368339300023
J	Godlee, F				Godlee, Fiona			DOCTORS' STRIKE 2016 How Jeremy Hunt derailed clinician led progress towards a seven day NHS	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							WEEKEND; DEATH; RISK					fgodlee@bmj.com						[Anonymous], 2013, 7 DAYS WEEK FOR SUMM; [Anonymous], 2015, BBC NEWS; Aylin P, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4652; Crump H, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4473; Freemantle N, 2012, J ROY SOC MED, V105, P74, DOI 10.1258/jrsm.2012.120009; Freemantle N, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4596; House of Commons Health Committee, 2015, OR EV NHS CURR ISS, P32; House of Commons Health Committee, 2015, COMMUNICATION   0720; Moberly T., 2011, GP              0721; Moberly T., 2011, GP              0705; NHS England, 2013, ROYAL COLL BACK 7 DA; Rimmer A., 2015, BMJ BLOG        0904	12	4	4	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 13	2016	352								i187	10.1136/bmj.i187	http://dx.doi.org/10.1136/bmj.i187			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DB2YL	26762361				2022-12-28	WOS:000368376500011
J	Tripathy, K; Sharma, YR				Tripathy, Koushik; Sharma, Yog Raj			SPOT DIAGNOSIS Poor vision in a patient with white hair and pale skin	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Tripathy, Koushik; Sharma, Yog Raj] All India Inst Med Sci AIIMS, Dr Rajendra Prasad Ctr Ophthalm Sci, New Delhi 110029, India	All India Institute of Medical Sciences (AIIMS) New Delhi; Dr. Rajendra Prasad Centre for Ophthalmic Sciences	Tripathy, K (corresponding author), All India Inst Med Sci AIIMS, Dr Rajendra Prasad Ctr Ophthalm Sci, New Delhi 110029, India.	koushiktripathy@gmail.com	Tripathy, Koushik/O-1801-2019	Tripathy, Koushik/0000-0002-9756-128X					0	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 13	2016	352								i24	10.1136/bmj.i24	http://dx.doi.org/10.1136/bmj.i24			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DB2YL	26762602				2022-12-28	WOS:000368376500019
J	Jajoo, R; Jung, Y; Huh, D; Viana, MP; Rafelski, SM; Springer, M; Paulsson, J				Jajoo, Rishi; Jung, Yoonseok; Huh, Dann; Viana, Matheus P.; Rafelski, Susanne M.; Springer, Michael; Paulsson, Johan			Accurate concentration control of mitochondria and nucleoids	SCIENCE			English	Article							FISSION YEAST; DYNAMIC MICROTUBULES; SPINDLE POLES; CELL-DIVISION; IN-VIVO; NETWORK; SIZE; DNA; ASSOCIATION; SEGREGATION	All cellular materials are partitioned between daughters at cell division, but by various mechanisms and with different accuracy. In the yeast Schizosaccharomyces pombe, the mitochondria are pushed to the cell poles by the spindle. We found that mitochondria spatially reequilibrate just before division, and that the mitochondrial volume and DNA-containing nucleoids instead segregate in proportion to the cytoplasm inherited by each daughter. However, nucleoid partitioning errors are suppressed by control at two levels: Mitochondrial volume is actively distributed throughout a cell, and nucleoids are spaced out in semiregular arrays within mitochondria. During the cell cycle, both mitochondria and nucleoids appear to be produced without feedback, creating a net control of fluctuations that is just accurate enough to avoid substantial growth defects.	[Jajoo, Rishi; Jung, Yoonseok; Huh, Dann; Springer, Michael; Paulsson, Johan] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Viana, Matheus P.; Rafelski, Susanne M.] Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92697 USA	Harvard University; Harvard Medical School; University of California System; University of California Irvine	Paulsson, J (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA.	johan_paulsson@harvard.edu			NIH [GM095784, GM080177]; NSF [1137676, MCB-1330451]; Samsung Scholarship; Ellison Medical Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM080177, R01GM095784] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Samsung Scholarship(Samsung); Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by NIH grant GM095784 and NSF award 1137676 (J.P., R.J., and Y.J.), NIH training grant GM080177 (R.J.), a Samsung Scholarship (Y.J.), NSF grant MCB-1330451 (M.P.V. and S.M.R.), and the Ellison Medical Foundation (S.M.R.). We thank B. Ward, S. Reuveni, Z. Wunderlich, and S. Bakshi for helpful discussions and critical reading of the manuscript, and D. Landgraf, F. Winston, N. Rhind, B. Westermann, and T. Fox for gifts of strains and reagents.	Briggs C, 2005, ACTA HISTOCHEM, V107, P301, DOI 10.1016/j.acthis.2005.06.010; Chan YHM, 2012, SCIENCE, V337, P1186, DOI 10.1126/science.1223539; Duchen Michael R., 2004, Molecular Aspects of Medicine, V25, P365, DOI 10.1016/j.mam.2004.03.001; Fu CH, 2011, CURR BIOL, V21, P1431, DOI 10.1016/j.cub.2011.07.013; Garner EC, 2007, SCIENCE, V315, P1270, DOI 10.1126/science.1138527; Hoppins S, 2012, SCIENCE, V337, P1052, DOI 10.1126/science.1224709; Huh D, 2011, P NATL ACAD SCI USA, V108, P15004, DOI 10.1073/pnas.1013171108; Iborra FJ, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-9; Kruger N, 2008, CURR BIOL, V18, pR646, DOI 10.1016/j.cub.2008.06.069; Landgraf D, 2012, NAT METHODS, V9, P480, DOI [10.1038/NMETH.1955, 10.1038/nmeth.1955]; Lestas I, 2010, NATURE, V467, P174, DOI 10.1038/nature09333; Liu ZC, 2006, ANNU REV GENET, V40, P159, DOI 10.1146/annurev.genet.40.110405.090613; Mukherji S, 2014, ELIFE, V3, DOI 10.7554/eLife.02678; Osman C, 2015, P NATL ACAD SCI USA, V112, pE947, DOI 10.1073/pnas.1501737112; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Paulsson J, 2001, Q REV BIOPHYS, V34, P1, DOI 10.1017/S0033583501003663; Rafelski SM, 2012, SCIENCE, V338, P822, DOI 10.1126/science.1225720; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; Savage DF, 2010, SCIENCE, V327, P1258, DOI 10.1126/science.1186090; Sivakumar S, 2004, METHODS, V33, P213, DOI 10.1016/j.ymeth.2003.11.016; Taheri-Araghi S, 2015, CURR BIOL, V25, P385, DOI 10.1016/j.cub.2014.12.009; Tal S, 2012, PLASMID, V67, P167, DOI 10.1016/j.plasmid.2012.01.004; Tauber J, 2013, INT J BIOCHEM CELL B, V45, P593, DOI 10.1016/j.biocel.2012.11.019; Viana MP, 2015, METHOD CELL BIOL, V125, P77, DOI 10.1016/bs.mcb.2014.10.003; Yaffe MP, 1996, P NATL ACAD SCI USA, V93, P11664, DOI 10.1073/pnas.93.21.11664; Yaffe MP, 2003, P NATL ACAD SCI USA, V100, P11424, DOI 10.1073/pnas.1534703100	27	46	46	0	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 8	2016	351	6269					169	172		10.1126/science.aaa8714	http://dx.doi.org/10.1126/science.aaa8714			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4XQ	26744405	Green Accepted			2022-12-28	WOS:000367806500041
J	Kimura, M; Isogai, K; Kato, T; Ueda, Y; Nakahira, S; Shidatsu, M; Enoto, T; Hori, T; Nogami, D; Littlefield, C; Ishioka, R; Chen, YT; King, SK; Wen, CY; Wang, SY; Lehner, MJ; Schwamb, ME; Wang, JH; Zhang, ZW; Alcock, C; Axelrod, T; Bianco, FB; Byun, YI; Chen, WP; Cook, KH; Kim, DW; Lee, T; Marshall, SL; Pavlenko, EP; Antonyuk, OI; Antonyuk, KA; Pit, NV; Sosnovskij, AA; Babina, JV; Baklanov, AV; Pozanenko, AS; Mazaeva, ED; Schmalz, SE; Reva, IV; Belan, SP; Inasaridze, RY; Tungalag, N; Volnova, AA; Molotov, IE; de Miguel, E; Kasai, K; Stein, WL; Dubovsky, PA; Kiyota, S; Miller, I; Richmond, M; Goff, W; Andreev, MV; Takahashi, H; Kojiguchi, N; Sugiura, Y; Takeda, N; Yamada, E; Matsumoto, K; James, N; Pickard, RD; Tordai, T; Maeda, Y; Ruiz, J; Miyashita, A; Cook, LM; Imada, A; Uemura, M				Kimura, Mariko; Isogai, Keisuke; Kato, Taichi; Ueda, Yoshihiro; Nakahira, Satoshi; Shidatsu, Megumi; Enoto, Teruaki; Hori, Takafumi; Nogami, Daisaku; Littlefield, Colin; Ishioka, Ryoko; Chen, Ying-Tung; King, Sun-Kun; Wen, Chih-Yi; Wang, Shiang-Yu; Lehner, Matthew J.; Schwamb, Megan E.; Wang, Jen-Hung; Zhang, Zhi-Wei; Alcock, Charles; Axelrod, Tim; Bianco, Federica B.; Byun, Yong-Ik; Chen, Wen-Ping; Cook, Kem H.; Kim, Dae-Won; Lee, Typhoon; Marshall, Stuart L.; Pavlenko, Elena P.; Antonyuk, Oksana I.; Antonyuk, Kirill A.; Pit, Nikolai V.; Sosnovskij, Aleksei A.; Babina, Julia V.; Baklanov, Aleksei V.; Pozanenko, Alexei S.; Mazaeva, Elena D.; Schmalz, Sergei E.; Reva, Inna V.; Belan, Sergei P.; Inasaridze, Raguli Ya.; Tungalag, Namkhai; Volnova, Alina A.; Molotov, Igor E.; de Miguel, Enrique; Kasai, Kiyoshi; Stein, William L.; Dubovsky, Pavol A.; Kiyota, Seiichiro; Miller, Ian; Richmond, Michael; Goff, William; Andreev, Maksim V.; Takahashi, Hiromitsu; Kojiguchi, Naoto; Sugiura, Yuki; Takeda, Nao; Yamada, Eiji; Matsumoto, Katsura; James, Nick; Pickard, Roger D.; Tordai, Tamas; Maeda, Yutaka; Ruiz, Javier; Miyashita, Atsushi; Cook, Lewis M.; Imada, Akira; Uemura, Makoto			Repetitive patterns in rapid optical variations in the nearby black-hole binary V404 Cygni	NATURE			English	Article							X-RAY BINARY; TRANSIENT GS 2023+338; LIGHT CURVES; PARALLAX DISTANCE; RELATIVISTIC JETS; V4641 SAGITTARII; IGR J17091-3624; GRS 1915+105; COMPACT JET; OUTBURST	How black holes accrete surrounding matter is a fundamental yet unsolved question in astrophysics. It is generally believed that matter is absorbed into black holes via accretion disks, the state of which depends primarily on the mass-accretion rate. When this rate approaches the critical rate (the Eddington limit), thermal instability is supposed to occur in the inner disk, causing repetitive patterns of large-amplitude X-ray variability (oscillations) on timescales of minutes to hours(1). In fact, such oscillations have been observed only in sources with a high mass-accretion rate, such as GRS 1915+105 (refs 2, 3). These large-amplitude, relatively slow timescale, phenomena are thought to have physical origins distinct from those of X-ray or optical variations with small amplitudes and fast timescales (less than about 10 seconds) often observed in other black-hole binaries-for example, XTE J1118+480 (ref. 4) and GX 339-4 (ref. 5). Here we report an extensive multi-colour optical photometric data set of V404 Cygni, an X-ray transient source(6) containing a black hole of nine solar masses(7) (and a companion star) at a distance of 2.4 kiloparsecs (ref. 8). Our data show that optical oscillations on timescales of 100 seconds to 2.5 hours can occur at mass-accretion rates more than ten times lower than previously thought(1). This suggests that the accretion rate is not the critical parameter for inducing inner-disk instabilities. Instead, we propose that a long orbital period is a key condition for these large-amplitude oscillations, because the outer part of the large disk in binaries with long orbital periods will have surface densities too low to maintain sustained mass accretion to the inner part of the disk. The lack of sustained accretion-not the actual rate-would then be the critical factor causing large-amplitude oscillations in long-period systems.	[Kimura, Mariko; Isogai, Keisuke; Kato, Taichi; Ueda, Yoshihiro; Enoto, Teruaki; Hori, Takafumi; Nogami, Daisaku] Kyoto Univ, Grad Sch Sci, Dept Astron, Sakyo Ku, Kyoto 6068502, Japan; [Nakahira, Satoshi] Japan Aerosp Explorat Agcy, Human Spaceflight Technol Directorate, JEM Mission Operat & Integrat Ctr, 2-1-1 Sengen, Tsukuba, Ibaraki 3058505, Japan; [Shidatsu, Megumi] RIKEN, MAXI Team, 2-1 Hirosawa, Wako, Saitama 3510198, Japan; [Enoto, Teruaki] Kyoto Univ, Hakubi Ctr Adv Res, Kyoto 6068302, Japan; [Littlefield, Colin] Wesleyan Univ, Dept Astron, Middletown, CT 06459 USA; [Ishioka, Ryoko; Chen, Ying-Tung; King, Sun-Kun; Wen, Chih-Yi; Wang, Shiang-Yu; Lehner, Matthew J.; Schwamb, Megan E.; Wang, Jen-Hung; Zhang, Zhi-Wei; Cook, Kem H.; Lee, Typhoon] Acad Sinica, Inst Astron & Astrophys, 11F Astron Math Bldg,AS NTU 1,Sect 4,Roosevelt Rd, Taipei 10617, Taiwan; [Lehner, Matthew J.] Univ Penn, Dept Phys & Astron, 209 South 33rd St, Philadelphia, PA 19125 USA; [Lehner, Matthew J.; Alcock, Charles] Harvard Smithsonian Ctr Astrophys, 60 Garden St, Cambridge, MA 02138 USA; [Axelrod, Tim] Univ Arizona, Steward Observ, Tucson, AZ 85721 USA; [Bianco, Federica B.] NYU, Ctr Cosmol & Particle Phys, 4 Washington Pl, New York, NY 10003 USA; [Byun, Yong-Ik] Yonsei Univ, Dept Astron, Seoul 120749, South Korea; [Byun, Yong-Ik] Yonsei Univ, Univ Observ, Seoul 120749, South Korea; [Chen, Wen-Ping] Natl Cent Univ, Inst Astron, Chungli 32054, Taiwan; [Chen, Wen-Ping] Natl Cent Univ, Dept Phys, Chungli 32054, Taiwan; [Kim, Dae-Won] Max Planck Inst Astron, Konigstuhl 17, D-69117 Heidelberg, Germany; [Marshall, Stuart L.] Stanford Univ, KIPAC, 452 Lomita Mall, Stanford, CA 94309 USA; [Pavlenko, Elena P.; Antonyuk, Oksana I.; Antonyuk, Kirill A.; Pit, Nikolai V.; Sosnovskij, Aleksei A.; Babina, Julia V.; Baklanov, Aleksei V.; Belan, Sergei P.] Crimean Astrophys Observ, Nauchnyi, Crimea, Ukraine; [Pozanenko, Alexei S.; Mazaeva, Elena D.; Volnova, Alina A.] Russian Acad Sci, Space Res Inst, Moscow 117997, Russia; [Pozanenko, Alexei S.] Natl Res Nucl Univ, MEPhI Moscow Engn Phys Inst, Moscow, Russia; [Schmalz, Sergei E.] Leibniz Inst Astrophys, Potsdam, Germany; [Reva, Inna V.] Fesenkov Astrophys Inst, Alma Ata, Kazakhstan; [Inasaridze, Raguli Ya.] Ilia State Univ, Kharadze Abastumani Astrophys Observ, Tbilisi, Georgia; [Tungalag, Namkhai] Mongolian Acad Sci, Inst Astron & Geophys, Ulaanbaatar 13343, Mongolia; [Molotov, Igor E.] Russian Acad Sci, Keldysh Inst Appl Math, Moscow, Russia; [de Miguel, Enrique] Univ Huelva, Fac Ciencias Expt, Dept Fis Aplicada, Huelva 21071, Spain; [de Miguel, Enrique] Observ CIECEM, Ctr Backyard Astrophys, Parque Dunar, Almonte 21760, Huelva, Spain; [Kasai, Kiyoshi] Baselstr 133D, CH-4132 Muttenz, Switzerland; [Stein, William L.] 6025 Calle Paraiso, Las Cruces, NM 88012 USA; [Dubovsky, Pavol A.] Vihorlat Observ, Mierova 4, Humenne, Slovakia; [Kiyota, Seiichiro] VSOLJ, 7-1 Kitahatsutomi, Chiba 2730126, Japan; [Miller, Ian] Furzehill House, Swansea SA2 7LE, W Glam, Wales; [Richmond, Michael] Rochester Inst Technol, Dept Phys, Rochester, NY 14623 USA; [Goff, William] AAVSO, 13508 Monitor Lane, Sutter Creek, CA 95685 USA; [Andreev, Maksim V.] Russian Acad Sci, Inst Astron, Peak Terskol 361605, Kabardino Balka, Russia; [Andreev, Maksim V.] Natl Acad Sci Ukraine, Int Ctr Astron Med & Ecol Res, 27 Akad Zabolotnoho St, UA-03680 Kiev, Ukraine; [Takahashi, Hiromitsu] Hiroshima Univ, Sch Sci, Dept Phys Sci, 1-3-1 Kagamiyama, Hiroshima 7398526, Japan; [Kojiguchi, Naoto; Sugiura, Yuki; Takeda, Nao; Yamada, Eiji; Matsumoto, Katsura] Osaka Kyoiku Univ, 4-698-1 Asahigaoka, Osaka 5828582, Japan; [James, Nick] 1 Tavistock Rd, Chelmsford CM1 6JL, Essex, England; [Pickard, Roger D.] BAA VSS, Burlington House, London W1J 0DU, England; [Pickard, Roger D.] 3 Birches, Leominster HR6 9NG, Hereford, England; [Tordai, Tamas] Hungarian Astron Assoc, Polaris Observ, Laborc Utca 2-C, H-1037 Budapest, Hungary; [Maeda, Yutaka] 112-14 Kaminishiyama Machi, Nagasaki, Nagasaki 8500006, Japan; [Ruiz, Javier] Observ Cantabria, Carretera Rocamundo Sin Numero, Valderredible, Cantabria, Spain; [Ruiz, Javier] CSIC UC, Inst Fis Cantabria, Ave Los Castros Sin Numero, E-39005 Santander, Cantabria, Spain; [Ruiz, Javier] Agrupac Astron Cantabra, Apartado 573, Santander 39080, Spain; [Miyashita, Atsushi] Seikei High Sch, Seikei Meteorol Observ, Kichijoji Kitamachi 3-10-13, Tokyo 1808633, Japan; [Cook, Lewis M.] Ctr Backyard Astrophys Concord, 1730 Helix Court, Concord, CA 94518 USA; [Imada, Akira] Kyoto Univ, Kwasan Observ, Yamashina Ku, Kitakazan Ohmine Cho, Kyoto 6078471, Japan; [Imada, Akira] Kyoto Univ, Hida Observ, Yamashina Ku, Kitakazan Ohmine Cho, Kyoto 6078471, Japan; [Uemura, Makoto] Hiroshima Univ, Hiroshima Astrophys Sci Ctr, Kagamiyama 1-3-1, Hiroshima 7398526, Japan	Kyoto University; Japan Aerospace Exploration Agency (JAXA); RIKEN; Kyoto University; Wesleyan University; Academia Sinica - Taiwan; University of Pennsylvania; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; University of Arizona; New York University; Yonsei University; Yonsei University; National Central University; National Central University; Max Planck Society; Stanford University; Russian Academy of Sciences; Crimean Astrophysical Observatory; Russian Academy of Sciences; Space Research Institute of the Russian Academy of Sciences; National Research Nuclear University MEPhI (Moscow Engineering Physics Institute); Leibniz Institut fur Astrophysik Potsdam (AIP); Fesenkov Astrophysical Institute; Ilia State University; Mongolian Academy of Sciences; Russian Academy of Sciences; Keldysh Institute of Applied Mathematics; Universidad de Huelva; Rochester Institute of Technology; Institute of Astronomy of the Russian Academy of Sciences; Russian Academy of Sciences; National Academy of Sciences Ukraine; International Center for Astronomical & Medico-Ecological Research NASU; Hiroshima University; Osaka University of Education; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Cantabria; CSIC - Instituto de Fisica de Cantabria (IFCA); Kyoto University; Kyoto University; Hiroshima University	Kimura, M (corresponding author), Kyoto Univ, Grad Sch Sci, Dept Astron, Sakyo Ku, Kyoto 6068502, Japan.	mkimura@kusastro.kyoto-u.ac.jp	Enoto, Teruaki/GQH-0674-2022; Shidatsu, Megumi/C-5742-2017; Antoniuk, Oksana/AAX-9086-2021; Volnova, Alina/AGP-3946-2022; Pozanenko, Alexei/ABA-9307-2021; Lehner, Matthew/ABA-3818-2020; Baklanov, Alexey/ABH-6575-2020; Antoniuk, Kirill/AAX-9102-2021; Molotov, Igor/P-8020-2018; 溫志懿, Chih-Yi Wen/ABB-7241-2020; Sosnovskij, Aleksei A./I-6443-2015; Pit, Nikolay/AAN-6396-2020; Enoto, Teruaki/I-9948-2019; Belan, Sergey/AAN-4838-2020; Reva, Inna/AAS-6009-2020; de Miguel, Enrique/F-3734-2016; Nogami, Daisaku/Q-8582-2019; Mazaeva, Elena/AAM-6112-2020; Pit, Nikolay/AAX-8866-2021; Wang, Shiang-Yu/AAZ-2695-2020; 汪仁鴻, Andrew Wang/ABA-7785-2020; Takahashi, Hiromitsu H/T-2713-2017	Enoto, Teruaki/0000-0003-1244-3100; Volnova, Alina/0000-0003-3554-1037; Lehner, Matthew/0000-0003-4077-0985; Baklanov, Alexey/0000-0001-7684-059X; Molotov, Igor/0000-0001-8755-4804; 溫志懿, Chih-Yi Wen/0000-0003-4058-3303; Sosnovskij, Aleksei A./0000-0003-3771-4974; Enoto, Teruaki/0000-0003-1244-3100; de Miguel, Enrique/0000-0002-1381-8843; Pit, Nikolay/0000-0002-1878-8508; Wang, Shiang-Yu/0000-0001-6491-1901; 汪仁鴻, Andrew Wang/0000-0003-4708-5964; Takahashi, Hiromitsu H/0000-0001-6314-5897; Schwamb, Megan/0000-0003-4365-1455; Andreev, Maksym/0000-0002-1619-2807; Uemura, Makoto/0000-0002-7375-7405; Cook, Lewis/0000-0003-3332-9649; Dubovsky, Pavol/0000-0001-5541-2836; Inasaridze, Raguli/0000-0002-6653-0915; Pozanenko, Alexei/0000-0001-9435-1327; Littlefield, Colin/0000-0001-7746-5795; , Antoniuk/0000-0003-2754-8925; NAKAHIRA, Satoshi/0000-0001-9307-046X; Shidatsu, Megumi/0000-0001-8195-6546; Achilova, Diyora/0000-0002-7645-9497; Schmalz, Sergei/0000-0001-5783-3888; Pavlenko, Elena/0000-0003-4612-3703; Kim, Dae-Won/0000-0002-4932-698X	thematic research program [AS-88-TP-A02]; Russian Science Foundation [15-12-30016]; grant RUSTAVELI [FR/379/6-300/14]; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [25120007, 26400228]; Grants-in-Aid for Scientific Research [26400228] Funding Source: KAKEN	thematic research program; Russian Science Foundation(Russian Science Foundation (RSF)); grant RUSTAVELI; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We acknowledge the variable star observations from the AAVSO International Database contributed by observers worldwide and used in this research. We also thank the INTEGRAL groups for making the products of the ToO data public online at the INTEGRAL Science Data Centre. Work at ASIAA was supported in part by the thematic research program AS-88-TP-A02. A.S.P., E.D.M. and A.A.V. are grateful to the Russian Science Foundation (grant 15-12-30016) for support. R.Ya.I. is grateful for partial support by the grant RUSTAVELI FR/379/6-300/14. We thank H. Maehara, H. Akazawa, K. Hirosawa and J. Lluis for their optical observations. This work was supported by the Grant-in-Aid "Initiative for High-Dimensional Data-Driven Science through Deepening of Sparse Modeling" from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan (25120007 TK and 26400228 YU).	AAVSO American Association of Variable Star Observers, VAR STAR PLOTT; AAVSO American Association of Variable Star Observers, DOWNL DAT; Alcock C, 2003, EARTH MOON PLANETS, V92, P459, DOI 10.1023/B:MOON.0000031960.82021.26; Altamirano D, 2011, ASTROPHYS J LETT, V742, DOI 10.1088/2041-8205/742/2/L17; Bagnoli T, 2015, MON NOT R ASTRON SOC, V450, pL52, DOI 10.1093/mnrasl/slv045; Bagnoli T, 2013, MON NOT R ASTRON SOC, V431, P1947, DOI 10.1093/mnras/stt312; Barthelmy S. D., 2015, GRB COORD NETW CIRC, V17929; Belloni T, 2000, ASTRON ASTROPHYS, V355, P271; Belloni T, 1997, ASTROPHYS J, V479, pL145, DOI 10.1086/310595; BLANDFORD RD, 1979, ASTROPHYS J, V232, P34, DOI 10.1086/157262; BOHLIN RC, 1978, ASTROPHYS J, V224, P132, DOI 10.1086/156357; Cannizzo JK, 1996, ASTROPHYS J, V473, pL41, DOI 10.1086/310389; Cannizzo JK, 2012, ASTROPHYS J, V747, DOI 10.1088/0004-637X/747/2/117; CARDELLI JA, 1989, ASTROPHYS J, V345, P245, DOI 10.1086/167900; CASARES J, 1994, MON NOT R ASTRON SOC, V271, pL5, DOI 10.1093/mnras/271.1.L5; CASARES J, 1993, MON NOT R ASTRON SOC, V265, P834, DOI 10.1093/mnras/265.4.834; CASARES J, 1991, MON NOT R ASTRON SOC, V250, P712, DOI 10.1093/mnras/250.4.712; CASARES J, 1992, NATURE, V355, P614, DOI 10.1038/355614a0; Chen Y. T., 2015, ASTRON TELEGR, V7722; CHEVALIER C, 1995, ASTRON ASTROPHYS, V297, P103; Corbel S, 2002, ASTROPHYS J, V573, pL35, DOI 10.1086/341870; Fender R, 2004, ANNU REV ASTRON ASTR, V42, P317, DOI 10.1146/annurev.astro.42.053102.134031; Fender RP, 2001, MON NOT R ASTRON SOC, V322, P31, DOI 10.1046/j.1365-8711.2001.04080.x; Fender RP, 1999, MON NOT R ASTRON SOC, V304, P865, DOI 10.1046/j.1365-8711.1999.02364.x; Gandhi P, 2011, ASTROPHYS J LETT, V740, DOI 10.1088/2041-8205/740/1/L13; Gandhi P, 2015, ASTRON TELEGR, V7686; Gandhi P., 2015, ASTRON TELEGR, P7727; Gies DR, 2008, ASTROPHYS J, V678, P1237, DOI 10.1086/586690; Golenetskii S., 2015, GRB COORD NETW CIRC, V17938; Goranskij V. P., 1978, ASTRON TSIRK, V1024, P3; Hameury JM, 1998, MON NOT R ASTRON SOC, V298, P1048, DOI 10.1046/j.1365-8711.1998.01773.x; Hjellming RM, 2000, ASTROPHYS J, V544, P977, DOI 10.1086/317255; Hynes RI, 2009, MON NOT R ASTRON SOC, V399, P2239, DOI 10.1111/j.1365-2966.2009.15419.x; Hynes R. I., 2015, ASTRON TELEGR, V7677; Hynes R. I., 2015, ASTRON TELEGR, V7710; Hynes RI, 2003, MON NOT R ASTRON SOC, V345, P292, DOI 10.1046/j.1365-8711.2003.06938.x; IMAMURA JN, 1990, ASTROPHYS J, V365, P312, DOI 10.1086/169484; INTEGRAL Science Data Centre, 2015, INTEGRAL DAT AN; Itoh R., 2015, ASTRON TELEGR, P7709; Janiuk A, 2015, ASTRON ASTROPHYS, V574, DOI 10.1051/0004-6361/201425003; Janiuk A, 2011, MON NOT R ASTRON SOC, V414, P2186, DOI 10.1111/j.1365-2966.2011.18544.x; Jeong S., 2015, ASTRON TELEGR, V7699; Kaptein RG, 2000, ASTRON ASTROPHYS, V358, pL71; Kato T, 2004, PUBL ASTRON SOC JPN, V56, pS1, DOI 10.1093/pasj/56.sp1.S1; Kato T., 1999, INFORM B VARIABLE ST, P4777; Khargharia J, 2010, ASTROPHYS J, V716, P1105, DOI 10.1088/0004-637X/716/2/1105; KIM SW, 1992, ASTROPHYS J, V384, P269, DOI 10.1086/170870; King AL, 2012, ASTROPHYS J LETT, V746, DOI 10.1088/2041-8205/746/2/L20; King AR, 1998, MON NOT R ASTRON SOC, V293, pL42, DOI 10.1046/j.1365-8711.1998.01295.x; Kloppenborg Brian K., 2012, Journal of the American Association of Variable Star Observers, V40, P815; Lasota JP, 2001, NEW ASTRON REV, V45, P449, DOI 10.1016/S1387-6473(01)00112-9; Lehner MJ, 2009, PUBL ASTRON SOC PAC, V121, P138, DOI 10.1086/597516; LEWIN WHG, 1976, ASTROPHYS J, V207, pL95, DOI 10.1086/182188; MacDonald RKD, 2014, ASTROPHYS J, V784, DOI 10.1088/0004-637X/784/1/2; Makino F., 1989, IAU CIRC, V4782; Mandal S, 2015, ASTROPHYS J, V807, P108; MEYER F, 1984, ASTRON ASTROPHYS, V131, P303; Miller-Jones JCA, 2009, ASTROPHYS J LETT, V706, pL230, DOI 10.1088/0004-637X/706/2/L230; Mirabel IF, 1999, ANNU REV ASTRON ASTR, V37, P409, DOI 10.1146/annurev.astro.37.1.409; MOTCH C, 1982, ASTRON ASTROPHYS, V109, pL1; Munoz-Darias T., 2015, ASTRON TELEGR, V7669; Muyllaert E., 2015, BAAVSS ALERT, P4101; Negoro H., 2015, ASTRON TELEGR, V7646; Neilsen J, 2011, ASTROPHYS J, V737, DOI 10.1088/0004-637X/737/2/69; Orosz JA, 2001, ASTROPHYS J, V555, P489, DOI 10.1086/321442; Osaki Y, 2002, ASTRON ASTROPHYS, V383, P574, DOI 10.1051/0004-6361:20011744; Osaki Y, 1996, PUBL ASTRON SOC PAC, V108, P39, DOI 10.1086/133689; Panopoulou G., 2015, ASTRON TELEGR, P7674; Reid MJ, 2014, ASTROPHYS J, V796, DOI 10.1088/0004-637X/796/1/2; Revnivtsev M, 2002, ASTRON ASTROPHYS, V385, P904, DOI 10.1051/0004-6361:20020189; Russell TD, 2014, MON NOT R ASTRON SOC, V439, P1390, DOI 10.1093/mnras/stt2498; Sala G, 2012, ASTROPHYS J, V752, DOI 10.1088/0004-637X/752/2/158; Samus N. N., 1999, IAU CIRC, V7277; Savoury CDJ, 2011, MON NOT R ASTRON SOC, V415, P2025, DOI 10.1111/j.1365-2966.2011.18707.x; Scarpaci J., 2015, ASTRON TELEGR, V7737; Steeghs D, 2013, ASTROPHYS J, V768, DOI 10.1088/0004-637X/768/2/185; Stubbings R., 1999, IAU CIRC, V7253; Szkody P, 1989, IAU CIRC, V4794; Tanaka Y, 1996, ANNU REV ASTRON ASTR, V34, P607, DOI 10.1146/annurev.astro.34.1.607; Tybulev P. G., 2015, ASTRON TELEGR, V7667; Uemura M, 2004, PUBL ASTRON SOC JPN, V56, P823, DOI 10.1093/pasj/56.5.823; Uemura M, 2004, PUBL ASTRON SOC JPN, V56, pS61, DOI 10.1093/pasj/56.sp1.S61; Uemura M, 2002, PUBL ASTRON SOC JPN, V54, pL79, DOI 10.1093/pasj/54.5.L79; Uemura M, 2002, PUBL ASTRON SOC JPN, V54, P95, DOI 10.1093/pasj/54.1.95; Uemura M., 2005, INFORM B VARIABLE ST, V5626, P1; WAGNER RM, 1991, ASTROPHYS J, V378, P293, DOI 10.1086/170429; Wang JH, 2008, ASTROPHYS J LETT, V679, pL5, DOI 10.1086/588814; WHELAN JAJ, 1977, MON NOT R ASTRON SOC, V180, P657, DOI 10.1093/mnras/180.4.657; Wijnands R, 2012, MON NOT R ASTRON SOC, V422, pL91, DOI 10.1111/j.1745-3933.2012.01245.x; Zhang ZW, 2013, ASTRON J, V146, DOI 10.1088/0004-6256/146/1/14; Zycki PT, 1999, MON NOT R ASTRON SOC, V309, P561, DOI 10.1046/j.1365-8711.1999.02885.x	91	61	61	0	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 7	2016	529	7584					54	+		10.1038/nature16452	http://dx.doi.org/10.1038/nature16452			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6VY	26738590	Green Accepted, Green Submitted			2022-12-28	WOS:000367944900024
J	Gilmartin, HM				Gilmartin, Heather M.			Use hand cleaning to prompt mindfulness in clinic	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Gilmartin, Heather M.] Eastern Colorado Hlth Care Syst, Denver Seattle Ctr Innovat, Dept Vet Affairs, Denver, CO 80401 USA		Gilmartin, HM (corresponding author), Eastern Colorado Hlth Care Syst, Denver Seattle Ctr Innovat, Dept Vet Affairs, Denver, CO 80401 USA.	heather.gilmartin@va.gov		Gilmartin, Heather/0000-0002-0264-4059				Bishop SR, 2004, CLIN PSYCHOL-SCI PR, V11, P230, DOI 10.1093/clipsy/bph077; Croskerry P, 2013, NEW ENGL J MED, V368, P2445, DOI 10.1056/NEJMp1303712; Hanley A, 2015, MINDFULNESS, V6, P202, DOI 10.1007/s12671-013-0245-3; Kabat-Zinn J., 1990, FULL CATASTROPHE LIV, V1st, DOI DOI 10.1097/00006205-199202000-00020; Kahneman D., 2011, THINKING FAST SLOW; Kiyoshi-Teo H, 2013, INFECT CONT HOSP EP, V34, P1099, DOI 10.1086/673147; Shapiro S. L., 2005, INT J STRESS MANAGE, V12, P164, DOI [10.1037/1072-5245.12.2.164, DOI 10.1037/1072-5245.12.2.164]	7	6	6	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 4	2016	352								i13	10.1136/bmj.i13	http://dx.doi.org/10.1136/bmj.i13			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DA8LR	26728590				2022-12-28	WOS:000368056800001
J	Bower, GC				Bower, Geoffrey C.			The screams of a star being ripped apart	SCIENCE			English	Editorial Material							MASSIVE BLACK-HOLE; TIDAL DISRUPTION; ACCRETION; JET		[Bower, Geoffrey C.] Acad Sinica, Inst Astron & Astrophys, Hilo, HI 96720 USA	Academia Sinica - Taiwan	Bower, GC (corresponding author), Acad Sinica, Inst Astron & Astrophys, Hilo, HI 96720 USA.	gbower@asiaa.sinica.edu.tw	Bower, Geoffrey/ABC-8386-2020	Bower, Geoffrey/0000-0003-4056-9982				Best PN, 2012, MON NOT R ASTRON SOC, V421, P1569, DOI 10.1111/j.1365-2966.2012.20414.x; Bloom JS, 2011, SCIENCE, V333, P203, DOI 10.1126/science.1207150; Bower GC, 2011, ASTROPHYS J LETT, V732, DOI 10.1088/2041-8205/732/1/L12; Fender R, 2004, ANNU REV ASTRON ASTR, V42, P317, DOI 10.1146/annurev.astro.42.053102.134031; Genzel R, 2010, REV MOD PHYS, V82, DOI 10.1103/RevModPhys.82.3121; Gezari S, 2008, ASTROPHYS J, V676, P944, DOI 10.1086/529008; Livio M, 1999, PHYS REP, V311, P225, DOI 10.1016/S0370-1573(98)00102-1; REES MJ, 1988, NATURE, V333, P523, DOI 10.1038/333523a0; SHAKURA NI, 1973, ASTRON ASTROPHYS, V24, P337; van Velzen S, 2016, SCIENCE, V351, P62, DOI 10.1126/science.aad1182; Wang JX, 2004, ASTROPHYS J, V600, P149, DOI 10.1086/379767; Yuan F, 2014, ANNU REV ASTRON ASTR, V52, P529, DOI 10.1146/annurev-astro-082812-141003; Zauderer BA, 2011, NATURE, V476, P425, DOI 10.1038/nature10366	13	0	0	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 1	2016	351	6268					30	31		10.1126/science.aad5541	http://dx.doi.org/10.1126/science.aad5541			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ8QM	26721990				2022-12-28	WOS:000367364200028
J	Mandelblatt, JS; Stout, NK; Schechter, CB; van den Broek, JJ; Miglioretti, DL; Krapcho, M; Trentham-Dietz, A; Munoz, D; Lee, SJ; Berry, DA; van Ravesteyn, NT; Alagoz, O; Kerlikowske, K; Tosteson, ANA; Near, AM; Hoeffken, A; Chang, YJ; Heijnsdijk, EA; Chisholm, G; Huang, XL; Huang, H; Ergun, MA; Gangnon, R; Sprague, BL; Plevritis, S; Feuer, E; de Koning, HJ; Cronin, KA				Mandelblatt, Jeanne S.; Stout, Natasha K.; Schechter, Clyde B.; van den Broek, Jeroen J.; Miglioretti, Diana L.; Krapcho, Martin; Trentham-Dietz, Amy; Munoz, Diego; Lee, Sandra J.; Berry, Donald A.; van Ravesteyn, Nicolien T.; Alagoz, Oguzhan; Kerlikowske, Karla; Tosteson, Anna N. A.; Near, Aimee M.; Hoeffken, Amanda; Chang, Yaojen; Heijnsdijk, Eveline A.; Chisholm, Gary; Huang, Xuelin; Huang, Hui; Ergun, Mehmet Ali; Gangnon, Ronald; Sprague, Brian L.; Plevritis, Sylvia; Feuer, Eric; de Koning, Harry J.; Cronin, Kathleen A.			Collaborative Modeling of the Benefits and Harms Associated With Different US Breast Cancer Screening Strategies	ANNALS OF INTERNAL MEDICINE			English	Article							AGE 40 YEARS; COST-EFFECTIVENESS; UNITED-STATES; COMMUNITY PRACTICE; MENOPAUSAL STATUS; FOLLOW-UP; MAMMOGRAPHY; MORTALITY; RISK; POPULATION	Background: Controversy persists about optimal mammography screening strategies. Objective: To evaluate screening outcomes, taking into account advances in mammography and treatment of breast cancer. Design: Collaboration of 6 simulation models using national data on incidence, digital mammography performance, treatment effects, and other-cause mortality. Setting: United States. Patients: Average-risk U.S. female population and subgroups with varying risk, breast density, or comorbidity. Intervention: Eight strategies differing by age at which screening starts (40, 45, or 50 years) and screening interval (annual, biennial, and hybrid [annual for women in their 40s and biennial thereafter]). All strategies assumed 100% adherence and stopped at age 74 years. Measurements: Benefits (breast cancer-specific mortality reduction, breast cancer deaths averted, life-years, and quality adjusted life-years); number of mammograms used; harms (false-positive results, benign biopsies, and overdiagnosis); and ratios of harms (or use) and benefits (efficiency) per 1000 screens. Results: Biennial strategies were consistently the most efficient for average-risk women. Biennial screening from age 50 to 74 years avoided a median of 7 breast cancer deaths versus no screening; annual screening from age 40 to 74 years avoided an additional 3 deaths, but yielded 1988 more false-positive results and 11 more overdiagnoses per 1000 women screened. Annual screening from age 50 to 74 years was inefficient (similar benefits, but more harms than other strategies). For groups with a 2 to 4-fold increased risk, annual screening from age 40 years had similar harms and benefits as screening average-risk women biennially from 50 to 74 years. For groups with moderate or severe comorbidity, screening could stop at age 66 to 68 years. Limitation: Other imaging technologies, polygenic risk, and nonadherence were not considered. Conclusion: Biennial screening for breast cancer is efficient for average-risk populations. Decisions about starting ages and intervals will depend on population characteristics and the decision makers' weight given to the harms and benefits of screening.	[Mandelblatt, Jeanne S.] Lombardi Comprehens Canc Ctr, 3300 Whitehaven St,NW,Suite 4100, Washington, DC 20007 USA; [Stout, Natasha K.] Harvard Univ, Sch Med, Dept Populat Med, 133 Brookline Ave,6th Floor, Boston, MA 02215 USA; [Stout, Natasha K.] Harvard Pilgrim Hlth Care Inst, 133 Brookline Ave,6th Floor, Boston, MA 02215 USA; [Schechter, Clyde B.] Albert Einstein Coll Med, Dept Family & Social Med, 1300 Morris Pk Ave,Black Bldg 406, Bronx, NY 10461 USA; [van den Broek, Jeroen J.; van Ravesteyn, Nicolien T.; Heijnsdijk, Eveline A.; de Koning, Harry J.] Univ Med Ctr Rotterdam, Erasmus MC, POB 2040, NL-3000 CA Rotterdam, Netherlands; [Miglioretti, Diana L.] Univ Calif Davis, Sch Med, Dept Publ Hlth Sci, One Shields Ave,Med Sci 1C,Room 145, Davis, CA 95616 USA; [Krapcho, Martin] Information Management Serv Inc, 3901 Calverton Blvd,Suite 200, Calverton, MD 20705 USA; [Trentham-Dietz, Amy] Univ Wisconsin, Carbone Canc Ctr, 610 Walnut St,WARE Room 307, Madison, WI 53726 USA; [Munoz, Diego] Stanford Univ, 318 Campus Dr,Room S255, Stanford, CA 94305 USA; [Lee, Sandra J.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Mailstop CLS11007,450 Brookline Ave, Boston, MA 02215 USA; [Berry, Donald A.] Univ Texas MD Anderson Canc Ctr, Dept Biostat, 1400 Pressler St,4-5062 Pickens Acad Tower, Houston, TX 77030 USA; [Alagoz, Oguzhan] Univ Wisconsin, 1513 Univ Ave, Madison, WI 53706 USA; [Kerlikowske, Karla] Vet Affairs Med Ctr 111A1, 4150 Clement St, San Francisco, CA 94121 USA; [Tosteson, Anna N. A.] Geisel Sch Med Dartmouth, One Med Ctr Dr HB7505, Lebanon, NH 03756 USA; [Near, Aimee M.; Chang, Yaojen] Georgetown Univ, Lombardi Comprehens Canc Ctr, 3300 Whitehaven St NW,Suite 4100, Washington, DC 20007 USA; [Chisholm, Gary] Univ Texas MD Anderson Canc Ctr, Dept Gynecol Oncol & Reprod Med, Unit 1362,POB 301439, Houston, TX 77230 USA; [Huang, Xuelin] Univ Texas MD Anderson Canc Ctr, 1400 Pressler St,Unit 1411,POB 301402, Houston, TX 77230 USA; [Huang, Hui] Dana Farber Canc Inst, Dept Biostat & Computat Biol, 450 Brookline Ave, Boston, MA 02215 USA; [Ergun, Mehmet Ali] Univ Wisconsin, 3233 Mech Engn Bldg,1513 Univ Ave, Madison, WI 53706 USA; [Gangnon, Ronald] Univ Wisconsin, Dept Populat Hlth Sci, 610 Walnut St, Madison, WI 53726 USA; [Sprague, Brian L.] Univ Vermont, Off Hlth Promot Res, 1 South Prospect St, Burlington, VT 05401 USA; [Plevritis, Sylvia] Stanford Univ, James H Clark Ctr, Dept Radiol, Room S255,MC 5442,318 Campus Dr, Stanford, CA 94305 USA; [Feuer, Eric; Cronin, Kathleen A.] NCI, Div Canc Control & Populat Sci, 9609 Med Ctr Dr,MSC 9765,Room 4E534, Bethesda, MD 20892 USA	Harvard University; Harvard Medical School; Harvard Pilgrim Health Care; Yeshiva University; Albert Einstein College of Medicine; Erasmus University Rotterdam; Erasmus MC; University of California System; University of California Davis; University of Wisconsin System; University of Wisconsin Madison; Stanford University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; University of Texas System; UTMD Anderson Cancer Center; University of Wisconsin System; University of Wisconsin Madison; Dartmouth College; Georgetown University; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Harvard University; Dana-Farber Cancer Institute; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Vermont; Stanford University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Mandelblatt, JS (corresponding author), Lombardi Comprehens Canc Ctr, 3300 Whitehaven St,NW,Suite 4100, Washington, DC 20007 USA.	mandelbj@georgetown.edu	Ergun, Mehmet/AAB-9782-2019; de+Koning, Harry/AAF-9062-2019	Ergun, Mehmet/0000-0002-2480-8077; de+Koning, Harry/0000-0003-4682-3646; Alagoz, Oguzhan/0000-0002-5133-1382; Gangnon, Ronald/0000-0003-2587-6714	National Institutes of Health; NATIONAL CANCER INSTITUTE [U01CA152958, U54CA163303, P01CA154292, R01CA164301, P30CA023108, P30CA016672, U01CA199218] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	National Institutes of Health.	Albain K, 2012, LANCET, V379, P432, DOI 10.1016/S0140-6736(11)61625-5; Barlow WE, 2006, JNCI-J NATL CANCER I, V98, P1204, DOI 10.1093/jnci/djj331; Berry DA, 2005, NEW ENGL J MED, V353, P1784, DOI 10.1056/NEJMoa050518; Berry Donald A, 2006, J Natl Cancer Inst Monogr, P30, DOI 10.1093/jncimonographs/lgj006; Biller-Andorno N, 2014, NEW ENGL J MED, V370, P1965, DOI 10.1056/NEJMp1401875; Braithwaite D, 2013, JNCI-J NATL CANCER I, V105, P334, DOI 10.1093/jnci/djs645; Broeders M, 2012, J MED SCREEN, V19, P14, DOI 10.1258/jms.2012.012078; Calonge N, 2009, ANN INTERN MED, V151, P716, DOI 10.7326/0003-4819-151-10-200911170-00008; Carter JL, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.g7773; Chang YJ, 2012, BREAST CANCER RES TR, V136, P823, DOI 10.1007/s10549-012-2274-3; Cho H, 2013, ANN INTERN MED, V159, P667, DOI 10.7326/0003-4819-159-10-201311190-00005; Clarke Lauren D, 2006, J Natl Cancer Inst Monogr, P96, DOI 10.1093/jncimonographs/lgj013; de Gelder R, 2015, INT J CANCER, V137, P165, DOI 10.1002/ijc.29364; DEHAES JCJM, 1991, INT J CANCER, V49, P538, DOI 10.1002/ijc.2910490411; Dittus K, 2013, J GEN INTERN MED, V28, P1454, DOI 10.1007/s11606-013-2507-0; Elmore JG, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3824; Etzioni R, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju315; Etzioni R, 2013, ANN INTERN MED, V158, P831, DOI 10.7326/0003-4819-158-11-201306040-00008; Fenton JJ, 2013, ANN INTERN MED, V158, P580, DOI 10.7326/0003-4819-158-8-201304160-00002; Friedewald SM, 2014, JAMA-J AM MED ASSOC, V311, P2499, DOI 10.1001/jama.2014.6095; Fryback Dennis G, 2006, J Natl Cancer Inst Monogr, P37, DOI 10.1093/jncimonographs/lgj007; Gangnon RE, 2015, CANCER EPIDEM BIOMAR, V24, P905, DOI 10.1158/1055-9965.EPI-14-1286; Garcia-Closas M, 2013, NAT GENET, V45, P392, DOI 10.1038/ng.2561; Gotzsche PC, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001877.pub5; Hanmer J, 2006, MED DECIS MAKING, V26, P391, DOI 10.1177/0272989X06290497; Hoffmann TC, 2015, JAMA INTERN MED, V175, P274, DOI 10.1001/jamainternmed.2014.6016; Holford Theodore R, 2006, J Natl Cancer Inst Monogr, P19, DOI 10.1093/jncimonographs/lgj016; Kerlikowske K, 2008, J NATL CANCER I, V100, P1724, DOI 10.1093/jnci/djn388; Kerlikowske K, 2015, ANN INTERN MED, V162, P673, DOI 10.7326/M14-1465; Kerlikowske K, 2013, JAMA INTERN MED, V173, P807, DOI 10.1001/jamainternmed.2013.307; Kerlikowske K, 2011, ANN INTERN MED, V155, P493, DOI 10.7326/0003-4819-155-8-201110180-00005; Lansdorp-Vogelaar I, 2014, ANN INTERN MED, V161, P104, DOI 10.7326/M13-2867; Lauby-Secretan B, 2015, NEW ENGL J MED, V372, P2353, DOI 10.1056/NEJMsr1504363; Lee CI, 2013, J AM COLL RADIOL, V10, P913, DOI 10.1016/j.jacr.2013.09.010; Lee Sandra, 2006, J Natl Cancer Inst Monogr, P79, DOI 10.1093/jncimonographs/lgj011; Mandelblatt JCK, 2015, AHRQ PUBLICATION; Mandelblatt Jeanne, 2006, J Natl Cancer Inst Monogr, P47, DOI 10.1093/jncimonographs/lgj008; Mandelblatt JS, 2009, ANN INTERN MED, V151, P738, DOI 10.7326/0003-4819-151-10-200911170-00010; Mandelblatt JS, 1997, J GEN INTERN MED, V12, P551, DOI 10.1046/j.1525-1497.1997.07107.x; Mariotto AB, 2013, J CLIN EPIDEMIOL, V66, P1376, DOI 10.1016/j.jclinepi.2013.07.002; Matamala N, 2015, CLIN CHEM, V61, P1098, DOI 10.1373/clinchem.2015.238691; Mavaddat N, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv036; Miglioretti DL, 2015, RAD INDUCED BREAST C; Miller AB, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g366; Moss SM, 2006, LANCET, V368, P2053, DOI 10.1016/S0140-6736(06)69834-6; Moss SM, 2015, LANCET ONCOL, V16, P1123, DOI 10.1016/S1470-2045(15)00128-X; Moynihan R, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0125165, DOI 10.1371/J0URNAL.P0NE.0125165]; Munoz D, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju289; National Comprehensive Cancer Network, 2014, NCCN CLIN PRACT GUID; Nelson HD, 2012, ANN INTERN MED, V156, P635, DOI 10.7326/0003-4819-156-9-201205010-00006; Nystrom L, 2002, LANCET, V359, P909, DOI 10.1016/S0140-6736(02)08020-0; Paci E, 2014, CANCER EPIDEM BIOMAR, V23, P1159, DOI 10.1158/1055-9965.EPI-13-0320; Park JY, 2014, AM J ROENTGENOL, V203, P223, DOI 10.2214/AJR.13.11566; Pisano ED, 2005, NEW ENGL J MED, V353, P1773, DOI 10.1056/NEJMoa052911; Plevritis Sylvia K, 2006, J Natl Cancer Inst Monogr, P86, DOI 10.1093/jncimonographs/lgj012; Rechtman LR, 2014, AM J ROENTGENOL, V202, P293, DOI 10.2214/AJR.13.11585; Rosenberg RD, 2006, RADIOLOGY, V241, P55, DOI 10.1148/radiol.2411051504; Schonberg MA, 2011, J AM GERIATR SOC, V59, P1444, DOI 10.1111/j.1532-5415.2011.03523.x; Schousboe JT, 2011, ANN INTERN MED, V155, P10, DOI 10.7326/0003-4819-155-1-201107050-00003; Smith RA, 2014, CANCER EPIDEM BIOMAR, V23, P1139, DOI 10.1158/1055-9965.EPI-13-0946; Smith RA, 2012, CA-CANCER J CLIN, V62, P129, DOI 10.3322/caac.20143; Sprague BL, 2015, ANN INTERN MED, V162, P157, DOI 10.7326/M14-0692; Sprague BL, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju255; Stevens KN, 2013, CANCER RES, V73, P2025, DOI 10.1158/0008-5472.CAN-12-1699; Stout NK, 2006, JNCI-J NATL CANCER I, V98, P774, DOI 10.1093/jnci/djj210; Tabar L, 2000, RADIOL CLIN N AM, V38, P625, DOI 10.1016/S0033-8389(05)70191-3; Tan Sita Y G L, 2006, J Natl Cancer Inst Monogr, P56, DOI 10.1093/jncimonographs/lgj009; Tice JA, 2013, JNCI-J NATL CANCER I, V105, P1043, DOI 10.1093/jnci/djt124; Trentham-Dietz A, 2014, BREAST CANCER RES TR, V145, P165, DOI 10.1007/s10549-014-2905-y; United States Food and Drug Administration, 2013, MAMM QUAL STAND ACT; van Ravesteyn NT, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv103; van Ravesteyn NT, 2012, ANN INTERN MED, V156, P609, DOI 10.7326/0003-4819-156-9-201205010-00002; Vilaprinyo E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086858; Walter LC, 2001, JAMA-J AM MED ASSOC, V285, P2750, DOI 10.1001/jama.285.21.2750; Welch HG, 2014, JAMA INTERN MED, V174, P448, DOI 10.1001/jamainternmed.2013.13635	75	162	165	0	31	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 16	2016	164	4					215	+		10.7326/M15-1536	http://dx.doi.org/10.7326/M15-1536			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DD7WK	26756606	Green Accepted			2022-12-28	WOS:000370135300012
J	Froen, JF; Friberg, IK; Lawn, JE; Bhutta, ZA; Pattinson, RC; Allanson, ER; Flenady, V; McClure, EM; Franco, L; Goldenberg, RL; Kinney, MV; Leisher, SH; Pitt, C; Islam, M; Khera, A; Dhaliwal, L; Aggarwal, N; Raina, N; Temmerman, M				Froen, J. Frederik; Friberg, Ingrid K.; Lawn, Joy E.; Bhutta, Zulfiqar A.; Pattinson, Robert C.; Allanson, Emma R.; Flenady, Vicki; McClure, Elizabeth M.; Franco, Lynne; Goldenberg, Robert L.; Kinney, Mary V.; Leisher, Susannah Hopkins; Pitt, Catherine; Islam, Monir; Khera, Ajay; Dhaliwal, Lakhbir; Aggarwal, Neelam; Raina, Neena; Temmerman, Marleen		Lancet Ending Preventable Stillbir	Stillbirths: progress and unfinished business	LANCET			English	Article							GENERATING POLITICAL PRIORITY; PERINATAL-MORTALITY; GLOBAL HEALTH; CARE; CHILDRENS; WOMENS	This first paper of the Lancet Series on ending preventable stillbirths reviews progress in essential areas, identified in the 2011 call to action for stillbirth prevention, to inform the integrated post-2015 agenda for maternal and newborn health. Worldwide attention to babies who die in stillbirth is rapidly increasing, from integration within the new Global Strategy for Women's, Children's and Adolescents' Health, to country policies inspired by the Every Newborn Action Plan. Supportive new guidance and metrics including stillbirth as a core health indicator and measure of quality of care are emerging. Prenatal health is a crucial biological foundation to life-long health. A key priority is to integrate action for prenatal health within the continuum of care for maternal and newborn health. Still, specific actions for stillbirths are needed for advocacy, policy formulation, monitoring, and research, including improvement in the dearth of data for effective coverage of proven interventions for prenatal survival. Strong leadership is needed worldwide and in countries. Institutions with a mandate to lead global efforts for mothers and their babies must assert their leadership to reduce stillbirths by promoting healthy and safe pregnancies.	[Froen, J. Frederik; Friberg, Ingrid K.] Norwegian Inst Publ Hlth, Dept Int Publ Hlth, N-0403 Oslo, Norway; [Froen, J. Frederik] Univ Bergen, Ctr Intervent Sci Maternal & Child Hlth, Bergen, Norway; [Lawn, Joy E.] Maternal Adolescent Reprod & Child Hlth Ctr, London, England; [Pitt, Catherine] Dept Global Healthand Dev, London, England; [Bhutta, Zulfiqar A.] Dept Infect Dis Epidemiol, London, England; [Bhutta, Zulfiqar A.] London Sch Hyg & Trop Med, London WC1, England; [Bhutta, Zulfiqar A.] Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Bhutta, Zulfiqar A.] Ctr Excellence Women & Child Hlth, Karachi, Pakistan; [Bhutta, Zulfiqar A.] Aga Khan Univ, Karachi, Pakistan; [Pattinson, Robert C.] Univ Pretoria, Dept Obstet & Gynaecol, Maternal & Infant Hlth Care Strategies Unit, South African Med Res Council, ZA-0002 Pretoria, South Africa; [Allanson, Emma R.] Univ Western Australia, Fac Med Dent & Hlth Sci, Sch Womens & Infants Hlth, Crawley, Australia; [Allanson, Emma R.] WHO, World Bank Special Programme Res, UNICEF, UNDP,UN Populat fund, CH-1211 Geneva, Switzerland; [Temmerman, Marleen] WHO, Dept Reprod Hlth & Res, Dev & Res Training Human Reprod, CH-1211 Geneva, Switzerland; [Flenady, Vicki; Leisher, Susannah Hopkins] Univ Queensland, Mater Res Inst, Brisbane, Qld, Australia; [Flenady, Vicki; Leisher, Susannah Hopkins] Int Stillbirth Alliance, Millburn, NJ USA; [McClure, Elizabeth M.] Res Triangle Int, Durham, NC USA; [Franco, Lynne] EnCompass LLC, Rockville, MD USA; [Goldenberg, Robert L.] Columbia Univ, Dept Obstet & Gynecol, New York, NY USA; [Kinney, Mary V.] Save Children, Saving Newborn Lives, Edgemead, South Africa; [Islam, Monir] WHO Country Off, Windhoek, Namibia; [Khera, Ajay] Govt India, Minist Hlth & Family Welf, Delhi, India; [Dhaliwal, Lakhbir; Aggarwal, Neelam] Postgrad Inst Med Educ & Res, Dept Obstet & Gynecol, Chandigarh 160012, India; [Raina, Neena] WHO Reg Off South East Asia, Dept Child & Adolescent Hlth, Delhi, India	Norwegian Institute of Public Health (NIPH); University of Bergen; University of London; London School of Hygiene & Tropical Medicine; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Aga Khan University; South African Medical Research Council; University of Pretoria; University of Western Australia; The World Bank; United Nations Population Fund; World Health Organization; World Health Organization; Mater Research; University of Queensland; Columbia University; Save the Children; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh	Froen, JF (corresponding author), Norwegian Inst Publ Hlth, Dept Int Publ Hlth, N-0403 Oslo, Norway.	frederik.froen@fhi.no	Kinney, Mary V/M-6952-2013; Lawn, Joy/ABE-6382-2020; Pitt, Catherine K/K-3001-2012; Leisher, Susannah H H/S-8995-2016; Flenady, Vicki Jane/O-9609-2014; Leisher, Susannah/N-4451-2019	Kinney, Mary V/0000-0002-2903-0161; Lawn, Joy/0000-0002-4573-1443; Pitt, Catherine K/0000-0003-4967-8966; Leisher, Susannah H H/0000-0002-0191-8863; Flenady, Vicki Jane/0000-0001-8114-7677; Leisher, Susannah/0000-0002-0191-8863; Froen Froen, Jahn Frederik/0000-0001-9390-8509; McClure, Elizabeth/0000-0001-8659-5444; Blencowe, Hannah/0000-0003-1556-3159	Norwegian Agency for Development Cooperation; Centre for Intervention Science in Maternal and Child Health [223269]; Research Council of Norway through its Centers of Excellence; US Fund for UNICEF; Bill AMP; Melinda Gates Foundation [OPP1058954]; University of Western Australia (Crawley, Australia); Women and Infants Research Foundation; University of Bergen, Norway	Norwegian Agency for Development Cooperation; Centre for Intervention Science in Maternal and Child Health; Research Council of Norway through its Centers of Excellence; US Fund for UNICEF; Bill AMP; Melinda Gates Foundation; University of Western Australia (Crawley, Australia); Women and Infants Research Foundation; University of Bergen, Norway	We thank Aleena Wojcieszek for her extensive coordination and technical support for this Series, Zachariah J Falconer-Stout and Kelsey Simmons for their contributions to the organisational network analysis, Wenche Jacobsen and Birgit Vartdal for their assistance with literature searches, and the Lancet Ending Preventable Stillbirths Series Advisory Group for their valuable inputs to the concepts of this Series paper. The views expressed in this article do not necessarily represent the decisions, policy, or views of the authors' affiliations. JFF and IKF were funded in part by a technical support grant from the Norwegian Agency for Development Cooperation. JFF was supported in part by the Centre for Intervention Science in Maternal and Child Health (project number 223269), which is funded by the Research Council of Norway through its Centers of Excellence scheme and the University of Bergen, Norway. CP was funded through a Sub-grant from the US Fund for UNICEF under their Countdown to 2015 for Maternal, Newborn and Child Survival Grant (#OPP1058954) from the Bill & Melinda Gates Foundation. ERA was funded as a PhD candidate at the University of Western Australia (Crawley, Australia) by an Australian postgraduate award, an Athelstan and Amy Saw Medical top-up scholarship, and by the Women and Infants Research Foundation with a Gordon King Doctor of Philosophy scholarship.	Allanson E, 2016, WHO B IN PRESS; Allanson ER, 2015, B WORLD HEALTH ORGAN, V93, P424, DOI 10.2471/BLT.14.144683; [Anonymous], 2011, LANCET, V377, P1720, DOI 10.1016/S0140-6736(11)60715-0; Bhutto ZA, 2011, LANCET, V377, P1523, DOI 10.1016/S0140-6736(10)62269-6; Blencowe H, 2016, LANCET GLOB HLTH; Chou D, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4255; Confederation Suisse, 2016, SWISS POS FRAM SUST; Cousens S, 2011, LANCET, V377, P1319, DOI 10.1016/S0140-6736(10)62310-0; Darmstadt GL, 2014, LANCET, V384, P174, DOI 10.1016/S0140-6736(14)60458-X; Dowswell T, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000934.pub2; Fernandes QF, 2014, LANCET GLOB HEALTH, V2, pE468, DOI 10.1016/S2214-109X(14)70276-1; Flenady V, 2016, LANCET, V387, P691, DOI 10.1016/S0140-6736(15)01020-X; Flenady V, 2011, LANCET, V377, P1703, DOI 10.1016/S0140-6736(11)60064-0; Froen JF, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0801-7; Froen JF, 2011, LANCET, V377, P1353, DOI 10.1016/S0140-6736(10)62232-5; Goldenberg RL, 2011, LANCET, V377, P1798, DOI 10.1016/S0140-6736(10)62235-0; Heazell AEP, 2016, LANCET, V387, P604, DOI 10.1016/S0140-6736(15)00836-3; Howson C, 2012, BORN TOO SOON GLOBAL; Independent Expert Review Group, 2015, 2014 REP EV WOM EV C; Independent Expert Review Group, 2015, EV WOM EV CHILD EB A; Kerber K, 2015, BMC PREGNANCY CHILDB, V15, P59; Kinney MV, 2016, LANCET; Labrique AB, 2013, GLOB HEALTH-SCI PRAC, V1, P160, DOI 10.9745/GHSP-D-13-00031; Lawn JE, 2016, LANCET; Lawn JE, 2011, LANCET, V377, P1448, DOI 10.1016/S0140-6736(10)62187-3; Leitao J, 2013, GLOBAL HEALTH ACTION, V6, DOI 10.3402/gha.v6i0.21518; McClure EM, 2011, ACTA OBSTET GYN SCAN, V90, P1379, DOI 10.1111/j.1600-0412.2011.01275.x; McDougall L, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4327; Mehl G, 2014, SCIENCE, V345, P1284, DOI 10.1126/science.1258926; Michalow J, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0456-9; Nausheen S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076933; Pattinson R, 2011, LANCET, V377, P1610, DOI 10.1016/S0140-6736(10)62306-9; Pattinson R, 2009, INT J GYNECOL OBSTET, V107, pS113, DOI 10.1016/j.ijgo.2009.07.011; Pitt C, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001332; Qureshi ZU, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4620; Saastad E, 2007, ACTA OBSTET GYN SCAN, V86, P444, DOI 10.1080/00016340701207724; Saving Newborn Lives Save the Children, 2015, M REPORT NEWBORN HLT; Shiffman J, 2015, HLTH POLICY PLAN, DOI 10.1093/heapol/czu046; Shiffman J, 2007, LANCET, V370, P1370, DOI 10.1016/S0140-6736(07)61579-7; Shiffman J, 2013, AM J PUBLIC HEALTH, V103, P623, DOI 10.2105/AJPH.2012.300919; Shiffman J, 2010, LANCET, V375, P2045, DOI 10.1016/S0140-6736(10)60710-6; Smith SL, 2015, HLTH POLICY PLAN, DOI 10.1093/heapol/czu114; Smith SL, 2014, GLOB PUBLIC HEALTH, V9, P538, DOI 10.1080/17441692.2014.904918; Stenberg K, 2014, LANCET, V383, P1333, DOI 10.1016/S0140-6736(13)62231-X; Temmerman M, 2015, BMJ-BRIT MED J, V351; ten Hoope-Bender P, 2014, LANCET, V384, P1226, DOI 10.1016/S0140-6736(14)60930-2; The Partnership for Maternal Newborn & Child Health, 2015, PLAC HLTH WOM CHILD; The World Bank, 2015, BUS PLAN GLOB FIN FA; Travis P, 2004, LANCET, V364, P900, DOI 10.1016/S0140-6736(04)16987-0; Tuncalp O, 2015, BJOG-INT J OBSTET GY, V122, P1045, DOI 10.1111/1471-0528.13451; UN, 2015, SURV THRIV TRANSF GL; UN. Commission on the Status of Women, 2014, COMM STAT WOM REV AP; UNFPA, 2014, STAT WORLDS MODW 201; United Nations, 2015, SAV LIV PROT FUT PRO; United Nations Population Fund (UNFPA), 2013, BASIS HUMAN RIGHTS; United Nations Women (UNWomen), 2015, GEND EQ HUM RIGHTS; Vogel JP, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-19; Walker N, 2011, LANCET, V377, P1292, DOI 10.1016/S0140-6736(10)62355-0; Walt G, 2008, HEALTH POLICY PLANN, V23, P308, DOI 10.1093/heapol/czn024; WHO, 2014, ACC WOM CHILDR HLTH; WHO, 2015, WHO PROGR REP, VWHA68/A68.36; WHO, 2015, MON ACH HLTH REL MIL; WHO, 2014, PREV EL DISR AB FACI; WHO, 2014, 134 WHO EX BOARD M N; WHO, 2014, WHA672014REC1 WHO; WHO, 2013, H4 PARTN JOINT COUNT; WHO & UNICEF, 2015, EV NEWB ACT PLAN PRO; WHO (World Health Organization), 2015, STRAT END PREV MAT M; World Bank USAID and WHO, 2015, ROADM HLTH MEAS ACC; World Bank WHO USAID, 2015, HLTH MEAS ACC POST 2; World Health Organisation, 2021, MENT HLTH ACT PLAN 2; World Health Organization, 2015, GLOB REF LIST 100 CA; World Health Organization, 2004, ICD 10 INT STAT CLAS, DOI 10/2016/en#/II; World Health Organization, 2011, WHO STAT ANT CAR; World Health Organization, 2012, WHO APPL ICD 10 DEAT; World Health Organization, 2014, EV NEWB ACT PLAN END; World Health Organization UNICEF, 2015, COUNTD 2015 MAT NEWB	77	92	95	1	13	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 6	2016	387	10018					574	586		10.1016/S0140-6736(15)00818-1	http://dx.doi.org/10.1016/S0140-6736(15)00818-1			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DD3PV	26794077	Bronze			2022-12-28	WOS:000369835800036
J	Ee, C; Xue, C; Chondros, P; Myers, SP; French, SD; Teede, H; Pirotta, M				Ee, Carolyn; Xue, Charlie; Chondros, Patty; Myers, Stephen P.; French, Simon D.; Teede, Helena; Pirotta, Marie			Acupuncture for Menopausal Hot Flashes A Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							QUALITY-OF-LIFE; POSTMENOPAUSAL WOMEN; VASOMOTOR SYMPTOMS; FLUSHES; HEALTH; PERIMENOPAUSAL; MEDICINE; MANAGEMENT; SEVERITY; ACUFLASH	Background: Hot flashes (HFs) affect up to 75% of menopausal women and pose a considerable health and financial burden. Evidence of acupuncture efficacy as an HF treatment is conflicting. Objective: To assess the efficacy of Chinese medicine acupuncture against sham acupuncture for menopausal HFs. Design: Stratified, blind (participants, outcome assessors, and investigators, but not treating acupuncturists), parallel, randomized, sham-controlled trial with equal allocation. (Australia New Zealand Clinical Trials Registry: ACTRN12611000393954) Setting: Community in Australia. Participants: Women older than 40 years in the late menopausal transition or postmenopause with at least 7 moderate HFs daily, meeting criteria for Chinese medicine diagnosis of kidney yin deficiency. Interventions: 10 treatments over 8 weeks of either standardized Chinese medicine needle acupuncture designed to treat kidney yin deficiency or noninsertive sham acupuncture. Measurements: The primary outcome was HF score at the end of treatment. Secondary outcomes included quality of life, anxi-ety, depression, and adverse events. Participants were assessed at 4 weeks, the end of treatment, and then 3 and 6 months after the end of treatment. Intention-to-treat analysis was conducted with linear mixed-effects models. Results: 327 women were randomly assigned to acupuncture (n = 163) or sham acupuncture (n = 164). At the end of treatment, 16% of participants in the acupuncture group and 13% in the sham group were lost to follow-up. Mean HF scores at the end of treatment were 15.36 in the acupuncture group and 15.04 in the sham group (mean difference, 0.33 [95% CI, -1.87 to 2.52]; P = 0.77). No serious adverse events were reported. Limitation: Participants were predominantly Caucasian and did not have breast cancer or surgical menopause. Conclusion: Chinese medicine acupuncture was not superior to noninsertive sham acupuncture for women with moderately severe menopausal HFs.	[Ee, Carolyn; Pirotta, Marie] Univ Melbourne, Dept Gen Practice, 200 Berkeley St, Carlton, Vic 3053, Australia; [Xue, Charlie] Royal Melbourne Inst Technol RMIT Univ, Sch Hlth Sci, POB 71, Bundoora, Vic 3083, Australia; [Myers, Stephen P.] So Cross Univ, NatMed Res Unit, POB 157, Lismore, Qld 2480, Australia; [French, Simon D.] Queens Univ, Sch Rehabil Therapy, Louise D Acton Bldg,3 George St, Kingston, ON K7L 3N6, Canada; [Teede, Helena] Monash Ctr Hlth Res & Implementat, Sch Publ Hlth & Prevent Med, Level 1,43-51 Kanooka Grove, Clayton, Vic 3168, Australia	University of Melbourne; Royal Melbourne Institute of Technology (RMIT); Southern Cross University; Queens University - Canada	Ee, C (corresponding author), Univ Melbourne, Dept Gen Practice, 200 Berkeley St, Carlton, Vic 3053, Australia.	ccee@unimelb.edu.au	Xue, Charlie C/F-1244-2014; Chondros, Patty/AAT-6426-2020; Ee, Carolyn/V-5070-2019	Ee, Carolyn/0000-0002-3363-9199; Xue, Charlie/0000-0001-6937-9088; Teede, Helena/0000-0001-7609-577X; Chondros, Patty/0000-0003-0393-8734; French, Simon/0000-0002-7061-7706	National Health and Medical Research Council (NHMRC) of Australia [APP 1004406]; NHMRC Career Development Fellowship; NHMRC Postgraduate Scholarship; NHMRC Practitioner Fellowship	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Career Development Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Postgraduate Scholarship(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Practitioner Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	By the National Health and Medical Research Council (NHMRC) of Australia (project grant APP 1004406). Dr. Pirotta is supported by an NHMRC Career Development Fellowship. Dr. Ee is supported by an NHMRC Postgraduate Scholarship. Dr. Teede is supported by an NHMRC Practitioner Fellowship.	Archer DF, 2011, CLIMACTERIC, V14, P515, DOI 10.3109/13697137.2011.608596; Australian Bureau of Statistics, 2011, 65230 AUSTR BUR STAT; Bang HJ, 2004, CONTROL CLIN TRIALS, V25, P143, DOI 10.1016/j.cct.2003.10.016; Bordeleau L, 2007, CLIN THER, V29, P230, DOI 10.1016/j.clinthera.2007.02.006; Borud E, 2010, AUTON NEUROSCI-BASIC, V157, P57, DOI 10.1016/j.autneu.2010.04.004; Borud E, 2010, MATURITAS, V66, P131, DOI 10.1016/j.maturitas.2009.12.010; Borud EK, 2009, ACUPUNCT MED, V27, P101, DOI 10.1136/aim.2009.000612; Borud EK, 2009, MENOPAUSE, V16, P484, DOI 10.1097/gme.0b013e31818c02ad; Butt DA, 2007, MENOPAUSE, V14, P203, DOI 10.1097/01.gme.0000235370.32103.4c; Chiu HY, 2015, MENOPAUSE, V22, P234, DOI [10.1097/GME.0000000000000260, 10.1097/gme.0000000000000260]; Cho SH, 2009, MENOPAUSE, V16, P1065, DOI 10.1097/gme.0b013e3181a48abd; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Devilly GJ, 2000, J BEHAV THER EXP PSY, V31, P73, DOI 10.1016/S0005-7916(00)00012-4; Dodin S, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007410.pub2; Eriksson I, 2001, INT J EPIDEMIOL, V30, P326, DOI 10.1093/ije/30.2.326; Fitzmaurice G, 2011, APPL LONGITUDINAL AN, V2nd; Freeman EW, 2007, CLIMACTERIC, V10, P197, DOI 10.1080/13697130601181486; Freeman EW, 2007, OBSTET GYNECOL, V110, P230, DOI 10.1097/01.AOG.0000270153.59102.40; Gerlinger C, 2012, MENOPAUSE, V19, P799, DOI 10.1097/gme.0b013e31823de8ba; Keenan NL, 2003, MENOPAUSE, V10, P507, DOI 10.1097/01.GME.0000064865.58809.3E; Kim DI, 2011, ACUPUNCT MED, V29, P249, DOI 10.1136/aim.2011.004085; Kim KH, 2010, MENOPAUSE, V17, P269, DOI 10.1097/gme.0b013e3181bfac3b; Lee MS, 2009, CLIMACTERIC, V12, P16, DOI 10.1080/13697130802566980; Leung L, 2012, J ACUPUNCT MERIDIAN, V5, P261, DOI 10.1016/j.jams.2012.07.017; Lewis JE, 2005, MATURITAS, V50, P209, DOI 10.1016/j.maturitas.2004.06.015; LITTLE RJA, 1993, J AM STAT ASSOC, V88, P125, DOI 10.1080/01621459.1993.10594302; Loprinzi CL, 2009, MENOPAUSE, V16, P621, DOI 10.1097/gme.0b013e3181a85107; Lund Irene, 2006, Acupunct Med, V24, P13; Lundeberg T, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/nep049; Maciocia G, 1998, OBSTET GYNECOLOGY CH; Nahin Richard L, 2009, Natl Health Stat Report, P1; Nir Y, 2007, MATURITAS, V56, P383, DOI 10.1016/j.maturitas.2006.11.001; Painovich JM, 2012, MENOPAUSE, V19, P54, DOI 10.1097/gme.0b013e31821f9171; Pariente J, 2005, NEUROIMAGE, V25, P1161, DOI 10.1016/j.neuroimage.2005.01.016; Park Jongbae, 2002, Acupunct Med, V20, P168; Pirotta M, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-224; Riley EH, 2004, J GEN INTERN MED, V19, P740, DOI 10.1007/s11606-004-0002-3; Sassarini J, 2013, CLIMACTERIC, V16, P31, DOI 10.3109/13697137.2013.805525; Sloan JA, 2001, J CLIN ONCOL, V19, P4280, DOI 10.1200/JCO.2001.19.23.4280; SNAITH RP, 1986, BRIT MED J, V292, P344, DOI 10.1136/bmj.292.6516.344; Soules M R, 2001, Climacteric, V4, P267; van der Sluijs CP, 2007, MENOPAUSE, V14, P397, DOI 10.1097/01.gme.0000236937.36078.f4; Villaseca P, 2012, CLIMACTERIC, V15, P115, DOI 10.3109/13697137.2011.624214; Vincent A, 2007, MENOPAUSE, V14, P45, DOI 10.1097/01.gme.0000227854.27603.7d; White A, 2008, ACUPUNCT MED, V26, P111, DOI 10.1136/aim.26.2.111; White AR, 2001, COMPLEMENT THER MED, V9, P237, DOI 10.1054/ctim.2001.0489; White IR, 2012, CLIN TRIALS, V9, P396, DOI 10.1177/1740774512450098; Whiteley J, 2013, MENOPAUSE, V20, P518, DOI [10.1097/gme.0b013e31827d38a5, 10.1097/GME.0b013e31827d38a5]; Whiteman MK, 2003, J WOMEN HEALTH GEN-B, V12, P459, DOI 10.1089/154099903766651586; Whiteman MK, 2003, OBSTET GYNECOL, V101, P264, DOI 10.1016/S0029-7844(02)02593-0; Witt CM, 2009, FORSCH KOMPLEMENTMED, V16, P91, DOI 10.1159/000209315; Wyrwich KW, 2008, MENOPAUSE, V15, P698, DOI 10.1097/gme.0b013e31815f892d; Zell B, 2000, MENOPAUSE, V7, P129, DOI 10.1097/00042192-200007020-00010	53	48	54	1	51	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 2	2016	164	3					146	U135		10.7326/M15-1380	http://dx.doi.org/10.7326/M15-1380			20	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DC4DD	26784863				2022-12-28	WOS:000369169400003
J	Coombes, R				Coombes, Rebecca			INVESTIGATIVE JOURNALISM Attacking the devil: the thalidomide story	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												rcoombes@bmj.com							0	3	3	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 21	2016	352								i353	10.1136/bmj.i353	http://dx.doi.org/10.1136/bmj.i353			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DC4ZU	26797696				2022-12-28	WOS:000369230300007
J	Pulla, P				Pulla, Priyanka			WORKFORCE PLANNING Are India's quacks the answer to its shortage of doctors?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												priyanka@gmail.com						Banerjee A, 2003, WEALTH HLTH HLTH SER; Centre for Economic and Social Studies, 2006, METH PRACT NEX QUAL; Centre for Policy Research, 2011, MAPP MED PROV RUR IN; Das J, 2015, QUALITY ACCOUNTABILI; Ditta R, 2013, IOSR J HUMANITIES SO, V14, P44, DOI [DOI 10.9790/0837-1424453, 10.9790/0837-1424453]; Gautham M, 2014, HEALTH POLICY PLANN, V29, pI20, DOI 10.1093/heapol/czt050; IANS, 2015, HINDUSTAN TIMES 1129; Kumar A, 2015, TELANGANA STATE PARA; Sood A, 2012, INDIAN J GASTROENTER, V31, P232, DOI 10.1007/s12664-012-0251-8; World Bank, PHYS PER 1000 PEOPL	10	10	10	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 21	2016	352								i291	10.1136/bmj.i291	http://dx.doi.org/10.1136/bmj.i291			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DC4ZU	26797712				2022-12-28	WOS:000369230300003
J	Reisman, A				Reisman, Anna			Gifts	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Reisman, Anna] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA	Yale University	Reisman, A (corresponding author), Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA.								0	0	0	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 21	2016	374	3					208	209		10.1056/NEJMp1510630	http://dx.doi.org/10.1056/NEJMp1510630			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DB3IS	26789869				2022-12-28	WOS:000368404800005
J	Sacks, HS				Sacks, Henry S.			Preexposure tenofovir-emtricitabine reduced HIV infection in men who have unprotected anal sex with men	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							ANTIRETROVIRAL PROPHYLAXIS; PREVENTION		[Sacks, Henry S.] Icahn Sch Med Mt Sinai, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Sacks, HS (corresponding author), Icahn Sch Med Mt Sinai, New York, NY 10029 USA.							Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Centers for Disease Control and Prevention, 2014, PREEXP PROPH PREV HI, P1; Choopanya K, 2013, LANCET, V381, P2083, DOI 10.1016/S0140-6736(13)61127-7; Marrazzo JM, 2014, JAMA-J AM MED ASSOC, V312, P390, DOI 10.1001/jama.2014.7999; Schackman BR, 2015, MED CARE, V53, P293, DOI 10.1097/MLR.0000000000000308; Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711; Young J, 2012, AIDS, V26, P567, DOI 10.1097/QAD.0b013e32834f337c	7	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 19	2016	164	2					JC3	JC3		10.7326/ACPJC-2016-164-2-003	http://dx.doi.org/10.7326/ACPJC-2016-164-2-003			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DB0CI	26784493				2022-12-28	WOS:000368175800002
J	Smith, JM				Smith, Jeanette M.			The Doctor Henri Vaquez (1860-1936), Cardiologist	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 19	2016	315	3					230	231		10.1001/jama.2015.14060	http://dx.doi.org/10.1001/jama.2015.14060			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DB2WN	26784751				2022-12-28	WOS:000368371400001
J	Duffy, S				Duffy, Stella			WHAT YOUR PATIENT IS THINKING I chose reconstruction, but not to "look good"	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 18	2016	352								h6786	10.1136/bmj.h6786	http://dx.doi.org/10.1136/bmj.h6786			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DC4ZM	26783241	Bronze, Green Published			2022-12-28	WOS:000369229500002
J	Bieling, P; Li, TD; Weichsel, J; McGorty, R; Jreij, P; Huang, B; Fletcher, DA; Mullins, RD				Bieling, Peter; Li, Tai-De; Weichsel, Julian; McGorty, Ryan; Jreij, Pamela; Huang, Bo; Fletcher, Daniel A.; Mullins, R. Dyche			Force Feedback Controls Motor Activity and Mechanical Properties of Self-Assembling Branched Actin Networks	CELL			English	Article							ARP2/3 COMPLEX; FILAMIN-A; DENDRITIC ORGANIZATION; BIOPOLYMER NETWORKS; CAPPING PROTEIN; LEADING-EDGE; CELL; FILAMENTS; LAMELLIPODIA; DETERMINES	Branched actin networks-created by the Arp2/3 complex, capping protein, and a nucleation promoting factor-generate and transmit forces required for many cellular processes, but their response to force is poorly understood. To address this, we assembled branched actin networks in vitro from purified components and used simultaneous fluorescence and atomic force microscopy to quantify their molecular composition and material properties under various forces. Remarkably, mechanical loading of these self-assembling materials increases their density, power, and efficiency. Microscopically, increased density reflects increased filament number and altered geometry but no change in average length. Macroscopically, increased density enhances network stiffness and resistance to mechanical failure beyond those of isotropic actin networks. These effects endow branched actin networks with memory of their mechanical history that shapes their material properties and motor activity. This work reveals intrinsic force feedback mechanisms by which mechanical resistance makes self-assembling actin networks stiffer, stronger, and more powerful.	[Bieling, Peter; Mullins, R. Dyche] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Bieling, Peter; Mullins, R. Dyche] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Bieling, Peter; Li, Tai-De; Jreij, Pamela; Fletcher, Daniel A.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Bieling, Peter; Li, Tai-De; Jreij, Pamela; Fletcher, Daniel A.] Univ Calif Berkeley, Biophys Program, Berkeley, CA 94720 USA; [Li, Tai-De; Fletcher, Daniel A.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Li, Tai-De] CUNY, Advance Sci Res Ctr, New York, NY 10031 USA; [Weichsel, Julian] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [McGorty, Ryan; Huang, Bo] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; City University of New York (CUNY) System; University of California System; University of California Berkeley; University of California System; University of California San Francisco	Fletcher, DA (corresponding author), Univ Calif Berkeley, Dept Bioengn, 648 Stanley Hall,MC 1762, Berkeley, CA 94720 USA.	fletch@berkeley.edu; dyche.mullins@ucsf.edu		Bieling, Peter/0000-0002-7458-4358; McGorty, Ryan/0000-0002-6577-060X; Li, Tai-De/0000-0003-0515-5135	NIH [R01 GM074751, R01 GM061010]; HHMI; HFSP [LT-000843/2010]; EMBO [ALTF 854-2009]; Taiwan National Science Council; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061010, R01GM074751, R35GM118119] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD008479] Funding Source: NIH RePORTER; Div Of Civil, Mechanical, & Manufact Inn [1235569] Funding Source: National Science Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI(Howard Hughes Medical Institute); HFSP(Human Frontier Science Program); EMBO(European Molecular Biology Organization (EMBO)); Taiwan National Science Council(Ministry of Science and Technology, Taiwan); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Div Of Civil, Mechanical, & Manufact Inn(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	We thank Scott Hansen for reagents, discussions, and comments on the manuscript; Thomas Surrey, Michael Vahey, and Marcus Taylor for comments on the manuscript; and members of the D.A.F. and R.D.M. labs for discussions. This work was supported by NIH R01 GM074751 (D.A.F.), NIH R01 GM061010 (R.D.M.), HHMI (R.D.M.), HFSP LT-000843/2010 (P.B.), and EMBO ALTF 854-2009 (P.B.). T.-D.L. was supported by the Taiwan National Science Council. This project was an equal collaboration between the laboratories of D.A.F. and R.D.M. The order in which the corresponding authors are listed was determined by flipping a coin.	Akin O, 2008, CELL, V133, P841, DOI 10.1016/j.cell.2008.04.011; Beltzner CC, 2008, J BIOL CHEM, V283, P7135, DOI 10.1074/jbc.M705894200; Bisi S, 2013, CURR OPIN CELL BIOL, V25, P565, DOI 10.1016/j.ceb.2013.04.001; Cameron LA, 2001, CURR BIOL, V11, P130, DOI 10.1016/S0960-9822(01)00022-7; Carter NJ, 2005, NATURE, V435, P308, DOI 10.1038/nature03528; Chaudhuri O, 2007, NATURE, V445, P295, DOI 10.1038/nature05459; Clark AG, 2009, CURR BIOL, V19, P1389, DOI 10.1016/j.cub.2009.06.044; Flanagan LA, 2001, J CELL BIOL, V155, P511, DOI 10.1083/jcb.200105148; Fourniol FJ, 2014, METHOD ENZYMOL, V540, P339, DOI 10.1016/B978-0-12-397924-7.00019-4; Gardel ML, 2008, J CELL BIOL, V183, P999, DOI 10.1083/jcb.200810060; Gardel ML, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.188102; Gardel ML, 2006, P NATL ACAD SCI USA, V103, P1762, DOI 10.1073/pnas.0504777103; Gardel ML, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.158302; Gardel ML, 2004, SCIENCE, V304, P1301, DOI 10.1126/science.1095087; HILL TL, 1982, INT REV CYTOL, V78, P1, DOI 10.1016/S0074-7696(08)60105-9; Huang B, 2008, SCIENCE, V319, P810, DOI 10.1126/science.1153529; Insall RH, 2009, DEV CELL, V17, P310, DOI 10.1016/j.devcel.2009.08.012; JANMEY PA, 1991, J CELL BIOL, V113, P155, DOI 10.1083/jcb.113.1.155; Janmey PA, 2007, ANNU REV BIOMED ENG, V9, P1, DOI 10.1146/annurev.bioeng.9.060906.151927; Kasza KE, 2007, CURR OPIN CELL BIOL, V19, P101, DOI 10.1016/j.ceb.2006.12.002; MACKINTOSH FC, 1995, PHYS REV LETT, V75, P4425, DOI 10.1103/PhysRevLett.75.4425; Maly IV, 2001, P NATL ACAD SCI USA, V98, P11324, DOI 10.1073/pnas.181338798; Marcy Y, 2004, P NATL ACAD SCI USA, V101, P5992, DOI 10.1073/pnas.0307704101; Mogilner A, 1996, BIOPHYS J, V71, P3030, DOI 10.1016/S0006-3495(96)79496-1; Mooren OL, 2012, ANNU REV BIOCHEM, V81, P661, DOI 10.1146/annurev-biochem-060910-094416; Mullins RD, 1998, P NATL ACAD SCI USA, V95, P6181, DOI 10.1073/pnas.95.11.6181; Nakamura F, 2002, J BIOL CHEM, V277, P9148, DOI 10.1074/jbc.M111297200; Nakamura F, 2007, J CELL BIOL, V179, P1011, DOI 10.1083/jcb.200707073; PANTALONI D, 1993, CELL, V75, P1007, DOI 10.1016/0092-8674(93)90544-Z; Parekh SH, 2005, NAT CELL BIOL, V7, P1219, DOI 10.1038/ncb1336; PESKIN CS, 1993, BIOPHYS J, V65, P316, DOI 10.1016/S0006-3495(93)81035-X; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Prass M, 2006, J CELL BIOL, V174, P767, DOI 10.1083/jcb.200601159; Pujol T, 2012, P NATL ACAD SCI USA, V109, P10364, DOI 10.1073/pnas.1121238109; Renkawitz J, 2009, NAT CELL BIOL, V11, P1438, DOI 10.1038/ncb1992; Reymann AC, 2011, MOL BIOL CELL, V22, P2541, DOI 10.1091/mbc.E11-01-0052; Reymann AC, 2010, NAT MATER, V9, P827, DOI 10.1038/nmat2855; Schafer DA, 1996, J CELL BIOL, V135, P169, DOI 10.1083/jcb.135.1.169; Schaus TE, 2007, P NATL ACAD SCI USA, V104, P7086, DOI 10.1073/pnas.0701943104; Storm C, 2005, NATURE, V435, P191, DOI 10.1038/nature03521; Stricker J, 2010, J BIOMECH, V43, P9, DOI 10.1016/j.jbiomech.2009.09.003; Svitkina TM, 1999, J CELL BIOL, V145, P1009, DOI 10.1083/jcb.145.5.1009; TILNEY LG, 1983, J CELL BIOL, V97, P112, DOI 10.1083/jcb.97.1.112; Vinzenz M, 2012, J CELL SCI, V125, P2775, DOI 10.1242/jcs.107623; WACHSSTOCK DH, 1993, BIOPHYS J, V65, P205, DOI 10.1016/S0006-3495(93)81059-2; Wagner B, 2006, P NATL ACAD SCI USA, V103, P13974, DOI 10.1073/pnas.0510190103; Weichsel J, 2012, CYTOM PART A, V81A, P496, DOI 10.1002/cyto.a.22050; Welch MD, 2013, CELL HOST MICROBE, V14, P242, DOI 10.1016/j.chom.2013.08.011; Wu CY, 2012, CELL, V148, P973, DOI 10.1016/j.cell.2011.12.034; Yamaguchi H, 2005, J CELL BIOL, V168, P441, DOI 10.1083/jcb.200407076	50	133	134	1	66	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 14	2016	164	1-2					115	127		10.1016/j.cell.2015.11.057	http://dx.doi.org/10.1016/j.cell.2015.11.057			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DB2LE	26771487	Bronze, Green Accepted			2022-12-28	WOS:000368339300014
J	Martens, EC				Martens, Eric C.			Fibre for the future	NATURE			English	Editorial Material							GUT MICROBIOTA		[Martens, Eric C.] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Martens, EC (corresponding author), Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA.	emartens@umich.edu						Clemente JC, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500183; Cuskin F, 2015, NATURE, V517, P165, DOI 10.1038/nature13995; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; El Kaoutari A, 2013, NAT REV MICROBIOL, V11, P497, DOI 10.1038/nrmicro3050; Larsbrink J, 2014, NATURE, V506, P498, DOI 10.1038/nature12907; Martens EC, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001221; Schnorr SL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4654; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Sonnenburg E., 2015, THE GOOD GUT; Sonnenburg ED, 2016, NATURE, V529, P212, DOI 10.1038/nature16504	10	16	18	2	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 14	2016	529	7585					158	159		10.1038/529158a	http://dx.doi.org/10.1038/529158a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA7WK	26762451				2022-12-28	WOS:000368015700021
J	Ponce-Salvatierra, A; Wawrzyniak-Turek, K; Steuerwald, U; Hobartner, C; Pena, V				Ponce-Salvatierra, Almudena; Wawrzyniak-Turek, Katarzyna; Steuerwald, Ulrich; Hoebartner, Claudia; Pena, Vladimir			Crystal structure of a DNA catalyst	NATURE			English	Article							PHOSPHOROTHIOATE OLIGONUCLEOTIDES; EFFICIENT SYNTHESIS; RNA; RIBOZYME; COMPLEX; DEOXYRIBOZYME	Catalysis in biology is restricted to RNA (ribozymes) and protein enzymes, but synthetic biomolecular catalysts can also be made of DNA (deoxyribozymes)(1) or synthetic genetic polymers(2). In vitro selection from synthetic random DNA libraries identified DNA catalysts for various chemical reactions beyond RNA backbone cleavage(3). DNA-catalysed reactions include RNA and DNA ligation in various topologies(4,5), hydrolytic cleavage(6,7) and photorepair of DNA(8), as well as reactions of peptides(9,10) and small molecules(11,12). In spite of comprehensive biochemical studies of DNA catalysts for two decades, fundamental mechanistic understanding of their function is lacking in the absence of three-dimensional models at atomic resolution. Early attempts to solve the crystal structure of an RNA-cleaving deoxyribozyme resulted in a catalytically irrelevant nucleic acid fold(13). Here we report the crystal structure of the RNA-ligating deoxyribozyme 9DB1 (ref. 14) at 2.8 angstrom resolution. The structure captures the ligation reaction in the post-catalytic state, revealing a compact folding unit stabilized by numerous tertiary interactions, and an unanticipated organization of the catalytic centre. Structure-guided mutagenesis provided insights into the basis for regioselectivity of the ligation reaction and allowed remarkable manipulation of substrate recognition and reaction rate. Moreover, the structure highlights how the specific properties of deoxyribose are reflected in the backbone conformation of the DNA catalyst, in support of its intricate three-dimensional organization. The structural principles underlying the catalytic ability of DNA elucidate differences and similarities in DNA versus RNA catalysts, which is relevant for comprehending the privileged position of folded RNA in the prebiotic world and in current organisms.	[Ponce-Salvatierra, Almudena; Wawrzyniak-Turek, Katarzyna; Hoebartner, Claudia] Max Planck Inst Biophys Chem, Max Planck Res Grp Nucle Acid Chem, D-37077 Gottingen, Germany; [Ponce-Salvatierra, Almudena; Steuerwald, Ulrich; Pena, Vladimir] Max Planck Inst Biophys Chem, Res Grp Macromol Crystallog, D-37077 Gottingen, Germany; [Wawrzyniak-Turek, Katarzyna; Hoebartner, Claudia] Univ Gottingen, Inst Organ & Biomol Chem, D-37077 Gottingen, Germany	Max Planck Society; Max Planck Society; University of Gottingen	Pena, V (corresponding author), Max Planck Inst Biophys Chem, Res Grp Macromol Crystallog, Fassberg 11, D-37077 Gottingen, Germany.	choebar1@gwdg.de; vpena@gwdg.de	Höbartner, Claudia/E-8462-2010; Ponce-Salvatierra, Almudena/AAP-8043-2020; Höbartner, Claudia/O-2182-2019	Höbartner, Claudia/0000-0002-4548-2299; Höbartner, Claudia/0000-0002-4548-2299; Ponce-Salvatierra, Almudena/0000-0003-3966-8123	Max Planck Society	Max Planck Society(Max Planck Society)	This work was supported by the Max Planck Society. We thank J. Ludwig for a gift of 5'-triphosphorylated RNAs, J. Seikowski for assistance with RNA and DNA synthesis, F. Wachowius and B. Samanta for initial crystallization samples, P. Afonine and members of the Pena and Hobartner laboratories for discussions, and the beamline staff at the Swiss Light Source, Villigen, Switzerland for assistance with data collection.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; BARTEL DP, 1993, SCIENCE, V261, P1411, DOI 10.1126/science.7690155; Breaker R R, 1994, Chem Biol, V1, P223, DOI 10.1016/1074-5521(94)90014-0; Buttner L, 2013, BIOORGAN MED CHEM, V21, P6171, DOI 10.1016/j.bmc.2013.04.007; Chandra M, 2008, J AM CHEM SOC, V130, P2936, DOI 10.1021/ja7111965; Chandra M, 2009, NAT CHEM BIOL, V5, P718, DOI 10.1038/nchembio.201; Chandrasekar J, 2013, P NATL ACAD SCI USA, V110, P5315, DOI 10.1073/pnas.1221946110; Chinnapen DJF, 2004, P NATL ACAD SCI USA, V101, P65, DOI 10.1073/pnas.0305943101; Coppins RL, 2004, J AM CHEM SOC, V126, P16426, DOI 10.1021/ja045817x; Coppins RL, 2004, NAT STRUCT MOL BIOL, V11, P270, DOI 10.1038/nsmb727; Davies DR, 2012, P NATL ACAD SCI USA, V109, P19971, DOI 10.1073/pnas.1213933109; Doudna JA, 2002, NATURE, V418, P222, DOI 10.1038/418222a; EKLAND EH, 1995, SCIENCE, V269, P364, DOI 10.1126/science.7618102; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fedor MJ, 2005, NAT REV MOL CELL BIO, V6, P399, DOI 10.1038/nrm1647; Frederiksen JK, 2009, METHOD ENZYMOL, V468, P289, DOI 10.1016/S0076-6879(09)68014-9; Goldeck M, 2014, ANGEW CHEM INT EDIT, V53, P4694, DOI 10.1002/anie.201400672; Gu HZ, 2013, J AM CHEM SOC, V135, P9121, DOI 10.1021/ja403585e; Ikawa Y, 2004, P NATL ACAD SCI USA, V101, P13750, DOI 10.1073/pnas.0405886101; Jaeger L, 1999, P NATL ACAD SCI USA, V96, P14712, DOI 10.1073/pnas.96.26.14712; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Keating KS, 2012, ACTA CRYSTALLOGR D, V68, P985, DOI 10.1107/S0907444912018549; Koch M, 2015, P NATL ACAD SCI USA, V112, pE2561, DOI 10.1073/pnas.1505231112; Kumar RK, 2007, NUCLEOS NUCLEOT NUCL, V26, P181, DOI 10.1080/15257770601112739; Li YF, 1996, NAT STRUCT BIOL, V3, P743, DOI 10.1038/nsb0996-743; LUDWIG J, 1989, J ORG CHEM, V54, P631, DOI 10.1021/jo00264a024; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nowakowski J, 1999, NAT STRUCT BIOL, V6, P151; Pitsch S, 2001, HELV CHIM ACTA, V84, P3773, DOI 10.1002/1522-2675(20011219)84:12<3773::AID-HLCA3773>3.0.CO;2-E; Pitt JN, 2009, J AM CHEM SOC, V131, P3532, DOI 10.1021/ja8067325; Purtha WE, 2005, J AM CHEM SOC, V127, P13124, DOI 10.1021/ja0533702; Ren AM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6534; Robertson MP, 2007, SCIENCE, V315, P1549, DOI 10.1126/science.1136231; Schlosser K, 2009, CHEM BIOL, V16, P311, DOI 10.1016/j.chembiol.2009.01.008; Shechner DM, 2011, NAT STRUCT MOL BIOL, V18, P1036, DOI 10.1038/nsmb.2107; Shechner DM, 2009, SCIENCE, V326, P1271, DOI 10.1126/science.1174676; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Sreedhara A, 2004, J AM CHEM SOC, V126, P3454, DOI 10.1021/ja039713i; Sun G, 2004, J CHEM INF COMP SCI, V44, P1752, DOI 10.1021/ci049881+; Taylor AI, 2015, NATURE, V518, P427, DOI 10.1038/nature13982; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; Vicens Q, 2009, NAT CHEM BIOL, V5, P97, DOI 10.1038/nchembio.136; Wachowius F, 2011, J AM CHEM SOC, V133, P14888, DOI 10.1021/ja205894w; Wachowius F, 2010, ANGEW CHEM INT EDIT, V49, P8504, DOI 10.1002/anie.201003940; Walsh SM, 2013, J AM CHEM SOC, V135, P14928, DOI 10.1021/ja407586u	46	84	86	3	176	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 14	2016	529	7585					231	U272		10.1038/nature16471	http://dx.doi.org/10.1038/nature16471			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA7WK	26735012	Green Published			2022-12-28	WOS:000368015700041
J	Marijon, E; Uy-Evanado, A; Dumas, F; Karam, N; Reinier, K; Teodorescu, C; Narayanan, K; Gunson, K; Jui, J; Jouven, X; Chugh, SS				Marijon, Eloi; Uy-Evanado, Audrey; Dumas, Florence; Karam, Nicole; Reinier, Kyndaron; Teodorescu, Carmen; Narayanan, Kumar; Gunson, Karen; Jui, Jonathan; Jouven, Xavier; Chugh, Sumeet S.			Warning Symptoms Are Associated With Survival From Sudden Cardiac Arrest	ANNALS OF INTERNAL MEDICINE			English	Article							VENTRICULAR-FIBRILLATION; PRODROMAL SYMPTOMS; SEX-DIFFERENCES; DEATH; EPIDEMIOLOGY; WOMEN	Background: Survival after sudden cardiac arrest (SCA) remains low, and tools for improved prediction of patients at long-term risk for SCA are lacking. Alternative short-term approaches aimed at preemptive risk stratification and prevention are needed. Objective: To assess characteristics of symptoms in the 4 weeks before SCA and whether response to these symptoms is associated with better outcomes. Design: Ongoing prospective population-based study. Setting: Northwestern United States (2002 to 2012). Patients: Residents aged 35 to 65 years with SCA. Measurement: Assessment of symptoms in the 4 weeks preceding SCA and association with survival to hospital discharge. Results: Of 839 patients with SCA and comprehensive assessment of symptoms (mean age, 52.6 years [SD, 8]; 75% men), 430 (51%) had warning symptoms (50% of men vs. 53% of women; P = 0.59), mainly chest pain and dyspnea. In most symptomatic patients (93%), symptoms recurred within the 24 hours preceding SCA. Only 81 patients (19%) called emergency medical services (911) to report symptoms before SCA; these persons were more likely to be patients with a history of heart disease (P < 0.001) or continuous chest pain (P < 0.001). Survival when 911 was called in response to symptoms was 32.1% (95% CI, 21.8% to 42.4%) compared with 6.0% (CI, 3.5% to 8.5%) in those who did not call (P < 0.001). Limitation: Potential for recall and response bias, symptom assessment not available in 24% of patients, and missing data for some patients and SCA characteristics. Conclusion: Warning symptoms frequently occur before SCA, but most are ignored. Emergent medical care was associated with survival in patients with symptoms, so new approaches are needed for short-term prevention of SCA.	Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA; Paris Descartes Univ, Paris, France; Hop Europeen Georges Pompidou, Paris, France; Oregon Hlth & Sci Univ, Portland, OR 97201 USA	Cedars Sinai Medical Center; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Oregon Health & Science University	Chugh, SS (corresponding author), Cedars Sinai Med Ctr, Inst Heart, Adv Hlth Sci Pavil,Suite A3100, Los Angeles, CA 90048 USA.	sumeet.chugh@cshs.org	Karam, Nicole/AAP-9686-2021	Karam, Nicole/0000-0002-3861-6914	National Heart, Lung, and Blood Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL122492, R01HL105170] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	National Heart, Lung, and Blood Institute.	Achtelik M, 2005, ANN INTERN MED, V143, P756, DOI 10.7326/0003-4819-143-10-200511150-00017; Adabag AS, 2010, NAT REV CARDIOL, V7, P216, DOI 10.1038/nrcardio.2010.3; Albert CM, 2003, CIRCULATION, V107, P2096, DOI 10.1161/01.CIR.0000065223.21530.11; ALONZO AA, 1975, CIRCULATION, V52, P1056, DOI 10.1161/01.CIR.52.6.1056; Bougouin W, 2014, EUR HEART J, V35, P116, DOI 10.1093/eurheartj/eht453; Chugh SS, 2004, J AM COLL CARDIOL, V44, P1268, DOI 10.1016/j.jacc.2004.06.029; COBB LA, 1992, CIRCULATION, V85, P98; Go AS, 2014, CIRCULATION, V129, P399, DOI 10.1161/01.cir.0000442015.53336.12; Graham MM, 2008, AM HEART J, V156, P1210, DOI 10.1016/j.ahj.2008.07.016; Jacobs I, 2004, RESUSCITATION, V63, P233, DOI 10.1016/j.resuscitation.2004.09.008; Kannel WB, 1998, AM HEART J, V136, P205, DOI 10.1053/hj.1998.v136.90226; Khan NA, 2013, JAMA INTERN MED, V173, P1863, DOI 10.1001/jamainternmed.2013.10149; Meischke H, 1997, AM J PUBLIC HEALTH, V87, P1705, DOI 10.2105/AJPH.87.10.1705; Moriel M, 2013, JAMA INTERN MED, V173, P1929, DOI 10.1001/jamainternmed.2013.9788; Muller D, 2006, CIRCULATION, V114, P1146, DOI 10.1161/CIRCULATIONAHA.106.616318; Narayanan K, 2013, CIRCULATION, V128, P1733, DOI 10.1161/CIRCULATIONAHA.113.002539; Nishiyama C, 2013, RESUSCITATION, V84, P558, DOI 10.1016/j.resuscitation.2012.10.006; Noheria A, 2013, INT J CARDIOL, V168, P3495, DOI 10.1016/j.ijcard.2013.04.207; Pauker SG, 2005, ANN INTERN MED, V142, P664, DOI 10.7326/0003-4819-142-8-200504190-00015; Sasson C, 2010, CIRC-CARDIOVASC QUAL, V3, P63, DOI 10.1161/CIRCOUTCOMES.109.889576; Steinhubl SR, 2013, JAMA-J AM MED ASSOC, V310, P2395, DOI 10.1001/jama.2013.281078; Sterne Jonathan A C, 2009, BMJ, V338, pb2393, DOI 10.1136/bmj.b2393; Teodorescu C, 2012, J INTERV CARD ELECTR, V34, P219, DOI 10.1007/s10840-012-9669-2; Teodorescu C, 2010, CIRCULATION, V122, P2116, DOI 10.1161/CIRCULATIONAHA.110.966333; Topol EJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000484; Vandenbroucke JP, 2007, EPIDEMIOLOGY, V18, P797, DOI 10.1097/EDE.0b013e318157725d; Vandenbroucke JP, 2007, ANN INTERN MED, V147, pW163, DOI 10.7326/0003-4819-147-8-200710160-00010-w1; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067	28	86	87	0	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 5	2016	164	1					23	+		10.7326/M14-2342	http://dx.doi.org/10.7326/M14-2342			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DA4WC	26720493	Green Accepted			2022-12-28	WOS:000367801700007
J	Cho, HC; Jeong, SH; Park, MH; Kim, YH; Wolf, C; Lee, CL; Heo, JH; Sadhanala, A; Myoung, N; Yoo, S; Im, SH; Friend, RH; Lee, TW				Cho, Himchan; Jeong, Su-Hun; Park, Min-Ho; Kim, Young-Hoon; Wolf, Christoph; Lee, Chang-Lyoul; Heo, Jin Hyuck; Sadhanala, Aditya; Myoung, NoSoung; Yoo, Seunghyup; Im, Sang Hyuk; Friend, Richard H.; Lee, Tae-Woo			Overcoming the electroluminescence efficiency limitations of perovskite light-emitting diodes	SCIENCE			English	Article							ORGANOMETAL HALIDE PEROVSKITE; PERFORMANCE SOLAR-CELLS; INTERFACIAL CONTROL; HYBRID PEROVSKITE; TRIHALIDE; DEPOSITION; DIFFUSION; CRYSTALS; GROWTH; PB	Organic-inorganic hybrid perovskites are emerging low-cost emitters with very high color purity, but their low luminescent efficiency is a critical drawback. We boosted the current efficiency (CE) of perovskite light-emitting diodes with a simple bilayer structure to 42.9 candela per ampere, similar to the CE of phosphorescent organic light-emitting diodes, with two modifications: We prevented the formation of metallic lead (Pb) atoms that cause strong exciton quenching through a small increase in methylammonium bromide (MABr) molar proportion, and we spatially confined the exciton in uniform MAPbBr3 nanograins (average diameter = 99.7 nanometers) formed by a nanocrystal pinning process and concomitant reduction of exciton diffusion length to 67 nanometers. These changes caused substantial increases in steady-state photoluminescence intensity and efficiency of MAPbBr(3) nanograin layers.	[Cho, Himchan; Jeong, Su-Hun; Park, Min-Ho; Kim, Young-Hoon; Wolf, Christoph; Lee, Tae-Woo] Pohang Univ Sci & Technol POSTECH, Dept Mat Sci & Engn, Pohang 790784, Gyungbuk, South Korea; [Lee, Chang-Lyoul; Myoung, NoSoung] Gwangju Inst Sci & Technol GIST, Adv Photon Res Inst APRI, Gwangju 500712, South Korea; [Heo, Jin Hyuck; Im, Sang Hyuk] Kyung Hee Univ, Coll Engn, Dept Chem Engn, Youngin Si 446701, Gyeonggi Do, South Korea; [Sadhanala, Aditya; Friend, Richard H.] Univ Cambridge, Cavendish Lab, Cambridge CB3 0HE, England; [Yoo, Seunghyup] Korea Adv Inst Sci & Technol, Dept Elect Engn, Daejeon 305701, South Korea; [Lee, Tae-Woo] Pohang Univ Sci & Technol POSTECH, Sch Environm Sci & Engn, Div Adv Mat Sci, Dept Chem Engn, Pohang 790784, Gyungbuk, South Korea	Pohang University of Science & Technology (POSTECH); Gwangju Institute of Science & Technology (GIST); Kyung Hee University; University of Cambridge; Korea Advanced Institute of Science & Technology (KAIST); Pohang University of Science & Technology (POSTECH)	Lee, TW (corresponding author), Pohang Univ Sci & Technol POSTECH, Dept Mat Sci & Engn, 77 Cheongam Ro, Pohang 790784, Gyungbuk, South Korea.	twlee@postech.ac.kr	Yoo, Seunghyup/C-1656-2011; Lee, Tae-Woo/AAE-7298-2019; Sadhanala, Aditya/J-1212-2017; Cho, Himchan/S-5674-2016; Cho, Himchan/AAY-6549-2020; Im, Sang Hyuk/V-3255-2019	Yoo, Seunghyup/0000-0003-1887-6118; Lee, Tae-Woo/0000-0002-6449-6725; Sadhanala, Aditya/0000-0003-2832-4894; Cho, Himchan/0000-0001-6372-5787; Im, Sang Hyuk/0000-0001-7081-5959; Myoung, NoSoung/0000-0001-5822-2851; Friend, Richard Henry/0000-0001-6565-6308	Samsung Research Funding Center of Samsung Electronics [SRFC-MA-1402-07]; Engineering and Physical Sciences Research Council (UK); Engineering and Physical Sciences Research Council [EP/G060738/1, EP/M005143/1] Funding Source: researchfish; EPSRC [EP/M005143/1, EP/G060738/1] Funding Source: UKRI	Samsung Research Funding Center of Samsung Electronics(Samsung); Engineering and Physical Sciences Research Council (UK)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was partially supported by Samsung Research Funding Center of Samsung Electronics under Project Number SRFC-MA-1402-07. A.S. was partially supported by the Engineering and Physical Sciences Research Council (UK). All data are available in the main text and the supplementary materials.	Chen Q, 2014, NANO LETT, V14, P4158, DOI 10.1021/nl501838y; Dulkeith E, 2005, NANO LETT, V5, P585, DOI 10.1021/nl0480969; Eperon GE, 2014, ENERG ENVIRON SCI, V7, P982, DOI 10.1039/c3ee43822h; Filip MR, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6757; Gonzalez-Carrero S, 2015, J MATER CHEM A, V3, P9187, DOI 10.1039/c4ta05878j; Heo JH, 2014, ADV MATER, V26, P8179, DOI 10.1002/adma.201403140; Hoye RLZ, 2015, ADV MATER, V27, P1414, DOI 10.1002/adma.201405044; Im JH, 2014, NAT NANOTECHNOL, V9, P927, DOI [10.1038/nnano.2014.181, 10.1038/NNANO.2014.181]; Jeon NJ, 2015, NATURE, V517, P476, DOI 10.1038/nature14133; Jeon NJ, 2014, NAT MATER, V13, P897, DOI [10.1038/NMAT4014, 10.1038/nmat4014]; KANBE JI, 1977, J PHYS SOC JPN, V43, P1280, DOI 10.1143/JPSJ.43.1280; Kim H, 2016, ENERG ENVIRON SCI, V9, P12, DOI 10.1039/c5ee02194d; Kim YH, 2015, ADV MATER, V27, P1248, DOI 10.1002/adma.201403751; Koh TM, 2014, J PHYS CHEM C, V118, P16458, DOI 10.1021/jp411112k; Koutselas IB, 1996, J PHYS-CONDENS MAT, V8, P1217, DOI 10.1088/0953-8984/8/9/012; Kumawat NK, 2015, ACS APPL MATER INTER, V7, P13119, DOI 10.1021/acsami.5b02159; Kumawat NK, 2015, ACS PHOTONICS, V2, P349, DOI 10.1021/acsphotonics.5b00018; Li GR, 2015, NANO LETT, V15, P2640, DOI 10.1021/acs.nanolett.5b00235; Lindblad R, 2015, J PHYS CHEM C, V119, P1818, DOI 10.1021/jp509460h; Liu MZ, 2013, NATURE, V501, P395, DOI 10.1038/nature12509; Mitzi DB, 1996, CHEM MATER, V8, P791, DOI 10.1021/cm9505097; Noh JH, 2013, NANO LETT, V13, P1764, DOI 10.1021/nl400349b; Sadhanala A, 2015, ADV ELECTRON MATER, V1, DOI 10.1002/aelm.201500008; Schulz P, 2014, ENERG ENVIRON SCI, V7, P1377, DOI 10.1039/c4ee00168k; Sheng R, 2015, J PHYS CHEM C, V119, P3545, DOI 10.1021/jp512936z; Shi D, 2015, SCIENCE, V347, P519, DOI 10.1126/science.aaa2725; Shkrob IA, 2014, J PHYS CHEM LETT, V5, P1066, DOI 10.1021/jz5004022; Stranks SD, 2013, SCIENCE, V342, P341, DOI 10.1126/science.1243982; Tan ZK, 2014, NAT NANOTECHNOL, V9, P687, DOI [10.1038/nnano.2014.149, 10.1038/NNANO.2014.149]; Tanaka K, 2003, SOLID STATE COMMUN, V127, P619, DOI 10.1016/S0038-1098(03)00566-0; Wang JP, 2015, ADV MATER, V27, P2311, DOI 10.1002/adma.201405217; Xiao ZG, 2014, ADV MATER, V26, P6503, DOI 10.1002/adma.201401685; Yang WS, 2015, SCIENCE, V348, P1234, DOI 10.1126/science.aaa9272; Yu JC, 2015, ADV MATER, V27, P3492, DOI 10.1002/adma.201500465	34	1994	2016	87	2093	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 4	2015	350	6265					1222	1225		10.1126/science.aad1818	http://dx.doi.org/10.1126/science.aad1818			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX4WG	26785482	Green Accepted			2022-12-28	WOS:000365700500069
J	Haddad, NM				Haddad, Nick M.			Corridors for people, corridors for nature	SCIENCE			English	Editorial Material									[Haddad, Nick M.] N Carolina State Univ, Dept Appl Ecol, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University	Haddad, NM (corresponding author), N Carolina State Univ, Dept Appl Ecol, Raleigh, NC 27695 USA.	nick_haddad@ncsu.ed						[Anonymous], 2013, WORLD FACTB 2013 14; Barber CP, 2014, BIOL CONSERV, V177, P203, DOI 10.1016/j.biocon.2014.07.004; Barrington-Leigh C, 2015, P NATL ACAD SCI USA, V112, P8244, DOI 10.1073/pnas.1504033112; Beckmann J. P., 2012, SAFE PASSAGES HIGHWA; Chaplin-Kramer R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10158; Clevenger A., 2011, WILDLIFE CROSSING ST; Dulac J., 2013, GLOBAL LAND TRANSPOR; Epps CW, 2005, ECOL LETT, V8, P1029, DOI 10.1111/j.1461-0248.2005.00804.x; Grollemund R, 2015, P NATL ACAD SCI USA, V112, P13296, DOI 10.1073/pnas.1503793112; Laurance WF, 2014, NATURE, V513, P229, DOI 10.1038/nature13717; Lister NM, 2015, FRONT ECOL ENVIRON, V13, P493, DOI 10.1890/150080; Mandle L., 2014, NATURAL CAPITAL ROAD; Mandle L, 2016, CONSERV LETT, V9, P221, DOI 10.1111/conl.12201; Riitters KH, 2003, FRONT ECOL ENVIRON, V1, P125, DOI 10.1890/1540-9295(2003)001[0125:HFTTNR]2.0.CO;2; Terando AJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102261	15	18	19	1	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 4	2015	350	6265					1166	1167		10.1126/science.aad5072	http://dx.doi.org/10.1126/science.aad5072			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CX4WG	26785459				2022-12-28	WOS:000365700500044
J	Hansen, JD; Reich, J				Hansen, John D.; Reich, Justin			Democratizing education? Examining access and usage patterns in massive open online courses	SCIENCE			English	Article							EQUITY	Massive open online courses (MOOCs) are often characterized as remedies to educational disparities related to social class. Using data from 68 MOOCs offered by Harvard and MIT between 2012 and 2014, we found that course participants from the United States tended to live in more-affluent and better-educated neighborhoods than the average U.S. resident. Among those who did register for courses, students with greater socioeconomic resources were more likely to earn a certificate. Furthermore, these differences in MOOC access and completion were larger for adolescents and young adults, the traditional ages where people find on-ramps into science, technology, engineering, and mathematics (STEM) course work and careers. Our findings raise concerns that MOOCs and similar approaches to online learning can exacerbate rather than reduce disparities in educational outcomes related to socioeconomic status.	[Hansen, John D.] Harvard Univ, Harvard Grad Sch Educ, Cambridge, MA 02138 USA; [Reich, Justin] MIT, Off Digital Learning, Cambridge, MA 02139 USA	Harvard University; Massachusetts Institute of Technology (MIT)	Hansen, JD (corresponding author), Harvard Univ, Harvard Grad Sch Educ, Cambridge, MA 02138 USA.	john_hansen@mail.harvard.edu			Dean's Office of the Harvard Graduate School of Education	Dean's Office of the Harvard Graduate School of Education	This work was funded in part by the Dean's Office of the Harvard Graduate School of Education. We are grateful to the HarvardX, MITx, and VPAL-Research research communities for comments and support and to three anonymous reviewers for helpful feedback. Data on HarvardX and MITx students are available from the Harvard Dataverse at http://dx.doi.org/10.7910/DVN/29779. These study files also include Stata code and log files for all analyses. Student-level data are restricted to qualified researchers approved by Harvard VPAL-Research. Esri data are available for a fee from www.esri.com. The American Community Survey microdata are publicly available at www.ipums.org. The American Community survey ZIP Code-level data are available at http://factfinder2.census.gov/faces/nav/jsf/pages/download_center.xhtml.	Attewell P, 1999, INFORM SOC, V15, P1; Attewell P, 2001, SOCIOL EDUC, V74, P252, DOI 10.2307/2673277; Boser Ulrich, 2013, ARE SCH GETTING BIG; Chuang I, 2014, SSRN SCHOLARLY PAPER; Cook Thomas D, 1975, SESAME STREET REVISI; Cowan CD., 2012, IMPROVING MEASUREMEN; Cuban L., 1986, TEACHERS MACHINES CL; Emanuel EJ, 2013, NATURE, V503, P342, DOI 10.1038/503342a; Faust D., 2013, BOSTON GLOBE; Finn C. E., 2012, ED NEXT; Ford Foundation, 1961, TEACH TEL; Hansen John, 2015, SOCIOECONOMIC STATUS; Ho A. D., 2015, 10 HARVARDX; Horn M. B., 2014, ED NEXT, V14, P82; Kanani R., 2014, FORBES; Kearney M. S., 2015, 104 NBER; Koller D., 2013, EDSURGE         1231; Lewin T., 2015, NY TIMES, pA14; Reardon SF, 2011, WHITHER OPPORTUNITY?: RISING INEQUALITY, SCHOOLS, AND CHILDREN'S LIFE CHANCES, P91; Reich J., 2014, EDUCAUSE REV ONLINE; Reich J, 2012, EDUC RESEARCHER, V41, P7, DOI 10.3102/0013189X11427083; Schlesselman JJ, 1982, CASE CONTROL STUDIES; Sirin SR, 2005, REV EDUC RES, V75, P417, DOI 10.3102/00346543075003417; Warschauer M, 2004, EDUC POLICY, V18, P562, DOI 10.1177/0895904804266469; Wenglinsky H., 1998, DOES IT COMPUTE RELA	25	99	99	3	158	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 4	2015	350	6265					1245	1248		10.1126/science.aab3782	http://dx.doi.org/10.1126/science.aab3782			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CX4WG	26785488	Green Submitted			2022-12-28	WOS:000365700500075
J	Fauci, AS; Morens, DM				Fauci, Anthony S.; Morens, David M.			Zika Virus in the Americas - Yet Another Arbovirus Threat	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Fauci, Anthony S.; Morens, David M.] NIAID, 9000 Rockville Pike, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Fauci, AS (corresponding author), NIAID, 9000 Rockville Pike, Bethesda, MD 20892 USA.		Ulatan, Jeffrey/AAM-5560-2020	Ulatan, Jeffrey/0000-0002-3756-0568				DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4; European Centre for Disease Prevention and Control, 2015, MICR BRAZ POT LINK Z, DOI DOI 10.1056/NEJMP1600297; Marcondes C.B., 2015, REV SOC BRAS MED TRO; Morens DM, 2014, NEW ENGL J MED, V371, P885, DOI 10.1056/NEJMp1408509; Pierson TC, 2014, FIELDS VIROLOGY, V1, P746	5	659	712	2	87	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 18	2016	374	7					601	604		10.1056/NEJMp1600297	http://dx.doi.org/10.1056/NEJMp1600297			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DD9ER	26761185	Bronze			2022-12-28	WOS:000370229000003
J	Sharma, U; Conine, CC; Shea, JM; Boskovic, A; Derr, AG; Bing, XY; Belleannee, C; Kucukural, A; Serra, RW; Sun, FY; Song, L; Carone, BR; Ricci, EP; Li, XZ; Fauquier, L; Moore, MJ; Sullivan, R; Mello, CC; Garber, M; Rando, OJ				Sharma, Upasna; Conine, Colin C.; Shea, Jeremy M.; Boskovic, Ana; Derr, Alan G.; Bing, Xin Y.; Belleannee, Clemence; Kucukural, Alper; Serra, Ryan W.; Sun, Fengyun; Song, Lina; Carone, Benjamin R.; Ricci, Emiliano P.; Li, Xin Z.; Fauquier, Lucas; Moore, Melissa J.; Sullivan, Robert; Mello, Craig C.; Garber, Manuel; Rando, Oliver J.			Biogenesis and function of tRNA fragments during sperm maturation and fertilization in mammals	SCIENCE			English	Article							TRANSGENERATIONAL EPIGENETIC INHERITANCE; EPIDIDYMAL TRANSIT; CELLS; EXPRESSION	Several recent studies link parental environments to phenotypes in subsequent generations. In this work, we investigate the mechanism by which paternal diet affects offspring metabolism. Protein restriction in mice affects small RNA (sRNA) levels in mature sperm, with decreased let-7 levels and increased amounts of 5' fragments of glycine transfer RNAs (tRNAs). In testicular sperm, tRNA fragments are scarce but increase in abundance as sperm mature in the epididymis. Epididymosomes (vesicles that fuse with sperm during epididymal transit) carry RNA payloads matching those of mature sperm and can deliver RNAs to immature sperm in vitro. Functionally, tRNA-glycine-GCC fragments repress genes associated with the endogenous retroelement MERVL, in both embryonic stem cells and embryos. Our results shed light on sRNA biogenesis and its dietary regulation during posttesticular sperm maturation, and they also link tRNA fragments to regulation of endogenous retroelements active in the preimplantation embryo.	[Sharma, Upasna; Conine, Colin C.; Shea, Jeremy M.; Boskovic, Ana; Bing, Xin Y.; Serra, Ryan W.; Sun, Fengyun; Song, Lina; Carone, Benjamin R.; Li, Xin Z.; Fauquier, Lucas; Moore, Melissa J.; Rando, Oliver J.] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA; [Derr, Alan G.; Kucukural, Alper; Mello, Craig C.; Garber, Manuel] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; [Derr, Alan G.; Kucukural, Alper; Garber, Manuel] Univ Massachusetts, Sch Med, Program Bioinformat & Integrat Biol, Worcester, MA 01605 USA; [Belleannee, Clemence; Sullivan, Robert] Univ Laval, Ctr Hosp Univ Quebec Res Ctr, Dept Obstet Gynecol & Reprod, Quebec City, PQ G1V 4G2, Canada; [Ricci, Emiliano P.; Li, Xin Z.; Moore, Melissa J.; Mello, Craig C.] Univ Massachusetts, Sch Med, RNAi Therapeut Inst, Worcester, MA 01605 USA; [Moore, Melissa J.; Mello, Craig C.] Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Laval University; University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester	Rando, OJ (corresponding author), Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA.	oliver.rando@umassmed.edu	Kucukural, Alper/AAJ-7758-2020; sharma, upasna/HGB-5941-2022; Ricci, Emiliano/G-7619-2012; Sharma, Upasna/I-1344-2019; Kucukural, Alper/T-3563-2018	Kucukural, Alper/0000-0001-9983-394X; Ricci, Emiliano/0000-0002-9789-5837; Kucukural, Alper/0000-0001-9983-394X; Boskovic, Ana/0000-0003-1258-4376; Derr, Alan/0000-0003-2935-0453; Carone, Benjamin/0000-0002-9822-4218; Conine, Colin/0000-0001-7915-0463	NIH [R01HD080224, DP1ES025458]; March of Dimes [FY13-1268]; Helen Hay Whitney Postdoctoral Fellowship; Human Frontiers Science Program Fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007439, R01HD080224, R00HD078482] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001453] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [DP1ES025458] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes(March of Dimes); Helen Hay Whitney Postdoctoral Fellowship; Human Frontiers Science Program Fellowship(Human Frontier Science Program); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank H. Florman, P. Visconti, R. Sadeh, and N. Friedman for reading the manuscript; P. Visconti and M. Jungnickel for training in caput sperm purification; K. Sutton for training in ICSI; A. Shalek and A. Regev for training in single-cell RNA-seq; T. Fazzio, S. Hainer, and B. Chen for assistance with ES studies; and J. Lawrence and K. Creamer for help with microscopy. This research was supported by NIH grants R01HD080224 and DP1ES025458 and March of Dimes grant FY13-1268. C.C.C. was supported by a Helen Hay Whitney Postdoctoral Fellowship, and A.B. was supported by a Human Frontiers Science Program Fellowship. Data can be accessed at Gene Expression Omnibus with accession numbers GSE74537, GSE75613, and GSE75622.	Caballero JN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065364; Carone BR, 2010, CELL, V143, P1084, DOI 10.1016/j.cell.2010.12.008; Couvillion MT, 2010, GENE DEV, V24, P2742, DOI 10.1101/gad.1996210; Dacheux JL, 2014, REPRODUCTION, V147, pR27, DOI 10.1530/REP-13-0420; Daxinger L, 2012, NAT REV GENET, V13, P153, DOI 10.1038/nrg3188; Heard E, 2014, CELL, V157, P95, DOI 10.1016/j.cell.2014.02.045; Krapf D, 2012, DEV BIOL, V369, P43, DOI 10.1016/j.ydbio.2012.06.017; Macfarlan TS, 2012, NATURE, V487, P57, DOI 10.1038/nature11244; Mitchell M, 2011, FERTIL STERIL, V95, P1349, DOI 10.1016/j.fertnstert.2010.09.038; Nixon B, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.115.132209; Peng HY, 2012, CELL RES, V22, P1609, DOI 10.1038/cr.2012.141; Ramskold D, 2012, NAT BIOTECHNOL, V30, P777, DOI 10.1038/nbt.2282; Rando OJ, 2015, CELL, V161, P93, DOI 10.1016/j.cell.2015.02.021; Rando OJ, 2012, CELL, V151, P702, DOI 10.1016/j.cell.2012.10.020; Regev-Rudzki N, 2013, CELL, V153, P1120, DOI 10.1016/j.cell.2013.04.029; Shalek AK, 2013, NATURE, V498, P236, DOI 10.1038/nature12172; Sobala A, 2011, WIRES RNA, V2, P853, DOI 10.1002/wrna.96; Sullivan R, 2007, ASIAN J ANDROL, V9, P483, DOI 10.1111/j.1745-7262.2007.00281.x; Sullivan R, 2013, REPRODUCTION, V146, pR21, DOI 10.1530/REP-13-0058; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596	20	674	696	9	167	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 22	2016	351	6271					391	396		10.1126/science.aad6780	http://dx.doi.org/10.1126/science.aad6780			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB3VH	26721685	Green Accepted, Green Submitted			2022-12-28	WOS:000368440500042
J	Lahr, MM; Rivera, F; Power, RK; Mounier, A; Copsey, B; Crivellaro, F; Edung, JE; Fernandez, JMM; Kiarie, C; Lawrence, J; Leakey, A; Mbua, E; Miller, H; Muigai, A; Mukhongo, DM; Van Baelen, A; Wood, R; Schwenninger, JL; Grun, R; Achyuthan, H; Wilshaw, A; Foley, RA				Lahr, M. Mirazon; Rivera, F.; Power, R. K.; Mounier, A.; Copsey, B.; Crivellaro, F.; Edung, J. E.; Maillo Fernandez, J. M.; Kiarie, C.; Lawrence, J.; Leakey, A.; Mbua, E.; Miller, H.; Muigai, A.; Mukhongo, D. M.; Van Baelen, A.; Wood, R.; Schwenninger, J. -L.; Gruen, R.; Achyuthan, H.; Wilshaw, A.; Foley, R. A.			Inter-group violence among early Holocene hunter-gatherers of West Turkana, Kenya	NATURE			English	Article							SINGLE-ALIQUOT; FRACTURE PATTERNS; LETHAL AGGRESSION; LAKE TURKANA; QUARTZ; LUMINESCENCE; INJURIES; TRAUMA; WARFARE; BONE	The nature of inter-group relations among prehistoric hunter-gatherers remains disputed, with arguments in favour and against the existence of warfare before the development of sedentary societies(1,2). Here we report on a case of inter-group violence towards a group of hunter-gatherers from Nataruk, west of Lake Turkana, which during the late Pleistocene/early Holocene period extended about 30 km beyond its present-day shore(3). Ten of the twelve articulated skeletons found at Nataruk show evidence of having died violently at the edge of a lagoon, into which some of the bodies fell. The remains from Nataruk are unique, preserved by the particular conditions of the lagoon with no evidence of deliberate burial. They offer a rare glimpse into the life and death of past foraging people, and evidence that warfare was part of the repertoire of inter-group relations among prehistoric hunter-gatherers.	[Lahr, M. Mirazon; Rivera, F.; Power, R. K.; Mounier, A.; Copsey, B.; Crivellaro, F.; Lawrence, J.; Miller, H.; Mukhongo, D. M.; Van Baelen, A.; Wilshaw, A.; Foley, R. A.] Univ Cambridge, Dept Archaeol & Anthropol, Leverhulme Ctr Human Evolutionary Studies, Cambridge CB2 1QH, England; [Lahr, M. Mirazon; Kiarie, C.; Leakey, A.; Foley, R. A.] Turkana Basin Inst, Nairobi, Kenya; [Edung, J. E.] Natl Museums Kenya, Lodwar, Kenya; [Maillo Fernandez, J. M.] UNED, Dept Prehist & Arqueol, Madrid 28040, Spain; [Mbua, E.] Natl Museums Kenya, Nairobi, Kenya; [Muigai, A.] Jomo Kenyatta Univ Agr & Technol, Nairobi, Kenya; [Wood, R.; Gruen, R.] Australian Natl Univ, Res Sch Earth Sci, Acton, ACT 2601, Australia; [Schwenninger, J. -L.] Univ Oxford, Res Lab Archaeol & Hist Art, Oxford OX1 3QY, England; [Gruen, R.] Griffith Univ, Res Ctr Human Evolut, Environm Futures Res Inst, Nathan, Qld 4111, Australia; [Achyuthan, H.] Anna Univ, Dept Geol, Madras 600025, Tamil Nadu, India	University of Cambridge; Universidad Nacional de Educacion a Distancia (UNED); Jomo Kenyatta University of Agriculture & Technology; Australian National University; University of Oxford; Griffith University; Anna University; Anna University Chennai	Lahr, MM (corresponding author), Univ Cambridge, Dept Archaeol & Anthropol, Leverhulme Ctr Human Evolutionary Studies, Fitzwilliam St, Cambridge CB2 1QH, England.	mbml1@cam.ac.uk; raf10@cam.ac.uk	Rivera, Frances/AAU-9144-2020; Grun, Rainer/A-1437-2012; Achyuthan, Hema/AAA-6898-2022; Wood, Rachel/K-5577-2016; Maíllo-Fernández, José-Manuel/AAU-3715-2020	Grun, Rainer/0000-0003-1366-3674; Wood, Rachel/0000-0002-1694-3295; Maíllo-Fernández, José-Manuel/0000-0002-7555-4943; Van Baelen, Ann/0000-0002-8595-9485; Power, Ronika/0000-0002-1092-8131; Wilshaw, Alex/0000-0001-7459-7784; Mounier, Aurelien/0000-0001-9713-7246; Achyuthan, Hema/0000-0001-5495-4115; Crivellaro, Federica/0000-0003-1656-8605; Mirazon Lahr, Marta/0000-0001-5752-5770	European Research Council (IN-AFRICA) [ERC 295907]; Newby Trust; McDonald Institute for Archaeological Research, University of Cambridge	European Research Council (IN-AFRICA); Newby Trust; McDonald Institute for Archaeological Research, University of Cambridge(University of Cambridge)	We thank the Office of the President of Kenya, the Turkana Province government, and the National Museums of Kenya for permission to conduct research (NCST/5/002/R/419), the Turkana people of Locher Akwan, Lokwar Ankhaleso, Lotukumo, Eporon, and Natome for permission to work in their area and assistance, the Turkana Basin Institute for logistical and laboratory support, the British Institute in Eastern Africa, R. Leakey, M. Leakey, and L. Martin for support and advice, the staff at the TBI Turkwell facility, especially K. Onesmus Ngela, and the 2012 IN-AFRICA field team (E. Murungi, J. Oltimbao, J. Lokuruka, D. Lomuria, M. Lokinei, J. Ekeno, J. Erupe, J. Lopua, R. Ng'irotin, P. Amuk, P. Atadeit, M. Emusugut, F. Lowan, R. Ng'ichila, S. Eperon, P. Eperon, T. Echulum), especially P. Ebeya who found the site. We thank S. Black and C. Cunningham for advice on the foetal remains, Beta Analytic for advice and assistance, and F. Lahr for assistance with imaging and illustrations. Funding was provided by a European Research Council Advanced Award to M. M. L. (IN-AFRICA, ERC 295907), the Newby Trust, and the McDonald Institute for Archaeological Research, University of Cambridge.	Angel J. L., 1980, LATE STONE AGE FISHE; ANGEL JL, 1974, ANTHROPOL KOZLEM, V18, P9; Banerjee D, 2001, RADIAT MEAS, V33, P73, DOI 10.1016/S1350-4487(00)00101-3; Barthelme J.W., 1985, FISHER HUNTERS NEOLI; Bass W. M., 2005, HUMAN OSTEOLOGY LAB, V5th; Berryman H.E., 1998, FORENSIC OSTEOLOGY A, P333; BERRYMAN HE, 1996, INT J OSTEOARCHAEOL, V6, P2; Beyin A., 2011, NYAME AKUMA, V75, P40; Botter-Jensen L, 1997, RADIAT MEAS, V27, P749, DOI 10.1016/S1350-4487(97)00206-0; Bowles S, 2009, SCIENCE, V324, P1293, DOI 10.1126/science.1168112; Brickley M, 2006, AM ANTHROPOL, V108, P163, DOI 10.1525/aa.2006.108.1.163; Brink O, 1998, INJURY, V29, P705, DOI 10.1016/S0020-1383(98)00176-4; Broadbent B.H.S., 1975, BOLTON STANDARDS DEN; Brooks S, 1990, HUM EVOL, V5, P227, DOI DOI 10.1007/BF02437238; Brothwell D., 1981, DIGGING BONES EXCAVA; Brown, 1922, ANDAMAN ISLANDERS ST; Buikstra J. E., 1994, STANDARDS DATA COLLE; Burch, 2005, ALLIANCE CONFLICT WO, DOI 10.2307/j.ctv6gqqgg; De Corte F, 2006, NUCL INSTRUM METH A, V564, P743, DOI 10.1016/j.nima.2006.04.009; Dietze M, QUAT GEOCHR IN PRESS; Duller G.A.T., 2015, ANCIENT TL, V33, P35; EMBER CR, 1978, ETHNOLOGY, V17, P439, DOI 10.2307/3773193; Fallon SJ, 2010, NUCL INSTRUM METH B, V268, P898, DOI 10.1016/j.nimb.2009.10.059; Fibiger L, 2013, AM J PHYS ANTHROPOL, V150, P190, DOI 10.1002/ajpa.22192; Forman SL, 2014, QUATERNARY SCI REV, V97, P84, DOI 10.1016/j.quascirev.2014.05.005; Fry D. P, 2004, WAR HUMAN POTENTIAL; Fry DP, 2013, SCIENCE, V341, P270, DOI 10.1126/science.1235675; Galbraith RF, 1999, ARCHAEOMETRY, V41, P339, DOI 10.1111/j.1475-4754.1999.tb00987.x; Galloway A., 1999, BROKEN BONES ANTHR A, P81; Garcin Y, 2009, QUATERNARY SCI REV, V28, P911, DOI 10.1016/j.quascirev.2008.12.006; Goldschmidt W., 1988, SOCIAL DYNAMICS PEAC, P47; Grun R, 2014, PALAEOGEOGR PALAEOCL, V416, P150, DOI 10.1016/j.palaeo.2014.07.023; Grun R., 1990, ANC TL, V29, P26; Guerin G., 2011, ANCIENT TL, V29, P5; Hansen V, 2015, RADIAT MEAS, V81, P123, DOI 10.1016/j.radmeas.2015.02.017; Hobhouse L. T., 1915, MAT CULTURE SOCIAL I; ISCAN MY, 1984, AM J PHYS ANTHROPOL, V65, P147, DOI 10.1002/ajpa.1330650206; ISCAN MY, 1985, J FORENSIC SCI, V30, P853; Jurmain R, 2009, AM J PHYS ANTHROPOL, V139, P462, DOI 10.1002/ajpa.21002; Keely LH., 1996, WAR CIVILIZATION; Kelly RC, 2005, P NATL ACAD SCI USA, V102, P15294, DOI 10.1073/pnas.0505955102; Kimmerle EH, 2008, SKELETAL TRAUMA: IDENTIFICATION OF INJURIES RESULTING FROM HUMAN RIGHTS ABUSE AND ARMED CONFLICT, P1, DOI 10.1201/9781420009118; KJAERULFF H, 1989, FORENSIC SCI INT, V41, P169, DOI 10.1016/0379-0738(89)90248-X; Knusel C.J., 2005, WARFARE VIOLENCE SLA, P49; Kreutzer S., 2012, ANC TL, V30, P1, DOI DOI 10.1007/978-94-007-6326-5_121-2; LEAVITT GC, 1977, SOCIOL INQ, V47, P49, DOI 10.1111/j.1475-682X.1977.tb00778.x; Letourneux C, 2008, J ARCHAEOL SCI, V35, P2849, DOI 10.1016/j.jas.2008.05.014; Levin L, 2008, J ORAL MAXIL SURG, V66, P1630, DOI 10.1016/j.joms.2007.11.028; Lovell NC, 1997, YEARB PHYS ANTHROPOL, V40, P139; Martin D. L., 1997, TROUBLED TIMES OSTEO; MEJDAHL V, 1979, ARCHAEOMETRY, V21, P61, DOI 10.1111/j.1475-4754.1979.tb00241.x; Murray AS, 2000, RADIAT MEAS, V32, P57, DOI 10.1016/S1350-4487(99)00253-X; Otterbein K., 2004, HOW WAR BEGAN; Owsley D., 1977, PLAINS ANTHR MEMOIR, V13, P119, DOI DOI 10.1080/2052546.1977.11908859; Passalacqua NV, 2012, BLACKW COMPANION ANT, P400; PRESCOTT JR, 1994, RADIAT MEAS, V23, P497, DOI 10.1016/1350-4487(94)90086-8; Quatrehomme G, 1997, FORENSIC SCI INT, V89, P155, DOI 10.1016/S0379-0738(97)00113-8; R Development Core Team, R LANG ENV STAT COMP; Ramsey CB, 2013, RADIOCARBON, V55, P2021; Raul JS, 2008, SKELETAL TRAUMA: IDENTIFICATION OF INJURIES RESULTING FROM HUMAN RIGHTS ABUSE AND ARMED CONFLICT, P21; ReesJones J, 1997, ARCHAEOMETRY, V39, P177, DOI 10.1111/j.1475-4754.1997.tb00797.x; Reimer PJ, 2013, RADIOCARBON, V55, P1869, DOI 10.2458/azu_js_rc.55.16947; Robbins L. H., 1974, THE LOTHAGAM SITE; ROBBINS LH, 1975, CURR ANTHROPOL, V16, P632, DOI 10.1086/201630; Robbins LH, 2006, ETHNOHISTORY, V53, P71, DOI 10.1215/00141801-53-1-71; Roberts C., 1991, HUMAN PALEOPATHOLOGY, P225; Rodriguez-Martin C, 2006, FORENSIC ANTHROPOLOGY AND MEDICINE: COMPLEMENTARY SCIENCES FROM RECOVERY TO CAUSE OF DEATH, P197, DOI 10.1007/978-1-59745-099-7_8; Sambridge M, 2012, QUAT GEOCHRONOL, V9, P42, DOI 10.1016/j.quageo.2012.02.010; Sauer N.J., 1998, FORENSIC OSTEOLOGY A, VSecond, P321; Schapera I., 1930, KHOISAN PEOPLES S AF; Scheuer L, 2000, DEV JUVENILE OSTEOLO; SHEPHERD JP, 1990, J ROY SOC MED, V83, P75, DOI 10.1177/014107689008300206; SMITH BH, 1991, ADVANCES IN DENTAL ANTHROPOLOGY, P143; Smith MO, 2003, AM J PHYS ANTHROPOL, V121, P303, DOI 10.1002/ajpa.10232; Steadman DW, 2008, AM J PHYS ANTHROPOL, V136, P51, DOI 10.1002/ajpa.20778; SUTTON SR, 1978, ARCHAEOMETRY, V20, P67, DOI 10.1111/j.1475-4754.1978.tb00214.x; Thorpe I. J. N, 2005, BRIT ARCHAEOLOGICAL, P1; Vandenberghe D, 2008, RADIAT MEAS, V43, P771, DOI 10.1016/j.radmeas.2008.01.016; Walker P., 1997, TROUBLED TIMES VIOLE, P145; Wallinga J, 2002, RADIAT PROT DOSIM, V101, P367, DOI 10.1093/oxfordjournals.rpd.a006003; Wendorf F, 1968, PREHISTORY NUBIA, V2, P954; Wheatley BP, 2008, J FORENSIC SCI, V53, P69, DOI 10.1111/j.1556-4029.2008.00593.x; Wilson ML, 2014, NATURE, V513, P414, DOI 10.1038/nature13727; Wilson ML, 2003, ANNU REV ANTHROPOL, V32, P363, DOI 10.1146/annurev.anthro.32.061002.120046; Wintle AG, 2006, RADIAT MEAS, V41, P369, DOI 10.1016/j.radmeas.2005.11.001; Wrangham RW, 2012, HUM NATURE-INT BIOS, V23, P5, DOI 10.1007/s12110-012-9132-1; Wright Quincy, 1942, STUDY WAR; ZIMMERMA.DW, 1971, ARCHAEOMETRY, V13, P29, DOI 10.1111/j.1475-4754.1971.tb00028.x	88	103	105	1	71	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 21	2016	529	7586					394	+		10.1038/nature16477	http://dx.doi.org/10.1038/nature16477			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	DB2QT	26791728	Green Accepted			2022-12-28	WOS:000368354800046
J	Podolsky, SH; Kesselheim, AS				Podolsky, Scott H.; Kesselheim, Aaron S.			Regulating Homeopathic Products - A Century of Dilute Interest	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Podolsky, Scott H.] Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Boston, MA 02115 USA; [Kesselheim, Aaron S.] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, PORTAL, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Podolsky, SH (corresponding author), Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Boston, MA 02115 USA.							Haller J., 2009, HIST AM HOMEOPATHY R	1	7	7	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 21	2016	374	3					201	203		10.1056/NEJMp1513393	http://dx.doi.org/10.1056/NEJMp1513393			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DB3IS	26789866	Bronze			2022-12-28	WOS:000368404800002
J	Blecker, S; Johnson, NJ; Altekruse, S; Horwitz, LI				Blecker, Saul; Johnson, Norman J.; Altekruse, Sean; Horwitz, Leora I.			Association of Occupation as a Physician With Likelihood of Dying in a Hospital	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							OF-LIFE CARE; PLACE; DEATH		[Blecker, Saul; Horwitz, Leora I.] NYU, Sch Med, Dept Populat Hlth, New York, NY 10016 USA; [Johnson, Norman J.] US Bur Census, Natl Longitudinal Mortal Study Branch, Suitland, MD USA; [Altekruse, Sean] NCI, Div Canc Control & Populat Sci, Rockville, MD USA	New York University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Blecker, S (corresponding author), NYU, Sch Med, 227 E 30th St,648, New York, NY 10016 USA.	saul.blecker@nyumc.org	Horwitz, Leora/ABD-1292-2020		AHRQ HHS [K08HS23683, K08 HS023683] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K08HS023683] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		[Anonymous], 2015, DYING AM IMPROVING Q; Barnato AE, 2007, MED CARE, V45, P386, DOI 10.1097/01.mlr.0000255248.79308.41; Murray K, 2015, DOCTORS DIE ITS NOT; Teno JM, 2013, JAMA-J AM MED ASSOC, V309, P470, DOI 10.1001/jama.2012.207624; TOWNSEND J, 1990, BRIT MED J, V301, P415, DOI 10.1136/bmj.301.6749.415	5	15	17	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 19	2016	315	3					301	303		10.1001/jama.2015.16976	http://dx.doi.org/10.1001/jama.2015.16976			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DB2WN	26784781	Green Accepted, Bronze			2022-12-28	WOS:000368371400029
J	Callaghan, BC; Burke, JF; Feldman, EL				Callaghan, Brian C.; Burke, James F.; Feldman, Eva L.			Electrodiagnostic Tests in Polyneuropathy and Radiculopathy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							LUMBOSACRAL RADICULOPATHY		[Callaghan, Brian C.; Burke, James F.; Feldman, Eva L.] Univ Michigan, Dept Neurol, Ann Arbor, MI 48104 USA	University of Michigan System; University of Michigan	Callaghan, BC (corresponding author), Univ Michigan, Dept Neurol, A109 Zina Pitcher Pl,4021 BSRB, Ann Arbor, MI 48104 USA.	bcallagh@med.umich.edu		Feldman, Eva/0000-0002-9162-2694	NIDDK NIH HHS [DP3DK094292, R24 DK082841, DP3 DK094292] Funding Source: Medline; NIMHD NIH HHS [R01 MD008879] Funding Source: Medline; NINDS NIH HHS [K23 NS079417, K08 NS082597, K23 NS079417-01] Funding Source: Medline; PHS HHS [R24 082841] Funding Source: Medline; Novo Nordisk Fonden [NNF14OC0011633] Funding Source: researchfish; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK082841, DP3DK094292] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS082597, K23NS079417] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [R01MD008879] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIMHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); Novo Nordisk Fonden(Novo Nordisk Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))		Cho SC, 2010, MUSCLE NERVE, V42, P276, DOI 10.1002/mus.21759; Coster S, 2010, J NEUROL, V257, P332, DOI 10.1007/s00415-009-5316-y; Dyck PJ, 2011, MUSCLE NERVE, V44, P340, DOI 10.1002/mus.22074; FRANKLIN GM, 1990, AM J EPIDEMIOL, V131, P633, DOI 10.1093/oxfordjournals.aje.a115547; Haig AJ, 2005, SPINE, V30, P2667, DOI 10.1097/01.brs.0000188400.11490.5f; Jarvik JJ, 2001, SPINE, V26, P1158, DOI 10.1097/00007632-200105150-00014; Rutkove SB, 1997, MUSCLE NERVE, V20, P1236, DOI 10.1002/(SICI)1097-4598(199710)20:10<1236::AID-MUS5>3.3.CO;2-P; Taruilli AW, 2007, NEUROL CLIN, V25, P387, DOI 10.1016/j.ncl.2007.01.008	8	2	2	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 19	2016	315	3					297	298		10.1001/jama.2015.16832	http://dx.doi.org/10.1001/jama.2015.16832			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DB2WN	26784779	Green Accepted			2022-12-28	WOS:000368371400028
J	Boussageon, R; Gueyffier, F; Cornu, C				Boussageon, Remy; Gueyffier, Francois; Cornu, Catherine			Metformin as firstline treatment for type 2 diabetes: are we sure?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							INTENSIVE GLUCOSE CONTROL; FOLLOW-UP; MORTALITY; OUTCOMES; TRIALS; METAANALYSIS	Remy Boussageon and colleagues ask whether metformin is bringing practical benefit to patients and question the focus on surrogate measures Metformin is recommended as the first glucose lowering treatment for people with type 2 diabetes.(1) The recommendation is based on the supposedly conclusive results of the UK Prospective Diabetes Study (UKPDS 34) published in 1998.(2) The study found a reduction in 10 year mortality from any cause (relative risk 0.64, 95% confidence interval 0.45 to 0.91), and myocardial infarction (0.61, 95% CI 0.41 to 0.89). The number needed to treat to avoid one death was 14 and the absolute risk reduction was 0.07. However, these impressive results were obtained in a randomised subgroup of obese patients (342 patients in the metformin group and 411 in the conventional group) and have never been reproduced.(3) From a scientific point of view, the reproducibility of results is an essential validity criterion. Meta-analyses of randomised controlled trials evaluating the effectiveness of metformin in patients with type 2 diabetes found that metformin did not significantly modify clinically relevant outcomes (table 1 double down arrow).(4 5) The analysis of all types of trial shows no efficacy of metformin at all.	[Boussageon, Remy] Fac Poitiers, Dept Gen Practice, F-86000 Poitiers, France; [Gueyffier, Francois; Cornu, Catherine] Univ Lyon 1, CNRS, Lab Biometrie & Biol Evolut, UMR 5558, F-69365 Lyon, France; [Gueyffier, Francois; Cornu, Catherine] Lyon Univ, Louis Pradel Hosp, Lyon, France; [Cornu, Catherine] INSERM, Clin Invest Ctr CIC1407, F-69008 Lyon, France	Universite de Poitiers; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup; CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm)	Boussageon, R (corresponding author), 11 Route Clos Bardien, F-79290 St Martin De Sanzay, France.	remy.boussageon2@wanadoo.fr	Cornu, Catherine/AAV-9003-2020; Boussageon, Rémy RB/O-3782-2015					Bailey CJ, 1996, NEW ENGL J MED, V334, P574, DOI 10.1056/NEJM199602293340906; Boussageon R, 2014, DIABETES METAB, V40, P169, DOI 10.1016/j.diabet.2013.12.010; Boussageon R, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-107; Boussageon R, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001204; Chowdhury TA, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1758; de Jager J, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2181; Ewart RM, 2001, BMJ-BRIT MED J, V323, P854, DOI 10.1136/bmj.323.7317.854; Fitzgerald E, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3660; Greenberg Steven A, 2009, BMJ, V339, pb2680, DOI 10.1136/bmj.b2680; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Holman RR, 2014, LANCET, V383, P2008, DOI 10.1016/S0140-6736(14)60794-7; Holman RR, 2009, NEW ENGL J MED, V360, P418; Hrobjartsson A, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1119; Huang WY, 2015, J DIABETES COMPLICAT, V29, P1261, DOI 10.1016/j.jdiacomp.2015.06.001; Hung SC, 2015, LANCET DIABETES ENDO, V3, P605, DOI 10.1016/S2213-8587(15)00123-0; Inzucchi SE, 2015, DIABETOLOGIA, V58, P429, DOI 10.1007/s00125-014-3460-0; Kunz R, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000012.pub2; Lamanna C, 2011, DIABETES OBES METAB, V13, P221, DOI 10.1111/j.1463-1326.2010.01349.x; Moye L. A., 2003, MULTIPLE ANAL CLIN T; Muhlhauser I, 2009, NEW ENGL J MED, V360, P417; Nathan DM, 1998, LANCET, V352, P832, DOI 10.1016/S0140-6736(98)22937-0; Scirica BM, 2013, NEW ENGL J MED, V369, P1317, DOI 10.1056/NEJMoa1307684; Stevens RJ, 2012, DIABETOLOGIA, V55, P2593, DOI 10.1007/s00125-012-2653-7; The University Group Diabetes Program, 1975, DIABETES, V24, P65; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Zinman B, 2015, NEW ENGL J MED, V373, P2117, DOI 10.1056/NEJMoa1504720	27	19	19	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 8	2016	352								h6748	10.1136/bmj.h6748	http://dx.doi.org/10.1136/bmj.h6748			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DA8NF	26747716	Green Published			2022-12-28	WOS:000368061200005
J	McMeekin, DP; Sadoughi, G; Rehman, W; Eperon, GE; Saliba, M; Horantner, MT; Haghighirad, A; Sakai, N; Korte, L; Rech, B; Johnston, MB; Herz, LM; Snaith, HJ				McMeekin, David P.; Sadoughi, Golnaz; Rehman, Waqaas; Eperon, Giles E.; Saliba, Michael; Hoerantner, Maximilian T.; Haghighirad, Amir; Sakai, Nobuya; Korte, Lars; Rech, Bernd; Johnston, Michael B.; Herz, Laura M.; Snaith, Henry J.			A mixed-cation lead mixed-halide perovskite absorber for tandem solar cells	SCIENCE			English	Article							EFFICIENT; PHASE; MOBILITIES; SILICON	Metal halide perovskite photovoltaic cells could potentially boost the efficiency of commercial silicon photovoltaic modules from similar to 20 toward 30% when used in tandem architectures. An optimum perovskite cell optical band gap of similar to 1.75 electron volts (eV) can be achieved by varying halide composition, but to date, such materials have had poor photostability and thermal stability. Here we present a highly crystalline and compositionally photostable material, [HC(NH2)(2)](0.83)Cs0.17Pb(I0.6Br0.4)(3), with an optical band gap of similar to 1.74 eV, and we fabricated perovskite cells that reached open-circuit voltages of 1.2 volts and power conversion efficiency of over 17% on small areas and 14.7% on 0.715 cm(2) cells. By combining these perovskite cells with a 19%-efficient silicon cell, we demonstrated the feasibility of achieving >25%-efficient four-terminal tandem cells.	[McMeekin, David P.; Sadoughi, Golnaz; Rehman, Waqaas; Eperon, Giles E.; Saliba, Michael; Hoerantner, Maximilian T.; Haghighirad, Amir; Sakai, Nobuya; Johnston, Michael B.; Herz, Laura M.; Snaith, Henry J.] Univ Oxford, Clarendon Lab, Oxford OX1 3PU, England; [Korte, Lars; Rech, Bernd] Helmholtz Zentrum Berlin Mat & Energie, Inst Silicon Photovolta, D-12489 Berlin, Germany	University of Oxford; Helmholtz Association; Helmholtz-Zentrum fuer Materialien und Energie GmbH (HZB)	Snaith, HJ (corresponding author), Univ Oxford, Clarendon Lab, Parks Rd, Oxford OX1 3PU, England.	henry.snaith@physics.ox.ac.uk	Eperon, Giles/J-2316-2015; Johnston, Michael/B-9813-2008; Korte, Lars/P-7408-2019; Herz, Laura/B-9789-2008; Saliba, Michael/I-1945-2016; Rech, Bernd/J-4720-2013; Haghighirad, Amir-Abbas/ABE-6071-2020; Snaith, Henry J/A-7367-2016	Eperon, Giles/0000-0001-9600-4847; Johnston, Michael/0000-0002-0301-8033; Korte, Lars/0000-0002-9207-9048; Herz, Laura/0000-0001-9621-334X; Saliba, Michael/0000-0002-6818-9781; Rech, Bernd/0000-0002-9718-8665; Haghighirad, Amir-Abbas/0000-0003-4723-4966; Snaith, Henry J/0000-0001-8511-790X	Engineering and Physical Sciences Research Council through the Supergen Solar Energy Hub SuperSolar [EP/M024881/1, EP/M014797/1]; European Research Council; European Union [604032]; U.S. Office of Naval Research; Oxford PV Ltd.; Hans-Boeckler-Foundation; Engineering and Physical Sciences Research Council [EP/L024667/1, 1511477, EP/M024881/1, 1659412, EP/M014797/1] Funding Source: researchfish; EPSRC [EP/L024667/1, EP/M014797/1, EP/M024881/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council through the Supergen Solar Energy Hub SuperSolar(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); European Research Council(European Research Council (ERC)European Commission); European Union(European Commission); U.S. Office of Naval Research(Office of Naval Research); Oxford PV Ltd.; Hans-Boeckler-Foundation; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This project was funded in part by the Engineering and Physical Sciences Research Council through the Supergen Solar Energy Hub SuperSolar (EP/M024881/1, EP/M014797/1) and the European Research Council through the Stg-2011 Hybrid Photovoltaic Energy Relays and the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement 604032 of the MESO project, and the U.S. Office of Naval Research. M.H. is funded by Oxford PV Ltd. W.R. is supported by the Hans-Boeckler-Foundation. We thank our colleagues from the Centre For Renewable Energy Technologies Photovoltaic Measurement and Testing Laboratory, Loughborough University, for their contributions to the measurements of the semi-transparent devices. We also thank K. Jacob and M. Wittig [Helmholtz-Zentrum Berlin (HZB), Institute for Silicon Photovoltaics], L. Mazzarella, and S. Kirner (HZB, Institute PVcomB) for their contributions to fabricating the SHJ cell. The University of Oxford has filed a patent related to this work. The project was designed and conceptualized by D.M. and H.J.S. D.M. performed experiments, analyzed data, and wrote the first draft of the paper. G.S. fabricated and measured devices with semi-transparent electrodes. W.R. characterized the material using THz spectroscopy. G.E. helped with the experimental work and provided technical feedback on the writing of the paper. M. S. provided input and technical direction on the FA/Cs cation mixture. M.H. performed simulations for the optical modeling and calculated the maximum achievable VOC. A.H. analyzed XRD data. N.S. provided input on the preparation of thin films using chemical bath depositions. L.K. and B.R. designed and supervised the fabrication of the SHJ cells. M.J. performed and analyzed EQE measurements. L.H. supervised and analyzed the THz spectroscopy measurements. H.J.S. supervised the overall conception and design of this project. All authors contributed to the writing of the paper.	Albrecht S., 2015, ENERG ENVIRON SCI, V9, P81, DOI DOI 10.1039/C5EE02965A; Bailie CD, 2015, ENERG ENVIRON SCI, V8, P956, DOI 10.1039/c4ee03322a; Bi C, 2015, ADV ENERGY MATER, V5, DOI 10.1002/aenm.201401616; Binek A, 2015, J PHYS CHEM LETT, V6, P1249, DOI 10.1021/acs.jpclett.5b00380; Burschka J, 2013, NATURE, V499, P316, DOI 10.1038/nature12340; Choi H, 2014, NANO ENERGY, V7, P80, DOI 10.1016/j.nanoen.2014.04.017; Conings B, 2015, ADV ENERGY MATER, V5, DOI 10.1002/aenm.201500477; De Wolf S, 2014, J PHYS CHEM LETT, V5, P1035, DOI 10.1021/jz500279b; Eperon GE, 2014, ENERG ENVIRON SCI, V7, P982, DOI 10.1039/c3ee43822h; Green MA, 2015, PROG PHOTOVOLTAICS, V23, P805, DOI 10.1002/pip.2637; Green MA, 2014, NAT PHOTONICS, V8, P506, DOI [10.1038/nphoton.2014.134, 10.1038/NPHOTON.2014.134]; Hoke ET, 2015, CHEM SCI, V6, P613, DOI 10.1039/c4sc03141e; Jeon NJ, 2015, NATURE, V517, P476, DOI 10.1038/nature14133; Jeon NJ, 2014, NAT MATER, V13, P897, DOI [10.1038/NMAT4014, 10.1038/nmat4014]; Kagan CR, 1999, SCIENCE, V286, P945, DOI 10.1126/science.286.5441.945; Kojima A., 2009, PRIV COMMUN, V1, P1; Lee JW, 2015, ADV ENERGY MATER, V5, DOI 10.1002/aenm.201501310; Lee MM, 2012, SCIENCE, V338, P643, DOI 10.1126/science.1228604; Liu MZ, 2013, NATURE, V501, P395, DOI 10.1038/nature12509; Loper P, 2015, PHYS CHEM CHEM PHYS, V17, P1619, DOI 10.1039/c4cp03788j; Mazzarella L, 2015, APPL PHYS LETT, V106, DOI 10.1063/1.4905906; Milot RL, 2015, ADV FUNCT MATER, V25, P6218, DOI 10.1002/adfm.201502340; Noh JH, 2013, NANO LETT, V13, P1764, DOI 10.1021/nl400349b; Pang SP, 2014, CHEM MATER, V26, P1485, DOI 10.1021/cm404006p; Pellet N, 2014, ANGEW CHEM INT EDIT, V53, P3151, DOI 10.1002/anie.201309361; Rau U, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.085303; Rehman W, 2015, ADV MATER, V27, P7938, DOI 10.1002/adma.201502969; Sadhanala A, 2014, J PHYS CHEM LETT, V5, P2501, DOI 10.1021/jz501332v; Shah A, 1999, SCIENCE, V285, P692, DOI 10.1126/science.285.5428.692; Sivaram V, 2015, SCI AM, V313, P54, DOI 10.1038/scientificamerican0715-54; Snaith HJ, 2010, ADV FUNCT MATER, V20, P13, DOI 10.1002/adfm.200901476; Stoumpos CC, 2013, INORG CHEM, V52, P9019, DOI 10.1021/ic401215x; Stranks SD, 2015, NAT NANOTECHNOL, V10, P391, DOI [10.1038/NNANO.2015.90, 10.1038/nnano.2015.90]; Tress W, 2015, ADV ENERGY MATER, V5, DOI 10.1002/aenm.201400812; Tvingstedt K, 2014, SCI REP-UK, V4, DOI 10.1038/srep06071; Yang WS, 2015, SCIENCE, V348, P1234, DOI 10.1126/science.aaa9272	36	2082	2113	69	1671	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 8	2016	351	6269					151	155		10.1126/science.aad5845	http://dx.doi.org/10.1126/science.aad5845			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA4XQ	26744401	Green Submitted			2022-12-28	WOS:000367806500036
J	Winemiller, KO; McIntyre, PB; Castello, L; Fluet-Chouinard, E; Giarrizzo, T; Nam, S; Baird, IG; Darwall, W; Lujan, NK; Harrison, I; Stiassny, MLJ; Silvano, RAM; Fitzgerald, DB; Pelicice, FM; Agostinho, AA; Gomes, LC; Albert, JS; Baran, E; Petrere, M; Zarfl, C; Mulligan, M; Sullivan, JP; Arantes, CC; Sousa, LM; Koning, AA; Hoeinghaus, DJ; Sabaj, M; Lundberg, JG; Armbruster, J; Thieme, ML; Petry, P; Zuanon, J; Vilara, GT; Snoeks, J; Ou, C; Rainboth, W; Pavanelli, CS; Akama, A; van Soesbergen, A; Saenz, L				Winemiller, K. O.; McIntyre, P. B.; Castello, L.; Fluet-Chouinard, E.; Giarrizzo, T.; Nam, S.; Baird, I. G.; Darwall, W.; Lujan, N. K.; Harrison, I.; Stiassny, M. L. J.; Silvano, R. A. M.; Fitzgerald, D. B.; Pelicice, F. M.; Agostinho, A. A.; Gomes, L. C.; Albert, J. S.; Baran, E.; Petrere, M., Jr.; Zarfl, C.; Mulligan, M.; Sullivan, J. P.; Arantes, C. C.; Sousa, L. M.; Koning, A. A.; Hoeinghaus, D. J.; Sabaj, M.; Lundberg, J. G.; Armbruster, J.; Thieme, M. L.; Petry, P.; Zuanon, J.; Vilara, G. Torrente; Snoeks, J.; Ou, C.; Rainboth, W.; Pavanelli, C. S.; Akama, A.; van Soesbergen, A.; Saenz, L.			Balancing hydropower and biodiversity in the Amazon, Congo, and Mekong	SCIENCE			English	Editorial Material							DAMS		[Winemiller, K. O.; Fitzgerald, D. B.; Arantes, C. C.] Texas A&M Univ, College Stn, TX 77843 USA; [McIntyre, P. B.; Fluet-Chouinard, E.; Baird, I. G.; Koning, A. A.] Univ Wisconsin, Madison, WI 53706 USA; [Castello, L.] Virginia Polytech Inst & State Univ, Blacksburg, VA 24061 USA; [Giarrizzo, T.] Fed Univ Para, BR-66077830 Belem, Para, Brazil; [Nam, S.] Mekong River Commiss Secretariat, Phnom Penh, Cambodia; [Darwall, W.] IUCN, Cambridge CB2 3QZ, Cambs, England; [Lujan, N. K.; Sabaj, M.; Lundberg, J. G.] Univ Toronto, Toronto, ON M1C 1A4, Canada; [Harrison, I.] IUCN, Conservat Int, Arlington, VA 22202 USA; [Stiassny, M. L. J.] Amer Museum Nat Hist, New York, NY 10024 USA; [Silvano, R. A. M.] Univ Fed Rio Grande do Sul, BR-91501970 Porto Alegre, RS, Brazil; [Pelicice, F. M.] Univ Fed Tocantins, BR-77500000 Porto Nacl, Tocantins, Brazil; [Agostinho, A. A.; Gomes, L. C.; Pavanelli, C. S.] Univ Estadual Maringa, BR-87020900 Maringa, Parana, Brazil; [Albert, J. S.] Univ Louisiana, Dept Biol, Lafayette, LA 70451 USA; [Baran, E.] WorldFish Ctr, Phnom Penh, Cambodia; [Petrere, M., Jr.] Univ Fed Sao Carlos, Sao Paulo, Brazil; [Petrere, M., Jr.] UNISANTA, UFSCar, BR-11045907 Sao Paulo, Brazil; [Zarfl, C.] IGB, D-12587 Berlin, Germany; [Zarfl, C.] Univ Tubingen, D-72074 Tubingen, Germany; [Mulligan, M.] Kings Coll London, London WC2R 2LS, England; [Sullivan, J. P.] Cornell Univ, Ithaca, NY 14850 USA; [Sousa, L. M.] Fed Univ Para, BR-68372040 Altamira, Para, Brazil; [Hoeinghaus, D. J.] Univ N Texas, Denton, TX 76203 USA; [Armbruster, J.] Auburn Univ, Auburn, AL 36849 USA; [Thieme, M. L.] World Wildlife Fund, Washington, DC 20037 USA; [Petry, P.] Nature Conservancy, Arlington, VA 22203 USA; [Zuanon, J.] Inst Nacl de Pesquisas da Amazonia, BR-69067375 Manaus, Amazonas, Brazil; [Vilara, G. Torrente] Univ Fed Amazonas, BR-69077000 Manaus, Amazonas, Brazil; [Snoeks, J.] Royal Museum Cent Africa, Tervuren, Belgium; [Ou, C.] Sch Field Studies, Siem Reap, Cambodia; [Rainboth, W.] Univ Wisconsin, Oshkosh, WI 54901 USA; [Akama, A.] Museu Paraense Emilio Goeldi, Belem, Para, Brazil; [van Soesbergen, A.] UNEP World Conservat Monitoring Ctr, Cambridge CB3 0DL, England; [Saenz, L.] Conservat Int, Arlington, VA 22202 USA	Texas A&M University System; Texas A&M University College Station; University of Wisconsin System; University of Wisconsin Madison; Virginia Polytechnic Institute & State University; Universidade Federal do Para; University of Toronto; Conservation International; American Museum of Natural History (AMNH); Universidade Federal do Rio Grande do Sul; Universidade Federal do Tocantins (UFT); Universidade Estadual de Maringa; University of Louisiana Lafayette; CGIAR; Worldfish; Universidade Federal de Sao Carlos; Universidade Federal de Sao Carlos; Universidade Santa Cecilia; Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB); Eberhard Karls University of Tubingen; University of London; King's College London; Cornell University; Universidade Federal do Para; University of North Texas System; University of North Texas Denton; Auburn University System; Auburn University; World Wildlife Fund; Nature Conservancy; Institute Nacional de Pesquisas da Amazonia; Universidade Federal de Amazonas; Royal Museum for Central Africa; University of Wisconsin System; Museu Paraense Emilio Goeldi; Conservation International	Winemiller, KO (corresponding author), Texas A&M Univ, College Stn, TX 77843 USA.	k-winemiller@tamu.edu	Torrente-Vilara, Gislene/K-5558-2013; Castello, Leandro/K-4389-2012; Pavanelli, Carla/G-6399-2012; Giarrizzo, Tommaso/G-8482-2016; Agostinho, Angelo Antonio/S-1538-2019; Gomes, Luiz/D-5886-2013; Sousa, Leandro/AAX-2811-2021; Torrente-Vilara, Gislene/AAF-1559-2021; Agostini, Angelo/D-5888-2013; Zuanon, Jansen A. S./E-5791-2013; Baird, Ian G./AAA-4727-2021; Mulligan, Mark/V-9275-2019; de Sousa, Leandro Melo/I-6108-2012; SULLIVAN, JOHN P./ABH-8966-2020; Fapesp, Biota/F-8655-2017; Silvano, Renato A. M./G-1282-2012	Torrente-Vilara, Gislene/0000-0002-2048-7691; Castello, Leandro/0000-0002-9968-1584; Pavanelli, Carla/0000-0003-4059-984X; Giarrizzo, Tommaso/0000-0002-5116-5206; Agostinho, Angelo Antonio/0000-0002-4707-9444; Sousa, Leandro/0000-0002-0793-9737; Torrente-Vilara, Gislene/0000-0002-2048-7691; Agostini, Angelo/0000-0002-4707-9444; Zuanon, Jansen A. S./0000-0001-8354-2750; Baird, Ian G./0000-0001-7747-2485; de Sousa, Leandro Melo/0000-0002-0793-9737; Fapesp, Biota/0000-0002-9887-8449; Thieme, Michele/0000-0003-3216-9129; van Soesbergen, Arnout/0000-0002-3263-4011; gomes, Luiz/0000-0001-7295-723X; Fluet-Chouinard, Etienne/0000-0003-4380-2153; Winemiller, Kirk/0000-0003-0236-5129; Petrere Jr, Miguel/0000-0003-2000-6699; Silvano, Renato/0000-0003-0171-6628; Sullivan, John P./0000-0003-0585-5617; Mulligan, Mark/0000-0002-0132-0888	Direct For Biological Sciences [1354511] Funding Source: National Science Foundation	Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))		Ansar A, 2014, ENERG POLICY, V69, P43, DOI 10.1016/j.enpol.2013.10.069; Castello L, 2016, GLOBAL CHANGE BIOL, V22, P990, DOI 10.1111/gcb.13173; Finer M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035126; Foran T., 2009, CONTESTED WATERSCAPE, P55, DOI DOI 10.4324/9781849770866; Grill G, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/1/015001; Hoeinghaus DJ, 2009, CONSERV BIOL, V23, P1222, DOI 10.1111/j.1523-1739.2009.01248.x; Jackson D., 2001, DAMS; Kondolf GM, 2014, WATER RESOUR RES, V50, P5158, DOI 10.1002/2013WR014651; Lehner B, 2011, FRONT ECOL ENVIRON, V9, P494, DOI 10.1890/100125; McCluney KE, 2014, FRONT ECOL ENVIRON, V12, P48, DOI 10.1890/120367; Orr S, 2012, GLOBAL ENVIRON CHANG, V22, P925, DOI 10.1016/j.gloenvcha.2012.06.002; Pelicice FM, 2008, CONSERV BIOL, V22, P180, DOI 10.1111/j.1523-1739.2007.00849.x; Perez M. Sabaj, 2015, SCI AM, V103, P395; Poff NL, 2016, NAT CLIM CHANGE, V6, P25, DOI [10.1038/nclimate2765, 10.1038/NCLIMATE2765]; Pompeu PS, 2012, RIVER RES APPL, V28, P504, DOI 10.1002/rra.1557; Showers KB, 2011, ENG EARTH IMPACTS ME, P1651, DOI DOI 10.1007/978-90-481-9920-4_95; Stone R, 2011, SCIENCE, V333, P817, DOI 10.1126/science.333.6044.817; Zarfl C, 2015, AQUAT SCI, V77, P161, DOI 10.1007/s00027-014-0377-0; Ziv G, 2012, P NATL ACAD SCI USA, V109, P5609, DOI 10.1073/pnas.1201423109	19	794	829	25	450	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 8	2016	351	6269					128	129		10.1126/science.aac7082	http://dx.doi.org/10.1126/science.aac7082			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA4XQ	26744397	Green Submitted			2022-12-28	WOS:000367806500018
J	Khanna, RR; Wachter, RM; Blum, M				Khanna, Raman R.; Wachter, Robert M.; Blum, Michael			Reimagining Electronic Clinical Communication in the Post-Pager, Smartphone Era	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CARE		[Khanna, Raman R.; Wachter, Robert M.] Univ Calif San Francisco, Dept Med, Div Hosp Med, San Francisco, CA USA; [Khanna, Raman R.; Blum, Michael] Univ Calif San Francisco, Sch Med, Ctr Digital Hlth Innovat, San Francisco, CA USA; [Blum, Michael] Univ Calif San Francisco, Dept Med, Div Cardiol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Khanna, RR (corresponding author), Ctr Digital Hlth Innovat, 533 Parnassus Ave, San Francisco, CA 94143 USA.	raman.khanna@ucsf.edu						Brynjolfsson E, PRODUCTIVITY PARADOX; Frizzell JD, 2014, J AM COLL CARDIOL, V64, P2703, DOI 10.1016/j.jacc.2014.11.001; Plant MA, 2015, TEACH LEARN MED, V27, P215, DOI 10.1080/10401334.2015.1011646; Scheuermeyer FX, 2016, J TELEMED TELECARE, V22, P105, DOI 10.1177/1357633X15587626; Shah DR, 2013, J SURG EDUC, V70, P826, DOI [10.7016/j.jsurg.2012.05.003, 10.1016/j.jsurg.2012.05.003]; Wachter RM, WHY MED RECORD NEEDS; Wu R, 2015, J HOSP MED, V10, P83, DOI 10.1002/jhm.2278	7	9	9	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 5	2016	315	1					21	22		10.1001/jama.2015.17025	http://dx.doi.org/10.1001/jama.2015.17025			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DA0YH	26746450				2022-12-28	WOS:000367523000006
J	Wang, Y; Hekimi, S				Wang, Ying; Hekimi, Siegfried			Mitochondrial dysfunction and longevity in animals: Untangling the knot	SCIENCE			English	Review							UNFOLDED-PROTEIN RESPONSE; CAENORHABDITIS-ELEGANS; LIFE-SPAN; ELECTRON-TRANSPORT; OXIDATIVE STRESS; DNA MUTATIONS; MUTATOR MICE; APOPTOSIS; PATHWAY; ROS	Mitochondria generate adenosine 5'-triphosphate (ATP) and are a source of potentially toxic reactive oxygen species (ROS). It has been suggested that the gradual mitochondrial dysfunction that is observed to accompany aging could in fact be causal to the aging process. Here we review findings that suggest that age-dependent mitochondrial dysfunction is not sufficient to limit life span. Furthermore, mitochondrial ROS are not always deleterious and can even stimulate pro-longevity pathways. Thus, mitochondrial dysfunction plays a complex role in regulating longevity.	[Wang, Ying; Hekimi, Siegfried] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada	McGill University	Hekimi, S (corresponding author), McGill Univ, Dept Biol, 1205 Doctor Penfield Ave, Montreal, PQ H3A 1B1, Canada.	siegfried.hekimi@mcgill.ca	Wang, Ying/AAI-6756-2020	Wang, Ying/0000-0003-1339-9017	Canadian Institutes of Health Research [MOP-114891, MOP-123295, MOP-97869]; McGill University	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); McGill University	We thank C. Yee for useful discussions and R. Branicky for reading the manuscript. Our laboratory is funded by grants from the Canadian Institutes of Health Research (grants MOP-114891, MOP-123295, and MOP-97869) and by McGill University. S.H. holds the Strathcona Chair of Zoology and the Campbell Chair in Developmental Biology.	Baker BM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002760; Baruah A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004097; Bennett CF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4483; Copeland JM, 2009, CURR BIOL, V19, P1591, DOI 10.1016/j.cub.2009.08.016; Dai DF, 2010, AGING CELL, V9, P536, DOI 10.1111/j.1474-9726.2010.00581.x; Deepa SS, 2013, FASEB J, V27, P1371, DOI 10.1096/fj.12-221879; Dell'Agnello C, 2007, HUM MOL GENET, V16, P431, DOI 10.1093/hmg/ddl477; Dillin A, 2002, SCIENCE, V298, P2398, DOI 10.1126/science.1077780; Dillon LM, 2012, IUBMB LIFE, V64, P231, DOI 10.1002/iub.608; DiMauro S, 2013, NAT REV NEUROL, V9, P429, DOI 10.1038/nrneurol.2013.126; Durieux J, 2011, CELL, V144, P79, DOI 10.1016/j.cell.2010.12.016; Felkai S, 1999, EMBO J, V18, P1783, DOI 10.1093/emboj/18.7.1783; Feng JL, 2001, DEV CELL, V1, P633, DOI 10.1016/S1534-5807(01)00071-5; Gomes AP, 2013, CELL, V155, P1624, DOI 10.1016/j.cell.2013.11.037; Haynes CM, 2013, TRENDS CELL BIOL, V23, P311, DOI 10.1016/j.tcb.2013.02.002; Hekimi S, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.23793; Hekimi S, 2011, TRENDS CELL BIOL, V21, P569, DOI 10.1016/j.tcb.2011.06.008; Houtkooper RH, 2013, NATURE, V497, P451, DOI 10.1038/nature12188; Hwang AB, 2014, P NATL ACAD SCI USA, V111, pE4458, DOI 10.1073/pnas.1411199111; Itsara LS, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1003974; Kennedy SR, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003794; Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125; Kujoth GC, 2007, PLOS GENET, V3, P161, DOI 10.1371/journal.pgen.0030024; Lee SS, 2003, NAT GENET, V33, P40, DOI 10.1038/ng1056; Logan A, 2014, AGING CELL, V13, P765, DOI 10.1111/acel.12212; Mouchiroud L, 2013, CELL, V154, P430, DOI 10.1016/j.cell.2013.06.016; Paek J, 2012, CELL METAB, V16, P526, DOI 10.1016/j.cmet.2012.09.007; Picard Martin, 2010, Aging Cell, V9, P1032, DOI 10.1111/j.1474-9726.2010.00628.x; Pulliam DA, 2014, BIOCHEM J, V462, P359, DOI 10.1042/BJ20140291; Rera M, 2011, CELL METAB, V14, P623, DOI 10.1016/j.cmet.2011.09.013; Schroeder EA, 2013, CELL METAB, V17, P954, DOI 10.1016/j.cmet.2013.04.003; Schulz TJ, 2007, CELL METAB, V6, P280, DOI 10.1016/j.cmet.2007.08.011; Schumacher B, 2005, CELL DEATH DIFFER, V12, P153, DOI 10.1038/sj.cdd.4401539; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102; Van Remmen H, 2003, PHYSIOL GENOMICS, V16, P29, DOI 10.1152/physiolgenomics.00122.2003; Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988; Wallace DC, 2009, GENE DEV, V23, P1714, DOI 10.1101/gad.1784909; Walter L, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001084; Wang Y, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7393; Xie LTX, 2012, J BIOL CHEM, V287, P23571, DOI 10.1074/jbc.M112.360354; Yang W, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000556; Yang W, 2010, AGING CELL, V9, P433, DOI 10.1111/j.1474-9726.2010.00571.x; Yee C, 2014, CELL, V157, P897, DOI 10.1016/j.cell.2014.02.055; Zarse K, 2012, CELL METAB, V15, P451, DOI 10.1016/j.cmet.2012.02.013	45	160	171	2	82	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 4	2015	350	6265					1204	1207		10.1126/science.aac4357	http://dx.doi.org/10.1126/science.aac4357			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX4WG	26785479	Green Submitted			2022-12-28	WOS:000365700500064
J	van Os, J; Kapur, S				van Os, Jim; Kapur, Shitij			Schizophrenia	LANCET			English	Review							GENE-ENVIRONMENT INTERACTIONS; RANDOMIZED CONTROLLED-TRIAL; CANNABIS-INDUCED PSYCHOSIS; SEVERE MENTAL-ILLNESS; FOLLOW-UP; 1ST-EPISODE SCHIZOPHRENIA; BIPOLAR DISORDER; LONG-TERM; SCHIZOAFFECTIVE DISORDER; NONAFFECTIVE PSYCHOSES	Schizophrenia is still one of the most mysterious and costliest mental disorders in terms of human suffering and societal expenditure. Here, we focus on the key developments in biology, epidemiology, and pharmacology of schizophrenia and provide a syndromal framework in which these aspects can be understood together. Symptoms typically emerge in adolescence and early adulthood. The incidence of the disorder varies greatly across places and migrant groups, as do symptoms, course, and treatment response across individuals. Genetic vulnerability is shared in part with bipolar disorder and recent molecular genetic findings also indicate an overlap with developmental disorders such as autism. The diagnosis of schizophrenia is associated with demonstrable alterations in brain structure and changes in dopamine neurotransmission, the latter being directly related to hallucinations and delusions. Pharmacological treatments, which block the dopamine system, are effective for delusions and hallucinations but less so for disabling cognitive and motivational impairments. Specific vocational and psychological interventions, in combination with antipsychotic medication in a context of community-case management, can improve functional outcome but are not widely available. 100 years after being so named, research is beginning to understand the biological mechanisms underlying the symptoms of schizophrenia and the psychosocial factors that moderate their expression. Although current treatments provide control rather than cure, long-term hospitalisation is not required and prognosis is better than traditionally assumed.	[van Os, Jim] Maastricht Univ, Med Ctr, Dept Psychiat & Psychol,EURON, S Limburg Mental Hlth Res & Teaching Network, NL-6200 MD Maastricht, Netherlands; [van Os, Jim; Kapur, Shitij] Kings Coll London, Div Psychol Med, Inst Psychiat, London WC2R 2LS, England	Maastricht University; University of London; King's College London	van Os, J (corresponding author), Maastricht Univ, Med Ctr, Dept Psychiat & Psychol,EURON, S Limburg Mental Hlth Res & Teaching Network, POB 616, NL-6200 MD Maastricht, Netherlands.	j.vanos@sp.unimaas.nl	van Os, Jim/C-2113-2014; Vasconcelos, Ana Carolina Souza de/GXW-3453-2022; van Os, Jim/V-8884-2019; Zhang, Xiao/V-9027-2017; Mortensen, Preben Bo/D-2358-2015	van Os, Jim/0000-0002-7245-1586; Zhang, Xiao/0000-0002-2932-5875; Mortensen, Preben Bo/0000-0002-5230-9865; Kapur, Shitij/0000-0002-2231-2924	Medical Research Council [G0800509, MR/L010305/1] Funding Source: Medline; Medical Research Council [G0701748] Funding Source: Medline; NIDA NIH HHS [R21 DA040127, DA-040127] Funding Source: Medline; NIMH NIH HHS [MH-092443, MH-069853, MH-105660, MH-084018, MH-094268, MH-085226, R01 MH105660, R01 MH092443, P50 MH094268, MH-088753] Funding Source: Medline; Wellcome Trust Funding Source: Medline; MRC [G0701748] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Agid O, 2008, EXPERT OPIN EMERG DR, V13, P479, DOI [10.1517/14728214.13.3.479, 10.1517/14728214.13.3.479 ]; ALLARDYCE J, 2008, DIMENSIONAL APPROACH, P53; Allen AJ, 2009, SCHIZOPHR RES, V109, P24, DOI 10.1016/j.schres.2009.01.016; An Der Heiden W., 1995, Nervenarzt, V66, P820; Arendt M, 2005, BRIT J PSYCHIAT, V187, P510, DOI 10.1192/bjp.187.6.510; Arendt M, 2008, ARCH GEN PSYCHIAT, V65, P1269, DOI 10.1001/archpsyc.65.11.1269; Artaloytia JF, 2006, AM J PSYCHIAT, V163, P488, DOI 10.1176/appi.ajp.163.3.488; Arts B, 2008, PSYCHOL MED, V38, P771, DOI 10.1017/S0033291707001675; Beauchamp G, 2004, SOC PSYCH PSYCH EPID, V39, P1017, DOI 10.1007/s00127-004-0844-3; Bentall R, 2006, MED HYPOTHESES, V66, P220, DOI 10.1016/j.mehy.2005.09.026; Berridge KC, 2003, TRENDS NEUROSCI, V26, P507, DOI 10.1016/S0166-2236(03)00233-9; Bertelsen M, 2008, ARCH GEN PSYCHIAT, V65, P762, DOI 10.1001/archpsyc.65.7.762; BLAND RC, 1978, ARCH GEN PSYCHIAT, V35, P72; Boevink WA, 2006, SCHIZOPHRENIA BULL, V32, P17, DOI 10.1093/schbul/sbi068; Boos HBM, 2007, ARCH GEN PSYCHIAT, V64, P297, DOI 10.1001/archpsyc.64.3.297; Boydell J, 2001, BMJ-BRIT MED J, V323, P1336, DOI 10.1136/bmj.323.7325.1336; Bramon E, 2005, NEUROIMAGE, V27, P960, DOI 10.1016/j.neuroimage.2005.05.022; Brockington I., 1992, European Psychiatry, V7, P203; Brown AS, 2008, SCHIZOPHRENIA BULL, V34, P1054, DOI 10.1093/schbul/sbn096; Brown AS, 2006, SCHIZOPHRENIA BULL, V32, P200, DOI 10.1093/schbul/sbj052; Buchanan RW, 2007, SCHIZOPHRENIA BULL, V33, P1120, DOI 10.1093/schbul/sbm083; Buckley PF, 2007, ACTA PSYCHIAT SCAND, V115, P93, DOI 10.1111/j.1600-0447.2007.00992.x; Burns T, 2007, LANCET, V370, P1146, DOI 10.1016/S0140-6736(07)61516-5; Burns T, 2007, BRIT MED J, V335, P336, DOI 10.1136/bmj.39251.599259.55; Cannon M, 2002, ARCH GEN PSYCHIAT, V59, P449, DOI 10.1001/archpsyc.59.5.449; Cannon M, 2002, AM J PSYCHIAT, V159, P1080, DOI 10.1176/appi.ajp.159.7.1080; Cannon TD, 2007, SCHIZOPHRENIA BULL, V33, P661, DOI 10.1093/schbul/sbm031; Cantor-Graae E, 2005, AM J PSYCHIAT, V162, P12, DOI 10.1176/appi.ajp.162.1.12; Cardno AG, 2002, AM J PSYCHIAT, V159, P539, DOI 10.1176/appi.ajp.159.4.539; CASTLE DJ, 1993, BRIT J PSYCHIAT, V162, P658, DOI 10.1192/bjp.162.5.658; CHAPMAN LJ, 1994, J ABNORM PSYCHOL, V103, P171, DOI 10.1037/0021-843X.103.2.171; CIOMPI L, 1980, SCHIZOPHRENIA BULL, V6, P606, DOI 10.1093/schbul/6.4.606; Cleary M, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001088.pub2; Cougnard A, 2005, SCHIZOPHR RES, V74, P27, DOI 10.1016/j.schres.2004.09.018; Craddock N, 2007, WORLD PSYCHIATRY, V6, P20; D'Souza DC, 2005, BIOL PSYCHIAT, V57, P594, DOI 10.1016/j.biopsych.2004.12.006; D'Souza DC, 2004, NEUROPSYCHOPHARMACOL, V29, P1558, DOI 10.1038/sj.npp.1300496; Dominguez MDG, 2011, SCHIZOPHRENIA BULL, V37, P84, DOI 10.1093/schbul/sbp022; Dominguez MD, 2009, PSYCHOL BULL, V135, P157, DOI 10.1037/a0014415; EATON WW, 1995, ARCH GEN PSYCHIAT, V52, P127; Ellison-Wright I, 2009, SCHIZOPHR RES, V108, P3, DOI 10.1016/j.schres.2008.11.021; Fine Cordelia, 2007, Cogn Neuropsychiatry, V12, P46, DOI 10.1080/13546800600750597; Fioravanti M, 2005, NEUROPSYCHOL REV, V15, P73, DOI 10.1007/s11065-005-6254-9; Fletcher PC, 2009, NAT REV NEUROSCI, V10, P48, DOI 10.1038/nrn2536; Freeman D, 2008, SCHIZOPHRENIA BULL, V34, P605, DOI 10.1093/schbul/sbn020; Frese FJ, 2009, SCHIZOPHRENIA BULL, V35, P370, DOI 10.1093/schbul/sbn175; Fusar-Poli P, 2007, NEUROSCI BIOBEHAV R, V31, P465, DOI 10.1016/j.neubiorev.2006.11.006; Ganev K, 1998, ACTA PSYCHIAT SCAND, V98, P200, DOI 10.1111/j.1600-0447.1998.tb10067.x; Garety PA, 2001, PSYCHOL MED, V31, P189, DOI 10.1017/S0033291701003312; Glahn DC, 2008, BIOL PSYCHIAT, V64, P774, DOI 10.1016/j.biopsych.2008.03.031; Goldberg TE, 2007, ARCH GEN PSYCHIAT, V64, P1115, DOI 10.1001/archpsyc.64.10.1115; Goldman AL, 2008, BIOL PSYCHIAT, V63, P475, DOI 10.1016/j.biopsych.2007.06.006; Green MF, 2000, SCHIZOPHRENIA BULL, V26, P119, DOI 10.1093/oxfordjournals.schbul.a033430; Greenwood TA, 2007, ARCH GEN PSYCHIAT, V64, P1242, DOI 10.1001/archpsyc.64.11.1242; Guillin O, 2007, INT REV NEUROBIOL, V78, P1, DOI 10.1016/S0074-7742(06)78001-1; Hall FS, 1999, SYNAPSE, V32, P37; Hanssen M, 2005, BRIT J CLIN PSYCHOL, V44, P181, DOI 10.1348/014466505X29611; Henquet C, 2006, NEUROPSYCHOPHARMACOL, V31, P2748, DOI 10.1038/sj.npp.1301197; Jacobs N, 2006, PSYCHOSOM MED, V68, P201, DOI 10.1097/01.psy.0000204919.15727.43; Jensen J, 2008, NEUROPSYCHOPHARMACOL, V33, P473, DOI 10.1038/sj.npp.1301437; Kaminsky ZA, 2009, NAT GENET, V41, P240, DOI 10.1038/ng.286; Kapur S, 2003, PROG NEURO-PSYCHOPH, V27, P1081, DOI 10.1016/j.pnpbp.2003.09.004; Kapur S, 2003, AM J PSYCHIAT, V160, P13, DOI 10.1176/appi.ajp.160.1.13; Kapur S, 2004, TRENDS PHARMACOL SCI, V25, P402, DOI 10.1016/j.tips.2004.06.005; Kapur Shitij, 2006, NeuroRx, V3, P10, DOI 10.1016/j.nurx.2005.12.003; KENDLER KS, 1993, ARCH GEN PSYCHIAT, V50, P645; Khashan AS, 2008, ARCH GEN PSYCHIAT, V65, P146, DOI 10.1001/archgenpsychiatry.2007.20; Kingdon D, 2008, SOC PSYCH PSYCH EPID, V43, P239, DOI 10.1007/s00127-007-0284-y; Kirov G, 2008, HUM MOL GENET, V17, P458, DOI 10.1093/hmg/ddm323; Kirov G, 2009, HUM MOL GENET, V18, P1497, DOI 10.1093/hmg/ddp043; Krabbendam L, 2005, SCHIZOPHRENIA BULL, V31, P795, DOI 10.1093/schbul/sbi060; Laruelle M, 1998, Q J NUCL MED, V42, P211; Leboyer M, 2008, SCHIZOPHR RES, V102, P21, DOI 10.1016/j.schres.2008.04.003; Leucht S, 2009, LANCET, V373, P31, DOI 10.1016/S0140-6736(08)61764-X; Lichtenstein P, 2009, LANCET, V373, P234, DOI 10.1016/S0140-6736(09)60072-6; Linscott RJ, 2010, SCHIZOPHRENIA BULL, V36, P811, DOI 10.1093/schbul/sbn181; March D, 2008, EPIDEMIOL REV, V30, P84, DOI 10.1093/epirev/mxn006; MARNEROS A, 1992, BRIT J PSYCHIAT, V161, P44, DOI 10.1192/S0007125000297043; Marshall M, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004718.pub2; Marshall M, 2000, COCHRANE DB SYST REV, V2, DOI [10.1002/14651858.CD001089, DOI 10.1002/14651858.CD001089]; Mason P, 1996, BRIT J PSYCHIAT, V169, P580, DOI 10.1192/bjp.169.5.580; MCCREADIE RG, 1989, ACTA PSYCHIAT SCAND, V80, P597; McGrath J, 2008, EPIDEMIOL REV, V30, P67, DOI 10.1093/epirev/mxn001; McGurk SR, 2007, AM J PSYCHIAT, V164, P1791, DOI 10.1176/appi.ajp.2007.07060906; Menezes NM, 2006, PSYCHOL MED, V36, P1349, DOI 10.1017/S0033291706007951; Mizrahi R, 2007, AM J PSYCHIAT, V164, P630, DOI 10.1176/appi.ajp.164.4.630; Moore THM, 2007, LANCET, V370, P319, DOI 10.1016/S0140-6736(07)61162-3; Morgan C, 2008, PSYCHOL MED, V38, P1701, DOI 10.1017/S0033291708004534; Morrison AP, 2003, BRIT J CLIN PSYCHOL, V42, P331, DOI 10.1348/014466503322528892; Morrison PD, 2009, PSYCHOL MED, V39, P1607, DOI 10.1017/S0033291709005522; Mortensen PB, 2003, ARCH GEN PSYCHIAT, V60, P1209, DOI 10.1001/archpsyc.60.12.1209; Moskvina V, 2009, MOL PSYCHIATR, V14, P252, DOI 10.1038/mp.2008.133; Muller V, 1951, MON PSYCHIATR NEUROL, V122, P257; Mueser KT, 2004, LANCET, V363, P2063, DOI 10.1016/S0140-6736(04)16458-1; Murray RM, 2007, NAT REV NEUROSCI, V8, P885, DOI 10.1038/nrn2253; Myin-Germeys I, 2001, ARCH GEN PSYCHIAT, V58, P1137, DOI 10.1001/archpsyc.58.12.1137; Myin-Germeys I, 2009, PSYCHOL MED, V39, P1533, DOI 10.1017/S0033291708004947; Nose M, 2003, BRIT J PSYCHIAT, V183, P197, DOI 10.1192/bjp.183.3.197; Nuechterlein KH, 2008, AM J PSYCHIAT, V165, P203, DOI 10.1176/appi.ajp.2007.07010042; O'Donovan MC, 2008, NAT GENET, V40, P1053, DOI 10.1038/ng.201; O'Donovan MC, 2008, NAT GENET, V40, P1392, DOI 10.1038/ng1208-1392; Patel JK, 2009, SCHIZOPHR RES, V111, P9, DOI 10.1016/j.schres.2009.03.025; Patterson JV, 2008, PSYCHIAT RES, V158, P226, DOI 10.1016/j.psychres.2007.02.009; Perala J, 2007, ARCH GEN PSYCHIAT, V64, P19, DOI 10.1001/archpsyc.64.1.19; Poulton R, 2000, ARCH GEN PSYCHIAT, V57, P1053, DOI 10.1001/archpsyc.57.11.1053; RABINER CJ, 1986, AM J PSYCHIAT, V143, P1155; Reichenberg A, 2002, AM J PSYCHIAT, V159, P2027, DOI 10.1176/appi.ajp.159.12.2027; Robinson D, 1999, ARCH GEN PSYCHIAT, V56, P241, DOI 10.1001/archpsyc.56.3.241; Roiser JP, 2009, PSYCHOL MED, V39, P199, DOI 10.1017/S0033291708003863; Roy MA, 2001, SCHIZOPHR RES, V47, P141, DOI 10.1016/S0920-9964(99)00231-5; Rujescu D, 2009, HUM MOL GENET, V18, P988, DOI 10.1093/hmg/ddn351; Saha S, 2007, ARCH GEN PSYCHIAT, V64, P1123, DOI 10.1001/archpsyc.64.10.1123; SALOKANGAS RKR, 1983, BRIT J PSYCHIAT, V142, P145, DOI 10.1192/bjp.142.2.145; SARTORIUS N, 1986, PSYCHOL MED, V16, P909, DOI 10.1017/S0033291700011910; Sato M, 2006, WORLD PSYCHIATRY, V5, P53; Schultz W, 2007, ANNU REV NEUROSCI, V30, P259, DOI 10.1146/annurev.neuro.28.061604.135722; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; SHEPHERD M, 1989, PSYCHOL MED S, V15, P46; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; STEPHENS JH, 1978, SCHIZOPHRENIA BULL, V4, P25, DOI 10.1093/schbul/4.1.25; Stirling J, 2003, SCHIZOPHR RES, V65, P75, DOI 10.1016/S0920-9964(03)00014-8; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Szoke A, 2008, BRIT J PSYCHIAT, V192, P248, DOI 10.1192/bjp.bp.106.029009; Tarbox SI, 2008, PSYCHOL BULL, V134, P561, DOI 10.1037/0033-2909.34.4.561; THARA R, 1994, ACTA PSYCHIAT SCAND, V90, P329, DOI 10.1111/j.1600-0447.1994.tb01602.x; Thompson A, 2008, PSYCHOL MED, V38, P705, DOI 10.1017/S003329170700147X; Thornicroft G, 2009, LANCET, V373, P408, DOI 10.1016/S0140-6736(08)61817-6; Toulopoulou T, 2007, ARCH GEN PSYCHIAT, V64, P1348, DOI 10.1001/archpsyc.64.12.1348; Twamley EW, 2003, J NERV MENT DIS, V191, P515, DOI 10.1097/01.nmd.0000082213.42509.69; van Os J, 2009, PSYCHOL MED, V39, P179, DOI 10.1017/S0033291708003814; van Os J, 2008, SCHIZOPHRENIA BULL, V34, P1066, DOI 10.1093/schbul/sbn117; van Os J, 2009, BRIT J PSYCHIAT, V194, P101, DOI 10.1192/bjp.bp.108.054254; van Veldhuizen JR, 2007, COMMUNITY MENT HLT J, V43, P421, DOI 10.1007/s10597-007-9089-4; van Zelst C, 2009, SCHIZOPHRENIA BULL, V35, P293, DOI 10.1093/schbul/sbn184; VANOS J, 2009, KAPLAN SADO IN PRESS; Vazquez-Barquero JL, 1999, BRIT J PSYCHIAT, V174, P141, DOI 10.1192/bjp.174.2.141; Veling W, 2008, AM J PSYCHIAT, V165, P66, DOI 10.1176/appi.ajp.2007.07030423; Vita A, 2006, SCHIZOPHR RES, V82, P75, DOI 10.1016/j.schres.2005.11.004; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Weiser M, 2009, SCHIZOPHRENIA BULL, V35, P74; WELHAM J, 2009, PSYCHOL MED, V166, P567; Welham J, 2009, SCHIZOPHRENIA BULL, V35, P603, DOI 10.1093/schbul/sbn084; Wiersma D, 1998, SCHIZOPHRENIA BULL, V24, P75, DOI 10.1093/oxfordjournals.schbul.a033315; Wieselgren IM, 1996, ACTA PSYCHIAT SCAND, V94, P311, DOI 10.1111/j.1600-0447.1996.tb09866.x; Wobrock T, 2008, PROG NEURO-PSYCHOPH, V32, P1375, DOI 10.1016/j.pnpbp.2008.02.008; Wohl M, 2007, EUR PSYCHIAT, V22, P22, DOI 10.1016/j.eurpsy.2006.08.007; Woodberry KA, 2008, AM J PSYCHIAT, V165, P579, DOI 10.1176/appi.ajp.2008.07081242; Wright C, 2004, SOC PSYCH PSYCH EPID, V39, P789, DOI 10.1007/s00127-004-0818-5; Wykes T, 2008, SCHIZOPHRENIA BULL, V34, P523, DOI 10.1093/schbul/sbm114; Yung AR, 1996, SCHIZOPHRENIA BULL, V22, P283, DOI 10.1093/schbul/22.2.283; Zammit S, 2004, ARCH GEN PSYCHIAT, V61, P354, DOI 10.1001/archpsyc.61.4.354; Zygmunt A, 2002, AM J PSYCHIAT, V159, P1653, DOI 10.1176/appi.ajp.159.10.1653	152	1626	1674	48	856	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 22	2009	374	9690					635	645		10.1016/S0140-6736(09)60995-8	http://dx.doi.org/10.1016/S0140-6736(09)60995-8			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	486TU	19700006				2022-12-28	WOS:000269222600024
J	Ivey, A; Hills, RK; Simpson, MA; Jovanovic, JV; Gilkes, A; Grech, A; Patel, Y; Bhudia, N; Farah, H; Mason, J; Wall, K; Akiki, S; Griffiths, M; Solomon, E; McCaughan, F; Linch, DC; Gale, RE; Vyas, P; Freeman, SD; Russell, N; Burnett, AK; Grimwade, D				Ivey, A.; Hills, R. K.; Simpson, M. A.; Jovanovic, J. V.; Gilkes, A.; Grech, A.; Patel, Y.; Bhudia, N.; Farah, H.; Mason, J.; Wall, K.; Akiki, S.; Griffiths, M.; Solomon, E.; McCaughan, F.; Linch, D. C.; Gale, R. E.; Vyas, P.; Freeman, S. D.; Russell, N.; Burnett, A. K.; Grimwade, D.		UK Natl Canc Res Inst	Assessment of Minimal Residual Disease in Standard-Risk AML	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACUTE MYELOID-LEUKEMIA; POLYMERASE-CHAIN-REACTION; DNMT3A MUTATIONS; EUROPEAN LEUKEMIANET; PROGNOSTIC RELEVANCE; YOUNGER ADULTS; NPM1 MUTATIONS; 1ST REMISSION; RELAPSE; NUCLEOPHOSMIN	BACKGROUND Despite the molecular heterogeneity of standard-risk acute myeloid leukemia (AML), treatment decisions are based on a limited number of molecular genetic markers and morphology-based assessment of remission. Sensitive detection of a leukemia-specific marker (e.g., a mutation in the gene encoding nucleophosmin [NPM1]) could improve prognostication by identifying submicroscopic disease during remission. METHODS We used a reverse-transcriptase quantitative polymerase-chain-reaction assay to detect minimal residual disease in 2569 samples obtained from 346 patients with NPM1-mutated AML who had undergone intensive treatment in the National Cancer Research Institute AML17 trial. We used a custom 51-gene panel to perform targeted sequencing of 223 samples obtained at the time of diagnosis and 49 samples obtained at the time of relapse. Mutations associated with preleukemic clones were tracked by means of digital polymerase chain reaction. RESULTS Molecular profiling highlighted the complexity of NPM1-mutated AML, with segregation of patients into more than 150 subgroups, thus precluding reliable outcome prediction. The determination of minimal-residual-disease status was more informative. Persistence of NPM1-mutated transcripts in blood was present in 15% of the patients after the second chemotherapy cycle and was associated with a greater risk of relapse after 3 years of follow-up than was an absence of such transcripts (82% vs. 30%; hazard ratio, 4.80; 95% confidence interval [CI], 2.95 to 7.80; P<0.001) and a lower rate of survival (24% vs. 75%; hazard ratio for death, 4.38; 95% CI, 2.57 to 7.47; P<0.001). The presence of minimal residual disease was the only independent prognostic factor for death in multivariate analysis (hazard ratio, 4.84; 95% CI, 2.57 to 9.15; P<0.001). These results were validated in an independent cohort. On sequential monitoring of minimal residual disease, relapse was reliably predicted by a rising level of NPM1-mutated transcripts. Although mutations associated with preleukemic clones remained detectable during ongoing remission after chemotherapy, NPM1 mutations were detected in 69 of 70 patients at the time of relapse and provided a better marker of disease status. CONCLUSIONS The presence of minimal residual disease, as determined by quantitation of NPM1-mutated transcripts, provided powerful prognostic information independent of other risk factors.	[Ivey, A.; Grimwade, D.] Guys Hosp, Dept Med & Mol Genet, Canc Genet Lab, 8th Fl,Tower Wing, London SE1 9RT, England; [Ivey, A.] Guys Hosp, Dept Med & Mol Genet, Mol Oncol Unit, London SE1 9RT, England; [Simpson, M. A.; Jovanovic, J. V.; Solomon, E.; Grimwade, D.] Kings Coll London, Fac Life Sci & Med, Dept Med & Mol Genet, London, England; [Farah, H.; McCaughan, F.] Kings Coll London, Fac Life Sci & Med, Dept Asthma Allergy & Resp Sci, London, England; [Patel, Y.; Linch, D. C.; Gale, R. E.] UCL, Dept Haematol, London, England; [Bhudia, N.] Canc Res UK, Innovat Dept, London, England; [Gilkes, A.] Cardiff Univ, Sch Med, Expt Canc Med Ctr, Cardiff CF10 3AX, S Glam, Wales; [Hills, R. K.; Burnett, A. K.] Cardiff Univ, Sch Med, Dept Haematol, Cardiff CF10 3AX, S Glam, Wales; [Grech, A.] Cardiff Univ, Haematol Clin Trials Unit, Cardiff CF10 3AX, S Glam, Wales; [Mason, J.; Wall, K.; Akiki, S.; Griffiths, M.] West Midlands Reg Genet Lab, Birmingham, W Midlands, England; [Vyas, P.] Univ Oxford, Weatherall Inst Mol Med, Oxford, England; [Vyas, P.] Univ Oxford, Dept Haematol, Oxford, England; [Vyas, P.] Oxford Univ Hosp NHS Trust, Oxford, England; [Vyas, P.] Oxford Biomed Res Ctr, Natl Inst Hlth Res, Oxford, England; [Freeman, S. D.] Univ Birmingham, Dept Clin Immunol, Birmingham, W Midlands, England; [Russell, N.] Univ Nottingham Hosp, Ctr Clin Haematol, Nottingham NG7 2UH, England	Guy's & St Thomas' NHS Foundation Trust; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of London; King's College London; University of London; University College London; Cancer Research UK; Cardiff University; Cardiff University; Cardiff University; University of Oxford; University of Oxford; Oxford University Hospitals NHS Foundation Trust; University of Oxford; University of Birmingham; University of Nottingham	Grimwade, D (corresponding author), Guys Hosp, Dept Med & Mol Genet, Canc Genet Lab, 8th Fl,Tower Wing, London SE1 9RT, England.	david.grimwade@kcl.ac.uk	Ades, lionel/T-6882-2019; Vyas, Paresh/B-5708-2009; Simpson, Michael/F-4737-2011	Vyas, Paresh/0000-0003-3931-0914; Simpson, Michael/0000-0002-8539-8753; Hills, Robert/0000-0003-0166-0062; Freeman, Sylvie/0000-0003-1869-180X	Bloodwise; National Institute for Health Research; Cancer Research UK [9948, 15556] Funding Source: researchfish; Medical Research Council [G1000729, MR/L008963/1, G1000801c, G0500392] Funding Source: researchfish; National Institute for Health Research [RP-PG-0108-10093, NF-SI-0507-10370, NF-SI-0513-10144] Funding Source: researchfish	Bloodwise; National Institute for Health Research(National Institute for Health Research (NIHR)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	Funded by Bloodwise and the National Institute for Health Research; Current Controlled Trials number, ISRCTN55675535.	Burnett AK, 2006, BLOOD, V108, p8A, DOI 10.1182/blood.V108.11.18.18; Burnett AK, 2015, BLOOD, V125, P3878, DOI 10.1182/blood-2015-01-623447; Cheson BD, 2003, J CLIN ONCOL, V21, P4642, DOI 10.1200/JCO.2003.04.036; Chou WC, 2007, LEUKEMIA, V21, P998, DOI 10.1038/sj.leu.2404637; Corces-Zimmerman MR, 2014, P NATL ACAD SCI USA, V111, P2548, DOI 10.1073/pnas.1324297111; Cornelissen JJ, 2012, NAT REV CLIN ONCOL, V9, P579, DOI 10.1038/nrclinonc.2012.150; Dohner H, 2010, BLOOD, V115, P453, DOI 10.1182/blood-2009-07-235358; Falini B, 2005, NEW ENGL J MED, V352, P254, DOI 10.1056/NEJMoa041974; Gabert J, 2003, LEUKEMIA, V17, P2318, DOI 10.1038/sj.leu.2403135; Gale RP, 2014, LEUKEMIA, V28, P1949, DOI 10.1038/leu.2014.129; Gale RE, 2015, J CLIN ONCOL, V33, P2072, DOI 10.1200/JCO.2014.59.2022; Gorello P, 2006, LEUKEMIA, V20, P1103, DOI 10.1038/sj.leu.2404149; Grimwade D, 2016, BLOOD, V127, P29, DOI 10.1182/blood-2015-07-604496; Grimwade D, 2014, BLOOD, V124, P3345, DOI [10.1182/blood-2014-05-577593, 10.1182/asheducation-2014.1.222]; Grimwade D, 2010, BLOOD, V116, P354, DOI 10.1182/blood-2009-11-254441; Grimwade D, 2009, J CLIN ONCOL, V27, P3650, DOI 10.1200/JCO.2008.20.1533; Grossmann V, 2012, BLOOD, V120, P2963, DOI 10.1182/blood-2012-03-419622; Hubmann M, 2014, HAEMATOLOGICA, V99, P1317, DOI 10.3324/haematol.2014.104133; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Kronke J, 2013, BLOOD, V122, P100, DOI 10.1182/blood-2013-01-479188; Kronke J, 2011, J CLIN ONCOL, V29, P2709, DOI 10.1200/JCO.2011.35.0371; Kuhnl A, 2015, BLOOD, V125, P2985, DOI 10.1182/blood-2014-12-613703; Lambert J, 2014, ONCOTARGET, V5, P6280, DOI 10.18632/oncotarget.2196; Lazenby M, 2014, LEUKEMIA, V28, P1953, DOI 10.1038/leu.2014.90; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Ley TJ, 2010, NEW ENGL J MED, V363, P2424, DOI 10.1056/NEJMoa1005143; Linch DC, 2014, BLOOD, V124, P273, DOI 10.1182/blood-2014-02-554667; Ling V, 2013, BRIT J HAEMATOL, V160, P861, DOI 10.1111/bjh.12178; Marcucci G, 2012, J CLIN ONCOL, V30, P742, DOI 10.1200/JCO.2011.39.2092; Patel JP, 2012, NEW ENGL J MED, V366, P1079, DOI 10.1056/NEJMoa1112304; Peterlin P, 2015, HAEMATOLOGICA, V100, DOI 10.3324/haematol.2014.115576; Ploen GG, 2014, BRIT J HAEMATOL, V167, P478, DOI 10.1111/bjh.13062; Raghavan M, 2008, BLOOD, V112, P814, DOI 10.1182/blood-2008-01-132431; Sanz MA, 2009, BLOOD, V113, P1875, DOI 10.1182/blood-2008-04-150250; Schlenk RF, 2008, NEW ENGL J MED, V358, P1909, DOI 10.1056/NEJMoa074306; Schnittger S, 2009, BLOOD, V114, P2220, DOI 10.1182/blood-2009-03-213389; Schrappe M, 2014, HEMATOL-AM SOC HEMAT, P244, DOI 10.1182/asheducation-2014.1.244; Shayegi N, 2013, BLOOD, V122, P83, DOI 10.1182/blood-2012-10-461749; Shlush LI, 2014, NATURE, V506, P328, DOI 10.1038/nature13038	39	503	517	1	40	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 4	2016	374	5					422	433		10.1056/NEJMoa1507471	http://dx.doi.org/10.1056/NEJMoa1507471			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DC6GX	26789727	Green Published			2022-12-28	WOS:000369319100005
